"reads_downloaded_1_1","mapped_read_count_1_1","auc_1_1","bigwig_file_1_1","gdc_cases.case_id_1_1","gdc_file_id_1_1","gdc_updated_datetime_1_1","gdc_file_name_1_1","gdc_submitter_id_1_1","gdc_file_size_1_1","gdc_platform_1_1","gdc_md5sum_1_1","gdc_data_format_1_1","gdc_center.code_1_1","gdc_center.name_1_1","gdc_center.short_name_1_1","gdc_center.center_id_1_1","gdc_center.namespace_1_1","gdc_metadata_files.updated_datetime.analysis_1_1","gdc_metadata_files.created_datetime.analysis_1_1","gdc_metadata_files.file_name.analysis_1_1","gdc_metadata_files.md5sum.analysis_1_1","gdc_metadata_files.file_id.analysis_1_1","gdc_metadata_files.file_size.analysis_1_1","gdc_metadata_files.updated_datetime.experiment_1_1","gdc_metadata_files.file_name.experiment_1_1","gdc_metadata_files.md5sum.experiment_1_1","gdc_metadata_files.file_id.experiment_1_1","gdc_metadata_files.file_size.experiment_1_1","gdc_metadata_files.updated_datetime.run_1_1","gdc_metadata_files.file_name.run_1_1","gdc_metadata_files.md5sum.run_1_1","gdc_metadata_files.file_id.run_1_1","gdc_metadata_files.file_size.run_1_1","gdc_cases.updated_datetime_1_1","gdc_cases.submitter_id_1_1","gdc_cases.demographic.updated_datetime_1_1","gdc_cases.demographic.gender_1_1","gdc_cases.demographic.submitter_id_1_1","gdc_cases.demographic.year_of_birth_1_1","gdc_cases.demographic.race_1_1","gdc_cases.demographic.demographic_id_1_1","gdc_cases.demographic.ethnicity_1_1","gdc_cases.demographic.year_of_death_1_1","gdc_cases.project.name_1_1","gdc_cases.project.primary_site_1_1","gdc_cases.project.project_id_1_1","gdc_cases.tissue_source_site.project_1_1","gdc_cases.tissue_source_site.bcr_id_1_1","gdc_cases.tissue_source_site.code_1_1","gdc_cases.tissue_source_site.tissue_source_site_id_1_1","gdc_cases.tissue_source_site.name_1_1","gdc_cases.diagnoses.classification_of_tumor_1_1","gdc_cases.diagnoses.primary_diagnosis_1_1","gdc_cases.diagnoses.submitter_id_1_1","gdc_cases.diagnoses.tumor_stage_1_1","gdc_cases.diagnoses.age_at_diagnosis_1_1","gdc_cases.diagnoses.vital_status_1_1","gdc_cases.diagnoses.morphology_1_1","gdc_cases.diagnoses.days_to_death_1_1","gdc_cases.diagnoses.days_to_last_follow_up_1_1","gdc_cases.diagnoses.diagnosis_id_1_1","gdc_cases.diagnoses.tissue_or_organ_of_origin_1_1","gdc_cases.diagnoses.days_to_birth_1_1","gdc_cases.diagnoses.treatments.submitter_id_1_1","gdc_cases.diagnoses.treatments.treatment_id_1_1","gdc_cases.samples.sample_type_id_1_1","gdc_cases.samples.oct_embedded_1_1","gdc_cases.samples.submitter_id_1_1","gdc_cases.samples.intermediate_dimension_1_1","gdc_cases.samples.sample_id_1_1","gdc_cases.samples.is_ffpe_1_1","gdc_cases.samples.pathology_report_uuid_1_1","gdc_cases.samples.sample_type_1_1","gdc_cases.samples.shortest_dimension_1_1","gdc_cases.samples.days_to_collection_1_1","gdc_cases.samples.initial_weight_1_1","gdc_cases.samples.longest_dimension_1_1","gdc_cases.samples.portions.creation_datetime_1_1","gdc_cases.samples.portions.portion_number_1_1","gdc_cases.samples.portions.weight_1_1","gdc_cases.samples.portions.submitter_id_1_1","gdc_cases.samples.portions.slides_percent_tumor_nuclei_1","gdc_cases.samples.portions.slides_percent_tumor_nuclei_2","gdc_cases.samples.portions.slides_percent_monocyte_infiltration_1","gdc_cases.samples.portions.slides_percent_monocyte_infiltration_2","gdc_cases.samples.portions.slides_percent_normal_cells_1","gdc_cases.samples.portions.slides_percent_normal_cells_2","gdc_cases.samples.portions.slides_percent_stromal_cells_1","gdc_cases.samples.portions.slides_percent_stromal_cells_2","gdc_cases.samples.portions.slides_updated_datetime_1","gdc_cases.samples.portions.slides_updated_datetime_2","gdc_cases.samples.portions.slides_percent_lymphocyte_infiltration_1","gdc_cases.samples.portions.slides_percent_lymphocyte_infiltration_2","gdc_cases.samples.portions.slides_percent_neutrophil_infiltration_1","gdc_cases.samples.portions.slides_percent_neutrophil_infiltration_2","gdc_cases.samples.portions.slides_section_location_1","gdc_cases.samples.portions.slides_section_location_2","gdc_cases.samples.portions.slides_percent_necrosis_1","gdc_cases.samples.portions.slides_percent_necrosis_2","gdc_cases.samples.portions.slides_slide_id_1","gdc_cases.samples.portions.slides_slide_id_2","gdc_cases.samples.portions.slides_submitter_id_1","gdc_cases.samples.portions.slides_submitter_id_2","gdc_cases.samples.portions.slides_percent_tumor_cells_1","gdc_cases.samples.portions.slides_percent_tumor_cells_2","gdc_cases.samples.portions.portion_id_1_1","gdc_cases.samples.portions.analytes.analyte_type_1_1","gdc_cases.samples.portions.analytes.submitter_id_1_1","gdc_cases.samples.portions.analytes.analyte_id_1_1","gdc_cases.samples.portions.analytes.a260_a280_ratio_1_1","gdc_cases.samples.portions.analytes.concentration_1_1","gdc_cases.samples.portions.analytes.spectrophotometer_method_1_1","gdc_cases.samples.portions.analytes.analyte_type_id_1_1","gdc_cases.samples.portions.analytes.aliquots.source_center_1_1","gdc_cases.samples.portions.analytes.aliquots.submitter_id_1_1","gdc_cases.samples.portions.analytes.aliquots.aliquot_id_1_1","gdc_cases.samples.portions.analytes.aliquots.concentration_1_1","gdc_cases.exposures.cigarettes_per_day_1_1","gdc_cases.exposures.weight_1_1","gdc_cases.exposures.bmi_1_1","gdc_cases.exposures.height_1_1","gdc_cases.exposures.exposure_id_1_1","gdc_cases.exposures.submitter_id_1_1","cgc_filename_1_1","cgc_file_upload_date_1_1","cgc_file_last_modified_date_1_1","cgc_file_submitter_id_1_1","cgc_file_sample_1_1","cgc_file_data_subtype_1_1","cgc_file_size_1_1","cgc_file_access_level_1_1","cgc_file_platform_1_1","cgc_file_investigation_1_1","cgc_file_experimental_strategy_1_1","cgc_file_data_type_1_1","cgc_file_aliquot_1_1","cgc_file_data_submitting_center_1_1","cgc_file_file_id_1_1","cgc_file_case_1_1","cgc_file_disease_type_1_1","cgc_file_data_format_1_1","cgc_file_portion_1_1","cgc_file_published_date_1_1","cgc_file_analyte_1_1","cgc_sample_country_of_sample_procurement_1_1","cgc_sample_is_ffpe_1_1","cgc_sample_sample_type_code_1_1","cgc_sample_shortest_dimension_1_1","cgc_sample_sample_type_1_1","cgc_sample_tissue_source_site_1_1","cgc_sample_days_to_collection_1_1","cgc_sample_portion_1_1","cgc_sample_intermediate_dimension_1_1","cgc_sample_tissue_source_site_code_1_1","cgc_sample_file_1_1","cgc_sample_initial_weight_1_1","cgc_sample_id_1_1","cgc_sample_longest_dimension_1_1","cgc_case_drug_therapy_1_1","cgc_case_program_1_1","cgc_case_year_of_diagnosis_1_1","cgc_case_new_tumor_event_1_1","cgc_case_primary_therapy_outcome_success_1_1","cgc_case_tumor_status_1_1","cgc_case_sample_1_1","cgc_case_age_at_diagnosis_1_1","cgc_case_file_1_1","cgc_case_vital_status_1_1","cgc_case_days_to_death_1_1","cgc_case_id_1_1","cgc_case_ethnicity_1_1","cgc_case_follow_up_1_1","cgc_case_new_tumor_event_after_initial_treatment_1_1","cgc_case_days_to_last_follow_up_1_1","cgc_case_prior_diagnosis_1_1","cgc_case_primary_site_1_1","cgc_case_icd_o3site_1_1","cgc_case_pathologic_n_1_1","cgc_case_histological_diagnosis_1_1","cgc_case_performance_status_score_ecog_1_1","cgc_case_performance_status_score_timing_1_1","cgc_case_clinical_stage_1_1","cgc_case_pathologic_stage_1_1","cgc_case_performance_status_score_karnofsky_1_1","cgc_case_pathologic_t_1_1","cgc_case_icd_o3histology_1_1","cgc_case_gender_1_1","cgc_case_icd10_1_1","cgc_case_batch_number_1_1","cgc_case_clinical_m_1_1","cgc_case_radiation_therapy_1_1","cgc_case_race_1_1","cgc_case_clinical_t_1_1","cgc_portion_portion_number_1_1","cgc_portion_weight_1_1","cgc_portion_slide_1_1","cgc_portion_analyte_1_1","cgc_portion_file_1_1","cgc_portion_id_1_1","cgc_slide_percent_tumor_nuclei_1_1","cgc_slide_percent_normal_cells_1_1","cgc_slide_percent_monocyte_infiltration_1_1","cgc_slide_percent_lymphocyte_infiltration_1_1","cgc_slide_percent_stromal_cells_1_1","cgc_slide_section_location_1_1","cgc_slide_percent_necrosis_1_1","cgc_slide_percent_neutrophil_infiltration_1_1","cgc_slide_id_1_1","cgc_slide_percent_tumor_cells_1_1","cgc_drug_therapy_drug_name_1_1","cgc_drug_therapy_pharmaceutical_therapy_type_1_1","cgc_drug_therapy_id_1_1","cgc_radiation_therapy_id_1_1","cgc_radiation_therapy_radiation_type_1_1","cgc_radiation_therapy_radiation_therapy_site_1_1","cgc_follow_up_new_tumor_event_1_1","cgc_follow_up_new_tumor_event_after_initial_treatment_1_1","cgc_follow_up_days_to_last_follow_up_1_1","cgc_follow_up_tumor_status_1_1","cgc_follow_up_vital_status_1_1","cgc_follow_up_days_to_death_1_1","cgc_follow_up_id_1_1","xml_bcr_patient_barcode_1_1","xml_additional_studies_1_1","xml_tissue_source_site_1_1","xml_patient_id_1_1","xml_informed_consent_verified_1_1","xml_icd_o_3_site_1_1","xml_icd_o_3_histology_1_1","xml_icd_10_1_1","xml_tissue_prospective_collection_indicator_1_1","xml_tissue_retrospective_collection_indicator_1_1","xml_days_to_birth_1_1","xml_gender_1_1","xml_race_list_1_1","xml_ethnicity_1_1","xml_other_dx_1_1","xml_history_of_neoadjuvant_treatment_1_1","xml_vital_status_1_1","xml_days_to_last_followup_1_1","xml_days_to_death_1_1","xml_radiation_therapy_1_1","xml_postoperative_rx_tx_1_1","xml_person_neoplasm_cancer_status_1_1","xml_has_new_tumor_events_information_1_1","xml_day_of_form_completion_1_1","xml_month_of_form_completion_1_1","xml_year_of_form_completion_1_1","xml_has_follow_ups_information_1_1","xml_has_drugs_information_1_1","xml_has_radiations_information_1_1","xml_primary_pathology_days_to_initial_pathologic_diagnosis_1_1","xml_primary_pathology_age_at_initial_pathologic_diagnosis_1_1","xml_primary_pathology_year_of_initial_pathologic_diagnosis_1_1","xml_tumor_tissue_site_1_1","xml_histological_type_1_1","xml_anatomic_neoplasm_subdivision_1_1","xml_days_to_initial_pathologic_diagnosis_1_1","xml_age_at_initial_pathologic_diagnosis_1_1","xml_year_of_initial_pathologic_diagnosis_1_1","xml_initial_pathologic_diagnosis_method_1_1","xml_primary_lymph_node_presentation_assessment_1_1","xml_lymph_node_examined_count_1_1","xml_number_of_lymphnodes_positive_by_he_1_1","xml_neoplasm_histologic_grade_1_1","xml_residual_tumor_1_1","xml_tobacco_smoking_history_1_1","xml_stopped_smoking_year_1_1","xml_number_pack_years_smoked_1_1","xml_targeted_molecular_therapy_1_1","xml_primary_therapy_outcome_success_1_1","xml_stage_event_system_version_1_1","xml_stage_event_clinical_stage_1_1","xml_stage_event_pathologic_stage_1_1","xml_stage_event_tnm_categories_1_1","xml_kras_gene_analysis_performed_1_1","xml_karnofsky_performance_score_1_1","xml_eastern_cancer_oncology_group_1_1","xml_performance_status_scale_timing_1_1","xml_laterality_1_1","xml_menopause_status_1_1","xml_anatomic_neoplasm_subdivisions_1_1","xml_breast_carcinoma_surgical_procedure_name_1_1","xml_breast_carcinoma_progesterone_receptor_status_1_1","xml_margin_status_1_1","xml_breast_carcinoma_estrogen_receptor_status_1_1","xml_diagnosis_1_1"
32181629,30633250,2298569925,"46C422D1-E1A1-42E5-8FB1-918C0DAE533D.bw","001e0309-9c50-42b0-9e38-347883ee2cd3","46c422d1-e1a1-42e5-8fb1-918c0dae533d","2016-08-05T10:13:26.533465-05:00","UNCID_2209922.ab241aac-4962-4ccd-919c-140031a13dba.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_6.tar.gz","a2e5c04f-0233-4bd4-a8f2-5114fed80370",2151540059,"Illumina GA","9d2a862d3f0cbaaa53fa4c0afddac6b5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:37:48.177251-05:00","2016-05-03T11:15:47.413267-05:00","a2e5c04f-0233-4bd4-a8f2-5114fed80370_analysis.xml","d9aae62345fc3350d75bf01b8e8b6441","e3e4c818-13a6-44f5-9c92-c9fad15248f0",2121,"2016-09-29T22:41:07.099991-05:00","a2e5c04f-0233-4bd4-a8f2-5114fed80370_experiment.xml","4c781f7c89e4f7c5dde3e6cc870120a0","c0afebbc-d81e-4a24-add8-3964304f782d",2257,"2016-09-29T21:52:29.918873-05:00","a2e5c04f-0233-4bd4-a8f2-5114fed80370_run.xml","bafe9eccc93c1213631e9ae5b90ce611","a2a6e55c-8687-485f-b018-74a71d664c98",347,"2016-09-08T10:37:50.016295-05:00","TCGA-D1-A17N","2016-09-02T18:50:42.909079-05:00","female","TCGA-D1-A17N_demographic",1963,"not reported","e00830e7-7afa-5262-95b1-9ec093cf6ff4","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17N_diagnosis","not reported",17045,"alive","8380/3",NA,46,"1973302c-ef19-59e0-b80f-4404565763c7","c54.1",-17045,"TCGA-D1-A17N_treatment","d733b7ec-b2b8-5b4b-92bd-92dee7f97bf0","01","false","TCGA-D1-A17N-01A",NA,"f93931ba-8333-4e22-a430-ca02d9da3ffc",FALSE,"AD892375-1A50-4D9E-8235-A9A495C35B97","Primary Tumor",NA,451,110,NA,1294358400,"11",30,"TCGA-D1-A17N-01A-11",80,NA,0,NA,15,NA,0,NA,"2016-09-08T10:37:50.016295-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"14fe51ab-2a95-46f0-a293-c5662bd3311a",NA,"TCGA-D1-A17N-01A-01-TS1",NA,85,NA,"5696bced-e7d8-4195-aa5e-74fb6dea814c","RNA","TCGA-D1-A17N-01A-11R","85511dab-f0df-42e4-9271-0d02d0f0bb0f",1.75,0.16,"UV Spec","R","23","TCGA-D1-A17N-01A-11R-A12I-07","ab241aac-4962-4ccd-919c-140031a13dba",0.16,NA,134,48.628247931485,166,"c0426f0f-6801-5b8b-92ac-eced861458a5","TCGA-D1-A17N_exposure","UNCID_2209922.ab241aac-4962-4ccd-919c-140031a13dba.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_6.tar.gz","2013-10-02T01:55:04.000Z","2013-10-02T02:09:03.000Z","A2E5C04F-0233-4BD4-A8F2-5114FED80370","F93931BA-8333-4E22-A430-CA02D9DA3FFC","Unaligned reads",2151540059,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","AB241AAC-4962-4CCD-919C-140031A13DBA","University of North Carolina","566078f5e4b016715ab6a0c1","001E0309-9C50-42B0-9E38-347883EE2CD3","Uterine Corpus Endometrial Carcinoma","TARGZ","5696BCED-E7D8-4195-AA5E-74FB6DEA814C","2013-10-02T02:09:03.000Z","85511DAB-F0DF-42E4-9271-0D02D0F0BB0F","None","NO",1,NA,"Primary Tumor","Mayo Clinic",451,"5696BCED-E7D8-4195-AA5E-74FB6DEA814C",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2CC2A0B7-B673-4572-94CA-C7FEDD1DB0AC.txt",110,"TCGA-D1-A17N-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","F93931BA-8333-4E22-A430-CA02D9DA3FFC",46,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2CC2A0B7-B673-4572-94CA-C7FEDD1DB0AC.txt","Alive",NA,"TCGA-D1-A17N","NOT HISPANIC OR LATINO","981AD167-D52B-47A5-AC3F-59B2C6307D64",NA,46,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,NA,NA,11,30,"14FE51AB-2A95-46F0-A293-C5662BD3311A","ED3A52DE-67C1-4791-95DB-F2D1E7A9FF32","TCGA-D1-A17N-01A-11D-A12J-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-D1-A17N-01A-11",80,15,0,0,0,"TOP",0,0,"TCGA-D1-A17N-01A-01-TS1",85,NA,NA,NA,NA,NA,NA,NA,"NO",46,"TUMOR FREE","Alive",NA,"TCGA-D1-A17N-F20274","TCGA-D1-A17N",1,"D1","A17N","YES","C54.1","8380/3","C54.1","NO","YES",-17045,"FEMALE",NA,"NOT HISPANIC OR LATINO","No","No","Alive",46,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,46,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
31465810,31251199,2295367156,"FCD43986-D877-4856-A4E0-F35AF0A5117D.bw","002724fa-7051-49fa-9c58-4bcb7eba4ac6","fcd43986-d877-4856-a4e0-f35af0a5117d","2016-08-09T14:17:05.701651-05:00","UNCID_2214803.989bcd83-f8c2-4027-a10c-19ce3b67e348.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_1.tar.gz","b65db3f7-9619-45db-b793-b14c99cbcc3f",1928573054,"Illumina GA","5a5579491adf1d322f30d336f66afcd7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:05:56.238179-05:00","2016-05-03T11:17:14.905409-05:00","b65db3f7-9619-45db-b793-b14c99cbcc3f_analysis.xml","a33d768795d391ff6b60ceeff8c3795e","85bec5c0-924e-49dd-bf42-fa764a1d1fd1",2120,"2016-10-07T16:00:15.848315-05:00","b65db3f7-9619-45db-b793-b14c99cbcc3f_experiment.xml","83265de7c24b41e9197b7a5de3fd0335","d2ffe109-2d93-4a65-9a6c-ffeaa7f124a9",2256,"2016-09-29T22:40:58.965664-05:00","b65db3f7-9619-45db-b793-b14c99cbcc3f_run.xml","8e9a982356c3e953e996d6ea4fa3f538","c09875f8-2560-4d43-8b1d-72182d956acd",345,"2016-09-08T10:27:42.613266-05:00","TCGA-BG-A0M6","2016-09-02T18:48:04.624488-05:00","female","TCGA-BG-A0M6_demographic",1935,"white","3e7266d1-dce3-556c-ab45-4ed485d16350","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0M6_diagnosis","not reported",26666,"dead","8441/3",671,241,"1d9b02ad-e4a7-5861-8f48-040a0b558207","c54.1",-26666,"TCGA-BG-A0M6_treatment","80930add-59eb-55a4-907e-75b402c24473","01","true","TCGA-BG-A0M6-01A",NA,"66e4b080-e6ef-4531-9b69-1b27f15c5669",FALSE,"39EC3673-5B31-403B-8328-9DEA5FF7CD1A","Primary Tumor",NA,618,320,NA,1280275200,"31",30,"TCGA-BG-A0M6-01A-31",80,60,0,0,20,40,0,0,"2016-09-08T10:27:42.613266-05:00","2016-09-08T10:27:42.613266-05:00",10,10,0,0,"TOP","BOTTOM",10,10,"5ccd474e-0a7c-49c5-94e2-bc967d66b018","a3099859-7626-46c3-bb96-d58499e20eed","TCGA-BG-A0M6-01A-03-TSC","TCGA-BG-A0M6-01A-03-BSC",70,50,"5d8398d3-dd49-4589-87a1-02ef9db420c1","RNA","TCGA-BG-A0M6-01A-31R","39bec55d-8c08-43e3-af07-06eb84289a12",1.69,0.14,"UV Spec","R","23","TCGA-BG-A0M6-01A-31R-A104-07","989bcd83-f8c2-4027-a10c-19ce3b67e348",0.14,NA,55,23.8054016620499,152,"9f90326d-c8de-5788-99f6-7ea88ef9781a","TCGA-BG-A0M6_exposure","UNCID_2214803.989bcd83-f8c2-4027-a10c-19ce3b67e348.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_1.tar.gz","2013-10-03T21:26:04.000Z","2013-10-03T21:38:02.000Z","B65DB3F7-9619-45DB-B793-B14C99CBCC3F","66E4B080-E6EF-4531-9B69-1B27F15C5669","Unaligned reads",1928573054,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","989BCD83-F8C2-4027-A10C-19CE3B67E348","University of North Carolina","5660785ee4b0ec1099f8d457","002724FA-7051-49FA-9C58-4BCB7EBA4AC6","Uterine Corpus Endometrial Carcinoma","TARGZ","5D8398D3-DD49-4589-87A1-02EF9DB420C1","2013-10-03T21:38:02.000Z","39BEC55D-8C08-43E3-AF07-06EB84289A12","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",618,"5D8398D3-DD49-4589-87A1-02EF9DB420C1",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.61AE62D3-8662-47BB-B2A1-FE0A5D787E24.txt",320,"TCGA-BG-A0M6-01A",NA,"B4CF6C89-A536-4617-ABAE-C5E112A5DD9C","TCGA",2008,NA,NA,"TUMOR FREE","66E4B080-E6EF-4531-9B69-1B27F15C5669",73,"nationwidechildrens.org_clinical.TCGA-BG-A0M6.xml","Alive",NA,"TCGA-BG-A0M6","NOT HISPANIC OR LATINO","900487CB-AB7E-4527-842D-AAA793170E73",NA,241,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",73,NA,"50069BBA-CE75-47E5-BB6C-30DCE3C2E880","WHITE",NA,31,30,"A3099859-7626-46C3-BB96-D58499E20EED","D191ECF6-CA5C-4A4E-9A5A-33FFA4C1D135","UNCID_258716.TCGA-BG-A0M6-01A-31R-A104-07.101124_UNC1-RDR301647_00032_FC_62HT2AAXX.1.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-BG-A0M6-01A-31",60,40,0,10,0,"BOTTOM",10,0,"TCGA-BG-A0M6-01A-03-BSC",50,"PACLITAXEL","Chemotherapy","TCGA-BG-A0M6-D4439","TCGA-BG-A0M6-R4437","IMPLANTS","Primary Tumor Field",NA,"NO",NA,"TUMOR FREE","Dead",671,"TCGA-BG-A0M6-F19331","TCGA-BG-A0M6",1,"BG","A0M6","YES","C54.1","8441/3","C54.1","NO","YES",-26666,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",241,NA,NA,NA,"TUMOR FREE","NO",1,12,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,73,2008,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
10058251,9822984,741796053,"122D1D3C-8C13-4BFF-A135-2A308C6A9483.bw","0119eab6-00e7-4346-aa52-cbbeeba3621d","122d1d3c-8c13-4bff-a135-2a308c6a9483","2016-08-31T12:24:57.828950-05:00","UNCID_2209805.8cfdaa7a-34fe-4b0f-9916-60e7158c893e.110426_UNC6-RDR300211_00099_FC_634Y9AAXX_6.tar.gz","a56ce062-3bc6-4a63-89d0-193b762bc336",608405644,"Illumina GA","7de9e3372814b815301a961435a2d0b7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:30:40.846488-05:00","2016-05-03T11:15:06.075346-05:00","a56ce062-3bc6-4a63-89d0-193b762bc336_analysis.xml","1941f00f255f20870d688e7848cf08df","df6c2023-5fa5-4ca9-9a48-794bbd709ebb",2121,"2016-10-07T17:48:47.973482-05:00","a56ce062-3bc6-4a63-89d0-193b762bc336_experiment.xml","5e89e423698275b0525cc30fded6f536","578ab9e4-36ec-44fb-97db-3ee6b4b3682d",2257,"2016-09-29T23:43:52.542611-05:00","a56ce062-3bc6-4a63-89d0-193b762bc336_run.xml","ede8f28996973c149ccd5e9a87dade06","e7b40fcd-863c-49bc-8803-aca3aea115c5",347,"2016-09-08T10:32:36.726059-05:00","TCGA-AX-A05T","2016-09-02T18:52:43.366388-05:00","female","TCGA-AX-A05T_demographic",1927,"white","52e346ab-59e4-5cfc-97c1-ea275e8769a6","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A05T_diagnosis","not reported",30137,"alive","8380/3",NA,1010,"9d060ff9-8e33-5477-b0d0-9bc80e8b207a","c54.1",-30137,"TCGA-AX-A05T_treatment","035425d3-a234-51cb-990e-cacf2f6d8a49","01","false","TCGA-AX-A05T-01A",NA,"bc2885b5-c7cd-4467-88a3-a32cf602b3d5",FALSE,"85F75553-6E10-4AF5-9BDF-DAB52D00615B","Primary Tumor",NA,310,160,NA,1275868800,"11",30,"TCGA-AX-A05T-01A-11",85,85,3,1,2,2,5,5,"2016-09-08T10:32:36.726059-05:00","2016-09-08T10:32:36.726059-05:00",1,1,1,1,"BOTTOM","TOP",10,10,"6de3101f-6d2a-4a5a-b5c5-0e3ad9d70c70","c0be94a0-c678-476f-8260-b5b260838036","TCGA-AX-A05T-01A-01-BS1","TCGA-AX-A05T-01A-01-TS1",83,83,"2937f423-d0a4-412b-a0ed-bd6b1e293789","RNA","TCGA-AX-A05T-01A-11R","ef614467-7ef9-4fa0-9fd1-798d5086b037",1.71,0.16,"UV Spec","R","23","TCGA-AX-A05T-01A-11R-A00V-07","8cfdaa7a-34fe-4b0f-9916-60e7158c893e",0.16,NA,61,23.5330427066857,161,"0a6b5095-5e84-5f75-89f8-ae2f8682027b","TCGA-AX-A05T_exposure","UNCID_2209805.8cfdaa7a-34fe-4b0f-9916-60e7158c893e.110426_UNC6-RDR300211_00099_FC_634Y9AAXX_6.tar.gz","2013-10-01T17:06:04.000Z","2013-10-01T17:18:03.000Z","A56CE062-3BC6-4A63-89D0-193B762BC336","BC2885B5-C7CD-4467-88A3-A32CF602B3D5","Unaligned reads",608405644,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8CFDAA7A-34FE-4B0F-9916-60E7158C893E","University of North Carolina","564a39f3e4b08c5d86910bda","0119EAB6-00E7-4346-AA52-CBBEEBA3621D","Uterine Corpus Endometrial Carcinoma","TARGZ","2937F423-D0A4-412B-A0ED-BD6B1E293789","2013-10-01T17:18:03.000Z","EF614467-7EF9-4FA0-9FD1-798D5086B037","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",310,"2937F423-D0A4-412B-A0ED-BD6B1E293789",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.92B1BAEC-3052-4773-AB10-466CFB9CCE84.txt",160,"TCGA-AX-A05T-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","E81DF288-5DB2-47E5-998F-35FDE828CFBF",82,"nationwidechildrens.org_clinical.TCGA-AX-A05T.xml","Alive",NA,"TCGA-AX-A05T",NA,"71286F89-C3D3-4AC4-92F4-ABBAEAD43542",NA,603,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"WHITE",NA,11,30,"C0BE94A0-C678-476F-8260-B5B260838036","870A9202-8F59-4221-B6CD-602AA1CCD6B4","TCGA-AX-A05T-01A-11W-A027-09_IlluminaGA-DNASeq_exome.bam","TCGA-AX-A05T-01A-11",85,2,1,1,5,"TOP",10,1,"TCGA-AX-A05T-01A-01-TS1",83,NA,NA,NA,NA,NA,NA,NA,NA,603,"TUMOR FREE","Alive",NA,"TCGA-AX-A05T-F5581","TCGA-AX-A05T",1,"AX","A05T","YES","C54.1","8380/3","C54.1","NO","YES",-30137,"FEMALE","WHITE",NA,"No","No","Alive",603,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,82,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31843921,31482292,2340276481,"BACA9F84-971B-43B5-834F-8C524D378998.bw","016e515e-7f78-4997-9b97-3628464d9222","baca9f84-971b-43b5-834f-8c524d378998","2016-08-09T14:00:00.266595-05:00","UNCID_2189015.c890843b-4712-4d9f-998d-8ddcb2c39c3c.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_4.tar.gz","19f3eb6e-2f17-48f6-be7a-272e059108eb",2023639318,"Illumina GA","2d9ebf85f691cc2be2fef20dbbd9f2dc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:38:51.482445-05:00","2016-05-03T11:05:01.518052-05:00","19f3eb6e-2f17-48f6-be7a-272e059108eb_analysis.xml","0c5065e552095f60d713b12e59dee45e","74c90713-44a8-4da2-8883-2903e4fa09da",2122,"2016-09-29T19:27:32.351803-05:00","19f3eb6e-2f17-48f6-be7a-272e059108eb_experiment.xml","3afca467dab84d58fa1720abbd5f077b","4906c3c0-dfa2-4dbd-8a13-939e7094e398",2258,"2016-09-29T21:58:21.693670-05:00","19f3eb6e-2f17-48f6-be7a-272e059108eb_run.xml","2e17b96465df3a76c68f64e3ba3154e9","a6578a12-08fc-49c5-9b58-f5fc320b3eb6",349,"2016-09-08T11:15:15.993649-05:00","TCGA-D1-A2G5","2016-09-02T18:52:33.480698-05:00","female","TCGA-D1-A2G5_demographic",1957,"white","b2b94f43-6ae2-5741-a03e-9bd5b9d71433","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A2G5_diagnosis","not reported",18322,"alive","8380/3",NA,1455,"c67e3e07-6dd1-5141-8c19-a1091989b5f2","c54.1",-18322,"TCGA-D1-A2G5_treatment","1a5f6f8a-873c-56fe-968d-810328798059","01","true","TCGA-D1-A2G5-01A",NA,"7aafad6c-6329-41e5-ba2e-74ae104ddcb1",FALSE,"741AB1D9-493E-4659-BC2E-BF77A7E1CC14","Primary Tumor",NA,1354,70,NA,1308700800,"11",30,"TCGA-D1-A2G5-01A-11",90,NA,0,NA,10,NA,0,NA,"2016-09-08T11:15:15.993649-05:00",NA,10,NA,10,NA,"TOP",NA,10,NA,"a8e51297-f320-497d-a450-a3e3460708e2",NA,"TCGA-D1-A2G5-01A-01-TS1",NA,80,NA,"6c40aed7-05c5-4356-bccd-09bcb3cd12e4","RNA","TCGA-D1-A2G5-01A-11R","db28909e-7365-435a-93bd-a3eed8ff59cd",1.83,0.16,"UV Spec","R","23","TCGA-D1-A2G5-01A-11R-A17B-07","c890843b-4712-4d9f-998d-8ddcb2c39c3c",0.16,NA,143,47.7797453974406,173,"bd9b1ba4-d376-5ec7-b120-2c769eb4ba91","TCGA-D1-A2G5_exposure","UNCID_2189015.c890843b-4712-4d9f-998d-8ddcb2c39c3c.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_4.tar.gz","2013-09-18T14:06:04.000Z","2013-09-18T14:18:01.000Z","19F3EB6E-2F17-48F6-BE7A-272E059108EB","7AAFAD6C-6329-41E5-BA2E-74AE104DDCB1","Unaligned reads",2023639318,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C890843B-4712-4D9F-998D-8DDCB2C39C3C","University of North Carolina","564a3876e4b0298dd2c776be","016E515E-7F78-4997-9B97-3628464D9222","Uterine Corpus Endometrial Carcinoma","TARGZ","6C40AED7-05C5-4356-BCCD-09BCB3CD12E4","2013-09-18T14:18:01.000Z","DB28909E-7365-435A-93BD-A3EED8FF59CD","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",1354,"6C40AED7-05C5-4356-BCCD-09BCB3CD12E4",NA,"D1","1df1a6d4c03ddc9d73c990a0d662e1f0.bam",70,"TCGA-D1-A2G5-01A",NA,NA,"TCGA",2007,NA,NA,"WITH TUMOR","7AAFAD6C-6329-41E5-BA2E-74AE104DDCB1",50,"nationwidechildrens.org_clinical.TCGA-D1-A2G5.xml","Alive",NA,"TCGA-D1-A2G5","NOT HISPANIC OR LATINO","EDE9F505-9276-491F-BFC4-15A9F44535F9",NA,1260,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"A8E51297-F320-497D-A450-A3E3460708E2","8F19A001-BC64-4F90-9A78-61846E3B273B","TCGA-D1-A2G5-01A-11R-A17A-13.isoform.quantification.txt","TCGA-D1-A2G5-01A-11",90,10,0,10,0,"TOP",10,10,"TCGA-D1-A2G5-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-D1-A2G5-F41443_NTE-1","YES",1455,NA,"Alive",NA,"TCGA-D1-A2G5-F41443","TCGA-D1-A2G5",1,"D1","A2G5","YES","C54.1","8380/3","C54.1","NO","YES",-18322,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",1260,NA,NA,NA,"WITH TUMOR","NO",11,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,50,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34242617,33919949,2539455811,"38F5957E-0A99-432D-8F0B-B48E03F17668.bw","01ed791e-3187-4e24-a5ff-afff0778c152","38f5957e-0a99-432d-8f0b-b48e03f17668","2016-08-05T05:47:00.563304-05:00","UNCID_2189536.00ea54c2-1043-4a7f-ae62-e2851eb94ba1.120524_UNC2-RDR300275_00121_FC_64KREAAXX_8.tar.gz","d797cbe0-abf1-4b6c-893d-9f2d3635d4ea",2122479549,"Illumina GA","c019d65c9175a34324df47f3d43588a2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:50:09.014361-05:00","2016-05-03T11:05:01.517061-05:00","d797cbe0-abf1-4b6c-893d-9f2d3635d4ea_analysis.xml","522602337f83f64e8ccf2d7ddcc7471a","a125e6ed-4981-41c1-915d-5187679feba1",2122,"2016-09-29T19:33:52.562914-05:00","d797cbe0-abf1-4b6c-893d-9f2d3635d4ea_experiment.xml","9862b95d0a2a01d1f307247c32c842a3","4cf286dd-43e3-4ee2-bf3e-2e3cee2392cf",2258,"2016-09-29T22:46:49.547496-05:00","d797cbe0-abf1-4b6c-893d-9f2d3635d4ea_run.xml","6d0cd2223dae9778f904a54faeab5395","c43b1a80-87d2-43b7-9216-c58550e8d6d9",349,"2016-09-08T10:27:55.769696-05:00","TCGA-D1-A1O7","2016-09-02T18:52:19.791547-05:00","female","TCGA-D1-A1O7_demographic",1950,"white","cb0d8efa-9f52-5939-9cb2-bc1759bf7fdf","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1O7_diagnosis","not reported",22037,"alive","8380/3",NA,32,"2e4c434e-b8e7-5db1-ac83-907d844bcf30","c54.1",-22037,"TCGA-D1-A1O7_treatment","235fafd2-6cc7-5be6-a1be-e11fd76f1a84","01","false","TCGA-D1-A1O7-01A",NA,"c38210f9-bb16-471c-91e1-2cdebfe23345",FALSE,"37C25226-AD56-487E-969B-1538E6E00A5D","Primary Tumor",NA,154,50,NA,1302048000,"11",30,"TCGA-D1-A1O7-01A-11",70,NA,10,NA,10,NA,15,NA,"2016-09-08T10:27:55.769696-05:00",NA,40,NA,40,NA,"TOP",NA,5,NA,"1e4723c7-83af-4d56-8903-de7d2cc5fa6e",NA,"TCGA-D1-A1O7-01A-01-TS1",NA,70,NA,"5bc8aae4-7ddc-45f5-8f70-39b8a04f7d2b","RNA","TCGA-D1-A1O7-01A-11R","c4aa25a7-efaa-4386-ab9c-d4711eef27ae",1.76,0.16,"UV Spec","R","23","TCGA-D1-A1O7-01A-11R-A14D-07","00ea54c2-1043-4a7f-ae62-e2851eb94ba1",0.16,NA,96,43.827611395179,148,"3d2140bf-eb5d-5bdb-b454-65e0c043eacd","TCGA-D1-A1O7_exposure","UNCID_2189536.00ea54c2-1043-4a7f-ae62-e2851eb94ba1.120524_UNC2-RDR300275_00121_FC_64KREAAXX_8.tar.gz","2013-09-19T02:37:05.000Z","2013-09-19T02:50:02.000Z","D797CBE0-ABF1-4B6C-893D-9F2D3635D4EA","C38210F9-BB16-471C-91E1-2CDEBFE23345","Unaligned reads",2122479549,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","00EA54C2-1043-4A7F-AE62-E2851EB94BA1","University of North Carolina","564a4152e4b0298dd2ca4f48","01ED791E-3187-4E24-A5FF-AFFF0778C152","Uterine Corpus Endometrial Carcinoma","TARGZ","5BC8AAE4-7DDC-45F5-8F70-39B8A04F7D2B","2013-09-19T02:50:02.000Z","C4AA25A7-EFAA-4386-AB9C-D4711EEF27AE","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",154,"5BC8AAE4-7DDC-45F5-8F70-39B8A04F7D2B",NA,"D1","D1-A1O7-01A-11D_BCR3730_2011-09-21_044.fsa",50,"TCGA-D1-A1O7-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","C38210F9-BB16-471C-91E1-2CDEBFE23345",60,"CHEEP_p_TCGA_b120_121_SNP_N_GenomeWideSNP_6_D09_777576.hg19.seg.txt","Alive",NA,"TCGA-D1-A1O7","NOT HISPANIC OR LATINO","519269E2-FD78-4766-8F98-B42E292CAD6D",NA,32,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,11,30,"1E4723C7-83AF-4D56-8903-DE7D2CC5FA6E","DB971BD1-3437-4795-A2FC-7F1EC31C89F4","TCGA-D1-A1O7-01A-11R-A14C-13_mirna.bam","TCGA-D1-A1O7-01A-11",70,10,10,40,15,"TOP",5,40,"TCGA-D1-A1O7-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,NA,"NO",32,"TUMOR FREE","Alive",NA,"TCGA-D1-A1O7-F21637","TCGA-D1-A1O7",1,"D1","A1O7","YES","C54.1","8380/3","C54.1","NO","YES",-22037,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",32,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
110449272,108104629,5158727705,"48A2AAEB-7F60-4284-808E-2058A531B17C.bw","0264c9c2-6b6a-485c-98f5-aed4f52ed0ca","48a2aaeb-7f60-4284-808e-2058a531b17c","2016-08-05T15:03:20.339065-05:00","UNCID_2167299.b2d5d73b-6669-438a-b6fd-0e29b7bce645.130613_UNC9-SN296_0375_BD27CGACXX_1_ATCACG.tar.gz","a4963578-3f66-469d-ac45-17b56408ac4e",5425653772,"Illumina HiSeq","b0c3872f41fd70968c1f8902dd01f20a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:30:51.591981-05:00","2016-05-03T11:07:07.492763-05:00","a4963578-3f66-469d-ac45-17b56408ac4e_analysis.xml","b2d525b3094b7e7be1fac663299dbcdf","df8d2c48-7404-45fe-a809-bcdd9ba8da27",2121,"2016-09-30T00:12:02.471196-05:00","a4963578-3f66-469d-ac45-17b56408ac4e_experiment.xml","ad2ed1ed5d33d6b7be6aa260f9adcc44","f8f650ca-18d3-4cbb-9050-648dbf5642ca",2431,"2016-09-29T20:24:58.394775-05:00","a4963578-3f66-469d-ac45-17b56408ac4e_run.xml","6edf08c5b534875ba7f53c3f3ecdbe2c","6c5c1426-f9d1-418b-80f9-3520a2b744f0",354,"2016-09-08T10:29:05.860209-05:00","TCGA-KP-A3W3","2016-09-02T18:49:38.872739-05:00","female","TCGA-KP-A3W3_demographic",1938,"white","2e5d8b2d-f3a4-5ebd-a612-2fd511f12455","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","KP","821aedb4-8788-5cb9-ae05-e670f0be1f9f","British Columbia Cancer Agency","not reported","c54.1","TCGA-KP-A3W3_diagnosis","not reported",26310,"alive","8441/3",NA,794,"5bb79aec-bb1a-5619-a006-0cf8edcb82f4","c54.1",-26310,"TCGA-KP-A3W3_treatment","f68f37cc-4f05-5ca2-b716-52f6a66f169a","01","true","TCGA-KP-A3W3-01A",NA,"d54f4476-7191-4a52-a310-8392f62404cb",FALSE,"9D8F170A-A4B1-463A-B92C-357870762EAD","Primary Tumor",NA,739,680,NA,1335398400,"11",30,"TCGA-KP-A3W3-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T10:29:05.860209-05:00",NA,60,NA,10,NA,"TOP",NA,5,NA,"d8ebc5eb-9f64-4146-bce2-018338e5c447",NA,"TCGA-KP-A3W3-01A-01-TS1",NA,90,NA,"5a71f937-2d46-4083-99f1-1441ca54e010","RNA","TCGA-KP-A3W3-01A-11R","5cfda0bd-c9f8-4980-b556-02a1769213bf",1.83,0.15,"UV Spec","R","23","TCGA-KP-A3W3-01A-11R-A22K-07","b2d5d73b-6669-438a-b6fd-0e29b7bce645",0.15,NA,126,46.8471148126115,164,"2ba473f0-9d61-52b3-8674-bbaa7b27d4df","TCGA-KP-A3W3_exposure","UNCID_2167299.b2d5d73b-6669-438a-b6fd-0e29b7bce645.130613_UNC9-SN296_0375_BD27CGACXX_1_ATCACG.tar.gz","2013-09-21T05:01:04.000Z","2013-09-21T05:17:01.000Z","A4963578-3F66-469D-AC45-17B56408AC4E","D54F4476-7191-4A52-A310-8392F62404CB","Unaligned reads",5425653772,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","B2D5D73B-6669-438A-B6FD-0E29B7BCE645","University of North Carolina","564a3791e4b0298dd2c72df3","0264C9C2-6B6A-485C-98F5-AED4F52ED0CA","Uterine Corpus Endometrial Carcinoma","TARGZ","5A71F937-2D46-4083-99F1-1441CA54E010","2013-09-21T05:17:01.000Z","5CFDA0BD-C9F8-4980-B556-02A1769213BF","Canada","NO",1,NA,"Primary Tumor","British Columbia Cancer Agency",739,"5A71F937-2D46-4083-99F1-1441CA54E010",NA,"KP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.D0D776F7-12A4-4219-A969-DB67B1908683.txt",680,"TCGA-KP-A3W3-01A",NA,NA,"TCGA",2010,"TCGA-KP-A3W3_NTE-2","Complete Remission/Response","WITH TUMOR","D54F4476-7191-4A52-A310-8392F62404CB",72,"FLUES_p_TCGASNP_228_229_230_N_GenomeWideSNP_6_G05_1148944.nocnv_hg19.seg.txt","Alive",NA,"TCGA-KP-A3W3","NOT HISPANIC OR LATINO",NA,"YES",794,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"D8EBC5EB-9F64-4146-BCE2-018338E5C447","D4512746-7CCB-4F68-96D4-65DA7641CA2E","UNCID_2086654.b2d5d73b-6669-438a-b6fd-0e29b7bce645.sorted_genome_alignments.bam","TCGA-KP-A3W3-01A-11",90,0,20,60,5,"TOP",5,10,"TCGA-KP-A3W3-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-KP-A3W3",1,"KP","A3W3","YES","C54.1","8441/3","C54.1","NO","YES",-26310,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",794,NA,"YES","YES","WITH TUMOR","YES",19,7,2012,"NO","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,72,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34739809,34074092,2555371045,"0E4F9C8A-3DE5-4893-8ED9-BBF12169F199.bw","027b2a29-2fad-4ca8-a7cd-eb913d0205f8","0e4f9c8a-3de5-4893-8ed9-bbf12169f199","2016-08-09T14:15:09.774290-05:00","UNCID_2210388.4f3e68ae-cf3c-491d-a3ed-0fc30261ead3.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_6.tar.gz","f2f89e51-67f0-456e-a136-c70817dd1970",2357778044,"Illumina GA","efc4df12cdb19a50a6445f0dba3dd46e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:07:39.212509-05:00","2016-05-03T11:15:47.420908-05:00","f2f89e51-67f0-456e-a136-c70817dd1970_analysis.xml","5e3086e07ddedac6b1bf2c685343f6fd","d121ed7d-b29b-4920-b41c-ce8305a820e4",2121,"2016-09-29T17:44:24.352084-05:00","f2f89e51-67f0-456e-a136-c70817dd1970_experiment.xml","df4f81c96c9ea224e68d42e277b972be","08182da8-e785-4fee-85b3-e9c23c3ae049",2257,"2016-09-29T18:08:13.840689-05:00","f2f89e51-67f0-456e-a136-c70817dd1970_run.xml","742419b9b1b5f7484927a6d39b87604d","1730e04f-07f4-4a73-a4be-30fe26f88494",347,"2016-09-08T11:06:46.721075-05:00","TCGA-B5-A11J","2016-09-02T18:49:26.940609-05:00","female","TCGA-B5-A11J_demographic",1942,"white","95491576-be63-50fd-a69a-453ec41714bb","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11J_diagnosis","not reported",23485,"alive","8380/3",NA,1656,"e611e793-17c5-5251-ac80-d2947a148d81","c54.1",-23485,"TCGA-B5-A11J_treatment","171dd5bf-4e87-53f0-a4ce-adbe5478f20d","01","true","TCGA-B5-A11J-01A",NA,"1eccac56-e4de-4ffd-a0d8-f93d7b8b63f7",FALSE,"1F9E7FAB-ADA0-4EFF-8A86-F5344357ADED","Primary Tumor",NA,1536,90,NA,1289865600,"11",30,"TCGA-B5-A11J-01A-11",92,95,10,8,0,0,7,4,"2016-09-08T11:06:46.721075-05:00","2016-09-08T11:06:46.721075-05:00",8,5,1,1,"BOTTOM","TOP",1,1,"e16173f1-c773-4fd0-b996-b07d8e7fcf9c","8184df9b-39c0-45ae-a0b1-75b949872115","TCGA-B5-A11J-01A-01-BS1","TCGA-B5-A11J-01A-01-TS1",92,95,"7b6ebf9f-de36-40e7-aa77-4c53fe5f9abd","RNA","TCGA-B5-A11J-01A-11R","517cb1de-d507-4f4d-9c79-b3b4eff9666c",1.9,0.16,"UV Spec","R","23","TCGA-B5-A11J-01A-11R-A118-07","4f3e68ae-cf3c-491d-a3ed-0fc30261ead3",0.16,NA,134,NA,NA,"d774d67f-cdd0-54b7-a25a-504e057adf07","TCGA-B5-A11J_exposure","UNCID_2210388.4f3e68ae-cf3c-491d-a3ed-0fc30261ead3.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_6.tar.gz","2013-10-02T10:06:04.000Z","2013-10-02T10:25:02.000Z","F2F89E51-67F0-456E-A136-C70817DD1970","1ECCAC56-E4DE-4FFD-A0D8-F93D7B8B63F7","Unaligned reads",2357778044,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4F3E68AE-CF3C-491D-A3ED-0FC30261EAD3","University of North Carolina","56607a2ee4b0b37b3d991d7f","027B2A29-2FAD-4CA8-A7CD-EB913D0205F8","Uterine Corpus Endometrial Carcinoma","TARGZ","7B6EBF9F-DE36-40E7-AA77-4C53FE5F9ABD","2013-10-02T10:25:02.000Z","517CB1DE-D507-4F4D-9C79-B3B4EFF9666C","United States","NO",1,NA,"Primary Tumor","Duke",1536,"7B6EBF9F-DE36-40E7-AA77-4C53FE5F9ABD",NA,"B5","37a94b172ceb6c11fd1e726137408b36.bam",90,"TCGA-B5-A11J-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","1ECCAC56-E4DE-4FFD-A0D8-F93D7B8B63F7",64,"nationwidechildrens.org_clinical.TCGA-B5-A11J.xml","Alive",NA,"TCGA-B5-A11J",NA,"50220273-6EF2-4593-8ADB-3C531FC73691",NA,1291,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"E16173F1-C773-4FD0-B996-B07D8E7FCF9C","A2129023-827F-4CAB-9620-428966ADEA37","37a94b172ceb6c11fd1e726137408b36.bam","TCGA-B5-A11J-01A-11",95,0,8,5,4,"TOP",1,1,"TCGA-B5-A11J-01A-01-TS1",95,NA,NA,NA,NA,NA,NA,NA,"NO",1656,"TUMOR FREE","Alive",NA,"TCGA-B5-A11J-F17687","TCGA-B5-A11J",1,"B5","A11J","YES","C54.1","8380/3","C54.1","NO","YES",-23485,"FEMALE","WHITE",NA,"No","No","Alive",1291,NA,NA,NA,"TUMOR FREE","NO",9,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2006,"Office Endometrial Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
112555328,110976629,5298163733,"D50BAB19-5050-4C27-9F6B-6CB1C865552D.bw","029f0f1d-dd22-44d2-a623-cb9a33cb9438","d50bab19-5050-4c27-9f6b-6cb1c865552d","2016-08-05T10:32:31.465285-05:00","UNCID_2178571.fe9055e4-f25c-4b7b-9479-a8468c36310f.130402_UNC11-SN627_0289_AD22HMACXX_4_GTGGCC.tar.gz","7985e73d-0e29-4a3d-bd96-4cf70cd5ecbe",4768764707,"Illumina HiSeq","77be1b3c182f814088971b26384ee45b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:52:06.327224-05:00","2016-05-03T10:57:27.712069-05:00","7985e73d-0e29-4a3d-bd96-4cf70cd5ecbe_analysis.xml","de6eaf75b829c7e3a409c28e70a30ee5","0d03bac4-883c-4010-ae54-ab3712807166",2123,"2016-09-29T23:22:10.546369-05:00","7985e73d-0e29-4a3d-bd96-4cf70cd5ecbe_experiment.xml","4fd097cc91963700b9c2cdb8ea03cd89","da0a362a-4bbc-49c7-8aa4-888388a75d46",2431,"2016-09-30T00:16:52.670564-05:00","7985e73d-0e29-4a3d-bd96-4cf70cd5ecbe_run.xml","363ee232946eae09e4fe57686eaac2c9","fbf878e7-99f7-4bae-a128-479040573fd0",354,"2016-09-08T10:30:46.886413-05:00","TCGA-EY-A2OQ","2016-09-02T18:48:00.593501-05:00","female","TCGA-EY-A2OQ_demographic",1950,"white","30f06462-90ed-5004-81de-422d8ce9b270","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A2OQ_diagnosis","not reported",22309,"alive","8380/3",NA,885,"cfe4c1f5-1020-5c29-9267-81b5d63b9c55","c54.1",-22309,"TCGA-EY-A2OQ_treatment","b24a85dc-4b3f-5b43-bded-f68333ec9758","01","false","TCGA-EY-A2OQ-01A",NA,"a5f68889-4f7d-44d7-a999-c01bcb0ee56e",FALSE,"BD1FB0FF-176C-42D9-843E-2F2BF2EBCCC2","Primary Tumor",NA,217,1,NA,1318896000,"11",10,"TCGA-EY-A2OQ-01A-11",60,NA,0,NA,0,NA,10,NA,"2016-09-08T10:30:46.886413-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"2bb3dd5b-ea1b-48be-9fd0-bd5714975dc5",NA,"TCGA-EY-A2OQ-01A-01-TS1",NA,90,NA,"72c4a7bc-9ac2-4125-bef8-785dbd82da78","RNA","TCGA-EY-A2OQ-01A-11R","f1489a2d-026e-415d-bbb6-d9fe9c427431",1.8,0.18,"UV Spec","R","23","TCGA-EY-A2OQ-01A-11R-A19W-07","fe9055e4-f25c-4b7b-9479-a8468c36310f",0.18,NA,79,32.8824141519251,155,"fd1551a0-b902-539b-8480-49df933ae3a0","TCGA-EY-A2OQ_exposure","UNCID_2178571.fe9055e4-f25c-4b7b-9479-a8468c36310f.130402_UNC11-SN627_0289_AD22HMACXX_4_GTGGCC.tar.gz","2013-09-12T05:06:05.000Z","2013-09-12T05:19:01.000Z","7985E73D-0E29-4A3D-BD96-4CF70CD5ECBE","A5F68889-4F7D-44D7-A999-C01BCB0EE56E","Unaligned reads",4768764707,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","FE9055E4-F25C-4B7B-9479-A8468C36310F","University of North Carolina","564a3681e4b0298dd2c6d58e","029F0F1D-DD22-44D2-A623-CB9A33CB9438","Uterine Corpus Endometrial Carcinoma","TARGZ","72C4A7BC-9AC2-4125-BEF8-785DBD82DA78","2013-09-12T05:19:01.000Z","F1489A2D-026E-415D-BBB6-D9FE9C427431","United States","NO",1,NA,"Primary Tumor","University of North Carolina",217,"72C4A7BC-9AC2-4125-BEF8-785DBD82DA78",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6075ABA3-3438-4ABE-9C56-BD9A57640AB8.txt",1,"TCGA-EY-A2OQ-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","A5F68889-4F7D-44D7-A999-C01BCB0EE56E",61,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6075ABA3-3438-4ABE-9C56-BD9A57640AB8.txt","Alive",NA,"TCGA-EY-A2OQ","NOT HISPANIC OR LATINO","6EF1AD4D-69BB-4982-B5A7-3EA031EF93C8",NA,294,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,"WHITE",NA,11,10,"2BB3DD5B-EA1B-48BE-9FD0-BD5714975DC5","F1489A2D-026E-415D-BBB6-D9FE9C427431","e95c8c49f1603248b3f0e5ab4e369fd4.bam","TCGA-EY-A2OQ-01A-11",60,0,0,0,10,"TOP",0,0,"TCGA-EY-A2OQ-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-EY-A2OQ-F44835_NTE-1","NO",885,"TUMOR FREE","Alive",NA,"TCGA-EY-A2OQ-F44835","TCGA-EY-A2OQ",1,"EY","A2OQ","YES","C54.1","8380/3","C54.1","YES","NO",-22309,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",294,NA,NA,NA,"TUMOR FREE","NO",15,11,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31817526,31499691,2271617300,"ABCF168A-484E-4AF7-8E2C-918F8244765F.bw","02af18ee-ab8e-4ac3-b22e-dec80c201058","abcf168a-484e-4af7-8e2c-918f8244765f","2016-08-09T14:04:02.490816-05:00","UNCID_2194903.a644742b-ae08-41e3-810e-800bf0eef8fe.120306_UNC6-RDR300211_00136_FC_650PFAAXX_4.tar.gz","a4f53691-5b08-4133-9aab-f1ab917f3362",2010436679,"Illumina GA","7a45a3d960378b41d08f282bac4d6a48","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:05:07.396729-05:00","2016-05-03T11:07:49.533775-05:00","a4f53691-5b08-4133-9aab-f1ab917f3362_analysis.xml","c823bb8a6b22f7550343d8043f232525","153e3d27-097f-4f72-aee8-7c4930d8f89e",2121,"2016-09-29T22:39:50.478330-05:00","a4f53691-5b08-4133-9aab-f1ab917f3362_experiment.xml","f2dab9292ff82537e3ae1a6a8d33d428","bfe4a1e6-602d-49e8-bc7c-9ca7c95963d9",2257,"2016-09-29T20:46:32.915452-05:00","a4f53691-5b08-4133-9aab-f1ab917f3362_run.xml","1c95f18cdf8a4653fd45330c08a1c94d","7994c662-784e-4bc5-9d49-79024d27f756",347,"2016-09-08T11:10:33.193587-05:00","TCGA-B5-A1MR","2016-09-02T18:52:14.013066-05:00","female","TCGA-B5-A1MR_demographic",1930,"white","f3f20b72-0419-5862-a8ab-db01ed67c608","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A1MR_diagnosis","not reported",24017,"alive","8380/3",NA,6859,"a21fbabe-e875-5677-9e68-6b37282186d6","c54.1",-24017,"TCGA-B5-A1MR_treatment","332578c7-1409-5142-8456-ef31512df5d6","01","true","TCGA-B5-A1MR-01A",NA,"f2d9d82b-aa3f-44f8-b882-1381704f6cc5",FALSE,"BA4793F4-FBB3-4953-8204-A9C360D32D76","Primary Tumor",NA,5556,240,NA,1301529600,"31",30,"TCGA-B5-A1MR-01A-31",60,NA,20,NA,0,NA,20,NA,"2016-09-08T11:10:33.193587-05:00",NA,40,NA,20,NA,"TOP",NA,20,NA,"1c52c4b0-b214-4121-bc0c-b974fb2af770",NA,"TCGA-B5-A1MR-01A-03-TSC",NA,60,NA,"41014d52-529f-403d-b41e-63b77de683f2","RNA","TCGA-B5-A1MR-01A-31R","0595bd19-925f-49dc-9491-a79e908def49",1.54,0.16,"UV Spec","R","23","TCGA-B5-A1MR-01A-31R-A14D-07","a644742b-ae08-41e3-810e-800bf0eef8fe",0.16,NA,58,NA,NA,"c7be8bfb-1658-574f-afc8-bf5f3b73067b","TCGA-B5-A1MR_exposure","UNCID_2194903.a644742b-ae08-41e3-810e-800bf0eef8fe.120306_UNC6-RDR300211_00136_FC_650PFAAXX_4.tar.gz","2013-09-23T04:46:04.000Z","2013-09-23T04:58:01.000Z","A4F53691-5B08-4133-9AAB-F1AB917F3362","F2D9D82B-AA3F-44F8-B882-1381704F6CC5","Unaligned reads",2010436679,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A644742B-AE08-41E3-810E-800BF0EEF8FE","University of North Carolina","564a33b6e4b0ef121817fa75","02AF18EE-AB8E-4AC3-B22E-DEC80C201058","Uterine Corpus Endometrial Carcinoma","TARGZ","41014D52-529F-403D-B41E-63B77DE683F2","2013-09-23T04:58:01.000Z","0595BD19-925F-49DC-9491-A79E908DEF49","United States","NO",1,NA,"Primary Tumor","Duke",5556,"41014D52-529F-403D-B41E-63B77DE683F2",NA,"B5","UNCID_1011939.a644742b-ae08-41e3-810e-800bf0eef8fe.120306_UNC6-RDR300211_00136_FC_650PFAAXX.4.trimmed.annotated.translated_to_genomic.bam.bai",240,"TCGA-B5-A1MR-01A",NA,NA,"TCGA",1995,NA,NA,"TUMOR FREE","F2D9D82B-AA3F-44F8-B882-1381704F6CC5",65,"nationwidechildrens.org_clinical.TCGA-B5-A1MR.xml","Alive",NA,"TCGA-B5-A1MR",NA,"DBCD39A6-49C5-4107-A8F8-2C5D2B437217",NA,5691,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,"B630A5C2-1084-46F0-9DF9-D0D88EDE995D","WHITE",NA,31,30,"1C52C4B0-B214-4121-BC0C-B974FB2AF770","17FD15EC-2250-46EB-B84F-AB6111786745","UNCID_1011939.a644742b-ae08-41e3-810e-800bf0eef8fe.120306_UNC6-RDR300211_00136_FC_650PFAAXX.4.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-B5-A1MR-01A-31",60,0,20,40,20,"TOP",20,20,"TCGA-B5-A1MR-01A-03-TSC",60,NA,NA,NA,"TCGA-B5-A1MR-R14327","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",5835,"TUMOR FREE","Alive",NA,"TCGA-B5-A1MR-F19108","TCGA-B5-A1MR",1,"B5","A1MR","YES","C54.1","8380/3","C54.1","NO","YES",-24017,"FEMALE","WHITE",NA,"No","No","Alive",5691,NA,NA,NA,"TUMOR FREE","NO",19,7,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,1995,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36430542,35421108,2662054059,"D4E58BFB-9859-4D77-A581-1D713AA54B0B.bw","02b25675-094d-4098-96da-51d121380fec","d4e58bfb-9859-4d77-a581-1d713aa54b0b","2016-08-09T14:11:49.104014-05:00","UNCID_2207071.0824e6ac-f3f0-4b71-81a3-7ee671a256eb.110728_UNC2-RDR300275_00080_FC_63145AAXX_6.tar.gz","4958ccf0-9e31-4910-8bd7-70f54c059179",2326167398,"Illumina GA","0361488e69eba475e2f3d6455099cd0f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:19:15.872601-05:00","2016-05-03T11:13:42.364824-05:00","4958ccf0-9e31-4910-8bd7-70f54c059179_analysis.xml","a8a18b3544803e1f56b8790cbf7c6a79","b318197f-345b-4897-8416-1ef3fa7e3ab4",2121,"2016-09-30T00:14:12.194875-05:00","4958ccf0-9e31-4910-8bd7-70f54c059179_experiment.xml","6dd2bc4b9a95216c61bb192dc4929311","fa577234-73f4-48fe-95b4-cfde2296eea3",2257,"2016-09-29T23:12:09.668819-05:00","4958ccf0-9e31-4910-8bd7-70f54c059179_run.xml","ebc4f342ad2b79fac960ab98983c5a6e","d3fc64f2-f70e-4d42-8af3-e00573b6167d",347,"2016-09-08T11:27:50.928304-05:00","TCGA-A5-A0R7","2016-09-02T18:47:48.340951-05:00","female","TCGA-A5-A0R7_demographic",1955,"white","65b14ddc-7ed2-577d-b70b-affa93ccebdd","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0R7_diagnosis","not reported",20250,"alive","8380/3",NA,535,"527f39b6-f271-5c52-b8cb-5decddec860d","c54.1",-20250,"TCGA-A5-A0R7_treatment","5ab445cf-b9da-5100-9c92-916dcfdd43be","01","true","TCGA-A5-A0R7-01A",NA,"550c6341-260a-4156-b00c-0ae9031d647f",FALSE,"3BBA7591-082A-44CE-829F-23D16A91772D","Primary Tumor",NA,173,290,NA,1282089600,"31",30,"TCGA-A5-A0R7-01A-31",70,70,10,30,0,0,30,25,"2016-09-08T11:27:50.928304-05:00","2016-09-08T11:27:50.928304-05:00",40,40,20,30,"BOTTOM","TOP",0,5,"4383ecfb-54c6-4419-97bb-4b95ee449c25","916eec2a-d8a0-4bf1-a596-98bb4399aeb0","TCGA-A5-A0R7-01A-03-BSC","TCGA-A5-A0R7-01A-03-MSC",70,70,"8d90e4ab-c4a7-4ad9-bb88-95b67a1133d7","RNA","TCGA-A5-A0R7-01A-31R","8160c1e1-300d-4dfb-a38c-00a3176df4d3",1.91,0.16,"UV Spec","R","23","TCGA-A5-A0R7-01A-31R-A16W-07","0824e6ac-f3f0-4b71-81a3-7ee671a256eb",0.16,NA,136,49.9540863177227,165,"63615cb5-ba1f-58b0-9fdc-07f788207315","TCGA-A5-A0R7_exposure","UNCID_2207071.0824e6ac-f3f0-4b71-81a3-7ee671a256eb.110728_UNC2-RDR300275_00080_FC_63145AAXX_6.tar.gz","2013-09-29T06:46:04.000Z","2013-09-29T07:05:02.000Z","4958CCF0-9E31-4910-8BD7-70F54C059179","550C6341-260A-4156-B00C-0AE9031D647F","Unaligned reads",2326167398,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0824E6AC-F3F0-4B71-81A3-7EE671A256EB","University of North Carolina","56607965e4b0b37b3d991965","02B25675-094D-4098-96DA-51D121380FEC","Uterine Corpus Endometrial Carcinoma","TARGZ","8D90E4AB-C4A7-4AD9-BB88-95B67A1133D7","2013-09-29T07:05:02.000Z","8160C1E1-300D-4DFB-A38C-00A3176DF4D3","None","NO",1,NA,"Primary Tumor","Cedars Sinai",173,"8D90E4AB-C4A7-4AD9-BB88-95B67A1133D7",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.819982FF-44F4-47CA-8897-9718955ECA98.txt",290,"TCGA-A5-A0R7-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","5C81E333-C8DC-497D-9DB0-E9D419149F59",55,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.819982FF-44F4-47CA-8897-9718955ECA98.txt","Alive",NA,"TCGA-A5-A0R7","NOT HISPANIC OR LATINO","B1541AEC-5D12-4A07-B6CA-457CEBF88E2A",NA,40,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,31,30,"916EEC2A-D8A0-4BF1-A596-98BB4399AEB0","D4A08D27-56E1-49F1-9CB5-DB938E6FC6A2","TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted.bam","TCGA-A5-A0R7-01A-31",70,0,10,40,30,"BOTTOM",0,20,"TCGA-A5-A0R7-01A-03-BSC",70,NA,NA,NA,NA,NA,NA,NA,NA,40,"TUMOR FREE","Alive",NA,"TCGA-A5-A0R7-F5662","TCGA-A5-A0R7",1,"A5","A0R7","YES","C54.1","8380/3","C54.1","NO","YES",-20250,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",40,NA,NA,NA,"TUMOR FREE","NO",15,11,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
20156157,20027385,1488190234,"278DBFBE-6831-4335-8750-0B76406779FB.bw","02b2cd50-221f-437c-a1ce-6da1467ec809","278dbfbe-6831-4335-8750-0b76406779fb","2016-08-04T20:43:58.380956-05:00","UNCID_2207430.7e8a4ecc-07b0-4765-a8da-5868523736f5.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_8.tar.gz","6d6e1408-7136-417e-9c18-c21d20593866",1304762177,"Illumina GA","6d58f1159481c2e2403823c1df579241","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:50:39.182376-05:00","2016-05-03T11:13:42.378529-05:00","6d6e1408-7136-417e-9c18-c21d20593866_analysis.xml","660caa5c978cdf57cfd9ec667df11183","0c0b9455-6c48-4a65-b427-98d1516a281f",2121,"2016-09-29T20:49:11.006438-05:00","6d6e1408-7136-417e-9c18-c21d20593866_experiment.xml","6b1a655dab0ce21e30665bfd0d6a6a77","7b34e084-d742-4a1a-b3b6-089ec8674caa",2257,"2016-09-29T23:35:11.617838-05:00","6d6e1408-7136-417e-9c18-c21d20593866_run.xml","f7bdfdddbcbbd3896969c59b776e3f42","e23d317f-e865-47d2-8d15-e8b6592534c3",347,"2016-09-08T12:15:59.875257-05:00","TCGA-D1-A17M","2016-09-02T18:50:42.169331-05:00","female","TCGA-D1-A17M_demographic",1953,"white","196b8cc4-bb1e-5790-9ba1-218e0a0309a2","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17M_diagnosis","not reported",20685,"alive","8380/3",NA,311,"20b0d629-74ae-5329-b423-57586cbea3b1","c54.1",-20685,"TCGA-D1-A17M_treatment","c76664c7-f9f7-5ddc-b6c1-509eac7499a1","01","false","TCGA-D1-A17M-01A",NA,"027f53c8-0687-495f-917a-4dc6894216a6",FALSE,"E69EF984-AF58-4EB0-93D2-CADE53DF0A6D","Primary Tumor",NA,454,140,NA,1294185600,"21",30,"TCGA-D1-A17M-01A-21",65,NA,2,NA,0,NA,35,NA,"2016-09-08T12:15:59.875257-05:00",NA,10,NA,3,NA,"BOTTOM",NA,0,NA,"2258ba92-6aa3-411b-afad-91ee27b5fd06",NA,"TCGA-D1-A17M-01A-02-TS2",NA,65,NA,"b6919532-ca53-4c16-a4d5-403f77ae73a7","RNA","TCGA-D1-A17M-01A-21R","0a8fd77b-6e5a-4be2-b6ed-1b28110bcc94",1.8,0.16,"UV Spec","R","23","TCGA-D1-A17M-01A-21R-A12I-07","7e8a4ecc-07b0-4765-a8da-5868523736f5",0.16,NA,142,53.4457450412134,163,"0efc3a6b-6582-5a6b-9790-9b52cb0addec","TCGA-D1-A17M_exposure","UNCID_2207430.7e8a4ecc-07b0-4765-a8da-5868523736f5.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_8.tar.gz","2013-09-30T00:43:06.000Z","2013-09-30T00:55:01.000Z","6D6E1408-7136-417E-9C18-C21D20593866","027F53C8-0687-495F-917A-4DC6894216A6","Unaligned reads",1304762177,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7E8A4ECC-07B0-4765-A8DA-5868523736F5","University of North Carolina","56607a4fe4b016715ab6a893","02B2CD50-221F-437C-A1CE-6DA1467EC809","Uterine Corpus Endometrial Carcinoma","TARGZ","B6919532-CA53-4C16-A4D5-403F77AE73A7","2013-09-30T00:55:01.000Z","0A8FD77B-6E5A-4BE2-B6ED-1B28110BCC94","None","NO",1,NA,"Primary Tumor","Mayo Clinic",454,"B6919532-CA53-4C16-A4D5-403F77AE73A7",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C86897DA-DA1F-47F9-9C4C-3922E75EBE55.txt",140,"TCGA-D1-A17M-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","FAB732F8-5B6F-4714-917C-FA1DB6777091",56,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C86897DA-DA1F-47F9-9C4C-3922E75EBE55.txt","Alive",NA,"TCGA-D1-A17M","NOT HISPANIC OR LATINO","C72D8D66-3047-42B5-89B0-8A7DF74E9FEB",NA,311,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"74596487-D89F-4294-B8B4-1DC464CFF671","WHITE",NA,21,30,"2258BA92-6AA3-411B-AFAD-91EE27B5FD06","5FF303A0-E48D-404F-91D6-8090098DB1F7","UNCID_1625921.7e8a4ecc-07b0-4765-a8da-5868523736f5.sorted_genome_alignments.bam","TCGA-D1-A17M-01A-21",65,0,2,10,35,"BOTTOM",0,3,"TCGA-D1-A17M-01A-02-TS2",65,NA,NA,NA,"TCGA-D1-A17M-R20273","IMPLANTS","Regional site",NA,"NO",311,"TUMOR FREE","Alive",NA,"TCGA-D1-A17M-F20272","TCGA-D1-A17M",1,"D1","A17M","YES","C54.1","8380/3","C54.1","NO","YES",-20685,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",311,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32196799,31375580,2361536675,"2A02A359-28A1-41B9-8EDD-2477C95CD00A.bw","0305db4a-62ee-4ecb-bede-032981298732","2a02a359-28a1-41b9-8edd-2477c95cd00a","2016-08-09T14:16:09.577062-05:00","UNCID_2210034.9336e8ea-7afe-45b3-b9e7-add7141ecca0.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_6.tar.gz","d4fb362d-40f5-43c8-b438-77224b37890a",2048939975,"Illumina GA","162f88286ace62e1405dfab1ee8e311b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:01:31.571645-05:00","2016-05-03T11:15:47.403263-05:00","d4fb362d-40f5-43c8-b438-77224b37890a_analysis.xml","15a213ba5d89e1b3ae52130141c8a4f1","f2900ec8-6fd4-4157-add3-522b153412b6",2121,"2016-08-28T05:54:21.883189-05:00","d4fb362d-40f5-43c8-b438-77224b37890a_experiment.xml","99f3e50ffbcf2c6e1a8462c04c782d1c","575bdddc-6fe2-4025-9da4-a3ff4475dff2",2257,"2016-09-29T21:56:39.085083-05:00","d4fb362d-40f5-43c8-b438-77224b37890a_run.xml","f718fff8247912d9f3c8d0b04cf1edf2","a54871b1-01c1-440a-9f53-c73a62a19701",347,"2016-09-08T10:54:04.071810-05:00","TCGA-D1-A161","2016-09-02T18:49:57.021183-05:00","female","TCGA-D1-A161_demographic",1930,"white","3c625a1d-559a-5c1f-a2ac-a798cda8da14","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A161_diagnosis","not reported",28695,"alive","8380/3",NA,892,"e0980a3b-3670-52a5-ad47-b6f1b4467acc","c54.1",-28695,"TCGA-D1-A161_treatment","2b6b0ec2-b4fd-5d34-b117-87d3a3ac016d","01","false","TCGA-D1-A161-01A",NA,"94ad0779-7342-4f52-a6da-aed090129cd1",FALSE,"E68A0ED2-CBE3-40A9-8DBF-A3BBC49204DD","Primary Tumor",NA,864,170,NA,1292976000,"11",30,"TCGA-D1-A161-01A-11",60,NA,0,NA,25,NA,0,NA,"2016-09-08T10:54:04.071810-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"42f8d0d2-50e6-4583-80e7-5f1732ba48ce",NA,"TCGA-D1-A161-01A-01-TS1",NA,75,NA,"bdf0e0e8-d1e5-4822-8c3e-d77c72e1bb52","RNA","TCGA-D1-A161-01A-11R","8c5dc308-4728-440f-8041-c910df7e0e17",1.85,0.16,"UV Spec","R","23","TCGA-D1-A161-01A-11R-A118-07","9336e8ea-7afe-45b3-b9e7-add7141ecca0",0.16,NA,71,28.084332107116,159,"7e4283df-2ac2-50d7-b858-b1a9ac7f8d38","TCGA-D1-A161_exposure","UNCID_2210034.9336e8ea-7afe-45b3-b9e7-add7141ecca0.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_6.tar.gz","2013-10-02T04:56:06.000Z","2013-10-02T05:10:02.000Z","D4FB362D-40F5-43C8-B438-77224B37890A","94AD0779-7342-4F52-A6DA-AED090129CD1","Unaligned reads",2048939975,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","9336E8EA-7AFE-45B3-B9E7-ADD7141ECCA0","University of North Carolina","56607b3ce4b018727fea2978","0305DB4A-62EE-4ECB-BEDE-032981298732","Uterine Corpus Endometrial Carcinoma","TARGZ","BDF0E0E8-D1E5-4822-8C3E-D77C72E1BB52","2013-10-02T05:10:02.000Z","8C5DC308-4728-440F-8041-C910DF7E0E17","None","NO",1,NA,"Primary Tumor","Mayo Clinic",864,"BDF0E0E8-D1E5-4822-8C3E-D77C72E1BB52",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E9312DE7-7981-4E1C-864B-5C4273A4C04B.txt",170,"TCGA-D1-A161-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","94AD0779-7342-4F52-A6DA-AED090129CD1",78,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E9312DE7-7981-4E1C-864B-5C4273A4C04B.txt","Alive",NA,"TCGA-D1-A161","NOT HISPANIC OR LATINO","347C2310-9D8D-45CC-8CC7-1B932268EE0F",NA,892,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"42F8D0D2-50E6-4583-80E7-5F1732BA48CE","F0E92117-4204-4996-B628-F87D79815B60","UNCID_2210034.9336e8ea-7afe-45b3-b9e7-add7141ecca0.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_6.tar.gz","TCGA-D1-A161-01A-11",60,25,0,0,0,"TOP",0,0,"TCGA-D1-A161-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,NA,"NO",892,"TUMOR FREE","Alive",NA,"TCGA-D1-A161-F18478","TCGA-D1-A161",1,"D1","A161","YES","C54.1","8380/3","C54.1","NO","YES",-28695,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",892,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,78,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1995",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
108216086,105555693,5031964494,"3DA9560E-8181-4BAD-A90E-E4EE558E6EAF.bw","03381d49-e25f-4376-8e36-f47063a7d3fb","3da9560e-8181-4bad-a90e-e4ee558e6eaf","2016-08-25T18:36:24.326657-05:00","UNCID_2316565.618b52e3-9797-4c61-a0dd-1ffa8ea6d321.130909_UNC15-SN850_0326_AC2BWBACXX_2_TAGCTT.tar.gz","fc86016f-3bb3-4153-967b-82db8f353b9d",4883172027,"Illumina HiSeq","cf1ef1a412eb675b767441c4ddd5078c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:50:07.001529-05:00","2016-05-03T11:28:50.207865-05:00","fc86016f-3bb3-4153-967b-82db8f353b9d_analysis.xml","1d5431a9407d37c2f14e31236563e6d9","7bcf5ab7-a317-489b-b5d1-b490b2132838",2123,"2016-10-07T16:48:17.880541-05:00","fc86016f-3bb3-4153-967b-82db8f353b9d_experiment.xml","26e0c2eeedc6837c53164de048fe2b79","e7dda7b0-d6bc-4c3a-87f3-1ca5523fe52b",2628,"2016-09-29T23:22:02.896993-05:00","fc86016f-3bb3-4153-967b-82db8f353b9d_run.xml","3e8cb73103b6b49cd3bec5f0f47d4786","d9f2c84f-135f-4cd7-8916-48115e08ce58",354,"2016-09-08T11:11:30.061731-05:00","TCGA-QS-A5YQ","2016-09-02T18:51:25.628462-05:00","female","TCGA-QS-A5YQ_demographic",1958,"black or african american","e2e24506-9147-5af7-abf8-8e974293db26","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","QS","c4c083cd-4644-53b2-9d7e-ca2ae833c525","Candler","not reported","c54.1","TCGA-QS-A5YQ_diagnosis","not reported",20425,"alive","8380/3",NA,759,"c086b653-e209-5155-bd29-8da62fd7ec9a","c54.1",-20425,"TCGA-QS-A5YQ_treatment","0fb5dc43-a72f-5993-929a-3ef1486249cb","01","false","TCGA-QS-A5YQ-01A",NA,"c38114c8-744b-4919-8f2a-c8f30fba38b3",FALSE,"D1631D6F-F055-4D35-A6DD-FE7A251BD4C2","Primary Tumor",NA,43,370,NA,1363737600,"11",30,"TCGA-QS-A5YQ-01A-11",70,NA,0,NA,0,NA,30,NA,"2016-09-08T11:11:30.061731-05:00",NA,20,NA,0,NA,"TOP",NA,0,NA,"bac674d2-c637-4b09-80ee-3a629b812233",NA,"TCGA-QS-A5YQ-01A-01-TS1",NA,70,NA,"0149346e-899b-4ee5-bcdd-5803743f741d","RNA","TCGA-QS-A5YQ-01A-11R","e2920509-ba32-4e21-93fb-e9414ded2fc4",1.88,0.16,"UV Spec","R","23","TCGA-QS-A5YQ-01A-11R-A31O-07","618b52e3-9797-4c61-a0dd-1ffa8ea6d321",0.16,NA,83,32.421875,160,"a0e17bf8-c36e-530a-ab8d-e5923a933b83","TCGA-QS-A5YQ_exposure","UNCID_2316565.618b52e3-9797-4c61-a0dd-1ffa8ea6d321.130909_UNC15-SN850_0326_AC2BWBACXX_2_TAGCTT.tar.gz","2014-01-07T02:59:29.000Z","2014-01-07T03:32:02.000Z","FC86016F-3BB3-4153-967B-82DB8F353B9D","C38114C8-744B-4919-8F2A-C8F30FBA38B3","Unaligned reads",4883172027,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","618B52E3-9797-4C61-A0DD-1FFA8EA6D321","University of North Carolina","56607f62e4b018727fea3a4d","03381D49-E25F-4376-8E36-F47063A7D3FB","Uterine Corpus Endometrial Carcinoma","TARGZ","0149346E-899B-4EE5-BCDD-5803743F741D","2014-01-07T03:32:02.000Z","E2920509-BA32-4E21-93FB-E9414DED2FC4","United States","NO",1,NA,"Primary Tumor","Candler",43,"0149346E-899B-4EE5-BCDD-5803743F741D",NA,"QS","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E9379320-2726-431E-B512-78858CEA26C3.txt",370,"TCGA-QS-A5YQ-01A",NA,"DB80D6EC-BF5B-46C0-9DA9-B9605C3ECC42","TCGA",2013,"TCGA-QS-A5YQ_NTE-1",NA,"TUMOR FREE","CE5C29CB-32AD-4E61-AC25-61ACECA232E2",55,"SWEDE_p_TCGAb322_23_24_25_26NSP_GenomeWideSNP_6_D03_1364924.ismpolish.data.txt","Alive",NA,"TCGA-QS-A5YQ","NOT HISPANIC OR LATINO","710F40D3-3395-4A2D-B27F-C8BD7BE2150C","NO",128,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",324,NA,"0A927A0D-C269-45AE-A82C-7FEAA0F3454C","BLACK OR AFRICAN AMERICAN",NA,11,30,"BAC674D2-C637-4B09-80EE-3A629B812233","E2920509-BA32-4E21-93FB-E9414DED2FC4","UNCID_2316565.618b52e3-9797-4c61-a0dd-1ffa8ea6d321.130909_UNC15-SN850_0326_AC2BWBACXX_2_TAGCTT.tar.gz","TCGA-QS-A5YQ-01A-11",70,0,0,20,30,"TOP",0,0,"TCGA-QS-A5YQ-01A-01-TS1",70,"Carboplatin","Chemotherapy","TCGA-QS-A5YQ-D43752","TCGA-QS-A5YQ-R43112","External","Primary Tumor Field","TCGA-QS-A5YQ-F59570_NTE-1","NO",759,"TUMOR FREE","Alive",NA,"TCGA-QS-A5YQ-F59570","TCGA-QS-A5YQ",1,"QS","A5YQ","YES","C54.1","8380/3","C54.1","YES","NO",-20425,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",128,NA,"YES","YES","TUMOR FREE","YES",14,5,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2013,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34263393,33319957,2498851887,"A8D65DDB-516A-4F8C-8038-483A254D41B1.bw","0547cdfa-c488-4da0-9bb5-4cc63a637179","a8d65ddb-516a-4f8c-8038-483a254d41b1","2016-08-09T14:17:03.623204-05:00","UNCID_2214995.0ac50ce8-8c72-4b83-98c3-6efdb138d7a1.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_5.tar.gz","c6c383bf-2a91-4745-823d-c116a5fa3d74",2121650838,"Illumina GA","0ff0ce56ac561438ab61d3ae4f505669","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:38:51.584413-05:00","2016-05-03T11:17:14.882251-05:00","c6c383bf-2a91-4745-823d-c116a5fa3d74_analysis.xml","4d49b41e65bb2f1505c32d2af05f58df","4ffd76da-6b4f-4147-b36e-2644d1972b8c",2122,"2016-09-29T17:45:47.254458-05:00","c6c383bf-2a91-4745-823d-c116a5fa3d74_experiment.xml","d84b764ee96089c6ae09a88a4cda9b43","09058c6d-49a5-49c8-9af1-10fea29ac83f",2256,"2016-09-29T23:06:04.415424-05:00","c6c383bf-2a91-4745-823d-c116a5fa3d74_run.xml","1883b3b6c6c72537044025c357849744","d02131ed-3fb4-472c-8013-c95a19cec136",345,"2016-09-08T10:25:27.807505-05:00","TCGA-A5-A0GP","2016-09-02T18:54:13.215019-05:00","female","TCGA-A5-A0GP_demographic",1949,"asian","15dac957-20b9-50f8-8f86-a1d216f696d3","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GP_diagnosis","not reported",21365,"alive","8380/3",NA,1416,"d22e87fc-a446-5e6f-8544-18705a43a8e7","c54.1",-21365,"TCGA-A5-A0GP_treatment","2682baa7-0d1d-5ec3-94ba-6653052f3a15","01","true","TCGA-A5-A0GP-01A",NA,"1797c4d9-1677-4ff6-ba71-98331d53f6c6",FALSE,"A730192C-227E-4A86-96B9-8670D3F5EF59","Primary Tumor",NA,1030,160,NA,1275609600,"11",30,"TCGA-A5-A0GP-01A-11",90,90,0,0,0,0,0,0,"2016-09-08T10:25:27.807505-05:00","2016-09-08T10:25:27.807505-05:00",1,1,0,0,"TOP","BOTTOM",0,0,"468dd530-f978-41ef-abb9-b9a61c83a5f8","73838b4c-68eb-4058-879e-67edaf12bee3","TCGA-A5-A0GP-01A-01-TSA","TCGA-A5-A0GP-01A-01-BSA",100,100,"463d7fcd-90f1-4538-a648-98660c285c16","RNA","TCGA-A5-A0GP-01A-11R","b6e47841-861a-454f-852c-1723863e02c7",1.87,0.16,"UV Spec","R","23","TCGA-A5-A0GP-01A-11R-A040-07","0ac50ce8-8c72-4b83-98c3-6efdb138d7a1",0.16,NA,60,23.4375,160,"08df5808-4a2c-58d9-b265-baa39fe40f5d","TCGA-A5-A0GP_exposure","UNCID_2214995.0ac50ce8-8c72-4b83-98c3-6efdb138d7a1.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_5.tar.gz","2013-10-03T22:56:04.000Z","2013-10-03T23:08:03.000Z","C6C383BF-2A91-4745-823D-C116A5FA3D74","1797C4D9-1677-4FF6-BA71-98331D53F6C6","Unaligned reads",2121650838,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0AC50CE8-8C72-4B83-98C3-6EFDB138D7A1","University of North Carolina","564a3f40e4b0ef12181bab57","0547CDFA-C488-4DA0-9BB5-4CC63A637179","Uterine Corpus Endometrial Carcinoma","TARGZ","463D7FCD-90F1-4538-A648-98660C285C16","2013-10-03T23:08:03.000Z","B6E47841-861A-454F-852C-1723863E02C7","None","NO",1,NA,"Primary Tumor","Cedars Sinai",1030,"463D7FCD-90F1-4538-A648-98660C285C16",NA,"A5","TCGA-A5-A0GP-01A-11W-A062-09_IlluminaGA-DNASeq_exome.bam.bai",160,"TCGA-A5-A0GP-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","CA7169E9-F65E-451A-92B1-5A210D79F993",58,"MODEM_p_TCGAb59_SNP_N_GenomeWideSNP_6_G03_680498.birdseed.data.txt","Alive",NA,"TCGA-A5-A0GP","NOT HISPANIC OR LATINO","4CE153EC-9BD9-439A-B494-7313462C5661",NA,1087,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"ASIAN",NA,11,30,"73838B4C-68EB-4058-879E-67EDAF12BEE3","A1EBB4C7-E3E7-4056-9E74-542368AD443E","TCGA-A5-A0GP-01A-11W-A062-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-A5-A0GP-01A-11",90,0,0,1,0,"TOP",0,0,"TCGA-A5-A0GP-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",1416,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GP-F17152","TCGA-A5-A0GP",1,"A5","A0GP","YES","C54.1","8380/3","C54.1","NO","YES",-21365,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",1087,NA,NA,NA,"TUMOR FREE","NO",10,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2007,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32469901,31691901,2383920241,"1D34604D-44C1-431F-B6E5-8C78B11F5A9E.bw","0648f046-2206-4b97-9b6e-419c2e325b6d","1d34604d-44c1-431f-b6e5-8c78b11f5a9e","2016-08-09T14:16:16.081939-05:00","UNCID_2210711.b07b341a-32ba-4863-b202-6fae769d1dd2.110323_UNC3-RDR300156_00085_FC_706FWAAXX_3.tar.gz","02d42445-475d-443d-ae10-10f0934ffcbe",2125549217,"Illumina GA","669567fbf46f25e2986a0932878a0186","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:46:30.211877-05:00","2016-05-03T11:15:47.421196-05:00","02d42445-475d-443d-ae10-10f0934ffcbe_analysis.xml","e7d5517c2cb5caf96fea98574bf7f4a2","798bdae7-658a-4b60-ba18-3f2588ebf041",2121,"2016-10-07T15:45:36.799962-05:00","02d42445-475d-443d-ae10-10f0934ffcbe_experiment.xml","6a060394eb50b4265d39f9b77f5937ec","b9c1adc0-7a8b-4274-86ec-e8d66d869246",2257,"2016-09-29T23:28:27.670464-05:00","02d42445-475d-443d-ae10-10f0934ffcbe_run.xml","82f19ae5c411531b100e33effb19bdd1","ddff3cd8-c6f0-42ab-b927-095f780eee11",347,"2016-09-08T11:51:35.327232-05:00","TCGA-A5-A0VO","2016-09-02T18:48:42.978275-05:00","female","TCGA-A5-A0VO_demographic",1946,"white","123d4916-d5a9-5a00-9e89-34b4acda61e5","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0VO_diagnosis","not reported",23547,"dead","8380/3",875,364,"2c7303ce-f4f8-5671-9283-42959b0788c2","c54.1",-23547,"TCGA-A5-A0VO_treatment","1c203ba4-a944-5a35-8f30-275b1d3abe76","01","true","TCGA-A5-A0VO-01A",NA,"925bc760-6132-4b03-961e-7570acf33d5e",FALSE,"6ABBA2C9-8920-4785-BFAB-40E560D2DBE6","Primary Tumor",NA,133,320,NA,1286755200,"21",30,"TCGA-A5-A0VO-01A-21",70,70,0,0,20,0,0,10,"2016-09-08T11:51:35.327232-05:00","2016-09-08T11:51:35.327232-05:00",20,0,20,0,"BOTTOM","TOP",10,0,"e22a1156-04ad-4ac8-9576-20639e098c66","e03a04e3-daf4-4227-80e4-6b2b6fdd7961","TCGA-A5-A0VO-01A-02-BSB","TCGA-A5-A0VO-01A-02-MSB",70,90,"490e3050-1cea-423f-af06-ff54082eae4b","RNA","TCGA-A5-A0VO-01A-21R","f80755b3-8c07-4fe9-8300-b9aac4a836a4",1.86,0.17,"UV Spec","R","23","TCGA-A5-A0VO-01A-21R-A109-07","b07b341a-32ba-4863-b202-6fae769d1dd2",0.17,NA,86,32.3685498136926,163,"ee7c640b-ca61-5867-b9a7-d654aeb49589","TCGA-A5-A0VO_exposure","UNCID_2210711.b07b341a-32ba-4863-b202-6fae769d1dd2.110323_UNC3-RDR300156_00085_FC_706FWAAXX_3.tar.gz","2013-10-02T15:13:04.000Z","2013-10-02T15:26:02.000Z","02D42445-475D-443D-AE10-10F0934FFCBE","925BC760-6132-4B03-961E-7570ACF33D5E","Unaligned reads",2125549217,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B07B341A-32BA-4863-B202-6FAE769D1DD2","University of North Carolina","564a3736e4b0ef1218191a31","0648F046-2206-4B97-9B6E-419C2E325B6D","Uterine Corpus Endometrial Carcinoma","TARGZ","490E3050-1CEA-423F-AF06-FF54082EAE4B","2013-10-02T15:26:02.000Z","F80755B3-8C07-4FE9-8300-B9AAC4A836A4","None","NO",1,NA,"Primary Tumor","Cedars Sinai",133,"490E3050-1CEA-423F-AF06-FF54082EAE4B",NA,"A5","jhu-usc.edu_UCEC.HumanMethylation450.1.lvl-2.TCGA-A5-A0VO-01A-21D-A10A-05.txt",320,"TCGA-A5-A0VO-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","925BC760-6132-4B03-961E-7570ACF33D5E",64,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5D42C10D-E328-4165-961D-CF8EEE9EFBE1.txt","Alive",NA,"TCGA-A5-A0VO","NOT HISPANIC OR LATINO","BF453DE3-7A81-40C3-8650-6230B3C1ED04",NA,128,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",75,NA,"B3ACA258-541B-4739-BD85-DFCA0426B412","WHITE",NA,21,30,"E22A1156-04AD-4AC8-9576-20639E098C66","F80755B3-8C07-4FE9-8300-B9AAC4A836A4","unc.edu.b07b341a-32ba-4863-b202-6fae769d1dd2.1635042.junction_quantification.txt","TCGA-A5-A0VO-01A-21",70,20,0,20,0,"BOTTOM",10,20,"TCGA-A5-A0VO-01A-02-BSB",70,NA,NA,NA,"TCGA-A5-A0VO-R4463","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",364,"TUMOR FREE","Alive",NA,"TCGA-A5-A0VO-F17168","TCGA-A5-A0VO",1,"A5","A0VO","YES","C54.1","8380/3","C54.1","NO","YES",-23547,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",128,NA,NA,NA,"TUMOR FREE","NO",6,12,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
107195366,105641199,4991914210,"F3C17A4E-3940-4DAB-8D00-FA6A16118B75.bw","06728b1b-6b69-4467-8e10-a8a4e6328ac8","f3c17a4e-3940-4dab-8d00-fa6a16118b75","2016-08-09T13:15:07.048085-05:00","UNCID_2173031.eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8.130509_UNC10-SN254_0462_AC232JACXX_5_AGTTCC.tar.gz","3a56e1e6-42f0-4795-9d50-dbc51d231b99",4974420247,"Illumina HiSeq","ade53d75b22224e5794ae4167e0aeb0c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:48:01.723547-05:00","2016-05-03T10:55:55.600288-05:00","3a56e1e6-42f0-4795-9d50-dbc51d231b99_analysis.xml","384bf9e5279d3cb3077f689e01b859b3","7a77b560-8aa6-4cca-8519-e3bbc1e4c577",2123,"2016-10-07T16:54:18.443617-05:00","3a56e1e6-42f0-4795-9d50-dbc51d231b99_experiment.xml","bf1239cd4fd28f91c8c8923da6f80e81","18645c76-3eec-4a2b-8440-cefbe191cae3",2431,"2016-09-29T19:35:07.744421-05:00","3a56e1e6-42f0-4795-9d50-dbc51d231b99_run.xml","28dd8652e8144389bad912b5c5e961b1","4db2c7ea-0ad7-4827-9c53-5d4dddcbb96c",354,"2016-09-08T10:39:47.492677-05:00","TCGA-EY-A3L3","2016-09-02T18:49:31.633352-05:00","female","TCGA-EY-A3L3_demographic",1929,"black or african american","cc57dcd7-5e85-5e52-b35b-4adf130b31d7","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A3L3_diagnosis","not reported",30138,"alive","8380/3",NA,832,"03da229e-75bb-588f-90bf-84d998331fe1","c54.1",-30138,"TCGA-EY-A3L3_treatment","cad43da4-7e03-5555-87a4-121b24947e13","01","false","TCGA-EY-A3L3-01A",NA,"9895a2ad-1c08-4e2e-acca-88a3927a2c2d",FALSE,"DBCC8E6F-3AB9-41B2-8266-341509A9FDB3","Primary Tumor",NA,198,1020,NA,1325548800,"11",30,"TCGA-EY-A3L3-01A-11",90,NA,0,NA,0,NA,0,NA,"2016-09-08T10:39:47.492677-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"0c120c7b-6dd1-4e15-831d-cd00762d823d",NA,"TCGA-EY-A3L3-01A-01-TSA",NA,100,NA,"f1052d2e-cc51-4d1d-bbf5-e0ef19ca7bc5","RNA","TCGA-EY-A3L3-01A-11R","247f573c-f013-468d-a5f2-8b0c0c4ec829",1.83,0.15,"UV Spec","R","23","TCGA-EY-A3L3-01A-11R-A22K-07","eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8",0.15,NA,92,35.4924578527063,161,"f4e1aa59-e9c8-5a53-82f8-c5ad1ccde310","TCGA-EY-A3L3_exposure","UNCID_2173031.eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8.130509_UNC10-SN254_0462_AC232JACXX_5_AGTTCC.tar.gz","2013-09-09T07:36:10.000Z","2013-09-09T07:58:02.000Z","3A56E1E6-42F0-4795-9D50-DBC51D231B99","9895A2AD-1C08-4E2E-ACCA-88A3927A2C2D","Unaligned reads",4974420247,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","EACFDC9C-B044-4DD5-A153-1ED9B62B0FB8","University of North Carolina","564a3e8ae4b0ef12181b7145","06728B1B-6B69-4467-8E10-A8A4E6328AC8","Uterine Corpus Endometrial Carcinoma","TARGZ","F1052D2E-CC51-4D1D-BBF5-E0EF19CA7BC5","2013-09-09T07:58:02.000Z","247F573C-F013-468D-A5F2-8B0C0C4EC829","United States","NO",1,NA,"Primary Tumor","University of North Carolina",198,"F1052D2E-CC51-4D1D-BBF5-E0EF19CA7BC5",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.560982E6-96AF-414D-A20B-5F136CB71629.txt",1020,"TCGA-EY-A3L3-01A",NA,"6AC34DE1-0DA4-4121-92C8-4D606A4150A0","TCGA",2011,NA,NA,"TUMOR FREE","9895A2AD-1C08-4E2E-ACCA-88A3927A2C2D",82,"TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_H02_1151330.CEL","Alive",NA,"TCGA-EY-A3L3","NOT HISPANIC OR LATINO","6ECFD302-B634-4F70-BE02-D03C0A40ECD0",NA,258,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"4BA18061-C847-4F72-9FA4-1901DFA2E494","BLACK OR AFRICAN AMERICAN",NA,11,30,"0C120C7B-6DD1-4E15-831D-CD00762D823D","38E2D371-57D8-439C-81B6-478A9A6F7B76","UNCID_2031594.eacfdc9c-b044-4dd5-a153-1ed9b62b0fb8.sorted_genome_alignments.bam","TCGA-EY-A3L3-01A-11",90,0,0,2,0,"TOP",0,0,"TCGA-EY-A3L3-01A-01-TSA",100,"Taxol","Chemotherapy","TCGA-EY-A3L3-D38201","TCGA-EY-A3L3-R38203","Internal","Primary Tumor Field","TCGA-EY-A3L3-F38200_NTE-1","NO",545,"TUMOR FREE","Alive",NA,"TCGA-EY-A3L3-F38200","TCGA-EY-A3L3",1,"EY","A3L3","YES","C54.1","8380/3","C54.1","YES","NO",-30138,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",258,NA,NA,NA,"TUMOR FREE","NO",23,4,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,82,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
101733726,100633281,4799293742,"2AE27B42-030A-4801-8B03-0AFF4F1AEA3E.bw","068016e2-7829-493c-b8be-d3b85beaab13","2ae27b42-030a-4801-8b03-0aff4f1aea3e","2016-08-09T13:17:22.604004-05:00","UNCID_2177797.060787cf-a4a0-402f-8534-742157bb4a2c.130402_UNC10-SN254_0447_BC22WAACXX_8_GATCAG.tar.gz","19d3dd0e-0ee2-4e18-aee6-e3e1f806bd53",4301216839,"Illumina HiSeq","9bef80a9ce23c14b6ff8006efb5c1d95","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:41:50.528030-05:00","2016-05-03T10:56:47.877475-05:00","19d3dd0e-0ee2-4e18-aee6-e3e1f806bd53_analysis.xml","7b36e18f768c8d2c79dec2e8616c340e","51e2c2b1-6f1f-410d-82df-b62273f267f8",2122,"2016-08-13T02:12:22.627523-05:00","19d3dd0e-0ee2-4e18-aee6-e3e1f806bd53_experiment.xml","224558fe0b46e2c38749d8827336064e","45b3cc0f-1081-46a5-ac51-e9e3c4ea9696",2431,"2016-09-29T23:06:09.573732-05:00","19d3dd0e-0ee2-4e18-aee6-e3e1f806bd53_run.xml","ded6ebf94cf9fb4a470ed303ba3c6788","d02ee706-c545-420b-846c-19fdca718b0d",354,"2016-09-08T10:38:28.401962-05:00","TCGA-EY-A2OO","2016-09-02T18:47:59.487167-05:00","female","TCGA-EY-A2OO_demographic",1953,"white","c37ab2c0-3978-59ee-a387-6e4a98de35ec","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A2OO_diagnosis","not reported",20797,"alive","8441/3",NA,1392,"baa98524-f76b-54a8-8de1-9c3ee7b39b65","c54.1",-20797,"TCGA-EY-A2OO_treatment","e01f2849-0f29-5eff-a940-5422e4c675b5","01","false","TCGA-EY-A2OO-01A",NA,"e254c2ba-0de8-42f1-bc83-94adb11c71f7",FALSE,"CC94C4BA-FBF6-4F0D-93DD-C2D98D965DF8","Primary Tumor",NA,715,1,NA,1318896000,"11",30,"TCGA-EY-A2OO-01A-11",75,NA,0,NA,0,NA,10,NA,"2016-09-08T10:38:28.401962-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"59b7b50d-4699-4f11-b093-c5fa6c797e45",NA,"TCGA-EY-A2OO-01A-01-TS1",NA,90,NA,"04e95dea-7512-4709-b450-97089f0c6a47","RNA","TCGA-EY-A2OO-01A-11R","66b325fa-d3b3-4574-ae9c-5ea51e5e5df1",1.85,0.17,"UV Spec","R","23","TCGA-EY-A2OO-01A-11R-A19W-07","060787cf-a4a0-402f-8534-742157bb4a2c",0.17,NA,79,25.7959183673469,175,"226a951f-b436-5594-a465-e8b8ae31a09a","TCGA-EY-A2OO_exposure","UNCID_2177797.060787cf-a4a0-402f-8534-742157bb4a2c.130402_UNC10-SN254_0447_BC22WAACXX_8_GATCAG.tar.gz","2013-09-11T18:16:09.000Z","2013-09-11T18:31:01.000Z","19D3DD0E-0EE2-4E18-AEE6-E3E1F806BD53","E254C2BA-0DE8-42F1-BC83-94ADB11C71F7","Unaligned reads",4301216839,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","060787CF-A4A0-402F-8534-742157BB4A2C","University of North Carolina","56607d11e4b016715ab6b524","068016E2-7829-493C-B8BE-D3B85BEAAB13","Uterine Corpus Endometrial Carcinoma","TARGZ","04E95DEA-7512-4709-B450-97089F0C6A47","2013-09-11T18:31:01.000Z","66B325FA-D3B3-4574-AE9C-5EA51E5E5DF1","United States","NO",1,NA,"Primary Tumor","University of North Carolina",715,"04E95DEA-7512-4709-B450-97089F0C6A47",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.71B9F996-932C-46AD-B6B1-C5ECEB19A332.txt",1,"TCGA-EY-A2OO-01A",NA,"F3F452D5-1549-4D94-80BF-6AF749480881","TCGA",2009,NA,NA,"TUMOR FREE","E254C2BA-0DE8-42F1-BC83-94ADB11C71F7",56,"nationwidechildrens.org_clinical.TCGA-EY-A2OO.xml","Alive",NA,"TCGA-EY-A2OO","NOT HISPANIC OR LATINO","CC33A71A-3555-49CA-A68A-33387FDBED11",NA,774,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",186,NA,"54ACA39B-DBA1-4834-A081-6650AF599BA4","WHITE",NA,11,30,"59B7B50D-4699-4F11-B093-C5FA6C797E45","970D0D0D-6CD1-4A39-A9F8-90935AFCD297","1966b115313149a777515023e6011434.bam","TCGA-EY-A2OO-01A-11",75,0,0,0,10,"TOP",0,0,"TCGA-EY-A2OO-01A-01-TS1",90,"Taxol","Chemotherapy","TCGA-EY-A2OO-D18376","TCGA-EY-A2OO-R18379","IMPLANTS","Regional site","TCGA-EY-A2OO-F34159_NTE-1","NO",1065,"TUMOR FREE","Alive",NA,"TCGA-EY-A2OO-F34159","TCGA-EY-A2OO",1,"EY","A2OO","YES","C54.1","8441/3","C54.1","NO","YES",-20797,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",774,NA,NA,NA,"TUMOR FREE","NO",15,11,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,56,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30321096,29272865,2204672476,"6A37EAD0-5083-426C-A6D9-274EB0F8D42C.bw","06d16b6b-9ca6-4cec-a785-f27aa4323cec","6a37ead0-5083-426c-a6d9-274eb0f8d42c","2016-08-09T14:17:07.418394-05:00","UNCID_2214525.414c904a-29d0-44d0-bceb-ce7d024f1a58.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_2.tar.gz","6b47f6ca-52ae-4446-8a29-338bd8ca54af",2014275401,"Illumina GA","ed0f9e6f103a02dc238b081be2b1e9cc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:57:59.956452-05:00","2016-05-03T11:17:14.896869-05:00","6b47f6ca-52ae-4446-8a29-338bd8ca54af_analysis.xml","4aa7c0bd9e8dc21e8991201546618fed","cb172f64-5f5c-4bbf-945e-1d50491a1b8d",2121,"2016-09-29T20:23:40.098777-05:00","6b47f6ca-52ae-4446-8a29-338bd8ca54af_experiment.xml","b12f2e49ee3a8d3571177ca4c427b5e7","6b855d82-0b95-4687-8a64-76e7e003ed5d",2257,"2016-09-29T19:02:38.713530-05:00","6b47f6ca-52ae-4446-8a29-338bd8ca54af_run.xml","bc8bdd17aac28ca807d61ddd2b6766fb","3958ff70-d3f5-4ab2-836a-7f2996f7522b",347,"2016-09-08T11:24:35.822468-05:00","TCGA-A5-A0R8","2016-09-02T18:47:48.902181-05:00","female","TCGA-A5-A0R8_demographic",1929,"white","ee2f47ac-33f2-5a9e-8205-33f5961263b8","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0R8_diagnosis","not reported",29777,"alive","8380/3",NA,596,"ab21d7de-ea75-54ed-9d30-65a64b56122b","c54.1",-29777,"TCGA-A5-A0R8_treatment","5271e7b4-b7b4-5dc1-ac6d-170f56e2d9d4","01","true","TCGA-A5-A0R8-01A",NA,"5b5cc2ba-6a10-4279-a0aa-8ddae94d56ea",FALSE,"CA537524-B83F-4AC5-B721-38570E5B21BB","Primary Tumor",NA,155,180,NA,1280275200,"11",30,"TCGA-A5-A0R8-01A-11",75,70,20,30,0,0,20,20,"2016-09-08T11:24:35.822468-05:00","2016-09-08T11:24:35.822468-05:00",30,30,30,30,"TOP","BOTTOM",5,10,"35ffff87-d27b-4b80-854c-dfda7289d623","8436f37d-8adc-4dcb-a451-31a0a7e7ac56","TCGA-A5-A0R8-01A-01-TSA","TCGA-A5-A0R8-01A-01-BSA",75,70,"d00bf723-ad13-4048-b331-9f45e773502b","RNA","TCGA-A5-A0R8-01A-11R","9aa48c97-5f2f-44a3-aeb2-c9b358b4d71b",1.82,0.13,"UV Spec","R","23","TCGA-A5-A0R8-01A-11R-A104-07","414c904a-29d0-44d0-bceb-ce7d024f1a58",0.13,NA,62,24.21875,160,"9a3b9763-c28e-5614-b373-67b590fcc410","TCGA-A5-A0R8_exposure","UNCID_2214525.414c904a-29d0-44d0-bceb-ce7d024f1a58.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_2.tar.gz","2013-10-03T16:46:04.000Z","2013-10-03T16:58:02.000Z","6B47F6CA-52AE-4446-8A29-338BD8CA54AF","5B5CC2BA-6A10-4279-A0AA-8DDAE94D56EA","Unaligned reads",2014275401,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","414C904A-29D0-44D0-BCEB-CE7D024F1A58","University of North Carolina","564a32d0e4b08c5d868ec619","06D16B6B-9CA6-4CEC-A785-F27AA4323CEC","Uterine Corpus Endometrial Carcinoma","TARGZ","D00BF723-AD13-4048-B331-9F45E773502B","2013-10-03T16:58:02.000Z","9AA48C97-5F2F-44A3-AEB2-C9B358B4D71B","None","NO",1,NA,"Primary Tumor","Cedars Sinai",155,"D00BF723-AD13-4048-B331-9F45E773502B",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9C6EC7CC-4E83-4DE9-B194-F83829765C1D.txt",180,"TCGA-A5-A0R8-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","5B5CC2BA-6A10-4279-A0AA-8DDAE94D56EA",81,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9C6EC7CC-4E83-4DE9-B194-F83829765C1D.txt","Alive",NA,"TCGA-A5-A0R8","NOT HISPANIC OR LATINO","5E775960-9F68-42FD-9BB7-95DC075C209A",NA,126,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"233DBDB3-7F2B-4C9D-BE39-7ED1D07BC9A9","WHITE",NA,11,30,"8436F37D-8ADC-4DCB-A451-31A0A7E7AC56","9AA48C97-5F2F-44A3-AEB2-C9B358B4D71B","UNCID_362796.TCGA-A5-A0R8-01A-11R-A104-07.110208_UNC3-RDR300156_00070_FC_62J3NAAXX.2.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-A5-A0R8-01A-11",70,0,30,30,20,"BOTTOM",10,30,"TCGA-A5-A0R8-01A-01-BSA",70,NA,NA,NA,"TCGA-A5-A0R8-R5064","IMPLANTS","Primary Tumor Field",NA,NA,126,"TUMOR FREE","Alive",NA,"TCGA-A5-A0R8-F5060","TCGA-A5-A0R8",1,"A5","A0R8","YES","C54.1","8380/3","C54.1","NO","YES",-29777,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",126,NA,NA,NA,"TUMOR FREE","NO",17,12,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,81,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
119564364,118615069,5657048058,"EF5618C6-6AFB-4FB5-A32B-7946F18E9736.bw","077bdc90-1bbd-49ec-93a5-729b1ac1ba8d","ef5618c6-6afb-4fb5-a32b-7946f18e9736","2016-08-05T05:08:56.862791-05:00","UNCID_2177804.08576085-2f37-41fc-82f6-39d396d75862.130402_UNC10-SN254_0447_BC22WAACXX_8_ACTTGA.tar.gz","d2e6314e-5078-4cc3-8a42-8c59bcca3337",5043725596,"Illumina HiSeq","adb3bcbfa67f25df7e5bf072995267e0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:48:12.944021-05:00","2016-05-03T10:56:47.890899-05:00","d2e6314e-5078-4cc3-8a42-8c59bcca3337_analysis.xml","95cbe3e2d903c0fe37b3af11f0b72baa","55ce87b9-ec83-4593-8403-3ac262e607bb",2123,"2016-09-29T22:51:44.989401-05:00","d2e6314e-5078-4cc3-8a42-8c59bcca3337_experiment.xml","aaca0475fe37d7a36570b31153c13a72","c745d736-15c0-4bda-83e0-7aa39831d360",2431,"2016-09-29T22:37:19.818977-05:00","d2e6314e-5078-4cc3-8a42-8c59bcca3337_run.xml","45967e7dd4f85310405cf82e7458512b","be4b8343-b865-40f3-a53c-ef91f0d1cf29",354,"2016-09-08T10:52:38.275683-05:00","TCGA-E6-A2P9","2016-09-02T18:47:54.534937-05:00","female","TCGA-E6-A2P9_demographic",1946,"white","f4b4d94a-2b7d-53bd-8d10-811b893eed5d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","E6","39aa3c67-c7d9-5001-8ed1-3bf83eac7872","Roswell Park","not reported","c54.1","TCGA-E6-A2P9_diagnosis","not reported",24088,"alive","8380/3",NA,1386,"659e3007-fec4-561b-a424-41c0e035dc24","c54.1",-24088,"TCGA-E6-A2P9_treatment","5c509bb2-9e60-5357-b17b-4706277ea7e5","01","true","TCGA-E6-A2P9-01A",NA,"9c35e13b-87fc-4dc4-a847-dba192079ec1",FALSE,"EF7B01C4-0952-4FE8-B128-2A43FA31E6F5","Primary Tumor",NA,189,230,NA,1314316800,"11",30,"TCGA-E6-A2P9-01A-11",96,NA,0,NA,0,NA,5,NA,"2016-09-08T10:52:38.275683-05:00",NA,3,NA,0,NA,"TOP",NA,0,NA,"9774fa25-45d4-4d09-9c0c-69f2aee08602",NA,"TCGA-E6-A2P9-01A-01-TSA",NA,95,NA,"ac1f6b84-e195-46f2-a9ec-ab75565ce486","RNA","TCGA-E6-A2P9-01A-11R","f801ec7c-c5d2-46b1-bae8-bf564e59087e",1.86,0.17,"UV Spec","R","23","TCGA-E6-A2P9-01A-11R-A19W-07","08576085-2f37-41fc-82f6-39d396d75862",0.17,NA,125,41.7655117110495,173,"939c26c6-a93e-5caa-989b-16e875224c8f","TCGA-E6-A2P9_exposure","UNCID_2177804.08576085-2f37-41fc-82f6-39d396d75862.130402_UNC10-SN254_0447_BC22WAACXX_8_ACTTGA.tar.gz","2013-09-11T18:46:08.000Z","2013-09-11T07:02:01.000Z","D2E6314E-5078-4CC3-8A42-8C59BCCA3337","9C35E13B-87FC-4DC4-A847-DBA192079EC1","Unaligned reads",5043725596,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","08576085-2F37-41FC-82F6-39D396D75862","University of North Carolina","5660745de4b016715ab6742b","077BDC90-1BBD-49EC-93A5-729B1AC1BA8D","Uterine Corpus Endometrial Carcinoma","TARGZ","AC1F6B84-E195-46F2-A9EC-AB75565CE486","2013-09-11T07:02:01.000Z","F801EC7C-C5D2-46B1-BAE8-BF564E59087E","United States","NO",1,NA,"Primary Tumor","Roswell Park",189,"AC1F6B84-E195-46F2-A9EC-AB75565CE486",NA,"E6","NULLS_p_TCGA_183_185_186_SNP_N_GenomeWideSNP_6_E07_914172.raw.copynumber.data.txt",230,"TCGA-E6-A2P9-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","FFB3442C-ED45-46C1-814D-C76B30143F78",65,"nationwidechildrens.org_clinical.TCGA-E6-A2P9.xml","Alive",NA,"TCGA-E6-A2P9","NOT HISPANIC OR LATINO","EC90A893-2056-4CB4-BA6A-CC908D046442",NA,203,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,"D81F2184-D052-402A-BE16-475CAD2C414D","WHITE",NA,11,30,"9774FA25-45D4-4D09-9C0C-69F2AEE08602","1567ABF4-C8EC-474B-BFE1-66CDE116B9B4","E6-A2P9-10B-01D_BCR3730_2012-02-28_008.fsa","TCGA-E6-A2P9-01A-11",96,0,0,3,5,"TOP",0,0,"TCGA-E6-A2P9-01A-01-TSA",95,NA,NA,NA,"TCGA-E6-A2P9-R45645","Internal","Primary Tumor Field","TCGA-E6-A2P9-F68580_NTE-1",NA,1386,NA,"Alive",NA,"TCGA-E6-A2P9-F68580","TCGA-E6-A2P9",1,"E6","A2P9","YES","C54.1","8380/3","C54.1","NO","YES",-24088,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",203,NA,NA,NA,"TUMOR FREE","NO",21,12,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29915704,29157782,2189894415,"B3029936-1EEF-4378-AA28-D5B2A32CDC86.bw","07b24a23-3d9f-4591-800f-8738cc232f9a","b3029936-1eef-4378-aa28-d5b2a32cdc86","2016-08-06T17:56:20.174651-05:00","UNCID_2194482.d262b256-5452-4df1-9526-9a1b11da775f.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_2.tar.gz","fa172a8c-bae0-4263-868d-46aa3a095b7b",1877994943,"Illumina GA","f0166714cf542ee221ae25b25937f90a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:38:22.749633-05:00","2016-05-03T11:07:49.533431-05:00","fa172a8c-bae0-4263-868d-46aa3a095b7b_analysis.xml","0292fb57cea1b373ff7789465b0f9de9","04255819-3fab-4a53-a10c-2421f1581ba4",2121,"2016-10-07T16:06:40.269355-05:00","fa172a8c-bae0-4263-868d-46aa3a095b7b_experiment.xml","452299872dc6d4666556d4344321d020","0351efb3-83da-4627-a209-1a7efbd21388",2258,"2016-09-29T21:10:11.219195-05:00","fa172a8c-bae0-4263-868d-46aa3a095b7b_run.xml","9c4b2f6f77794d8774e4cc4acc74647e","886f27eb-4679-4d6f-88e2-1d398c263f1c",349,"2016-09-08T11:04:15.627906-05:00","TCGA-B5-A11L","2016-09-02T18:51:47.305564-05:00","female","TCGA-B5-A11L_demographic",1936,"white","1ed66275-6c77-5a3c-9c2f-beae4c94d66f","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11L_diagnosis","not reported",26120,"dead","8380/3",2240,1396,"708bf6ee-ba97-507f-b1b3-3b4a66d91444","c54.1",-26120,"TCGA-B5-A11L_treatment","fdc31081-01fe-5709-a770-61d7a84f6f05","01","true","TCGA-B5-A11L-01B",NA,"790ace35-d090-4933-bd57-5efc61889c85",FALSE,"ABA26FE8-0C80-459A-9DF8-537D1A08A92E","Primary Tumor",NA,1297,90,NA,1300060800,"21",20,"TCGA-B5-A11L-01B-21",70,NA,3,NA,0,NA,30,NA,"2016-09-08T11:04:15.627906-05:00",NA,15,NA,3,NA,"TOP",NA,3,NA,"3fa9d2d1-14f1-44fd-bcbb-0afd20eee75b",NA,"TCGA-B5-A11L-01B-02-TSB",NA,67,NA,"1c0549c7-5b9a-404e-8831-bb38bf268b2e","RNA","TCGA-B5-A11L-01B-21R","2344201a-e4ba-4905-8599-00f4c5a0892f",1.95,0.16,"UV Spec","R","23","TCGA-B5-A11L-01B-21R-A13S-07","d262b256-5452-4df1-9526-9a1b11da775f",0.16,NA,92,34.626820730927,163,"0b518b72-5dfa-5a37-a99c-a27a7a9d5b6d","TCGA-B5-A11L_exposure","UNCID_2194482.d262b256-5452-4df1-9526-9a1b11da775f.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_2.tar.gz","2013-09-22T23:36:04.000Z","2013-09-22T23:48:02.000Z","FA172A8C-BAE0-4263-868D-46AA3A095B7B","790ACE35-D090-4933-BD57-5EFC61889C85","Unaligned reads",1877994943,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","D262B256-5452-4DF1-9526-9A1B11DA775F","University of North Carolina","56607db4e4b0b37b3d992d0b","07B24A23-3D9F-4591-800F-8738CC232F9A","Uterine Corpus Endometrial Carcinoma","TARGZ","1C0549C7-5B9A-404E-8831-BB38BF268B2E","2013-09-22T23:48:02.000Z","2344201A-E4BA-4905-8599-00F4C5A0892F","United States","NO",1,NA,"Primary Tumor","Duke",1297,"1C0549C7-5B9A-404E-8831-BB38BF268B2E",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8D1A88C2-9AD4-4A1B-80CE-864D78A2089A.txt",90,"TCGA-B5-A11L-01B",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","FECACE4B-9DEE-4C13-A339-49D9BFFBE4BB",71,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8D1A88C2-9AD4-4A1B-80CE-864D78A2089A.txt","Alive",NA,"TCGA-B5-A11L",NA,"67768C42-4137-4ED0-B058-D8A1B8F697C9",NA,1396,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,"1B350472-8A96-4539-9872-A6D14D8D5862","WHITE",NA,21,20,"3FA9D2D1-14F1-44FD-BCBB-0AFD20EEE75B","E4BDB8FD-B583-46FD-AA58-9A5BE732A7DD","UNCID_1604214.d262b256-5452-4df1-9526-9a1b11da775f.sorted_genome_alignments.bam.bai","TCGA-B5-A11L-01B-21",70,0,3,15,30,"TOP",3,3,"TCGA-B5-A11L-01B-02-TSB",67,NA,NA,NA,"TCGA-B5-A11L-R14740","COMBINATION","Regional site","TCGA-B5-A11L-F37005_NTE-1","YES",NA,NA,"Dead",2240,"TCGA-B5-A11L-F37005","TCGA-B5-A11L",1,"B5","A11L","YES","C54.1","8380/3","C54.1","NO","YES",-26120,"FEMALE","WHITE",NA,"No","No","Alive",1396,NA,NA,NA,"TUMOR FREE","NO",9,8,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,71,2007,"Dilation and curettage procedure",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
150954146,149152802,7122223538,"39A9B95F-186B-4550-9271-001151B1A626.bw","07c805c2-ff09-4d5a-95f8-1d7d9f84c33c","39a9b95f-186b-4550-9271-001151b1a626","2016-08-09T13:14:26.918223-05:00","UNCID_2173317.10c76952-15aa-44e9-8197-26529889bb6a.130502_UNC12-SN629_0289_AC236KACXX_8_ACTGAT.tar.gz","427c3ba1-3eb2-4a38-b4b8-12ade25ce644",7107768262,"Illumina HiSeq","0eaa67271cbe1a79bb8af45d5df00e0d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:07:19.164885-05:00","2016-05-03T10:55:55.610281-05:00","427c3ba1-3eb2-4a38-b4b8-12ade25ce644_analysis.xml","7925940158ba6c2c5bec218979aff7d2","3c4e2579-5b4c-46d2-a8ad-18d25c2c5e22",2123,"2016-09-29T19:01:37.382715-05:00","427c3ba1-3eb2-4a38-b4b8-12ade25ce644_experiment.xml","3e67ebea22ca096016462145c2efe01a","389de0e1-b115-4346-ad04-9d227317fb46",2431,"2016-09-29T23:47:26.169246-05:00","427c3ba1-3eb2-4a38-b4b8-12ade25ce644_run.xml","e12cade9e5ef6500b54ff1652bb78937","e9eb8241-4a70-4ac7-a108-2d6bb99e1262",354,"2016-09-08T11:57:51.176518-05:00","TCGA-D1-A3JQ","2016-09-02T18:49:26.323839-05:00","female","TCGA-D1-A3JQ_demographic",1950,"white","95fd1298-1173-577a-ad75-1755f2ea7291","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A3JQ_diagnosis","not reported",22297,"alive","8441/3",NA,526,"65a1716c-81fe-5861-8c2e-3b5efd86410a","c54.1",-22297,"TCGA-D1-A3JQ_treatment","ae83943f-8697-5029-adb3-d384e8911b45","01","true","TCGA-D1-A3JQ-01A",NA,"720b03f2-b46f-43a0-9ab0-fb0734e691f1",FALSE,"2001A1EC-1385-4EB3-BC9E-7E48143FD663","Primary Tumor",NA,77,150,NA,1325030400,"11",30,"TCGA-D1-A3JQ-01A-11",75,NA,8,NA,0,NA,25,NA,"2016-09-08T11:57:51.176518-05:00",NA,15,NA,5,NA,"TOP",NA,5,NA,"f375aa8a-10e9-47d6-b5a7-1fc0d0f567c3",NA,"TCGA-D1-A3JQ-01A-01-TSA",NA,70,NA,"6443fe4a-c1dc-4c13-815c-d437ffbfbc81","RNA","TCGA-D1-A3JQ-01A-11R","7e3259a4-3745-49de-88ac-1c2ab0215edb",1.79,0.17,"UV Spec","R","23","TCGA-D1-A3JQ-01A-11R-A22K-07","10c76952-15aa-44e9-8197-26529889bb6a",0.17,NA,121,46.6802978280159,161,"628ff40d-2571-5c5a-8f90-cf698fe3730b","TCGA-D1-A3JQ_exposure","UNCID_2173317.10c76952-15aa-44e9-8197-26529889bb6a.130502_UNC12-SN629_0289_AC236KACXX_8_ACTGAT.tar.gz","2013-09-09T16:56:09.000Z","2013-09-09T17:18:02.000Z","427C3BA1-3EB2-4A38-B4B8-12ADE25CE644","720B03F2-B46F-43A0-9AB0-FB0734E691F1","Unaligned reads",7107768262,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","10C76952-15AA-44E9-8197-26529889BB6A","University of North Carolina","564a35cee4b0298dd2c69c6b","07C805C2-FF09-4D5A-95F8-1D7D9F84C33C","Uterine Corpus Endometrial Carcinoma","TARGZ","6443FE4A-C1DC-4C13-815C-D437FFBFBC81","2013-09-09T17:18:02.000Z","7E3259A4-3745-49DE-88AC-1C2AB0215EDB","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",77,"6443FE4A-C1DC-4C13-815C-D437FFBFBC81",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.1EE04796-47C3-4BC2-8316-36ED0C56C6BB.txt",150,"TCGA-D1-A3JQ-01A",NA,"CD25CB70-0A77-4D34-BA51-EDAC23F112FA","TCGA",2011,"TCGA-D1-A3JQ_NTE-1","Complete Remission/Response","TUMOR FREE","720B03F2-B46F-43A0-9AB0-FB0734E691F1",61,"nationwidechildrens.org_clinical.TCGA-D1-A3JQ.xml","Alive",NA,"TCGA-D1-A3JQ","NOT HISPANIC OR LATINO","0145CE08-DC4E-4D41-B75F-BA5B62A065B3","NO",526,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"C56DCCC5-D710-4D2D-8C0C-DFE484BBB299","WHITE",NA,11,30,"F375AA8A-10E9-47D6-B5A7-1FC0D0F567C3","CBE91E65-0F4D-4307-9CB1-3A5CA90F214E","TCGA-D1-A3JQ-01A-11R-A22I-13_mirna.bam","TCGA-D1-A3JQ-01A-11",75,0,8,15,25,"TOP",5,5,"TCGA-D1-A3JQ-01A-01-TSA",70,"Paclitaxel","Chemotherapy","TCGA-D1-A3JQ-D41414","TCGA-D1-A3JQ-R41517","External","Regional site","TCGA-D1-A3JQ-F41416_NTE-1","NO",526,"TUMOR FREE","Alive",NA,"TCGA-D1-A3JQ-F41416","TCGA-D1-A3JQ",1,"D1","A3JQ","YES","C54.1","8441/3","C54.1","NO","YES",-22297,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",526,NA,"YES","YES","TUMOR FREE","YES",19,3,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,61,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28621089,27825171,2088764268,"536FEED2-6251-41BC-AA61-EA46744EAB05.bw","07d1aef3-31c7-4c44-a078-16a9eb096d58","536feed2-6251-41bc-aa61-ea46744eab05","2016-08-10T21:44:45.171181-05:00","UNCID_2207687.c5d7f9d3-70d3-469d-8588-5a125a24efa3.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_1.tar.gz","b4c9feef-8400-440a-b148-3b3708cbba3d",1828704411,"Illumina GA","85b1b93339ed37bb3405e147d905ba43","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:17:31.421932-05:00","2016-05-03T11:14:23.401440-05:00","b4c9feef-8400-440a-b148-3b3708cbba3d_analysis.xml","972759f64154a2e8948a35ce35a9f58d","fc5f6e3c-e337-437e-bdea-9fabb7368fda",2120,"2016-09-29T21:35:46.190115-05:00","b4c9feef-8400-440a-b148-3b3708cbba3d_experiment.xml","194eea5fd4d86ed45dce46decd58fcc8","98362198-c73c-4b91-9351-1d418c4a1f98",2257,"2016-09-29T18:55:23.039395-05:00","b4c9feef-8400-440a-b148-3b3708cbba3d_run.xml","7bc06df01775dacfe6dc2a4301020a74","34c7ec18-7e18-4e9e-90cc-662bf33b3e6e",347,"2016-09-08T10:50:18.958195-05:00","TCGA-AP-A1DH","2016-09-02T18:51:23.196884-05:00","female","TCGA-AP-A1DH_demographic",1943,"white","a0172345-d345-5bd2-b785-7f054781a0fe","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1DH_diagnosis","not reported",22652,"alive","8380/3",NA,2180,"8cbd7dd9-f707-56af-ac1b-85833817d15f","c54.1",-22652,"TCGA-AP-A1DH_treatment","88d7374c-c7c5-592f-8902-6d0c75bdcdcd","01","true","TCGA-AP-A1DH-01A",NA,"da4b6bf2-0e9d-495a-8220-93359d2afa67",FALSE,"B77EE1CD-716C-4441-B4A9-CCCC37BD1379","Primary Tumor",NA,1843,150,NA,1296086400,"31",30,"TCGA-AP-A1DH-01A-31",80,NA,0,NA,0,NA,0,NA,"2016-09-08T10:50:18.958195-05:00",NA,0,NA,0,NA,"TOP",NA,15,NA,"406241a4-f5e7-404a-99b6-a2cab4029025",NA,"TCGA-AP-A1DH-01A-03-TSC",NA,85,NA,"f1e0f761-a45b-48a0-bed6-9861369c50b4","RNA","TCGA-AP-A1DH-01A-31R","66fed9ce-e05b-462c-91bb-4b756a0f6f8a",1.95,0.17,"UV Spec","R","23","TCGA-AP-A1DH-01A-31R-A137-07","c5d7f9d3-70d3-469d-8588-5a125a24efa3",0.17,NA,127,44.9971655328798,168,"69e79316-783f-5c93-92a6-2fd795d7937a","TCGA-AP-A1DH_exposure","UNCID_2207687.c5d7f9d3-70d3-469d-8588-5a125a24efa3.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_1.tar.gz","2013-09-30T04:43:15.000Z","2013-09-30T04:55:02.000Z","B4C9FEEF-8400-440A-B148-3B3708CBBA3D","DA4B6BF2-0E9D-495A-8220-93359D2AFA67","Unaligned reads",1828704411,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C5D7F9D3-70D3-469D-8588-5A125A24EFA3","University of North Carolina","564a33eee4b0298dd2c6026d","07D1AEF3-31C7-4C44-A078-16A9EB096D58","Uterine Corpus Endometrial Carcinoma","TARGZ","F1E0F761-A45B-48A0-BED6-9861369C50B4","2013-09-30T04:55:02.000Z","66FED9CE-E05B-462C-91BB-4B756A0F6F8A","None","NO",1,NA,"Primary Tumor","MSKCC",1843,"F1E0F761-A45B-48A0-BED6-9861369C50B4",NA,"AP","UNCID_408750.TCGA-AP-A1DH-01A-31R-A137-07.110628_UNC6-RDR300211_00110_FC_70K9TAAXX.1.trimmed.annotated.translated_to_genomic.exon.quantification.txt",150,"TCGA-AP-A1DH-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","DA4B6BF2-0E9D-495A-8220-93359D2AFA67",62,"nationwidechildrens.org_clinical.TCGA-AP-A1DH.xml","Alive",NA,"TCGA-AP-A1DH",NA,"30243D03-5A07-4EE6-8D69-94461553DAAE",NA,1816,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"8B7B20DB-46FF-4133-B251-EFCF06FDA9A2","WHITE",NA,31,30,"406241A4-F5E7-404A-99B6-A2CAB4029025","BD6BBEDA-0978-4B33-B446-D56001AAAE12","UNCID_1626100.c5d7f9d3-70d3-469d-8588-5a125a24efa3.sorted_genome_alignments.bam.bai","TCGA-AP-A1DH-01A-31",80,0,0,0,0,"TOP",15,0,"TCGA-AP-A1DH-01A-03-TSC",85,NA,NA,NA,"TCGA-AP-A1DH-R13622","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"NO",2180,"TUMOR FREE","Alive",NA,"TCGA-AP-A1DH-F29050","TCGA-AP-A1DH",1,"AP","A1DH","YES","C54.1","8380/3","C54.1","NO","YES",-22652,"FEMALE","WHITE",NA,"No","No","Alive",1816,NA,NA,NA,"TUMOR FREE","NO",9,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30507919,30116480,2255553435,"AA26E72A-924D-423E-90F6-96C67A7DFBBE.bw","082e32c5-7f82-466a-b52d-a3293a8f8e57","aa26e72a-924d-423e-90f6-96c67a7dfbbe","2016-08-04T21:27:30.113687-05:00","UNCID_2214399.578f3ec4-17e0-4cf9-bfa8-56624d174374.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_3.tar.gz","131d8758-7577-4589-9be3-034f67b390a3",1892951004,"Illumina GA","d275df79c4cfbd067134eb581c21346e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:40:15.027860-05:00","2016-05-03T11:17:14.896869-05:00","131d8758-7577-4589-9be3-034f67b390a3_analysis.xml","d22987e887a3a5e98ba02182f5465a6f","0559fcf6-0ca9-4038-82a7-89bf044942a2",2121,"2016-09-29T18:06:39.342656-05:00","131d8758-7577-4589-9be3-034f67b390a3_experiment.xml","997d9c17775d92ce16583c9755033455","163d0a0f-747a-43b9-a28a-07a2f37b7b0b",2257,"2016-09-29T23:47:19.294661-05:00","131d8758-7577-4589-9be3-034f67b390a3_run.xml","2db62398c317ca8818372403cd69d282","e9dd3ed0-96f9-43a2-ad05-22bf4a889f37",347,"2016-09-08T11:51:20.807146-05:00","TCGA-BG-A0MT","2016-09-02T18:48:08.725564-05:00","female","TCGA-BG-A0MT_demographic",1945,"white","4d444b66-2a61-5097-8234-82701fa74420","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MT_diagnosis","not reported",23574,"alive","8380/3",NA,644,"c00a7e30-e559-5fe1-afb0-4c86b798c6f3","c54.1",-23574,"TCGA-BG-A0MT_treatment","01012744-f996-5de6-92e4-8b7a2748ae4e","01","true","TCGA-BG-A0MT-01A",NA,"91f629f5-6938-4f5c-ba2e-1f519ce6b255",FALSE,"89610F48-AC0D-431D-8A9E-FC9E51CF8FC0","Primary Tumor",NA,344,820,NA,1279065600,"11",30,"TCGA-BG-A0MT-01A-11",85,85,3,5,0,0,3,9,"2016-09-08T11:51:20.807146-05:00","2016-09-08T11:51:20.807146-05:00",6,7,0,1,"TOP","BOTTOM",1,1,"8c5de964-11ad-45c0-8934-e0ea8709cc6e","70501f20-6431-488c-a5c3-b8c6204c3815","TCGA-BG-A0MT-01A-01-TSA","TCGA-BG-A0MT-01A-01-BSA",96,90,"e425c3fc-14c3-411b-8c37-c88c81e18af9","RNA","TCGA-BG-A0MT-01A-11R","90d8cc09-2030-4722-a297-86c0b21a9374",1.91,0.14,"UV Spec","R","23","TCGA-BG-A0MT-01A-11R-A104-07","578f3ec4-17e0-4cf9-bfa8-56624d174374",0.14,NA,73,25.8645124716553,168,"1734a103-cfca-587e-9438-f68d00dbb2ee","TCGA-BG-A0MT_exposure","UNCID_2214399.578f3ec4-17e0-4cf9-bfa8-56624d174374.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_3.tar.gz","2013-10-03T15:31:04.000Z","2013-10-03T15:43:02.000Z","131D8758-7577-4589-9BE3-034F67B390A3","91F629F5-6938-4F5C-BA2E-1F519CE6B255","Unaligned reads",1892951004,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","578F3EC4-17E0-4CF9-BFA8-56624D174374","University of North Carolina","564a349de4b08c5d868f583c","082E32C5-7F82-466A-B52D-A3293A8F8E57","Uterine Corpus Endometrial Carcinoma","TARGZ","E425C3FC-14C3-411B-8C37-C88C81E18AF9","2013-10-03T15:43:02.000Z","90D8CC09-2030-4722-A297-86C0B21A9374","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",344,"E425C3FC-14C3-411B-8C37-C88C81E18AF9",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9170FA52-8CC4-465C-8DE7-94199FF1E4E4.txt",820,"TCGA-BG-A0MT-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","91F629F5-6938-4F5C-BA2E-1F519CE6B255",64,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9170FA52-8CC4-465C-8DE7-94199FF1E4E4.txt","Alive",NA,"TCGA-BG-A0MT","NOT HISPANIC OR LATINO","95FB09AA-375C-4972-8E14-29DC06191F8D",NA,240,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,11,30,"8C5DE964-11AD-45C0-8934-E0EA8709CC6E","C7BB2500-9053-4E54-9E8F-C89A1CBE34C9","UNCID_362785.TCGA-BG-A0MT-01A-11R-A104-07.110208_UNC2-RDR300275_00049_FC_62J3VAAXX.3.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-BG-A0MT-01A-11",85,0,3,6,3,"TOP",1,0,"TCGA-BG-A0MT-01A-01-TSA",96,NA,NA,NA,NA,NA,NA,NA,"YES",644,"TUMOR FREE","Alive",NA,"TCGA-BG-A0MT-F19318","TCGA-BG-A0MT",1,"BG","A0MT","YES","C54.1","8380/3","C54.1","NO","YES",-23574,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",240,NA,NA,NA,"TUMOR FREE","NO",9,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
111791932,109852457,5236493036,"A8E11B1B-B6CD-4723-8042-AB86B044AD8D.bw","0878e44d-bdc8-4d5f-9bf4-31101f14f797","a8e11b1b-b6cd-4723-8042-ab86b044ad8d","2016-08-09T13:15:40.825599-05:00","UNCID_2177832.8025c2b5-a137-4c88-9ac4-cc4be43e4f25.130402_UNC10-SN254_0447_BC22WAACXX_6_TAGCTT.tar.gz","979abeb1-38f2-4d2e-8a8a-deef815b57c7",4704718086,"Illumina HiSeq","34d90387239e68d8b743982a9634cdef","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:52:11.358323-05:00","2016-05-03T10:56:47.890899-05:00","979abeb1-38f2-4d2e-8a8a-deef815b57c7_analysis.xml","dc4875b5b3a71ffd1ae16d3950730448","0d0e41cd-62fe-4786-9a90-63dff8615d87",2122,"2016-08-13T09:32:45.108752-05:00","979abeb1-38f2-4d2e-8a8a-deef815b57c7_experiment.xml","6f45c90c7094887bdc5b3f3f578ad923","ca8ecd01-924b-4144-9159-7d7351862ec2",2431,"2016-09-29T20:47:17.516011-05:00","979abeb1-38f2-4d2e-8a8a-deef815b57c7_run.xml","b271d4bb202cd2384932c76ad34d98fe","7a036e04-9d4b-49c7-a8ad-6cca1562cdc1",354,"2016-09-08T10:27:30.342745-05:00","TCGA-EO-A3AY","2016-09-02T18:47:56.909314-05:00","female","TCGA-EO-A3AY_demographic",1953,"not reported","6fd6df70-ae97-57fd-97f6-997004450695","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3AY_diagnosis","not reported",21291,"alive","8380/3",NA,1158,"063e134c-a2d4-54d2-ab38-c1a92c528dc1","c54.1",-21291,"TCGA-EO-A3AY_treatment","ab0cdeb3-034c-5006-afe9-3964d0eda6f7","01","false","TCGA-EO-A3AY-01A",NA,"47bf70a1-6738-495f-9e61-92feaf33c28c",FALSE,"330AEFE0-D564-4799-8928-B05280BACA91","Primary Tumor",NA,227,150,NA,1317686400,"12",20,"TCGA-EO-A3AY-01A-12",90,NA,0,NA,0,NA,8,NA,"2016-09-08T10:27:30.342745-05:00",NA,0,NA,0,NA,"TOP",NA,2,NA,"faa2afb3-619a-41e0-ac2d-13b910845187",NA,"TCGA-EO-A3AY-01A-01-TSA",NA,90,NA,"346e1b39-e960-4f14-805d-5c1c14fc5ff1","RNA","TCGA-EO-A3AY-01A-12R","026f6965-6363-417e-b4a8-1c8c57de1fca",1.84,0.16,"UV Spec","R","23","TCGA-EO-A3AY-01A-12R-A19W-07","8025c2b5-a137-4c88-9ac4-cc4be43e4f25",0.16,NA,76,28.256989886972,164,"f4db310b-c3ac-5116-af33-3bfb83aa14db","TCGA-EO-A3AY_exposure","UNCID_2177832.8025c2b5-a137-4c88-9ac4-cc4be43e4f25.130402_UNC10-SN254_0447_BC22WAACXX_6_TAGCTT.tar.gz","2013-09-11T07:16:09.000Z","2013-09-11T07:31:01.000Z","979ABEB1-38F2-4D2E-8A8A-DEEF815B57C7","47BF70A1-6738-495F-9E61-92FEAF33C28C","Unaligned reads",4704718086,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8025C2B5-A137-4C88-9AC4-CC4BE43E4F25","University of North Carolina","564a3ca0e4b0ef12181ad4b5","0878E44D-BDC8-4D5F-9BF4-31101F14F797","Uterine Corpus Endometrial Carcinoma","TARGZ","346E1B39-E960-4F14-805D-5C1C14FC5FF1","2013-09-11T07:31:01.000Z","026F6965-6363-417E-B4A8-1C8C57DE1FCA","Canada","NO",1,NA,"Primary Tumor","University Health Network",227,"346E1B39-E960-4F14-805D-5C1C14FC5FF1",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.018AE6E3-62FC-46D9-95F5-F114322C89D4.txt",150,"TCGA-EO-A3AY-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","77C21664-37EC-405A-907C-EE0C6B2092A6",58,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.018AE6E3-62FC-46D9-95F5-F114322C89D4.txt","Alive",NA,"TCGA-EO-A3AY",NA,"F7C21DDD-DD47-40EA-AFDC-92C1508D0AD6",NA,392,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,NA,NA,12,20,"FAA2AFB3-619A-41E0-AC2D-13B910845187","222AA549-3E80-4D28-AB85-41FD37CEF793","ea8aad322147646e8227904f45b68ab3.bam","TCGA-EO-A3AY-01A-12",90,0,0,0,8,"TOP",2,0,"TCGA-EO-A3AY-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,"TCGA-EO-A3AY-F38252_NTE-1","NO",523,"TUMOR FREE","Alive",NA,"TCGA-EO-A3AY-F38252","TCGA-EO-A3AY",1,"EO","A3AY","YES","C54.1","8380/3","C54.1",NA,"YES",-21291,"FEMALE",NA,NA,"No","No","Alive",392,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
19211092,17700186,1334559177,"5ACFF57E-8B40-4A68-98B9-1F80D80B3F00.bw","08b11e0e-5b8e-45ea-9b6b-30e3185b03d7","5acff57e-8b40-4a68-98b9-1f80d80b3f00","2016-08-05T05:18:21.955823-05:00","UNCID_2216304.63ba785b-9345-4cc3-b0af-a1a1d45b59b3.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_6.tar.gz","2cb3d1d6-c3ea-48a3-ae5f-1f29bdf8f5e4",1133016570,"Illumina GA","d621ef422139203b96a4a976e6fdc228","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:12:56.856913-05:00","2016-05-03T11:18:47.010651-05:00","2cb3d1d6-c3ea-48a3-ae5f-1f29bdf8f5e4_analysis.xml","baf69e034b2b4ecf7b1006dd51135382","8a29a5e8-fdfe-48ce-bd05-879125b381a4",2119,"2016-09-29T23:05:35.170183-05:00","2cb3d1d6-c3ea-48a3-ae5f-1f29bdf8f5e4_experiment.xml","428de21a7e3878b155dddf6e8946b79c","cfcea75e-64ea-4461-a432-bcb49f02e9e5",2256,"2016-09-30T00:12:29.345978-05:00","2cb3d1d6-c3ea-48a3-ae5f-1f29bdf8f5e4_run.xml","d265a7e73833a46b3dc9ac4ccd403f04","f93ce007-b903-42d8-8be1-1e7e96d94657",345,"2016-09-08T10:36:46.982525-05:00","TCGA-AP-A05N","2016-09-02T18:52:41.893344-05:00","female","TCGA-AP-A05N_demographic",1951,"white","04149f27-e7a1-546d-816b-906f65010536","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A05N_diagnosis","not reported",21254,"dead","8380/3",726,239,"0d8675f4-8c52-557b-a5c1-7e8f13b5e3e1","c54.1",-21254,"TCGA-AP-A05N_treatment","753da8f8-9301-5718-a4ae-94f838f7f76c","01","true","TCGA-AP-A05N-01A",NA,"67a90941-d6ec-4465-a727-7193504c8982",FALSE,"E4FF43F2-5CBD-4B68-9CD5-BE4E84AD67D5","Primary Tumor",NA,232,350,NA,1275955200,"11",30,"TCGA-AP-A05N-01A-11",65,75,10,5,0,0,30,20,"2016-09-08T10:36:46.982525-05:00","2016-09-08T10:36:46.982525-05:00",15,20,20,10,"TOP","BOTTOM",5,5,"69e97962-4160-47d8-90ec-cabace0aa478","c3c8530a-5143-4878-8077-2e00ab18e09e","TCGA-AP-A05N-01A-01-TS1","TCGA-AP-A05N-01A-01-BS1",65,75,"51bd6de3-87aa-4440-b64f-fcd6928bcf87","RNA","TCGA-AP-A05N-01A-11R","5f722a1c-54bb-49da-a24f-a5aa6e020dc7",1.8,0.14,"UV Spec","R","23","TCGA-AP-A05N-01A-11R-A00V-07","63ba785b-9345-4cc3-b0af-a1a1d45b59b3",0.14,NA,123,46.8678555098308,162,"f33d9c15-8838-5df2-aaad-623ba88d7cbd","TCGA-AP-A05N_exposure","UNCID_2216304.63ba785b-9345-4cc3-b0af-a1a1d45b59b3.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_6.tar.gz","2013-10-04T07:55:04.000Z","2013-10-04T08:07:02.000Z","2CB3D1D6-C3EA-48A3-AE5F-1F29BDF8F5E4","67A90941-D6EC-4465-A727-7193504C8982","Unaligned reads",1133016570,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","63BA785B-9345-4CC3-B0AF-A1A1D45B59B3","University of North Carolina","566078abe4b0ca319164ed23","08B11E0E-5B8E-45EA-9B6B-30E3185B03D7","Uterine Corpus Endometrial Carcinoma","TARGZ","51BD6DE3-87AA-4440-B64F-FCD6928BCF87","2013-10-04T08:07:02.000Z","5F722A1C-54BB-49DA-A24F-A5AA6E020DC7","None","NO",1,NA,"Primary Tumor","MSKCC",232,"51BD6DE3-87AA-4440-B64F-FCD6928BCF87",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E5EB1353-69A4-4A11-BB90-B4C98225B1DA.txt",350,"TCGA-AP-A05N-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","CD4BBA71-27A0-4A69-8DB3-C6045AD573EC",58,"nationwidechildrens.org_clinical.TCGA-AP-A05N.xml","Alive",NA,"TCGA-AP-A05N",NA,"432BE0EF-06EF-4CF8-8709-EC358052BF63",NA,239,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,"4F690DDF-BBE6-457D-9FFD-9A3858EF1BD9","WHITE",NA,11,30,"C3C8530A-5143-4878-8077-2E00AB18E09E","8D554516-F9ED-4CC0-8C00-F02A2AE8ED9A","UNCID_1610902.63ba785b-9345-4cc3-b0af-a1a1d45b59b3.sorted_genome_alignments.bam.bai","TCGA-AP-A05N-01A-11",65,0,10,15,30,"TOP",5,20,"TCGA-AP-A05N-01A-01-TS1",65,NA,NA,NA,"TCGA-AP-A05N-R3498","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"NO",NA,"TUMOR FREE","Dead",726,"TCGA-AP-A05N-F16693","TCGA-AP-A05N",1,"AP","A05N","YES","C54.1","8380/3","C54.1","NO","YES",-21254,"FEMALE","WHITE",NA,"No","No","Alive",239,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
14160334,13814776,1039613295,"383EF488-AA5B-432F-93B4-C136E4AA9A74.bw","09066fbf-6a1d-46c9-a4c5-c53340c3d1ba","383ef488-aa5b-432f-93b4-c136e4aa9a74","2016-08-09T14:15:24.732930-05:00","UNCID_2211384.8edc23c4-43f8-4dd3-8c40-257297393492.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_3.tar.gz","f769d54e-8963-410b-b7da-09ebd42a3329",835324221,"Illumina GA","b36df0df92bd49ad99056dbd9e095d30","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:12:46.380758-05:00","2016-05-03T11:16:29.221188-05:00","f769d54e-8963-410b-b7da-09ebd42a3329_analysis.xml","371ac8788a6ab6f4f7cf22057375ff5f","af1c0db5-4043-4a6c-9d15-1b5a2ad88019",2121,"2016-09-29T19:36:01.057178-05:00","f769d54e-8963-410b-b7da-09ebd42a3329_experiment.xml","550d1ce41525e6dd0d9fb733ddf40344","4e3de942-d406-4d8b-b788-ce47d54e7e6f",2257,"2016-09-29T23:39:30.830329-05:00","f769d54e-8963-410b-b7da-09ebd42a3329_run.xml","335f57b373f2266c4255ce6cf1a5c681","e4eb7c98-dde5-4d40-9087-ad51d4d5a494",347,"2016-09-08T10:40:03.731808-05:00","TCGA-BS-A0TE","2016-09-02T18:48:24.159976-05:00","female","TCGA-BS-A0TE_demographic",1970,"asian","23a46023-c970-5abe-aaaf-3bdc2e5b5cdb","not hispanic or latino",2005,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.9","TCGA-BS-A0TE_diagnosis","not reported",12983,"dead","8380/3",146,NA,"d5fa3d4b-bfb9-5720-8ce5-6dfeab7ef6a1","c54.9",-12983,"TCGA-BS-A0TE_treatment","603f066d-4e7e-52c4-a1f1-2fbe9a5366d7","01","false","TCGA-BS-A0TE-01A",NA,"2d1226a1-1c88-422b-9a8d-316bebeb65fd",FALSE,"8FD57BC9-19A1-4427-B68F-3E58639FEA40","Primary Tumor",NA,1835,50,NA,1282089600,"11",20,"TCGA-BS-A0TE-01A-11",85,80,20,20,0,0,5,10,"2016-09-08T10:40:03.731808-05:00","2016-09-08T10:40:03.731808-05:00",40,40,30,30,"BOTTOM","TOP",10,10,"6c8d0b82-77de-42e1-8513-fdd133c95db4","f7dc183e-d3f4-4c00-8b8d-2ab62af3bd83","TCGA-BS-A0TE-01A-01-BS1","TCGA-BS-A0TE-01A-01-MS1",85,80,"17623c7f-c680-4822-b893-5a4a9f8dda1b","RNA","TCGA-BS-A0TE-01A-11R","0da9ed06-b23b-47aa-9f9b-72f2566be73e",1.82,0.16,"UV Spec","R","23","TCGA-BS-A0TE-01A-11R-A104-07","8edc23c4-43f8-4dd3-8c40-257297393492",0.16,NA,91,32.2420634920635,168,"4894509c-6db8-53f0-9707-4932f8f9ca69","TCGA-BS-A0TE_exposure","UNCID_2211384.8edc23c4-43f8-4dd3-8c40-257297393492.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_3.tar.gz","2013-10-02T22:01:04.000Z","2013-10-02T22:24:01.000Z","F769D54E-8963-410B-B7DA-09EBD42A3329","2D1226A1-1C88-422B-9A8D-316BEBEB65FD","Unaligned reads",835324221,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8EDC23C4-43F8-4DD3-8C40-257297393492","University of North Carolina","566073dbe4b016715ab66cd9","09066FBF-6A1D-46C9-A4C5-C53340C3D1BA","Uterine Corpus Endometrial Carcinoma","TARGZ","17623C7F-C680-4822-B893-5A4A9F8DDA1B","2013-10-02T22:24:02.000Z","0DA9ED06-B23B-47AA-9F9B-72F2566BE73E","None","NO",1,NA,"Primary Tumor","University of Hawaii",1835,"17623C7F-C680-4822-B893-5A4A9F8DDA1B",NA,"BS","TCGA-BS-A0TE-01A-11D-A10B-09_IlluminaGA-DNASeq_exome_1.bam",50,"TCGA-BS-A0TE-01A",NA,"9F6DE715-E2EF-462C-ADF2-EB96C3DB806E","TCGA",2005,NA,NA,"WITH TUMOR","2D1226A1-1C88-422B-9A8D-316BEBEB65FD",35,"nationwidechildrens.org_clinical.TCGA-BS-A0TE.xml","Dead",146,"TCGA-BS-A0TE","NOT HISPANIC OR LATINO","647F6BA1-E59B-41C8-9885-F4B78E9FD75F",NA,NA,"No","Uterus","C54.9",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.9",73,NA,"16A4A2D5-499E-482E-A2CF-85B0C18469BC","ASIAN",NA,11,20,"F7DC183E-D3F4-4C00-8B8D-2AB62AF3BD83","F73A0E1C-B008-4FB4-80A2-62C1DF57F6C0","30e285b326196b3c05f1a202424a5b2f.bam.bai","TCGA-BS-A0TE-01A-11",80,0,20,40,10,"TOP",10,30,"TCGA-BS-A0TE-01A-01-MS1",80,"carboplatin","Chemotherapy","TCGA-BS-A0TE-D4415","TCGA-BS-A0TE-R4402","EXTERNAL BEAM","Distant Recurrence",NA,NA,NA,"WITH TUMOR","Dead",146,"TCGA-BS-A0TE-F4407","TCGA-BS-A0TE",1,"BS","A0TE","YES","C54.9","8380/3","C54.9","NO","YES",-12983,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,146,NA,NA,"WITH TUMOR","NO",19,11,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,35,2005,"Other method, specify:",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
127808718,123350887,5881429560,"4135380D-3C13-4D97-BEB9-2C59457AD356.bw","09621bd6-3eed-4af4-8416-cdacffce68d9","4135380d-3c13-4d97-beb9-2c59457ad356","2016-08-09T13:14:24.479610-05:00","UNCID_2173848.0c5df2a7-417c-478d-9a7e-675a8777747c.130503_UNC9-SN296_0361_AC23VLACXX_3_GTGGCC.tar.gz","478af2c8-3c63-4767-9d4b-42e999bdc143",6136459859,"Illumina HiSeq","2913c124abbf1bb6d7118dcdb9daa18b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:49:27.698466-05:00","2016-05-03T10:56:47.870562-05:00","478af2c8-3c63-4767-9d4b-42e999bdc143_analysis.xml","8abac21736c925d40f94f830344d729d","c5d4a44f-af51-49a7-9f60-0d525967a1d9",2121,"2016-09-29T22:26:17.014899-05:00","478af2c8-3c63-4767-9d4b-42e999bdc143_experiment.xml","c972ee610b5f6ff7550df59a8587b27b","b761ab0b-3571-4905-b827-8e24476a13a8",2431,"2016-09-29T19:53:35.909160-05:00","478af2c8-3c63-4767-9d4b-42e999bdc143_run.xml","4aa05c062c5fbd291d487b033adb278b","59390e02-4e4d-464a-9888-1f05e070e548",354,"2016-09-08T11:07:47.331368-05:00","TCGA-FL-A1YI",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YI-11A",NA,"5cd8fef0-e1f7-4d00-b2bb-357bac222d9c",FALSE,"BC17ABB4-DBAA-43FD-BBBA-C48C71BEDE62","Solid Tissue Normal",NA,NA,120,NA,1302480000,"11",30,"TCGA-FL-A1YI-11A-11",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T11:07:47.331368-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"6d819055-db2e-443f-b7c2-6b0e4475f95e",NA,"TCGA-FL-A1YI-11A-01-TSA",NA,0,NA,"e10ebe87-615e-4870-b8e2-2f0bf5dc1ec0","RNA","TCGA-FL-A1YI-11A-11R","3f0b831d-6851-4c32-8b59-02a48cf237f5",1.71,0.16,"UV Spec","R","23","TCGA-FL-A1YI-11A-11R-A16F-07","0c5df2a7-417c-478d-9a7e-675a8777747c",0.16,NA,NA,NA,NA,NA,NA,"UNCID_2173848.0c5df2a7-417c-478d-9a7e-675a8777747c.130503_UNC9-SN296_0361_AC23VLACXX_3_GTGGCC.tar.gz","2013-09-10T02:06:04.000Z","2013-09-10T02:20:02.000Z","478AF2C8-3C63-4767-9D4B-42E999BDC143","5CD8FEF0-E1F7-4D00-B2BB-357BAC222D9C","Unaligned reads",6136459859,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0C5DF2A7-417C-478D-9A7E-675A8777747C","University of North Carolina","564a4001e4b08c5d8692fa9e","09621BD6-3EED-4AF4-8416-CDACFFCE68D9","Uterine Corpus Endometrial Carcinoma","TARGZ","E10EBE87-615E-4870-B8E2-2F0BF5DC1EC0","2013-09-10T02:20:02.000Z","3F0B831D-6851-4C32-8B59-02A48CF237F5","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"E10EBE87-615E-4870-B8E2-2F0BF5DC1EC0",NA,"FL","TCGA-FL-A1YI-11A-11R-A16E-13_mirna.bam",120,"TCGA-FL-A1YI-11A",NA,NA,"TCGA",NA,NA,NA,NA,"5CD8FEF0-E1F7-4D00-B2BB-357BAC222D9C",NA,"TCGA-FL-A1YI-11A-11R-A16E-13_mirna.bam",NA,NA,"TCGA-FL-A1YI",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,143,NA,NA,NA,NA,11,30,"6D819055-DB2E-443F-B7C2-6B0E4475F95E","B52D89C0-EE41-4E76-B4BC-C9A76751E9DC","TCGA-FL-A1YI-11A-11R-A16E-13_mirna.bam","TCGA-FL-A1YI-11A-11",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YI-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34506856,34119858,2512422045,"A7734BCC-B913-4229-A50D-4A7B6111CD1B.bw","0a9faff7-ec4d-4b5a-aa83-6fa358f72074","a7734bcc-b913-4229-a50d-4a7b6111cd1b","2016-08-05T02:12:31.108732-05:00","UNCID_2203958.e0397750-69a4-41ef-bcb0-70bc4b2d7c87.111020_UNC6-RDR300211_00129_FC_62EA9AAXX_1.tar.gz","78be27b5-e1f3-4232-9e6f-8ce7227e3042",2327124452,"Illumina GA","1c728517a4592c44a2f29ad8ca29baf0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:05:09.465704-05:00","2016-05-03T11:19:30.078695-05:00","78be27b5-e1f3-4232-9e6f-8ce7227e3042_analysis.xml","653f09f76de116ea873be3d39e5029f2","f4af39be-4f32-491a-a14a-5d76ff0a7330",2121,"2016-08-26T21:33:23.428426-05:00","78be27b5-e1f3-4232-9e6f-8ce7227e3042_experiment.xml","e258bd22f37e2bcc2349aba2327d04bd","0792cca3-e7d3-4a77-b3c3-34713e3a0b2f",2257,"2016-09-29T22:37:24.129410-05:00","78be27b5-e1f3-4232-9e6f-8ce7227e3042_run.xml","8b8f4a4a8c4abb1fff684a189aae3014","be57888e-0000-4554-9fbc-75e12e246570",347,"2016-09-08T11:35:43.016856-05:00","TCGA-D1-A1NY","2016-09-02T18:52:45.618175-05:00","female","TCGA-D1-A1NY_demographic",1943,"white","1d5ce98d-18ee-5c7e-8b0e-2fe2da9bb1e9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1NY_diagnosis","not reported",24683,"alive","8380/3",NA,513,"bd8b549a-18d5-511c-bb8b-1dfc8cf0b32a","c54.1",-24683,"TCGA-D1-A1NY_treatment","7881606d-f7c3-5b9b-b820-3215466d5aac","01","false","TCGA-D1-A1NY-01A",NA,"4d1fc186-32c8-4f12-a4c3-f683cee53737",FALSE,"8F963009-F6C3-4F45-B714-0E96F5D5E526","Primary Tumor",NA,199,110,NA,1304985600,"11",30,"TCGA-D1-A1NY-01A-11",80,NA,1,NA,5,NA,20,NA,"2016-09-08T11:35:43.016856-05:00",NA,8,NA,2,NA,"TOP",NA,3,NA,"5a066661-053b-4165-90b3-4107e5a925e5",NA,"TCGA-D1-A1NY-01A-01-TSA",NA,72,NA,"65d40dda-e75f-4c38-894c-810428d9ce8d","RNA","TCGA-D1-A1NY-01A-11R","d7aa5b67-e542-4c9f-83e5-116ee7e910ac",1.88,0.17,"UV Spec","R","23","TCGA-D1-A1NY-01A-11R-A16F-07","e0397750-69a4-41ef-bcb0-70bc4b2d7c87",0.17,NA,97,34.3679138321995,168,"7c4429b1-d131-5d8e-82b9-2391b25045d1","TCGA-D1-A1NY_exposure","UNCID_2203958.e0397750-69a4-41ef-bcb0-70bc4b2d7c87.111020_UNC6-RDR300211_00129_FC_62EA9AAXX_1.tar.gz","2013-10-04T14:56:04.000Z","2013-10-04T16:02:03.000Z","78BE27B5-E1F3-4232-9E6F-8CE7227E3042","4D1FC186-32C8-4F12-A4C3-F683CEE53737","Unaligned reads",2327124452,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E0397750-69A4-41EF-BCB0-70BC4B2D7C87","University of North Carolina","56607e6ee4b0ca3191650882","0A9FAFF7-EC4D-4B5A-AA83-6FA358F72074","Uterine Corpus Endometrial Carcinoma","TARGZ","65D40DDA-E75F-4C38-894C-810428D9CE8D","2013-10-04T16:02:03.000Z","D7AA5B67-E542-4C9F-83E5-116EE7E910AC","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",199,"65D40DDA-E75F-4C38-894C-810428D9CE8D",NA,"D1","unc.edu.e0397750-69a4-41ef-bcb0-70bc4b2d7c87.1615030.junction_quantification.txt",110,"TCGA-D1-A1NY-01A",NA,"6ED78C74-6DD4-492A-A5D4-813FF4A2D998","TCGA",2010,NA,NA,"TUMOR FREE","9FB84247-3C5E-4B40-AE10-478C4650C376",67,"6264509044_R04C01_Grn.idat","Alive",NA,"TCGA-D1-A1NY","NOT HISPANIC OR LATINO","C8BE2E5C-2D32-4B14-A285-846992617BE9",NA,396,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",143,NA,"90BBA296-F761-42D9-8E5F-03D9B8D2B857","WHITE",NA,11,30,"5A066661-053B-4165-90B3-4107E5A925E5","E75F745D-8ABA-4BE6-B2A8-8210775DE24C","UNCID_2203958.e0397750-69a4-41ef-bcb0-70bc4b2d7c87.111020_UNC6-RDR300211_00129_FC_62EA9AAXX_1.tar.gz","TCGA-D1-A1NY-01A-11",80,5,1,8,20,"TOP",3,2,"TCGA-D1-A1NY-01A-01-TSA",72,"Carboplatin","Chemotherapy","TCGA-D1-A1NY-D21631","TCGA-D1-A1NY-R21632","IMPLANTS","Primary Tumor Field",NA,"NO",513,"TUMOR FREE","Alive",NA,"TCGA-D1-A1NY-F21629","TCGA-D1-A1NY",1,"D1","A1NY","YES","C54.1","8380/3","C54.1","NO","YES",-24683,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",396,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
114715916,111538053,5319488796,"FCE788C2-DBF8-4083-9EA2-10A08B857E9C.bw","0b0a54ac-bb74-40a4-b647-d067fb9de1ff","fce788c2-dbf8-4083-9ea2-10a08b857e9c","2016-08-09T13:14:28.605464-05:00","UNCID_2173874.b80bd803-b042-474e-864e-b2c6ee4708e5.130503_UNC9-SN296_0361_AC23VLACXX_2_GTTTCG.tar.gz","b78f90bd-a5da-46ec-a999-f4f925c5bf50",5588732923,"Illumina HiSeq","1871110180fe447c4e58f714261afa37","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:22:02.355621-05:00","2016-05-03T10:56:47.870562-05:00","b78f90bd-a5da-46ec-a999-f4f925c5bf50_analysis.xml","6cad17339a33714c22bf94f2190c9090","6a80fc5f-7652-4d21-8827-32b033bb5364",2121,"2016-09-29T20:12:06.729207-05:00","b78f90bd-a5da-46ec-a999-f4f925c5bf50_experiment.xml","3b7b8d94cc8d606b7d6c8eeba7f275f9","6474b5a2-a211-4d2b-b9d6-27980303c66e",2431,"2016-09-29T17:32:13.520544-05:00","b78f90bd-a5da-46ec-a999-f4f925c5bf50_run.xml","b597322f2360f7ba097b6e3781c5e7f0","00573a69-61c7-413a-9a0c-46677aa76e2c",354,"2016-09-08T10:39:01.566153-05:00","TCGA-FL-A1YF",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YF-11A",NA,"2efbdfb5-99ec-4c46-af68-e10d7ea6f3ce",FALSE,"77548105-E280-4614-A76D-0177207D77D2","Solid Tissue Normal",NA,NA,130,NA,1302480000,"12",30,"TCGA-FL-A1YF-11A-12",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T10:39:01.566153-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"25cba401-385b-48f5-9123-5535b2c6c802",NA,"TCGA-FL-A1YF-11A-01-TSA",NA,0,NA,"5fb1b16e-b4e2-4bdd-b3c6-ab9f5e7e9175","RNA","TCGA-FL-A1YF-11A-12R","8d0ce078-9c06-4d29-8f48-feb368a0b1fb",1.75,0.17,"UV Spec","R","23","TCGA-FL-A1YF-11A-12R-A16F-07","b80bd803-b042-474e-864e-b2c6ee4708e5",0.17,NA,NA,NA,NA,NA,NA,"UNCID_2173874.b80bd803-b042-474e-864e-b2c6ee4708e5.130503_UNC9-SN296_0361_AC23VLACXX_2_GTTTCG.tar.gz","2013-09-10T02:21:03.000Z","2013-09-10T02:41:02.000Z","B78F90BD-A5DA-46EC-A999-F4F925C5BF50","2EFBDFB5-99EC-4C46-AF68-E10D7EA6F3CE","Unaligned reads",5588732923,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","B80BD803-B042-474E-864E-B2C6EE4708E5","University of North Carolina","56607cfde4b0ca31916502d4","0B0A54AC-BB74-40A4-B647-D067FB9DE1FF","Uterine Corpus Endometrial Carcinoma","TARGZ","5FB1B16E-B4E2-4BDD-B3C6-AB9F5E7E9175","2013-09-10T02:41:02.000Z","8D0CE078-9C06-4D29-8F48-FEB368A0B1FB","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"5FB1B16E-B4E2-4BDD-B3C6-AB9F5E7E9175",NA,"FL","UNCID_2173874.b80bd803-b042-474e-864e-b2c6ee4708e5.130503_UNC9-SN296_0361_AC23VLACXX_2_GTTTCG.tar.gz",130,"TCGA-FL-A1YF-11A",NA,NA,"TCGA",NA,NA,NA,NA,"2EFBDFB5-99EC-4C46-AF68-E10D7EA6F3CE",NA,"UNCID_2173874.b80bd803-b042-474e-864e-b2c6ee4708e5.130503_UNC9-SN296_0361_AC23VLACXX_2_GTTTCG.tar.gz",NA,NA,"TCGA-FL-A1YF",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,143,NA,NA,NA,NA,12,30,"25CBA401-385B-48F5-9123-5535B2C6C802","8D0CE078-9C06-4D29-8F48-FEB368A0B1FB","UNCID_2173874.b80bd803-b042-474e-864e-b2c6ee4708e5.130503_UNC9-SN296_0361_AC23VLACXX_2_GTTTCG.tar.gz","TCGA-FL-A1YF-11A-12",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YF-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
29586541,29358687,2192322344,"8CCCBF95-D001-46E6-BDD3-0B5125534C0F.bw","0b2eb188-dd23-4dbf-91bb-02e3c81a69bc","8cccbf95-d001-46e6-bdd3-0b5125534c0f","2016-08-05T08:02:08.699619-05:00","UNCID_2207675.2a549626-7bc3-4ba9-9822-35af631afd0c.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_3.tar.gz","8e6f12d3-480c-4d6d-8cd3-242ec3e29da2",1881990310,"Illumina GA","65856dff76690205c740cbf8aaf9192d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:00:09.556023-05:00","2016-05-03T11:14:23.401440-05:00","8e6f12d3-480c-4d6d-8cd3-242ec3e29da2_analysis.xml","8322ce7948c861ed29fb096654117d0a","a772a0f0-b103-47fd-b9c4-94cc0021a955",2120,"2016-10-07T16:50:18.830765-05:00","8e6f12d3-480c-4d6d-8cd3-242ec3e29da2_experiment.xml","e6041835a2a3f96cf235b3d794e5ef8d","f76841f0-4771-4b3f-bca3-9544f15489a0",2257,"2016-09-29T17:59:11.398078-05:00","8e6f12d3-480c-4d6d-8cd3-242ec3e29da2_run.xml","ae9cf8d391aee0b4a38de34635720885","11719efe-cb18-4fd0-a136-2de6bc4b30c4",347,"2016-09-08T10:35:29.488382-05:00","TCGA-AP-A1E4","2016-09-02T18:51:29.891112-05:00","female","TCGA-AP-A1E4_demographic",1956,"white","82bb1cb6-76bd-50d7-9942-d28b2ec7d3d6","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1E4_diagnosis","not reported",19814,"alive","8380/3",NA,1555,"f9ba839c-3e1d-5954-8333-9dc646667389","c54.1",-19814,"TCGA-AP-A1E4_treatment","f31bafdc-f2a9-5f90-adb3-f5ac66931044","01","true","TCGA-AP-A1E4-01A",NA,"0e845d2c-7928-46a8-a751-a5df677e8041",FALSE,"1E33ABA3-0B55-4021-A370-DB8E2CA4C022","Primary Tumor",NA,154,90,NA,1296000000,"12",20,"TCGA-AP-A1E4-01A-12",75,NA,0,NA,0,NA,20,NA,"2016-09-08T10:35:29.488382-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"549613d7-3f51-4622-8c37-627582ecadda",NA,"TCGA-AP-A1E4-01A-01-TSA",NA,80,NA,"9c744a94-bcd4-46d7-9c28-4eed4c1c9c70","RNA","TCGA-AP-A1E4-01A-12R","ea24652d-3fce-4cfd-8b57-732cc572e92b",1.58,0.17,"UV Spec","R","23","TCGA-AP-A1E4-01A-12R-A137-07","2a549626-7bc3-4ba9-9822-35af631afd0c",0.17,NA,54,20.3244382551093,163,"68e4e4bc-27ba-52a1-affb-ea0307581c0f","TCGA-AP-A1E4_exposure","UNCID_2207675.2a549626-7bc3-4ba9-9822-35af631afd0c.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_3.tar.gz","2013-09-30T04:26:04.000Z","2013-09-30T04:38:02.000Z","8E6F12D3-480C-4D6D-8CD3-242EC3E29DA2","0E845D2C-7928-46A8-A751-A5DF677E8041","Unaligned reads",1881990310,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2A549626-7BC3-4BA9-9822-35AF631AFD0C","University of North Carolina","564a3dcbe4b08c5d869245a0","0B2EB188-DD23-4DBF-91BB-02E3C81A69BC","Uterine Corpus Endometrial Carcinoma","TARGZ","9C744A94-BCD4-46D7-9C28-4EED4C1C9C70","2013-09-30T04:38:02.000Z","EA24652D-3FCE-4CFD-8B57-732CC572E92B","None","NO",1,NA,"Primary Tumor","MSKCC",154,"9C744A94-BCD4-46D7-9C28-4EED4C1C9C70",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.50B326F9-9A74-4C1D-A08D-46B5DDDFACDF.txt",90,"TCGA-AP-A1E4-01A",NA,"F308AF29-4335-4BB5-9E88-B86DF3E5094B","TCGA",2010,NA,NA,"WITH TUMOR","20507E68-86A8-4835-B26F-0F5E1B435EA2",54,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.50B326F9-9A74-4C1D-A08D-46B5DDDFACDF.txt","Alive",NA,"TCGA-AP-A1E4",NA,"A6197513-E81F-4DDA-A77E-526A1EC0A4B8",NA,267,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,12,20,"549613D7-3F51-4622-8C37-627582ECADDA","EA24652D-3FCE-4CFD-8B57-732CC572E92B","GAMMA_p_TCGA_b103_104_SNP_N_GenomeWideSNP_6_F01_755832.ismpolish.data.txt","TCGA-AP-A1E4-01A-12",75,0,0,0,20,"TOP",0,0,"TCGA-AP-A1E4-01A-01-TSA",80,"Carboplatin","Chemotherapy","TCGA-AP-A1E4-D13643",NA,NA,NA,NA,"NO",494,"TUMOR FREE","Alive",NA,"TCGA-AP-A1E4-F29064","TCGA-AP-A1E4",1,"AP","A1E4","YES","C54.1","8380/3","C54.1","NO","YES",-19814,"FEMALE","WHITE",NA,"No","No","Alive",267,NA,NA,NA,"WITH TUMOR","NO",9,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30740028,29478363,2204622160,"A18441D3-09EE-4D6C-8E7D-22DCE1BFD94B.bw","0b670df6-c487-4ed6-9b48-ef4b01a1aec3","a18441d3-09ee-4d6c-8e7d-22dce1bfd94b","2016-08-09T14:13:53.009165-05:00","UNCID_2208081.7c0fca0e-60ff-4c7e-a337-fb7489f69151.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_7.tar.gz","9660bd64-40d0-41fe-a2ed-b79eeaf9d863",2011462138,"Illumina GA","f95001796b6c10efde0f7106bd3e4841","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:12:40.749643-05:00","2016-05-03T11:14:23.412460-05:00","9660bd64-40d0-41fe-a2ed-b79eeaf9d863_analysis.xml","443e2d6ef87de726d606782693422cd3","f95ea18c-5997-49ee-8ce9-963e2aa27b96",2121,"2016-09-29T22:53:17.860223-05:00","9660bd64-40d0-41fe-a2ed-b79eeaf9d863_experiment.xml","a082872558d718c180c2aedefecd486b","c841366a-e7d0-4cc9-8c27-4203e07e3423",2257,"2016-09-29T18:04:12.216752-05:00","9660bd64-40d0-41fe-a2ed-b79eeaf9d863_run.xml","a664507f065fffc1862ad0b8a3f01564","14ac3287-5aa5-4377-a2da-b67a0287c715",347,"2016-09-08T11:17:09.365477-05:00","TCGA-D1-A16S","2016-09-02T18:50:30.338543-05:00","female","TCGA-D1-A16S_demographic",1940,"white","267743ea-2830-5b40-b683-f5e00d34c6c2","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16S_diagnosis","not reported",25690,"alive","8441/3",NA,568,"5d61a85d-1db9-5712-834f-4150227d8901","c54.1",-25690,"TCGA-D1-A16S_treatment","80f40263-8080-5cae-a72a-bd0022c8a164","01","false","TCGA-D1-A16S-01A",NA,"8e157714-099f-4496-ad37-0b83c76797bc",FALSE,"D69D2E09-B195-4F3F-B5A1-821A87852266","Primary Tumor",NA,177,290,NA,1294617600,"11",30,"TCGA-D1-A16S-01A-11",60,NA,4,NA,0,NA,40,NA,"2016-09-08T11:17:09.365477-05:00",NA,3,NA,1,NA,"TOP",NA,3,NA,"f3d1e93e-ee76-4682-abd7-1bbf57723e72",NA,"TCGA-D1-A16S-01A-01-TS1",NA,57,NA,"13f67c25-13a7-4d64-8395-aa6450bdda14","RNA","TCGA-D1-A16S-01A-11R","4e28fde9-1f2b-4abc-aa2b-608eade3548c",1.32,0.17,"UV Spec","R","23","TCGA-D1-A16S-01A-11R-A12I-07","7c0fca0e-60ff-4c7e-a337-fb7489f69151",0.17,NA,59,22.4813290656912,162,"5056a931-5627-5465-9f76-8edf8b6b27bb","TCGA-D1-A16S_exposure","UNCID_2208081.7c0fca0e-60ff-4c7e-a337-fb7489f69151.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_7.tar.gz","2013-09-30T08:31:04.000Z","2013-09-30T08:43:02.000Z","9660BD64-40D0-41FE-A2ED-B79EEAF9D863","8E157714-099F-4496-AD37-0B83C76797BC","Unaligned reads",2011462138,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7C0FCA0E-60FF-4C7E-A337-FB7489F69151","University of North Carolina","564a34f6e4b0298dd2c656ab","0B670DF6-C487-4ED6-9B48-EF4B01A1AEC3","Uterine Corpus Endometrial Carcinoma","TARGZ","13F67C25-13A7-4D64-8395-AA6450BDDA14","2013-09-30T08:43:02.000Z","4E28FDE9-1F2B-4ABC-AA2B-608EADE3548C","None","NO",1,NA,"Primary Tumor","Mayo Clinic",177,"13F67C25-13A7-4D64-8395-AA6450BDDA14",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.70A0402E-460F-443A-8851-58C7A2D0BD97.txt",290,"TCGA-D1-A16S-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","8E157714-099F-4496-AD37-0B83C76797BC",70,"SCAUR_p_TCGA_b94_SNP_N_GenomeWideSNP_6_H01_755288.nocnv_hg19.seg.txt","Alive",NA,"TCGA-D1-A16S","NOT HISPANIC OR LATINO","C2493CAE-D48B-4FA0-B0D4-1D12960B11FD",NA,238,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"F3D1E93E-EE76-4682-ABD7-1BBF57723E72","4E28FDE9-1F2B-4ABC-AA2B-608EADE3548C","UNCID_364185.TCGA-D1-A16S-01A-11R-A12I-07.110624_UNC6-RDR300211_00108_FC_634Y6AAXX.7.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-D1-A16S-01A-11",60,0,4,3,40,"TOP",3,1,"TCGA-D1-A16S-01A-01-TS1",57,NA,NA,NA,NA,NA,NA,NA,"NO",568,"TUMOR FREE","Alive",NA,"TCGA-D1-A16S-F20314","TCGA-D1-A16S",1,"D1","A16S","YES","C54.1","8441/3","C54.1","NO","YES",-25690,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",238,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,70,2010,"Office Endometrial Biopsy",NA,NA,NA,"High Grade","R0",NA,NA,NA,NA,NA,"2009",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31177700,30117727,2267099570,"7337C0EA-0D5E-4B6A-A30C-23664EBC901A.bw","0b672aa4-fc13-476f-b61e-5f2c3a615c23","7337c0ea-0d5e-4b6a-a30c-23664ebc901a","2016-08-09T14:14:07.376846-05:00","UNCID_2210361.714254dd-834a-4b70-8f88-c48bc7b4fdb8.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_8.tar.gz","e10d5bfd-5764-46a6-9249-fb8535a863bf",2093684759,"Illumina GA","173a54741e8983be0aafc02038fad73a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:14:16.543476-05:00","2016-05-03T11:15:47.420908-05:00","e10d5bfd-5764-46a6-9249-fb8535a863bf_analysis.xml","b5abbe3dea7f5124325158919211a232","fa63474b-780e-405a-9ed3-772e7f1f0600",2121,"2016-08-13T06:35:01.186281-05:00","e10d5bfd-5764-46a6-9249-fb8535a863bf_experiment.xml","5feed312635619af614fbe6fe8209791","f92bdd2d-d3c6-4f51-8ee4-4ffcd5d45880",2257,"2016-09-29T17:56:26.312176-05:00","e10d5bfd-5764-46a6-9249-fb8535a863bf_run.xml","b9d4d4114915079369a08a9cf0831554","0fafb794-a27c-4bb9-bce7-c27fad9f0bc6",347,"2016-09-08T10:57:41.114337-05:00","TCGA-B5-A11U","2016-09-02T18:49:35.813432-05:00","female","TCGA-B5-A11U_demographic",1935,"black or african american","c0fa632c-0f09-59bd-9e43-fb1211bd54cb","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11U_diagnosis","not reported",27160,"alive","8380/3",NA,509,"99639fd2-381e-57f3-8de0-6e9f3dd7f6fc","c54.1",-27160,"TCGA-B5-A11U_treatment","a9964f6a-2edd-5200-9d60-f08d94beb79a","01","true","TCGA-B5-A11U-01A",NA,"52265b60-6f79-4e28-92a9-f4f5bee5a95e",FALSE,"1EF2CB28-A515-4E9D-9148-CC1A2DF77F60","Primary Tumor",NA,371,220,NA,1291680000,"11",30,"TCGA-B5-A11U-01A-11",40,70,4,0,0,0,60,30,"2016-09-08T10:57:41.114337-05:00","2016-09-08T10:57:41.114337-05:00",35,10,3,10,"BOTTOM","TOP",4,20,"0e174eee-6e4b-4a58-83e4-7cfbfce8e8f6","e4ef60a3-41c0-4117-9e9e-6ab34eb43ea8","TCGA-B5-A11U-01A-01-MSA","TCGA-B5-A11U-01A-01-TSA",36,50,"a6725c0d-3e12-467b-bdaf-e75d6492f246","RNA","TCGA-B5-A11U-01A-11R","4dac50b4-2009-4e64-b1a0-6d97210fef67",1.86,0.17,"UV Spec","R","23","TCGA-B5-A11U-01A-11R-A118-07","714254dd-834a-4b70-8f88-c48bc7b4fdb8",0.17,NA,61,26.4023545706371,152,"b5ac85f0-3b75-50ce-925d-40898d003acc","TCGA-B5-A11U_exposure","UNCID_2210361.714254dd-834a-4b70-8f88-c48bc7b4fdb8.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_8.tar.gz","2013-10-02T09:56:05.000Z","2013-10-02T10:08:01.000Z","E10D5BFD-5764-46A6-9249-FB8535A863BF","52265B60-6F79-4E28-92A9-F4F5BEE5A95E","Unaligned reads",2093684759,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","714254DD-834A-4B70-8F88-C48BC7B4FDB8","University of North Carolina","56607e3ae4b016715ab6b96a","0B672AA4-FC13-476F-B61E-5F2C3A615C23","Uterine Corpus Endometrial Carcinoma","TARGZ","A6725C0D-3E12-467B-BDAF-E75D6492F246","2013-10-02T10:08:01.000Z","4DAC50B4-2009-4E64-B1A0-6D97210FEF67","United States","NO",1,NA,"Primary Tumor","Duke",371,"A6725C0D-3E12-467B-BDAF-E75D6492F246",NA,"B5","TCGA-B5-A11U-01A-11R-A119-13_mirna.bam",220,"TCGA-B5-A11U-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","52265B60-6F79-4E28-92A9-F4F5BEE5A95E",74,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.73AE6942-57B1-4104-8D42-3D5BA79480B2.txt","Alive",NA,"TCGA-B5-A11U",NA,"BCD56FEA-CD1D-4B67-8282-A8F91839B752",NA,271,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"16380B85-2A23-46EC-BC67-3F5E6D5ECBBE","BLACK OR AFRICAN AMERICAN",NA,11,30,"E4EF60A3-41C0-4117-9E9E-6AB34EB43EA8","70F36FED-FCC1-4181-A9CF-5E5C1A5EA8DE","CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_A03_735716.hg19.seg.txt","TCGA-B5-A11U-01A-11",40,0,4,35,60,"BOTTOM",4,3,"TCGA-B5-A11U-01A-01-MSA",36,NA,NA,NA,"TCGA-B5-A11U-R10455","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",509,"TUMOR FREE","Alive",NA,"TCGA-B5-A11U-F17774","TCGA-B5-A11U",1,"B5","A11U","YES","C54.1","8380/3","C54.1","NO","YES",-27160,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",271,NA,NA,NA,"TUMOR FREE","NO",22,2,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2009,"Dilation and curettage procedure",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34093396,33251770,2495267639,"0F1F152F-E14D-4A46-83F0-3D26F795D79F.bw","0c01c673-e396-47b2-9562-4144d7705ebf","0f1f152f-e14d-4a46-83f0-3d26f795d79f","2016-08-04T21:36:37.179104-05:00","UNCID_2211988.45676252-677e-45f6-a1e3-3052d3615472.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_6.tar.gz","f3088e19-0412-43d5-a846-00c81435b2fa",2141628504,"Illumina GA","9182910fac4a645e0cae92c98654a72b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:02:46.923300-05:00","2016-05-03T11:16:29.242391-05:00","f3088e19-0412-43d5-a846-00c81435b2fa_analysis.xml","bd1f854a5fb1bc95abdbe0d67b5b2fb9","cdfb1b45-6d64-483a-a509-ddf12277a1c3",2121,"2016-08-13T10:17:00.404594-05:00","f3088e19-0412-43d5-a846-00c81435b2fa_experiment.xml","c88070a94297f34e9ce00caa49080b10","9438b563-f903-48d7-814b-1972bba8d598",2257,"2016-09-29T18:44:06.046942-05:00","f3088e19-0412-43d5-a846-00c81435b2fa_run.xml","16e98ce951008f4aa5b2aa508a1af90c","2da054a9-d623-4e2a-b39d-c2eef4f6f399",347,"2016-09-08T10:38:03.875255-05:00","TCGA-D1-A0ZV","2016-09-02T18:49:13.500468-05:00","female","TCGA-D1-A0ZV_demographic",1951,"white","c172bc97-df3f-59ab-b64c-63529d29ba3d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A0ZV_diagnosis","not reported",21374,"alive","8380/3",NA,728,"54abed21-c1a1-55fb-95a4-1018adbd0293","c54.1",-21374,"TCGA-D1-A0ZV_treatment","9847d6e2-f1f8-5c53-a200-8ea26e33ecf5","01","false","TCGA-D1-A0ZV-01A",NA,"a1cb5589-26dd-4d0e-9447-375ebeca6b78",FALSE,"C9AE2762-705F-4061-B3B6-325426D0C0C8","Primary Tumor",NA,324,110,NA,1288656000,"11",30,"TCGA-D1-A0ZV-01A-11",80,80,0,0,0,0,20,20,"2016-09-08T10:38:03.875255-05:00","2016-09-08T10:38:03.875255-05:00",20,20,20,20,"BOTTOM","TOP",10,10,"991664d7-c175-4508-8217-a47ece7ba41f","8cfb7bc6-3f83-45e5-b5a4-b4ea43acdc7a","TCGA-D1-A0ZV-01A-01-BS1","TCGA-D1-A0ZV-01A-01-TS1",70,70,"c3856358-55c6-4e69-aa82-9f6b8e22758b","RNA","TCGA-D1-A0ZV-01A-11R","0af87a76-6e98-4afe-a6c2-431c17d92bd7",1.86,0.17,"UV Spec","R","23","TCGA-D1-A0ZV-01A-11R-A10J-07","45676252-677e-45f6-a1e3-3052d3615472",0.17,NA,77,26.643598615917,170,"674c54c8-3196-5b89-a6cc-c8d7b869f842","TCGA-D1-A0ZV_exposure","UNCID_2211988.45676252-677e-45f6-a1e3-3052d3615472.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_6.tar.gz","2013-10-03T05:01:04.000Z","2013-10-03T05:14:02.000Z","F3088E19-0412-43D5-A846-00C81435B2FA","A1CB5589-26DD-4D0E-9447-375EBECA6B78","Unaligned reads",2141628504,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","45676252-677E-45F6-A1E3-3052D3615472","University of North Carolina","56607893e4b016715ab69e59","0C01C673-E396-47B2-9562-4144D7705EBF","Uterine Corpus Endometrial Carcinoma","TARGZ","C3856358-55C6-4E69-AA82-9F6B8E22758B","2013-10-03T05:14:02.000Z","0AF87A76-6E98-4AFE-A6C2-431C17D92BD7","None","NO",1,NA,"Primary Tumor","Mayo Clinic",324,"C3856358-55C6-4E69-AA82-9F6B8E22758B",NA,"D1","UNCID_340134.TCGA-D1-A0ZV-01A-11R-A10J-07.110303_UNC3-RDR300156_00077_FC_62J3HAAXX.6.trimmed.annotated.translated_to_genomic.bam.bai",110,"TCGA-D1-A0ZV-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","A1CB5589-26DD-4D0E-9447-375EBECA6B78",58,"nationwidechildrens.org_clinical.TCGA-D1-A0ZV.xml","Alive",NA,"TCGA-D1-A0ZV","NOT HISPANIC OR LATINO","B3F57583-E342-4248-B392-8A0BDCF1E122",NA,350,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,11,30,"991664D7-C175-4508-8217-A47ECE7BA41F","6B51CDC4-0B6C-4E2B-A733-25259AE4A4A1","UNCID_340134.TCGA-D1-A0ZV-01A-11R-A10J-07.110303_UNC3-RDR300156_00077_FC_62J3HAAXX.6.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-D1-A0ZV-01A-11",80,0,0,20,20,"BOTTOM",10,20,"TCGA-D1-A0ZV-01A-01-BS1",70,NA,NA,NA,NA,NA,NA,NA,"NO",728,"TUMOR FREE","Alive",NA,"TCGA-D1-A0ZV-F19531","TCGA-D1-A0ZV",1,"D1","A0ZV","YES","C54.1","8380/3","C54.1","NO","YES",-21374,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",350,NA,NA,NA,"TUMOR FREE","NO",8,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
101071860,97664797,4647843353,"DDAAF948-34BA-471B-AB9C-B43F3BE265CF.bw","0c1946a8-ee54-4b9b-8054-9a7bece74d33","ddaaf948-34ba-471b-ab9c-b43f3be265cf","2016-08-09T13:16:56.096234-05:00","UNCID_2177911.0421d738-8236-46c5-8b98-6b261defb294.130402_UNC10-SN254_0447_BC22WAACXX_2_GTTTCG.tar.gz","707f6df2-a358-4f3c-82c6-ed0f606e2fe6",4286044310,"Illumina HiSeq","10c6b9028a48ab2d3bf182fc1d1b8dfa","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:22:33.002227-05:00","2016-05-03T10:56:47.877475-05:00","707f6df2-a358-4f3c-82c6-ed0f606e2fe6_analysis.xml","77919d71af17a8b8bf8f1072bdf7145f","b5105d06-7bcc-4a7c-a5a3-846a7105167b",2122,"2016-09-29T21:08:23.178798-05:00","707f6df2-a358-4f3c-82c6-ed0f606e2fe6_experiment.xml","dcd183133abe4bb53e5a2e4de32f4389","8748982b-8c06-4a3a-b212-d14cb5875917",2431,"2016-09-29T23:17:13.021901-05:00","707f6df2-a358-4f3c-82c6-ed0f606e2fe6_run.xml","c3635c17619393f9e9afb82451ca7a71","d6f9ed96-cbf0-4ded-893e-f984c8ab609d",354,"2016-09-08T10:25:16.867963-05:00","TCGA-B5-A3FB","2016-09-02T18:47:36.522418-05:00","female","TCGA-B5-A3FB_demographic",1933,"black or african american","9f7d00ec-c32d-54a4-b535-29f67966f7b6","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A3FB_diagnosis","not reported",26779,"alive","8380/3",NA,2844,"a6abf562-401d-58f2-9205-ef490b917966","c54.1",-26779,"TCGA-B5-A3FB_treatment","597ee7fc-bf02-5e62-9081-33f15bc255fa","01","true","TCGA-B5-A3FB-01A",NA,"0cea1bde-18ed-4e42-b5f6-3d4ff182b0c0",FALSE,"FA278AFC-C294-48A5-BE7B-B26F4AE3FC5B","Primary Tumor",NA,2066,350,NA,1321574400,"11",30,"TCGA-B5-A3FB-01A-11",80,NA,5,NA,0,NA,0,NA,"2016-09-08T10:25:16.867963-05:00",NA,1,NA,5,NA,"TOP",NA,15,NA,"02567037-92cb-4e4a-9b7c-a7618aa2201b",NA,"TCGA-B5-A3FB-01A-01-TSA",NA,85,NA,"8bdfbd16-52aa-4b9d-8020-a479efc00be3","RNA","TCGA-B5-A3FB-01A-11R","2251d71c-d3fc-483d-abd2-2c5b3b1abcad",1.8,0.17,"UV Spec","R","23","TCGA-B5-A3FB-01A-11R-A19W-07","0421d738-8236-46c5-8b98-6b261defb294",0.17,NA,115,39.7923875432526,170,"5867147e-8b9e-5d2f-9597-3f071ac84e40","TCGA-B5-A3FB_exposure","UNCID_2177911.0421d738-8236-46c5-8b98-6b261defb294.130402_UNC10-SN254_0447_BC22WAACXX_2_GTTTCG.tar.gz","2013-09-11T20:36:05.000Z","2013-09-11T20:49:01.000Z","707F6DF2-A358-4F3C-82C6-ED0F606E2FE6","0CEA1BDE-18ED-4E42-B5F6-3D4FF182B0C0","Unaligned reads",4286044310,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0421D738-8236-46C5-8B98-6B261DEFB294","University of North Carolina","564a3ecfe4b0298dd2c97ee3","0C1946A8-EE54-4B9B-8054-9A7BECE74D33","Uterine Corpus Endometrial Carcinoma","TARGZ","8BDFBD16-52AA-4B9D-8020-A479EFC00BE3","2013-09-11T20:49:01.000Z","2251D71C-D3FC-483D-ABD2-2C5B3B1ABCAD","United States","NO",1,NA,"Primary Tumor","Duke",2066,"8BDFBD16-52AA-4B9D-8020-A479EFC00BE3",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.296D37E4-A844-4792-869D-B1639FF420BE.txt",350,"TCGA-B5-A3FB-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","B0B7850E-963F-4B16-9134-E7024BF74C4A",73,"nationwidechildrens.org_clinical.TCGA-B5-A3FB.xml","Alive",NA,"TCGA-B5-A3FB",NA,"74EB513E-47EA-4AFE-8463-44DA02871FF3",NA,2096,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"02567037-92CB-4E4A-9B7C-A7618AA2201B","51E57CB4-9BFD-4598-AE62-8534DE1A7448","TCGA-B5-A3FB-01A-11R-A19V-13_mirna.bam","TCGA-B5-A3FB-01A-11",80,0,5,1,0,"TOP",15,5,"TCGA-B5-A3FB-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,"TCGA-B5-A3FB-F37050_NTE-1","NO",2397,"TUMOR FREE","Alive",NA,"TCGA-B5-A3FB-F37050","TCGA-B5-A3FB",1,"B5","A3FB","YES","C54.1","8380/3","C54.1","NO","YES",-26779,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",2096,NA,NA,NA,"TUMOR FREE","NO",23,3,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35670528,35125963,2607630424,"B2AD9EFE-14C4-40C1-B91B-D1F9AC6DFB28.bw","0cc9a11f-1ac4-431d-8f94-52a3bc02b572","b2ad9efe-14c4-40c1-b91b-d1f9ac6dfb28","2016-08-09T14:10:08.042162-05:00","UNCID_2206597.f9814b3c-60f3-4d83-885e-1e1a88e520a9.110928_UNC6-RDR300211_00126_FC_6348UAAXX_3.tar.gz","83e5ced7-f114-48ff-820e-593923a13c67",2361897603,"Illumina GA","338c1c5383d55def43360aa8bd7d6955","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:59:14.750079-05:00","2016-05-03T11:11:34.779998-05:00","83e5ced7-f114-48ff-820e-593923a13c67_analysis.xml","28932b5b5dcd634e529453b5bdb2ebb9","37302b67-1262-4ae5-ac9d-ca304febf542",2121,"2016-09-29T23:23:58.477917-05:00","83e5ced7-f114-48ff-820e-593923a13c67_experiment.xml","fef7dd41a307d19daaaae80573e0538d","db246386-517a-49aa-ba30-f11df863c68e",2257,"2016-09-29T22:12:11.030984-05:00","83e5ced7-f114-48ff-820e-593923a13c67_run.xml","a413f0667c5c1e4bf62f0322582ea8b8","aeba394c-a5de-4295-8268-b3052a4bc351",347,"2016-09-08T11:10:27.956203-05:00","TCGA-EO-A2CH","2016-09-02T18:53:58.513524-05:00","female","TCGA-EO-A2CH_demographic",1936,"not reported","0941ebb2-1a6b-5219-84c0-ff018fe2668f","not reported",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A2CH_diagnosis","not reported",26966,"dead","8441/3",590,NA,"70b51cda-35f6-5d26-b3cf-78d6593f9bca","c54.1",-26966,"TCGA-EO-A2CH_treatment","9f59d7e7-2c25-5d39-95c9-ebebeb98ee6b","01","false","TCGA-EO-A2CH-01A",NA,"f0906353-4c3b-4f71-9b0b-cb1477450013",FALSE,"B4A5577E-C043-4D25-8D53-77A43C5EC0CC","Primary Tumor",NA,802,80,NA,1309305600,"11",20,"TCGA-EO-A2CH-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T11:10:27.956203-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"83da9bfc-01d3-4207-b89c-8d3d633b4a49",NA,"TCGA-EO-A2CH-01A-01-TSA",NA,100,NA,"89c245c9-69a2-4c31-b2b0-e70374098004","RNA","TCGA-EO-A2CH-01A-11R","931fa953-a71d-4d26-ac5c-ba25bceb5254",1.76,0.17,"UV Spec","R","23","TCGA-EO-A2CH-01A-11R-A180-07","f9814b3c-60f3-4d83-885e-1e1a88e520a9",0.17,NA,66,28.5664819944598,152,"27d5dc16-87d0-5b6f-b708-e697b47c17d7","TCGA-EO-A2CH_exposure","UNCID_2206597.f9814b3c-60f3-4d83-885e-1e1a88e520a9.110928_UNC6-RDR300211_00126_FC_6348UAAXX_3.tar.gz","2013-09-27T12:01:03.000Z","2013-09-27T12:14:02.000Z","83E5CED7-F114-48FF-820E-593923A13C67","F0906353-4C3B-4F71-9B0B-CB1477450013","Unaligned reads",2361897603,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","F9814B3C-60F3-4D83-885E-1E1A88E520A9","University of North Carolina","566074d3e4b016715ab67a79","0CC9A11F-1AC4-431D-8F94-52A3BC02B572","Uterine Corpus Endometrial Carcinoma","TARGZ","89C245C9-69A2-4C31-B2B0-E70374098004","2013-09-27T12:14:02.000Z","931FA953-A71D-4D26-AC5C-BA25BCEB5254","Canada","NO",1,NA,"Primary Tumor","University Health Network",802,"89C245C9-69A2-4C31-B2B0-E70374098004",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3CF90784-6646-4288-8671-ACE67B983808.txt",80,"TCGA-EO-A2CH-01A",NA,"EFD83836-6B57-413E-92BD-726D33E21538","TCGA",2009,NA,NA,"WITH TUMOR","F0906353-4C3B-4F71-9B0B-CB1477450013",73,"WHIRR_p_TCGA_168_169_170_redo_N_GenomeWideSNP_6_G02_845218.nocnv_hg19.seg.txt","Dead",590,"TCGA-EO-A2CH",NA,"AA13D25C-1D8A-4CB4-ACD6-51BAFFEF0961",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",168,NA,"E70B245D-527B-44F0-B08E-08EE012599A1",NA,NA,11,20,"83DA9BFC-01D3-4207-B89C-8D3D633B4A49","931FA953-A71D-4D26-AC5C-BA25BCEB5254","UNCID_1619377.f9814b3c-60f3-4d83-885e-1e1a88e520a9.sorted_genome_alignments.bam","TCGA-EO-A2CH-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-EO-A2CH-01A-01-TSA",100,"taxol","Chemotherapy","TCGA-EO-A2CH-D56868","TCGA-EO-A2CH-R56872","External","Distant Recurrence","TCGA-EO-A2CH-F70417_NTE-3","YES",NA,"WITH TUMOR","Dead",590,"TCGA-EO-A2CH-F70417","TCGA-EO-A2CH",1,"EO","A2CH","YES","C54.1","8441/3","C54.1","NO","YES",-26966,"FEMALE",NA,NA,"No","No","Dead",NA,590,NA,NA,"WITH TUMOR","NO",26,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,73,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31467873,30843962,2311515599,"69E55FC1-FD9B-49D0-9786-4C96F9D5C195.bw","0ce940f2-9eb1-4757-8f8f-147a4f3a1e67","69e55fc1-fd9b-49d0-9786-4c96f9d5c195","2016-08-09T14:15:59.594477-05:00","UNCID_2212196.41f4268d-a222-4d6b-b4aa-515bb8765c6c.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_4.tar.gz","bf041efc-6c6c-4506-806d-3abee3c0bcb3",1954545215,"Illumina GA","56dbab3d0e9265d4222c869816ce83fe","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:19:19.967624-05:00","2016-05-03T11:16:29.242391-05:00","bf041efc-6c6c-4506-806d-3abee3c0bcb3_analysis.xml","436b08bcd07d114aac3c660a61710120","b322d3e0-b084-4a44-a684-b2c6a6b69008",2121,"2016-09-29T23:59:24.826044-05:00","bf041efc-6c6c-4506-806d-3abee3c0bcb3_experiment.xml","ba7be25ccd7512cdfeaf84e3582f8f63","f14d7ef6-6279-4291-a4bb-a9aac5560063",2257,"2016-09-29T18:43:29.729270-05:00","bf041efc-6c6c-4506-806d-3abee3c0bcb3_run.xml","0c4169fe814ebbc1b6d77d7262517a27","2d3f0ecd-0c1d-4a08-9bff-6d1267e10056",347,"2016-09-08T11:13:23.897441-05:00","TCGA-D1-A0ZR","2016-09-02T18:49:12.290300-05:00","female","TCGA-D1-A0ZR_demographic",1952,"white","7013e283-d503-51f1-b15e-14770b692036","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A0ZR_diagnosis","not reported",21157,"alive","8380/3",NA,17,"dd662e50-f856-549e-b8c3-3d974418f62a","c54.1",-21157,"TCGA-D1-A0ZR_treatment","1c79c103-84a2-5df3-a04c-23e6078fe081","01","false","TCGA-D1-A0ZR-01A",NA,"6647e6db-bba8-4e27-b24f-fc886d777906",FALSE,"ECC5B77F-7B6C-4C4A-A32C-1346DC3AF24D","Primary Tumor",NA,537,240,NA,1288310400,"21",30,"TCGA-D1-A0ZR-01A-21",90,70,0,0,0,0,10,30,"2016-09-08T11:13:23.897441-05:00","2016-09-08T11:13:23.897441-05:00",20,20,10,20,"BOTTOM","TOP",10,10,"660250c8-1893-4175-b6a6-e568732f263e","1dad6c1e-2f1a-4a06-86c3-a2572f486261","TCGA-D1-A0ZR-01A-02-BS2","TCGA-D1-A0ZR-01A-01-BS1",80,60,"48b63274-2f66-4501-abe1-625e161763ef","RNA","TCGA-D1-A0ZR-01A-21R","49be2dbd-3142-40a8-8031-c605b5aeb4a2",1.82,0.16,"UV Spec","R","23","TCGA-D1-A0ZR-01A-21R-A10J-07","41f4268d-a222-4d6b-b4aa-515bb8765c6c",0.16,NA,117,42.9752066115702,165,"30bb3a9b-216e-5039-99c9-9780f7827b82","TCGA-D1-A0ZR_exposure","UNCID_2212196.41f4268d-a222-4d6b-b4aa-515bb8765c6c.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_4.tar.gz","2013-10-03T06:16:03.000Z","2013-10-03T06:28:02.000Z","BF041EFC-6C6C-4506-806D-3ABEE3C0BCB3","6647E6DB-BBA8-4E27-B24F-FC886D777906","Unaligned reads",1954545215,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","41F4268D-A222-4D6B-B4AA-515BB8765C6C","University of North Carolina","5660776ae4b018727fea14a1","0CE940F2-9EB1-4757-8F8F-147A4F3A1E67","Uterine Corpus Endometrial Carcinoma","TARGZ","48B63274-2F66-4501-ABE1-625E161763EF","2013-10-03T06:28:02.000Z","49BE2DBD-3142-40A8-8031-C605B5AEB4A2","None","NO",1,NA,"Primary Tumor","Mayo Clinic",537,"48B63274-2F66-4501-ABE1-625E161763EF",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B7CAE504-6F63-49DF-8575-2409EEAD4418.txt",240,"TCGA-D1-A0ZR-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","C4027278-B2EA-483D-ABA6-A3B8757559A2",57,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B7CAE504-6F63-49DF-8575-2409EEAD4418.txt","Alive",NA,"TCGA-D1-A0ZR","NOT HISPANIC OR LATINO","0C356884-ED96-47EA-98FC-8485B2D8B7D0",NA,17,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,21,30,"660250C8-1893-4175-B6A6-E568732F263E","E7371425-429B-46F4-8FC8-264798632887","UNCID_2212196.41f4268d-a222-4d6b-b4aa-515bb8765c6c.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_4.tar.gz","TCGA-D1-A0ZR-01A-21",70,0,0,20,30,"TOP",10,20,"TCGA-D1-A0ZR-01A-01-BS1",60,NA,NA,NA,NA,NA,NA,NA,"NO",17,"TUMOR FREE","Alive",NA,"TCGA-D1-A0ZR-F17748","TCGA-D1-A0ZR",1,"D1","A0ZR","YES","C54.1","8380/3","C54.1","NO","YES",-21157,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",17,NA,NA,NA,"TUMOR FREE","NO",8,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
30121507,29376534,2212989155,"ED86F92E-6B39-4C0C-9A60-870984F53C4D.bw","0da7bbd4-ed8d-474b-b494-cb93c5fa811e","ed86f92e-6b39-4c0c-9a60-870984f53c4d","2016-08-05T16:26:11.406628-05:00","UNCID_2214547.a18fa5ae-5c28-426a-a7ae-d0c0b223991f.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_6.tar.gz","40fd543f-f771-4502-8405-a7fd91824711",1998765695,"Illumina GA","97def20f425008d1e28272f990189bc4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:41:18.399442-05:00","2016-05-03T11:17:14.896869-05:00","40fd543f-f771-4502-8405-a7fd91824711_analysis.xml","69e6559b91499daacce6876b700d2b39","060b1b35-34f5-4d51-85a2-dc250b70d439",2121,"2016-09-29T18:09:24.207010-05:00","40fd543f-f771-4502-8405-a7fd91824711_experiment.xml","dbfd620b3b3477b9e393728c3a88f0e7","17e97fa3-65e0-48a2-bdb6-d461a99181dc",2257,"2016-09-30T00:17:23.517694-05:00","40fd543f-f771-4502-8405-a7fd91824711_run.xml","c0788184fe4017732b22169c1c604fbf","fc4a9adb-799c-41a8-95dc-8824cd9590e3",347,"2016-09-08T12:13:25.693018-05:00","TCGA-B5-A0JS","2016-09-02T18:47:57.326196-05:00","female","TCGA-B5-A0JS_demographic",1953,"white","9a587a49-7e43-57b6-9599-0dfd29696ad7","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0JS_diagnosis","not reported",19995,"alive","8380/3",NA,2627,"3046aeb0-f512-5573-88e3-35b4dd8c25bd","c54.1",-19995,"TCGA-B5-A0JS_treatment","96cf4c75-104b-516c-be24-5c709faaa2cc","01","true","TCGA-B5-A0JS-01A",NA,"d0b88b1c-150d-4abc-9f9e-8c51cb208efa",FALSE,"56BA86BF-9345-4956-952A-8EBA8C05926A","Primary Tumor",NA,1183,140,NA,1276732800,"11",30,"TCGA-B5-A0JS-01A-11",85,80,0,0,0,0,0,0,"2016-09-08T12:13:25.693018-05:00","2016-09-08T12:13:25.693018-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"5015e127-ad75-491f-afe9-d331532e701c","fb0ef224-c1c6-4c7e-be5a-c304128d1263","TCGA-B5-A0JS-01A-01-BSA","TCGA-B5-A0JS-01A-01-TSA",100,100,"e7cdfb87-dc65-4b3a-9380-5b0ba87e9bda","RNA","TCGA-B5-A0JS-01A-11R","23550e55-6a3f-41d0-a881-bc58199bfd63",1.78,0.15,"UV Spec","R","23","TCGA-B5-A0JS-01A-11R-A104-07","a18fa5ae-5c28-426a-a7ae-d0c0b223991f",0.15,NA,110,38.0622837370242,170,"0d6e2c5e-0f9c-5bde-8386-15f4accb414f","TCGA-B5-A0JS_exposure","UNCID_2214547.a18fa5ae-5c28-426a-a7ae-d0c0b223991f.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_6.tar.gz","2013-10-03T16:55:04.000Z","2013-10-03T17:07:01.000Z","40FD543F-F771-4502-8405-A7FD91824711","D0B88B1C-150D-4ABC-9F9E-8C51CB208EFA","Unaligned reads",1998765695,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A18FA5AE-5C28-426A-A7AE-D0C0B223991F","University of North Carolina","5660762fe4b018727fea08b7","0DA7BBD4-ED8D-474B-B494-CB93C5FA811E","Uterine Corpus Endometrial Carcinoma","TARGZ","E7CDFB87-DC65-4B3A-9380-5B0BA87E9BDA","2013-10-03T17:07:01.000Z","23550E55-6A3F-41D0-A881-BC58199BFD63","United States","NO",1,NA,"Primary Tumor","Duke",1183,"E7CDFB87-DC65-4B3A-9380-5B0BA87E9BDA",NA,"B5","UNCID_1636552.a18fa5ae-5c28-426a-a7ae-d0c0b223991f.sorted_genome_alignments.bam",140,"TCGA-B5-A0JS-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","DEAC81F9-E5C9-402A-9B45-121E2C7DCF7A",54,"nationwidechildrens.org_clinical.TCGA-B5-A0JS.xml","Alive",NA,"TCGA-B5-A0JS",NA,"BE682834-F267-4375-9652-85138A1A9ACB",NA,1241,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,11,30,"FB0EF224-C1C6-4C7E-BE5A-C304128D1263","E93267DC-02DC-4217-A85A-D68710F28EAB","CAUSE_p_TCGAb73_SNP_N_GenomeWideSNP_6_H03_698232.ismpolish.data.txt","TCGA-B5-A0JS-01A-11",80,0,0,0,0,"TOP",0,0,"TCGA-B5-A0JS-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",1422,"TUMOR FREE","Alive",NA,"TCGA-B5-A0JS-F12982","TCGA-B5-A0JS",1,"B5","A0JS","YES","C54.1","8380/3","C54.1","NO","YES",-19995,"FEMALE","WHITE",NA,"No","No","Alive",1241,NA,NA,NA,"TUMOR FREE","NO",8,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2007,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33747683,32912059,2475900740,"5B65768D-0E81-4469-9D69-69B07ED5ACD5.bw","0e9c36fd-2d5d-48da-8364-f8c5edc3d873","5b65768d-0e81-4469-9d69-69b07ed5acd5","2016-08-09T14:14:45.354721-05:00","UNCID_2209935.486755e1-9b18-4310-a1bb-ddd325f212b0.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_1.tar.gz","5a9229cb-e65d-4ce8-9698-773bb0791e57",2257106752,"Illumina GA","d6f09bc76e727ef7cce57ea077f73248","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:18:43.178861-05:00","2016-05-03T11:15:47.413267-05:00","5a9229cb-e65d-4ce8-9698-773bb0791e57_analysis.xml","1818136e753fcdde07581d3b8d6c8a2d","1d9556d0-9579-4d01-87d2-efe99e6c7789",2121,"2016-09-29T20:46:17.734166-05:00","5a9229cb-e65d-4ce8-9698-773bb0791e57_experiment.xml","3678ea4ecdd35d8e22a110029338a61b","796e62b7-7c52-4a4d-bfcb-00fc1ade4011",2257,"2016-09-29T17:59:52.086099-05:00","5a9229cb-e65d-4ce8-9698-773bb0791e57_run.xml","9f03fccc24c001ea02bd7470702a02c4","11dc8b85-32e6-4b64-9176-1077c72cd791",347,"2016-09-08T10:58:33.690511-05:00","TCGA-D1-A16Y","2016-09-02T18:50:32.173619-05:00","female","TCGA-D1-A16Y_demographic",1953,"white","8802988a-0d68-5a09-bdc4-3b21e28f31f8","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16Y_diagnosis","not reported",20455,"alive","8380/3",NA,532,"8bc6d042-8041-55ba-93f4-86fc56b8bcf6","c54.1",-20455,"TCGA-D1-A16Y_treatment","82762a59-3efa-5b1f-8d1f-3bf5927c05dd","01","false","TCGA-D1-A16Y-01A",NA,"56b2dbc4-9ab6-43ef-9d86-a39d4a60a18d",FALSE,"0A0451C4-2A58-4404-934E-3517443E4CEE","Primary Tumor",NA,610,220,NA,1294185600,"31",30,"TCGA-D1-A16Y-01A-31",75,NA,2,NA,0,NA,25,NA,"2016-09-08T10:58:33.690511-05:00",NA,4,NA,1,NA,"TOP",NA,0,NA,"758c48e8-05e0-4699-ad05-5b2af3043dd5",NA,"TCGA-D1-A16Y-01A-03-TS3",NA,75,NA,"e899a9fd-d75b-4a9e-ba2d-10c8ec0cf2df","RNA","TCGA-D1-A16Y-01A-31R","c910f364-b904-4a0e-89d6-ab20d9459bb9",1.84,0.16,"UV Spec","R","23","TCGA-D1-A16Y-01A-31R-A12I-07","486755e1-9b18-4310-a1bb-ddd325f212b0",0.16,NA,87,35.7495069033531,156,"e4c724b9-9f82-54fa-96c7-86b6218ac8c6","TCGA-D1-A16Y_exposure","UNCID_2209935.486755e1-9b18-4310-a1bb-ddd325f212b0.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_1.tar.gz","2013-10-02T02:16:04.000Z","2013-10-02T02:29:03.000Z","5A9229CB-E65D-4CE8-9698-773BB0791E57","56B2DBC4-9AB6-43EF-9D86-A39D4A60A18D","Unaligned reads",2257106752,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","486755E1-9B18-4310-A1BB-DDD325F212B0","University of North Carolina","564a3e19e4b0ef12181b4cec","0E9C36FD-2D5D-48DA-8364-F8C5EDC3D873","Uterine Corpus Endometrial Carcinoma","TARGZ","E899A9FD-D75B-4A9E-BA2D-10C8EC0CF2DF","2013-10-02T02:29:03.000Z","C910F364-B904-4A0E-89D6-AB20D9459BB9","None","NO",1,NA,"Primary Tumor","Mayo Clinic",610,"E899A9FD-D75B-4A9E-BA2D-10C8EC0CF2DF",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B3D6CAEC-CBFC-4417-8810-8CB3BF4AE37B.txt",220,"TCGA-D1-A16Y-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","56B2DBC4-9AB6-43EF-9D86-A39D4A60A18D",56,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B3D6CAEC-CBFC-4417-8810-8CB3BF4AE37B.txt","Alive",NA,"TCGA-D1-A16Y","NOT HISPANIC OR LATINO","173BC925-9ECA-4C17-A51D-1826D1A49D34",NA,532,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,31,30,"758C48E8-05E0-4699-AD05-5B2AF3043DD5","D50D9CE7-ED57-4972-B6D5-3843C96979E3","TCGA-D1-A16Y-01A-31D-A12J-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-D1-A16Y-01A-31",75,0,2,4,25,"TOP",0,1,"TCGA-D1-A16Y-01A-03-TS3",75,NA,NA,NA,NA,NA,NA,NA,"NO",532,"TUMOR FREE","Alive",NA,"TCGA-D1-A16Y-F20232","TCGA-D1-A16Y",1,"D1","A16Y","YES","C54.1","8380/3","C54.1","NO","YES",-20455,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",532,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","RX",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32605243,32039036,2397928492,"52B323DD-011C-417C-B0F3-311037D7C0F0.bw","0f064588-2d7e-439a-90a6-dfa17bb8af15","52b323dd-011c-417c-b0f3-311037d7c0f0","2016-08-09T14:12:48.032064-05:00","UNCID_2207203.2aacc974-7ee5-4be2-b511-1543745df0bf.110719_UNC2-RDR300275_00077_FC_70KATAAXX_4.tar.gz","eb4e2c48-ba46-4b75-831b-400554f80145",2020801769,"Illumina GA","b7688fb7b6197f9510786a0ecce8c530","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:02:29.947471-05:00","2016-05-03T11:13:42.375045-05:00","eb4e2c48-ba46-4b75-831b-400554f80145_analysis.xml","d86db4b43f41d6f10138137005000095","837fe5d4-5829-43e9-b207-26d5530a44dd",2121,"2016-09-29T23:33:31.621842-05:00","eb4e2c48-ba46-4b75-831b-400554f80145_experiment.xml","988029f6de7fa8ccd121f92e90a3e530","e13c9bb1-f692-4bb8-b8f7-67821016817f",2257,"2016-09-29T17:47:27.590098-05:00","eb4e2c48-ba46-4b75-831b-400554f80145_run.xml","dd0dec7ddc06f870e22810cbc44e6465","0a106cf1-0c56-4a1a-bbdb-14b9bee8e979",347,"2016-09-09T16:39:07.370885-05:00","TCGA-AP-A1DR","2016-09-02T18:51:26.926710-05:00","female","TCGA-AP-A1DR_demographic",1949,"black or african american","af4a58b5-00b5-54cb-9916-1f23f97edda9","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1DR_diagnosis","not reported",21904,"alive","8380/3",NA,1495,"7958c319-6c8a-5ba4-99d0-4133f679682f","c54.1",-21904,"TCGA-AP-A1DR_treatment","7d3bee46-6a25-5eae-be92-a210085b7b0a","01","true","TCGA-AP-A1DR-01A",NA,"438480e7-9b80-44a4-89d8-6b7a27028f35",FALSE,"75A10A08-04CB-49C2-8086-5F7B1D57524E","Primary Tumor",NA,1095,270,NA,1295395200,"11",30,"TCGA-AP-A1DR-01A-11",90,NA,6,NA,0,NA,10,NA,"2016-09-09T16:39:07.370885-05:00",NA,4,NA,2,NA,"TOP",NA,2,NA,"22258451-b020-41e5-a02e-7f8121c85285",NA,"TCGA-AP-A1DR-01A-01-TSA",NA,88,NA,"83a8deaa-6db9-4554-afb9-953c76d377a5","RNA","TCGA-AP-A1DR-01A-11R","d6cc0fb3-b39c-423c-8736-517198c10b76",1.82,0.18,"UV Spec","R","23","TCGA-AP-A1DR-01A-11R-A137-07","2aacc974-7ee5-4be2-b511-1543745df0bf",0.18,NA,109,42.578125,160,"07fb36b0-b3e2-5f89-82bc-2479fd1930ee","TCGA-AP-A1DR_exposure","UNCID_2207203.2aacc974-7ee5-4be2-b511-1543745df0bf.110719_UNC2-RDR300275_00077_FC_70KATAAXX_4.tar.gz","2013-09-29T17:55:04.000Z","2013-09-29T18:07:01.000Z","EB4E2C48-BA46-4B75-831B-400554F80145","438480E7-9B80-44A4-89D8-6B7A27028F35","Unaligned reads",2020801769,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2AACC974-7EE5-4BE2-B511-1543745DF0BF","University of North Carolina","564a3ab0e4b0ef12181a3605","0F064588-2D7E-439A-90A6-DFA17BB8AF15","Uterine Corpus Endometrial Carcinoma","TARGZ","83A8DEAA-6DB9-4554-AFB9-953C76D377A5","2013-09-29T18:07:01.000Z","D6CC0FB3-B39C-423C-8736-517198C10B76","None","NO",1,NA,"Primary Tumor","MSKCC",1095,"83A8DEAA-6DB9-4554-AFB9-953C76D377A5",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F10639F4-19FB-4548-ADC6-F6E92B342732.txt",270,"TCGA-AP-A1DR-01A",NA,"F28A5D76-6DB1-4279-B8D8-CE825F7D81FD","TCGA",2008,NA,NA,"TUMOR FREE","448EC0D5-6458-4788-AF2A-FFF5288ECB0B",59,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F10639F4-19FB-4548-ADC6-F6E92B342732.txt","Alive",NA,"TCGA-AP-A1DR",NA,"DBA2A65A-9BF9-4CD0-855A-094DCB0A213C",NA,1131,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"8A7775D4-8E0F-4FA6-9CE1-B511B7B33DF2","BLACK OR AFRICAN AMERICAN",NA,11,30,"22258451-B020-41E5-A02E-7F8121C85285","D6CC0FB3-B39C-423C-8736-517198C10B76","TCGA-AP-A1DR-01A-11R-A136-13_mirna.bam.bai","TCGA-AP-A1DR-01A-11",90,0,6,4,10,"TOP",2,2,"TCGA-AP-A1DR-01A-01-TSA",88,"Cisplatin","Chemotherapy","TCGA-AP-A1DR-D13629","TCGA-AP-A1DR-R13628","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",1332,"TUMOR FREE","Alive",NA,"TCGA-AP-A1DR-F13626","TCGA-AP-A1DR",1,"AP","A1DR","YES","C54.1","8380/3","C54.1","NO","YES",-21904,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1131,NA,NA,NA,"TUMOR FREE","NO",9,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2008,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34371878,33970192,2549902483,"5513114D-2503-4D11-ADA4-35BE010510E5.bw","0f361166-2b7d-4ef5-9f8f-ee2488548a0b","5513114d-2503-4d11-ada4-35be010510e5","2016-08-05T09:47:15.831908-05:00","UNCID_2189525.adddccb0-d276-4450-a8cf-aef663a6f45c.120524_UNC2-RDR300275_00121_FC_64KREAAXX_1.tar.gz","1a4f19e0-7e38-49e5-9925-acf5fdfa6be8",2125431976,"Illumina GA","50007cf3730e938a90b7d4b51ab94166","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:25:47.592101-05:00","2016-05-03T11:05:01.523277-05:00","1a4f19e0-7e38-49e5-9925-acf5fdfa6be8_analysis.xml","0a3f1e36a9c661781cb97fabe96d45f8","dc577dec-4d3c-4ef7-a25e-e78181e0965c",2122,"2016-09-29T17:38:55.312291-05:00","1a4f19e0-7e38-49e5-9925-acf5fdfa6be8_experiment.xml","f2435a8a7a87d6f0b9f4b7a88a861561","04804198-0079-4788-a03f-b1d62d0ae39c",2258,"2016-09-30T00:00:14.572268-05:00","1a4f19e0-7e38-49e5-9925-acf5fdfa6be8_run.xml","380b3f9828fa5656b1a55d50e4bff89d","f1ca0a8a-f91b-448e-a9ab-eab20c7dfb1b",349,"2016-09-08T10:56:50.685051-05:00","TCGA-A5-A1OJ","2016-09-02T18:52:10.825675-05:00","female","TCGA-A5-A1OJ_demographic",1979,"asian","e5720da2-a49b-5fb5-abcc-a6160a9f1e5b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A1OJ_diagnosis","not reported",11635,"alive","8380/3",NA,1006,"f0133f94-0d43-5f2d-9cb6-85f8dd31a950","c54.1",-11635,"TCGA-A5-A1OJ_treatment","f2737e46-f6d1-5acd-a707-0daed1edd884","01","true","TCGA-A5-A1OJ-01A",NA,"effd3ebc-fa75-4317-a3cb-37ca27d3208c",FALSE,"F696BCE9-707C-4825-8A53-EFED20EBF656","Primary Tumor",NA,161,170,NA,1301270400,"11",30,"TCGA-A5-A1OJ-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T10:56:50.685051-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"d4e86c5d-02dc-434c-9946-d5fb4503f1ff",NA,"TCGA-A5-A1OJ-01A-01-TSA",NA,80,NA,"1a007182-c3d2-45b2-9fc3-d6380158b4d3","RNA","TCGA-A5-A1OJ-01A-11R","e7ef9613-3bed-4520-a7ae-3d32846a4ec5",1.88,0.18,"UV Spec","R","23","TCGA-A5-A1OJ-01A-11R-A14D-07","adddccb0-d276-4450-a8cf-aef663a6f45c",0.18,NA,94,39.1259105098855,155,"dbad19fd-fb0f-558c-a8bf-1eb2b82f744b","TCGA-A5-A1OJ_exposure","UNCID_2189525.adddccb0-d276-4450-a8cf-aef663a6f45c.120524_UNC2-RDR300275_00121_FC_64KREAAXX_1.tar.gz","2013-09-19T00:56:03.000Z","2013-09-19T01:07:02.000Z","1A4F19E0-7E38-49E5-9925-ACF5FDFA6BE8","EFFD3EBC-FA75-4317-A3CB-37CA27D3208C","Unaligned reads",2125431976,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","ADDDCCB0-D276-4450-A8CF-AEF663A6F45C","University of North Carolina","56607f4ce4b018727fea3a0f","0F361166-2B7D-4EF5-9F8F-EE2488548A0B","Uterine Corpus Endometrial Carcinoma","TARGZ","1A007182-C3D2-45B2-9FC3-D6380158B4D3","2013-09-19T01:07:02.000Z","E7EF9613-3BED-4520-A7AE-3D32846A4EC5","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",161,"1A007182-C3D2-45B2-9FC3-D6380158B4D3",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F8816AD0-EFF9-40C9-9A73-0D95CA01B355.txt",170,"TCGA-A5-A1OJ-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","EFFD3EBC-FA75-4317-A3CB-37CA27D3208C",31,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F8816AD0-EFF9-40C9-9A73-0D95CA01B355.txt","Alive",NA,"TCGA-A5-A1OJ","NOT HISPANIC OR LATINO","A687DAD7-EF3F-495B-BD98-A456CA9434E0",NA,292,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"ASIAN",NA,11,30,"D4E86C5D-02DC-434C-9946-D5FB4503F1FF","28FADEFD-42B6-40BB-9F07-D33A7552186C","e3e4302c9fab754badf6c9b9b79d8610.bam.bai","TCGA-A5-A1OJ-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-A5-A1OJ-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,"NO",292,"TUMOR FREE","Alive",NA,"TCGA-A5-A1OJ-F14491","TCGA-A5-A1OJ",1,"A5","A1OJ","YES","C54.1","8380/3","C54.1","YES","NO",-11635,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",292,NA,NA,NA,"TUMOR FREE","NO",1,8,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,31,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
36550014,35966243,2683205568,"B933A84B-7F0A-4FCB-B864-ABDF0F2DF1AD.bw","0f36c3a2-0ba5-4c43-a3f0-78d125e5d0ac","b933a84b-7f0a-4fcb-b864-abdf0f2df1ad","2016-08-09T13:57:58.085866-05:00","UNCID_2189521.ef62242e-872b-4bd3-ac3d-a6645f771020.120524_UNC2-RDR300275_00121_FC_64KREAAXX_4.tar.gz","b78e7e73-63e6-432e-96e6-1883e6cb0865",2339797677,"Illumina GA","1a0b832168c3e6136ed4ac8e4a069540","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:35:20.494873-05:00","2016-05-03T11:05:01.523277-05:00","b78e7e73-63e6-432e-96e6-1883e6cb0865_analysis.xml","306592de8403dc6230e947810f824ebe","27f56c1b-a33a-4275-bcb9-90c24b06158f",2122,"2016-08-13T05:23:06.316068-05:00","b78e7e73-63e6-432e-96e6-1883e6cb0865_experiment.xml","76a549e6c77976551a493939f889851d","c6f23588-b6fb-4c26-82b1-f4411e33555b",2258,"2016-09-29T21:56:36.039053-05:00","b78e7e73-63e6-432e-96e6-1883e6cb0865_run.xml","76804434cab06abf9a3271c892f81e85","a53e75a5-86f1-43d8-a54f-a93dc81aff93",349,"2016-09-08T11:24:34.999493-05:00","TCGA-B5-A1MV","2016-09-02T18:52:14.496805-05:00","female","TCGA-B5-A1MV_demographic",1926,"white","62e5753a-c900-5b22-b3ab-7d11afe47bdf","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A1MV_diagnosis","not reported",30926,"alive","8380/3",NA,1565,"1dfe36df-e4de-5a59-83e4-d4b83ab864b4","c54.1",-30926,"TCGA-B5-A1MV_treatment","81ad654f-04f2-5ca0-91c3-65fe8350599d","01","true","TCGA-B5-A1MV-01A",NA,"efd221c1-8513-4129-99ba-43ab94d1a6b9",FALSE,"E536759E-F47A-4EE9-B855-AFEC6BCF5EE0","Primary Tumor",NA,226,470,NA,1301529600,"31",30,"TCGA-B5-A1MV-01A-31",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:24:34.999493-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"6cf0aa75-b7b7-4fb9-bb21-f7d50845fdb5",NA,"TCGA-B5-A1MV-01A-03-TSC",NA,70,NA,"3bd6644c-db72-4cc1-8af2-ff59bd4664e7","RNA","TCGA-B5-A1MV-01A-31R","2e2d3e01-5d0d-400c-893e-66af9ed5dd7c",1.79,0.15,"UV Spec","R","23","TCGA-B5-A1MV-01A-31R-A14D-07","ef62242e-872b-4bd3-ac3d-a6645f771020",0.15,NA,72,31.5775623876146,151,"0e4fcdc3-82ce-5c03-8032-d6ee1b25dc39","TCGA-B5-A1MV_exposure","UNCID_2189521.ef62242e-872b-4bd3-ac3d-a6645f771020.120524_UNC2-RDR300275_00121_FC_64KREAAXX_4.tar.gz","2013-09-19T00:36:05.000Z","2013-09-19T00:49:01.000Z","B78E7E73-63E6-432E-96E6-1883E6CB0865","EFD221C1-8513-4129-99BA-43AB94D1A6B9","Unaligned reads",2339797677,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","EF62242E-872B-4BD3-AC3D-A6645F771020","University of North Carolina","566076a4e4b018727fea0d6a","0F36C3A2-0BA5-4C43-A3F0-78D125E5D0AC","Uterine Corpus Endometrial Carcinoma","TARGZ","3BD6644C-DB72-4CC1-8AF2-FF59BD4664E7","2013-09-19T00:49:01.000Z","2E2D3E01-5D0D-400C-893E-66AF9ED5DD7C","United States","NO",1,NA,"Primary Tumor","Duke",226,"3BD6644C-DB72-4CC1-8AF2-FF59BD4664E7",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F062FF19-5D49-4994-9952-F263FDB3B0B6.txt",470,"TCGA-B5-A1MV-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","F4390757-28D2-4C49-AB8E-6F27673BF555",84,"nationwidechildrens.org_clinical.TCGA-B5-A1MV.xml","Alive",NA,"TCGA-B5-A1MV",NA,"BBED1082-A2A5-4C2E-AB61-424397467BF7",NA,380,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,31,30,"6CF0AA75-B7B7-4FB9-BB21-F7D50845FDB5","35AE12CA-A218-4073-A3E6-90E584C181DE","B5-A1MV-10A-01D_BCR3730_2011-09-21_029.fsa","TCGA-B5-A1MV-01A-31",70,0,20,40,20,"TOP",10,20,"TCGA-B5-A1MV-01A-03-TSC",70,NA,NA,NA,NA,NA,NA,NA,"NO",438,"TUMOR FREE","Alive",NA,"TCGA-B5-A1MV-F21608","TCGA-B5-A1MV",1,"B5","A1MV","YES","C54.1","8380/3","C54.1","NO","YES",-30926,"FEMALE","WHITE",NA,"No","No","Alive",380,NA,NA,NA,"TUMOR FREE","NO",15,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,84,2010,"Dilation and curettage procedure",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34948510,34354407,2559677775,"CCA012D6-E956-44A2-B4ED-046B02103242.bw","0f59bb0a-135c-4793-b1a7-5ad5172ed82d","cca012d6-e956-44a2-b4ed-046b02103242","2016-08-05T03:05:48.839037-05:00","UNCID_2209894.3486bd36-927d-46c7-8efe-5f2d6c80ac5e.110420_UNC6-RDR300211_00096_FC_634WMAAXX_1.tar.gz","1fe8c441-0fd8-4bdd-bf25-7bffdf949639",2320283886,"Illumina GA","9ee249f1f50f54e9b08b0d1328903eea","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:54:08.142717-05:00","2016-05-03T11:15:47.414649-05:00","1fe8c441-0fd8-4bdd-bf25-7bffdf949639_analysis.xml","aef2b2b7bee609a48601c0743cad4910","7e561ff4-8732-4cb4-b260-59d282cf330b",2121,"2016-08-13T06:14:10.283229-05:00","1fe8c441-0fd8-4bdd-bf25-7bffdf949639_experiment.xml","cc001bfce53088a382f794ecf19ffc41","f6d086d1-cde2-4b44-a9e0-59a32657e8f3",2257,"2016-09-30T00:00:07.311012-05:00","1fe8c441-0fd8-4bdd-bf25-7bffdf949639_run.xml","41cd3aa85ac5ff7e52fbf30fa0b51b83","f1b5a9b6-f93a-43ca-b722-2274c9df0a9b",347,"2016-09-08T11:10:28.253583-05:00","TCGA-BG-A187","2016-09-02T18:49:59.127452-05:00","female","TCGA-BG-A187_demographic",1945,"white","0f4a1aa0-c451-5604-8efd-ca457cdff74c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A187_diagnosis","not reported",24099,"alive","8380/3",NA,448,"e8487744-febb-5b64-a59f-86367bf55cd4","c54.1",-24099,"TCGA-BG-A187_treatment","d3514da6-ca59-52b6-91c3-6d8386390293","01","true","TCGA-BG-A187-01A",NA,"1738b7d6-c860-449a-aae9-065ef65a149b",FALSE,"CB8E915A-CE5D-4181-9303-22BD8CBCB80D","Primary Tumor",NA,97,360,NA,1294358400,"11",20,"TCGA-BG-A187-01A-11",70,NA,0,NA,0,NA,0,NA,"2016-09-08T11:10:28.253583-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"ef51e171-34c5-4b11-acff-8fad08440a53",NA,"TCGA-BG-A187-01A-01-TSA",NA,100,NA,"c484bfe7-7e72-477b-a239-4d8f9556cdd2","RNA","TCGA-BG-A187-01A-11R","066b80e6-7b89-498a-9a9a-7ccacf7b8daa",1.83,0.16,"UV Spec","R","23","TCGA-BG-A187-01A-11R-A12I-07","3486bd36-927d-46c7-8efe-5f2d6c80ac5e",0.16,NA,61,23.828125,160,"d65d846e-71c0-5f2f-97b2-d597b935cf6d","TCGA-BG-A187_exposure","UNCID_2209894.3486bd36-927d-46c7-8efe-5f2d6c80ac5e.110420_UNC6-RDR300211_00096_FC_634WMAAXX_1.tar.gz","2013-10-02T00:26:03.000Z","2013-10-02T00:39:03.000Z","1FE8C441-0FD8-4BDD-BF25-7BFFDF949639","1738B7D6-C860-449A-AAE9-065EF65A149B","Unaligned reads",2320283886,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3486BD36-927D-46C7-8EFE-5F2D6C80AC5E","University of North Carolina","56607a59e4b0ca319164f69d","0F59BB0A-135C-4793-B1A7-5AD5172ED82D","Uterine Corpus Endometrial Carcinoma","TARGZ","C484BFE7-7E72-477B-A239-4D8F9556CDD2","2013-10-02T00:39:03.000Z","066B80E6-7B89-498A-9A9A-7CCACF7B8DAA","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",97,"C484BFE7-7E72-477B-A239-4D8F9556CDD2",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F00FE736-702F-4CFE-9019-012CFD2D2BA0.txt",360,"TCGA-BG-A187-01A",NA,NA,"TCGA",2010,NA,NA,NA,"CD3FDD86-6DE6-4054-9F0E-E0F02E67DA94",65,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F00FE736-702F-4CFE-9019-012CFD2D2BA0.txt","Alive",NA,"TCGA-BG-A187","NOT HISPANIC OR LATINO","B34753B9-31E1-4ACB-81D6-5245E5EFBF7F",NA,231,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,20,"EF51E171-34C5-4B11-ACFF-8FAD08440A53","5661928E-DEBC-4E81-93D7-1DA946A89302","UNCID_200803.TCGA-BG-A187-01A-11R-A12I-07.110420_UNC6-RDR300211_00096_FC_634WMAAXX.1.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-BG-A187-01A-11",70,0,0,0,0,"TOP",0,0,"TCGA-BG-A187-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",448,"TUMOR FREE","Alive",NA,"TCGA-BG-A187-F28645","TCGA-BG-A187",1,"BG","A187","YES","C54.1","8380/3","C54.1","NO","YES",-24099,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",231,NA,NA,NA,NA,"NO",16,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
113491798,110356555,5265887390,"22E980A6-BC64-4A7E-8A08-8342AA92245F.bw","10eb7dfa-d43d-479f-8c46-c0424207f958","22e980a6-bc64-4a7e-8a08-8342aa92245f","2016-08-05T06:36:14.403182-05:00","UNCID_2166998.ca6bff3c-e95e-42e6-8eff-76d66e8031b0.130621_UNC14-SN744_0352_BC253TACXX_3_TGACCA.tar.gz","47ffecdf-8a08-4ebf-8313-f04a6b01c9c9",4995244334,"Illumina HiSeq","b052e139f6492fbaf6854744f94e1da7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:28:45.301146-05:00","2016-05-03T11:07:07.511815-05:00","47ffecdf-8a08-4ebf-8313-f04a6b01c9c9_analysis.xml","3190f4aa4e5a83a7b1c2c08b993c3a9f","940385c3-232d-4ad2-91c6-87a01a0c9491",2123,"2016-08-28T07:37:17.296893-05:00","47ffecdf-8a08-4ebf-8313-f04a6b01c9c9_experiment.xml","aa7e78f292d7e34d6488ac62b2b9a93f","f0b2812f-c789-4924-84f8-38dc874ceaae",2431,"2016-09-29T23:57:19.721045-05:00","47ffecdf-8a08-4ebf-8313-f04a6b01c9c9_run.xml","a76cc623245c51c372df74d2e97e2a51","f0030fc0-9119-4d36-9f91-2965b7694ad2",354,"2016-09-08T11:00:45.026907-05:00","TCGA-EO-A22X","2016-09-02T18:53:56.760840-05:00","female","TCGA-EO-A22X_demographic",1972,"not reported","692609e2-c553-550a-ac55-c875089ec9f1","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A22X_diagnosis","not reported",13245,"alive","8380/3",NA,1752,"ba89b860-0f53-5836-9e61-24f89de6f90c","c54.1",-13245,"TCGA-EO-A22X_treatment","7f11a2ae-e375-59b4-b31d-a96df7b1d6e5","01","false","TCGA-EO-A22X-01A",NA,"0c6fd9ef-cffe-4b5b-b2fb-8136285da058",FALSE,"4D919902-FBCE-4AAC-ACD2-38A2F1D8E901","Primary Tumor",NA,842,110,NA,1304899200,"11",30,"TCGA-EO-A22X-01A-11",70,NA,20,NA,0,NA,30,NA,"2016-09-08T11:00:45.026907-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"ad9e3dc0-0129-4966-a0fc-aaa97d8fcff3",NA,"TCGA-EO-A22X-01A-01-TSA",NA,70,NA,"716977a4-761c-48b8-a3f8-6281f3b989b2","RNA","TCGA-EO-A22X-01A-11R","dd80fb08-6e32-4906-a34c-01f9c0c22094",1.81,0.17,"UV Spec","R","23","TCGA-EO-A22X-01A-11R-A180-07","ca6bff3c-e95e-42e6-8eff-76d66e8031b0",0.17,NA,56,24.2382271468144,152,"67ccad95-5f1b-5ac3-9a9d-4bbb7c28fe1f","TCGA-EO-A22X_exposure","UNCID_2166998.ca6bff3c-e95e-42e6-8eff-76d66e8031b0.130621_UNC14-SN744_0352_BC253TACXX_3_TGACCA.tar.gz","2013-09-21T07:13:06.000Z","2013-09-21T07:29:02.000Z","47FFECDF-8A08-4EBF-8313-F04A6B01C9C9","0C6FD9EF-CFFE-4B5B-B2FB-8136285DA058","Unaligned reads",4995244334,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","CA6BFF3C-E95E-42E6-8EFF-76D66E8031B0","University of North Carolina","56607e2de4b018727fea3605","10EB7DFA-D43D-479F-8C46-C0424207F958","Uterine Corpus Endometrial Carcinoma","TARGZ","716977A4-761C-48B8-A3F8-6281F3B989B2","2013-09-21T07:29:02.000Z","DD80FB08-6E32-4906-A34C-01F9C0C22094","Canada","NO",1,NA,"Primary Tumor","University Health Network",842,"716977A4-761C-48B8-A3F8-6281F3B989B2",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.38F062A0-F499-4E30-A858-EC1133DD37E4.txt",110,"TCGA-EO-A22X-01A",NA,"FC7FC150-BE27-440E-9A6D-C267DB7A9EEA","TCGA",2008,NA,NA,"TUMOR FREE","85B8B67A-D160-43A2-AB8C-9263CAD8631C",36,"nationwidechildrens.org_clinical.TCGA-EO-A22X.xml","Alive",NA,"TCGA-EO-A22X",NA,"ECBC8C86-63B2-4994-A7C2-114FCE9E48E8",NA,982,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,NA,NA,NA,11,30,"AD9E3DC0-0129-4966-A0FC-AAA97D8FCFF3","DD80FB08-6E32-4906-A34C-01F9C0C22094","UNCID_2166998.ca6bff3c-e95e-42e6-8eff-76d66e8031b0.130621_UNC14-SN744_0352_BC253TACXX_3_TGACCA.tar.gz","TCGA-EO-A22X-01A-11",70,0,20,40,30,"TOP",0,20,"TCGA-EO-A22X-01A-01-TSA",70,"Carboplatin","Chemotherapy","TCGA-EO-A22X-D39979",NA,NA,NA,NA,"NO",1164,NA,"Alive",NA,"TCGA-EO-A22X-F32592","TCGA-EO-A22X",1,"EO","A22X","YES","C54.1","8380/3","C54.1","NO","YES",-13245,"FEMALE",NA,NA,"No","No","Alive",982,NA,NA,NA,"TUMOR FREE","NO",26,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,36,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
49362800,48599938,2321216219,"480836ED-A4A4-47E5-AE6F-5CCCADD0E490.bw","11285dc5-8742-477a-8692-af1b6e2c1434","480836ed-a4a4-47e5-ae6f-5cccadd0e490","2016-08-09T14:02:12.513281-05:00","UNCID_2167240.9d6c70ea-ec88-4b78-a495-cd31cc048ece.130613_UNC9-SN296_0375_BD27CGACXX_5_AGTCAA.tar.gz","e1005469-57b9-478d-b160-44f893cf3466",2429141621,"Illumina HiSeq","4d30a6f69ce46aa4e6647fd585bac375","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:30:23.740448-05:00","2016-05-03T11:07:07.492763-05:00","e1005469-57b9-478d-b160-44f893cf3466_analysis.xml","8b66587525677d0b9c6cffea80b09600","4adbf598-9e6b-4215-8ad0-84e828988101",2121,"2016-08-27T04:09:18.670353-05:00","e1005469-57b9-478d-b160-44f893cf3466_experiment.xml","ef0018541b18ba19424f42919e5cfb26","20ccfedf-6359-4fab-8030-bebdc1817175",2431,"2016-09-29T23:52:59.814971-05:00","e1005469-57b9-478d-b160-44f893cf3466_run.xml","73e60daea3395ba91b8f5af4bcc90bfa","ed59cb35-8d6e-4fe0-a3f2-9d5e566e7e4f",354,"2016-09-08T11:18:50.214498-05:00","TCGA-AX-A0IZ","2016-09-02T18:49:24.604923-05:00","female","TCGA-AX-A0IZ_demographic",1954,"white","400b2e1e-7ebf-56da-a404-7bc683ec14ce","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A0IZ_diagnosis","not reported",19364,"alive","8380/3",NA,1333,"fa08e52e-a08c-5dff-992d-48d8f2399ce4","c54.1",-19364,"TCGA-AX-A0IZ_treatment","81d10302-589d-5a62-be62-0151793a6cea","11","false","TCGA-AX-A0IZ-11A",NA,"e6ffcb81-f76d-40ee-ac9b-f71ed0c6c92d",FALSE,NA,"Solid Tissue Normal",NA,1485,160,NA,1308182400,"11",30,"TCGA-AX-A0IZ-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T11:18:50.214498-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"2477ae69-3d24-4dbf-97ea-f911e1d70287",NA,"TCGA-AX-A0IZ-11A-01-TSA",NA,0,NA,"a9a423f7-da11-40d4-9aa1-fac02ce78966","RNA","TCGA-AX-A0IZ-11A-11R","ced36f9c-58b0-405f-b4fe-944e7578d575",1.84,0.15,"UV Spec","R","23","TCGA-AX-A0IZ-11A-11R-A27V-07","9d6c70ea-ec88-4b78-a495-cd31cc048ece",0.15,NA,60,23.4375,160,"37e36409-538a-5401-8e30-97f40c5c253e","TCGA-AX-A0IZ_exposure","UNCID_2167240.9d6c70ea-ec88-4b78-a495-cd31cc048ece.130613_UNC9-SN296_0375_BD27CGACXX_5_AGTCAA.tar.gz","2013-09-21T05:37:05.000Z","2013-09-21T05:49:02.000Z","E1005469-57B9-478D-B160-44F893CF3466","E6FFCB81-F76D-40EE-AC9B-F71ED0C6C92D","Unaligned reads",2429141621,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","9D6C70EA-EC88-4B78-A495-CD31CC048ECE","University of North Carolina","566073bfe4b0b37b3d98e178","11285DC5-8742-477A-8692-AF1B6E2C1434","Uterine Corpus Endometrial Carcinoma","TARGZ","A9A423F7-DA11-40D4-9AA1-FAC02CE78966","2013-09-21T05:49:02.000Z","CED36F9C-58B0-405F-B4FE-944E7578D575","United States","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",1485,"A9A423F7-DA11-40D4-9AA1-FAC02CE78966",NA,"AX","jhu-usc.edu_UCEC.HumanMethylation450.3.lvl-2.TCGA-AX-A0IZ-11A-11D-A27Y-05.txt",160,"TCGA-AX-A0IZ-11A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","E6FFCB81-F76D-40EE-AC9B-F71ED0C6C92D",53,"9285451158_R05C01_Grn.idat","Alive",NA,"TCGA-AX-A0IZ","NOT HISPANIC OR LATINO","B7CCB6D5-6B25-4E32-B6AD-D32F11D5FF53",NA,1333,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"2477AE69-3D24-4DBF-97EA-F911E1D70287","CED36F9C-58B0-405F-B4FE-944E7578D575","UNCID_2085542.9d6c70ea-ec88-4b78-a495-cd31cc048ece.sorted_genome_alignments.bam","TCGA-AX-A0IZ-11A-11",0,100,0,0,0,"TOP",0,0,"TCGA-AX-A0IZ-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,1333,"TUMOR FREE","Alive",NA,"TCGA-AX-A0IZ-F10299","TCGA-AX-A0IZ",1,"AX","A0IZ","YES","C54.1","8380/3","C54.1","NO","YES",-19364,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1333,NA,NA,NA,"TUMOR FREE","NO",18,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32849080,30924072,2283052085,"84A40FCB-DE48-48B2-A70D-BC10BD75B9EE.bw","11285dc5-8742-477a-8692-af1b6e2c1434","84a40fcb-de48-48b2-a70d-bc10bd75b9ee","2016-08-05T04:57:14.322414-05:00","UNCID_2210468.e76c4434-3eaf-4ab2-a994-6c27237d344d.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_5.tar.gz","f99ebe04-2112-486a-ad52-4b427ea5254b",2046145817,"Illumina GA","fdb00216d1d48596bcfe391dbae4896a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:48:37.876439-05:00","2016-05-03T11:15:47.427352-05:00","f99ebe04-2112-486a-ad52-4b427ea5254b_analysis.xml","613a6972baed165cad7e5631cf88ee30","7adda86c-e350-45c6-a22f-0ea0c467fd6f",2121,"2016-09-29T18:26:16.399024-05:00","f99ebe04-2112-486a-ad52-4b427ea5254b_experiment.xml","66a19d1f56618786489ff8b7dad1dfd8","224cff1b-d5a2-4ab2-8f89-548e34aa68d2",2257,"2016-09-29T21:48:46.969358-05:00","f99ebe04-2112-486a-ad52-4b427ea5254b_run.xml","37f4614477f0ac409a8c9cfbb380907f","a0455cef-5e51-441d-8369-9b0d1a638975",347,"2016-09-08T11:18:50.214498-05:00","TCGA-AX-A0IZ","2016-09-02T18:49:24.604923-05:00","female","TCGA-AX-A0IZ_demographic",1954,"white","400b2e1e-7ebf-56da-a404-7bc683ec14ce","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A0IZ_diagnosis","not reported",19364,"alive","8380/3",NA,1333,"fa08e52e-a08c-5dff-992d-48d8f2399ce4","c54.1",-19364,"TCGA-AX-A0IZ_treatment","81d10302-589d-5a62-be62-0151793a6cea","01","false","TCGA-AX-A0IZ-01A",NA,"4c64f7c4-f1ee-4590-8bdc-b6a81e92b328",FALSE,"1DEA7C0C-3280-4E11-B0A4-13562DDF307B","Primary Tumor",NA,1114,200,NA,1291248000,"11",30,"TCGA-AX-A0IZ-01A-11",60,55,0,0,0,0,40,40,"2016-09-08T11:18:50.214498-05:00","2016-09-08T11:18:50.214498-05:00",4,4,0,0,"TOP","BOTTOM",3,3,"1a4e8665-1030-4ec9-be94-097380f6040e","52e564e7-95f0-444a-8edc-53ef50e8b0e4","TCGA-AX-A0IZ-01A-01-TSA","TCGA-AX-A0IZ-01A-01-BSA",57,57,"c995d4e8-60ff-46fd-addf-89fe636f109f","RNA","TCGA-AX-A0IZ-01A-11R","62cc9aef-299b-4463-a4c4-f4e86c5f5850",1.85,0.16,"UV Spec","R","23","TCGA-AX-A0IZ-01A-11R-A118-07","e76c4434-3eaf-4ab2-a994-6c27237d344d",0.16,NA,60,23.4375,160,"37e36409-538a-5401-8e30-97f40c5c253e","TCGA-AX-A0IZ_exposure","UNCID_2210468.e76c4434-3eaf-4ab2-a994-6c27237d344d.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_5.tar.gz","2013-10-02T11:26:05.000Z","2013-10-02T11:39:02.000Z","F99EBE04-2112-486A-AD52-4B427EA5254B","4C64F7C4-F1EE-4590-8BDC-B6A81E92B328","Unaligned reads",2046145817,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E76C4434-3EAF-4AB2-A994-6C27237D344D","University of North Carolina","564a3e9ce4b08c5d86928735","11285DC5-8742-477A-8692-AF1B6E2C1434","Uterine Corpus Endometrial Carcinoma","TARGZ","C995D4E8-60FF-46FD-ADDF-89FE636F109F","2013-10-02T11:39:02.000Z","62CC9AEF-299B-4463-A4C4-F4E86C5F5850","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1114,"C995D4E8-60FF-46FD-ADDF-89FE636F109F",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9AADB315-ED0B-44AB-9391-6E3E04B0B4FA.txt",200,"TCGA-AX-A0IZ-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","E6FFCB81-F76D-40EE-AC9B-F71ED0C6C92D",53,"9285451158_R05C01_Grn.idat","Alive",NA,"TCGA-AX-A0IZ","NOT HISPANIC OR LATINO","B7CCB6D5-6B25-4E32-B6AD-D32F11D5FF53",NA,1333,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"52E564E7-95F0-444A-8EDC-53EF50E8B0E4","62CC9AEF-299B-4463-A4C4-F4E86C5F5850","UNCID_202315.TCGA-AX-A0IZ-01A-11R-A118-07.110406_UNC1-RDR301647_00058_FC_70EYTAAXX.5.trimmed.annotated.translated_to_genomic.bam","TCGA-AX-A0IZ-01A-11",55,0,0,4,40,"BOTTOM",3,0,"TCGA-AX-A0IZ-01A-01-BSA",57,NA,NA,NA,NA,NA,NA,NA,NA,1333,"TUMOR FREE","Alive",NA,"TCGA-AX-A0IZ-F10299","TCGA-AX-A0IZ",1,"AX","A0IZ","YES","C54.1","8380/3","C54.1","NO","YES",-19364,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1333,NA,NA,NA,"TUMOR FREE","NO",18,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
167436630,164171355,7828759763,"CBD7775A-2802-4EB7-9F62-6B80D7667AED.bw","119b1761-a5b4-42b6-9971-ece11fb0e0f6","cbd7775a-2802-4eb7-9f62-6b80d7667aed","2016-09-29T22:59:20.912226-05:00","UNCID_2365334.abec519f-1747-400d-944d-7e53d12d6dea.140124_UNC12-SN629_0346_BC375JACXX_1_AGTCAA.tar.gz","65a7da62-9a5b-442e-82db-8abf50659dca",7449818986,"Illumina HiSeq","52144ab71ab97e1483387bf813f98d69","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:13:45.994218-05:00","2016-05-03T11:39:34.521514-05:00","65a7da62-9a5b-442e-82db-8abf50659dca_analysis.xml","c8673f3313cc71955cb76245ced71df3","fa1096fa-d491-48ba-998d-e0a5f2ee286d",2124,"2016-10-07T16:34:39.242997-05:00","65a7da62-9a5b-442e-82db-8abf50659dca_experiment.xml","3f498b8af76925e36040e0429247d961","ce82cb86-3ddc-41a9-90d2-1a5fe9447264",2628,"2016-09-29T19:32:18.996169-05:00","65a7da62-9a5b-442e-82db-8abf50659dca_run.xml","5ae7b4b4b1d31db560885c5cff8368c1","4c000aaf-3ad5-4349-8b46-809acf9b0ef3",354,"2016-09-08T11:05:52.327640-05:00","TCGA-BK-A6W3","2016-09-02T18:51:30.326116-05:00","female","TCGA-BK-A6W3_demographic",1979,"black or african american","50b47db9-0041-58d4-b3a7-b028b78418ec","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A6W3_diagnosis","not reported",12590,"alive","8380/3",NA,305,"5971e3ee-854f-5eef-a4bb-26c6b52d6ab7","c54.1",-12590,"TCGA-BK-A6W3_treatment","424728c5-477a-57f2-82b8-6b6bd092f1b1","01","false","TCGA-BK-A6W3-01A",NA,"bb8c1148-9006-4819-920e-827bcfa9adb5",FALSE,"15A94B35-48FD-4F94-94E4-25F8084F8B91","Primary Tumor",NA,94,150,NA,1374537600,"12",30,"TCGA-BK-A6W3-01A-12",80,NA,1,NA,10,NA,10,NA,"2016-09-08T11:05:52.327640-05:00",NA,5,NA,1,NA,"TOP",NA,0,NA,"be05c301-413d-4677-a8ed-6d62ba707bd5",NA,"TCGA-BK-A6W3-01A-01-TS1",NA,80,NA,"8c495337-fe9d-40c3-b875-4b32c9d922fe","RNA","TCGA-BK-A6W3-01A-12R","250c2c11-b1c8-4e0d-b0cf-e2e1c0cdd3bd",1.83,0.15,"UV Spec","R","23","TCGA-BK-A6W3-01A-12R-A34R-07","abec519f-1747-400d-944d-7e53d12d6dea",0.15,NA,89,31.9122234572771,167,"a827836b-5c04-5260-9f8f-fb012c5e5685","TCGA-BK-A6W3_exposure","UNCID_2365334.abec519f-1747-400d-944d-7e53d12d6dea.140124_UNC12-SN629_0346_BC375JACXX_1_AGTCAA.tar.gz","2014-03-05T15:33:03.000Z","2014-03-05T15:58:01.000Z","65A7DA62-9A5B-442E-82DB-8ABF50659DCA","BB8C1148-9006-4819-920E-827BCFA9ADB5","Unaligned reads",7449818986,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","ABEC519F-1747-400D-944D-7E53D12D6DEA","University of North Carolina","56607838e4b0ec1099f8d36d","119B1761-A5B4-42B6-9971-ECE11FB0E0F6","Uterine Corpus Endometrial Carcinoma","TARGZ","8C495337-FE9D-40C3-B875-4B32C9D922FE","2014-03-05T15:58:01.000Z","250C2C11-B1C8-4E0D-B0CF-E2E1C0CDD3BD","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",94,"8C495337-FE9D-40C3-B875-4B32C9D922FE",NA,"BK","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.42DDB0FE-9C22-4E46-AF94-D56C01B6C949.txt",150,"TCGA-BK-A6W3-01A",NA,NA,"TCGA",2013,"TCGA-BK-A6W3_NTE-1","Complete Remission/Response","TUMOR FREE","BB8C1148-9006-4819-920E-827BCFA9ADB5",34,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.42DDB0FE-9C22-4E46-AF94-D56C01B6C949.txt","Alive",NA,"TCGA-BK-A6W3","NOT HISPANIC OR LATINO","9A14BE2B-FB06-4792-906F-665C8153E724","NO",86,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",354,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,12,30,"BE05C301-413D-4677-A8ED-6D62BA707BD5","E260618C-4507-4DBF-B849-F8D1D9B0C0E6","TCGA-BK-A6W3-01A-12R-A34O-13_mirna.bam","TCGA-BK-A6W3-01A-12",80,10,1,5,10,"TOP",0,1,"TCGA-BK-A6W3-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-BK-A6W3-F57503_NTE-1","NO",305,"TUMOR FREE","Alive",NA,"TCGA-BK-A6W3-F57503","TCGA-BK-A6W3",1,"BK","A6W3","YES","C54.1","8380/3","C54.1","YES","NO",-12590,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",86,NA,"NO","NO","TUMOR FREE","YES",29,11,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,34,2013,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",5,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
35703604,34262216,2561386899,"DB6A57B5-92A1-441B-885F-3E26AC89F289.bw","1200c8b7-a058-4c01-bbe2-04ec09a65245","db6a57b5-92a1-441b-885f-3e26ac89f289","2016-08-05T04:26:01.431110-05:00","UNCID_2214967.c094698b-0de5-4f14-9b3e-7f2deedde428.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_8.tar.gz","2dc86365-4c0f-4914-8759-b1e7092dd790",2218367961,"Illumina GA","276ed384f934bd2c704de814a02330de","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:15:35.967928-05:00","2016-05-03T11:17:59.899725-05:00","2dc86365-4c0f-4914-8759-b1e7092dd790_analysis.xml","ff119cb35d54871788ff0449c276ed03","fb3ccbe7-4188-4a27-8cd2-20c236e0eae2",2122,"2016-08-29T05:11:04.130298-05:00","2dc86365-4c0f-4914-8759-b1e7092dd790_experiment.xml","91754ea92922e02c90191172e768f5e4","69535f08-d865-45d3-ab51-38195c063d86",2256,"2016-09-29T21:29:38.990034-05:00","2dc86365-4c0f-4914-8759-b1e7092dd790_run.xml","09399521ca0514f622955966773bcb52","9498b15e-7b32-42fe-803d-7bf3aec75ff7",345,"2016-09-08T12:15:23.054563-05:00","TCGA-AP-A0LD","2016-09-02T18:54:26.319943-05:00","female","TCGA-AP-A0LD_demographic",1939,"white","89dd9b5b-71a2-599c-b86a-9631ef174de5","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LD_diagnosis","not reported",23216,"alive","8380/3",NA,3589,"66cf797e-30dd-5bbf-9874-1af349475018","c54.1",-23216,"TCGA-AP-A0LD_treatment","edeaddd9-bddb-507f-9589-3733e7be4968","01","true","TCGA-AP-A0LD-01A",NA,"649dadda-5823-4b0d-b5a2-49f501adc029",FALSE,"10B9E917-C1FB-480D-9DB2-8E93FA446ADC","Primary Tumor",NA,2993,230,NA,1278633600,"11",30,"TCGA-AP-A0LD-01A-11",90,90,0,0,10,10,0,0,"2016-09-08T12:15:23.054563-05:00","2016-09-08T12:15:23.054563-05:00",10,10,10,10,"TOP","BOTTOM",10,10,"cba345f3-ea2e-4abd-864f-1583023cea4a","406a0fd7-3184-4191-a8b8-f707b02edb1b","TCGA-AP-A0LD-01A-01-TS1","TCGA-AP-A0LD-01A-01-BS1",80,80,"8638c26b-ac27-4141-8230-142700670f81","RNA","TCGA-AP-A0LD-01A-11R","0a20a604-abcc-4a47-afb7-2b41ed85ba1a",1.89,0.14,"UV Spec","R","23","TCGA-AP-A0LD-01A-11R-A040-07","c094698b-0de5-4f14-9b3e-7f2deedde428",0.14,NA,68,27.2392244832559,158,"0906c4b6-640a-5ac1-9849-aa0c90791233","TCGA-AP-A0LD_exposure","UNCID_2214967.c094698b-0de5-4f14-9b3e-7f2deedde428.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_8.tar.gz","2013-10-04T00:07:05.000Z","2013-10-04T01:00:02.000Z","2DC86365-4C0F-4914-8759-B1E7092DD790","649DADDA-5823-4B0D-B5A2-49F501ADC029","Unaligned reads",2218367961,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C094698B-0DE5-4F14-9B3E-7F2DEEDDE428","University of North Carolina","5660765ee4b016715ab68dd8","1200C8B7-A058-4C01-BBE2-04EC09A65245","Uterine Corpus Endometrial Carcinoma","TARGZ","8638C26B-AC27-4141-8230-142700670F81","2013-10-04T01:00:02.000Z","0A20A604-ABCC-4A47-AFB7-2B41ED85BA1A","None","NO",1,NA,"Primary Tumor","MSKCC",2993,"8638C26B-AC27-4141-8230-142700670F81",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.833628B6-91CA-4896-9796-6D9F0F57DCF1.txt",230,"TCGA-AP-A0LD-01A",NA,NA,"TCGA",2002,NA,NA,"TUMOR FREE","9D49BB1E-896D-4545-8CAC-E85405093B83",63,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.833628B6-91CA-4896-9796-6D9F0F57DCF1.txt","Alive",NA,"TCGA-AP-A0LD",NA,"F434C559-31E6-43E5-AE0D-7785225A5F33",NA,2907,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"DC4F3B20-A952-41B7-B484-E35D5B0FB589","WHITE",NA,11,30,"CBA345F3-EA2E-4ABD-864F-1583023CEA4A","27B39E4E-80FE-4637-A7AF-06CDFD5C5D53","UNCID_2214967.c094698b-0de5-4f14-9b3e-7f2deedde428.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_8.tar.gz","TCGA-AP-A0LD-01A-11",90,10,0,10,0,"BOTTOM",10,10,"TCGA-AP-A0LD-01A-01-BS1",80,NA,NA,NA,"TCGA-AP-A0LD-R3940","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",3589,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LD-F29043","TCGA-AP-A0LD",1,"AP","A0LD","YES","C54.1","8380/3","C54.1","NO","YES",-23216,"FEMALE","WHITE",NA,"No","No","Alive",2907,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2002,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34089597,32354295,2442274600,"368ACD26-C7FB-4974-BB7F-0AE22670CB0E.bw","129a49d4-edb8-4a1d-aabb-51b9ad5a8dd1","368acd26-c7fb-4974-bb7f-0ae22670cb0e","2016-08-09T14:18:28.863239-05:00","UNCID_2209566.67a8a629-6001-48cb-99b1-588a69f49ecc.110509_UNC2-RDR300275_00065_FC_634Y5AAXX_1.tar.gz","c2f8351a-4413-487d-b7d2-8ccc694b2df1",2234826798,"Illumina GA","1e64ab0f1f26a44e48778d2db4728b42","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:45:26.705529-05:00","2016-05-03T11:15:06.073526-05:00","c2f8351a-4413-487d-b7d2-8ccc694b2df1_analysis.xml","2374bf5bae3f7976264d673f8513e225","54175547-7c62-4142-88c8-374591176fdf",2119,"2016-09-29T18:17:15.323950-05:00","c2f8351a-4413-487d-b7d2-8ccc694b2df1_experiment.xml","1984e3b8cf8ed5a8742883b5f00c2fd6","1cba2e2a-5739-4236-ac9d-ccd6dec1d87c",2261,"2016-09-29T19:28:19.223564-05:00","c2f8351a-4413-487d-b7d2-8ccc694b2df1_run.xml","be8f837d9c5f6824731d80e47b8a98d6","49868350-827d-40bb-933c-dfd7f7a98432",351,"2016-09-08T11:08:51.628958-05:00","TCGA-D1-A17F","2016-09-02T18:50:38.192019-05:00","female","TCGA-D1-A17F_demographic",1942,"white","484728d0-24db-5eb6-af3c-0702a2907055","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17F_diagnosis","not reported",25116,"alive","8380/3",NA,39,"56b0f462-b736-5a75-9c4d-a1fe4352c8fd","c54.1",-25116,"TCGA-D1-A17F_treatment","b5f7e265-6cd5-5b61-9322-faa8e910a3c6","01","false","TCGA-D1-A17F-01A",NA,"9592e87f-f3e4-49e9-919c-6f679a4b9110",FALSE,"62F464EA-9410-4511-8DE8-F0E62AB1E482","Primary Tumor",NA,269,200,NA,1294185600,"11",30,"TCGA-D1-A17F-01A-11",65,NA,5,NA,2,NA,35,NA,"2016-09-08T11:08:51.628958-05:00",NA,3,NA,2,NA,"TOP",NA,0,NA,"299baf41-4137-4574-b0d9-59b6e2e18be3",NA,"TCGA-D1-A17F-01A-01-TSA",NA,63,NA,"4240aa7a-4d1b-4f3e-85b8-678ec68715cf","RNA","TCGA-D1-A17F-01A-11R","fd17a8e3-bbae-4a98-965c-8c38c9ec2878",1.83,0.17,"UV Spec","R","23","TCGA-D1-A17F-01A-11R-A12I-07","67a8a629-6001-48cb-99b1-588a69f49ecc",0.17,NA,79,31.6455696202532,158,"61614981-5411-546c-873f-aab3edc2cd21","TCGA-D1-A17F_exposure","UNCID_2209566.67a8a629-6001-48cb-99b1-588a69f49ecc.110509_UNC2-RDR300275_00065_FC_634Y5AAXX_1.tar.gz","2013-10-01T09:26:05.000Z","2013-10-01T09:45:02.000Z","C2F8351A-4413-487D-B7D2-8CCC694B2DF1","9592E87F-F3E4-49E9-919C-6F679A4B9110","Unaligned reads",2234826798,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","67A8A629-6001-48CB-99B1-588A69F49ECC","University of North Carolina","564a3d90e4b0298dd2c91a40","129A49D4-EDB8-4A1D-AABB-51B9AD5A8DD1","Uterine Corpus Endometrial Carcinoma","TARGZ","4240AA7A-4D1B-4F3E-85B8-678EC68715CF","2013-10-01T09:45:02.000Z","FD17A8E3-BBAE-4A98-965C-8C38C9EC2878","None","NO",1,NA,"Primary Tumor","Mayo Clinic",269,"4240AA7A-4D1B-4F3E-85B8-678EC68715CF",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4F996645-41F2-42CA-9D4E-F34184B6F95F.txt",200,"TCGA-D1-A17F-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","E68531F2-A471-411C-9031-12708A28C90F",68,"nationwidechildrens.org_clinical.TCGA-D1-A17F.xml","Alive",NA,"TCGA-D1-A17F","NOT HISPANIC OR LATINO","486D3CCA-8DA8-4773-953A-35CCC7968D3D",NA,39,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"299BAF41-4137-4574-B0D9-59B6E2E18BE3","FD17A8E3-BBAE-4A98-965C-8C38C9EC2878","TCGA-D1-A17F-01A-11R-A12H-13_mirna.bam","TCGA-D1-A17F-01A-11",65,2,5,3,35,"TOP",0,2,"TCGA-D1-A17F-01A-01-TSA",63,NA,NA,NA,NA,NA,NA,NA,"NO",39,"TUMOR FREE","Alive",NA,"TCGA-D1-A17F-F20300","TCGA-D1-A17F",1,"D1","A17F","YES","C54.1","8380/3","C54.1","NO","YES",-25116,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",39,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28015035,27211759,2040435706,"DD127E63-1CEC-4EAC-90B7-725FB5C25BF6.bw","12d36a1d-9922-4311-bbda-71f32ac2c03b","dd127e63-1cec-4eac-90b7-725fb5c25bf6","2016-08-05T11:58:41.418188-05:00","UNCID_2214417.37d2da87-d591-440d-87d3-a34a038bef5b.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_1.tar.gz","8dcedd52-fdd8-4db8-b4a0-d848326fc861",1716431076,"Illumina GA","978002d13b46d83b72d566c2d0c3e0b2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:27:54.747827-05:00","2016-05-03T11:17:14.896869-05:00","8dcedd52-fdd8-4db8-b4a0-d848326fc861_analysis.xml","cf076b72a722570285e9500b083266e9","937a6682-4350-4d67-98b1-ed62356f2092",2121,"2016-09-29T17:36:52.671271-05:00","8dcedd52-fdd8-4db8-b4a0-d848326fc861_experiment.xml","8b3ccaad376efee0192c1c7fc1959312","032cb148-3613-4a36-82a1-0673e7a45fd3",2257,"2016-09-30T00:17:47.717619-05:00","8dcedd52-fdd8-4db8-b4a0-d848326fc861_run.xml","6dfdf53f1300804133e8397374140f10","fc896a04-d88e-4754-a03e-e359b7834dcb",347,"2016-09-08T10:52:43.210655-05:00","TCGA-BG-A0MQ","2016-09-02T18:48:07.573969-05:00","female","TCGA-BG-A0MQ_demographic",1937,"white","1cfbb428-8eb0-51c0-ab30-92967445c79e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MQ_diagnosis","not reported",26284,"alive","8380/3",NA,1817,"2435de46-4c58-55df-94eb-1e49bf074da5","c54.1",-26284,"TCGA-BG-A0MQ_treatment","85eb8154-5e49-5f0d-84fd-c80b6ee653b1","01","true","TCGA-BG-A0MQ-01A",NA,"3d1fa321-d2e8-4460-ae87-356ab1ca6281",FALSE,"3252AEB3-3B0D-4066-B18E-31096F928D63","Primary Tumor",NA,692,120,NA,1279065600,"11",30,"TCGA-BG-A0MQ-01A-11",90,88,1,1,0,0,3,5,"2016-09-08T10:52:43.210655-05:00","2016-09-08T10:52:43.210655-05:00",4,5,2,3,"TOP","BOTTOM",18,18,"0c8a0211-b7ea-4e2b-a09c-36d9bc41bb8e","7f714485-37ad-40a6-880d-c79f20d949bd","TCGA-BG-A0MQ-01A-01-TSA","TCGA-BG-A0MQ-01A-01-BSA",79,77,"f3b41b53-0740-4933-8dc0-efa3f146f9e9","RNA","TCGA-BG-A0MQ-01A-11R","76053f6a-e79b-4cbc-b7b3-9e65c08c49a5",1.79,0.15,"UV Spec","R","23","TCGA-BG-A0MQ-01A-11R-A104-07","37d2da87-d591-440d-87d3-a34a038bef5b",0.15,NA,101,37.0982552800735,165,"bf13eff6-5567-5374-9d44-e69975009781","TCGA-BG-A0MQ_exposure","UNCID_2214417.37d2da87-d591-440d-87d3-a34a038bef5b.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_1.tar.gz","2013-10-03T15:37:04.000Z","2013-10-03T15:49:01.000Z","8DCEDD52-FDD8-4DB8-B4A0-D848326FC861","3D1FA321-D2E8-4460-AE87-356AB1CA6281","Unaligned reads",1716431076,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","37D2DA87-D591-440D-87D3-A34A038BEF5B","University of North Carolina","564a358de4b093830b67662e","12D36A1D-9922-4311-BBDA-71F32AC2C03B","Uterine Corpus Endometrial Carcinoma","TARGZ","F3B41B53-0740-4933-8DC0-EFA3F146F9E9","2013-10-03T15:49:01.000Z","76053F6A-E79B-4CBC-B7B3-9E65C08C49A5","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",692,"F3B41B53-0740-4933-8DC0-EFA3F146F9E9",NA,"BG","UNCID_362781.TCGA-BG-A0MQ-01A-11R-A104-07.110208_UNC2-RDR300275_00049_FC_62J3VAAXX.1.trimmed.annotated.translated_to_genomic.bam.bai",120,"TCGA-BG-A0MQ-01A",NA,NA,"TCGA",2008,NA,NA,"WITH TUMOR","3D1FA321-D2E8-4460-AE87-356AB1CA6281",71,"nationwidechildrens.org_clinical.TCGA-BG-A0MQ.xml","Alive",NA,"TCGA-BG-A0MQ","NOT HISPANIC OR LATINO","D56AB064-9857-4C91-A4AD-E6ED48A92B97",NA,761,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,11,30,"7F714485-37AD-40A6-880D-C79F20D949BD","FDFE5F3C-F38A-45A3-9BCB-9CF628AE137B","UNCID_362781.TCGA-BG-A0MQ-01A-11R-A104-07.110208_UNC2-RDR300275_00049_FC_62J3VAAXX.1.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-BG-A0MQ-01A-11",90,0,1,4,3,"TOP",18,2,"TCGA-BG-A0MQ-01A-01-TSA",79,NA,NA,NA,NA,NA,NA,NA,"NO",1196,"WITH TUMOR","Alive",NA,"TCGA-BG-A0MQ-F19286","TCGA-BG-A0MQ",1,"BG","A0MQ","YES","C54.1","8380/3","C54.1","NO","YES",-26284,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",761,NA,NA,NA,"WITH TUMOR","NO",9,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,71,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
112362254,110608564,5281085535,"2502A23E-E168-4A78-9C14-B93FBC9715B1.bw","12df24c6-1229-4777-ad90-7dd66259b65f","2502a23e-e168-4a78-9c14-b93fbc9715b1","2016-08-06T03:08:38.858210-05:00","UNCID_2172994.33dc8709-5c3e-4944-8e41-2bc36b26fced.130509_UNC10-SN254_0462_AC232JACXX_8_ACTGAT.tar.gz","7b1faccd-a530-4b9a-9332-5a39f09d42ad",5081458112,"Illumina HiSeq","be22c362214aa4eb56d2741b995398d4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:40:34.565112-05:00","2016-05-03T10:55:55.600288-05:00","7b1faccd-a530-4b9a-9332-5a39f09d42ad_analysis.xml","1a8b90f3beb38a0d611d7c14d9c55845","c05976db-9278-456e-b8ee-49e3ec704a32",2123,"2016-09-29T18:21:12.748407-05:00","7b1faccd-a530-4b9a-9332-5a39f09d42ad_experiment.xml","d22ef7cbbfc3fe4cce01f57d2260ac68","1f0c92e5-217f-4746-b83a-9eae51496704",2431,"2016-09-29T23:21:44.811708-05:00","7b1faccd-a530-4b9a-9332-5a39f09d42ad_run.xml","3f5135e9fed658293ddb6c44c8748053","d9be1e28-54cc-4c63-bdff-f75f4622f902",354,"2016-09-08T11:28:58.321120-05:00","TCGA-AJ-A3OK","2016-09-02T18:49:06.569234-05:00","female","TCGA-AJ-A3OK_demographic",1938,"white","44ebf565-e6c0-59c5-a3d6-7e355683c90a","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3OK_diagnosis","not reported",26851,"alive","8441/3",NA,485,"07254dcb-569e-5834-90ca-0fa36cd3db19","c54.1",-26851,"TCGA-AJ-A3OK_treatment","d6d44d5d-f1f6-5a2e-bc44-823d5dfe6d98","01","false","TCGA-AJ-A3OK-01A",NA,"d349d257-56da-4693-815e-9b90aee59b23",FALSE,"54D4BBBE-D458-44B2-8F7C-0185DD16D961","Primary Tumor",NA,162,80,NA,1328572800,"12",10,"TCGA-AJ-A3OK-01A-12",85,NA,0,NA,5,NA,0,NA,"2016-09-08T11:28:58.321120-05:00",NA,3,NA,1,NA,"TOP",NA,3,NA,"9af2da7a-d0ae-4925-96d6-05819d0c3093",NA,"TCGA-AJ-A3OK-01A-01-TSA",NA,92,NA,"6ce8f692-8ed6-474e-8465-e5b455cfd4b3","RNA","TCGA-AJ-A3OK-01A-12R","557bc021-6d3e-440f-8b0a-99237317d000",1.83,0.15,"UV Spec","R","23","TCGA-AJ-A3OK-01A-12R-A22K-07","33dc8709-5c3e-4944-8e41-2bc36b26fced",0.15,NA,75,29.296875,160,"7ed8aaa5-9712-5f2a-8c31-492883af953b","TCGA-AJ-A3OK_exposure","UNCID_2172994.33dc8709-5c3e-4944-8e41-2bc36b26fced.130509_UNC10-SN254_0462_AC232JACXX_8_ACTGAT.tar.gz","2013-09-09T05:16:08.000Z","2013-09-09T05:31:01.000Z","7B1FACCD-A530-4B9A-9332-5A39F09D42AD","D349D257-56DA-4693-815E-9B90AEE59B23","Unaligned reads",5081458112,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","33DC8709-5C3E-4944-8E41-2BC36B26FCED","University of North Carolina","564a3d02e4b0ef12181af3e0","12DF24C6-1229-4777-AD90-7DD66259B65F","Uterine Corpus Endometrial Carcinoma","TARGZ","6CE8F692-8ED6-474E-8465-E5B455CFD4B3","2013-09-09T05:31:01.000Z","557BC021-6D3E-440F-8B0A-99237317D000","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",162,"6CE8F692-8ED6-474E-8465-E5B455CFD4B3",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F7EB2D40-8596-4F8A-8AAF-D3F1A41F6AC5.txt",80,"TCGA-AJ-A3OK-01A",NA,"E39263BA-D6DB-4346-A475-A521DB6AB5BE","TCGA",2011,NA,NA,"TUMOR FREE","EBE9AA06-3DE7-4ADD-8542-33EC77C8B011",73,"nationwidechildrens.org_clinical.TCGA-AJ-A3OK.xml","Alive",NA,"TCGA-AJ-A3OK",NA,"6BECE9ED-AE4D-41B3-99F1-17B7417DAAD0",NA,142,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"9A74EC57-8994-4C9A-9C0F-B866F0D6F0D8","WHITE",NA,12,10,"9AF2DA7A-D0AE-4925-96D6-05819D0C3093","9190804B-D159-46C9-AB34-6D6DC7A85942","TCGA-AJ-A3OK-01A-12R-A22I-13_mirna.bam","TCGA-AJ-A3OK-01A-12",85,5,0,3,0,"TOP",3,1,"TCGA-AJ-A3OK-01A-01-TSA",92,"Taxotere","Chemotherapy","TCGA-AJ-A3OK-D45622","TCGA-AJ-A3OK-R45624","Internal","Primary Tumor Field","TCGA-AJ-A3OK-F45615_NTE-1","NO",485,NA,"Alive",NA,"TCGA-AJ-A3OK-F45615","TCGA-AJ-A3OK",1,"AJ","A3OK","YES","C54.1","8441/3","C54.1","YES","NO",-26851,"FEMALE","WHITE",NA,"No","No","Alive",142,NA,NA,NA,"TUMOR FREE","NO",19,4,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,73,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
99926944,97762219,4656936268,"EC319D0D-96C5-49DB-A2C4-BB6BFED6844F.bw","139e2c5a-cc0c-43a2-b30e-b8ac17c0b5f2","ec319d0d-96c5-49db-a2c4-bb6bfed6844f","2016-08-09T13:17:30.157053-05:00","UNCID_2177859.2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7.130402_UNC10-SN254_0447_BC22WAACXX_5_GTTTCG.tar.gz","6255a5ae-9d3d-44aa-b84f-e68b547275f5",4103321517,"Illumina HiSeq","0520d45984f837bf25276bb6fff7efc1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:18:52.418334-05:00","2016-05-03T10:56:47.890899-05:00","6255a5ae-9d3d-44aa-b84f-e68b547275f5_analysis.xml","af2395dfc556747e91a680337bec2732","8ddf0a81-2412-4ca4-a0c7-76676d7e2189",2123,"2016-08-27T07:36:02.734894-05:00","6255a5ae-9d3d-44aa-b84f-e68b547275f5_experiment.xml","1983504a8dc419d360ef1e695e9e1e99","db10ae93-ebf5-4119-9525-2fcaea75d317",2431,"2016-09-29T22:51:51.974054-05:00","6255a5ae-9d3d-44aa-b84f-e68b547275f5_run.xml","9b467e61709ae6a2790aeace787f9604","c75b8027-21fc-49fb-bd21-d7ed08e76a96",354,"2016-09-08T10:58:33.861003-05:00","TCGA-B5-A3FH","2016-09-02T18:47:37.641947-05:00","female","TCGA-B5-A3FH_demographic",1937,"black or african american","deb86788-08c6-59ba-9c5d-5637dd170b6e","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A3FH_diagnosis","not reported",27221,"alive","8380/3",NA,841,"600b71c3-44e0-59ff-b7b7-997e8563788c","c54.1",-27221,"TCGA-B5-A3FH_treatment","bf84eb09-d3e2-50f8-a63c-9292ae243dee","01","true","TCGA-B5-A3FH-01A",NA,"f7c02f75-ca0a-4d2d-bd45-d40e77fe74fc",FALSE,"05AD8EE1-E2F8-42F7-8E6A-380A8EE4770E","Primary Tumor",NA,97,480,NA,1321574400,"11",30,"TCGA-B5-A3FH-01A-11",80,NA,5,NA,0,NA,0,NA,"2016-09-08T10:58:33.861003-05:00",NA,1,NA,2,NA,"TOP",NA,15,NA,"b669c243-7a48-4b1f-8224-b01c34ce7b75",NA,"TCGA-B5-A3FH-01A-01-TSA",NA,85,NA,"22937cfe-0834-433f-96a3-e9c87b35542c","RNA","TCGA-B5-A3FH-01A-11R","53852682-4845-47aa-abb9-d5e667df072f",1.78,0.17,"UV Spec","R","23","TCGA-B5-A3FH-01A-11R-A19W-07","2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7",0.17,NA,85,33.203125,160,"3d9772e1-9dfd-5ad8-afdf-e378219ddd6d","TCGA-B5-A3FH_exposure","UNCID_2177859.2bb3a670-627e-4aa7-8dfc-88f6cc06d1a7.130402_UNC10-SN254_0447_BC22WAACXX_5_GTTTCG.tar.gz","2013-09-11T07:21:04.000Z","2013-09-11T07:40:02.000Z","6255A5AE-9D3D-44AA-B84F-E68B547275F5","F7C02F75-CA0A-4D2D-BD45-D40E77FE74FC","Unaligned reads",4103321517,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","2BB3A670-627E-4AA7-8DFC-88F6CC06D1A7","University of North Carolina","564a3440e4b09c884b222d48","139E2C5A-CC0C-43A2-B30E-B8AC17C0B5F2","Uterine Corpus Endometrial Carcinoma","TARGZ","22937CFE-0834-433F-96A3-E9C87B35542C","2013-09-11T07:40:02.000Z","53852682-4845-47AA-ABB9-D5E667DF072F","United States","NO",1,NA,"Primary Tumor","Duke",97,"22937CFE-0834-433F-96A3-E9C87B35542C",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6FCB4E7F-DE11-4F45-8BEB-5D60942D06B7.txt",480,"TCGA-B5-A3FH-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","F7C02F75-CA0A-4D2D-BD45-D40E77FE74FC",74,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6FCB4E7F-DE11-4F45-8BEB-5D60942D06B7.txt","Alive",NA,"TCGA-B5-A3FH",NA,"96D9BC7C-415A-42FB-A1A9-1D11F33D33CC",NA,197,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"B669C243-7A48-4B1F-8224-B01C34CE7B75","D1E55784-8E6D-442F-A7C6-02DDE2515A6C","3e7cc84cdfb7a2ea33f6139354d905dd.bam","TCGA-B5-A3FH-01A-11",80,0,5,1,0,"TOP",15,2,"TCGA-B5-A3FH-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,"TCGA-B5-A3FH-F63411_NTE-1","NO",841,"TUMOR FREE","Alive",NA,"TCGA-B5-A3FH-F63411","TCGA-B5-A3FH",1,"B5","A3FH","YES","C54.1","8380/3","C54.1","NO","YES",-27221,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",197,NA,NA,NA,"TUMOR FREE","NO",23,3,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
26217814,25078686,1884298064,"1352B654-6F4D-42A0-AB1F-9BE50AB80A1A.bw","13f31bcb-befd-4ed2-adc0-dc9e9ce52b75","1352b654-6f4d-42a0-ab1f-9be50ab80a1a","2016-08-09T14:11:42.039831-05:00","UNCID_2207063.5fcefe73-6ed0-42f2-beda-3afc67aba867.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_6.tar.gz","6a87ed37-6e36-4078-9018-989b138428e6",1654942558,"Illumina GA","670b9cd4480c15f40b297756e933ac9e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:05:39.933766-05:00","2016-05-03T11:13:42.364824-05:00","6a87ed37-6e36-4078-9018-989b138428e6_analysis.xml","5df268937ed97619f62b05da03f3d302","858fec40-f97e-4407-ab3b-5439db23f4a2",2121,"2016-08-13T04:17:00.638416-05:00","6a87ed37-6e36-4078-9018-989b138428e6_experiment.xml","115dcdfe00dc30b119f400e927d201bf","8b0c9290-7aae-4cad-bb93-c0df7dcb55e3",2257,"2016-09-30T00:10:33.171342-05:00","6a87ed37-6e36-4078-9018-989b138428e6_run.xml","f749e2865c0fe072a5dbc66ab2b5ccac","f80813aa-ecc9-4b12-85dc-3c987a320bdc",347,"2016-09-08T12:23:19.372178-05:00","TCGA-BS-A0TG","2016-09-02T18:48:24.903888-05:00","female","TCGA-BS-A0TG_demographic",1945,"white","a761f58b-17f5-5a95-9d10-299a4fbf98e7","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0TG_diagnosis","not reported",22043,"alive","8380/3",NA,2371,"6473de9e-e3af-5f99-975c-a8373c55a391","c54.1",-22043,"TCGA-BS-A0TG_treatment","a0fd16e3-f175-5918-9b7f-dca383e84e83","01","false","TCGA-BS-A0TG-01A",NA,"36e44603-a1ee-4a5b-9506-49a9358bf8d0",FALSE,"7A7B4B4B-5EE2-4D8D-A90A-DDFB96AE49A8","Primary Tumor",NA,1996,270,NA,1284422400,"32",10,"TCGA-BS-A0TG-01A-32",100,70,0,0,10,0,0,20,"2016-09-08T12:23:19.372178-05:00","2016-09-08T12:23:19.372178-05:00",10,0,0,0,"BOTTOM","TOP",20,0,"5660dd6f-fb70-4a95-9307-f1571363d3e6","935c776c-6ec2-4a67-892d-b1756b3ea029","TCGA-BS-A0TG-01A-03-MSC","TCGA-BS-A0TG-01A-03-TSC",70,80,"1f1a7386-bffd-483d-860e-0f1eabe0f04d","RNA","TCGA-BS-A0TG-01A-32R","e9f19ecc-948b-4eeb-b144-55c8674cea03",1.68,0.17,"UV Spec","R","23","TCGA-BS-A0TG-01A-32R-A16W-07","5fcefe73-6ed0-42f2-beda-3afc67aba867",0.17,NA,64,24.0882231171666,163,"3dc8bc0a-c45f-556a-988e-46bfb67f0de9","TCGA-BS-A0TG_exposure","UNCID_2207063.5fcefe73-6ed0-42f2-beda-3afc67aba867.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_6.tar.gz","2013-09-29T06:06:04.000Z","2013-09-29T06:18:01.000Z","6A87ED37-6E36-4078-9018-989B138428E6","36E44603-A1EE-4A5B-9506-49A9358BF8D0","Unaligned reads",1654942558,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","5FCEFE73-6ED0-42F2-BEDA-3AFC67ABA867","University of North Carolina","564a3e62e4b0298dd2c95cb6","13F31BCB-BEFD-4ED2-ADC0-DC9E9CE52B75","Uterine Corpus Endometrial Carcinoma","TARGZ","1F1A7386-BFFD-483D-860E-0F1EABE0F04D","2013-09-29T06:18:01.000Z","E9F19ECC-948B-4EEB-B144-55C8674CEA03","None","NO",1,NA,"Primary Tumor","University of Hawaii",1996,"1F1A7386-BFFD-483D-860E-0F1EABE0F04D",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.70DE1BC1-F8A6-49A4-B2B2-22905D8C2A48.txt",270,"TCGA-BS-A0TG-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","36E44603-A1EE-4A5B-9506-49A9358BF8D0",60,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.70DE1BC1-F8A6-49A4-B2B2-22905D8C2A48.txt","Alive",NA,"TCGA-BS-A0TG","NOT HISPANIC OR LATINO","C0842F33-CE8F-4EA0-8E41-8AAEAAFB731C",NA,2035,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"990475F5-D0BD-4359-90D2-072F839D7908","WHITE",NA,32,10,"935C776C-6EC2-4A67-892D-B1756B3EA029","E9F19ECC-948B-4EEB-B144-55C8674CEA03","UNCID_1623493.5fcefe73-6ed0-42f2-beda-3afc67aba867.sorted_genome_alignments.bam","TCGA-BS-A0TG-01A-32",100,10,0,10,0,"BOTTOM",20,0,"TCGA-BS-A0TG-01A-03-MSC",70,NA,NA,NA,"TCGA-BS-A0TG-R4396","EXTERNAL BEAM","Regional site",NA,NA,2371,"WITH TUMOR","Alive",NA,"TCGA-BS-A0TG-F4395","TCGA-BS-A0TG",1,"BS","A0TG","YES","C54.1","8380/3","C54.1","NO","YES",-22043,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2035,NA,NA,NA,"TUMOR FREE","NO",19,11,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2005,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35060192,34738664,2596050974,"3F458A99-ED35-41E2-A90C-D78483268A68.bw","1486a031-b74d-4976-8b0b-4569e6978f49","3f458a99-ed35-41e2-a90c-d78483268a68","2016-08-09T14:12:05.276972-05:00","UNCID_2207030.7e36dab1-7cb0-42df-acfc-615f7c0bba2c.110728_UNC2-RDR300275_00080_FC_63145AAXX_1.tar.gz","efb7027e-a26c-450c-bcf7-83a5776f8940",2273662735,"Illumina GA","729c2203bd1b3d4e809863d1c8252867","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:02:34.852114-05:00","2016-05-03T11:13:02.646906-05:00","efb7027e-a26c-450c-bcf7-83a5776f8940_analysis.xml","2a6c5228563c202f5e07b9615ad44282","5eb179e2-2a05-4339-b1c8-8eccc67058c5",2121,"2016-09-29T18:41:41.794779-05:00","efb7027e-a26c-450c-bcf7-83a5776f8940_experiment.xml","7514ebeae125a8e49de2e1d3607f0d4a","2c14aa11-69bb-403d-93cc-4242b5ea5b9e",2257,"2016-09-29T20:30:16.962800-05:00","efb7027e-a26c-450c-bcf7-83a5776f8940_run.xml","5ca0a69e60b1b4375025c3d5b8a8dcdd","6f90823a-a26c-40b7-b770-22b86200965a",347,"2016-09-08T11:54:41.402420-05:00","TCGA-A5-A0GD","2016-09-02T18:54:07.810189-05:00","female","TCGA-A5-A0GD_demographic",1924,"white","46557fd9-7911-588f-a680-4f45ad150016","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GD_diagnosis","not reported",27399,"dead","8380/3",3423,98,"90623af9-2c1f-599e-9e2c-f2079e4715d6","c54.1",-27399,"TCGA-A5-A0GD_treatment","dffa6065-3577-52b2-90a9-5d28505c6d5e","01","true","TCGA-A5-A0GD-01A",NA,"f449f50a-7664-4ddc-87aa-6a061ee7190c",FALSE,"44561792-F2F8-42F7-B697-5D7752F8430E","Primary Tumor",NA,4119,170,NA,1275955200,"11",30,"TCGA-A5-A0GD-01A-11",80,85,0,0,0,0,0,0,"2016-09-08T11:54:41.402420-05:00","2016-09-08T11:54:41.402420-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"5e6779bc-1ac5-4dd3-9ac6-ad375f7a5d79","a2cb73af-073c-41e4-abae-c8d04a0aae3a","TCGA-A5-A0GD-01A-01-TSA","TCGA-A5-A0GD-01A-01-BSA",100,100,"21d2b089-0712-4b8f-bbb8-fca83097f098","RNA","TCGA-A5-A0GD-01A-11R","e6dd4417-7688-4dd2-aecf-5c99de5750a9",1.88,0.17,"UV Spec","R","23","TCGA-A5-A0GD-01A-11R-A16W-07","7e36dab1-7cb0-42df-acfc-615f7c0bba2c",0.17,NA,74,27.8520079792239,163,"7d108e66-179e-588e-aa96-216b4e546186","TCGA-A5-A0GD_exposure","UNCID_2207030.7e36dab1-7cb0-42df-acfc-615f7c0bba2c.110728_UNC2-RDR300275_00080_FC_63145AAXX_1.tar.gz","2013-09-29T02:55:05.000Z","2013-09-29T03:08:02.000Z","EFB7027E-A26C-450C-BCF7-83A5776F8940","F449F50A-7664-4DDC-87AA-6A061EE7190C","Unaligned reads",2273662735,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7E36DAB1-7CB0-42DF-ACFC-615F7C0BBA2C","University of North Carolina","564a3f6de4b093830b6a8e15","1486A031-B74D-4976-8B0B-4569E6978F49","Uterine Corpus Endometrial Carcinoma","TARGZ","21D2B089-0712-4B8F-BBB8-FCA83097F098","2013-09-29T03:08:02.000Z","E6DD4417-7688-4DD2-AECF-5C99DE5750A9","None","NO",1,NA,"Primary Tumor","Cedars Sinai",4119,"21D2B089-0712-4B8F-BBB8-FCA83097F098",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F1A29822-A75F-46F5-ACAD-6A8C99D7B543.txt",170,"TCGA-A5-A0GD-01A",NA,NA,"TCGA",1999,NA,NA,"TUMOR FREE","FEA14411-8A57-4794-AD7F-D83C19104636",75,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F1A29822-A75F-46F5-ACAD-6A8C99D7B543.txt","Alive",NA,"TCGA-A5-A0GD",NA,"D8C9D35F-ECB7-47CC-BC8C-5E60FFFFDC4B",NA,98,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"A2CB73AF-073C-41E4-ABAE-C8D04A0AAE3A","BFFB6D14-1EC3-440C-B08E-DD5FD57A0C5E","UNCID_2207030.7e36dab1-7cb0-42df-acfc-615f7c0bba2c.110728_UNC2-RDR300275_00080_FC_63145AAXX_1.tar.gz","TCGA-A5-A0GD-01A-11",85,0,0,0,0,"BOTTOM",0,0,"TCGA-A5-A0GD-01A-01-BSA",100,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TUMOR FREE","Dead",3423,"TCGA-A5-A0GD-F3456","TCGA-A5-A0GD",1,"A5","A0GD","YES","C54.1","8380/3","C54.1","NO","YES",-27399,"FEMALE","WHITE",NA,"No","No","Alive",98,NA,NA,NA,"TUMOR FREE","NO",16,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,75,1999,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33419326,32758676,2462986089,"EACD1021-7B52-4531-8806-B7555B73AC84.bw","14c03068-8930-472a-9fd1-49c9fd4db47d","eacd1021-7b52-4531-8806-b7555b73ac84","2016-08-05T01:30:07.294103-05:00","UNCID_2210198.51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_8.tar.gz","b4b63141-9f0b-4331-a585-99c935f96730",2139788783,"Illumina GA","bf962e0c959645614a16de2192703492","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:38:15.073295-05:00","2016-05-03T11:15:47.407128-05:00","b4b63141-9f0b-4331-a585-99c935f96730_analysis.xml","76c5e525cb811df1d67e3a2fea19e0c4","4fa2c3f4-b856-4775-97d3-694fcf1ad4a7",2121,"2016-09-29T19:58:44.114294-05:00","b4b63141-9f0b-4331-a585-99c935f96730_experiment.xml","8c8ecd28ee2c2b68bcb2ef3c4f467cd4","5c5b9950-e04a-42f0-b1a3-7d3361e9fba7",2257,"2016-09-29T22:59:28.644438-05:00","b4b63141-9f0b-4331-a585-99c935f96730_run.xml","99d392b0067e4626b60be3b1d99a31b9","cbed5a55-ae76-49df-a61b-60fe868a19bb",347,"2016-09-08T11:08:30.192689-05:00","TCGA-D1-A15X","2016-09-02T18:49:54.591259-05:00","female","TCGA-D1-A15X_demographic",1963,"white","94e5d21e-5343-553f-80b3-79fb4e38d0ba","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A15X_diagnosis","not reported",16532,"alive","8441/3",NA,909,"b4a0d69d-3c39-5956-b8c4-c05c4d083263","c54.1",-16532,"TCGA-D1-A15X_treatment","9c4236e1-86dc-5ef7-84c0-1e6fc2893d99","01","false","TCGA-D1-A15X-01A",NA,"c81d521c-70f9-4299-87d2-02173751efc8",FALSE,"F32EB1C9-4802-4873-8F0E-E10724DA9C15","Primary Tumor",NA,897,130,NA,1292976000,"11",30,"TCGA-D1-A15X-01A-11",70,NA,0,NA,0,NA,0,NA,"2016-09-08T11:08:30.192689-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"a499993c-96cd-4517-ad4c-0a4bb86f8e8b",NA,"TCGA-D1-A15X-01A-01-TSA",NA,100,NA,"1a23bd8c-d6b9-43a5-84ff-e0625b00d50c","RNA","TCGA-D1-A15X-01A-11R","f9c21e2d-74ef-4e3f-8417-499b3fa7a386",1.88,0.17,"UV Spec","R","23","TCGA-D1-A15X-01A-11R-A118-07","51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1",0.17,NA,72,25.2092013584959,169,"fe7af538-d2aa-51db-99b6-0106e7685ea8","TCGA-D1-A15X_exposure","UNCID_2210198.51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_8.tar.gz","2013-10-02T07:16:04.000Z","2013-10-02T07:29:03.000Z","B4B63141-9F0B-4331-A585-99C935F96730","C81D521C-70F9-4299-87D2-02173751EFC8","Unaligned reads",2139788783,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","51F60923-90F4-4BF7-9CC4-0BCDD9ED50E1","University of North Carolina","564a3d67e4b09c884b24f8c8","14C03068-8930-472A-9FD1-49C9FD4DB47D","Uterine Corpus Endometrial Carcinoma","TARGZ","1A23BD8C-D6B9-43A5-84FF-E0625B00D50C","2013-10-02T07:29:03.000Z","F9C21E2D-74EF-4E3F-8417-499B3FA7A386","None","NO",1,NA,"Primary Tumor","Mayo Clinic",897,"1A23BD8C-D6B9-43A5-84FF-E0625B00D50C",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D5DF60B0-AEC5-44E0-BB4C-99DF11B9AE51.txt",130,"TCGA-D1-A15X-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","C81D521C-70F9-4299-87D2-02173751EFC8",45,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D5DF60B0-AEC5-44E0-BB4C-99DF11B9AE51.txt","Alive",NA,"TCGA-D1-A15X","NOT HISPANIC OR LATINO","A3ACB8A4-619B-43A9-953E-5C4249919BB7",NA,909,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",92,NA,"3D56BF5D-D7D7-499B-8155-6401D127B544","WHITE",NA,11,30,"A499993C-96CD-4517-AD4C-0A4BB86F8E8B","F9C21E2D-74EF-4E3F-8417-499B3FA7A386","UNCID_1630968.51f60923-90f4-4bf7-9cc4-0bcdd9ed50e1.sorted_genome_alignments.bam","TCGA-D1-A15X-01A-11",70,0,0,0,0,"TOP",0,0,"TCGA-D1-A15X-01A-01-TSA",100,NA,NA,NA,"TCGA-D1-A15X-R18474","OTHER: SPECIFY IN NOTES","Regional site",NA,"NO",909,"TUMOR FREE","Alive",NA,"TCGA-D1-A15X-F18473","TCGA-D1-A15X",1,"D1","A15X","YES","C54.1","8441/3","C54.1","NO","YES",-16532,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",909,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,45,2008,"Office Endometrial Biopsy",NA,NA,NA,"High Grade","R0",NA,NA,NA,NA,NA,"1995",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
115327142,113965470,5436366486,"AAC76EDF-5E5A-4D7E-8450-2B699A70EAA3.bw","14db56ef-ec5e-4775-a229-5d83e58e027c","aac76edf-5e5a-4d7e-8450-2b699a70eaa3","2016-08-05T16:45:55.007155-05:00","UNCID_2178396.1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4.130328_UNC10-SN254_0443_AD238RACXX_7_TTAGGC.tar.gz","9d97df80-e171-4dd6-9828-01937af3d1b4",4790091871,"Illumina HiSeq","8d4a885f1f00356ee5a27b9efa249413","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:03:11.246481-05:00","2016-05-03T10:57:27.710156-05:00","9d97df80-e171-4dd6-9828-01937af3d1b4_analysis.xml","b9bb4adee9c23913b22e3fd05c23a214","14003c11-18e3-4458-bfd3-b8af99f4d46d",2123,"2016-09-29T23:25:41.260589-05:00","9d97df80-e171-4dd6-9828-01937af3d1b4_experiment.xml","37e7a19ea23d5bcb2ac60d2fb0c7c019","dc42d08e-83ae-45cc-8011-e6006b2a2b21",2431,"2016-09-29T23:34:57.189517-05:00","9d97df80-e171-4dd6-9828-01937af3d1b4_run.xml","95009fce53b6add29951032da4991649","e2190b2e-3177-481e-b6f4-2d7a4bce2149",354,"2016-09-08T10:25:10.431800-05:00","TCGA-AJ-A3EK","2016-09-02T18:47:35.445935-05:00","female","TCGA-AJ-A3EK_demographic",1958,"white","d53f1a50-e0f6-56cd-8d86-3f2c7fa50cd5","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3EK_diagnosis","not reported",19609,"alive","8441/3",NA,446,"7ae32546-37ad-563a-b07c-259612c7d3c2","c54.1",-19609,"TCGA-AJ-A3EK_treatment","471a8465-9e03-5c43-ac81-aa90ee210f5e","01","false","TCGA-AJ-A3EK-01A",NA,"01747185-0d0d-4b27-b956-115df4d90bed",FALSE,"F153EAC2-7347-4CEF-916A-995C7BB8B0F1","Primary Tumor",NA,127,220,NA,1320624000,"11",30,"TCGA-AJ-A3EK-01A-11",85,NA,0,NA,5,NA,0,NA,"2016-09-08T10:25:10.431800-05:00",NA,4,NA,0,NA,"TOP",NA,5,NA,"97dd19e3-8852-4ae5-a7e2-92734ddb2cb7",NA,"TCGA-AJ-A3EK-01A-01-TS1",NA,90,NA,"32ba9ade-7638-4f78-9446-b092fe695a7b","RNA","TCGA-AJ-A3EK-01A-11R","7c03dc0f-2992-4185-ad84-72b61a9c1f53",1.86,0.16,"UV Spec","R","23","TCGA-AJ-A3EK-01A-11R-A19W-07","1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4",0.16,NA,60,24.3417582863402,157,"9d1be268-1969-5e24-beac-7646f39b5c61","TCGA-AJ-A3EK_exposure","UNCID_2178396.1ff9e0b8-b682-4da8-86f3-c510b7e6e1f4.130328_UNC10-SN254_0443_AD238RACXX_7_TTAGGC.tar.gz","2013-09-12T13:36:05.000Z","2013-09-12T13:49:01.000Z","9D97DF80-E171-4DD6-9828-01937AF3D1B4","01747185-0D0D-4B27-B956-115DF4D90BED","Unaligned reads",4790091871,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","1FF9E0B8-B682-4DA8-86F3-C510B7E6E1F4","University of North Carolina","564a383ae4b09c884b23638a","14DB56EF-EC5E-4775-A229-5D83E58E027C","Uterine Corpus Endometrial Carcinoma","TARGZ","32BA9ADE-7638-4F78-9446-B092FE695A7B","2013-09-12T13:49:01.000Z","7C03DC0F-2992-4185-AD84-72B61A9C1F53","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",127,"32BA9ADE-7638-4F78-9446-B092FE695A7B",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5A19C935-72ED-45F3-B42D-5AC8BFDB4789.txt",220,"TCGA-AJ-A3EK-01A",NA,"739D84CA-E206-428C-A852-CA1955C1F8BA","TCGA",2011,NA,NA,"TUMOR FREE","01747185-0D0D-4B27-B956-115DF4D90BED",53,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5A19C935-72ED-45F3-B42D-5AC8BFDB4789.txt","Alive",NA,"TCGA-AJ-A3EK","HISPANIC OR LATINO","92C14E07-528F-4034-B0DA-D459DB27DC2C",NA,64,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",186,NA,"78EB0294-89E9-4767-BD5B-9926E839F5AB","WHITE",NA,11,30,"97DD19E3-8852-4AE5-A7E2-92734DDB2CB7","64EBA7E4-9CC0-4668-960F-21F2EFF5F180","CLUBS_p_TCGA_186_188_SNP_N_GenomeWideSNP_6_B01_914072.raw.copynumber.data.txt","TCGA-AJ-A3EK-01A-11",85,5,0,4,0,"TOP",5,0,"TCGA-AJ-A3EK-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-AJ-A3EK-D45628","TCGA-AJ-A3EK-R45630","Internal","Primary Tumor Field","TCGA-AJ-A3EK-F45626_NTE-1","NO",446,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3EK-F45626","TCGA-AJ-A3EK",1,"AJ","A3EK","YES","C54.1","8441/3","C54.1","YES","NO",-19609,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",64,NA,NA,NA,"TUMOR FREE","NO",15,2,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
101928578,100090098,4775917412,"C6E39F86-9DEF-4BCA-930B-2A3993D18901.bw","16745dfb-8b28-4f5d-9ef1-2aa31ccb7293","c6e39f86-9def-4bca-930b-2a3993d18901","2016-08-09T13:17:17.530327-05:00","UNCID_2178344.11e82091-a9fb-4b7b-b0a2-7908e50e2c60.130328_UNC10-SN254_0443_AD238RACXX_8_ATCACG.tar.gz","31c4029e-3588-4b74-8444-ac423669e347",4224380924,"Illumina HiSeq","71b362bba7f6f2b201ec99d0ed4ec3f4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:09:17.956808-05:00","2016-05-03T10:56:47.878169-05:00","31c4029e-3588-4b74-8444-ac423669e347_analysis.xml","6b01d53103e248211df0d493f03d9419","f73ded90-0a93-4d59-958a-ce0f00e567b3",2123,"2016-08-29T09:57:29.567014-05:00","31c4029e-3588-4b74-8444-ac423669e347_experiment.xml","4f8dea5e3c97f68e7d9c3a38d88783a8","29cb521a-6aa0-4b1d-b0c4-fe3af0507093",2431,"2016-09-29T23:15:45.407727-05:00","31c4029e-3588-4b74-8444-ac423669e347_run.xml","bdba2c7c4b10d6d3c897086ae1dc4a10","d62731dd-aa6e-4b1c-ba1a-2b7849779900",354,"2016-09-08T11:03:16.246463-05:00","TCGA-AX-A3G3","2016-09-02T18:48:23.565969-05:00","female","TCGA-AX-A3G3_demographic",1951,"white","bfa17d93-143b-53bf-953e-b442f40b66da","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3G3_diagnosis","not reported",21308,"alive","8441/3",NA,42,"ffc1671e-9b30-5a81-b25f-0e651261e367","c54.1",-21308,"TCGA-AX-A3G3_treatment","f439094c-f8d9-583b-857a-dbe1c4f015c1","01","false","TCGA-AX-A3G3-01A",NA,"5efdace8-5790-4239-8e8a-6349f88b10dd",FALSE,"3D86258F-2C9B-4DF2-86C5-E12B3FCB480D","Primary Tumor",NA,713,140,NA,1322784000,"11",30,"TCGA-AX-A3G3-01A-11",97,NA,0,NA,0,NA,3,NA,"2016-09-08T11:03:16.246463-05:00",NA,0,NA,0,NA,"TOP",NA,15,NA,"279081b2-ed01-4949-bdef-2a72abca5131",NA,"TCGA-AX-A3G3-01A-01-TS1",NA,82,NA,"347e1242-0979-4b60-84c9-e4f2a333fe7e","RNA","TCGA-AX-A3G3-01A-11R","8298c48a-8f0e-451e-8af0-9725ec53e925",1.83,0.17,"UV Spec","R","23","TCGA-AX-A3G3-01A-11R-A213-07","11e82091-a9fb-4b7b-b0a2-7908e50e2c60",0.17,NA,55,19.7210369679802,167,"f70826d8-a67f-53bc-9521-d690b78c711e","TCGA-AX-A3G3_exposure","UNCID_2178344.11e82091-a9fb-4b7b-b0a2-7908e50e2c60.130328_UNC10-SN254_0443_AD238RACXX_8_ATCACG.tar.gz","2013-09-12T01:01:08.000Z","2013-09-12T01:18:01.000Z","31C4029E-3588-4B74-8444-AC423669E347","5EFDACE8-5790-4239-8E8A-6349F88B10DD","Unaligned reads",4224380924,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","11E82091-A9FB-4B7B-B0A2-7908E50E2C60","University of North Carolina","566078f0e4b0ca319164eec1","16745DFB-8B28-4F5D-9EF1-2AA31CCB7293","Uterine Corpus Endometrial Carcinoma","TARGZ","347E1242-0979-4B60-84C9-E4F2A333FE7E","2013-09-12T01:18:01.000Z","8298C48A-8F0E-451E-8AF0-9725EC53E925","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",713,"347E1242-0979-4B60-84C9-E4F2A333FE7E",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8FBE82B9-42A9-4451-A36F-9DE16D55BEB3.txt",140,"TCGA-AX-A3G3-01A",NA,NA,"TCGA",2009,NA,NA,NA,"60D29A8C-5FE1-4AE0-AE5A-98958989D8AB",58,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8FBE82B9-42A9-4451-A36F-9DE16D55BEB3.txt","Alive",NA,"TCGA-AX-A3G3",NA,"99EED834-57D0-4A3C-87B8-939AF801A9A0",NA,1,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",201,NA,NA,"WHITE",NA,11,30,"279081B2-ED01-4949-BDEF-2A72ABCA5131","64A79431-5D39-42B4-A155-A3F51DD8E95B","522f3c29c88e8d286ba229eb979d572d.bam","TCGA-AX-A3G3-01A-11",97,0,0,0,3,"TOP",15,0,"TCGA-AX-A3G3-01A-01-TS1",82,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3G3-F58287_NTE-1",NA,42,NA,"Alive",NA,"TCGA-AX-A3G3-F58287","TCGA-AX-A3G3",1,"AX","A3G3","YES","C54.1","8441/3","C54.1","NO","YES",-21308,"FEMALE","WHITE",NA,"Yes","No","Alive",1,NA,NA,NA,NA,"NO",2,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,58,2009,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
152782978,150172708,7167636978,"160972CF-CFDE-439F-A990-4869F96EEA3A.bw","16ac4341-cf8f-45e2-b90b-2d12d5f74a59","160972cf-cfde-439f-a990-4869f96eea3a","2016-08-25T02:53:47.328706-05:00","UNCID_2581804.4a299385-e7a5-4a82-940b-ff6e36c596c2.140404_UNC11-SN627_0350_BC3K66ACXX_6_ATTCCT.tar.gz","4e3a7df6-f338-4969-bc11-0d5a7036051e",6807315091,"Illumina HiSeq","adf90939d3db164de10b0b375b47cd6e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:30:23.067064-05:00","2016-05-03T11:55:56.226464-05:00","4e3a7df6-f338-4969-bc11-0d5a7036051e_analysis.xml","3943ee96892590977c0fbf94bda3d0c4","b9fec10c-443c-4675-b66b-67d6b224c952",2124,"2016-09-29T19:31:19.666808-05:00","4e3a7df6-f338-4969-bc11-0d5a7036051e_experiment.xml","63bb44f6afa0995da2bb748fb6b53a50","4b736877-183f-40a1-848d-550cea7df327",2628,"2016-09-29T20:06:01.899974-05:00","4e3a7df6-f338-4969-bc11-0d5a7036051e_run.xml","e4942f8cde2c87a44d66f77a62ad3aaa","60c5ceed-d613-412f-87ce-fcc4f3441a79",354,"2016-09-08T10:47:18.804052-05:00","TCGA-5B-A90C","2016-09-02T18:51:41.368402-05:00","female","TCGA-5B-A90C_demographic",1942,"black or african american","554b34de-9690-5845-a36e-4302ca06a99b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","5B","52292193-7bbd-590c-82af-3a6c30a26cb4","Medical College of Wisconsin","not reported","c54.1","TCGA-5B-A90C_diagnosis","not reported",25518,"alive","8380/3",NA,1202,"db9169d0-b9bd-544f-990f-924e37e052ae","c54.1",-25518,"TCGA-5B-A90C_treatment","d263a3e8-8229-540b-a6fa-44d003157433","01","false","TCGA-5B-A90C-01A",NA,"f1fb39e5-8275-4f45-a349-af82d6cd6ff7",FALSE,"608E2698-6A3A-4673-89D2-3BE98A74EBE5","Primary Tumor",NA,811,50,NA,1388361600,"11",30,"TCGA-5B-A90C-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T10:47:18.804052-05:00",NA,60,NA,20,NA,"TOP",NA,10,NA,"ed0ddb75-4627-42f4-96d4-cdeffe02e0aa",NA,"TCGA-5B-A90C-01A-01-TS1",NA,80,NA,"34f42fdd-9eb7-4f33-9deb-724c5acabfa2","RNA","TCGA-5B-A90C-01A-11R","68e7e413-c5ba-4c5e-8c73-f7886b7d59ce",1.86,0.17,"UV Spec","R","23","TCGA-5B-A90C-01A-11R-A37O-07","4a299385-e7a5-4a82-940b-ff6e36c596c2",0.17,NA,98,39.2565294023394,158,"f03fa1fc-f318-52e9-95d4-29f1fa68d4dd","TCGA-5B-A90C_exposure","UNCID_2581804.4a299385-e7a5-4a82-940b-ff6e36c596c2.140404_UNC11-SN627_0350_BC3K66ACXX_6_ATTCCT.tar.gz","2014-08-15T12:36:04.000Z","2014-08-15T13:03:10.000Z","4E3A7DF6-F338-4969-BC11-0D5A7036051E","F1FB39E5-8275-4F45-A349-AF82D6CD6FF7","Unaligned reads",6807315091,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","4A299385-E7A5-4A82-940B-FF6E36C596C2","University of North Carolina","564a334ce4b093830b66acf2","16AC4341-CF8F-45E2-B90B-2D12D5F74A59","Uterine Corpus Endometrial Carcinoma","TARGZ","34F42FDD-9EB7-4F33-9DEB-724C5ACABFA2","2014-08-15T13:03:10.000Z","68E7E413-C5BA-4C5E-8C73-F7886B7D59CE","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",811,"34F42FDD-9EB7-4F33-9DEB-724C5ACABFA2",NA,"5B","SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_H01_1465224.hg18.seg.txt",50,"TCGA-5B-A90C-01A",NA,"30F8962E-59E4-42C2-AC7C-736C39EDEF0D","TCGA",2011,"TCGA-5B-A90C_NTE-1",NA,"TUMOR FREE","F1FB39E5-8275-4F45-A349-AF82D6CD6FF7",69,"nationwidechildrens.org_clinical.TCGA-5B-A90C.xml","Alive",NA,"TCGA-5B-A90C","NOT HISPANIC OR LATINO","A733EEF7-D513-4BD2-83B3-7988FB6699CD","YES",883,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",381,NA,"0AFFD00A-4853-4656-A60D-232CDAD295A2","BLACK OR AFRICAN AMERICAN",NA,11,30,"ED0DDB75-4627-42F4-96D4-CDEFFE02E0AA","CC6505C6-9EF3-4BA7-AF57-57268BF215F6","UNCID_2412001.4a299385-e7a5-4a82-940b-ff6e36c596c2.sorted_genome_alignments.bam.bai","TCGA-5B-A90C-01A-11",80,0,20,60,10,"TOP",10,20,"TCGA-5B-A90C-01A-01-TS1",80,"Paclitaxel","Chemotherapy","TCGA-5B-A90C-D58622","TCGA-5B-A90C-R58620","Internal","Regional site","TCGA-5B-A90C-F69362_NTE-1","YES",1202,"TUMOR FREE","Alive",NA,"TCGA-5B-A90C-F69362","TCGA-5B-A90C",1,"5B","A90C","YES","C54.1","8380/3","C54.1","NO","YES",-25518,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",883,NA,"YES","NO","TUMOR FREE","YES",17,4,2014,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2011,"Office Endometrial Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
25945203,25739289,1920511172,"BA96CB79-F522-45D0-B0BC-E779C88393AE.bw","16bde24f-61b8-458d-aca3-df4806abbd1b","ba96cb79-f522-45d0-b0bc-e779c88393ae","2016-08-09T14:00:12.552698-05:00","UNCID_2189187.e505cac9-a568-42db-bc67-d90af57e5265.120531_UNC2-RDR300275_00125_FC_64VUHAAXX_4.tar.gz","deae73bb-3cbd-46b3-9fd3-6d476228e85b",1795422181,"Illumina GA","cdf617eb0a0c3ff1ab8a59241ee73903","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:41:13.888832-05:00","2016-05-03T11:05:01.516668-05:00","deae73bb-3cbd-46b3-9fd3-6d476228e85b_analysis.xml","3978db6f26d04f0752f4e7b6edc2a492","2bc7c33c-d9a8-467d-b739-9957cf687c44",2122,"2016-08-27T14:32:13.053506-05:00","deae73bb-3cbd-46b3-9fd3-6d476228e85b_experiment.xml","1a8162e5a8403a7c136ad524052880ed","d8975f5a-8e52-4daa-9c1b-e37e25619230",2258,"2016-09-29T18:44:19.917996-05:00","deae73bb-3cbd-46b3-9fd3-6d476228e85b_run.xml","5621618ef8be7eb415c642fa52d0b09a","2dc48f8c-5ef8-4693-b98e-8954b96e5f9d",349,"2016-09-08T11:41:49.270411-05:00","TCGA-EY-A1GI","2016-09-02T18:51:53.813971-05:00","female","TCGA-EY-A1GI_demographic",1957,"white","15b9957d-8c31-5525-b249-cb4e25a082fd","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GI_diagnosis","not reported",19117,"alive","8380/3",NA,710,"a6b29f73-2887-5de1-88ea-25441a3379e9","c54.1",-19117,"TCGA-EY-A1GI_treatment","aae9d72c-f9dd-50d1-9ebf-f0c2b3c5860c","01","false","TCGA-EY-A1GI-01A",NA,"9618747c-19fc-4243-ab49-d277992544e5",FALSE,"1D56F7CA-A3F0-4078-B8E3-A10CD97873D4","Primary Tumor",NA,444,150,NA,1297900800,"11",30,"TCGA-EY-A1GI-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T11:41:49.270411-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"3f4486b1-11c5-4b46-be64-696584cf1eea",NA,"TCGA-EY-A1GI-01A-01-TSA",NA,100,NA,"c2b44ff4-894e-4f9e-b1cb-9d9ab72f2a77","RNA","TCGA-EY-A1GI-01A-11R","66e7c24b-7511-4333-932b-43c9342a9373",1.83,0.17,"UV Spec","R","23","TCGA-EY-A1GI-01A-11R-A13S-07","e505cac9-a568-42db-bc67-d90af57e5265",0.17,NA,69,25.3443526170799,165,"841d200b-8a8b-5e41-97fe-b7e3d4ba9cf6","TCGA-EY-A1GI_exposure","UNCID_2189187.e505cac9-a568-42db-bc67-d90af57e5265.120531_UNC2-RDR300275_00125_FC_64VUHAAXX_4.tar.gz","2013-09-18T18:26:03.000Z","2013-09-18T18:37:02.000Z","DEAE73BB-3CBD-46B3-9FD3-6D476228E85B","9618747C-19FC-4243-AB49-D277992544E5","Unaligned reads",1795422181,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E505CAC9-A568-42DB-BC67-D90AF57E5265","University of North Carolina","564a3762e4b0ef121819279d","16BDE24F-61B8-458D-ACA3-DF4806ABBD1B","Uterine Corpus Endometrial Carcinoma","TARGZ","C2B44FF4-894E-4F9E-B1CB-9D9AB72F2A77","2013-09-18T18:37:02.000Z","66E7C24B-7511-4333-932B-43C9342A9373","United States","NO",1,NA,"Primary Tumor","University of North Carolina",444,"C2B44FF4-894E-4F9E-B1CB-9D9AB72F2A77",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.27280176-FA3E-4547-BC14-810694C91270.txt",150,"TCGA-EY-A1GI-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","FF307127-B03D-49E7-BAD6-CC0C15CE6F84",52,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.27280176-FA3E-4547-BC14-810694C91270.txt","Alive",NA,"TCGA-EY-A1GI","NOT HISPANIC OR LATINO","5B608B16-4E05-4EB3-A204-0AF06751DE45",NA,507,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,"2E7E53BE-FB1A-43DC-BEB2-D16F99CDE1E0","WHITE",NA,11,30,"3F4486B1-11C5-4B46-BE64-696584CF1EEA","66E7C24B-7511-4333-932B-43C9342A9373","d1b5c8ccd3b72777e0e0ee1f5f7e3725.bam","TCGA-EY-A1GI-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-EY-A1GI-01A-01-TSA",100,NA,NA,NA,"TCGA-EY-A1GI-R11871","OTHER: SPECIFY IN NOTES","Regional site",NA,"NO",710,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GI-F19727","TCGA-EY-A1GI",1,"EY","A1GI","YES","C54.1","8380/3","C54.1","NO","YES",-19117,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",507,NA,NA,NA,"TUMOR FREE","NO",18,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,52,2009,"Excisional Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
33020938,32811782,2437930316,"F6CFDC1D-064B-4275-AD97-CAA5D0716E5C.bw","16e69011-c295-479f-b521-86e66fba498d","f6cfdc1d-064b-4275-ad97-caa5d0716e5c","2016-08-05T10:56:55.884585-05:00","UNCID_2207468.deeb2238-8ed6-4651-8b63-428c76914c94.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_5.tar.gz","aae1d6e5-d41d-4ce3-9def-35c37601cf61",2128340755,"Illumina GA","ea960bec04aac177a39cbbe313032928","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:22:33.549058-05:00","2016-05-03T11:14:23.412796-05:00","aae1d6e5-d41d-4ce3-9def-35c37601cf61_analysis.xml","06aa355f82b99fa0df069243764ddc2b","1ff24fdc-ec2d-44c5-9c7b-96c71d933610",2121,"2016-09-29T18:56:43.216430-05:00","aae1d6e5-d41d-4ce3-9def-35c37601cf61_experiment.xml","1d123d71cf73591c0feb269de92f19fa","35a6c96a-5d76-445d-8d73-07adbf3fa664",2257,"2016-09-29T20:57:23.581968-05:00","aae1d6e5-d41d-4ce3-9def-35c37601cf61_run.xml","0420015f41392615edd285bdf45a800d","8057a923-8ec5-4e5b-aad4-ecdaf2f4de89",347,"2016-09-08T11:53:36.105722-05:00","TCGA-D1-A16G","2016-09-02T18:50:25.348752-05:00","female","TCGA-D1-A16G_demographic",1934,"white","3078ca72-dee9-5c7d-8a6a-a75206adc1bd","not hispanic or latino",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16G_diagnosis","not reported",27065,"dead","8441/3",834,NA,"e5f2e1a4-d619-5852-88a9-7951d63188d1","c54.1",-27065,"TCGA-D1-A16G_treatment","2ce1e51d-937d-5861-81d1-3df10bf5369a","01","false","TCGA-D1-A16G-01A",NA,"4c34ecb0-9351-4a55-9ff5-2062b7cb391a",FALSE,"778F9F58-841E-48F3-B6EA-7CF58463808B","Primary Tumor",NA,769,250,NA,1294185600,"31",30,"TCGA-D1-A16G-01A-31",60,NA,0,NA,0,NA,40,NA,"2016-09-08T11:53:36.105722-05:00",NA,10,NA,30,NA,"TOP",NA,0,NA,"07c2e2e7-7541-4d59-bbf1-bbafb95cdb72",NA,"TCGA-D1-A16G-01A-03-TS3",NA,60,NA,"a7688e3b-76f9-4274-9a9a-c880b7d0b05b","RNA","TCGA-D1-A16G-01A-31R","15665d54-3bab-4df7-8bb7-e330b978614f",1.91,0.16,"UV Spec","R","23","TCGA-D1-A16G-01A-31R-A12I-07","deeb2238-8ed6-4651-8b63-428c76914c94",0.16,NA,75,25.0593070266297,173,"b917f59e-8638-508b-b956-7166198e6edf","TCGA-D1-A16G_exposure","UNCID_2207468.deeb2238-8ed6-4651-8b63-428c76914c94.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_5.tar.gz","2013-09-30T01:36:06.000Z","2013-09-30T01:49:02.000Z","AAE1D6E5-D41D-4CE3-9DEF-35C37601CF61","4C34ECB0-9351-4A55-9FF5-2062B7CB391A","Unaligned reads",2128340755,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","DEEB2238-8ED6-4651-8B63-428C76914C94","University of North Carolina","56607b94e4b018727fea2b16","16E69011-C295-479F-B521-86E66FBA498D","Uterine Corpus Endometrial Carcinoma","TARGZ","A7688E3B-76F9-4274-9A9A-C880B7D0B05B","2013-09-30T01:49:02.000Z","15665D54-3BAB-4DF7-8BB7-E330B978614F","None","NO",1,NA,"Primary Tumor","Mayo Clinic",769,"A7688E3B-76F9-4274-9A9A-C880B7D0B05B",NA,"D1","TCGA-D1-A16G-01A-31R-A12H-13_mirna.bam.bai",250,"TCGA-D1-A16G-01A",NA,"F5DC0735-DDEB-4739-80C6-BA9BF7409378","TCGA",2008,NA,NA,"WITH TUMOR","5F56BA05-2FAF-4052-B4C7-1F6E0C349C51",74,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D63DB6BF-75DA-431D-947C-1609C481A48A.txt","Dead",834,"TCGA-D1-A16G","NOT HISPANIC OR LATINO","0C203C8F-9A4A-4131-88B4-194AC9A246F1",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C54.1",94,NA,"61850D09-EF4E-4080-BC15-13088AE40899","WHITE",NA,31,30,"07C2E2E7-7541-4D59-BBF1-BBAFB95CDB72","E18DE4E1-7366-41E2-88BA-00F798E8BAAD","UNCID_2207468.deeb2238-8ed6-4651-8b63-428c76914c94.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_5.tar.gz","TCGA-D1-A16G-01A-31",60,0,0,10,40,"TOP",0,30,"TCGA-D1-A16G-01A-03-TS3",60,"Taxol","Chemotherapy","TCGA-D1-A16G-D18566","TCGA-D1-A16G-R18569","EXTERNAL BEAM","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",834,"TCGA-D1-A16G-F18560","TCGA-D1-A16G",1,"D1","A16G","YES","C54.1","8441/3","C54.1","NO","YES",-27065,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,834,NA,NA,"WITH TUMOR","NO",13,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,74,2008,"Office Endometrial Biopsy",NA,NA,NA,"High Grade","RX",NA,NA,NA,NA,NA,"1995",14,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31802828,30478436,2294718443,"956357FB-9AB3-497C-BB55-9D15B486A422.bw","170bbbac-940f-4e1b-b0b8-60fa36d0fa23","956357fb-9ab3-497c-bb55-9d15b486a422","2016-08-09T14:14:53.619948-05:00","UNCID_2210319.ac9c8753-ae35-4367-9aef-d42522bc8db7.110407_UNC6-RDR300211_00095_FC64GJRAAXX_8.tar.gz","d1435bd4-9dbd-4ed5-b6eb-c73058d2e716",2086141608,"Illumina GA","1582c0025d119287abcfb10aef498db7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:19:21.205589-05:00","2016-05-03T11:15:47.420908-05:00","d1435bd4-9dbd-4ed5-b6eb-c73058d2e716_analysis.xml","382091f995505454083dcea76a12de8f","b3259292-8d05-4141-8021-6e938d5c4a27",2119,"2016-09-29T22:20:11.234711-05:00","d1435bd4-9dbd-4ed5-b6eb-c73058d2e716_experiment.xml","ffdd9b39361d2b14af8f12d21ac2e0ad","b39c91b2-830f-4d63-a91e-21d9de9deaa2",2257,"2016-09-29T23:44:30.942817-05:00","d1435bd4-9dbd-4ed5-b6eb-c73058d2e716_run.xml","5bffe35802c7fc067455d470e5b287b1","e81bcc9d-d838-436a-a831-6df46e7e0acf",347,"2016-09-08T10:43:18.296448-05:00","TCGA-D1-A160","2016-09-02T18:49:56.414762-05:00","female","TCGA-D1-A160_demographic",1938,"white","0225e9ef-fd53-5fbb-8fe7-d11be0fd4d83","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A160_diagnosis","not reported",25673,"alive","8380/3",NA,112,"3851b957-4645-5b14-9890-0123848bfb32","c54.1",-25673,"TCGA-D1-A160_treatment","7d5bd713-96d1-5014-b55c-08eb26b1bae4","01","false","TCGA-D1-A160-01A",NA,"b36ecf21-9d51-43dc-b2fb-6f6156e85875",FALSE,"F349C87E-F324-4A8E-81E1-153C99173E21","Primary Tumor",NA,895,100,NA,1292976000,"11",30,"TCGA-D1-A160-01A-11",85,NA,0,NA,0,NA,5,NA,"2016-09-08T10:43:18.296448-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"64e12c1a-6c19-4eb8-8597-948cbbee9b7b",NA,"TCGA-D1-A160-01A-01-TSA",NA,95,NA,"a648846c-0389-46db-a79b-4b298957c0fb","RNA","TCGA-D1-A160-01A-11R","860b0e56-ed28-4234-b0f5-747efbd206c2",1.87,0.16,"UV Spec","R","23","TCGA-D1-A160-01A-11R-A118-07","ac9c8753-ae35-4367-9aef-d42522bc8db7",0.16,NA,122,41.2385073012439,172,"e0638df4-37ec-54cc-b654-f051afb9675f","TCGA-D1-A160_exposure","UNCID_2210319.ac9c8753-ae35-4367-9aef-d42522bc8db7.110407_UNC6-RDR300211_00095_FC64GJRAAXX_8.tar.gz","2013-10-02T09:16:05.000Z","2013-10-02T09:47:02.000Z","D1435BD4-9DBD-4ED5-B6EB-C73058D2E716","B36ECF21-9D51-43DC-B2FB-6F6156E85875","Unaligned reads",2086141608,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","AC9C8753-AE35-4367-9AEF-D42522BC8DB7","University of North Carolina","564a404de4b09c884b25d398","170BBBAC-940F-4E1B-B0B8-60FA36D0FA23","Uterine Corpus Endometrial Carcinoma","TARGZ","A648846C-0389-46DB-A79B-4B298957C0FB","2013-10-02T09:47:02.000Z","860B0E56-ED28-4234-B0F5-747EFBD206C2","None","NO",1,NA,"Primary Tumor","Mayo Clinic",895,"A648846C-0389-46DB-A79B-4B298957C0FB",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A35BF473-635A-43CF-8507-E4328B2155FC.txt",100,"TCGA-D1-A160-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","B36ECF21-9D51-43DC-B2FB-6F6156E85875",70,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A35BF473-635A-43CF-8507-E4328B2155FC.txt","Alive",NA,"TCGA-D1-A160","NOT HISPANIC OR LATINO","6C396147-7011-4F83-BE28-FDEC61E798F0",NA,112,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"64E12C1A-6C19-4EB8-8597-948CBBEE9B7B","860B0E56-ED28-4234-B0F5-747EFBD206C2","UNCID_199069.TCGA-D1-A160-01A-11R-A118-07.110407_UNC6-RDR300211_00095_FC64GJRAAXX.8.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-D1-A160-01A-11",85,0,0,0,5,"TOP",0,0,"TCGA-D1-A160-01A-01-TSA",95,NA,NA,NA,NA,NA,NA,NA,"NO",112,"TUMOR FREE","Alive",NA,"TCGA-D1-A160-F18477","TCGA-D1-A160",1,"D1","A160","YES","C54.1","8380/3","C54.1","NO","YES",-25673,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",112,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,70,2008,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
133553464,129600275,6178323703,"81FC1829-1BFE-48B7-AF60-AB6FAF039204.bw","1944e155-b765-48c3-9602-6787c105e551","81fc1829-1bfe-48b7-af60-ab6faf039204","2016-08-25T22:20:54.928706-05:00","UNCID_2316578.894b867a-591d-4d05-b008-db1a90b18a60.130827_UNC15-SN850_0324_AC2B28ACXX_7_ACTTGA.tar.gz","dfee92eb-314b-4ea0-9071-47da463bec4d",5990170253,"Illumina HiSeq","a66c88d1f50722f4160ce7f4fd3c27f6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:50:41.543034-05:00","2016-05-03T11:28:50.231867-05:00","dfee92eb-314b-4ea0-9071-47da463bec4d_analysis.xml","50268f25d1177c17910a65e3632e94b3","ebde3537-66fd-487e-9557-7ee91a9ea36d",2122,"2016-10-07T16:52:21.694714-05:00","dfee92eb-314b-4ea0-9071-47da463bec4d_experiment.xml","e25af9c0b919dda3f2c06285ec54b75e","0fc6bae5-e4a5-4267-94c7-5d2405a5e45e",2628,"2016-09-29T22:57:45.313827-05:00","dfee92eb-314b-4ea0-9071-47da463bec4d_run.xml","78efb8436211042712d08862006ca000","caed34dc-57c5-4e3c-8718-e1205b7c4670",354,"2016-09-08T10:46:35.029286-05:00","TCGA-EY-A5W2","2016-09-02T18:50:45.335654-05:00","female","TCGA-EY-A5W2_demographic",1940,"black or african american","e7a98c2c-539d-501e-8a18-f269636399ec","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A5W2_diagnosis","not reported",26498,"alive","8380/3",NA,516,"c192dd75-28e1-5ce0-9b66-234a0ad768d9","c54.1",-26498,"TCGA-EY-A5W2_treatment","355c8539-8e1b-5d0d-abdf-69bea260650a","01","false","TCGA-EY-A5W2-01A",NA,"d50bb383-3384-47d9-92b8-1f0604ac2725",FALSE,"C09EED3C-50CC-47CB-BA81-96D05E53D9F0","Primary Tumor",NA,105,870,NA,1362528000,"11",30,"TCGA-EY-A5W2-01A-11",80,NA,0,NA,0,NA,20,NA,"2016-09-08T10:46:35.029286-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"98509a6c-f812-4678-89db-dc9e4e4006b6",NA,"TCGA-EY-A5W2-01A-01-TS1",NA,80,NA,"830e980e-468b-46de-836b-49571d8c1672","RNA","TCGA-EY-A5W2-01A-11R","f67fdc7c-2430-4a3e-a722-ebb356e1418b",1.83,0.17,"UV Spec","R","23","TCGA-EY-A5W2-01A-11R-A31O-07","894b867a-591d-4d05-b008-db1a90b18a60",0.17,NA,83,32.0203695845068,161,"22aac06c-86ee-5665-874d-4b3c71ce81a1","TCGA-EY-A5W2_exposure","UNCID_2316578.894b867a-591d-4d05-b008-db1a90b18a60.130827_UNC15-SN850_0324_AC2B28ACXX_7_ACTTGA.tar.gz","2014-01-07T08:26:03.000Z","2014-01-07T08:46:01.000Z","DFEE92EB-314B-4EA0-9071-47DA463BEC4D","D50BB383-3384-47D9-92B8-1F0604AC2725","Unaligned reads",5990170253,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","894B867A-591D-4D05-B008-DB1A90B18A60","University of North Carolina","564a363be4b0ef121818c7ed","1944E155-B765-48C3-9602-6787C105E551","Uterine Corpus Endometrial Carcinoma","TARGZ","830E980E-468B-46DE-836B-49571D8C1672","2014-01-07T08:46:01.000Z","F67FDC7C-2430-4A3E-A722-EBB356E1418B","United States","NO",1,NA,"Primary Tumor","University of North Carolina",105,"830E980E-468B-46DE-836B-49571D8C1672",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7F27E4E1-84E6-4CD1-A925-56A28A53D371.txt",870,"TCGA-EY-A5W2-01A",NA,NA,"TCGA",2012,"TCGA-EY-A5W2_NTE-1","Complete Remission/Response","TUMOR FREE","DD20A6F3-9593-41BF-971E-53DC2C4B7307",72,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7F27E4E1-84E6-4CD1-A925-56A28A53D371.txt","Alive",NA,"TCGA-EY-A5W2","NOT HISPANIC OR LATINO","4ED0E602-105A-44E0-B8C3-1B91511194D7","NO",161,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",324,NA,"CDA6CF1C-AB39-4A83-A5BA-32CA9B31C2BB","BLACK OR AFRICAN AMERICAN",NA,11,30,"98509A6C-F812-4678-89DB-DC9E4E4006B6","F67FDC7C-2430-4A3E-A722-EBB356E1418B","TCGA-EY-A5W2-01A-11R-A31S-13_mirna.bam","TCGA-EY-A5W2-01A-11",80,0,0,0,20,"TOP",0,0,"TCGA-EY-A5W2-01A-01-TS1",80,NA,NA,NA,"TCGA-EY-A5W2-R43407","Internal","Regional site","TCGA-EY-A5W2-F58696_NTE-1","NO",516,"TUMOR FREE","Alive",NA,"TCGA-EY-A5W2-F58696","TCGA-EY-A5W2",1,"EY","A5W2","YES","C54.1","8380/3","C54.1","YES","NO",-26498,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",161,NA,"YES","NO","TUMOR FREE","YES",20,5,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,72,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32289700,31630534,2373885373,"407BC25E-900D-4CDC-B6A1-2D00A40F9280.bw","19511f9e-7b0e-4a06-998d-c1837d37c6ec","407bc25e-900d-4cdc-b6a1-2d00a40f9280","2016-08-09T14:15:24.612084-05:00","UNCID_2210342.3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3.110407_UNC6-RDR300211_00095_FC64GJRAAXX_2.tar.gz","f3ff848f-f8b9-45b8-acb1-7c11007a4468",2155669787,"Illumina GA","1aca75dc31f2291796145b9df148fa24","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:22:47.994633-05:00","2016-05-03T11:15:47.420908-05:00","f3ff848f-f8b9-45b8-acb1-7c11007a4468_analysis.xml","3a7606d188765eb63ad4452f06868c8c","da6e21df-af12-48ce-923f-2331890e11e1",2119,"2016-09-29T22:21:11.014100-05:00","f3ff848f-f8b9-45b8-acb1-7c11007a4468_experiment.xml","e31d578a7dcae499209a744130816c7d","b4326e63-a92c-45b0-8677-0fdae843aa63",2257,"2016-09-29T17:52:13.279520-05:00","f3ff848f-f8b9-45b8-acb1-7c11007a4468_run.xml","e47ac8a31da6d6fd51a44c87faafce0c","0d14093e-36dd-497e-ae83-10b7ef634e39",347,"2016-09-08T10:46:25.880311-05:00","TCGA-B5-A121","2016-09-02T18:49:36.855742-05:00","female","TCGA-B5-A121_demographic",1953,"white","519905a6-d464-5f72-bbe1-83bc661c1821","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A121_diagnosis","not reported",21018,"alive","8380/3",NA,504,"c8c3a343-0666-5f03-866f-bdfe11bb12ed","c54.1",-21018,"TCGA-B5-A121_treatment","9628bbe7-f630-591b-b8d4-a05ad6f7eddd","01","true","TCGA-B5-A121-01A",NA,"d7a7ecf1-7771-49c0-9756-302adba3a2c9",FALSE,"82B20A1F-99AC-4CC8-BAF2-B7132809D4F2","Primary Tumor",NA,188,280,NA,1291680000,"31",30,"TCGA-B5-A121-01A-31",NA,85,NA,3,NA,0,NA,15,"2016-09-08T10:46:25.880311-05:00","2016-09-08T10:46:25.880311-05:00",NA,25,NA,0,"BOTTOM","TOP",NA,0,"9c9b2d19-3901-4818-9c4f-d0a6f8e931ec","f7e46d60-f100-429d-a482-75cbd14a1a69","TCGA-B5-A121-01A-03-BS3","TCGA-B5-A121-01A-03-TS3",NA,85,"d9209347-8eec-434a-83d7-aac36f7ae26b","RNA","TCGA-B5-A121-01A-31R","4b1f1fb5-2f05-4846-9fc8-5c1fb9f6ceae",1.87,0.16,"UV Spec","R","23","TCGA-B5-A121-01A-31R-A118-07","3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3",0.16,NA,80,29.3847566574839,165,"4ee57eea-fd10-5615-9b3e-77b11ae176ab","TCGA-B5-A121_exposure","UNCID_2210342.3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3.110407_UNC6-RDR300211_00095_FC64GJRAAXX_2.tar.gz","2013-10-02T09:46:04.000Z","2013-10-02T10:05:03.000Z","F3FF848F-F8B9-45B8-ACB1-7C11007A4468","D7A7ECF1-7771-49C0-9756-302ADBA3A2C9","Unaligned reads",2155669787,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3E0F0D9D-31CC-4E48-B4CA-D53DEEC9B7D3","University of North Carolina","566077e0e4b016715ab69a7a","19511F9E-7B0E-4A06-998D-C1837D37C6EC","Uterine Corpus Endometrial Carcinoma","TARGZ","D9209347-8EEC-434A-83D7-AAC36F7AE26B","2013-10-02T10:05:03.000Z","4B1F1FB5-2F05-4846-9FC8-5C1FB9F6CEAE","United States","NO",1,NA,"Primary Tumor","Duke",188,"D9209347-8EEC-434A-83D7-AAC36F7AE26B",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A4DA0446-B32E-4A47-8D1D-F4934D134F1D.txt",280,"TCGA-B5-A121-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","D7A7ECF1-7771-49C0-9756-302ADBA3A2C9",57,"nationwidechildrens.org_clinical.TCGA-B5-A121.xml","Alive",NA,"TCGA-B5-A121",NA,"DA348492-6A53-4DDC-B15F-DB3BD2388186",NA,259,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"07941129-25C5-44C1-B8CF-B470B74149B0","WHITE",NA,31,30,"F7E46D60-F100-429D-A482-75CBD14A1A69","4B1F1FB5-2F05-4846-9FC8-5C1FB9F6CEAE","UNCID_2210342.3e0f0d9d-31cc-4e48-b4ca-d53deec9b7d3.110407_UNC6-RDR300211_00095_FC64GJRAAXX_2.tar.gz","TCGA-B5-A121-01A-31",85,0,3,25,15,"TOP",0,0,"TCGA-B5-A121-01A-03-TS3",85,NA,NA,NA,"TCGA-B5-A121-R10649","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",504,"TUMOR FREE","Alive",NA,"TCGA-B5-A121-F17838","TCGA-B5-A121",1,"B5","A121","YES","C54.1","8380/3","C54.1","NO","YES",-21018,"FEMALE","WHITE",NA,"No","No","Alive",259,NA,NA,NA,"TUMOR FREE","NO",23,3,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34052604,33409822,2482713798,"C0C10950-ABC5-4125-A33E-5AFA2D2574B0.bw","1a094c2b-9fba-4bb1-929d-bb2cdf874bee","c0c10950-abc5-4125-a33e-5afa2d2574b0","2016-08-09T14:09:00.473611-05:00","UNCID_2206509.9713963c-c7c7-47a0-ba01-6710bd4e9fea.110921_UNC6-RDR300211_00125_FC_634F4AAXX_5.tar.gz","06424652-99f3-4a92-8688-bd30b9d846d0",2224594326,"Illumina GA","a8103b41338adbb61aeb66927ca56b04","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:21:47.507183-05:00","2016-05-03T11:11:34.765256-05:00","06424652-99f3-4a92-8688-bd30b9d846d0_analysis.xml","80c39dbbb6e60e5b3fb8777016426ce8","6a56cf6b-f0db-48e6-98f6-fbe5e9ccfec2",2121,"2016-08-13T06:44:33.157992-05:00","06424652-99f3-4a92-8688-bd30b9d846d0_experiment.xml","03ec084a8e5404969bda4d8de0d6add1","859a9831-0951-4720-a205-c3666abc2896",2257,"2016-09-29T19:25:54.471224-05:00","06424652-99f3-4a92-8688-bd30b9d846d0_run.xml","89f306cbcb11c55305eaaaa8795cc1b8","48010a33-cd72-4817-8114-a618e5582150",347,"2016-09-08T11:51:24.402707-05:00","TCGA-EY-A1GM","2016-09-02T18:52:26.392358-05:00","female","TCGA-EY-A1GM_demographic",1950,"black or african american","ab1d9537-bbcc-55e7-8d2b-f3582eced474","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GM_diagnosis","not reported",22010,"dead","8441/3",995,210,"77eb7ced-0eb8-5255-9645-643a4fed5f93","c54.1",-22010,"TCGA-EY-A1GM_treatment","4e2ae154-79b8-5258-9d89-3f465a92f361","01","false","TCGA-EY-A1GM-01A",NA,"95fded4f-677e-4dcf-a5c4-6b344fbccfd4",FALSE,"C3599CB9-3B69-4083-AA2E-5BB52CF1ED93","Primary Tumor",NA,323,140,NA,1297641600,"12",10,"TCGA-EY-A1GM-01A-12",90,NA,20,NA,0,NA,5,NA,"2016-09-08T11:51:24.402707-05:00",NA,20,NA,40,NA,"TOP",NA,5,NA,"f2098f55-a021-491e-b5b8-d72f76fc67f0",NA,"TCGA-EY-A1GM-01A-01-TSA",NA,90,NA,"935a9ad0-9ef9-4cf9-86d4-253ebc132e56","RNA","TCGA-EY-A1GM-01A-12R","f0312ff5-70ec-43d5-b9b3-0e0862c56864",1.77,0.16,"UV Spec","R","23","TCGA-EY-A1GM-01A-12R-A14D-07","9713963c-c7c7-47a0-ba01-6710bd4e9fea",0.16,NA,71,28.8044139721693,157,"feaa3c34-26ba-59ad-a575-e61f06c14246","TCGA-EY-A1GM_exposure","UNCID_2206509.9713963c-c7c7-47a0-ba01-6710bd4e9fea.110921_UNC6-RDR300211_00125_FC_634F4AAXX_5.tar.gz","2013-09-27T06:07:04.000Z","2013-09-27T06:20:02.000Z","06424652-99F3-4A92-8688-BD30B9D846D0","95FDED4F-677E-4DCF-A5C4-6B344FBCCFD4","Unaligned reads",2224594326,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","9713963C-C7C7-47A0-BA01-6710BD4E9FEA","University of North Carolina","566074a8e4b016715ab6783d","1A094C2B-9FBA-4BB1-929D-BB2CDF874BEE","Uterine Corpus Endometrial Carcinoma","TARGZ","935A9AD0-9EF9-4CF9-86D4-253EBC132E56","2013-09-27T06:20:02.000Z","F0312FF5-70EC-43D5-B9B3-0E0862C56864","United States","NO",1,NA,"Primary Tumor","University of North Carolina",323,"935A9AD0-9EF9-4CF9-86D4-253EBC132E56",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2C36E07A-174A-4CBC-8CCD-AD830A4BB1DF.txt",140,"TCGA-EY-A1GM-01A",NA,"DEC72B13-2260-4B4D-95FC-51D6F67FCA9D","TCGA",2010,NA,NA,"TUMOR FREE","9B2E6B68-335D-440D-B31A-54622B750DEE",60,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2C36E07A-174A-4CBC-8CCD-AD830A4BB1DF.txt","Alive",NA,"TCGA-EY-A1GM",NA,"EACE7A9C-116C-4E40-992A-05D20AACAF97",NA,210,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",121,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,12,10,"F2098F55-A021-491E-B5B8-D72F76FC67F0","F0312FF5-70EC-43D5-B9B3-0E0862C56864","UNCID_1619705.9713963c-c7c7-47a0-ba01-6710bd4e9fea.sorted_genome_alignments.bam","TCGA-EY-A1GM-01A-12",90,0,20,20,5,"TOP",5,40,"TCGA-EY-A1GM-01A-01-TSA",90,"Taxol","Chemotherapy","TCGA-EY-A1GM-D11894",NA,NA,NA,NA,"NO",210,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GM-F19758","TCGA-EY-A1GM",1,"EY","A1GM","YES","C54.1","8441/3","C54.1","YES","NO",-22010,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",210,NA,NA,NA,"TUMOR FREE","NO",18,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,60,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
155244604,152378668,7270633576,"CFA08182-F204-403A-A5C3-067F099953AB.bw","1a36d5de-a097-4323-90e9-f1b924a8a5d8","cfa08182-f204-403a-a5c3-067f099953ab","2016-08-09T13:14:17.572860-05:00","UNCID_2173366.ad229cea-5cac-422d-a773-370ed37152e9.130502_UNC12-SN629_0289_AC236KACXX_7_GTTTCG.tar.gz","d09b5eac-c5c6-4023-9471-057859351fa8",7421482065,"Illumina HiSeq","5c69a567295c288313cb0f4171f9c6ea","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:35:21.721556-05:00","2016-05-03T10:55:55.610281-05:00","d09b5eac-c5c6-4023-9471-057859351fa8_analysis.xml","33499dc966c54070dccce1703092ae6b","e258ba3c-e4c7-4212-a9bc-a1b092081c99",2123,"2016-09-29T23:17:55.455941-05:00","d09b5eac-c5c6-4023-9471-057859351fa8_experiment.xml","664858be24b79bff25191984126ff34e","d765bcc7-bf54-47cb-924f-59aa88e7999a",2431,"2016-09-29T19:58:43.773962-05:00","d09b5eac-c5c6-4023-9471-057859351fa8_run.xml","069d61f73d2456fb6bf8f6ad25dc1800","5c5af482-35ec-455f-9d50-461a3292ad80",354,"2016-09-08T11:04:43.679584-05:00","TCGA-KJ-A3U4","2016-09-02T18:49:36.562595-05:00","female","TCGA-KJ-A3U4_demographic",1957,"white","fdbce5bb-88bb-572b-8b58-e3f94a340c33","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","KJ","9f510fcc-aa89-5390-8090-ad65821881e5","University of Miami","not reported","c54.1","TCGA-KJ-A3U4_diagnosis","not reported",20392,"alive","8441/3",NA,1095,"9f60a2c7-9963-59e1-8563-8e4da64db571","c54.1",-20392,"TCGA-KJ-A3U4_treatment","0d132b73-1dfe-5233-9592-6d9194d74605","01","true","TCGA-KJ-A3U4-01A",NA,"7fcbd3e2-4a71-4ef2-96df-d4be66352d9e",FALSE,"F0B04416-21FE-4DBC-84BB-7188131399B6","Primary Tumor",NA,56,420,NA,1334534400,"11",30,"TCGA-KJ-A3U4-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:04:43.679584-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"1fb56eb4-61b8-4656-a22c-07410e9ef641",NA,"TCGA-KJ-A3U4-01A-01-TS1",NA,100,NA,"4909aed3-a030-40d5-9ec1-7d200d119011","RNA","TCGA-KJ-A3U4-01A-11R","825f8eb5-4da1-45fd-a2de-2f9dac894bb1",1.83,0.17,"UV Spec","R","23","TCGA-KJ-A3U4-01A-11R-A22K-07","ad229cea-5cac-422d-a773-370ed37152e9",0.17,NA,96,35.2617079889807,165,"19cf3c90-19d8-5055-bce8-3a2ee8d532a9","TCGA-KJ-A3U4_exposure","UNCID_2173366.ad229cea-5cac-422d-a773-370ed37152e9.130502_UNC12-SN629_0289_AC236KACXX_7_GTTTCG.tar.gz","2013-09-09T17:56:09.000Z","2013-09-09T18:15:01.000Z","D09B5EAC-C5C6-4023-9471-057859351FA8","7FCBD3E2-4A71-4EF2-96DF-D4BE66352D9E","Unaligned reads",7421482065,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","AD229CEA-5CAC-422D-A773-370ED37152E9","University of North Carolina","564a3ea5e4b0ef12181b78ba","1A36D5DE-A097-4323-90E9-F1B924A8A5D8","Uterine Corpus Endometrial Carcinoma","TARGZ","4909AED3-A030-40D5-9EC1-7D200D119011","2013-09-09T18:15:01.000Z","825F8EB5-4DA1-45FD-A2DE-2F9DAC894BB1","United States","NO",1,NA,"Primary Tumor","University of Miami",56,"4909AED3-A030-40D5-9EC1-7D200D119011",NA,"KJ","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.99182DDF-D675-4FD2-9EB4-FE8D00804C93.txt",420,"TCGA-KJ-A3U4-01A",NA,NA,"TCGA",2012,NA,NA,"TUMOR FREE","7FCBD3E2-4A71-4EF2-96DF-D4BE66352D9E",55,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.99182DDF-D675-4FD2-9EB4-FE8D00804C93.txt","Alive",NA,"TCGA-KJ-A3U4","HISPANIC OR LATINO",NA,NA,74,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"1FB56EB4-61B8-4656-A22C-07410E9EF641","825F8EB5-4DA1-45FD-A2DE-2F9DAC894BB1","UNCID_2034744.ad229cea-5cac-422d-a773-370ed37152e9.sorted_genome_alignments.bam","TCGA-KJ-A3U4-01A-11",80,0,0,2,0,"TOP",0,0,"TCGA-KJ-A3U4-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-KJ-A3U4",1,"KJ","A3U4","YES","C54.1","8441/3","C54.1","YES","NO",-20392,"FEMALE","WHITE","HISPANIC OR LATINO","Yes","No","Alive",74,NA,NA,NA,"TUMOR FREE","NO",24,5,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,55,2012,"Tumor resection",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
154353676,152481835,7279424309,"CC112597-9D59-44C2-9AFC-1850CB5A8107.bw","1addcd66-79ab-4976-9679-37f0f31ba1df","cc112597-9d59-44c2-9afc-1850cb5a8107","2016-08-09T13:15:14.473925-05:00","UNCID_2173647.3bf26a40-da0a-4b9f-9c8d-ef307c8f239b.130502_UNC12-SN629_0289_AC236KACXX_4_GGCTAC.tar.gz","ec6bb5fd-ec78-40a2-90be-c438fdb244c3",7285300047,"Illumina HiSeq","1335c8768b5f9e9e1c1a0ba38f49ca7c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:49:12.682005-05:00","2016-05-03T10:55:55.610281-05:00","ec6bb5fd-ec78-40a2-90be-c438fdb244c3_analysis.xml","03eebf7c3e6de879a494da68c538e017","eaf9ee5f-84e9-4d4a-a03d-ccce4215cd3d",2123,"2016-09-29T23:58:46.454171-05:00","ec6bb5fd-ec78-40a2-90be-c438fdb244c3_experiment.xml","4297262213d82e0b2af43ed72ed0c5a8","f0e51b64-fc75-4f31-9115-5f35ff94a804",2431,"2016-09-29T18:05:50.944857-05:00","ec6bb5fd-ec78-40a2-90be-c438fdb244c3_run.xml","4ac624ad8d20dc2187b924fd50b19e83","15b43843-5ee5-4d48-a74e-9b6d1d520fc4",354,"2016-09-08T11:03:29.982270-05:00","TCGA-AJ-A3NG","2016-09-02T18:49:03.793788-05:00","female","TCGA-AJ-A3NG_demographic",1928,"white","2c8a958c-50b3-5c17-ad90-42e58160c400","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3NG_diagnosis","not reported",30351,"alive","8441/3",NA,475,"0f62a787-347f-5b47-b491-0d3bd876229e","c54.1",-30351,"TCGA-AJ-A3NG_treatment","1d73f60c-5dd4-5d8c-a79d-9ec14b486e78","01","false","TCGA-AJ-A3NG-01A",NA,"c19de866-bec5-4ce7-9d50-883fec094838",FALSE,"32C3C850-5F65-424E-894C-75B4725BBD09","Primary Tumor",NA,101,150,NA,1328054400,"11",30,"TCGA-AJ-A3NG-01A-11",90,NA,0,NA,13,NA,0,NA,"2016-09-08T11:03:29.982270-05:00",NA,2,NA,1,NA,"TOP",NA,2,NA,"0a07456b-9eb8-4030-877b-bcc241ffb5b5",NA,"TCGA-AJ-A3NG-01A-01-TSA",NA,85,NA,"8289fdeb-b266-4281-a76b-569ff9141412","RNA","TCGA-AJ-A3NG-01A-11R","b24a8000-0fba-4c37-b705-75111e71d869",1.82,0.17,"UV Spec","R","23","TCGA-AJ-A3NG-01A-11R-A22K-07","3bf26a40-da0a-4b9f-9c8d-ef307c8f239b",0.17,NA,93,38.7096774193548,155,"ffb0023e-aa65-5492-b74a-15015d4bcb5a","TCGA-AJ-A3NG_exposure","UNCID_2173647.3bf26a40-da0a-4b9f-9c8d-ef307c8f239b.130502_UNC12-SN629_0289_AC236KACXX_4_GGCTAC.tar.gz","2013-09-09T21:07:57.000Z","2013-09-09T21:58:01.000Z","EC6BB5FD-EC78-40A2-90BE-C438FDB244C3","C19DE866-BEC5-4CE7-9D50-883FEC094838","Unaligned reads",7285300047,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","3BF26A40-DA0A-4B9F-9C8D-EF307C8F239B","University of North Carolina","56607d4ce4b0ec1099f8eca5","1ADDCD66-79AB-4976-9679-37F0F31BA1DF","Uterine Corpus Endometrial Carcinoma","TARGZ","8289FDEB-B266-4281-A76B-569FF9141412","2013-09-09T21:58:01.000Z","B24A8000-0FBA-4C37-B705-75111E71D869","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",101,"8289FDEB-B266-4281-A76B-569FF9141412",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.FD29E3BB-3256-48A8-877D-E9D5CDC953BC.txt",150,"TCGA-AJ-A3NG-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","C2F477C9-895E-4C65-ACDF-B404AF35EA2D",83,"7796806104_R02C01_Grn.idat","Alive",NA,"TCGA-AJ-A3NG","NOT HISPANIC OR LATINO","00E35E9A-AC30-47D8-B40F-E95D3C919857",NA,52,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"EC60DAC8-529D-4ED8-81E6-42695256BD50","WHITE",NA,11,30,"0A07456B-9EB8-4030-877B-BCC241FFB5B5","B24A8000-0FBA-4C37-B705-75111E71D869","UNCID_2173647.3bf26a40-da0a-4b9f-9c8d-ef307c8f239b.130502_UNC12-SN629_0289_AC236KACXX_4_GGCTAC.tar.gz","TCGA-AJ-A3NG-01A-11",90,13,0,2,0,"TOP",2,1,"TCGA-AJ-A3NG-01A-01-TSA",85,NA,NA,NA,"TCGA-AJ-A3NG-R47020","External","Primary Tumor Field","TCGA-AJ-A3NG-F47019_NTE-1","NO",475,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3NG-F47019","TCGA-AJ-A3NG",1,"AJ","A3NG","YES","C54.1","8441/3","C54.1","YES","NO",-30351,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",52,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,83,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31593135,31462939,2330273929,"1C8DCA5B-965B-485A-83B6-5CBEB2117E47.bw","1b35d083-f7c9-47d2-9a9e-718788f9e39a","1c8dca5b-965b-485a-83b6-5cbeb2117e47","2016-08-09T14:07:52.684210-05:00","UNCID_2203739.e8736e4d-6e9b-49b0-a321-0e42740a11c1.111103_UNC6-RDR300211_00130_FC_638P5AAXX_3.tar.gz","c6696e8a-f76a-45d5-b4b7-e6da0c93124e",2034998198,"Illumina GA","78a14746821c6e1e045e6e4de58c2a41","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:59:34.567112-05:00","2016-05-03T11:10:47.515830-05:00","c6696e8a-f76a-45d5-b4b7-e6da0c93124e_analysis.xml","25c28c2ed9a2e8018d6c7fdcb4714111","f1659c37-b0f7-49b8-8b09-35eb8b4bcf38",2121,"2016-09-30T00:06:37.088221-05:00","c6696e8a-f76a-45d5-b4b7-e6da0c93124e_experiment.xml","a0c8638eba8d2e26831dfeb5dd905805","f59f70c6-1c2b-4401-8107-fdd6a27124f5",2257,"2016-09-29T20:03:19.294048-05:00","c6696e8a-f76a-45d5-b4b7-e6da0c93124e_run.xml","e3de4ecf2c373ec89089e65412c7f1a9","5f240c94-f990-4956-a9d5-7a763ca053f6",347,"2016-09-08T10:41:44.834533-05:00","TCGA-FI-A2D0","2016-09-02T18:52:54.239653-05:00","female","TCGA-FI-A2D0_demographic",1953,"white","7fe5583a-aa8c-5ce8-896a-0397ead74a1a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2D0_diagnosis","not reported",20393,"alive","8380/3",NA,1023,"2942c9b3-ec72-5212-9a2b-cffefc5e8d1d","c54.1",-20393,"TCGA-FI-A2D0_treatment","ef840ec7-a121-5fdf-ac01-541c3728ec9a","01","true","TCGA-FI-A2D0-01A",NA,"a2d2a29a-5abc-48c3-ac17-76b8b9ee1717",FALSE,"DCA05B9F-A09D-459F-AAB3-63020E15069D","Primary Tumor",NA,945,80,NA,1308700800,"11",30,"TCGA-FI-A2D0-01A-11",60,NA,6,NA,0,NA,40,NA,"2016-09-08T10:41:44.834533-05:00",NA,3,NA,8,NA,"TOP",NA,3,NA,"ab0d3e9a-a497-4a70-961b-c2650a5325e3",NA,"TCGA-FI-A2D0-01A-01-TSA",NA,57,NA,"a0203b43-e5ca-486e-9c86-d3c938540739","RNA","TCGA-FI-A2D0-01A-11R","88d7e67d-49d2-4e1c-9dbc-5e40e62b944b",1.92,0.18,"UV Spec","R","23","TCGA-FI-A2D0-01A-11R-A17B-07","e8736e4d-6e9b-49b0-a321-0e42740a11c1",0.18,NA,135,54.0778721358757,158,"c6616d67-57dc-5737-8e7e-c2cd866ef0e0","TCGA-FI-A2D0_exposure","UNCID_2203739.e8736e4d-6e9b-49b0-a321-0e42740a11c1.111103_UNC6-RDR300211_00130_FC_638P5AAXX_3.tar.gz","2013-09-26T16:31:04.000Z","2013-09-26T16:43:01.000Z","C6696E8A-F76A-45D5-B4B7-E6DA0C93124E","A2D2A29A-5ABC-48C3-AC17-76B8B9EE1717","Unaligned reads",2034998198,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E8736E4D-6E9B-49B0-A321-0E42740A11C1","University of North Carolina","56607d8fe4b0b37b3d992c6d","1B35D083-F7C9-47D2-9A9E-718788F9E39A","Uterine Corpus Endometrial Carcinoma","TARGZ","A0203B43-E5CA-486E-9C86-D3C938540739","2013-09-26T16:43:01.000Z","88D7E67D-49D2-4E1C-9DBC-5E40E62B944B","United States","NO",1,NA,"Primary Tumor","Washington University",945,"A0203B43-E5CA-486E-9C86-D3C938540739",NA,"FI","UNCID_2203739.e8736e4d-6e9b-49b0-a321-0e42740a11c1.111103_UNC6-RDR300211_00130_FC_638P5AAXX_3.tar.gz",80,"TCGA-FI-A2D0-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","A2D2A29A-5ABC-48C3-AC17-76B8B9EE1717",55,"jhu-usc.edu_UCEC.HumanMethylation450.12.lvl-2.TCGA-FI-A2D0-01A-11D-A17F-05.txt","Alive",NA,"TCGA-FI-A2D0","NOT HISPANIC OR LATINO","6C15A11D-CC7E-4B69-912E-02B775844A92",NA,1034,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"AB0D3E9A-A497-4A70-961B-C2650A5325E3","FF01E792-5FDC-4D8C-BF88-A2A53F98E432","UNCID_609960.TCGA-FI-A2D0-01A-11R-A17B-07.111103_UNC6-RDR300211_00130_FC_638P5AAXX.3.trimmed.annotated.translated_to_genomic.spljxn.quantification.txt","TCGA-FI-A2D0-01A-11",60,0,6,3,40,"TOP",3,8,"TCGA-FI-A2D0-01A-01-TSA",57,NA,NA,NA,NA,NA,NA,NA,"NO",1213,"TUMOR FREE","Alive",NA,"TCGA-FI-A2D0-F31611","TCGA-FI-A2D0",1,"FI","A2D0","YES","C54.1","8380/3","C54.1","NO","YES",-20393,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1034,NA,NA,NA,"TUMOR FREE","NO",28,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
33795727,33489284,2522435218,"8EE0CB87-7F15-4BA9-912C-D9BA18B28666.bw","1b685c46-57b3-4052-b5b9-1f704809bf04","8ee0cb87-7f15-4ba9-912c-d9ba18b28666","2016-08-09T14:04:16.584913-05:00","UNCID_2194794.ca0261c0-0935-450b-9e9c-db02f92ecb0e.120313_UNC6-RDR300211_00137_FC_650V5AAXX_2.tar.gz","38d4c446-1ca6-4c12-ad57-cf2cc82fd916",2262742720,"Illumina GA","22628587983f7bc51c6594ff66548f2c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:33:55.558192-05:00","2016-05-03T11:07:49.533775-05:00","38d4c446-1ca6-4c12-ad57-cf2cc82fd916_analysis.xml","161d5f072f3e5c4abb04ff4160039c29","bc28162c-b19f-49db-9d33-63584127577d",2122,"2016-10-07T16:17:58.762847-05:00","38d4c446-1ca6-4c12-ad57-cf2cc82fd916_experiment.xml","6a15ba31ca814eaac8f4acc81303d1eb","fc4a3d40-3208-4a60-93d7-64752659504f",2258,"2016-09-29T22:13:57.572135-05:00","38d4c446-1ca6-4c12-ad57-cf2cc82fd916_run.xml","b984588046f68419fe261ad476ed7327","afdae56a-5758-4ad7-86ae-28e0250b8454",349,"2016-09-08T10:27:22.708694-05:00","TCGA-AP-A1DV","2016-09-02T18:51:27.636499-05:00","female","TCGA-AP-A1DV_demographic",1949,"white","48e7f835-6a07-549a-8f3e-d1ccdfb2ae3a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1DV_diagnosis","not reported",21901,"alive","8380/3",NA,204,"516469f0-fecc-5018-8591-11518519030a","c54.1",-21901,"TCGA-AP-A1DV_treatment","5006618c-9c08-561a-b3b6-e5ae6d803668","01","true","TCGA-AP-A1DV-01A",NA,"a03f9020-3ded-4c1c-bf7e-1fa3a47e76de",FALSE,"F3163501-DD37-4C13-A921-3C2A74928BA7","Primary Tumor",NA,876,170,NA,1295395200,"21",30,"TCGA-AP-A1DV-01A-21",90,NA,4,NA,0,NA,10,NA,"2016-09-08T10:27:22.708694-05:00",NA,2,NA,2,NA,"TOP",NA,5,NA,"a24d2925-7d50-4c42-8b11-7ead4d8d2454",NA,"TCGA-AP-A1DV-01A-02-TSB",NA,85,NA,"f43d132c-e33b-44c2-9b51-cd7285287fc0","RNA","TCGA-AP-A1DV-01A-21R","db24b079-abdd-4ede-95cd-025eecc06fd6",1.83,0.16,"UV Spec","R","23","TCGA-AP-A1DV-01A-21R-A137-07","ca0261c0-0935-450b-9e9c-db02f92ecb0e",0.16,NA,46,21.2874265352399,147,"d5da959d-fe14-5422-8d4a-5bcd9304353c","TCGA-AP-A1DV_exposure","UNCID_2194794.ca0261c0-0935-450b-9e9c-db02f92ecb0e.120313_UNC6-RDR300211_00137_FC_650V5AAXX_2.tar.gz","2013-09-23T03:37:04.000Z","2013-09-23T03:50:02.000Z","38D4C446-1CA6-4C12-AD57-CF2CC82FD916","A03F9020-3DED-4C1C-BF7E-1FA3A47E76DE","Unaligned reads",2262742720,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CA0261C0-0935-450B-9E9C-DB02F92ECB0E","University of North Carolina","564a5818e4b09c884b26c326","1B685C46-57B3-4052-B5B9-1F704809BF04","Uterine Corpus Endometrial Carcinoma","TARGZ","F43D132C-E33B-44C2-9B51-CD7285287FC0","2013-09-23T03:50:02.000Z","DB24B079-ABDD-4EDE-95CD-025EECC06FD6","None","NO",1,NA,"Primary Tumor","MSKCC",876,"F43D132C-E33B-44C2-9B51-CD7285287FC0",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.CA09409F-45A8-4006-BA8A-23FC3847BFD0.txt",170,"TCGA-AP-A1DV-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","A03F9020-3DED-4C1C-BF7E-1FA3A47E76DE",59,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.CA09409F-45A8-4006-BA8A-23FC3847BFD0.txt","Alive",NA,"TCGA-AP-A1DV","NOT HISPANIC OR LATINO","D235D382-5680-4E9D-9B27-8614CCEBAC18",NA,204,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"68C9356C-F258-4E25-B59D-A9952498F763","WHITE",NA,21,30,"A24D2925-7D50-4C42-8B11-7EAD4D8D2454","DB24B079-ABDD-4EDE-95CD-025EECC06FD6","e8fd46e0d753bfed3c8e357c220422f3.bam.bai","TCGA-AP-A1DV-01A-21",90,0,4,2,10,"TOP",5,2,"TCGA-AP-A1DV-01A-02-TSB",85,NA,NA,NA,"TCGA-AP-A1DV-R13636","OTHER: SPECIFY IN NOTES",NA,NA,"NO",204,"TUMOR FREE","Alive",NA,"TCGA-AP-A1DV-F13635","TCGA-AP-A1DV",1,"AP","A1DV","YES","C54.1","8380/3","C54.1","NO","YES",-21901,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",204,NA,NA,NA,"TUMOR FREE","NO",9,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2008,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
153913092,152615033,7289667491,"BE56F908-42DD-4019-A8AC-48884DA788B1.bw","1c4d225e-e065-4e26-9413-78f54a7e0cf5","be56f908-42dd-4019-a8ac-48884da788b1","2016-08-09T14:01:46.606549-05:00","UNCID_2168408.31bd06c7-98c1-4d2e-81ff-4e210e7bba75.130610_UNC14-SN744_0347_BD28NBACXX_3_ACTTGA.tar.gz","8bcf271f-c274-41a9-bc77-25d4da1ad195",7069116942,"Illumina HiSeq","6b9d65e7ff6949b910693999801f1227","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:33:48.363351-05:00","2016-05-03T11:06:28.634121-05:00","8bcf271f-c274-41a9-bc77-25d4da1ad195_analysis.xml","13cd63588fad8efd7651af1f8d9e21cf","970ba800-3068-49be-a9e5-01b714d02de4",2123,"2016-10-07T16:06:08.255388-05:00","8bcf271f-c274-41a9-bc77-25d4da1ad195_experiment.xml","bc720747206fb7c3fad1dabd524dc4c0","d3b17509-25cb-4c4e-966b-2f9954eac71a",2431,"2016-09-29T19:40:44.512534-05:00","8bcf271f-c274-41a9-bc77-25d4da1ad195_run.xml","88f880c8fc0d50b784b4074918b794ba","512641d0-bb68-4617-a07c-efeb84538a72",354,"2016-09-09T16:00:37.909689-05:00","TCGA-BK-A4ZD","2016-09-02T18:50:02.319999-05:00","female","TCGA-BK-A4ZD_demographic",1970,"black or african american","932b5f34-279f-58a1-b7ea-5ac264c68f39","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A4ZD_diagnosis","not reported",15536,"alive","8380/3",NA,506,"52ef00ac-cc39-502a-9e36-18076721f0be","c54.1",-15536,"TCGA-BK-A4ZD_treatment","8b8b5ac1-2427-574c-aad5-0051111ddbf0","01","false","TCGA-BK-A4ZD-01A",NA,"115d93c2-9396-48bd-ba90-4cc4888ab821",FALSE,"388C7674-9CA2-446C-A67D-9639A28ADEB4","Primary Tumor",NA,92,300,NA,1352419200,"11",30,"TCGA-BK-A4ZD-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-09T16:00:37.909689-05:00",NA,3,NA,0,NA,"TOP",NA,0,NA,"532c0c42-5519-41f3-b328-6fdc51aa8275",NA,"TCGA-BK-A4ZD-01A-01-TS1",NA,100,NA,"e2c29bcf-1d07-403b-90e9-a8ebc1048bbd","RNA","TCGA-BK-A4ZD-01A-11R","d312542b-42f9-4713-8c56-628c562af64f",2.02,0.18,"UV Spec","R","23","TCGA-BK-A4ZD-01A-11R-A27V-07","31bd06c7-98c1-4d2e-81ff-4e210e7bba75",0.18,NA,142,53.4457450412134,163,"fa681863-042a-56d1-bae9-ace2cce9c4f7","TCGA-BK-A4ZD_exposure","UNCID_2168408.31bd06c7-98c1-4d2e-81ff-4e210e7bba75.130610_UNC14-SN744_0347_BD28NBACXX_3_ACTTGA.tar.gz","2013-09-20T07:46:05.000Z","2013-09-20T08:01:01.000Z","8BCF271F-C274-41A9-BC77-25D4DA1AD195","115D93C2-9396-48BD-BA90-4CC4888AB821","Unaligned reads",7069116942,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","31BD06C7-98C1-4D2E-81FF-4E210E7BBA75","University of North Carolina","564a3535e4b08c5d868f88e0","1C4D225E-E065-4E26-9413-78F54A7E0CF5","Uterine Corpus Endometrial Carcinoma","TARGZ","E2C29BCF-1D07-403B-90E9-A8EBC1048BBD","2013-09-20T08:01:01.000Z","D312542B-42F9-4713-8C56-628C562AF64F","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",92,"E2C29BCF-1D07-403B-90E9-A8EBC1048BBD",NA,"BK","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BD615DAC-024C-47F4-A6AE-99344CA93774.txt",300,"TCGA-BK-A4ZD-01A",NA,NA,"TCGA",2012,"TCGA-BK-A4ZD_NTE-1","Complete Remission/Response","TUMOR FREE","D2D95B5E-DA49-4E75-88C2-D44870A740C5",42,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BD615DAC-024C-47F4-A6AE-99344CA93774.txt","Alive",NA,"TCGA-BK-A4ZD","NOT HISPANIC OR LATINO","ECEDED39-E468-457C-BD84-5032AAB192EC","NO",211,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",289,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"532C0C42-5519-41F3-B328-6FDC51AA8275","D312542B-42F9-4713-8C56-628C562AF64F","UNCID_2088207.31bd06c7-98c1-4d2e-81ff-4e210e7bba75.sorted_genome_alignments.bam.bai","TCGA-BK-A4ZD-01A-11",75,0,0,3,0,"TOP",0,0,"TCGA-BK-A4ZD-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-BK-A4ZD-F52698_NTE-1","NO",506,"TUMOR FREE","Alive",NA,"TCGA-BK-A4ZD-F52698","TCGA-BK-A4ZD",1,"BK","A4ZD","YES","C54.1","8380/3","C54.1","YES","NO",-15536,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",211,NA,"NO","NO","TUMOR FREE","YES",28,2,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,42,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
123761390,122704629,5861814450,"080E7B67-6568-47DD-AE45-9705A181582D.bw","1c4d225e-e065-4e26-9413-78f54a7e0cf5","080e7b67-6568-47dd-ae45-9705a181582d","2016-08-05T06:56:01.538520-05:00","UNCID_2169072.babe74ee-b0dc-41c3-9968-2faac94addf2.130610_UNC14-SN744_0347_BD28NBACXX_4_TAGCTT.tar.gz","e81485de-803d-4c50-853f-42a76c929369",5452255808,"Illumina HiSeq","1d7e3e493fe538c870dc907b0149f411","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:32:04.431921-05:00","2016-05-03T11:05:42.727154-05:00","e81485de-803d-4c50-853f-42a76c929369_analysis.xml","2d96b10bb2390b5add3294a4af40afc6","bb059864-acd3-4278-8604-cd1aa61d405e",2123,"2016-09-29T19:17:47.352725-05:00","e81485de-803d-4c50-853f-42a76c929369_experiment.xml","ec1abbd923a182a8089b791d588eee90","42e42462-aeb0-4375-8477-3d4be1c013a0",2431,"2016-09-29T18:02:39.028227-05:00","e81485de-803d-4c50-853f-42a76c929369_run.xml","afec65ef72c78a2f575b3e45b6de1f95","13a6d6e2-241a-4051-9baa-740ba2f987b3",354,"2016-09-09T16:00:37.909689-05:00","TCGA-BK-A4ZD","2016-09-02T18:50:02.319999-05:00","female","TCGA-BK-A4ZD_demographic",1970,"black or african american","932b5f34-279f-58a1-b7ea-5ac264c68f39","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A4ZD_diagnosis","not reported",15536,"alive","8380/3",NA,506,"52ef00ac-cc39-502a-9e36-18076721f0be","c54.1",-15536,"TCGA-BK-A4ZD_treatment","8b8b5ac1-2427-574c-aad5-0051111ddbf0","11","false","TCGA-BK-A4ZD-11A",NA,"a24e32e7-0ac4-481f-a69f-f42b1f1e3eef",FALSE,NA,"Solid Tissue Normal",NA,92,210,NA,1352419200,"12",20,"TCGA-BK-A4ZD-11A-12",0,NA,0,NA,100,NA,0,NA,"2016-09-09T16:00:37.909689-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"245899f6-aa6a-409e-928e-aa87c2467c6a",NA,"TCGA-BK-A4ZD-11A-01-TS1",NA,0,NA,"23e95626-647a-4dea-91e1-ac0c8e6c3946","RNA","TCGA-BK-A4ZD-11A-12R","4034814b-4f0e-47ac-81cd-b47e1b2c6edf",1.77,0.15,"UV Spec","R","23","TCGA-BK-A4ZD-11A-12R-A27V-07","babe74ee-b0dc-41c3-9968-2faac94addf2",0.15,NA,142,53.4457450412134,163,"fa681863-042a-56d1-bae9-ace2cce9c4f7","TCGA-BK-A4ZD_exposure","UNCID_2169072.babe74ee-b0dc-41c3-9968-2faac94addf2.130610_UNC14-SN744_0347_BD28NBACXX_4_TAGCTT.tar.gz","2013-09-19T23:56:03.000Z","2013-09-20T00:10:01.000Z","E81485DE-803D-4C50-853F-42A76C929369","A24E32E7-0AC4-481F-A69F-F42B1F1E3EEF","Unaligned reads",5452255808,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","BABE74EE-B0DC-41C3-9968-2FAAC94ADDF2","University of North Carolina","564a3536e4b093830b6749f0","1C4D225E-E065-4E26-9413-78F54A7E0CF5","Uterine Corpus Endometrial Carcinoma","TARGZ","23E95626-647A-4DEA-91E1-AC0C8E6C3946","2013-09-20T00:10:01.000Z","4034814B-4F0E-47AC-81CD-B47E1B2C6EDF","United States","NO",11,NA,"Solid Tissue Normal","Christiana Healthcare",92,"23E95626-647A-4DEA-91E1-AC0C8E6C3946",NA,"BK","UNCID_2087527.babe74ee-b0dc-41c3-9968-2faac94addf2.sorted_genome_alignments.bam",210,"TCGA-BK-A4ZD-11A",NA,NA,"TCGA",2012,"TCGA-BK-A4ZD_NTE-1","Complete Remission/Response","TUMOR FREE","D2D95B5E-DA49-4E75-88C2-D44870A740C5",42,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BD615DAC-024C-47F4-A6AE-99344CA93774.txt","Alive",NA,"TCGA-BK-A4ZD","NOT HISPANIC OR LATINO","ECEDED39-E468-457C-BD84-5032AAB192EC","NO",211,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",289,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,12,20,"245899F6-AA6A-409E-928E-AA87C2467C6A","43448A2A-75E5-49CC-8DFF-10B7A17A4C3F","UNCID_2087527.babe74ee-b0dc-41c3-9968-2faac94addf2.sorted_genome_alignments.bam","TCGA-BK-A4ZD-11A-12",0,100,0,2,0,"TOP",0,0,"TCGA-BK-A4ZD-11A-01-TS1",0,NA,NA,NA,NA,NA,NA,"TCGA-BK-A4ZD-F52698_NTE-1","NO",506,"TUMOR FREE","Alive",NA,"TCGA-BK-A4ZD-F52698","TCGA-BK-A4ZD",1,"BK","A4ZD","YES","C54.1","8380/3","C54.1","YES","NO",-15536,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",211,NA,"NO","NO","TUMOR FREE","YES",28,2,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,42,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
32597707,31820787,2385383777,"3F8D01A3-5449-48A1-BDBA-BFE4D908AE31.bw","1c7b41fc-daa7-4a6e-b553-aff73e8ebac6","3f8d01a3-5449-48a1-bdba-bfe4d908ae31","2016-08-06T07:32:04.517865-05:00","UNCID_2210710.cb236783-68e6-4522-8618-ea19fd0b8ab5.110323_UNC3-RDR300156_00085_FC_706FWAAXX_5.tar.gz","d7a9ee31-8f8f-4a88-85fe-ebd3e6cde035",2103461054,"Illumina GA","0f1b61ec397f33bc2e12257fb801f3e7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:04:32.153838-05:00","2016-05-03T11:15:47.421196-05:00","d7a9ee31-8f8f-4a88-85fe-ebd3e6cde035_analysis.xml","eb6dcac285a4dedd241b8e1c0280413f","aa269cda-6792-4994-b345-1196aa71df20",2121,"2016-09-29T20:09:32.122335-05:00","d7a9ee31-8f8f-4a88-85fe-ebd3e6cde035_experiment.xml","47567f97541529d3239a3305134eb8f1","62dec588-926c-4554-abf4-2263a78a6ce7",2257,"2016-09-29T18:03:29.152370-05:00","d7a9ee31-8f8f-4a88-85fe-ebd3e6cde035_run.xml","992b8daf307daa7fcaa46f6148977785","143411c5-f58a-4ee2-80ca-658a04410c2a",347,"2016-09-08T10:47:51.898669-05:00","TCGA-AX-A0J0","2016-09-02T18:49:00.134120-05:00","female","TCGA-AX-A0J0_demographic",1959,"white","0740835f-f4ed-5dc5-8ff0-d9df87dbd640","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A0J0_diagnosis","not reported",17466,"alive","8380/3",NA,1220,"316a64b1-581c-573b-95c0-487c977868d8","c54.1",-17466,"TCGA-AX-A0J0_treatment","3b53d30b-df55-5124-bb8e-b2b07424b9df","01","false","TCGA-AX-A0J0-01A",NA,"e5dea504-d715-4682-ab51-fc6f52fc39a3",FALSE,"EC377A34-B219-4A4F-95DB-DF6E0050A63A","Primary Tumor",NA,1581,180,NA,1275609600,"11",30,"TCGA-AX-A0J0-01A-11",90,90,0,0,0,0,5,5,"2016-09-08T10:47:51.898669-05:00","2016-09-08T10:47:51.898669-05:00",0,1,0,0,"TOP","BOTTOM",10,20,"f965c24e-d39f-4950-abd6-e914f3c64c5d","4986bc48-d678-4373-98e8-d7e06c4a4914","TCGA-AX-A0J0-01A-01-TSA","TCGA-AX-A0J0-01A-01-BSA",85,75,"a00efc1b-eaf5-4375-b5de-5be95e8b0f23","RNA","TCGA-AX-A0J0-01A-11R","1b498aef-2501-4b86-8c9f-2bce296b7422",1.9,0.16,"UV Spec","R","23","TCGA-AX-A0J0-01A-11R-A109-07","cb236783-68e6-4522-8618-ea19fd0b8ab5",0.16,NA,53,19.9480597689036,163,"aed00cc4-a090-5c04-a038-bd3cbc563952","TCGA-AX-A0J0_exposure","UNCID_2210710.cb236783-68e6-4522-8618-ea19fd0b8ab5.110323_UNC3-RDR300156_00085_FC_706FWAAXX_5.tar.gz","2013-10-02T15:16:04.000Z","2013-10-02T15:28:02.000Z","D7A9EE31-8F8F-4A88-85FE-EBD3E6CDE035","E5DEA504-D715-4682-AB51-FC6F52FC39A3","Unaligned reads",2103461054,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CB236783-68E6-4522-8618-EA19FD0B8AB5","University of North Carolina","564a3dcae4b0ef12181b3360","1C7B41FC-DAA7-4A6E-B553-AFF73E8EBAC6","Uterine Corpus Endometrial Carcinoma","TARGZ","A00EFC1B-EAF5-4375-B5DE-5BE95E8B0F23","2013-10-02T15:28:02.000Z","1B498AEF-2501-4B86-8C9F-2BCE296B7422","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1581,"A00EFC1B-EAF5-4375-B5DE-5BE95E8B0F23",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2B44D365-A7F6-4A4E-99C5-019A2BDC6384.txt",180,"TCGA-AX-A0J0-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","FD43286B-455A-47AD-93EC-CA7C276DBDFD",47,"SHUCK_p_TCGAb74and75_SNP_N_GenomeWideSNP_6_C09_731044.hg19.seg.txt","Alive",NA,"TCGA-AX-A0J0","NOT HISPANIC OR LATINO","C4376335-CE6D-408B-B6D6-6DA7184BE2A1",NA,1220,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",75,NA,NA,"WHITE",NA,11,30,"F965C24E-D39F-4950-ABD6-E914F3C64C5D","6989C835-B9EF-4AF5-8FFF-D88322721D8E","TCGA-AX-A0J0-01A-11R-A108-13_mirna.bam.bai","TCGA-AX-A0J0-01A-11",90,0,0,0,5,"TOP",10,0,"TCGA-AX-A0J0-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,NA,NA,1220,"TUMOR FREE","Alive",NA,"TCGA-AX-A0J0-F5464","TCGA-AX-A0J0",1,"AX","A0J0","YES","C54.1","8380/3","C54.1","NO","YES",-17466,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1220,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,47,2006,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
111173478,109608117,5235702907,"B8C2D019-00C9-4E1E-8383-4FE2FFB4D2D7.bw","1c7b41fc-daa7-4a6e-b553-aff73e8ebac6","b8c2d019-00c9-4e1e-8383-4fe2ffb4d2d7","2016-08-09T14:01:41.819898-05:00","UNCID_2167251.bdb31196-8bc4-4c2a-bbcf-641e1916733f.130613_UNC9-SN296_0375_BD27CGACXX_4_GGCTAC.tar.gz","80f63d01-b3be-43c2-867b-c780ae02af88",5451803250,"Illumina HiSeq","90d15e322e8c2737fb46b61c5f7eb0ca","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:10:34.288547-05:00","2016-05-03T11:07:07.492763-05:00","80f63d01-b3be-43c2-867b-c780ae02af88_analysis.xml","33882b61ffbee496852007588cee677f","88b0ae9d-58fe-4741-aa08-94ec9f783bf8",2121,"2016-09-29T22:35:52.897217-05:00","80f63d01-b3be-43c2-867b-c780ae02af88_experiment.xml","10fff7268b1f546b63576d9d438bdccb","bd60b59b-27b6-42a3-8669-f27435f1a227",2431,"2016-09-29T21:01:49.562474-05:00","80f63d01-b3be-43c2-867b-c780ae02af88_run.xml","4388e8c2ca1cf002bb64e35269ae48aa","8321ee64-7bc1-4270-97f6-7df0f10b4536",354,"2016-09-08T10:47:51.898669-05:00","TCGA-AX-A0J0","2016-09-02T18:49:00.134120-05:00","female","TCGA-AX-A0J0_demographic",1959,"white","0740835f-f4ed-5dc5-8ff0-d9df87dbd640","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A0J0_diagnosis","not reported",17466,"alive","8380/3",NA,1220,"316a64b1-581c-573b-95c0-487c977868d8","c54.1",-17466,"TCGA-AX-A0J0_treatment","3b53d30b-df55-5124-bb8e-b2b07424b9df","11","false","TCGA-AX-A0J0-11A",NA,"06731fda-e0ba-49d4-9d61-9c6cab663097",FALSE,NA,"Solid Tissue Normal",NA,1952,110,NA,1308182400,"11",30,"TCGA-AX-A0J0-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T10:47:51.898669-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"8ce25dca-40dc-4a86-a816-f80140d6bad2",NA,"TCGA-AX-A0J0-11A-01-TSA",NA,0,NA,"d109341e-3e6d-44a0-9870-c0d794168352","RNA","TCGA-AX-A0J0-11A-11R","14265853-5d27-412e-bea6-bd817d94683c",1.87,0.17,"UV Spec","R","23","TCGA-AX-A0J0-11A-11R-A27V-07","bdb31196-8bc4-4c2a-bbcf-641e1916733f",0.17,NA,53,19.9480597689036,163,"aed00cc4-a090-5c04-a038-bd3cbc563952","TCGA-AX-A0J0_exposure","UNCID_2167251.bdb31196-8bc4-4c2a-bbcf-641e1916733f.130613_UNC9-SN296_0375_BD27CGACXX_4_GGCTAC.tar.gz","2013-09-21T05:31:05.000Z","2013-09-21T05:48:02.000Z","80F63D01-B3BE-43C2-867B-C780AE02AF88","06731FDA-E0BA-49D4-9D61-9C6CAB663097","Unaligned reads",5451803250,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","BDB31196-8BC4-4C2A-BBCF-641E1916733F","University of North Carolina","564a3dcae4b093830b6a086a","1C7B41FC-DAA7-4A6E-B553-AFF73E8EBAC6","Uterine Corpus Endometrial Carcinoma","TARGZ","D109341E-3E6D-44A0-9870-C0D794168352","2013-09-21T05:48:02.000Z","14265853-5D27-412E-BEA6-BD817D94683C","None","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",1952,"D109341E-3E6D-44A0-9870-C0D794168352",NA,"AX","19caba97397e59481adfdcf8f7942ced.bam",110,"TCGA-AX-A0J0-11A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","FD43286B-455A-47AD-93EC-CA7C276DBDFD",47,"SHUCK_p_TCGAb74and75_SNP_N_GenomeWideSNP_6_C09_731044.hg19.seg.txt","Alive",NA,"TCGA-AX-A0J0","NOT HISPANIC OR LATINO","C4376335-CE6D-408B-B6D6-6DA7184BE2A1",NA,1220,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",75,NA,NA,"WHITE",NA,11,30,"8CE25DCA-40DC-4A86-A816-F80140D6BAD2","14265853-5D27-412E-BEA6-BD817D94683C","19caba97397e59481adfdcf8f7942ced.bam","TCGA-AX-A0J0-11A-11",0,100,0,0,0,"TOP",0,0,"TCGA-AX-A0J0-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,1220,"TUMOR FREE","Alive",NA,"TCGA-AX-A0J0-F5464","TCGA-AX-A0J0",1,"AX","A0J0","YES","C54.1","8380/3","C54.1","NO","YES",-17466,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1220,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,47,2006,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
27226944,26830704,1970806709,"1755116D-2A3D-4F1F-B635-43B5053580DE.bw","1d9c2113-ddcb-4440-89c3-cd21cee6d401","1755116d-2a3d-4f1f-b635-43b5053580de","2016-08-09T14:16:09.567778-05:00","UNCID_2215070.a832a6a6-1998-41c2-9dab-87076a1f11cf.101014_UNC2-RDR300275_00039_FC_706C1AAXX_6.tar.gz","268061c8-93c5-4a67-8b84-dc15d3aeca16",1649536391,"Illumina GA","913c441262fc5bef497f6346abbce65a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:32:43.740755-05:00","2016-05-03T11:17:14.878442-05:00","268061c8-93c5-4a67-8b84-dc15d3aeca16_analysis.xml","a6a1539e9eb3971b5eddc31db187a4aa","4c43c0fc-0627-4b5d-85dd-1879936e264a",2120,"2016-10-07T16:13:49.264913-05:00","268061c8-93c5-4a67-8b84-dc15d3aeca16_experiment.xml","c29edeb7a221bc77a4df999eb8d37095","0400294a-23a0-49b0-b6c7-1a08fd44092a",2256,"2016-09-29T20:29:06.208081-05:00","268061c8-93c5-4a67-8b84-dc15d3aeca16_run.xml","1eaec2d8228f30c055359d7d486c7e05","6edae7c7-b39e-4ab2-b372-d6c8ab881ef9",345,"2016-09-08T10:47:53.292733-05:00","TCGA-BG-A0M7","2016-09-02T18:54:47.596401-05:00","female","TCGA-BG-A0M7_demographic",1948,"white","a5a0d889-9d31-55c0-80a8-9c3eb31ed85d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0M7_diagnosis","not reported",22096,"alive","8380/3",NA,1937,"ca893451-6c23-52c1-86ed-65da0df32661","c54.1",-22096,"TCGA-BG-A0M7_treatment","1d000dea-f4e2-5d05-9167-287fd41901f8","01","true","TCGA-BG-A0M7-01A",NA,"d053fa9e-5d19-4940-8915-4a03cb479263",FALSE,"F9128DAE-F3D0-4738-AC20-E665F22DDC63","Primary Tumor",NA,659,260,NA,1279584000,"11",30,"TCGA-BG-A0M7-01A-11",75,80,0,0,0,0,0,0,"2016-09-08T10:47:53.292733-05:00","2016-09-08T10:47:53.292733-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"05ade59e-bee2-465b-b1c1-68ee5d03607a","6e229e68-dfd1-458e-aaa8-bcd622a3c6d2","TCGA-BG-A0M7-01A-01-BSA","TCGA-BG-A0M7-01A-01-TSA",100,100,"9dba01e9-2702-4ef1-910c-ebd9f5ac430c","RNA","TCGA-BG-A0M7-01A-11R","700a9d82-11b0-473e-8ae4-0419c41550b2",1.9,0.15,"UV Spec","R","23","TCGA-BG-A0M7-01A-11R-A040-07","a832a6a6-1998-41c2-9dab-87076a1f11cf",0.15,NA,102,39.84375,160,"7ba83248-6954-5f93-b34f-1c416bdd7a23","TCGA-BG-A0M7_exposure","UNCID_2215070.a832a6a6-1998-41c2-9dab-87076a1f11cf.101014_UNC2-RDR300275_00039_FC_706C1AAXX_6.tar.gz","2013-10-03T23:46:04.000Z","2013-10-03T23:58:02.000Z","268061C8-93C5-4A67-8B84-DC15D3AECA16","D053FA9E-5D19-4940-8915-4A03CB479263","Unaligned reads",1649536391,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A832A6A6-1998-41C2-9DAB-87076A1F11CF","University of North Carolina","564a355ee4b0298dd2c67803","1D9C2113-DDCB-4440-89C3-CD21CEE6D401","Uterine Corpus Endometrial Carcinoma","TARGZ","9DBA01E9-2702-4EF1-910C-EBD9F5AC430C","2013-10-03T23:58:02.000Z","700A9D82-11B0-473E-8AE4-0419C41550B2","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",659,"9DBA01E9-2702-4EF1-910C-EBD9F5AC430C",NA,"BG","UNCID_257804.TCGA-BG-A0M7-01A-11R-A040-07.101014_UNC2-RDR300275_00039_FC_706C1AAXX.6.trimmed.annotated.translated_to_genomic.bam.bai",260,"TCGA-BG-A0M7-01A",NA,"C741932C-F86C-4808-AD00-4606ADF82F21","TCGA",2008,NA,NA,"TUMOR FREE","133045D3-0348-4B42-9E50-038574103C2D",60,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7CEAF55F-FB25-46A2-B3B8-24CA17F2477D.txt","Alive",NA,"TCGA-BG-A0M7","NOT HISPANIC OR LATINO","3BCDAA71-CA2A-48EB-A1B6-6DB762C5307B",NA,698,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"4AC8F651-98CD-4865-8770-F5C627E35E2E","WHITE",NA,11,30,"6E229E68-DFD1-458E-AAA8-BCD622A3C6D2","AA5A05F0-C428-488B-82B6-365115DDF5BC","TCGA-BG-A0M7-01A-11R-A041-13_mirna.bam.bai","TCGA-BG-A0M7-01A-11",75,0,0,0,0,"BOTTOM",0,0,"TCGA-BG-A0M7-01A-01-BSA",100,"CARBOPLATIN","Chemotherapy","TCGA-BG-A0M7-D4453","TCGA-BG-A0M7-R4451","EXTERNAL BEAM","Primary Tumor Field","TCGA-BG-A0M7-F71767_NTE-1","NO",1937,"TUMOR FREE","Alive",NA,"TCGA-BG-A0M7-F71767","TCGA-BG-A0M7",1,"BG","A0M7","YES","C54.1","8380/3","C54.1","NO","YES",-22096,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",698,NA,NA,NA,"TUMOR FREE","NO",1,12,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2008,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
137400694,132954858,6342524757,"E96AE267-3E23-4EA9-93E2-D92558155A17.bw","1dcf33e9-4c9b-4b2b-914e-15e6be5dcd07","e96ae267-3e23-4ea9-93e2-d92558155a17","2016-08-08T10:46:13.862812-05:00","UNCID_2173749.b4a85000-c0fd-4287-83f2-fc0757fe4a60.130502_UNC12-SN629_0289_AC236KACXX_2_TGACCA.tar.gz","fc2833b5-58a4-486a-8a52-acb437a5008f",6626554040,"Illumina HiSeq","12144d15a42cf24a5a33ccddb5be49b4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:33:08.539920-05:00","2016-05-03T10:56:47.870562-05:00","fc2833b5-58a4-486a-8a52-acb437a5008f_analysis.xml","4f732c97ff216506df23fd7a4af0daeb","714483d1-1d19-4530-9d5a-31717eea3f83",2123,"2016-09-29T18:06:54.630319-05:00","fc2833b5-58a4-486a-8a52-acb437a5008f_experiment.xml","c6bafa83bdcf4b450a2308d19f3265ec","166364b3-76c2-4a0d-ab9a-11f5b350966e",2431,"2016-09-29T17:43:34.549500-05:00","fc2833b5-58a4-486a-8a52-acb437a5008f_run.xml","8a31dd422e38ceea19bd2c517a6806d2","078489c1-4b13-48fa-95b5-27176adba4c0",354,"2016-09-08T10:28:54.294644-05:00","TCGA-AJ-A3NE","2016-09-02T18:49:02.749499-05:00","female","TCGA-AJ-A3NE_demographic",1965,"white","7cd0bfbb-89d6-5f79-8bee-d7a676d2e60d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3NE_diagnosis","not reported",16957,"alive","8380/3",NA,628,"18780bc0-1bba-5cd3-8b89-1ad711411545","c54.1",-16957,"TCGA-AJ-A3NE_treatment","2e5afb49-8cc8-53c3-8444-1b285a628db9","11","false","TCGA-AJ-A3NE-11A",NA,"6436be59-08e6-4db6-9d8d-fbecfbc00b7c",FALSE,NA,"Solid Tissue Normal",NA,134,80,NA,1328054400,"11",30,"TCGA-AJ-A3NE-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T10:28:54.294644-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"de5980fa-a4fd-43f7-a8cc-e20e18b890b8",NA,"TCGA-AJ-A3NE-11A-01-TS1",NA,0,NA,"ab420324-a508-4e09-9be6-8a421be7a5d5","RNA","TCGA-AJ-A3NE-11A-11R","b814ac8a-7d7d-4007-bf95-28c4680a27a4",1.86,0.17,"UV Spec","R","23","TCGA-AJ-A3NE-11A-11R-A22K-07","b4a85000-c0fd-4287-83f2-fc0757fe4a60",0.17,NA,80,31.25,160,"b060a9fc-e273-5591-ac58-29e05312788e","TCGA-AJ-A3NE_exposure","UNCID_2173749.b4a85000-c0fd-4287-83f2-fc0757fe4a60.130502_UNC12-SN629_0289_AC236KACXX_2_TGACCA.tar.gz","2013-09-09T23:16:10.000Z","2013-09-09T23:34:01.000Z","FC2833B5-58A4-486A-8A52-ACB437A5008F","6436BE59-08E6-4DB6-9D8D-FBECFBC00B7C","Unaligned reads",6626554040,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","B4A85000-C0FD-4287-83F2-FC0757FE4A60","University of North Carolina","564a345ae4b09c884b22362f","1DCF33E9-4C9B-4B2B-914E-15E6BE5DCD07","Uterine Corpus Endometrial Carcinoma","TARGZ","AB420324-A508-4E09-9BE6-8A421BE7A5D5","2013-09-09T23:34:01.000Z","B814AC8A-7D7D-4007-BF95-28C4680A27A4","United States","NO",11,NA,"Solid Tissue Normal","International Genomics Conosrtium",134,"AB420324-A508-4E09-9BE6-8A421BE7A5D5",NA,"AJ","TCGA-AJ-A3NE-11A-11R-A22I-13_mirna.bam",80,"TCGA-AJ-A3NE-11A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","A1EC8680-C144-4A99-8D51-AE9A68F15D67",46,"TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_H06_1151340.ismpolish.data.txt","Alive",NA,"TCGA-AJ-A3NE","NOT HISPANIC OR LATINO","348D5ED3-1F3A-4A95-9001-C8135FC346DD",NA,78,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"DE5980FA-A4FD-43F7-A8CC-E20E18B890B8","C2B2AC3F-755C-484A-8490-9E2737245ACA","TCGA-AJ-A3NE-11A-11R-A22I-13_mirna.bam","TCGA-AJ-A3NE-11A-11",0,100,0,1,0,"TOP",0,0,"TCGA-AJ-A3NE-11A-01-TS1",0,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3NE-F47713_NTE-1","NO",628,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3NE-F47713","TCGA-AJ-A3NE",1,"AJ","A3NE","YES","C54.1","8380/3","C54.1","YES","NO",-16957,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",78,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,46,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
126950610,124705909,5953057463,"CAF246CF-659B-4C64-B0AA-125B11D23E43.bw","1dcf33e9-4c9b-4b2b-914e-15e6be5dcd07","caf246cf-659b-4c64-b0aa-125b11d23e43","2016-08-09T13:14:25.393921-05:00","UNCID_2173455.a133035a-7076-4fe7-b260-f866b409aba4.130502_UNC12-SN629_0289_AC236KACXX_6_GTCCGC.tar.gz","208d00b6-2e5d-4762-b9af-2f3e0ef2c884",6136589660,"Illumina HiSeq","34f9309c5504915cdfd44ee5a35fb4dd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:10:41.242304-05:00","2016-05-03T10:55:55.600288-05:00","208d00b6-2e5d-4762-b9af-2f3e0ef2c884_analysis.xml","ad08e03414f50e2c7bfb7f285b8f14b5","6393ecb3-5e45-4b50-ac43-ae6384b0ab15",2123,"2016-09-29T19:07:46.966911-05:00","208d00b6-2e5d-4762-b9af-2f3e0ef2c884_experiment.xml","bcc930f7f024f52f5aa20e06f8c719b0","3c91d9b9-08d7-43aa-af01-198910316b27",2431,"2016-09-29T21:41:41.329842-05:00","208d00b6-2e5d-4762-b9af-2f3e0ef2c884_run.xml","859bd86c771d515dda6b6fb719a8b9f8","9bdaa223-83f5-46a7-b7b3-b1778847a372",354,"2016-09-08T10:28:54.294644-05:00","TCGA-AJ-A3NE","2016-09-02T18:49:02.749499-05:00","female","TCGA-AJ-A3NE_demographic",1965,"white","7cd0bfbb-89d6-5f79-8bee-d7a676d2e60d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3NE_diagnosis","not reported",16957,"alive","8380/3",NA,628,"18780bc0-1bba-5cd3-8b89-1ad711411545","c54.1",-16957,"TCGA-AJ-A3NE_treatment","2e5afb49-8cc8-53c3-8444-1b285a628db9","01","false","TCGA-AJ-A3NE-01A",NA,"a1ec8680-c144-4a99-8d51-ae9a68f15d67",FALSE,"4618A1F6-B969-4746-8190-7D856A21C25F","Primary Tumor",NA,134,23,NA,1327449600,"11",30,"TCGA-AJ-A3NE-01A-11",60,65,0,0,0,0,15,15,"2016-09-08T10:28:54.294644-05:00","2016-09-08T10:28:54.294644-05:00",0,0,0,0,"TOP","BOTTOM",5,5,"6f2b775a-26f6-42ac-a9b1-9daf1c4be9fe","9390be15-d93a-4e83-9f8e-9ca10592e95e","TCGA-AJ-A3NE-01A-01-TS1","TCGA-AJ-A3NE-01A-01-BS1",80,80,"6e9b4037-da5a-4429-9b25-7570ff433ef5","RNA","TCGA-AJ-A3NE-01A-11R","02084bcc-967d-49b4-8d32-e5b2d2c73d0b",1.76,0.18,"UV Spec","R","23","TCGA-AJ-A3NE-01A-11R-A22K-07","a133035a-7076-4fe7-b260-f866b409aba4",0.18,NA,80,31.25,160,"b060a9fc-e273-5591-ac58-29e05312788e","TCGA-AJ-A3NE_exposure","UNCID_2173455.a133035a-7076-4fe7-b260-f866b409aba4.130502_UNC12-SN629_0289_AC236KACXX_6_GTCCGC.tar.gz","2013-09-09T18:56:09.000Z","2013-09-09T07:12:01.000Z","208D00B6-2E5D-4762-B9AF-2F3E0EF2C884","A1EC8680-C144-4A99-8D51-AE9A68F15D67","Unaligned reads",6136589660,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","A133035A-7076-4FE7-B260-F866B409ABA4","University of North Carolina","564a345ae4b08c5d868f43a8","1DCF33E9-4C9B-4B2B-914E-15E6BE5DCD07","Uterine Corpus Endometrial Carcinoma","TARGZ","6E9B4037-DA5A-4429-9B25-7570FF433EF5","2013-09-09T07:12:01.000Z","02084BCC-967D-49B4-8D32-E5B2D2C73D0B","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",134,"6E9B4037-DA5A-4429-9B25-7570FF433EF5",NA,"AJ","UNCID_2034601.a133035a-7076-4fe7-b260-f866b409aba4.sorted_genome_alignments.bam",23,"TCGA-AJ-A3NE-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","A1EC8680-C144-4A99-8D51-AE9A68F15D67",46,"TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_H06_1151340.ismpolish.data.txt","Alive",NA,"TCGA-AJ-A3NE","NOT HISPANIC OR LATINO","348D5ED3-1F3A-4A95-9001-C8135FC346DD",NA,78,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"9390BE15-D93A-4E83-9F8E-9CA10592E95E","3DC46CE1-C895-498E-BE97-DB5F730D8F82","UNCID_2034601.a133035a-7076-4fe7-b260-f866b409aba4.sorted_genome_alignments.bam","TCGA-AJ-A3NE-01A-11",60,0,0,0,15,"TOP",5,0,"TCGA-AJ-A3NE-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3NE-F47713_NTE-1","NO",628,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3NE-F47713","TCGA-AJ-A3NE",1,"AJ","A3NE","YES","C54.1","8380/3","C54.1","YES","NO",-16957,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",78,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,46,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
122188342,119039205,5678127850,"0B853889-AEDD-4BAF-A1F3-A25120D2C3E4.bw","1e5053ae-9a78-41ed-81cd-1a43756fca09","0b853889-aedd-4baf-a1f3-a25120d2c3e4","2016-08-24T16:31:04.919257-05:00","UNCID_2327180.2532b16b-1217-43df-aa69-cdbb5f9c3778.131118_UNC15-SN850_0339_AC347DACXX_8_GCCAAT.tar.gz","6eccded2-070d-455b-a6c6-6243a34b30ca",5525709268,"Illumina HiSeq","510a7b80bd80cbff5731dbae7a0aa65f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:21:32.329202-05:00","2016-05-03T11:34:55.532339-05:00","6eccded2-070d-455b-a6c6-6243a34b30ca_analysis.xml","a42cee1c0cc241758fd9bfad4f5dd5a6","45431936-8634-4ed8-9294-733954f96bee",2124,"2016-09-29T22:30:54.257828-05:00","6eccded2-070d-455b-a6c6-6243a34b30ca_experiment.xml","7dc4c804b8d3dc97a10e0ad1e81046fd","ba5141c6-2a2c-446a-b3a0-88cefad4ac78",2628,"2016-09-29T23:36:00.676677-05:00","6eccded2-070d-455b-a6c6-6243a34b30ca_run.xml","509c140fe30f420ee59c7f87e6cc1dca","e2c2f8bf-185e-496e-9cdf-53240487ac81",354,"2016-09-08T12:19:48.231000-05:00","TCGA-FL-A1YT",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YT-11A",NA,"b67349d0-bc63-43e0-9b52-13095e184b94",FALSE,"4E2E650A-F057-4B4E-84FD-2ECFC6D13C4D","Solid Tissue Normal",NA,NA,70,NA,1302480000,"12",10,"TCGA-FL-A1YT-11A-12",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T12:19:48.231000-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"35602b14-252e-4483-b163-64ca8793da18",NA,"TCGA-FL-A1YT-11A-01-TSA",NA,0,NA,"73f47bf4-fe72-45df-a3f1-7f0606087892","RNA","TCGA-FL-A1YT-11A-12R","63cd901b-709b-4d17-9ed9-bbfb3d4796d4",1.86,0.12,"UV Spec","R","23","TCGA-FL-A1YT-11A-12R-A32Y-07","2532b16b-1217-43df-aa69-cdbb5f9c3778",0.12,NA,NA,NA,NA,NA,NA,"UNCID_2327180.2532b16b-1217-43df-aa69-cdbb5f9c3778.131118_UNC15-SN850_0339_AC347DACXX_8_GCCAAT.tar.gz","2014-01-24T23:52:13.000Z","2014-01-25T00:08:02.000Z","6ECCDED2-070D-455B-A6C6-6243A34B30CA","B67349D0-BC63-43E0-9B52-13095E184B94","Unaligned reads",5525709268,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","2532B16B-1217-43DF-AA69-CDBB5F9C3778","University of North Carolina","56607f5ce4b0ec1099f8f441","1E5053AE-9A78-41ED-81CD-1A43756FCA09","Uterine Corpus Endometrial Carcinoma","TARGZ","73F47BF4-FE72-45DF-A3F1-7F0606087892","2014-01-25T00:08:02.000Z","63CD901B-709B-4D17-9ED9-BBFB3D4796D4","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"73F47BF4-FE72-45DF-A3F1-7F0606087892",NA,"FL","jhu-usc.edu_UCEC.HumanMethylation450.12.lvl-2.TCGA-FL-A1YT-11A-12D-A17F-05.txt",70,"TCGA-FL-A1YT-11A",NA,NA,"TCGA",NA,NA,NA,NA,"B67349D0-BC63-43E0-9B52-13095E184B94",NA,"jhu-usc.edu_UCEC.HumanMethylation450.12.lvl-2.TCGA-FL-A1YT-11A-12D-A17F-05.txt",NA,NA,"TCGA-FL-A1YT",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,156,NA,NA,NA,NA,12,10,"35602B14-252E-4483-B163-64CA8793DA18","D08C71C3-6B14-4A03-9539-175475BAF466","jhu-usc.edu_UCEC.HumanMethylation450.12.lvl-2.TCGA-FL-A1YT-11A-12D-A17F-05.txt","TCGA-FL-A1YT-11A-12",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YT-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110892674,109084687,5191316252,"FD3BD018-3B83-4689-BC70-CE6E98F83790.bw","1f9b1b71-8753-4cd5-a585-708bea8ff1fa","fd3bd018-3b83-4689-bc70-ce6e98f83790","2016-08-07T11:26:32.351172-05:00","UNCID_2177896.1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3.130402_UNC10-SN254_0447_BC22WAACXX_3_TAGCTT.tar.gz","acb9a462-1b17-4757-8007-5de5d4b5f4f4",4666934685,"Illumina HiSeq","a0d4d6fb54b2661169a3506966d28312","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:00:26.451795-05:00","2016-05-03T10:56:47.877475-05:00","acb9a462-1b17-4757-8007-5de5d4b5f4f4_analysis.xml","2e14d7447f8fba00e10f8935d19d5eeb","a79cc86d-607b-4e78-a823-84cc4b07ebb0",2123,"2016-10-07T16:28:17.376240-05:00","acb9a462-1b17-4757-8007-5de5d4b5f4f4_experiment.xml","af3ac314a7c5bab59f54ad7582d0c7aa","a5ecf6f0-9406-413f-85d5-6b193f2470d0",2431,"2016-09-29T20:18:58.827539-05:00","acb9a462-1b17-4757-8007-5de5d4b5f4f4_run.xml","2d3ad0829842104a238295fb8d79c1d0","68946df1-4436-42fc-bc1f-1ab3b6139411",354,"2016-09-08T10:38:46.304112-05:00","TCGA-BG-A0MK","2016-09-02T18:47:38.293647-05:00","female","TCGA-BG-A0MK_demographic",1954,"black or african american","a4b71057-d927-5959-83ac-9a5e77c626eb","not hispanic or latino",2009,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MK_diagnosis","not reported",19034,"dead","8380/3",1317,NA,"d4f3ce8c-2851-5c83-b8ab-35ab88dbe5ed","c54.1",-19034,"TCGA-BG-A0MK_treatment","a73bdb4d-be63-5b60-86b5-2ae334cd5c9c","01","true","TCGA-BG-A0MK-01A",NA,"24678d73-94e1-49b4-a772-bda6a02d6075",FALSE,"9D631FCB-78A9-4CA9-A033-D66CB78D8CA3","Primary Tumor",NA,1399,1100,NA,1317340800,"51",26,"TCGA-BG-A0MK-01A-51",60,NA,0,NA,0,NA,15,NA,"2016-09-08T10:38:46.304112-05:00",NA,0,NA,0,NA,"TOP",NA,15,NA,"cedc4148-a29a-4a96-8862-6db908805e6c",NA,"TCGA-BG-A0MK-01A-05-TS5",NA,70,NA,"079c2833-c221-4766-9eff-1761441a1427","RNA","TCGA-BG-A0MK-01A-51R","fe6f1bc1-3e94-47ae-be64-b1bd3fd3c4ff",1.79,0.18,"UV Spec","R","23","TCGA-BG-A0MK-01A-51R-A19W-07","1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3",0.18,NA,NA,NA,NA,"fdbdaae8-8c77-515c-9825-dbe9990a51bf","TCGA-BG-A0MK_exposure","UNCID_2177896.1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3.130402_UNC10-SN254_0447_BC22WAACXX_3_TAGCTT.tar.gz","2013-09-11T20:31:08.000Z","2013-09-11T20:47:01.000Z","ACB9A462-1B17-4757-8007-5DE5D4B5F4F4","24678D73-94E1-49B4-A772-BDA6A02D6075","Unaligned reads",4666934685,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","1F577D0A-AB0B-4464-B75D-4D3DC2B80CD3","University of North Carolina","564a3a2ae4b0ef12181a0cbb","1F9B1B71-8753-4CD5-A585-708BEA8FF1FA","Uterine Corpus Endometrial Carcinoma","TARGZ","079C2833-C221-4766-9EFF-1761441A1427","2013-09-11T20:47:01.000Z","FE6F1BC1-3E94-47AE-BE64-B1BD3FD3C4FF","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",1399,"079C2833-C221-4766-9EFF-1761441A1427",NA,"BG","UNCID_1973362.1f577d0a-ab0b-4464-b75d-4d3dc2b80cd3.sorted_genome_alignments.bam.bai",1100,"TCGA-BG-A0MK-01A",NA,NA,"TCGA",2006,NA,NA,"WITH TUMOR","8D61F36E-EB89-4BA4-BE24-C946FDD36947",52,"nationwidechildrens.org_clinical.TCGA-BG-A0MK.xml","Dead",1317,"TCGA-BG-A0MK","NOT HISPANIC OR LATINO","360FA554-F726-4DEA-B3F0-1B3C578CAE9E",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,"F9CCB583-AD67-4192-9ACA-B068BEE2E36B","BLACK OR AFRICAN AMERICAN",NA,51,26,"CEDC4148-A29A-4A96-8862-6DB908805E6C","785F6E57-FB47-43B3-BAE7-CB1D46548E91","TCGA-BG-A0MK-01A-51R-A19V-13_mirna.bam","TCGA-BG-A0MK-01A-51",60,0,0,0,15,"TOP",15,0,"TCGA-BG-A0MK-01A-05-TS5",70,NA,NA,NA,"TCGA-BG-A0MK-R43327","Internal","Primary Tumor Field","TCGA-BG-A0MK-F39617_NTE-1","NO",NA,"WITH TUMOR","Dead",1317,"TCGA-BG-A0MK-F39617","TCGA-BG-A0MK",1,"BG","A0MK","YES","C54.1","8380/3","C54.1","YES","NO",-19034,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,1317,NA,NA,"WITH TUMOR","NO",29,3,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,52,2006,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1995",7,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
29506267,29266881,2183669323,"47747595-686A-46B5-9EF4-A4CFB85D746D.bw","20dcf91a-0529-4e96-99a2-362a41fbe4a4","47747595-686a-46b5-9ef4-a4cfb85d746d","2016-08-09T14:14:34.367136-05:00","UNCID_2207660.c588b29f-0abf-47c6-bff2-d0589ea506ee.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_8.tar.gz","7790bb04-1c64-4309-b244-6879221c6eef",1876669841,"Illumina GA","52bc64831e59c4c9fcf1aa4e7789844f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:10:59.936358-05:00","2016-05-03T11:14:23.412796-05:00","7790bb04-1c64-4309-b244-6879221c6eef_analysis.xml","a292fa2acb0b49df8a2e35f7227ba2f3","f84e2f1b-577d-4d7d-9f22-f861027fb0ed",2121,"2016-08-29T15:00:25.536373-05:00","7790bb04-1c64-4309-b244-6879221c6eef_experiment.xml","624bc74416e0373a739ca6e58bcb4325","1133b8dc-3b4a-452d-beaf-9c06693a5e24",2257,"2016-09-29T21:22:08.596306-05:00","7790bb04-1c64-4309-b244-6879221c6eef_run.xml","6be19577749079369d29a64d7829bb75","8fdb3e4e-1701-4e55-8e96-9c4ef1b2571b",347,"2016-09-08T10:27:28.998183-05:00","TCGA-AX-A1CF","2016-09-02T18:51:41.535871-05:00","female","TCGA-AX-A1CF_demographic",1935,"white","349f3d0a-a11d-5b87-9dd2-13ac1f4b68c2","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CF_diagnosis","not reported",25300,"alive","8380/3",NA,2337,"151e2065-1540-58b5-b88a-fb97d6841ad8","c54.1",-25300,"TCGA-AX-A1CF_treatment","c2f051d1-56b2-5b7d-8906-c5c26e591706","11","false","TCGA-AX-A1CF-11A",NA,"ca311bb9-f50f-4d7b-a18f-a0c5c5011c57",FALSE,NA,"Solid Tissue Normal",NA,2284,50,NA,1295222400,"11",30,"TCGA-AX-A1CF-11A-11",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T10:27:28.998183-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"fee0b9b5-08f2-4fc8-88c0-545f078b8185",NA,"TCGA-AX-A1CF-11A-01-TS1",NA,0,NA,"064863e5-bf37-4a85-9623-2b12370b5c66","RNA","TCGA-AX-A1CF-11A-11R","ae35f9c9-9924-4ae4-b37f-d0bf9904fc5b",1.87,0.18,"UV Spec","R","23","TCGA-AX-A1CF-11A-11R-A137-07","c588b29f-0abf-47c6-bff2-d0589ea506ee",0.18,NA,79,35.1111111111111,150,"2508b214-bc0e-5d24-8bb4-1ccaee13fd7f","TCGA-AX-A1CF_exposure","UNCID_2207660.c588b29f-0abf-47c6-bff2-d0589ea506ee.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_8.tar.gz","2013-09-30T04:16:04.000Z","2013-09-30T04:28:01.000Z","7790BB04-1C64-4309-B244-6879221C6EEF","CA311BB9-F50F-4D7B-A18F-A0C5C5011C57","Unaligned reads",1876669841,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C588B29F-0ABF-47C6-BFF2-D0589EA506EE","University of North Carolina","566078d4e4b0ec1099f8d71d","20DCF91A-0529-4E96-99A2-362A41FBE4A4","Uterine Corpus Endometrial Carcinoma","TARGZ","064863E5-BF37-4A85-9623-2B12370B5C66","2013-09-30T04:28:01.000Z","AE35F9C9-9924-4AE4-B37F-D0BF9904FC5B","None","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",2284,"064863E5-BF37-4A85-9623-2B12370B5C66",NA,"AX","TCGA-AX-A1CF-11A-11R-A136-13_mirna.bam.bai",50,"TCGA-AX-A1CF-11A",NA,"694F4296-D3D4-4D80-916E-D76659AAC723","TCGA",2004,NA,NA,"WITH TUMOR","CA311BB9-F50F-4D7B-A18F-A0C5C5011C57",69,"nationwidechildrens.org_clinical.TCGA-AX-A1CF.xml","Alive",NA,"TCGA-AX-A1CF","NOT HISPANIC OR LATINO","53489918-F995-4DB7-8188-B4B4E5C9DD00",NA,2337,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"5F8901D4-3C6A-4F64-A2B3-353C51C95C98","WHITE",NA,11,30,"FEE0B9B5-08F2-4FC8-88C0-545F078B8185","AE35F9C9-9924-4AE4-B37F-D0BF9904FC5B","TCGA-AX-A1CF-11A-11R-A136-13_mirna.bam.bai","TCGA-AX-A1CF-11A-11",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-AX-A1CF-11A-01-TS1",0,"Paclitaxel","Chemotherapy","TCGA-AX-A1CF-D12374","TCGA-AX-A1CF-R12376",NA,"Distant Recurrence",NA,NA,2337,"WITH TUMOR","Alive",NA,"TCGA-AX-A1CF-F10338","TCGA-AX-A1CF",1,"AX","A1CF","YES","C54.1","8380/3","C54.1","NO","YES",-25300,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2337,NA,NA,NA,"WITH TUMOR","NO",10,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2004,"Office Endometrial Biopsy",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
31158210,30932456,2290658531,"C5986AA8-D1C7-47BB-946F-1AE00503A444.bw","20dcf91a-0529-4e96-99a2-362a41fbe4a4","c5986aa8-d1c7-47bb-946f-1ae00503a444","2016-08-09T14:13:15.288362-05:00","UNCID_2207661.ee60f261-392f-4583-8ddb-b29f07f20e6e.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_7.tar.gz","7a54cfa3-8b61-4b00-8d07-2a006f3212b8",2012103876,"Illumina GA","32843765bc5b5ad917e952e301763574","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:03:40.290248-05:00","2016-05-03T11:14:23.412796-05:00","7a54cfa3-8b61-4b00-8d07-2a006f3212b8_analysis.xml","4ff254c356cfa7c7835864e1ccc8a7d8","f3dfeb94-b19d-4bfe-8861-0af01396779f",2121,"2016-10-07T16:01:35.709898-05:00","7a54cfa3-8b61-4b00-8d07-2a006f3212b8_experiment.xml","de92f2041e2d2f35c9eaaf83bd440615","1384fd41-0b3a-437f-bb9e-e9c2634dc4f9",2257,"2016-09-29T19:37:44.251682-05:00","7a54cfa3-8b61-4b00-8d07-2a006f3212b8_run.xml","1754d2e22d6d8c37dc73c4f25549bcf3","4f51635d-0586-4e29-8b70-a70a4acfb231",347,"2016-09-08T10:27:28.998183-05:00","TCGA-AX-A1CF","2016-09-02T18:51:41.535871-05:00","female","TCGA-AX-A1CF_demographic",1935,"white","349f3d0a-a11d-5b87-9dd2-13ac1f4b68c2","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CF_diagnosis","not reported",25300,"alive","8380/3",NA,2337,"151e2065-1540-58b5-b88a-fb97d6841ad8","c54.1",-25300,"TCGA-AX-A1CF_treatment","c2f051d1-56b2-5b7d-8906-c5c26e591706","01","false","TCGA-AX-A1CF-01A",NA,"4c219685-44e4-489b-a72f-cfcba405588c",FALSE,"CB16E769-AFE1-4555-A65D-691266C4898E","Primary Tumor",NA,2284,130,NA,1295222400,"11",30,"TCGA-AX-A1CF-01A-11",75,NA,0,NA,20,NA,5,NA,"2016-09-08T10:27:28.998183-05:00",NA,1,NA,0,NA,"TOP",NA,2,NA,"bba8185b-535c-4671-bb73-3fca1bfb9066",NA,"TCGA-AX-A1CF-01A-01-TS1",NA,73,NA,"4e8cca5c-71ae-45f3-be82-10565c36256f","RNA","TCGA-AX-A1CF-01A-11R","9b47c263-d8a5-4a1f-88fb-64e9441c966c",1.87,0.16,"UV Spec","R","23","TCGA-AX-A1CF-01A-11R-A137-07","ee60f261-392f-4583-8ddb-b29f07f20e6e",0.16,NA,79,35.1111111111111,150,"2508b214-bc0e-5d24-8bb4-1ccaee13fd7f","TCGA-AX-A1CF_exposure","UNCID_2207661.ee60f261-392f-4583-8ddb-b29f07f20e6e.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_7.tar.gz","2013-09-30T04:13:10.000Z","2013-09-30T04:25:02.000Z","7A54CFA3-8B61-4B00-8D07-2A006F3212B8","4C219685-44E4-489B-A72F-CFCBA405588C","Unaligned reads",2012103876,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","EE60F261-392F-4583-8DDB-B29F07F20E6E","University of North Carolina","566078d7e4b0b37b3d991616","20DCF91A-0529-4E96-99A2-362A41FBE4A4","Uterine Corpus Endometrial Carcinoma","TARGZ","4E8CCA5C-71AE-45F3-BE82-10565C36256F","2013-09-30T04:25:02.000Z","9B47C263-D8A5-4A1F-88FB-64E9441C966C","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",2284,"4E8CCA5C-71AE-45F3-BE82-10565C36256F",NA,"AX","UNCID_2207661.ee60f261-392f-4583-8ddb-b29f07f20e6e.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_7.tar.gz",130,"TCGA-AX-A1CF-01A",NA,"694F4296-D3D4-4D80-916E-D76659AAC723","TCGA",2004,NA,NA,"WITH TUMOR","CA311BB9-F50F-4D7B-A18F-A0C5C5011C57",69,"nationwidechildrens.org_clinical.TCGA-AX-A1CF.xml","Alive",NA,"TCGA-AX-A1CF","NOT HISPANIC OR LATINO","53489918-F995-4DB7-8188-B4B4E5C9DD00",NA,2337,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"5F8901D4-3C6A-4F64-A2B3-353C51C95C98","WHITE",NA,11,30,"BBA8185B-535C-4671-BB73-3FCA1BFB9066","D3C079D0-7131-4786-BBD2-93D10123B292","UNCID_2207661.ee60f261-392f-4583-8ddb-b29f07f20e6e.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_7.tar.gz","TCGA-AX-A1CF-01A-11",75,20,0,1,5,"TOP",2,0,"TCGA-AX-A1CF-01A-01-TS1",73,"Paclitaxel","Chemotherapy","TCGA-AX-A1CF-D12374","TCGA-AX-A1CF-R12376",NA,"Distant Recurrence",NA,NA,2337,"WITH TUMOR","Alive",NA,"TCGA-AX-A1CF-F10338","TCGA-AX-A1CF",1,"AX","A1CF","YES","C54.1","8380/3","C54.1","NO","YES",-25300,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2337,NA,NA,NA,"WITH TUMOR","NO",10,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2004,"Office Endometrial Biopsy",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
118576060,115504686,5509713794,"834D12DB-0925-422C-B15B-20A60A5F658C.bw","211b2c52-1ad8-4d33-af0b-69ec1a56c821","834d12db-0925-422c-b15b-20a60a5f658c","2016-08-09T13:15:49.165314-05:00","UNCID_2178318.c6b592eb-d131-4344-9135-7d9964143c28.130404_UNC12-SN629_0271_AC24VNACXX_8_TAGCTT.tar.gz","086e0ef4-5635-46a3-a879-54a9682d7d47",5386319757,"Illumina HiSeq","28aec78a05208f93a56d05aafb9d47a8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:16:38.946516-05:00","2016-05-03T10:56:47.878169-05:00","086e0ef4-5635-46a3-a879-54a9682d7d47_analysis.xml","abc152f9ec4d0f13ebd3fb180b880532","d6a7cb80-e38a-4cc0-98ea-a31f154cfdca",2123,"2016-09-29T18:56:26.343838-05:00","086e0ef4-5635-46a3-a879-54a9682d7d47_experiment.xml","fb1047b440659b239074c548954e12c5","35732792-e37c-4f49-8f0c-c3dc7c0a978e",2431,"2016-09-29T18:40:48.535119-05:00","086e0ef4-5635-46a3-a879-54a9682d7d47_run.xml","8c275bf59c7f8749596c07bf5c6cc138","2b81d570-375a-4809-8d03-8c6b844e332d",354,"2016-09-08T10:38:40.704667-05:00","TCGA-AP-A3K1","2016-09-02T18:48:22.230507-05:00","female","TCGA-AP-A3K1_demographic",1954,"white","26763d38-c1a0-5f96-bad2-1a24c1c5555b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A3K1_diagnosis","not reported",20594,"dead","8441/3",666,555,"d168edea-fbee-5c65-b2e7-ad373b611c87","c54.1",-20594,"TCGA-AP-A3K1_treatment","6fc79bdc-4403-54d8-801a-e8030d10d55c","01","true","TCGA-AP-A3K1-01A",NA,"8a78f37c-8bc5-4a51-bb76-e77ded648289",FALSE,"A2E4C9FE-F82D-440E-AA52-88379EBC2442","Primary Tumor",NA,450,190,NA,1325635200,"11",30,"TCGA-AP-A3K1-01A-11",95,NA,0,NA,0,NA,0,NA,"2016-09-08T10:38:40.704667-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"dc088cbf-4362-4820-91be-2208b620afa8",NA,"TCGA-AP-A3K1-01A-01-TSA",NA,100,NA,"3fc9464a-dcdc-44c4-a90d-3136d33a9d97","RNA","TCGA-AP-A3K1-01A-11R","b436c88e-c9a5-48e2-8d9a-df697f078f93",1.81,0.17,"UV Spec","R","23","TCGA-AP-A3K1-01A-11R-A213-07","c6b592eb-d131-4344-9135-7d9964143c28",0.17,NA,60,24.3417582863402,157,"6b853ec4-f9df-50af-a109-7ff2b76e2390","TCGA-AP-A3K1_exposure","UNCID_2178318.c6b592eb-d131-4344-9135-7d9964143c28.130404_UNC12-SN629_0271_AC24VNACXX_8_TAGCTT.tar.gz","2013-09-12T00:21:05.000Z","2013-09-12T00:35:01.000Z","086E0EF4-5635-46A3-A879-54A9682D7D47","8A78F37C-8BC5-4A51-BB76-E77DED648289","Unaligned reads",5386319757,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","C6B592EB-D131-4344-9135-7D9964143C28","University of North Carolina","56607953e4b0ec1099f8da03","211B2C52-1AD8-4D33-AF0B-69EC1A56C821","Uterine Corpus Endometrial Carcinoma","TARGZ","3FC9464A-DCDC-44C4-A90D-3136D33A9D97","2013-09-12T00:35:01.000Z","B436C88E-C9A5-48E2-8D9A-DF697F078F93","United States","NO",1,NA,"Primary Tumor","MSKCC",450,"3FC9464A-DCDC-44C4-A90D-3136D33A9D97",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B8160651-765E-4FDD-A02A-1612113DA755.txt",190,"TCGA-AP-A3K1-01A",NA,"E86FFFCA-37BD-485D-89ED-6C7C29996571","TCGA",2010,NA,NA,"WITH TUMOR","F2DD2CFD-E999-48C1-9A62-7616AEB810AF",56,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B8160651-765E-4FDD-A02A-1612113DA755.txt","Alive",NA,"TCGA-AP-A3K1","NOT HISPANIC OR LATINO","851EA2EE-7DD4-41E9-B1AE-7772CF23F0DB",NA,555,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",201,NA,NA,"WHITE",NA,11,30,"DC088CBF-4362-4820-91BE-2208B620AFA8","B436C88E-C9A5-48E2-8D9A-DF697F078F93","UNCID_2178318.c6b592eb-d131-4344-9135-7d9964143c28.130404_UNC12-SN629_0271_AC24VNACXX_8_TAGCTT.tar.gz","TCGA-AP-A3K1-01A-11",95,0,0,1,0,"TOP",0,0,"TCGA-AP-A3K1-01A-01-TSA",100,"Paclitaxel","Chemotherapy","TCGA-AP-A3K1-D38427",NA,NA,NA,"TCGA-AP-A3K1-F38425_NTE-1","YES",NA,"WITH TUMOR","Dead",666,"TCGA-AP-A3K1-F38425","TCGA-AP-A3K1",1,"AP","A3K1","YES","C54.1","8441/3","C54.1","NO","YES",-20594,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",555,NA,NA,NA,"WITH TUMOR","NO",16,4,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,56,2010,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"High Grade","RX",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
23711087,23447606,1746755416,"057B580C-13FD-4185-943C-9DD5266B8554.bw","214a09bb-ce52-4055-b036-065e8cb7ac7d","057b580c-13fd-4185-943c-9dd5266b8554","2016-08-09T14:03:38.016840-05:00","UNCID_2196797.16ce8070-8c04-4cc7-b00a-c094a524b133.120208_UNC2-RDR300275_00112_FC_64V42AAXX_6.tar.gz","7074bfe3-433c-40e9-9e22-4f8c6c02f90a",1557009271,"Illumina GA","d9c4033d698db4d2974fbaaf1be46771","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:48:09.122589-05:00","2016-05-03T11:08:33.752363-05:00","7074bfe3-433c-40e9-9e22-4f8c6c02f90a_analysis.xml","70053549dfba809cb6854eb0a63d3400","9fe44502-5151-423a-9530-1dbd4d958421",2121,"2016-08-13T08:13:04.073802-05:00","7074bfe3-433c-40e9-9e22-4f8c6c02f90a_experiment.xml","885b3d2e5ba97eb3ab002cd10d969650","6f581e51-54ba-441e-a8dd-1352ada2db42",2257,"2016-09-29T20:03:54.818953-05:00","7074bfe3-433c-40e9-9e22-4f8c6c02f90a_run.xml","c7bcd211a2672ab8f4da4787eaaf7d3f","5f7b3873-a4a4-4eb4-811f-52da85682206",347,"2016-09-08T10:38:11.574355-05:00","TCGA-BG-A2L7","2016-09-02T18:54:16.800175-05:00","female","TCGA-BG-A2L7_demographic",1943,"white","608b1f93-afe7-5b95-bf1c-dfd43e6e96ae","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A2L7_diagnosis","not reported",25091,"alive","8380/3",NA,612,"b17bbee7-7e2f-56ad-8810-13b9ea30fe3a","c54.1",-25091,"TCGA-BG-A2L7_treatment","9102dc7e-d93d-5801-a075-5306c4b9b07d","01","true","TCGA-BG-A2L7-01A",NA,"68328de4-7de9-4893-a402-f15c64c7718e",FALSE,"6A14E5E4-ED0F-415A-B54B-DE16D7DC6E78","Primary Tumor",NA,141,110,NA,1313712000,"11",30,"TCGA-BG-A2L7-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T10:38:11.574355-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"2f952857-803e-4170-8807-8e1b699c14c7",NA,"TCGA-BG-A2L7-01A-01-TSA",NA,70,NA,"ffc556c5-02b0-4ae3-b880-e9c9b1b9b09e","RNA","TCGA-BG-A2L7-01A-11R","5631b611-fca5-44a5-b952-369d67fedf27",1.79,0.17,"UV Spec","R","23","TCGA-BG-A2L7-01A-11R-A18M-07","16ce8070-8c04-4cc7-b00a-c094a524b133",0.17,NA,NA,NA,NA,"4337fe9e-5c79-5836-bb3d-8042e99e9b16","TCGA-BG-A2L7_exposure","UNCID_2196797.16ce8070-8c04-4cc7-b00a-c094a524b133.120208_UNC2-RDR300275_00112_FC_64V42AAXX_6.tar.gz","2013-09-23T22:16:04.000Z","2013-09-23T22:28:02.000Z","7074BFE3-433C-40E9-9E22-4F8C6C02F90A","68328DE4-7DE9-4893-A402-F15C64C7718E","Unaligned reads",1557009271,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","16CE8070-8C04-4CC7-B00A-C094A524B133","University of North Carolina","564a3395e4b093830b66c4a0","214A09BB-CE52-4055-B036-065E8CB7AC7D","Uterine Corpus Endometrial Carcinoma","TARGZ","FFC556C5-02B0-4AE3-B880-E9C9B1B9B09E","2013-09-23T22:28:02.000Z","5631B611-FCA5-44A5-B952-369D67FEDF27","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",141,"FFC556C5-02B0-4AE3-B880-E9C9B1B9B09E",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9C365A47-24D5-4301-B47E-FD745ABBE8E7.txt",110,"TCGA-BG-A2L7-01A",NA,"32E13037-A275-4FAC-8D36-32FDD3E2958A","TCGA",2011,NA,NA,"TUMOR FREE","68328DE4-7DE9-4893-A402-F15C64C7718E",68,"6929718105_R04C01_Grn.idat","Alive",NA,"TCGA-BG-A2L7","NOT HISPANIC OR LATINO","CB3459DA-B554-4C67-B7D2-9D3FCD6BFA9C",NA,177,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,"5D576C80-7DFC-4A1E-9AF4-642F33850257","WHITE",NA,11,30,"2F952857-803E-4170-8807-8E1B699C14C7","FE0760E7-2540-4FEE-BD2A-7E358AC18EBB","TCGA-BG-A2L7-01A-11R-A18L-13_mirna.bam.bai","TCGA-BG-A2L7-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-BG-A2L7-01A-01-TSA",70,"Carboplatin","Chemotherapy","TCGA-BG-A2L7-D63225","TCGA-BG-A2L7-R63227","Internal","Primary Tumor Field","TCGA-BG-A2L7-F49554_NTE-1","NO",612,"TUMOR FREE","Alive",NA,"TCGA-BG-A2L7-F49554","TCGA-BG-A2L7",1,"BG","A2L7","YES","C54.1","8380/3","C54.1","NO","YES",-25091,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",177,NA,NA,NA,"TUMOR FREE","NO",18,1,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
108369096,105486492,5034164598,"16EBB885-A692-42A6-9027-F6AD769E0ABB.bw","21941181-8ed5-4211-867d-516ad09fbe06","16ebb885-a692-42a6-9027-f6ad769e0abb","2016-08-09T13:14:44.384573-05:00","UNCID_2173068.654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd.130509_UNC10-SN254_0462_AC232JACXX_4_CTTGTA.tar.gz","5755e130-2493-4370-865d-63d0b7ddc526",4920941350,"Illumina HiSeq","820b94af04a5054ec343424cc266776a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:25:11.368832-05:00","2016-05-03T10:55:55.600288-05:00","5755e130-2493-4370-865d-63d0b7ddc526_analysis.xml","bbae58e7daf71a9fb5d6d9e258385270","91bd657f-e5f2-4e7b-b474-f9da25d6634b",2123,"2016-08-27T00:40:09.751510-05:00","5755e130-2493-4370-865d-63d0b7ddc526_experiment.xml","ae18502ce16de828abed94a5c8158c61","3d765347-08b4-4671-8b74-6c9955c05a70",2431,"2016-09-29T19:09:06.529114-05:00","5755e130-2493-4370-865d-63d0b7ddc526_run.xml","1c5fc9665cb61b0df6fe01076c4bd6ba","3d692a9b-7339-416d-9372-aeeabd4121e6",354,"2016-09-08T10:29:57.036511-05:00","TCGA-B5-A3F9","2016-09-02T18:49:15.924593-05:00","female","TCGA-B5-A3F9_demographic",1947,"black or african american","50c45796-e968-564d-9c4b-165c22625230","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A3F9_diagnosis","not reported",20523,"alive","8380/3",NA,4155,"75d7b4cd-1568-54e7-b463-0d5313354c90","c54.1",-20523,"TCGA-B5-A3F9_treatment","56621181-87be-5d42-bdb2-fcfc5e0c6101","01","true","TCGA-B5-A3F9-01A",NA,"7fc15cfc-2cd8-49af-bf92-913f0bc4c1a8",FALSE,"E4AD1574-653C-444D-BB43-B4DE701B109F","Primary Tumor",NA,3159,110,NA,1322179200,"21",30,"TCGA-B5-A3F9-01A-21",95,NA,2,NA,0,NA,0,NA,"2016-09-08T10:29:57.036511-05:00",NA,1,NA,0,NA,"TOP",NA,3,NA,"ea577ad1-6d9a-4a18-b24c-b756dd76c55b",NA,"TCGA-B5-A3F9-01A-02-TSB",NA,97,NA,"3e5482d7-64fe-49b0-a526-25c0cbe669ad","RNA","TCGA-B5-A3F9-01A-21R","93a81dd3-7470-460b-8c87-1a57cd675957",1.85,0.17,"UV Spec","R","23","TCGA-B5-A3F9-01A-21R-A22K-07","654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd",0.17,NA,155,56.2490927565684,166,"1e2e3587-f4f2-5851-bbf4-0cb755c9c6ba","TCGA-B5-A3F9_exposure","UNCID_2173068.654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd.130509_UNC10-SN254_0462_AC232JACXX_4_CTTGTA.tar.gz","2013-09-09T08:56:08.000Z","2013-09-09T09:15:01.000Z","5755E130-2493-4370-865D-63D0B7DDC526","7FC15CFC-2CD8-49AF-BF92-913F0BC4C1A8","Unaligned reads",4920941350,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","654F3C17-DC98-4E53-8FF8-B1F92D6BD8BD","University of North Carolina","56607abde4b0ec1099f8e1c6","21941181-8ED5-4211-867D-516AD09FBE06","Uterine Corpus Endometrial Carcinoma","TARGZ","3E5482D7-64FE-49B0-A526-25C0CBE669AD","2013-09-09T09:15:01.000Z","93A81DD3-7470-460B-8C87-1A57CD675957","United States","NO",1,NA,"Primary Tumor","Duke",3159,"3E5482D7-64FE-49B0-A526-25C0CBE669AD",NA,"B5","UNCID_2173068.654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd.130509_UNC10-SN254_0462_AC232JACXX_4_CTTGTA.tar.gz",110,"TCGA-B5-A3F9-01A",NA,NA,"TCGA",2003,NA,NA,"TUMOR FREE","BE57B4F7-31B7-48C7-AA3F-C5DE3562E4E7",56,"b411cbd885fdbbdb4c3b850c9ca025e4.bam","Alive",NA,"TCGA-B5-A3F9",NA,"00C4FFB9-75EA-4844-ABEC-F59D01652148",NA,3264,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,21,30,"EA577AD1-6D9A-4A18-B24C-B756DD76C55B","93A81DD3-7470-460B-8C87-1A57CD675957","UNCID_2173068.654f3c17-dc98-4e53-8ff8-b1f92d6bd8bd.130509_UNC10-SN254_0462_AC232JACXX_4_CTTGTA.tar.gz","TCGA-B5-A3F9-01A-21",95,0,2,1,0,"TOP",3,0,"TCGA-B5-A3F9-01A-02-TSB",97,NA,NA,NA,NA,NA,NA,"TCGA-B5-A3F9-F37012_NTE-2","NO",3536,"TUMOR FREE","Alive",NA,"TCGA-B5-A3F9-F37012","TCGA-B5-A3F9",1,"B5","A3F9","YES","C54.1","8380/3","C54.1","NO","YES",-20523,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",3264,NA,NA,NA,"TUMOR FREE","NO",19,3,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2003,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32462113,31100260,2193635392,"0D20BF4B-C0F9-48F3-8845-2A92D4E3248C.bw","21faf1a4-f6d3-4cc6-a49a-04b8541ef598","0d20bf4b-c0f9-48f3-8845-2a92d4e3248c","2016-08-05T04:49:39.183483-05:00","UNCID_2194891.980faf04-5313-4f74-99b7-ca004f698a93.120306_UNC6-RDR300211_00136_FC_650PFAAXX_6.tar.gz","04e09e55-28ca-4e95-ac4a-4c14ca2b865b",2019262988,"Illumina GA","74a98d64453d197004ad4f30d0580cf7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:47:01.985380-05:00","2016-05-03T11:07:49.533775-05:00","04e09e55-28ca-4e95-ac4a-4c14ca2b865b_analysis.xml","43996cb679e9fd3a9cf98e7a2685ac00","c45c3727-45bb-49ef-a872-8f3a27b7af47",2121,"2016-09-29T18:52:04.807823-05:00","04e09e55-28ca-4e95-ac4a-4c14ca2b865b_experiment.xml","186fd827a2ef3942db9ec8a5ed19ddc7","32ad258f-2e73-4290-9a25-4acebe739a13",2257,"2016-09-29T19:31:59.999383-05:00","04e09e55-28ca-4e95-ac4a-4c14ca2b865b_run.xml","4213a1644e18e2f0461680ecb308f46c","4bdd3e16-4a10-484a-9abb-eda57731e291",347,"2016-09-08T10:34:11.538402-05:00","TCGA-D1-A1O8","2016-09-02T18:52:20.323215-05:00","female","TCGA-D1-A1O8_demographic",1940,"white","2e3c3f4c-ceef-53e4-b6b8-a078693197c6","not hispanic or latino",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1O8_diagnosis","not reported",25789,"dead","8380/3",120,NA,"161cef11-d172-5366-9b02-fd2be1a2bb60","c54.1",-25789,"TCGA-D1-A1O8_treatment","17f36da0-2cc8-5370-a870-ad3811c808c7","01","false","TCGA-D1-A1O8-01A",NA,"1efc3a5a-d36d-4973-a725-2eeb73cce08e",FALSE,"8E7FDFD5-892F-4671-8172-FC2BFB800AE9","Primary Tumor",NA,147,200,NA,1302048000,"11",30,"TCGA-D1-A1O8-01A-11",80,NA,30,NA,0,NA,10,NA,"2016-09-08T10:34:11.538402-05:00",NA,30,NA,30,NA,"TOP",NA,10,NA,"ad550d7e-4eb0-4ec5-8abd-f896d891c6fe",NA,"TCGA-D1-A1O8-01A-01-TSA",NA,80,NA,"d1f1a2cf-f1eb-4337-8d89-ccc80433e1f0","RNA","TCGA-D1-A1O8-01A-11R","26e613ad-8d3a-47ae-b48a-e7dd1a5d4b06",1.77,0.16,"UV Spec","R","23","TCGA-D1-A1O8-01A-11R-A14D-07","980faf04-5313-4f74-99b7-ca004f698a93",0.16,NA,85,31.2213039485767,165,"350173d6-e34b-5828-bedd-8f24bd9a7533","TCGA-D1-A1O8_exposure","UNCID_2194891.980faf04-5313-4f74-99b7-ca004f698a93.120306_UNC6-RDR300211_00136_FC_650PFAAXX_6.tar.gz","2013-09-23T04:36:04.000Z","2013-09-23T04:48:01.000Z","04E09E55-28CA-4E95-AC4A-4C14CA2B865B","1EFC3A5A-D36D-4973-A725-2EEB73CCE08E","Unaligned reads",2019262988,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","980FAF04-5313-4F74-99B7-CA004F698A93","University of North Carolina","564a40e3e4b09c884b25ffbc","21FAF1A4-F6D3-4CC6-A49A-04B8541EF598","Uterine Corpus Endometrial Carcinoma","TARGZ","D1F1A2CF-F1EB-4337-8D89-CCC80433E1F0","2013-09-23T04:48:01.000Z","26E613AD-8D3A-47AE-B48A-E7DD1A5D4B06","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",147,"D1F1A2CF-F1EB-4337-8D89-CCC80433E1F0",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B02713DD-EA3F-4965-B8E7-EF2B40F7A599.txt",200,"TCGA-D1-A1O8-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","F7FBD421-2973-4647-8CD5-C60939A3069C",70,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B02713DD-EA3F-4965-B8E7-EF2B40F7A599.txt","Dead",120,"TCGA-D1-A1O8","NOT HISPANIC OR LATINO","4B71FD42-F804-45F7-8D99-F77B93C378BF",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,11,30,"AD550D7E-4EB0-4EC5-8ABD-F896D891C6FE","B6C2823B-8574-4501-BA7B-5E27226A17CA","TCGA-D1-A1O8-01A-11R-A14C-13_mirna.bam.bai","TCGA-D1-A1O8-01A-11",80,0,30,30,10,"TOP",10,30,"TCGA-D1-A1O8-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,"NO",NA,"TUMOR FREE","Dead",120,"TCGA-D1-A1O8-F21635","TCGA-D1-A1O8",1,"D1","A1O8","YES","C54.1","8380/3","C54.1","NO","YES",-25789,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,120,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,70,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31531823,30848078,2286271651,"E5F34574-DEDC-4A72-939B-DD9F6CFA3869.bw","22618073-4ef0-4c3a-97b9-90ba1caa1d72","e5f34574-dedc-4a72-939b-dd9f6cfa3869","2016-08-09T14:17:42.726930-05:00","UNCID_2209880.4468bb31-bb94-4353-9d13-556d4b8a892a.110420_UNC6-RDR300211_00096_FC_634WMAAXX_8.tar.gz","93a551bc-b8e0-4502-a2bf-21d19688567a",2087432789,"Illumina GA","ee88ce2965182da3edf1ac91d906893c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:58:08.134109-05:00","2016-05-03T11:18:47.010651-05:00","93a551bc-b8e0-4502-a2bf-21d19688567a_analysis.xml","ddc6d8c1e3b4d68915d625059253a975","80d23baf-8cb7-4259-85f8-fc792def9865",2121,"2016-10-07T16:19:10.279809-05:00","93a551bc-b8e0-4502-a2bf-21d19688567a_experiment.xml","0a85d184fba62b31e3376c53e90fa83d","f44e450d-b6bb-4cd1-8b8a-d8a882a8c242",2257,"2016-09-29T17:56:34.880986-05:00","93a551bc-b8e0-4502-a2bf-21d19688567a_run.xml","b364660bf8a564d140f5e0c4040ab10a","0fc6b82d-4db6-4639-b93c-b9ec8e21fc86",347,"2016-09-08T11:33:40.387992-05:00","TCGA-D1-A16X","2016-09-02T18:50:31.585254-05:00","female","TCGA-D1-A16X_demographic",1955,"white","21211a7f-bfde-54df-8a7d-c139cb0922c9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16X_diagnosis","not reported",19799,"alive","8380/3",NA,111,"2adb3bfe-3072-512c-ae66-781ce266d5eb","c54.1",-19799,"TCGA-D1-A16X_treatment","25bc91ad-9658-5359-aa17-6e1072c35894","01","false","TCGA-D1-A16X-01A",NA,"6421d807-9bec-4ad4-8b75-8f9dd594a977",FALSE,"0C395D2C-1864-448E-8FB7-09BFE5FF4C50","Primary Tumor",NA,618,230,NA,1293494400,"11",30,"TCGA-D1-A16X-01A-11",95,NA,10,NA,0,NA,5,NA,"2016-09-08T11:33:40.387992-05:00",NA,3,NA,15,NA,"TOP",NA,1,NA,"3a60b134-2b7d-486f-8623-b5ea0555868a",NA,"TCGA-D1-A16X-01A-01-TS1",NA,94,NA,"0f03c16f-84b8-4777-a327-8d923daf9ec4","RNA","TCGA-D1-A16X-01A-11R","b5f6b397-6ab9-4620-980b-3f1337f5dc95",2.04,0.17,"UV Spec","R","23","TCGA-D1-A16X-01A-11R-A12I-07","4468bb31-bb94-4353-9d13-556d4b8a892a",0.17,NA,101,39.453125,160,"e380828d-919b-588a-aadb-fc5ee42607f1","TCGA-D1-A16X_exposure","UNCID_2209880.4468bb31-bb94-4353-9d13-556d4b8a892a.110420_UNC6-RDR300211_00096_FC_634WMAAXX_8.tar.gz","2013-10-04T04:56:05.000Z","2013-10-04T08:40:01.000Z","93A551BC-B8E0-4502-A2BF-21D19688567A","6421D807-9BEC-4AD4-8B75-8F9DD594A977","Unaligned reads",2087432789,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4468BB31-BB94-4353-9D13-556D4B8A892A","University of North Carolina","56607c0ae4b0b37b3d9925eb","22618073-4EF0-4C3A-97B9-90BA1CAA1D72","Uterine Corpus Endometrial Carcinoma","TARGZ","0F03C16F-84B8-4777-A327-8D923DAF9EC4","2013-10-04T08:40:01.000Z","B5F6B397-6AB9-4620-980B-3F1337F5DC95","None","NO",1,NA,"Primary Tumor","Mayo Clinic",618,"0F03C16F-84B8-4777-A327-8D923DAF9EC4",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3845198C-CE52-4BAC-936E-CB1FC79D2176.txt",230,"TCGA-D1-A16X-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","6E19DB42-C247-4736-9204-E279B2C50B37",54,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3845198C-CE52-4BAC-936E-CB1FC79D2176.txt","Alive",NA,"TCGA-D1-A16X","NOT HISPANIC OR LATINO","7ECCB0A6-3CE2-44B7-B5B4-72D2559B7B78",NA,111,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"3A60B134-2B7D-486F-8623-B5EA0555868A","F4723C26-F509-49A0-A017-6266CE3C54D5","UNCID_2209880.4468bb31-bb94-4353-9d13-556d4b8a892a.110420_UNC6-RDR300211_00096_FC_634WMAAXX_8.tar.gz","TCGA-D1-A16X-01A-11",95,0,10,3,5,"TOP",1,15,"TCGA-D1-A16X-01A-01-TS1",94,NA,NA,NA,NA,NA,NA,NA,"NO",111,"TUMOR FREE","Alive",NA,"TCGA-D1-A16X-F20231","TCGA-D1-A16X",1,"D1","A16X","YES","C54.1","8380/3","C54.1","NO","YES",-19799,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",111,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
123684072,122440528,5845596036,"D47C7B74-BB01-4614-B683-652F7130729C.bw","22669a01-21d3-404c-ac19-cf0a6c03bb1d","d47c7b74-bb01-4614-b683-652f7130729c","2016-08-06T03:24:20.422560-05:00","UNCID_2168981.47e8bbd2-fd10-4dc8-882e-cb88ca27338d.130610_UNC14-SN744_0347_BD28NBACXX_3_GATCAG.tar.gz","9e38e9bd-05fe-4257-b5ea-a23fc1d827d9",5691728385,"Illumina HiSeq","175a1ea9fc8cef4c4a09403d3fc70b52","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:03:08.462987-05:00","2016-05-03T10:55:55.601106-05:00","9e38e9bd-05fe-4257-b5ea-a23fc1d827d9_analysis.xml","802a8038f1071d41cb3de62f6b9bbeb1","f38f2342-b5f8-47ed-a3b8-78b66ebd005b",2129,"2016-08-30T03:54:46.588820-05:00","9e38e9bd-05fe-4257-b5ea-a23fc1d827d9_experiment.xml","2fc72f4973a26f03d29e33cc70d31315","63a55e4d-47fe-4183-8557-778d1304948a",2600,"2016-09-29T22:15:23.923369-05:00","9e38e9bd-05fe-4257-b5ea-a23fc1d827d9_run.xml","8e17633ea960ae7bdcf99efa5c1bbbdb","b0c51505-a6fc-409e-8f63-1d0d2598a91c",343,"2016-09-08T10:55:18.363240-05:00","TCGA-PG-A5BC","2016-09-02T18:50:06.277807-05:00","female","TCGA-PG-A5BC_demographic",1940,"black or african american","0feea406-ba2e-5a9f-b989-213d6a3964aa","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","PG","69bd8326-4904-56a0-8230-1615a777173b","Montefiore Medical Center","not reported","c54.1","TCGA-PG-A5BC_diagnosis","not reported",26436,"alive","8441/3",NA,707,"c2f153c2-baf7-5c96-90bb-fc25436f0e97","c54.1",-26436,"TCGA-PG-A5BC_treatment","0efbfe60-a787-5529-a05d-3399466a47a1","01","true","TCGA-PG-A5BC-01A",NA,"0a63bf84-a720-4b8b-8312-4ec59d14982e",FALSE,"040F4583-2683-42A8-B185-56A08874F3A0","Primary Tumor",NA,205,120,NA,1356566400,"12",10,"TCGA-PG-A5BC-01A-12",80,NA,0,NA,0,NA,0,NA,"2016-09-08T10:55:18.363240-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"1d7d81f6-69d9-4348-8f4d-2f801e392fba",NA,"TCGA-PG-A5BC-01A-01-TSA",NA,100,NA,"40af8ad8-5bce-48a8-99ba-bc75134d24f6","RNA","TCGA-PG-A5BC-01A-12R","e38888b3-d14c-403e-9d21-75e552a0b885",1.79,0.18,"UV Spec","R","23","TCGA-PG-A5BC-01A-12R-A27V-07","47e8bbd2-fd10-4dc8-882e-cb88ca27338d",0.18,NA,87,32.7449282998984,163,"e88c8640-fff8-5f71-b5fb-4e12e262b714","TCGA-PG-A5BC_exposure","UNCID_2168981.47e8bbd2-fd10-4dc8-882e-cb88ca27338d.130610_UNC14-SN744_0347_BD28NBACXX_3_GATCAG.tar.gz","2013-08-31T22:26:16.000Z","2013-09-01T00:59:01.000Z","9E38E9BD-05FE-4257-B5EA-A23FC1D827D9","0A63BF84-A720-4B8B-8312-4EC59D14982E","Unaligned reads",5691728385,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","47E8BBD2-FD10-4DC8-882E-CB88CA27338D","University of North Carolina","564a3c67e4b093830b699722","22669A01-21D3-404C-AC19-CF0A6C03BB1D","Uterine Corpus Endometrial Carcinoma","TARGZ","40AF8AD8-5BCE-48A8-99BA-BC75134D24F6","2013-09-01T00:59:01.000Z","E38888B3-D14C-403E-9D21-75E552A0B885","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",205,"40AF8AD8-5BCE-48A8-99BA-BC75134D24F6",NA,"PG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.19F3BEE7-5B36-4114-A3B4-47A3F1BC941E.txt",120,"TCGA-PG-A5BC-01A",NA,NA,"TCGA",2012,"TCGA-PG-A5BC_NTE-1",NA,"TUMOR FREE","1DDB6A9E-1D85-48E4-86E8-C1064CEDC2E6",72,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.19F3BEE7-5B36-4114-A3B4-47A3F1BC941E.txt","Alive",NA,"TCGA-PG-A5BC","NOT HISPANIC OR LATINO","D4C72AD6-A39D-4E56-AB28-AC693324274C","NO",329,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",289,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,12,10,"1D7D81F6-69D9-4348-8F4D-2F801E392FBA","AFD9DE7E-6A33-4160-BF0A-BF4827F73914","b40b06cdbdb0178f16f483380b0880e2.bam.bai","TCGA-PG-A5BC-01A-12",80,0,0,2,0,"TOP",0,0,"TCGA-PG-A5BC-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,"TCGA-PG-A5BC-F59222_NTE-1","NO",707,"TUMOR FREE","Alive",NA,"TCGA-PG-A5BC-F59222","TCGA-PG-A5BC",1,"PG","A5BC","YES","C54.1","8441/3","C54.1","NO","YES",-26436,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",329,NA,"NO","NO","TUMOR FREE","YES",20,5,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,72,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29703848,29427029,2203531275,"65947DEA-8A0D-4180-82DF-DF21895FF368.bw","233e947a-d5e2-48e5-a8ce-5da1abb20681","65947dea-8a0d-4180-82df-df21895ff368","2016-08-09T14:17:10.539802-05:00","UNCID_2214540.39b1ee4d-b57a-44d5-8b14-20b02f878123.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_7.tar.gz","591152da-bdc8-40ff-902b-202373c41cf7",1980395034,"Illumina GA","4275f706f3cc87e388ce829f37d79d22","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:19:42.811673-05:00","2016-05-03T11:17:14.896869-05:00","591152da-bdc8-40ff-902b-202373c41cf7_analysis.xml","ab05e998fc239c85632129e2622fa43c","6906bc4e-8de0-4635-8960-e51a74564766",2120,"2016-08-27T12:49:38.122463-05:00","591152da-bdc8-40ff-902b-202373c41cf7_experiment.xml","b97e6fb070cbbbc8b97f90969a32bb24","3ad9fc97-5942-4bf8-8d50-27bde6d7a07b",2257,"2016-09-30T00:12:00.394227-05:00","591152da-bdc8-40ff-902b-202373c41cf7_run.xml","1318e27ae4516c527b5ad3ccc8f3878c","f8f06475-f8f4-48c5-9ae3-b4e75b547b12",347,"2016-09-08T11:29:07.450757-05:00","TCGA-B5-A0JV","2016-09-02T18:47:57.804711-05:00","female","TCGA-B5-A0JV_demographic",1944,"black or african american","e88ad5a0-3e91-5f6f-a2b5-19a6bc04e25a","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0JV_diagnosis","not reported",23295,"alive","8380/3",NA,2616,"70a965e0-7f44-5ba2-9ae0-b5dbb74d7153","c54.1",-23295,"TCGA-B5-A0JV_treatment","7eaa452e-2be9-5498-865e-0275bd34a32c","01","true","TCGA-B5-A0JV-01A",NA,"42199e5a-9f4f-4445-9e6e-114d47ba67fa",FALSE,"71A1DE5B-7CE5-4884-A91E-3BE753036E4F","Primary Tumor",NA,1001,40,NA,1277251200,"11",30,"TCGA-B5-A0JV-01A-11",70,85,0,0,5,10,25,5,"2016-09-08T11:29:07.450757-05:00","2016-09-08T11:29:07.450757-05:00",30,10,10,10,"TOP","BOTTOM",20,20,"323cb82d-2a86-4366-b7de-78ca47c001bf","9edda9a0-2d77-4a13-89b0-85acb7c165a7","TCGA-B5-A0JV-01A-01-TSA","TCGA-B5-A0JV-01A-01-BSA",50,65,"a3b9e5ea-7f25-4cef-9d15-5ecc50d4c843","RNA","TCGA-B5-A0JV-01A-11R","f4fe664c-cb75-4568-9d4f-aa30d439ec73",1.77,0.15,"UV Spec","R","23","TCGA-B5-A0JV-01A-11R-A104-07","39b1ee4d-b57a-44d5-8b14-20b02f878123",0.15,NA,94,34.1123530265641,166,"ba6cb989-30cf-5ad9-b46c-d98eea024943","TCGA-B5-A0JV_exposure","UNCID_2214540.39b1ee4d-b57a-44d5-8b14-20b02f878123.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_7.tar.gz","2013-10-03T16:56:03.000Z","2013-10-03T17:08:02.000Z","591152DA-BDC8-40FF-902B-202373C41CF7","42199E5A-9F4F-4445-9E6E-114D47BA67FA","Unaligned reads",1980395034,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","39B1EE4D-B57A-44D5-8B14-20B02F878123","University of North Carolina","56607706e4b018727fea10ea","233E947A-D5E2-48E5-A8CE-5DA1ABB20681","Uterine Corpus Endometrial Carcinoma","TARGZ","A3B9E5EA-7F25-4CEF-9D15-5ECC50D4C843","2013-10-03T17:08:02.000Z","F4FE664C-CB75-4568-9D4F-AA30D439EC73","United States","NO",1,NA,"Primary Tumor","Duke",1001,"A3B9E5EA-7F25-4CEF-9D15-5ECC50D4C843",NA,"B5","UNCID_2214540.39b1ee4d-b57a-44d5-8b14-20b02f878123.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_7.tar.gz",40,"TCGA-B5-A0JV-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","9F2AD0C0-34CC-4100-9788-492988A0283B",63,"nationwidechildrens.org_clinical.TCGA-B5-A0JV.xml","Alive",NA,"TCGA-B5-A0JV",NA,"7FAA1D05-4FFF-436E-8DBF-B488DBF4211E",NA,1125,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"18494A76-FF86-479E-83CD-787AAD3F37D0","BLACK OR AFRICAN AMERICAN",NA,11,30,"9EDDA9A0-2D77-4A13-89B0-85ACB7C165A7","F4FE664C-CB75-4568-9D4F-AA30D439EC73","UNCID_2214540.39b1ee4d-b57a-44d5-8b14-20b02f878123.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_7.tar.gz","TCGA-B5-A0JV-01A-11",85,10,0,10,5,"BOTTOM",20,10,"TCGA-B5-A0JV-01A-01-BSA",65,NA,NA,NA,"TCGA-B5-A0JV-R4762","OTHER: SPECIFY IN NOTES","Primary Tumor Field","TCGA-B5-A0JV-F72216_NTE-1","NO",2616,"TUMOR FREE","Alive",NA,"TCGA-B5-A0JV-F72216","TCGA-B5-A0JV",1,"B5","A0JV","YES","C54.1","8380/3","C54.1","NO","YES",-23295,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1125,NA,NA,NA,"TUMOR FREE","NO",10,12,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2007,"Dilation and curettage procedure",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32874059,31348361,2349624128,"C269539F-FDAD-49BD-AB16-C3B7C66E4662.bw","23489245-48d7-4f19-8a42-e23b1181412b","c269539f-fdad-49bd-ab16-c3b7c66e4662","2016-08-05T11:27:27.522756-05:00","UNCID_2214569.e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_3.tar.gz","d702ec08-2d08-4bd1-bfef-8b76c6298494",2053880926,"Illumina GA","5441ba27aa7b5df2845ac0d71bec56fa","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:18:24.186132-05:00","2016-05-03T11:17:14.896869-05:00","d702ec08-2d08-4bd1-bfef-8b76c6298494_analysis.xml","67ebda880dbda51e0e24e303cc41f884","b29b7381-ce4f-4a0b-b2b8-46a30746aa6d",2121,"2016-08-28T04:12:56.937151-05:00","d702ec08-2d08-4bd1-bfef-8b76c6298494_experiment.xml","1df5d663668d0c4f78425b0b580da00a","7999a389-6ac0-4919-91ea-1a894d6f1a8c",2257,"2016-09-29T21:28:29.666029-05:00","d702ec08-2d08-4bd1-bfef-8b76c6298494_run.xml","e50fe00c36615943108c20ddbc9fcef3","93d8fbdc-2c78-48b3-b453-32d4875c7a77",347,"2016-09-08T10:35:40.236794-05:00","TCGA-A5-A0VQ","2016-09-02T18:47:51.498722-05:00","female","TCGA-A5-A0VQ_demographic",1948,"not reported","a1684e59-c0e1-56da-b466-e8365faf08b9","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0VQ_diagnosis","not reported",22995,"alive","8380/3",NA,485,"ba1222b9-d518-5a52-8a8e-a57934b985f1","c54.1",-22995,"TCGA-A5-A0VQ_treatment","6ff4b65e-578e-5226-8c6a-276afbfda6ec","01","true","TCGA-A5-A0VQ-01A",NA,"952cb6a5-7527-470a-978e-edd44e3a368f",FALSE,"6FE81DF0-D9DF-420F-8A91-40421175A12F","Primary Tumor",NA,133,320,NA,1285632000,"11",30,"TCGA-A5-A0VQ-01A-11",90,70,0,0,0,20,10,10,"2016-09-08T10:35:40.236794-05:00","2016-09-08T10:35:40.236794-05:00",10,20,10,10,"TOP","BOTTOM",10,10,"98c682c5-0192-4c14-90aa-99ad80ae3feb","ed5d178c-9d20-4b8c-8600-9de6fef1b83b","TCGA-A5-A0VQ-01A-01-TSA","TCGA-A5-A0VQ-01A-01-BSA",80,60,"80541928-e001-4bf2-8a46-610bf4f0e177","RNA","TCGA-A5-A0VQ-01A-11R","74bc971d-be37-408a-b5d1-d2f9de52c98e",1.88,0.15,"UV Spec","R","23","TCGA-A5-A0VQ-01A-11R-A104-07","e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d",0.15,NA,89,35.6513379266143,158,"2c703da9-e449-5f9e-a2fb-74d325f0b3df","TCGA-A5-A0VQ_exposure","UNCID_2214569.e8b8fe3e-29ff-4f1a-af7a-d12b8cd5560d.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_3.tar.gz","2013-10-03T17:36:06.000Z","2013-10-03T17:49:01.000Z","D702EC08-2D08-4BD1-BFEF-8B76C6298494","952CB6A5-7527-470A-978E-EDD44E3A368F","Unaligned reads",2053880926,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E8B8FE3E-29FF-4F1A-AF7A-D12B8CD5560D","University of North Carolina","564a3438e4b0298dd2c61967","23489245-48D7-4F19-8A42-E23B1181412B","Uterine Corpus Endometrial Carcinoma","TARGZ","80541928-E001-4BF2-8A46-610BF4F0E177","2013-10-03T17:49:02.000Z","74BC971D-BE37-408A-B5D1-D2F9DE52C98E","None","NO",1,NA,"Primary Tumor","Cedars Sinai",133,"80541928-E001-4BF2-8A46-610BF4F0E177",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9E0707C4-CBB5-4AFD-8528-FB9F95EC5A91.txt",320,"TCGA-A5-A0VQ-01A",NA,"E2BDD433-9356-4EC4-86A5-96378B96589A","TCGA",2010,NA,NA,"TUMOR FREE","AE0455A3-3C16-4A66-B282-65C8108A9481",62,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9E0707C4-CBB5-4AFD-8528-FB9F95EC5A91.txt","Alive",NA,"TCGA-A5-A0VQ","HISPANIC OR LATINO","960ECC7E-6F99-4829-BFE4-1E06837B3A51",NA,177,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"3B8180B1-6258-46CA-8DF3-19BA5618AB5C",NA,NA,11,30,"ED5D178C-9D20-4B8C-8600-9DE6FEF1B83B","74BC971D-BE37-408A-B5D1-D2F9DE52C98E","jhu-usc.edu_UCEC.HumanMethylation27.3.lvl-2.TCGA-A5-A0VQ-01A-11D-A10Q-05.txt","TCGA-A5-A0VQ-01A-11",90,0,0,10,10,"TOP",10,10,"TCGA-A5-A0VQ-01A-01-TSA",80,"Carboplatin","Chemotherapy","TCGA-A5-A0VQ-D3376","TCGA-A5-A0VQ-R3377","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",485,"TUMOR FREE","Alive",NA,"TCGA-A5-A0VQ-F17167","TCGA-A5-A0VQ",1,"A5","A0VQ","YES","C54.1","8380/3","C54.1","NO","YES",-22995,"FEMALE",NA,"HISPANIC OR LATINO","No","No","Alive",177,NA,NA,NA,"TUMOR FREE","NO",15,11,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
126980832,123257136,5874933895,"0534B9BB-AA7F-415D-A7C6-DB3B2F7A0863.bw","23e1d96e-6175-4145-8267-8f0a88f54c4d","0534b9bb-aa7f-415d-a7c6-db3b2f7a0863","2016-08-09T13:14:59.574941-05:00","UNCID_2174361.a7a5bc3b-d82d-447d-8679-47b48612834a.130423_UNC11-SN627_0293_AC23BAACXX_1_ATCACG.tar.gz","b385abf8-58e6-4853-b731-4503c229df3c",5585605708,"Illumina HiSeq","b9c544cd52d0a8bff59d41c0530f0ac8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:01:15.289479-05:00","2016-05-03T10:56:47.893137-05:00","b385abf8-58e6-4853-b731-4503c229df3c_analysis.xml","d9f0fc776ef69a3c1f28e6746f9e51dd","386380df-1281-43e7-a23f-7641ae46bc0b",2123,"2016-09-29T20:06:16.167531-05:00","b385abf8-58e6-4853-b731-4503c229df3c_experiment.xml","7b6f920fd351cc1a913cf16dd2214138","60e88710-66e6-4a2c-9db5-2e030a83a413",2431,"2016-09-29T19:09:39.193087-05:00","b385abf8-58e6-4853-b731-4503c229df3c_run.xml","87c5a18a83f5dac8e6e889611ce904cd","3dc12f2a-75cc-47ad-8400-e1ec47f122c7",354,"2016-09-08T10:40:31.702619-05:00","TCGA-AJ-A3EL","2016-09-02T18:48:16.092316-05:00","female","TCGA-AJ-A3EL_demographic",1963,"native hawaiian or other pacific islander","0427721e-1969-585e-96ef-584f2d46f0fc","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3EL_diagnosis","not reported",17442,"alive","8380/3",NA,684,"99f23a7d-b458-552a-b214-67ede6224c8f","c54.1",-17442,"TCGA-AJ-A3EL_treatment","e805f4ce-753c-5b66-9c83-4f12fba5debc","01","false","TCGA-AJ-A3EL-01A",NA,"f82eeaf4-aa1a-422b-b16e-790241eea904",FALSE,"CB5EF343-EDD4-46B1-82DD-48C49FF7E778","Primary Tumor",NA,317,20,NA,1320105600,"11",20,"TCGA-AJ-A3EL-01A-11",85,NA,0,NA,0,NA,10,NA,"2016-09-08T10:40:31.702619-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"0cc3718e-f67a-46cc-9926-5ac056631340",NA,"TCGA-AJ-A3EL-01A-01-TS1",NA,90,NA,"79f3be31-a1fb-4eb1-a2ad-701b51a9b8ce","RNA","TCGA-AJ-A3EL-01A-11R","f6308920-b4d8-4dd5-a458-7c533232a365",1.75,0.18,"UV Spec","R","23","TCGA-AJ-A3EL-01A-11R-A213-07","a7a5bc3b-d82d-447d-8679-47b48612834a",0.18,NA,57,23.7252861602497,155,"473a3a15-c909-5680-be4a-1f72b3b0f9cc","TCGA-AJ-A3EL_exposure","UNCID_2174361.a7a5bc3b-d82d-447d-8679-47b48612834a.130423_UNC11-SN627_0293_AC23BAACXX_1_ATCACG.tar.gz","2013-09-10T08:56:09.000Z","2013-09-10T09:12:01.000Z","B385ABF8-58E6-4853-B731-4503C229DF3C","F82EEAF4-AA1A-422B-B16E-790241EEA904","Unaligned reads",5585605708,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","A7A5BC3B-D82D-447D-8679-47B48612834A","University of North Carolina","56607de7e4b0ca319165066a","23E1D96E-6175-4145-8267-8F0A88F54C4D","Uterine Corpus Endometrial Carcinoma","TARGZ","79F3BE31-A1FB-4EB1-A2AD-701B51A9B8CE","2013-09-10T09:12:01.000Z","F6308920-B4D8-4DD5-A458-7C533232A365","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",317,"79F3BE31-A1FB-4EB1-A2AD-701B51A9B8CE",NA,"AJ","UNCID_2174361.a7a5bc3b-d82d-447d-8679-47b48612834a.130423_UNC11-SN627_0293_AC23BAACXX_1_ATCACG.tar.gz",20,"TCGA-AJ-A3EL-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","F82EEAF4-AA1A-422B-B16E-790241EEA904",47,"nationwidechildrens.org_clinical.TCGA-AJ-A3EL.xml","Alive",NA,"TCGA-AJ-A3EL",NA,"59E27AFA-C880-4EAB-BED1-5EB73C11EC2B",NA,65,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",201,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,11,20,"0CC3718E-F67A-46CC-9926-5AC056631340","F6308920-B4D8-4DD5-A458-7C533232A365","UNCID_2066376.a7a5bc3b-d82d-447d-8679-47b48612834a.sorted_genome_alignments.bam","TCGA-AJ-A3EL-01A-11",85,0,0,0,10,"TOP",0,0,"TCGA-AJ-A3EL-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3EL-F46677_NTE-1","NO",684,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3EL-F46677","TCGA-AJ-A3EL",1,"AJ","A3EL","YES","C54.1","8380/3","C54.1","YES","NO",-17442,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,"No","No","Alive",65,NA,NA,NA,"TUMOR FREE","NO",15,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,47,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
34398207,34015758,2545473096,"55014E93-9FF0-4DBA-98E3-37F0963A8616.bw","24118b8f-59fe-482a-aed3-7b1bde1571b7","55014e93-9ff0-4dba-98e3-37f0963a8616","2016-08-05T07:04:20.648581-05:00","UNCID_2206504.71cdc7a1-4bbb-461c-ab98-34cad8c3a767.110921_UNC2-RDR300275_00086_FC634HAAAXX_3.tar.gz","fcded466-28aa-4f92-bbcd-6f58c6053224",2178226050,"Illumina GA","4802ac26842d3eb130de99a120056687","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:50:46.932533-05:00","2016-05-03T11:11:34.765256-05:00","fcded466-28aa-4f92-bbcd-6f58c6053224_analysis.xml","a9e66fc43a20fd02c5a8c870dfc1307d","7c341929-a9b6-4a13-af0a-57cfb0501584",2119,"2016-09-30T00:16:37.181594-05:00","fcded466-28aa-4f92-bbcd-6f58c6053224_experiment.xml","cd3d97d0bfb3efd2dcaf0b8565877ec5","fbd40dae-58a2-4bfb-a5db-e39bced6a2f8",2257,"2016-09-29T21:59:48.634591-05:00","fcded466-28aa-4f92-bbcd-6f58c6053224_run.xml","825e658aaebfcd10f954cc1997aa0a21","a73e1a10-135f-4590-b08c-c1c114ade737",347,"2016-09-08T10:41:33.734974-05:00","TCGA-B5-A0K8","2016-09-02T18:52:28.718034-05:00","female","TCGA-B5-A0K8_demographic",1938,"white","a44ec5e7-b90f-5892-bdaa-19fe891d1b50","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0K8_diagnosis","not reported",25992,"alive","8441/3",NA,847,"47d73528-9f12-5d55-9afb-eb467c56f0bb","c54.1",-25992,"TCGA-B5-A0K8_treatment","5d24a41d-346a-50e7-bbf8-65e21c19272c","01","true","TCGA-B5-A0K8-01A",NA,"66184035-af3e-4c2b-901a-0709c49dc54e",FALSE,"1E7C9CA2-73AA-4443-A125-D5588F93BEF9","Primary Tumor",NA,191,260,NA,1277424000,"11",30,"TCGA-B5-A0K8-01A-11",90,70,0,0,0,0,10,30,"2016-09-08T10:41:33.734974-05:00","2016-09-08T10:41:33.734974-05:00",10,10,0,0,"BOTTOM","TOP",10,10,"de390c6e-0914-4d9e-8819-f2b80a8262f4","195413a2-6bad-4766-94e6-de0efeabb0c3","TCGA-B5-A0K8-01A-01-BSA","TCGA-B5-A0K8-01A-01-TSA",80,60,"b0c32eec-6008-4dd4-94a8-8e3309085a4f","RNA","TCGA-B5-A0K8-01A-11R","b8317b8c-892e-470e-97b6-45fabb957157",1.78,0.13,"UV Spec","R","23","TCGA-B5-A0K8-01A-11R-A14M-07","71cdc7a1-4bbb-461c-ab98-34cad8c3a767",0.13,NA,61,23.828125,160,"3f246748-70da-5b1b-a340-9fd2a322aa18","TCGA-B5-A0K8_exposure","UNCID_2206504.71cdc7a1-4bbb-461c-ab98-34cad8c3a767.110921_UNC2-RDR300275_00086_FC634HAAAXX_3.tar.gz","2013-09-27T05:46:07.000Z","2013-09-27T05:58:02.000Z","FCDED466-28AA-4F92-BBCD-6F58C6053224","66184035-AF3E-4C2B-901A-0709C49DC54E","Unaligned reads",2178226050,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","71CDC7A1-4BBB-461C-AB98-34CAD8C3A767","University of North Carolina","564a4105e4b093830b6b13ae","24118B8F-59FE-482A-AED3-7B1BDE1571B7","Uterine Corpus Endometrial Carcinoma","TARGZ","B0C32EEC-6008-4DD4-94A8-8E3309085A4F","2013-09-27T05:58:02.000Z","B8317B8C-892E-470E-97B6-45FABB957157","United States","NO",1,NA,"Primary Tumor","Duke",191,"B0C32EEC-6008-4DD4-94A8-8E3309085A4F",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FDF53DCD-50F1-4C8A-83A2-FA68972DDA16.txt",260,"TCGA-B5-A0K8-01A",NA,"8065962E-F6EE-43E7-B949-BCBD53A3203A","TCGA",2009,NA,NA,"TUMOR FREE","66184035-AF3E-4C2B-901A-0709C49DC54E",71,"nationwidechildrens.org_clinical.TCGA-B5-A0K8.xml","Alive",NA,"TCGA-B5-A0K8",NA,"0F60B8E7-C747-4F3C-A841-EF5C72314317",NA,543,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",125,NA,NA,"WHITE",NA,11,30,"DE390C6E-0914-4D9E-8819-F2B80A8262F4","FB78391D-4CD7-431B-9D3E-F40EECF375CE","UNCID_568682.71cdc7a1-4bbb-461c-ab98-34cad8c3a767.110921_UNC2-RDR300275_00086_FC634HAAAXX.3.trimmed.annotated.translated_to_genomic.bam","TCGA-B5-A0K8-01A-11",70,0,0,10,30,"TOP",10,0,"TCGA-B5-A0K8-01A-01-TSA",60,"Carboplatin","Chemotherapy","TCGA-B5-A0K8-D14631",NA,NA,NA,NA,"NO",847,"TUMOR FREE","Alive",NA,"TCGA-B5-A0K8-F32705","TCGA-B5-A0K8",1,"B5","A0K8","YES","C54.1","8441/3","C54.1","NO","YES",-25992,"FEMALE","WHITE",NA,"No","No","Alive",543,NA,NA,NA,"TUMOR FREE","NO",5,8,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,71,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31356161,29019577,2184997707,"81A1567C-ACC1-4DE7-A7F5-257DCAF2EEA7.bw","24434832-46fc-485a-9ff4-2aa95c3d3936","81a1567c-acc1-4de7-a7f5-257dcaf2eea7","2016-08-05T16:02:14.781349-05:00","UNCID_2209562.dcd43fa2-2529-47e6-9d9f-931cbf8d4da5.110509_UNC2-RDR300275_00065_FC_634Y5AAXX_2.tar.gz","f48b3453-22ed-459e-98ad-e6f6a4da08d1",2029187649,"Illumina GA","4d09aa0c10a6b6ae72c51b153d07d9a3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:55:33.157281-05:00","2016-05-03T11:15:06.073526-05:00","f48b3453-22ed-459e-98ad-e6f6a4da08d1_analysis.xml","591fad40cd15d9ffe180a402b3eccec4","0f249b0f-19e7-431d-801f-737cc77b2113",2120,"2016-09-29T18:53:29.590776-05:00","f48b3453-22ed-459e-98ad-e6f6a4da08d1_experiment.xml","c4f3b6410797834ecf3887bde8f37076","339323b8-98fc-4b9e-ad28-72c93918d7a0",2261,"2016-09-29T21:24:50.371947-05:00","f48b3453-22ed-459e-98ad-e6f6a4da08d1_run.xml","939f89cf740947290bebba0213f9f2d1","918a4d51-38df-40b6-adbe-47097c9d9c67",351,"2016-09-08T10:27:49.590512-05:00","TCGA-D1-A17S","2016-09-02T18:50:44.698853-05:00","female","TCGA-D1-A17S_demographic",1950,"white","b85bd397-ef0d-53ff-a97e-1078fd412234","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17S_diagnosis","not reported",21794,"alive","8380/3",NA,739,"9aac47c0-49ae-5dc3-963a-a75f57f52e1d","c54.1",-21794,"TCGA-D1-A17S_treatment","491783be-d724-5305-bb44-aa53c2d2f7cd","01","false","TCGA-D1-A17S-01A",NA,"5f4de8f1-b75f-4a53-9b4d-6a2f5422d6ca",FALSE,"54337BED-9366-4CB6-BA95-BB5999CBF342","Primary Tumor",NA,419,280,NA,1294358400,"11",30,"TCGA-D1-A17S-01A-11",90,NA,0,NA,0,NA,0,NA,"2016-09-08T10:27:49.590512-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"c9fa012c-3785-4f79-9294-d9501d5c722e",NA,"TCGA-D1-A17S-01A-01-TSA",NA,100,NA,"f55f98f2-7c75-403e-be32-43b08e5c2774","RNA","TCGA-D1-A17S-01A-11R","a29659b2-7eb6-4d6f-9f58-4813e5b619e0",1.73,0.17,"UV Spec","R","23","TCGA-D1-A17S-01A-11R-A12I-07","dcd43fa2-2529-47e6-9d9f-931cbf8d4da5",0.17,NA,109,42.578125,160,"89feeb90-6c29-56c6-ae4c-0aaa2078987d","TCGA-D1-A17S_exposure","UNCID_2209562.dcd43fa2-2529-47e6-9d9f-931cbf8d4da5.110509_UNC2-RDR300275_00065_FC_634Y5AAXX_2.tar.gz","2013-10-01T09:13:05.000Z","2013-10-01T09:25:02.000Z","F48B3453-22ED-459E-98AD-E6F6A4DA08D1","5F4DE8F1-B75F-4A53-9B4D-6A2F5422D6CA","Unaligned reads",2029187649,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","DCD43FA2-2529-47E6-9D9F-931CBF8D4DA5","University of North Carolina","564a378de4b0298dd2c72bc6","24434832-46FC-485A-9FF4-2AA95C3D3936","Uterine Corpus Endometrial Carcinoma","TARGZ","F55F98F2-7C75-403E-BE32-43B08E5C2774","2013-10-01T09:25:02.000Z","A29659B2-7EB6-4D6F-9F58-4813E5B619E0","None","NO",1,NA,"Primary Tumor","Mayo Clinic",419,"F55F98F2-7C75-403E-BE32-43B08E5C2774",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3A7C1301-5B80-4043-97F5-99E5B02456A1.txt",280,"TCGA-D1-A17S-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","9D8512B9-05C0-41AF-B7A5-D5C6F23CF90A",59,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3A7C1301-5B80-4043-97F5-99E5B02456A1.txt","Alive",NA,"TCGA-D1-A17S","NOT HISPANIC OR LATINO","9C13CC04-C9C2-4EBC-88DB-69049BCD8AB4",NA,326,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"C9FA012C-3785-4F79-9294-D9501D5C722E","A29659B2-7EB6-4D6F-9F58-4813E5B619E0","TCGA-D1-A17S-01A-11D-A12J-09_IlluminaGA-DNASeq_exome.bam","TCGA-D1-A17S-01A-11",90,0,0,0,0,"TOP",0,0,"TCGA-D1-A17S-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",739,"TUMOR FREE","Alive",NA,"TCGA-D1-A17S-F20288","TCGA-D1-A17S",1,"D1","A17S","YES","C54.1","8380/3","C54.1","NO","YES",-21794,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",326,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
27191939,26835517,1953723014,"6BF28F22-A2BF-486D-B823-4DFF86B8A97C.bw","25e7d9d6-7381-40e1-b7ed-1d8c936b7c5c","6bf28f22-a2bf-486d-b823-4dff86b8a97c","2016-08-09T14:10:51.835481-05:00","UNCID_2203687.2aef2acc-a065-4196-a278-1c1ce689e689.111103_UNC6-RDR300211_00130_FC_638P5AAXX_8.tar.gz","51878ea9-16b9-4d7a-a4f2-57bb3e0ee068",1766552469,"Illumina GA","16c1f31d8cc5b40a5e60de114244ee95","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:00:27.443599-05:00","2016-05-03T11:10:47.515830-05:00","51878ea9-16b9-4d7a-a4f2-57bb3e0ee068_analysis.xml","9ff70033e710df6e81bfcf3eb892aa58","123f6902-fc44-4cb7-9ba3-301fd79cc77e",2121,"2016-10-07T15:49:08.765442-05:00","51878ea9-16b9-4d7a-a4f2-57bb3e0ee068_experiment.xml","37ba242ca2061440054d1db9e44118c9","a9fb2220-5236-4693-97c0-16aa186838e5",2257,"2016-09-30T00:02:40.426088-05:00","51878ea9-16b9-4d7a-a4f2-57bb3e0ee068_run.xml","369d6b938522a68a8e1b1fce1823e48a","f340ec46-fc65-45ec-bb36-95b18587bcb7",347,"2016-09-08T11:06:18.756294-05:00","TCGA-FI-A2F9","2016-09-02T18:53:00.829167-05:00","female","TCGA-FI-A2F9_demographic",1930,"white","b66db2b7-1f4f-5998-bc30-50af2b0a5309","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2F9_diagnosis","not reported",28886,"alive","8380/3",NA,1803,"ff559877-2c95-5ed7-822e-73243281e99f","c54.1",-28886,"TCGA-FI-A2F9_treatment","5403b64c-e62d-582b-be76-64325085a36d","01","true","TCGA-FI-A2F9-01A",NA,"d62280fd-4b51-4ec9-9ddc-1aa04f6578f3",FALSE,"5D03E085-0588-47A8-8B1C-E243D8127325","Primary Tumor",NA,709,60,NA,1308268800,"11",30,"TCGA-FI-A2F9-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T11:06:18.756294-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"0a372772-5768-4f60-8f3b-31d785317358",NA,"TCGA-FI-A2F9-01A-01-TS1",NA,90,NA,"a8ce39e3-f15c-42b9-8984-7bdd1aa6549c","RNA","TCGA-FI-A2F9-01A-11R","e21a71b2-6b4e-4104-bfe1-0db9db29e8f2",1.78,0.16,"UV Spec","R","23","TCGA-FI-A2F9-01A-11R-A17B-07","2aef2acc-a065-4196-a278-1c1ce689e689",0.16,NA,99,32.3265306122449,175,"5c30bd44-6542-5a9a-8576-3ceb40638f69","TCGA-FI-A2F9_exposure","UNCID_2203687.2aef2acc-a065-4196-a278-1c1ce689e689.111103_UNC6-RDR300211_00130_FC_638P5AAXX_8.tar.gz","2013-09-26T16:06:05.000Z","2013-09-26T16:18:01.000Z","51878EA9-16B9-4D7A-A4F2-57BB3E0EE068","D62280FD-4B51-4EC9-9DDC-1AA04F6578F3","Unaligned reads",1766552469,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2AEF2ACC-A065-4196-A278-1C1CE689E689","University of North Carolina","56607a45e4b016715ab6a85d","25E7D9D6-7381-40E1-B7ED-1D8C936B7C5C","Uterine Corpus Endometrial Carcinoma","TARGZ","A8CE39E3-F15C-42B9-8984-7BDD1AA6549C","2013-09-26T16:18:02.000Z","E21A71B2-6B4E-4104-BFE1-0DB9DB29E8F2","United States","NO",1,NA,"Primary Tumor","Washington University",709,"A8CE39E3-F15C-42B9-8984-7BDD1AA6549C",NA,"FI","TCGA-FI-A2F9-01A-11R-A17A-13_mirna.bam",60,"TCGA-FI-A2F9-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","D62280FD-4B51-4EC9-9DDC-1AA04F6578F3",79,"nationwidechildrens.org_clinical.TCGA-FI-A2F9.xml","Alive",NA,"TCGA-FI-A2F9","NOT HISPANIC OR LATINO","A9641960-A912-4815-BC78-511201617310",NA,791,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,"4D5F335D-8CA0-4DBB-9E3E-0A81053CBD52","WHITE",NA,11,30,"0A372772-5768-4F60-8F3B-31D785317358","2D4E49B2-B5E3-4CCC-8F67-E2C8516FA6F7","TCGA-FI-A2F9-01A-11R-A17A-13_mirna.bam","TCGA-FI-A2F9-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-FI-A2F9-01A-01-TS1",90,NA,NA,NA,"TCGA-FI-A2F9-R31817","IMPLANTS","Primary Tumor Field","TCGA-FI-A2F9-F71672_NTE-1","NO",1803,"TUMOR FREE","Alive",NA,"TCGA-FI-A2F9-F71672","TCGA-FI-A2F9",1,"FI","A2F9","YES","C54.1","8380/3","C54.1","NO","YES",-28886,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",791,NA,NA,NA,"TUMOR FREE","NO",28,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,79,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31591146,31304262,2349037929,"8775E227-ECFD-4C3D-AD35-A0567B55D13D.bw","2714af93-e200-4b4a-9df8-7d837b37489f","8775e227-ecfd-4c3d-ad35-a0567b55d13d","2016-08-05T22:24:14.881979-05:00","UNCID_2207195.a5a45936-135b-499e-a0bb-7c2d992ef962.110719_UNC2-RDR300275_00077_FC_70KATAAXX_8.tar.gz","d71777a7-ffcb-4557-96ec-d00da76268af",1949806678,"Illumina GA","5c87197a78b10fd3ade18f42735b70ad","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:50:21.306010-05:00","2016-05-03T11:13:42.375045-05:00","d71777a7-ffcb-4557-96ec-d00da76268af_analysis.xml","1c7a9920d038a683c093a78ccdf2915b","0be3f535-80a5-487d-9542-3e27c05ba216",2121,"2016-09-29T20:54:38.328796-05:00","d71777a7-ffcb-4557-96ec-d00da76268af_experiment.xml","61c843ee8e4f211fdb11787cf30e5e01","7ea33d8a-3396-4b4d-871f-1a137feefcb1",2257,"2016-09-29T20:53:43.732080-05:00","d71777a7-ffcb-4557-96ec-d00da76268af_run.xml","212789f1797581bc211c4b277cfb3bac","7e1031d5-401d-4001-963f-c32d202c5b2b",347,"2016-09-08T11:05:39.569529-05:00","TCGA-AX-A1C9","2016-09-02T18:51:39.005638-05:00","female","TCGA-AX-A1C9_demographic",1936,"white","97f38906-f4fd-584b-9a15-679d55409e68","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1C9_diagnosis","not reported",26903,"alive","8380/3",NA,802,"22b7a7e7-adde-5ac9-9f96-19c6f2c6128a","c54.1",-26903,"TCGA-AX-A1C9_treatment","0a758b1f-d674-525d-a6ce-421ae5ed0567","01","false","TCGA-AX-A1C9-01A",NA,"227cdca5-931d-4cda-a885-8e3aeb874d99",FALSE,"54E63A5C-C0E4-408B-9911-CE822CECD362","Primary Tumor",NA,521,110,NA,1295308800,"11",30,"TCGA-AX-A1C9-01A-11",80,NA,0,NA,0,NA,10,NA,"2016-09-08T11:05:39.569529-05:00",NA,8,NA,6,NA,"TOP",NA,1,NA,"3053cc89-aa91-4041-acc6-dc1435041f79",NA,"TCGA-AX-A1C9-01A-01-TS1",NA,89,NA,"49ad18f5-096a-42da-8832-27431259f97c","RNA","TCGA-AX-A1C9-01A-11R","2bc2e234-441b-4e78-84b0-be601c2f3246",1.91,0.17,"UV Spec","R","23","TCGA-AX-A1C9-01A-11R-A137-07","a5a45936-135b-499e-a0bb-7c2d992ef962",0.17,NA,73,31.5962603878116,152,"3be60701-b63b-513f-9811-57f5182b88e0","TCGA-AX-A1C9_exposure","UNCID_2207195.a5a45936-135b-499e-a0bb-7c2d992ef962.110719_UNC2-RDR300275_00077_FC_70KATAAXX_8.tar.gz","2013-09-29T17:31:03.000Z","2013-09-29T17:44:02.000Z","D71777A7-FFCB-4557-96EC-D00DA76268AF","227CDCA5-931D-4CDA-A885-8E3AEB874D99","Unaligned reads",1949806678,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A5A45936-135B-499E-A0BB-7C2D992EF962","University of North Carolina","56607685e4b018727fea0c37","2714AF93-E200-4B4A-9DF8-7D837B37489F","Uterine Corpus Endometrial Carcinoma","TARGZ","49AD18F5-096A-42DA-8832-27431259F97C","2013-09-29T17:44:02.000Z","2BC2E234-441B-4E78-84B0-BE601C2F3246","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",521,"49AD18F5-096A-42DA-8832-27431259F97C",NA,"AX","UNCID_1624841.a5a45936-135b-499e-a0bb-7c2d992ef962.sorted_genome_alignments.bam",110,"TCGA-AX-A1C9-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","9733477C-87FE-450F-ADB4-32050A78377E",73,"nationwidechildrens.org_clinical.TCGA-AX-A1C9.xml","Alive",NA,"TCGA-AX-A1C9","NOT HISPANIC OR LATINO","476B802B-9308-45CC-88CD-370E2A6E5470",NA,464,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"3053CC89-AA91-4041-ACC6-DC1435041F79","A44BA353-6D63-4FB2-AA7B-864FB7CBEB3D","UNCID_510165.TCGA-AX-A1C9-01A-11R-A137-07.110719_UNC2-RDR300275_00077_FC_70KATAAXX.8.trimmed.annotated.translated_to_genomic.exon.quantification.txt","TCGA-AX-A1C9-01A-11",80,0,0,8,10,"TOP",1,6,"TCGA-AX-A1C9-01A-01-TS1",89,NA,NA,NA,NA,NA,NA,NA,NA,464,"TUMOR FREE","Alive",NA,"TCGA-AX-A1C9-F10350","TCGA-AX-A1C9",1,"AX","A1C9","YES","C54.1","8380/3","C54.1","NO","YES",-26903,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",464,NA,NA,NA,"TUMOR FREE","NO",10,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31495915,31030414,2316091376,"164E155E-179F-4E64-A85C-2D9C88CBCA82.bw","282ddc43-922d-4f1f-80c7-6ba2de23b7bc","164e155e-179f-4e64-a85c-2d9c88cbca82","2016-08-09T14:17:05.349083-05:00","UNCID_2214567.cf1bf8d7-3971-4919-93ef-2ef85b3dc61d.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_7.tar.gz","20a8dc42-866d-4605-8bf2-75b6726e850c",1945563654,"Illumina GA","61096410de67629643cca6b3a4b91113","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:48:50.696438-05:00","2016-05-03T11:17:14.896869-05:00","20a8dc42-866d-4605-8bf2-75b6726e850c_analysis.xml","8bcb727af7438d0308239c4d8bca578e","5638343e-39a2-451b-a860-2248a2406dff",2121,"2016-09-29T23:08:07.094866-05:00","20a8dc42-866d-4605-8bf2-75b6726e850c_experiment.xml","5b021577ec695d338255826dbb6d73bc","d16d756d-a109-44a7-86a3-ef71065e23f0",2257,"2016-09-29T22:22:20.609749-05:00","20a8dc42-866d-4605-8bf2-75b6726e850c_run.xml","9271be0f606aa89257270bedf35bd262","b4ee0ac4-c05d-4a04-ab94-ae30603fd3b0",347,"2016-09-08T11:11:38.982278-05:00","TCGA-BS-A0U7","2016-09-02T18:48:26.642770-05:00","female","TCGA-BS-A0U7_demographic",1940,"white","4a0c54c1-ff0b-5393-b614-c022bb0a0ace","not hispanic or latino",2005,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0U7_diagnosis","not reported",23166,"dead","8380/3",935,NA,"fb3b9f51-ed44-507f-b588-e6080170cedf","c54.1",-23166,"TCGA-BS-A0U7_treatment","b9e5f331-24ec-5b4d-87ea-640d24b17ef0","01","false","TCGA-BS-A0U7-01A",NA,"803c6d51-0eba-475a-9c3c-7b3401787907",FALSE,"BE83021F-D4D5-4ECA-8484-8A37B2FE67C0","Primary Tumor",NA,2466,190,NA,1285804800,"21",30,"TCGA-BS-A0U7-01A-21",80,80,20,10,0,0,15,15,"2016-09-08T11:11:38.982278-05:00","2016-09-08T11:11:38.982278-05:00",30,30,40,40,"TOP","BOTTOM",5,5,"4dcaa447-1ca4-408e-969d-3f1064c1cc45","b12f3b4c-40d9-43b8-ab29-84295ed11fda","TCGA-BS-A0U7-01A-02-TSB","TCGA-BS-A0U7-01A-02-BSB",80,80,"22839ec3-102f-4651-8fc9-3f1b0cb21553","RNA","TCGA-BS-A0U7-01A-21R","b96b6d73-476d-4c95-a281-b30a829b0630",1.75,0.16,"UV Spec","R","23","TCGA-BS-A0U7-01A-21R-A104-07","cf1bf8d7-3971-4919-93ef-2ef85b3dc61d",0.16,NA,66,24.2424242424242,165,"5ddc200a-7101-59e9-a9a0-5f46406544f9","TCGA-BS-A0U7_exposure","UNCID_2214567.cf1bf8d7-3971-4919-93ef-2ef85b3dc61d.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_7.tar.gz","2013-10-03T17:31:03.000Z","2013-10-03T17:49:01.000Z","20A8DC42-866D-4605-8BF2-75B6726E850C","803C6D51-0EBA-475A-9C3C-7B3401787907","Unaligned reads",1945563654,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CF1BF8D7-3971-4919-93EF-2EF85B3DC61D","University of North Carolina","564a3d5de4b0298dd2c90a45","282DDC43-922D-4F1F-80C7-6BA2DE23B7BC","Uterine Corpus Endometrial Carcinoma","TARGZ","22839EC3-102F-4651-8FC9-3F1B0CB21553","2013-10-03T17:49:02.000Z","B96B6D73-476D-4C95-A281-B30A829B0630","None","NO",1,NA,"Primary Tumor","University of Hawaii",2466,"22839EC3-102F-4651-8FC9-3F1B0CB21553",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.D35AAF56-A418-4154-BF07-5E0F655276D1.txt",190,"TCGA-BS-A0U7-01A",NA,NA,"TCGA",2003,NA,NA,"TUMOR FREE","9D663867-F946-46AA-B126-959232A2E855",63,"nationwidechildrens.org_clinical.TCGA-BS-A0U7.xml","Dead",935,"TCGA-BS-A0U7","NOT HISPANIC OR LATINO","C5886896-2D0C-4F81-847F-DDDE97E17D08",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,21,30,"B12F3B4C-40D9-43B8-AB29-84295ED11FDA","D0AF28AD-7344-4061-9980-3A5AB73AF3D3","UNCID_362798.TCGA-BS-A0U7-01A-21R-A104-07.110208_UNC2-RDR300275_00049_FC_62J3VAAXX.7.trimmed.annotated.translated_to_genomic.bam","TCGA-BS-A0U7-01A-21",80,0,20,30,15,"TOP",5,40,"TCGA-BS-A0U7-01A-02-TSB",80,NA,NA,NA,NA,NA,NA,NA,"NO",NA,"TUMOR FREE","Dead",935,"TCGA-BS-A0U7-F16698","TCGA-BS-A0U7",1,"BS","A0U7","YES","C54.1","8380/3","C54.1","NO","YES",-23166,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,935,NA,NA,"TUMOR FREE","NO",25,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2003,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29644968,28952400,2180493355,"4D9B6519-2084-4FA7-8199-7AFFC2CE9579.bw","284174fd-1320-4617-9e99-75bd75df9bf3","4d9b6519-2084-4fa7-8199-7affc2ce9579","2016-08-09T14:16:45.767693-05:00","UNCID_2214431.d4ab800e-e0c4-40ae-8256-7271d22d1470.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_3.tar.gz","5d7abf9c-a28d-4e82-946e-c3b61b19e546",1952682985,"Illumina GA","deb891fe4a338f0383b07a3e8da2254a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:14:14.474900-05:00","2016-05-03T11:17:14.896869-05:00","5d7abf9c-a28d-4e82-946e-c3b61b19e546_analysis.xml","d02c6af294b74c4fedf28e46de6b5a7d","d5496a8c-ca08-44ee-9cb4-de63e0c3f75f",2121,"2016-08-26T07:23:27.885244-05:00","5d7abf9c-a28d-4e82-946e-c3b61b19e546_experiment.xml","4a971c32bc0bd9141c52a186036f28e1","272d3d36-0c42-477f-b8eb-72954a664788",2257,"2016-09-29T18:29:25.870903-05:00","5d7abf9c-a28d-4e82-946e-c3b61b19e546_run.xml","97653f17f2a94a18251bd181b8a8b0d7","244fef32-5143-4bee-9d08-3b0c7938854f",347,"2016-09-08T12:04:44.608945-05:00","TCGA-A5-A0R9","2016-09-02T18:47:49.450744-05:00","female","TCGA-A5-A0R9_demographic",1958,"white","e1dc80db-4a53-5b1c-9d21-5577d2a116db","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0R9_diagnosis","not reported",18982,"alive","8380/3",NA,749,"c1a50eaf-8bbe-5be7-b81e-efb5e1921af2","c54.1",-18982,"TCGA-A5-A0R9_treatment","339de67c-c87f-5567-8418-61f2d754ece7","01","true","TCGA-A5-A0R9-01A",NA,"986ac6ac-087f-412b-bb0c-9be10d104989",FALSE,"0AAD58D4-7865-4235-AE18-8685DC5F4FE1","Primary Tumor",NA,471,270,NA,1282608000,"11",30,"TCGA-A5-A0R9-01A-11",95,98,0,0,0,0,5,0,"2016-09-08T12:04:44.608945-05:00","2016-09-08T12:04:44.608945-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"726730b2-c031-484f-983f-31459814b896","0e41ca6e-6334-4f76-819b-400649cbaf08","TCGA-A5-A0R9-01A-01-BSA","TCGA-A5-A0R9-01A-01-TSA",95,100,"1436aff8-872d-459c-bf4e-a3349130331b","RNA","TCGA-A5-A0R9-01A-11R","005001c8-0bd5-49ed-8c86-30b8a3765ed0",1.81,0.16,"UV Spec","R","23","TCGA-A5-A0R9-01A-11R-A104-07","d4ab800e-e0c4-40ae-8256-7271d22d1470",0.16,NA,145,54.5748804998306,163,"0d99fb9b-4664-57eb-ac00-ed3f48bf8905","TCGA-A5-A0R9_exposure","UNCID_2214431.d4ab800e-e0c4-40ae-8256-7271d22d1470.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_3.tar.gz","2013-10-03T15:55:04.000Z","2013-10-03T16:07:02.000Z","5D7ABF9C-A28D-4E82-946E-C3B61B19E546","986AC6AC-087F-412B-BB0C-9BE10D104989","Unaligned reads",1952682985,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","D4AB800E-E0C4-40AE-8256-7271D22D1470","University of North Carolina","564a36b0e4b09c884b22ecc5","284174FD-1320-4617-9E99-75BD75DF9BF3","Uterine Corpus Endometrial Carcinoma","TARGZ","1436AFF8-872D-459C-BF4E-A3349130331B","2013-10-03T16:07:02.000Z","005001C8-0BD5-49ED-8C86-30B8A3765ED0","None","NO",1,NA,"Primary Tumor","Cedars Sinai",471,"1436AFF8-872D-459C-BF4E-A3349130331B",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3B00EFD8-7548-464C-879B-67DA5D69F15C.txt",270,"TCGA-A5-A0R9-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","A1B31C24-B03A-4305-89DE-5E1EE65405E6",51,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3B00EFD8-7548-464C-879B-67DA5D69F15C.txt","Alive",NA,"TCGA-A5-A0R9","NOT HISPANIC OR LATINO","F1D7DF43-B421-4C98-AF7A-02AEEA2C0CAE",NA,294,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"8937842E-0220-460C-9041-3196F24DA0A8","WHITE",NA,11,30,"726730B2-C031-484F-983F-31459814B896","913A10B1-7108-46A2-9D3B-DA8A375A06D3","UNCID_362818.TCGA-A5-A0R9-01A-11R-A104-07.110208_UNC3-RDR300156_00070_FC_62J3NAAXX.3.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-A5-A0R9-01A-11",98,0,0,0,0,"TOP",0,0,"TCGA-A5-A0R9-01A-01-TSA",100,NA,NA,NA,"TCGA-A5-A0R9-R5844","IMPLANTS","Primary Tumor Field",NA,"NO",749,"TUMOR FREE","Alive",NA,"TCGA-A5-A0R9-F17161","TCGA-A5-A0R9",1,"A5","A0R9","YES","C54.1","8380/3","C54.1","NO","YES",-18982,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",294,NA,NA,NA,"TUMOR FREE","NO",7,1,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,51,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1995",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
25778487,25501566,1788248557,"A57E6132-9B76-493A-A167-8462263B7CDB.bw","286c112d-7b73-40a1-b23c-99911388fdef","a57e6132-9b76-493a-a167-8462263b7cdb","2016-08-09T14:03:10.927437-05:00","UNCID_2194939.56fa9065-a4cd-435b-941b-d4507aef815b.120306_UNC6-RDR300211_00136_FC_650PFAAXX_1.tar.gz","a2a22a36-e7f6-4198-a220-a7d8722cc709",1626390752,"Illumina GA","ca20c7515162f67261ddfd21665c84ec","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:57:29.651927-05:00","2016-05-03T11:07:49.533775-05:00","a2a22a36-e7f6-4198-a220-a7d8722cc709_analysis.xml","ab0b5ccffbd3898e888560f5afa29ecb","cac44a3e-7c51-4422-9e52-c1771eea8a19",2121,"2016-08-13T05:40:28.826539-05:00","a2a22a36-e7f6-4198-a220-a7d8722cc709_experiment.xml","2b3dbf7e0731b14e721ad7a3edcd5740","c6d2410a-41ad-4676-9e5c-3aa3f19c3998",2257,"2016-09-29T21:27:35.549808-05:00","a2a22a36-e7f6-4198-a220-a7d8722cc709_run.xml","dbc556d5bbc31aff1da825fa86e1af6c","93474d9c-27b3-4533-8f47-f1fb51418a72",347,"2016-09-08T11:16:08.534860-05:00","TCGA-A5-A1OF","2016-09-02T18:52:08.327625-05:00","female","TCGA-A5-A1OF_demographic",1963,"not reported","914f33d3-f471-5217-ab80-a340b1a61a93","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A1OF_diagnosis","not reported",17308,"alive","8441/3",NA,973,"650ef48f-88b9-5e34-a7e6-b86c220ce3d0","c54.1",-17308,"TCGA-A5-A1OF_treatment","5c56574b-b9b5-5411-9463-bd91887e65d0","01","true","TCGA-A5-A1OF-01A",NA,"68c51551-232a-4adc-a0a0-fcecd7125f59",FALSE,"C0A753A3-5202-4DD2-948E-2921AFBCB3BC","Primary Tumor",NA,128,210,NA,1300406400,"11",30,"TCGA-A5-A1OF-01A-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T11:16:08.534860-05:00",NA,30,NA,10,NA,"TOP",NA,20,NA,"50ac8957-bfc0-44e4-b78c-d9e320d7d24e",NA,"TCGA-A5-A1OF-01A-01-TS1",NA,70,NA,"d597d39e-0392-465a-abdc-2c5b582e6a70","RNA","TCGA-A5-A1OF-01A-11R","0fe4da29-648e-4f66-8b85-cf817360ecc3",1.79,0.17,"UV Spec","R","23","TCGA-A5-A1OF-01A-11R-A14D-07","56fa9065-a4cd-435b-941b-d4507aef815b",0.17,NA,70,29.1363163371488,155,"6032a121-a8ac-597b-9f1e-a30b6ae41c99","TCGA-A5-A1OF_exposure","UNCID_2194939.56fa9065-a4cd-435b-941b-d4507aef815b.120306_UNC6-RDR300211_00136_FC_650PFAAXX_1.tar.gz","2013-09-23T04:56:06.000Z","2013-09-23T05:08:01.000Z","A2A22A36-E7F6-4198-A220-A7D8722CC709","68C51551-232A-4ADC-A0A0-FCECD7125F59","Unaligned reads",1626390752,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","56FA9065-A4CD-435B-941B-D4507AEF815B","University of North Carolina","56607d7ce4b0ca31916504c8","286C112D-7B73-40A1-B23C-99911388FDEF","Uterine Corpus Endometrial Carcinoma","TARGZ","D597D39E-0392-465A-ABDC-2C5B582E6A70","2013-09-23T05:08:01.000Z","0FE4DA29-648E-4F66-8B85-CF817360ECC3","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",128,"D597D39E-0392-465A-ABDC-2C5B582E6A70",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3992BB1A-39A7-456D-B706-8AD7048A3EFB.txt",210,"TCGA-A5-A1OF-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","D6244520-E870-457D-AC40-EF103FA92B43",47,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3992BB1A-39A7-456D-B706-8AD7048A3EFB.txt","Alive",NA,"TCGA-A5-A1OF","HISPANIC OR LATINO","FD6CE3EF-F604-4DE6-9118-060143237472",NA,241,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",121,NA,"A75412C0-398E-4C63-B746-FBF079578567",NA,NA,11,30,"50AC8957-BFC0-44E4-B78C-D9E320D7D24E","AE7AE28B-89FF-4F95-9401-7B53C9DD4E75","UNCID_2194939.56fa9065-a4cd-435b-941b-d4507aef815b.120306_UNC6-RDR300211_00136_FC_650PFAAXX_1.tar.gz","TCGA-A5-A1OF-01A-11",90,0,0,30,10,"TOP",20,10,"TCGA-A5-A1OF-01A-01-TS1",70,NA,NA,NA,"TCGA-A5-A1OF-R14494","EXTERNAL BEAM","Primary Tumor Field","TCGA-A5-A1OF-F53494_NTE-1","NO",973,"TUMOR FREE","Alive",NA,"TCGA-A5-A1OF-F53494","TCGA-A5-A1OF",1,"A5","A1OF","YES","C54.1","8441/3","C54.1","YES","NO",-17308,"FEMALE",NA,"HISPANIC OR LATINO","No","No","Alive",241,NA,NA,NA,"TUMOR FREE","NO",1,8,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,47,2010,"Office Endometrial Biopsy",NA,NA,NA,"High Grade","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35847679,35490159,2650810580,"854F3575-FA15-4C19-A5AD-F9E596AFBC3F.bw","29c8f468-5ac1-4d6c-8376-e36e6d246926","854f3575-fa15-4c19-a5ad-f9e596afbc3f","2016-08-05T05:46:59.677453-05:00","UNCID_2206810.2df1abb0-b25b-4486-a5ed-728964eb0a1b.110829_UNC2-RDR300275_00084_FC_634GCAAXX_6.tar.gz","e16dcf10-43dd-4c45-a65f-2943dfb6800f",2356148208,"Illumina GA","82f43360200fc794df93d7834624f2e2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:31:42.599310-05:00","2016-05-03T11:12:13.672306-05:00","e16dcf10-43dd-4c45-a65f-2943dfb6800f_analysis.xml","9ea0044689539cd205ff94f971c00b4a","e01b084b-ac02-44c1-98b9-f254c8ebfab7",2121,"2016-08-13T03:16:10.135193-05:00","e16dcf10-43dd-4c45-a65f-2943dfb6800f_experiment.xml","53de2b7cd04c91ea4d0d79f9cfcee173","62142a87-e4d9-4571-9c8f-aab580b3f5ba",2257,"2016-09-30T00:11:11.958222-05:00","e16dcf10-43dd-4c45-a65f-2943dfb6800f_run.xml","f043784845fb2fe4e1c34d8837451736","f86cf01a-95ef-440e-8b3b-f8bb777ac7aa",347,"2016-09-08T10:48:37.807416-05:00","TCGA-B5-A0K0","2016-09-02T18:54:42.796514-05:00","female","TCGA-B5-A0K0_demographic",1960,"white","c4dacc00-24ae-5643-ba9f-f81668f7fc01","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0K0_diagnosis","not reported",17810,"alive","8380/3",NA,1478,"0e1b6dbb-ed50-5171-9dc6-383802394d94","c54.1",-17810,"TCGA-B5-A0K0_treatment","a4192721-05db-5d1a-8ae2-248c038bb76b","01","true","TCGA-B5-A0K0-01A",NA,"11c43948-e7c9-4436-a654-82fa8033b625",FALSE,"6284E0A9-FACB-4297-ABC6-308715ABAFCD","Primary Tumor",NA,615,440,NA,1277424000,"11",30,"TCGA-B5-A0K0-01A-11",80,NA,0,NA,10,NA,10,NA,"2016-09-08T10:48:37.807416-05:00","2016-09-08T10:48:37.807416-05:00",30,NA,10,NA,"BOTTOM","TOP",10,NA,"269b2160-8e78-4c6c-af9a-e1b81724c74e","c773ec96-62bc-46ef-a329-6d2cdbf59b6c","TCGA-B5-A0K0-01A-01-BSA","TCGA-B5-A0K0-01A-01-TSA",70,NA,"5da0bd98-9e70-4ff5-8c9c-4b144baadd48","RNA","TCGA-B5-A0K0-01A-11R","ad89ea44-203c-4ce8-a648-3a0e58fa986b",1.93,0.14,"UV Spec","R","23","TCGA-B5-A0K0-01A-11R-A16W-07","2df1abb0-b25b-4486-a5ed-728964eb0a1b",0.14,NA,140,49.6031746031746,168,"d1d589bf-9b98-5d44-ba6e-7f6760f085ad","TCGA-B5-A0K0_exposure","UNCID_2206810.2df1abb0-b25b-4486-a5ed-728964eb0a1b.110829_UNC2-RDR300275_00084_FC_634GCAAXX_6.tar.gz","2013-09-28T07:43:05.000Z","2013-09-28T07:56:02.000Z","E16DCF10-43DD-4C45-A65F-2943DFB6800F","11C43948-E7C9-4436-A654-82FA8033B625","Unaligned reads",2356148208,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2DF1ABB0-B25B-4486-A5ED-728964EB0A1B","University of North Carolina","56607832e4b018727fea1948","29C8F468-5AC1-4D6C-8376-E36E6D246926","Uterine Corpus Endometrial Carcinoma","TARGZ","5DA0BD98-9E70-4FF5-8C9C-4B144BAADD48","2013-09-28T07:56:02.000Z","AD89EA44-203C-4CE8-A648-3A0E58FA986B","United States","NO",1,NA,"Primary Tumor","Duke",615,"5DA0BD98-9E70-4FF5-8C9C-4B144BAADD48",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.712B8668-113A-4AE1-92C6-8D3104282749.txt",440,"TCGA-B5-A0K0-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","1DF69E2E-F392-465F-8E61-4671BA2FCD35",48,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.712B8668-113A-4AE1-92C6-8D3104282749.txt","Alive",NA,"TCGA-B5-A0K0",NA,"D258982D-037F-4F65-9B31-B5F601820F01",NA,679,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"C773EC96-62BC-46EF-A329-6D2CDBF59B6C","AD89EA44-203C-4CE8-A648-3A0E58FA986B","UNCID_1622219.2df1abb0-b25b-4486-a5ed-728964eb0a1b.sorted_genome_alignments.bam","TCGA-B5-A0K0-01A-11",NA,NA,NA,NA,NA,"TOP",NA,NA,"TCGA-B5-A0K0-01A-01-TSA",NA,NA,NA,NA,NA,NA,NA,NA,"NO",862,"TUMOR FREE","Alive",NA,"TCGA-B5-A0K0-F12995","TCGA-B5-A0K0",1,"B5","A0K0","YES","C54.1","8380/3","C54.1","NO","YES",-17810,"FEMALE","WHITE",NA,"No","No","Alive",679,NA,NA,NA,"TUMOR FREE","NO",5,1,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,48,2008,"Dilation and curettage procedure",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
145424154,140871180,6716301274,"F781C72C-3357-4038-AD89-5651FE3A1E20.bw","2a19051e-3ad1-444a-9d02-f895c26ac02c","f781c72c-3357-4038-ad89-5651fe3a1e20","2016-08-27T04:47:53.800495-05:00","UNCID_2316545.1be5c0c6-8645-4894-8573-05ece1839689.130909_UNC15-SN850_0326_AC2BWBACXX_3_TTAGGC.tar.gz","81a6f6a5-db2d-4a42-9be4-5f744d927101",6798226198,"Illumina HiSeq","b2681695480cea5412cdaa22250daba8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:06:07.812307-05:00","2016-05-03T11:28:50.231867-05:00","81a6f6a5-db2d-4a42-9be4-5f744d927101_analysis.xml","46d4cdca6d0d6c33604e2ddbe4c1e27e","ab24d48a-33d0-4f31-859c-c8c68c8d14ee",2124,"2016-10-07T16:21:51.121067-05:00","81a6f6a5-db2d-4a42-9be4-5f744d927101_experiment.xml","bf7ed570ee3632429870148014432cdb","8670ef5e-c35d-4f52-ac78-476f40f8f79b",2628,"2016-09-30T00:04:25.575414-05:00","81a6f6a5-db2d-4a42-9be4-5f744d927101_run.xml","893347ee596abba0a8d351969f6a2075","f45261e2-a779-471c-98c5-52953c7de87b",354,"2016-09-08T10:56:11.233342-05:00","TCGA-SL-A6JA","2016-09-02T18:51:27.659040-05:00","female","TCGA-SL-A6JA_demographic",1936,"black or african american","ab0425be-3d1c-5564-b557-614a4080be6a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","SL","54704c4f-95dd-5a29-a680-878bb1a36612","St. Joseph's Hospital AZ","not reported","c54.1","TCGA-SL-A6JA_diagnosis","not reported",28401,"alive","8380/3",NA,7,"e78ab9fc-8c16-5b13-a3a6-592314fe0141","c54.1",-28401,"TCGA-SL-A6JA_treatment","fff63bc4-5160-5d59-b261-a47fba285a1c","01","true","TCGA-SL-A6JA-01A",NA,"691fc8b9-2221-444b-8de6-960aabd0cddd",FALSE,"60CDA761-5DF1-4580-AD84-1CE9A15F31F8","Primary Tumor",NA,45,200,NA,1372118400,"11",30,"TCGA-SL-A6JA-01A-11",85,NA,1,NA,5,NA,5,NA,"2016-09-08T10:56:11.233342-05:00",NA,1,NA,1,NA,"TOP",NA,5,NA,"be66cc07-4fad-4c4a-9fca-33a80f4fe0a7",NA,"TCGA-SL-A6JA-01A-01-TSA",NA,85,NA,"45b054d7-def5-4e29-9588-ed01e9179edd","RNA","TCGA-SL-A6JA-01A-11R","f9b6e31e-c3e7-43dd-a623-c2edc0bd4539",1.9,0.16,"UV Spec","R","23","TCGA-SL-A6JA-01A-11R-A31O-07","1be5c0c6-8645-4894-8573-05ece1839689",0.16,NA,129,46.2547957976263,167,"39e9b646-4d53-5b93-8c60-db9621bd2d9e","TCGA-SL-A6JA_exposure","UNCID_2316545.1be5c0c6-8645-4894-8573-05ece1839689.130909_UNC15-SN850_0326_AC2BWBACXX_3_TTAGGC.tar.gz","2014-01-07T02:16:21.000Z","2014-01-07T03:48:01.000Z","81A6F6A5-DB2D-4A42-9BE4-5F744D927101","691FC8B9-2221-444B-8DE6-960AABD0CDDD","Unaligned reads",6798226198,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","1BE5C0C6-8645-4894-8573-05ECE1839689","University of North Carolina","56607c22e4b018727fea2daa","2A19051E-3AD1-444A-9D02-F895C26AC02C","Uterine Corpus Endometrial Carcinoma","TARGZ","45B054D7-DEF5-4E29-9588-ED01E9179EDD","2014-01-07T03:48:01.000Z","F9B6E31E-C3E7-43DD-A623-C2EDC0BD4539","United States","NO",1,NA,"Primary Tumor","St. Joseph's Hospital AZ",45,"45B054D7-DEF5-4E29-9588-ED01E9179EDD",NA,"SL","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8D9E4270-BBA4-483C-82D0-88CD5FF6DA4C.txt",200,"TCGA-SL-A6JA-01A",NA,NA,"TCGA",2013,"TCGA-SL-A6JA_NTE-1","Complete Remission/Response","TUMOR FREE","691FC8B9-2221-444B-8DE6-960AABD0CDDD",77,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8D9E4270-BBA4-483C-82D0-88CD5FF6DA4C.txt","Alive",NA,"TCGA-SL-A6JA","NOT HISPANIC OR LATINO","37D563B9-49E4-4917-8B4E-80033DCE13E1",NA,7,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",324,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"BE66CC07-4FAD-4C4A-9FCA-33A80F4FE0A7","3FB5D38B-1AEC-4A3C-8E01-493C69338F23","TCGA-SL-A6JA-01A-01D-YYYY-23.txt","TCGA-SL-A6JA-01A-11",85,5,1,1,5,"TOP",5,1,"TCGA-SL-A6JA-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,"TCGA-SL-A6JA-F68333_NTE-1",NA,7,"TUMOR FREE","Alive",NA,"TCGA-SL-A6JA-F68333","TCGA-SL-A6JA",1,"SL","A6JA","YES","C54.1","8380/3","C54.1","NO","YES",-28401,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",7,NA,"NO","NO","TUMOR FREE","NO",12,11,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,77,2013,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,"Complete Remission/Response","2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
153816350,150761898,7196395610,"85EED4EA-7881-48BE-BC80-29FDCB3FACD0.bw","2a2bc155-ca7c-48b2-bb77-ccfd6313710a","85eed4ea-7881-48be-bc80-29fdcb3facd0","2016-08-09T13:15:45.006309-05:00","UNCID_2173122.70a9e739-6f24-44b7-97cc-7197097a4f83.130509_UNC10-SN254_0462_AC232JACXX_3_CAGATC.tar.gz","a49ff990-21d3-42f9-bd0a-6b3641b7bfc6",7123910564,"Illumina HiSeq","65763d0939b999317d0e0fb14b1790a5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:33:35.497639-05:00","2016-05-03T10:55:55.600288-05:00","a49ff990-21d3-42f9-bd0a-6b3641b7bfc6_analysis.xml","7b00a8b18c6c52ac1ab4e49fbad2523f","4cc5ee70-495f-4086-9ac3-6fa56e110915",2122,"2016-09-29T21:15:23.813111-05:00","a49ff990-21d3-42f9-bd0a-6b3641b7bfc6_experiment.xml","6f43d9484c5f5bc85cc3db2a3a8f9f2c","8ba9a21b-075a-4ccd-8460-98556b5e3c32",2431,"2016-09-29T18:55:51.243115-05:00","a49ff990-21d3-42f9-bd0a-6b3641b7bfc6_run.xml","f433eb160a73e9af8174b517cfefb184","3511eb67-fd28-4d88-ae74-f73eff32d186",354,"2016-09-08T11:16:28.297659-05:00","TCGA-A5-A3LO","2016-09-02T18:48:44.589816-05:00","female","TCGA-A5-A3LO_demographic",1947,"white","a86dfa2e-5d13-51d3-bf8e-cad075653a3d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A3LO_diagnosis","not reported",23401,"alive","8380/3",NA,776,"2baac3d4-74dd-5577-af66-fc9044528a99","c54.1",-23401,"TCGA-A5-A3LO_treatment","033a2cd6-0b64-5a43-ad81-91b705778d83","01","true","TCGA-A5-A3LO-01A",NA,"3bf209df-55b0-4f3f-b98e-9a13fe5e8955",FALSE,"2AB1F28D-151D-4AFE-807A-9F98B48C51CE","Primary Tumor",NA,182,160,NA,1326067200,"11",30,"TCGA-A5-A3LO-01A-11",75,NA,0,NA,0,NA,15,NA,"2016-09-08T11:16:28.297659-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"115cccfd-8398-4fdc-b63b-06facab374a4",NA,"TCGA-A5-A3LO-01A-01-TS1",NA,85,NA,"1a07b773-354d-4d65-b390-41e4eb7d3904","RNA","TCGA-A5-A3LO-01A-11R","58d96e0c-f5f4-4f22-8b0c-e5e398dd4bb0",1.77,0.16,"UV Spec","R","23","TCGA-A5-A3LO-01A-11R-A22K-07","70a9e739-6f24-44b7-97cc-7197097a4f83",0.16,NA,103,36.4937641723356,168,"166fe51d-f5e5-54d4-8d0d-f457d2efbff6","TCGA-A5-A3LO_exposure","UNCID_2173122.70a9e739-6f24-44b7-97cc-7197097a4f83.130509_UNC10-SN254_0462_AC232JACXX_3_CAGATC.tar.gz","2013-09-09T10:16:09.000Z","2013-09-09T10:33:01.000Z","A49FF990-21D3-42F9-BD0A-6B3641B7BFC6","3BF209DF-55B0-4F3F-B98E-9A13FE5E8955","Unaligned reads",7123910564,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","70A9E739-6F24-44B7-97CC-7197097A4F83","University of North Carolina","56607a67e4b0ec1099f8dffa","2A2BC155-CA7C-48B2-BB77-CCFD6313710A","Uterine Corpus Endometrial Carcinoma","TARGZ","1A07B773-354D-4D65-B390-41E4EB7D3904","2013-09-09T10:33:01.000Z","58D96E0C-F5F4-4F22-8B0C-E5E398DD4BB0","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",182,"1A07B773-354D-4D65-B390-41E4EB7D3904",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4E001E6E-EB22-4F46-BDF4-CEDD10AA9338.txt",160,"TCGA-A5-A3LO-01A",NA,"F8BF146B-4B48-41DA-8D16-FD5F38CC0407","TCGA",2011,NA,NA,"TUMOR FREE","3BF209DF-55B0-4F3F-B98E-9A13FE5E8955",64,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4E001E6E-EB22-4F46-BDF4-CEDD10AA9338.txt","Alive",NA,"TCGA-A5-A3LO","NOT HISPANIC OR LATINO","2E0ED631-2526-4DCA-A5A7-3131B044916F",NA,223,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"6E1DF211-95C0-4124-A3F3-ADD63E6AB8C8","WHITE",NA,11,30,"115CCCFD-8398-4FDC-B63B-06FACAB374A4","58D96E0C-F5F4-4F22-8B0C-E5E398DD4BB0","UNCID_2173122.70a9e739-6f24-44b7-97cc-7197097a4f83.130509_UNC10-SN254_0462_AC232JACXX_3_CAGATC.tar.gz","TCGA-A5-A3LO-01A-11",75,0,0,0,15,"TOP",0,0,"TCGA-A5-A3LO-01A-01-TS1",85,"Carboplatin","Chemotherapy","TCGA-A5-A3LO-D29476","TCGA-A5-A3LO-R29477","IMPLANTS","Primary Tumor Field",NA,"NO",223,"TUMOR FREE","Alive",NA,"TCGA-A5-A3LO-F29474","TCGA-A5-A3LO",1,"A5","A3LO","YES","C54.1","8380/3","C54.1","YES","NO",-23401,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",223,NA,NA,NA,"TUMOR FREE","NO",15,3,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29875037,29478149,2211951301,"15AF0A2E-8C09-4B6E-9BA0-9CA1E1CC4884.bw","2b60ef45-336c-42e0-aa3f-577069310d1f","15af0a2e-8c09-4b6e-9ba0-9ca1e1cc4884","2016-08-09T14:03:39.911233-05:00","UNCID_2196649.0c622763-f905-4eaa-a05b-ea27dbd49888.120216_UNC2-RDR300275_00113_FC_650PDAAXX_8.tar.gz","6a551502-cb01-4199-9897-26578346a843",1933357515,"Illumina GA","8d22083ff26774641dd496e2bb90a660","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:39:39.042343-05:00","2016-05-03T11:07:49.541765-05:00","6a551502-cb01-4199-9897-26578346a843_analysis.xml","b064f10d83bff9d86a3c65b53db6298f","507b221b-f0cd-45ff-a09c-7de1e5183112",2121,"2016-09-29T18:03:51.128208-05:00","6a551502-cb01-4199-9897-26578346a843_experiment.xml","c62852b12d5927199cec9d509ab37c47","146f0f68-4119-4512-ab02-e693507e1a4c",2257,"2016-09-29T21:57:00.245071-05:00","6a551502-cb01-4199-9897-26578346a843_run.xml","73c8309c928ce7daa6f24eb43d6dce17","a57bf3a7-c950-40a7-ac47-151e5abd2901",347,"2016-09-08T10:28:55.333730-05:00","TCGA-EY-A2OM","2016-09-02T18:54:20.709325-05:00","female","TCGA-EY-A2OM_demographic",1956,"white","913d2af6-77a5-5410-a188-fe74d2567774","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A2OM_diagnosis","not reported",20398,"alive","8380/3",NA,694,"3b3e60e4-d5c1-5cf1-9ead-8a675165db70","c54.1",-20398,"TCGA-EY-A2OM_treatment","1f4cc020-97aa-5d2d-b98f-66837d8741e8","01","false","TCGA-EY-A2OM-01A",NA,"2d9888f8-fa53-44a3-8e1c-20479cee4584",FALSE,"7C46CE28-FC96-47FD-A133-B95EA93E1D8B","Primary Tumor",NA,176,640,NA,1314662400,"11",30,"TCGA-EY-A2OM-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T10:28:55.333730-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"92d727ec-d04e-4421-8c65-a4dbaa27f86d",NA,"TCGA-EY-A2OM-01A-01-TS1",NA,70,NA,"55dbf8c7-b7f1-4253-875e-55b68b09180b","RNA","TCGA-EY-A2OM-01A-11R","c7277159-d6ac-41b5-829b-2a034209bb35",1.79,0.17,"UV Spec","R","23","TCGA-EY-A2OM-01A-11R-A18M-07","0c622763-f905-4eaa-a05b-ea27dbd49888",0.17,NA,110,47.6108033240997,152,"84aa203b-21cb-5150-bfab-32dda360a4f0","TCGA-EY-A2OM_exposure","UNCID_2196649.0c622763-f905-4eaa-a05b-ea27dbd49888.120216_UNC2-RDR300275_00113_FC_650PDAAXX_8.tar.gz","2013-09-23T07:31:05.000Z","2013-09-23T07:49:01.000Z","6A551502-CB01-4199-9897-26578346A843","2D9888F8-FA53-44A3-8E1C-20479CEE4584","Unaligned reads",1933357515,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0C622763-F905-4EAA-A05B-EA27DBD49888","University of North Carolina","564a5894e4b0ef12181d41ab","2B60EF45-336C-42E0-AA3F-577069310D1F","Uterine Corpus Endometrial Carcinoma","TARGZ","55DBF8C7-B7F1-4253-875E-55B68B09180B","2013-09-23T07:49:01.000Z","C7277159-D6AC-41B5-829B-2A034209BB35","United States","NO",1,NA,"Primary Tumor","University of North Carolina",176,"55DBF8C7-B7F1-4253-875E-55B68B09180B",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B6FE1435-A4DC-48E9-A92E-B7D599544F66.txt",640,"TCGA-EY-A2OM-01A",NA,"2CBF5E14-5D00-4BEB-B905-23DDDA6D38C0","TCGA",2011,NA,NA,"TUMOR FREE","CFE22A68-5592-4841-AD18-1B5658BEEDF6",55,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B6FE1435-A4DC-48E9-A92E-B7D599544F66.txt","Alive",NA,"TCGA-EY-A2OM","NOT HISPANIC OR LATINO","3E3EE02F-9847-4374-B192-153D38D3F978",NA,236,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,"AA2E707E-6A42-4B57-9D9E-84A20E0637F9","WHITE",NA,11,30,"92D727EC-D04E-4421-8C65-A4DBAA27F86D","BCBAA830-E60B-4049-BF60-3A8951968938","f687cf23ab0598932da8b81631c103ca.bam","TCGA-EY-A2OM-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-EY-A2OM-01A-01-TS1",70,"Taxol","Chemotherapy","TCGA-EY-A2OM-D18362","TCGA-EY-A2OM-R18364","IMPLANTS","Regional site","TCGA-EY-A2OM-F34170_NTE-1","NO",393,"TUMOR FREE","Alive",NA,"TCGA-EY-A2OM-F34170","TCGA-EY-A2OM",1,"EY","A2OM","YES","C54.1","8380/3","C54.1","YES","NO",-20398,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",236,NA,NA,NA,"TUMOR FREE","NO",14,11,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32486437,26109841,1958428140,"F6B26185-139B-47A7-91EC-E885D94AC882.bw","2b76cc9c-c379-43e4-9c3f-56197a3353be","f6b26185-139b-47a7-91ec-e885d94ac882","2016-08-05T07:35:52.954627-05:00","UNCID_2251247.1c908135-7fdf-4257-8b9e-92e6aa0850a6.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_3.tar.gz","7eec1989-1959-40fb-83a0-16dfd5ac3787",2048624211,"Illumina GA","902fcf4ed6531fec47e8ae96e1d6308a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:29:47.039197-05:00","2016-05-03T11:20:52.084724-05:00","7eec1989-1959-40fb-83a0-16dfd5ac3787_analysis.xml","7d045b6d4c330be191c6e28e3ca9eb8a","6f46eef7-bf20-45d5-8f31-c6059b2bd79a",2121,"2016-10-07T17:31:27.088135-05:00","7eec1989-1959-40fb-83a0-16dfd5ac3787_experiment.xml","7652174c69b70a8879cd11a85dcb1752","7c7ee157-70e1-4946-8908-dafc6e8c5a4d",2257,"2016-09-29T21:37:43.604757-05:00","7eec1989-1959-40fb-83a0-16dfd5ac3787_run.xml","411eb70b55f67cef2eb8ad5fe90d612d","99746c01-8efa-4685-b2cb-53337fef2dd9",347,"2016-09-08T11:59:50.318321-05:00","TCGA-BS-A0V8","2016-09-02T18:49:50.785105-05:00","female","TCGA-BS-A0V8_demographic",1938,"native hawaiian or other pacific islander","3fecafa2-72e6-51c6-83b4-ad54786e9d2b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0V8_diagnosis","not reported",24981,"alive","8380/3",NA,2544,"c46365fa-932f-5775-863a-dd410c14bb57","c54.1",-24981,"TCGA-BS-A0V8_treatment","4ae250ef-1fe7-516e-82e8-af91b922d990","01","false","TCGA-BS-A0V8-01A",NA,"cf369a2c-d3c3-4fa3-b004-e4269530ceff",FALSE,"A024F121-F6C9-4CDF-B0ED-B58708DB6DFE","Primary Tumor",NA,1410,120,NA,1291334400,"11",30,"TCGA-BS-A0V8-01A-11",70,15,0,0,30,59,0,15,"2016-09-08T11:59:50.318321-05:00","2016-09-08T11:59:50.318321-05:00",10,5,20,0,"BOTTOM","TOP",20,1,"6905cf0c-45da-4d04-9323-2eadebd2d138","a748951f-36e9-4fcd-8505-5176a2f06241","TCGA-BS-A0V8-01A-01-BS1","TCGA-BS-A0V8-01A-01-MS1",50,25,"df819909-c92a-48e4-a2ae-5370f5d5cbad","RNA","TCGA-BS-A0V8-01A-11R","81615c81-ee48-474e-8ada-c3dec066ce19",1.84,0.15,"UV Spec","R","23","TCGA-BS-A0V8-01A-11R-A118-07","1c908135-7fdf-4257-8b9e-92e6aa0850a6",0.15,NA,85,34.4841575723153,157,"c6ebc8ea-a471-5359-801e-7ed317567e8a","TCGA-BS-A0V8_exposure","UNCID_2251247.1c908135-7fdf-4257-8b9e-92e6aa0850a6.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_3.tar.gz","2013-10-26T23:36:06.000Z","2013-10-27T00:01:01.000Z","7EEC1989-1959-40FB-83A0-16DFD5AC3787","CF369A2C-D3C3-4FA3-B004-E4269530CEFF","Unaligned reads",2048624211,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1C908135-7FDF-4257-8B9E-92E6AA0850A6","University of North Carolina","564a3f7ce4b0298dd2c9b7a2","2B76CC9C-C379-43E4-9C3F-56197A3353BE","Uterine Corpus Endometrial Carcinoma","TARGZ","DF819909-C92A-48E4-A2AE-5370F5D5CBAD","2013-10-27T00:01:01.000Z","81615C81-EE48-474E-8ADA-C3DEC066CE19","None","NO",1,NA,"Primary Tumor","University of Hawaii",1410,"DF819909-C92A-48E4-A2AE-5370F5D5CBAD",NA,"BS","a94a5ada9a0bb0f8ace6de28512984f7.bam.bai",120,"TCGA-BS-A0V8-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","CF369A2C-D3C3-4FA3-B004-E4269530CEFF",68,"nationwidechildrens.org_clinical.TCGA-BS-A0V8.xml","Alive",NA,"TCGA-BS-A0V8","NOT HISPANIC OR LATINO","8FDEE814-3FBA-4311-B1C9-A6E286768DD0",NA,1507,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,11,30,"A748951F-36E9-4FCD-8505-5176A2F06241","81615C81-EE48-474E-8ADA-C3DEC066CE19","CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_E08_735734.nocnv_hg18.seg.txt","TCGA-BS-A0V8-01A-11",70,30,0,10,0,"BOTTOM",20,20,"TCGA-BS-A0V8-01A-01-BS1",50,NA,NA,NA,NA,NA,NA,"TCGA-BS-A0V8-F68989_NTE-1","NO",2544,"TUMOR FREE","Alive",NA,"TCGA-BS-A0V8-F68989","TCGA-BS-A0V8",1,"BS","A0V8","YES","C54.1","8380/3","C54.1","NO","YES",-24981,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","NOT HISPANIC OR LATINO","No","No","Alive",1507,NA,NA,NA,"TUMOR FREE","NO",28,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2006,"Office Endometrial Biopsy",NA,NA,NA,"G2","R1",NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32249484,31942574,2389056235,"E3DEE7D1-60A8-447E-822F-6B2C7FE0F295.bw","2b85b84f-e680-4b5c-93ea-3c71567227e8","e3dee7d1-60a8-447e-822f-6b2c7fe0f295","2016-08-09T14:13:00.862506-05:00","UNCID_2207210.2e11f69d-8c0d-484e-8f22-1ad97f26c78d.110719_UNC2-RDR300275_00077_FC_70KATAAXX_5.tar.gz","0c3e0c51-58f5-40f8-9799-bbb3a5f335c4",1980870376,"Illumina GA","777245cd65867be6afee49c482bc70b3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:22:14.406339-05:00","2016-05-03T11:13:42.375045-05:00","0c3e0c51-58f5-40f8-9799-bbb3a5f335c4_analysis.xml","7b39942e1df2aa536ffe7df4cd1fcb88","da10422c-966a-45e9-9dfa-76076df96fb6",2121,"2016-09-29T20:08:56.426778-05:00","0c3e0c51-58f5-40f8-9799-bbb3a5f335c4_experiment.xml","5394c09dfac26113a584e805a368b891","6284c072-a8ba-45c9-8e2d-8243b1eb6205",2257,"2016-09-29T22:39:39.757683-05:00","0c3e0c51-58f5-40f8-9799-bbb3a5f335c4_run.xml","369beb3546a79e24eb346e1be36484be","bfc6338c-0110-4c89-9427-17bd62ec91a5",347,"2016-09-08T11:21:38.454700-05:00","TCGA-AP-A1E1","2016-09-02T18:51:28.764824-05:00","female","TCGA-AP-A1E1_demographic",1935,"white","b9d31f87-628e-584a-b7ad-d7a6d69e6f91","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1E1_diagnosis","not reported",27072,"alive","8380/3",NA,1395,"9797428f-80a0-5e9e-a2a2-83a4610630c9","c54.1",-27072,"TCGA-AP-A1E1_treatment","2fbb8ff6-5b57-5765-87b7-703703ff0c3f","01","true","TCGA-AP-A1E1-01A",NA,"1a9a1020-c9ee-4bbf-98e8-fbe5041a6099",FALSE,"E8873536-294D-4E41-9165-EE403A11B439","Primary Tumor",NA,470,260,NA,1295913600,"11",30,"TCGA-AP-A1E1-01A-11",70,NA,0,NA,0,NA,0,NA,"2016-09-08T11:21:38.454700-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"63c5d357-4ab2-4f5b-9ec6-8eed98998ebe",NA,"TCGA-AP-A1E1-01A-01-TSA",NA,100,NA,"b25d8369-84e9-4f22-80d4-f7fd4222db98","RNA","TCGA-AP-A1E1-01A-11R","6d602654-6a9c-4669-bf4d-05bc31ad36d3",1.81,0.17,"UV Spec","R","23","TCGA-AP-A1E1-01A-11R-A137-07","2e11f69d-8c0d-484e-8f22-1ad97f26c78d",0.17,NA,73,28.515625,160,"8efb30f9-cde3-5d4d-87bd-c1a88f16c2fd","TCGA-AP-A1E1_exposure","UNCID_2207210.2e11f69d-8c0d-484e-8f22-1ad97f26c78d.110719_UNC2-RDR300275_00077_FC_70KATAAXX_5.tar.gz","2013-09-29T18:26:04.000Z","2013-09-29T18:40:02.000Z","0C3E0C51-58F5-40F8-9799-BBB3A5F335C4","1A9A1020-C9EE-4BBF-98E8-FBE5041A6099","Unaligned reads",1980870376,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2E11F69D-8C0D-484E-8F22-1AD97F26C78D","University of North Carolina","564a3f5fe4b08c5d8692c6e8","2B85B84F-E680-4B5C-93EA-3C71567227E8","Uterine Corpus Endometrial Carcinoma","TARGZ","B25D8369-84E9-4F22-80D4-F7FD4222DB98","2013-09-29T18:40:02.000Z","6D602654-6A9C-4669-BF4D-05BC31AD36D3","None","NO",1,NA,"Primary Tumor","MSKCC",470,"B25D8369-84E9-4F22-80D4-F7FD4222DB98",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.601B63EA-312B-4BFF-A107-2DC549F295C2.txt",260,"TCGA-AP-A1E1-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","32A3FA91-9BB8-4190-98BB-1D308993AAD6",74,"nationwidechildrens.org_clinical.TCGA-AP-A1E1.xml","Alive",NA,"TCGA-AP-A1E1",NA,"EEF34890-513D-4EC5-AD8D-8E7A9AE5E194",NA,317,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"63C5D357-4AB2-4F5B-9EC6-8EED98998EBE","6D602654-6A9C-4669-BF4D-05BC31AD36D3","TCGA-AP-A1E1-01A-11R-A136-13_mirna.bam.bai","TCGA-AP-A1E1-01A-11",70,0,0,0,0,"TOP",0,0,"TCGA-AP-A1E1-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,"TCGA-AP-A1E1-F68437_NTE-1","NO",1395,"TUMOR FREE","Alive",NA,"TCGA-AP-A1E1-F68437","TCGA-AP-A1E1",1,"AP","A1E1","YES","C54.1","8380/3","C54.1","NO","YES",-27072,"FEMALE","WHITE",NA,"No","No","Alive",317,NA,NA,NA,"TUMOR FREE","NO",9,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
194913542,192976697,9238055079,"3459C5E7-E111-4B45-BFEE-3FFC1D77D5EA.bw","2b865f8c-539f-4cb2-8f08-41709e9511e5","3459c5e7-e111-4b45-bfee-3ffc1d77d5ea","2016-08-25T14:25:28.728301-05:00","UNCID_2332720.00055bad-54b7-4898-a9ae-3dd8036e62d3.130718_UNC12-SN629_0321_AC2E6WACXX_3_GCCAAT.tar.gz","79309235-c27b-4be9-b06c-d17b0852317c",7841988811,"Illumina HiSeq","a071aab82cf9b5e7543dd9f93116c5a5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:52:33.258778-05:00","2016-05-03T11:35:41.339088-05:00","79309235-c27b-4be9-b06c-d17b0852317c_analysis.xml","b86843a85ad1039fc54da0154d1cd65d","ed105add-8622-40a6-994e-fe1fccf03376",2124,"2016-09-29T19:54:01.009390-05:00","79309235-c27b-4be9-b06c-d17b0852317c_experiment.xml","305e6b0a3574356aabd3859cf1b2b6a2","5975d996-df9d-4dbb-8a60-9c2492e7b841",2884,"2016-09-29T17:52:50.302634-05:00","79309235-c27b-4be9-b06c-d17b0852317c_run.xml","43c5f539fe155f403bb627fb4e59aeb6","0d77b9f9-b753-4fe2-bf11-91320943c211",355,"2016-09-08T11:32:35.591495-05:00","TCGA-BK-A0CC","2016-09-02T18:52:53.030525-05:00","female","TCGA-BK-A0CC_demographic",1941,"black or african american","f3903f35-c35d-54f4-be3d-4c655da416f4","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A0CC_diagnosis","not reported",25479,"alive","8441/3",NA,1067,"7924d7fd-572e-5f05-920f-de2bc56e759f","c54.1",-25479,"TCGA-BK-A0CC_treatment","af85e4ac-f4ce-532c-ad60-f6c582a60a9e","01","false","TCGA-BK-A0CC-01A",NA,"ed22cb10-ebde-4019-9b6d-e19ab573ca94",FALSE,"6A2AAC78-98B9-44D4-AF8D-9A132579CC2D","Primary Tumor",NA,52,310,NA,1275955200,"21",40,"TCGA-BK-A0CC-01A-21",75,70,0,0,0,0,15,30,"2016-09-08T11:32:35.591495-05:00","2016-09-08T11:32:35.591495-05:00",0,0,0,0,"BOTTOM","TOP",25,0,"8e809120-284a-41e9-8b5e-051de7337526","23e497e5-c8f5-464c-a30d-46ef45319bca","TCGA-BK-A0CC-01A-02-BS2","TCGA-BK-A0CC-01A-01-BS1",60,70,"c88e4282-7594-4921-879d-09693b5804d5","RNA","TCGA-BK-A0CC-01A-21R","81af7b1c-2c63-4d4e-b432-8016a39d1c54",1.78,0.15,"UV Spec","R","23","TCGA-BK-A0CC-01A-21R-A277-07","00055bad-54b7-4898-a9ae-3dd8036e62d3",0.15,NA,72,31.1634349030471,152,"d11893ab-e091-5b1f-955d-00e087fb439a","TCGA-BK-A0CC_exposure","UNCID_2332720.00055bad-54b7-4898-a9ae-3dd8036e62d3.130718_UNC12-SN629_0321_AC2E6WACXX_3_GCCAAT.tar.gz","2014-01-29T11:37:04.000Z","2014-01-29T11:58:02.000Z","79309235-C27B-4BE9-B06C-D17B0852317C","ED22CB10-EBDE-4019-9B6D-E19AB573CA94","Unaligned reads",7841988811,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","00055BAD-54B7-4898-A9AE-3DD8036E62D3","University of North Carolina","56607427e4b0ca319164bfb8","2B865F8C-539F-4CB2-8F08-41709E9511E5","Uterine Corpus Endometrial Carcinoma","TARGZ","C88E4282-7594-4921-879D-09693B5804D5","2014-01-29T11:58:02.000Z","81AF7B1C-2C63-4D4E-B432-8016A39D1C54","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",52,"C88E4282-7594-4921-879D-09693B5804D5",NA,"BK","US82800149_251976011873_S01_GE2_105_Dec08.txt",310,"TCGA-BK-A0CC-01A",NA,"BC56E92C-5DE8-431D-8C2C-F166CAD0FEF9","TCGA",2010,NA,NA,"WITH TUMOR","ED22CB10-EBDE-4019-9B6D-E19AB573CA94",69,"45d8009fe017f814c4cd066fa993ed8f.bam","Alive",NA,"TCGA-BK-A0CC","HISPANIC OR LATINO","8B899112-C4DA-4890-870E-C0246817DE5C",NA,212,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",49,NA,"117C5D50-9C84-46E2-94DB-ED8F47361F2E","BLACK OR AFRICAN AMERICAN",NA,21,40,"8E809120-284A-41E9-8B5E-051DE7337526","C36E14D6-CA65-4BAA-BEED-DE43345DCAE7","UNCID_2207042.ac44efb2-7079-49a7-8bc6-285ae009ad89.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_5.tar.gz","TCGA-BK-A0CC-01A-21",70,0,0,0,30,"TOP",0,0,"TCGA-BK-A0CC-01A-01-BS1",70,"Taxol","Chemotherapy","TCGA-BK-A0CC-D5133","TCGA-BK-A0CC-R5134","EXTERNAL BEAM","Primary Tumor Field",NA,NA,311,"TUMOR FREE","Alive",NA,"TCGA-BK-A0CC-F5131","TCGA-BK-A0CC",2,"BK","A0CC","YES","C54.1","8441/3","C54.1","YES","NO",-25479,"FEMALE","BLACK OR AFRICAN AMERICAN","HISPANIC OR LATINO","No","No","Alive",212,NA,NA,NA,"WITH TUMOR","NO",8,10,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,69,2010,"Incisional Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
27246706,26788552,1988122632,"D50BBFC7-7774-4B12-938C-8D5373C12DFC.bw","2b865f8c-539f-4cb2-8f08-41709e9511e5","d50bbfc7-7774-4b12-938c-8d5373c12dfc","2016-08-09T14:11:09.589652-05:00","UNCID_2207042.ac44efb2-7079-49a7-8bc6-285ae009ad89.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_5.tar.gz","955fee25-8fa0-4871-90c6-6e4c16f421e4",1721493820,"Illumina GA","ce694526f311386972a212874a10b839","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:04:00.653435-05:00","2016-05-03T11:13:42.364824-05:00","955fee25-8fa0-4871-90c6-6e4c16f421e4_analysis.xml","cf81fbe093643e90ee625190806a9475","a9cff32e-79a7-4d1f-a1b5-dddbef32a607",2121,"2016-09-29T20:42:19.382370-05:00","955fee25-8fa0-4871-90c6-6e4c16f421e4_experiment.xml","184a987d5b63096541b65a8213a98467","76ef62a0-2565-4c30-9d08-ceccea4ca83e",2257,"2016-09-29T21:17:44.465454-05:00","955fee25-8fa0-4871-90c6-6e4c16f421e4_run.xml","3c02f11c90b5c374819fb8594cacfe33","8d1fa874-8651-45ec-8223-99fe76dafe52",347,"2016-09-08T11:32:35.591495-05:00","TCGA-BK-A0CC","2016-09-02T18:52:53.030525-05:00","female","TCGA-BK-A0CC_demographic",1941,"black or african american","f3903f35-c35d-54f4-be3d-4c655da416f4","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A0CC_diagnosis","not reported",25479,"alive","8441/3",NA,1067,"7924d7fd-572e-5f05-920f-de2bc56e759f","c54.1",-25479,"TCGA-BK-A0CC_treatment","af85e4ac-f4ce-532c-ad60-f6c582a60a9e","01","false","TCGA-BK-A0CC-01A",NA,"ed22cb10-ebde-4019-9b6d-e19ab573ca94",FALSE,"6A2AAC78-98B9-44D4-AF8D-9A132579CC2D","Primary Tumor",NA,52,310,NA,1275955200,"21",40,"TCGA-BK-A0CC-01A-21",75,70,0,0,0,0,15,30,"2016-09-08T11:32:35.591495-05:00","2016-09-08T11:32:35.591495-05:00",0,0,0,0,"BOTTOM","TOP",25,0,"8e809120-284a-41e9-8b5e-051de7337526","23e497e5-c8f5-464c-a30d-46ef45319bca","TCGA-BK-A0CC-01A-02-BS2","TCGA-BK-A0CC-01A-01-BS1",60,70,"c88e4282-7594-4921-879d-09693b5804d5","RNA","TCGA-BK-A0CC-01A-21R","81af7b1c-2c63-4d4e-b432-8016a39d1c54",1.78,0.15,"UV Spec","R","23","TCGA-BK-A0CC-01A-21R-A16W-07","ac44efb2-7079-49a7-8bc6-285ae009ad89",0.15,NA,72,31.1634349030471,152,"d11893ab-e091-5b1f-955d-00e087fb439a","TCGA-BK-A0CC_exposure","UNCID_2207042.ac44efb2-7079-49a7-8bc6-285ae009ad89.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_5.tar.gz","2013-09-29T03:56:04.000Z","2013-09-29T04:08:02.000Z","955FEE25-8FA0-4871-90C6-6E4C16F421E4","ED22CB10-EBDE-4019-9B6D-E19AB573CA94","Unaligned reads",1721493820,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","AC44EFB2-7079-49A7-8BC6-285AE009AD89","University of North Carolina","5660742ce4b0ca319164bffc","2B865F8C-539F-4CB2-8F08-41709E9511E5","Uterine Corpus Endometrial Carcinoma","TARGZ","C88E4282-7594-4921-879D-09693B5804D5","2013-09-29T04:08:02.000Z","81AF7B1C-2C63-4D4E-B432-8016A39D1C54","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",52,"C88E4282-7594-4921-879D-09693B5804D5",NA,"BK","US82800149_251976011873_S01_GE2_105_Dec08.txt",310,"TCGA-BK-A0CC-01A",NA,"BC56E92C-5DE8-431D-8C2C-F166CAD0FEF9","TCGA",2010,NA,NA,"WITH TUMOR","ED22CB10-EBDE-4019-9B6D-E19AB573CA94",69,"45d8009fe017f814c4cd066fa993ed8f.bam","Alive",NA,"TCGA-BK-A0CC","HISPANIC OR LATINO","8B899112-C4DA-4890-870E-C0246817DE5C",NA,212,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",49,NA,"117C5D50-9C84-46E2-94DB-ED8F47361F2E","BLACK OR AFRICAN AMERICAN",NA,21,40,"8E809120-284A-41E9-8B5E-051DE7337526","C36E14D6-CA65-4BAA-BEED-DE43345DCAE7","UNCID_2207042.ac44efb2-7079-49a7-8bc6-285ae009ad89.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_5.tar.gz","TCGA-BK-A0CC-01A-21",70,0,0,0,30,"TOP",0,0,"TCGA-BK-A0CC-01A-01-BS1",70,"Taxol","Chemotherapy","TCGA-BK-A0CC-D5133","TCGA-BK-A0CC-R5134","EXTERNAL BEAM","Primary Tumor Field",NA,NA,311,"TUMOR FREE","Alive",NA,"TCGA-BK-A0CC-F5131","TCGA-BK-A0CC",2,"BK","A0CC","YES","C54.1","8441/3","C54.1","YES","NO",-25479,"FEMALE","BLACK OR AFRICAN AMERICAN","HISPANIC OR LATINO","No","No","Alive",212,NA,NA,NA,"WITH TUMOR","NO",8,10,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,69,2010,"Incisional Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
159646206,157911872,7552449757,"4664FF20-60E6-4FBD-9760-5F543F725443.bw","2b865f8c-539f-4cb2-8f08-41709e9511e5","4664ff20-60e6-4fbd-9760-5f543f725443","2016-08-25T23:39:00.334438-05:00","UNCID_2337804.80ab3bb7-f083-4414-8d50-122ea25e6526.130702_UNC12-SN629_0317_AD29BFACXX_3_ACAGTG.tar.gz","507b0933-5c44-4a19-8907-d9e97626a5a5",6815405887,"Illumina HiSeq","0889c7ccc21ca384f0c148172e144f8d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:21:38.378632-05:00","2016-05-03T11:35:41.364390-05:00","507b0933-5c44-4a19-8907-d9e97626a5a5_analysis.xml","167a43a12d888cf0de97b35e77b2d80e","ff06fa35-3767-41ff-a8bb-701972d0b152",2124,"2016-08-13T07:57:36.519151-05:00","507b0933-5c44-4a19-8907-d9e97626a5a5_experiment.xml","6317090a7e5683aa9420596afc57b383","c2c64ff9-e88b-4060-8559-d77e3bb17cbb",2882,"2016-09-29T21:32:27.599075-05:00","507b0933-5c44-4a19-8907-d9e97626a5a5_run.xml","4e027bc15cda34c2358b24ba5489c664","963bc102-cd38-49f2-9bdd-4faf6074bd37",355,"2016-09-08T11:32:35.591495-05:00","TCGA-BK-A0CC","2016-09-02T18:52:53.030525-05:00","female","TCGA-BK-A0CC_demographic",1941,"black or african american","f3903f35-c35d-54f4-be3d-4c655da416f4","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A0CC_diagnosis","not reported",25479,"alive","8441/3",NA,1067,"7924d7fd-572e-5f05-920f-de2bc56e759f","c54.1",-25479,"TCGA-BK-A0CC_treatment","af85e4ac-f4ce-532c-ad60-f6c582a60a9e","01","false","TCGA-BK-A0CC-01B",NA,"23659618-8933-4944-8cb2-adf8ed51d7a5",TRUE,"6A2AAC78-98B9-44D4-AF8D-9A132579CC2D","Primary Tumor",NA,645,NA,NA,1360281600,"04",400,"TCGA-BK-A0CC-01B-04",60,60,0,0,0,0,0,0,"2016-09-08T11:32:35.591495-05:00","2016-09-08T11:32:35.591495-05:00",4,4,2,2,"BOTTOM","TOP",0,0,"5dc72acb-fc02-4eba-8909-5d75449e0ead","78178275-d31a-46e1-a050-3e6e55f281e1","TCGA-BK-A0CC-01B-04-BS4","TCGA-BK-A0CC-01B-03-BS3",100,100,"35a08123-ef8e-43e3-a58b-f06283017fac","RNA","TCGA-BK-A0CC-01B-04R","31e8158b-0dc7-4aad-b9ae-728359c68faf",1.85,0.15,"UV Spec","R","23","TCGA-BK-A0CC-01B-04R-A277-07","80ab3bb7-f083-4414-8d50-122ea25e6526",0.15,NA,72,31.1634349030471,152,"d11893ab-e091-5b1f-955d-00e087fb439a","TCGA-BK-A0CC_exposure","UNCID_2337804.80ab3bb7-f083-4414-8d50-122ea25e6526.130702_UNC12-SN629_0317_AD29BFACXX_3_ACAGTG.tar.gz","2014-02-04T08:37:03.000Z","2014-02-04T08:58:02.000Z","507B0933-5C44-4A19-8907-D9E97626A5A5","23659618-8933-4944-8CB2-ADF8ED51D7A5","Unaligned reads",6815405887,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","80AB3BB7-F083-4414-8D50-122EA25E6526","University of North Carolina","5660742de4b0b37b3d98e7b6","2B865F8C-539F-4CB2-8F08-41709E9511E5","Uterine Corpus Endometrial Carcinoma","TARGZ","35A08123-EF8E-43E3-A58B-F06283017FAC","2014-02-04T08:58:02.000Z","31E8158B-0DC7-4AAD-B9AE-728359C68FAF","None","YES",1,NA,"Primary Tumor","Christiana Healthcare",645,"35A08123-EF8E-43E3-A58B-F06283017FAC",NA,"BK","UNCID_2337804.80ab3bb7-f083-4414-8d50-122ea25e6526.130702_UNC12-SN629_0317_AD29BFACXX_3_ACAGTG.tar.gz",NA,"TCGA-BK-A0CC-01B",NA,"BC56E92C-5DE8-431D-8C2C-F166CAD0FEF9","TCGA",2010,NA,NA,"WITH TUMOR","ED22CB10-EBDE-4019-9B6D-E19AB573CA94",69,"45d8009fe017f814c4cd066fa993ed8f.bam","Alive",NA,"TCGA-BK-A0CC","HISPANIC OR LATINO","8B899112-C4DA-4890-870E-C0246817DE5C",NA,212,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",49,NA,"117C5D50-9C84-46E2-94DB-ED8F47361F2E","BLACK OR AFRICAN AMERICAN",NA,4,400,"78178275-D31A-46E1-A050-3E6E55F281E1","31E8158B-0DC7-4AAD-B9AE-728359C68FAF","UNCID_2337804.80ab3bb7-f083-4414-8d50-122ea25e6526.130702_UNC12-SN629_0317_AD29BFACXX_3_ACAGTG.tar.gz","TCGA-BK-A0CC-01B-04",60,0,0,4,0,"BOTTOM",0,2,"TCGA-BK-A0CC-01B-04-BS4",100,"Taxol","Chemotherapy","TCGA-BK-A0CC-D5133","TCGA-BK-A0CC-R5134","EXTERNAL BEAM","Primary Tumor Field",NA,NA,311,"TUMOR FREE","Alive",NA,"TCGA-BK-A0CC-F5131","TCGA-BK-A0CC",2,"BK","A0CC","YES","C54.1","8441/3","C54.1","YES","NO",-25479,"FEMALE","BLACK OR AFRICAN AMERICAN","HISPANIC OR LATINO","No","No","Alive",212,NA,NA,NA,"WITH TUMOR","NO",8,10,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,69,2010,"Incisional Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
93730842,92132349,4387837096,"E85AE97F-43CF-4250-B2BF-63E6FA8044E8.bw","2c3e95b5-2c63-43c7-baa2-47ef914b25a8","e85ae97f-43cf-4250-b2bf-63e6fa8044e8","2016-08-09T13:15:30.878582-05:00","UNCID_2177865.0ce294d7-8111-474c-be3a-19195f5d49ab.130402_UNC10-SN254_0447_BC22WAACXX_5_GGCTAC.tar.gz","668c9d82-b037-4b97-bb8e-187ed11fe62e",3883162167,"Illumina HiSeq","f06a8055449bffe7819b0d4839f7f1bf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:49:04.615675-05:00","2016-05-03T10:56:47.890899-05:00","668c9d82-b037-4b97-bb8e-187ed11fe62e_analysis.xml","b061db052c2305e153113c05421146cd","eae6425d-d085-4398-a3cd-cc10c6e42182",2123,"2016-09-29T17:57:56.190449-05:00","668c9d82-b037-4b97-bb8e-187ed11fe62e_experiment.xml","ebcb4d0fc8554ae81e10115145f4a1d6","10a3a6c6-dd8f-4070-be69-7f718685bc54",2431,"2016-09-29T20:57:36.937854-05:00","668c9d82-b037-4b97-bb8e-187ed11fe62e_run.xml","7a12e80b6df8ad97ed26385100386d3c","807c5d51-56e3-4f48-8394-9e9f7acd0b07",354,"2016-09-08T12:12:16.613211-05:00","TCGA-EO-A3AS","2016-09-02T18:47:54.996472-05:00","female","TCGA-EO-A3AS_demographic",1923,"not reported","15d4e11d-5881-5dc0-b3ab-6deca92452a2","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3AS_diagnosis","not reported",31450,"alive","8380/3",NA,1046,"8f40046d-b2de-5d19-a62d-566622b93e6c","c54.1",-31450,"TCGA-EO-A3AS_treatment","4896604c-0cf5-5425-93af-bc80f526a66c","01","false","TCGA-EO-A3AS-01A",NA,"ddb6e07d-8764-4278-978d-7a878522de6d",FALSE,"844799B1-4C96-473A-8ECB-71ACB080F95E","Primary Tumor",NA,850,70,NA,1317600000,"11",30,"TCGA-EO-A3AS-01A-11",80,NA,0,NA,0,NA,18,NA,"2016-09-08T12:12:16.613211-05:00",NA,0,NA,0,NA,"TOP",NA,2,NA,"037be131-53ea-4b16-9634-d2da2e9d655a",NA,"TCGA-EO-A3AS-01A-01-TS1",NA,80,NA,"6b52a44d-1ab7-4c32-98ef-56da5833432c","RNA","TCGA-EO-A3AS-01A-11R","31c37438-dd19-48b7-a50d-087c4fc2e5de",1.85,0.17,"UV Spec","R","23","TCGA-EO-A3AS-01A-11R-A19W-07","0ce294d7-8111-474c-be3a-19195f5d49ab",0.17,NA,58,26.8406682400851,147,"b070a23e-2110-5b11-9cc8-6fc260fe0a3b","TCGA-EO-A3AS_exposure","UNCID_2177865.0ce294d7-8111-474c-be3a-19195f5d49ab.130402_UNC10-SN254_0447_BC22WAACXX_5_GGCTAC.tar.gz","2013-09-11T07:31:09.000Z","2013-09-11T07:44:02.000Z","668C9D82-B037-4B97-BB8E-187ED11FE62E","DDB6E07D-8764-4278-978D-7A878522DE6D","Unaligned reads",3883162167,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0CE294D7-8111-474C-BE3A-19195F5D49AB","University of North Carolina","56607e66e4b016715ab6ba0e","2C3E95B5-2C63-43C7-BAA2-47EF914B25A8","Uterine Corpus Endometrial Carcinoma","TARGZ","6B52A44D-1AB7-4C32-98EF-56DA5833432C","2013-09-11T07:44:02.000Z","31C37438-DD19-48B7-A50D-087C4FC2E5DE","Canada","NO",1,NA,"Primary Tumor","University Health Network",850,"6B52A44D-1AB7-4C32-98EF-56DA5833432C",NA,"EO","TCGA-EO-A3AS-01A-11R-A19V-13_mirna.bam",70,"TCGA-EO-A3AS-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","DDB6E07D-8764-4278-978D-7A878522DE6D",86,"nationwidechildrens.org_clinical.TCGA-EO-A3AS.xml","Alive",NA,"TCGA-EO-A3AS",NA,"8218FFEC-D87B-43F5-B7DD-D72D9C2F1997",NA,1046,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,NA,NA,11,30,"037BE131-53EA-4B16-9634-D2DA2E9D655A","DBC6B64B-4CB1-43FF-8AA3-DC20D4920244","TCGA-EO-A3AS-01A-11R-A19V-13_mirna.bam","TCGA-EO-A3AS-01A-11",80,0,0,0,18,"TOP",2,0,"TCGA-EO-A3AS-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-EO-A3AS-F38250_NTE-2","NO",1046,"TUMOR FREE","Alive",NA,"TCGA-EO-A3AS-F38250","TCGA-EO-A3AS",1,"EO","A3AS","YES","C54.1","8380/3","C54.1",NA,"YES",-31450,"FEMALE",NA,NA,"No","No","Alive",1046,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,86,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
103053566,100724642,4801374876,"3C5F7739-5DCC-4EAA-BB35-369C99B721C5.bw","2cf8de9f-b305-4d98-bfd4-33377bf6138f","3c5f7739-5dcc-4eaa-bb35-369c99b721c5","2016-08-09T13:16:07.404786-05:00","UNCID_2177803.2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f.130402_UNC10-SN254_0447_BC22WAACXX_7_GGCTAC.tar.gz","37691841-f776-48bf-bbf8-9eae605ab34a",4367365963,"Illumina HiSeq","7380ab4937aeef0ef97538e02d3903e1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:34:52.322636-05:00","2016-05-03T10:56:47.877475-05:00","37691841-f776-48bf-bbf8-9eae605ab34a_analysis.xml","5e2083c1c44d4b1a3e3d83b93f01f0b0","27a0fe5c-41db-43f9-846e-57814874b75f",2123,"2016-10-07T16:48:24.588029-05:00","37691841-f776-48bf-bbf8-9eae605ab34a_experiment.xml","a95e10702757ff8afde5bf08414b138d","3fc97ca7-4a46-4878-8f8b-929c5059cba0",2431,"2016-09-29T18:02:45.056345-05:00","37691841-f776-48bf-bbf8-9eae605ab34a_run.xml","a0d3de8190b968d0383a4d878cb69468","13b8fd8d-57b9-4b51-9413-d87844586a7c",354,"2016-09-08T11:26:24.242739-05:00","TCGA-EO-A3B1","2016-09-02T18:47:58.921686-05:00","female","TCGA-EO-A3B1_demographic",1948,"not reported","6f899329-75a0-56df-99c2-e4cc79c2a1c4","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3B1_diagnosis","not reported",23162,"alive","8441/3",NA,820,"fa7982cc-0b59-5be3-807e-b2dafcb02b85","c54.1",-23162,"TCGA-EO-A3B1_treatment","4ee400d4-e725-523a-bcbc-69b3cdb89b08","01","false","TCGA-EO-A3B1-01A",NA,"7407e162-9e38-49d0-9957-6e98775f5475",FALSE,"D3309430-5427-4FAD-BDD6-A6E9BABE29D2","Primary Tumor",NA,163,90,NA,1317686400,"12",10,"TCGA-EO-A3B1-01A-12",90,NA,20,NA,0,NA,10,NA,"2016-09-08T11:26:24.242739-05:00",NA,60,NA,20,NA,"TOP",NA,0,NA,"81b9161e-3271-4f85-bbb7-0612926e14fe",NA,"TCGA-EO-A3B1-01A-01-TSA",NA,90,NA,"89ad22ab-e48e-442f-aedf-959538892860","RNA","TCGA-EO-A3B1-01A-12R","ad00956a-3274-4ce1-a55f-a8caa7e2b3cb",1.79,0.15,"UV Spec","R","23","TCGA-EO-A3B1-01A-12R-A19W-07","2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f",0.15,NA,93,32.1799307958478,170,"36d80709-11f7-5660-b71b-12487da44b23","TCGA-EO-A3B1_exposure","UNCID_2177803.2b0670d8-a2b4-4e1b-a3b3-4ec277e0078f.130402_UNC10-SN254_0447_BC22WAACXX_7_GGCTAC.tar.gz","2013-09-11T18:36:04.000Z","2013-09-11T18:51:01.000Z","37691841-F776-48BF-BBF8-9EAE605AB34A","7407E162-9E38-49D0-9957-6E98775F5475","Unaligned reads",4367365963,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","2B0670D8-A2B4-4E1B-A3B3-4EC277E0078F","University of North Carolina","564a40d3e4b0298dd2ca2653","2CF8DE9F-B305-4D98-BFD4-33377BF6138F","Uterine Corpus Endometrial Carcinoma","TARGZ","89AD22AB-E48E-442F-AEDF-959538892860","2013-09-11T18:51:01.000Z","AD00956A-3274-4CE1-A55F-A8CAA7E2B3CB","Canada","NO",1,NA,"Primary Tumor","University Health Network",163,"89AD22AB-E48E-442F-AEDF-959538892860",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.266FC9A2-C102-471E-B05A-2A596507E0FB.txt",90,"TCGA-EO-A3B1-01A",NA,"88CFF985-56F3-40FF-A124-978DEC024914","TCGA",2011,NA,NA,"TUMOR FREE","7407E162-9E38-49D0-9957-6E98775F5475",63,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.266FC9A2-C102-471E-B05A-2A596507E0FB.txt","Alive",NA,"TCGA-EO-A3B1",NA,"B53F1C01-6965-49C2-B1F5-473765A87A0A",NA,337,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",186,NA,"EDAACCE5-2A7A-4981-9A48-172F64FA4993",NA,NA,12,10,"81B9161E-3271-4F85-BBB7-0612926E14FE","F7BF0456-C9A2-415B-836B-A3BE21A8458B","TCGA-EO-A3B1-01A-12R-A19V-13_mirna.bam","TCGA-EO-A3B1-01A-12",90,0,20,60,10,"TOP",0,20,"TCGA-EO-A3B1-01A-01-TSA",90,"carboplatin","Chemotherapy","TCGA-EO-A3B1-D39920","TCGA-EO-A3B1-R48644","External","Primary Tumor Field","TCGA-EO-A3B1-F48637_NTE-1","NO",820,"TUMOR FREE","Alive",NA,"TCGA-EO-A3B1-F48637","TCGA-EO-A3B1",1,"EO","A3B1","YES","C54.1","8441/3","C54.1","NO","YES",-23162,"FEMALE",NA,NA,"No","No","Alive",337,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,63,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
128859042,127559487,6093245725,"B544A291-0157-46F2-B686-8D80E6BDA6B2.bw","2d166dc0-8890-4b00-ab73-9e2dbb6c530d","b544a291-0157-46f2-b686-8d80e6bda6b2","2016-09-27T17:22:50.083139-05:00","UNCID_2168980.5d83ceb3-a3f0-419e-945a-a5cf49d439e9.130610_UNC14-SN744_0347_BD28NBACXX_4_CTTGTA.tar.gz","30518eb4-2783-4988-bcd4-36a1a8bb4dfa",5668623460,"Illumina HiSeq","6a5ac34beb7943905fc3e32eb06d62b4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:19:44.272757-05:00","2016-05-03T10:56:47.892124-05:00","30518eb4-2783-4988-bcd4-36a1a8bb4dfa_analysis.xml","349a8e1436c70a90029ab74915854518","fdcd5a19-d001-4ef0-bd12-1c584223ce0d",2129,"2016-09-29T23:06:04.346009-05:00","30518eb4-2783-4988-bcd4-36a1a8bb4dfa_experiment.xml","2515f9c35f288150377340933dc71dec","d0208e13-7068-40fd-b34f-f4bfb42e0a25",2600,"2016-09-29T23:27:34.926489-05:00","30518eb4-2783-4988-bcd4-36a1a8bb4dfa_run.xml","3067da8d5b0fe24327b68b8876922b19","dd780575-e4cc-47a6-9615-7bf7918a4e74",343,"2016-09-08T11:13:56.942185-05:00","TCGA-BK-A56F","2016-09-02T18:50:02.927100-05:00","female","TCGA-BK-A56F_demographic",1937,"black or african american","eb35520c-df45-5f2c-a0c9-e8edc9832a81","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A56F_diagnosis","not reported",27523,"alive","8380/3",NA,401,"8121aad3-2741-5b93-a575-16463d2f87f1","c54.1",-27523,"TCGA-BK-A56F_treatment","e8ca6047-6cfd-5ff0-9bb0-29364dff36a7","01","false","TCGA-BK-A56F-01A",NA,"ef8e84ff-3e1b-4543-99ee-56ee8687795c",FALSE,"2778F3EE-0211-4B51-8FBE-050FC7A4D0FF","Primary Tumor",NA,93,360,NA,1356652800,"32",30,"TCGA-BK-A56F-01A-32",60,NA,0,NA,0,NA,0,NA,"2016-09-08T11:13:56.942185-05:00",NA,3,NA,0,NA,"TOP",NA,10,NA,"5a054b42-a230-4735-ac43-5db1376d3b02",NA,"TCGA-BK-A56F-01A-03-TS3",NA,90,NA,"9e0ce335-1b3c-40e3-8766-94bf707a33c0","RNA","TCGA-BK-A56F-01A-32R","cd92de77-749b-4bcf-ae15-05d048ba7db6",1.9,0.16,"UV Spec","R","23","TCGA-BK-A56F-01A-32R-A27V-07","5d83ceb3-a3f0-419e-945a-a5cf49d439e9",0.16,NA,84,31.6157928412812,163,"19430dbe-c729-5990-96d3-f2c22aa354ab","TCGA-BK-A56F_exposure","UNCID_2168980.5d83ceb3-a3f0-419e-945a-a5cf49d439e9.130610_UNC14-SN744_0347_BD28NBACXX_4_CTTGTA.tar.gz","2013-09-01T00:56:27.000Z","2013-09-10T15:52:01.000Z","30518EB4-2783-4988-BCD4-36A1A8BB4DFA","EF8E84FF-3E1B-4543-99EE-56EE8687795C","Unaligned reads",5668623460,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","5D83CEB3-A3F0-419E-945A-A5CF49D439E9","University of North Carolina","564a3b4fe4b093830b693d54","2D166DC0-8890-4B00-AB73-9E2DBB6C530D","Uterine Corpus Endometrial Carcinoma","TARGZ","9E0CE335-1B3C-40E3-8766-94BF707A33C0","2013-09-10T15:52:01.000Z","CD92DE77-749B-4BCF-AE15-05D048BA7DB6","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",93,"9E0CE335-1B3C-40E3-8766-94BF707A33C0",NA,"BK","DOUSE_p_TCGA_287_288_289_N_GenomeWideSNP_6_C12_1361112.ismpolish.data.txt",360,"TCGA-BK-A56F-01A",NA,NA,"TCGA",2012,"TCGA-BK-A56F_NTE-1","Complete Remission/Response","TUMOR FREE","EF8E84FF-3E1B-4543-99EE-56EE8687795C",75,"96326e33b68be86b4b70ae4381a5204b.bam.bai","Alive",NA,"TCGA-BK-A56F","NOT HISPANIC OR LATINO","D14FF341-1079-46B4-A9E3-0E3844A50F50","NO",200,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",289,NA,"8027EDB3-45F5-4EB9-840C-6633671E2B2E","BLACK OR AFRICAN AMERICAN",NA,32,30,"5A054B42-A230-4735-AC43-5DB1376D3B02","CD92DE77-749B-4BCF-AE15-05D048BA7DB6","UNCID_2088033.5d83ceb3-a3f0-419e-945a-a5cf49d439e9.sorted_genome_alignments.bam.bai","TCGA-BK-A56F-01A-32",60,0,0,3,0,"TOP",10,0,"TCGA-BK-A56F-01A-03-TS3",90,NA,NA,NA,"TCGA-BK-A56F-R41866","Internal","Primary Tumor Field","TCGA-BK-A56F-F49745_NTE-1","NO",401,"TUMOR FREE","Alive",NA,"TCGA-BK-A56F-F49745","TCGA-BK-A56F",1,"BK","A56F","YES","C54.1","8380/3","C54.1","YES","NO",-27523,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",200,NA,"YES","NO","TUMOR FREE","YES",2,4,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,75,2012,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34856611,33379405,2499902883,"2B2A92C8-005A-4724-9AE0-55450D65A809.bw","2d750c67-24a2-4b12-b4f2-dbd65f2f27f0","2b2a92c8-005a-4724-9ae0-55450d65a809","2016-08-05T00:52:03.370369-05:00","UNCID_2210668.85dd6956-38ee-4f12-9210-ffe2a8964aef.110323_UNC3-RDR300156_00085_FC_706FWAAXX_8.tar.gz","2e01f3cb-d777-440a-9e32-82ee3195d1a5",2347644295,"Illumina GA","c5b1b6bc2829c2f657468e0816d2ea7c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:04:44.680597-05:00","2016-05-03T11:15:47.421196-05:00","2e01f3cb-d777-440a-9e32-82ee3195d1a5_analysis.xml","765e5c2f2950820448f62b310922d30c","15037647-4b28-41be-ba2e-eaee60f113d1",2121,"2016-10-07T17:46:01.517337-05:00","2e01f3cb-d777-440a-9e32-82ee3195d1a5_experiment.xml","699145af116183f707f0346d9849a77b","46d4a853-9afe-42ca-951c-7240fdc006ce",2257,"2016-09-29T20:58:48.057614-05:00","2e01f3cb-d777-440a-9e32-82ee3195d1a5_run.xml","3b79c8c34f7bc8fa8fe163747142d994","813f86c2-d239-429d-91d9-db288423b390",347,"2016-09-08T11:19:15.728288-05:00","TCGA-BG-A0W1","2016-09-02T18:49:01.335917-05:00","female","TCGA-BG-A0W1_demographic",1918,"white","2b410e4c-7ff6-5e08-9cd0-f4797aa28dc8","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0W1_diagnosis","not reported",32750,"alive","8380/3",NA,1607,"2f57195e-be66-5f99-a9cf-800a9d022168","c54.1",-32750,"TCGA-BG-A0W1_treatment","a93e2a76-3c1c-5b5e-86dc-a889d27ac599","01","true","TCGA-BG-A0W1-01A",NA,"13dec3d1-c7f8-4b95-bd54-2d3136cee001",FALSE,"BE7CC54D-8220-4AC6-9F8D-016DE4167B35","Primary Tumor",NA,1014,100,NA,1286841600,"12",30,"TCGA-BG-A0W1-01A-12",70,70,20,20,0,0,25,25,"2016-09-08T11:19:15.728288-05:00","2016-09-08T11:19:15.728288-05:00",30,40,40,30,"TOP","BOTTOM",5,5,"b9956c37-9819-452f-8801-060a34b6d8a2","c7710ddc-5e2b-477c-b3b3-15288725879e","TCGA-BG-A0W1-01A-01-TSA","TCGA-BG-A0W1-01A-01-BSA",70,70,"b0a10b30-eb19-4394-a58f-0ebe0e9d8840","RNA","TCGA-BG-A0W1-01A-12R","5816c645-9360-4310-aec6-8c7e47a9b6f5",1.87,0.16,"UV Spec","R","23","TCGA-BG-A0W1-01A-12R-A109-07","85dd6956-38ee-4f12-9210-ffe2a8964aef",0.16,NA,56,33.1360946745562,130,"2059e12b-1bdf-525d-8340-75d46aa61b61","TCGA-BG-A0W1_exposure","UNCID_2210668.85dd6956-38ee-4f12-9210-ffe2a8964aef.110323_UNC3-RDR300156_00085_FC_706FWAAXX_8.tar.gz","2013-10-02T14:43:05.000Z","2013-10-02T14:56:03.000Z","2E01F3CB-D777-440A-9E32-82EE3195D1A5","13DEC3D1-C7F8-4B95-BD54-2D3136CEE001","Unaligned reads",2347644295,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","85DD6956-38EE-4F12-9210-FFE2A8964AEF","University of North Carolina","564a414ae4b08c5d86936652","2D750C67-24A2-4B12-B4F2-DBD65F2F27F0","Uterine Corpus Endometrial Carcinoma","TARGZ","B0A10B30-EB19-4394-A58F-0EBE0E9D8840","2013-10-02T14:56:03.000Z","5816C645-9360-4310-AEC6-8C7E47A9B6F5","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",1014,"B0A10B30-EB19-4394-A58F-0EBE0E9D8840",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.882F0777-CF03-43CE-ACAD-42A6E98D7D64.txt",100,"TCGA-BG-A0W1-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","19AF9EB8-1EB3-4E2C-A329-F9A12E4ED672",89,"nationwidechildrens.org_clinical.TCGA-BG-A0W1.xml","Alive",NA,"TCGA-BG-A0W1","NOT HISPANIC OR LATINO","78B50566-6118-4C17-972E-7B214F01CB67",NA,908,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",75,NA,NA,"WHITE",NA,12,30,"C7710DDC-5E2B-477C-B3B3-15288725879E","FFB45D83-93C9-44F3-B23C-E5D09793880F","UNCID_294281.TCGA-BG-A0W1-01A-12R-A109-07.110323_UNC3-RDR300156_00085_FC_706FWAAXX.8.trimmed.annotated.translated_to_genomic.bam","TCGA-BG-A0W1-01A-12",70,0,20,40,25,"BOTTOM",5,30,"TCGA-BG-A0W1-01A-01-BSA",70,NA,NA,NA,NA,NA,NA,"TCGA-BG-A0W1-F34127_NTE-1","NO",1607,"TUMOR FREE","Alive",NA,"TCGA-BG-A0W1-F34127","TCGA-BG-A0W1",1,"BG","A0W1","YES","C54.1","8380/3","C54.1","NO","YES",-32750,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",908,NA,NA,NA,"TUMOR FREE","NO",18,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,89,2007,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32010218,30885865,2309753449,"E3C1D3D8-1C78-4C16-B0E5-56B5CCE3C6B4.bw","2db0fb62-64ce-457c-9e22-dd05ef59f684","e3c1d3d8-1c78-4c16-b0e5-56b5cce3c6b4","2016-08-06T04:20:06.695564-05:00","UNCID_2214571.65e557db-24de-47df-827c-d8336cb099eb.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_2.tar.gz","3d127e39-d41d-46d9-af98-5a1ae551a8e4",2016484136,"Illumina GA","f5a4ae41b33d17e83a00ffd2f7a4f908","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:59:22.581257-05:00","2016-05-03T11:17:14.875385-05:00","3d127e39-d41d-46d9-af98-5a1ae551a8e4_analysis.xml","169e5c6c5091d95b1c2b198ff04a0acd","f14652fe-91ac-4fe3-978c-7048ebf0f515",2121,"2016-09-29T21:31:13.400779-05:00","3d127e39-d41d-46d9-af98-5a1ae551a8e4_experiment.xml","aea7e7447c3d6f20d33cd7b04adc52fb","957bfb92-48de-43f4-bc54-c74c99e0b0aa",2257,"2016-09-29T22:42:34.820794-05:00","3d127e39-d41d-46d9-af98-5a1ae551a8e4_run.xml","58b02e9342aae5a06ea30d032f53b695","c19291e6-610c-4234-9d62-16286752ee78",347,"2016-09-08T11:10:58.240470-05:00","TCGA-A5-A0VP","2016-09-02T18:47:50.896745-05:00","female","TCGA-A5-A0VP_demographic",1934,"white","ad5dab9e-da95-57a2-aee7-1d0708b16f05","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0VP_diagnosis","not reported",27335,"alive","8380/3",NA,1288,"956c0fb2-eb4d-52ce-9e44-b01eaab459fb","c54.1",-27335,"TCGA-A5-A0VP_treatment","a3666392-744d-5d18-800e-443e3171d222","01","true","TCGA-A5-A0VP-01A",NA,"f1fbe4ac-f3fd-4609-9a2b-507820abe77e",FALSE,"960B26D6-F9BA-4099-B6F4-6D1DEA6C0F0F","Primary Tumor",NA,930,210,NA,1285200000,"21",30,"TCGA-A5-A0VP-01A-21",100,100,0,0,0,0,0,0,"2016-09-08T11:10:58.240470-05:00","2016-09-08T11:10:58.240470-05:00",20,10,20,10,"TOP","BOTTOM",20,10,"abdeff57-30c9-4dbb-8cae-3fa75f69985a","c26c680b-9d2a-4184-9f1a-5d37e003fec2","TCGA-A5-A0VP-01A-02-TSB","TCGA-A5-A0VP-01A-02-BSB",80,90,"01e32eb2-846e-4cda-b5a4-4aaff5b0a017","RNA","TCGA-A5-A0VP-01A-21R","7baaba1e-ffff-4427-b357-e7ae29e6d850",1.83,0.14,"UV Spec","R","23","TCGA-A5-A0VP-01A-21R-A104-07","65e557db-24de-47df-827c-d8336cb099eb",0.14,NA,58,21.8299521999323,163,"4ca458f8-e709-5c31-8435-d938e8b0e5d8","TCGA-A5-A0VP_exposure","UNCID_2214571.65e557db-24de-47df-827c-d8336cb099eb.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_2.tar.gz","2013-10-03T17:46:05.000Z","2013-10-03T17:59:02.000Z","3D127E39-D41D-46D9-AF98-5A1AE551A8E4","F1FBE4AC-F3FD-4609-9A2B-507820ABE77E","Unaligned reads",2016484136,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","65E557DB-24DE-47DF-827C-D8336CB099EB","University of North Carolina","5660760fe4b016715ab68a75","2DB0FB62-64CE-457C-9E22-DD05EF59F684","Uterine Corpus Endometrial Carcinoma","TARGZ","01E32EB2-846E-4CDA-B5A4-4AAFF5B0A017","2013-10-03T17:59:02.000Z","7BAABA1E-FFFF-4427-B357-E7AE29E6D850","None","NO",1,NA,"Primary Tumor","Cedars Sinai",930,"01E32EB2-846E-4CDA-B5A4-4AAFF5B0A017",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.82ADD7F4-FACD-40DF-A2F0-FAC4DCFEB876.txt",210,"TCGA-A5-A0VP-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","F1FBE4AC-F3FD-4609-9A2B-507820ABE77E",74,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.82ADD7F4-FACD-40DF-A2F0-FAC4DCFEB876.txt","Alive",NA,"TCGA-A5-A0VP","NOT HISPANIC OR LATINO","AA184B9B-42B9-49B1-BE89-EA7928F2075C",NA,928,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"AB06BCA0-EC76-4839-8670-BE15D018E065","WHITE",NA,21,30,"C26C680B-9D2A-4184-9F1A-5D37E003FEC2","E1EC61C8-FB5D-49A8-9737-FD216F9B7C62","TCGA-A5-A0VP-01A-21R-A103-13_mirna.bam.bai","TCGA-A5-A0VP-01A-21",100,0,0,10,0,"BOTTOM",10,10,"TCGA-A5-A0VP-01A-02-BSB",90,NA,NA,NA,"TCGA-A5-A0VP-R3372","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",1288,"TUMOR FREE","Alive",NA,"TCGA-A5-A0VP-F17166","TCGA-A5-A0VP",1,"A5","A0VP","YES","C54.1","8380/3","C54.1","NO","YES",-27335,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",928,NA,NA,NA,"TUMOR FREE","NO",15,11,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34444698,33263568,2495397729,"3C9FDA2A-01C8-4F17-BBF1-5CAEAE3764D4.bw","2e5cf721-90b1-4470-b430-f055a1297c7f","3c9fda2a-01c8-4f17-bbf1-5caeae3764d4","2016-08-31T12:38:40.736665-05:00","UNCID_2212167.0cbb432d-fbb9-4c0e-b126-3bb862ab8602.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_1.tar.gz","8a6b3eae-43fc-471a-acde-84fb4492eb7b",2140012448,"Illumina GA","7d781c1ef0c0c850754d436be2196f85","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:31:59.255976-05:00","2016-05-03T11:16:29.242391-05:00","8a6b3eae-43fc-471a-acde-84fb4492eb7b_analysis.xml","2a85797dfd78723cfa1fbecce8f707cc","002d3e63-51d9-4104-9623-a2211e49f80d",2121,"2016-09-29T18:09:46.623487-05:00","8a6b3eae-43fc-471a-acde-84fb4492eb7b_experiment.xml","6f24ae620df1698019e5509cdaa8a9e5","1827aa31-258a-45b7-bdb6-7581b6b245ec",2257,"2016-09-29T22:06:10.445347-05:00","8a6b3eae-43fc-471a-acde-84fb4492eb7b_run.xml","ad28d4fef54da65a7021c4b8e414dd3e","ab2a67b6-6d8e-48ca-861c-d34a7dbd3427",347,"2016-09-08T10:48:09.952891-05:00","TCGA-AX-A0IS","2016-09-02T18:49:04.440661-05:00","female","TCGA-AX-A0IS_demographic",1956,"white","811f735d-e0fb-5847-abb3-90d83e5f56da","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A0IS_diagnosis","not reported",19173,"dead","8380/3",1858,1541,"50933fe1-0bd4-5217-b7aa-17045b465258","c54.1",-19173,"TCGA-AX-A0IS_treatment","d0266d3d-1b6e-5a98-9ece-15666d89b317","01","false","TCGA-AX-A0IS-01A",NA,"f46f87a5-2edd-469d-9d28-a37284bd077a",FALSE,"35606B48-9820-4F59-8090-1F8D448DB9FB","Primary Tumor",NA,805,90,NA,1275609600,"12",20,"TCGA-AX-A0IS-01A-12",80,90,0,0,10,0,10,15,"2016-09-08T10:48:09.952891-05:00","2016-09-08T10:48:09.952891-05:00",8,4,1,0,"TOP","BOTTOM",3,2,"940a4fcc-0a93-4a1c-8fb0-0ea7f3ae6dde","2c300c3b-6b48-43b5-acc6-392052fd93e0","TCGA-AX-A0IS-01A-01-TSA","TCGA-AX-A0IS-01A-01-BSA",77,83,"86ccf475-4da8-470f-b476-5fe408a09669","RNA","TCGA-AX-A0IS-01A-12R","5bb9485b-97bb-4f90-b640-4526c13df4fd",1.73,0.14,"UV Spec","R","23","TCGA-AX-A0IS-01A-12R-A10J-07","0cbb432d-fbb9-4c0e-b126-3bb862ab8602",0.14,NA,132,46.7687074829932,168,"40793c86-8c9d-5529-85ed-e713735ed9e5","TCGA-AX-A0IS_exposure","UNCID_2212167.0cbb432d-fbb9-4c0e-b126-3bb862ab8602.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_1.tar.gz","2013-10-03T06:01:04.000Z","2013-10-03T06:19:02.000Z","8A6B3EAE-43FC-471A-ACDE-84FB4492EB7B","F46F87A5-2EDD-469D-9D28-A37284BD077A","Unaligned reads",2140012448,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0CBB432D-FBB9-4C0E-B126-3BB862AB8602","University of North Carolina","564a3a3be4b0ef12181a1123","2E5CF721-90B1-4470-B430-F055A1297C7F","Uterine Corpus Endometrial Carcinoma","TARGZ","86CCF475-4DA8-470F-B476-5FE408A09669","2013-10-03T06:19:02.000Z","5BB9485B-97BB-4F90-B640-4526C13DF4FD","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",805,"86CCF475-4DA8-470F-B476-5FE408A09669",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BD9FE914-A8A6-4F03-9C96-557466D03CAC.txt",90,"TCGA-AX-A0IS-01A",NA,"DE843F83-2D05-474D-894B-730CC46BEEC9","TCGA",2008,NA,NA,"WITH TUMOR","F46F87A5-2EDD-469D-9D28-A37284BD077A",52,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BD9FE914-A8A6-4F03-9C96-557466D03CAC.txt","Alive",NA,"TCGA-AX-A0IS","NOT HISPANIC OR LATINO","406BCFB3-EAAD-407B-9FBE-34D357C586F5",NA,1065,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,12,20,"940A4FCC-0A93-4A1C-8FB0-0EA7F3AE6DDE","C259189F-2D0B-4FA4-B6E9-EEA18A16288E","TCGA-AX-A0IS-01A-12R-A10I-13_mirna.bam.bai","TCGA-AX-A0IS-01A-12",80,10,0,8,10,"TOP",3,1,"TCGA-AX-A0IS-01A-01-TSA",77,"Gemzar",NA,"TCGA-AX-A0IS-D9735",NA,NA,NA,NA,NA,1065,"WITH TUMOR","Alive",NA,"TCGA-AX-A0IS-F9731","TCGA-AX-A0IS",1,"AX","A0IS","YES","C54.1","8380/3","C54.1","NO","YES",-19173,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1065,NA,NA,NA,"WITH TUMOR","NO",17,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,52,2008,"Other method, specify:",NA,NA,NA,"G2","R1",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34577369,32591980,2448600794,"604E7A74-7B6D-4E9B-8FDF-A1CCEE6FD2E6.bw","2f0640bc-598c-4714-9e9b-7e0f2ca4567f","604e7a74-7b6d-4e9b-8fdf-a1ccee6fd2e6","2016-08-09T14:17:35.151831-05:00","UNCID_2214442.444a9114-2e40-4e7c-979a-624bc95d4c47.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_5.tar.gz","bc02f4bb-51ca-423f-99c7-8151ac3f7c0e",2150368028,"Illumina GA","b82f0d221ab2a6a9d48d1d76e8a84be8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:59:12.300088-05:00","2016-05-03T11:17:14.896869-05:00","bc02f4bb-51ca-423f-99c7-8151ac3f7c0e_analysis.xml","f1dafe11baaedda964e610d295f6c5e4","37276e6d-fdc7-49e3-9a92-7f6c07596f2d",2121,"2016-08-13T09:26:13.883731-05:00","bc02f4bb-51ca-423f-99c7-8151ac3f7c0e_experiment.xml","f4f41ee64cc5241eb38a3e90b234e8c7","bc445052-3873-4b80-ad01-cdfdac889af9",2257,"2016-09-30T00:10:09.428241-05:00","bc02f4bb-51ca-423f-99c7-8151ac3f7c0e_run.xml","89f7788ed4f13b0ebc423d1a49517f88","f7c65524-810e-4fa8-96d8-0b1be7d8b0c1",347,"2016-09-08T10:57:35.166558-05:00","TCGA-B5-A0K7","2016-09-02T18:48:00.039446-05:00","female","TCGA-B5-A0K7_demographic",1945,"white","a7d688f5-0410-5408-8e94-f4d5621df1df","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0K7_diagnosis","not reported",23429,"alive","8380/3",NA,1933,"2db53c86-27d4-5a81-a2a0-6ac0e682102b","c54.1",-23429,"TCGA-B5-A0K7_treatment","3e5c4e8d-5a8a-55ea-bd1b-7b7f72c11076","01","true","TCGA-B5-A0K7-01A",NA,"51e8577d-6849-422e-8f37-2ea8c400bbe5",FALSE,"5C3818CE-5DA9-403E-B895-61DEA4BBFA57","Primary Tumor",NA,184,1160,NA,1277769600,"11",30,"TCGA-B5-A0K7-01A-11",85,85,0,0,0,0,0,0,"2016-09-08T10:57:35.166558-05:00","2016-09-08T10:57:35.166558-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"3c196ee4-4510-4904-a038-94a81ac1c9b9","b8636a59-070b-4875-9692-4d7b6c74a799","TCGA-B5-A0K7-01A-01-TSA","TCGA-B5-A0K7-01A-01-BSA",100,100,"e7178389-6e08-43eb-be9f-64668d92d56f","RNA","TCGA-B5-A0K7-01A-11R","4f755ee1-c93b-407d-b8d0-cecbe9dcc033",1.72,0.13,"UV Spec","R","23","TCGA-B5-A0K7-01A-11R-A104-07","444a9114-2e40-4e7c-979a-624bc95d4c47",0.13,NA,61,21.6128117913832,168,"1c2dd909-f3cc-53db-8dd5-44b2b72cbf49","TCGA-B5-A0K7_exposure","UNCID_2214442.444a9114-2e40-4e7c-979a-624bc95d4c47.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_5.tar.gz","2013-10-03T16:06:06.000Z","2013-10-03T16:20:03.000Z","BC02F4BB-51CA-423F-99C7-8151AC3F7C0E","51E8577D-6849-422E-8F37-2EA8C400BBE5","Unaligned reads",2150368028,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","444A9114-2E40-4E7C-979A-624BC95D4C47","University of North Carolina","564a332be4b0ef121817ce55","2F0640BC-598C-4714-9E9B-7E0F2CA4567F","Uterine Corpus Endometrial Carcinoma","TARGZ","E7178389-6E08-43EB-BE9F-64668D92D56F","2013-10-03T16:20:03.000Z","4F755EE1-C93B-407D-B8D0-CECBE9DCC033","United States","NO",1,NA,"Primary Tumor","Duke",184,"E7178389-6E08-43EB-BE9F-64668D92D56F",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4CC6CB63-CD6A-4683-B5C9-4C9F9FBF09C8.txt",1160,"TCGA-B5-A0K7-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","7CC26CBE-ED1E-4AB4-A83A-C776DFCB4FFD",64,"nationwidechildrens.org_clinical.TCGA-B5-A0K7.xml","Alive",NA,"TCGA-B5-A0K7",NA,"8FEAFE5B-4925-459C-A849-35ADAC50E788",NA,372,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"6823EC0A-CD8E-42FF-BFCC-AD438B72EBD1","WHITE",NA,11,30,"B8636A59-070B-4875-9692-4D7B6C74A799","D122E4EE-8A96-422E-AF06-56C362AFDCAA","TCGA-B5-A0K7-01A-11R-A103-13_mirna.bam","TCGA-B5-A0K7-01A-11",85,0,0,0,0,"BOTTOM",0,0,"TCGA-B5-A0K7-01A-01-BSA",100,NA,NA,NA,"TCGA-B5-A0K7-R10036","EXTERNAL BEAM","Local Recurrence",NA,"YES",520,"TUMOR FREE","Alive",NA,"TCGA-B5-A0K7-F13511","TCGA-B5-A0K7",1,"B5","A0K7","YES","C54.1","8380/3","C54.1","NO","YES",-23429,"FEMALE","WHITE",NA,"No","No","Alive",372,NA,NA,NA,"TUMOR FREE","NO",20,1,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35893206,35615839,2632753553,"FECFA1E7-2578-405C-A707-DA877BF4B2FF.bw","2f4458b6-3caf-4e33-890e-a04722badd1b","fecfa1e7-2578-405c-a707-da877bf4b2ff","2016-08-05T11:52:10.237023-05:00","UNCID_2215028.12960b87-9d83-41e5-8980-a1ebe955fd73.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_2.tar.gz","f4eb7824-a499-47b6-a908-a30d0e584868",2259422224,"Illumina GA","c068d5b933af7332760bc916368a4dc4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:21:01.076955-05:00","2016-05-03T11:17:14.882251-05:00","f4eb7824-a499-47b6-a908-a30d0e584868_analysis.xml","c9c5b3ac5445df70b379f69019d76a16","b415032b-d4c4-4454-b603-533c0bddcc08",2122,"2016-09-29T19:43:47.954290-05:00","f4eb7824-a499-47b6-a908-a30d0e584868_experiment.xml","83f9e582608287470d555601af6498a1","5314078d-f15c-4df3-a9f6-edc354bb8212",2256,"2016-09-29T19:56:15.550398-05:00","f4eb7824-a499-47b6-a908-a30d0e584868_run.xml","bc783f71c03c9234e9a148e218991ce5","5ade8e88-01a9-4e2d-bfda-8a5315355207",345,"2016-09-08T10:37:17.540555-05:00","TCGA-A5-A0GB","2016-09-02T18:54:07.199434-05:00","female","TCGA-A5-A0GB_demographic",1943,"white","b6988514-2f1c-5264-b604-412054c5d4ec","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GB_diagnosis","not reported",23883,"alive","8380/3",NA,997,"aafd3d0a-9b88-5dbe-8e83-18aaccc30289","c54.1",-23883,"TCGA-A5-A0GB_treatment","7197d523-7793-5e75-9fc6-af3694d40210","01","true","TCGA-A5-A0GB-01A",NA,"130744ca-a9a2-4c99-8abb-20fe76e0a955",FALSE,"8AC80DBE-46DE-46D5-B900-C807CBE941A6","Primary Tumor",NA,583,190,NA,1275955200,"11",30,"TCGA-A5-A0GB-01A-11",90,90,0,0,0,0,0,0,"2016-09-08T10:37:17.540555-05:00","2016-09-08T10:37:17.540555-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"53aac88b-c777-4c27-ba31-97d351b51b80","25405f52-e599-41e8-82e7-248e9f2a2fc6","TCGA-A5-A0GB-01A-01-BSA","TCGA-A5-A0GB-01A-01-TSA",100,100,"15061268-90ca-45a4-a72f-b88b5f81d52a","RNA","TCGA-A5-A0GB-01A-11R","b60870d7-218a-4a10-8a7f-e1431632918d",1.86,0.16,"UV Spec","R","23","TCGA-A5-A0GB-01A-11R-A040-07","12960b87-9d83-41e5-8980-a1ebe955fd73",0.16,NA,122,44.811753902663,165,"e4415b90-5857-57a7-a438-acd9c9e531b6","TCGA-A5-A0GB_exposure","UNCID_2215028.12960b87-9d83-41e5-8980-a1ebe955fd73.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_2.tar.gz","2013-10-03T23:16:03.000Z","2013-10-03T23:28:03.000Z","F4EB7824-A499-47B6-A908-A30D0E584868","130744CA-A9A2-4C99-8ABB-20FE76E0A955","Unaligned reads",2259422224,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","12960B87-9D83-41E5-8980-A1EBE955FD73","University of North Carolina","566079dfe4b0b37b3d991be7","2F4458B6-3CAF-4E33-890E-A04722BADD1B","Uterine Corpus Endometrial Carcinoma","TARGZ","15061268-90CA-45A4-A72F-B88B5F81D52A","2013-10-03T23:28:03.000Z","B60870D7-218A-4A10-8A7F-E1431632918D","None","NO",1,NA,"Primary Tumor","Cedars Sinai",583,"15061268-90CA-45A4-A72F-B88B5F81D52A",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3E2E3076-D429-48E0-8EB2-4021717BEDB3.txt",190,"TCGA-A5-A0GB-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","BD040510-4425-4F67-836F-AD1523E2E035",65,"TCGA-A5-A0GB-01A-11W-A062-09_IlluminaGA-DNASeq_exome.bam.bai","Alive",NA,"TCGA-A5-A0GB",NA,"DC73EE1F-293D-4A73-BDB9-7A46037E39BC",NA,275,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"CCA58577-5AB1-4D50-A2F9-65DA5FF2CD7C","WHITE",NA,11,30,"53AAC88B-C777-4C27-BA31-97D351B51B80","B759CBF1-7E4C-4785-A7D2-9E1FA8B8FABD","TCGA-A5-A0GB-01A-11W-A062-09_IlluminaGA-DNASeq_exome.bam","TCGA-A5-A0GB-01A-11",90,0,0,0,0,"BOTTOM",0,0,"TCGA-A5-A0GB-01A-01-BSA",100,NA,NA,NA,"TCGA-A5-A0GB-R3046","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",997,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GB-F17157","TCGA-A5-A0GB",1,"A5","A0GB","YES","C54.1","8380/3","C54.1","NO","YES",-23883,"FEMALE","WHITE",NA,"No","No","Alive",275,NA,NA,NA,"TUMOR FREE","NO",10,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35160194,34756462,2592346441,"F34C6373-2BC9-49FC-A920-1889E9356D9E.bw","2fe46394-cfc5-44bb-81a9-e438a0126f5b","f34c6373-2bc9-49fc-a920-1889e9356d9e","2016-08-09T14:17:38.897986-05:00","UNCID_2203923.f26a449d-f3c6-4968-a2f7-4708a5686707.111018_UNC2-RDR300275_00092_FC_634BHAAXX_1.tar.gz","bee5541c-a6e0-4ce8-a7de-f96fc5d5b6ac",2318254850,"Illumina GA","2bd548f01c9934d26179ccd190ac47de","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:18:12.255178-05:00","2016-05-03T11:18:47.010651-05:00","bee5541c-a6e0-4ce8-a7de-f96fc5d5b6ac_analysis.xml","51665899f0d4ea4a631dd27935583bde","fcca808a-6960-4174-ac69-a97b22c94710",2121,"2016-08-26T18:01:56.975096-05:00","bee5541c-a6e0-4ce8-a7de-f96fc5d5b6ac_experiment.xml","8da86a18f55deaddd9e4ba1b2fd1dba2","7b6a3a32-9a85-44cd-a568-769883730a21",2257,"2016-09-29T20:09:46.077929-05:00","bee5541c-a6e0-4ce8-a7de-f96fc5d5b6ac_run.xml","0755365a3cae2c40d843b5b587012ef1","63051560-ae9d-41a8-91d9-671ec30c2862",347,"2016-09-08T10:39:36.289979-05:00","TCGA-A5-A1OK","2016-09-02T18:52:27.554753-05:00","female","TCGA-A5-A1OK_demographic",1947,"white","b346824d-c961-5a69-978a-f04452f8b1f0","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A1OK_diagnosis","not reported",23179,"alive","8380/3",NA,917,"e73b3dc2-47fc-5c48-8b85-fa0416bad555","c54.1",-23179,"TCGA-A5-A1OK_treatment","59b1d10b-6e11-599b-b664-f48e0bf1bc14","01","true","TCGA-A5-A1OK-01A",NA,"0eaf63cf-3cf6-4049-b0ab-aedb65db648d",FALSE,"1B0C95FC-7AA7-4F82-807D-85C579B6BF74","Primary Tumor",NA,113,250,NA,1301270400,"11",30,"TCGA-A5-A1OK-01A-11",80,NA,20,NA,0,NA,15,NA,"2016-09-08T10:39:36.289979-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"0c3d307c-8019-4790-b303-42aa5d30ccb8",NA,"TCGA-A5-A1OK-01A-01-TSA",NA,80,NA,"69bbd232-5c94-4874-972e-def4f9e494a4","RNA","TCGA-A5-A1OK-01A-11R","2f9b747a-2227-4414-8473-46faebcfb8a2",1.92,0.16,"UV Spec","R","23","TCGA-A5-A1OK-01A-11R-A14M-07","f26a449d-f3c6-4968-a2f7-4708a5686707",0.16,NA,87,31.9559228650138,165,"2093f8b4-d6c1-5c15-ba5a-53d89e5b372c","TCGA-A5-A1OK_exposure","UNCID_2203923.f26a449d-f3c6-4968-a2f7-4708a5686707.111018_UNC2-RDR300275_00092_FC_634BHAAXX_1.tar.gz","2013-10-04T07:46:05.000Z","2013-10-04T07:59:02.000Z","BEE5541C-A6E0-4CE8-A7DE-F96FC5D5B6AC","0EAF63CF-3CF6-4049-B0AB-AEDB65DB648D","Unaligned reads",2318254850,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","F26A449D-F3C6-4968-A2F7-4708A5686707","University of North Carolina","56607566e4b0ec1099f8b90a","2FE46394-CFC5-44BB-81A9-E438A0126F5B","Uterine Corpus Endometrial Carcinoma","TARGZ","69BBD232-5C94-4874-972E-DEF4F9E494A4","2013-10-04T07:59:02.000Z","2F9B747A-2227-4414-8473-46FAEBCFB8A2","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",113,"69BBD232-5C94-4874-972E-DEF4F9E494A4",NA,"A5","TCGA-A5-A1OK-01A-11R-A14L-13_mirna.bam.bai",250,"TCGA-A5-A1OK-01A",NA,"E070191B-E5FA-4DF8-8218-C0A3C56E2D05","TCGA",2010,NA,NA,"TUMOR FREE","65208656-D7E1-493A-8806-90B4E82D701F",63,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.89E5A639-E1A4-424B-9739-8A19067FFAE0.txt","Alive",NA,"TCGA-A5-A1OK","NOT HISPANIC OR LATINO","DB8F3F3B-8C88-487B-B496-7820E9506CE9",NA,244,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",125,NA,"F796841A-52E4-4594-BBBB-85FD3DCECD3C","WHITE",NA,11,30,"0C3D307C-8019-4790-B303-42AA5D30CCB8","B9B3F36C-4F65-4DDE-BC8D-55FE7CFF110B","UNCID_596823.f26a449d-f3c6-4968-a2f7-4708a5686707.111018_UNC2-RDR300275_00092_FC_634BHAAXX.1.trimmed.annotated.translated_to_genomic.bam","TCGA-A5-A1OK-01A-11",80,0,20,40,15,"TOP",5,20,"TCGA-A5-A1OK-01A-01-TSA",80,"Carboplatin","Chemotherapy","TCGA-A5-A1OK-D14472","TCGA-A5-A1OK-R14474","IMPLANTS","Primary Tumor Field","TCGA-A5-A1OK-F51587_NTE-1","NO",917,"TUMOR FREE","Alive",NA,"TCGA-A5-A1OK-F51587","TCGA-A5-A1OK",1,"A5","A1OK","YES","C54.1","8380/3","C54.1","YES","NO",-23179,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",244,NA,NA,NA,"TUMOR FREE","NO",1,8,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
117716958,112229079,5352713930,"AFFB9247-0AD0-4569-A1FB-643FC8492850.bw","3052065a-b8b1-48d3-971d-9d605292249c","affb9247-0ad0-4569-a1fb-643fc8492850","2016-08-09T13:14:52.427102-05:00","UNCID_2173523.bbf7786d-0996-47fc-8af9-482d2087ccb1.130502_UNC12-SN629_0289_AC236KACXX_5_ATGTCA.tar.gz","33ed2d3e-08e3-42f8-b8a9-ebbee2be193c",5489839707,"Illumina HiSeq","6adaa8ac9b4dbb6d6f8175bc1c4b8eaf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:14:08.381661-05:00","2016-05-03T10:55:55.600288-05:00","33ed2d3e-08e3-42f8-b8a9-ebbee2be193c_analysis.xml","84fc9888ee03d0c17f5d22722b3ab675","1ac4aa36-a4c6-4b9d-b823-a12f24069b59",2123,"2016-09-29T22:28:54.794914-05:00","33ed2d3e-08e3-42f8-b8a9-ebbee2be193c_experiment.xml","4a0efb8293e645b6e3377030151677a7","b90e8469-f6c2-4e13-bf20-ca3f46313d31",2431,"2016-09-30T00:19:03.144478-05:00","33ed2d3e-08e3-42f8-b8a9-ebbee2be193c_run.xml","87bead1ba7ccd84de2bc3e51554d8a20","fd5b4135-a4b5-46c0-8921-8a5978f1a39a",354,"2016-09-08T11:00:57.828869-05:00","TCGA-AX-A3FW","2016-09-02T18:49:11.005693-05:00","female","TCGA-AX-A3FW_demographic",1943,"white","7150706f-be8d-5f53-8882-93c479869817","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3FW_diagnosis","not reported",24419,"alive","8380/3",NA,17,"6c0615cd-0061-5fca-8bef-3ca10ce6383a","c54.1",-24419,"TCGA-AX-A3FW_treatment","fbbc28cf-2e15-50bb-8b1e-a9ee98107e79","01","false","TCGA-AX-A3FW-01A",NA,"d3deb563-5420-4890-b763-01ca855b4b61",FALSE,"AAB4F0FC-D6D5-4D5F-B36C-E4D4869E1A15","Primary Tumor",NA,723,90,NA,1322784000,"11",30,"TCGA-AX-A3FW-01A-11",95,NA,1,NA,0,NA,2,NA,"2016-09-08T11:00:57.828869-05:00",NA,2,NA,0,NA,"TOP",NA,2,NA,"d08631c4-0f25-42e5-a0d5-ac2003c49207",NA,"TCGA-AX-A3FW-01A-01-TS1",NA,96,NA,"d509477d-a220-4470-a7d9-f82f12d64238","RNA","TCGA-AX-A3FW-01A-11R","b6360f85-7f3f-47e8-b867-3ca159514662",1.89,0.18,"UV Spec","R","23","TCGA-AX-A3FW-01A-11R-A22K-07","bbf7786d-0996-47fc-8af9-482d2087ccb1",0.18,NA,84,30.1194019147334,167,"d236da69-c009-5d64-8704-74c62edad450","TCGA-AX-A3FW_exposure","UNCID_2173523.bbf7786d-0996-47fc-8af9-482d2087ccb1.130502_UNC12-SN629_0289_AC236KACXX_5_ATGTCA.tar.gz","2013-09-09T07:36:09.000Z","2013-09-09T07:56:01.000Z","33ED2D3E-08E3-42F8-B8A9-EBBEE2BE193C","D3DEB563-5420-4890-B763-01CA855B4B61","Unaligned reads",5489839707,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","BBF7786D-0996-47FC-8AF9-482D2087CCB1","University of North Carolina","56607a31e4b016715ab6a7f7","3052065A-B8B1-48D3-971D-9D605292249C","Uterine Corpus Endometrial Carcinoma","TARGZ","D509477D-A220-4470-A7D9-F82F12D64238","2013-09-09T07:56:01.000Z","B6360F85-7F3F-47E8-B867-3CA159514662","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",723,"D509477D-A220-4470-A7D9-F82F12D64238",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.21B45816-6F8E-4657-9E16-9953FD234D09.txt",90,"TCGA-AX-A3FW-01A",NA,NA,"TCGA",2009,NA,NA,NA,"D3DEB563-5420-4890-B763-01CA855B4B61",66,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.21B45816-6F8E-4657-9E16-9953FD234D09.txt","Alive",NA,"TCGA-AX-A3FW","NOT HISPANIC OR LATINO","6B882E61-1C9A-48EA-A826-3B1160EFCA46",NA,10,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"D08631C4-0F25-42E5-A0D5-AC2003C49207","E4947CEF-670B-4AAB-8589-E15F6004CC3A","UNCID_2034943.bbf7786d-0996-47fc-8af9-482d2087ccb1.sorted_genome_alignments.bam.bai","TCGA-AX-A3FW-01A-11",95,0,1,2,2,"TOP",2,0,"TCGA-AX-A3FW-01A-01-TS1",96,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3FW-F58282_NTE-1",NA,17,NA,"Alive",NA,"TCGA-AX-A3FW-F58282","TCGA-AX-A3FW",1,"AX","A3FW","YES","C54.1","8380/3","C54.1","NO","YES",-24419,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",10,NA,NA,NA,NA,"NO",3,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,66,2009,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
119221844,116387056,5556447472,"6869ABAF-343B-4C9B-8975-B26A2C895123.bw","30b62630-fc6d-4620-874a-1e15fd4f40ea","6869abaf-343b-4c9b-8975-b26a2c895123","2016-08-09T14:01:50.283673-05:00","UNCID_2167096.b8e18fd7-ff5d-44b9-b977-945622d2a59e.130621_UNC14-SN744_0352_BC253TACXX_1_CGATGT.tar.gz","e4b49fda-bc51-4b22-9ca3-b76fa917bc43",5206639822,"Illumina HiSeq","f95af642434957deb25454a29e3fdf91","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:49:36.010260-05:00","2016-05-03T11:07:07.492763-05:00","e4b49fda-bc51-4b22-9ca3-b76fa917bc43_analysis.xml","7e1141f084e1ef8e7c0c8635ad1dba73","7b761d6c-eb8b-40a6-8157-a89f9fe7d43c",2123,"2016-09-29T21:16:12.701558-05:00","e4b49fda-bc51-4b22-9ca3-b76fa917bc43_experiment.xml","ae2d14e5627f9cd7f6e3e379039abe8d","8c2dfe10-fc34-40c8-96f5-c8164cdcc502",2431,"2016-09-29T17:52:42.957123-05:00","e4b49fda-bc51-4b22-9ca3-b76fa917bc43_run.xml","386aaf73860f0d30a238dc0f3c6ffc8f","0d6392de-f44f-4c51-aa4b-3e4cd25a9e92",354,"2016-09-08T11:07:27.510197-05:00","TCGA-DF-A2KR","2016-09-02T18:53:20.576769-05:00","female","TCGA-DF-A2KR_demographic",NA,"not reported","1db96901-2fe2-55cd-84fa-dc1d0da97ede","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DF","bd439172-ab1d-57cc-a1ee-7282ceebd41a","Ontario Institute for Cancer Research","not reported","c54.1","TCGA-DF-A2KR_diagnosis","not reported",31007,"alive","8380/3",NA,2178,"483b7756-5065-5f57-adc2-4cb2e906d3f9","c54.1",-31007,"TCGA-DF-A2KR_treatment","155a92d0-f44a-58c0-9d49-33190002e34c","01","false","TCGA-DF-A2KR-01A",NA,"acdc8a17-c1b8-4f45-a1af-7c7953c346a4",FALSE,"7252DF0D-0D16-48DD-9484-9C4B83012927","Primary Tumor",NA,NA,80,NA,1313452800,"11",30,"TCGA-DF-A2KR-01A-11",95,NA,15,NA,0,NA,5,NA,"2016-09-08T11:07:27.510197-05:00",NA,25,NA,5,NA,"TOP",NA,2,NA,"97d82fa3-b458-4ecc-9e59-52ec294951b6",NA,"TCGA-DF-A2KR-01A-01-TSA",NA,93,NA,"d8d00dbf-4727-4c86-81f3-e3452b84711c","RNA","TCGA-DF-A2KR-01A-11R","01a5d05c-425c-4f1f-bd6b-76ed815f8658",1.79,0.16,"UV Spec","R","23","TCGA-DF-A2KR-01A-11R-A180-07","b8e18fd7-ff5d-44b9-b977-945622d2a59e",0.16,NA,NA,NA,NA,"50cf868d-febd-59e4-9df6-365194e7c4af","TCGA-DF-A2KR_exposure","UNCID_2167096.b8e18fd7-ff5d-44b9-b977-945622d2a59e.130621_UNC14-SN744_0352_BC253TACXX_1_CGATGT.tar.gz","2013-09-21T06:46:05.000Z","2013-09-21T07:01:02.000Z","E4B49FDA-BC51-4B22-9CA3-B76FA917BC43","ACDC8A17-C1B8-4F45-A1AF-7C7953C346A4","Unaligned reads",5206639822,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","B8E18FD7-FF5D-44B9-B977-945622D2A59E","University of North Carolina","56607c2ae4b018727fea2dd4","30B62630-FC6D-4620-874A-1E15FD4F40EA","Uterine Corpus Endometrial Carcinoma","TARGZ","D8D00DBF-4727-4C86-81F3-E3452B84711C","2013-09-21T07:01:02.000Z","01A5D05C-425C-4F1F-BD6B-76ED815F8658","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"D8D00DBF-4727-4C86-81F3-E3452B84711C",NA,"DF","81a48617827b34f64ccdaff5d94d5bd3.bam.bai",80,"TCGA-DF-A2KR-01A",NA,NA,"TCGA",NA,"TCGA-DF-A2KR_NTE-1",NA,"TUMOR FREE","ACDC8A17-C1B8-4F45-A1AF-7C7953C346A4",84,"nationwidechildrens.org_clinical.TCGA-DF-A2KR.xml","Alive",NA,"TCGA-DF-A2KR",NA,"39F90219-8126-4580-B839-23E55D5EF788","NO",2178,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,"B877A5F3-800B-47B7-94FE-88CBBDCB7943",NA,NA,11,30,"97D82FA3-B458-4ECC-9E59-52EC294951B6","9CE1A10E-5308-4CDB-AF8F-D98F7784D9AE","UNCID_2077337.b8e18fd7-ff5d-44b9-b977-945622d2a59e.sorted_genome_alignments.bam.bai","TCGA-DF-A2KR-01A-11",95,0,15,25,5,"TOP",2,5,"TCGA-DF-A2KR-01A-01-TSA",93,NA,NA,NA,"TCGA-DF-A2KR-R49887","External","Regional site","TCGA-DF-A2KR-F49885_NTE-1","YES",2178,"TUMOR FREE","Alive",NA,"TCGA-DF-A2KR-F49885","TCGA-DF-A2KR",1,"DF","A2KR","YES","C54.1","8380/3","C54.1","NO","YES",-31007,"FEMALE",NA,NA,"No","No","Alive",2178,NA,"YES","NO","TUMOR FREE","YES",14,10,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,NA,84,NA,"Other method, specify:",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
116106984,112967197,5391931861,"89E948DC-B3AE-4155-B8A1-ADD2B1C300BD.bw","30bc72d5-07b5-48d2-b025-bba9bcf2f09f","89e948dc-b3ae-4155-b8a1-add2b1c300bd","2016-08-09T14:02:34.143443-05:00","UNCID_2167007.3513c95d-9ea0-4c3b-9e8e-0f148231bc83.130621_UNC14-SN744_0352_BC253TACXX_3_AGTTCC.tar.gz","4bcc2e54-1579-4974-a24b-5c1fba5fd4ce",5110571355,"Illumina HiSeq","623baf127d8fb94d4c7d3ab85cea2501","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:14:52.744557-05:00","2016-05-03T11:07:07.492763-05:00","4bcc2e54-1579-4974-a24b-5c1fba5fd4ce_analysis.xml","4909cbab22548a843b6e80565797c773","410c00dc-819d-454e-adc4-900e098e5e09",2123,"2016-08-13T02:18:02.028891-05:00","4bcc2e54-1579-4974-a24b-5c1fba5fd4ce_experiment.xml","abc8de5ce458a41687660d50794e7fbb","e321bf97-fb35-491d-9e84-501824ab2093",2431,"2016-09-29T23:50:31.055676-05:00","4bcc2e54-1579-4974-a24b-5c1fba5fd4ce_run.xml","3478a9a12acc1b987cbc3a9b68184e75","ebc25065-8733-428f-a3c8-4933c4ba8d54",354,"2016-09-08T10:27:13.483575-05:00","TCGA-EO-A22U","2016-09-02T18:53:56.294626-05:00","female","TCGA-EO-A22U_demographic",1926,"white","e8d75a74-9bea-5427-ac4c-e20566531835","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A22U_diagnosis","not reported",30557,"alive","8380/3",NA,1407,"36f0913f-9b70-5403-9b6d-d8e3cced5f58","c54.1",-30557,"TCGA-EO-A22U_treatment","782a304e-53c4-5a39-b015-8b7f6eaf353b","01","false","TCGA-EO-A22U-01A",NA,"4eb2e033-34f4-4a2d-837e-c927c1e52359",FALSE,"DB7D72BC-F9C7-4726-98F4-A4F642B125C6","Primary Tumor",NA,758,110,NA,1304899200,"11",30,"TCGA-EO-A22U-01A-11",80,NA,20,NA,0,NA,15,NA,"2016-09-08T10:27:13.483575-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"213b24d5-572d-4622-ae8c-1d95667cc82b",NA,"TCGA-EO-A22U-01A-01-TSA",NA,80,NA,"1e53b284-8163-4788-a1fc-c50ab76c2543","RNA","TCGA-EO-A22U-01A-11R","a95ea16d-5f34-44b9-8347-aa5e279376a2",1.93,0.17,"UV Spec","R","23","TCGA-EO-A22U-01A-11R-A180-07","3513c95d-9ea0-4c3b-9e8e-0f148231bc83",0.17,NA,59,26.2222222222222,150,"602ddb15-e1ed-5e7e-82dc-7d725ff0727c","TCGA-EO-A22U_exposure","UNCID_2167007.3513c95d-9ea0-4c3b-9e8e-0f148231bc83.130621_UNC14-SN744_0352_BC253TACXX_3_AGTTCC.tar.gz","2013-09-21T07:07:08.000Z","2013-09-21T07:21:01.000Z","4BCC2E54-1579-4974-A24B-5C1FBA5FD4CE","4EB2E033-34F4-4A2D-837E-C927C1E52359","Unaligned reads",5110571355,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","3513C95D-9EA0-4C3B-9E8E-0F148231BC83","University of North Carolina","56607d09e4b018727fea316f","30BC72D5-07B5-48D2-B025-BBA9BCF2F09F","Uterine Corpus Endometrial Carcinoma","TARGZ","1E53B284-8163-4788-A1FC-C50AB76C2543","2013-09-21T07:21:01.000Z","A95EA16D-5F34-44B9-8347-AA5E279376A2","Canada","NO",1,NA,"Primary Tumor","University Health Network",758,"1E53B284-8163-4788-A1FC-C50AB76C2543",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.451C5655-3310-4746-895F-9038D36FE619.txt",110,"TCGA-EO-A22U-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","6FE36F7C-F188-4F2D-B9C2-A2E4CCC56D48",83,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.451C5655-3310-4746-895F-9038D36FE619.txt","Alive",NA,"TCGA-EO-A22U",NA,"44F40C61-C067-4F9D-99A1-B80C52D85CCC",NA,825,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,"276E14DD-A591-4336-943A-9E4ED0FF05D4","WHITE",NA,11,30,"213B24D5-572D-4622-AE8C-1D95667CC82B","A95EA16D-5F34-44B9-8347-AA5E279376A2","UNCID_2167007.3513c95d-9ea0-4c3b-9e8e-0f148231bc83.130621_UNC14-SN744_0352_BC253TACXX_3_AGTTCC.tar.gz","TCGA-EO-A22U-01A-11",80,0,20,40,15,"TOP",5,20,"TCGA-EO-A22U-01A-01-TSA",80,NA,NA,NA,"TCGA-EO-A22U-R62598","External","Primary Tumor Field","TCGA-EO-A22U-F62597_NTE-1","NO",1407,"TUMOR FREE","Alive",NA,"TCGA-EO-A22U-F62597","TCGA-EO-A22U",1,"EO","A22U","YES","C54.1","8380/3","C54.1","NO","YES",-30557,"FEMALE","WHITE",NA,"No","No","Alive",825,NA,NA,NA,"TUMOR FREE","NO",26,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,83,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33248661,32770405,2445119455,"9095FDD8-EEB2-4B17-85AB-3CDAC0BEC759.bw","32398808-c46a-41bf-a0a8-e08723b40ea2","9095fdd8-eeb2-4b17-85ab-3cdac0bec759","2016-08-04T21:08:19.779143-05:00","UNCID_2203681.b3b47f11-3e7c-475e-8f39-cefb8db8fa35.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_4.tar.gz","b36e732c-c2d6-48ed-ad71-e7b7051d4301",2086203112,"Illumina GA","2d7b87bcd6b70e5b5bc5daed95738dcf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:21:31.059311-05:00","2016-05-03T11:10:47.515830-05:00","b36e732c-c2d6-48ed-ad71-e7b7051d4301_analysis.xml","154c55c42eb0da95cdc0fff1a746610b","b46a5bad-476d-4280-ad02-833c7dff2502",2121,"2016-09-29T23:23:40.309282-05:00","b36e732c-c2d6-48ed-ad71-e7b7051d4301_experiment.xml","d40bfe07455ee6f414745d42c75a953c","daf41b3c-f4f4-4c3e-b6bb-5d0935f2165e",2257,"2016-09-29T17:40:55.442651-05:00","b36e732c-c2d6-48ed-ad71-e7b7051d4301_run.xml","6547ed3155c73e3426d7543a58902fdc","05cf6464-42eb-429d-8f4e-f59153d3f167",347,"2016-09-08T10:38:53.884230-05:00","TCGA-AX-A2HJ","2016-09-02T18:52:30.253418-05:00","female","TCGA-AX-A2HJ_demographic",1974,"asian","5a34c9fd-6e43-566b-8e12-af41e66ca002","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HJ_diagnosis","not reported",13112,"alive","8380/3",NA,935,"4af5b840-400a-5d19-820c-3b9fd60ba6e3","c54.1",-13112,"TCGA-AX-A2HJ_treatment","4ec967a9-ecd8-5df2-a50d-46f9f46f0731","01","false","TCGA-AX-A2HJ-01A",NA,"cced4976-8c11-4910-b5d4-6279be4851be",FALSE,"84FF1AB9-47F4-4884-9345-43878BDEF379","Primary Tumor",NA,779,140,NA,1308182400,"11",30,"TCGA-AX-A2HJ-01A-11",90,NA,0,NA,0,NA,25,NA,"2016-09-08T10:38:53.884230-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"2581d097-54c6-43ad-9f20-d06b2a1be069",NA,"TCGA-AX-A2HJ-01A-01-TSA",NA,70,NA,"f42eaa74-6e93-4c42-b970-4bb92b1b9249","RNA","TCGA-AX-A2HJ-01A-11R","4dedf641-dd4c-41f9-aac1-14a451f23cc7",2.4,0.16,"UV Spec","R","23","TCGA-AX-A2HJ-01A-11R-A17B-07","b3b47f11-3e7c-475e-8f39-cefb8db8fa35",0.16,NA,56,24.2382271468144,152,"d77ef2f2-abd6-523c-b9ab-ad6bbf65b167","TCGA-AX-A2HJ_exposure","UNCID_2203681.b3b47f11-3e7c-475e-8f39-cefb8db8fa35.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_4.tar.gz","2013-09-26T15:46:05.000Z","2013-09-26T16:00:02.000Z","B36E732C-C2D6-48ED-AD71-E7B7051D4301","CCED4976-8C11-4910-B5D4-6279BE4851BE","Unaligned reads",2086203112,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B3B47F11-3E7C-475E-8F39-CEFB8DB8FA35","University of North Carolina","564a38dee4b09c884b2396c7","32398808-C46A-41BF-A0A8-E08723B40EA2","Uterine Corpus Endometrial Carcinoma","TARGZ","F42EAA74-6E93-4C42-B970-4BB92B1B9249","2013-09-26T16:00:02.000Z","4DEDF641-DD4C-41F9-AAC1-14A451F23CC7","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",779,"F42EAA74-6E93-4C42-B970-4BB92B1B9249",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4E7CA333-8EC4-4C6D-A98F-554F67D74087.txt",140,"TCGA-AX-A2HJ-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","EFA672E2-F561-465E-842C-E3C90B0C5015",35,"nationwidechildrens.org_clinical.TCGA-AX-A2HJ.xml","Alive",NA,"TCGA-AX-A2HJ","NOT HISPANIC OR LATINO","EF7159F3-0298-4A62-96C8-D0140E8E55BE",NA,831,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,"0528DDB2-4F17-48A3-BA9C-378410E41CE8","ASIAN",NA,11,30,"2581D097-54C6-43AD-9F20-D06B2A1BE069","4DEDF641-DD4C-41F9-AAC1-14A451F23CC7","TCGA-AX-A2HJ-01A-11R-A17A-13_mirna.bam.bai","TCGA-AX-A2HJ-01A-11",90,0,0,1,25,"TOP",5,0,"TCGA-AX-A2HJ-01A-01-TSA",70,NA,NA,NA,"TCGA-AX-A2HJ-R31585","OTHER: SPECIFY IN NOTES","Local Recurrence",NA,"NO",935,"TUMOR FREE","Alive",NA,"TCGA-AX-A2HJ-F31575","TCGA-AX-A2HJ",1,"AX","A2HJ","YES","C54.1","8380/3","C54.1","NO","YES",-13112,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",831,NA,NA,NA,"TUMOR FREE","NO",31,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,35,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33265436,29633991,2236341666,"D4276C6F-9F0F-4F74-A85E-1E54272ADDED.bw","32b5d0e4-a242-44d1-ac20-6e5ca2f35b71","d4276c6f-9f0f-4f74-a85e-1e54272added","2016-08-04T21:36:55.748682-05:00","UNCID_2206665.bddd28d0-8d22-4949-b890-9cd54a4a0f29.111006_UNC2-RDR300275_00089_FC_634EEAAXX_8.tar.gz","25d37416-7a1c-4618-be04-3c4e43fd8671",2142300869,"Illumina GA","064050ffe522531b620eb4abb86d3749","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:19:13.129684-05:00","2016-05-03T11:12:13.642315-05:00","25d37416-7a1c-4618-be04-3c4e43fd8671_analysis.xml","0f7b473143a7f781dfa8fa290a506cd3","1ddcfe31-aafb-44d6-a25e-de2a4e944263",2121,"2016-09-30T00:08:54.908856-05:00","25d37416-7a1c-4618-be04-3c4e43fd8671_experiment.xml","4f098d2e5c4f3466a088135a89f87147","f702e76b-d2d4-4d04-989b-d90ceccb69d9",2257,"2016-09-29T18:49:30.651924-05:00","25d37416-7a1c-4618-be04-3c4e43fd8671_run.xml","07a049bdb6cdf4fbf4c4dc01af31f5bb","310631d7-103a-45c2-b198-7d44661d96f6",347,"2016-09-08T10:42:01.757811-05:00","TCGA-D1-A2G7","2016-09-02T18:53:15.099678-05:00","female","TCGA-D1-A2G7_demographic",1942,"white","7a1a5571-514e-589e-afbb-0c731011e50c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A2G7_diagnosis","not reported",23913,"dead","8441/3",1793,1365,"37e5cf6e-ef1e-500e-8588-bbba65048663","c54.1",-23913,"TCGA-D1-A2G7_treatment","96f6d679-6203-54a2-9a1e-b4162d4516ac","01","true","TCGA-D1-A2G7-01A",NA,"9c10d27c-4372-4c1f-8a92-f84a387a1161",FALSE,"5D25FD0B-EEE9-435C-82C7-BC44B0758A14","Primary Tumor",NA,1339,110,NA,1309392000,"21",30,"TCGA-D1-A2G7-01A-21",80,NA,0,NA,20,NA,0,NA,"2016-09-08T10:42:01.757811-05:00",NA,10,NA,10,NA,"TOP",NA,20,NA,"744a0f72-653c-486f-8f9f-4d0f92874225",NA,"TCGA-D1-A2G7-01A-02-TSB",NA,60,NA,"45945f32-8f50-4929-bc74-a7cb3ff2bff6","RNA","TCGA-D1-A2G7-01A-21R","760cb960-c405-4ba1-b374-9879c1c6cc51",1.78,0.17,"UV Spec","R","23","TCGA-D1-A2G7-01A-21R-A180-07","bddd28d0-8d22-4949-b890-9cd54a4a0f29",0.17,NA,133,49.4497323022011,164,"56eaffbd-49cc-5acc-88e7-5c7bede08b8c","TCGA-D1-A2G7_exposure","UNCID_2206665.bddd28d0-8d22-4949-b890-9cd54a4a0f29.111006_UNC2-RDR300275_00089_FC_634EEAAXX_8.tar.gz","2013-09-27T18:36:05.000Z","2013-09-27T18:50:03.000Z","25D37416-7A1C-4618-BE04-3C4E43FD8671","9C10D27C-4372-4C1F-8A92-F84A387A1161","Unaligned reads",2142300869,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","BDDD28D0-8D22-4949-B890-9CD54A4A0F29","University of North Carolina","56607994e4b016715ab6a486","32B5D0E4-A242-44D1-AC20-6E5CA2F35B71","Uterine Corpus Endometrial Carcinoma","TARGZ","45945F32-8F50-4929-BC74-A7CB3FF2BFF6","2013-09-27T18:50:03.000Z","760CB960-C405-4BA1-B374-9879C1C6CC51","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",1339,"45945F32-8F50-4929-BC74-A7CB3FF2BFF6",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4874B9A7-5E58-4F1A-B972-582F6E39C71B.txt",110,"TCGA-D1-A2G7-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","9C10D27C-4372-4C1F-8A92-F84A387A1161",65,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4874B9A7-5E58-4F1A-B972-582F6E39C71B.txt","Alive",NA,"TCGA-D1-A2G7","NOT HISPANIC OR LATINO","7AA242ED-02E2-4D24-9218-F6C7AA8DA44F",NA,1365,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",168,NA,NA,"WHITE",NA,21,30,"744A0F72-653C-486F-8F9F-4D0F92874225","760CB960-C405-4BA1-B374-9879C1C6CC51","UNCID_2206665.bddd28d0-8d22-4949-b890-9cd54a4a0f29.111006_UNC2-RDR300275_00089_FC_634EEAAXX_8.tar.gz","TCGA-D1-A2G7-01A-21",80,20,0,10,0,"TOP",20,10,"TCGA-D1-A2G7-01A-02-TSB",60,NA,NA,NA,NA,NA,NA,"TCGA-D1-A2G7-F41607_NTE-1","NO",NA,NA,"Dead",1793,"TCGA-D1-A2G7-F41607","TCGA-D1-A2G7",1,"D1","A2G7","YES","C54.1","8441/3","C54.1","NO","YES",-23913,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1365,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,65,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
32765943,32005461,2392412581,"F6527F1F-B7E3-4281-B97A-282C97B71C00.bw","32e33897-29c8-48f2-b833-98f37204e0e7","f6527f1f-b7e3-4281-b97a-282c97b71c00","2016-08-04T18:23:05.787160-05:00","UNCID_2206812.ec3e03af-251e-497f-8cb4-b05816df2e12.110829_UNC2-RDR300275_00084_FC_634GCAAXX_2.tar.gz","b59e0d46-f9fd-44cc-a44d-be87c050b16f",2102776021,"Illumina GA","3ecc630a26334a950f829e403525383a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:26:43.001823-05:00","2016-05-03T11:12:13.672306-05:00","b59e0d46-f9fd-44cc-a44d-be87c050b16f_analysis.xml","54d6c6b44328733d706ae1f7edee13e2","dceb17d1-002b-426f-adae-6d54e804399d",2120,"2016-09-29T23:12:03.416862-05:00","b59e0d46-f9fd-44cc-a44d-be87c050b16f_experiment.xml","aa8a08be9f84d1b5fb52106185d2bd9e","d3f096d3-43e5-49e3-80b9-b92115db22bb",2257,"2016-09-30T00:06:52.560416-05:00","b59e0d46-f9fd-44cc-a44d-be87c050b16f_run.xml","91b91b051d20ffe0790899ba0bc61111","f5c90a57-2740-4099-b151-c7bdf9993c51",347,"2016-09-08T10:37:41.910802-05:00","TCGA-A5-A0GH","2016-09-02T18:54:09.189937-05:00","female","TCGA-A5-A0GH_demographic",1947,"white","d5ecc0c8-b648-567c-bef5-093fbf06a6cf","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GH_diagnosis","not reported",21090,"alive","8380/3",NA,2254,"e572117a-2fb1-5066-8813-9a18c7f4fe90","c54.1",-21090,"TCGA-A5-A0GH_treatment","c86ccec8-f08c-5efd-8ccd-c80ec68500b4","01","true","TCGA-A5-A0GH-01A",NA,"853196b6-8c1d-462f-af8f-acf2551f633d",FALSE,"8E29A939-5581-4176-B19E-14076F17726B","Primary Tumor",NA,2256,230,NA,1275955200,"21",30,"TCGA-A5-A0GH-01A-21",90,95,0,0,10,5,0,0,"2016-09-08T10:37:41.910802-05:00","2016-09-08T10:37:41.910802-05:00",20,20,10,10,"TOP","BOTTOM",10,20,"84333999-23ec-45d3-a566-fc6f14d430b1","6cac7f11-4e15-4e16-b0c5-e55776aa78cd","TCGA-A5-A0GH-01A-02-TSB","TCGA-A5-A0GH-01A-02-BSB",80,75,"62685856-c69b-498e-84db-50425157bec2","RNA","TCGA-A5-A0GH-01A-21R","153ccaee-b4d7-4c6e-8b0d-69c068404957",1.81,0.15,"UV Spec","R","23","TCGA-A5-A0GH-01A-21R-A16W-07","ec3e03af-251e-497f-8cb4-b05816df2e12",0.15,NA,55,20.7008167413151,163,"0857e489-8b2a-5a2d-8a29-3f890aacc8c7","TCGA-A5-A0GH_exposure","UNCID_2206812.ec3e03af-251e-497f-8cb4-b05816df2e12.110829_UNC2-RDR300275_00084_FC_634GCAAXX_2.tar.gz","2013-09-28T07:55:03.000Z","2013-09-28T08:08:03.000Z","B59E0D46-F9FD-44CC-A44D-BE87C050B16F","853196B6-8C1D-462F-AF8F-ACF2551F633D","Unaligned reads",2102776021,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","EC3E03AF-251E-497F-8CB4-B05816DF2E12","University of North Carolina","56607bf1e4b018727fea2cc0","32E33897-29C8-48F2-B833-98F37204E0E7","Uterine Corpus Endometrial Carcinoma","TARGZ","62685856-C69B-498E-84DB-50425157BEC2","2013-09-28T08:08:03.000Z","153CCAEE-B4D7-4C6E-8B0D-69C068404957","None","NO",1,NA,"Primary Tumor","Cedars Sinai",2256,"62685856-C69B-498E-84DB-50425157BEC2",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.0893B82F-1B83-470D-B60F-6200E66E10F7.txt",230,"TCGA-A5-A0GH-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","853196B6-8C1D-462F-AF8F-ACF2551F633D",57,"nationwidechildrens.org_clinical.TCGA-A5-A0GH.xml","Alive",NA,"TCGA-A5-A0GH","NOT HISPANIC OR LATINO","FA92C9BE-EDE3-439C-A073-DDDC6DC41669",NA,1672,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,21,30,"84333999-23EC-45D3-A566-FC6F14D430B1","C22AA2CA-92B2-4A83-900E-CB6B2D4BCD1B","UNCID_2206812.ec3e03af-251e-497f-8cb4-b05816df2e12.110829_UNC2-RDR300275_00084_FC_634GCAAXX_2.tar.gz","TCGA-A5-A0GH-01A-21",90,10,0,20,0,"TOP",10,10,"TCGA-A5-A0GH-01A-02-TSB",80,NA,NA,NA,NA,NA,NA,NA,"NO",2254,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GH-F17143","TCGA-A5-A0GH",1,"A5","A0GH","YES","C54.1","8380/3","C54.1","NO","YES",-21090,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1672,NA,NA,NA,"TUMOR FREE","NO",13,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2004,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33947025,33487896,2504816062,"B57D8141-37A5-48A7-9213-C256464943C0.bw","3348a7aa-f5c3-4fba-9968-68da5cedfd7e","b57d8141-37a5-48a7-9213-c256464943c0","2016-08-09T14:12:55.078245-05:00","UNCID_2207206.6ff22866-1896-4200-bef2-f05724bf15a3.110719_UNC2-RDR300275_00077_FC_70KATAAXX_2.tar.gz","7d31bb67-5d5a-4d94-b82e-d03f1c76d2cb",2091394421,"Illumina GA","5d2c4899761b67d5f9dfec1c76cae9f6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:24:00.796907-05:00","2016-05-03T11:13:42.375045-05:00","7d31bb67-5d5a-4d94-b82e-d03f1c76d2cb_analysis.xml","322843915caa078609d5c5ea04ecc2f4","b5f77aa3-67ff-43d9-a7f2-059cbd9e1531",2121,"2016-08-13T07:53:47.223072-05:00","7d31bb67-5d5a-4d94-b82e-d03f1c76d2cb_experiment.xml","0fb71d3151df9921999af198426b4a70","01ba4487-a786-4dd2-9c3d-7e5fe5554fc3",2257,"2016-09-29T20:56:58.767034-05:00","7d31bb67-5d5a-4d94-b82e-d03f1c76d2cb_run.xml","6db3823f056dd8a3fa2a4935841a8b06","80223266-e1c4-48af-af12-3edc21f85331",347,"2016-09-08T11:34:59.920345-05:00","TCGA-AP-A1DO","2016-09-02T18:51:24.984808-05:00","female","TCGA-AP-A1DO_demographic",1945,"white","2e4bcad2-f344-56f7-888b-3fca2afe52df","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1DO_diagnosis","not reported",22787,"alive","8380/3",NA,952,"58d53b8b-44f2-50b9-8188-a1b3b9ba9a9a","c54.1",-22787,"TCGA-AP-A1DO_treatment","e378758c-1a50-506a-bee0-2ce85c6c7aa7","01","true","TCGA-AP-A1DO-01A",NA,"f2b59490-86fe-409a-89f1-e11f744e0d75",FALSE,"EAC1A113-68BB-4D45-AB57-E59E392029BC","Primary Tumor",NA,1210,220,NA,1295395200,"11",30,"TCGA-AP-A1DO-01A-11",98,NA,1,NA,0,NA,2,NA,"2016-09-08T11:34:59.920345-05:00",NA,2,NA,2,NA,"TOP",NA,20,NA,"de3b48ca-34de-4e56-9fd6-7c6751c97368",NA,"TCGA-AP-A1DO-01A-01-TSA",NA,78,NA,"487af34a-3b83-4627-8947-a4a8b59abc2e","RNA","TCGA-AP-A1DO-01A-11R","258e2ca4-7b9b-47bb-82fa-33742f4cd331",1.91,0.17,"UV Spec","R","23","TCGA-AP-A1DO-01A-11R-A137-07","6ff22866-1896-4200-bef2-f05724bf15a3",0.17,NA,80,32.8731097961867,156,"34a4f505-23d3-5d3d-8c4c-3c71337ef343","TCGA-AP-A1DO_exposure","UNCID_2207206.6ff22866-1896-4200-bef2-f05724bf15a3.110719_UNC2-RDR300275_00077_FC_70KATAAXX_2.tar.gz","2013-09-29T18:01:04.000Z","2013-09-29T18:19:01.000Z","7D31BB67-5D5A-4D94-B82E-D03F1C76D2CB","F2B59490-86FE-409A-89F1-E11F744E0D75","Unaligned reads",2091394421,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","6FF22866-1896-4200-BEF2-F05724BF15A3","University of North Carolina","5660763fe4b0ec1099f8c355","3348A7AA-F5C3-4FBA-9968-68DA5CEDFD7E","Uterine Corpus Endometrial Carcinoma","TARGZ","487AF34A-3B83-4627-8947-A4A8B59ABC2E","2013-09-29T18:19:01.000Z","258E2CA4-7B9B-47BB-82FA-33742F4CD331","None","NO",1,NA,"Primary Tumor","MSKCC",1210,"487AF34A-3B83-4627-8947-A4A8B59ABC2E",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.88B9B7C3-CFE9-4AC9-9B91-110B626EBA6E.txt",220,"TCGA-AP-A1DO-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","FBA10F3E-861E-4E48-839D-FD60EB9C337E",62,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.88B9B7C3-CFE9-4AC9-9B91-110B626EBA6E.txt","Alive",NA,"TCGA-AP-A1DO","NOT HISPANIC OR LATINO","AC6B54FB-C06B-4254-AE6B-75970CCBB75F",NA,952,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"DE3B48CA-34DE-4E56-9FD6-7C6751C97368","258E2CA4-7B9B-47BB-82FA-33742F4CD331","UNCID_1625102.6ff22866-1896-4200-bef2-f05724bf15a3.sorted_genome_alignments.bam.bai","TCGA-AP-A1DO-01A-11",98,0,1,2,2,"TOP",20,2,"TCGA-AP-A1DO-01A-01-TSA",78,NA,NA,NA,NA,NA,NA,NA,"NO",952,"TUMOR FREE","Alive",NA,"TCGA-AP-A1DO-F13624","TCGA-AP-A1DO",1,"AP","A1DO","YES","C54.1","8380/3","C54.1","NO","YES",-22787,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",952,NA,NA,NA,"TUMOR FREE","NO",9,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2007,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32472108,31806829,2395794106,"9DE372FA-FA7F-41AB-BE52-B0B7D957CF9D.bw","33efe6c6-9159-48e8-b759-fba9ddbde761","9de372fa-fa7f-41ab-be52-b0b7d957cf9d","2016-08-09T14:04:51.289212-05:00","UNCID_2194457.5d109d0e-7bc8-4d3e-898b-a48ab288a5ee.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_4.tar.gz","0edd23d2-90da-44e3-8582-a2b2c07bd6c0",2036524533,"Illumina GA","7e0f0636fadb201250588f733369149a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:46:11.912981-05:00","2016-05-03T11:07:49.533431-05:00","0edd23d2-90da-44e3-8582-a2b2c07bd6c0_analysis.xml","37645ae56df11605c3f8c6f1a7ec7f8d","2ef5a0b3-6f9b-4995-9d0b-e29934f31c64",2122,"2016-08-13T06:40:44.147488-05:00","0edd23d2-90da-44e3-8582-a2b2c07bd6c0_experiment.xml","25627a582943f6bd845c6ffb87beea9e","971233a4-7073-4628-ad52-637cba024abe",2258,"2016-09-29T20:21:22.953004-05:00","0edd23d2-90da-44e3-8582-a2b2c07bd6c0_run.xml","94d29546f112aee1ea4e1145b78d4189","6a123dfe-7bb3-4d49-8204-1b96a84a3e84",349,"2016-09-08T12:47:27.243899-05:00","TCGA-EY-A1GD","2016-09-02T18:51:51.475154-05:00","female","TCGA-EY-A1GD_demographic",1958,"black or african american","20432a64-7226-55a6-bc3f-2c6dd69a4572","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GD_diagnosis","not reported",18638,"alive","8380/3",NA,1639,"b6287040-362f-59f2-b7a3-a5fef7595c2f","c54.1",-18638,"TCGA-EY-A1GD_treatment","1370eb32-cec4-518f-bf6d-6686ab485217","01","false","TCGA-EY-A1GD-01A",NA,"486403dc-c250-4088-9eed-a4032391d9d8",FALSE,"65C636F7-B24D-479C-A607-FEFEE7D7E30D","Primary Tumor",NA,511,230,NA,1297900800,"11",30,"TCGA-EY-A1GD-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:47:27.243899-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"e77980d3-cfdf-4540-8a9e-8ff44d28d121",NA,"TCGA-EY-A1GD-01A-01-TS1",NA,100,NA,"7d6ac060-782c-49dc-91a1-ed5c6e1455d1","RNA","TCGA-EY-A1GD-01A-11R","4d8cf0c6-804f-4d0a-bc9e-0380eb83be02",1.82,0.16,"UV Spec","R","23","TCGA-EY-A1GD-01A-11R-A13S-07","5d109d0e-7bc8-4d3e-898b-a48ab288a5ee",0.16,NA,79,32.0499817436813,157,"e4a2989a-aafc-5560-96e7-5e7b98fac1de","TCGA-EY-A1GD_exposure","UNCID_2194457.5d109d0e-7bc8-4d3e-898b-a48ab288a5ee.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_4.tar.gz","2013-09-22T23:37:04.000Z","2013-09-22T23:49:01.000Z","0EDD23D2-90DA-44E3-8582-A2B2C07BD6C0","486403DC-C250-4088-9EED-A4032391D9D8","Unaligned reads",2036524533,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","5D109D0E-7BC8-4D3E-898B-A48AB288A5EE","University of North Carolina","56607e84e4b0ca31916508ce","33EFE6C6-9159-48E8-B759-FBA9DDBDE761","Uterine Corpus Endometrial Carcinoma","TARGZ","7D6AC060-782C-49DC-91A1-ED5C6E1455D1","2013-09-22T23:49:01.000Z","4D8CF0C6-804F-4D0A-BC9E-0380EB83BE02","United States","NO",1,NA,"Primary Tumor","University of North Carolina",511,"7D6AC060-782C-49DC-91A1-ED5C6E1455D1",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.482B940B-57EA-48B1-97D5-1F5F105A5829.txt",230,"TCGA-EY-A1GD-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","C51453B8-5642-4330-B492-D461B26B8FA6",51,"nationwidechildrens.org_clinical.TCGA-EY-A1GD.xml","Alive",NA,"TCGA-EY-A1GD","NOT HISPANIC OR LATINO","543C6BDC-B453-4D68-96E5-5FF650AC4B41",NA,248,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"E77980D3-CFDF-4540-8A9E-8FF44D28D121","7CDD5A92-5650-4E08-90AD-336B296363A0","UNCID_2194457.5d109d0e-7bc8-4d3e-898b-a48ab288a5ee.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_4.tar.gz","TCGA-EY-A1GD-01A-11",80,0,0,0,0,"TOP",0,0,"TCGA-EY-A1GD-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-EY-A1GD-F70252_NTE-1","NO",1639,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GD-F70252","TCGA-EY-A1GD",1,"EY","A1GD","YES","C54.1","8380/3","C54.1","NO","YES",-18638,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",248,NA,NA,NA,"TUMOR FREE","NO",2,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,51,2009,"Tumor resection",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
32439234,31913229,2319601373,"110C1AC6-BFE4-40B8-99EF-5FD901B1ECCF.bw","3405c549-7da5-48ee-ba48-177a67bbcc5d","110c1ac6-bfe4-40b8-99ef-5fd901b1eccf","2016-08-05T01:39:47.931368-05:00","UNCID_2195170.eb32a70b-8e73-4c44-8a44-c623158e87b1.120306_UNC6-RDR300211_00136_FC_650PFAAXX_5.tar.gz","4f940837-d725-4b73-96e2-b0ccfbb50cd1",2038551429,"Illumina GA","b0ffaeda72ebd5bc19900d58c32c00f4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:29:38.796531-05:00","2016-05-03T11:07:49.541765-05:00","4f940837-d725-4b73-96e2-b0ccfbb50cd1_analysis.xml","90b9691f909d88842eae5c1854eafe20","949847a9-651c-459b-9954-f75dc2d3dd14",2121,"2016-09-29T18:09:30.411201-05:00","4f940837-d725-4b73-96e2-b0ccfbb50cd1_experiment.xml","55d4642b3fc3f69539d3647c778839be","17fe40f7-d04e-4ca4-8414-4bd66bf61912",2257,"2016-09-29T21:21:45.448122-05:00","4f940837-d725-4b73-96e2-b0ccfbb50cd1_run.xml","3aa9358d61a399af957341e1a0dd3e96","8f9b8110-35d9-4410-84bd-1644a61398a4",347,"2016-09-08T12:12:34.942857-05:00","TCGA-BS-A0VI","2016-09-02T18:52:16.893035-05:00","female","TCGA-BS-A0VI_demographic",1948,"white","7a1bcab4-1dc6-5dff-bebc-6d77458d082e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0VI_diagnosis","not reported",21198,"alive","8380/3",NA,2646,"a960398d-abc0-599d-9f97-3f67d347ca15","c54.1",-21198,"TCGA-BS-A0VI_treatment","2fce146a-389a-5380-b325-fff653bc5446","01","false","TCGA-BS-A0VI-01A",NA,"698a5085-0137-4bd8-a8c0-f749d03fbd95",FALSE,"EC10AA0B-A597-4224-8807-52F7228C6D07","Primary Tumor",NA,1514,340,NA,1301356800,"11",30,"TCGA-BS-A0VI-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T12:12:34.942857-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"a95e3df8-dfa9-4372-99c8-bc960746a524",NA,"TCGA-BS-A0VI-01A-01-TS1",NA,70,NA,"5c2dc624-280f-4b02-99ce-0ee186011d04","RNA","TCGA-BS-A0VI-01A-11R","db7a56e7-2a09-410e-9133-63a45769d0e6",1.82,0.15,"UV Spec","R","23","TCGA-BS-A0VI-01A-11R-A14D-07","eb32a70b-8e73-4c44-8a44-c623158e87b1",0.15,NA,91,34.2504422447213,163,"4224c6ab-8894-5e63-98e6-9de7ebb40439","TCGA-BS-A0VI_exposure","UNCID_2195170.eb32a70b-8e73-4c44-8a44-c623158e87b1.120306_UNC6-RDR300211_00136_FC_650PFAAXX_5.tar.gz","2013-09-23T08:07:04.000Z","2013-09-23T08:19:01.000Z","4F940837-D725-4B73-96E2-B0CCFBB50CD1","698A5085-0137-4BD8-A8C0-F749D03FBD95","Unaligned reads",2038551429,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","EB32A70B-8E73-4C44-8A44-C623158E87B1","University of North Carolina","564a37ffe4b093830b682d76","3405C549-7DA5-48EE-BA48-177A67BBCC5D","Uterine Corpus Endometrial Carcinoma","TARGZ","5C2DC624-280F-4B02-99CE-0EE186011D04","2013-09-23T08:19:02.000Z","DB7A56E7-2A09-410E-9133-63A45769D0E6","None","NO",1,NA,"Primary Tumor","University of Hawaii",1514,"5C2DC624-280F-4B02-99CE-0EE186011D04",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.98BED513-3C0E-4D93-95BC-5F6736F69ADC.txt",340,"TCGA-BS-A0VI-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","698A5085-0137-4BD8-A8C0-F749D03FBD95",58,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.98BED513-3C0E-4D93-95BC-5F6736F69ADC.txt","Alive",NA,"TCGA-BS-A0VI","NOT HISPANIC OR LATINO","F2CB2D48-E98A-4080-9F8B-8ED66A254FF0",NA,1661,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,11,30,"A95E3DF8-DFA9-4372-99C8-BC960746A524","DB7A56E7-2A09-410E-9133-63A45769D0E6","UNCID_1606638.eb32a70b-8e73-4c44-8a44-c623158e87b1.sorted_genome_alignments.bam.bai","TCGA-BS-A0VI-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-BS-A0VI-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,"TCGA-BS-A0VI-F68993_NTE-1","NO",2646,"TUMOR FREE","Alive",NA,"TCGA-BS-A0VI-F68993","TCGA-BS-A0VI",1,"BS","A0VI","YES","C54.1","8380/3","C54.1","NO","YES",-21198,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1661,NA,NA,NA,"TUMOR FREE","NO",28,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
123126108,121750466,5813079786,"B2A0B149-3C97-4E86-B1B2-6D382EDED8E0.bw","3424120f-248f-451a-948c-e320c19d1b19","b2a0b149-3c97-4e86-b1b2-6d382eded8e0","2016-08-09T14:02:19.485486-05:00","UNCID_2168977.cc3bf52b-7b69-40c9-9358-f66cb7b1dd87.130610_UNC14-SN744_0347_BD28NBACXX_6_CCGTCC.tar.gz","a8c100ed-2d1e-437e-a799-8134db0662e2",5674929477,"Illumina HiSeq","99fdb2dfb8c3f466b810f807618226d5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:36:13.482532-05:00","2016-05-03T11:06:28.634130-05:00","a8c100ed-2d1e-437e-a799-8134db0662e2_analysis.xml","b25f4cf302bd06e7ff0745d5eede8ca3","02cc123f-2523-4303-bf0f-4ba0aff9f42a",2123,"2016-09-29T18:55:10.128694-05:00","a8c100ed-2d1e-437e-a799-8134db0662e2_experiment.xml","8688b63061064cbf13a2ae731679d8f7","34a0da48-2b61-44a1-9bb0-4e89c0177826",2431,"2016-09-29T18:42:32.237609-05:00","a8c100ed-2d1e-437e-a799-8134db0662e2_run.xml","b0e72ccbb3fcb7c42ce16fc0145dce50","2c9f8a8b-8b87-4bf4-8334-e9c1175fdce2",354,"2016-09-08T10:59:22.282030-05:00","TCGA-EY-A547","2016-09-02T18:50:03.992335-05:00","female","TCGA-EY-A547_demographic",1936,"black or african american","399576fd-07c2-54de-bfad-53f280417976","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A547_diagnosis","not reported",27686,"alive","8380/3",NA,545,"af37ed24-16f1-5b06-b606-2fd25594ecdc","c54.1",-27686,"TCGA-EY-A547_treatment","83f289c0-5cd8-5688-9db9-efa2c7902a10","01","false","TCGA-EY-A547-01A",NA,"52338734-9eec-4793-b4a7-5cd84322e797",FALSE,"59662419-D77B-4C25-A888-CE993D412FD1","Primary Tumor",NA,645,610,NA,1355184000,"11",30,"TCGA-EY-A547-01A-11",80,NA,2,NA,0,NA,0,NA,"2016-09-08T10:59:22.282030-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"c095d9a6-5999-4a95-b737-091795954afc",NA,"TCGA-EY-A547-01A-01-TS1",NA,100,NA,"83280b9e-b826-4593-8c11-f4853156f679","RNA","TCGA-EY-A547-01A-11R","b7bd1947-631c-4d07-a754-f00c51f2e3f1",1.86,0.16,"UV Spec","R","23","TCGA-EY-A547-01A-11R-A27V-07","cc3bf52b-7b69-40c9-9358-f66cb7b1dd87",0.16,NA,108,39.1929162432864,166,"6e11faff-d613-5e56-81ff-596e88c2eb93","TCGA-EY-A547_exposure","UNCID_2168977.cc3bf52b-7b69-40c9-9358-f66cb7b1dd87.130610_UNC14-SN744_0347_BD28NBACXX_6_CCGTCC.tar.gz","2013-09-20T06:16:05.000Z","2013-09-20T06:35:01.000Z","A8C100ED-2D1E-437E-A799-8134DB0662E2","52338734-9EEC-4793-B4A7-5CD84322E797","Unaligned reads",5674929477,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","CC3BF52B-7B69-40C9-9358-F66CB7B1DD87","University of North Carolina","56607c05e4b0b37b3d9925d4","3424120F-248F-451A-948C-E320C19D1B19","Uterine Corpus Endometrial Carcinoma","TARGZ","83280B9E-B826-4593-8C11-F4853156F679","2013-09-20T06:35:01.000Z","B7BD1947-631C-4D07-A754-F00C51F2E3F1","United States","NO",1,NA,"Primary Tumor","University of North Carolina",645,"83280B9E-B826-4593-8C11-F4853156F679",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C1DA4818-1742-461D-934C-4D1CFD051585.txt",610,"TCGA-EY-A547-01A",NA,NA,"TCGA",2011,"TCGA-EY-A547_NTE-1","Complete Remission/Response","TUMOR FREE","F8BD4FB3-8B26-4000-B971-2BB60D6E34E0",75,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C1DA4818-1742-461D-934C-4D1CFD051585.txt","Alive",NA,"TCGA-EY-A547","NOT HISPANIC OR LATINO","133F0C37-96CF-448D-901E-94C487D288DA","NO",545,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",289,NA,"BACC5B01-CFCC-47AD-8999-BECB3BBC2BC9","BLACK OR AFRICAN AMERICAN",NA,11,30,"C095D9A6-5999-4A95-B737-091795954AFC","B7BD1947-631C-4D07-A754-F00C51F2E3F1","UNCID_2168977.cc3bf52b-7b69-40c9-9358-f66cb7b1dd87.130610_UNC14-SN744_0347_BD28NBACXX_6_CCGTCC.tar.gz","TCGA-EY-A547-01A-11",80,0,2,2,0,"TOP",0,0,"TCGA-EY-A547-01A-01-TS1",100,NA,NA,NA,"TCGA-EY-A547-R40736","Internal","Primary Tumor Field","TCGA-EY-A547-F55805_NTE-1","NO",545,NA,"Alive",NA,"TCGA-EY-A547-F55805","TCGA-EY-A547",1,"EY","A547","YES","C54.1","8380/3","C54.1","YES","NO",-27686,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes","No","Alive",545,NA,"YES","NO","TUMOR FREE","YES",27,2,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,75,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response",NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
80414266,79064306,3775353794,"308B8E36-4131-41E5-90A1-677A65353288.bw","3789ae3f-286b-42f0-a805-320ad69ea1df","308b8e36-4131-41e5-90a1-677a65353288","2016-08-09T14:01:17.245190-05:00","UNCID_2167252.77db73b5-24ef-47a3-b54b-4457ae62d562.130613_UNC9-SN296_0375_BD27CGACXX_3_CAGATC.tar.gz","26d46988-baad-4908-85c9-26516b23a09e",3964961718,"Illumina HiSeq","48c8e56c11f8f482441e097432bcf265","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:29:48.964323-05:00","2016-05-03T11:07:07.492763-05:00","26d46988-baad-4908-85c9-26516b23a09e_analysis.xml","1025a5ba1ac99b5fcd1cc5e8ae501630","4a795843-5e1b-4714-a1dc-beca5aeaf374",2121,"2016-09-29T23:11:28.326480-05:00","26d46988-baad-4908-85c9-26516b23a09e_experiment.xml","bb758135f2e66d18ba8e829d8c95b929","d39100f7-bfac-4704-872b-477e7429b67a",2431,"2016-09-29T20:55:12.308369-05:00","26d46988-baad-4908-85c9-26516b23a09e_run.xml","a4c851e6feade9b281852f420280f0c1","7f002787-9703-4d16-a751-2f7b785a060f",354,"2016-09-08T11:13:59.807585-05:00","TCGA-B5-A3S1","2016-09-02T18:49:17.105702-05:00","female","TCGA-B5-A3S1_demographic",1940,"white","f8e5ff46-e164-5917-9a43-dcb119802be6","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A3S1_diagnosis","not reported",26031,"alive","8441/3",NA,902,"0abb0115-7e82-55e9-8956-7920cf4aa855","c54.1",-26031,"TCGA-B5-A3S1_treatment","a2b38aaa-1518-523c-890a-af4332701700","01","true","TCGA-B5-A3S1-01A",NA,"4715fda8-7e8e-40f5-9ddb-80349a38c626",FALSE,"72F97A0D-1245-4C80-B2D2-B7B217BEC06B","Primary Tumor",NA,127,140,NA,1333411200,"11",30,"TCGA-B5-A3S1-01A-11",90,NA,1,NA,0,NA,0,NA,"2016-09-08T11:13:59.807585-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"dd605e90-d91c-45a0-8cb0-2e4facbd78e2",NA,"TCGA-B5-A3S1-01A-01-TS1",NA,95,NA,"1da1b044-1dc3-4c44-b444-9791989025bf","RNA","TCGA-B5-A3S1-01A-11R","ba2ee445-09db-481a-a0d4-09eea4104497",1.84,0.16,"UV Spec","R","23","TCGA-B5-A3S1-01A-11R-A22K-07","77db73b5-24ef-47a3-b54b-4457ae62d562",0.16,NA,68,28.3038501560874,155,"433e26dd-30fd-5042-8420-3e0a7c832726","TCGA-B5-A3S1_exposure","UNCID_2167252.77db73b5-24ef-47a3-b54b-4457ae62d562.130613_UNC9-SN296_0375_BD27CGACXX_3_CAGATC.tar.gz","2013-09-21T05:16:04.000Z","2013-09-21T05:31:01.000Z","26D46988-BAAD-4908-85C9-26516B23A09E","4715FDA8-7E8E-40F5-9DDB-80349A38C626","Unaligned reads",3964961718,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","77DB73B5-24EF-47A3-B54B-4457AE62D562","University of North Carolina","56607f28e4b0b37b3d993275","3789AE3F-286B-42F0-A805-320AD69EA1DF","Uterine Corpus Endometrial Carcinoma","TARGZ","1DA1B044-1DC3-4C44-B444-9791989025BF","2013-09-21T05:31:01.000Z","BA2EE445-09DB-481A-A0D4-09EEA4104497","United States","NO",1,NA,"Primary Tumor","Duke",127,"1DA1B044-1DC3-4C44-B444-9791989025BF",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2F5C90A3-2306-4D8D-A5F3-DDAFD7B6E298.txt",140,"TCGA-B5-A3S1-01A",NA,"FA0A3E62-B062-4EE1-A5FA-569616F4AB85","TCGA",2011,NA,NA,"WITH TUMOR","4715FDA8-7E8E-40F5-9DDB-80349A38C626",71,"nationwidechildrens.org_clinical.TCGA-B5-A3S1.xml","Alive",NA,"TCGA-B5-A3S1",NA,"DCAC3E81-1A53-47A5-A7B2-6D270F4554FD",NA,153,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"95438AEE-2538-4149-87B6-EA9B677B7F5D","WHITE",NA,11,30,"DD605E90-D91C-45A0-8CB0-2E4FACBD78E2","D26F7A6F-71CE-47B5-A3D6-8DAB3DADEE4F","UNCID_2167252.77db73b5-24ef-47a3-b54b-4457ae62d562.130613_UNC9-SN296_0375_BD27CGACXX_3_CAGATC.tar.gz","TCGA-B5-A3S1-01A-11",90,0,1,1,0,"TOP",5,0,"TCGA-B5-A3S1-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-B5-A3S1-D31858","TCGA-B5-A3S1-R31859","EXTERNAL BEAM","Regional site","TCGA-B5-A3S1-F59469_NTE-1","NO",902,NA,"Alive",NA,"TCGA-B5-A3S1-F59469","TCGA-B5-A3S1",1,"B5","A3S1","YES","C54.1","8441/3","C54.1","NO","YES",-26031,"FEMALE","WHITE",NA,"No","No","Alive",153,NA,NA,NA,"WITH TUMOR","NO",9,5,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,71,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34025277,33425509,2471034506,"F3BA6259-9F68-47D0-ABDD-1272AE112CAB.bw","37981e2c-4761-4f82-aaf2-4e6963a71603","f3ba6259-9f68-47d0-abdd-1272ae112cab","2016-08-09T14:08:07.060188-05:00","UNCID_2206482.6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23.110921_UNC6-RDR300211_00125_FC_634F4AAXX_8.tar.gz","8ffd0855-7114-443b-b551-21c63c2b393f",2209064866,"Illumina GA","8b3e560193eccc42b594d9843aa1cf81","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:40:01.721284-05:00","2016-05-03T11:11:34.765256-05:00","8ffd0855-7114-443b-b551-21c63c2b393f_analysis.xml","148d49d16ea7508b6d30c09feb4fbe0d","9ace853c-81e3-4c40-911d-c94a2e17b6c5",2121,"2016-08-13T03:31:56.702464-05:00","8ffd0855-7114-443b-b551-21c63c2b393f_experiment.xml","4b10e995132da114c90867242f707f46","e27ac733-fcda-4c1e-8958-7963cf0bfa33",2257,"2016-09-29T23:57:55.087101-05:00","8ffd0855-7114-443b-b551-21c63c2b393f_run.xml","eb1739b5f308967d8459fd2ed33aa21c","f05a2cc9-be3a-424f-baf3-0fc2bb7c5b7c",347,"2016-09-08T11:10:55.790277-05:00","TCGA-EY-A212","2016-09-02T18:52:34.812832-05:00","female","TCGA-EY-A212_demographic",1927,"white","2785b834-3a90-5c9b-81e7-57fe5805f684","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A212_diagnosis","not reported",30680,"dead","8460/3",310,110,"f60eaf41-3996-5c10-80d0-d0d5e5ac5d9d","c54.1",-30680,"TCGA-EY-A212_treatment","2025919e-8fee-5a03-8d58-7d8101277621","01","false","TCGA-EY-A212-01A",NA,"996c027f-d9c7-4a2c-8154-5ef9573fb0d0",FALSE,"3E8012E3-97F1-48A2-B1C0-5C814DF8EE01","Primary Tumor",NA,112,290,NA,1302566400,"11",30,"TCGA-EY-A212-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T11:10:55.790277-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"4f3f9d1b-9d4c-47df-9aa5-633e6d160b6e",NA,"TCGA-EY-A212-01A-01-TSA",NA,90,NA,"b3e04fc4-eb30-4ac0-98dc-5b187d02203e","RNA","TCGA-EY-A212-01A-11R","19a77986-0fbc-41b2-b63b-16ab8eae21a5",1.83,0.17,"UV Spec","R","23","TCGA-EY-A212-01A-11R-A14M-07","6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23",0.17,NA,81,32.0398718405126,159,"95df1103-22f3-51e2-87cc-5668779db70f","TCGA-EY-A212_exposure","UNCID_2206482.6c1a95ef-3b5a-49ac-aaeb-dcd8071bed23.110921_UNC6-RDR300211_00125_FC_634F4AAXX_8.tar.gz","2013-09-27T03:36:04.000Z","2013-09-27T03:54:03.000Z","8FFD0855-7114-443B-B551-21C63C2B393F","996C027F-D9C7-4A2C-8154-5EF9573FB0D0","Unaligned reads",2209064866,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","6C1A95EF-3B5A-49AC-AAEB-DCD8071BED23","University of North Carolina","5660766ae4b0b37b3d99044d","37981E2C-4761-4F82-AAF2-4E6963A71603","Uterine Corpus Endometrial Carcinoma","TARGZ","B3E04FC4-EB30-4AC0-98DC-5B187D02203E","2013-09-27T03:54:03.000Z","19A77986-0FBC-41B2-B63B-16AB8EAE21A5","United States","NO",1,NA,"Primary Tumor","University of North Carolina",112,"B3E04FC4-EB30-4AC0-98DC-5B187D02203E",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.0AD26348-0444-4AA1-B64C-57F26CD91A94.txt",290,"TCGA-EY-A212-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","CCFF59B2-A9E4-4ED3-A506-60D9477F7CBB",83,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.0AD26348-0444-4AA1-B64C-57F26CD91A94.txt","Alive",NA,"TCGA-EY-A212","NOT HISPANIC OR LATINO","8C35E1F4-E1F6-49C3-AB23-15966362E554",NA,110,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8460/3","FEMALE","C54.1",125,NA,NA,"WHITE",NA,11,30,"4F3F9D1B-9D4C-47DF-9AA5-633E6D160B6E","71D05B77-9A15-4809-82C2-C58C8B14434A","2fa4a2e05492abfc332b19feec5309f4.bam","TCGA-EY-A212-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-EY-A212-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,"NO",NA,"WITH TUMOR","Dead",310,"TCGA-EY-A212-F21719","TCGA-EY-A212",1,"EY","A212","YES","C54.1","8460/3","C54.1","YES","NO",-30680,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",110,NA,NA,NA,"TUMOR FREE","NO",8,7,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,83,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36788502,36536718,2750651746,"24AE4256-3483-404F-BDE5-3ED03028ADEA.bw","37bac6ba-be93-42cc-892b-efd0bdb850bd","24ae4256-3483-404f-bde5-3ed03028adea","2016-08-09T14:02:35.523760-05:00","UNCID_2194820.1cb61aae-c6d4-4afc-889e-4060d109c83e.120307_UNC2-RDR300275_00118_FC_650V8AAXX_7.tar.gz","e2969663-55d9-4025-b2c7-0e3c47670e48",2370375185,"Illumina GA","a139a33a09a594936d55637f39562e62","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:53:15.951242-05:00","2016-05-03T11:07:49.533775-05:00","e2969663-55d9-4025-b2c7-0e3c47670e48_analysis.xml","067521b3a8b41013e03168fa7b0d5613","ed861afd-8884-486b-81a0-5f543617a655",2121,"2016-09-29T21:34:31.317387-05:00","e2969663-55d9-4025-b2c7-0e3c47670e48_experiment.xml","067506c3716b8c95f940afc37c7198f7","97751eac-a1e3-4a1d-bda9-48f14b626965",2257,"2016-09-29T20:10:57.372407-05:00","e2969663-55d9-4025-b2c7-0e3c47670e48_run.xml","b3d3a0f3f35ef28ef7d5f9da8124c1f1","63bbf69e-bc70-4750-a4bc-03a56a1b582d",347,"2016-09-08T12:08:47.036494-05:00","TCGA-B5-A1MX","2016-09-02T18:52:03.673194-05:00","female","TCGA-B5-A1MX_demographic",1963,"white","9c2b69c8-d692-58c7-aa43-f7ed2aaa6dc7","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A1MX_diagnosis","not reported",17320,"alive","8380/3",NA,1473,"2c4fc6a9-529d-59ce-8ea1-4e4dadf8380c","c54.1",-17320,"TCGA-B5-A1MX_treatment","e8d186bb-8b17-5f60-95ef-9caced8d79f1","01","true","TCGA-B5-A1MX-01A",NA,"68e7d2d6-3313-4ffc-bb4f-ba9167a7b669",FALSE,"C8962646-1A09-4EAA-8864-2539A0CCEC4C","Primary Tumor",NA,103,560,NA,1300406400,"11",30,"TCGA-B5-A1MX-01A-11",97,NA,2,NA,0,NA,3,NA,"2016-09-08T12:08:47.036494-05:00",NA,5,NA,2,NA,"TOP",NA,2,NA,"fcb3e3cf-f205-433b-ba60-005001e43f01",NA,"TCGA-B5-A1MX-01A-01-TSA",NA,95,NA,"184a6b11-ce6b-48bc-80a0-0c06b5b84db3","RNA","TCGA-B5-A1MX-01A-11R","0c15a0ee-34db-4b1b-b148-7152df624d73",1.72,0.16,"UV Spec","R","23","TCGA-B5-A1MX-01A-11R-A144-07","1cb61aae-c6d4-4afc-889e-4060d109c83e",0.16,NA,58,25.1038781163435,152,"93a59612-d60a-53cf-b284-a1154720a04d","TCGA-B5-A1MX_exposure","UNCID_2194820.1cb61aae-c6d4-4afc-889e-4060d109c83e.120307_UNC2-RDR300275_00118_FC_650V8AAXX_7.tar.gz","2013-09-23T03:46:04.000Z","2013-09-23T03:59:02.000Z","E2969663-55D9-4025-B2C7-0E3C47670E48","68E7D2D6-3313-4FFC-BB4F-BA9167A7B669","Unaligned reads",2370375185,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1CB61AAE-C6D4-4AFC-889E-4060D109C83E","University of North Carolina","564a3d34e4b0ef12181b03c4","37BAC6BA-BE93-42CC-892B-EFD0BDB850BD","Uterine Corpus Endometrial Carcinoma","TARGZ","184A6B11-CE6B-48BC-80A0-0C06B5B84DB3","2013-09-23T03:59:02.000Z","0C15A0EE-34DB-4B1B-B148-7152DF624D73","United States","NO",1,NA,"Primary Tumor","Duke",103,"184A6B11-CE6B-48BC-80A0-0C06B5B84DB3",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FB207C5A-C3BE-44FF-85C1-9757F354DA68.txt",560,"TCGA-B5-A1MX-01A",NA,"73F50EDD-34FA-4E17-93BC-17ADEC3AE898","TCGA",2010,NA,NA,"TUMOR FREE","68E7D2D6-3313-4FFC-BB4F-BA9167A7B669",47,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FB207C5A-C3BE-44FF-85C1-9757F354DA68.txt","Alive",NA,"TCGA-B5-A1MX",NA,"B6170F88-D324-4822-B43B-13E9DFDC1839",NA,175,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",118,NA,"40E97EDE-95AE-478D-AD46-299EDF8DE049","WHITE",NA,11,30,"FCB3E3CF-F205-433B-BA60-005001E43F01","F2B6117B-4643-47B0-B792-4FEA5F5C5F5A","TCGA-B5-A1MX-01A-11R-A143-13_mirna.bam.bai","TCGA-B5-A1MX-01A-11",97,0,2,5,3,"TOP",2,2,"TCGA-B5-A1MX-01A-01-TSA",95,"Megace","Hormone Therapy","TCGA-B5-A1MX-D21623","TCGA-B5-A1MX-R21622","EXTERNAL BEAM","Regional site",NA,"NO",356,"TUMOR FREE","Alive",NA,"TCGA-B5-A1MX-F21625","TCGA-B5-A1MX",1,"B5","A1MX","YES","C54.1","8380/3","C54.1","NO","YES",-17320,"FEMALE","WHITE",NA,"No","No","Alive",175,NA,NA,NA,"TUMOR FREE","NO",16,2,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,47,2010,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
34835138,34599308,2555369406,"B4DC0995-06D9-4AC9-82D4-CE98A3958283.bw","37d5c1d9-3ff5-44fe-afdc-ff430a0f3510","b4dc0995-06d9-4ac9-82d4-ce98a3958283","2016-08-09T14:13:30.760522-05:00","UNCID_2208091.c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09.110624_UNC2-RDR300275_00073_FC70KA5AAXX_2.tar.gz","abde80a6-2f4d-48e3-afb2-3c45ea1a4ebc",2176861793,"Illumina GA","b00aa0f4ba9f28c8549ecf1be6f78524","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:19:11.944154-05:00","2016-05-03T11:14:23.412460-05:00","abde80a6-2f4d-48e3-afb2-3c45ea1a4ebc_analysis.xml","b725760bf3c894ef37db7e0385aa9b4f","68b58b08-e18e-4821-8dfb-2e1e750fddeb",2119,"2016-09-29T18:21:25.711668-05:00","abde80a6-2f4d-48e3-afb2-3c45ea1a4ebc_experiment.xml","4ade9d4a8ecf73e77f1758f3bb1fe46a","1f2e32db-7e64-4f6b-ac9c-c1cf0ecb02f7",2257,"2016-09-29T17:51:27.652660-05:00","abde80a6-2f4d-48e3-afb2-3c45ea1a4ebc_run.xml","9bfbacf9e009db956cf3207f6053992c","0c96bc25-5cfb-4115-9118-4615472fe730",347,"2016-09-08T12:03:42.407241-05:00","TCGA-D1-A179","2016-09-02T18:50:35.276343-05:00","female","TCGA-D1-A179_demographic",1934,"white","81cd252c-e9e4-51f3-8c0f-6b4b20f25bf4","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A179_diagnosis","not reported",28037,"dead","8441/3",448,206,"09cbb646-8d49-589d-8ef2-f934f3dfd0be","c54.1",-28037,"TCGA-D1-A179_treatment","9bad8611-91b3-5a82-a51b-bf1aff93f46a","01","false","TCGA-D1-A179-01A",NA,"ba812542-9161-4060-93cd-8b730adb4d40",FALSE,"F8F4C024-B723-424C-B98D-AA885C38CDFB","Primary Tumor",NA,230,250,NA,1294099200,"11",30,"TCGA-D1-A179-01A-11",70,NA,10,NA,0,NA,10,NA,"2016-09-08T12:03:42.407241-05:00",NA,40,NA,40,NA,"TOP",NA,20,NA,"3975398f-c750-4d42-9d59-6b24043b653d",NA,"TCGA-D1-A179-01A-01-TS1",NA,70,NA,"7e329ecf-7120-4612-af2e-c9ca19b1c9c9","RNA","TCGA-D1-A179-01A-11R","056c7cc3-708e-4cf0-813d-a4b0d366e5d7",1.86,0.15,"UV Spec","R","23","TCGA-D1-A179-01A-11R-A12I-07","c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09",0.15,NA,95,36.1987501905197,162,"fad08a06-54d8-5318-a690-d2824525517d","TCGA-D1-A179_exposure","UNCID_2208091.c64d52eb-c0aa-4ebe-a21d-0e7f11be7d09.110624_UNC2-RDR300275_00073_FC70KA5AAXX_2.tar.gz","2013-09-30T08:36:04.000Z","2013-09-30T08:49:02.000Z","ABDE80A6-2F4D-48E3-AFB2-3C45EA1A4EBC","BA812542-9161-4060-93CD-8B730ADB4D40","Unaligned reads",2176861793,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C64D52EB-C0AA-4EBE-A21D-0E7F11BE7D09","University of North Carolina","564a3ac1e4b0ef12181a3bda","37D5C1D9-3FF5-44FE-AFDC-FF430A0F3510","Uterine Corpus Endometrial Carcinoma","TARGZ","7E329ECF-7120-4612-AF2E-C9CA19B1C9C9","2013-09-30T08:49:02.000Z","056C7CC3-708E-4CF0-813D-A4B0D366E5D7","None","NO",1,NA,"Primary Tumor","Mayo Clinic",230,"7E329ECF-7120-4612-AF2E-C9CA19B1C9C9",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.1DBC4EDF-4733-486E-9F7E-FE0BFF8A4428.txt",250,"TCGA-D1-A179-01A",NA,"664E8458-557E-489A-8614-B8A0F19B7AD6","TCGA",2010,NA,NA,"TUMOR FREE","BA812542-9161-4060-93CD-8B730ADB4D40",76,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.1DBC4EDF-4733-486E-9F7E-FE0BFF8A4428.txt","Alive",NA,"TCGA-D1-A179","HISPANIC OR LATINO","A63313BA-19C9-41DE-BE7C-E520815FCC5A",NA,206,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"3975398F-C750-4D42-9D59-6B24043B653D","81B8A1F2-7532-4C59-AB3D-679C4F86F7C9","TCGA-D1-A179-01A-11R-A12H-13_mirna.bam","TCGA-D1-A179-01A-11",70,0,10,40,10,"TOP",20,40,"TCGA-D1-A179-01A-01-TS1",70,"Carboplatin","Chemotherapy","TCGA-D1-A179-D20306",NA,NA,NA,NA,"YES",NA,"WITH TUMOR","Dead",448,"TCGA-D1-A179-F20304","TCGA-D1-A179",1,"D1","A179","YES","C54.1","8441/3","C54.1","NO","YES",-28037,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",206,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,76,2010,"Office Endometrial Biopsy",NA,NA,NA,"High Grade","R0",NA,NA,NA,NA,NA,"2009",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35198998,33525811,2527077611,"9BA9A60C-977E-4FC9-8B9B-CE66EBE6960F.bw","38243a33-073a-479b-8cf6-c8847aeb5a48","9ba9a60c-977e-4fc9-8b9b-ce66ebe6960f","2016-08-09T14:15:01.411431-05:00","UNCID_2210231.650687c0-616b-41a5-ae29-322ba9cfc462.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_4.tar.gz","bf60da28-c34b-4f48-a4e3-11271e7e9971",2252587669,"Illumina GA","7fee901aefae56e61959815112d4a66e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:25:15.663373-05:00","2016-05-03T11:15:47.407128-05:00","bf60da28-c34b-4f48-a4e3-11271e7e9971_analysis.xml","b94d4232c63fedf00352d771299bc099","6c8a119d-33d1-410a-8b89-f31a78c5b73a",2121,"2016-10-07T15:59:48.141593-05:00","bf60da28-c34b-4f48-a4e3-11271e7e9971_experiment.xml","d2cd1e227bb522cf52577ab608b4caf7","93ff5401-6677-4112-ade9-ee70d60cd542",2257,"2016-09-29T21:22:59.363247-05:00","bf60da28-c34b-4f48-a4e3-11271e7e9971_run.xml","bcc93936a19108de43d2cc08859c8af2","906a6b00-5dcc-4fec-a43c-705c820e379e",347,"2016-09-08T10:45:38.326291-05:00","TCGA-D1-A0ZQ","2016-09-02T18:49:52.332515-05:00","female","TCGA-D1-A0ZQ_demographic",1919,"white","94dfa136-8422-58f4-a7c3-0856703cb127","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A0ZQ_diagnosis","not reported",32872,"alive","8380/3",NA,260,"25abd952-109e-5bdf-95e0-cac38a8354c0","c54.1",-32872,"TCGA-D1-A0ZQ_treatment","b2eda5ce-233a-53a7-9b16-0e87b8918ed3","01","false","TCGA-D1-A0ZQ-01A",NA,"e20471d5-a261-448b-9a6f-fd3be8ed5c04",FALSE,"BAC6E925-0499-41AD-9F58-2CB8E3EE058E","Primary Tumor",NA,540,120,NA,1287619200,"11",30,"TCGA-D1-A0ZQ-01A-11",30,70,0,0,0,20,67,10,"2016-09-08T10:45:38.326291-05:00","2016-09-08T10:45:38.326291-05:00",8,20,2,20,"TOP","BOTTOM",3,20,"33217517-811e-4a56-944d-ff357667ea75","5a63eca8-461b-419b-bc1a-d19223f33170","TCGA-D1-A0ZQ-01A-01-MS1","TCGA-D1-A0ZQ-01A-01-BS1",30,50,"6ad4fb52-e988-4bf3-960e-91ff8e04aece","RNA","TCGA-D1-A0ZQ-01A-11R","5043f07b-28c5-4bed-8356-2b65b6fb71a1",1.88,0.14,"UV Spec","R","23","TCGA-D1-A0ZQ-01A-11R-A118-07","650687c0-616b-41a5-ae29-322ba9cfc462",0.14,NA,69,28.7200832466181,155,"6f3567eb-401a-560f-bc9e-3eacb32d62fc","TCGA-D1-A0ZQ_exposure","UNCID_2210231.650687c0-616b-41a5-ae29-322ba9cfc462.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_4.tar.gz","2013-10-02T07:43:07.000Z","2013-10-02T07:56:02.000Z","BF60DA28-C34B-4F48-A4E3-11271E7E9971","E20471D5-A261-448B-9A6F-FD3BE8ED5C04","Unaligned reads",2252587669,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","650687C0-616B-41A5-AE29-322BA9CFC462","University of North Carolina","564a3473e4b0ef1218183608","38243A33-073A-479B-8CF6-C8847AEB5A48","Uterine Corpus Endometrial Carcinoma","TARGZ","6AD4FB52-E988-4BF3-960E-91FF8E04AECE","2013-10-02T07:56:02.000Z","5043F07B-28C5-4BED-8356-2B65B6FB71A1","None","NO",1,NA,"Primary Tumor","Mayo Clinic",540,"6AD4FB52-E988-4BF3-960E-91FF8E04AECE",NA,"D1","nationwidechildrens.org_biospecimen.TCGA-D1-A0ZQ.xml",120,"TCGA-D1-A0ZQ-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","E20471D5-A261-448B-9A6F-FD3BE8ED5C04",90,"nationwidechildrens.org_clinical.TCGA-D1-A0ZQ.xml","Alive",NA,"TCGA-D1-A0ZQ","NOT HISPANIC OR LATINO","8F332327-DE00-4165-A986-0E3D961013E7",NA,8,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"5A63ECA8-461B-419B-BC1A-D19223F33170","F951D5CD-B84F-4C75-9CC7-4C03B84BFBDB","TCGA-D1-A0ZQ-01A-11R-A119-13_mirna.bam","TCGA-D1-A0ZQ-01A-11",70,20,0,20,10,"BOTTOM",20,20,"TCGA-D1-A0ZQ-01A-01-BS1",50,NA,NA,NA,NA,NA,NA,NA,"NO",260,"TUMOR FREE","Alive",NA,"TCGA-D1-A0ZQ-F17747","TCGA-D1-A0ZQ",1,"D1","A0ZQ","YES","C54.1","8380/3","C54.1","NO","YES",-32873,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",8,NA,NA,NA,"TUMOR FREE","NO",7,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,90,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34511597,33996679,2503325319,"F7A99180-9A3E-460B-B137-5E09B8A9D483.bw","3878f58e-76ba-4480-a784-88505bd464d0","f7a99180-9a3e-460b-b137-5e09b8a9d483","2016-09-02T20:51:10.748185-05:00","UNCID_2206592.06745c8c-5e2b-4131-93a5-9023c32665ac.110928_UNC6-RDR300211_00126_FC_6348UAAXX_7.tar.gz","35ab7004-00d8-459c-9e30-0022f1e0293a",2300824160,"Illumina GA","5aebc15bc0ff01e98640f678a34be6b3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:02:45.717894-05:00","2016-05-03T11:11:34.779998-05:00","35ab7004-00d8-459c-9e30-0022f1e0293a_analysis.xml","46b42f3492e05eeff66d9567ac206277","396b8e90-dd04-4842-b5f7-0a4e0010a37e",2121,"2016-08-27T18:04:25.108406-05:00","35ab7004-00d8-459c-9e30-0022f1e0293a_experiment.xml","57bac3bf1307b4e63436e006450a86e2","428d753b-b140-46c4-83aa-ae5f5ca2e21a",2257,"2016-09-29T18:04:18.545131-05:00","35ab7004-00d8-459c-9e30-0022f1e0293a_run.xml","b3d4ca300d154910272e67fe4d11161e","14bdd386-fc1a-4241-8a44-73d74f24d56a",347,"2016-09-08T10:50:07.531999-05:00","TCGA-FI-A2EX","2016-09-02T18:52:58.922569-05:00","female","TCGA-FI-A2EX_demographic",1947,"white","62496790-a6d7-551d-98e3-2cccd01e73d2","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2EX_diagnosis","not reported",21489,"alive","8441/3",NA,284,"a4feb6ed-8fc3-5bcb-bd28-bedc292581a5","c54.1",-21489,"TCGA-FI-A2EX_treatment","f14ce906-d403-51e4-bf63-21aee21356b9","01","true","TCGA-FI-A2EX-01A",NA,"0a2eaf88-6c98-409f-bf63-4d62c844193c",FALSE,"68355069-2D77-4C5C-9AA9-E93A0C3CFD94","Primary Tumor",NA,2201,110,NA,1308268800,"11",30,"TCGA-FI-A2EX-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T10:50:07.531999-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"22a21910-624d-4a3c-acdb-ce30e6c97235",NA,"TCGA-FI-A2EX-01A-01-TSA",NA,90,NA,"c59ee5a8-7481-4464-b7a2-21b171e39e6e","RNA","TCGA-FI-A2EX-01A-11R","30b80c51-db89-4ced-8ed7-5b3ccdbe206d",1.77,0.15,"UV Spec","R","23","TCGA-FI-A2EX-01A-11R-A17B-07","06745c8c-5e2b-4131-93a5-9023c32665ac",0.15,NA,89,37.5274076572778,154,"229570c0-3a7a-5b12-9c12-ae3fd9ce3587","TCGA-FI-A2EX_exposure","UNCID_2206592.06745c8c-5e2b-4131-93a5-9023c32665ac.110928_UNC6-RDR300211_00126_FC_6348UAAXX_7.tar.gz","2013-09-27T11:46:04.000Z","2013-09-27T12:00:02.000Z","35AB7004-00D8-459C-9E30-0022F1E0293A","0A2EAF88-6C98-409F-BF63-4D62C844193C","Unaligned reads",2300824160,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","06745C8C-5E2B-4131-93A5-9023C32665AC","University of North Carolina","564a3d27e4b0298dd2c8f85b","3878F58E-76BA-4480-A784-88505BD464D0","Uterine Corpus Endometrial Carcinoma","TARGZ","C59EE5A8-7481-4464-B7A2-21B171E39E6E","2013-09-27T12:00:02.000Z","30B80C51-DB89-4CED-8ED7-5B3CCDBE206D","United States","NO",1,NA,"Primary Tumor","Washington University",2201,"C59EE5A8-7481-4464-B7A2-21B171E39E6E",NA,"FI","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.10FFCFD0-5CD9-4530-AA2D-EB697F20CCA4.txt",110,"TCGA-FI-A2EX-01A",NA,"B72831D6-8FC8-45BB-BABD-47AA4035A915","TCGA",2005,NA,NA,"WITH TUMOR","A789BFB4-DFFA-4B6B-BC0E-B47ABF83D4B8",58,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.10FFCFD0-5CD9-4530-AA2D-EB697F20CCA4.txt","Alive",NA,"TCGA-FI-A2EX","NOT HISPANIC OR LATINO","153FAA9C-36F8-46AA-ADF7-A31145B64C55",NA,276,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"22A21910-624D-4A3C-ACDB-CE30E6C97235","AF25A7F6-0BC1-47EA-805D-C6626B7EA3EC","TATTY_p_TCGA_b52_156_SNP_N_GenomeWideSNP_6_E03_809032.birdseed.data.txt","TCGA-FI-A2EX-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-FI-A2EX-01A-01-TSA",90,"Paclitaxel","Chemotherapy","TCGA-FI-A2EX-D31796",NA,NA,NA,NA,"YES",284,"WITH TUMOR","Alive",NA,"TCGA-FI-A2EX-F31519","TCGA-FI-A2EX",1,"FI","A2EX","YES","C54.1","8441/3","C54.1","NO","YES",-21489,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",276,NA,NA,NA,"WITH TUMOR","NO",27,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,58,2005,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31819539,31568561,2354724309,"BEDD1191-F918-42BE-A6BE-581BFD10A53B.bw","38a3ea92-8965-4bda-9dbd-144832975cdd","bedd1191-f918-42be-a6be-581bfd10a53b","2016-08-31T13:08:01.730501-05:00","UNCID_2211978.7e923dc8-9920-4f06-a98b-085a5935b29c.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_2.tar.gz","69bafffe-06be-466a-99f6-6051f11faa80",1939766651,"Illumina GA","c24fe61e96c752a9666615cb68a5f2c4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:16:08.320964-05:00","2016-05-03T11:16:29.242391-05:00","69bafffe-06be-466a-99f6-6051f11faa80_analysis.xml","3f151779c34d0aef99e0ec1301f70f3c","fb8f7c19-9e52-47b3-89ca-4906498454a3",2121,"2016-08-13T03:13:13.183774-05:00","69bafffe-06be-466a-99f6-6051f11faa80_experiment.xml","b8aa5f2d8d2da199277776cd10f48c27","d8c172f9-ead9-4cba-9fbf-c37f168d06ba",2257,"2016-09-29T20:48:13.970825-05:00","69bafffe-06be-466a-99f6-6051f11faa80_run.xml","f731a22fa2fc64c834288d7b5a93a10c","7a9d0efe-8761-42c1-bcf6-65dae608952a",347,"2016-09-08T11:55:44.484899-05:00","TCGA-B5-A11E","2016-09-02T18:49:05.158551-05:00","female","TCGA-B5-A11E_demographic",1957,"white","bac1495d-3338-556a-b9d6-93239b967de8","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11E_diagnosis","not reported",19458,"alive","8380/3",NA,1820,"1b2d6833-a1ee-5d20-9567-173f86e5af4d","c54.1",-19458,"TCGA-B5-A11E_treatment","9a3d0025-acb8-59da-bf52-9c4bccdfcc24","01","true","TCGA-B5-A11E-01A",NA,"cd68a1a9-039f-4da5-9a53-3cd60a261f7f",FALSE,"2058131C-09EA-4DC7-A84A-EB055A68F1B6","Primary Tumor",NA,198,890,NA,1289865600,"11",30,"TCGA-B5-A11E-01A-11",96,95,0,0,0,0,1,3,"2016-09-08T11:55:44.484899-05:00","2016-09-08T11:55:44.484899-05:00",4,4,1,1,"BOTTOM","TOP",3,2,"1d1b836a-9771-4806-ba0d-fc09b4608cde","6220bbcd-62ad-4215-8208-63341b6f8e2e","TCGA-B5-A11E-01A-01-BSA","TCGA-B5-A11E-01A-01-TSA",96,95,"2af664be-61cb-4253-b242-3c018ad1ba37","RNA","TCGA-B5-A11E-01A-11R","7de87cac-7ea1-455c-b86b-ffceac3080c9",1.86,0.15,"UV Spec","R","23","TCGA-B5-A11E-01A-11R-A10J-07","7e923dc8-9920-4f06-a98b-085a5935b29c",0.15,NA,52,19.1000918273646,165,"66760adc-d607-5bb3-a2da-738c1d73ee46","TCGA-B5-A11E_exposure","UNCID_2211978.7e923dc8-9920-4f06-a98b-085a5935b29c.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_2.tar.gz","2013-10-03T04:36:05.000Z","2013-10-03T04:49:02.000Z","69BAFFFE-06BE-466A-99F6-6051F11FAA80","CD68A1A9-039F-4DA5-9A53-3CD60A261F7F","Unaligned reads",1939766651,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7E923DC8-9920-4F06-A98B-085A5935B29C","University of North Carolina","566079abe4b0ec1099f8dbf3","38A3EA92-8965-4BDA-9DBD-144832975CDD","Uterine Corpus Endometrial Carcinoma","TARGZ","2AF664BE-61CB-4253-B242-3C018AD1BA37","2013-10-03T04:49:02.000Z","7DE87CAC-7EA1-455C-B86B-FFCEAC3080C9","United States","NO",1,NA,"Primary Tumor","Duke",198,"2AF664BE-61CB-4253-B242-3C018AD1BA37",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E4F73CB4-DF3F-467F-BE19-6037F9871CCE.txt",890,"TCGA-B5-A11E-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","CD68A1A9-039F-4DA5-9A53-3CD60A261F7F",53,"nationwidechildrens.org_clinical.TCGA-B5-A11E.xml","Alive",NA,"TCGA-B5-A11E",NA,"BE56C58D-A575-4312-A89F-CDD470E4D059",NA,265,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,11,30,"6220BBCD-62AD-4215-8208-63341B6F8E2E","7DE87CAC-7EA1-455C-B86B-FFCEAC3080C9","UNCID_2211978.7e923dc8-9920-4f06-a98b-085a5935b29c.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_2.tar.gz","TCGA-B5-A11E-01A-11",96,0,0,4,1,"BOTTOM",3,1,"TCGA-B5-A11E-01A-01-BSA",96,NA,NA,NA,NA,NA,NA,"TCGA-B5-A11E-F72226_NTE-1","NO",1820,"TUMOR FREE","Alive",NA,"TCGA-B5-A11E-F72226","TCGA-B5-A11E",1,"B5","A11E","YES","C54.1","8380/3","C54.1","NO","YES",-19458,"FEMALE","WHITE",NA,"No","No","Alive",265,NA,NA,NA,"TUMOR FREE","NO",22,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
108530504,105005099,4996040958,"5E92E940-A41F-41FC-BDF6-F6D7E0F16E5B.bw","38bf8476-fde7-423b-bbaa-15483207de39","5e92e940-a41f-41fc-bdf6-f6d7e0f16e5b","2016-08-06T14:15:19.962094-05:00","UNCID_2177815.78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f.130402_UNC10-SN254_0447_BC22WAACXX_7_GTTTCG.tar.gz","e0022d80-897a-4ca9-8e32-5fb0f8791516",4530624189,"Illumina HiSeq","3cb2918b6765d44efed1aae519e2660a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:16:29.992394-05:00","2016-05-03T10:56:47.890899-05:00","e0022d80-897a-4ca9-8e32-5fb0f8791516_analysis.xml","a4e61066792cf1c19f3fc44737cd392e","67160340-9284-4e5b-af1c-253066643460",2123,"2016-10-07T17:46:06.204372-05:00","e0022d80-897a-4ca9-8e32-5fb0f8791516_experiment.xml","92c886e891036138fcc1d2c546bb26b7","66f548b7-0eea-45a1-a993-c36d4cd11599",2431,"2016-09-29T18:53:09.821657-05:00","e0022d80-897a-4ca9-8e32-5fb0f8791516_run.xml","786b34b57e49806cd6d43e2e3e0f4fc0","335ef2fd-91b0-4478-b451-28bb2ba028e8",354,"2016-09-08T10:39:19.048687-05:00","TCGA-EO-A3AZ","2016-09-02T18:47:57.606111-05:00","female","TCGA-EO-A3AZ_demographic",1931,"not reported","4d5a76c9-3887-5675-bb43-b0fb50bc0d49","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3AZ_diagnosis","not reported",29234,"alive","8441/3",NA,826,"6a15561f-5eee-51c1-81ef-a8c63d313591","c54.1",-29234,"TCGA-EO-A3AZ_treatment","6f41146a-6ec2-5aca-b679-e2554e0fea90","01","false","TCGA-EO-A3AZ-01A",NA,"de7f0a98-8365-4dfc-856f-138eae9cef16",FALSE,"EA5D2C1C-703B-46BE-8B16-C40CE4BA0B46","Primary Tumor",NA,241,120,NA,1317686400,"12",20,"TCGA-EO-A3AZ-01A-12",80,NA,10,NA,0,NA,15,NA,"2016-09-08T10:39:19.048687-05:00",NA,70,NA,10,NA,"TOP",NA,5,NA,"7eafe5b3-1fc6-4495-9dae-4d33a9f8c31e",NA,"TCGA-EO-A3AZ-01A-01-TSA",NA,80,NA,"9f08642a-4681-446c-919a-90d4dafd248b","RNA","TCGA-EO-A3AZ-01A-12R","486115fa-86c7-4201-b3e3-53ea07455e98",1.79,0.17,"UV Spec","R","23","TCGA-EO-A3AZ-01A-12R-A19W-07","78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f",0.17,NA,78,39.7959183673469,140,"723116d3-1dfd-53e0-844f-5e68c7bdb32d","TCGA-EO-A3AZ_exposure","UNCID_2177815.78ab0c5d-29cf-4660-bd1f-1a0eb5edaf2f.130402_UNC10-SN254_0447_BC22WAACXX_7_GTTTCG.tar.gz","2013-09-11T18:51:05.000Z","2013-09-11T07:10:01.000Z","E0022D80-897A-4CA9-8E32-5FB0F8791516","DE7F0A98-8365-4DFC-856F-138EAE9CEF16","Unaligned reads",4530624189,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","78AB0C5D-29CF-4660-BD1F-1A0EB5EDAF2F","University of North Carolina","56607e4be4b016715ab6b99e","38BF8476-FDE7-423B-BBAA-15483207DE39","Uterine Corpus Endometrial Carcinoma","TARGZ","9F08642A-4681-446C-919A-90D4DAFD248B","2013-09-11T07:10:01.000Z","486115FA-86C7-4201-B3E3-53EA07455E98","Canada","NO",1,NA,"Primary Tumor","University Health Network",241,"9F08642A-4681-446C-919A-90D4DAFD248B",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FBF232C4-9838-4991-8623-DC86F7A60FC8.txt",120,"TCGA-EO-A3AZ-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","DE7F0A98-8365-4DFC-856F-138EAE9CEF16",80,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FBF232C4-9838-4991-8623-DC86F7A60FC8.txt","Alive",NA,"TCGA-EO-A3AZ",NA,"99B27495-4541-43B4-9F08-B6214B1049A6",NA,469,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",186,NA,NA,NA,NA,12,20,"7EAFE5B3-1FC6-4495-9DAE-4D33A9F8C31E","A93A1C10-13B3-4C2A-B602-9A0321CD17EA","804f31692cafb868e513b31414ea270e.bam","TCGA-EO-A3AZ-01A-12",80,0,10,70,15,"TOP",5,10,"TCGA-EO-A3AZ-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,"TCGA-EO-A3AZ-F48635_NTE-1","NO",826,"TUMOR FREE","Alive",NA,"TCGA-EO-A3AZ-F48635","TCGA-EO-A3AZ",1,"EO","A3AZ","YES","C54.1","8441/3","C54.1","NO","YES",-29234,"FEMALE",NA,NA,"No","No","Alive",469,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,80,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
38218558,37992373,2751075158,"60AFD798-AF56-41CC-9EA9-2F1CA1986886.bw","38f9fe64-de79-498c-b3ca-1c83af0ed72a","60afd798-af56-41cc-9ea9-2f1ca1986886","2016-08-09T14:16:40.307884-05:00","UNCID_2215623.dbe07c69-fd67-4dcd-b69d-6bdc4a85110c.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_3.tar.gz","8144f70d-e9a0-4a86-a570-dee9e4fd5b40",2313917065,"Illumina GA","51409288a81400ea3506ebfe885329f9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:32:09.799212-05:00","2016-05-03T11:18:46.977159-05:00","8144f70d-e9a0-4a86-a570-dee9e4fd5b40_analysis.xml","6135bb674171522aba28fecf94de5dea","bb16f34f-88be-422d-9c92-0a3839b882f0",2122,"2016-10-07T16:09:59.984528-05:00","8144f70d-e9a0-4a86-a570-dee9e4fd5b40_experiment.xml","b9133fd4e254f87ac2c232dabec6c952","e42882a0-fe79-438c-b86b-f9bb68809891",2256,"2016-09-29T22:50:58.639808-05:00","8144f70d-e9a0-4a86-a570-dee9e4fd5b40_run.xml","286574a50d8aa882ab83d30cd2d8e5cb","c6c6f91b-c27b-4297-a315-508e6e3e7def",345,"2016-09-08T11:09:20.980681-05:00","TCGA-AP-A05J","2016-09-02T18:52:41.151033-05:00","female","TCGA-AP-A05J_demographic",1942,"white","ffb5b981-6cb5-5f4e-b50f-0fd3b4d6dcea","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A05J_diagnosis","not reported",24119,"alive","8441/3",NA,1122,"ba11f1ed-4646-5adf-b91e-6b8562dbf59d","c54.1",-24119,"TCGA-AP-A05J_treatment","7a3dfec1-6e94-5740-a56f-17dae998b581","01","true","TCGA-AP-A05J-01A",NA,"203c6ed3-2e18-400d-83ee-69a8fd9bb386",FALSE,"C6426DA0-86C5-49CC-9983-A0002DA0D4F2","Primary Tumor",NA,566,170,NA,1275868800,"11",30,"TCGA-AP-A05J-01A-11",95,95,0,1,0,0,5,5,"2016-09-08T11:09:20.980681-05:00","2016-09-08T11:09:20.980681-05:00",0,0,0,0,"BOTTOM","TOP",10,5,"9658ed08-b17d-472b-8a1f-38d957e4e6ce","c7360473-2dac-4bad-a794-36ca8e4c7bba","TCGA-AP-A05J-01A-01-BSA","TCGA-AP-A05J-01A-01-TSA",85,90,"ea79f9cd-5812-47fe-b022-b9ed694c8b14","RNA","TCGA-AP-A05J-01A-11R","0ab885f2-df5b-4236-98c5-8fe234bf6cdb",1.76,0.17,"UV Spec","R","23","TCGA-AP-A05J-01A-11R-A00V-07","dbe07c69-fd67-4dcd-b69d-6bdc4a85110c",0.17,NA,79,27.9903628117914,168,"0b697c65-bbce-5a15-b6c8-51f80b075019","TCGA-AP-A05J_exposure","UNCID_2215623.dbe07c69-fd67-4dcd-b69d-6bdc4a85110c.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_3.tar.gz","2013-10-04T03:55:04.000Z","2013-10-04T04:09:02.000Z","8144F70D-E9A0-4A86-A570-DEE9E4FD5B40","203C6ED3-2E18-400D-83EE-69A8FD9BB386","Unaligned reads",2313917065,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","DBE07C69-FD67-4DCD-B69D-6BDC4A85110C","University of North Carolina","564a32a5e4b0ef121817a2d2","38F9FE64-DE79-498C-B3CA-1C83AF0ED72A","Uterine Corpus Endometrial Carcinoma","TARGZ","EA79F9CD-5812-47FE-B022-B9ED694C8B14","2013-10-04T04:09:02.000Z","0AB885F2-DF5B-4236-98C5-8FE234BF6CDB","None","NO",1,NA,"Primary Tumor","MSKCC",566,"EA79F9CD-5812-47FE-B022-B9ED694C8B14",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7B9D2566-40DC-4A4F-A4BE-A5CD1E56BFA2.txt",170,"TCGA-AP-A05J-01A",NA,"E924FF94-35DC-4C2A-89EE-0684FA0D0A46","TCGA",2008,NA,NA,"TUMOR FREE","45E98F51-5225-4BB1-8185-FB63A139101C",66,"nationwidechildrens.org_clinical.TCGA-AP-A05J.xml","Alive",NA,"TCGA-AP-A05J",NA,"B2D513E2-C190-4D2C-96CE-812017E11E26",NA,639,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",49,NA,"D08CA9CD-8E66-4213-AB44-5352B1E76258","WHITE",NA,11,30,"C7360473-2DAC-4BAD-A794-36CA8E4C7BBA","791F3AE7-7377-4E0F-BC9F-9554F1DC5989","TCGA-AP-A05J-01A-11W-A027-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-AP-A05J-01A-11",95,0,1,0,5,"TOP",5,0,"TCGA-AP-A05J-01A-01-TSA",90,"Paclitaxel","Chemotherapy","TCGA-AP-A05J-D3491","TCGA-AP-A05J-R3494","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"NO",1122,"TUMOR FREE","Alive",NA,"TCGA-AP-A05J-F29060","TCGA-AP-A05J",1,"AP","A05J","YES","C54.1","8441/3","C54.1","NO","YES",-24119,"FEMALE","WHITE",NA,"No","No","Alive",639,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,66,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28202782,27987897,2091304726,"C638E896-3DB7-496F-AEE6-FB9030F4EEB5.bw","39609d3c-f5d3-4bc4-b356-1403c6dd1cb5","c638e896-3db7-496f-aee6-fb9030f4eeb5","2016-08-05T11:27:54.605756-05:00","UNCID_2214821.20977188-9019-4672-a435-760abd19ee5b.101124_UNC4-RDR3001561_00054_FC_62FKEAAXX_1.tar.gz","c29c6cfe-f3ec-4d24-95fe-cc8c2344b72d",1741478893,"Illumina GA","ab32f905f560981dfe68b0c0edccd07a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:16:09.520928-05:00","2016-05-03T11:17:14.905409-05:00","c29c6cfe-f3ec-4d24-95fe-cc8c2344b72d_analysis.xml","2f6169182870fcf55bcdb1c838796812","b1459027-2fc4-46b3-8f42-a36cda3343ed",2122,"2016-10-07T17:27:54.474693-05:00","c29c6cfe-f3ec-4d24-95fe-cc8c2344b72d_experiment.xml","3d0174dbc2d2afa41f62a36c5929caed","6ba3662c-419f-4bd3-97eb-bfcaf0123b52",2256,"2016-09-30T00:16:20.438738-05:00","c29c6cfe-f3ec-4d24-95fe-cc8c2344b72d_run.xml","fbe5f92b751176c011973b02ec592b4f","fba9dd04-87e2-4a6d-847a-ce45a4e0f5ac",345,"2016-09-08T10:27:04.177055-05:00","TCGA-A5-A0R6","2016-09-02T18:47:47.592707-05:00","female","TCGA-A5-A0R6_demographic",1945,"white","ed7b2087-cf0f-5360-be88-97a509a5dcbf","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0R6_diagnosis","not reported",23449,"alive","8441/3",NA,1153,"34a9e020-9e90-5fd4-beca-55bb8f8e18bd","c54.1",-23449,"TCGA-A5-A0R6_treatment","790f4370-75ac-582d-a918-aa5048071600","01","true","TCGA-A5-A0R6-01A",NA,"836bd487-091b-4728-bcd7-8065e5b76465",FALSE,"2F8BAD18-8A37-4F1A-A1BA-31494035E05F","Primary Tumor",NA,259,200,NA,1280188800,"11",30,"TCGA-A5-A0R6-01A-11",70,75,15,15,0,10,20,5,"2016-09-08T10:27:04.177055-05:00","2016-09-08T10:27:04.177055-05:00",30,30,35,25,"TOP","BOTTOM",10,10,"8f6ba218-fba3-49b1-b830-da5b1509f9d9","006d1ac4-db60-4b08-aaf4-c89494b8dbbd","TCGA-A5-A0R6-01A-01-TS1","TCGA-A5-A0R6-01A-01-BS1",70,75,"21216431-57f5-4250-9b00-a05df4790e26","RNA","TCGA-A5-A0R6-01A-11R","bc9073b0-38e4-48e8-9617-31049b887434",1.86,0.17,"UV Spec","R","23","TCGA-A5-A0R6-01A-11R-A104-07","20977188-9019-4672-a435-760abd19ee5b",0.17,NA,68,27.5873260578522,157,"a34dc1c3-35a9-596a-8427-f198544bccca","TCGA-A5-A0R6_exposure","UNCID_2214821.20977188-9019-4672-a435-760abd19ee5b.101124_UNC4-RDR3001561_00054_FC_62FKEAAXX_1.tar.gz","2013-10-03T21:36:04.000Z","2013-10-03T21:48:02.000Z","C29C6CFE-F3EC-4D24-95FE-CC8C2344B72D","836BD487-091B-4728-BCD7-8065E5B76465","Unaligned reads",1741478893,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","20977188-9019-4672-A435-760ABD19EE5B","University of North Carolina","5660749fe4b016715ab677db","39609D3C-F5D3-4BC4-B356-1403C6DD1CB5","Uterine Corpus Endometrial Carcinoma","TARGZ","21216431-57F5-4250-9B00-A05DF4790E26","2013-10-03T21:48:02.000Z","BC9073B0-38E4-48E8-9617-31049B887434","None","NO",1,NA,"Primary Tumor","Cedars Sinai",259,"21216431-57F5-4250-9B00-A05DF4790E26",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.353D2D07-37FD-40EC-9D30-D608AB218149.txt",200,"TCGA-A5-A0R6-01A",NA,"6134DF03-DB34-406B-9B85-E7605941A59D","TCGA",2009,NA,NA,"TUMOR FREE","836BD487-091B-4728-BCD7-8065E5B76465",64,"nationwidechildrens.org_clinical.TCGA-A5-A0R6.xml","Alive",NA,"TCGA-A5-A0R6","HISPANIC OR LATINO","8EF25587-EBC8-4FED-A6BC-EA56DEC86B20",NA,369,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8441/3","FEMALE","C54.1",73,NA,"828CA905-F989-43F6-A7EC-FA1AFBEA4CE6","WHITE",NA,11,30,"8F6BA218-FBA3-49B1-B830-DA5B1509F9D9","CE9B1DC5-7765-4EDF-A6C5-7DEDF3A4F87F","TCGA-A5-A0R6-01A-11R-A103-13_mirna.bam","TCGA-A5-A0R6-01A-11",75,10,15,30,5,"BOTTOM",10,25,"TCGA-A5-A0R6-01A-01-BS1",75,"Taxol","Chemotherapy","TCGA-A5-A0R6-D6810","TCGA-A5-A0R6-R6811","IMPLANTS","Primary Tumor Field",NA,NA,369,"TUMOR FREE","Alive",NA,"TCGA-A5-A0R6-F6809","TCGA-A5-A0R6",1,"A5","A0R6","YES","C54.1","8441/3","C54.1","NO","YES",-23449,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",369,NA,NA,NA,"TUMOR FREE","NO",27,1,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,64,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34205215,33741993,2489739819,"0F185AF0-D779-4E1D-AA23-D19ED8127A35.bw","397b2672-d014-4b57-88dd-17e66ff8be4d","0f185af0-d779-4e1d-aa23-d19ed8127a35","2016-08-09T14:07:45.088943-05:00","UNCID_2203889.0e8881cf-4745-4fb5-9842-dface6532da3.111018_UNC2-RDR300275_00092_FC_634BHAAXX_7.tar.gz","887db29c-942d-496f-a772-879c371fd1a1",2215035460,"Illumina GA","7e7d301c09a63fb061c2b0c830fb27fa","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:54:32.044504-05:00","2016-05-03T11:10:47.509879-05:00","887db29c-942d-496f-a772-879c371fd1a1_analysis.xml","1243d6304a65149d46a69cfb0714eef5","ee510cc9-4ffe-4515-83ea-12270ca41204",2121,"2016-10-07T17:20:18.791155-05:00","887db29c-942d-496f-a772-879c371fd1a1_experiment.xml","99c5c8b414fa4a885b58d440a0ca4883","417e83cf-04fe-46f3-900b-cc9e5b5aacf8",2257,"2016-09-29T18:24:03.659348-05:00","887db29c-942d-496f-a772-879c371fd1a1_run.xml","801783de8e90feb036ce1cac71d22c85","20ee8f66-c0d2-4490-82d0-729381d1a2f3",347,"2016-09-08T12:46:10.713355-05:00","TCGA-BG-A222","2016-09-02T18:52:38.884587-05:00","female","TCGA-BG-A222_demographic",1962,"white","7fa24ac1-267b-525f-8deb-3a2b9b0e64a9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A222_diagnosis","not reported",18220,"alive","8380/3",NA,291,"0e900d10-ce62-519e-aa93-27cd4b5ab78c","c54.1",-18220,"TCGA-BG-A222_treatment","05449b6f-5ed0-5476-9414-33013a97f947","01","true","TCGA-BG-A222-01A",NA,"002eb27d-18c4-49d0-a977-8d2717e7ee42",FALSE,"32837D2C-0D2B-4A47-9E42-1A809CB4A25A","Primary Tumor",NA,50,630,NA,1302480000,"11",30,"TCGA-BG-A222-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T12:46:10.713355-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"846fe31d-2c0e-4bd6-a101-6fda03c00e2a",NA,"TCGA-BG-A222-01A-01-TSA",NA,80,NA,"3e71a9de-b5fb-464b-b382-d544d8147691","RNA","TCGA-BG-A222-01A-11R","acba69fd-53bb-48ed-ab56-5d32fa5a3a66",1.71,0.16,"UV Spec","R","23","TCGA-BG-A222-01A-11R-A157-07","0e8881cf-4745-4fb5-9842-dface6532da3",0.16,NA,132,47.3304887231525,167,"f08c6cf3-534a-5ea6-9899-31c80648f197","TCGA-BG-A222_exposure","UNCID_2203889.0e8881cf-4745-4fb5-9842-dface6532da3.111018_UNC2-RDR300275_00092_FC_634BHAAXX_7.tar.gz","2013-09-26T07:37:05.000Z","2013-09-26T07:50:01.000Z","887DB29C-942D-496F-A772-879C371FD1A1","002EB27D-18C4-49D0-A977-8D2717E7EE42","Unaligned reads",2215035460,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0E8881CF-4745-4FB5-9842-DFACE6532DA3","University of North Carolina","56607985e4b016715ab6a41d","397B2672-D014-4B57-88DD-17E66FF8BE4D","Uterine Corpus Endometrial Carcinoma","TARGZ","3E71A9DE-B5FB-464B-B382-D544D8147691","2013-09-26T07:50:01.000Z","ACBA69FD-53BB-48ED-AB56-5D32FA5A3A66","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",50,"3E71A9DE-B5FB-464B-B382-D544D8147691",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.0426C930-B68C-4971-A8C8-8449D94146BC.txt",630,"TCGA-BG-A222-01A",NA,NA,"TCGA",2011,NA,NA,NA,"1E30378A-FEBF-4DA4-B4C7-BA6F6C208861",49,"nationwidechildrens.org_clinical.TCGA-BG-A222.xml","Alive",NA,"TCGA-BG-A222","NOT HISPANIC OR LATINO","06B1F7FD-600E-4120-A213-F31CE61EFCC3",NA,14,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,NA,"WHITE",NA,11,30,"846FE31D-2C0E-4BD6-A101-6FDA03C00E2A","FA1A8F9F-A9F6-4DC0-8E11-BA17C884A0D7","TCGA-BG-A222-01A-11R-A156-13_mirna.bam","TCGA-BG-A222-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-BG-A222-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,"NO",291,"TUMOR FREE","Alive",NA,"TCGA-BG-A222-F28654","TCGA-BG-A222",1,"BG","A222","YES","C54.1","8380/3","C54.1","NO","YES",-18220,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",14,NA,NA,NA,NA,"NO",28,9,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,49,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
14236199,13610083,1024762511,"6D34BF1E-E1D9-4775-B375-4E5D01191752.bw","3a4a6aff-4720-41fc-a114-85f38610ebb1","6d34bf1e-e1d9-4775-b375-4e5d01191752","2016-08-31T12:18:39.612643-05:00","UNCID_2216272.f9533750-9b2f-44a2-8b4e-941fe0c53acb.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_8.tar.gz","5632c242-5ad0-4d74-b59f-89662c12b724",818615839,"Illumina GA","99aa9f1cc61152c9ddf58da4a679219f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:10:36.147601-05:00","2016-05-03T11:18:47.010651-05:00","5632c242-5ad0-4d74-b59f-89662c12b724_analysis.xml","b1ce461dbd7ebecfa03a02262eace31b","adc791b7-963a-49a2-abda-bfa0d3eefba4",2120,"2016-09-29T23:04:45.924483-05:00","5632c242-5ad0-4d74-b59f-89662c12b724_experiment.xml","6b25c8c8ab16cce7c5f4dfd7dd72935d","cf3caf61-250d-479d-8e6f-8f78df25a994",2256,"2016-09-29T23:30:19.242336-05:00","5632c242-5ad0-4d74-b59f-89662c12b724_run.xml","f757b7cbd0970772168fc79ce5aa8649","df2e1dbd-62e7-45e8-b633-455e9719ab1f",345,"2016-09-08T11:05:02.259745-05:00","TCGA-AX-A05S","2016-09-02T18:52:42.606449-05:00","female","TCGA-AX-A05S_demographic",1927,"white","6fcf1e15-6b38-500f-9d76-b481914a30cb","not hispanic or latino",2009,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A05S_diagnosis","not reported",29928,"dead","8380/3",413,NA,"40d99eb2-715c-55b0-a86d-61e61cb4232d","c54.1",-29928,"TCGA-AX-A05S_treatment","66071faf-6cc8-5867-9e12-8dac95934630","01","false","TCGA-AX-A05S-01A",NA,"3d8f263f-6866-4b92-aaee-743ec5514865",FALSE,"571B1EC2-3698-4FF2-89DD-7C5A8A048660","Primary Tumor",NA,507,230,NA,1275868800,"11",30,"TCGA-AX-A05S-01A-11",70,80,0,0,25,14,0,0,"2016-09-08T11:05:02.259745-05:00","2016-09-08T11:05:02.259745-05:00",1,14,1,0,"BOTTOM","TOP",10,1,"a40fd806-db5e-4b99-a0fa-d6f7bc9b98fc","ab708406-0c86-406d-a97b-a64defb00f99","TCGA-AX-A05S-01A-01-BS1","TCGA-AX-A05S-01A-01-TS1",65,85,"6489b452-1e63-4d7a-9086-b904fa192e7e","RNA","TCGA-AX-A05S-01A-11R","9f3f895a-20e3-49c4-a0bc-fc7ddee8065c",1.86,0.15,"UV Spec","R","23","TCGA-AX-A05S-01A-11R-A00V-07","f9533750-9b2f-44a2-8b4e-941fe0c53acb",0.15,NA,48,20.7756232686981,152,"b77e2ab2-0227-51af-877e-01dd6f888ba3","TCGA-AX-A05S_exposure","UNCID_2216272.f9533750-9b2f-44a2-8b4e-941fe0c53acb.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_8.tar.gz","2013-10-04T07:46:04.000Z","2013-10-04T07:58:02.000Z","5632C242-5AD0-4D74-B59F-89662C12B724","3D8F263F-6866-4B92-AAEE-743EC5514865","Unaligned reads",818615839,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","F9533750-9B2F-44A2-8B4E-941FE0C53ACB","University of North Carolina","56607c53e4b0ec1099f8e8a4","3A4A6AFF-4720-41FC-A114-85F38610EBB1","Uterine Corpus Endometrial Carcinoma","TARGZ","6489B452-1E63-4D7A-9086-B904FA192E7E","2013-10-04T07:58:02.000Z","9F3F895A-20E3-49C4-A0BC-FC7DDEE8065C","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",507,"6489B452-1E63-4D7A-9086-B904FA192E7E",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.51E13F14-0AA7-4DF2-A28C-9B20734EEC2E.txt",230,"TCGA-AX-A05S-01A",NA,"DB45013E-6D45-4748-B07F-36125C804F98","TCGA",2008,NA,NA,"WITH TUMOR","A223F336-672C-436E-8B42-5662E74E2676",81,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.51E13F14-0AA7-4DF2-A28C-9B20734EEC2E.txt","Dead",413,"TCGA-AX-A05S","NOT HISPANIC OR LATINO","3611C094-CB7B-44B5-B9BF-6A0D1EFC1919",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,"448FC6D5-D514-4BF0-BE56-1A4679A70E0B","WHITE",NA,11,30,"AB708406-0C86-406D-A97B-A64DEFB00F99","DCA5165E-4AAC-4329-A02C-246B5D4B0ADC","UNCID_250800.TCGA-AX-A05S-01A-11R-A00V-07.100903_UNC3-RDR300156_00028_FC_62ELKAAXX.8.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-AX-A05S-01A-11",70,25,0,1,0,"BOTTOM",10,1,"TCGA-AX-A05S-01A-01-BS1",65,"Carboplatin & Paclitaxel","Chemotherapy","TCGA-AX-A05S-D12766","TCGA-AX-A05S-R12767",NA,NA,NA,NA,NA,"WITH TUMOR","Dead",413,"TCGA-AX-A05S-F5583","TCGA-AX-A05S",1,"AX","A05S","YES","C54.1","8380/3","C54.1","NO","YES",-29928,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,413,NA,NA,"WITH TUMOR","NO",23,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,81,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31355335,30911890,2313373421,"34349A18-443A-47AB-811A-8AD6359B421E.bw","3abaa1b6-7513-40e0-b79c-b968e788e932","34349a18-443a-47ab-811a-8ad6359b421e","2016-08-09T14:12:41.665913-05:00","UNCID_2207471.d979abda-1498-41e5-848c-8dc20d6c7eee.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_3.tar.gz","692f8715-1aa9-4073-9c7c-8f5b9d7f2a66",1987788357,"Illumina GA","224a0b7175ebdf5908ccfce25383277d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:22:31.127485-05:00","2016-05-03T11:14:23.412796-05:00","692f8715-1aa9-4073-9c7c-8f5b9d7f2a66_analysis.xml","f03450bd04018b53f506d7c0f9ecc5dd","ff902b9c-eca7-4938-bca3-e832ad77a5dc",2121,"2016-09-29T18:47:00.072309-05:00","692f8715-1aa9-4073-9c7c-8f5b9d7f2a66_experiment.xml","176717318b03d2709ee8d19e4f315b49","2f7b3ea2-b4f5-4e7a-b170-305bba27134a",2257,"2016-09-29T20:55:16.865401-05:00","692f8715-1aa9-4073-9c7c-8f5b9d7f2a66_run.xml","1bf95b1ae9af80849b40863027ee2d53","7f0a852a-f832-4e8b-b0a6-d83448e37327",347,"2016-09-08T10:30:31.257090-05:00","TCGA-AX-A1CR","2016-09-02T18:51:44.965301-05:00","female","TCGA-AX-A1CR_demographic",1940,"white","e6a8c88e-d05a-5bd9-9167-6afdcb41699d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CR_diagnosis","not reported",25812,"alive","8441/3",NA,701,"e394d111-8a67-537c-afde-898a8a049ea5","c54.1",-25812,"TCGA-AX-A1CR_treatment","b1a9b813-6a53-5263-a6dd-ee5e7d5812f9","01","false","TCGA-AX-A1CR-01A",NA,"8d14edd5-b754-48af-b636-4e655fce9cbe",FALSE,"7623CA86-87C5-43E8-A0A7-25BD9526D1AA","Primary Tumor",NA,274,110,NA,1295222400,"12",20,"TCGA-AX-A1CR-01A-12",88,NA,0,NA,10,NA,9,NA,"2016-09-08T10:30:31.257090-05:00",NA,4,NA,1,NA,"TOP",NA,1,NA,"fb507ade-f7a1-44e0-8ace-7b1f60b368c9",NA,"TCGA-AX-A1CR-01A-01-TS1",NA,80,NA,"0889964c-c9e1-417c-949f-23ee9d0a74de","RNA","TCGA-AX-A1CR-01A-12R","8303069b-26c3-4929-93d0-1354519816f3",1.83,0.18,"UV Spec","R","23","TCGA-AX-A1CR-01A-12R-A137-07","d979abda-1498-41e5-848c-8dc20d6c7eee",0.18,NA,97,35.6290174471993,165,"4bc8366c-9a6e-5315-a5b6-eca515c1f520","TCGA-AX-A1CR_exposure","UNCID_2207471.d979abda-1498-41e5-848c-8dc20d6c7eee.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_3.tar.gz","2013-09-30T01:46:03.000Z","2013-09-30T01:58:02.000Z","692F8715-1AA9-4073-9C7C-8F5B9D7F2A66","8D14EDD5-B754-48AF-B636-4E655FCE9CBE","Unaligned reads",1987788357,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","D979ABDA-1498-41E5-848C-8DC20D6C7EEE","University of North Carolina","564a5874e4b09c884b26dca2","3ABAA1B6-7513-40E0-B79C-B968E788E932","Uterine Corpus Endometrial Carcinoma","TARGZ","0889964C-C9E1-417C-949F-23EE9D0A74DE","2013-09-30T01:58:02.000Z","8303069B-26C3-4929-93D0-1354519816F3","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",274,"0889964C-C9E1-417C-949F-23EE9D0A74DE",NA,"AX","UNCID_364161.TCGA-AX-A1CR-01A-12R-A137-07.110628_UNC2-RDR300275_00075_FC_70K9LAAXX.3.trimmed.annotated.translated_to_genomic.bam",110,"TCGA-AX-A1CR-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","E634BD94-1FBF-4730-87E2-1173DEC6008C",70,"nationwidechildrens.org_clinical.TCGA-AX-A1CR.xml","Alive",NA,"TCGA-AX-A1CR","NOT HISPANIC OR LATINO","47510700-6F87-4C79-B12D-8538FA6EAC2E",NA,337,"Yes","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIB",NA,NA,NA,"8441/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,12,20,"FB507ADE-F7A1-44E0-8ACE-7B1F60B368C9","BF2589CD-FC84-4087-9A96-700B3DE35DF4","UNCID_364161.TCGA-AX-A1CR-01A-12R-A137-07.110628_UNC2-RDR300275_00075_FC_70K9LAAXX.3.trimmed.annotated.translated_to_genomic.bam","TCGA-AX-A1CR-01A-12",88,10,0,4,9,"TOP",1,1,"TCGA-AX-A1CR-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,"NO",337,"TUMOR FREE","Alive",NA,"TCGA-AX-A1CR-F12541","TCGA-AX-A1CR",1,"AX","A1CR","YES","C54.1","8441/3","C54.1","NO","YES",-25812,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",337,NA,NA,NA,"TUMOR FREE","NO",12,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,70,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
89492296,84349430,3999235216,"F6606A8E-ACC6-4826-9547-E0017521724D.bw","3b218ab7-5c2e-4458-a0ac-5152ec3d2b94","f6606a8e-acc6-4826-9547-e0017521724d","2016-08-09T13:15:38.469816-05:00","UNCID_2178003.dff76521-f81c-4de8-9a80-d75d18fe7982.130405_UNC9-SN296_0354_AC24DCACXX_8_GGCTAC.tar.gz","5171536f-c1d0-4ba3-a37f-ba34f42755d3",4460915566,"Illumina HiSeq","c6bac7f0321d03445c628ec81cf12a9b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:47:02.289574-05:00","2016-05-03T10:56:47.877475-05:00","5171536f-c1d0-4ba3-a37f-ba34f42755d3_analysis.xml","5a1454acf98baa26cd1c58962a5b593f","c45cdc19-8a45-4470-8142-50436c812dc3",2121,"2016-09-29T23:22:59.507427-05:00","5171536f-c1d0-4ba3-a37f-ba34f42755d3_experiment.xml","2f6dda601e2f06e96e8cfb6b11ece674","da8e8d56-0bed-498a-a889-48e10a336f25",2431,"2016-09-29T17:55:58.495386-05:00","5171536f-c1d0-4ba3-a37f-ba34f42755d3_run.xml","fe8ed28079bf3d8e6b238539d4f86aaf","0f6963cf-6901-4ca4-a871-938cc0b5f425",354,"2016-09-08T10:44:32.062405-05:00","TCGA-DF-A2KZ","2016-09-02T18:48:43.427556-05:00","female","TCGA-DF-A2KZ_demographic",NA,"not reported","1b0c592e-7c31-555e-bf54-a9b7dc83eaa5","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DF","bd439172-ab1d-57cc-a1ee-7282ceebd41a","Ontario Institute for Cancer Research","not reported","c54.1","TCGA-DF-A2KZ_diagnosis","not reported",31973,"alive","8380/3",NA,826,"3d756b40-2ccd-55bc-bef9-5e5e5c2cd5c3","c54.1",-31973,"TCGA-DF-A2KZ_treatment","36b28f02-115f-5576-a922-2e892bd9708a","01","false","TCGA-DF-A2KZ-01A",NA,"76d43b40-612e-4580-abd7-d1837d8fd5d0",FALSE,"D69C73D1-1CEB-4AF5-AAF2-8E707EF4CA38","Primary Tumor",NA,NA,450,NA,1321401600,"11",30,"TCGA-DF-A2KZ-01A-11",75,NA,0,NA,0,NA,25,NA,"2016-09-08T10:44:32.062405-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"ee9d1389-ee04-4791-a4d9-a60e079c1931",NA,"TCGA-DF-A2KZ-01A-01-TS1",NA,75,NA,"fe465d53-bedc-4270-9ee8-93cb17e536c5","RNA","TCGA-DF-A2KZ-01A-11R","7a460195-d92b-4b74-a168-139fbebf957e",1.73,0.15,"UV Spec","R","23","TCGA-DF-A2KZ-01A-11R-A213-07","dff76521-f81c-4de8-9a80-d75d18fe7982",0.15,NA,NA,NA,NA,"ab646904-b25d-5bac-96ba-865546c8afec","TCGA-DF-A2KZ_exposure","UNCID_2178003.dff76521-f81c-4de8-9a80-d75d18fe7982.130405_UNC9-SN296_0354_AC24DCACXX_8_GGCTAC.tar.gz","2013-09-11T21:16:09.000Z","2013-09-11T21:32:01.000Z","5171536F-C1D0-4BA3-A37F-BA34F42755D3","76D43B40-612E-4580-ABD7-D1837D8FD5D0","Unaligned reads",4460915566,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","DFF76521-F81C-4DE8-9A80-D75D18FE7982","University of North Carolina","564a3bbce4b0298dd2c8833e","3B218AB7-5C2E-4458-A0AC-5152EC3D2B94","Uterine Corpus Endometrial Carcinoma","TARGZ","FE465D53-BEDC-4270-9EE8-93CB17E536C5","2013-09-11T21:32:01.000Z","7A460195-D92B-4B74-A168-139FBEBF957E","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"FE465D53-BEDC-4270-9EE8-93CB17E536C5",NA,"DF","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.16936733-EEF7-44F7-9DC0-C1C8922C8ACA.txt",450,"TCGA-DF-A2KZ-01A",NA,NA,"TCGA",NA,"TCGA-DF-A2KZ_NTE-1",NA,"TUMOR FREE","B4592435-C274-4D83-B81F-172BA64827CB",87,"nationwidechildrens.org_clinical.TCGA-DF-A2KZ.xml","Alive",NA,"TCGA-DF-A2KZ",NA,NA,"NO",826,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",201,NA,NA,NA,NA,11,30,"EE9D1389-EE04-4791-A4D9-A60E079C1931","97BB8049-A5E0-4E2D-A0ED-5D2A6E50AA61","d43835353902bf62c77095bb19ea71bd.bam","TCGA-DF-A2KZ-01A-11",75,0,0,0,25,"TOP",0,0,"TCGA-DF-A2KZ-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-DF-A2KZ",1,"DF","A2KZ","YES","C54.1","8380/3","C54.1","NO","YES",-31973,"FEMALE",NA,NA,"No","No","Alive",826,NA,"YES","NO","TUMOR FREE","YES",11,6,2014,"NO","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,87,NA,"Tumor resection",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32600667,32022132,2345299713,"20152BF5-FA56-4B98-8F20-FFEE20F8B1CB.bw","3b21b47e-a15c-4b10-9702-62a14afdfb8c","20152bf5-fa56-4b98-8f20-ffee20f8b1cb","2016-08-05T04:57:53.828057-05:00","UNCID_2215188.ccf469e7-f403-4661-b5c4-e3ea020901b5.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_4.tar.gz","ca0ea1ee-ae39-4e07-be6b-7802d59e4c91",2016312196,"Illumina GA","ee490bb89c21ca610a6427b10c6952ad","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:45:24.659422-05:00","2016-05-03T11:17:59.900236-05:00","ca0ea1ee-ae39-4e07-be6b-7802d59e4c91_analysis.xml","be3bc5c47c36d4a1111e84e774fc7f3a","78e64b0f-e021-4f1a-951b-327941b36498",2122,"2016-09-29T21:43:05.302242-05:00","ca0ea1ee-ae39-4e07-be6b-7802d59e4c91_experiment.xml","5609967daa0906bcb39f6f7edd0a15d6","9cba1eb2-83c3-4705-b936-8d2b4d6640f7",2256,"2016-09-29T23:30:02.532573-05:00","ca0ea1ee-ae39-4e07-be6b-7802d59e4c91_run.xml","1e7ddc632a3edf3f177dd351dc565f8b","df00bf77-de7d-45f4-95fa-cd71e7fa3593",345,"2016-09-08T10:41:53.428580-05:00","TCGA-A5-A0GI","2016-09-02T18:54:09.915585-05:00","female","TCGA-A5-A0GI_demographic",1942,"white","542d2c0f-96a1-52fb-89c7-b31e2e9cd8b9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GI_diagnosis","not reported",23195,"alive","8380/3",NA,2682,"31803be2-1086-5476-b922-3506e5f2d6c0","c54.1",-23195,"TCGA-A5-A0GI_treatment","0ac03464-cc57-51b5-a427-3e0e8b6ae472","01","true","TCGA-A5-A0GI-01A",NA,"dd02a477-06c0-4bda-9752-896491eddd95",FALSE,"F1D23669-8247-4727-8D38-BD444C16FAAE","Primary Tumor",NA,1779,130,NA,1275609600,"11",30,"TCGA-A5-A0GI-01A-11",90,90,0,0,0,0,0,0,"2016-09-08T10:41:53.428580-05:00","2016-09-08T10:41:53.428580-05:00",1,1,0,0,"BOTTOM","TOP",0,0,"b7416c08-b846-4919-894b-aa5664dd2aab","d892734a-77e3-4f66-ba1b-2333e861019e","TCGA-A5-A0GI-01A-01-BSA","TCGA-A5-A0GI-01A-01-TSA",100,100,"54ecb70d-b317-4ed5-8c55-a86a45746faa","RNA","TCGA-A5-A0GI-01A-11R","14c8618e-5e85-42d7-bfe7-48fab69c690b",1.87,0.16,"UV Spec","R","23","TCGA-A5-A0GI-01A-11R-A040-07","ccf469e7-f403-4661-b5c4-e3ea020901b5",0.16,NA,66,23.3843537414966,168,"a1be734a-3f3c-5e88-9cae-071ee9d1669e","TCGA-A5-A0GI_exposure","UNCID_2215188.ccf469e7-f403-4661-b5c4-e3ea020901b5.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_4.tar.gz","2013-10-04T00:56:04.000Z","2013-10-04T01:08:03.000Z","CA0EA1EE-AE39-4E07-BE6B-7802D59E4C91","DD02A477-06C0-4BDA-9752-896491EDDD95","Unaligned reads",2016312196,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CCF469E7-F403-4661-B5C4-E3EA020901B5","University of North Carolina","56607b79e4b0b37b3d99235f","3B21B47E-A15C-4B10-9702-62A14AFDFB8C","Uterine Corpus Endometrial Carcinoma","TARGZ","54ECB70D-B317-4ED5-8C55-A86A45746FAA","2013-10-04T01:08:03.000Z","14C8618E-5E85-42D7-BFE7-48FAB69C690B","None","NO",1,NA,"Primary Tumor","Cedars Sinai",1779,"54ECB70D-B317-4ED5-8C55-A86A45746FAA",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.604B177E-903C-4CC5-AE62-6E473FF21EAF.txt",130,"TCGA-A5-A0GI-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","DD02A477-06C0-4BDA-9752-896491EDDD95",63,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.604B177E-903C-4CC5-AE62-6E473FF21EAF.txt","Alive",NA,"TCGA-A5-A0GI","NOT HISPANIC OR LATINO","5723F4C0-27F3-49FE-9A7D-E9B86E1356A6",NA,1750,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"B055AF7A-F9D9-4AFB-A0AA-9723066CBABD","WHITE",NA,11,30,"D892734A-77E3-4F66-BA1B-2333E861019E","AF0BBDFF-9554-4CCB-A021-2CE2188128E1","UNCID_2215188.ccf469e7-f403-4661-b5c4-e3ea020901b5.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_4.tar.gz","TCGA-A5-A0GI-01A-11",90,0,0,1,0,"BOTTOM",0,0,"TCGA-A5-A0GI-01A-01-BSA",100,NA,NA,NA,"TCGA-A5-A0GI-R4925","IMPLANTS","Primary Tumor Field","TCGA-A5-A0GI-F53353_NTE-1","NO",2682,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GI-F53353","TCGA-A5-A0GI",1,"A5","A0GI","YES","C54.1","8380/3","C54.1","NO","YES",-23195,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",1750,NA,NA,NA,"TUMOR FREE","NO",15,12,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2005,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
138608418,135669487,6405096250,"791D9EB8-42E0-4192-B064-B1126CA14481.bw","3bce9803-e74c-462e-bd40-8ec337a66f3a","791d9eb8-42e0-4192-b064-b1126ca14481","2016-08-05T10:36:23.772500-05:00","UNCID_2173012.b1ee7148-ddae-404a-b796-004539c02aa7.130509_UNC10-SN254_0462_AC232JACXX_6_GTGAAA.tar.gz","f20554c3-5d9d-4c9e-acc5-3b543053f0df",6472565099,"Illumina HiSeq","1d775fe09d6d8ee451968ef97f21dd9f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:16:09.148559-05:00","2016-05-03T10:55:55.600288-05:00","f20554c3-5d9d-4c9e-acc5-3b543053f0df_analysis.xml","8d48edbb2d2e1adb9d010555e1be5120","b143f279-a6e8-4f2c-91ec-8e10c75c7c46",2123,"2016-08-13T09:43:09.836950-05:00","f20554c3-5d9d-4c9e-acc5-3b543053f0df_experiment.xml","8a8033b2967b8fd0ea9fe4c7daf5c8ee","eefcd013-35ef-4eab-9840-903ae16c245a",2431,"2016-09-29T19:24:33.220506-05:00","f20554c3-5d9d-4c9e-acc5-3b543053f0df_run.xml","85bd7a2b525db6eb3390ce3fec236bd4","472589f3-8131-4c43-84df-135d701055c2",354,"2016-09-08T10:30:17.202648-05:00","TCGA-KP-A3W1","2016-09-02T18:49:38.345869-05:00","female","TCGA-KP-A3W1_demographic",1935,"not reported","877f9a19-9723-5331-bde9-2b6313f89de2","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","KP","821aedb4-8788-5cb9-ae05-e670f0be1f9f","British Columbia Cancer Agency","not reported","c54.1","TCGA-KP-A3W1_diagnosis","not reported",27902,"alive","8441/3",NA,288,"08dc5ad6-6bd9-5771-b249-46fa848dc1e8","c54.1",-27902,"TCGA-KP-A3W1_treatment","99fd35f6-5cc5-5425-baf3-1c742b048649","01","true","TCGA-KP-A3W1-01A",NA,"1ad2a1ca-75e0-4f9f-808d-768cb14bdff3",FALSE,"58145248-B111-463A-A1CC-32DA993F0B26","Primary Tumor",NA,198,710,NA,1335398400,"11",30,"TCGA-KP-A3W1-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T10:30:17.202648-05:00",NA,60,NA,10,NA,"TOP",NA,5,NA,"9f0c6ab0-95ac-482b-8121-af2c88ec6f17",NA,"TCGA-KP-A3W1-01A-01-TS1",NA,90,NA,"fa733adc-358d-4c12-b78a-c283504c9e4e","RNA","TCGA-KP-A3W1-01A-11R","29b243bb-1db4-4821-bad5-e77cc08fffa7",1.87,0.15,"UV Spec","R","23","TCGA-KP-A3W1-01A-11R-A22K-07","b1ee7148-ddae-404a-b796-004539c02aa7",0.15,NA,66,22.8373702422145,170,"3482948f-557a-524b-aaa6-4af5b5f79fda","TCGA-KP-A3W1_exposure","UNCID_2173012.b1ee7148-ddae-404a-b796-004539c02aa7.130509_UNC10-SN254_0462_AC232JACXX_6_GTGAAA.tar.gz","2013-09-09T07:16:08.000Z","2013-09-09T07:33:01.000Z","F20554C3-5D9D-4C9E-ACC5-3B543053F0DF","1AD2A1CA-75E0-4F9F-808D-768CB14BDFF3","Unaligned reads",6472565099,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","B1EE7148-DDAE-404A-B796-004539C02AA7","University of North Carolina","564a3bb1e4b093830b695cd6","3BCE9803-E74C-462E-BD40-8EC337A66F3A","Uterine Corpus Endometrial Carcinoma","TARGZ","FA733ADC-358D-4C12-B78A-C283504C9E4E","2013-09-09T07:33:01.000Z","29B243BB-1DB4-4821-BAD5-E77CC08FFFA7","Canada","NO",1,NA,"Primary Tumor","British Columbia Cancer Agency",198,"FA733ADC-358D-4C12-B78A-C283504C9E4E",NA,"KP","UNCID_2031700.b1ee7148-ddae-404a-b796-004539c02aa7.sorted_genome_alignments.bam.bai",710,"TCGA-KP-A3W1-01A",NA,NA,"TCGA",2011,"TCGA-KP-A3W1_NTE-1","Complete Remission/Response","TUMOR FREE","63000FEC-5CA2-4883-A628-940344DC38E2",76,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.23F4AE6E-5C55-4107-8B98-CE129078D051.txt","Alive",NA,"TCGA-KP-A3W1",NA,NA,"NO",288,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,NA,NA,11,30,"9F0C6AB0-95AC-482B-8121-AF2C88EC6F17","DDC26BAC-11CC-465D-B19F-C4FFC32CDE50","UNCID_2031700.b1ee7148-ddae-404a-b796-004539c02aa7.sorted_genome_alignments.bam.bai","TCGA-KP-A3W1-01A-11",90,0,20,60,5,"TOP",5,10,"TCGA-KP-A3W1-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-KP-A3W1",1,"KP","A3W1","YES","C54.1","8441/3","C54.1","NO","YES",-27902,"FEMALE",NA,NA,"No","No","Alive",288,NA,"YES","YES","TUMOR FREE","YES",19,7,2012,"NO","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,76,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
160626600,157908721,7532225151,"51EB8800-9AA0-4160-AE4A-E00DD193894F.bw","3c2a6e30-a507-49f6-8b1f-36eb3aa41e60","51eb8800-9aa0-4160-ae4a-e00dd193894f","2016-08-25T02:52:44.398296-05:00","UNCID_2364787.0d5a9a1e-e473-4b9a-bc27-60147dca9fe6.140114_UNC15-SN850_0348_BC35G8ACXX_4_GCCAAT.tar.gz","b0000850-dd0a-42f7-80e2-2aa17c867640",7373185354,"Illumina HiSeq","509fb91793cc140de89fa771917bc10a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:27:54.246212-05:00","2016-05-03T11:39:34.500988-05:00","b0000850-dd0a-42f7-80e2-2aa17c867640_analysis.xml","5c259a76359bd40f07997899ddfa4e53","2359bd91-e8a1-4c6a-aea3-4225ca55a8d0",2124,"2016-09-29T20:55:26.590119-05:00","b0000850-dd0a-42f7-80e2-2aa17c867640_experiment.xml","7038d1e89db40e60805ff377b6341315","7f2893b0-363f-4101-a96f-daa248e7f6e1",2628,"2016-09-29T21:40:10.672417-05:00","b0000850-dd0a-42f7-80e2-2aa17c867640_run.xml","98aff7275e1a8814af04f5cae8f76f6b","9ae544d2-5366-47cb-b80a-460e85681d87",354,"2016-09-08T11:13:49.178111-05:00","TCGA-SJ-A6ZI","2016-09-02T18:51:34.316713-05:00","female","TCGA-SJ-A6ZI_demographic",1949,"black or african american","9414ed5c-c3bf-5195-b220-09297a960ba8","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","SJ","73bf98ff-1984-5b37-9963-519695e99a1d","Albert Einstein Medical Center","not reported","c54.1","TCGA-SJ-A6ZI_diagnosis","not reported",23653,"alive","8380/3",NA,631,"fc4ddf2e-0c66-5936-8e76-4dd8e54823a2","c54.1",-23653,"TCGA-SJ-A6ZI_treatment","cb2eb786-9ad0-5af7-8361-153e87ed660d","01","false","TCGA-SJ-A6ZI-01A",NA,"629770a3-4982-480b-a066-e85c609dfa3f",FALSE,"2CA0FD3F-7635-4395-A13B-C3BB9D3FF0D8","Primary Tumor",NA,88,880,NA,1375142400,"12",30,"TCGA-SJ-A6ZI-01A-12",80,NA,0,NA,0,NA,20,NA,"2016-09-08T11:13:49.178111-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"f9ce9e77-0ef0-491f-aeaa-e1f8a90fa7e8",NA,"TCGA-SJ-A6ZI-01A-01-TS1",NA,80,NA,"26014226-b5e9-422d-b062-4b5da6b6a990","RNA","TCGA-SJ-A6ZI-01A-12R","879c12bd-740f-4233-a596-1359f92d5a31",1.85,0.18,"UV Spec","R","23","TCGA-SJ-A6ZI-01A-12R-A34R-07","0d5a9a1e-e473-4b9a-bc27-60147dca9fe6",0.18,NA,93,213.498622589532,66,"d28b637f-e6a8-5bbb-bec1-67fed0cea4de","TCGA-SJ-A6ZI_exposure","UNCID_2364787.0d5a9a1e-e473-4b9a-bc27-60147dca9fe6.140114_UNC15-SN850_0348_BC35G8ACXX_4_GCCAAT.tar.gz","2014-03-04T08:33:05.000Z","2014-03-04T21:03:02.000Z","B0000850-DD0A-42F7-80E2-2AA17C867640","629770A3-4982-480B-A066-E85C609DFA3F","Unaligned reads",7373185354,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0D5A9A1E-E473-4B9A-BC27-60147DCA9FE6","University of North Carolina","56607e8ee4b018727fea377f","3C2A6E30-A507-49F6-8B1F-36EB3AA41E60","Uterine Corpus Endometrial Carcinoma","TARGZ","26014226-B5E9-422D-B062-4B5DA6B6A990","2014-03-04T21:03:02.000Z","879C12BD-740F-4233-A596-1359F92D5A31","United States","NO",1,NA,"Primary Tumor","Albert Einstein Medical Center",88,"26014226-B5E9-422D-B062-4B5DA6B6A990",NA,"SJ","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.43EBE86A-68BA-46A4-A4B9-A6AD5E615BFE.txt",880,"TCGA-SJ-A6ZI-01A",NA,NA,"TCGA",2013,"TCGA-SJ-A6ZI_NTE-1","Complete Remission/Response","TUMOR FREE","629770A3-4982-480B-A066-E85C609DFA3F",64,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.43EBE86A-68BA-46A4-A4B9-A6AD5E615BFE.txt","Alive",NA,"TCGA-SJ-A6ZI","NOT HISPANIC OR LATINO","9577A917-2577-44BD-8853-84ECCC0449AE","NO",128,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",354,NA,"41C4E2FA-8A26-44BF-9111-D0D2A6FF38D5","BLACK OR AFRICAN AMERICAN",NA,12,30,"F9CE9E77-0EF0-491F-AEAA-E1F8A90FA7E8","E7EB88B8-4FD1-477B-9589-1B337619F6B5","0c08eb43b261888f33c7ddbaf4db344b.bam.bai","TCGA-SJ-A6ZI-01A-12",80,0,0,5,20,"TOP",0,0,"TCGA-SJ-A6ZI-01A-01-TS1",80,NA,NA,NA,"TCGA-SJ-A6ZI-R64735","Internal","Primary Tumor Field","TCGA-SJ-A6ZI-F59212_NTE-1","NO",428,"TUMOR FREE","Alive",NA,"TCGA-SJ-A6ZI-F59212","TCGA-SJ-A6ZI",1,"SJ","A6ZI","YES","C54.1","8380/3","C54.1","YES","NO",-23653,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",128,NA,"YES","NO","TUMOR FREE","YES",11,11,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2013,"Other method, specify:",NA,NA,NA,"G1","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36762674,35959170,2706690150,"4522D871-9379-4643-B15E-9ACB556276C4.bw","3cb83517-78a4-47b8-8b1e-57e765dbdd2e","4522d871-9379-4643-b15e-9acb556276c4","2016-08-05T11:04:53.695753-05:00","UNCID_2207023.167b2ac1-034d-4eac-982e-b96f65bedfb2.110728_UNC2-RDR300275_00080_FC_63145AAXX_8.tar.gz","6df3243b-35a8-4045-a8f4-3a49bb374efb",2347913244,"Illumina GA","3ecb23c599af4dbc3d066bd068586285","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:29:27.461933-05:00","2016-05-03T11:13:02.631277-05:00","6df3243b-35a8-4045-a8f4-3a49bb374efb_analysis.xml","c357e7ff2549f7864adb77fb35e122ee","947a2d00-a43f-4d81-bb0d-891afbe4c2b1",2121,"2016-09-29T22:37:11.905744-05:00","6df3243b-35a8-4045-a8f4-3a49bb374efb_experiment.xml","298d395b74e79d1860c934cfefd4b26b","be35afc4-7994-4a6d-90a1-768ae6d5dee1",2257,"2016-09-29T21:52:38.145101-05:00","6df3243b-35a8-4045-a8f4-3a49bb374efb_run.xml","bdcbadab9384846a79e7b3d7e620830c","a2b8e747-97b9-458f-b039-1cc15be7ae93",347,"2016-09-08T10:40:06.423609-05:00","TCGA-AP-A05P","2016-09-02T18:54:24.461012-05:00","female","TCGA-AP-A05P_demographic",1955,"asian","34b18611-fa05-568a-8e4c-358e8525c1ef","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A05P_diagnosis","not reported",20017,"alive","8380/3",NA,636,"638ceddb-6bcf-511d-a998-b487df53824f","c54.1",-20017,"TCGA-AP-A05P_treatment","c8b1c095-7106-5184-b148-62f9893d35b1","01","true","TCGA-AP-A05P-01A",NA,"f51f7b0e-3ea6-4232-9de4-a4dd63b23bb5",FALSE,"5BA23C70-805A-4356-B739-AFBAFD29D7FC","Primary Tumor",NA,203,170,NA,1275955200,"11",20,"TCGA-AP-A05P-01A-11",85,90,5,5,0,0,10,10,"2016-09-08T10:40:06.423609-05:00","2016-09-08T10:40:06.423609-05:00",5,10,10,10,"TOP","BOTTOM",5,0,"630bd0d2-60e8-41e9-adfc-7adf9b41a2fc","0cd19382-d4d6-4cf8-861e-616d6a8b105d","TCGA-AP-A05P-01A-01-MS1","TCGA-AP-A05P-01A-01-BS1",85,90,"8ab8bf7d-6c02-4524-adfd-7a22fac01eb0","RNA","TCGA-AP-A05P-01A-11R","825e518b-8e14-45df-b2a6-3cc7c9d6f3a6",1.75,0.14,"UV Spec","R","23","TCGA-AP-A05P-01A-11R-A16W-07","167b2ac1-034d-4eac-982e-b96f65bedfb2",0.14,NA,74,28.5482813163072,161,"94c5b31d-18e4-517d-8676-96c5ce9b7e9e","TCGA-AP-A05P_exposure","UNCID_2207023.167b2ac1-034d-4eac-982e-b96f65bedfb2.110728_UNC2-RDR300275_00080_FC_63145AAXX_8.tar.gz","2013-09-29T02:31:04.000Z","2013-09-29T02:50:02.000Z","6DF3243B-35A8-4045-A8F4-3A49BB374EFB","F51F7B0E-3EA6-4232-9DE4-A4DD63B23BB5","Unaligned reads",2347913244,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","167B2AC1-034D-4EAC-982E-B96F65BEDFB2","University of North Carolina","564a3579e4b0298dd2c68047","3CB83517-78A4-47B8-8B1E-57E765DBDD2E","Uterine Corpus Endometrial Carcinoma","TARGZ","8AB8BF7D-6C02-4524-ADFD-7A22FAC01EB0","2013-09-29T02:50:02.000Z","825E518B-8E14-45DF-B2A6-3CC7C9D6F3A6","None","NO",1,NA,"Primary Tumor","MSKCC",203,"8AB8BF7D-6C02-4524-ADFD-7A22FAC01EB0",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.7E58EFEF-758A-4B54-A989-7E76AD97D014.txt",170,"TCGA-AP-A05P-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","F51F7B0E-3EA6-4232-9DE4-A4DD63B23BB5",54,"nationwidechildrens.org_clinical.TCGA-AP-A05P.xml","Alive",NA,"TCGA-AP-A05P","NOT HISPANIC OR LATINO","88EEB568-09E9-428B-9C10-91EE76BFA6CF",NA,260,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"ASIAN",NA,11,20,"630BD0D2-60E8-41E9-ADFC-7ADF9B41A2FC","6E62DB78-D51B-45A8-8AA2-68622AF28B7D","TCGA-AP-A05P-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_5_rg.sorted.bam.bai","TCGA-AP-A05P-01A-11",90,0,5,10,10,"BOTTOM",0,10,"TCGA-AP-A05P-01A-01-BS1",90,NA,NA,NA,NA,NA,NA,NA,"NO",636,"TUMOR FREE","Alive",NA,"TCGA-AP-A05P-F16694","TCGA-AP-A05P",1,"AP","A05P","YES","C54.1","8380/3","C54.1","NO","YES",-20017,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",260,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
29238274,29004512,2179420790,"F38BBE3D-3C37-4ED8-A194-B7D723DDD39C.bw","3d215e20-9eea-47e0-849e-cff1fee5634d","f38bbe3d-3c37-4ed8-a194-b7d723ddd39c","2016-08-09T14:15:05.625976-05:00","UNCID_2210030.09807f16-30aa-47b0-ace0-0dfb6a5342c2.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_8.tar.gz","de33bc57-bd61-4ab1-b74e-220fcd060779",1816622149,"Illumina GA","185b2980a18a3988151d4c3e3204b5c5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:47:40.430546-05:00","2016-05-03T11:15:47.403263-05:00","de33bc57-bd61-4ab1-b74e-220fcd060779_analysis.xml","7b67276f822115e3f43f140530219f90","2fecb061-f2ae-4315-badd-dd057445a6a1",2120,"2016-09-29T17:45:30.478343-05:00","de33bc57-bd61-4ab1-b74e-220fcd060779_experiment.xml","04e51aa4e54f3e67a2e3c0cb1988d252","08d92200-08fa-4751-a15a-12713549af77",2257,"2016-09-29T21:17:36.103220-05:00","de33bc57-bd61-4ab1-b74e-220fcd060779_run.xml","6b33ea140948713f6a96f916784b971a","8d06c39d-a3ea-4265-99c1-81d908087c64",347,"2016-09-08T10:26:28.187230-05:00","TCGA-D1-A167","2016-09-02T18:50:10.076131-05:00","female","TCGA-D1-A167_demographic",1938,"white","a968b7ee-1a75-5678-b036-8721f572b4d3","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A167_diagnosis","not reported",25575,"alive","8380/3",NA,478,"65b84fd5-a017-5f29-b0be-353641c5d933","c54.1",-25575,"TCGA-D1-A167_treatment","faedf77f-c33d-582f-9d6c-7b8f4969d379","01","false","TCGA-D1-A167-01A",NA,"96112beb-64c2-40bc-b1f9-784581cc88e3",FALSE,"4E67EAA4-3069-4B62-A403-9300A9FA494C","Primary Tumor",NA,841,140,NA,1293062400,"11",30,"TCGA-D1-A167-01A-11",85,NA,1,NA,0,NA,15,NA,"2016-09-08T10:26:28.187230-05:00",NA,4,NA,3,NA,"TOP",NA,3,NA,"c7fa7adb-806c-47ba-bbe0-2a2aaee2b5cb",NA,"TCGA-D1-A167-01A-01-TS1",NA,82,NA,"b0a26083-d54a-4a3a-a9e8-f134e04b8f3f","RNA","TCGA-D1-A167-01A-11R","648d6071-8e87-4d47-b853-3d32aca46136",1.81,0.17,"UV Spec","R","23","TCGA-D1-A167-01A-11R-A12I-07","09807f16-30aa-47b0-ace0-0dfb6a5342c2",0.17,NA,72,31.1634349030471,152,"3eedaef6-b98d-594c-ad3c-6d0c3931c92c","TCGA-D1-A167_exposure","UNCID_2210030.09807f16-30aa-47b0-ace0-0dfb6a5342c2.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_8.tar.gz","2013-10-02T04:43:04.000Z","2013-10-02T04:55:03.000Z","DE33BC57-BD61-4AB1-B74E-220FCD060779","96112BEB-64C2-40BC-B1F9-784581CC88E3","Unaligned reads",1816622149,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","09807F16-30AA-47B0-ACE0-0DFB6A5342C2","University of North Carolina","564a3c1be4b08c5d8691bc0d","3D215E20-9EEA-47E0-849E-CFF1FEE5634D","Uterine Corpus Endometrial Carcinoma","TARGZ","B0A26083-D54A-4A3A-A9E8-F134E04B8F3F","2013-10-02T04:55:03.000Z","648D6071-8E87-4D47-B853-3D32ACA46136","None","NO",1,NA,"Primary Tumor","Mayo Clinic",841,"B0A26083-D54A-4A3A-A9E8-F134E04B8F3F",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8ABC7390-66A1-4E32-B8B5-747673551370.txt",140,"TCGA-D1-A167-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","C91A0839-2EAC-4A3E-8A8A-8DCEAF022FE1",70,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8ABC7390-66A1-4E32-B8B5-747673551370.txt","Alive",NA,"TCGA-D1-A167","NOT HISPANIC OR LATINO","A0045FE6-E3C1-4A4F-9E15-A9D8F27EABAC",NA,478,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"E615F96B-922F-4D85-83CE-5FC89EE4B19E","WHITE",NA,11,30,"C7FA7ADB-806C-47BA-BBE0-2A2AAEE2B5CB","F3D5B092-3D5F-495C-96C5-DA27CBA2CF16","TCGA-D1-A167-01A-11D-A12J-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-D1-A167-01A-11",85,0,1,4,15,"TOP",3,3,"TCGA-D1-A167-01A-01-TS1",82,NA,NA,NA,"TCGA-D1-A167-R18495","IMPLANTS","Regional site",NA,"NO",478,"TUMOR FREE","Alive",NA,"TCGA-D1-A167-F18494","TCGA-D1-A167",1,"D1","A167","YES","C54.1","8380/3","C54.1","NO","YES",-25575,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",478,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,70,2008,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1995",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
142077658,139766607,6671942471,"F37E118C-1066-4A84-B190-B9B78E265D94.bw","3d9828ae-eb65-4d0a-8d7a-cc09e98b5e99","f37e118c-1066-4a84-b190-b9b78e265d94","2016-08-10T21:40:09.664630-05:00","UNCID_2168976.4cbce4ad-3208-4463-a06d-75edce32ed3f.130610_UNC14-SN744_0347_BD28NBACXX_6_GTGAAA.tar.gz","2547bec9-5a1b-425e-9161-43773f145549",6499780486,"Illumina HiSeq","dae96d5f759d3c40eeceed186dd7c04c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:53:56.476279-05:00","2016-05-03T11:06:28.634121-05:00","2547bec9-5a1b-425e-9161-43773f145549_analysis.xml","a3af32523e2444621597ad4a332b18e9","33d82256-b5a6-4e8d-a9e4-deaa6110247a",2123,"2016-10-07T17:46:27.493503-05:00","2547bec9-5a1b-425e-9161-43773f145549_experiment.xml","7c4da6369018c16873bb02c2830765df","7f36ac7a-8913-4711-87eb-782ce688a0bd",2431,"2016-09-29T21:50:29.097593-05:00","2547bec9-5a1b-425e-9161-43773f145549_run.xml","39705fc1c5bd7e61a7e355672d0e3642","a15a8801-8009-4365-989e-c616fab817b1",354,"2016-09-08T10:42:16.194605-05:00","TCGA-EY-A549","2016-09-02T18:50:05.226687-05:00","female","TCGA-EY-A549_demographic",1934,"black or african american","48c62578-8e2e-5d1a-a37a-f971a6d5b7f2","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.9","TCGA-EY-A549_diagnosis","not reported",28570,"alive","8380/3",NA,605,"5c7588e5-e56e-597d-8aa3-3822164e4464","c54.9",-28570,"TCGA-EY-A549_treatment","f6fe67bd-fdcd-50af-b5f7-66f286c11193","01","false","TCGA-EY-A549-01A",NA,"2b096dd7-4d46-4c71-91c3-fa084ade57cb",FALSE,"F6D1F090-C601-4212-951E-BEE086DDD24F","Primary Tumor",NA,191,370,NA,1355184000,"11",30,"TCGA-EY-A549-01A-11",80,NA,2,NA,0,NA,0,NA,"2016-09-08T10:42:16.194605-05:00",NA,3,NA,0,NA,"TOP",NA,5,NA,"1a4b17bb-3ce5-4a06-8ef2-8b60c5d7e39a",NA,"TCGA-EY-A549-01A-01-TS1",NA,95,NA,"d7642abc-1e4a-4001-9b67-2f91c8b100b2","RNA","TCGA-EY-A549-01A-11R","2e0d3c55-be2d-46bb-a135-fc44f74d4946",1.87,0.17,"UV Spec","R","23","TCGA-EY-A549-01A-11R-A27V-07","4cbce4ad-3208-4463-a06d-75edce32ed3f",0.17,NA,74,27.1808999081726,165,"435d73c9-1b70-5694-9b0a-dbbf7b810af5","TCGA-EY-A549_exposure","UNCID_2168976.4cbce4ad-3208-4463-a06d-75edce32ed3f.130610_UNC14-SN744_0347_BD28NBACXX_6_GTGAAA.tar.gz","2013-09-20T06:26:04.000Z","2013-09-20T06:46:01.000Z","2547BEC9-5A1B-425E-9161-43773F145549","2B096DD7-4D46-4C71-91C3-FA084ADE57CB","Unaligned reads",6499780486,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","4CBCE4AD-3208-4463-A06D-75EDCE32ED3F","University of North Carolina","564a3f6de4b093830b6a8e5f","3D9828AE-EB65-4D0A-8D7A-CC09E98B5E99","Uterine Corpus Endometrial Carcinoma","TARGZ","D7642ABC-1E4A-4001-9B67-2F91C8B100B2","2013-09-20T06:46:01.000Z","2E0D3C55-BE2D-46BB-A135-FC44F74D4946","United States","NO",1,NA,"Primary Tumor","University of North Carolina",191,"D7642ABC-1E4A-4001-9B67-2F91C8B100B2",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E18E8B7F-FB1D-4E71-99AF-81A632FC381A.txt",370,"TCGA-EY-A549-01A",NA,NA,"TCGA",2012,"TCGA-EY-A549_NTE-1","Complete Remission/Response","TUMOR FREE","474A4907-0D3D-4DD3-B5F6-3F9E6ECB19E9",78,"nationwidechildrens.org_clinical.TCGA-EY-A549.xml","Alive",NA,"TCGA-EY-A549","NOT HISPANIC OR LATINO","559A11E7-F8C1-45CA-8B4E-3CEC1EF2BA7E",NA,212,"Yes","Uterus","C54.9",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.9",289,NA,"0D949557-523E-4B78-BD43-D3ABE285A95F","BLACK OR AFRICAN AMERICAN",NA,11,30,"1A4B17BB-3CE5-4A06-8EF2-8B60C5D7E39A","4B09E0A4-0946-4CD6-B78C-F28CD0B38FB2","UNCID_2087410.4cbce4ad-3208-4463-a06d-75edce32ed3f.sorted_genome_alignments.bam.bai","TCGA-EY-A549-01A-11",80,0,2,3,0,"TOP",5,0,"TCGA-EY-A549-01A-01-TS1",95,NA,NA,NA,"TCGA-EY-A549-R40745","Internal","Primary Tumor Field","TCGA-EY-A549-F55760_NTE-1","NO",605,NA,"Alive",NA,"TCGA-EY-A549-F55760","TCGA-EY-A549",1,"EY","A549","YES","C54.9","8380/3","C54.9","YES","NO",-28570,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes","No","Alive",212,NA,"YES","NO","TUMOR FREE","NO",27,2,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,78,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response",NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35156964,34780881,2603499652,"81F30B6F-3E9A-4913-986B-C56D5F107A17.bw","3dab68d3-232c-4b4f-81a4-ca8f72d69a43","81f30b6f-3e9a-4913-986b-c56d5f107a17","2016-08-09T14:14:01.502401-05:00","UNCID_2208065.46b06f7a-18ed-42a6-9cb9-75e6dc98b30e.110624_UNC2-RDR300275_00073_FC70KA5AAXX_8.tar.gz","cfa03fc9-5c49-45f9-ade2-1ca3db6dfb03",2229352039,"Illumina GA","930267e73cbebe5716120e7079512d78","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:20:42.962165-05:00","2016-05-03T11:14:23.412460-05:00","cfa03fc9-5c49-45f9-ade2-1ca3db6dfb03_analysis.xml","3753c3dcd7180d57dab2415ea10d3e34","b3e71411-3a7e-4da7-8d99-9c8228566471",2119,"2016-10-07T16:39:41.598476-05:00","cfa03fc9-5c49-45f9-ade2-1ca3db6dfb03_experiment.xml","41857bc45c50aabf8cd608a567454f5f","0ebfbbb4-d32e-43b9-8a6f-1b84e61bbe80",2257,"2016-09-29T19:14:09.082711-05:00","cfa03fc9-5c49-45f9-ade2-1ca3db6dfb03_run.xml","ad9d90747c23411995c3c8a30702ea4a","409e3407-f7a0-4ff4-add6-46619d0cccd2",347,"2016-09-08T10:49:16.943333-05:00","TCGA-DI-A0WH","2016-09-02T18:50:46.681231-05:00","female","TCGA-DI-A0WH_demographic",1946,"white","d4e997f3-b77d-5c7b-8e71-f598cfd8f14a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A0WH_diagnosis","not reported",23692,"alive","8380/3",NA,496,"da620a34-6f3c-58dc-afeb-42eb7cdbc88c","c54.1",-23692,"TCGA-DI-A0WH_treatment","4102c9a2-0615-5daa-ba44-3e3762c431d2","01","false","TCGA-DI-A0WH-01A",NA,"89f499fb-e061-4002-a8e8-dc3366e14a12",FALSE,"3D6B2D82-2F6D-40E6-8138-4DBF33DE8BEF","Primary Tumor",NA,244,180,NA,1286841600,"12",30,"TCGA-DI-A0WH-01A-12",90,95,0,0,0,0,10,5,"2016-09-08T10:49:16.943333-05:00","2016-09-08T10:49:16.943333-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"64122e86-c360-49a1-bd7f-0c98c36a2eae","2a5441e5-1f83-4fba-a497-d790ba2bd037","TCGA-DI-A0WH-01A-01-BS1","TCGA-DI-A0WH-01A-01-TS1",90,95,"3c55e054-1233-4f41-8253-d1e0ea8a81f9","RNA","TCGA-DI-A0WH-01A-12R","a236ce40-e5eb-4509-b18e-858ec9ef24aa",1.87,0.16,"UV Spec","R","23","TCGA-DI-A0WH-01A-12R-A12I-07","46b06f7a-18ed-42a6-9cb9-75e6dc98b30e",0.16,NA,107,35.7512780246584,173,"ca24e1d6-4c02-5148-bfea-7db76ca33709","TCGA-DI-A0WH_exposure","UNCID_2208065.46b06f7a-18ed-42a6-9cb9-75e6dc98b30e.110624_UNC2-RDR300275_00073_FC70KA5AAXX_8.tar.gz","2013-09-30T08:16:05.000Z","2013-09-30T08:39:02.000Z","CFA03FC9-5C49-45F9-ADE2-1CA3DB6DFB03","89F499FB-E061-4002-A8E8-DC3366E14A12","Unaligned reads",2229352039,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","46B06F7A-18ED-42A6-9CB9-75E6DC98B30E","University of North Carolina","56607d8ae4b016715ab6b6ee","3DAB68D3-232C-4B4F-81A4-CA8F72D69A43","Uterine Corpus Endometrial Carcinoma","TARGZ","3C55E054-1233-4F41-8253-D1E0EA8A81F9","2013-09-30T08:39:02.000Z","A236CE40-E5EB-4509-B18E-858EC9EF24AA","United States","NO",1,NA,"Primary Tumor","MD Anderson",244,"3C55E054-1233-4F41-8253-D1E0EA8A81F9",NA,"DI","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3F62FDDF-883B-41E2-8BA6-226563893CE0.txt",180,"TCGA-DI-A0WH-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","FBCC42E7-5529-4A78-9973-048E35EAF0FF",64,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3F62FDDF-883B-41E2-8BA6-226563893CE0.txt","Alive",NA,"TCGA-DI-A0WH","NOT HISPANIC OR LATINO","196EA226-0C34-4144-9DE4-CF7A4306FD3E",NA,405,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"8047277B-A27B-42F9-96EB-ADF32B561BB5","WHITE",NA,12,30,"64122E86-C360-49A1-BD7F-0C98C36A2EAE","A236CE40-E5EB-4509-B18E-858EC9EF24AA","UNCID_2208065.46b06f7a-18ed-42a6-9cb9-75e6dc98b30e.110624_UNC2-RDR300275_00073_FC70KA5AAXX_8.tar.gz","TCGA-DI-A0WH-01A-12",95,0,0,0,5,"TOP",0,0,"TCGA-DI-A0WH-01A-01-TS1",95,NA,NA,NA,"TCGA-DI-A0WH-R16138","OTHER: SPECIFY IN NOTES","Regional site",NA,"NO",496,"TUMOR FREE","Alive",NA,"TCGA-DI-A0WH-F16112","TCGA-DI-A0WH",1,"DI","A0WH","YES","C54.1","8380/3","C54.1","NO","YES",-23692,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",405,NA,NA,NA,"TUMOR FREE","NO",12,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
144873960,141226009,6736206048,"9C2C1195-DB04-4A0C-BD6D-CF3408FF1CA0.bw","3e240dc0-80b7-41ea-81b3-33ece2753c2b","9c2c1195-db04-4a0c-bd6d-cf3408ff1ca0","2016-08-25T19:07:07.558829-05:00","UNCID_2316580.0dfc3298-73ab-4c7b-b4f5-1314a5713c92.130827_UNC15-SN850_0324_AC2B28ACXX_7_GTTTCG.tar.gz","c57d8bdf-8ab6-4930-88a6-761740b22bec",6508168876,"Illumina HiSeq","cfd683b5fc7ca37e9c930986b1241b1d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:56:10.692143-05:00","2016-05-03T11:28:50.231867-05:00","c57d8bdf-8ab6-4930-88a6-761740b22bec_analysis.xml","934cb9883e89fd1790e95e1901fad620","0f886a8b-fe2e-4fed-8545-ed309979d141",2124,"2016-08-13T04:03:37.469781-05:00","c57d8bdf-8ab6-4930-88a6-761740b22bec_experiment.xml","20eb49c0dc14c1c301e28921a1085b78","f0465fa4-1c78-4a10-ac1a-9f10a69f18ad",2628,"2016-09-29T18:33:00.784659-05:00","c57d8bdf-8ab6-4930-88a6-761740b22bec_run.xml","9ab1bd1c65cd1432ebf25c4a4b881b3c","26703b1e-3e0f-4e64-94e1-59dbd643f7bc",354,"2016-09-08T11:04:11.638071-05:00","TCGA-B5-A5OD","2016-09-02T18:50:37.653142-05:00","female","TCGA-B5-A5OD_demographic",1944,"black or african american","8a10febd-d599-50a1-a42c-6dee0e428a6a","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A5OD_diagnosis","not reported",24775,"alive","8441/3",NA,1038,"396a29cc-f50f-56bd-85ee-8fbb80e73e3c","c54.1",-24775,"TCGA-B5-A5OD_treatment","89c32f7a-7690-546f-b303-d1a69c53ad64","01","true","TCGA-B5-A5OD-01A",NA,"71994580-4a7f-433d-80d3-71e408d44eb3",FALSE,"8A0B9737-98D2-4A61-95FF-18842056A6DE","Primary Tumor",NA,662,370,NA,1360800000,"11",30,"TCGA-B5-A5OD-01A-11",85,NA,2,NA,0,NA,15,NA,"2016-09-08T11:04:11.638071-05:00",NA,2,NA,2,NA,"TOP",NA,5,NA,"3220b10f-e059-4d82-bc74-fad9910ac8ea",NA,"TCGA-B5-A5OD-01A-01-TS1",NA,80,NA,"70846809-7a93-491a-a328-d1004da4cdc3","RNA","TCGA-B5-A5OD-01A-11R","411e8d74-17c9-44c5-982d-2e5cd63ce9c2",1.9,0.16,"UV Spec","R","23","TCGA-B5-A5OD-01A-11R-A31O-07","0dfc3298-73ab-4c7b-b4f5-1314a5713c92",0.16,NA,NA,NA,NA,"14fc2263-ab01-58ae-860b-da570cd43ae2","TCGA-B5-A5OD_exposure","UNCID_2316580.0dfc3298-73ab-4c7b-b4f5-1314a5713c92.130827_UNC15-SN850_0324_AC2B28ACXX_7_GTTTCG.tar.gz","2014-01-07T08:16:04.000Z","2014-01-07T08:43:02.000Z","C57D8BDF-8AB6-4930-88A6-761740B22BEC","71994580-4A7F-433D-80D3-71E408D44EB3","Unaligned reads",6508168876,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0DFC3298-73AB-4C7B-B4F5-1314A5713C92","University of North Carolina","564a40e8e4b0298dd2ca2cf2","3E240DC0-80B7-41EA-81B3-33ECE2753C2B","Uterine Corpus Endometrial Carcinoma","TARGZ","70846809-7A93-491A-A328-D1004DA4CDC3","2014-01-07T08:43:02.000Z","411E8D74-17C9-44C5-982D-2E5CD63CE9C2","United States","NO",1,NA,"Primary Tumor","Duke",662,"70846809-7A93-491A-A328-D1004DA4CDC3",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.16DD0C81-5825-4E38-8230-090E6783721B.txt",370,"TCGA-B5-A5OD-01A",NA,"8BC4F48F-5147-4B4A-A7CC-7224CE2BCA06","TCGA",2011,"TCGA-B5-A5OD_NTE-1",NA,NA,"99DA92B5-9D81-4E12-A698-C06FBDE1681C",67,"nationwidechildrens.org_clinical.TCGA-B5-A5OD.xml","Alive",NA,"TCGA-B5-A5OD",NA,"DEBCA480-29AC-4A8F-A650-D3D4AD66A0B5","NO",772,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",324,NA,"FE646869-43BA-4207-AD46-8355F65A95F8","BLACK OR AFRICAN AMERICAN",NA,11,30,"3220B10F-E059-4D82-BC74-FAD9910AC8EA","8CC58527-8CE2-4C4E-A3C6-1DF00C71E716","jhu-usc.edu_UCEC.HumanMethylation450.20.lvl-3.TCGA-B5-A5OD-01A-11D-A31V-05.txt","TCGA-B5-A5OD-01A-11",85,0,2,2,15,"TOP",5,2,"TCGA-B5-A5OD-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-B5-A5OD-D57494","TCGA-B5-A5OD-R57496","External","Primary Tumor Field","TCGA-B5-A5OD-F59472_NTE-1","NO",1038,"TUMOR FREE","Alive",NA,"TCGA-B5-A5OD-F59472","TCGA-B5-A5OD",1,"B5","A5OD","YES","C54.1","8441/3","C54.1","YES","NO",-24775,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",772,NA,"YES","YES",NA,"YES",20,8,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,2011,NA,NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
102841194,90623841,4319390384,"981584D3-10DB-455C-8132-E8E5F44E1222.bw","3e41cf2f-3de9-44c1-a819-bce693baf67d","981584d3-10db-455c-8132-e8e5f44e1222","2016-08-05T07:59:23.654793-05:00","UNCID_2661006.e860c29e-5d8d-4aee-b631-f55664403bdc.140711_UNC12-SN629_0381_AC4M54ACXX_4_ACTTGA.tar.gz","dd6a889c-c53a-47d2-a7ec-c0e6082de5b7",4421098718,"Illumina HiSeq","55f7771c66f8ef30e21ae6782a18b816","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:36:43.606810-05:00","2016-06-22T11:15:44.245302-05:00","dd6a889c-c53a-47d2-a7ec-c0e6082de5b7_analysis.xml","bfdfa6203852ce9da024001d98c93b1b","28dd608c-56ae-4d0c-8bb7-61b62ecae2c6",2124,"2016-10-07T16:53:21.366480-05:00","dd6a889c-c53a-47d2-a7ec-c0e6082de5b7_experiment.xml","8b743adc4758fe86bb2999ee18958dcc","ffa1bcd0-be7c-4567-b6ae-6f68b72d31ce",2628,"2016-09-29T22:21:01.923864-05:00","dd6a889c-c53a-47d2-a7ec-c0e6082de5b7_run.xml","a3935440424d34e32ad264c4be987687","b41854da-fa56-4f1f-9a39-c69d8f9334ef",354,"2016-09-08T12:15:01.233562-05:00","TCGA-JU-AAVI","2016-09-02T18:52:15.910913-05:00","female","TCGA-JU-AAVI_demographic",1952,"black or african american","f907a2a5-22a2-58dd-866e-d9feb0d7969f","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","JU","bea84955-9db7-5390-bed1-9e3033b516d3","BLN - Baylor","not reported","c54.1","TCGA-JU-AAVI_diagnosis","not reported",22289,"dead","8441/3",540,236,"f3001592-e8ec-56a5-8d72-3d58846fe180","c54.1",-22289,"TCGA-JU-AAVI_treatment","b3f73560-67d6-545c-9828-aa622d764e30","01","true","TCGA-JU-AAVI-01A",NA,"1b186f8e-06a6-488b-b4ce-f59cb0318034",FALSE,"8639CE54-3D67-4E2E-BECB-26755EE726C5","Primary Tumor",NA,139,20,NA,1391558400,"11",20,"TCGA-JU-AAVI-01A-11",70,NA,20,NA,0,NA,25,NA,"2016-09-08T12:15:01.233562-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"10379d62-7652-49df-a79e-5ea5309dce09",NA,"TCGA-JU-AAVI-01A-01-TS1",NA,70,NA,"46ed15de-e90c-4e4a-ae47-f0e69c6fc60e","RNA","TCGA-JU-AAVI-01A-11R","31ec5057-1917-42bd-99d9-3b0566ab73f7",1.89,0.17,"UV Spec","R","23","TCGA-JU-AAVI-01A-11R-A40A-07","e860c29e-5d8d-4aee-b631-f55664403bdc",0.17,NA,121,53.7777777777778,150,"2fda767d-3b7e-5a8f-8783-ac99625a5402","TCGA-JU-AAVI_exposure","UNCID_2661006.e860c29e-5d8d-4aee-b631-f55664403bdc.140711_UNC12-SN629_0381_AC4M54ACXX_4_ACTTGA.tar.gz","2014-11-14T21:47:04.000Z","2014-11-14T22:02:38.000Z","DD6A889C-C53A-47D2-A7EC-C0E6082DE5B7","1B186F8E-06A6-488B-B4CE-F59CB0318034","Unaligned reads",4421098718,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","E860C29E-5D8D-4AEE-B631-F55664403BDC","University of North Carolina","56607f67e4b018727fea3a59","3E41CF2F-3DE9-44C1-A819-BCE693BAF67D","Uterine Corpus Endometrial Carcinoma","TARGZ","46ED15DE-E90C-4E4A-AE47-F0E69C6FC60E","2014-11-14T22:02:38.000Z","31EC5057-1917-42BD-99D9-3B0566AB73F7","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",139,"46ED15DE-E90C-4E4A-AE47-F0E69C6FC60E",NA,"JU","TCGA-JU-AAVI-01A-11R-A404-13_mirna.bam.bai",20,"TCGA-JU-AAVI-01A",NA,NA,"TCGA",2013,"TCGA-JU-AAVI_NTE-1",NA,"TUMOR FREE","C682F80D-5429-4BB9-8001-439D6BAA838F",61,"jhu-usc.edu_UCEC.HumanMethylation450.23.lvl-3.TCGA-JU-AAVI-01A-11D-A409-05.txt","Alive",NA,"TCGA-JU-AAVI","NOT HISPANIC OR LATINO",NA,"NO",236,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8441/3","FEMALE","C54.1",421,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,20,"10379D62-7652-49DF-A79E-5EA5309DCE09","31EC5057-1917-42BD-99D9-3B0566AB73F7","TCGA-JU-AAVI-01A-11R-A404-13_mirna.bam.bai","TCGA-JU-AAVI-01A-11",70,0,20,40,25,"TOP",5,20,"TCGA-JU-AAVI-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-JU-AAVI",1,"JU","AAVI","YES","C54.1","8441/3","C54.1","YES","NO",-22289,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",236,NA,"YES","YES","TUMOR FREE","YES",3,4,2014,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,61,2013,"Incisional Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
118488082,116431540,5557758065,"B802DA89-05FC-4D14-BBED-4CF74B250ACF.bw","3e8e34c8-766a-4514-97f4-8000b5350ab9","b802da89-05fc-4d14-bbed-4cf74b250acf","2016-08-09T14:02:46.173581-05:00","UNCID_2167272.773a978c-a52f-470b-b659-4c06de8a7e5b.130613_UNC9-SN296_0375_BD27CGACXX_2_GCCAAT.tar.gz","00a4429d-6e6e-47a4-8857-5ee2868b7faa",5904889552,"Illumina HiSeq","361b8eb86fc1ccd160a533dbf2a0a80e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:27:32.176184-05:00","2016-05-03T11:07:07.492763-05:00","00a4429d-6e6e-47a4-8857-5ee2868b7faa_analysis.xml","2de8feef2ee18f551ee6c11db7f9bc7c","49061bf9-903d-4f18-90b9-4539ff49a3cc",2121,"2016-08-13T06:29:34.729115-05:00","00a4429d-6e6e-47a4-8857-5ee2868b7faa_experiment.xml","d75bc05d6ec675e283c9a8e9a41ce3cd","eeac3555-3706-4ff4-8537-9bd8b47037f7",2431,"2016-09-29T22:51:29.058459-05:00","00a4429d-6e6e-47a4-8857-5ee2868b7faa_run.xml","856cfedbfad12f7ca81126974f819b87","c7169d4a-6129-46c4-b39c-979f50b32bf6",354,"2016-09-08T10:48:58.862684-05:00","TCGA-FI-A3PX","2016-09-02T18:49:33.548169-05:00","female","TCGA-FI-A3PX_demographic",1951,"white","42272efd-0292-5bdf-b4cc-8a767f9dfc7f","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A3PX_diagnosis","not reported",21063,"alive","8441/3",NA,2384,"e041e648-069c-5ebb-a0a2-d4c311ae000d","c54.1",-21063,"TCGA-FI-A3PX_treatment","90a0fd69-2c28-5d6c-bf20-9ff6caa18cf1","01","true","TCGA-FI-A3PX-01A",NA,"9a1614c1-0c60-4a98-ac4c-447bfdf26576",FALSE,"5E3FD49D-DE9B-4A5B-B4FC-2825CCB48B46","Primary Tumor",NA,1280,130,NA,1330473600,"11",30,"TCGA-FI-A3PX-01A-11",90,NA,0,NA,0,NA,0,NA,"2016-09-08T10:48:58.862684-05:00",NA,0,NA,0,NA,"TOP",NA,15,NA,"d9eb834b-e1f0-4e36-88cf-6f1bb076d994",NA,"TCGA-FI-A3PX-01A-01-TS1",NA,85,NA,"c50025c8-0973-4cd0-bc94-62c902e64f31","RNA","TCGA-FI-A3PX-01A-11R","bfeddf87-f72b-4afa-b7cb-1ef9c00d64a7",1.96,0.17,"UV Spec","R","23","TCGA-FI-A3PX-01A-11R-A22K-07","773a978c-a52f-470b-b659-4c06de8a7e5b",0.17,NA,90,31.1418685121107,170,"b3c4d76a-96e3-55cb-aed5-d9847a2c3b9e","TCGA-FI-A3PX_exposure","UNCID_2167272.773a978c-a52f-470b-b659-4c06de8a7e5b.130613_UNC9-SN296_0375_BD27CGACXX_2_GCCAAT.tar.gz","2013-09-21T05:13:05.000Z","2013-09-21T05:28:01.000Z","00A4429D-6E6E-47A4-8857-5EE2868B7FAA","9A1614C1-0C60-4A98-AC4C-447BFDF26576","Unaligned reads",5904889552,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","773A978C-A52F-470B-B659-4C06DE8A7E5B","University of North Carolina","56607aa9e4b018727fea26e9","3E8E34C8-766A-4514-97F4-8000B5350AB9","Uterine Corpus Endometrial Carcinoma","TARGZ","C50025C8-0973-4CD0-BC94-62C902E64F31","2013-09-21T05:28:01.000Z","BFEDDF87-F72B-4AFA-B7CB-1EF9C00D64A7","United States","NO",1,NA,"Primary Tumor","Washington University",1280,"C50025C8-0973-4CD0-BC94-62C902E64F31",NA,"FI","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.219D9644-1FAC-4682-A1DC-37448FA3823A.txt",130,"TCGA-FI-A3PX-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","9A1614C1-0C60-4A98-AC4C-447BFDF26576",57,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.219D9644-1FAC-4682-A1DC-37448FA3823A.txt","Alive",NA,"TCGA-FI-A3PX","NOT HISPANIC OR LATINO","6348ACA2-FD95-4219-B4F2-485003060AB8",NA,1369,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"D9EB834B-E1F0-4E36-88CF-6F1BB076D994","F11D0E7E-AE12-4642-B338-DD8D43BBE5FD","a6bb02437ec812c7f328ceef7e423afc.bam","TCGA-FI-A3PX-01A-11",90,0,0,0,0,"TOP",15,0,"TCGA-FI-A3PX-01A-01-TS1",85,NA,NA,NA,NA,NA,NA,"TCGA-FI-A3PX-F71661_NTE-1","NO",2384,"TUMOR FREE","Alive",NA,"TCGA-FI-A3PX-F71661","TCGA-FI-A3PX",1,"FI","A3PX","YES","C54.1","8441/3","C54.1","NO","YES",-21063,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1369,NA,NA,NA,"TUMOR FREE","NO",15,6,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,57,2008,"Dilation and curettage procedure",NA,NA,NA,"High Grade","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34365588,34006252,2542420838,"E15EAAB4-0860-4716-9922-667F604CDF12.bw","3ea53b15-37f0-446e-a130-6bb2dee56865","e15eaab4-0860-4716-9922-667f604cdf12","2016-08-09T14:16:17.578951-05:00","UNCID_2212161.fb1c341a-34f7-482c-a954-de07652990b1.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_3.tar.gz","b0f4d0d6-0990-41f4-9392-238613291eef",2123336031,"Illumina GA","3c9a7f032a1c64e89fef29054a326ed2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:50:35.470247-05:00","2016-05-03T11:16:29.242391-05:00","b0f4d0d6-0990-41f4-9392-238613291eef_analysis.xml","80edba04e2bdc24500e766eb3d017d83","7c1ceafb-6cd0-4646-8295-5e8882b3e907",2121,"2016-09-29T17:41:29.180808-05:00","b0f4d0d6-0990-41f4-9392-238613291eef_experiment.xml","a17ce4f0ac22844b2aa0b9de173f55c3","06262005-d899-4e98-a3f8-af9e036e4eee",2257,"2016-09-29T21:32:14.724720-05:00","b0f4d0d6-0990-41f4-9392-238613291eef_run.xml","2936d29f6ea115a1a97e7e5a757c3ad8","961a4392-d1ed-438e-bed8-b50ab5188644",347,"2016-09-08T11:22:57.956939-05:00","TCGA-B5-A11F","2016-09-02T18:49:06.149299-05:00","female","TCGA-B5-A11F_demographic",1940,"white","de77fb9d-02b5-5d16-994a-46fa5a3e323b","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11F_diagnosis","not reported",20171,"alive","8380/3",NA,5651,"c1904f6f-f484-5afb-85e3-f1c6eace9af7","c54.1",-20171,"TCGA-B5-A11F_treatment","0e128094-cd09-58df-ae15-7738a966ef59","01","true","TCGA-B5-A11F-01A",NA,"a4dabdb5-4a72-4e31-981b-2c501c8dc7ab",FALSE,"228E437D-FB45-452B-A5A0-299C125F4CC4","Primary Tumor",NA,5482,380,NA,1289865600,"11",30,"TCGA-B5-A11F-01A-11",99,90,6,6,0,0,0,5,"2016-09-08T11:22:57.956939-05:00","2016-09-08T11:22:57.956939-05:00",2,3,1,1,"TOP","BOTTOM",1,5,"e4d98993-6567-436f-b48e-ca52818693b2","8b6d2a81-402d-4e95-97c1-f30b11a3e4f7","TCGA-B5-A11F-01A-01-TSA","TCGA-B5-A11F-01A-01-BSA",99,90,"f113093d-c776-4255-b05f-24745ea2aeab","RNA","TCGA-B5-A11F-01A-11R","63a780b1-e01b-4e82-a6f9-6cfd37bcaf6a",1.89,0.16,"UV Spec","R","23","TCGA-B5-A11F-01A-11R-A10J-07","fb1c341a-34f7-482c-a954-de07652990b1",0.16,NA,NA,NA,NA,"f143835a-fdff-516a-95d2-0fb21e7d3efc","TCGA-B5-A11F_exposure","UNCID_2212161.fb1c341a-34f7-482c-a954-de07652990b1.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_3.tar.gz","2013-10-03T05:55:04.000Z","2013-10-03T06:08:02.000Z","B0F4D0D6-0990-41F4-9392-238613291EEF","A4DABDB5-4A72-4E31-981B-2C501C8DC7AB","Unaligned reads",2123336031,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","FB1C341A-34F7-482C-A954-DE07652990B1","University of North Carolina","56607c26e4b0ca319164ff1d","3EA53B15-37F0-446E-A130-6BB2DEE56865","Uterine Corpus Endometrial Carcinoma","TARGZ","F113093D-C776-4255-B05F-24745EA2AEAB","2013-10-03T06:08:02.000Z","63A780B1-E01B-4E82-A6F9-6CFD37BCAF6A","United States","NO",1,NA,"Primary Tumor","Duke",5482,"F113093D-C776-4255-B05F-24745EA2AEAB",NA,"B5","B5-A11F-01A-11D_BCR3730_2011-09-20_011.fsa",380,"TCGA-B5-A11F-01A",NA,"4FD24910-B142-4CB6-A948-21C6107C9147","TCGA",1995,NA,NA,"TUMOR FREE","A4DABDB5-4A72-4E31-981B-2C501C8DC7AB",55,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8C6D529C-DAD0-4264-A2FD-D7250A73C825.txt","Alive",NA,"TCGA-B5-A11F",NA,"A49B65B0-1140-4664-AAA7-6D5A4F5670C4",NA,5280,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,"385C2C19-ED94-4010-9438-EA78A441B180","WHITE",NA,11,30,"E4D98993-6567-436F-B48E-CA52818693B2","63A780B1-E01B-4E82-A6F9-6CFD37BCAF6A","TCGA-B5-A11F-01A-11R-A10I-13_mirna.bam.bai","TCGA-B5-A11F-01A-11",90,0,6,3,5,"BOTTOM",5,1,"TCGA-B5-A11F-01A-01-BSA",90,"Megace","Hormone Therapy","TCGA-B5-A11F-D10043","TCGA-B5-A11F-R10454","EXTERNAL BEAM","Regional site",NA,"YES",5651,"TUMOR FREE","Alive",NA,"TCGA-B5-A11F-F17642","TCGA-B5-A11F",1,"B5","A11F","YES","C54.1","8380/3","C54.1","NO","YES",-20171,"FEMALE","WHITE",NA,"No","No","Alive",5280,NA,NA,NA,"TUMOR FREE","NO",26,1,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,1995,"Office Endometrial Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29507946,28977597,2163404443,"D7195D9D-406B-421F-BF0E-90B8D6C51AF1.bw","3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee","d7195d9d-406b-421f-bf0e-90b8d6c51af1","2016-08-05T02:08:21.649078-05:00","UNCID_2207671.cadf8449-cd8e-4581-ad35-37a0aa2f7a9b.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_6.tar.gz","7797773b-a779-4d2c-9be1-c5c783a2e50f",1874010732,"Illumina GA","217381a1280cae9fd424804c145a3cc4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:13:45.141332-05:00","2016-05-03T11:14:23.401440-05:00","7797773b-a779-4d2c-9be1-c5c783a2e50f_analysis.xml","d962f5c2c76a512d87646975955303a7","8aaaab5f-5f9d-4115-b654-a01a87e58c26",2120,"2016-09-29T18:56:06.739424-05:00","7797773b-a779-4d2c-9be1-c5c783a2e50f_experiment.xml","2cf8f8e26ec5966fe0a3b09c1c2f6c97","3540c7c3-0dcf-4615-9362-f08070c66008",2257,"2016-09-29T23:01:16.468562-05:00","7797773b-a779-4d2c-9be1-c5c783a2e50f_run.xml","5bd0e8eb38255c3229112a8ffbc94504","ccffe627-60e3-4265-ad92-a22b42ed3c88",347,"2016-09-08T10:54:40.044043-05:00","TCGA-AX-A1CA","2016-09-02T18:51:39.541001-05:00","female","TCGA-AX-A1CA_demographic",1939,"black or african american","ce12f12d-6909-5e15-b949-98cea3d19440","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CA_diagnosis","not reported",25817,"alive","8441/3",NA,974,"c05fa32f-6e1d-5526-ab18-4df2d3d31107","c54.1",-25817,"TCGA-AX-A1CA_treatment","e421e734-144e-5e2c-ae81-2b6908b7e337","01","false","TCGA-AX-A1CA-01A",NA,"b627e715-006f-45ac-a168-85d37e9dc6e1",FALSE,"5906346F-CB34-421F-BBC3-3B6D2239AA7F","Primary Tumor",NA,591,110,NA,1295222400,"12",30,"TCGA-AX-A1CA-01A-12",60,NA,0,NA,30,NA,10,NA,"2016-09-08T10:54:40.044043-05:00",NA,1,NA,0,NA,"TOP",NA,1,NA,"ebb49626-ca18-44b1-b56b-8811f228d278",NA,"TCGA-AX-A1CA-01A-01-TS1",NA,59,NA,"ec8bd7a6-131e-4dbf-a0a8-438e0ea49c3c","RNA","TCGA-AX-A1CA-01A-12R","3090e3bc-3701-402a-b69f-d2c91b0a7b6d",1.85,0.18,"UV Spec","R","23","TCGA-AX-A1CA-01A-12R-A137-07","cadf8449-cd8e-4581-ad35-37a0aa2f7a9b",0.18,NA,77,31.2385898008033,157,"9354678d-05c4-53ec-9bb3-306f2a9732e5","TCGA-AX-A1CA_exposure","UNCID_2207671.cadf8449-cd8e-4581-ad35-37a0aa2f7a9b.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_6.tar.gz","2013-09-30T04:36:04.000Z","2013-09-30T04:48:02.000Z","7797773B-A779-4D2C-9BE1-C5C783A2E50F","B627E715-006F-45AC-A168-85D37E9DC6E1","Unaligned reads",1874010732,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CADF8449-CD8E-4581-AD35-37A0AA2F7A9B","University of North Carolina","566073b6e4b0ec1099f8a23b","3EDE5DFF-8CF5-43E8-BF4B-E8AD75BF68EE","Uterine Corpus Endometrial Carcinoma","TARGZ","EC8BD7A6-131E-4DBF-A0A8-438E0EA49C3C","2013-09-30T04:48:02.000Z","3090E3BC-3701-402A-B69F-D2C91B0A7B6D","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",591,"EC8BD7A6-131E-4DBF-A0A8-438E0EA49C3C",NA,"AX","UNCID_2207671.cadf8449-cd8e-4581-ad35-37a0aa2f7a9b.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_6.tar.gz",110,"TCGA-AX-A1CA-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","B627E715-006F-45AC-A168-85D37E9DC6E1",70,"nationwidechildrens.org_clinical.TCGA-AX-A1CA.xml","Alive",NA,"TCGA-AX-A1CA","NOT HISPANIC OR LATINO","09359C8E-8632-4892-9C8C-E78216864E01",NA,617,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",104,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,12,30,"EBB49626-CA18-44B1-B56B-8811F228D278","E005584F-9E10-4524-82A9-F4E0430D7A71","UNCID_2207671.cadf8449-cd8e-4581-ad35-37a0aa2f7a9b.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_6.tar.gz","TCGA-AX-A1CA-01A-12",60,30,0,1,10,"TOP",1,0,"TCGA-AX-A1CA-01A-01-TS1",59,NA,NA,NA,NA,NA,NA,NA,NA,617,"TUMOR FREE","Alive",NA,"TCGA-AX-A1CA-F10391","TCGA-AX-A1CA",1,"AX","A1CA","YES","C54.1","8441/3","C54.1","NO","YES",-25817,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",617,NA,NA,NA,"TUMOR FREE","NO",11,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,70,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
118814516,113262802,5392264399,"F2BC32E5-4117-468E-B637-9EDB6E9CC6C7.bw","3f305a1f-1020-4ebb-82ab-fd132bcaea02","f2bc32e5-4117-468e-b637-9edb6e9cc6c7","2016-08-27T02:52:06.583293-05:00","UNCID_2316572.016f584a-453b-4e91-a311-0c0120e127d0.130909_UNC15-SN850_0327_BD2DT1ACXX_5_AGTCAA.tar.gz","60f5d745-1531-4d26-8f81-09c958c554c2",5402371364,"Illumina HiSeq","023e8a503f20d344998116c49b5ee50c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:40:26.433631-05:00","2016-05-03T11:28:50.231867-05:00","60f5d745-1531-4d26-8f81-09c958c554c2_analysis.xml","b0a95e40ad5049dc14a603e969b30295","e57c8668-c28a-48b9-8bbe-4b25f075cc61",2124,"2016-10-07T17:29:42.289146-05:00","60f5d745-1531-4d26-8f81-09c958c554c2_experiment.xml","b291aaea52d19167352407981c7d3df4","6c0ac15a-55cf-48e4-b043-64e581c5e3e0",2628,"2016-09-29T23:19:57.585684-05:00","60f5d745-1531-4d26-8f81-09c958c554c2_run.xml","9af2ee492e2b17bec0f686659014bab1","d89e743e-5c87-464e-b171-eed21ee417ac",354,"2016-09-08T11:04:02.751287-05:00","TCGA-DI-A1C3","2016-09-02T18:51:46.761165-05:00","female","TCGA-DI-A1C3_demographic",1970,"white","2861a82d-0e91-541e-b77d-c4585dc408e9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A1C3_diagnosis","not reported",13885,"alive","8380/3",NA,739,"fc1a25b2-20be-5150-bc58-c647c3513ace","c54.1",-13885,"TCGA-DI-A1C3_treatment","a87dd9ac-58c0-5fc7-aba9-3fa3e6f9f6d0","01","false","TCGA-DI-A1C3-01A",NA,"d4ab43b5-5ff7-4a06-8efb-f05eba3b2a7f",FALSE,"63A6706E-823B-456E-A3BC-65755C07CF62","Primary Tumor",NA,755,170,NA,1297728000,"41",30,"TCGA-DI-A1C3-01A-41",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:04:02.751287-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"e396aa3c-4b5e-4e6f-bc0c-15bbb36b4dd3",NA,"TCGA-DI-A1C3-01A-04-TSD",NA,80,NA,"a8f1b8c1-a18d-4eca-8c04-5698d6af3fce","RNA","TCGA-DI-A1C3-01A-41R","298a1e76-aefe-4725-a5a2-b8115d7194a1",1.85,0.18,"UV Spec","R","23","TCGA-DI-A1C3-01A-41R-A137-07","016f584a-453b-4e91-a311-0c0120e127d0",0.18,NA,144,49.2459218220991,171,"ab93a779-9047-555e-afc6-2d862441b0e2","TCGA-DI-A1C3_exposure","UNCID_2316572.016f584a-453b-4e91-a311-0c0120e127d0.130909_UNC15-SN850_0327_BD2DT1ACXX_5_AGTCAA.tar.gz","2014-01-07T09:16:04.000Z","2014-01-07T09:40:01.000Z","60F5D745-1531-4D26-8F81-09C958C554C2","D4AB43B5-5FF7-4A06-8EFB-F05EBA3B2A7F","Unaligned reads",5402371364,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","016F584A-453B-4E91-A311-0C0120E127D0","University of North Carolina","564a5843e4b08c5d869430f0","3F305A1F-1020-4EBB-82AB-FD132BCAEA02","Uterine Corpus Endometrial Carcinoma","TARGZ","A8F1B8C1-A18D-4ECA-8C04-5698D6AF3FCE","2014-01-07T09:40:01.000Z","298A1E76-AEFE-4725-A5A2-B8115D7194A1","United States","NO",1,NA,"Primary Tumor","MD Anderson",755,"A8F1B8C1-A18D-4ECA-8C04-5698D6AF3FCE",NA,"DI","TCGA-DI-A1C3-01A-41R-A136-13_mirna.bam",170,"TCGA-DI-A1C3-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","DD7D4F94-F93D-4F44-B7DD-7EC630CE80A3",38,"nationwidechildrens.org_clinical.TCGA-DI-A1C3.xml","Alive",NA,"TCGA-DI-A1C3","NOT HISPANIC OR LATINO","4CACD96D-A8AB-4326-9273-705F0734DA6D",NA,739,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,41,30,"E396AA3C-4B5E-4E6F-BC0C-15BBB36B4DD3","96DFEB1F-A19B-43FF-9B49-6E56C2CAF406","37c438f2e4e0cdfb2c16898ac0c1aa73.bam.bai","TCGA-DI-A1C3-01A-41",80,0,20,40,10,"TOP",10,20,"TCGA-DI-A1C3-01A-04-TSD",80,NA,NA,NA,NA,NA,NA,NA,"NO",739,"TUMOR FREE","Alive",NA,"TCGA-DI-A1C3-F20968","TCGA-DI-A1C3",1,"DI","A1C3","YES","C54.1","8380/3","C54.1","NO","YES",-13885,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",739,NA,NA,NA,"TUMOR FREE","NO",12,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,38,2008,"Other method, specify:",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
29228897,28894401,2172680894,"50314689-519F-4B27-884C-7816DD64CF4E.bw","3f96b142-77b6-40a1-8e16-6581b964583b","50314689-519f-4b27-884c-7816dd64cf4e","2016-08-06T23:32:30.198920-05:00","UNCID_2210031.4f440484-1605-442b-b1e5-b3534277b9c2.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_7.tar.gz","c105ddaf-ce13-4e7a-b904-d5146d7e891d",1817601831,"Illumina GA","998a877b25079689faeeee08bd10ae74","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:13:29.032483-05:00","2016-05-03T11:15:47.403263-05:00","c105ddaf-ce13-4e7a-b904-d5146d7e891d_analysis.xml","26bc1f205d02db198dc2abb9da128aa3","d4d71011-81cf-4b2b-b734-123d36ad62cc",2121,"2016-09-29T23:40:39.099075-05:00","c105ddaf-ce13-4e7a-b904-d5146d7e891d_experiment.xml","86916624165d05bcb92eb95e7da0fff7","e59f9bdd-9a68-4926-b340-4a279b4fa94e",2257,"2016-09-29T22:50:09.757080-05:00","c105ddaf-ce13-4e7a-b904-d5146d7e891d_run.xml","f11f4ea5790890e19d75c4e620847d9d","c6444ebc-a643-433d-85ff-685712e6ab8b",347,"2016-09-08T12:16:58.687162-05:00","TCGA-D1-A162","2016-09-02T18:49:57.788113-05:00","female","TCGA-D1-A162_demographic",1939,"white","a9871d31-b21f-58cf-99c9-c43961029a80","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A162_diagnosis","not reported",25543,"alive","8380/3",NA,1145,"02aed327-1439-5bbf-b166-8638931a8e41","c54.1",-25543,"TCGA-D1-A162_treatment","3c3c641d-bca9-52cd-8ce6-a091443e8692","01","false","TCGA-D1-A162-01A",NA,"4357a0dc-7d05-4c36-949f-8b30e91e208a",FALSE,"CB5E7FA1-33EE-492F-B2B0-F4C9332640A9","Primary Tumor",NA,874,180,NA,1292976000,"11",30,"TCGA-D1-A162-01A-11",70,NA,0,NA,25,NA,0,NA,"2016-09-08T12:16:58.687162-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"ba165261-a11f-4442-9550-6f5d48e6c506",NA,"TCGA-D1-A162-01A-01-TSA",NA,75,NA,"484b363f-7a38-44ab-b2fa-7869546aa877","RNA","TCGA-D1-A162-01A-11R","c6fb62c3-0d2c-45b5-8624-7d07a46c2a73",1.82,0.16,"UV Spec","R","23","TCGA-D1-A162-01A-11R-A118-07","4f440484-1605-442b-b1e5-b3534277b9c2",0.16,NA,100,34.6020761245675,170,"77bc2efa-4279-55e9-9cca-732994f31c53","TCGA-D1-A162_exposure","UNCID_2210031.4f440484-1605-442b-b1e5-b3534277b9c2.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_7.tar.gz","2013-10-02T04:46:04.000Z","2013-10-02T04:58:02.000Z","C105DDAF-CE13-4E7A-B904-D5146D7E891D","4357A0DC-7D05-4C36-949F-8B30E91E208A","Unaligned reads",1817601831,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4F440484-1605-442B-B1E5-B3534277B9C2","University of North Carolina","566077ede4b016715ab69ac3","3F96B142-77B6-40A1-8E16-6581B964583B","Uterine Corpus Endometrial Carcinoma","TARGZ","484B363F-7A38-44AB-B2FA-7869546AA877","2013-10-02T04:58:02.000Z","C6FB62C3-0D2C-45B5-8624-7D07A46C2A73","None","NO",1,NA,"Primary Tumor","Mayo Clinic",874,"484B363F-7A38-44AB-B2FA-7869546AA877",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.192B1720-C24A-43FE-9F8B-D9164E4C37C0.txt",180,"TCGA-D1-A162-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","5671ED0C-6F59-4E1A-81DA-A735F5895FBF",69,"nationwidechildrens.org_clinical.TCGA-D1-A162.xml","Alive",NA,"TCGA-D1-A162","NOT HISPANIC OR LATINO","3D83ED67-D115-4CF7-8898-0B6E3F9BEA26",NA,976,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"BA165261-A11F-4442-9550-6F5D48E6C506","9884A8D4-AA56-4BFC-B949-5BBF967848AD","UNCID_1629941.4f440484-1605-442b-b1e5-b3534277b9c2.sorted_genome_alignments.bam.bai","TCGA-D1-A162-01A-11",70,25,0,0,0,"TOP",0,0,"TCGA-D1-A162-01A-01-TSA",75,NA,NA,NA,NA,NA,NA,NA,"NO",1145,"TUMOR FREE","Alive",NA,"TCGA-D1-A162-F18479","TCGA-D1-A162",1,"D1","A162","YES","C54.1","8380/3","C54.1","NO","YES",-25543,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",976,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
102608610,101716317,4857156583,"6B1F8A0B-FE7F-4EDF-8F1E-8C703B8234EB.bw","40287cdc-19dd-4370-a6a0-f324960e1148","6b1f8a0b-fe7f-4edf-8f1e-8c703b8234eb","2016-08-09T13:15:49.178048-05:00","UNCID_2178406.f282d6e9-6a6a-4515-8efd-d5fff0367ee8.130328_UNC10-SN254_0443_AD238RACXX_5_ACTTGA.tar.gz","d39de7b7-3ba0-49c5-b61d-509ad98f614a",4220459351,"Illumina HiSeq","82d037815de08644a6e8e1d20f187a30","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:00:41.307906-05:00","2016-05-03T10:56:47.880266-05:00","d39de7b7-3ba0-49c5-b61d-509ad98f614a_analysis.xml","c61c6098221f92355b82b4efe1b4f9a1","126796fd-a4c5-48b5-b7a5-0782789d3be3",2123,"2016-09-29T20:52:22.962068-05:00","d39de7b7-3ba0-49c5-b61d-509ad98f614a_experiment.xml","f456ba21c9967b234878731f39842c16","7d3ce744-35c1-4861-af46-00db862e21db",2431,"2016-09-29T21:55:31.935307-05:00","d39de7b7-3ba0-49c5-b61d-509ad98f614a_run.xml","883266adf751380e0cb27bf2c87f7f85","a4962f76-1554-4cb8-93c0-037169b77ba9",354,"2016-09-08T10:29:18.115146-05:00","TCGA-AJ-A3BF","2016-09-02T18:48:14.752312-05:00","female","TCGA-AJ-A3BF_demographic",1946,"white","ffc30aed-dee2-51e6-b47a-6040fd685f9e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3BF_diagnosis","not reported",23906,"alive","8460/3",NA,551,"4919e8d0-23a1-55d8-a0b0-5e138272b8e3","c54.1",-23906,"TCGA-AJ-A3BF_treatment","444dfdac-c3b7-523a-9fb6-4326cef8fdd0","01","false","TCGA-AJ-A3BF-01A",NA,"ef33dd67-2e71-4a81-91dc-f5e404fb25f7",FALSE,"3673A111-6F2E-4374-A0E7-BA436D644F0D","Primary Tumor",NA,92,150,NA,1317859200,"11",30,"TCGA-AJ-A3BF-01A-11",90,NA,1,NA,5,NA,3,NA,"2016-09-08T10:29:18.115146-05:00",NA,2,NA,0,NA,"TOP",NA,2,NA,"649ac754-02cd-421e-9a2f-776a2e39c0a7",NA,"TCGA-AJ-A3BF-01A-01-TS1",NA,90,NA,"61dcd5dd-f7b8-41e6-9175-17c93301facc","RNA","TCGA-AJ-A3BF-01A-11R","3a50ead7-dcdd-41f5-b05b-e90c50080e3f",1.37,0.16,"UV Spec","R","23","TCGA-AJ-A3BF-01A-11R-A213-07","f282d6e9-6a6a-4515-8efd-d5fff0367ee8",0.16,NA,113,39.1003460207612,170,"1f4c9689-496d-57ed-9ec9-2d864d77b7d3","TCGA-AJ-A3BF_exposure","UNCID_2178406.f282d6e9-6a6a-4515-8efd-d5fff0367ee8.130328_UNC10-SN254_0443_AD238RACXX_5_ACTTGA.tar.gz","2013-09-12T02:06:03.000Z","2013-09-12T02:20:01.000Z","D39DE7B7-3BA0-49C5-B61D-509AD98F614A","EF33DD67-2E71-4A81-91DC-F5E404FB25F7","Unaligned reads",4220459351,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","F282D6E9-6A6A-4515-8EFD-D5FFF0367EE8","University of North Carolina","564a3973e4b093830b68a470","40287CDC-19DD-4370-A6A0-F324960E1148","Uterine Corpus Endometrial Carcinoma","TARGZ","61DCD5DD-F7B8-41E6-9175-17C93301FACC","2013-09-12T02:20:01.000Z","3A50EAD7-DCDD-41F5-B05B-E90C50080E3F","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",92,"61DCD5DD-F7B8-41E6-9175-17C93301FACC",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9B9F7D60-88B6-4A7B-8FDC-6878C65E00B5.txt",150,"TCGA-AJ-A3BF-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","EF33DD67-2E71-4A81-91DC-F5E404FB25F7",65,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9B9F7D60-88B6-4A7B-8FDC-6878C65E00B5.txt","Alive",NA,"TCGA-AJ-A3BF","NOT HISPANIC OR LATINO",NA,NA,34,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8460/3","FEMALE","C54.1",201,NA,NA,"WHITE",NA,11,30,"649AC754-02CD-421E-9A2F-776A2E39C0A7","A975A215-BA61-40B8-8E19-04E495E94F55","TCGA-AJ-A3BF-01A-11R-A214-13.mirna.quantification.txt","TCGA-AJ-A3BF-01A-11",90,5,1,2,3,"TOP",2,0,"TCGA-AJ-A3BF-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3BF",1,"AJ","A3BF","YES","C54.1","8460/3","C54.1","YES","NO",-23906,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",34,NA,NA,NA,"TUMOR FREE","NO",3,2,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,65,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
25303829,24861017,1860812057,"135743C3-829E-46DC-BBA9-FF07C8067612.bw","40a3ed98-3892-449c-b07e-7b7612bd997e","135743c3-829e-46dc-bba9-ff07c8067612","2016-08-05T15:06:38.831570-05:00","UNCID_2207043.bacdb0de-d29b-4ac1-a163-35376a7b2b9b.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_4.tar.gz","ef54d811-c0ee-44c2-82b4-0d627749f05c",1584504725,"Illumina GA","22db4cb2955a6191644c9cad21fe1646","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:56:52.751988-05:00","2016-05-03T11:13:02.646906-05:00","ef54d811-c0ee-44c2-82b4-0d627749f05c_analysis.xml","e87bb779bb91aa962c1336f16bdd00dd","800e17f1-535b-4256-9ce2-6a4faa6bd26b",2121,"2016-09-29T22:03:47.368171-05:00","ef54d811-c0ee-44c2-82b4-0d627749f05c_experiment.xml","e9f43721b13c3f950f0a237a281d7a2a","a9b066f4-ca1a-46a4-ad5d-9b142c03f56c",2257,"2016-09-29T18:10:25.700426-05:00","ef54d811-c0ee-44c2-82b4-0d627749f05c_run.xml","5119cf9f5aa93ee7b20423b5f6e11405","188251a6-57c1-4360-b038-aa933ef831a7",347,"2016-09-08T11:17:51.646597-05:00","TCGA-B5-A0K1","2016-09-02T18:54:43.408289-05:00","female","TCGA-B5-A0K1_demographic",1939,"white","3eb25b7a-aeb5-5adc-b873-2ff37b59675f","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0K1_diagnosis","not reported",25291,"alive","8380/3",NA,1110,"442389b3-5644-5d77-b051-326272c14d85","c54.1",-25291,"TCGA-B5-A0K1_treatment","7de3abe3-f926-51d2-a411-a8730af5d70c","01","true","TCGA-B5-A0K1-01A",NA,"b514f636-dee3-45f3-bb31-197ca6a171f1",FALSE,"826BF8E6-F928-4962-9322-78FA74F9FB0E","Primary Tumor",NA,636,180,NA,1277769600,"11",30,"TCGA-B5-A0K1-01A-11",85,85,0,0,0,0,0,0,"2016-09-08T11:17:51.646597-05:00","2016-09-08T11:17:51.646597-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"f4e3cd27-e087-45dc-9da5-402665521528","2d24011d-0a77-4c61-956b-3f8d293ae2f9","TCGA-B5-A0K1-01A-01-TS1","TCGA-B5-A0K1-01A-01-BS1",100,100,"d43f22a5-d609-4c3e-843f-64c94834437e","RNA","TCGA-B5-A0K1-01A-11R","687a482c-dd60-4682-82a7-877d72a2ff5c",1.86,0.16,"UV Spec","R","23","TCGA-B5-A0K1-01A-11R-A16W-07","bacdb0de-d29b-4ac1-a163-35376a7b2b9b",0.16,NA,117,38.6444708680143,174,"15910fc2-9b86-5dbc-bf5c-23d22a647661","TCGA-B5-A0K1_exposure","UNCID_2207043.bacdb0de-d29b-4ac1-a163-35376a7b2b9b.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_4.tar.gz","2013-09-29T03:55:04.000Z","2013-09-29T04:03:02.000Z","EF54D811-C0EE-44C2-82B4-0D627749F05C","B514F636-DEE3-45F3-BB31-197CA6A171F1","Unaligned reads",1584504725,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","BACDB0DE-D29B-4AC1-A163-35376A7B2B9B","University of North Carolina","564a379ce4b0298dd2c7300f","40A3ED98-3892-449C-B07E-7B7612BD997E","Uterine Corpus Endometrial Carcinoma","TARGZ","D43F22A5-D609-4C3E-843F-64C94834437E","2013-09-29T04:03:02.000Z","687A482C-DD60-4682-82A7-877D72A2FF5C","United States","NO",1,NA,"Primary Tumor","Duke",636,"D43F22A5-D609-4C3E-843F-64C94834437E",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6E5666F2-50BE-4591-878C-723948CDF9C8.txt",180,"TCGA-B5-A0K1-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","DCD30DE0-1752-4D6B-A20A-5054F63EC7C8",69,"TCGA-B5-A0K1-10A-01W-A062-09_IlluminaGA-DNASeq_exome_1.bam.bai","Alive",NA,"TCGA-B5-A0K1",NA,"8B62814A-875D-49BD-AE01-7BA65370E119",NA,746,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"F4E3CD27-E087-45DC-9DA5-402665521528","EB9946AA-379B-4DF6-A6D1-BB381B602D5D","TCGA-B5-A0K1-01A-11R-A041-13_mirna.bam","TCGA-B5-A0K1-01A-11",85,0,0,0,0,"BOTTOM",0,0,"TCGA-B5-A0K1-01A-01-BS1",100,NA,NA,NA,NA,NA,NA,NA,"NO",928,"TUMOR FREE","Alive",NA,"TCGA-B5-A0K1-F12996","TCGA-B5-A0K1",1,"B5","A0K1","YES","C54.1","8380/3","C54.1","NO","YES",-25291,"FEMALE","WHITE",NA,"No","No","Alive",746,NA,NA,NA,"TUMOR FREE","NO",5,1,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36190363,35977238,2707288502,"CDAFAFEA-365B-4F25-AEC0-639B6E0CB626.bw","40ce24c6-b331-4be2-baf9-2fa7dc855f9b","cdafafea-365b-4f25-aec0-639b6e0cb626","2016-08-05T10:32:35.798220-05:00","UNCID_2194773.58623d8a-f51b-470a-bde3-f31e91f9bd80.120313_UNC6-RDR300211_00137_FC_650V5AAXX_4.tar.gz","73a20714-f175-4cb1-b0c8-8bd337f87772",2409359170,"Illumina GA","04fa6d13c4f2032ae5530857acca6863","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:25:46.395673-05:00","2016-05-03T11:07:49.533775-05:00","73a20714-f175-4cb1-b0c8-8bd337f87772_analysis.xml","3519a365856d61059aad6a6b4c8145bd","21f85b6e-74b3-40f5-9471-db6960c4b806",2122,"2016-09-29T23:21:17.659472-05:00","73a20714-f175-4cb1-b0c8-8bd337f87772_experiment.xml","33d4829a66baeb0fb7068dd1bcc16ef3","d97b3b2c-650e-43e3-89c4-967b4fb264cd",2258,"2016-09-29T20:34:18.481110-05:00","73a20714-f175-4cb1-b0c8-8bd337f87772_run.xml","026cade646f36dbaf1dac4ca89be5d7e","71ed0a04-11b5-4f97-9d30-2e13162a762c",349,"2016-09-08T11:30:54.163416-05:00","TCGA-AX-A1C4","2016-09-02T18:51:30.445851-05:00","female","TCGA-AX-A1C4_demographic",1957,"white","f5abb0b7-7d51-5bf3-87e8-b27e9cba66c3","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1C4_diagnosis","not reported",19209,"alive","8380/3",NA,404,"d13c3b46-984f-5d2f-b490-90fc9053caea","c54.1",-19209,"TCGA-AX-A1C4_treatment","71b7f65b-6e7b-5617-811c-65652dccc1b8","01","false","TCGA-AX-A1C4-01A",NA,"48977d80-9f8f-488d-9292-661d7487e089",FALSE,"81C6DDE6-ACC3-4659-91EC-D986671B592A","Primary Tumor",NA,575,120,NA,1295222400,"11",30,"TCGA-AX-A1C4-01A-11",95,NA,0,NA,6,NA,2,NA,"2016-09-08T11:30:54.163416-05:00",NA,1,NA,0,NA,"TOP",NA,1,NA,"df686b3d-f729-495e-9fd3-bd34f945a4b9",NA,"TCGA-AX-A1C4-01A-01-TS1",NA,91,NA,"6712d9df-c213-43e8-803b-5dd3808941bd","RNA","TCGA-AX-A1C4-01A-11R","5fc924b9-ad0d-4f8d-a8e9-9821ce9696f1",1.91,0.17,"UV Spec","R","23","TCGA-AX-A1C4-01A-11R-A137-07","58623d8a-f51b-470a-bde3-f31e91f9bd80",0.17,NA,115,36.2959222320414,178,"559b1575-8ecf-5fa1-8782-bc2b5dcc88d7","TCGA-AX-A1C4_exposure","UNCID_2194773.58623d8a-f51b-470a-bde3-f31e91f9bd80.120313_UNC6-RDR300211_00137_FC_650V5AAXX_4.tar.gz","2013-09-23T03:06:07.000Z","2013-09-23T03:19:02.000Z","73A20714-F175-4CB1-B0C8-8BD337F87772","48977D80-9F8F-488D-9292-661D7487E089","Unaligned reads",2409359170,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","58623D8A-F51B-470A-BDE3-F31E91F9BD80","University of North Carolina","56607d33e4b0ca31916503aa","40CE24C6-B331-4BE2-BAF9-2FA7DC855F9B","Uterine Corpus Endometrial Carcinoma","TARGZ","6712D9DF-C213-43E8-803B-5DD3808941BD","2013-09-23T03:19:02.000Z","5FC924B9-AD0D-4F8D-A8E9-9821CE9696F1","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",575,"6712D9DF-C213-43E8-803B-5DD3808941BD",NA,"AX","UNCID_2194773.58623d8a-f51b-470a-bde3-f31e91f9bd80.120313_UNC6-RDR300211_00137_FC_650V5AAXX_4.tar.gz",120,"TCGA-AX-A1C4-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","639F7B07-DB17-45B5-9E56-30964F3038FE",52,"nationwidechildrens.org_clinical.TCGA-AX-A1C4.xml","Alive",NA,"TCGA-AX-A1C4","NOT HISPANIC OR LATINO","FE5833EB-D2D7-459F-9D68-920D3EAAB41F",NA,404,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"E9C8D5FD-3E6F-4F37-A3E4-06DB1B7EEB60","WHITE",NA,11,30,"DF686B3D-F729-495E-9FD3-BD34F945A4B9","19C6D9B9-5DF3-48DB-B929-146682377EA1","UNCID_2194773.58623d8a-f51b-470a-bde3-f31e91f9bd80.120313_UNC6-RDR300211_00137_FC_650V5AAXX_4.tar.gz","TCGA-AX-A1C4-01A-11",95,6,0,1,2,"TOP",1,0,"TCGA-AX-A1C4-01A-01-TS1",91,NA,NA,NA,"TCGA-AX-A1C4-R12536","COMBINATION","Primary Tumor Field",NA,NA,404,NA,"Alive",NA,"TCGA-AX-A1C4-F10395","TCGA-AX-A1C4",1,"AX","A1C4","YES","C54.1","8380/3","C54.1","NO","YES",-19209,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",404,NA,NA,NA,"TUMOR FREE","NO",12,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,52,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R1",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
32856943,32502381,2402404120,"F8DF1543-E00E-4741-804E-F577BD88874E.bw","40f43483-b504-4ea7-ad24-40682b10caac","f8df1543-e00e-4741-804e-f577bd88874e","2016-08-09T14:12:51.556488-05:00","UNCID_2208093.16c07e59-0ad4-4a8d-82a0-a77c78119175.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_6.tar.gz","3a103d52-9f4c-40f9-921a-f0a8977dd1cd",2157589262,"Illumina GA","d9c2468be8a69256dabe4d1ffe442c99","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:09:57.003804-05:00","2016-05-03T11:14:23.412460-05:00","3a103d52-9f4c-40f9-921a-f0a8977dd1cd_analysis.xml","ed95ade25a7089bea0d65162e80e711c","183ae315-4a16-45e0-8322-711890473ab0",2121,"2016-09-29T20:45:33.153857-05:00","3a103d52-9f4c-40f9-921a-f0a8977dd1cd_experiment.xml","aeb73a08918f1a6e52a29fbf8176ee25","78fd7e42-927b-49a5-bb29-d3d3efb07f0f",2257,"2016-09-29T18:20:24.233660-05:00","3a103d52-9f4c-40f9-921a-f0a8977dd1cd_run.xml","2b4e18314344ac4fe190766878124b3b","1e91146e-4032-4136-83bb-55162f69bc30",347,"2016-09-08T11:06:54.280783-05:00","TCGA-D1-A16R","2016-09-02T18:50:29.599187-05:00","female","TCGA-D1-A16R_demographic",1971,"white","f9768205-d7e5-5d5e-bf59-37e064d73669","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16R_diagnosis","not reported",14465,"alive","8380/3",NA,21,"267a5524-e18d-51ad-a054-5e2ae97eb8c2","c54.1",-14465,"TCGA-D1-A16R_treatment","354197a5-3d09-509d-ae82-ba787b2a26be","01","false","TCGA-D1-A16R-01A",NA,"f57eb4ed-4393-4dc3-9362-a4757ef8b21d",FALSE,"D9641375-D204-4469-989A-ED08DDE66408","Primary Tumor",NA,161,290,NA,1293062400,"11",30,"TCGA-D1-A16R-01A-11",70,NA,0,NA,10,NA,20,NA,"2016-09-08T11:06:54.280783-05:00",NA,10,NA,0,NA,"TOP",NA,20,NA,"46ccf388-57bd-4105-b94c-48b210bb4705",NA,"TCGA-D1-A16R-01A-01-TS1",NA,50,NA,"3fc965ec-b774-4638-a70e-0912f5b34e34","RNA","TCGA-D1-A16R-01A-11R","08d47677-c4ea-4bd1-b038-e0647ce30eab",1.28,0.16,"UV Spec","R","23","TCGA-D1-A16R-01A-11R-A12I-07","16c07e59-0ad4-4a8d-82a0-a77c78119175",0.16,NA,105,41.5331672006645,159,"1d09d225-660a-5d0a-8624-c0860743a0c3","TCGA-D1-A16R_exposure","UNCID_2208093.16c07e59-0ad4-4a8d-82a0-a77c78119175.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_6.tar.gz","2013-09-30T08:46:03.000Z","2013-09-30T08:59:02.000Z","3A103D52-9F4C-40F9-921A-F0A8977DD1CD","F57EB4ED-4393-4DC3-9362-A4757EF8B21D","Unaligned reads",2157589262,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","16C07E59-0AD4-4A8D-82A0-A77C78119175","University of North Carolina","56607b04e4b0ec1099f8e303","40F43483-B504-4EA7-AD24-40682B10CAAC","Uterine Corpus Endometrial Carcinoma","TARGZ","3FC965EC-B774-4638-A70E-0912F5B34E34","2013-09-30T08:59:02.000Z","08D47677-C4EA-4BD1-B038-E0647CE30EAB","None","NO",1,NA,"Primary Tumor","Mayo Clinic",161,"3FC965EC-B774-4638-A70E-0912F5B34E34",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B11290FB-906E-40FD-BB7C-B6F5660388EB.txt",290,"TCGA-D1-A16R-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","F57EB4ED-4393-4DC3-9362-A4757EF8B21D",39,"nationwidechildrens.org_clinical.TCGA-D1-A16R.xml","Alive",NA,"TCGA-D1-A16R","NOT HISPANIC OR LATINO","92A0D476-B163-4749-9A89-0ABBE496EA0B",NA,21,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"46CCF388-57BD-4105-B94C-48B210BB4705","11525D6B-C16F-4745-8799-4AE4238B611C","TCGA-D1-A16R-01A-11D-A12J-09_IlluminaGA-DNASeq_exome.bam","TCGA-D1-A16R-01A-11",70,10,0,10,20,"TOP",20,0,"TCGA-D1-A16R-01A-01-TS1",50,NA,NA,NA,NA,NA,NA,NA,"NO",21,"TUMOR FREE","Alive",NA,"TCGA-D1-A16R-F20316","TCGA-D1-A16R",1,"D1","A16R","YES","C54.1","8380/3","C54.1","NO","YES",-14465,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",21,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,39,2010,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
35707954,34858601,2599077680,"20A2BF82-E250-4E86-B1E1-1A6EB1ECFB3E.bw","4125e3e5-51c0-4577-9935-10cd086fc415","20a2bf82-e250-4e86-b1e1-1a6eb1ecfb3e","2016-08-09T13:59:06.433495-05:00","UNCID_2188983.32d0d293-ce07-487a-b914-062548072260.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_7.tar.gz","b9ea6aa4-0b10-4525-a165-5da129a6be56",2275496133,"Illumina GA","dcb2c21f716fb7b17804bbb3056c0b66","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:30:10.785113-05:00","2016-05-03T11:05:01.518052-05:00","b9ea6aa4-0b10-4525-a165-5da129a6be56_analysis.xml","af2367696a8ee4cc4f6915902a3db940","b9da19b7-4a25-416d-876f-3e5b9f5ba673",2122,"2016-09-29T18:50:57.030727-05:00","b9ea6aa4-0b10-4525-a165-5da129a6be56_experiment.xml","f665b009bb21169cf3534e7aae72da02","31f3dd0d-47db-425e-a25d-00a010cdbdb0",2258,"2016-09-29T21:48:58.935266-05:00","b9ea6aa4-0b10-4525-a165-5da129a6be56_run.xml","29f37fcc10f5338b19e173d702cf1fc6","a063fe03-c0ee-4ec5-b2f8-e9461419f71b",349,"2016-09-08T11:19:10.191206-05:00","TCGA-EY-A214","2016-09-02T18:52:42.683410-05:00","female","TCGA-EY-A214_demographic",1944,"white","628a9231-6a6f-58ee-bb03-77194c4e2534","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A214_diagnosis","not reported",24136,"alive","8380/3",NA,438,"85dd8c26-31ae-5062-9499-e4bec29fab1f","c54.1",-24136,"TCGA-EY-A214_treatment","1e1fe118-9a3d-5d96-9855-2075379c7802","01","false","TCGA-EY-A214-01A",NA,"5ed2b603-507e-4bef-bacd-46d0e98badb4",FALSE,"90B0CBB0-3AC0-44F8-9C49-310CFFE0370C","Primary Tumor",NA,160,330,NA,1302566400,"12",30,"TCGA-EY-A214-01A-12",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:19:10.191206-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"aab4aff1-9427-4061-8fd3-144ccc6058f1",NA,"TCGA-EY-A214-01A-01-TSA",NA,70,NA,"13e6a506-79ff-45bf-8160-c4d2e9189273","RNA","TCGA-EY-A214-01A-12R","129b0d0c-cabe-4b05-9d77-c76ca34fe42a",2.08,0.17,"UV Spec","R","23","TCGA-EY-A214-01A-12R-A157-07","32d0d293-ce07-487a-b914-062548072260",0.17,NA,94,34.5270890725436,165,"3e1e7dc5-308d-5e51-b63e-9491ec4dc8b8","TCGA-EY-A214_exposure","UNCID_2188983.32d0d293-ce07-487a-b914-062548072260.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_7.tar.gz","2013-09-18T13:37:04.000Z","2013-09-18T13:49:02.000Z","B9EA6AA4-0B10-4525-A165-5DA129A6BE56","5ED2B603-507E-4BEF-BACD-46D0E98BADB4","Unaligned reads",2275496133,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","32D0D293-CE07-487A-B914-062548072260","University of North Carolina","56607524e4b0b37b3d98f485","4125E3E5-51C0-4577-9935-10CD086FC415","Uterine Corpus Endometrial Carcinoma","TARGZ","13E6A506-79FF-45BF-8160-C4D2E9189273","2013-09-18T13:49:02.000Z","129B0D0C-CABE-4B05-9D77-C76CA34FE42A","United States","NO",1,NA,"Primary Tumor","University of North Carolina",160,"13E6A506-79FF-45BF-8160-C4D2E9189273",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8BD01A29-72D8-46DD-BE1A-444403EB2F4C.txt",330,"TCGA-EY-A214-01A",NA,"B331A48C-AD2B-4B63-B581-0C28B1F9C030","TCGA",2010,NA,NA,"TUMOR FREE","83279518-3AE7-4D2F-8D78-C2DAA6095959",66,"unc.edu.32d0d293-ce07-487a-b914-062548072260.1600126.junction_quantification.txt","Alive",NA,"TCGA-EY-A214",NA,"F7C2D1B1-5374-4843-B775-FA4A47861D0B",NA,252,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,"E0FCBAD3-130F-4691-9537-F046A28D98F0","WHITE",NA,12,30,"AAB4AFF1-9427-4061-8FD3-144CCC6058F1","6D3A3F0B-F35A-4A57-99FD-1FF92A478ECC","UNCID_2188983.32d0d293-ce07-487a-b914-062548072260.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_7.tar.gz","TCGA-EY-A214-01A-12",70,0,20,40,20,"TOP",10,20,"TCGA-EY-A214-01A-01-TSA",70,"Carboplatin","Chemotherapy","TCGA-EY-A214-D21728","TCGA-EY-A214-R21730","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",438,"TUMOR FREE","Alive",NA,"TCGA-EY-A214-F22091","TCGA-EY-A214",1,"EY","A214","YES","C54.1","8380/3","C54.1","YES","NO",-24136,"FEMALE","WHITE",NA,"Yes","No","Alive",252,NA,NA,NA,"TUMOR FREE","NO",8,7,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,66,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33082990,32510690,2431633199,"9133A8E4-DE95-4F2B-8F2F-CB52355D8045.bw","41893e97-7e90-4b03-b738-260f288ade4c","9133a8e4-de95-4f2b-8f2f-cb52355d8045","2016-08-09T14:16:12.132706-05:00","UNCID_2209892.9ca7ed26-2a2c-47cd-8423-f9b100beccc3.110420_UNC6-RDR300211_00096_FC_634WMAAXX_3.tar.gz","1ff21d1c-7618-445e-90a5-90634ddcc6ab",2199614749,"Illumina GA","bd18b3553c7662a8468f488fa448260f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:22:28.962710-05:00","2016-05-03T11:15:47.414649-05:00","1ff21d1c-7618-445e-90a5-90634ddcc6ab_analysis.xml","e38007bc704eca4ac57318b240fb23f2","b5040ad4-cec0-4a00-ac9c-eea29c085f68",2120,"2016-09-29T22:42:06.829105-05:00","1ff21d1c-7618-445e-90a5-90634ddcc6ab_experiment.xml","1a933e22d36729c2b71eb354f21774a4","c14fefce-2496-4958-bb77-0196811181b9",2257,"2016-09-29T23:44:50.952832-05:00","1ff21d1c-7618-445e-90a5-90634ddcc6ab_run.xml","6ed83f9bc1799910392d71649cc2c409","e8503b1c-3ff5-486b-8cb4-96c154fc3e26",347,"2016-09-08T10:46:29.044706-05:00","TCGA-D1-A168","2016-09-02T18:50:11.085829-05:00","female","TCGA-D1-A168_demographic",1941,"white","877d24ed-dd52-5247-95aa-d023b682a6dd","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A168_diagnosis","not reported",24586,"alive","8380/3",NA,1098,"a6f898ce-d3bf-5b6a-bf29-7a86fb211048","c54.1",-24586,"TCGA-D1-A168_treatment","21bac08b-e29c-5198-ae5c-4eea3bb311b6","01","false","TCGA-D1-A168-01A",NA,"b44c673e-9560-4b59-9ff3-34ce230cad1c",FALSE,"B9D9D808-17B1-415F-9E58-4FDBC1BF30C0","Primary Tumor",NA,821,120,NA,1293667200,"31",20,"TCGA-D1-A168-01A-31",95,NA,0,NA,0,NA,5,NA,"2016-09-08T10:46:29.044706-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"4593601c-0515-4fd9-b602-535be165a090",NA,"TCGA-D1-A168-01A-03-TSC",NA,90,NA,"84a93681-3ae8-4056-8a98-db24a436c460","RNA","TCGA-D1-A168-01A-31R","c0a13869-3777-49d2-b2dc-5f600394db50",1.84,0.16,"UV Spec","R","23","TCGA-D1-A168-01A-31R-A12I-07","9ca7ed26-2a2c-47cd-8423-f9b100beccc3",0.16,NA,76,28.9590001524158,162,"4880dd0e-c6a3-59cc-a796-22b6c0e428b3","TCGA-D1-A168_exposure","UNCID_2209892.9ca7ed26-2a2c-47cd-8423-f9b100beccc3.110420_UNC6-RDR300211_00096_FC_634WMAAXX_3.tar.gz","2013-10-02T00:16:04.000Z","2013-10-02T00:29:03.000Z","1FF21D1C-7618-445E-90A5-90634DDCC6AB","B44C673E-9560-4B59-9FF3-34CE230CAD1C","Unaligned reads",2199614749,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","9CA7ED26-2A2C-47CD-8423-F9B100BECCC3","University of North Carolina","56607ab4e4b0ec1099f8e192","41893E97-7E90-4B03-B738-260F288ADE4C","Uterine Corpus Endometrial Carcinoma","TARGZ","84A93681-3AE8-4056-8A98-DB24A436C460","2013-10-02T00:29:03.000Z","C0A13869-3777-49D2-B2DC-5F600394DB50","None","NO",1,NA,"Primary Tumor","Mayo Clinic",821,"84A93681-3AE8-4056-8A98-DB24A436C460",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.770C564F-5591-4122-9855-BA6C3CE96517.txt",120,"TCGA-D1-A168-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","B44C673E-9560-4B59-9FF3-34CE230CAD1C",67,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.770C564F-5591-4122-9855-BA6C3CE96517.txt","Alive",NA,"TCGA-D1-A168","NOT HISPANIC OR LATINO","94CCB1C0-B431-4F3B-87A8-B01C349866F0",NA,913,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"B10B7AA0-D055-4CCE-96EC-4B1663294B99","WHITE",NA,31,20,"4593601C-0515-4FD9-B602-535BE165A090","FE823D69-D44A-4762-B1EE-C4E6B4BC6532","UNCID_200053.TCGA-D1-A168-01A-31R-A12I-07.110420_UNC6-RDR300211_00096_FC_634WMAAXX.3.trimmed.annotated.translated_to_genomic.bam","TCGA-D1-A168-01A-31",95,0,0,0,5,"TOP",5,0,"TCGA-D1-A168-01A-03-TSC",90,NA,NA,NA,"TCGA-D1-A168-R18502","IMPLANTS","Regional site",NA,"NO",1098,"TUMOR FREE","Alive",NA,"TCGA-D1-A168-F18501","TCGA-D1-A168",1,"D1","A168","YES","C54.1","8380/3","C54.1","NO","YES",-24586,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",913,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33380563,32944338,2466960099,"D6F6A960-F91F-464E-BEA2-810206AA5EE7.bw","41dcafa0-b196-46dd-ab07-58cb747c9ebc","d6f6a960-f91f-464e-bea2-810206aa5ee7","2016-08-09T14:06:52.490399-05:00","UNCID_2203900.f26378d3-9f18-4367-a553-1a6c02e72575.111018_UNC2-RDR300275_00092_FC_634BHAAXX_5.tar.gz","98aeaff2-46b0-499c-8ac7-1f28651f1045",2160783641,"Illumina GA","aba35bd3b910561684413efc9ce02b03","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:15:16.081663-05:00","2016-05-03T11:10:47.509879-05:00","98aeaff2-46b0-499c-8ac7-1f28651f1045_analysis.xml","be8f2e3182533d3d3c1d74eac8e8749e","fb051b42-0694-4ab2-bf21-98f9a7245fa0",2121,"2016-08-27T23:06:44.225380-05:00","98aeaff2-46b0-499c-8ac7-1f28651f1045_experiment.xml","a8287773f994f07ff5b9304a5e9aa7f4","674ce937-e458-4ead-aa84-63858b2f34c0",2257,"2016-09-29T21:21:33.330573-05:00","98aeaff2-46b0-499c-8ac7-1f28651f1045_run.xml","678a2b67f633eaecaad5ad9be2582875","8f7ba8dc-6a67-4111-9716-78e1189114dd",347,"2016-09-08T10:27:08.690973-05:00","TCGA-BG-A220","2016-09-02T18:52:37.707895-05:00","female","TCGA-BG-A220_demographic",1941,"white","fbd9da68-0278-5568-957d-94cbc2f6de8a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A220_diagnosis","not reported",25346,"alive","8380/3",NA,434,"cbe109ac-6baf-5aed-92d5-45aa7db3e8fe","c54.1",-25346,"TCGA-BG-A220_treatment","04c547cc-072b-57a6-b4d3-5d996fb47dfe","01","true","TCGA-BG-A220-01A",NA,"b88002d7-76cb-4ea7-b894-8572d49411ab",FALSE,"59CD459F-FB2B-4B0E-9E16-3E26BDF252E1","Primary Tumor",NA,110,190,NA,1302480000,"11",30,"TCGA-BG-A220-01A-11",90,NA,10,NA,0,NA,5,NA,"2016-09-08T10:27:08.690973-05:00",NA,40,NA,30,NA,"TOP",NA,5,NA,"75475254-532d-45ac-ac0d-ac4b260b1d3b",NA,"TCGA-BG-A220-01A-01-TSA",NA,90,NA,"d76503af-7002-472a-af3c-cf02a9276039","RNA","TCGA-BG-A220-01A-11R","53a065fe-0af3-4c95-9d42-f20f8ea774b1",1.77,0.18,"UV Spec","R","23","TCGA-BG-A220-01A-11R-A157-07","f26378d3-9f18-4367-a553-1a6c02e72575",0.18,NA,127,NA,NA,"2172194b-1f36-5e20-a58a-92884ccc2d8e","TCGA-BG-A220_exposure","UNCID_2203900.f26378d3-9f18-4367-a553-1a6c02e72575.111018_UNC2-RDR300275_00092_FC_634BHAAXX_5.tar.gz","2013-09-26T07:36:04.000Z","2013-09-26T07:49:02.000Z","98AEAFF2-46B0-499C-8AC7-1F28651F1045","B88002D7-76CB-4EA7-B894-8572D49411AB","Unaligned reads",2160783641,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","F26378D3-9F18-4367-A553-1A6C02E72575","University of North Carolina","566073cfe4b0ca319164bab0","41DCAFA0-B196-46DD-AB07-58CB747C9EBC","Uterine Corpus Endometrial Carcinoma","TARGZ","D76503AF-7002-472A-AF3C-CF02A9276039","2013-09-26T07:49:02.000Z","53A065FE-0AF3-4C95-9D42-F20F8EA774B1","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",110,"D76503AF-7002-472A-AF3C-CF02A9276039",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3F856469-13FA-4F9E-957A-172BCD5064AE.txt",190,"TCGA-BG-A220-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","EFB47962-DA0E-4400-A249-71B113D49F48",69,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3F856469-13FA-4F9E-957A-172BCD5064AE.txt","Alive",NA,"TCGA-BG-A220","NOT HISPANIC OR LATINO","0270F30A-A7A6-46FF-99C1-A4B1C5BD0644",NA,221,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,NA,"WHITE",NA,11,30,"75475254-532D-45AC-AC0D-AC4B260B1D3B","CEE1D150-BBCE-457B-9988-26C1826A2313","UNCID_596838.f26378d3-9f18-4367-a553-1a6c02e72575.111018_UNC2-RDR300275_00092_FC_634BHAAXX.5.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-BG-A220-01A-11",90,0,10,40,5,"TOP",5,30,"TCGA-BG-A220-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,"NO",434,"TUMOR FREE","Alive",NA,"TCGA-BG-A220-F28651","TCGA-BG-A220",1,"BG","A220","YES","C54.1","8380/3","C54.1","NO","YES",-25346,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",221,NA,NA,NA,"TUMOR FREE","NO",28,9,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164773896,161222792,7687221793,"C16B498D-B5A9-451F-83CA-8F27492E1FB9.bw","41e14a71-95df-46d3-a357-a227a00029cf","c16b498d-b5a9-451f-83ca-8f27492e1fb9","2016-09-29T22:42:20.641865-05:00","UNCID_2365019.31594ace-9586-4e98-ab81-1dfe4fb9d20e.140124_UNC13-SN749_0327_BC36RUACXX_8_TTAGGC.tar.gz","94d76916-79e2-4724-bac3-b5b2464ff552",7655044238,"Illumina HiSeq","9ea736d756fae2fd0f61aec7920044e9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:26:43.407210-05:00","2016-05-03T11:39:34.521514-05:00","94d76916-79e2-4724-bac3-b5b2464ff552_analysis.xml","fe076476ecb9de68001b071a0e49bfd4","b7a8ec82-aef7-4f38-b1dd-6ba8e0231305",2124,"2016-08-13T02:09:35.423114-05:00","94d76916-79e2-4724-bac3-b5b2464ff552_experiment.xml","edfb3bcae4d914018238f5e31fe6e712","ae8db82a-2819-4a14-9744-2b3f91428fd3",2628,"2016-09-29T20:07:54.058344-05:00","94d76916-79e2-4724-bac3-b5b2464ff552_run.xml","3596ff3f04065089bf6e01615d6186d7","61e26fc5-e2be-470c-a687-bbbd9cded12a",354,"2016-09-08T11:07:30.095613-05:00","TCGA-AJ-A6NU","2016-09-02T18:51:29.846959-05:00","female","TCGA-AJ-A6NU_demographic",1948,"black or african american","2f20b9e2-817b-5e08-a486-b2009adaea1f","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A6NU_diagnosis","not reported",23498,"alive","8380/3",NA,632,"ec644a47-fd68-5f24-817a-9757acec06d4","c54.1",-23498,"TCGA-AJ-A6NU_treatment","6ce3636b-6379-5e1e-b73c-59210b7bf1d4","01","false","TCGA-AJ-A6NU-01A",NA,"c1d8a26d-4b1f-455e-a378-06d4ad191c02",FALSE,"43BA8AFC-DE95-4260-88BF-EB184430B5A4","Primary Tumor",NA,439,50,NA,1374796800,"11",30,"TCGA-AJ-A6NU-01A-11",80,NA,0,NA,10,NA,10,NA,"2016-09-08T11:07:30.095613-05:00",NA,5,NA,5,NA,"TOP",NA,0,NA,"5b0b5629-a6b2-48d0-8c0c-59fe0282565b",NA,"TCGA-AJ-A6NU-01A-01-TS1",NA,80,NA,"aa64247a-eff8-48fe-a20a-5a8457d01b7b","RNA","TCGA-AJ-A6NU-01A-11R","7ee1f861-ecd1-46ab-b561-150d0771f96b",1.8,0.16,"UV Spec","R","23","TCGA-AJ-A6NU-01A-11R-A34R-07","31594ace-9586-4e98-ab81-1dfe4fb9d20e",0.16,NA,167,61.3406795224977,165,"4da44e81-93fe-5434-bd8a-65687e24e0b0","TCGA-AJ-A6NU_exposure","UNCID_2365019.31594ace-9586-4e98-ab81-1dfe4fb9d20e.140124_UNC13-SN749_0327_BC36RUACXX_8_TTAGGC.tar.gz","2014-03-05T12:33:05.000Z","2014-03-05T13:03:02.000Z","94D76916-79E2-4724-BAC3-B5B2464FF552","C1D8A26D-4B1F-455E-A378-06D4AD191C02","Unaligned reads",7655044238,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","31594ACE-9586-4E98-AB81-1DFE4FB9D20E","University of North Carolina","566076cde4b018727fea0ee1","41E14A71-95DF-46D3-A357-A227A00029CF","Uterine Corpus Endometrial Carcinoma","TARGZ","AA64247A-EFF8-48FE-A20A-5A8457D01B7B","2014-03-05T13:03:02.000Z","7EE1F861-ECD1-46AB-B561-150D0771F96B","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",439,"AA64247A-EFF8-48FE-A20A-5A8457D01B7B",NA,"AJ","UNCID_2349254.31594ace-9586-4e98-ab81-1dfe4fb9d20e.sorted_genome_alignments.bam.bai",50,"TCGA-AJ-A6NU-01A",NA,NA,"TCGA",2012,"TCGA-AJ-A6NU_NTE-1","Complete Remission/Response","TUMOR FREE","C1D8A26D-4B1F-455E-A378-06D4AD191C02",64,"nationwidechildrens.org_clinical.TCGA-AJ-A6NU.xml","Alive",NA,"TCGA-AJ-A6NU","NOT HISPANIC OR LATINO","1CEEB191-060D-4D0D-BA15-4CF05F7028FA","NO",30,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",354,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"5B0B5629-A6B2-48D0-8C0C-59FE0282565B","4A730D52-0231-44B2-AA07-500042758A93","UNCID_2349254.31594ace-9586-4e98-ab81-1dfe4fb9d20e.sorted_genome_alignments.bam","TCGA-AJ-A6NU-01A-11",80,10,0,5,10,"TOP",0,5,"TCGA-AJ-A6NU-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A6NU-F66207_NTE-1","NO",632,"TUMOR FREE","Alive",NA,"TCGA-AJ-A6NU-F66207","TCGA-AJ-A6NU",1,"AJ","A6NU","YES","C54.1","8380/3","C54.1","YES","NO",-23498,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",30,NA,NA,NA,"TUMOR FREE","YES",30,6,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2012,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
126275410,119063711,5674225670,"CD3B289F-FAE1-405F-875F-23C1D2609DFC.bw","423da953-30aa-4f7e-96b5-1f6fd24f8874","cd3b289f-fae1-405f-875f-23c1d2609dfc","2016-08-09T13:14:16.195015-05:00","UNCID_2173751.4383201e-ca97-4192-8e89-c63b10caaa0c.130502_UNC12-SN629_0289_AC236KACXX_1_TTAGGC.tar.gz","d34bd73e-b249-4a3a-918e-4345fc41453a",6052086816,"Illumina HiSeq","e994cf7c58b98bd2d218f79bbe28647e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:18:17.254520-05:00","2016-05-03T10:56:47.870562-05:00","d34bd73e-b249-4a3a-918e-4345fc41453a_analysis.xml","882a7b067ddc38820f09c45ce25f077d","43336ea1-2da6-4248-8c2c-2580dd22694e",2123,"2016-09-29T22:26:23.024257-05:00","d34bd73e-b249-4a3a-918e-4345fc41453a_experiment.xml","8444df2a128360850ebd4e11d9aa9c44","b77035aa-f0c2-4278-bb05-138535cc7256",2431,"2016-09-29T19:33:36.638691-05:00","d34bd73e-b249-4a3a-918e-4345fc41453a_run.xml","5198d5396b1c1585c5c37f28675062e7","4cc89da1-38d9-4dd2-858b-dffebdb4f488",354,"2016-09-08T11:21:43.762017-05:00","TCGA-EO-A3L0","2016-09-02T18:49:31.045234-05:00","female","TCGA-EO-A3L0_demographic",1934,"white","12fbd795-9cb8-5b5b-9c91-533a3df57bfc","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3L0_diagnosis","not reported",28003,"alive","8380/3",NA,1554,"08eb6f0f-476b-5808-81b4-ccfa2541d5bd","c54.1",-28003,"TCGA-EO-A3L0_treatment","fccef7e2-d697-541a-91fc-4807fca8bf5e","01","false","TCGA-EO-A3L0-01A",NA,"73d4918c-8bab-4753-9d47-355b51dbbbfa",FALSE,"AD1F0EEC-20B6-416B-9728-BC103D2B3B87","Primary Tumor",NA,422,110,NA,1325721600,"11",30,"TCGA-EO-A3L0-01A-11",95,NA,0,NA,0,NA,0,NA,"2016-09-08T11:21:43.762017-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"7fb4d425-4de9-4073-a8c7-7f8e86df0f40",NA,"TCGA-EO-A3L0-01A-01-TS1",NA,100,NA,"54e7f9b8-68cb-4975-9e28-dcee6bf2b8f8","RNA","TCGA-EO-A3L0-01A-11R","d5635271-eda9-4e96-aa16-09cca20cd1e5",1.86,0.16,"UV Spec","R","23","TCGA-EO-A3L0-01A-11R-A22K-07","4383201e-ca97-4192-8e89-c63b10caaa0c",0.16,NA,110,43.5109370673628,159,"aca0d12f-3eac-591b-aac4-080757b8d9d4","TCGA-EO-A3L0_exposure","UNCID_2173751.4383201e-ca97-4192-8e89-c63b10caaa0c.130502_UNC12-SN629_0289_AC236KACXX_1_TTAGGC.tar.gz","2013-09-09T23:36:09.000Z","2013-09-10T00:11:02.000Z","D34BD73E-B249-4A3A-918E-4345FC41453A","73D4918C-8BAB-4753-9D47-355B51DBBBFA","Unaligned reads",6052086816,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","4383201E-CA97-4192-8E89-C63B10CAAA0C","University of North Carolina","564a3972e4b0298dd2c7c83e","423DA953-30AA-4F7E-96B5-1F6FD24F8874","Uterine Corpus Endometrial Carcinoma","TARGZ","54E7F9B8-68CB-4975-9E28-DCEE6BF2B8F8","2013-09-10T00:11:02.000Z","D5635271-EDA9-4E96-AA16-09CCA20CD1E5","Canada","NO",1,NA,"Primary Tumor","University Health Network",422,"54E7F9B8-68CB-4975-9E28-DCEE6BF2B8F8",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BA066AC9-3E99-41B7-913A-E6E05347406E.txt",110,"TCGA-EO-A3L0-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","73D4918C-8BAB-4753-9D47-355B51DBBBFA",76,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BA066AC9-3E99-41B7-913A-E6E05347406E.txt","Alive",NA,"TCGA-EO-A3L0","NOT HISPANIC OR LATINO","DF8BF477-0D59-4CA0-9C31-A93643347C5E",NA,577,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"8827BB72-F669-4D17-8B7C-DE0EF5EAD25C","WHITE",NA,11,30,"7FB4D425-4DE9-4073-A8C7-7F8E86DF0F40","D5635271-EDA9-4E96-AA16-09CCA20CD1E5","0b482e9bbc2de21295be745653c36323.bam.bai","TCGA-EO-A3L0-01A-11",95,0,0,1,0,"TOP",0,0,"TCGA-EO-A3L0-01A-01-TS1",100,NA,NA,NA,"TCGA-EO-A3L0-R39977","Internal","Primary Tumor Field","TCGA-EO-A3L0-F39975_NTE-1","NO",757,"TUMOR FREE","Alive",NA,"TCGA-EO-A3L0-F39975","TCGA-EO-A3L0",1,"EO","A3L0","YES","C54.1","8380/3","C54.1","NO","YES",-28003,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",577,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,76,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35907615,35402793,2595558676,"BF53898F-F173-42B5-8265-819F6B64A94B.bw","4284a85d-d9b6-40ee-aac4-c2c03554528e","bf53898f-f173-42b5-8265-819f6b64a94b","2016-08-09T14:07:48.518133-05:00","UNCID_2206594.1d3ec463-a3c0-4aa5-8fc0-d221be3a0700.110928_UNC6-RDR300211_00126_FC_6348UAAXX_5.tar.gz","0714e83c-0daf-4b85-9d3d-26bccf4a73b5",2382345837,"Illumina GA","9073add3e60e3373830a6e9a7eb7bfa5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:00:05.494544-05:00","2016-05-03T11:11:34.779998-05:00","0714e83c-0daf-4b85-9d3d-26bccf4a73b5_analysis.xml","aef9c5418fe8deb391d040e58678c8df","8204c31f-7654-4c1f-9968-6d816b835b09",2121,"2016-09-30T00:11:54.616118-05:00","0714e83c-0daf-4b85-9d3d-26bccf4a73b5_experiment.xml","100c07da0e8baca5da5d1a66ff2ab2fa","f8e2a1a3-2ec8-4886-a9f3-505f7941d2c8",2257,"2016-09-29T22:44:36.400886-05:00","0714e83c-0daf-4b85-9d3d-26bccf4a73b5_run.xml","e8b88a8912ca63431057c36df86d7cdf","c2d54c51-f206-469d-a8c5-64c86dd97ca3",347,"2016-09-08T10:37:55.140685-05:00","TCGA-FI-A2EU","2016-09-02T18:52:57.739376-05:00","female","TCGA-FI-A2EU_demographic",1935,"not reported","ae46540d-b520-585f-941d-5492c9ae03bb","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2EU_diagnosis","not reported",24837,"alive","8441/3",NA,2941,"57b6e82a-baa3-5a30-90e5-787f6f2b905e","c54.1",-24837,"TCGA-FI-A2EU_treatment","5ff0ab24-6512-58c4-b147-2a0aad2850be","01","true","TCGA-FI-A2EU-01A",NA,"af843246-e00f-40f4-849f-3c5ba74a7479",FALSE,"95F8FB60-A533-4A37-8B4B-FC6811A77636","Primary Tumor",NA,2779,110,NA,1308182400,"11",30,"TCGA-FI-A2EU-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T10:37:55.140685-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"3c2579f4-c41f-455b-9347-695267902624",NA,"TCGA-FI-A2EU-01A-01-TSA",NA,90,NA,"d3bdad06-62c7-4a52-94b2-5b5866051a17","RNA","TCGA-FI-A2EU-01A-11R","f619aa64-8e20-4eed-8423-b369fca5f23a",1.81,0.16,"UV Spec","R","23","TCGA-FI-A2EU-01A-11R-A17B-07","1d3ec463-a3c0-4aa5-8fc0-d221be3a0700",0.16,NA,93,32.9506802721088,168,"e4a3672c-0ba4-52a2-97c6-3b10e635bf19","TCGA-FI-A2EU_exposure","UNCID_2206594.1d3ec463-a3c0-4aa5-8fc0-d221be3a0700.110928_UNC6-RDR300211_00126_FC_6348UAAXX_5.tar.gz","2013-09-27T11:55:04.000Z","2013-09-27T12:08:02.000Z","0714E83C-0DAF-4B85-9D3D-26BCCF4A73B5","AF843246-E00F-40F4-849F-3C5BA74A7479","Unaligned reads",2382345837,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1D3EC463-A3C0-4AA5-8FC0-D221BE3A0700","University of North Carolina","564a4143e4b093830b6b2870","4284A85D-D9B6-40EE-AAC4-C2C03554528E","Uterine Corpus Endometrial Carcinoma","TARGZ","D3BDAD06-62C7-4A52-94B2-5B5866051A17","2013-09-27T12:08:02.000Z","F619AA64-8E20-4EED-8423-B369FCA5F23A","United States","NO",1,NA,"Primary Tumor","Washington University",2779,"D3BDAD06-62C7-4A52-94B2-5B5866051A17",NA,"FI","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.98F272A2-B83C-4E44-ACCC-BD15049DA4C3.txt",110,"TCGA-FI-A2EU-01A",NA,"EE97F906-C5C8-4EAE-BE16-D0C1EA923337","TCGA",2003,NA,NA,"TUMOR FREE","AF843246-E00F-40F4-849F-3C5BA74A7479",68,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.98F272A2-B83C-4E44-ACCC-BD15049DA4C3.txt","Alive",NA,"TCGA-FI-A2EU","NOT HISPANIC OR LATINO","71A5001D-9AE4-4052-A903-C6E58184EB93",NA,2557,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,NA,NA,NA,11,30,"3C2579F4-C41F-455B-9347-695267902624","4673092A-0AB9-4922-B86F-56AAFEB8E6B1","TCGA-FI-A2EU-01A-11R-A17A-13_mirna.bam","TCGA-FI-A2EU-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-FI-A2EU-01A-01-TSA",90,"Carboplatinum","Chemotherapy","TCGA-FI-A2EU-D31786",NA,NA,NA,NA,"NO",2941,"TUMOR FREE","Alive",NA,"TCGA-FI-A2EU-F31382","TCGA-FI-A2EU",1,"FI","A2EU","YES","C54.1","8441/3","C54.1","NO","YES",-24837,"FEMALE",NA,"NOT HISPANIC OR LATINO","No","No","Alive",2557,NA,NA,NA,"TUMOR FREE","NO",27,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,68,2003,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
109661262,108441946,5172927810,"A366BFCE-FADD-4032-A930-8261FFC71525.bw","42ebfec9-6e28-4d72-9b9f-23a836800921","a366bfce-fadd-4032-a930-8261ffc71525","2016-08-25T22:51:53.545374-05:00","UNCID_2327186.da44c9b1-d38b-4b75-887c-ec1646969758.131016_UNC10-SN254_0498_BC2KTUACXX_7_GTGGCC.tar.gz","81f44f63-86c8-4c59-b315-b5e9c56579dd",5303844525,"Illumina HiSeq","38dbc2bf2a46a2cb2f301864147c0036","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:51:49.326998-05:00","2016-05-03T11:34:55.532339-05:00","81f44f63-86c8-4c59-b315-b5e9c56579dd_analysis.xml","3103f0ee514cb235faa1999e906f4670","c753924d-4b0a-46b7-8f54-2808d39bd19a",2124,"2016-09-29T19:47:00.154432-05:00","81f44f63-86c8-4c59-b315-b5e9c56579dd_experiment.xml","363b418b68340a6f3075abacf7350455","550bc0bb-c0ac-4e89-a4b9-15edead0df97",2628,"2016-09-29T21:46:59.274953-05:00","81f44f63-86c8-4c59-b315-b5e9c56579dd_run.xml","7aa6da1a6f7c3baa62c3c314bbb536da","9f2ca5e9-9eac-43f1-a784-1a9f5df24fb5",354,"2016-09-08T11:15:22.367393-05:00","TCGA-FL-A1YV",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YV-11A",NA,"2748d061-eb8e-4331-a88f-f4559a5433c3",FALSE,"DE7868BF-DA24-4C11-B331-6064E4CCCEAF","Solid Tissue Normal",NA,NA,110,NA,1302480000,"12",30,"TCGA-FL-A1YV-11A-12",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T11:15:22.367393-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"b6ebeabd-2660-42d0-9955-2a2a8da0a416",NA,"TCGA-FL-A1YV-11A-01-TSA",NA,0,NA,"8b732f0e-5004-455d-8a4c-6a987fe2ba14","RNA","TCGA-FL-A1YV-11A-12R","7afadb8e-c2b7-44e9-9ec5-784270896b97",1.96,0.15,"UV Spec","R","23","TCGA-FL-A1YV-11A-12R-A32Y-07","da44c9b1-d38b-4b75-887c-ec1646969758",0.15,NA,NA,NA,NA,NA,NA,"UNCID_2327186.da44c9b1-d38b-4b75-887c-ec1646969758.131016_UNC10-SN254_0498_BC2KTUACXX_7_GTGGCC.tar.gz","2014-01-25T04:22:36.000Z","2014-01-25T04:51:02.000Z","81F44F63-86C8-4C59-B315-B5E9C56579DD","2748D061-EB8E-4331-A88F-F4559A5433C3","Unaligned reads",5303844525,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","DA44C9B1-D38B-4B75-887C-EC1646969758","University of North Carolina","564a3e01e4b08c5d869255f0","42EBFEC9-6E28-4D72-9B9F-23A836800921","Uterine Corpus Endometrial Carcinoma","TARGZ","8B732F0E-5004-455D-8A4C-6A987FE2BA14","2014-01-25T04:51:02.000Z","7AFADB8E-C2B7-44E9-9EC5-784270896B97","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"8B732F0E-5004-455D-8A4C-6A987FE2BA14",NA,"FL","UNCID_2253964.da44c9b1-d38b-4b75-887c-ec1646969758.sorted_genome_alignments.bam",110,"TCGA-FL-A1YV-11A",NA,NA,"TCGA",NA,NA,NA,NA,"2748D061-EB8E-4331-A88F-F4559A5433C3",NA,"UNCID_2253964.da44c9b1-d38b-4b75-887c-ec1646969758.sorted_genome_alignments.bam",NA,NA,"TCGA-FL-A1YV",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,156,NA,NA,NA,NA,12,30,"B6EBEABD-2660-42D0-9955-2A2A8DA0A416","B740708E-505B-4181-A466-1DF443002790","UNCID_2253964.da44c9b1-d38b-4b75-887c-ec1646969758.sorted_genome_alignments.bam","TCGA-FL-A1YV-11A-12",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YV-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
31653679,31468780,2330899741,"8CB71499-1B35-417D-95E1-D85CE71A2D8A.bw","43476c88-86bc-4a65-9327-f0d24a41c971","8cb71499-1b35-417d-95e1-d85ce71a2d8a","2016-08-07T00:42:37.678370-05:00","UNCID_2203693.14198ecd-3508-4ece-8fea-8141d3e4b1e7.111103_UNC6-RDR300211_00130_FC_638P5AAXX_7.tar.gz","4965ec4a-5e09-400f-b14f-373f7f3bb25a",2046653087,"Illumina GA","6f5a63109920d363634bee4d2a9f73d1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:16:28.941374-05:00","2016-05-03T11:10:47.515830-05:00","4965ec4a-5e09-400f-b14f-373f7f3bb25a_analysis.xml","4d61d666aef64da6fc06771ff2fe7964","1c3f18b3-372b-4e60-8c46-1397c3617896",2121,"2016-08-28T07:37:47.418273-05:00","4965ec4a-5e09-400f-b14f-373f7f3bb25a_experiment.xml","db47612ce6125b956375ae2da5e260d6","38bf1eb4-52ef-42e7-9fc0-603a22717cff",2257,"2016-09-29T21:45:51.042106-05:00","4965ec4a-5e09-400f-b14f-373f7f3bb25a_run.xml","a1408e5fb3f909cbed13aeb2ef47557b","9e736b86-e5b8-4d20-97a6-e7cd9c3cfb25",347,"2016-09-08T10:35:25.629236-05:00","TCGA-FI-A2F4","2016-09-02T18:52:59.457159-05:00","female","TCGA-FI-A2F4_demographic",1945,"black or african american","c7999b4d-27ca-56c5-bf89-79ad97db1621","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2F4_diagnosis","not reported",23621,"alive","8380/3",NA,2230,"e001828e-632e-5044-993e-67f821ca7c0f","c54.1",-23621,"TCGA-FI-A2F4_treatment","3c12b331-e51a-529c-87e6-dce892fc320e","01","true","TCGA-FI-A2F4-01A",NA,"79ca02f0-936e-4485-9cb3-85afa2cee9a3",FALSE,"B57570A5-2AE1-4D8B-9284-AB5769DDFDA6","Primary Tumor",NA,860,60,NA,1308268800,"11",30,"TCGA-FI-A2F4-01A-11",90,NA,30,NA,0,NA,5,NA,"2016-09-08T10:35:25.629236-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"2c9c3a46-d646-44bb-a30f-75aace6c45a4",NA,"TCGA-FI-A2F4-01A-01-TS1",NA,90,NA,"2ee5a728-befa-43f1-8e7e-c68f6b33624a","RNA","TCGA-FI-A2F4-01A-11R","ab8a1e92-0788-4aac-8e11-d754561bc259",1.77,0.15,"UV Spec","R","23","TCGA-FI-A2F4-01A-11R-A17B-07","14198ecd-3508-4ece-8fea-8141d3e4b1e7",0.15,NA,74,27.1808999081726,165,"a990ee00-9075-5ab8-acd1-02152e1fbbce","TCGA-FI-A2F4_exposure","UNCID_2203693.14198ecd-3508-4ece-8fea-8141d3e4b1e7.111103_UNC6-RDR300211_00130_FC_638P5AAXX_7.tar.gz","2013-09-26T16:36:04.000Z","2013-09-26T16:49:01.000Z","4965EC4A-5E09-400F-B14F-373F7F3BB25A","79CA02F0-936E-4485-9CB3-85AFA2CEE9A3","Unaligned reads",2046653087,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","14198ECD-3508-4ECE-8FEA-8141D3E4B1E7","University of North Carolina","564a33f3e4b0298dd2c60488","43476C88-86BC-4A65-9327-F0D24A41C971","Uterine Corpus Endometrial Carcinoma","TARGZ","2EE5A728-BEFA-43F1-8E7E-C68F6B33624A","2013-09-26T16:49:01.000Z","AB8A1E92-0788-4AAC-8E11-D754561BC259","United States","NO",1,NA,"Primary Tumor","Washington University",860,"2EE5A728-BEFA-43F1-8E7E-C68F6B33624A",NA,"FI","acd644ca809bc4ec82acc61084638947.bam.bai",60,"TCGA-FI-A2F4-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","CF58CF42-E8B3-4B56-ACC2-AD465313B28E",64,"nationwidechildrens.org_clinical.TCGA-FI-A2F4.xml","Alive",NA,"TCGA-FI-A2F4","NOT HISPANIC OR LATINO","EC7D5C6E-B7B5-42B6-8DE7-04BEC54771F4",NA,881,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"2C9C3A46-D646-44BB-A30F-75AACE6C45A4","D07DE8D2-9FE1-4A7D-AE30-3237ED9E6ABC","acd644ca809bc4ec82acc61084638947.bam.bai","TCGA-FI-A2F4-01A-11",90,0,30,40,5,"TOP",5,20,"TCGA-FI-A2F4-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,"NO",519,"TUMOR FREE","Alive",NA,"TCGA-FI-A2F4-F31736","TCGA-FI-A2F4",1,"FI","A2F4","YES","C54.1","8380/3","C54.1","NO","YES",-23621,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes","No","Alive",881,NA,NA,NA,"TUMOR FREE","NO",27,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31356109,31002679,2319105405,"1C47A87B-C033-4705-B903-DB33B8C6EC34.bw","43714e9a-e9c4-4206-af92-1d00d2a8ae35","1c47a87b-c033-4705-b903-db33b8c6ec34","2016-08-05T06:09:11.114594-05:00","UNCID_2214917.cda60e53-f917-454b-b1f5-d1f0f8b8f130.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_2.tar.gz","7f8c5106-9d52-48c6-92f6-e967a0dbd9d1",1882684462,"Illumina GA","90799294ce9ffb7a96bfec03be4cdf08","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:22:06.396923-05:00","2016-05-03T11:17:14.905409-05:00","7f8c5106-9d52-48c6-92f6-e967a0dbd9d1_analysis.xml","891f01960f12a594042d7390ad0d8467","b4c966da-3241-4f95-af27-f55fb0e7d2a1",2120,"2016-09-30T00:12:47.903377-05:00","7f8c5106-9d52-48c6-92f6-e967a0dbd9d1_experiment.xml","1258fce7d75af4fbe67f303d4439b619","f973a427-0185-4d74-8449-b3b21cb7f378",2256,"2016-09-29T18:11:14.066533-05:00","7f8c5106-9d52-48c6-92f6-e967a0dbd9d1_run.xml","df3dd275a51ea2c64cf0b7531a7fb072","19030f49-7217-4c30-9519-fc9c1170d1f0",345,"2016-09-08T10:42:24.643638-05:00","TCGA-AP-A0LT","2016-09-02T18:54:39.113555-05:00","female","TCGA-AP-A0LT_demographic",1949,"white","dbfb019a-7f60-5b22-9d2f-87c1f3c2f6fd","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LT_diagnosis","not reported",21107,"alive","8380/3",NA,1497,"7c15d92c-4f55-5d8d-9d22-73ed30c7c263","c54.1",-21107,"TCGA-AP-A0LT_treatment","1780bc7b-9a02-5689-afde-c779776cd6bf","01","true","TCGA-AP-A0LT-01A",NA,"c94dd7a5-dd58-4702-a7d1-8199d3f8c9cc",FALSE,"4A25211C-354E-4FC8-B81B-29766B7962D4","Primary Tumor",NA,1404,200,NA,1278547200,"11",30,"TCGA-AP-A0LT-01A-11",90,80,0,0,0,0,0,0,"2016-09-08T10:42:24.643638-05:00","2016-09-08T10:42:24.643638-05:00",0,0,0,0,"BOTTOM","TOP",5,15,"4d77b90e-c3a2-4e6c-b9cd-8912c94941e9","9d20af32-e591-490f-8a58-51ed8595ebbd","TCGA-AP-A0LT-01A-01-BS1","TCGA-AP-A0LT-01A-01-TS1",95,85,"3e5c403d-45df-4670-9747-893bafd9f5f5","RNA","TCGA-AP-A0LT-01A-11R","a140cd41-ef62-4fdb-bd09-f894012c6b63",1.8,0.14,"UV Spec","R","23","TCGA-AP-A0LT-01A-11R-A040-07","cda60e53-f917-454b-b1f5-d1f0f8b8f130",0.14,NA,91,33.425160697888,165,"53b99fdc-901c-53df-a4a3-677374b20978","TCGA-AP-A0LT_exposure","UNCID_2214917.cda60e53-f917-454b-b1f5-d1f0f8b8f130.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_2.tar.gz","2013-10-03T22:26:04.000Z","2013-10-03T22:44:02.000Z","7F8C5106-9D52-48C6-92F6-E967A0DBD9D1","C94DD7A5-DD58-4702-A7D1-8199D3F8C9CC","Unaligned reads",1882684462,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CDA60E53-F917-454B-B1F5-D1F0F8B8F130","University of North Carolina","56607d45e4b0b37b3d992b41","43714E9A-E9C4-4206-AF92-1D00D2A8AE35","Uterine Corpus Endometrial Carcinoma","TARGZ","3E5C403D-45DF-4670-9747-893BAFD9F5F5","2013-10-03T22:44:02.000Z","A140CD41-EF62-4FDB-BD09-F894012C6B63","None","NO",1,NA,"Primary Tumor","MSKCC",1404,"3E5C403D-45DF-4670-9747-893BAFD9F5F5",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.D535B5D0-490A-41CE-8FBF-9D6B01DD164A.txt",200,"TCGA-AP-A0LT-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","C94DD7A5-DD58-4702-A7D1-8199D3F8C9CC",57,"MODEM_p_TCGAb59_SNP_N_GenomeWideSNP_6_H03_680456.nocnv_hg18.seg.txt","Alive",NA,"TCGA-AP-A0LT",NA,"96728E76-7B61-4479-B89F-61C731882099",NA,1185,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"462ACF3B-3411-49FF-92C2-8E33E4061B71","WHITE",NA,11,30,"9D20AF32-E591-490F-8A58-51ED8595EBBD","1DC1F94C-9387-4168-9C99-B76EC0939C81","UNCID_2214917.cda60e53-f917-454b-b1f5-d1f0f8b8f130.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_2.tar.gz","TCGA-AP-A0LT-01A-11",80,0,0,0,0,"TOP",15,0,"TCGA-AP-A0LT-01A-01-TS1",85,NA,NA,NA,"TCGA-AP-A0LT-R4045","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,NA,1185,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LT-F4044","TCGA-AP-A0LT",1,"AP","A0LT","YES","C54.1","8380/3","C54.1","NO","YES",-21107,"FEMALE","WHITE",NA,"No","No","Alive",1185,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2006,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
125439444,120495483,5740391468,"71836734-C824-4BD1-9D8F-BD794DBBC9A2.bw","43e08773-767e-4b81-94e4-8848565c23e9","71836734-c824-4bd1-9d8f-bd794dbbc9a2","2016-08-25T15:47:45.331439-05:00","UNCID_2581695.409104d7-db15-448e-96c6-e50fb7e5d67b.140416_UNC11-SN627_0352_AC3M6RACXX_7_GATCAG.tar.gz","6e31ad8a-d526-47fe-981d-3beb39d2b2ef",5611197957,"Illumina HiSeq","5631000fea50cbdeddb6da733e8b4bed","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:43:52.999521-05:00","2016-05-03T11:55:56.226464-05:00","6e31ad8a-d526-47fe-981d-3beb39d2b2ef_analysis.xml","08dc7e433ba09c48bd8ea9a807854ac3","e7b680c9-ad87-49ea-a96c-d28886492b65",2124,"2016-10-07T15:49:25.030706-05:00","6e31ad8a-d526-47fe-981d-3beb39d2b2ef_experiment.xml","ccaf895c9684fc90d6c0d25789816036","1a649d03-e51e-4b38-a3b0-ed69986fe283",2628,"2016-09-29T21:39:11.513257-05:00","6e31ad8a-d526-47fe-981d-3beb39d2b2ef_run.xml","c79a954e5c190ead84449df77e01df43","9a4dfb34-2466-40ce-94ad-4ea73068169c",354,"2016-09-08T11:05:28.759956-05:00","TCGA-AJ-A8CW","2016-09-02T18:51:44.272848-05:00","female","TCGA-AJ-A8CW_demographic",1947,"black or african american","6890a0be-464d-57fe-a1e4-40299008de2c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A8CW_diagnosis","not reported",23554,"alive","8380/3",NA,4,"65763f7d-c3f8-5db5-a71e-f921edcc96e4","c54.1",-23554,"TCGA-AJ-A8CW_treatment","8621a323-0eec-5454-be3a-119e8eabd5a3","01","false","TCGA-AJ-A8CW-01A",NA,"ca2da155-5ce0-4fe9-b82e-877295e4ad5e",FALSE,"146E0540-B6F0-495F-ADD5-90F7564C14CA","Primary Tumor",NA,840,90,NA,1384387200,"11",30,"TCGA-AJ-A8CW-01A-11",85,NA,0,NA,5,NA,8,NA,"2016-09-08T11:05:28.759956-05:00",NA,3,NA,0,NA,"TOP",NA,2,NA,"2af40cb3-2f71-449b-8482-70748e30d1f2",NA,"TCGA-AJ-A8CW-01A-01-TS1",NA,85,NA,"d59dd77e-d094-4d46-97e9-7651604344f8","RNA","TCGA-AJ-A8CW-01A-11R","037b7dd5-ca6b-4722-ae89-af708edfa631",1.89,0.18,"UV Spec","R","23","TCGA-AJ-A8CW-01A-11R-A37O-07","409104d7-db15-448e-96c6-e50fb7e5d67b",0.18,NA,134,47.4773242630385,168,"e28268bd-20d6-53a3-bc2e-94c09f11dcc6","TCGA-AJ-A8CW_exposure","UNCID_2581695.409104d7-db15-448e-96c6-e50fb7e5d67b.140416_UNC11-SN627_0352_AC3M6RACXX_7_GATCAG.tar.gz","2014-08-15T07:21:04.000Z","2014-08-15T07:36:33.000Z","6E31AD8A-D526-47FE-981D-3BEB39D2B2EF","CA2DA155-5CE0-4FE9-B82E-877295E4AD5E","Unaligned reads",5611197957,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","409104D7-DB15-448E-96C6-E50FB7E5D67B","University of North Carolina","564a3bf2e4b093830b697186","43E08773-767E-4B81-94E4-8848565C23E9","Uterine Corpus Endometrial Carcinoma","TARGZ","D59DD77E-D094-4D46-97E9-7651604344F8","2014-08-15T07:36:33.000Z","037B7DD5-CA6B-4722-AE89-AF708EDFA631","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",840,"D59DD77E-D094-4D46-97E9-7651604344F8",NA,"AJ","UNCID_2581695.409104d7-db15-448e-96c6-e50fb7e5d67b.140416_UNC11-SN627_0352_AC3M6RACXX_7_GATCAG.tar.gz",90,"TCGA-AJ-A8CW-01A",NA,NA,"TCGA",2011,"TCGA-AJ-A8CW_NTE-1",NA,"TUMOR FREE","CA2DA155-5CE0-4FE9-B82E-877295E4AD5E",64,"nationwidechildrens.org_clinical.TCGA-AJ-A8CW.xml","Alive",NA,"TCGA-AJ-A8CW","NOT HISPANIC OR LATINO",NA,"NO",4,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",381,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"2AF40CB3-2F71-449B-8482-70748E30D1F2","B4CB6854-F6E9-43D6-88CB-EF08A3C12BC5","UNCID_2581695.409104d7-db15-448e-96c6-e50fb7e5d67b.140416_UNC11-SN627_0352_AC3M6RACXX_7_GATCAG.tar.gz","TCGA-AJ-A8CW-01A-11",85,5,0,3,8,"TOP",2,0,"TCGA-AJ-A8CW-01A-01-TS1",85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A8CW",1,"AJ","A8CW","YES","C54.1","8380/3","C54.1","YES","NO",-23554,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",4,NA,NA,NA,"TUMOR FREE","YES",27,2,2014,"NO","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2011,"Tumor resection",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33611533,31494168,2371427274,"E8BCBDC5-E34E-422F-86C2-A4B30400EC86.bw","43e228ae-c890-444f-afbd-49385562e33a","e8bcbdc5-e34e-422f-86c2-a4b30400ec86","2016-08-09T14:15:55.370344-05:00","UNCID_2210413.db91880d-1e53-4852-8a94-dd40e2b9aa6c.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_2.tar.gz","c881373a-a1b7-4df3-9494-f1d4a51d7e85",2282588047,"Illumina GA","e98b28a37967f3bb3721c0fb448ec1c7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:42:15.303258-05:00","2016-05-03T11:15:47.427352-05:00","c881373a-a1b7-4df3-9494-f1d4a51d7e85_analysis.xml","17eacd90a3b1e4c094582e0c3acb7814","76e38ae1-1264-442b-8ed6-95ab8b653a46",2121,"2016-10-07T15:50:11.338794-05:00","c881373a-a1b7-4df3-9494-f1d4a51d7e85_experiment.xml","95245d5cdc526d02592af7876e31ee50","29d9b714-b7be-425d-b9a6-a1d9bc89df1e",2257,"2016-09-29T23:37:27.507958-05:00","c881373a-a1b7-4df3-9494-f1d4a51d7e85_run.xml","789857f9664318b6514aa9a6903e3dab","e3b2c107-aa95-4f62-8528-db24e0be2d9d",347,"2016-09-08T11:16:02.639025-05:00","TCGA-AP-A0LM","2016-09-02T18:49:21.877778-05:00","female","TCGA-AP-A0LM_demographic",1971,"black or african american","be5b9e06-57b9-58e8-b0f2-c984c40219a7","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LM_diagnosis","not reported",12309,"alive","8380/3",NA,825,"9fb6fe5c-fc24-57b1-90fb-68128caf82bc","c54.1",-12309,"TCGA-AP-A0LM_treatment","fbc51e68-0315-5a79-9663-7e6c6be0dabd","01","true","TCGA-AP-A0LM-01A",NA,"c8ab800a-ec4d-4a1c-bccf-8e17f7976978",FALSE,"BF380986-0279-41FC-AAE8-BA9772456CE6","Primary Tumor",NA,2019,200,NA,1291248000,"11",30,"TCGA-AP-A0LM-01A-11",65,30,0,0,15,60,0,0,"2016-09-08T11:16:02.639025-05:00","2016-09-08T11:16:02.639025-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"a7efc08a-f1a1-47bf-b3e8-c3d179058b3c","613751dc-6a2c-4487-b7da-fc8a0edf1a92","TCGA-AP-A0LM-01A-01-TSA","TCGA-AP-A0LM-01A-01-BSA",85,40,"b7657997-7eda-4c56-95cd-386a89b6763a","RNA","TCGA-AP-A0LM-01A-11R","12fb0d32-1a6b-4f76-8a5d-74a7c7da984c",1.82,0.16,"UV Spec","R","23","TCGA-AP-A0LM-01A-11R-A118-07","db91880d-1e53-4852-8a94-dd40e2b9aa6c",0.16,NA,100,36.2897372623022,166,"a2d5fcc4-5b76-5dab-aa2c-1e7067a1c5ff","TCGA-AP-A0LM_exposure","UNCID_2210413.db91880d-1e53-4852-8a94-dd40e2b9aa6c.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_2.tar.gz","2013-10-02T10:26:03.000Z","2013-10-02T10:39:03.000Z","C881373A-A1B7-4DF3-9494-F1D4A51D7E85","C8AB800A-EC4D-4A1C-BCCF-8E17F7976978","Unaligned reads",2282588047,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","DB91880D-1E53-4852-8A94-DD40E2B9AA6C","University of North Carolina","564a39d2e4b09c884b23e103","43E228AE-C890-444F-AFBD-49385562E33A","Uterine Corpus Endometrial Carcinoma","TARGZ","B7657997-7EDA-4C56-95CD-386A89B6763A","2013-10-02T10:39:03.000Z","12FB0D32-1A6B-4F76-8A5D-74A7C7DA984C","None","NO",1,NA,"Primary Tumor","MSKCC",2019,"B7657997-7EDA-4C56-95CD-386A89B6763A",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.11FA828B-C9E3-4BD4-B7C6-35F19EBEAA9A.txt",200,"TCGA-AP-A0LM-01A",NA,"60BC8D79-9AA9-49C8-AA66-74B69157CAD3","TCGA",2004,NA,NA,"TUMOR FREE","C8AB800A-EC4D-4A1C-BCCF-8E17F7976978",33,"nationwidechildrens.org_clinical.TCGA-AP-A0LM.xml","Alive",NA,"TCGA-AP-A0LM",NA,"99DAA82C-2441-45D5-885D-6F247BA3BDCB",NA,825,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"992A5125-4B22-47D7-B596-15A9FF2A49D2","BLACK OR AFRICAN AMERICAN",NA,11,30,"A7EFC08A-F1A1-47BF-B3E8-C3D179058B3C","7E96A736-435A-4F59-A6BB-00F07814B174","TCGA-AP-A0LM-01A-11R-A119-13_mirna.bam.bai","TCGA-AP-A0LM-01A-11",30,60,0,0,0,"BOTTOM",0,0,"TCGA-AP-A0LM-01A-01-BSA",40,"Cisplatin","Chemotherapy","TCGA-AP-A0LM-D8525","TCGA-AP-A0LM-R8524","EXTERNAL BEAM","Regional site",NA,NA,825,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LM-F6990","TCGA-AP-A0LM",1,"AP","A0LM","YES","C54.1","8380/3","C54.1","NO","YES",-12309,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",825,NA,NA,NA,"TUMOR FREE","NO",1,2,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,33,2004,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,13,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
128133112,126273236,6023628213,"3762BBD4-190F-4DE4-91E6-0C483D066B82.bw","4485cc98-5d58-4eb4-8325-7d1a617b6461","3762bbd4-190f-4de4-91e6-0c483d066b82","2016-08-25T15:35:51.632860-05:00","UNCID_2316574.ac3970c9-575a-4d72-a2b3-45f1ab671bbb.130909_UNC15-SN850_0327_BD2DT1ACXX_1_GCCAAT.tar.gz","b4383ab2-f275-4d47-adf0-4fc2fc5cc61a",5945722349,"Illumina HiSeq","8427f0d31bca400284022a0781e1188a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:13:28.342597-05:00","2016-05-03T11:28:50.231867-05:00","b4383ab2-f275-4d47-adf0-4fc2fc5cc61a_analysis.xml","91578b29ff40f5931d456391ef56ef3f","65469be1-8ac6-4db6-8dd7-59ffc8af8eb8",2124,"2016-08-13T06:53:47.213153-05:00","b4383ab2-f275-4d47-adf0-4fc2fc5cc61a_experiment.xml","6efaae3cc1b0abdc9fd7d1c5e51d9a61","027f5be7-d0bd-4c70-bb77-f4d1a8863444",2628,"2016-09-29T17:48:38.978142-05:00","b4383ab2-f275-4d47-adf0-4fc2fc5cc61a_run.xml","d53ef307da28bd2ea344edbe772fe6a2","0ad10576-d93c-429c-947d-6341ba157649",354,"2016-09-08T11:45:41.215527-05:00","TCGA-B5-A0K9","2016-09-02T18:48:00.768403-05:00","female","TCGA-B5-A0K9_demographic",1921,"white","7a511403-4d2c-5581-b0ba-8f177e17b6dc","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0K9_diagnosis","not reported",32289,"dead","8380/3",409,335,"309688e1-4ee9-5fba-8b99-74fd8ef540df","c54.1",-32289,"TCGA-B5-A0K9_treatment","c96d3ae9-3d27-5d1c-8137-629d5df17dc1","01","true","TCGA-B5-A0K9-01A",NA,"52a96216-708f-43f2-a923-130a1c35922d",FALSE,"8278F457-C0A5-4441-9105-3FC015E3F0EF","Primary Tumor",NA,182,600,NA,1277683200,"21",30,"TCGA-B5-A0K9-01A-21",80,80,0,0,20,20,0,0,"2016-09-08T11:45:41.215527-05:00","2016-09-08T11:45:41.215527-05:00",20,20,10,20,"TOP","BOTTOM",10,10,"9c0b063a-0af6-4404-9a1b-7ee17daa8b7c","99a06147-7fc5-45d9-8872-9206ec394beb","TCGA-B5-A0K9-01A-02-TSB","TCGA-B5-A0K9-01A-02-BSB",70,70,"df7d04b0-e641-43f2-8479-ef96b766b531","RNA","TCGA-B5-A0K9-01A-21R","dbeba3e1-271c-488a-b399-ad564295234a",1.86,0.16,"UV Spec","R","23","TCGA-B5-A0K9-01A-21R-A104-07","ac3970c9-575a-4d72-a2b3-45f1ab671bbb",0.16,NA,65,25.390625,160,"52641871-d85c-58a0-b473-0dd324e64ba9","TCGA-B5-A0K9_exposure","UNCID_2316574.ac3970c9-575a-4d72-a2b3-45f1ab671bbb.130909_UNC15-SN850_0327_BD2DT1ACXX_1_GCCAAT.tar.gz","2014-01-07T08:46:04.000Z","2014-01-07T09:16:02.000Z","B4383AB2-F275-4D47-ADF0-4FC2FC5CC61A","52A96216-708F-43F2-A923-130A1C35922D","Unaligned reads",5945722349,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","AC3970C9-575A-4D72-A2B3-45F1AB671BBB","University of North Carolina","564a32aee4b093830b667aae","4485CC98-5D58-4EB4-8325-7D1A617B6461","Uterine Corpus Endometrial Carcinoma","TARGZ","DF7D04B0-E641-43F2-8479-EF96B766B531","2014-01-07T09:16:02.000Z","DBEBA3E1-271C-488A-B399-AD564295234A","United States","NO",1,NA,"Primary Tumor","Duke",182,"DF7D04B0-E641-43F2-8479-EF96B766B531",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BFE971A5-CADC-45EE-8CE3-991809A3479E.txt",600,"TCGA-B5-A0K9-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","52A96216-708F-43F2-A923-130A1C35922D",88,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BFE971A5-CADC-45EE-8CE3-991809A3479E.txt","Alive",NA,"TCGA-B5-A0K9",NA,"9AF7B0D3-A467-47CB-AE7B-9AE7380CC142",NA,167,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"7144362B-F009-42C5-9D3B-2FB938AA3725","WHITE",NA,21,30,"99A06147-7FC5-45D9-8872-9206EC394BEB","DBEBA3E1-271C-488A-B399-AD564295234A","UNCID_2191863.ac3970c9-575a-4d72-a2b3-45f1ab671bbb.sorted_genome_alignments.bam","TCGA-B5-A0K9-01A-21",80,20,0,20,0,"BOTTOM",10,20,"TCGA-B5-A0K9-01A-02-BSB",70,NA,NA,NA,"TCGA-B5-A0K9-R13513","OTHER: SPECIFY IN NOTES","Regional site",NA,"NO",335,"TUMOR FREE",NA,NA,"TCGA-B5-A0K9-F13512","TCGA-B5-A0K9",1,"B5","A0K9","YES","C54.1","8380/3","C54.1","NO","YES",-32289,"FEMALE","WHITE",NA,"No","No","Alive",167,NA,NA,NA,"TUMOR FREE","NO",20,1,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,88,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32550760,31929217,2389420544,"5F86DB7A-1906-4E2F-BD50-0AEE3C80B17D.bw","44ac7093-a733-4c55-a964-0ba9ec141d2d","5f86db7a-1906-4e2f-bd50-0aee3c80b17d","2016-08-09T14:12:18.411525-05:00","UNCID_2207199.0aa199cd-4fa0-4773-9659-1a246e42ad88.110719_UNC2-RDR300275_00077_FC_70KATAAXX_6.tar.gz","42507f49-bb3a-46cd-8291-f8a3419c8c46",2010275856,"Illumina GA","5aa5dfc01902f15389213faca9792186","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:43:15.527955-05:00","2016-05-03T11:13:42.375045-05:00","42507f49-bb3a-46cd-8291-f8a3419c8c46_analysis.xml","a2e9c984fe3b153a956e536a746c9a4e","9cd21fde-494c-4363-8924-3ba58c90b32b",2121,"2016-09-29T20:18:54.469088-05:00","42507f49-bb3a-46cd-8291-f8a3419c8c46_experiment.xml","4764bcada818d0547cde792f52a9c2f0","68884a61-2142-45af-aabd-0273d219561f",2257,"2016-09-29T21:57:14.827543-05:00","42507f49-bb3a-46cd-8291-f8a3419c8c46_run.xml","026ee2b0c1992ffdcdc27e5eee3443b4","a5a6bea5-5f81-44f9-8ca4-c8c888a307b1",347,"2016-09-08T10:30:55.453216-05:00","TCGA-AP-A1E3","2016-09-02T18:51:29.386603-05:00","female","TCGA-AP-A1E3_demographic",1964,"white","036e7831-79a7-520f-9b55-d3fa32a88c71","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1E3_diagnosis","not reported",16544,"alive","8380/3",NA,847,"b00b4a47-9cfe-5954-8223-f8df456bc8ea","c54.1",-16544,"TCGA-AP-A1E3_treatment","2369dc6d-c770-537f-8e03-30e813bf5896","01","true","TCGA-AP-A1E3-01A",NA,"86b9fab8-8a90-4610-ac48-53f952665ac9",FALSE,"FDA2C217-5267-41CC-AC07-CBACFF8E7B8D","Primary Tumor",NA,440,350,NA,1296000000,"11",30,"TCGA-AP-A1E3-01A-11",60,NA,0,NA,0,NA,30,NA,"2016-09-08T10:30:55.453216-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"ac9ab353-35ee-4179-b26c-617dc084f09c",NA,"TCGA-AP-A1E3-01A-01-TSA",NA,65,NA,"f3138478-4586-4209-9ee5-ef788f030b45","RNA","TCGA-AP-A1E3-01A-11R","155f6ad1-dc4a-4c80-998e-1df21d220212",1.87,0.16,"UV Spec","R","23","TCGA-AP-A1E3-01A-11R-A137-07","0aa199cd-4fa0-4773-9659-1a246e42ad88",0.16,NA,130,48.9292032067447,163,"cb3b6ffc-3d77-5cbe-92c3-f71c98eb135a","TCGA-AP-A1E3_exposure","UNCID_2207199.0aa199cd-4fa0-4773-9659-1a246e42ad88.110719_UNC2-RDR300275_00077_FC_70KATAAXX_6.tar.gz","2013-09-29T17:43:06.000Z","2013-09-29T18:01:01.000Z","42507F49-BB3A-46CD-8291-F8A3419C8C46","86B9FAB8-8A90-4610-AC48-53F952665AC9","Unaligned reads",2010275856,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0AA199CD-4FA0-4773-9659-1A246E42AD88","University of North Carolina","56607439e4b018727fe9ef8d","44AC7093-A733-4C55-A964-0BA9EC141D2D","Uterine Corpus Endometrial Carcinoma","TARGZ","F3138478-4586-4209-9EE5-EF788F030B45","2013-09-29T18:01:01.000Z","155F6AD1-DC4A-4C80-998E-1DF21D220212","None","NO",1,NA,"Primary Tumor","MSKCC",440,"F3138478-4586-4209-9EE5-EF788F030B45",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.CD1D4130-E1BC-4829-934D-67ACF926D474.txt",350,"TCGA-AP-A1E3-01A",NA,"E5B6F694-9767-4495-87FA-EDD47105BE19","TCGA",2009,NA,NA,"WITH TUMOR","C7E8B90C-7FD9-4F6F-BB8E-DC49C22F14C9",45,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.CD1D4130-E1BC-4829-934D-67ACF926D474.txt","Alive",NA,"TCGA-AP-A1E3",NA,"471DEA13-F47B-4B22-AD8E-80FB5C3A6128",NA,523,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"AC9AB353-35EE-4179-B26C-617DC084F09C","F5FE5943-6277-4CCE-8D9E-01321D0AD9BC","TCGA-AP-A1E3-01A-11R-A136-13_mirna.bam","TCGA-AP-A1E3-01A-11",60,0,0,0,30,"TOP",5,0,"TCGA-AP-A1E3-01A-01-TSA",65,"Paclitaxel","Chemotherapy","TCGA-AP-A1E3-D14427",NA,NA,NA,NA,"NO",679,"WITH TUMOR","Alive",NA,"TCGA-AP-A1E3-F13655","TCGA-AP-A1E3",1,"AP","A1E3","YES","C54.1","8380/3","C54.1","NO","YES",-16544,"FEMALE","WHITE",NA,"No","No","Alive",523,NA,NA,NA,"WITH TUMOR","NO",9,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,45,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
33025235,32567831,2443762987,"8FA74D2B-69CA-4658-9AA8-E50FD5A80846.bw","4549bff6-6886-4102-a1de-02691b664c52","8fa74d2b-69ca-4658-9aa8-e50fd5a80846","2016-08-05T03:13:11.180675-05:00","UNCID_2210679.1d8b3e3b-590d-4087-9506-d6b0b2bab9a9.110323_UNC3-RDR300156_00085_FC_706FWAAXX_4.tar.gz","82c0810e-8693-42ab-9bb5-2de5bdcaadfb",2151591816,"Illumina GA","ea0ff7713acc43fc21ca79fbb97931d9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:10:51.795373-05:00","2016-05-03T11:15:47.421196-05:00","82c0810e-8693-42ab-9bb5-2de5bdcaadfb_analysis.xml","49ae0c38417f1bd66d220ea736a8c790","d32bd0e2-61ab-40fa-9e18-3ead7a10dbd8",2121,"2016-09-29T17:40:14.189232-05:00","82c0810e-8693-42ab-9bb5-2de5bdcaadfb_experiment.xml","3958e7df7f6950007154fd3c0a4de8d4","0557ce8f-a83e-451a-a442-56bac63a068e",2257,"2016-09-29T22:11:33.683928-05:00","82c0810e-8693-42ab-9bb5-2de5bdcaadfb_run.xml","a8f6172405bd272f24b5691de2890d36","ae5062e8-bee4-433a-bbf9-0e06182a68a0",347,"2016-09-08T11:59:26.214992-05:00","TCGA-AP-A059","2016-09-02T18:49:19.888534-05:00","female","TCGA-AP-A059_demographic",1937,"white","18454974-897b-5a0c-8f4e-a15d6a2da0f9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A059_diagnosis","not reported",25311,"alive","8380/3",NA,1461,"465fd288-52d6-53c1-a237-9e067167a270","c54.1",-25311,"TCGA-AP-A059_treatment","acb7d17f-61c2-5616-a447-397eb297b65c","01","true","TCGA-AP-A059-01A",NA,"6d6c8e8b-3423-4380-a498-6cf5bc8b070b",FALSE,"29A150D3-D5F0-4222-B082-6ABE35A2BB46","Primary Tumor",NA,1476,230,NA,1291161600,"21",30,"TCGA-AP-A059-01A-21",60,50,0,0,0,0,1,1,"2016-09-08T11:59:26.214992-05:00","2016-09-08T11:59:26.214992-05:00",25,40,2,0,"TOP","BOTTOM",1,1,"e10d472c-daac-4893-8885-581a0af20ce3","7bba0166-2cb6-4d67-b584-fce022b56d7e","TCGA-AP-A059-01A-01-BS1","TCGA-AP-A059-01A-02-BS2",98,98,"4db1dfb6-0910-46d4-946f-a7bdf18ac24a","RNA","TCGA-AP-A059-01A-21R","bff658d6-d8af-49de-a226-bc9fb955887c",1.79,0.15,"UV Spec","R","23","TCGA-AP-A059-01A-21R-A118-07","1d8b3e3b-590d-4087-9506-d6b0b2bab9a9",0.15,NA,99,38.671875,160,"67db3b7c-ea05-5419-81d6-28c8b2a36862","TCGA-AP-A059_exposure","UNCID_2210679.1d8b3e3b-590d-4087-9506-d6b0b2bab9a9.110323_UNC3-RDR300156_00085_FC_706FWAAXX_4.tar.gz","2013-10-02T14:56:06.000Z","2013-10-02T15:15:03.000Z","82C0810E-8693-42AB-9BB5-2DE5BDCAADFB","6D6C8E8B-3423-4380-A498-6CF5BC8B070B","Unaligned reads",2151591816,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1D8B3E3B-590D-4087-9506-D6B0B2BAB9A9","University of North Carolina","56607ac2e4b0ec1099f8e1de","4549BFF6-6886-4102-A1DE-02691B664C52","Uterine Corpus Endometrial Carcinoma","TARGZ","4DB1DFB6-0910-46D4-946F-A7BDF18AC24A","2013-10-02T15:15:03.000Z","BFF658D6-D8AF-49DE-A226-BC9FB955887C","None","NO",1,NA,"Primary Tumor","MSKCC",1476,"4DB1DFB6-0910-46D4-946F-A7BDF18AC24A",NA,"AP","TCGA-AP-A059-01A-21R-A119-13.isoform.quantification.txt",230,"TCGA-AP-A059-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","6D6C8E8B-3423-4380-A498-6CF5BC8B070B",69,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F2B96570-CB63-4102-95C8-A42A6F59F620.txt","Alive",NA,"TCGA-AP-A059","NOT HISPANIC OR LATINO","57C8BCE7-5C31-438E-88DF-9AD1CDE085A8",NA,1461,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"EBBD127A-C3A7-40FB-8760-4F2026AA1516","WHITE",NA,21,30,"E10D472C-DAAC-4893-8885-581A0AF20CE3","81D319D5-2BD9-41BE-9ACB-5454520FF463","UNCID_597818.TCGA-AP-A059-01A-21R-A118-07.110323_UNC3-RDR300156_00085_FC_706FWAAXX.4.trimmed.annotated.translated_to_genomic.exon.quantification.txt","TCGA-AP-A059-01A-21",50,0,0,40,1,"BOTTOM",1,0,"TCGA-AP-A059-01A-02-BS2",98,NA,NA,NA,"TCGA-AP-A059-R6994","IMPLANTS","Primary Tumor Field",NA,NA,1461,"TUMOR FREE","Alive",NA,"TCGA-AP-A059-F6985","TCGA-AP-A059",1,"AP","A059","YES","C54.1","8380/3","C54.1","NO","YES",-25311,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1461,NA,NA,NA,"TUMOR FREE","NO",1,2,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
119187410,116103377,5536321483,"A34C537D-632D-4992-958D-5B85D190382C.bw","4557d1fb-9786-4780-bd33-02e9da04b7e3","a34c537d-632d-4992-958d-5b85d190382c","2016-08-25T22:50:44.311280-05:00","UNCID_2581741.ff8eb6f4-876e-4b08-8ed7-8c7930765bee.140416_UNC11-SN627_0352_AC3M6RACXX_7_AGTCAA.tar.gz","dae2b475-c5f4-4894-bf59-41eee6c14bc7",5371549057,"Illumina HiSeq","5be47040cf7c81da3f93f58bc52c918b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:45:32.536751-05:00","2016-05-03T11:55:56.226464-05:00","dae2b475-c5f4-4894-bf59-41eee6c14bc7_analysis.xml","a9ab0f802dcf8b274f413ff56142e542","9e4245ce-0dc7-4cbb-8970-98a709d91940",2124,"2016-10-07T16:17:20.643675-05:00","dae2b475-c5f4-4894-bf59-41eee6c14bc7_experiment.xml","46978a99cc6328f87e2974e290753946","b4e441ec-e954-4b71-a4b2-47a6929c364c",2628,"2016-09-29T19:25:37.709600-05:00","dae2b475-c5f4-4894-bf59-41eee6c14bc7_run.xml","2241fcd278bfa1c8f87c8d88314efd49","47d11a76-b5a9-48a9-8cf3-d12804cb7fd4",354,"2016-09-08T10:59:05.882088-05:00","TCGA-AJ-A8CV","2016-09-02T18:51:43.194772-05:00","female","TCGA-AJ-A8CV_demographic",1953,"black or african american","2a8d54bd-2634-51fc-86cf-c8e882f98f3b","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A8CV_diagnosis","not reported",21336,"alive","8380/3",NA,1068,"de2aacc8-38c0-5d11-ba43-f8971d5d018b","c54.1",-21336,"TCGA-AJ-A8CV_treatment","75d14244-c9f0-56cf-9117-9e956bab128c","01","false","TCGA-AJ-A8CV-01A",NA,"9388a1b3-fb16-4cfb-9359-b1a3fb7fb048",FALSE,"9A08EA28-EF0B-40CE-B2B4-0A0B0EE1EDA7","Primary Tumor",NA,966,30,NA,1384387200,"11",30,"TCGA-AJ-A8CV-01A-11",60,NA,5,NA,10,NA,30,NA,"2016-09-08T10:59:05.882088-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"ec36b936-b8b7-4ea9-9040-50173ca4a907",NA,"TCGA-AJ-A8CV-01A-01-TS1",NA,60,NA,"cf43f7e0-8d6e-4b0c-b79a-2158bd30daff","RNA","TCGA-AJ-A8CV-01A-11R","25614d16-fbef-404d-af38-2eca2174ab2f",1.91,0.15,"UV Spec","R","23","TCGA-AJ-A8CV-01A-11R-A37O-07","ff8eb6f4-876e-4b08-8ed7-8c7930765bee",0.15,NA,86,35.3385930309007,156,"975f1253-f4cb-506a-8e58-08ee4c050d11","TCGA-AJ-A8CV_exposure","UNCID_2581741.ff8eb6f4-876e-4b08-8ed7-8c7930765bee.140416_UNC11-SN627_0352_AC3M6RACXX_7_AGTCAA.tar.gz","2014-08-15T08:06:04.000Z","2014-08-15T08:24:18.000Z","DAE2B475-C5F4-4894-BF59-41EEE6C14BC7","9388A1B3-FB16-4CFB-9359-B1A3FB7FB048","Unaligned reads",5371549057,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","FF8EB6F4-876E-4B08-8ED7-8C7930765BEE","University of North Carolina","564a3a86e4b0ef12181a2965","4557D1FB-9786-4780-BD33-02E9DA04B7E3","Uterine Corpus Endometrial Carcinoma","TARGZ","CF43F7E0-8D6E-4B0C-B79A-2158BD30DAFF","2014-08-15T08:24:18.000Z","25614D16-FBEF-404D-AF38-2ECA2174AB2F","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",966,"CF43F7E0-8D6E-4B0C-B79A-2158BD30DAFF",NA,"AJ","6697a77a7ca43ea743fd357f35acacd1.bam",30,"TCGA-AJ-A8CV-01A",NA,NA,"TCGA",2011,"TCGA-AJ-A8CV_NTE-1","Complete Remission/Response","TUMOR FREE","CC4DD529-2AE4-46B9-90AB-D22BC89D65BF",58,"SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_F04_1465240.ismpolish.data.txt","Alive",NA,"TCGA-AJ-A8CV",NA,"0D4A64AE-3C55-439D-9DA2-C3512388ADC6","NO",71,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",381,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"EC36B936-B8B7-4EA9-9040-50173CA4A907","DFFC1C95-5218-4541-BFB7-64FA6B93AFB3","6697a77a7ca43ea743fd357f35acacd1.bam","TCGA-AJ-A8CV-01A-11",60,10,5,5,30,"TOP",0,0,"TCGA-AJ-A8CV-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A8CV-F65831_NTE-1","NO",1068,"TUMOR FREE","Alive",NA,"TCGA-AJ-A8CV-F65831","TCGA-AJ-A8CV",1,"AJ","A8CV","YES","C54.1","8380/3","C54.1","YES","NO",-21336,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",71,NA,NA,NA,"TUMOR FREE","YES",27,2,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2011,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29338518,29068252,2160065391,"F23B0A1A-25AE-41D9-8C49-B692C4FDE1E4.bw","45d58088-d3f4-4eb0-b75c-bcb98c0981dc","f23b0a1a-25ae-41d9-8c49-b692c4fde1e4","2016-08-09T14:16:40.270307-05:00","UNCID_2215208.4575ca5e-968c-419d-9707-4e99d55dddb7.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_3.tar.gz","e98a084a-8cf2-42dd-a4b7-40f3288261cb",1797030572,"Illumina GA","ccb8cd3aaa33e2ff64dffaf61843c21d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:25:55.064775-05:00","2016-05-03T11:17:59.899725-05:00","e98a084a-8cf2-42dd-a4b7-40f3288261cb_analysis.xml","21ef02c6a8af1d783b02d3298d7ac39b","922c9bf3-d683-494e-8cf7-9c132779e19c",2122,"2016-09-29T19:15:39.866384-05:00","e98a084a-8cf2-42dd-a4b7-40f3288261cb_experiment.xml","be6291f2634866d10293af964c31f2ee","418b5853-5b7e-4d74-bae0-236cd45d8415",2256,"2016-09-29T18:58:14.835509-05:00","e98a084a-8cf2-42dd-a4b7-40f3288261cb_run.xml","12518c7661a431383139d99877de38e3","369265ed-77ae-434e-a42a-7f10fc14cfb2",345,"2016-09-08T10:27:50.379010-05:00","TCGA-A5-A0G9","2016-09-02T18:53:58.617484-05:00","female","TCGA-A5-A0G9_demographic",1925,"white","22ddbd13-3b49-5a2d-a251-a5cbe4b96c39","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0G9_diagnosis","not reported",29122,"alive","8380/3",NA,2540,"9efcef0b-9ec0-570a-9836-92d8c0bb01e2","c54.1",-29122,"TCGA-A5-A0G9_treatment","847742d4-328a-5ade-bbb9-b37c937bb5b7","01","true","TCGA-A5-A0G9-01A",NA,"117a5b33-42c5-4a52-babe-d9712f3e7472",FALSE,"32FB682E-B73F-4525-A845-7F240F9F40CE","Primary Tumor",NA,2095,210,NA,1275955200,"11",30,"TCGA-A5-A0G9-01A-11",85,85,0,0,0,0,0,0,"2016-09-08T10:27:50.379010-05:00","2016-09-08T10:27:50.379010-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"646ceca1-d91f-4d55-bc90-15eafb5ef0aa","8c640a35-85a2-4b75-952e-90dc7bc16428","TCGA-A5-A0G9-01A-01-TS1","TCGA-A5-A0G9-01A-01-BS1",100,100,"5f02dce1-c4fb-4f40-90a1-94302e9f36ca","RNA","TCGA-A5-A0G9-01A-11R","6d1b1d7e-ea19-4f29-a74c-d2dbf3532480",1.85,0.14,"UV Spec","R","23","TCGA-A5-A0G9-01A-11R-A040-07","4575ca5e-968c-419d-9707-4e99d55dddb7",0.14,NA,82,27.7176852352623,172,"e620f837-6883-519d-acc2-2cec62a42f3b","TCGA-A5-A0G9_exposure","UNCID_2215208.4575ca5e-968c-419d-9707-4e99d55dddb7.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_3.tar.gz","2013-10-04T00:55:04.000Z","2013-10-04T01:08:03.000Z","E98A084A-8CF2-42DD-A4B7-40F3288261CB","117A5B33-42C5-4A52-BABE-D9712F3E7472","Unaligned reads",1797030572,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4575CA5E-968C-419D-9707-4E99D55DDDB7","University of North Carolina","566076d6e4b0b37b3d99086f","45D58088-D3F4-4EB0-B75C-BCB98C0981DC","Uterine Corpus Endometrial Carcinoma","TARGZ","5F02DCE1-C4FB-4F40-90A1-94302E9F36CA","2013-10-04T01:08:03.000Z","6D1B1D7E-EA19-4F29-A74C-D2DBF3532480","None","NO",1,NA,"Primary Tumor","Cedars Sinai",2095,"5F02DCE1-C4FB-4F40-90A1-94302E9F36CA",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.807AC87F-D82C-4F87-8014-4414E40D4A0B.txt",210,"TCGA-A5-A0G9-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","824F35BF-457F-4E24-90FB-4F2934263C69",79,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.807AC87F-D82C-4F87-8014-4414E40D4A0B.txt","Alive",NA,"TCGA-A5-A0G9",NA,"BF0D0575-C5CE-4BBF-B91D-F0D6C360CE9C",NA,2165,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"8C640A35-85A2-4B75-952E-90DC7BC16428","FEE1A840-62FC-46E5-8099-59BAE3AFCBC6","UNCID_2215208.4575ca5e-968c-419d-9707-4e99d55dddb7.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_3.tar.gz","TCGA-A5-A0G9-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-A5-A0G9-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,NA,NA,2165,"TUMOR FREE","Alive",NA,"TCGA-A5-A0G9-F3086","TCGA-A5-A0G9",1,"A5","A0G9","YES","C54.1","8380/3","C54.1","NO","YES",-29122,"FEMALE","WHITE",NA,"No","No","Alive",2165,NA,NA,NA,"TUMOR FREE","NO",10,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,79,2004,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34944989,34673437,2614412518,"245967F0-EE1A-4B0C-BEE2-0283393DA722.bw","45effb44-0b5f-4081-a202-d85969c72f2b","245967f0-ee1a-4b0c-bee2-0283393da722","2016-08-09T14:03:12.999329-05:00","UNCID_2194494.3aba63fa-86d2-4ca9-b064-fe782a749161.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_1.tar.gz","f7e127f7-ecdb-40fd-bb20-2d703978f3d3",2239686526,"Illumina GA","4a04a7e453c20313fda60392299d0e6b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:38:04.751885-05:00","2016-05-03T11:07:49.533431-05:00","f7e127f7-ecdb-40fd-bb20-2d703978f3d3_analysis.xml","a422e3ebbd2d0af893ecc31ff14af9c7","03f5551f-a0a3-4684-9df1-b087d3ef525b",2122,"2016-09-29T19:35:01.333887-05:00","f7e127f7-ecdb-40fd-bb20-2d703978f3d3_experiment.xml","d61eaf651eea5b26e38fcf2522e76c2d","4da2d01c-9314-4362-8f05-c32246084614",2258,"2016-09-29T23:04:57.232203-05:00","f7e127f7-ecdb-40fd-bb20-2d703978f3d3_run.xml","6d62ed00952c31149b559a9898290473","cf5e69df-1bf9-4509-a145-dbd4a84e053c",349,"2016-09-08T11:39:00.239919-05:00","TCGA-AX-A1CK","2016-09-02T18:51:43.286787-05:00","female","TCGA-AX-A1CK_demographic",1947,"white","64bf5f32-7f0d-5ea2-80c1-8fc679a3de3b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CK_diagnosis","not reported",21200,"alive","8380/3",NA,2441,"5c32ec46-1a26-57af-ae73-42b96cd3a53d","c54.1",-21200,"TCGA-AX-A1CK_treatment","84d4a50f-57d8-543e-96de-b14d52a21af7","11","false","TCGA-AX-A1CK-11A",NA,"03680874-bc46-4805-9a01-f02a24a46948",FALSE,NA,"Solid Tissue Normal",NA,2115,100,NA,1295308800,"11",30,"TCGA-AX-A1CK-11A-11",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T11:39:00.239919-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"dfdccf13-762b-4c70-8233-2c524d10d681",NA,"TCGA-AX-A1CK-11A-01-TS1",NA,0,NA,"67dec63b-a84b-4828-83b1-f74e5c3f2e7a","RNA","TCGA-AX-A1CK-11A-11R","fd39c26b-b60b-4078-8a74-2906f6fad543",1.89,0.16,"UV Spec","R","23","TCGA-AX-A1CK-11A-11R-A137-07","3aba63fa-86d2-4ca9-b064-fe782a749161",0.16,NA,72,27.0992510068124,163,"fd7c70eb-a52b-5f34-83f0-777da3cb5c2b","TCGA-AX-A1CK_exposure","UNCID_2194494.3aba63fa-86d2-4ca9-b064-fe782a749161.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_1.tar.gz","2013-09-22T23:46:03.000Z","2013-09-22T23:59:02.000Z","F7E127F7-ECDB-40FD-BB20-2D703978F3D3","03680874-BC46-4805-9A01-F02A24A46948","Unaligned reads",2239686526,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3ABA63FA-86D2-4CA9-B064-FE782A749161","University of North Carolina","56607874e4b0ca319164ebf8","45EFFB44-0B5F-4081-A202-D85969C72F2B","Uterine Corpus Endometrial Carcinoma","TARGZ","67DEC63B-A84B-4828-83B1-F74E5C3F2E7A","2013-09-22T23:59:02.000Z","FD39C26B-B60B-4078-8A74-2906F6FAD543","None","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",2115,"67DEC63B-A84B-4828-83B1-F74E5C3F2E7A",NA,"AX","UNCID_2194494.3aba63fa-86d2-4ca9-b064-fe782a749161.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_1.tar.gz",100,"TCGA-AX-A1CK-11A",NA,"13B73BD6-A192-43A9-B501-78E1BF2623AE","TCGA",2005,NA,NA,NA,"7028EC96-26A1-4EC7-A044-9B263E50CA8D",58,"nationwidechildrens.org_clinical.TCGA-AX-A1CK.xml","Alive",NA,"TCGA-AX-A1CK","NOT HISPANIC OR LATINO",NA,NA,2053,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"DFDCCF13-762B-4C70-8233-2C524D10D681","FD39C26B-B60B-4078-8A74-2906F6FAD543","UNCID_2194494.3aba63fa-86d2-4ca9-b064-fe782a749161.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_1.tar.gz","TCGA-AX-A1CK-11A-11",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-AX-A1CK-11A-01-TS1",0,"Megace","Hormone Therapy","TCGA-AX-A1CK-D10306",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-AX-A1CK",1,"AX","A1CK","YES","C54.1","8380/3","C54.1","NO","YES",-21200,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2053,NA,NA,NA,NA,"NO",10,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2005,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36478021,35969998,2650714036,"899D9D68-F1BD-4ECD-ABAA-48488672A407.bw","46a1fdb9-548d-44d1-ab77-d51d44ac8198","899d9d68-f1bd-4ecd-abaa-48488672a407","2016-08-09T14:07:59.949266-05:00","UNCID_2206596.941d70e7-2ac8-4809-baa4-7752df3c2ee3.110928_UNC6-RDR300211_00126_FC_6348UAAXX_4.tar.gz","b8ded1b6-d565-42a6-abc9-21ae63a7642a",2423554334,"Illumina GA","10925ea4657d339a852f6239143b9a74","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:27:40.013888-05:00","2016-05-03T11:11:34.779998-05:00","b8ded1b6-d565-42a6-abc9-21ae63a7642a_analysis.xml","d69156813a96d1144462023ebc4c3886","2334b91d-98f2-4c76-9ecd-9441c75f1584",2121,"2016-09-29T23:40:17.996671-05:00","b8ded1b6-d565-42a6-abc9-21ae63a7642a_experiment.xml","46f2705f9d81439cba44f9cea2d59890","e56981bb-88fc-404d-b15f-7d99379cfba3",2257,"2016-09-30T00:13:06.871589-05:00","b8ded1b6-d565-42a6-abc9-21ae63a7642a_run.xml","0242ffbbac50b5f88589cdc9aa48292c","f9a58523-6369-4dee-9e87-904b314d5b65",347,"2016-09-08T10:29:56.542979-05:00","TCGA-FI-A2D2","2016-09-02T18:52:54.895787-05:00","female","TCGA-FI-A2D2_demographic",1942,"white","eba1519c-68e7-55ca-b7cb-8d2133a25108","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2D2_diagnosis","not reported",24260,"dead","8441/3",2352,1215,"d4f21a6a-c973-5e3b-8577-7ae13dc8940b","c54.1",-24260,"TCGA-FI-A2D2_treatment","6bbd9db0-e25d-5db8-b5a1-3fa7aa9c898b","01","true","TCGA-FI-A2D2-01A",NA,"88f8998f-3d6a-4f9d-8b82-3250d26f5065",FALSE,"75FB8F31-5C30-48C2-B4A5-2DA184DC039C","Primary Tumor",NA,975,70,NA,1308700800,"11",30,"TCGA-FI-A2D2-01A-11",98,NA,5,NA,0,NA,2,NA,"2016-09-08T10:29:56.542979-05:00",NA,5,NA,5,NA,"TOP",NA,2,NA,"20aa144e-37b9-4758-86e8-5ea6e409ce1d",NA,"TCGA-FI-A2D2-01A-01-TS1",NA,96,NA,"fb6cd920-0c8b-4726-b271-725cce48d973","RNA","TCGA-FI-A2D2-01A-11R","c9233516-26d9-4230-9b72-2512aedc6ca3",1.95,0.16,"UV Spec","R","23","TCGA-FI-A2D2-01A-11R-A17B-07","941d70e7-2ac8-4809-baa4-7752df3c2ee3",0.16,NA,166,58.8151927437642,168,"cceaba09-e187-5318-9464-f2d37f675654","TCGA-FI-A2D2_exposure","UNCID_2206596.941d70e7-2ac8-4809-baa4-7752df3c2ee3.110928_UNC6-RDR300211_00126_FC_6348UAAXX_4.tar.gz","2013-09-27T12:06:07.000Z","2013-09-27T12:19:02.000Z","B8DED1B6-D565-42A6-ABC9-21AE63A7642A","88F8998F-3D6A-4F9D-8B82-3250D26F5065","Unaligned reads",2423554334,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","941D70E7-2AC8-4809-BAA4-7752DF3C2EE3","University of North Carolina","564a37dce4b093830b68229b","46A1FDB9-548D-44D1-AB77-D51D44AC8198","Uterine Corpus Endometrial Carcinoma","TARGZ","FB6CD920-0C8B-4726-B271-725CCE48D973","2013-09-27T12:19:02.000Z","C9233516-26D9-4230-9B72-2512AEDC6CA3","United States","NO",1,NA,"Primary Tumor","Washington University",975,"FB6CD920-0C8B-4726-B271-725CCE48D973",NA,"FI","15c15000acf365d3e823e0828ed63855.bam",70,"TCGA-FI-A2D2-01A",NA,"1ABE5B06-85E2-4848-91D4-A94B3BE8D219","TCGA",2008,NA,NA,"TUMOR FREE","E23D6DDC-1112-4C82-9A4E-48528197A818",66,"nationwidechildrens.org_clinical.TCGA-FI-A2D2.xml","Alive",NA,"TCGA-FI-A2D2","NOT HISPANIC OR LATINO","29398CE2-2703-4D7B-A2FE-D035F581DB73",NA,1095,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"20AA144E-37B9-4758-86E8-5EA6E409CE1D","5A184ABE-979B-4BFF-B200-7313DEE8577E","15c15000acf365d3e823e0828ed63855.bam","TCGA-FI-A2D2-01A-11",98,0,5,5,2,"TOP",2,5,"TCGA-FI-A2D2-01A-01-TS1",96,"carboplatinum","Chemotherapy","TCGA-FI-A2D2-D31805",NA,NA,NA,NA,"NO",1215,"TUMOR FREE","Alive",NA,"TCGA-FI-A2D2-F31732","TCGA-FI-A2D2",1,"FI","A2D2","YES","C54.1","8441/3","C54.1","NO","YES",-24260,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1095,NA,NA,NA,"TUMOR FREE","NO",27,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,66,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35528034,35292950,2641589666,"FA8E73EA-649C-43ED-854E-B9472820D1C6.bw","46e064cc-933b-444b-9e15-80fadbc53487","fa8e73ea-649c-43ed-854e-b9472820d1c6","2016-08-09T14:05:14.824769-05:00","UNCID_2196683.05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2.120216_UNC2-RDR300275_00113_FC_650PDAAXX_4.tar.gz","8a010470-2c99-4e15-accb-eacaaad9ac00",2294342372,"Illumina GA","0d22ad00f48f3c542b04c9d974581bec","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:01:48.997631-05:00","2016-05-03T11:08:33.743897-05:00","8a010470-2c99-4e15-accb-eacaaad9ac00_analysis.xml","aea2e73bb6a97648d67b60879ef7a93b","83202db2-2c28-4f97-8975-ece63a8f46d3",2119,"2016-09-29T19:44:57.940292-05:00","8a010470-2c99-4e15-accb-eacaaad9ac00_experiment.xml","9e90adf84a520a6653bc8e6d61407805","53c95f52-5754-4716-8344-65c2145706b1",2257,"2016-09-29T17:37:36.117043-05:00","8a010470-2c99-4e15-accb-eacaaad9ac00_run.xml","97c315b3dccd3e35ce8e480a295ef5b3","03a31b59-3a93-4512-80e6-02996d4fae67",347,"2016-09-08T11:02:30.860005-05:00","TCGA-DF-A2KS","2016-09-02T18:54:17.640062-05:00","female","TCGA-DF-A2KS_demographic",NA,"not reported","e6364172-46ac-520d-af07-f1d3d5bedeb9","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DF","bd439172-ab1d-57cc-a1ee-7282ceebd41a","Ontario Institute for Cancer Research","not reported","c54.1","TCGA-DF-A2KS_diagnosis","not reported",25313,"alive","8380/3",NA,3318,"ab2d1531-0ac6-5197-9585-ee8cd6beb3b6","c54.1",-25313,"TCGA-DF-A2KS_treatment","e69b49da-4c68-5663-bc0e-a86af502a5ef","01","false","TCGA-DF-A2KS-01A",NA,"0e438d6a-52a7-473f-bb85-7805d63df150",FALSE,"C6638C17-4F05-491F-86ED-6D7DDB1B8FDE","Primary Tumor",NA,NA,120,NA,1313452800,"11",30,"TCGA-DF-A2KS-01A-11",95,NA,3,NA,0,NA,5,NA,"2016-09-08T11:02:30.860005-05:00",NA,5,NA,8,NA,"TOP",NA,20,NA,"6b888cc3-daeb-4320-a03a-e7b2c9eb047e",NA,"TCGA-DF-A2KS-01A-01-TS1",NA,75,NA,"2035248e-fabb-4943-99bf-707e6bde1091","RNA","TCGA-DF-A2KS-01A-11R","df0adcb3-d2b1-40e4-9a0d-996dd3ce6789",1.79,0.17,"UV Spec","R","23","TCGA-DF-A2KS-01A-11R-A18M-07","05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2",0.17,NA,66,NA,NA,"cca6be82-44f2-52e1-9eb5-7fba21d3e957","TCGA-DF-A2KS_exposure","UNCID_2196683.05a3cad5-b1a2-481d-a2b7-f0e80ec78ed2.120216_UNC2-RDR300275_00113_FC_650PDAAXX_4.tar.gz","2013-09-23T20:13:04.000Z","2013-09-23T20:26:01.000Z","8A010470-2C99-4E15-ACCB-EACAAAD9AC00","0E438D6A-52A7-473F-BB85-7805D63DF150","Unaligned reads",2294342372,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","05A3CAD5-B1A2-481D-A2B7-F0E80EC78ED2","University of North Carolina","5660751ee4b016715ab67e70","46E064CC-933B-444B-9E15-80FADBC53487","Uterine Corpus Endometrial Carcinoma","TARGZ","2035248E-FABB-4943-99BF-707E6BDE1091","2013-09-23T20:26:01.000Z","DF0ADCB3-D2B1-40E4-9A0D-996DD3CE6789","None","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"2035248E-FABB-4943-99BF-707E6BDE1091",NA,"DF","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.905BD3B7-05F2-4DE8-B4A2-4D839BC28908.txt",120,"TCGA-DF-A2KS-01A",NA,NA,"TCGA",NA,NA,NA,NA,"85321353-AB6C-404A-98BF-6438DA116895",NA,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.905BD3B7-05F2-4DE8-B4A2-4D839BC28908.txt",NA,NA,"TCGA-DF-A2KS",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,178,NA,NA,NA,NA,11,30,"6B888CC3-DAEB-4320-A03A-E7B2C9EB047E","EA43F25A-5C14-4E80-A110-BA51051481D8","TCGA-DF-A2KS-01A-11D_4-4-13-MSI-115_2013-04-04.fsa","TCGA-DF-A2KS-01A-11",95,0,3,5,5,"TOP",20,8,"TCGA-DF-A2KS-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-DF-A2KS",1,"DF","A2KS","YES","C54.1","8380/3","C54.1","NO","YES",-25313,"FEMALE",NA,NA,"No","No","Alive",2188,NA,"YES","NO","TUMOR FREE","NO",15,10,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,NA,69,NA,"Other method, specify:",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
104083898,100432425,4785310696,"1FBD0805-13AE-4A82-8B94-640E1C921262.bw","47c49c54-95f8-42c8-94e4-411280452512","1fbd0805-13ae-4a82-8b94-640e1c921262","2016-08-05T02:05:36.217418-05:00","UNCID_2173841.ba70deb1-e8c2-4f74-9883-46e7095f677d.130503_UNC9-SN296_0361_AC23VLACXX_3_GATCAG.tar.gz","6247927d-7eeb-4603-9f16-9de0b67cf8c5",4989952914,"Illumina HiSeq","c48302c827f0255fff574a49ea232050","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:42:43.358796-05:00","2016-05-03T10:56:47.870562-05:00","6247927d-7eeb-4603-9f16-9de0b67cf8c5_analysis.xml","98f8bf7d6b7826e70b87ce31ab64e355","06f6e2dd-c156-44af-bb6d-07fcdd66589b",2121,"2016-09-29T20:19:40.847901-05:00","6247927d-7eeb-4603-9f16-9de0b67cf8c5_experiment.xml","1f37896759debfaac9eec9628d74390c","6900d221-c034-467c-b27f-faaaa33f81e8",2431,"2016-09-29T18:53:34.145460-05:00","6247927d-7eeb-4603-9f16-9de0b67cf8c5_run.xml","489bec1d30083c6fceb3b2331ab0930f","339faa34-fd64-4673-8e47-11282cd4ac9f",354,"2016-09-08T11:32:17.601852-05:00","TCGA-FL-A1YH",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YH-11A",NA,"0e9c603f-5ec6-4fd7-87bb-bce23ca2c042",FALSE,"F49FD879-727C-4F5E-B4B8-6FE59B4C05FF","Solid Tissue Normal",NA,NA,310,NA,1302480000,"11",30,"TCGA-FL-A1YH-11A-11",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T11:32:17.601852-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"a2a056a5-8da6-45c1-b2fe-a8e3c8e0a4d0",NA,"TCGA-FL-A1YH-11A-01-TSA",NA,0,NA,"32f8c84c-73c9-4301-9e1a-7add1fe13f3e","RNA","TCGA-FL-A1YH-11A-11R","7539db96-fcea-4ce0-a6f9-f732e249a973",1.72,0.16,"UV Spec","R","23","TCGA-FL-A1YH-11A-11R-A16F-07","ba70deb1-e8c2-4f74-9883-46e7095f677d",0.16,NA,NA,NA,NA,NA,NA,"UNCID_2173841.ba70deb1-e8c2-4f74-9883-46e7095f677d.130503_UNC9-SN296_0361_AC23VLACXX_3_GATCAG.tar.gz","2013-09-10T01:51:05.000Z","2013-09-10T02:05:01.000Z","6247927D-7EEB-4603-9F16-9DE0B67CF8C5","0E9C603F-5EC6-4FD7-87BB-BCE23CA2C042","Unaligned reads",4989952914,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","BA70DEB1-E8C2-4F74-9883-46E7095F677D","University of North Carolina","564a3d6de4b0ef12181b1546","47C49C54-95F8-42C8-94E4-411280452512","Uterine Corpus Endometrial Carcinoma","TARGZ","32F8C84C-73C9-4301-9E1A-7ADD1FE13F3E","2013-09-10T02:05:01.000Z","7539DB96-FCEA-4CE0-A6F9-F732E249A973","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"32F8C84C-73C9-4301-9E1A-7ADD1FE13F3E",NA,"FL","UNCID_2033716.ba70deb1-e8c2-4f74-9883-46e7095f677d.sorted_genome_alignments.bam.bai",310,"TCGA-FL-A1YH-11A",NA,NA,"TCGA",NA,NA,NA,NA,"0E9C603F-5EC6-4FD7-87BB-BCE23CA2C042",NA,"UNCID_2033716.ba70deb1-e8c2-4f74-9883-46e7095f677d.sorted_genome_alignments.bam.bai",NA,NA,"TCGA-FL-A1YH",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,143,NA,NA,NA,NA,11,30,"A2A056A5-8DA6-45C1-B2FE-A8E3C8E0A4D0","D6B33FA4-A710-48F0-8120-75E0ACA85B9D","UNCID_2033716.ba70deb1-e8c2-4f74-9883-46e7095f677d.sorted_genome_alignments.bam.bai","TCGA-FL-A1YH-11A-11",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YH-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
31775748,31445963,2318275111,"C7997523-47CF-40F0-8803-AB873E38033C.bw","4806d9a6-e65d-4a82-b422-1b287980a0c6","c7997523-47cf-40f0-8803-ab873e38033c","2016-08-09T14:16:24.061591-05:00","UNCID_2215217.a7ed680c-2af2-47a1-846a-2169f7dd0971.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_2.tar.gz","a4e69780-6f18-4f09-9840-37af72935d7d",1956801524,"Illumina GA","67be5e07cbbd57e0ab09084ca6b07e44","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:51:35.895987-05:00","2016-05-03T11:17:59.918704-05:00","a4e69780-6f18-4f09-9840-37af72935d7d_analysis.xml","2f53be46dd0b7a4524ce0d5356b29b81","7cbd0d2b-68d6-4cd9-a837-6a5f7962a17d",2122,"2016-09-29T17:51:48.546072-05:00","a4e69780-6f18-4f09-9840-37af72935d7d_experiment.xml","f7c00b9733f0b0db12010fe28058e2d9","0cd25d1d-b257-4b44-b75d-3e94cb62e754",2256,"2016-09-29T20:27:48.744191-05:00","a4e69780-6f18-4f09-9840-37af72935d7d_run.xml","68d3a85adf5338b7c2ca87ed3653081c","6e14b808-3852-439c-bef1-b53508f7cede",345,"2016-09-08T11:08:22.340375-05:00","TCGA-A5-A0G5","2016-09-02T18:53:57.898395-05:00","female","TCGA-A5-A0G5_demographic",1935,"black or african american","8de932fa-c5e3-5a52-b36c-7989aee3737b","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0G5_diagnosis","not reported",26827,"alive","8310/3",NA,1126,"441b699d-7cc8-5b83-b985-f773df3101d5","c54.1",-26827,"TCGA-A5-A0G5_treatment","ecfdbad7-38fe-5b2b-bf45-864601a0f756","01","true","TCGA-A5-A0G5-01A",NA,"fa7392e8-335e-4465-9272-4a19dc99412e",FALSE,"C7C6ABB1-32EE-4D2B-898A-91A1F596EC53","Primary Tumor",NA,856,240,NA,1275609600,"11",30,"TCGA-A5-A0G5-01A-11",75,80,3,3,0,0,0,0,"2016-09-08T11:08:22.340375-05:00","2016-09-08T11:08:22.340375-05:00",20,15,0,0,"BOTTOM","TOP",0,5,"79fd5a38-82c7-4e63-8c0b-12f8de4fa780","64651390-974d-471f-81b1-6b938cfdf448","TCGA-A5-A0G5-01A-01-BS1","TCGA-A5-A0G5-01A-01-TS1",100,95,"d207c224-8fa0-498e-966d-591cd06401c4","RNA","TCGA-A5-A0G5-01A-11R","63d0edf2-0cc6-47b2-8bd1-0ad6e9f806ba",1.86,0.17,"UV Spec","R","23","TCGA-A5-A0G5-01A-11R-A040-07","a7ed680c-2af2-47a1-846a-2169f7dd0971",0.17,NA,48,18.75,160,"c208c176-cbf2-5994-b4b5-e39d2b9a6608","TCGA-A5-A0G5_exposure","UNCID_2215217.a7ed680c-2af2-47a1-846a-2169f7dd0971.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_2.tar.gz","2013-10-04T01:07:04.000Z","2013-10-04T01:19:03.000Z","A4E69780-6F18-4F09-9840-37AF72935D7D","FA7392E8-335E-4465-9272-4A19DC99412E","Unaligned reads",1956801524,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A7ED680C-2AF2-47A1-846A-2169F7DD0971","University of North Carolina","564a3610e4b0298dd2c6b150","4806D9A6-E65D-4A82-B422-1B287980A0C6","Uterine Corpus Endometrial Carcinoma","TARGZ","D207C224-8FA0-498E-966D-591CD06401C4","2013-10-04T01:19:03.000Z","63D0EDF2-0CC6-47B2-8BD1-0AD6E9F806BA","None","NO",1,NA,"Primary Tumor","Cedars Sinai",856,"D207C224-8FA0-498E-966D-591CD06401C4",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.105C061D-B8CC-4224-BA49-BBB94112091E.txt",240,"TCGA-A5-A0G5-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","FA7392E8-335E-4465-9272-4A19DC99412E",73,"nationwidechildrens.org_clinical.TCGA-A5-A0G5.xml","Alive",NA,"TCGA-A5-A0G5",NA,"F13F5095-D221-44E4-A3A4-742FEFB22D75",NA,790,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8310/3","FEMALE","C54.1",59,NA,"60C0961D-D0ED-4B4B-A519-EAB7BA574949","BLACK OR AFRICAN AMERICAN",NA,11,30,"79FD5A38-82C7-4E63-8C0B-12F8DE4FA780","D91E9684-8F0C-4488-8819-88B334AFE9A4","TCGA-A5-A0G5-01A-11W-A062-09_IlluminaGA-DNASeq_exome_1.bam.bai","TCGA-A5-A0G5-01A-11",75,0,3,20,0,"BOTTOM",0,0,"TCGA-A5-A0G5-01A-01-BS1",100,NA,NA,NA,"TCGA-A5-A0G5-R4419","EXTERNAL BEAM","Primary Tumor Field",NA,NA,790,"TUMOR FREE","Alive",NA,"TCGA-A5-A0G5-F4418","TCGA-A5-A0G5",1,"A5","A0G5","YES","C54.1","8310/3","C54.1","NO","YES",-26827,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",790,NA,NA,NA,"TUMOR FREE","NO",13,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,73,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
134468786,132417378,6317132358,"6359485C-2C6C-4D67-9C16-D76B06587391.bw","4846cb23-d7e7-47f4-972f-3abe229f7bdb","6359485c-2c6c-4d67-9c16-d76b06587391","2016-08-05T08:18:13.006727-05:00","UNCID_2173419.f579f0dc-d6e3-4960-9769-5038e69aa712.130502_UNC12-SN629_0289_AC236KACXX_6_CCGTCC.tar.gz","e90a581a-60e0-441c-8159-9f6cf5ba4c2e",6495079429,"Illumina HiSeq","7014ab695648d13ad7c5586a1c795afb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:58:28.380904-05:00","2016-05-03T10:55:55.610281-05:00","e90a581a-60e0-441c-8159-9f6cf5ba4c2e_analysis.xml","f8193b373cac015766bec27dc69065c7","36b53938-0f2f-457d-8043-cdd61485f9f9",2123,"2016-09-29T20:47:17.867112-05:00","e90a581a-60e0-441c-8159-9f6cf5ba4c2e_experiment.xml","5828c57207c072f2f480c736d8052cd4","7a04abcb-f056-4843-814b-60a33fbf0f67",2431,"2016-09-29T21:47:53.428243-05:00","e90a581a-60e0-441c-8159-9f6cf5ba4c2e_run.xml","93c8ae64c4a32bb970f4fc4f9af45f30","9fb884c6-e585-48d4-a574-804f7bbb1e52",354,"2016-09-08T11:18:35.258934-05:00","TCGA-D1-A3JP","2016-09-02T18:49:25.522792-05:00","female","TCGA-D1-A3JP_demographic",1950,"white","4c77a875-5eef-5480-b468-2ba87b6173ea","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A3JP_diagnosis","not reported",22538,"alive","8441/3",NA,515,"7f1cd09a-dbb3-551c-a67d-4f353409f807","c54.1",-22538,"TCGA-D1-A3JP_treatment","81dee702-5f57-5326-8857-fc80b738e1e9","01","true","TCGA-D1-A3JP-01A",NA,"29a581ed-3dca-4a65-ab6b-5a9656674f92",FALSE,"62290E86-409F-4590-AA2C-D3D2F77148FF","Primary Tumor",NA,101,170,NA,1325721600,"31",20,"TCGA-D1-A3JP-01A-31",60,NA,0,NA,0,NA,0,NA,"2016-09-08T11:18:35.258934-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"22aedcb8-b8d6-4e48-a7fa-eb136726eb06",NA,"TCGA-D1-A3JP-01A-03-TSC",NA,100,NA,"21edbd0a-0969-4838-b109-1161bcb2c517","RNA","TCGA-D1-A3JP-01A-31R","5209dfb0-4fcf-4151-9533-2313023c7df7",1.8,0.17,"UV Spec","R","23","TCGA-D1-A3JP-01A-31R-A22K-07","f579f0dc-d6e3-4960-9769-5038e69aa712",0.17,NA,59,23.3376844270401,159,"9eb18dc5-7c7b-5f04-b06b-f43ca73b9d65","TCGA-D1-A3JP_exposure","UNCID_2173419.f579f0dc-d6e3-4960-9769-5038e69aa712.130502_UNC12-SN629_0289_AC236KACXX_6_CCGTCC.tar.gz","2013-09-09T18:36:09.000Z","2013-09-09T18:52:01.000Z","E90A581A-60E0-441C-8159-9F6CF5BA4C2E","29A581ED-3DCA-4A65-AB6B-5A9656674F92","Unaligned reads",6495079429,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","F579F0DC-D6E3-4960-9769-5038E69AA712","University of North Carolina","56607c7de4b0b37b3d9927eb","4846CB23-D7E7-47F4-972F-3ABE229F7BDB","Uterine Corpus Endometrial Carcinoma","TARGZ","21EDBD0A-0969-4838-B109-1161BCB2C517","2013-09-09T18:52:01.000Z","5209DFB0-4FCF-4151-9533-2313023C7DF7","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",101,"21EDBD0A-0969-4838-B109-1161BCB2C517",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.881675F5-0526-4D86-B58F-40868B7B36B1.txt",170,"TCGA-D1-A3JP-01A",NA,NA,"TCGA",2011,"TCGA-D1-A3JP_NTE-1","Partial Remission/Response","TUMOR FREE","616A6540-7AE9-4EED-ACCD-85E8EC2C1ADC",61,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.881675F5-0526-4D86-B58F-40868B7B36B1.txt","Alive",NA,"TCGA-D1-A3JP","NOT HISPANIC OR LATINO",NA,"NO",515,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,31,20,"22AEDCB8-B8D6-4E48-A7FA-EB136726EB06","AF02DA89-2122-4951-9706-A678F8196A9C","8597ffe710e2a247a3d6dc8ded403805.bam.bai","TCGA-D1-A3JP-01A-31",60,0,0,0,0,"TOP",0,0,"TCGA-D1-A3JP-01A-03-TSC",100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-D1-A3JP",1,"D1","A3JP","YES","C54.1","8441/3","C54.1","NO","YES",-22538,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",515,NA,"YES","NO","TUMOR FREE","YES",20,3,2013,"NO","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,61,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Partial Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33129124,32100993,2396727035,"F244B7C9-5521-42F5-B1B9-6DDF412D5FCA.bw","48ab48a5-30e7-4f2e-8d0f-9bad7b8dc7db","f244b7c9-5521-42f5-b1b9-6ddf412d5fca","2016-08-05T02:59:56.025779-05:00","UNCID_2188979.9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_8.tar.gz","7a74278b-8204-4e01-804e-a45f9869051b",2072261363,"Illumina GA","6fcc4b8690cb1f62efb4998d06788edb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:23:49.813494-05:00","2016-05-03T11:05:01.518052-05:00","7a74278b-8204-4e01-804e-a45f9869051b_analysis.xml","655750aa8b845071b2a40754ae5c155c","db0e1ca7-c57a-412b-a213-a031c711c34a",2121,"2016-09-29T23:33:54.637456-05:00","7a74278b-8204-4e01-804e-a45f9869051b_experiment.xml","ff1c9b7c3245b84fe5d601b259754f23","e177441a-10a2-49cb-adcd-04688567efe8",2258,"2016-09-29T19:42:59.335322-05:00","7a74278b-8204-4e01-804e-a45f9869051b_run.xml","a00f3de7dd4fc6ed610ace7f8895a56b","528f0da2-1e51-408b-a8d8-d1a76bc7994e",349,"2016-09-08T10:51:27.433495-05:00","TCGA-EY-A215","2016-09-02T18:52:35.518635-05:00","female","TCGA-EY-A215_demographic",1950,"white","42256e3f-852f-5914-8b38-744378ef0cac","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A215_diagnosis","not reported",22076,"alive","8380/3",NA,574,"c0ab32b5-4c54-544a-9657-6efd97264221","c54.1",-22076,"TCGA-EY-A215_treatment","ed0a5ef1-8e27-595b-b379-323f7ea2c86b","01","false","TCGA-EY-A215-01A",NA,"4d692dbb-bbd7-429b-894e-ccb215ca41cc",FALSE,"C0F970E3-E534-4A34-B87A-4383FD261B53","Primary Tumor",NA,293,210,NA,1302566400,"11",30,"TCGA-EY-A215-01A-11",80,NA,40,NA,0,NA,10,NA,"2016-09-08T10:51:27.433495-05:00",NA,40,NA,10,NA,"TOP",NA,10,NA,"514d2f15-a2b6-4a9b-82a0-91905bab780a",NA,"TCGA-EY-A215-01A-01-TS1",NA,80,NA,"35dd2b5b-80fe-4f41-9bf1-e3878cd4cfbe","RNA","TCGA-EY-A215-01A-11R","32add62d-9842-4da5-8158-1d61b8bb45db",1.77,0.16,"UV Spec","R","23","TCGA-EY-A215-01A-11R-A14M-07","9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab",0.16,NA,49,17.3611111111111,168,"8a8b311e-b801-5651-b8a5-e00d87bfd032","TCGA-EY-A215_exposure","UNCID_2188979.9ea0e44d-a6c8-4e54-9e1f-ebdb82d0c5ab.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_8.tar.gz","2013-09-18T13:46:06.000Z","2013-09-18T13:58:02.000Z","7A74278B-8204-4E01-804E-A45F9869051B","4D692DBB-BBD7-429B-894E-CCB215CA41CC","Unaligned reads",2072261363,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","9EA0E44D-A6C8-4E54-9E1F-EBDB82D0C5AB","University of North Carolina","564a3b3de4b0298dd2c85ab8","48AB48A5-30E7-4F2E-8D0F-9BAD7B8DC7DB","Uterine Corpus Endometrial Carcinoma","TARGZ","35DD2B5B-80FE-4F41-9BF1-E3878CD4CFBE","2013-09-18T13:58:02.000Z","32ADD62D-9842-4DA5-8158-1D61B8BB45DB","United States","NO",1,NA,"Primary Tumor","University of North Carolina",293,"35DD2B5B-80FE-4F41-9BF1-E3878CD4CFBE",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.10A2C6D4-0F10-43F9-A5DD-9A61D34FA5B6.txt",210,"TCGA-EY-A215-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","4D692DBB-BBD7-429B-894E-CCB215CA41CC",60,"nationwidechildrens.org_clinical.TCGA-EY-A215.xml","Alive",NA,"TCGA-EY-A215","NOT HISPANIC OR LATINO","F2277409-0272-4331-8C66-F909C5ADDD3F",NA,391,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",125,NA,"044B2AC5-71F7-42DB-BB3D-2418D441E6A3","WHITE",NA,11,30,"514D2F15-A2B6-4A9B-82A0-91905BAB780A","F12904A1-06AB-4423-8FC5-501DF992ED32","CABAL_p_TCGA_b112_125_SNP_N_GenomeWideSNP_6_D11_780708.raw.copynumber.data.txt","TCGA-EY-A215-01A-11",80,0,40,40,10,"TOP",10,10,"TCGA-EY-A215-01A-01-TS1",80,NA,NA,NA,"TCGA-EY-A215-R13690","IMPLANTS","Regional site",NA,"NO",574,"TUMOR FREE","Alive",NA,"TCGA-EY-A215-F21735","TCGA-EY-A215",1,"EY","A215","YES","C54.1","8380/3","C54.1","YES","NO",-22076,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",391,NA,NA,NA,"TUMOR FREE","NO",8,7,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32144700,31794537,2385763158,"3B6A962A-09FF-487D-9F61-F7F9289FCBF7.bw","490ae247-ee67-48d4-94ed-93df5b9bbefe","3b6a962a-09ff-487d-9f61-f7f9289fcbf7","2016-08-09T14:08:31.848769-05:00","UNCID_2203722.c3c9142f-d5c8-44ef-90c2-9ae69846dc60.111103_UNC6-RDR300211_00130_FC_638P5AAXX_4.tar.gz","71a07c53-7e36-4c21-8078-db9e2c64e377",2062612110,"Illumina GA","0250b26f67d6b5a3cafbf176bb518da1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:11:57.903911-05:00","2016-05-03T11:10:47.515830-05:00","71a07c53-7e36-4c21-8078-db9e2c64e377_analysis.xml","787f0534e1389b69145af542d9b4c194","d3e1ef76-1bbf-4073-9395-f55a20fa9020",2121,"2016-10-07T16:46:44.836674-05:00","71a07c53-7e36-4c21-8078-db9e2c64e377_experiment.xml","838d87a7a113888530d1984b6350f101","f6f3da5b-f9b6-4437-a2e6-0778c7a579af",2257,"2016-09-29T21:02:08.719594-05:00","71a07c53-7e36-4c21-8078-db9e2c64e377_run.xml","baea9e4ee8435daecc99c2f68a5d52bc","834f11b1-9545-45d8-b8d7-6cf9e40a8aa2",347,"2016-09-08T11:13:20.731411-05:00","TCGA-FI-A2D4","2016-09-02T18:52:55.514754-05:00","female","TCGA-FI-A2D4_demographic",1965,"white","f8b39abc-ffd6-56f1-8b85-2075bcb14cf2","not reported",2009,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2D4_diagnosis","not reported",16163,"dead","8380/3",243,NA,"5c53c6e5-1b23-58c4-bfaa-18a833c3d53e","c54.1",-16163,"TCGA-FI-A2D4_treatment","c66873ab-1c74-560f-b865-a81cb0ac3ec8","01","true","TCGA-FI-A2D4-01A",NA,"a8393121-29df-4525-bf4f-fce0deaf25f5",FALSE,"A6419790-A6CE-47E2-8035-437820EC63EC","Primary Tumor",NA,853,50,NA,1308700800,"12",10,"TCGA-FI-A2D4-01A-12",85,NA,10,NA,0,NA,15,NA,"2016-09-08T11:13:20.731411-05:00",NA,5,NA,8,NA,"TOP",NA,5,NA,"8412ad8d-d3ee-4f6b-b718-000362d6c1d5",NA,"TCGA-FI-A2D4-01A-01-TSA",NA,80,NA,"ad3474bf-a6a3-4fed-8e2f-62765a30ceb6","RNA","TCGA-FI-A2D4-01A-12R","74105fa7-a8fb-4b10-97fc-573f4f745746",1.8,0.18,"UV Spec","R","23","TCGA-FI-A2D4-01A-12R-A17B-07","c3c9142f-d5c8-44ef-90c2-9ae69846dc60",0.18,NA,112,42.1543904550416,163,"60f23e20-46db-5425-817e-5836d43e5534","TCGA-FI-A2D4_exposure","UNCID_2203722.c3c9142f-d5c8-44ef-90c2-9ae69846dc60.111103_UNC6-RDR300211_00130_FC_638P5AAXX_4.tar.gz","2013-09-26T16:26:03.000Z","2013-09-26T16:45:01.000Z","71A07C53-7E36-4C21-8078-DB9E2C64E377","A8393121-29DF-4525-BF4F-FCE0DEAF25F5","Unaligned reads",2062612110,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C3C9142F-D5C8-44EF-90C2-9AE69846DC60","University of North Carolina","566074f1e4b018727fe9f968","490AE247-EE67-48D4-94ED-93DF5B9BBEFE","Uterine Corpus Endometrial Carcinoma","TARGZ","AD3474BF-A6A3-4FED-8E2F-62765A30CEB6","2013-09-26T16:45:01.000Z","74105FA7-A8FB-4B10-97FC-573F4F745746","United States","NO",1,NA,"Primary Tumor","Washington University",853,"AD3474BF-A6A3-4FED-8E2F-62765A30CEB6",NA,"FI","TCGA-FI-A2D4-01A-12R-A17A-13_mirna.bam",50,"TCGA-FI-A2D4-01A",NA,"5A0D5B78-FE7E-4707-9DDF-1B0A94D7C029","TCGA",2009,NA,NA,"WITH TUMOR","A8393121-29DF-4525-BF4F-FCE0DEAF25F5",44,"nationwidechildrens.org_clinical.TCGA-FI-A2D4.xml","Dead",243,"TCGA-FI-A2D4",NA,"96ABE770-A261-45A8-809A-C3CE4FF6C342",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,12,10,"8412AD8D-D3EE-4F6B-B718-000362D6C1D5","CB60062E-2280-4626-B629-32907F1211F5","TCGA-FI-A2D4-01A-12R-A17A-13_mirna.bam","TCGA-FI-A2D4-01A-12",85,0,10,5,15,"TOP",5,8,"TCGA-FI-A2D4-01A-01-TSA",80,"carboplatinum","Chemotherapy","TCGA-FI-A2D4-D31807",NA,NA,NA,NA,"NO",NA,"WITH TUMOR","Dead",243,"TCGA-FI-A2D4-F31734","TCGA-FI-A2D4",1,"FI","A2D4","YES","C54.1","8380/3","C54.1","NO","YES",-16163,"FEMALE","WHITE",NA,"No","No","Dead",NA,243,NA,NA,"WITH TUMOR","NO",28,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,44,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
31861644,30735641,2301498463,"4CBE0475-73DA-4DB3-AB71-29FE1AE332F6.bw","49431740-7ed1-4c67-8d66-730629825895","4cbe0475-73da-4db3-ab71-29fe1ae332f6","2016-08-04T20:58:55.088054-05:00","UNCID_2210473.00186124-cecf-4580-9dca-cef7c09f741c.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_2.tar.gz","ed44fe06-e917-48d1-a88d-198c2f7fe1fc",1993406681,"Illumina GA","79eb8fb7559eddb9a69520dd553bc060","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:46:20.804194-05:00","2016-05-03T11:15:47.427352-05:00","ed44fe06-e917-48d1-a88d-198c2f7fe1fc_analysis.xml","f9c481138ed4df868a61af8668227634","0962a3b5-9463-4262-bb3d-086324b48ce2",2121,"2016-09-29T21:22:47.119934-05:00","ed44fe06-e917-48d1-a88d-198c2f7fe1fc_experiment.xml","64d84f570029b10a4ccefecd12b2a352","9045a3cf-987a-4692-ac4d-ab2ac0c3a117",2257,"2016-09-29T21:08:29.989799-05:00","ed44fe06-e917-48d1-a88d-198c2f7fe1fc_run.xml","b073d2d6d921a019cdf4d865d0aa495d","875997a7-454a-47f8-80a3-b60948de072b",347,"2016-09-08T11:24:26.916918-05:00","TCGA-AP-A05O","2016-09-02T18:49:20.552625-05:00","female","TCGA-AP-A05O_demographic",1941,"white","a7d5fa96-a744-5b60-90ae-aecdafa90d04","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A05O_diagnosis","not reported",24978,"alive","8380/3",NA,384,"2efa2af1-2122-5915-b315-b04d67565aad","c54.1",-24978,"TCGA-AP-A05O_treatment","23d756a9-9cf5-55b0-91f0-13288b48e198","01","true","TCGA-AP-A05O-01A",NA,"4f1edc7f-e2ff-40f5-8227-d89a1006042c",FALSE,"9C8BD34A-DC49-4547-850A-80DCD2D073F8","Primary Tumor",NA,209,270,NA,1291161600,"12",20,"TCGA-AP-A05O-01A-12",45,60,20,20,0,0,50,35,"2016-09-08T11:24:26.916918-05:00","2016-09-08T11:24:26.916918-05:00",10,20,20,20,"BOTTOM","TOP",10,5,"cb794653-c825-4dea-b2db-f05fa6c2625d","ed321c6a-a6fb-4042-bcb3-cdd2b5aa6384","TCGA-AP-A05O-01A-01-BSA","TCGA-AP-A05O-01A-01-TSA",40,60,"53647516-3017-408c-8dc6-9e81419bc0f8","RNA","TCGA-AP-A05O-01A-12R","1c1178fe-3036-451c-8afc-e8cee0967f56",1.87,0.16,"UV Spec","R","23","TCGA-AP-A05O-01A-12R-A118-07","00186124-cecf-4580-9dca-cef7c09f741c",0.16,NA,103,41.2594135555199,158,"0c22462e-f9a6-5cc8-8ed8-f427a71e4e90","TCGA-AP-A05O_exposure","UNCID_2210473.00186124-cecf-4580-9dca-cef7c09f741c.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_2.tar.gz","2013-10-02T11:31:03.000Z","2013-10-02T11:44:03.000Z","ED44FE06-E917-48D1-A88D-198C2F7FE1FC","4F1EDC7F-E2FF-40F5-8227-D89A1006042C","Unaligned reads",1993406681,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","00186124-CECF-4580-9DCA-CEF7C09F741C","University of North Carolina","566073e5e4b0b37b3d98e3a8","49431740-7ED1-4C67-8D66-730629825895","Uterine Corpus Endometrial Carcinoma","TARGZ","53647516-3017-408C-8DC6-9E81419BC0F8","2013-10-02T11:44:03.000Z","1C1178FE-3036-451C-8AFC-E8CEE0967F56","None","NO",1,NA,"Primary Tumor","MSKCC",209,"53647516-3017-408C-8DC6-9E81419BC0F8",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.FA95D970-8B04-40E4-B2DF-1A2E9E2910E7.txt",270,"TCGA-AP-A05O-01A",NA,"E3CF15C9-B06B-4206-867A-B22F09178955","TCGA",2009,NA,NA,"TUMOR FREE","ACD91A26-99CC-425E-91E2-4BB9B4E07426",68,"CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_E06_735698.byallele.copynumber.data.txt","Alive",NA,"TCGA-AP-A05O",NA,"87ABD06C-BCD5-40A9-8D98-088FE882F03A",NA,384,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"E85B0E14-B7B3-4A43-B729-B085C8D353CA","WHITE",NA,12,20,"ED321C6A-A6FB-4042-BCB3-CDD2B5AA6384","4FA42F4C-FDF0-418E-A8CA-BF5F89A06319","734ded4eea39a8154f37203772585692.bam.bai","TCGA-AP-A05O-01A-12",45,0,20,10,50,"BOTTOM",10,20,"TCGA-AP-A05O-01A-01-BSA",40,"Carboplatin","Chemotherapy","TCGA-AP-A05O-D8515","TCGA-AP-A05O-R8514","IMPLANTS","Primary Tumor Field","TCGA-AP-A05O-F68484_NTE-1","YES",384,"TUMOR FREE","Alive",NA,"TCGA-AP-A05O-F68484","TCGA-AP-A05O",1,"AP","A05O","YES","C54.1","8380/3","C54.1","NO","YES",-24978,"FEMALE","WHITE",NA,"No","No","Alive",384,NA,NA,NA,"TUMOR FREE","NO",1,2,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
105799892,103429021,4932038269,"7D272E6C-826D-4D02-8383-6A3D5BBF3A5F.bw","49adc60f-211b-4547-84f6-094257767409","7d272e6c-826d-4d02-8383-6a3d5bbf3a5f","2016-08-09T13:16:05.698499-05:00","UNCID_2178274.be03335f-81c9-4cdc-8805-c47c3e7756a1.130405_UNC9-SN296_0354_AC24DCACXX_1_TTAGGC.tar.gz","7fb7f098-509b-479c-89e7-1f2f2baf11e3",5147609911,"Illumina HiSeq","2f1322f5356b2c789a0275bb985ea153","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:52:18.637802-05:00","2016-05-03T10:56:47.878169-05:00","7fb7f098-509b-479c-89e7-1f2f2baf11e3_analysis.xml","2a166af440c4b329c0d1450654cac013","ece7e11a-29c1-4fb7-ac07-152dfaca1820",2121,"2016-09-29T22:52:32.912877-05:00","7fb7f098-509b-479c-89e7-1f2f2baf11e3_experiment.xml","4952fee1871aeea557ee4e12bd26ba4c","c7cf19a0-eee1-4404-8dfa-530ab317d249",2431,"2016-09-29T19:07:32.358212-05:00","7fb7f098-509b-479c-89e7-1f2f2baf11e3_run.xml","fd246f976bf09f7adb14bf15ac038bdf","3c6e51f3-fbb1-4cab-8089-68c205237f65",354,"2016-09-08T10:54:46.121726-05:00","TCGA-BG-A2AD","2016-09-02T18:52:43.423898-05:00","female","TCGA-BG-A2AD_demographic",1948,"white","89d21b25-7c06-5b8c-b35c-4ae66fd0aa6d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A2AD_diagnosis","not reported",23064,"alive","8380/3",NA,609,"4ae53ec5-18e1-548f-bc61-82359ef2e1f8","c54.1",-23064,"TCGA-BG-A2AD_treatment","8c0ef4a5-2f57-5167-b4fb-6c811871c8ad","11","true","TCGA-BG-A2AD-11A",NA,"7d188988-d02b-4874-b3af-925c6173f51f",FALSE,NA,"Solid Tissue Normal",NA,45,120,NA,1306800000,"11",30,"TCGA-BG-A2AD-11A-11",0,NA,20,NA,100,NA,0,NA,"2016-09-08T10:54:46.121726-05:00",NA,30,NA,30,NA,"TOP",NA,0,NA,"7fa33e34-c888-41e2-ae95-855ad726865f",NA,"TCGA-BG-A2AD-11A-01-TSA",NA,0,NA,"4aac87a9-edd8-42a4-a21a-e956decbb2bc","RNA","TCGA-BG-A2AD-11A-11R","dd322ced-9aa2-4d10-83bd-c2daeb96c0bc",1.87,0.16,"UV Spec","R","23","TCGA-BG-A2AD-11A-11R-A16F-07","be03335f-81c9-4cdc-8805-c47c3e7756a1",0.16,NA,80,31.25,160,"c6931bad-ae18-5a74-b5a5-bd4838e3ff01","TCGA-BG-A2AD_exposure","UNCID_2178274.be03335f-81c9-4cdc-8805-c47c3e7756a1.130405_UNC9-SN296_0354_AC24DCACXX_1_TTAGGC.tar.gz","2013-09-11T23:36:03.000Z","2013-09-11T23:55:02.000Z","7FB7F098-509B-479C-89E7-1F2F2BAF11E3","7D188988-D02B-4874-B3AF-925C6173F51F","Unaligned reads",5147609911,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","BE03335F-81C9-4CDC-8805-C47C3E7756A1","University of North Carolina","564a3b09e4b0ef12181a534e","49ADC60F-211B-4547-84F6-094257767409","Uterine Corpus Endometrial Carcinoma","TARGZ","4AAC87A9-EDD8-42A4-A21A-E956DECBB2BC","2013-09-11T23:55:02.000Z","DD322CED-9AA2-4D10-83BD-C2DAEB96C0BC","United States","NO",11,NA,"Solid Tissue Normal","University of Pittsburgh",45,"4AAC87A9-EDD8-42A4-A21A-E956DECBB2BC",NA,"BG","UNCID_2178274.be03335f-81c9-4cdc-8805-c47c3e7756a1.130405_UNC9-SN296_0354_AC24DCACXX_1_TTAGGC.tar.gz",120,"TCGA-BG-A2AD-11A",NA,NA,"TCGA",2011,NA,NA,NA,"E0D9E0D1-94F7-448F-A208-841C6FF39082",63,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.90232DA4-577D-4CA4-9091-7C7BC7B16A08.txt","Alive",NA,"TCGA-BG-A2AD","NOT HISPANIC OR LATINO","30ED5651-6B78-43E6-BA48-46BD752B8A0B",NA,609,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8380/3","FEMALE","C54.1",143,NA,NA,"WHITE",NA,11,30,"7FA33E34-C888-41E2-AE95-855AD726865F","FB63ECDF-60CA-4C21-A422-E10FF4450923","UNCID_2178274.be03335f-81c9-4cdc-8805-c47c3e7756a1.130405_UNC9-SN296_0354_AC24DCACXX_1_TTAGGC.tar.gz","TCGA-BG-A2AD-11A-11",0,100,20,30,0,"TOP",0,30,"TCGA-BG-A2AD-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,"TCGA-BG-A2AD-F49552_NTE-1","NO",609,"TUMOR FREE","Alive",NA,"TCGA-BG-A2AD-F49552","TCGA-BG-A2AD",1,"BG","A2AD","YES","C54.1","8380/3","C54.1","NO","YES",-23064,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",609,NA,NA,NA,NA,"NO",28,9,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2011,"Dilation and curettage procedure",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",10,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36558319,36258442,2697512294,"DC48EC34-1AA3-431C-8ABD-7F2D7BD6D32A.bw","49adc60f-211b-4547-84f6-094257767409","dc48ec34-1aa3-431c-8abd-7f2d7bd6d32a","2016-08-09T14:07:02.542048-05:00","UNCID_2203886.a6ed9981-f7df-4f36-be2e-da4c96722680.111018_UNC2-RDR300275_00092_FC_634BHAAXX_8.tar.gz","adcbd5be-98b2-45be-8cc1-00149407eff3",2372445625,"Illumina GA","275d2bd00965b25e2f05bc585e5af357","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:37:10.084523-05:00","2016-05-03T11:10:47.509879-05:00","adcbd5be-98b2-45be-8cc1-00149407eff3_analysis.xml","ac6635262be870b8e0c0af601d0b9e02","73b705c7-c4d6-407c-b87a-59a6b26f8989",2121,"2016-10-07T17:51:26.848436-05:00","adcbd5be-98b2-45be-8cc1-00149407eff3_experiment.xml","fb58debfac38e11348f44347b6d14ce2","706385ec-b1e7-42c7-a356-e38467e07c3b",2257,"2016-09-29T21:15:57.921004-05:00","adcbd5be-98b2-45be-8cc1-00149407eff3_run.xml","a0219a2204c7c3efedb37b6e6b98d745","8c05ac8c-afc8-4639-8159-fd9f9945dedd",347,"2016-09-08T10:54:46.121726-05:00","TCGA-BG-A2AD","2016-09-02T18:52:43.423898-05:00","female","TCGA-BG-A2AD_demographic",1948,"white","89d21b25-7c06-5b8c-b35c-4ae66fd0aa6d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A2AD_diagnosis","not reported",23064,"alive","8380/3",NA,609,"4ae53ec5-18e1-548f-bc61-82359ef2e1f8","c54.1",-23064,"TCGA-BG-A2AD_treatment","8c0ef4a5-2f57-5167-b4fb-6c811871c8ad","01","true","TCGA-BG-A2AD-01A",NA,"d07bb656-7b30-4d4c-a804-e3336c881a20",FALSE,"E3FBF856-C09F-4F3A-975E-A1D07286A0EB","Primary Tumor",NA,45,770,NA,1306800000,"21",30,"TCGA-BG-A2AD-01A-21",60,NA,20,NA,0,NA,30,NA,"2016-09-08T10:54:46.121726-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"b5caff99-4c14-47da-9b77-104660462ca9",NA,"TCGA-BG-A2AD-01A-02-TSB",NA,60,NA,"56db1a09-6978-4a32-b4be-8bffe1b67788","RNA","TCGA-BG-A2AD-01A-21R","84c21683-723c-42b2-8c45-d94f7c63b83a",1.91,0.17,"UV Spec","R","23","TCGA-BG-A2AD-01A-21R-A16F-07","a6ed9981-f7df-4f36-be2e-da4c96722680",0.17,NA,80,31.25,160,"c6931bad-ae18-5a74-b5a5-bd4838e3ff01","TCGA-BG-A2AD_exposure","UNCID_2203886.a6ed9981-f7df-4f36-be2e-da4c96722680.111018_UNC2-RDR300275_00092_FC_634BHAAXX_8.tar.gz","2013-09-26T07:26:04.000Z","2013-09-26T07:39:01.000Z","ADCBD5BE-98B2-45BE-8CC1-00149407EFF3","D07BB656-7B30-4D4C-A804-E3336C881A20","Unaligned reads",2372445625,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A6ED9981-F7DF-4F36-BE2E-DA4C96722680","University of North Carolina","566073abe4b016715ab66a42","49ADC60F-211B-4547-84F6-094257767409","Uterine Corpus Endometrial Carcinoma","TARGZ","56DB1A09-6978-4A32-B4BE-8BFFE1B67788","2013-09-26T07:39:01.000Z","84C21683-723C-42B2-8C45-D94F7C63B83A","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",45,"56DB1A09-6978-4A32-B4BE-8BFFE1B67788",NA,"BG","UNCID_2203886.a6ed9981-f7df-4f36-be2e-da4c96722680.111018_UNC2-RDR300275_00092_FC_634BHAAXX_8.tar.gz",770,"TCGA-BG-A2AD-01A",NA,NA,"TCGA",2011,NA,NA,NA,"E0D9E0D1-94F7-448F-A208-841C6FF39082",63,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.90232DA4-577D-4CA4-9091-7C7BC7B16A08.txt","Alive",NA,"TCGA-BG-A2AD","NOT HISPANIC OR LATINO","30ED5651-6B78-43E6-BA48-46BD752B8A0B",NA,609,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8380/3","FEMALE","C54.1",143,NA,NA,"WHITE",NA,21,30,"B5CAFF99-4C14-47DA-9B77-104660462CA9","84C21683-723C-42B2-8C45-D94F7C63B83A","TCGA-BG-A2AD-01A-21R-A16E-13_mirna.bam","TCGA-BG-A2AD-01A-21",60,0,20,40,30,"TOP",10,20,"TCGA-BG-A2AD-01A-02-TSB",60,NA,NA,NA,NA,NA,NA,"TCGA-BG-A2AD-F49552_NTE-1","NO",609,"TUMOR FREE","Alive",NA,"TCGA-BG-A2AD-F49552","TCGA-BG-A2AD",1,"BG","A2AD","YES","C54.1","8380/3","C54.1","NO","YES",-23064,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",609,NA,NA,NA,NA,"NO",28,9,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2011,"Dilation and curettage procedure",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",10,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34213173,33836543,2515370746,"D63753B2-8D75-4D50-A8CB-24F3BAA58E92.bw","4abbd258-0f0c-4428-901d-625d47ad363a","d63753b2-8d75-4d50-a8cb-24f3baa58e92","2016-08-05T01:05:29.815416-05:00","UNCID_2206806.4b998fee-a0c6-4039-824f-e5f43d5a3dbc.110829_UNC2-RDR300275_00084_FC_634GCAAXX_1.tar.gz","0b3df294-7ae7-45e8-bdac-1a72836ea40e",2193618947,"Illumina GA","dbc0788f5c0c10c96e42500222d35a5e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:21:16.857112-05:00","2016-05-03T11:12:13.672306-05:00","0b3df294-7ae7-45e8-bdac-1a72836ea40e_analysis.xml","762a3b9529dfc76cf74589875209a22d","1f179dbf-8357-477b-978c-f81633b1421c",2121,"2016-10-07T15:34:54.574540-05:00","0b3df294-7ae7-45e8-bdac-1a72836ea40e_experiment.xml","3de44eb9aea849a128cd1448129fafc0","209125b1-0625-44d3-9f80-f5165ee14775",2257,"2016-09-29T19:10:07.033041-05:00","0b3df294-7ae7-45e8-bdac-1a72836ea40e_run.xml","a15af86a1e8546b39d53c1a430ea0515","3e0d1e38-99f8-4541-bde9-dec635665602",347,"2016-09-08T10:45:35.516348-05:00","TCGA-A5-A0G2","2016-09-02T18:53:53.223352-05:00","female","TCGA-A5-A0G2_demographic",1940,"asian","9d0e2902-bcba-53ff-bd4b-7c5d4e29e3ac","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0G2_diagnosis","not reported",20953,"alive","8441/3",NA,4549,"e6730fe7-a340-5923-b5aa-9f29e1b840e5","c54.1",-20953,"TCGA-A5-A0G2_treatment","f807d385-a797-5faa-ab2f-89396c895cba","01","true","TCGA-A5-A0G2-01A",NA,"771811e3-740e-42fe-be9c-fd485997eaae",FALSE,"A3CD42AF-D356-415B-958D-D14D7AC52693","Primary Tumor",NA,4825,200,NA,1275868800,"11",30,"TCGA-A5-A0G2-01A-11",90,90,0,0,5,10,0,0,"2016-09-08T10:45:35.516348-05:00","2016-09-08T10:45:35.516348-05:00",20,20,10,5,"BOTTOM","TOP",10,5,"9a87a97c-740b-4df5-8a5e-1c97188b511d","ac44810a-1366-4bc5-aa98-7d98ef8b6329","TCGA-A5-A0G2-01A-01-BS1","TCGA-A5-A0G2-01A-01-TS1",85,85,"09ec609b-ee52-4b9e-8ae0-7ebe5d306d29","RNA","TCGA-A5-A0G2-01A-11R","b8bfdc23-4a54-42d0-b5ef-1c453bdafd04",1.82,0.16,"UV Spec","R","23","TCGA-A5-A0G2-01A-11R-A16W-07","4b998fee-a0c6-4039-824f-e5f43d5a3dbc",0.16,NA,60,25.9695290858726,152,"2d4ab07d-5569-586c-a6f5-c31fb4f41718","TCGA-A5-A0G2_exposure","UNCID_2206806.4b998fee-a0c6-4039-824f-e5f43d5a3dbc.110829_UNC2-RDR300275_00084_FC_634GCAAXX_1.tar.gz","2013-09-28T07:31:04.000Z","2013-09-28T07:50:03.000Z","0B3DF294-7AE7-45E8-BDAC-1A72836EA40E","771811E3-740E-42FE-BE9C-FD485997EAAE","Unaligned reads",2193618947,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4B998FEE-A0C6-4039-824F-E5F43D5A3DBC","University of North Carolina","564a376fe4b093830b67ffff","4ABBD258-0F0C-4428-901D-625D47AD363A","Uterine Corpus Endometrial Carcinoma","TARGZ","09EC609B-EE52-4B9E-8AE0-7EBE5D306D29","2013-09-28T07:50:03.000Z","B8BFDC23-4A54-42D0-B5EF-1C453BDAFD04","None","NO",1,NA,"Primary Tumor","Cedars Sinai",4825,"09EC609B-EE52-4B9E-8AE0-7EBE5D306D29",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F1E8AA4E-0F31-4476-8BE4-4284B284CC3A.txt",200,"TCGA-A5-A0G2-01A",NA,NA,"TCGA",1997,NA,NA,"WITH TUMOR","D6272155-71A9-4B3F-A2E7-4D45E945236C",57,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F1E8AA4E-0F31-4476-8BE4-4284B284CC3A.txt","Alive",NA,"TCGA-A5-A0G2","NOT HISPANIC OR LATINO","F5BA1816-028A-42B6-A3F0-9E6D562BCAEC",NA,4054,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C54.1",59,NA,"A26A37C5-87CD-4B45-9568-2246C867381F","ASIAN",NA,11,30,"AC44810A-1366-4BC5-AA98-7D98EF8B6329","B8BFDC23-4A54-42D0-B5EF-1C453BDAFD04","TCGA-A5-A0G2-01A-11R-A041-13_mirna.bam","TCGA-A5-A0G2-01A-11",90,10,0,20,0,"TOP",5,5,"TCGA-A5-A0G2-01A-01-TS1",85,NA,NA,NA,"TCGA-A5-A0G2-R2637","EXTERNAL BEAM","Primary Tumor Field",NA,NA,4054,"WITH TUMOR","Alive",NA,"TCGA-A5-A0G2-F2640","TCGA-A5-A0G2",1,"A5","A0G2","YES","C54.1","8441/3","C54.1","NO","YES",-20953,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",4054,NA,NA,NA,"WITH TUMOR","NO",16,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,57,1997,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
153113606,144594353,6890105311,"7046C2F2-A8DE-4AE1-B27D-094CF2EF3B3D.bw","4adc20d7-5af1-4126-9073-c7d7ae465d92","7046c2f2-a8de-4ae1-b27d-094cf2ef3b3d","2016-08-25T15:27:34.872514-05:00","UNCID_2364783.460f0df0-00fb-43bf-9143-782a45ca490c.140128_UNC15-SN850_0350_BC39J2ACXX_5_TTAGGC.tar.gz","d73abbb5-1fc5-4020-8686-490293a4cba9",7365186059,"Illumina HiSeq","6ea0b6e2d31edc35a0b1bd412b729c9d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:53:03.571877-05:00","2016-05-03T11:39:34.500988-05:00","d73abbb5-1fc5-4020-8686-490293a4cba9_analysis.xml","651ce06e9e0674989d4311db91263fb8","7da6c073-5a91-43d1-b968-7559427d7e2f",2124,"2016-08-13T02:07:25.750854-05:00","d73abbb5-1fc5-4020-8686-490293a4cba9_experiment.xml","64bdc89d657cfd301d47b77efeab0c5c","f23b6dc9-cd5f-47a5-9b33-1930f9cd7382",2628,"2016-09-29T19:00:55.866278-05:00","d73abbb5-1fc5-4020-8686-490293a4cba9_run.xml","abee714b44064876879b4a650c0f2616","3826ac10-5195-4936-a0a3-a0c5f2264971",354,"2016-09-08T10:39:33.139837-05:00","TCGA-PG-A7D5","2016-09-02T18:51:32.987178-05:00","female","TCGA-PG-A7D5_demographic",1949,"black or african american","b18085fa-a9fc-591d-97c2-4ca241b9bc92","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","PG","69bd8326-4904-56a0-8230-1615a777173b","Montefiore Medical Center","not reported","c54.1","TCGA-PG-A7D5_diagnosis","not reported",23006,"alive","8441/3",NA,1177,"eee42fb5-89c1-530d-952e-d9c333442c28","c54.1",-23006,"TCGA-PG-A7D5_treatment","556eafb4-eeb5-5301-bed7-28236be7be40","01","true","TCGA-PG-A7D5-01A",NA,"f408c11a-cbc3-4d31-8cf3-c204423e798f",FALSE,"2E996CFE-9F6E-432F-9B09-6FBC2A920B24","Primary Tumor",NA,618,100,NA,1378339200,"11",30,"TCGA-PG-A7D5-01A-11",60,NA,20,NA,0,NA,30,NA,"2016-09-08T10:39:33.139837-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"1523ca04-a243-45a0-a525-b5e856cd14d5",NA,"TCGA-PG-A7D5-01A-01-TSA",NA,60,NA,"c566bd7a-6a64-4bdf-9e1d-1edd3bf84024","RNA","TCGA-PG-A7D5-01A-11R","77ceca33-e35d-428d-ad3b-96050a0629ad",1.92,0.17,"UV Spec","R","23","TCGA-PG-A7D5-01A-11R-A34R-07","460f0df0-00fb-43bf-9143-782a45ca490c",0.17,NA,79,31.6455696202532,158,"4b216d14-e4a7-569e-a85c-585afbb46bd4","TCGA-PG-A7D5_exposure","UNCID_2364783.460f0df0-00fb-43bf-9143-782a45ca490c.140128_UNC15-SN850_0350_BC39J2ACXX_5_TTAGGC.tar.gz","2014-03-04T18:33:04.000Z","2014-03-04T18:52:02.000Z","D73ABBB5-1FC5-4020-8686-490293A4CBA9","F408C11A-CBC3-4D31-8CF3-C204423E798F","Unaligned reads",7365186059,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","460F0DF0-00FB-43BF-9143-782A45CA490C","University of North Carolina","564a3c20e4b0ef12181aac8d","4ADC20D7-5AF1-4126-9073-C7D7AE465D92","Uterine Corpus Endometrial Carcinoma","TARGZ","C566BD7A-6A64-4BDF-9E1D-1EDD3BF84024","2014-03-04T18:52:02.000Z","77CECA33-E35D-428D-AD3B-96050A0629AD","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",618,"C566BD7A-6A64-4BDF-9E1D-1EDD3BF84024",NA,"PG","UNDID_p_TCGA_353_354_355_37_NSP_GenomeWideSNP_6_D07_1376950.birdseed.data.txt",100,"TCGA-PG-A7D5-01A",NA,"68197989-E32B-4A6C-A219-5BA4C19502DB","TCGA",2011,"TCGA-PG-A7D5_NTE-1","Stable Disease","TUMOR FREE","F408C11A-CBC3-4D31-8CF3-C204423E798F",62,"UNDID_p_TCGA_353_354_355_37_NSP_GenomeWideSNP_6_D06_1376938.nocnv_hg19.seg.txt","Alive",NA,"TCGA-PG-A7D5","NOT HISPANIC OR LATINO","2DFD5F43-3A9A-4AD1-9445-5E7411CA361C","NO",729,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",354,NA,"827BF730-C597-4A2E-91E8-47543F895E64","BLACK OR AFRICAN AMERICAN",NA,11,30,"1523CA04-A243-45A0-A525-B5E856CD14D5","BD69374E-99D2-401A-88AB-11793D982EF7","UNCID_2345190.460f0df0-00fb-43bf-9143-782a45ca490c.sorted_genome_alignments.bam.bai","TCGA-PG-A7D5-01A-11",60,0,20,40,30,"TOP",10,20,"TCGA-PG-A7D5-01A-01-TSA",60,"Carboplatin/Paclitaxel","Chemotherapy","TCGA-PG-A7D5-D71180","TCGA-PG-A7D5-R71181","Internal","Regional site","TCGA-PG-A7D5-F71179_NTE-1","NO",1177,"TUMOR FREE","Alive",NA,"TCGA-PG-A7D5-F71179","TCGA-PG-A7D5",1,"PG","A7D5","YES","C54.1","8441/3","C54.1","NO","YES",-23006,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",729,NA,"NO","NO","TUMOR FREE","YES",5,2,2014,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,62,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Stable Disease","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
16391634,15396551,1160420915,"4AEE4E66-F11A-4D09-BFDC-9F3FA94312CC.bw","4af65655-a3bd-4252-9b2f-2b2c4394f95c","4aee4e66-f11a-4d09-bfdc-9f3fa94312cc","2016-08-09T14:18:50.769941-05:00","UNCID_2216212.cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_4.tar.gz","ca28d66e-0f35-486a-a801-5258c07a84e8",949255285,"Illumina GA","b307e3a4142f7a3acbe5871e425d553d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:43:21.713304-05:00","2016-05-03T11:18:46.986610-05:00","ca28d66e-0f35-486a-a801-5258c07a84e8_analysis.xml","11c547f6747def5ded2d88369c7dc322","e75e5a3f-2694-459e-ac06-2692d2b410a8",2122,"2016-09-29T21:29:36.244350-05:00","ca28d66e-0f35-486a-a801-5258c07a84e8_experiment.xml","1611e990b56a046f6b9be74b590a9361","949183d6-e3c1-47f1-b18c-732fd13f001d",2256,"2016-09-30T00:01:29.092980-05:00","ca28d66e-0f35-486a-a801-5258c07a84e8_run.xml","03d3a02b9be82118d1d3077d9753954b","f2882845-e831-4c19-94a8-b7514197f9b6",345,"2016-09-08T11:13:30.760761-05:00","TCGA-AX-A062","2016-09-02T18:52:47.439195-05:00","female","TCGA-AX-A062_demographic",1952,"white","afb64fd6-7906-5bd8-87a9-03b43fb69900","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A062_diagnosis","not reported",19643,"alive","8380/3",NA,1399,"19b9b525-2fae-5676-b5d0-dde681d32629","c54.1",-19643,"TCGA-AX-A062_treatment","dfbd7fb2-ab5b-5a4e-b9be-dcb03e361957","01","false","TCGA-AX-A062-01A",NA,"9eac701b-9927-4aca-81eb-b516f90c643c",FALSE,"FAAFB078-A6DF-4E1B-BD5F-A3B30E45BE1E","Primary Tumor",NA,1610,200,NA,1275868800,"11",30,"TCGA-AX-A062-01A-11",85,85,0,0,14,11,1,2,"2016-09-08T11:13:30.760761-05:00","2016-09-08T11:13:30.760761-05:00",1,1,0,1,"TOP","BOTTOM",5,7,"ce9b635c-2ead-4691-a6df-bc1c5213027c","cf299089-97eb-4847-a7d1-5298b21624f6","TCGA-AX-A062-01A-01-TSA","TCGA-AX-A062-01A-01-BSA",80,80,"367f2e1c-80fc-44f7-816e-83e5e07a3692","RNA","TCGA-AX-A062-01A-11R","7ae9dfda-54c9-46e9-9884-cef61259fb5d",1.82,0.16,"UV Spec","R","23","TCGA-AX-A062-01A-11R-A00V-07","cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9",0.16,NA,122,40.7631394299843,173,"3dcfc97d-d368-5ae0-9311-e97362913e0c","TCGA-AX-A062_exposure","UNCID_2216212.cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_4.tar.gz","2013-10-04T07:36:04.000Z","2013-10-04T07:48:03.000Z","CA28D66E-0F35-486A-A801-5258C07A84E8","9EAC701B-9927-4ACA-81EB-B516F90C643C","Unaligned reads",949255285,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CFA7827B-F6BB-4714-BA9F-17E4ADFDF3A9","University of North Carolina","56607ea1e4b018727fea37bf","4AF65655-A3BD-4252-9B2F-2B2C4394F95C","Uterine Corpus Endometrial Carcinoma","TARGZ","367F2E1C-80FC-44F7-816E-83E5E07A3692","2013-10-04T07:48:03.000Z","7AE9DFDA-54C9-46E9-9884-CEF61259FB5D","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1610,"367F2E1C-80FC-44F7-816E-83E5E07A3692",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.DEC72ADB-614C-4E2A-A8DC-DB9FDABA89A6.txt",200,"TCGA-AX-A062-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","9EAC701B-9927-4ACA-81EB-B516F90C643C",53,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.DEC72ADB-614C-4E2A-A8DC-DB9FDABA89A6.txt","Alive",NA,"TCGA-AX-A062",NA,"010E9369-100E-4F56-BB07-12108F729E62",NA,1399,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"WHITE",NA,11,30,"CF299089-97EB-4847-A7D1-5298B21624F6","A6E14FE9-6F27-4475-96CE-31599027FBBD","UNCID_2216212.cfa7827b-f6bb-4714-ba9f-17e4adfdf3a9.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_4.tar.gz","TCGA-AX-A062-01A-11",85,14,0,1,1,"TOP",5,0,"TCGA-AX-A062-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,NA,1399,"TUMOR FREE","Alive",NA,"TCGA-AX-A062-F5504","TCGA-AX-A062",1,"AX","A062","YES","C54.1","8380/3","C54.1","NO","YES",-19643,"FEMALE","WHITE",NA,"No","No","Alive",1399,NA,NA,NA,"TUMOR FREE","NO",24,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2005,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
106523522,105378748,5025301723,"2FD813BF-AF0C-41FD-95A2-1874A3CEA53F.bw","4c2e6abf-02e1-4ef7-a0be-6a6d4069581d","2fd813bf-af0c-41fd-95a2-1874a3cea53f","2016-08-09T13:16:08.810405-05:00","UNCID_2177820.cad7a685-cb28-44bf-ad8e-e4528a73f0b6.130402_UNC10-SN254_0447_BC22WAACXX_7_ACTTGA.tar.gz","ab80bc7d-7c77-4364-8745-5f64c3d60986",4494513856,"Illumina HiSeq","fe98845942148c75ce21a69577d74585","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:19:19.631828-05:00","2016-05-03T10:56:47.890899-05:00","ab80bc7d-7c77-4364-8745-5f64c3d60986_analysis.xml","61e58fbff61498c23fffc7da5c50853b","d834dea8-6bd8-4776-a436-3b46d1054361",2123,"2016-09-29T20:57:28.161914-05:00","ab80bc7d-7c77-4364-8745-5f64c3d60986_experiment.xml","b3d2d3960d51a792e2235e8cbf097115","80630122-ff51-42b7-bd6f-f7fbc2204fd8",2431,"2016-09-29T17:48:30.282661-05:00","ab80bc7d-7c77-4364-8745-5f64c3d60986_run.xml","ca8f5045653c2e63937003f9d0a06084","0aba3a4c-a154-4720-bacc-0511b9318151",354,"2016-09-08T11:49:12.246913-05:00","TCGA-EO-A3B0","2016-09-02T18:47:58.067351-05:00","female","TCGA-EO-A3B0_demographic",1968,"asian","3b813f30-d519-5c0e-9aa7-ce07c2780822","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3B0_diagnosis","not reported",15954,"alive","8380/3",NA,1412,"3381b937-de4b-527c-ad36-5984ddcc6bb2","c54.1",-15954,"TCGA-EO-A3B0_treatment","3871232a-c174-5f4d-9cbd-9d74d3cc9124","01","false","TCGA-EO-A3B0-01A",NA,"87a5c4d3-9aa2-4a86-9cc9-f99a4b67feae",FALSE,"5B8CD9C0-148B-4421-AA68-C1F2DF7F9B28","Primary Tumor",NA,196,160,NA,1317686400,"12",30,"TCGA-EO-A3B0-01A-12",70,NA,0,NA,0,NA,20,NA,"2016-09-08T11:49:12.246913-05:00",NA,0,NA,0,NA,"TOP",NA,10,NA,"7c3b79ea-b874-4692-bf9a-4906cbc72868",NA,"TCGA-EO-A3B0-01A-01-TSA",NA,70,NA,"4864b645-7e80-43ce-bba4-da5fd2d4f926","RNA","TCGA-EO-A3B0-01A-12R","d945be03-3ad7-45a9-81e7-3692036fad78",1.85,0.17,"UV Spec","R","23","TCGA-EO-A3B0-01A-12R-A19W-07","cad7a685-cb28-44bf-ad8e-e4528a73f0b6",0.17,NA,53,22.9397506925208,152,"13186b2d-211b-5489-88d5-ce7a891827a1","TCGA-EO-A3B0_exposure","UNCID_2177820.cad7a685-cb28-44bf-ad8e-e4528a73f0b6.130402_UNC10-SN254_0447_BC22WAACXX_7_ACTTGA.tar.gz","2013-09-11T07:01:10.000Z","2013-09-11T07:17:01.000Z","AB80BC7D-7C77-4364-8745-5F64C3D60986","87A5C4D3-9AA2-4A86-9CC9-F99A4B67FEAE","Unaligned reads",4494513856,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","CAD7A685-CB28-44BF-AD8E-E4528A73F0B6","University of North Carolina","564a3d4de4b08c5d86921d91","4C2E6ABF-02E1-4EF7-A0BE-6A6D4069581D","Uterine Corpus Endometrial Carcinoma","TARGZ","4864B645-7E80-43CE-BBA4-DA5FD2D4F926","2013-09-11T07:17:01.000Z","D945BE03-3AD7-45A9-81E7-3692036FAD78","Canada","NO",1,NA,"Primary Tumor","University Health Network",196,"4864B645-7E80-43CE-BBA4-DA5FD2D4F926",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.31CAA926-B4B8-4574-A03C-893D2ED156B5.txt",160,"TCGA-EO-A3B0-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","87A5C4D3-9AA2-4A86-9CC9-F99A4B67FEAE",43,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.31CAA926-B4B8-4574-A03C-893D2ED156B5.txt","Alive",NA,"TCGA-EO-A3B0",NA,"2C5A931F-D97A-4F04-A0E1-66BEFBBF764C",NA,404,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,"ASIAN",NA,12,30,"7C3B79EA-B874-4692-BF9A-4906CBC72868","D9F26E88-FA0E-4970-96AA-DB7CE179406E","546b3968ed2801bc7ff6b5ae8ad8a189.bam","TCGA-EO-A3B0-01A-12",70,0,0,0,20,"TOP",10,0,"TCGA-EO-A3B0-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-EO-A3B0-F38253_NTE-1","NO",544,"TUMOR FREE","Alive",NA,"TCGA-EO-A3B0-F38253","TCGA-EO-A3B0",1,"EO","A3B0","YES","C54.1","8380/3","C54.1",NA,"YES",-15954,"FEMALE","ASIAN",NA,"No","No","Alive",404,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,43,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
36902720,36638474,2716746446,"D3FDEFAA-36C8-4933-98B0-0E392177FB5E.bw","4cb4dd07-0ce5-4de7-a0bd-546183949efe","d3fdefaa-36c8-4933-98b0-0e392177fb5e","2016-08-09T14:18:38.043869-05:00","UNCID_2235710.c9bdd9d8-f0f6-4abb-aca8-11d274f90995.111018_UNC2-RDR300275_00092_FC_634BHAAXX_3.tar.gz","9bdf0679-5c14-450a-9cc4-e17f5d5fd5e0",2428339411,"Illumina GA","30367dbe4ffb5a7941928c5c29a6ebda","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:43:00.308092-05:00","2016-05-03T11:20:13.148190-05:00","9bdf0679-5c14-450a-9cc4-e17f5d5fd5e0_analysis.xml","1ca9ee4286e71dcea1fa60e68ccdd518","2cedc922-9ff5-4746-8b74-35b45ecb3c24",2121,"2016-09-29T23:21:09.635328-05:00","9bdf0679-5c14-450a-9cc4-e17f5d5fd5e0_experiment.xml","bc9539a9eaaff0ac87275869838eda07","d9640c20-0e83-4679-bbff-99c1d429fb4f",2257,"2016-09-29T20:31:17.332901-05:00","9bdf0679-5c14-450a-9cc4-e17f5d5fd5e0_run.xml","6ad3534f0be96410d1ce70c82d263687","703227c8-4189-4bc2-80cc-210f7dcf0bc6",347,"2016-09-08T10:27:24.739794-05:00","TCGA-AW-A1PO","2016-09-02T18:52:37.169954-05:00","female","TCGA-AW-A1PO_demographic",1944,"white","725602a2-1229-515a-b401-94a1ead148af","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AW","ed373abb-a0bb-535b-a344-6a33270fed23","Cureline","not reported","c54.1","TCGA-AW-A1PO_diagnosis","not reported",24225,"alive","8380/3",NA,17,"35cb1cd4-f910-5479-81cf-31d0e38e0ee2","c54.1",-24225,"TCGA-AW-A1PO_treatment","ef2d4b93-0146-59e3-b0bf-3a126334bd82","01","true","TCGA-AW-A1PO-01A",NA,"1576c6c1-b9f0-4acd-9a75-e5f2d5a4ecc1",FALSE,"B5351001-32B2-4BA9-998D-F6631F6BE705","Primary Tumor",NA,331,190,NA,1302220800,"12",30,"TCGA-AW-A1PO-01A-12",70,NA,20,NA,0,NA,10,NA,"2016-09-08T10:27:24.739794-05:00",NA,40,NA,30,NA,"TOP",NA,20,NA,"5340cd5f-f6d0-4789-905b-55ae39f3912d",NA,"TCGA-AW-A1PO-01A-01-TSA",NA,70,NA,"c9b213f5-4469-43c8-bc6e-4b9fe9799e11","RNA","TCGA-AW-A1PO-01A-12R","feb5cf8a-fe87-4963-bfa4-daf0f6a9bdb3",1.92,0.16,"UV Spec","R","23","TCGA-AW-A1PO-01A-12R-A157-07","c9bdd9d8-f0f6-4abb-aca8-11d274f90995",0.16,NA,58,22.1002895900015,162,"02fc3e18-ba31-5456-b408-3aec1e39e596","TCGA-AW-A1PO_exposure","UNCID_2235710.c9bdd9d8-f0f6-4abb-aca8-11d274f90995.111018_UNC2-RDR300275_00092_FC_634BHAAXX_3.tar.gz","2013-10-19T11:51:05.000Z","2013-10-19T12:04:01.000Z","9BDF0679-5C14-450A-9CC4-E17F5D5FD5E0","1576C6C1-B9F0-4ACD-9A75-E5F2D5A4ECC1","Unaligned reads",2428339411,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C9BDD9D8-F0F6-4ABB-ACA8-11D274F90995","University of North Carolina","56607f0de4b0ca3191650b0a","4CB4DD07-0CE5-4DE7-A0BD-546183949EFE","Uterine Corpus Endometrial Carcinoma","TARGZ","C9B213F5-4469-43C8-BC6E-4B9FE9799E11","2013-10-19T12:04:01.000Z","FEB5CF8A-FE87-4963-BFA4-DAF0F6A9BDB3","Russia","NO",1,NA,"Primary Tumor","Cureline",331,"C9B213F5-4469-43C8-BC6E-4B9FE9799E11",NA,"AW","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BC4CAC82-65CC-46C9-880A-C933FEBEB7DE.txt",190,"TCGA-AW-A1PO-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","85EAF363-5B31-4335-AECD-3DE79EA6DE0F",66,"nationwidechildrens.org_clinical.TCGA-AW-A1PO.xml","Alive",NA,"TCGA-AW-A1PO","NOT HISPANIC OR LATINO","DEC2E9B1-2684-4B74-9C12-7C394929E108",NA,17,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,NA,"WHITE",NA,12,30,"5340CD5F-F6D0-4789-905B-55AE39F3912D","FEB5CF8A-FE87-4963-BFA4-DAF0F6A9BDB3","UNCID_600081.TCGA-AW-A1PO-01A-12R-A157-07.111018_UNC2-RDR300275_00092_FC_634BHAAXX.3.trimmed.annotated.translated_to_genomic.exon.quantification.txt","TCGA-AW-A1PO-01A-12",70,0,20,40,10,"TOP",20,30,"TCGA-AW-A1PO-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-AW-A1PO-F68990_NTE-1",NA,17,"TUMOR FREE","Alive",NA,"TCGA-AW-A1PO-F68990","TCGA-AW-A1PO",1,"AW","A1PO","YES","C54.1","8380/3","C54.1","NO","YES",-24225,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",17,NA,NA,NA,"TUMOR FREE","NO",5,8,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,66,2010,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36902720,36638487,2716749859,"337BA735-8F64-4888-B32B-B93C7474BA83.bw","4cb4dd07-0ce5-4de7-a0bd-546183949efe","337ba735-8f64-4888-b32b-b93c7474ba83","2016-08-09T14:09:21.355563-05:00","UNCID_2203914.c9bdd9d8-f0f6-4abb-aca8-11d274f90995.111018_UNC2-RDR300275_00092_FC_634BHAAXX_3.tar.gz","33058ed4-2f9b-4acf-9c69-6ae7de6ccff5",2428339411,"Illumina GA","040d60e3f45b5d8aeab6ed0788021767","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:03:14.672344-05:00","2016-05-03T11:10:47.529133-05:00","33058ed4-2f9b-4acf-9c69-6ae7de6ccff5_analysis.xml","73e76ec345c5bf6de52cf5ab3b59c258","f3a3ceed-89e6-4f8c-87ca-ea081803d60d",2121,"2016-09-30T00:08:58.624877-05:00","33058ed4-2f9b-4acf-9c69-6ae7de6ccff5_experiment.xml","bc9539a9eaaff0ac87275869838eda07","f70b7f5f-c81e-4b18-b2e6-ae751ad9cf69",2257,"2016-09-29T22:15:23.702292-05:00","33058ed4-2f9b-4acf-9c69-6ae7de6ccff5_run.xml","6ad3534f0be96410d1ce70c82d263687","b0c47baa-f370-4953-96bf-502798b30cf9",347,"2016-09-08T10:27:24.739794-05:00","TCGA-AW-A1PO","2016-09-02T18:52:37.169954-05:00","female","TCGA-AW-A1PO_demographic",1944,"white","725602a2-1229-515a-b401-94a1ead148af","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AW","ed373abb-a0bb-535b-a344-6a33270fed23","Cureline","not reported","c54.1","TCGA-AW-A1PO_diagnosis","not reported",24225,"alive","8380/3",NA,17,"35cb1cd4-f910-5479-81cf-31d0e38e0ee2","c54.1",-24225,"TCGA-AW-A1PO_treatment","ef2d4b93-0146-59e3-b0bf-3a126334bd82","01","true","TCGA-AW-A1PO-01A",NA,"1576c6c1-b9f0-4acd-9a75-e5f2d5a4ecc1",FALSE,"B5351001-32B2-4BA9-998D-F6631F6BE705","Primary Tumor",NA,331,190,NA,1302220800,"12",30,"TCGA-AW-A1PO-01A-12",70,NA,20,NA,0,NA,10,NA,"2016-09-08T10:27:24.739794-05:00",NA,40,NA,30,NA,"TOP",NA,20,NA,"5340cd5f-f6d0-4789-905b-55ae39f3912d",NA,"TCGA-AW-A1PO-01A-01-TSA",NA,70,NA,"c9b213f5-4469-43c8-bc6e-4b9fe9799e11","RNA","TCGA-AW-A1PO-01A-12R","feb5cf8a-fe87-4963-bfa4-daf0f6a9bdb3",1.92,0.16,"UV Spec","R","23","TCGA-AW-A1PO-01A-12R-A157-07","c9bdd9d8-f0f6-4abb-aca8-11d274f90995",0.16,NA,58,22.1002895900015,162,"02fc3e18-ba31-5456-b408-3aec1e39e596","TCGA-AW-A1PO_exposure","UNCID_2203914.c9bdd9d8-f0f6-4abb-aca8-11d274f90995.111018_UNC2-RDR300275_00092_FC_634BHAAXX_3.tar.gz","2013-09-26T07:56:04.000Z","2013-09-26T20:09:01.000Z","33058ED4-2F9B-4ACF-9C69-6AE7DE6CCFF5","1576C6C1-B9F0-4ACD-9A75-E5F2D5A4ECC1","Unaligned reads",2428339411,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C9BDD9D8-F0F6-4ABB-ACA8-11D274F90995","University of North Carolina","56607f0fe4b0ec1099f8f36f","4CB4DD07-0CE5-4DE7-A0BD-546183949EFE","Uterine Corpus Endometrial Carcinoma","TARGZ","C9B213F5-4469-43C8-BC6E-4B9FE9799E11","2013-09-26T20:09:01.000Z","FEB5CF8A-FE87-4963-BFA4-DAF0F6A9BDB3","Russia","NO",1,NA,"Primary Tumor","Cureline",331,"C9B213F5-4469-43C8-BC6E-4B9FE9799E11",NA,"AW","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BC4CAC82-65CC-46C9-880A-C933FEBEB7DE.txt",190,"TCGA-AW-A1PO-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","85EAF363-5B31-4335-AECD-3DE79EA6DE0F",66,"nationwidechildrens.org_clinical.TCGA-AW-A1PO.xml","Alive",NA,"TCGA-AW-A1PO","NOT HISPANIC OR LATINO","DEC2E9B1-2684-4B74-9C12-7C394929E108",NA,17,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,NA,"WHITE",NA,12,30,"5340CD5F-F6D0-4789-905B-55AE39F3912D","FEB5CF8A-FE87-4963-BFA4-DAF0F6A9BDB3","UNCID_600081.TCGA-AW-A1PO-01A-12R-A157-07.111018_UNC2-RDR300275_00092_FC_634BHAAXX.3.trimmed.annotated.translated_to_genomic.exon.quantification.txt","TCGA-AW-A1PO-01A-12",70,0,20,40,10,"TOP",20,30,"TCGA-AW-A1PO-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-AW-A1PO-F68990_NTE-1",NA,17,"TUMOR FREE","Alive",NA,"TCGA-AW-A1PO-F68990","TCGA-AW-A1PO",1,"AW","A1PO","YES","C54.1","8380/3","C54.1","NO","YES",-24225,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",17,NA,NA,NA,"TUMOR FREE","NO",5,8,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,66,2010,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34223745,33755119,2522093386,"668765BB-DEC9-4746-B932-C8CE643B6564.bw","4d3af3af-24f4-415a-9677-20b0f366a102","668765bb-dec9-4746-b932-c8ce643b6564","2016-08-05T08:20:49.941700-05:00","UNCID_2212125.b50b6ebf-8b11-47db-803b-e2739e7dd005.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_7.tar.gz","d0a7663d-431f-4042-a01d-5fce7ca47ca5",2168632366,"Illumina GA","5d256c88089806b1a29bbe817158dec4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:06:56.294563-05:00","2016-05-03T11:16:29.242391-05:00","d0a7663d-431f-4042-a01d-5fce7ca47ca5_analysis.xml","ffc8b53d3a723d8ebdb34798ea0a544b","16699072-7aeb-48ae-9834-c61374dde223",2121,"2016-09-29T23:28:37.192959-05:00","d0a7663d-431f-4042-a01d-5fce7ca47ca5_experiment.xml","62dad280ce5e03dda4432d105eb7f70f","de16f250-5764-40a9-a7fe-82be1a51e1ca",2257,"2016-09-29T18:48:07.629404-05:00","d0a7663d-431f-4042-a01d-5fce7ca47ca5_run.xml","f9fcacd3aa4e6e989d44c750357ca8b2","302f677c-c9b7-49ec-b196-34b412324da9",347,"2016-09-08T11:34:50.899238-05:00","TCGA-D1-A0ZZ","2016-09-02T18:49:14.207483-05:00","female","TCGA-D1-A0ZZ_demographic",1929,"white","f6beb124-7592-52b5-9440-69a20be0004e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A0ZZ_diagnosis","not reported",29420,"alive","8380/3",NA,686,"9710210a-9824-50a8-9373-b37370b16b27","c54.1",-29420,"TCGA-D1-A0ZZ_treatment","fdb6b901-e129-54b9-8578-85c19fc2b787","01","false","TCGA-D1-A0ZZ-01A",NA,"c797e9d4-3f3e-48d9-870f-e8ea6bddfd91",FALSE,"4339EAC6-F56E-49E6-8EF9-2256165CADB5","Primary Tumor",NA,349,220,NA,1288656000,"11",30,"TCGA-D1-A0ZZ-01A-11",90,75,0,0,0,0,0,15,"2016-09-08T11:34:50.899238-05:00","2016-09-08T11:34:50.899238-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"c79e59d5-0e43-4474-94e8-a61d3c1b4f24","2f2ab65d-279f-42f3-9a0b-53901ae7cbd7","TCGA-D1-A0ZZ-01A-01-TSA","TCGA-D1-A0ZZ-01A-01-BSA",100,85,"41029c0c-ed80-4065-a87e-8aa811f07a65","RNA","TCGA-D1-A0ZZ-01A-11R","3e7dc345-d648-410d-8078-5a70cd90a565",1.81,0.17,"UV Spec","R","23","TCGA-D1-A0ZZ-01A-11R-A10J-07","b50b6ebf-8b11-47db-803b-e2739e7dd005",0.17,NA,51,21.5044695564176,154,"cd9bbc3d-b543-5d2c-84c5-027447a766c8","TCGA-D1-A0ZZ_exposure","UNCID_2212125.b50b6ebf-8b11-47db-803b-e2739e7dd005.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_7.tar.gz","2013-10-03T05:46:04.000Z","2013-10-03T06:05:02.000Z","D0A7663D-431F-4042-A01D-5FCE7CA47CA5","C797E9D4-3F3E-48D9-870F-E8EA6BDDFD91","Unaligned reads",2168632366,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B50B6EBF-8B11-47DB-803B-E2739E7DD005","University of North Carolina","56607eabe4b018727fea37e3","4D3AF3AF-24F4-415A-9677-20B0F366A102","Uterine Corpus Endometrial Carcinoma","TARGZ","41029C0C-ED80-4065-A87E-8AA811F07A65","2013-10-03T06:05:02.000Z","3E7DC345-D648-410D-8078-5A70CD90A565","None","NO",1,NA,"Primary Tumor","Mayo Clinic",349,"41029C0C-ED80-4065-A87E-8AA811F07A65",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9AD5DB69-7DCA-4BE6-BA19-74509C89A963.txt",220,"TCGA-D1-A0ZZ-01A",NA,"DE6692C2-B1CD-42A2-B743-26B088F0B528","TCGA",2009,NA,NA,"TUMOR FREE","D2B2B0AF-5191-477A-81A0-35A48D988CAC",80,"DEBUT_p_TCGAb45_81_wRedosSNP_N_GenomeWideSNP_6_C11_729504.nocnv_hg18.seg.txt","Alive",NA,"TCGA-D1-A0ZZ","NOT HISPANIC OR LATINO","6374B70F-A4CB-4C9A-AE39-BC77C598AF77",NA,377,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,"686429D4-8CB5-464D-BBD7-2CEB156DE206","WHITE",NA,11,30,"C79E59D5-0E43-4474-94E8-A61D3C1B4F24","E4D5655D-92D1-47CE-AF89-F0FAE4894BA1","UNCID_2212125.b50b6ebf-8b11-47db-803b-e2739e7dd005.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_7.tar.gz","TCGA-D1-A0ZZ-01A-11",75,0,0,0,15,"BOTTOM",0,0,"TCGA-D1-A0ZZ-01A-01-BSA",85,"Paclitaxel","Chemotherapy","TCGA-D1-A0ZZ-D17766","TCGA-D1-A0ZZ-R17754","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"NO",686,"TUMOR FREE","Alive",NA,"TCGA-D1-A0ZZ-F17753","TCGA-D1-A0ZZ",1,"D1","A0ZZ","YES","C54.1","8380/3","C54.1","NO","YES",-29420,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",377,NA,NA,NA,"TUMOR FREE","NO",8,3,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,80,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34338620,33649869,2494417565,"D2417A9C-CBF0-47F6-B20C-FB32AF632A84.bw","4db4d048-016a-4186-a519-bfbad237762f","d2417a9c-cbf0-47f6-b20c-fb32af632a84","2016-08-05T06:31:03.775074-05:00","UNCID_2209883.43ae3721-059e-467e-a8a3-7875e738ccef.110420_UNC6-RDR300211_00096_FC_634WMAAXX_6.tar.gz","50a6ae4d-fdd4-4e78-a0f4-aa1342fedac6",2298045005,"Illumina GA","32add0902894d247634b62c518e047dd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:41:17.628775-05:00","2016-05-03T11:15:47.414649-05:00","50a6ae4d-fdd4-4e78-a0f4-aa1342fedac6_analysis.xml","0f881d58926a14a314a0548034f9d947","06083b70-f541-47b3-b05a-244aaa0cc6d6",2121,"2016-09-29T20:57:38.570557-05:00","50a6ae4d-fdd4-4e78-a0f4-aa1342fedac6_experiment.xml","31482e17d5d6336665ee224f4626beb5","80807034-9846-4d98-a663-69091c834623",2257,"2016-09-29T17:54:49.764627-05:00","50a6ae4d-fdd4-4e78-a0f4-aa1342fedac6_run.xml","f1ee36b6f01a9e7c1456bd8f8eb308db","0ea928a9-0c0a-4e37-bc17-cbbc982041b8",347,"2016-09-08T11:04:14.736233-05:00","TCGA-D1-A16J","2016-09-02T18:50:26.525624-05:00","female","TCGA-D1-A16J_demographic",1947,"white","e5131de6-df58-5310-8f3f-9792154e2d41","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16J_diagnosis","not reported",22319,"alive","8380/3",NA,910,"2f2c0c71-ca23-59b9-9d29-4677fde95ce5","c54.1",-22319,"TCGA-D1-A16J_treatment","7f670e55-3386-5dfb-95ba-8273d709d922","01","false","TCGA-D1-A16J-01A",NA,"535b69fc-e529-4615-b789-3756eddda1cd",FALSE,"7A1F7567-5D17-4074-B099-1E60C8069FA1","Primary Tumor",NA,735,150,NA,1294099200,"11",30,"TCGA-D1-A16J-01A-11",65,NA,0,NA,0,NA,20,NA,"2016-09-08T11:04:14.736233-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"ca1720b8-8d7e-480f-9fb6-c3ccb844cff3",NA,"TCGA-D1-A16J-01A-01-TSA",NA,80,NA,"6737e54f-c016-45fa-a39c-a17b42dc8373","RNA","TCGA-D1-A16J-01A-11R","73eeac9d-fe35-4f8c-ba91-7cddb6102f9e",1.94,0.16,"UV Spec","R","23","TCGA-D1-A16J-01A-11R-A12I-07","43ae3721-059e-467e-a8a3-7875e738ccef",0.16,NA,130,42.9383009644603,174,"d5883074-83b2-5809-82f8-872d65cba2aa","TCGA-D1-A16J_exposure","UNCID_2209883.43ae3721-059e-467e-a8a3-7875e738ccef.110420_UNC6-RDR300211_00096_FC_634WMAAXX_6.tar.gz","2013-10-01T23:55:04.000Z","2013-10-02T00:08:03.000Z","50A6AE4D-FDD4-4E78-A0F4-AA1342FEDAC6","535B69FC-E529-4615-B789-3756EDDDA1CD","Unaligned reads",2298045005,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","43AE3721-059E-467E-A8A3-7875E738CCEF","University of North Carolina","566075a6e4b0ec1099f8bc33","4DB4D048-016A-4186-A519-BFBAD237762F","Uterine Corpus Endometrial Carcinoma","TARGZ","6737E54F-C016-45FA-A39C-A17B42DC8373","2013-10-02T00:08:03.000Z","73EEAC9D-FE35-4F8C-BA91-7CDDB6102F9E","None","NO",1,NA,"Primary Tumor","Mayo Clinic",735,"6737E54F-C016-45FA-A39C-A17B42DC8373",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6C745697-65BC-44B8-8F15-B8482F902E85.txt",150,"TCGA-D1-A16J-01A",NA,"E4A7D04B-2F5D-425B-A0EF-A65584082BAF","TCGA",2008,NA,NA,"TUMOR FREE","535B69FC-E529-4615-B789-3756EDDDA1CD",61,"SCAUR_p_TCGA_b94_SNP_N_GenomeWideSNP_6_A12_755366.birdseed.data.txt","Alive",NA,"TCGA-D1-A16J","NOT HISPANIC OR LATINO","47758040-9E37-46DD-A5CE-06AAD4E76B03",NA,742,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"45452844-1540-40D9-873C-BAC119BC95EA","WHITE",NA,11,30,"CA1720B8-8D7E-480F-9FB6-C3CCB844CFF3","D622DAC8-B67F-46BC-83EB-09FA094F0F01","UNCID_2209883.43ae3721-059e-467e-a8a3-7875e738ccef.110420_UNC6-RDR300211_00096_FC_634WMAAXX_6.tar.gz","TCGA-D1-A16J-01A-11",65,0,0,0,20,"TOP",0,0,"TCGA-D1-A16J-01A-01-TSA",80,"Taxol","Chemotherapy","TCGA-D1-A16J-D18581","TCGA-D1-A16J-R18580","IMPLANTS","Regional site",NA,"NO",910,"TUMOR FREE","Alive",NA,"TCGA-D1-A16J-F18579","TCGA-D1-A16J",1,"D1","A16J","YES","C54.1","8380/3","C54.1","NO","YES",-22319,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",742,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2008,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1995",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32132191,31627957,2365969023,"E4B4D387-8583-4A94-B996-95BDF58DB6C1.bw","4eb95566-0e73-4260-853e-f7df650667a0","e4b4d387-8583-4a94-b996-95bdf58db6c1","2016-08-09T14:12:14.974579-05:00","UNCID_2208118.8947d611-8c3f-4096-9479-063660ee8607.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_1.tar.gz","4c5ef815-8ef5-4dcf-b28c-2e6ca15b8d92",2106646926,"Illumina GA","2365fcb24a554a8709c9a2ddcacba256","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:14:26.746217-05:00","2016-05-03T11:14:23.412460-05:00","4c5ef815-8ef5-4dcf-b28c-2e6ca15b8d92_analysis.xml","2a8e6077fae74b99f5878415d1af17ac","1af83105-f482-4e1f-b5fb-efd668ccb013",2121,"2016-09-29T17:39:48.239748-05:00","4c5ef815-8ef5-4dcf-b28c-2e6ca15b8d92_experiment.xml","357094f3ee85d68c8aef9e44ac6e6b8c","05102474-85a4-42b0-8703-4942a81a46bf",2257,"2016-09-29T19:13:51.436598-05:00","4c5ef815-8ef5-4dcf-b28c-2e6ca15b8d92_run.xml","f789cd530d4ce253cb4b3154e647f72a","40775fa4-1d0c-4666-bfb2-0d2896b83847",347,"2016-09-08T11:34:21.005371-05:00","TCGA-BS-A0T9","2016-09-02T18:50:06.957699-05:00","female","TCGA-BS-A0T9_demographic",1966,"native hawaiian or other pacific islander","d78ace8f-6085-5241-8f2c-ca6c81a6e286","not hispanic or latino",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0T9_diagnosis","not reported",14253,"dead","8380/3",1428,NA,"09579d8d-9ca2-5ee9-a9bb-ee05496857cf","c54.1",-14253,"TCGA-BS-A0T9_treatment","a22838a0-ead2-59c5-bf1d-975911f5ca40","01","false","TCGA-BS-A0T9-01A",NA,"3c9ff865-013f-427a-8d4d-c8e60ea346a1",FALSE,"C9151621-D012-48F9-B7E1-F540567E791C","Primary Tumor",NA,2009,600,NA,1281484800,"11",30,"TCGA-BS-A0T9-01A-11",80,70,10,5,0,0,15,15,"2016-09-08T11:34:21.005371-05:00","2016-09-08T11:34:21.005371-05:00",40,40,30,20,"BOTTOM","TOP",5,15,"4e3e1a9f-9dc7-407f-844a-3b74a90dc800","f1c68c45-c2e2-447a-9798-a60e4ff5da69","TCGA-BS-A0T9-01A-01-BSA","TCGA-BS-A0T9-01A-01-TSA",80,70,"5b7d0948-f8ad-431c-8b14-8fe39bc6ed0f","RNA","TCGA-BS-A0T9-01A-11R","3316e4da-ea92-442e-b8ed-2db8a0654cba",1.78,0.15,"UV Spec","R","23","TCGA-BS-A0T9-01A-11R-A12I-07","8947d611-8c3f-4096-9479-063660ee8607",0.15,NA,109,40.0367309458219,165,"5d92d908-9efc-583e-9ac1-358a855677e5","TCGA-BS-A0T9_exposure","UNCID_2208118.8947d611-8c3f-4096-9479-063660ee8607.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_1.tar.gz","2013-09-30T09:01:04.000Z","2013-09-30T09:16:02.000Z","4C5EF815-8EF5-4DCF-B28C-2E6CA15B8D92","3C9FF865-013F-427A-8D4D-C8E60EA346A1","Unaligned reads",2106646926,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8947D611-8C3F-4096-9479-063660EE8607","University of North Carolina","564a3c4fe4b0ef12181abad7","4EB95566-0E73-4260-853E-F7DF650667A0","Uterine Corpus Endometrial Carcinoma","TARGZ","5B7D0948-F8AD-431C-8B14-8FE39BC6ED0F","2013-09-30T09:16:02.000Z","3316E4DA-EA92-442E-B8ED-2DB8A0654CBA","None","NO",1,NA,"Primary Tumor","University of Hawaii",2009,"5B7D0948-F8AD-431C-8B14-8FE39BC6ED0F",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BA865E56-EF20-4543-AE3B-465967C47508.txt",600,"TCGA-BS-A0T9-01A",NA,"FB52775E-0E9B-45CA-B849-FBA324FB71E9","TCGA",2005,NA,NA,"WITH TUMOR","50B46A0F-A987-451F-A3C7-7252C1609FCC",39,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BA865E56-EF20-4543-AE3B-465967C47508.txt","Dead",1428,"TCGA-BS-A0T9","NOT HISPANIC OR LATINO","2909E61B-01FB-4C5D-ADF7-EC1866E50E96",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"2F593662-DC0A-4AD2-8C96-FA119D77C0C9","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,11,30,"F1C68C45-C2E2-447A-9798-A60E4FF5DA69","9EE3AB32-E923-43A7-B88F-3EA59B61DFF6","TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.bam.bai","TCGA-BS-A0T9-01A-11",70,0,5,40,15,"TOP",15,20,"TCGA-BS-A0T9-01A-01-TSA",70,"fulvestrant","Hormone Therapy","TCGA-BS-A0T9-D9197","TCGA-BS-A0T9-R9190","EXTERNAL BEAM","Regional site",NA,NA,NA,"WITH TUMOR","Dead",1428,"TCGA-BS-A0T9-F9188","TCGA-BS-A0T9",1,"BS","A0T9","YES","C54.1","8380/3","C54.1","NO","YES",-14253,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","NOT HISPANIC OR LATINO","No","No","Dead",NA,1428,NA,NA,"WITH TUMOR","NO",19,11,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,39,2005,"Tumor resection",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
20586772,20024531,1508014438,"21F95DBD-67B5-4D03-9A20-22883C4473A1.bw","4fd1cb59-6c50-4355-9d37-a341e1f4fad9","21f95dbd-67b5-4d03-9a20-22883c4473a1","2016-08-05T06:49:47.575792-05:00","UNCID_2211054.55874b54-441d-4a28-b2a7-a90e96774ff9.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_1.tar.gz","047a6a9b-e68f-4907-9298-1a8cca8ac1ce",1261155247,"Illumina GA","4a51f0b7873217bada9e8ba8a895fa01","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:09:22.405008-05:00","2016-05-03T11:16:29.236069-05:00","047a6a9b-e68f-4907-9298-1a8cca8ac1ce_analysis.xml","b9ab040119b17437491ee932d4211b0f","d2335806-f5d9-4aa0-b33b-86f15d6ff027",2121,"2016-09-29T18:41:41.311220-05:00","047a6a9b-e68f-4907-9298-1a8cca8ac1ce_experiment.xml","b3f66e13ae7ae404bff98c8b335a11ef","2c134eda-97a3-42a5-b689-c86e67f75c7d",2257,"2016-09-29T19:54:31.025303-05:00","047a6a9b-e68f-4907-9298-1a8cca8ac1ce_run.xml","7d459c630308a84dc25e27fba95f00c6","59c7d9fa-2bbf-4322-a581-28a283e9b3c1",347,"2016-09-08T10:30:22.398706-05:00","TCGA-BG-A0M9","2016-09-02T18:48:06.217914-05:00","female","TCGA-BG-A0M9_demographic",1935,"white","d762555b-0370-5081-905f-16fa84728790","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0M9_diagnosis","not reported",26708,"alive","8380/3",NA,2270,"9f5c213e-be1c-526f-9212-a644cca7a5f4","c54.1",-26708,"TCGA-BG-A0M9_treatment","032c27f3-c02c-5276-9bba-8ef0c0c4b394","01","true","TCGA-BG-A0M9-01A",NA,"dc487bbf-555b-423b-b7c0-3e92defa5a79",FALSE,"08D832C7-9B5F-4B6E-9C3E-2F3E58305016","Primary Tumor",NA,772,220,NA,1279584000,"21",30,"TCGA-BG-A0M9-01A-21",90,80,0,0,0,0,0,0,"2016-09-08T10:30:22.398706-05:00","2016-09-08T10:30:22.398706-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"0de4bd1e-fc47-4f35-aa76-9f0f59541d3e","e99c7a7d-bf1a-4242-a5e7-15089c716edc","TCGA-BG-A0M9-01A-02-BSB","TCGA-BG-A0M9-01A-02-TSB",100,100,"e90d4fcf-df50-490c-8494-fc0caa03d014","RNA","TCGA-BG-A0M9-01A-21R","f4381423-da7b-4245-911d-292a1e625faa",1.9,0.15,"UV Spec","R","23","TCGA-BG-A0M9-01A-21R-A104-07","55874b54-441d-4a28-b2a7-a90e96774ff9",0.15,NA,93,36.328125,160,"882e92e8-5f94-5ac4-9613-8d69716795aa","TCGA-BG-A0M9_exposure","UNCID_2211054.55874b54-441d-4a28-b2a7-a90e96774ff9.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_1.tar.gz","2013-10-02T20:06:09.000Z","2013-10-02T20:18:03.000Z","047A6A9B-E68F-4907-9298-1A8CCA8AC1CE","DC487BBF-555B-423B-B7C0-3E92DEFA5A79","Unaligned reads",1261155247,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","55874B54-441D-4A28-B2A7-A90E96774FF9","University of North Carolina","5660773de4b0ec1099f8cd16","4FD1CB59-6C50-4355-9D37-A341E1F4FAD9","Uterine Corpus Endometrial Carcinoma","TARGZ","E90D4FCF-DF50-490C-8494-FC0CAA03D014","2013-10-02T20:18:03.000Z","F4381423-DA7B-4245-911D-292A1E625FAA","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",772,"E90D4FCF-DF50-490C-8494-FC0CAA03D014",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6AF1C2FB-89E2-4FCC-9774-858ED6CAC492.txt",220,"TCGA-BG-A0M9-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","DC487BBF-555B-423B-B7C0-3E92DEFA5A79",73,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6AF1C2FB-89E2-4FCC-9774-858ED6CAC492.txt","Alive",NA,"TCGA-BG-A0M9","NOT HISPANIC OR LATINO","E07DD84D-49B4-4E3E-B64E-7777937BDE03",NA,765,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,21,30,"E99C7A7D-BF1A-4242-A5E7-15089C716EDC","FF19B881-16BD-4FE9-ABFA-A1C60B8C3653","TCGA-BG-A0M9-01A-21W-A10C-09_IlluminaGA-DNASeq_exome_1.bam.bai","TCGA-BG-A0M9-01A-21",80,0,0,0,0,"TOP",0,0,"TCGA-BG-A0M9-01A-02-TSB",100,NA,NA,NA,NA,NA,NA,NA,"NO",860,"TUMOR FREE","Alive",NA,"TCGA-BG-A0M9-F19282","TCGA-BG-A0M9",1,"BG","A0M9","YES","C54.1","8380/3","C54.1","NO","YES",-26708,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",765,NA,NA,NA,"TUMOR FREE","NO",8,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2008,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
110390734,108856007,5192631551,"B6BF8C22-03E4-44F0-B2EF-2A3DD6ADE7D7.bw","503e6c30-1b62-4f85-bcb4-e34c009894ab","b6bf8c22-03e4-44f0-b2ef-2a3dd6ade7d7","2016-08-09T13:15:10.203395-05:00","UNCID_2178398.18b41a91-88d1-4938-a57f-0464fc7422bc.130328_UNC10-SN254_0443_AD238RACXX_7_TAGCTT.tar.gz","56c09ced-1f26-4461-8350-93f098efa2d1",4574384211,"Illumina HiSeq","65ddb7d26ba1daef127c31f96d593c4b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:22:17.517258-05:00","2016-05-03T10:56:47.880266-05:00","56c09ced-1f26-4461-8350-93f098efa2d1_analysis.xml","a8b1d6296c3f14d24c42d301bbca31e8","6aa653bb-2889-4e55-9950-f11706e8671d",2123,"2016-09-29T20:16:08.911608-05:00","56c09ced-1f26-4461-8350-93f098efa2d1_experiment.xml","9edaa58aee738d8bfa0cfaf6ba2822a7","66e89bfb-3bd8-4711-ac6d-75bc987ee379",2431,"2016-09-29T23:22:53.393205-05:00","56c09ced-1f26-4461-8350-93f098efa2d1_run.xml","a85f114b15d821338c99d2c46f201b64","da7ea05e-8ceb-4440-86cd-fa7712602a89",354,"2016-09-08T11:25:43.729779-05:00","TCGA-AJ-A3BK","2016-09-02T18:54:51.596895-05:00","female","TCGA-AJ-A3BK_demographic",1942,"white","0926f2b4-a18a-531b-82a7-f798da65b318","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3BK_diagnosis","not reported",24943,"alive","8380/3",NA,1031,"e8ed2352-d01d-524f-ada4-cff9500d186c","c54.1",-24943,"TCGA-AJ-A3BK_treatment","38667152-25fb-562a-84b4-3db79cc955e2","01","false","TCGA-AJ-A3BK-01A",NA,"610660f1-07aa-489f-b09f-8da0b91fee6f",FALSE,"026350F0-3203-49E5-8CCC-9DE88B2C8625","Primary Tumor",NA,547,170,NA,1317859200,"11",30,"TCGA-AJ-A3BK-01A-11",90,NA,1,NA,10,NA,0,NA,"2016-09-08T11:25:43.729779-05:00",NA,2,NA,0,NA,"TOP",NA,5,NA,"fcf9e287-fe73-4127-b6a0-236d22b0dd76",NA,"TCGA-AJ-A3BK-01A-01-TS1",NA,85,NA,"4dc25faa-4c6c-4edd-8626-ad39daaf379c","RNA","TCGA-AJ-A3BK-01A-11R","1566f93a-2cd8-4490-b708-3aaf63327b4b",1.35,0.17,"UV Spec","R","23","TCGA-AJ-A3BK-01A-11R-A19W-07","18b41a91-88d1-4938-a57f-0464fc7422bc",0.17,NA,92,34.626820730927,163,"68c9a19c-d8ec-5df6-a715-f99a8b26f38d","TCGA-AJ-A3BK_exposure","UNCID_2178398.18b41a91-88d1-4938-a57f-0464fc7422bc.130328_UNC10-SN254_0443_AD238RACXX_7_TAGCTT.tar.gz","2013-09-12T02:16:09.000Z","2013-09-12T02:32:01.000Z","56C09CED-1F26-4461-8350-93F098EFA2D1","610660F1-07AA-489F-B09F-8DA0B91FEE6F","Unaligned reads",4574384211,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","18B41A91-88D1-4938-A57F-0464FC7422BC","University of North Carolina","56607645e4b0ca319164db02","503E6C30-1B62-4F85-BCB4-E34C009894AB","Uterine Corpus Endometrial Carcinoma","TARGZ","4DC25FAA-4C6C-4EDD-8626-AD39DAAF379C","2013-09-12T02:32:01.000Z","1566F93A-2CD8-4490-B708-3AAF63327B4B","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",547,"4DC25FAA-4C6C-4EDD-8626-AD39DAAF379C",NA,"AJ","CLUBS_p_TCGA_186_188_SNP_N_GenomeWideSNP_6_E09_914068.hg18.seg.txt",170,"TCGA-AJ-A3BK-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","610660F1-07AA-489F-B09F-8DA0B91FEE6F",68,"nationwidechildrens.org_clinical.TCGA-AJ-A3BK.xml","Alive",NA,"TCGA-AJ-A3BK","NOT HISPANIC OR LATINO","BA2E84B8-71FA-4E8D-8869-E65CB31065CD",NA,51,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,"2B7AC5D6-096B-4C63-8035-45FEAD1F516A","WHITE",NA,11,30,"FCF9E287-FE73-4127-B6A0-236D22B0DD76","6248B0C8-335C-467B-903C-629343FCBDAF","TCGA-AJ-A3BK-01A-11R-A19V-13_mirna.bam","TCGA-AJ-A3BK-01A-11",90,10,1,2,0,"TOP",5,0,"TCGA-AJ-A3BK-01A-01-TS1",85,NA,NA,NA,"TCGA-AJ-A3BK-R46676","External","Primary Tumor Field","TCGA-AJ-A3BK-F46662_NTE-1","NO",1031,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3BK-F46662","TCGA-AJ-A3BK",1,"AJ","A3BK","YES","C54.1","8380/3","C54.1","NO","YES",-24943,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",51,NA,NA,NA,"TUMOR FREE","NO",3,2,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
25237578,24774089,1839197685,"8292DCAE-B9B5-4E23-8846-182A2B9C53E6.bw","508bf716-46f9-44dc-8e39-09261dfb073e","8292dcae-b9b5-4e23-8846-182a2b9c53e6","2016-08-05T05:07:14.518320-05:00","UNCID_2196790.21aa44a9-e23e-4ab9-aa35-6942b118b066.120208_UNC2-RDR300275_00112_FC_64V42AAXX_7.tar.gz","a01eb13b-d91d-49c9-bcb5-cd23ff6c3ffb",1635855257,"Illumina GA","7209c96c0b624c8c2362f557fa2fedf6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:20:16.912568-05:00","2016-05-03T11:08:33.752363-05:00","a01eb13b-d91d-49c9-bcb5-cd23ff6c3ffb_analysis.xml","1cbd3697478476a94dce8a55d23ac1c0","8ebbc4cf-ac00-4fd9-bcd0-ffe9b3839c02",2121,"2016-10-07T16:16:21.522595-05:00","a01eb13b-d91d-49c9-bcb5-cd23ff6c3ffb_experiment.xml","6cd2cc973b0e90c91056579884c7fb6f","fc0d6b01-23e7-459a-90a2-06a60fda8da1",2257,"2016-09-30T00:06:38.899066-05:00","a01eb13b-d91d-49c9-bcb5-cd23ff6c3ffb_run.xml","4bf153612a6a2203b2f9526dc0211930","f5a58e8c-6aeb-4bf2-b280-7ee346eb8066",347,"2016-09-08T11:30:50.915014-05:00","TCGA-EO-A22R","2016-09-02T18:54:18.606366-05:00","female","TCGA-EO-A22R_demographic",1952,"not reported","1c25671b-2d5d-5bb4-b022-6c8571ccc85f","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A22R_diagnosis","not reported",20604,"alive","8380/3",NA,1878,"262813f0-6ba0-5775-a7e9-cb37b50f78a1","c54.1",-20604,"TCGA-EO-A22R_treatment","2f65a41f-081b-58b1-927c-29cb81517c29","01","false","TCGA-EO-A22R-01A",NA,"8f1f3c76-1cad-434e-b77a-bc17c7742e76",FALSE,"5B97D87A-5D28-417F-A942-21775156B46C","Primary Tumor",NA,925,130,NA,1304899200,"11",30,"TCGA-EO-A22R-01A-11",80,NA,20,NA,0,NA,15,NA,"2016-09-08T11:30:50.915014-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"2f6d56ac-7e3b-4af8-a457-3a6995dcde26",NA,"TCGA-EO-A22R-01A-01-TSA",NA,80,NA,"d9282b98-146f-41ff-a6b5-f3dd91ed2d8b","RNA","TCGA-EO-A22R-01A-11R","6afc456b-ac70-4834-950b-60557cbee5fe",1.87,0.16,"UV Spec","R","23","TCGA-EO-A22R-01A-11R-A18M-07","21aa44a9-e23e-4ab9-aa35-6942b118b066",0.16,NA,88,31.1791383219955,168,"6c9a2d2c-b273-56d5-9796-5fff29ca49fd","TCGA-EO-A22R_exposure","UNCID_2196790.21aa44a9-e23e-4ab9-aa35-6942b118b066.120208_UNC2-RDR300275_00112_FC_64V42AAXX_7.tar.gz","2013-09-23T22:13:09.000Z","2013-09-23T22:25:01.000Z","A01EB13B-D91D-49C9-BCB5-CD23FF6C3FFB","8F1F3C76-1CAD-434E-B77A-BC17C7742E76","Unaligned reads",1635855257,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","21AA44A9-E23E-4AB9-AA35-6942B118B066","University of North Carolina","564a32c4e4b09c884b21b749","508BF716-46F9-44DC-8E39-09261DFB073E","Uterine Corpus Endometrial Carcinoma","TARGZ","D9282B98-146F-41FF-A6B5-F3DD91ED2D8B","2013-09-23T22:25:01.000Z","6AFC456B-AC70-4834-950B-60557CBEE5FE","Canada","NO",1,NA,"Primary Tumor","University Health Network",925,"D9282B98-146F-41FF-A6B5-F3DD91ED2D8B",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F7096155-7582-491D-BC2C-4C28A7AC90B3.txt",130,"TCGA-EO-A22R-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","8F1F3C76-1CAD-434E-B77A-BC17C7742E76",56,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F7096155-7582-491D-BC2C-4C28A7AC90B3.txt","Alive",NA,"TCGA-EO-A22R",NA,"14A753DE-E117-46AE-8985-92BBD7D1D112",NA,972,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,"31D8CA1B-BEC5-4D20-AA26-312806F1AE90",NA,NA,11,30,"2F6D56AC-7E3B-4AF8-A457-3A6995DCDE26","723BFC1E-7308-4313-86CA-2D879201CA76","9c3f83cab07d73a5d1238ded44007c26.bam.bai","TCGA-EO-A22R-01A-11",80,0,20,40,15,"TOP",5,20,"TCGA-EO-A22R-01A-01-TSA",80,NA,NA,NA,"TCGA-EO-A22R-R62604","External","Primary Tumor Field","TCGA-EO-A22R-F62603_NTE-1","NO",1878,"TUMOR FREE","Alive",NA,"TCGA-EO-A22R-F62603","TCGA-EO-A22R",1,"EO","A22R","YES","C54.1","8380/3","C54.1","NO","YES",-20604,"FEMALE",NA,NA,"No","No","Alive",972,NA,NA,NA,"TUMOR FREE","NO",26,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
133416262,130769997,6240307758,"A470C3F2-6C74-45E1-B4C9-0A6612490FC5.bw","50edd97a-f440-40af-b94c-d88eca55d845","a470c3f2-6c74-45e1-b4c9-0a6612490fc5","2016-08-05T11:58:12.378284-05:00","UNCID_2173668.6b961695-40e4-4c88-976a-8fb6c99b4f0f.130502_UNC12-SN629_0289_AC236KACXX_3_CAGATC.tar.gz","7c6ab25f-19b8-440a-83c6-9ad6c4cbd540",6325323997,"Illumina HiSeq","e193e8e1477837e22057930cf9de74e3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:45:03.569377-05:00","2016-05-03T10:55:55.610281-05:00","7c6ab25f-19b8-440a-83c6-9ad6c4cbd540_analysis.xml","6b2d0775f84ce4273b35950766a4993f","78acb308-5609-4008-8079-6c57f5b59362",2123,"2016-09-29T23:25:06.142586-05:00","7c6ab25f-19b8-440a-83c6-9ad6c4cbd540_experiment.xml","3fd316924cd622e9a40bbc6f967acc51","dbe0eadf-7b9f-48e0-a7d5-ef4723253830",2431,"2016-09-29T18:56:51.994005-05:00","7c6ab25f-19b8-440a-83c6-9ad6c4cbd540_run.xml","84cd5d577349699409350f35e65f19eb","35bf3f76-aa14-4fa7-96de-295d069b9987",354,"2016-09-08T11:10:33.791045-05:00","TCGA-FL-A3WE",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","true","TCGA-FL-A3WE-11A",NA,"70c3b243-d83a-4d15-b803-999bdd1576a8",FALSE,"803BA1B3-9F78-43B8-B9CA-81D309E9FEDA","Solid Tissue Normal",NA,NA,80,NA,1336608000,"11",30,"TCGA-FL-A3WE-11A-11",0,NA,0,NA,30,NA,70,NA,"2016-09-08T11:10:33.791045-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"2d1146a7-7d78-46f5-bd8d-7270875fa9ee",NA,"TCGA-FL-A3WE-11A-01-TS1",NA,0,NA,"0dcdb8ff-adf3-4af5-807e-416344668e17","RNA","TCGA-FL-A3WE-11A-11R","fe23cfa6-61d5-4949-bd32-57e2ca2f7c18",1.84,0.16,"UV Spec","R","23","TCGA-FL-A3WE-11A-11R-A22K-07","6b961695-40e4-4c88-976a-8fb6c99b4f0f",0.16,NA,NA,NA,NA,NA,NA,"UNCID_2173668.6b961695-40e4-4c88-976a-8fb6c99b4f0f.130502_UNC12-SN629_0289_AC236KACXX_3_CAGATC.tar.gz","2013-09-09T21:24:34.000Z","2013-09-09T21:40:02.000Z","7C6AB25F-19B8-440A-83C6-9AD6C4CBD540","70C3B243-D83A-4D15-B803-999BDD1576A8","Unaligned reads",6325323997,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","6B961695-40E4-4C88-976A-8FB6C99B4F0F","University of North Carolina","564a3b30e4b0298dd2c856fa","50EDD97A-F440-40AF-B94C-D88ECA55D845","Uterine Corpus Endometrial Carcinoma","TARGZ","0DCDB8FF-ADF3-4AF5-807E-416344668E17","2013-09-09T21:40:02.000Z","FE23CFA6-61D5-4949-BD32-57E2CA2F7C18","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"0DCDB8FF-ADF3-4AF5-807E-416344668E17",NA,"FL","TCGA-FL-A3WE-11A-11R-A22I-13_mirna.bam",80,"TCGA-FL-A3WE-11A",NA,NA,"TCGA",NA,NA,NA,NA,"70C3B243-D83A-4D15-B803-999BDD1576A8",NA,"TCGA-FL-A3WE-11A-11R-A22I-13_mirna.bam",NA,NA,"TCGA-FL-A3WE",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,228,NA,NA,NA,NA,11,30,"2D1146A7-7D78-46F5-BD8D-7270875FA9EE","FE23CFA6-61D5-4949-BD32-57E2CA2F7C18","TCGA-FL-A3WE-11A-11R-A22I-13_mirna.bam","TCGA-FL-A3WE-11A-11",0,30,0,0,70,"TOP",0,0,"TCGA-FL-A3WE-11A-01-TS1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
184269424,181687431,8695115069,"FBE93EC7-CA18-41CE-8B85-50B4EC204278.bw","51bd85e2-2c60-4654-bfcb-83dccef8964b","fbe93ec7-ca18-41ce-8b85-50b4ec204278","2016-08-27T06:44:57.159425-05:00","UNCID_2332721.1b0bc4c7-b2b5-434b-8d15-05c2ad8e027a.130718_UNC12-SN629_0321_AC2E6WACXX_2_TGACCA.tar.gz","73a8dc7a-7eeb-426b-a454-3a821e76e113",7564640717,"Illumina HiSeq","ee180580ac6cb9af368f2a160fc605e2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:17:06.105539-05:00","2016-05-03T11:35:41.339088-05:00","73a8dc7a-7eeb-426b-a454-3a821e76e113_analysis.xml","e9229818138e51d8ffad0d0f5c2712c5","d6ec7c19-01c1-4755-af78-80b84325a1b8",2124,"2016-09-29T20:19:21.389131-05:00","73a8dc7a-7eeb-426b-a454-3a821e76e113_experiment.xml","0321231763ebd1f686542776d96ca3b6","68cecbdc-bc92-41aa-a477-bf4c48fed194",2884,"2016-09-29T23:17:36.606685-05:00","73a8dc7a-7eeb-426b-a454-3a821e76e113_run.xml","67d2fbdc5f24ce653d3dbeba977a6db4","d7343741-9d1f-4d57-a0f9-8188f1b99426",355,"2016-09-08T10:38:51.860584-05:00","TCGA-BK-A0CA","2016-09-02T18:49:39.928556-05:00","female","TCGA-BK-A0CA_demographic",1949,"white","3b6442dc-a44c-5d6d-91f4-9aabb0781977","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A0CA_diagnosis","not reported",22378,"alive","8441/3",NA,1064,"1b042946-cb3e-57aa-8321-29375cbfaf8c","c54.1",-22378,"TCGA-BK-A0CA_treatment","86795392-d88c-5bbc-8ae3-67ede9060efc","01","false","TCGA-BK-A0CA-01A",NA,"d836db96-83fb-4f25-a16c-aaaaf55d7b12",FALSE,"883D4832-75FB-495C-B93F-904FCA1AB18C","Primary Tumor",NA,86,300,NA,1291248000,"21",30,"TCGA-BK-A0CA-01A-21",0,75,0,0,50,0,50,25,"2016-09-08T10:38:51.860584-05:00","2016-09-08T10:38:51.860584-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"f22571d6-ffc4-4152-aaa1-8b01eaa5e3c5","04c00d4c-a3f4-4231-ab05-67cda5847ca5","TCGA-BK-A0CA-01A-02-BS2","TCGA-BK-A0CA-01A-01-BS1",0,75,"56df7696-d1f4-49e3-93d4-093c8c59ba2d","RNA","TCGA-BK-A0CA-01A-21R","0c2b324d-f151-4899-a15a-fcef11c4f15a",1.85,0.15,"UV Spec","R","23","TCGA-BK-A0CA-01A-21R-A277-07","1b0bc4c7-b2b5-434b-8d15-05c2ad8e027a",0.15,NA,NA,NA,163,"4feb395e-390e-5e3f-a5a0-52b36201e248","TCGA-BK-A0CA_exposure","UNCID_2332721.1b0bc4c7-b2b5-434b-8d15-05c2ad8e027a.130718_UNC12-SN629_0321_AC2E6WACXX_2_TGACCA.tar.gz","2014-01-29T12:07:04.000Z","2014-01-29T12:28:03.000Z","73A8DC7A-7EEB-426B-A454-3A821E76E113","D836DB96-83FB-4F25-A16C-AAAAF55D7B12","Unaligned reads",7564640717,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","1B0BC4C7-B2B5-434B-8D15-05C2AD8E027A","University of North Carolina","564a31d1e4b093830b663524","51BD85E2-2C60-4654-BFCB-83DCCEF8964B","Uterine Corpus Endometrial Carcinoma","TARGZ","56DF7696-D1F4-49E3-93D4-093C8C59BA2D","2014-01-29T12:28:03.000Z","0C2B324D-F151-4899-A15A-FCEF11C4F15A","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",86,"56DF7696-D1F4-49E3-93D4-093C8C59BA2D",NA,"BK","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.30A62556-2260-4232-BA09-E3EFCA44EF7E.txt",300,"TCGA-BK-A0CA-01A",NA,"BB5254BC-7922-4B42-BCF6-C77C8051C3BE","TCGA",2010,NA,NA,"TUMOR FREE","D836DB96-83FB-4F25-A16C-AAAAF55D7B12",61,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.30A62556-2260-4232-BA09-E3EFCA44EF7E.txt","Alive",NA,"TCGA-BK-A0CA","NOT HISPANIC OR LATINO","E0F45236-F0F8-40F3-A8EA-16F3847F6A04",NA,371,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,21,30,"F22571D6-FFC4-4152-AAA1-8B01EAA5E3C5","FA1B05DD-462A-4103-8033-04957AFEA2F1","19a4ba74278d57c8fcd7285bb631b0ca.bam","TCGA-BK-A0CA-01A-21",75,0,0,0,25,"TOP",0,0,"TCGA-BK-A0CA-01A-01-BS1",75,"Taxotere","Chemotherapy","TCGA-BK-A0CA-D7335",NA,NA,NA,"TCGA-BK-A0CA-F40261_NTE-1","NO",1064,NA,"Alive",NA,"TCGA-BK-A0CA-F40261","TCGA-BK-A0CA",2,"BK","A0CA","YES","C54.1","8441/3","C54.1","YES","NO",-22378,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",371,NA,NA,NA,"TUMOR FREE","NO",8,2,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,61,2010,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
172506508,171072188,8179718565,"6B15E85B-0882-487B-BDC2-950EA679A81D.bw","51bd85e2-2c60-4654-bfcb-83dccef8964b","6b15e85b-0882-487b-bdc2-950ea679a81d","2016-08-25T13:10:22.501539-05:00","UNCID_2337859.c0393618-b453-496b-b53b-c774054f9238.130702_UNC12-SN629_0318_BC25TVACXX_8_AGTTCC.tar.gz","2420ca5b-091b-4684-b76c-c50d71c45b60",7251099666,"Illumina HiSeq","ea1cd72815d840f8c792480617073894","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:35:22.739257-05:00","2016-05-03T11:35:41.364390-05:00","2420ca5b-091b-4684-b76c-c50d71c45b60_analysis.xml","1a7c34d3ff96f24028370299607385bb","e25c5255-4aa4-4fdf-8720-72dc63f683c3",2124,"2016-09-29T18:07:39.411207-05:00","2420ca5b-091b-4684-b76c-c50d71c45b60_experiment.xml","5da8c73326460696f8d2103d9e582831","16dbec13-2c08-4d71-97b2-ccfa84a8dba9",2882,"2016-09-29T19:04:56.302403-05:00","2420ca5b-091b-4684-b76c-c50d71c45b60_run.xml","8f59ff6341b03d6429420f22707dc5ec","3acbf5f6-c443-4f39-937a-3296dd5c3620",355,"2016-09-08T10:38:51.860584-05:00","TCGA-BK-A0CA","2016-09-02T18:49:39.928556-05:00","female","TCGA-BK-A0CA_demographic",1949,"white","3b6442dc-a44c-5d6d-91f4-9aabb0781977","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A0CA_diagnosis","not reported",22378,"alive","8441/3",NA,1064,"1b042946-cb3e-57aa-8321-29375cbfaf8c","c54.1",-22378,"TCGA-BK-A0CA_treatment","86795392-d88c-5bbc-8ae3-67ede9060efc","01","false","TCGA-BK-A0CA-01B",NA,"6d59526a-9360-4adb-8427-a97c1c419a96",TRUE,"883D4832-75FB-495C-B93F-904FCA1AB18C","Primary Tumor",NA,679,NA,NA,1360108800,"02",400,"TCGA-BK-A0CA-01B-02",80,80,0,0,0,0,0,0,"2016-09-08T10:38:51.860584-05:00","2016-09-08T10:38:51.860584-05:00",1,1,0,0,"BOTTOM","TOP",1,1,"a82d9022-25bc-41fd-a8d0-4f4b196198d0","2b3c271e-2abf-445e-b9b5-769bff3349a7","TCGA-BK-A0CA-01B-02-BS2","TCGA-BK-A0CA-01B-01-BS1",99,99,"458d4241-d629-45c4-abba-6fcda89305f5","RNA","TCGA-BK-A0CA-01B-02R","583d12c1-59a2-42be-9430-6610b7538898",1.86,0.16,"UV Spec","R","23","TCGA-BK-A0CA-01B-02R-A277-07","c0393618-b453-496b-b53b-c774054f9238",0.16,NA,NA,NA,163,"4feb395e-390e-5e3f-a5a0-52b36201e248","TCGA-BK-A0CA_exposure","UNCID_2337859.c0393618-b453-496b-b53b-c774054f9238.130702_UNC12-SN629_0318_BC25TVACXX_8_AGTTCC.tar.gz","2014-02-04T11:37:05.000Z","2014-02-04T11:59:01.000Z","2420CA5B-091B-4684-B76C-C50D71C45B60","6D59526A-9360-4ADB-8427-A97C1C419A96","Unaligned reads",7251099666,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","C0393618-B453-496B-B53B-C774054F9238","University of North Carolina","564a31d1e4b08c5d868e753e","51BD85E2-2C60-4654-BFCB-83DCCEF8964B","Uterine Corpus Endometrial Carcinoma","TARGZ","458D4241-D629-45C4-ABBA-6FCDA89305F5","2014-02-04T11:59:01.000Z","583D12C1-59A2-42BE-9430-6610B7538898","None","YES",1,NA,"Primary Tumor","Christiana Healthcare",679,"458D4241-D629-45C4-ABBA-6FCDA89305F5",NA,"BK","unc.edu.c0393618-b453-496b-b53b-c774054f9238.2278717.junction_quantification.txt",NA,"TCGA-BK-A0CA-01B",NA,"BB5254BC-7922-4B42-BCF6-C77C8051C3BE","TCGA",2010,NA,NA,"TUMOR FREE","D836DB96-83FB-4F25-A16C-AAAAF55D7B12",61,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.30A62556-2260-4232-BA09-E3EFCA44EF7E.txt","Alive",NA,"TCGA-BK-A0CA","NOT HISPANIC OR LATINO","E0F45236-F0F8-40F3-A8EA-16F3847F6A04",NA,371,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,2,400,"A82D9022-25BC-41FD-A8D0-4F4B196198D0","583D12C1-59A2-42BE-9430-6610B7538898","unc.edu.c0393618-b453-496b-b53b-c774054f9238.2278717.junction_quantification.txt","TCGA-BK-A0CA-01B-02",80,0,0,1,0,"TOP",1,0,"TCGA-BK-A0CA-01B-01-BS1",99,"Taxotere","Chemotherapy","TCGA-BK-A0CA-D7335",NA,NA,NA,"TCGA-BK-A0CA-F40261_NTE-1","NO",1064,NA,"Alive",NA,"TCGA-BK-A0CA-F40261","TCGA-BK-A0CA",2,"BK","A0CA","YES","C54.1","8441/3","C54.1","YES","NO",-22378,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",371,NA,NA,NA,"TUMOR FREE","NO",8,2,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,61,2010,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31857410,31171260,2344294434,"9CF4E7DC-E6E5-4D15-97A4-859D05551775.bw","51bd85e2-2c60-4654-bfcb-83dccef8964b","9cf4e7dc-e6e5-4d15-97a4-859d05551775","2016-08-06T10:43:49.104230-05:00","UNCID_2210331.20f433c2-0909-4b42-9429-215774b19604.110407_UNC6-RDR300211_00095_FC64GJRAAXX_6.tar.gz","02190b44-579d-492c-8e9c-c0103d252721",2093732815,"Illumina GA","03a1fab66aa78b6460654aa2b0df9a5f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:31:16.999686-05:00","2016-05-03T11:15:47.420908-05:00","02190b44-579d-492c-8e9c-c0103d252721_analysis.xml","dc083ddd94ccf0073cd029cf781a55e4","4b6c6c3f-b376-401d-89d5-b3db2121dcab",2119,"2016-09-29T23:49:52.745089-05:00","02190b44-579d-492c-8e9c-c0103d252721_experiment.xml","d03b929cb6c7db625c335115c9b1742e","eb5d6f1b-b33e-4781-8a02-0377293981b9",2257,"2016-09-29T21:39:12.254034-05:00","02190b44-579d-492c-8e9c-c0103d252721_run.xml","d0bcd1283132681b2a9cdb02b65f2e41","9a4faff1-ad97-4c40-9674-cc10a222f5da",347,"2016-09-08T10:38:51.860584-05:00","TCGA-BK-A0CA","2016-09-02T18:49:39.928556-05:00","female","TCGA-BK-A0CA_demographic",1949,"white","3b6442dc-a44c-5d6d-91f4-9aabb0781977","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A0CA_diagnosis","not reported",22378,"alive","8441/3",NA,1064,"1b042946-cb3e-57aa-8321-29375cbfaf8c","c54.1",-22378,"TCGA-BK-A0CA_treatment","86795392-d88c-5bbc-8ae3-67ede9060efc","01","false","TCGA-BK-A0CA-01A",NA,"d836db96-83fb-4f25-a16c-aaaaf55d7b12",FALSE,"883D4832-75FB-495C-B93F-904FCA1AB18C","Primary Tumor",NA,86,300,NA,1291248000,"21",30,"TCGA-BK-A0CA-01A-21",0,75,0,0,50,0,50,25,"2016-09-08T10:38:51.860584-05:00","2016-09-08T10:38:51.860584-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"f22571d6-ffc4-4152-aaa1-8b01eaa5e3c5","04c00d4c-a3f4-4231-ab05-67cda5847ca5","TCGA-BK-A0CA-01A-02-BS2","TCGA-BK-A0CA-01A-01-BS1",0,75,"56df7696-d1f4-49e3-93d4-093c8c59ba2d","RNA","TCGA-BK-A0CA-01A-21R","0c2b324d-f151-4899-a15a-fcef11c4f15a",1.85,0.15,"UV Spec","R","23","TCGA-BK-A0CA-01A-21R-A118-07","20f433c2-0909-4b42-9429-215774b19604",0.15,NA,NA,NA,163,"4feb395e-390e-5e3f-a5a0-52b36201e248","TCGA-BK-A0CA_exposure","UNCID_2210331.20f433c2-0909-4b42-9429-215774b19604.110407_UNC6-RDR300211_00095_FC64GJRAAXX_6.tar.gz","2013-10-02T09:16:04.000Z","2013-10-02T09:29:03.000Z","02190B44-579D-492C-8E9C-C0103D252721","D836DB96-83FB-4F25-A16C-AAAAF55D7B12","Unaligned reads",2093732815,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","20F433C2-0909-4B42-9429-215774B19604","University of North Carolina","56607a05e4b0ec1099f8dde5","51BD85E2-2C60-4654-BFCB-83DCCEF8964B","Uterine Corpus Endometrial Carcinoma","TARGZ","56DF7696-D1F4-49E3-93D4-093C8C59BA2D","2013-10-02T09:29:03.000Z","0C2B324D-F151-4899-A15A-FCEF11C4F15A","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",86,"56DF7696-D1F4-49E3-93D4-093C8C59BA2D",NA,"BK","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.30A62556-2260-4232-BA09-E3EFCA44EF7E.txt",300,"TCGA-BK-A0CA-01A",NA,"BB5254BC-7922-4B42-BCF6-C77C8051C3BE","TCGA",2010,NA,NA,"TUMOR FREE","D836DB96-83FB-4F25-A16C-AAAAF55D7B12",61,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.30A62556-2260-4232-BA09-E3EFCA44EF7E.txt","Alive",NA,"TCGA-BK-A0CA","NOT HISPANIC OR LATINO","E0F45236-F0F8-40F3-A8EA-16F3847F6A04",NA,371,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,21,30,"F22571D6-FFC4-4152-AAA1-8B01EAA5E3C5","FA1B05DD-462A-4103-8033-04957AFEA2F1","19a4ba74278d57c8fcd7285bb631b0ca.bam","TCGA-BK-A0CA-01A-21",75,0,0,0,25,"TOP",0,0,"TCGA-BK-A0CA-01A-01-BS1",75,"Taxotere","Chemotherapy","TCGA-BK-A0CA-D7335",NA,NA,NA,"TCGA-BK-A0CA-F40261_NTE-1","NO",1064,NA,"Alive",NA,"TCGA-BK-A0CA-F40261","TCGA-BK-A0CA",2,"BK","A0CA","YES","C54.1","8441/3","C54.1","YES","NO",-22378,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",371,NA,NA,NA,"TUMOR FREE","NO",8,2,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,61,2010,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32291497,31093103,2326144356,"39286936-7CC8-4045-9D84-8340D2A49CCA.bw","51de7e94-e2fa-420b-9aa2-3637d17fc6ea","39286936-7cc8-4045-9d84-8340d2a49cca","2016-08-09T14:13:27.015062-05:00","UNCID_2207216.13096ff9-ae2d-4ccb-8127-8e4238cef4d3.110719_UNC2-RDR300275_00077_FC_70KATAAXX_1.tar.gz","dd643648-2d5d-40ea-b5cf-59181c50fa7e",2005562560,"Illumina GA","fcdcfac0c6e1a9fe6fa7ef69952a3036","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:17:09.157489-05:00","2016-05-03T11:13:42.359647-05:00","dd643648-2d5d-40ea-b5cf-59181c50fa7e_analysis.xml","7ca93020115ca51bb20312121fc31052","1cab6420-792e-4f89-83b4-486be3147d5a",2121,"2016-09-29T21:37:26.418951-05:00","dd643648-2d5d-40ea-b5cf-59181c50fa7e_experiment.xml","d8d702ce6b439799871f527ce3623b4a","9948855c-79ab-4f7b-9daf-01d6270fb701",2257,"2016-09-29T19:21:04.573795-05:00","dd643648-2d5d-40ea-b5cf-59181c50fa7e_run.xml","6eb19565e37c8f2764a5d3ebbf69b2ed","44fb3a64-8135-4ab5-9fa4-a44b6a84116d",347,"2016-09-08T11:04:10.252129-05:00","TCGA-AP-A1DK","2016-09-02T18:51:23.726558-05:00","female","TCGA-AP-A1DK_demographic",1953,"white","2f3cfe29-af4d-5dcd-84a6-304a3717051a","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1DK_diagnosis","not reported",19509,"alive","8380/3",NA,2767,"8d4d021a-930e-59f9-a84e-62cca254ea07","c54.1",-19509,"TCGA-AP-A1DK_treatment","3f4425e9-8e50-5558-9a49-80680266ae7e","01","true","TCGA-AP-A1DK-01A",NA,"1cb12a0f-0081-441f-a86e-71d76ef5b8d0",FALSE,"9A3BB88B-F16F-4773-8912-CF519B847354","Primary Tumor",NA,1541,70,NA,1295827200,"11",30,"TCGA-AP-A1DK-01A-11",80,NA,0,NA,0,NA,20,NA,"2016-09-08T11:04:10.252129-05:00",NA,20,NA,20,NA,"TOP",NA,20,NA,"63ee7863-ddca-436d-9282-72b8b54de736",NA,"TCGA-AP-A1DK-01A-01-TSA",NA,60,NA,"8b4cac80-ad26-467c-b021-daf2ac15e1f3","RNA","TCGA-AP-A1DK-01A-11R","862f823c-0cc8-4b4f-a143-8eabf01c6996",1.93,0.18,"UV Spec","R","23","TCGA-AP-A1DK-01A-11R-A137-07","13096ff9-ae2d-4ccb-8127-8e4238cef4d3",0.18,NA,56,21.875,160,"9aff286b-26c6-58b1-b52a-7058e7f2c1a1","TCGA-AP-A1DK_exposure","UNCID_2207216.13096ff9-ae2d-4ccb-8127-8e4238cef4d3.110719_UNC2-RDR300275_00077_FC_70KATAAXX_1.tar.gz","2013-09-29T07:01:04.000Z","2013-09-29T07:13:02.000Z","DD643648-2D5D-40EA-B5CF-59181C50FA7E","1CB12A0F-0081-441F-A86E-71D76EF5B8D0","Unaligned reads",2005562560,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","13096FF9-AE2D-4CCB-8127-8E4238CEF4D3","University of North Carolina","564a3336e4b08c5d868ee7c6","51DE7E94-E2FA-420B-9AA2-3637D17FC6EA","Uterine Corpus Endometrial Carcinoma","TARGZ","8B4CAC80-AD26-467C-B021-DAF2AC15E1F3","2013-09-29T07:13:02.000Z","862F823C-0CC8-4B4F-A143-8EABF01C6996","None","NO",1,NA,"Primary Tumor","MSKCC",1541,"8B4CAC80-AD26-467C-B021-DAF2AC15E1F3",NA,"AP","TCGA-AP-A1DK-01A-11R-A136-13_mirna.bam.bai",70,"TCGA-AP-A1DK-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","5F33F283-750B-4EA1-9F6C-E248BD93D792",53,"AP-A1DK-01A-11D_BCR3730_2011-09-21_030.fsa","Alive",NA,"TCGA-AP-A1DK",NA,"CD5ABA23-3641-4CAF-98D5-BDC227BB6AF3",NA,1650,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"F944EBD2-3D55-4E39-A106-30604E8208D4","WHITE",NA,11,30,"63EE7863-DDCA-436D-9282-72B8B54DE736","5BC96E30-CBAD-4E3F-9645-831DECCA0528","TCGA-AP-A1DK-01A-01D-YYYY-23.txt","TCGA-AP-A1DK-01A-11",80,0,0,20,20,"TOP",20,20,"TCGA-AP-A1DK-01A-01-TSA",60,NA,NA,NA,"TCGA-AP-A1DK-R13646","IMPLANTS","Primary Tumor Field","TCGA-AP-A1DK-F68435_NTE-1","NO",2767,"TUMOR FREE","Alive",NA,"TCGA-AP-A1DK-F68435","TCGA-AP-A1DK",1,"AP","A1DK","YES","C54.1","8380/3","C54.1","NO","YES",-19509,"FEMALE","WHITE",NA,"No","No","Alive",1650,NA,NA,NA,"TUMOR FREE","NO",9,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2006,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
120102130,118015124,5627122621,"1E4EB005-99B0-4A92-B010-2A91C76D6FEA.bw","525fb4fc-2167-4506-b4fa-fb896bf64cd0","1e4eb005-99b0-4a92-b010-2a91c76d6fea","2016-08-09T13:15:25.612995-05:00","UNCID_2178392.5dc20b99-8440-4d30-a803-1e10cdb29dbe.130328_UNC10-SN254_0443_AD238RACXX_6_TAGCTT.tar.gz","92c8d487-3111-4a60-aaed-f7b68d96a7f5",4932893308,"Illumina HiSeq","6c8b6339332fbf56731c462e44411f4f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:32:37.364791-05:00","2016-05-03T10:56:47.878169-05:00","92c8d487-3111-4a60-aaed-f7b68d96a7f5_analysis.xml","850ebcbf33e6c76bc89376c7961814bf","9655ae6f-8992-410b-9f00-0cd8604647b1",2123,"2016-10-07T15:58:18.885294-05:00","92c8d487-3111-4a60-aaed-f7b68d96a7f5_experiment.xml","5d5e28e29b5a6e73aef4f206d8d0f681","cabef397-09a1-4b34-8984-df12fd6cf91e",2431,"2016-09-29T22:58:41.255170-05:00","92c8d487-3111-4a60-aaed-f7b68d96a7f5_run.xml","8bd248f407c279cf4fb9983b98e0b8f4","cb775563-7144-46b2-b53a-685d994ee234",354,"2016-09-08T10:40:22.236718-05:00","TCGA-AJ-A3BI","2016-09-02T18:48:15.337704-05:00","female","TCGA-AJ-A3BI_demographic",1944,"white","c5e55511-7437-599c-9032-552b66dedc28","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3BI_diagnosis","not reported",24623,"alive","8380/3",NA,575,"76791262-f3b4-5bfc-85aa-0244e4b2ac0f","c54.1",-24623,"TCGA-AJ-A3BI_treatment","19a961c6-bdb3-5294-afce-82e6ac0a525a","01","false","TCGA-AJ-A3BI-01A",NA,"b4d093ec-48a4-4edd-a88c-de51130a368c",FALSE,"19B5518D-075F-40BE-A104-75C925F133A4","Primary Tumor",NA,137,19,NA,1317340800,"11",19,"TCGA-AJ-A3BI-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T10:40:22.236718-05:00",NA,0,NA,0,NA,"TOP",NA,20,NA,"417a5b08-38ac-40c6-8774-2036aa15bdd5",NA,"TCGA-AJ-A3BI-01A-01-TS1",NA,80,NA,"3b3230c0-1d0c-4b66-ae79-da2a7c7ac62f","RNA","TCGA-AJ-A3BI-01A-11R","b80463e6-27e7-43b1-98f0-49b668250a51",1.8,0.17,"UV Spec","R","23","TCGA-AJ-A3BI-01A-11R-A213-07","5dc20b99-8440-4d30-a803-1e10cdb29dbe",0.17,NA,100,40.5695971439004,157,"fef3e0f2-340b-531a-b24f-a150ededc547","TCGA-AJ-A3BI_exposure","UNCID_2178392.5dc20b99-8440-4d30-a803-1e10cdb29dbe.130328_UNC10-SN254_0443_AD238RACXX_6_TAGCTT.tar.gz","2013-09-12T01:36:05.000Z","2013-09-12T02:03:01.000Z","92C8D487-3111-4A60-AAED-F7B68D96A7F5","B4D093EC-48A4-4EDD-A88C-DE51130A368C","Unaligned reads",4932893308,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","5DC20B99-8440-4D30-A803-1E10CDB29DBE","University of North Carolina","564a3869e4b0ef1218197c40","525FB4FC-2167-4506-B4FA-FB896BF64CD0","Uterine Corpus Endometrial Carcinoma","TARGZ","3B3230C0-1D0C-4B66-AE79-DA2A7C7AC62F","2013-09-12T02:03:01.000Z","B80463E6-27E7-43B1-98F0-49B668250A51","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",137,"3B3230C0-1D0C-4B66-AE79-DA2A7C7AC62F",NA,"AJ","UNCID_1971947.5dc20b99-8440-4d30-a803-1e10cdb29dbe.sorted_genome_alignments.bam",19,"TCGA-AJ-A3BI-01A",NA,"7BB8ECE4-8DE4-45BF-BDE8-5BD37D379F4D","TCGA",2011,NA,NA,"TUMOR FREE","B4D093EC-48A4-4EDD-A88C-DE51130A368C",67,"nationwidechildrens.org_clinical.TCGA-AJ-A3BI.xml","Alive",NA,"TCGA-AJ-A3BI","NOT HISPANIC OR LATINO","827D47F9-BB9F-4B1B-A007-66DEE720F668",NA,68,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",201,NA,NA,"WHITE",NA,11,19,"417A5B08-38AC-40C6-8774-2036AA15BDD5","B80463E6-27E7-43B1-98F0-49B668250A51","UNCID_1971947.5dc20b99-8440-4d30-a803-1e10cdb29dbe.sorted_genome_alignments.bam","TCGA-AJ-A3BI-01A-11",85,0,0,0,0,"TOP",20,0,"TCGA-AJ-A3BI-01A-01-TS1",80,"Paclitaxel","Chemotherapy","TCGA-AJ-A3BI-D43703",NA,NA,NA,"TCGA-AJ-A3BI-F43699_NTE-1","YES",575,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3BI-F43699","TCGA-AJ-A3BI",1,"AJ","A3BI","YES","C54.1","8380/3","C54.1","YES","NO",-24623,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",68,NA,NA,NA,"TUMOR FREE","NO",3,2,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
150819494,148932984,7111541187,"8ABD6FD1-CF73-4663-8E2A-B2C134AE7E6F.bw","5262d82d-fc43-41f4-9b23-c9ac6f237ff0","8abd6fd1-cf73-4663-8e2a-b2c134ae7e6f","2016-08-09T13:15:03.651520-05:00","UNCID_2173143.da84a25d-fd15-40ff-80c1-e3f2d2b2b301.130509_UNC10-SN254_0462_AC232JACXX_2_GCCAAT.tar.gz","6e35337d-e76d-4a4c-afc3-9b8d72750089",7128969940,"Illumina HiSeq","dd4bc60fed8f96eb7b621bcf421bc49b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:01:40.327587-05:00","2016-05-03T10:55:55.600288-05:00","6e35337d-e76d-4a4c-afc3-9b8d72750089_analysis.xml","81bd602b7ecc1178088f9092481d5059","cd3f4e0b-b932-47c6-aeaa-32f817e78376",2123,"2016-09-29T17:37:54.044919-05:00","6e35337d-e76d-4a4c-afc3-9b8d72750089_experiment.xml","632f8165e89f35f3b691bf71ad512d79","03d91302-8885-453b-992b-a07cceaeed2e",2431,"2016-09-29T20:40:10.215961-05:00","6e35337d-e76d-4a4c-afc3-9b8d72750089_run.xml","8f3c8648e0ab5520dd7e78ac427c6dd9","7599e2e8-51d2-4160-b06d-952ce3a9d648",354,"2016-09-08T11:04:40.130863-05:00","TCGA-AX-A3FZ","2016-09-02T18:49:12.188054-05:00","female","TCGA-AX-A3FZ_demographic",1977,"white","22d6ec5d-0d1f-56e3-babd-8ee6d909622c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3FZ_diagnosis","not reported",12331,"alive","8380/3",NA,2,"327da626-cc15-56c4-8c4d-aefe97dee801","c54.1",-12331,"TCGA-AX-A3FZ_treatment","b393e885-8aa9-5599-9315-f9c680b86c57","01","false","TCGA-AX-A3FZ-01A",NA,"3e114d9b-a96e-4b58-84a0-ad0ecf10b199",FALSE,"4989F66F-57F8-4B1C-97DD-69F3036EB0BA","Primary Tumor",NA,658,100,NA,1322784000,"11",30,"TCGA-AX-A3FZ-01A-11",96,NA,0,NA,0,NA,3,NA,"2016-09-08T11:04:40.130863-05:00",NA,1,NA,0,NA,"TOP",NA,3,NA,"0be8c3aa-52df-40c0-8024-eb0d7dc6ce5a",NA,"TCGA-AX-A3FZ-01A-01-TS1",NA,94,NA,"88534bcc-15c1-4001-a57f-af8008ef358c","RNA","TCGA-AX-A3FZ-01A-11R","273e5857-dbac-4437-b7da-f90410fbd6d6",1.8,0.17,"UV Spec","R","23","TCGA-AX-A3FZ-01A-11R-A22K-07","da84a25d-fd15-40ff-80c1-e3f2d2b2b301",0.17,NA,113,48.9092797783934,152,"61608024-72c8-5044-b4db-1eb7933b310d","TCGA-AX-A3FZ_exposure","UNCID_2173143.da84a25d-fd15-40ff-80c1-e3f2d2b2b301.130509_UNC10-SN254_0462_AC232JACXX_2_GCCAAT.tar.gz","2013-09-09T11:16:09.000Z","2013-09-09T11:45:01.000Z","6E35337D-E76D-4A4C-AFC3-9B8D72750089","3E114D9B-A96E-4B58-84A0-AD0ECF10B199","Unaligned reads",7128969940,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","DA84A25D-FD15-40FF-80C1-E3F2D2B2B301","University of North Carolina","56607d3be4b018727fea3249","5262D82D-FC43-41F4-9B23-C9AC6F237FF0","Uterine Corpus Endometrial Carcinoma","TARGZ","88534BCC-15C1-4001-A57F-AF8008EF358C","2013-09-09T11:45:01.000Z","273E5857-DBAC-4437-B7DA-F90410FBD6D6","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",658,"88534BCC-15C1-4001-A57F-AF8008EF358C",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.A6279404-9822-4FE1-A21E-949EAAF4A31F.txt",100,"TCGA-AX-A3FZ-01A",NA,NA,"TCGA",2010,NA,NA,NA,"94677C92-5D25-49F0-A533-9D0006E29A3C",33,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.A6279404-9822-4FE1-A21E-949EAAF4A31F.txt","Alive",NA,"TCGA-AX-A3FZ","NOT HISPANIC OR LATINO","B0930DE9-6BC7-44BD-881E-B8EEB07187AD",NA,6,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"0BE8C3AA-52DF-40C0-8024-EB0D7DC6CE5A","6D02E132-DF99-41F2-B419-9184B292F4E8","UNCID_2173143.da84a25d-fd15-40ff-80c1-e3f2d2b2b301.130509_UNC10-SN254_0462_AC232JACXX_2_GCCAAT.tar.gz","TCGA-AX-A3FZ-01A-11",96,0,0,1,3,"TOP",3,0,"TCGA-AX-A3FZ-01A-01-TS1",94,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3FZ-F58286_NTE-1",NA,2,NA,"Alive",NA,"TCGA-AX-A3FZ-F58286","TCGA-AX-A3FZ",1,"AX","A3FZ","YES","C54.1","8380/3","C54.1","NO","YES",-12331,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",6,NA,NA,NA,NA,"NO",3,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,33,2010,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136688052,134226191,6402243197,"07FB2A68-6847-493D-A5BB-C7490C26B52C.bw","52fef8a9-6860-48bd-b992-a56ccad1243c","07fb2a68-6847-493d-a5bb-c7490c26b52c","2016-08-24T09:58:10.845563-05:00","UNCID_2357771.9cfe7287-c1aa-4fc0-8d4f-dc72655b2810.131118_UNC15-SN850_0339_AC347DACXX_2_ATCACG.tar.gz","fafe7ee7-a497-4ac5-b6a0-45be8182e8b3",6478581109,"Illumina HiSeq","433859fc21a545d049bb55470e7d9803","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:14:50.538228-05:00","2016-05-03T11:37:12.430798-05:00","fafe7ee7-a497-4ac5-b6a0-45be8182e8b3_analysis.xml","674c3c674fcc58375e3ea9e33f2eb2b6","1b329e1c-6882-4949-8602-63b318f78e55",2124,"2016-08-13T02:57:12.020446-05:00","fafe7ee7-a497-4ac5-b6a0-45be8182e8b3_experiment.xml","6ecd4fe5b9c28180eed04420a655b8cc","be34a4d5-72db-4d37-84f1-3ee661cac117",2628,"2016-09-29T21:44:23.649660-05:00","fafe7ee7-a497-4ac5-b6a0-45be8182e8b3_run.xml","26fd721d4461fe7caed34d8493683470","9d8a5f31-526b-4c32-904d-3059a9d3b645",354,"2016-09-08T10:28:15.162106-05:00","TCGA-AX-A2HH","2016-09-02T18:52:29.604837-05:00","female","TCGA-AX-A2HH_demographic",1950,"white","5155c521-35ee-5ea9-be34-9912fa0d736b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HH_diagnosis","not reported",21924,"alive","8380/3",NA,540,"f32ae4a0-f573-5a9b-b3dc-97ac5ff847e5","c54.1",-21924,"TCGA-AX-A2HH_treatment","b7522251-1f1c-5103-ac45-92e2008a62a9","01","false","TCGA-AX-A2HH-01A",NA,"0e73eeac-251a-43fa-9141-636262ee3129",FALSE,"2EE7245F-7069-456A-A215-41E59D9FE606","Primary Tumor",NA,462,150,NA,1308182400,"11",30,"TCGA-AX-A2HH-01A-11",96,NA,0,NA,0,NA,2,NA,"2016-09-08T10:28:15.162106-05:00",NA,1,NA,0,NA,"TOP",NA,18,NA,"5810b3f2-6657-4383-a153-7a619f5650c7",NA,"TCGA-AX-A2HH-01A-01-TSA",NA,80,NA,"5fcef1d5-3dfa-44bb-8333-a90bf2abb63b","RNA","TCGA-AX-A2HH-01A-11R","4bdc122e-3872-4eb8-8fc7-af8a872e9682",1.75,0.15,"UV Spec","R","23","TCGA-AX-A2HH-01A-11R-A32Y-07","9cfe7287-c1aa-4fc0-8d4f-dc72655b2810",0.15,NA,65,27.0551508844953,155,"e15ec8c4-139a-5a3f-9d00-9d1932038f6b","TCGA-AX-A2HH_exposure","UNCID_2357771.9cfe7287-c1aa-4fc0-8d4f-dc72655b2810.131118_UNC15-SN850_0339_AC347DACXX_2_ATCACG.tar.gz","2014-02-25T03:03:04.000Z","2014-02-25T03:33:03.000Z","FAFE7EE7-A497-4AC5-B6A0-45BE8182E8B3","0E73EEAC-251A-43FA-9141-636262EE3129","Unaligned reads",6478581109,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","9CFE7287-C1AA-4FC0-8D4F-DC72655B2810","University of North Carolina","564a3767e4b0ef121819299f","52FEF8A9-6860-48BD-B992-A56CCAD1243C","Uterine Corpus Endometrial Carcinoma","TARGZ","5FCEF1D5-3DFA-44BB-8333-A90BF2ABB63B","2014-02-25T03:33:03.000Z","4BDC122E-3872-4EB8-8FC7-AF8A872E9682","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",462,"5FCEF1D5-3DFA-44BB-8333-A90BF2ABB63B",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E63D7EF7-EE98-4738-9BA6-D2BB407CBBCA.txt",150,"TCGA-AX-A2HH-01A",NA,NA,"TCGA",2010,NA,NA,"WITH TUMOR","241A35AA-97E5-4232-B0AD-3BF268B92318",60,"nationwidechildrens.org_clinical.TCGA-AX-A2HH.xml","Alive",NA,"TCGA-AX-A2HH","NOT HISPANIC OR LATINO","B8D3CF05-770C-441C-8595-C00B2B197E13",NA,540,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"5810B3F2-6657-4383-A153-7A619F5650C7","8B124CE3-F3C7-4A11-94FE-5F57937AD52A","UNCID_2281484.9cfe7287-c1aa-4fc0-8d4f-dc72655b2810.sorted_genome_alignments.bam.bai","TCGA-AX-A2HH-01A-11",96,0,0,1,2,"TOP",18,0,"TCGA-AX-A2HH-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,"NO",540,"WITH TUMOR","Alive",NA,"TCGA-AX-A2HH-F31851","TCGA-AX-A2HH",1,"AX","A2HH","YES","C54.1","8380/3","C54.1","NO","YES",-21924,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",540,NA,NA,NA,"WITH TUMOR","NO",31,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81492746,69419246,3295406499,"5C689B08-91FF-45D3-8294-2A8E84D9A018.bw","53245616-e095-4616-89bb-6062669122da","5c689b08-91ff-45d3-8294-2a8e84d9a018","2016-08-09T14:42:59.023314-05:00","UNCID_2668042.60728ff8-1098-4ed9-9cc0-b3d5523736d3.141031_UNC11-SN627_0387_AC5FAKACXX_1_TTAGGC.tar.gz","2810adfd-0302-449a-a114-cef8acb43a5a",3133952720,"Illumina HiSeq","f731be1dbc03e0a9fd435328893311a6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:46:09.086221-05:00","2016-06-22T11:18:40.518409-05:00","2810adfd-0302-449a-a114-cef8acb43a5a_analysis.xml","95d83c2df5ea881a40fc50b091dc7d70","e91f2463-4de3-4b8c-bbf9-36e6a2eee770",2124,"2016-08-13T06:30:29.016133-05:00","2810adfd-0302-449a-a114-cef8acb43a5a_experiment.xml","18131d90d94168b491a7024fcbab8c60","117af59e-2650-4eee-a568-168299b775c8",2628,"2016-09-29T21:05:15.324355-05:00","2810adfd-0302-449a-a114-cef8acb43a5a_run.xml","3e5ddcfc5f564a0e74fb27195a52df19","854d9e5f-113e-49db-a726-ec723286f606",354,"2016-09-08T10:49:52.239568-05:00","TCGA-DI-A1BU","2016-09-02T18:51:45.573332-05:00","female","TCGA-DI-A1BU_demographic",1953,"white","5e7522d0-0e5d-5ca7-84c7-e0ae4e82dfee","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A1BU_diagnosis","not reported",20114,"alive","8380/3",NA,1195,"0322cb67-0295-5910-8351-7749a26fb857","c54.1",-20114,"TCGA-DI-A1BU_treatment","31eafe0e-20ad-5676-b50e-a44dd52a62b3","01","false","TCGA-DI-A1BU-01A",NA,"241bfb1f-5cf8-458d-b335-18babf507e85",FALSE,"18A286FD-E85B-48FC-B193-456AB10D24B9","Primary Tumor",NA,903,140,NA,1296172800,"11",30,"TCGA-DI-A1BU-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T10:49:52.239568-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"6b7a8d1d-fe89-4aaf-ab70-15ae1f2c8196",NA,"TCGA-DI-A1BU-01A-01-TS1",NA,80,NA,"7f3adc76-2802-467d-9ee3-cb0d45d0b62c","RNA","TCGA-DI-A1BU-01A-11R","557ddaab-ab7d-430b-a125-608efc1a5ee1",1.86,0.16,"UV Spec","R","23","TCGA-DI-A1BU-01A-11R-A137-07","60728ff8-1098-4ed9-9cc0-b3d5523736d3",0.16,NA,93,31.804657843439,171,"bc3e44bb-535b-5cf3-a227-42686d835588","TCGA-DI-A1BU_exposure","UNCID_2668042.60728ff8-1098-4ed9-9cc0-b3d5523736d3.141031_UNC11-SN627_0387_AC5FAKACXX_1_TTAGGC.tar.gz","2015-01-28T07:27:04.000Z","2015-01-28T07:42:05.000Z","2810ADFD-0302-449A-A114-CEF8ACB43A5A","241BFB1F-5CF8-458D-B335-18BABF507E85","Unaligned reads",3133952720,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","60728FF8-1098-4ED9-9CC0-B3D5523736D3","University of North Carolina","56607bb9e4b016715ab6af18","53245616-E095-4616-89BB-6062669122DA","Uterine Corpus Endometrial Carcinoma","TARGZ","7F3ADC76-2802-467D-9EE3-CB0D45D0B62C","2015-01-28T07:42:05.000Z","557DDAAB-AB7D-430B-A125-608EFC1A5EE1","United States","NO",1,NA,"Primary Tumor","MD Anderson",903,"7F3ADC76-2802-467D-9EE3-CB0D45D0B62C",NA,"DI","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.11A1BC6D-8970-4733-A5F1-EE1D9E0821C3.txt",140,"TCGA-DI-A1BU-01A",NA,"E8C43E75-3E96-46E9-A2A3-F584F56B2D8A","TCGA",2008,NA,NA,"TUMOR FREE","565621D6-BB5C-42DE-85BF-3137AE9D22E2",55,"GAMMA_p_TCGA_b103_104_SNP_N_GenomeWideSNP_6_A12_755824.raw.copynumber.data.txt","Alive",NA,"TCGA-DI-A1BU","NOT HISPANIC OR LATINO","607B5723-05D6-44FC-B600-64B281E8CC9B",NA,1005,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"B2DFFAC9-09C0-4FE3-B65E-F7FE1EBFFF6D","WHITE",NA,11,30,"6B7A8D1D-FE89-4AAF-AB70-15AE1F2C8196","557DDAAB-AB7D-430B-A125-608EFC1A5EE1","TCGA-DI-A1BU-01A-11R-A136-13_mirna.bam.bai","TCGA-DI-A1BU-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-DI-A1BU-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-DI-A1BU-D20906","TCGA-DI-A1BU-R20911","OTHER: SPECIFY IN NOTES","Regional site",NA,"NO",1195,"TUMOR FREE","Alive",NA,"TCGA-DI-A1BU-F20903","TCGA-DI-A1BU",1,"DI","A1BU","YES","C54.1","8380/3","C54.1","NO","YES",-20114,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1005,NA,NA,NA,"TUMOR FREE","NO",13,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,55,2008,"Other method, specify:",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
30668058,30005372,2251483757,"944BB71C-6508-4743-BFE3-3F2970AEB780.bw","53707bb3-426a-43cb-830f-3eeed930295f","944bb71c-6508-4743-bfe3-3f2970aeb780","2016-08-09T14:14:18.411507-05:00","UNCID_2210190.c4bc1759-7de2-427c-a936-431f343ea929.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_1.tar.gz","ec0754ce-a0b4-4126-b0c6-94d7902df8fc",1923393081,"Illumina GA","8b72ec84d8b9c5a71997b04d040aea06","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:40:58.756444-05:00","2016-05-03T11:15:47.407128-05:00","ec0754ce-a0b4-4126-b0c6-94d7902df8fc_analysis.xml","1177311e1255fc29b9c4df22bc6a05a8","9b6c4986-c29b-4261-841e-46d6b298e2c7",2123,"2016-09-29T22:48:26.207289-05:00","ec0754ce-a0b4-4126-b0c6-94d7902df8fc_experiment.xml","7e318a4c55f9cfd00eb0f48c40e7fc59","c54270fb-6e71-4ab7-9e49-ea2f84567ed0",2257,"2016-09-29T17:53:20.532779-05:00","ec0754ce-a0b4-4126-b0c6-94d7902df8fc_run.xml","e200a4b72c867a713d1411d6356eec7c","0dca2cff-450c-45f4-b48f-ab9125a44328",347,"2016-09-08T11:14:42.919951-05:00","TCGA-A5-A0G1","2016-09-02T18:49:16.553591-05:00","female","TCGA-A5-A0G1_demographic",1929,"white","8520fd69-3ed2-5152-961f-02319d643e56","not hispanic or latino",2004,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0G1_diagnosis","not reported",24477,"dead","8441/3",3251,NA,"f504f44e-78b2-5166-bdd0-c3af786879ef","c54.1",-24477,"TCGA-A5-A0G1_treatment","80033256-0bb7-53b5-a5d8-3a946ca42d16","01","true","TCGA-A5-A0G1-01A",NA,"b7fb82ee-0219-4fd0-b656-0509b9eda5f2",FALSE,"A2EB7E85-E836-462E-ABBA-65D5110CEB1C","Primary Tumor",NA,5015,190,NA,1291248000,"11",30,"TCGA-A5-A0G1-01A-11",60,60,0,0,10,10,25,25,"2016-09-08T11:14:42.919951-05:00","2016-09-08T11:14:42.919951-05:00",90,90,0,0,"BOTTOM","TOP",5,5,"d4eae68d-4714-4eb3-a179-cf2860555943","68d08dd9-34ee-4b40-a1e1-e056dcf37de6","TCGA-A5-A0G1-01A-01-BS1","TCGA-A5-A0G1-01A-01-TS1",60,60,"fdbdb704-3dba-43b6-85e6-38f9a686aa18","RNA","TCGA-A5-A0G1-01A-11R","f3789bc7-913b-427b-9885-64a51007de61",1.87,0.16,"UV Spec","R","23","TCGA-A5-A0G1-01A-11R-A118-07","c4bc1759-7de2-427c-a936-431f343ea929",0.16,NA,59,20.9041950113379,168,"c161256e-3e59-5442-b8e6-05d300a7bd00","TCGA-A5-A0G1_exposure","UNCID_2210190.c4bc1759-7de2-427c-a936-431f343ea929.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_1.tar.gz","2013-10-02T07:13:04.000Z","2013-10-02T07:26:02.000Z","EC0754CE-A0B4-4126-B0C6-94D7902DF8FC","B7FB82EE-0219-4FD0-B656-0509B9EDA5F2","Unaligned reads",1923393081,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C4BC1759-7DE2-427C-A936-431F343EA929","University of North Carolina","566075fde4b018727fea0669","53707BB3-426A-43CB-830F-3EEED930295F","Uterine Corpus Endometrial Carcinoma","TARGZ","FDBDB704-3DBA-43B6-85E6-38F9A686AA18","2013-10-02T07:26:02.000Z","F3789BC7-913B-427B-9885-64A51007DE61","None","NO",1,NA,"Primary Tumor","Cedars Sinai",5015,"FDBDB704-3DBA-43B6-85E6-38F9A686AA18",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.CD92C224-42A7-4CC0-BBEF-FE688BE73F3E.txt",190,"TCGA-A5-A0G1-01A",NA,NA,"TCGA",1996,NA,NA,"TUMOR FREE","8E25F882-5134-41E3-80AD-3F61FB347C91",67,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.CD92C224-42A7-4CC0-BBEF-FE688BE73F3E.txt","Dead",3251,"TCGA-A5-A0G1","NOT HISPANIC OR LATINO","EC972B95-333F-4307-9542-A941CD0C6F65",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",92,NA,"D50D22FE-8E04-40FF-86B1-AC336FAB2802","WHITE",NA,11,30,"D4EAE68D-4714-4EB3-A179-CF2860555943","7456FDF7-476A-4092-AB53-480030396843","UNCID_2210190.c4bc1759-7de2-427c-a936-431f343ea929.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_1.tar.gz","TCGA-A5-A0G1-01A-11",60,10,0,90,25,"TOP",5,0,"TCGA-A5-A0G1-01A-01-TS1",60,NA,NA,NA,"TCGA-A5-A0G1-R5840","EXTERNAL BEAM","Primary Tumor Field",NA,NA,NA,"TUMOR FREE","Dead",3251,"TCGA-A5-A0G1-F5839","TCGA-A5-A0G1",1,"A5","A0G1","YES","C54.1","8441/3","C54.1","NO","YES",-24477,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,3251,NA,NA,"TUMOR FREE","NO",7,1,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,1996,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
38518482,38386925,2859718485,"C5C81E17-78C0-49A1-B5DE-1F42CEB14C93.bw","53e8e07e-18f9-4c9b-9783-a5b67ceddcf7","c5c81e17-78c0-49a1-b5de-1f42ceb14c93","2016-08-05T05:52:11.081636-05:00","UNCID_2203686.3e40a983-aba5-4454-88df-a271c296ada6.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_1.tar.gz","2855ff81-0ea5-40a0-a6c9-22b6d7264b02",2499615160,"Illumina GA","8c2ddd13b233d43e6aa95112e819ec82","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:33:25.107213-05:00","2016-05-03T11:10:47.515830-05:00","2855ff81-0ea5-40a0-a6c9-22b6d7264b02_analysis.xml","2eeed15576d85642e0e2a19e22c72e6c","26af28b0-9cdd-4707-b9ca-84c6cd34ae03",2121,"2016-09-29T17:36:51.584292-05:00","2855ff81-0ea5-40a0-a6c9-22b6d7264b02_experiment.xml","05f368142aff97a6b718a22a0a794a22","032a2892-a1ff-47cc-9757-97ba20b5a14b",2257,"2016-09-29T21:42:26.559865-05:00","2855ff81-0ea5-40a0-a6c9-22b6d7264b02_run.xml","855a16e28953b68d6fda6a8ed84b1e46","9c529070-5467-4e52-924a-e019ea029347",347,"2016-09-08T11:03:57.429674-05:00","TCGA-AX-A2HC","2016-09-02T18:52:27.327088-05:00","female","TCGA-AX-A2HC_demographic",1953,"black or african american","baa2500b-d4c9-5e0f-bc4a-41390e221f01","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HC_diagnosis","not reported",19485,"alive","8380/3",NA,1044,"338fe46f-b6a4-50ed-8fc2-2ff30bca40e1","c54.1",-19485,"TCGA-AX-A2HC_treatment","e28a8158-7cf7-535b-86c4-451eaa12d50a","01","false","TCGA-AX-A2HC-01A",NA,"1bacdcab-f02f-4c6e-89e5-4a221c2e3bc0",FALSE,"90DC9BBA-4666-4702-8BA1-F57253E43CDD","Primary Tumor",NA,1786,120,NA,1308182400,"11",30,"TCGA-AX-A2HC-01A-11",98,NA,0,NA,0,NA,3,NA,"2016-09-08T11:03:57.429674-05:00",NA,0,NA,0,NA,"TOP",NA,3,NA,"ce4ae04a-d4d4-4349-aeac-4cdb6f060455",NA,"TCGA-AX-A2HC-01A-01-TSA",NA,94,NA,"dd91c247-a15e-4d97-82bf-474eba0e5cd3","RNA","TCGA-AX-A2HC-01A-11R","1cc40be6-e9c6-467e-a5f6-735a8e567a84",1.65,0.16,"UV Spec","R","23","TCGA-AX-A2HC-01A-11R-A17B-07","3e40a983-aba5-4454-88df-a271c296ada6",0.16,NA,118,47.2680660150617,158,"6308ecf6-0bd6-5496-9db7-67a1943c1fc2","TCGA-AX-A2HC_exposure","UNCID_2203686.3e40a983-aba5-4454-88df-a271c296ada6.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_1.tar.gz","2013-09-26T16:01:04.000Z","2013-09-26T16:15:01.000Z","2855FF81-0EA5-40A0-A6C9-22B6D7264B02","1BACDCAB-F02F-4C6E-89E5-4A221C2E3BC0","Unaligned reads",2499615160,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3E40A983-ABA5-4454-88DF-A271C296ADA6","University of North Carolina","56607b87e4b016715ab6ae30","53E8E07E-18F9-4C9B-9783-A5B67CEDDCF7","Uterine Corpus Endometrial Carcinoma","TARGZ","DD91C247-A15E-4D97-82BF-474EBA0E5CD3","2013-09-26T16:15:01.000Z","1CC40BE6-E9C6-467E-A5F6-735A8E567A84","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1786,"DD91C247-A15E-4D97-82BF-474EBA0E5CD3",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.76DDEA74-3A3A-4604-A8F6-954228149A76.txt",120,"TCGA-AX-A2HC-01A",NA,"5227FAE7-1106-4F3C-9569-9C8B44F59613","TCGA",2006,NA,NA,"WITH TUMOR","82851D79-ABE1-4FA0-8F28-86B2A9656DC6",53,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.76DDEA74-3A3A-4604-A8F6-954228149A76.txt","Alive",NA,"TCGA-AX-A2HC","NOT HISPANIC OR LATINO","91E6730C-2A9C-4364-B3A7-89382808846B",NA,1016,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,"15B9269C-8FB8-4DEB-9408-682E1BD09E16","BLACK OR AFRICAN AMERICAN",NA,11,30,"CE4AE04A-D4D4-4349-AEAC-4CDB6F060455","96A03C2D-B72E-4A45-949F-A53023F16E26","UNCID_1615176.3e40a983-aba5-4454-88df-a271c296ada6.sorted_genome_alignments.bam","TCGA-AX-A2HC-01A-11",98,0,0,0,3,"TOP",3,0,"TCGA-AX-A2HC-01A-01-TSA",94,"Paclitaxel","Chemotherapy","TCGA-AX-A2HC-D31747","TCGA-AX-A2HC-R31751",NA,"Distant Recurrence",NA,"YES",1044,"WITH TUMOR","Alive",NA,"TCGA-AX-A2HC-F31735","TCGA-AX-A2HC",1,"AX","A2HC","YES","C54.1","8380/3","C54.1","NO","YES",-19485,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",1016,NA,NA,NA,"WITH TUMOR","NO",1,11,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110127178,109080741,5205708789,"A7F599EC-6C7F-4788-931D-28B5EDE53096.bw","53e8e07e-18f9-4c9b-9783-a5b67ceddcf7","a7f599ec-6c7f-4788-931d-28b5ede53096","2016-08-26T01:10:52.852121-05:00","UNCID_2316526.0959be20-00aa-4736-9cf1-41b3c1d5c5b4.131016_UNC15-SN850_0333_AC2MBAACXX_6_GGCTAC.tar.gz","5bf244ae-06b7-4037-9ce0-a585ce9932c4",4960789573,"Illumina HiSeq","1632c3fdcfa206ff41f17c915ff991a8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:10:49.135364-05:00","2016-05-03T11:28:50.207865-05:00","5bf244ae-06b7-4037-9ce0-a585ce9932c4_analysis.xml","f4af30ab2cac9cbc5e163bb14d2672d4","3e7d9a83-34eb-4f0a-a0e3-44ae2519ca58",2124,"2016-09-29T18:02:53.812994-05:00","5bf244ae-06b7-4037-9ce0-a585ce9932c4_experiment.xml","68157de8d23dcb1821541aaa388f979e","13d25ffc-4f20-4698-bde8-41dae88c0bb0",2628,"2016-09-29T23:47:53.680394-05:00","5bf244ae-06b7-4037-9ce0-a585ce9932c4_run.xml","2723e3599ab74a611adb25408d9d430b","ea2bd91a-3a1e-4a08-a68a-d66fea120460",354,"2016-09-08T11:03:57.429674-05:00","TCGA-AX-A2HC","2016-09-02T18:52:27.327088-05:00","female","TCGA-AX-A2HC_demographic",1953,"black or african american","baa2500b-d4c9-5e0f-bc4a-41390e221f01","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HC_diagnosis","not reported",19485,"alive","8380/3",NA,1044,"338fe46f-b6a4-50ed-8fc2-2ff30bca40e1","c54.1",-19485,"TCGA-AX-A2HC_treatment","e28a8158-7cf7-535b-86c4-451eaa12d50a","11","false","TCGA-AX-A2HC-11A",NA,"82851d79-abe1-4fa0-8f28-86b2a9656dc6",FALSE,NA,"Solid Tissue Normal",NA,1786,120,NA,1308182400,"11",30,"TCGA-AX-A2HC-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T11:03:57.429674-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"95b41504-359a-4c6c-a45a-715cee6caa0f",NA,"TCGA-AX-A2HC-11A-01-TSA",NA,0,NA,"d3b02fa7-c857-46b3-a74b-2bc75eb9c5bc","RNA","TCGA-AX-A2HC-11A-11R","4f3babc3-780b-410f-8b1c-e5f8fe269b95",1.82,0.15,"UV Spec","R","23","TCGA-AX-A2HC-11A-11R-A32Y-07","0959be20-00aa-4736-9cf1-41b3c1d5c5b4",0.15,NA,118,47.2680660150617,158,"6308ecf6-0bd6-5496-9db7-67a1943c1fc2","TCGA-AX-A2HC_exposure","UNCID_2316526.0959be20-00aa-4736-9cf1-41b3c1d5c5b4.131016_UNC15-SN850_0333_AC2MBAACXX_6_GGCTAC.tar.gz","2014-01-06T22:47:07.000Z","2014-01-06T23:04:01.000Z","5BF244AE-06B7-4037-9CE0-A585CE9932C4","82851D79-ABE1-4FA0-8F28-86B2A9656DC6","Unaligned reads",4960789573,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0959BE20-00AA-4736-9CF1-41B3C1D5C5B4","University of North Carolina","564a3e15e4b0ef12181b4aab","53E8E07E-18F9-4C9B-9783-A5B67CEDDCF7","Uterine Corpus Endometrial Carcinoma","TARGZ","D3B02FA7-C857-46B3-A74B-2BC75EB9C5BC","2014-01-06T23:04:01.000Z","4F3BABC3-780B-410F-8B1C-E5F8FE269B95","United States","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",1786,"D3B02FA7-C857-46B3-A74B-2BC75EB9C5BC",NA,"AX","TCGA-AX-A2HC-11A-11R-A17A-13_mirna.bam",120,"TCGA-AX-A2HC-11A",NA,"5227FAE7-1106-4F3C-9569-9C8B44F59613","TCGA",2006,NA,NA,"WITH TUMOR","82851D79-ABE1-4FA0-8F28-86B2A9656DC6",53,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.76DDEA74-3A3A-4604-A8F6-954228149A76.txt","Alive",NA,"TCGA-AX-A2HC","NOT HISPANIC OR LATINO","91E6730C-2A9C-4364-B3A7-89382808846B",NA,1016,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,"15B9269C-8FB8-4DEB-9408-682E1BD09E16","BLACK OR AFRICAN AMERICAN",NA,11,30,"95B41504-359A-4C6C-A45A-715CEE6CAA0F","88225C3F-6785-47E6-8CC0-8214D697BE34","TCGA-AX-A2HC-11A-11R-A17A-13_mirna.bam.bai","TCGA-AX-A2HC-11A-11",0,100,0,5,0,"TOP",0,0,"TCGA-AX-A2HC-11A-01-TSA",0,"Paclitaxel","Chemotherapy","TCGA-AX-A2HC-D31747","TCGA-AX-A2HC-R31751",NA,"Distant Recurrence",NA,"YES",1044,"WITH TUMOR","Alive",NA,"TCGA-AX-A2HC-F31735","TCGA-AX-A2HC",1,"AX","A2HC","YES","C54.1","8380/3","C54.1","NO","YES",-19485,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",1016,NA,NA,NA,"WITH TUMOR","NO",1,11,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33094963,31751089,2388014641,"FD6F6227-0FA2-4FDD-9BDD-E5604FB96D87.bw","5428c4b2-37c2-4f8c-a474-39fe1aacb26b","fd6f6227-0fa2-4fdd-9bdd-e5604fb96d87","2016-08-05T07:07:11.806146-05:00","UNCID_2210987.954c9805-885f-481a-9dac-024d4481256b.110316_UNC2-RDR300275_00058_FC_62J26AAXX_4.tar.gz","f95bfb37-217e-4f62-9227-2c1dea9c4f36",2072461783,"Illumina GA","dae984c6f08ab753a7f697a756b41942","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:33:15.505225-05:00","2016-05-03T11:15:47.407128-05:00","f95bfb37-217e-4f62-9227-2c1dea9c4f36_analysis.xml","2cb2a81378d22c166679f9f940ad1263","2694f3c7-621f-4c22-b344-bf1862428b98",2121,"2016-08-26T21:33:21.727229-05:00","f95bfb37-217e-4f62-9227-2c1dea9c4f36_experiment.xml","edb732eb1331b57a4ac73621c455932f","7d0fa3ac-e5a8-4d0a-b1a5-33311e6a429a",2257,"2016-09-29T23:50:07.953378-05:00","f95bfb37-217e-4f62-9227-2c1dea9c4f36_run.xml","28faa02676e091067a0cea1cf444fa6f","eb860c23-40f4-4a9a-b997-6799d3d66f9f",347,"2016-09-08T10:46:36.701176-05:00","TCGA-BS-A0UL","2016-09-02T18:49:03.282438-05:00","female","TCGA-BS-A0UL_demographic",1950,"native hawaiian or other pacific islander","c2e76a4c-ddb2-55de-baa7-c7067c1259f4","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0UL_diagnosis","not reported",19982,"alive","8380/3",NA,2481,"0209538e-826c-5cc3-92de-c19f17737c3f","c54.1",-19982,"TCGA-BS-A0UL_treatment","77c46c07-7ce3-57e1-9ad5-c49955c8340f","01","false","TCGA-BS-A0UL-01A",NA,"d9a2756b-472f-4eee-9d76-91f4320f8a1a",FALSE,"323FC36E-D8E3-4F6B-A8FE-2040F3E44BB9","Primary Tumor",NA,2155,70,NA,1286841600,"11",20,"TCGA-BS-A0UL-01A-11",70,75,0,0,0,0,25,0,"2016-09-08T10:46:36.701176-05:00","2016-09-08T10:46:36.701176-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"4b59c747-82cb-4898-aac9-ba0f1627f14d","93630db7-6ffa-4627-8fe2-a5f9c8a3f564","TCGA-BS-A0UL-01A-01-MS1","TCGA-BS-A0UL-01A-01-TS1",75,100,"e6c8ab51-28e1-4bf6-aa72-8128fc22bf72","RNA","TCGA-BS-A0UL-01A-11R","c723696b-4198-4ea5-913b-eb9e6f1088a0",1.89,0.16,"UV Spec","R","23","TCGA-BS-A0UL-01A-11R-A109-07","954c9805-885f-481a-9dac-024d4481256b",0.16,NA,114,39.4463667820069,170,"08bcfcd4-d0f2-5c36-80df-7667025ca9f7","TCGA-BS-A0UL_exposure","UNCID_2210987.954c9805-885f-481a-9dac-024d4481256b.110316_UNC2-RDR300275_00058_FC_62J26AAXX_4.tar.gz","2013-10-02T07:26:04.000Z","2013-10-02T07:38:02.000Z","F95BFB37-217E-4F62-9227-2C1DEA9C4F36","D9A2756B-472F-4EEE-9D76-91F4320F8A1A","Unaligned reads",2072461783,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","954C9805-885F-481A-9DAC-024D4481256B","University of North Carolina","564a5865e4b093830b6c02f0","5428C4B2-37C2-4F8C-A474-39FE1AACB26B","Uterine Corpus Endometrial Carcinoma","TARGZ","E6C8AB51-28E1-4BF6-AA72-8128FC22BF72","2013-10-02T07:38:02.000Z","C723696B-4198-4EA5-913B-EB9E6F1088A0","None","NO",1,NA,"Primary Tumor","University of Hawaii",2155,"E6C8AB51-28E1-4BF6-AA72-8128FC22BF72",NA,"BS","TCGA-BS-A0UL-01A-11R-A108-13_mirna.bam.bai",70,"TCGA-BS-A0UL-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","D9A2756B-472F-4EEE-9D76-91F4320F8A1A",54,"nationwidechildrens.org_clinical.TCGA-BS-A0UL.xml","Alive",NA,"TCGA-BS-A0UL","NOT HISPANIC OR LATINO","40A93962-C765-469E-92C3-801BA824AB8B",NA,36,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",75,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,11,20,"93630DB7-6FFA-4627-8FE2-A5F9C8A3F564","C723696B-4198-4EA5-913B-EB9E6F1088A0","TCGA-BS-A0UL-01A-11R-A108-13_mirna.bam.bai","TCGA-BS-A0UL-01A-11",75,0,0,0,0,"TOP",0,0,"TCGA-BS-A0UL-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,NA,"NO",2481,"TUMOR FREE","Alive",NA,"TCGA-BS-A0UL-F16702","TCGA-BS-A0UL",1,"BS","A0UL","YES","C54.1","8380/3","C54.1","NO","YES",-19982,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","NOT HISPANIC OR LATINO","No","No","Alive",36,NA,NA,NA,"TUMOR FREE","NO",25,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2004,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
98599452,97810530,4668361074,"37C7ABEC-5897-40C5-B507-57F12F56820D.bw","545ba049-b7c1-4b46-9ec2-9331dccd6c60","37c7abec-5897-40c5-b507-57f12f56820d","2016-08-25T15:43:14.609477-05:00","UNCID_2327187.21a04fd6-500e-4d42-846b-b6b7783098fb.131016_UNC10-SN254_0498_BC2KTUACXX_6_GGCTAC.tar.gz","ff14ff32-c64e-424e-9d7f-bfd441447a49",4669433742,"Illumina HiSeq","293c9acf9cb199d860a170b8706016b1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:44:21.359431-05:00","2016-05-03T11:34:55.532339-05:00","ff14ff32-c64e-424e-9d7f-bfd441447a49_analysis.xml","902c08103aadd13a2f02caacc5474aca","c2aa0550-72ad-4a0b-858a-7601740b0deb",2124,"2016-09-29T21:30:05.683151-05:00","ff14ff32-c64e-424e-9d7f-bfd441447a49_experiment.xml","88ae7d4bf8bbff5754df78be35b0b2c9","94d87987-7b45-4dad-ae0f-ce6e1e82a85a",2628,"2016-09-29T23:55:15.099238-05:00","ff14ff32-c64e-424e-9d7f-bfd441447a49_run.xml","1cba291985113bbb1d8855fb21c10ee4","eec9b0c1-ad72-4d9c-bc60-5fe6c3d799e1",354,"2016-09-08T10:54:59.944966-05:00","TCGA-FL-A1YQ",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YQ-11A",NA,"f6c7db6c-cf42-4e24-8ff9-aece36ee1842",FALSE,"A183E852-81EF-413C-85F0-122FB8F22DE2","Solid Tissue Normal",NA,NA,130,NA,1302480000,"11",30,"TCGA-FL-A1YQ-11A-11",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T10:54:59.944966-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"f93bc494-a7ba-4c52-a71b-434458a2ca4b",NA,"TCGA-FL-A1YQ-11A-01-TSA",NA,0,NA,"3ec6ad54-4714-464f-9e7b-7aef4c5ebb50","RNA","TCGA-FL-A1YQ-11A-11R","c0d6e758-9354-4bf4-a681-32787db1723b",2.15,0.18,"UV Spec","R","23","TCGA-FL-A1YQ-11A-11R-A32Y-07","21a04fd6-500e-4d42-846b-b6b7783098fb",0.18,NA,NA,NA,NA,NA,NA,"UNCID_2327187.21a04fd6-500e-4d42-846b-b6b7783098fb.131016_UNC10-SN254_0498_BC2KTUACXX_6_GGCTAC.tar.gz","2014-01-25T04:07:26.000Z","2014-01-25T04:31:02.000Z","FF14FF32-C64E-424E-9D7F-BFD441447A49","F6C7DB6C-CF42-4E24-8FF9-AECE36EE1842","Unaligned reads",4669433742,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","21A04FD6-500E-4D42-846B-B6B7783098FB","University of North Carolina","564a39b9e4b09c884b23d9eb","545BA049-B7C1-4B46-9EC2-9331DCCD6C60","Uterine Corpus Endometrial Carcinoma","TARGZ","3EC6AD54-4714-464F-9E7B-7AEF4C5EBB50","2014-01-25T04:31:02.000Z","C0D6E758-9354-4BF4-A681-32787DB1723B","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"3EC6AD54-4714-464F-9E7B-7AEF4C5EBB50",NA,"FL","39715c2eeddfcefcd260e13db7cfc583.bam",130,"TCGA-FL-A1YQ-11A",NA,NA,"TCGA",NA,NA,NA,NA,"F6C7DB6C-CF42-4E24-8FF9-AECE36EE1842",NA,"39715c2eeddfcefcd260e13db7cfc583.bam",NA,NA,"TCGA-FL-A1YQ",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,156,NA,NA,NA,NA,11,30,"F93BC494-A7BA-4C52-A71B-434458A2CA4B","9013C1F0-6306-4E40-B314-1D818B92341E","39715c2eeddfcefcd260e13db7cfc583.bam","TCGA-FL-A1YQ-11A-11",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YQ-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33505095,32810574,2430054087,"0A5B5D18-1A0E-44C3-BEEC-C3AD867DFE84.bw","548ec160-4183-459f-8393-f4b4672a3251","0a5b5d18-1a0e-44c3-beec-c3ad867dfe84","2016-08-05T16:27:57.483096-05:00","UNCID_2209886.21e840d7-f768-45b3-8a3a-bf228f7227e7.110420_UNC6-RDR300211_00096_FC_634WMAAXX_5.tar.gz","26662c9d-146f-4ce8-9506-ce8693ac3fa5",2236379316,"Illumina GA","03b77ab0177e0586b0d7617f3439260b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:44:39.350486-05:00","2016-05-03T11:15:47.414649-05:00","26662c9d-146f-4ce8-9506-ce8693ac3fa5_analysis.xml","86afaeaa75a8d04d8ae58c7619aced6f","0848fe24-7a9b-42b2-aec1-bfbc57d22bae",2120,"2016-09-29T20:45:48.933679-05:00","26662c9d-146f-4ce8-9506-ce8693ac3fa5_experiment.xml","3922e1ad93b552be2a150a5fa9aae85a","792c68ce-1414-4a54-94f3-aea5baaa8a7d",2257,"2016-09-29T18:32:47.247583-05:00","26662c9d-146f-4ce8-9506-ce8693ac3fa5_run.xml","84e4d79c3513459e0461f0f3db989bd7","2649a8a6-b671-45c2-af5d-51ea25eab9e5",347,"2016-09-08T10:54:50.291469-05:00","TCGA-D1-A16I","2016-09-02T18:50:25.895635-05:00","female","TCGA-D1-A16I_demographic",1946,"white","83564807-d14e-5322-865d-4869b93fc86d","not hispanic or latino",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16I_diagnosis","not reported",22836,"dead","8441/3",350,NA,"1e7f4048-0130-582a-9efb-c35579987389","c54.1",-22836,"TCGA-D1-A16I_treatment","ae66f263-4856-52b2-bc3d-702c88df34b3","01","false","TCGA-D1-A16I-01A",NA,"62a1ff9f-f730-4703-8271-89e1a123da65",FALSE,"3D30B053-444A-4F4D-B451-EB8746A157A2","Primary Tumor",NA,763,190,NA,1293667200,"11",30,"TCGA-D1-A16I-01A-11",90,NA,0,NA,0,NA,15,NA,"2016-09-08T10:54:50.291469-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"bd72b5e6-c9e2-466c-91aa-d5b8b34666d1",NA,"TCGA-D1-A16I-01A-01-TS1",NA,80,NA,"b8f3a04e-4b58-40b8-b53a-0dae9ad0a5c2","RNA","TCGA-D1-A16I-01A-11R","f80dd196-31ab-4391-bf7b-a053e8b1e8af",1.89,0.14,"UV Spec","R","23","TCGA-D1-A16I-01A-11R-A12I-07","21e840d7-f768-45b3-8a3a-bf228f7227e7",0.14,NA,84,31.6157928412812,163,"a2082423-f611-5d19-84fd-2b195e9dd8e7","TCGA-D1-A16I_exposure","UNCID_2209886.21e840d7-f768-45b3-8a3a-bf228f7227e7.110420_UNC6-RDR300211_00096_FC_634WMAAXX_5.tar.gz","2013-10-02T00:06:05.000Z","2013-10-02T00:19:03.000Z","26662C9D-146F-4CE8-9506-CE8693AC3FA5","62A1FF9F-F730-4703-8271-89E1A123DA65","Unaligned reads",2236379316,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","21E840D7-F768-45B3-8A3A-BF228F7227E7","University of North Carolina","564a3be1e4b0ef12181a97e3","548EC160-4183-459F-8393-F4B4672A3251","Uterine Corpus Endometrial Carcinoma","TARGZ","B8F3A04E-4B58-40B8-B53A-0DAE9AD0A5C2","2013-10-02T00:19:03.000Z","F80DD196-31AB-4391-BF7B-A053E8B1E8AF","None","NO",1,NA,"Primary Tumor","Mayo Clinic",763,"B8F3A04E-4B58-40B8-B53A-0DAE9AD0A5C2",NA,"D1","SCAUR_p_TCGA_b94_SNP_N_GenomeWideSNP_6_C09_755316.tangent.copynumber.data.txt",190,"TCGA-D1-A16I-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","8B82EE2F-7E21-485F-9830-A596521C981C",62,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.86D661F5-6386-4735-B9F1-04B2B4B96418.txt","Dead",350,"TCGA-D1-A16I","NOT HISPANIC OR LATINO","06854EA4-51C7-4716-B8D8-6F6DCCB15ED8",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8441/3","FEMALE","C54.1",94,NA,"A38E9D0C-F360-4134-A301-DC4419BDF83E","WHITE",NA,11,30,"BD72B5E6-C9E2-466C-91AA-D5B8B34666D1","CB378E48-BBFF-4665-A38D-64353B8A0680","TCGA-D1-A16I-01A-11R-A12H-13_mirna.bam.bai","TCGA-D1-A16I-01A-11",90,0,0,0,15,"TOP",5,0,"TCGA-D1-A16I-01A-01-TS1",80,NA,NA,NA,"TCGA-D1-A16I-R18578","IMPLANTS","Primary Tumor Field",NA,"NO",NA,"TUMOR FREE","Dead",350,"TCGA-D1-A16I-F18573","TCGA-D1-A16I",1,"D1","A16I","YES","C54.1","8441/3","C54.1","NO","YES",-22836,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,350,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,62,2008,"Office Endometrial Biopsy",NA,NA,NA,"High Grade","R0",NA,NA,NA,NA,NA,"1995",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
87957058,65861258,3100257592,"A4FDC009-60AD-4F30-9883-40C13D2F1F1F.bw","54ac877a-52ff-450c-9df9-b7cd3fc8e2e2","a4fdc009-60ad-4f30-9883-40c13d2f1f1f","2016-08-25T23:40:18.485404-05:00","UNCID_2581803.d05ea5d7-8d21-4fd6-9199-fdc606a9843c.140403_UNC15-SN850_0359_BC41CEACXX_2_ATTCCT.tar.gz","88e910d8-616c-436a-8bbe-2b3f374c0412",3586152228,"Illumina HiSeq","0ff28b33784522f55aefc99f987912ff","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:29:17.943397-05:00","2016-05-03T11:55:56.226464-05:00","88e910d8-616c-436a-8bbe-2b3f374c0412_analysis.xml","05ab946999811acafdfc17ee49622f87","de8da7d6-9fc5-40ee-aa34-f54c05817408",2124,"2016-09-29T21:15:02.030288-05:00","88e910d8-616c-436a-8bbe-2b3f374c0412_experiment.xml","7d0840cd727c4625034d370c94a1832f","8b73ef76-6505-4e2f-b843-7e894caa4fbe",2628,"2016-09-29T19:57:09.588750-05:00","88e910d8-616c-436a-8bbe-2b3f374c0412_run.xml","4c525cf7761463f3a4f7597f673c0355","5b6b525b-9311-47e7-8c7e-ee68da679a44",354,"2016-09-08T11:07:26.055035-05:00","TCGA-QS-A8F1","2016-09-02T18:52:09.346614-05:00","female","TCGA-QS-A8F1_demographic",1928,"black or african american","289d909f-5255-5016-8ff0-00454a0ca55a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","QS","c4c083cd-4644-53b2-9d7e-ca2ae833c525","Candler","not reported","c54.3","TCGA-QS-A8F1_diagnosis","not reported",31386,"dead","8441/3",135,125,"cf4f8fc1-67e6-5fac-a933-4266cfd81299","c54.3",-31386,"TCGA-QS-A8F1_treatment","ddc7c63f-7d14-5418-9ede-7f7ca88f8d50","01","false","TCGA-QS-A8F1-01A",NA,"7bc29acd-1306-4439-9042-27a9115eb563",FALSE,"563BDC27-AFA6-4DE0-AB17-8CFD93D1CA81","Primary Tumor",NA,29,250,NA,1384300800,"21",30,"TCGA-QS-A8F1-01A-21",70,NA,1,NA,5,NA,20,NA,"2016-09-08T11:07:26.055035-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"35c9f884-daff-45e8-8218-d3e3a6c3abd4",NA,"TCGA-QS-A8F1-01A-02-TS2",NA,70,NA,"2f0bb5c7-f40c-4d69-a2a4-f6f82e5aca45","RNA","TCGA-QS-A8F1-01A-21R","a2c880fd-daf4-4006-a63f-8be70a1b101b",1.7,0.15,"UV Spec","R","23","TCGA-QS-A8F1-01A-21R-A37O-07","d05ea5d7-8d21-4fd6-9199-fdc606a9843c",0.15,NA,75,26.5731292517007,168,"d9f1e147-690e-5e93-a498-9588908311f9","TCGA-QS-A8F1_exposure","UNCID_2581803.d05ea5d7-8d21-4fd6-9199-fdc606a9843c.140403_UNC15-SN850_0359_BC41CEACXX_2_ATTCCT.tar.gz","2014-08-15T12:21:03.000Z","2014-08-15T12:37:50.000Z","88E910D8-616C-436A-8BBE-2B3F374C0412","7BC29ACD-1306-4439-9042-27A9115EB563","Unaligned reads",3586152228,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","D05EA5D7-8D21-4FD6-9199-FDC606A9843C","University of North Carolina","56607a6ce4b0ec1099f8e027","54AC877A-52FF-450C-9DF9-B7CD3FC8E2E2","Uterine Corpus Endometrial Carcinoma","TARGZ","2F0BB5C7-F40C-4D69-A2A4-F6F82E5ACA45","2014-08-15T12:37:50.000Z","A2C880FD-DAF4-4006-A63F-8BE70A1B101B","United States","NO",1,NA,"Primary Tumor","Candler",29,"2F0BB5C7-F40C-4D69-A2A4-F6F82E5ACA45",NA,"QS","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F4063512-BBF4-4CB1-B21E-E63FC0753FD0.txt",250,"TCGA-QS-A8F1-01A",NA,"9B0EF2CF-5213-4B9B-8272-5A0ACEBD4A63","TCGA",2013,"TCGA-QS-A8F1_NTE-1","Progressive Disease","WITH TUMOR","8D5449B1-C1A5-487F-B089-195AF1D8EAA9",85,"nationwidechildrens.org_clinical.TCGA-QS-A8F1.xml","Alive",NA,"TCGA-QS-A8F1","NOT HISPANIC OR LATINO","305FF504-B5A7-4A6B-89A8-1AADA9531586","NO",125,"No","Uterus","C54.3",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.3",381,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,21,30,"35C9F884-DAFF-45E8-8218-D3E3A6C3ABD4","A2C880FD-DAF4-4006-A63F-8BE70A1B101B","UNCID_2581803.d05ea5d7-8d21-4fd6-9199-fdc606a9843c.140403_UNC15-SN850_0359_BC41CEACXX_2_ATTCCT.tar.gz","TCGA-QS-A8F1-01A-21",70,5,1,1,20,"TOP",5,0,"TCGA-QS-A8F1-01A-02-TS2",70,"Carboplatin","Chemotherapy","TCGA-QS-A8F1-D56573",NA,NA,NA,"TCGA-QS-A8F1-F66552_NTE-1","NO",NA,"WITH TUMOR","Dead",135,"TCGA-QS-A8F1-F66552","TCGA-QS-A8F1",1,"QS","A8F1","YES","C54.3","8441/3","C54.3","YES","NO",-31386,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",125,NA,"NO","YES","WITH TUMOR","YES",13,2,2014,"YES","YES","NO",NA,NA,NA,"Other  Specify","Serous endometrial adenocarcinoma",NA,0,85,2013,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,"Progressive Disease","2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30388251,30155700,2240742412,"B12D2F99-CA71-4C1B-8B97-C5C289D357E0.bw","553f0ccd-4e6f-4ae2-9b39-97529eb3d826","b12d2f99-ca71-4c1b-8b97-c5c289d357e0","2016-08-09T14:16:35.367979-05:00","UNCID_2214847.d98e99e1-ee3e-4427-90ec-24e624aa1b46.101123_UNC6-RDR300211_00053_FC_62FJGAAXX_8.tar.gz","e369f157-ca96-4d84-99fb-ad0e22a45735",1879488956,"Illumina GA","5982a1396ec02e69392a4cf35839e948","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:06:02.503939-05:00","2016-05-03T11:17:14.905409-05:00","e369f157-ca96-4d84-99fb-ad0e22a45735_analysis.xml","0248550c83797feaab1fce0fbf39fbd7","60c7b781-8735-48e5-9c64-02f13fbb3f9d",2120,"2016-09-29T20:23:34.108585-05:00","e369f157-ca96-4d84-99fb-ad0e22a45735_experiment.xml","2f42f1be05691579ddc1e9d40e7c6c15","6b727a56-eb62-474e-b642-34ec32d34572",2256,"2016-09-29T19:42:32.197269-05:00","e369f157-ca96-4d84-99fb-ad0e22a45735_run.xml","81a04ec35f930fe05a07630f7b5a9c6e","52492080-9b0b-4f3c-a3a9-91b970df0b6c",345,"2016-09-08T10:57:46.254813-05:00","TCGA-A5-A0GX","2016-09-02T18:54:15.654787-05:00","female","TCGA-A5-A0GX_demographic",1952,"white","129632b7-438f-510e-9eab-1d43fc365cc0","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GX_diagnosis","not reported",19625,"alive","8380/3",NA,2088,"cb8a0d82-3cce-5564-b5ab-04b7cec178c1","c54.1",-19625,"TCGA-A5-A0GX_treatment","7f31b194-84d2-520a-ad5c-e5a6ace5ab8b","01","true","TCGA-A5-A0GX-01A",NA,"983a35a9-c825-4961-86c0-4c6133b5c9c1",FALSE,"AE5229ED-8906-4D55-9B11-4E8E214D6446","Primary Tumor",NA,1654,250,NA,1276214400,"11",30,"TCGA-A5-A0GX-01A-11",85,85,0,0,10,10,0,0,"2016-09-08T10:57:46.254813-05:00","2016-09-08T10:57:46.254813-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"32dc4f47-f23e-4628-97b9-fdb6100ded86","45a8237f-5025-4858-a511-4ce774062c07","TCGA-A5-A0GX-01A-01-BSA","TCGA-A5-A0GX-01A-01-TSA",90,90,"88dd1be5-a195-41aa-a3b9-12a0914f5d27","RNA","TCGA-A5-A0GX-01A-11R","5c93f939-94b1-4565-8a4b-819eadf58845",1.8,0.15,"UV Spec","R","23","TCGA-A5-A0GX-01A-11R-A040-07","d98e99e1-ee3e-4427-90ec-24e624aa1b46",0.15,NA,108,40.1546698393813,164,"61616f36-63e0-57b8-bd6a-a53bc4610fa5","TCGA-A5-A0GX_exposure","UNCID_2214847.d98e99e1-ee3e-4427-90ec-24e624aa1b46.101123_UNC6-RDR300211_00053_FC_62FJGAAXX_8.tar.gz","2013-10-03T22:01:04.000Z","2013-10-03T22:12:02.000Z","E369F157-CA96-4D84-99FB-AD0E22A45735","983A35A9-C825-4961-86C0-4C6133B5C9C1","Unaligned reads",1879488956,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","D98E99E1-EE3E-4427-90EC-24E624AA1B46","University of North Carolina","564a3e40e4b093830b6a2d21","553F0CCD-4E6F-4AE2-9B39-97529EB3D826","Uterine Corpus Endometrial Carcinoma","TARGZ","88DD1BE5-A195-41AA-A3B9-12A0914F5D27","2013-10-03T22:12:02.000Z","5C93F939-94B1-4565-8A4B-819EADF58845","None","NO",1,NA,"Primary Tumor","Cedars Sinai",1654,"88DD1BE5-A195-41AA-A3B9-12A0914F5D27",NA,"A5","jhu-usc.edu_UCEC.HumanMethylation27.2.lvl-3.TCGA-A5-A0GX-01A-11D-A039-05.txt",250,"TCGA-A5-A0GX-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","FF637ADE-4B5A-4A0A-9712-4FF2FC5E5B9D",53,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8ABB876D-F6CD-4120-9949-8AA46323B51B.txt","Alive",NA,"TCGA-A5-A0GX",NA,"A2A68F84-FD3D-4F6C-8B16-054BA40CF4B8",NA,925,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"4A7EC005-A5DB-4CA5-B79F-237F12FEA67D","WHITE",NA,11,30,"45A8237F-5025-4858-A511-4CE774062C07","DE6C2C59-79C7-444B-9BEB-B1BEE832AF26","TCGA-A5-A0GX-01A-11W-A062-09_IlluminaGA-DNASeq_exome.bam","TCGA-A5-A0GX-01A-11",85,10,0,0,0,"BOTTOM",0,0,"TCGA-A5-A0GX-01A-01-BSA",90,NA,NA,NA,"TCGA-A5-A0GX-R3038","EXTERNAL BEAM","Primary Tumor Field",NA,NA,925,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GX-F3037","TCGA-A5-A0GX",1,"A5","A0GX","YES","C54.1","8380/3","C54.1","NO","YES",-19625,"FEMALE","WHITE",NA,"No","No","Alive",925,NA,NA,NA,"TUMOR FREE","NO",13,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2005,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33093746,31845903,2393756531,"50778806-52BD-47D0-B576-418ECE61EDC9.bw","5693302a-4548-4c0b-8725-0cb7c67bc4f8","50778806-52bd-47d0-b576-418ece61edc9","2016-08-09T14:15:15.312760-05:00","UNCID_2209571.619e7a96-8900-484b-b1e2-54ef91b9109d.110509_UNC6-RDR300211_00102_FC_634VYAAXX_6.tar.gz","417cbec9-7c7d-4635-9933-9b3d20a2af64",2207695857,"Illumina GA","afb9a6411ac20f2a34ee7f93119d785c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:23:03.521173-05:00","2016-05-03T11:15:06.073526-05:00","417cbec9-7c7d-4635-9933-9b3d20a2af64_analysis.xml","710792dcfa1fee525633e3498eb4f3d0","2049cfbd-c897-42ca-a055-6ba954ed4617",2121,"2016-09-29T18:59:13.718814-05:00","417cbec9-7c7d-4635-9933-9b3d20a2af64_experiment.xml","09c12dcda11645284f82d5cf866c7a1f","372cbe3d-d4b3-4c06-8636-56371317e632",2257,"2016-09-29T21:14:45.250087-05:00","417cbec9-7c7d-4635-9933-9b3d20a2af64_run.xml","c6cee104b354f2c90a7048c808da7f66","8b4d831e-da21-4393-bee8-f0b31b7a84c1",347,"2016-09-08T10:45:40.747959-05:00","TCGA-D1-A16D","2016-09-02T18:50:12.571561-05:00","female","TCGA-D1-A16D_demographic",1959,"white","202ea12b-b0a4-5b04-be06-d9780a653387","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16D_diagnosis","not reported",17933,"alive","8380/3",NA,1141,"f7f506c6-1101-55e6-b065-dd8d8b34b67c","c54.1",-17933,"TCGA-D1-A16D_treatment","f54eb415-176d-555a-b62f-b00ccdd0d020","01","false","TCGA-D1-A16D-01A",NA,"007bdfd3-81b6-42c3-a4a6-c4ddaf1be0ae",FALSE,"795A5264-493A-498D-A731-87ECB0A7F612","Primary Tumor",NA,799,130,NA,1293062400,"11",30,"TCGA-D1-A16D-01A-11",60,NA,8,NA,0,NA,40,NA,"2016-09-08T10:45:40.747959-05:00",NA,5,NA,12,NA,"TOP",NA,10,NA,"29eabeda-3653-4927-b660-8ce21a7fcc7a",NA,"TCGA-D1-A16D-01A-01-TSA",NA,50,NA,"4b64ab88-2e07-491f-83eb-0272caf6c330","RNA","TCGA-D1-A16D-01A-11R","9d3bf3c7-e34b-44b3-b54d-6099ca1374cf",1.86,0.15,"UV Spec","R","23","TCGA-D1-A16D-01A-11R-A12I-07","619e7a96-8900-484b-b1e2-54ef91b9109d",0.15,NA,151,56.1421772754313,164,"9423c63b-449c-5391-9ff5-9f74f203b791","TCGA-D1-A16D_exposure","UNCID_2209571.619e7a96-8900-484b-b1e2-54ef91b9109d.110509_UNC6-RDR300211_00102_FC_634VYAAXX_6.tar.gz","2013-10-01T09:31:04.000Z","2013-10-01T09:44:02.000Z","417CBEC9-7C7D-4635-9933-9B3D20A2AF64","007BDFD3-81B6-42C3-A4A6-C4DDAF1BE0AE","Unaligned reads",2207695857,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","619E7A96-8900-484B-B1E2-54EF91B9109D","University of North Carolina","56607a8ce4b0b37b3d991f6e","5693302A-4548-4C0B-8725-0CB7C67BC4F8","Uterine Corpus Endometrial Carcinoma","TARGZ","4B64AB88-2E07-491F-83EB-0272CAF6C330","2013-10-01T09:44:02.000Z","9D3BF3C7-E34B-44B3-B54D-6099CA1374CF","None","NO",1,NA,"Primary Tumor","Mayo Clinic",799,"4B64AB88-2E07-491F-83EB-0272CAF6C330",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5F2C5422-2513-4C05-9668-74E46BCA6563.txt",130,"TCGA-D1-A16D-01A",NA,"9AF0DBA5-CC62-4BF5-9F51-BC53D5FE53C6","TCGA",2008,NA,NA,"TUMOR FREE","9341A9C7-C7D3-4695-A721-2EE86F5F188D",49,"nationwidechildrens.org_clinical.TCGA-D1-A16D.xml","Alive",NA,"TCGA-D1-A16D","NOT HISPANIC OR LATINO","2B380B02-8AAB-4C38-9E15-1CA2554A863B",NA,908,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"0EB7209E-F59C-4344-A735-C17A2DB955F1","WHITE",NA,11,30,"29EABEDA-3653-4927-B660-8CE21A7FCC7A","9D3BF3C7-E34B-44B3-B54D-6099CA1374CF","UNCID_294240.TCGA-D1-A16D-01A-11R-A12I-07.110509_UNC6-RDR300211_00102_FC_634VYAAXX.6.trimmed.annotated.translated_to_genomic.bam","TCGA-D1-A16D-01A-11",60,0,8,5,40,"TOP",10,12,"TCGA-D1-A16D-01A-01-TSA",50,"Carboplatin","Chemotherapy","TCGA-D1-A16D-D19217","TCGA-D1-A16D-R18510","IMPLANTS","Regional site",NA,"NO",1141,"TUMOR FREE","Alive",NA,"TCGA-D1-A16D-F18509","TCGA-D1-A16D",1,"D1","A16D","YES","C54.1","8380/3","C54.1","NO","YES",-17933,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",908,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,49,2008,"Office Endometrial Biopsy",NA,NA,NA,"G2","RX",NA,NA,NA,NA,NA,"1995",4,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
147209442,145708580,6959940415,"89D297BE-DEC3-4886-9867-EE13CA3C27D0.bw","56bdb68c-a647-4aba-94ac-9cd52bb5344a","89d297be-dec3-4886-9867-ee13ca3c27d0","2016-08-06T11:39:15.499583-05:00","UNCID_2168978.32b29d34-5d28-4b68-9d64-61290448fca5.130610_UNC14-SN744_0347_BD28NBACXX_6_GTCCGC.tar.gz","41772539-5588-4cae-944b-2b2cd6c4e76e",6771619074,"Illumina HiSeq","c1e8ffe92f54f98558dd82e25bbf1864","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:00:37.150534-05:00","2016-05-03T11:06:28.634130-05:00","41772539-5588-4cae-944b-2b2cd6c4e76e_analysis.xml","5df4cd3c3cf675a97a2c15088fe0fb1f","f2036ff8-d4b4-4380-a483-89848de29735",2123,"2016-09-29T17:33:00.332432-05:00","41772539-5588-4cae-944b-2b2cd6c4e76e_experiment.xml","68c6b6b416bd11c262c898c5a8e16fd8","00d1c2a3-991c-4d92-9caa-3770ffc38ba4",2431,"2016-09-29T19:11:55.844153-05:00","41772539-5588-4cae-944b-2b2cd6c4e76e_run.xml","506d078d5338930b9782a40f7ee054ea","3f305330-ab7c-4fbb-9f6b-2eaec8e51806",354,"2016-09-08T10:42:14.489569-05:00","TCGA-EY-A548","2016-09-02T18:50:04.629609-05:00","female","TCGA-EY-A548_demographic",1929,"black or african american","2842e7d2-131b-560d-9b81-97d97647ff8a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A548_diagnosis","not reported",30544,"alive","8380/3",NA,430,"8f6aaac5-a59d-5d94-ba34-e90593e47aec","c54.1",-30544,"TCGA-EY-A548_treatment","777d2841-457c-5ff1-8176-3de8bc70bc8e","01","false","TCGA-EY-A548-01A",NA,"081ac69b-8390-42b1-917a-d7cd231c0156",FALSE,"A9ACF7BF-BB91-4B56-A398-C7A0FD473FC5","Primary Tumor",NA,169,850,NA,1355097600,"11",30,"TCGA-EY-A548-01A-11",80,NA,2,NA,0,NA,0,NA,"2016-09-08T10:42:14.489569-05:00",NA,3,NA,0,NA,"TOP",NA,0,NA,"29c8bf41-5ab3-4ffb-94ce-9c968fef67dd",NA,"TCGA-EY-A548-01A-01-TS1",NA,100,NA,"8f761f81-0771-4236-8c48-a0a956743cd0","RNA","TCGA-EY-A548-01A-11R","ecc65cc6-d279-4311-a80f-35160037546c",1.85,0.18,"UV Spec","R","23","TCGA-EY-A548-01A-11R-A27V-07","32b29d34-5d28-4b68-9d64-61290448fca5",0.18,NA,67,27.1816300864132,157,"8f520e23-09e2-51d3-b7fc-db30b2990ba5","TCGA-EY-A548_exposure","UNCID_2168978.32b29d34-5d28-4b68-9d64-61290448fca5.130610_UNC14-SN744_0347_BD28NBACXX_6_GTCCGC.tar.gz","2013-09-20T06:16:04.000Z","2013-09-20T06:32:01.000Z","41772539-5588-4CAE-944B-2B2CD6C4E76E","081AC69B-8390-42B1-917A-D7CD231C0156","Unaligned reads",6771619074,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","32B29D34-5D28-4B68-9D64-61290448FCA5","University of North Carolina","564a3411e4b0298dd2c60dba","56BDB68C-A647-4ABA-94AC-9CD52BB5344A","Uterine Corpus Endometrial Carcinoma","TARGZ","8F761F81-0771-4236-8C48-A0A956743CD0","2013-09-20T06:32:01.000Z","ECC65CC6-D279-4311-A80F-35160037546C","United States","NO",1,NA,"Primary Tumor","University of North Carolina",169,"8F761F81-0771-4236-8C48-A0A956743CD0",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.38F71989-9140-4D94-A813-CB38482A0CC3.txt",850,"TCGA-EY-A548-01A",NA,NA,"TCGA",2012,"TCGA-EY-A548_NTE-1","Complete Remission/Response","TUMOR FREE","081AC69B-8390-42B1-917A-D7CD231C0156",83,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.38F71989-9140-4D94-A813-CB38482A0CC3.txt","Alive",NA,"TCGA-EY-A548","NOT HISPANIC OR LATINO","6513A41F-F46C-442E-BD14-A20170878761","NO",65,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",289,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"29C8BF41-5AB3-4FFB-94CE-9C968FEF67DD","FB0E767F-9FAD-49AB-9F8E-2DBB9BEAADF7","34f429c1707a8cd7c27cd5ae0c84740d.bam","TCGA-EY-A548-01A-11",80,0,2,3,0,"TOP",0,0,"TCGA-EY-A548-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-EY-A548-F55806_NTE-1","NO",430,NA,"Alive",NA,"TCGA-EY-A548-F55806","TCGA-EY-A548",1,"EY","A548","YES","C54.1","8380/3","C54.1","YES","NO",-30544,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",65,NA,"NO","NO","TUMOR FREE","YES",27,2,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,83,2012,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,"Complete Remission/Response",NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
25507968,24827905,1874836248,"28BE96CA-7D9A-427F-8D42-A7D828E57AA0.bw","585a1f31-3804-43ca-81e9-4e571fe03642","28be96ca-7d9a-427f-8d42-a7d828e57aa0","2016-08-09T14:17:42.498916-05:00","UNCID_2216370.833990d5-5a6c-4d68-b15b-f2cc2309c611.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_4.tar.gz","e412f327-c36f-49cf-87ae-26037f74b452",1574514190,"Illumina GA","592aa7da264aeca78ebdd246ade7db0b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:14:57.246038-05:00","2016-05-03T11:18:47.010651-05:00","e412f327-c36f-49cf-87ae-26037f74b452_analysis.xml","fd5ace4cdbb4c29f8e772107485f9c8a","4117a772-a2f1-4606-99f5-9197579ba605",2120,"2016-09-29T22:25:20.643538-05:00","e412f327-c36f-49cf-87ae-26037f74b452_experiment.xml","2284102da19a9102a699e58a62e3b093","b6c917fb-0575-4dad-81c7-c9cedb1d4099",2256,"2016-09-29T18:36:17.015076-05:00","e412f327-c36f-49cf-87ae-26037f74b452_run.xml","d4e4232cd9df489767b021a8e0f2026d","2892c376-390f-4627-9b64-2f8a0b4a173a",345,"2016-09-08T11:02:48.015216-05:00","TCGA-AP-A056","2016-09-02T18:52:38.388919-05:00","female","TCGA-AP-A056_demographic",1940,"white","e8476897-909b-57ac-abe1-14a9f79e2a3a","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A056_diagnosis","not reported",23707,"alive","8380/3",NA,2618,"dca335c4-c79c-5c18-8bac-7e8070caebd4","c54.1",-23707,"TCGA-AP-A056_treatment","5c8b1d8c-39b7-5624-8cd9-93f44f9220bc","01","true","TCGA-AP-A056-01A",NA,"1d811231-b972-4977-890d-1fbb9109d61d",FALSE,"008786AD-6CA8-488D-A5AC-BA558985E765","Primary Tumor",NA,2017,400,NA,1275868800,"11",30,"TCGA-AP-A056-01A-11",88,60,0,0,0,0,25,40,"2016-09-08T11:02:48.015216-05:00","2016-09-08T11:02:48.015216-05:00",1,14,0,0,"TOP","BOTTOM",3,6,"e03de89a-1175-4559-99be-b79e4c014e70","ac762006-4ba4-4016-add7-a502e2ba45cd","TCGA-AP-A056-01A-01-TSA","TCGA-AP-A056-01A-01-BSA",72,54,"8976fb33-0aaf-434f-ab18-4b0ac4509e13","RNA","TCGA-AP-A056-01A-11R","64dbaa92-b80b-4c31-91f3-f955a1847324",1.81,0.15,"UV Spec","R","23","TCGA-AP-A056-01A-11R-A00V-07","833990d5-5a6c-4d68-b15b-f2cc2309c611",0.15,NA,56,24.560326301478,151,"73c2882c-5903-5d51-9ac9-2d83cff2197a","TCGA-AP-A056_exposure","UNCID_2216370.833990d5-5a6c-4d68-b15b-f2cc2309c611.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_4.tar.gz","2013-10-04T08:06:04.000Z","2013-10-04T08:18:02.000Z","E412F327-C36F-49CF-87AE-26037F74B452","1D811231-B972-4977-890D-1FBB9109D61D","Unaligned reads",1574514190,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","833990D5-5A6C-4D68-B15B-F2CC2309C611","University of North Carolina","56607487e4b0b37b3d98eca2","585A1F31-3804-43CA-81E9-4E571FE03642","Uterine Corpus Endometrial Carcinoma","TARGZ","8976FB33-0AAF-434F-AB18-4B0AC4509E13","2013-10-04T08:18:02.000Z","64DBAA92-B80B-4C31-91F3-F955A1847324","None","NO",1,NA,"Primary Tumor","MSKCC",2017,"8976FB33-0AAF-434F-AB18-4B0AC4509E13",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7940CC0D-31A6-4780-9516-A7DDF53EEBBF.txt",400,"TCGA-AP-A056-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","C85B3C6E-56FB-42C8-AF2F-3361F6EAC353",64,"nationwidechildrens.org_clinical.TCGA-AP-A056.xml","Alive",NA,"TCGA-AP-A056",NA,"3967D902-8CF9-40DE-8D6F-733E67CB19E6",NA,2026,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,"0C3F45E7-AC74-4320-90CF-CADF9BA205B4","WHITE",NA,11,30,"AC762006-4BA4-4016-ADD7-A502E2BA45CD","84A73EEE-0001-4836-9EF8-5167063DED61","UNCID_251484.TCGA-AP-A056-01A-11R-A00V-07.100903_UNC3-RDR300156_00028_FC_62ELKAAXX.4.trimmed.annotated.translated_to_genomic.bam","TCGA-AP-A056-01A-11",60,0,0,14,40,"BOTTOM",6,0,"TCGA-AP-A056-01A-01-BSA",54,NA,NA,NA,"TCGA-AP-A056-R3423","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",2618,"TUMOR FREE","Alive",NA,"TCGA-AP-A056-F29046","TCGA-AP-A056",1,"AP","A056","YES","C54.1","8380/3","C54.1","NO","YES",-23707,"FEMALE","WHITE",NA,"No","No","Alive",2026,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2004,"Other method, specify:",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34696845,34169347,2536849909,"C11294C4-9285-4BC2-B0F6-98054A63CF50.bw","586d7b3f-67a8-4a22-862f-cf50de3c1598","c11294c4-9285-4bc2-b0f6-98054a63cf50","2016-08-09T14:06:29.893128-05:00","UNCID_2203907.093be209-e5ac-4129-83b2-5f79f6a5c15f.111018_UNC2-RDR300275_00092_FC_634BHAAXX_4.tar.gz","2a174ad1-c753-422f-ac4f-3cc8479c16f8",2235068809,"Illumina GA","78845182ec917c5ee8ac6e878242a8cb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:21:08.262227-05:00","2016-05-03T11:10:47.509879-05:00","2a174ad1-c753-422f-ac4f-3cc8479c16f8_analysis.xml","e6a9e0881b857207ab66ecd476c41bab","45040ad7-203d-4a81-9904-d973a2400838",2121,"2016-09-29T17:33:52.491529-05:00","2a174ad1-c753-422f-ac4f-3cc8479c16f8_experiment.xml","df02f79a86d49604d28abc49d949f722","015ba68b-4f34-47a6-8fa3-444335cbb003",2257,"2016-09-29T23:31:20.486996-05:00","2a174ad1-c753-422f-ac4f-3cc8479c16f8_run.xml","1e992b5c220a495a5f5d8b415fd639e8","dfdd0d00-704b-48d5-81cd-7a03edd2b918",347,"2016-09-08T11:11:45.829729-05:00","TCGA-B5-A0JX","2016-09-02T18:52:28.162130-05:00","female","TCGA-B5-A0JX_demographic",1945,"white","6014440f-b492-52dc-a262-f14f49e88341","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0JX_diagnosis","not reported",22834,"alive","8380/3",NA,1787,"a401e5ac-82c4-54b0-976e-fa86731953d1","c54.1",-22834,"TCGA-B5-A0JX_treatment","40ee69f8-a8b5-569e-882d-41a9614b7a93","01","true","TCGA-B5-A0JX-01A",NA,"f4c448e1-8415-42a4-b8d4-b71bf57ad00b",FALSE,"E511CFF9-9687-4134-B85D-37C037B71643","Primary Tumor",NA,952,170,NA,1277251200,"21",30,"TCGA-B5-A0JX-01A-21",90,70,0,0,10,30,0,0,"2016-09-08T11:11:45.829729-05:00","2016-09-08T11:11:45.829729-05:00",20,20,10,10,"TOP","BOTTOM",10,20,"15084d96-0391-46de-95df-fe514cec6093","863f5e29-c989-4cd5-b65f-2c21c6f97b01","TCGA-B5-A0JX-01A-02-TSB","TCGA-B5-A0JX-01A-02-BSB",90,50,"ebba647c-371d-492f-95cc-a0baaa329c82","RNA","TCGA-B5-A0JX-01A-21R","99e9bfc2-372d-46db-9b7c-e502255138ba",1.7,0.15,"UV Spec","R","23","TCGA-B5-A0JX-01A-21R-A14M-07","093be209-e5ac-4129-83b2-5f79f6a5c15f",0.15,NA,113,40.0368480725624,168,"647bc5a5-316b-5300-a8b5-0db38783e259","TCGA-B5-A0JX_exposure","UNCID_2203907.093be209-e5ac-4129-83b2-5f79f6a5c15f.111018_UNC2-RDR300275_00092_FC_634BHAAXX_4.tar.gz","2013-09-26T07:46:05.000Z","2013-09-26T07:59:01.000Z","2A174AD1-C753-422F-AC4F-3CC8479C16F8","F4C448E1-8415-42A4-B8D4-B71BF57AD00B","Unaligned reads",2235068809,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","093BE209-E5AC-4129-83B2-5F79F6A5C15F","University of North Carolina","564a345ae4b09c884b22367b","586D7B3F-67A8-4A22-862F-CF50DE3C1598","Uterine Corpus Endometrial Carcinoma","TARGZ","EBBA647C-371D-492F-95CC-A0BAAA329C82","2013-09-26T07:59:01.000Z","99E9BFC2-372D-46DB-9B7C-E502255138BA","United States","NO",1,NA,"Primary Tumor","Duke",952,"EBBA647C-371D-492F-95CC-A0BAAA329C82",NA,"B5","CABAL_p_TCGA_b112_125_SNP_N_GenomeWideSNP_6_E09_780734.nocnv_hg18.seg.txt",170,"TCGA-B5-A0JX-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","F4C448E1-8415-42A4-B8D4-B71BF57AD00B",62,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.FD2FA120-9178-48CD-A4EF-B93D243FF172.txt","Alive",NA,"TCGA-B5-A0JX",NA,"95273968-B76C-4CDA-B5E0-E6620712E2D0",NA,1360,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",125,NA,NA,"WHITE",NA,21,30,"863F5E29-C989-4CD5-B65F-2C21C6F97B01","622076CF-C0A9-457E-90D9-049716F6777E","TCGA-B5-A0JX-01A-21R-A14L-13_mirna.bam","TCGA-B5-A0JX-01A-21",70,30,0,20,0,"BOTTOM",20,10,"TCGA-B5-A0JX-01A-02-BSB",50,NA,NA,NA,NA,NA,NA,"TCGA-B5-A0JX-F72217_NTE-1","NO",1787,"TUMOR FREE","Alive",NA,"TCGA-B5-A0JX-F72217","TCGA-B5-A0JX",1,"B5","A0JX","YES","C54.1","8380/3","C54.1","NO","YES",-22834,"FEMALE","WHITE",NA,"No","No","Alive",1360,NA,NA,NA,"TUMOR FREE","NO",5,8,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
104801690,96822438,4611951471,"1F3F8680-EEB6-4532-B81D-51957D1EA502.bw","59cebae6-632d-4632-b695-c48ae46b2e67","1f3f8680-eeb6-4532-b81d-51957d1ea502","2016-08-09T14:02:07.333361-05:00","UNCID_2167050.5378bbbf-3ddf-43bf-824d-fcb46028f571.130621_UNC14-SN744_0352_BC253TACXX_2_AGTCAA.tar.gz","0c42951d-4c09-4326-8b33-bc828661810d",4563528269,"Illumina HiSeq","440c499f6ce64a533cf1c16831e5e647","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:04:50.589118-05:00","2016-05-03T11:07:07.492763-05:00","0c42951d-4c09-4326-8b33-bc828661810d_analysis.xml","bdb0d040b6104918f611e5a47de9c809","aa585023-c8b2-4650-bb7d-1f4176ef39ca",2123,"2016-08-26T16:19:22.170422-05:00","0c42951d-4c09-4326-8b33-bc828661810d_experiment.xml","c0de663552ac36ca6a840e694938f626","5454fbb8-575b-4c3c-a6ea-94c34a1bfcb3",2431,"2016-09-29T19:38:54.410716-05:00","0c42951d-4c09-4326-8b33-bc828661810d_run.xml","5bdfcfe23adcc8efdede12d56a313d29","500672dc-80c1-4d00-88eb-103444e2261d",354,"2016-09-08T10:28:41.742700-05:00","TCGA-DF-A2KV","2016-09-02T18:53:55.169144-05:00","female","TCGA-DF-A2KV_demographic",NA,"not reported","65351b19-481f-5a72-9867-f1b3c0fad92d","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DF","bd439172-ab1d-57cc-a1ee-7282ceebd41a","Ontario Institute for Cancer Research","not reported","c54.1","TCGA-DF-A2KV_diagnosis","not reported",20160,"alive","8380/3",NA,2717,"1a85d10b-785d-5992-9efa-17360d4f462a","c54.1",-20160,"TCGA-DF-A2KV_treatment","02be3f87-9cd1-581f-80c7-78100f58abf4","01","false","TCGA-DF-A2KV-01A",NA,"0c713392-8713-40f2-93cf-4272be99427f",FALSE,"5717937B-AC81-452E-9B4D-3301FDA7CD0B","Primary Tumor",NA,NA,580,NA,1313452800,"11",30,"TCGA-DF-A2KV-01A-11",85,NA,5,NA,0,NA,15,NA,"2016-09-08T10:28:41.742700-05:00",NA,5,NA,25,NA,"TOP",NA,0,NA,"cdba507c-5dcb-4442-9f99-720917a0cdec",NA,"TCGA-DF-A2KV-01A-01-TSA",NA,85,NA,"de51ecbb-c9a9-458b-adf6-f21f523b4b34","RNA","TCGA-DF-A2KV-01A-11R","0daee1cd-9fb5-4462-a729-278bd58e4c8c",1.8,0.17,"UV Spec","R","23","TCGA-DF-A2KV-01A-11R-A180-07","5378bbbf-3ddf-43bf-824d-fcb46028f571",0.17,NA,NA,NA,NA,"d05ba4b9-fcf3-5136-834f-89adef4209b4","TCGA-DF-A2KV_exposure","UNCID_2167050.5378bbbf-3ddf-43bf-824d-fcb46028f571.130621_UNC14-SN744_0352_BC253TACXX_2_AGTCAA.tar.gz","2013-09-21T06:56:10.000Z","2013-09-21T07:10:01.000Z","0C42951D-4C09-4326-8B33-BC828661810D","0C713392-8713-40F2-93CF-4272BE99427F","Unaligned reads",4563528269,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","5378BBBF-3DDF-43BF-824D-FCB46028F571","University of North Carolina","564a39e8e4b09c884b23e739","59CEBAE6-632D-4632-B695-C48AE46B2E67","Uterine Corpus Endometrial Carcinoma","TARGZ","DE51ECBB-C9A9-458B-ADF6-F21F523B4B34","2013-09-21T07:10:01.000Z","0DAEE1CD-9FB5-4462-A729-278BD58E4C8C","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"DE51ECBB-C9A9-458B-ADF6-F21F523B4B34",NA,"DF","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6A4B246D-F732-4F90-8197-0BE951D9C954.txt",580,"TCGA-DF-A2KV-01A",NA,NA,"TCGA",NA,"TCGA-DF-A2KV_NTE-1",NA,"TUMOR FREE","CDB841F2-69F8-4696-9455-6E3E8089F330",55,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6A4B246D-F732-4F90-8197-0BE951D9C954.txt","Alive",NA,"TCGA-DF-A2KV",NA,"8E939975-4916-4957-B4F1-2BEEC9291451","NO",936,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,NA,NA,NA,11,30,"CDBA507C-5DCB-4442-9F99-720917A0CDEC","D2E0A089-4803-49D3-8089-31E67F4559D3","TCGA-DF-A2KV-01A-11R-A17X-13_mirna.bam","TCGA-DF-A2KV-01A-11",85,0,5,5,15,"TOP",0,25,"TCGA-DF-A2KV-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,"TCGA-DF-A2KV-F66260_NTE-1",NA,2717,NA,"Alive",NA,"TCGA-DF-A2KV-F66260","TCGA-DF-A2KV",1,"DF","A2KV","YES","C54.1","8380/3","C54.1","NO","YES",-20160,"FEMALE",NA,NA,"No","No","Alive",936,NA,NA,NA,"TUMOR FREE","YES",14,10,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,NA,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32967579,32352320,2431707262,"54B5A33B-3420-426F-83BF-73C5404677E8.bw","59e9029a-8ddd-4447-b35a-72bc39f82a30","54b5a33b-3420-426f-83bf-73c5404677e8","2016-08-05T05:53:12.043011-05:00","UNCID_2210155.7865a23a-f7a6-43b0-b395-16c8306cea2f.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_7.tar.gz","e8a4321b-4b0d-47a8-9683-15e55581d377",2090219547,"Illumina GA","6b9d3a2220ef230c9ccba68a177fef9e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:46:58.749385-05:00","2016-05-03T11:15:47.407128-05:00","e8a4321b-4b0d-47a8-9683-15e55581d377_analysis.xml","4b2fe1ac8f4fdb3a3c713a32c504c706","e9ac144b-d9d2-46bd-983d-ffe43d1a0595",2123,"2016-09-29T22:22:18.805332-05:00","e8a4321b-4b0d-47a8-9683-15e55581d377_experiment.xml","76df09a992d82e9ce00e992de9c06126","b4e9b877-c786-4ef0-a80a-4d6d784e309a",2257,"2016-09-29T23:03:44.890111-05:00","e8a4321b-4b0d-47a8-9683-15e55581d377_run.xml","cc6fcfc65ffd352aa52c0763e2e62c1a","ce983a2d-009f-4901-aad0-8e021a5388c8",347,"2016-09-08T11:05:09.142938-05:00","TCGA-BK-A0CB","2016-09-02T18:48:21.544010-05:00","female","TCGA-BK-A0CB_demographic",1950,"white","1f26523e-25cd-56bb-9040-3a6c41c9990a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A0CB_diagnosis","not reported",21930,"alive","8380/3",NA,1092,"5a486ede-eca5-51a6-bbec-2e5edf372fae","c54.1",-21930,"TCGA-BK-A0CB_treatment","08300f38-dec3-5766-bc08-c806044a2990","11","false","TCGA-BK-A0CB-11A",NA,"f1d2d79c-ce6a-4160-9de2-c169f0dab321",FALSE,NA,"Solid Tissue Normal",NA,64,420,NA,1284595200,"33",240,"TCGA-BK-A0CB-11A-33",NA,NA,0,0,100,100,NA,NA,"2016-09-08T11:05:09.142938-05:00","2016-09-08T11:05:09.142938-05:00",5,5,0,0,"TOP","TOP",NA,NA,"2a22dc45-cd67-414d-a706-9a21523bf136","31b8cd48-1eaf-4c06-a64c-1703f9dfd57f","TCGA-BK-A0CB-11A-02-TS2","TCGA-BK-A0CB-11A-04-TS4",0,0,"7fad667d-4279-44d7-a864-ed6666ea694c","RNA","TCGA-BK-A0CB-11A-33R","9f856f9d-697d-4f76-9032-cf33864b764c",1.8,0.16,"UV Spec","R","23","TCGA-BK-A0CB-11A-33R-A104-07","7865a23a-f7a6-43b0-b395-16c8306cea2f",0.16,NA,111,46.8038455051442,154,"e7ee05d7-b87a-522e-b770-bb7f1b74a1ee","TCGA-BK-A0CB_exposure","UNCID_2210155.7865a23a-f7a6-43b0-b395-16c8306cea2f.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_7.tar.gz","2013-10-02T06:43:04.000Z","2013-10-02T06:56:03.000Z","E8A4321B-4B0D-47A8-9683-15E55581D377","F1D2D79C-CE6A-4160-9DE2-C169F0DAB321","Unaligned reads",2090219547,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7865A23A-F7A6-43B0-B395-16C8306CEA2F","University of North Carolina","56607a9ce4b0ca319164f7e4","59E9029A-8DDD-4447-B35A-72BC39F82A30","Uterine Corpus Endometrial Carcinoma","TARGZ","7FAD667D-4279-44D7-A864-ED6666EA694C","2013-10-02T06:56:03.000Z","9F856F9D-697D-4F76-9032-CF33864B764C","None","NO",11,NA,"Solid Tissue Normal","Christiana Healthcare",64,"7FAD667D-4279-44D7-A864-ED6666EA694C",NA,"BK","TCGA-BK-A0CB-11A-33D-A10B-09_IlluminaGA-DNASeq_exome.bam",420,"TCGA-BK-A0CB-11A",NA,"A9ED4B47-70BB-44F4-9002-CB13EF22CE93","TCGA",2010,NA,NA,"TUMOR FREE","F1D2D79C-CE6A-4160-9DE2-C169F0DAB321",60,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.248C77AA-3235-42DD-AE94-A1415F70AB72.txt","Alive",NA,"TCGA-BK-A0CB","NOT HISPANIC OR LATINO","26D9C4D3-F98D-4997-94F6-5BE1EDA45611",NA,189,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,33,240,"91A84B56-6C1B-489F-8DC0-484F5E49BE06","FDEB0EBD-7C70-45D7-91B3-AEA4F469C465","TCGA-BK-A0CB-11A-33D-A10B-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-BK-A0CB-11A-33",NA,100,0,5,NA,"TOP",NA,0,"TCGA-BK-A0CB-11A-04-TS4",0,"Taxotere","Chemotherapy","TCGA-BK-A0CB-D3362",NA,NA,NA,NA,NA,189,"TUMOR FREE","Alive",NA,"TCGA-BK-A0CB-F3361","TCGA-BK-A0CB",1,"BK","A0CB","YES","C54.1","8380/3","C54.1","YES","NO",-21930,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",189,NA,NA,NA,"TUMOR FREE","NO",8,10,2010,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2010,"Incisional Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35099710,34528630,2590214316,"31D4B639-D1E5-479B-AEC2-34F758F2E470.bw","59e9029a-8ddd-4447-b35a-72bc39f82a30","31d4b639-d1e5-479b-aec2-34f758f2e470","2016-08-09T14:17:16.291125-05:00","UNCID_2214788.6b8a0d03-6a82-49ed-b3ee-66937dc06201.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_4.tar.gz","6d18101b-eb31-43a2-b21b-c15f57b39065",2170422194,"Illumina GA","dd615c44ce9afb638b6fa2b3e82e784b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:50:18.786539-05:00","2016-05-03T11:17:14.905409-05:00","6d18101b-eb31-43a2-b21b-c15f57b39065_analysis.xml","29ee82c6ac9a66975362ffd5501515ef","3187c22a-5f96-4b59-92ae-5e07b86ce03f",2120,"2016-09-29T23:38:47.510099-05:00","6d18101b-eb31-43a2-b21b-c15f57b39065_experiment.xml","8023e40194a1b92c981016ebfd8bab60","e472c783-f730-4a83-bd44-6313f3cde215",2256,"2016-09-29T19:59:29.218151-05:00","6d18101b-eb31-43a2-b21b-c15f57b39065_run.xml","732ed48509c933882cad813b7f496577","5cce6978-db1d-4d15-9b5a-b3a397f87f82",345,"2016-09-08T11:05:09.142938-05:00","TCGA-BK-A0CB","2016-09-02T18:48:21.544010-05:00","female","TCGA-BK-A0CB_demographic",1950,"white","1f26523e-25cd-56bb-9040-3a6c41c9990a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A0CB_diagnosis","not reported",21930,"alive","8380/3",NA,1092,"5a486ede-eca5-51a6-bbec-2e5edf372fae","c54.1",-21930,"TCGA-BK-A0CB_treatment","08300f38-dec3-5766-bc08-c806044a2990","01","false","TCGA-BK-A0CB-01A",NA,"7678c70d-a298-4472-89a0-427af1e93d28",FALSE,"37923E3D-3CCB-41DB-8F30-C19FDE7407CB","Primary Tumor",NA,64,450,NA,1277337600,"32",30,"TCGA-BK-A0CB-01A-32",75,70,0,1,0,15,25,14,"2016-09-08T11:05:09.142938-05:00","2016-09-08T11:05:09.142938-05:00",0,5,0,0,"TOP","BOTTOM",0,1,"f3b81218-6651-4c2c-84bb-592a44ea3e63","9d100a55-f190-49a0-ba18-0b4cadada132","TCGA-BK-A0CB-01A-02-BS2","TCGA-BK-A0CB-01A-03-BS3",75,70,"ae54fa86-b9fc-4460-ac58-5b7e5af4684e","RNA","TCGA-BK-A0CB-01A-32R","c8a72928-a591-4c2b-9086-87be224099d1",1.77,0.16,"UV Spec","R","23","TCGA-BK-A0CB-01A-32R-A104-07","6b8a0d03-6a82-49ed-b3ee-66937dc06201",0.16,NA,111,46.8038455051442,154,"e7ee05d7-b87a-522e-b770-bb7f1b74a1ee","TCGA-BK-A0CB_exposure","UNCID_2214788.6b8a0d03-6a82-49ed-b3ee-66937dc06201.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_4.tar.gz","2013-10-03T21:01:05.000Z","2013-10-03T21:14:03.000Z","6D18101B-EB31-43A2-B21B-C15F57B39065","7678C70D-A298-4472-89A0-427AF1E93D28","Unaligned reads",2170422194,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","6B8A0D03-6A82-49ED-B3EE-66937DC06201","University of North Carolina","56607a99e4b016715ab6aa13","59E9029A-8DDD-4447-B35A-72BC39F82A30","Uterine Corpus Endometrial Carcinoma","TARGZ","AE54FA86-B9FC-4460-AC58-5B7E5AF4684E","2013-10-03T21:14:03.000Z","C8A72928-A591-4C2B-9086-87BE224099D1","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",64,"AE54FA86-B9FC-4460-AC58-5B7E5AF4684E",NA,"BK","5821182004_B_Red.idat",450,"TCGA-BK-A0CB-01A",NA,"A9ED4B47-70BB-44F4-9002-CB13EF22CE93","TCGA",2010,NA,NA,"TUMOR FREE","F1D2D79C-CE6A-4160-9DE2-C169F0DAB321",60,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.248C77AA-3235-42DD-AE94-A1415F70AB72.txt","Alive",NA,"TCGA-BK-A0CB","NOT HISPANIC OR LATINO","26D9C4D3-F98D-4997-94F6-5BE1EDA45611",NA,189,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,32,30,"F3B81218-6651-4C2C-84BB-592A44EA3E63","C8A72928-A591-4C2B-9086-87BE224099D1","CAUSE_p_TCGAb73_SNP_N_GenomeWideSNP_6_D12_698300.CEL","TCGA-BK-A0CB-01A-32",70,15,1,5,14,"BOTTOM",1,0,"TCGA-BK-A0CB-01A-03-BS3",70,"Taxotere","Chemotherapy","TCGA-BK-A0CB-D3362",NA,NA,NA,NA,NA,189,"TUMOR FREE","Alive",NA,"TCGA-BK-A0CB-F3361","TCGA-BK-A0CB",1,"BK","A0CB","YES","C54.1","8380/3","C54.1","YES","NO",-21930,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",189,NA,NA,NA,"TUMOR FREE","NO",8,10,2010,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2010,"Incisional Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
126341310,123679962,5901670750,"70D7580A-3614-4FBA-802D-98751759FEB7.bw","5a61ef1e-61eb-4794-9429-2bddbbe7d09d","70d7580a-3614-4fba-802d-98751759feb7","2016-08-06T21:02:21.238916-05:00","UNCID_2173840.4ad4e642-d5fc-459e-8553-bb1c9795c09d.130503_UNC9-SN296_0361_AC23VLACXX_4_ACTTGA.tar.gz","5469b74f-16ff-4bfb-8a2d-5d84237bc845",6168206414,"Illumina HiSeq","58a7c6d6f103964694008c5def9ad54e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:08:15.368321-05:00","2016-05-03T10:56:47.870562-05:00","5469b74f-16ff-4bfb-8a2d-5d84237bc845_analysis.xml","0947c36ec5a333d3bc0bf2b4573cf67b","f69e0c4a-1f03-46f5-8aa6-a0e07b14921b",2121,"2016-09-29T19:29:54.773611-05:00","5469b74f-16ff-4bfb-8a2d-5d84237bc845_experiment.xml","b708e697d9e3c2c74dcec49df23ad735","4a880b4a-16b6-4b6c-b91a-4b75997633cd",2431,"2016-09-29T20:41:18.364986-05:00","5469b74f-16ff-4bfb-8a2d-5d84237bc845_run.xml","7e293f98cb730e5946930f36ef897d79","765156bc-080f-42cf-85eb-86f9800d0618",354,"2016-09-08T11:31:26.400543-05:00","TCGA-FL-A1YL",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YL-11A",NA,"69c9f329-8f1d-4ed6-ad22-d82371a3fc9c",FALSE,"5C686996-6F26-4A31-B53E-AC9561DAC9FC","Solid Tissue Normal",NA,NA,80,NA,1302480000,"11",30,"TCGA-FL-A1YL-11A-11",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T11:31:26.400543-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"b964232d-84c8-4903-bde4-524925eb2ba4",NA,"TCGA-FL-A1YL-11A-01-TSA",NA,0,NA,"f27373f9-0b42-4ed2-bca9-167a0b819069","RNA","TCGA-FL-A1YL-11A-11R","23077028-c794-489b-a3db-90b63a17660f",2,0.15,"UV Spec","R","23","TCGA-FL-A1YL-11A-11R-A16F-07","4ad4e642-d5fc-459e-8553-bb1c9795c09d",0.15,NA,NA,NA,NA,NA,NA,"UNCID_2173840.4ad4e642-d5fc-459e-8553-bb1c9795c09d.130503_UNC9-SN296_0361_AC23VLACXX_4_ACTTGA.tar.gz","2013-09-10T01:56:09.000Z","2013-09-10T02:12:01.000Z","5469B74F-16FF-4BFB-8A2D-5D84237BC845","69C9F329-8F1D-4ED6-AD22-D82371A3FC9C","Unaligned reads",6168206414,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","4AD4E642-D5FC-459E-8553-BB1C9795C09D","University of North Carolina","5660784ee4b0ca319164eb26","5A61EF1E-61EB-4794-9429-2BDDBBE7D09D","Uterine Corpus Endometrial Carcinoma","TARGZ","F27373F9-0B42-4ED2-BCA9-167A0B819069","2013-09-10T02:12:01.000Z","23077028-C794-489B-A3DB-90B63A17660F","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"F27373F9-0B42-4ED2-BCA9-167A0B819069",NA,"FL","UNCID_2173840.4ad4e642-d5fc-459e-8553-bb1c9795c09d.130503_UNC9-SN296_0361_AC23VLACXX_4_ACTTGA.tar.gz",80,"TCGA-FL-A1YL-11A",NA,NA,"TCGA",NA,NA,NA,NA,"69C9F329-8F1D-4ED6-AD22-D82371A3FC9C",NA,"UNCID_2173840.4ad4e642-d5fc-459e-8553-bb1c9795c09d.130503_UNC9-SN296_0361_AC23VLACXX_4_ACTTGA.tar.gz",NA,NA,"TCGA-FL-A1YL",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,143,NA,NA,NA,NA,11,30,"B964232D-84C8-4903-BDE4-524925EB2BA4","D97E0D18-B58E-4248-9613-09CDFC94F22A","UNCID_2173840.4ad4e642-d5fc-459e-8553-bb1c9795c09d.130503_UNC9-SN296_0361_AC23VLACXX_4_ACTTGA.tar.gz","TCGA-FL-A1YL-11A-11",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YL-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36850749,36288830,2720163811,"93910528-D681-4C69-86FD-326293B2F1C1.bw","5b6b9d0f-787c-4ae9-afd4-de7ce6c57a42","93910528-d681-4c69-86fd-326293b2f1c1","2016-08-05T08:52:39.830638-05:00","UNCID_2207027.1e4969e5-6bf8-4b8d-970e-96f4424356a8.110728_UNC2-RDR300275_00080_FC_63145AAXX_5.tar.gz","37a7e2fc-6d3f-46bb-9f29-e4b2480e8bc3",2394514477,"Illumina GA","c2f23557ef144d3a4b6cb459b0b350bd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:26:48.165178-05:00","2016-05-03T11:13:02.646906-05:00","37a7e2fc-6d3f-46bb-9f29-e4b2480e8bc3_analysis.xml","fcf070b17b2bd0deda970c600a2360b3","dcf8d381-2be8-49a0-a3bd-982c8e2f1d24",2121,"2016-09-29T18:50:17.901015-05:00","37a7e2fc-6d3f-46bb-9f29-e4b2480e8bc3_experiment.xml","bb31658f1c8d0a804f0524efd6bdc435","31852ca3-5e44-4950-9f24-ef9ae692e2c1",2257,"2016-09-29T19:54:14.561739-05:00","37a7e2fc-6d3f-46bb-9f29-e4b2480e8bc3_run.xml","c6896e6609371c2c45c1c4cbe806230f","599bae03-128b-4d20-8c08-5f7492f0a3b7",347,"2016-09-08T11:01:57.422479-05:00","TCGA-A5-A0GW","2016-09-02T18:54:15.032646-05:00","female","TCGA-A5-A0GW_demographic",1963,"asian","4b3d4da8-f22d-5391-8b1f-3dc0a47b2dcb","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GW_diagnosis","not reported",17092,"alive","8380/3",NA,706,"6b3d9176-5493-57f8-b6b2-0326c5e54e8e","c54.1",-17092,"TCGA-A5-A0GW_treatment","bcfbb83b-3ec2-572b-8f1f-83df371c1c62","01","true","TCGA-A5-A0GW-01A",NA,"e84d0533-e892-4c1e-9415-99f92aa9a360",FALSE,"0EE4FD56-D0BA-43E8-A434-CD86B21F21BF","Primary Tumor",NA,302,160,NA,1276214400,"11",30,"TCGA-A5-A0GW-01A-11",90,90,0,0,0,0,0,0,"2016-09-08T11:01:57.422479-05:00","2016-09-08T11:01:57.422479-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"08c77013-9fdf-466c-8b46-5d60134c5375","590452d2-00cb-4ba6-b90c-cd0833ec6338","TCGA-A5-A0GW-01A-01-BSA","TCGA-A5-A0GW-01A-01-TSA",100,100,"eebc10d2-0017-4837-920a-f778eace12c2","RNA","TCGA-A5-A0GW-01A-11R","5d5a722a-2e4e-45ec-bd01-b0b63b813466",1.85,0.15,"UV Spec","R","23","TCGA-A5-A0GW-01A-11R-A16W-07","1e4969e5-6bf8-4b8d-970e-96f4424356a8",0.15,NA,49,24.3007339813529,142,"6a9538f2-5843-5b07-b4fe-312276bcfd66","TCGA-A5-A0GW_exposure","UNCID_2207027.1e4969e5-6bf8-4b8d-970e-96f4424356a8.110728_UNC2-RDR300275_00080_FC_63145AAXX_5.tar.gz","2013-09-29T02:43:06.000Z","2013-09-29T03:02:03.000Z","37A7E2FC-6D3F-46BB-9F29-E4B2480E8BC3","E84D0533-E892-4C1E-9415-99F92AA9A360","Unaligned reads",2394514477,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1E4969E5-6BF8-4B8D-970E-96F4424356A8","University of North Carolina","56607850e4b016715ab69ce5","5B6B9D0F-787C-4AE9-AFD4-DE7CE6C57A42","Uterine Corpus Endometrial Carcinoma","TARGZ","EEBC10D2-0017-4837-920A-F778EACE12C2","2013-09-29T03:02:03.000Z","5D5A722A-2E4E-45EC-BD01-B0B63B813466","None","NO",1,NA,"Primary Tumor","Cedars Sinai",302,"EEBC10D2-0017-4837-920A-F778EACE12C2",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F6BCE3D4-F521-491C-AE2E-978BD90B9CAD.txt",160,"TCGA-A5-A0GW-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","E84D0533-E892-4C1E-9415-99F92AA9A360",46,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F6BCE3D4-F521-491C-AE2E-978BD90B9CAD.txt","Alive",NA,"TCGA-A5-A0GW","NOT HISPANIC OR LATINO","48B7B064-7310-4C00-91FC-E108B3411F7E",NA,385,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"388D3BBC-3EF3-4A7A-B2E7-BDAD714C76F9","ASIAN",NA,11,30,"590452D2-00CB-4BA6-B90C-CD0833EC6338","F8D46B4D-9AC2-48EE-9E6C-B89E2706E79F","TCGA-A5-A0GW-01A-11R-A041-13_mirna.bam","TCGA-A5-A0GW-01A-11",90,0,0,0,0,"BOTTOM",0,0,"TCGA-A5-A0GW-01A-01-BSA",100,NA,NA,NA,"TCGA-A5-A0GW-R3089","IMPLANTS","Primary Tumor Field",NA,"NO",706,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GW-F17162","TCGA-A5-A0GW",1,"A5","A0GW","YES","C54.1","8380/3","C54.1","NO","YES",-17092,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",385,NA,NA,NA,"TUMOR FREE","NO",27,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,46,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
114155808,110292762,5241173246,"F663E106-4E34-46C8-9CD9-AE5E9B8B27F0.bw","5bf97d66-cdc6-47d0-ac74-5c6280b31072","f663e106-4e34-46c8-9cd9-ae5e9b8b27f0","2016-08-05T07:06:29.843983-05:00","UNCID_2178020.872ef409-1ec0-4856-859c-37be70ebce35.130405_UNC9-SN296_0354_AC24DCACXX_6_GATCAG.tar.gz","87f84c1c-6f50-466b-be69-3b4fc14057c0",5530865903,"Illumina HiSeq","aef745b5034d1f240c4ceb8acc508275","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:39:41.198891-05:00","2016-05-03T10:56:47.878169-05:00","87f84c1c-6f50-466b-be69-3b4fc14057c0_analysis.xml","5b6d65abe47ca29d9411f21fc16f5fa6","507e9da5-e775-4b53-a837-d74c23aaad24",2121,"2016-09-29T20:58:58.352932-05:00","87f84c1c-6f50-466b-be69-3b4fc14057c0_experiment.xml","20227300bc75db2027c805d1ef5b8b98","8159a34f-c017-46a7-9b5b-7295766a3d36",2431,"2016-09-29T19:18:11.346235-05:00","87f84c1c-6f50-466b-be69-3b4fc14057c0_run.xml","830169be4a50ff077da366fc321f1b2d","432505f7-0cb6-441c-a79e-234accc53120",354,"2016-09-08T10:59:35.850451-05:00","TCGA-DF-A2KY","2016-09-02T18:48:42.926230-05:00","female","TCGA-DF-A2KY_demographic",NA,"not reported","176c0a99-0302-5a6a-b9ad-30ff04e3360c","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DF","bd439172-ab1d-57cc-a1ee-7282ceebd41a","Ontario Institute for Cancer Research","not reported","c54.1","TCGA-DF-A2KY_diagnosis","not reported",18086,"alive","8380/3",NA,332,"f5b6b0dd-46c1-5d14-bd23-e714eefaf0d4","c54.1",-18086,"TCGA-DF-A2KY_treatment","7f87c4f0-912b-53c6-84c5-9e51629bc7d5","01","false","TCGA-DF-A2KY-01A",NA,"5c46962c-67dc-45cd-842a-d0f71c747bbd",FALSE,"8A35F74A-AFA4-4B2D-931B-FA2DE895F010","Primary Tumor",NA,NA,960,NA,1321401600,"21",30,"TCGA-DF-A2KY-01A-21",90,NA,0,NA,0,NA,0,NA,"2016-09-08T10:59:35.850451-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"53786177-eb62-4b9f-8c9f-a7056baaa8d8",NA,"TCGA-DF-A2KY-01A-02-TS2",NA,100,NA,"8a407e04-c72d-4c8b-87b2-7658225605ab","RNA","TCGA-DF-A2KY-01A-21R","a24a04af-d49a-46e9-a31e-123b88d35121",1.81,0.15,"UV Spec","R","23","TCGA-DF-A2KY-01A-21R-A213-07","872ef409-1ec0-4856-859c-37be70ebce35",0.15,NA,NA,NA,NA,"d078f55d-b119-5767-955a-d6f46d6135e5","TCGA-DF-A2KY_exposure","UNCID_2178020.872ef409-1ec0-4856-859c-37be70ebce35.130405_UNC9-SN296_0354_AC24DCACXX_6_GATCAG.tar.gz","2013-09-11T22:06:04.000Z","2013-09-11T22:20:01.000Z","87F84C1C-6F50-466B-BE69-3B4FC14057C0","5C46962C-67DC-45CD-842A-D0F71C747BBD","Unaligned reads",5530865903,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","872EF409-1EC0-4856-859C-37BE70EBCE35","University of North Carolina","56607eb2e4b016715ab6bb36","5BF97D66-CDC6-47D0-AC74-5C6280B31072","Uterine Corpus Endometrial Carcinoma","TARGZ","8A407E04-C72D-4C8B-87B2-7658225605AB","2013-09-11T22:20:01.000Z","A24A04AF-D49A-46E9-A31E-123B88D35121","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"8A407E04-C72D-4C8B-87B2-7658225605AB",NA,"DF","COAPT_p_TCGASNP_197_201_204_N_GenomeWideSNP_6_D09_1051452.tangent.copynumber.data.txt",960,"TCGA-DF-A2KY-01A",NA,"B7CCA72C-C50F-4C10-845D-0924A8668759","TCGA",NA,"TCGA-DF-A2KY_NTE-1",NA,"WITH TUMOR","610872EC-AAD0-41BE-AF11-E296735E0318",49,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2CC0B84B-C141-4904-9895-9906F40CFB08.txt","Alive",NA,"TCGA-DF-A2KY",NA,NA,NA,332,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVA",NA,NA,NA,"8380/3","FEMALE","C54.1",201,NA,NA,NA,NA,21,30,"53786177-EB62-4B9F-8C9F-A7056BAAA8D8","CDCF9EB0-A498-4211-B97A-D51560522705","TCGA-DF-A2KY-01A-21R-A214-13_mirna.bam.bai","TCGA-DF-A2KY-01A-21",90,0,0,0,0,"TOP",0,0,"TCGA-DF-A2KY-01A-02-TS2",100,"Carboplatin","Chemotherapy","TCGA-DF-A2KY-D68285",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-DF-A2KY",1,"DF","A2KY","YES","C54.1","8380/3","C54.1","NO","YES",-18086,"FEMALE",NA,NA,"No","No","Alive",332,NA,"NO","YES","WITH TUMOR","NO",20,6,2014,"NO","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,49,NA,"Other method, specify:",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"2009",15,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
34997525,34690439,2562109295,"D1923C58-76B5-4AA4-B93D-49342748AFAD.bw","5c22c8d6-5805-455c-8e1c-e6b8006738e4","d1923c58-76b5-4aa4-b93d-49342748afad","2016-08-09T14:12:44.875953-05:00","UNCID_2208080.de485b7d-cd88-4889-aff4-e290027f26bb.110624_UNC2-RDR300275_00073_FC70KA5AAXX_4.tar.gz","4a03e408-ebdc-404e-acfd-08a3d1b1b62e",2203759625,"Illumina GA","5c053dfdd572dc651fffaef990bb1bd1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:43:15.910401-05:00","2016-05-03T11:14:23.412460-05:00","4a03e408-ebdc-404e-acfd-08a3d1b1b62e_analysis.xml","7522b0e77ea623affcde260b98c37547","c1fd7343-adab-45a9-8974-28e41d7657f2",2119,"2016-09-29T23:36:37.680596-05:00","4a03e408-ebdc-404e-acfd-08a3d1b1b62e_experiment.xml","38bb1f7e5537523da66b224f7aa71d57","e328824c-6b25-49e7-bbef-9ff8a5a3c115",2257,"2016-09-29T18:05:34.049201-05:00","4a03e408-ebdc-404e-acfd-08a3d1b1b62e_run.xml","d554f0476c50cf0850f1ddc6b77abc86","1586dcf8-6701-4747-bc68-c2291178f56d",347,"2016-09-08T12:16:48.910229-05:00","TCGA-D1-A17K","2016-09-02T18:50:40.545309-05:00","female","TCGA-D1-A17K_demographic",1935,"white","68902cda-85a5-5b5d-8aa5-69a8fc3b7da5","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17K_diagnosis","not reported",27283,"alive","8380/3",NA,854,"8924b9e4-ba8b-5514-ae8f-634829d050f5","c54.1",-27283,"TCGA-D1-A17K_treatment","e478cef9-e92d-5b9b-a744-f744825d6cff","01","false","TCGA-D1-A17K-01A",NA,"ca213835-efc5-4216-a762-a6b320b516bf",FALSE,"C9E1B85A-8637-4421-A8CD-2E4BB28B3A73","Primary Tumor",NA,513,140,NA,1294185600,"11",30,"TCGA-D1-A17K-01A-11",95,NA,10,NA,0,NA,5,NA,"2016-09-08T12:16:48.910229-05:00",NA,3,NA,2,NA,"TOP",NA,5,NA,"c4ec0e82-40ad-4eaf-9eca-bf4d0fc2ce3b",NA,"TCGA-D1-A17K-01A-01-TS1",NA,90,NA,"db0d5721-ec22-4275-9a1f-22ee25a6a345","RNA","TCGA-D1-A17K-01A-11R","42fb2faf-f405-4efb-9e7e-daf2ec274798",1.78,0.16,"UV Spec","R","23","TCGA-D1-A17K-01A-11R-A12I-07","de485b7d-cd88-4889-aff4-e290027f26bb",0.16,NA,97,37.4213957794838,161,"28ade17d-5cde-5a32-bd06-2771b0cd59c6","TCGA-D1-A17K_exposure","UNCID_2208080.de485b7d-cd88-4889-aff4-e290027f26bb.110624_UNC2-RDR300275_00073_FC70KA5AAXX_4.tar.gz","2013-09-30T08:37:05.000Z","2013-09-30T08:50:02.000Z","4A03E408-EBDC-404E-ACFD-08A3D1B1B62E","CA213835-EFC5-4216-A762-A6B320B516BF","Unaligned reads",2203759625,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","DE485B7D-CD88-4889-AFF4-E290027F26BB","University of North Carolina","564a4010e4b09c884b25c218","5C22C8D6-5805-455C-8E1C-E6B8006738E4","Uterine Corpus Endometrial Carcinoma","TARGZ","DB0D5721-EC22-4275-9A1F-22EE25A6A345","2013-09-30T08:50:02.000Z","42FB2FAF-F405-4EFB-9E7E-DAF2EC274798","None","NO",1,NA,"Primary Tumor","Mayo Clinic",513,"DB0D5721-EC22-4275-9A1F-22EE25A6A345",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.0C2F85CC-EEFA-46BA-ADF8-A437B7CFDC8E.txt",140,"TCGA-D1-A17K-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","CA213835-EFC5-4216-A762-A6B320B516BF",74,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.0C2F85CC-EEFA-46BA-ADF8-A437B7CFDC8E.txt","Alive",NA,"TCGA-D1-A17K","NOT HISPANIC OR LATINO","1DCA7583-C655-4F41-8AB6-EE85A0C8B4A9",NA,429,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"C4EC0E82-40AD-4EAF-9ECA-BF4D0FC2CE3B","42FB2FAF-F405-4EFB-9E7E-DAF2EC274798","TCGA-D1-A17K-01A-11D-A12J-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-D1-A17K-01A-11",95,0,10,3,5,"TOP",5,2,"TCGA-D1-A17K-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,"YES",854,"TUMOR FREE","Alive",NA,"TCGA-D1-A17K-F20268","TCGA-D1-A17K",1,"D1","A17K","YES","C54.1","8380/3","C54.1","NO","YES",-27283,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",429,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2009,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33004791,32771226,2443721080,"02588D5D-89CB-4D0B-9E96-A0270C3FF866.bw","5c3f826c-b447-457d-a90e-715bad3c7118","02588d5d-89cb-4d0b-9e96-a0270c3ff866","2016-08-06T05:39:21.650283-05:00","UNCID_2206480.f501c084-03d5-48ad-b365-085773a7bd2d.110921_UNC2-RDR300275_00086_FC634HAAAXX_1.tar.gz","2530f824-a329-4d02-ba88-a9b67b4a4a46",2076832021,"Illumina GA","c2e60cc42f37388248c05616fcf04ce6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:30:20.306988-05:00","2016-05-03T11:11:34.768699-05:00","2530f824-a329-4d02-ba88-a9b67b4a4a46_analysis.xml","7bb4ce6592884bf396273aeae3b9795f","6f9c55fd-eb06-4ce0-9317-e4d3fc6cb4c1",2119,"2016-09-29T23:06:39.218088-05:00","2530f824-a329-4d02-ba88-a9b67b4a4a46_experiment.xml","5eee7a2c64036de3c38513b5f64ae701","d080dbe2-9cfc-4345-bb06-ad7218682dd1",2257,"2016-09-29T17:36:36.484493-05:00","2530f824-a329-4d02-ba88-a9b67b4a4a46_run.xml","156ae20e7f33f8064ceb970bf25a2ce7","030965e3-efe1-4932-b605-9a3c06f1c5ad",347,"2016-09-08T11:13:27.247044-05:00","TCGA-A5-A1OG","2016-09-02T18:52:09.111794-05:00","female","TCGA-A5-A1OG_demographic",1945,"asian","0083a218-06f6-5278-ac8e-1bc4f0cf5124","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A1OG_diagnosis","not reported",23956,"dead","8441/3",973,348,"f853a784-588f-507c-9f83-400ecd132330","c54.1",-23956,"TCGA-A5-A1OG_treatment","d835223b-c175-5c78-bffa-0d96ffdc85a7","01","true","TCGA-A5-A1OG-01A",NA,"4cbc8fb7-9de4-4e17-8fb2-8571a224fb8d",FALSE,"7BE01FDF-C4CF-471E-B395-8D7C4531CD6F","Primary Tumor",NA,223,190,NA,1300406400,"11",30,"TCGA-A5-A1OG-01A-11",70,NA,0,NA,0,NA,30,NA,"2016-09-08T11:13:27.247044-05:00",NA,10,NA,10,NA,"TOP",NA,20,NA,"58ae39e5-f5ae-44ad-8d4a-cc442b18c5c3",NA,"TCGA-A5-A1OG-01A-01-TSA",NA,50,NA,"9e0a171b-69a9-43cf-9c24-e9ee59502eb8","RNA","TCGA-A5-A1OG-01A-11R","3359a3db-2dbb-4dd8-a2db-0bcaa598b81b",1.83,0.18,"UV Spec","R","23","TCGA-A5-A1OG-01A-11R-A14D-07","f501c084-03d5-48ad-b365-085773a7bd2d",0.18,NA,64,25.6369171607114,158,"f62f4c93-7a49-5216-ad9e-fd98d58316a6","TCGA-A5-A1OG_exposure","UNCID_2206480.f501c084-03d5-48ad-b365-085773a7bd2d.110921_UNC2-RDR300275_00086_FC634HAAAXX_1.tar.gz","2013-09-27T03:37:04.000Z","2013-09-27T03:50:03.000Z","2530F824-A329-4D02-BA88-A9B67B4A4A46","4CBC8FB7-9DE4-4E17-8FB2-8571A224FB8D","Unaligned reads",2076832021,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","F501C084-03D5-48AD-B365-085773A7BD2D","University of North Carolina","564a3b97e4b093830b6954bb","5C3F826C-B447-457D-A90E-715BAD3C7118","Uterine Corpus Endometrial Carcinoma","TARGZ","9E0A171B-69A9-43CF-9C24-E9EE59502EB8","2013-09-27T03:50:03.000Z","3359A3DB-2DBB-4DD8-A2DB-0BCAA598B81B","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",223,"9E0A171B-69A9-43CF-9C24-E9EE59502EB8",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7B3713CB-8B91-4E9C-9DEF-EA02D94F9D64.txt",190,"TCGA-A5-A1OG-01A",NA,"DD9A9130-FB9C-483D-A329-0226963D04E7","TCGA",2010,NA,NA,"WITH TUMOR","CC5C2390-0302-46C1-8D78-295234710504",65,"CHEEP_p_TCGA_b120_121_SNP_N_GenomeWideSNP_6_B06_777764.hg19.seg.txt","Alive",NA,"TCGA-A5-A1OG","NOT HISPANIC OR LATINO","FD13C911-7AFD-4BCE-8E89-D4853CD21190",NA,348,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",121,NA,"E8AC8132-4CFA-4417-9DE3-46E7AB728BF1","ASIAN",NA,11,30,"58AE39E5-F5AE-44AD-8D4A-CC442B18C5C3","EAE71F77-4F07-441A-AB10-9D18606C46B8","UNCID_1621391.f501c084-03d5-48ad-b365-085773a7bd2d.sorted_genome_alignments.bam.bai","TCGA-A5-A1OG-01A-11",70,0,0,10,30,"TOP",20,10,"TCGA-A5-A1OG-01A-01-TSA",50,"Taxol","Chemotherapy","TCGA-A5-A1OG-D14466","TCGA-A5-A1OG-R14467","EXTERNAL BEAM","Primary Tumor Field",NA,"YES",348,"WITH TUMOR","Alive",NA,"TCGA-A5-A1OG-F14462","TCGA-A5-A1OG",1,"A5","A1OG","YES","C54.1","8441/3","C54.1","YES","NO",-23956,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",348,NA,NA,NA,"WITH TUMOR","NO",1,8,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,65,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
24624984,23790113,1758579826,"18971368-40F0-42D3-B1A3-707850C53B18.bw","5cba9441-6812-49c0-a0f6-7928ed4e5b81","18971368-40f0-42d3-b1a3-707850c53b18","2016-08-06T12:45:53.058699-05:00","UNCID_2215088.4534628b-5eb9-4123-b56b-b00447ee730b.101014_UNC2-RDR300275_00039_FC_706C1AAXX_5.tar.gz","1c42e3ab-1fe1-40f9-acc3-3e83acbac516",1461829294,"Illumina GA","c717e36785d35fe4fd1b8f224deeeed8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:52:04.017945-05:00","2016-05-03T11:17:59.903755-05:00","1c42e3ab-1fe1-40f9-acc3-3e83acbac516_analysis.xml","f50eac8fdbcd306af054537bc191cb70","0cfa2eec-1f17-4745-9fcd-bc6d78bc7c88",2120,"2016-09-29T22:27:24.762775-05:00","1c42e3ab-1fe1-40f9-acc3-3e83acbac516_experiment.xml","4a8b3de1a2f0ea0c3bcae1d8b430d16f","b81b4583-314a-4b8c-9a9c-3bb488ae7301",2256,"2016-09-29T21:43:39.275977-05:00","1c42e3ab-1fe1-40f9-acc3-3e83acbac516_run.xml","908e39642758512a6d331d709dac87b5","9d1044a0-aacf-474a-9245-cd3bfde22455",345,"2016-09-08T11:03:16.399025-05:00","TCGA-B5-A0K6","2016-09-02T18:54:45.474400-05:00","female","TCGA-B5-A0K6_demographic",1951,"white","f2d6d9b4-f88a-5830-a5d4-499a571ee71f","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0K6_diagnosis","not reported",21515,"alive","8380/3",NA,1953,"6dbbb44b-9cf8-556a-8d00-bb62669b4dc2","c54.1",-21515,"TCGA-B5-A0K6_treatment","503605e8-109f-5b95-880b-f8ef58552673","01","true","TCGA-B5-A0K6-01A",NA,"69bf0d3a-b7ae-4ee1-b7d1-18a32fcfa67c",FALSE,"B7F34F79-DB7F-4C98-B1B3-80C3187AE91C","Primary Tumor",NA,206,110,NA,1277769600,"11",30,"TCGA-B5-A0K6-01A-11",60,90,0,0,0,0,20,0,"2016-09-08T11:03:16.399025-05:00","2016-09-08T11:03:16.399025-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"ff953551-3378-4a18-8ab0-22fc1bd8807f","642e077e-3572-453d-b612-c0ea50006a08","TCGA-B5-A0K6-01A-01-BSA","TCGA-B5-A0K6-01A-01-TSA",80,100,"71a355d0-d466-457f-bc68-83d3a1cf4eaa","RNA","TCGA-B5-A0K6-01A-11R","519b7d4e-f3ba-4c95-b191-81e5c4c8cde6",1.89,0.16,"UV Spec","R","23","TCGA-B5-A0K6-01A-11R-A040-07","4534628b-5eb9-4123-b56b-b00447ee730b",0.16,NA,132,47.3304887231525,167,"2ef23f4f-4729-5e66-95ae-f65d640aaa08","TCGA-B5-A0K6_exposure","UNCID_2215088.4534628b-5eb9-4123-b56b-b00447ee730b.101014_UNC2-RDR300275_00039_FC_706C1AAXX_5.tar.gz","2013-10-03T23:56:05.000Z","2013-10-04T00:08:03.000Z","1C42E3AB-1FE1-40F9-ACC3-3E83ACBAC516","69BF0D3A-B7AE-4EE1-B7D1-18A32FCFA67C","Unaligned reads",1461829294,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4534628B-5EB9-4123-B56B-B00447EE730B","University of North Carolina","564a32ade4b09c884b21aff3","5CBA9441-6812-49C0-A0F6-7928ED4E5B81","Uterine Corpus Endometrial Carcinoma","TARGZ","71A355D0-D466-457F-BC68-83D3A1CF4EAA","2013-10-04T00:08:03.000Z","519B7D4E-F3BA-4C95-B191-81E5C4C8CDE6","United States","NO",1,NA,"Primary Tumor","Duke",206,"71A355D0-D466-457F-BC68-83D3A1CF4EAA",NA,"B5","TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted.bam",110,"TCGA-B5-A0K6-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","8DCB31CF-3146-4698-A71B-BFEF58BE9FDC",58,"nationwidechildrens.org_clinical.TCGA-B5-A0K6.xml","Alive",NA,"TCGA-B5-A0K6",NA,"ACCCDE29-4383-428C-86AC-444D90130387",NA,418,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"FF953551-3378-4A18-8AB0-22FC1BD8807F","519B7D4E-F3BA-4C95-B191-81E5C4C8CDE6","TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted.bam","TCGA-B5-A0K6-01A-11",60,0,0,0,20,"BOTTOM",0,0,"TCGA-B5-A0K6-01A-01-BSA",80,NA,NA,NA,NA,NA,NA,NA,"NO",418,"TUMOR FREE","Alive",NA,"TCGA-B5-A0K6-F13281","TCGA-B5-A0K6",1,"B5","A0K6","YES","C54.1","8380/3","C54.1","NO","YES",-21515,"FEMALE","WHITE",NA,"No","No","Alive",418,NA,NA,NA,"TUMOR FREE","NO",19,1,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2009,"Dilation and curettage procedure",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34355871,34123034,2540162757,"553423BC-7594-4EA3-B04F-2857AE5EC7E5.bw","5d2f1a0f-a01b-48c2-b749-1ca710aa2bb4","553423bc-7594-4ea3-b04f-2857ae5ec7e5","2016-08-31T11:51:08.552400-05:00","UNCID_2206502.fcb43e1a-3b34-4ff1-8d3e-849fbf901877.110921_UNC2-RDR300275_00086_FC634HAAAXX_5.tar.gz","b40097e1-9713-4466-a09f-1a2b5e7962d2",2188829955,"Illumina GA","c636099839786617e2c8dacc480bf651","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:00:17.049447-05:00","2016-05-03T11:11:34.765256-05:00","b40097e1-9713-4466-a09f-1a2b5e7962d2_analysis.xml","1e1bc3e13c1b33790c9c567054f62b2e","f1d10d2f-fc5a-413e-80a0-861ef5800233",2119,"2016-09-29T18:35:07.309520-05:00","b40097e1-9713-4466-a09f-1a2b5e7962d2_experiment.xml","99e28239706194a7820f497dc4544623","27d10933-3db7-4b70-a48b-cd0b2d83160f",2257,"2016-09-29T18:13:58.542096-05:00","b40097e1-9713-4466-a09f-1a2b5e7962d2_run.xml","d29aca38ca99331522788a041db8ba60","1aaad6f0-4e30-45d9-9c5f-90f721e8dc55",347,"2016-09-08T12:17:52.343903-05:00","TCGA-B5-A1MY","2016-09-02T18:52:04.284312-05:00","female","TCGA-B5-A1MY_demographic",1948,"black or african american","f29ecfc9-9382-5135-8dc7-46978064f64e","not reported",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A1MY_diagnosis","not reported",22805,"dead","8441/3",361,NA,"fe06b940-4e3d-5573-a605-d51e85687e05","c54.1",-22805,"TCGA-B5-A1MY_treatment","5a8c6402-cd3b-59a8-962e-68bae816ecb6","01","true","TCGA-B5-A1MY-01A",NA,"26189cf5-ae49-44cf-842b-35a3063ab93c",FALSE,"A5328E25-1433-4331-83B8-148780F6A6DA","Primary Tumor",NA,128,360,NA,1300406400,"11",30,"TCGA-B5-A1MY-01A-11",80,NA,3,NA,0,NA,20,NA,"2016-09-08T12:17:52.343903-05:00",NA,3,NA,0,NA,"TOP",NA,5,NA,"c24337bd-b021-440a-9931-8b01fccb09ad",NA,"TCGA-B5-A1MY-01A-01-TSA",NA,75,NA,"c7791612-81f3-488d-a679-6ac20acf0b2e","RNA","TCGA-B5-A1MY-01A-11R","0f934ec8-09d8-4692-8833-f90c59cdeb22",1.48,0.15,"UV Spec","R","23","TCGA-B5-A1MY-01A-11R-A144-07","fcb43e1a-3b34-4ff1-8d3e-849fbf901877",0.15,NA,67,31.4317883280165,146,"dd6f13e5-0eed-5287-8c4c-b0ebdedca661","TCGA-B5-A1MY_exposure","UNCID_2206502.fcb43e1a-3b34-4ff1-8d3e-849fbf901877.110921_UNC2-RDR300275_00086_FC634HAAAXX_5.tar.gz","2013-09-27T06:36:07.000Z","2013-09-27T06:49:01.000Z","B40097E1-9713-4466-A09F-1A2B5E7962D2","26189CF5-AE49-44CF-842B-35A3063AB93C","Unaligned reads",2188829955,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","FCB43E1A-3B34-4FF1-8D3E-849FBF901877","University of North Carolina","56607c84e4b0b37b3d992811","5D2F1A0F-A01B-48C2-B749-1CA710AA2BB4","Uterine Corpus Endometrial Carcinoma","TARGZ","C7791612-81F3-488D-A679-6AC20ACF0B2E","2013-09-27T06:49:01.000Z","0F934EC8-09D8-4692-8833-F90C59CDEB22","United States","NO",1,NA,"Primary Tumor","Duke",128,"C7791612-81F3-488D-A679-6AC20ACF0B2E",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2CA50913-5945-4E8E-B67B-96BA996A7737.txt",360,"TCGA-B5-A1MY-01A",NA,"FF007808-6CF7-4F5D-9422-4544402E0CC8","TCGA",2010,NA,NA,"WITH TUMOR","DEF3BEF3-FE3D-4DB9-A733-CCB913591555",62,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2CA50913-5945-4E8E-B67B-96BA996A7737.txt","Dead",361,"TCGA-B5-A1MY",NA,NA,NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",118,NA,"C2061A0F-8B4F-4DCE-994D-E390E53B8666","BLACK OR AFRICAN AMERICAN",NA,11,30,"C24337BD-B021-440A-9931-8B01FCCB09AD","64CE376E-9F1E-490D-AB22-0C2FE28C4F11","UNCID_2206502.fcb43e1a-3b34-4ff1-8d3e-849fbf901877.110921_UNC2-RDR300275_00086_FC634HAAAXX_5.tar.gz","TCGA-B5-A1MY-01A-11",80,0,3,3,20,"TOP",5,0,"TCGA-B5-A1MY-01A-01-TSA",75,"Carboplatin","Chemotherapy","TCGA-B5-A1MY-D21850","TCGA-B5-A1MY-R21857","RADIOISOTOPES","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-B5-A1MY",1,"B5","A1MY","YES","C54.1","8441/3","C54.1","NO","YES",-22805,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Dead",NA,361,NA,NA,"WITH TUMOR","NO",17,2,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,62,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
145029818,142425894,6726234383,"3A2DFC20-49B1-4268-8F60-12F9B39B1C25.bw","5d39e9a2-1073-4db2-b02e-db05d59563a7","3a2dfc20-49b1-4268-8f60-12f9b39b1c25","2016-08-05T10:55:39.908652-05:00","UNCID_2173028.fefa50dc-29a7-4c27-a735-ab6eb500a5d5.130509_UNC10-SN254_0462_AC232JACXX_6_GTCCGC.tar.gz","10ad376b-bc4f-4bbf-a387-45385966239b",6829311030,"Illumina HiSeq","ca25015898c27f3e8afb06699a4545e0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:58:20.685826-05:00","2016-05-03T10:55:55.600288-05:00","10ad376b-bc4f-4bbf-a387-45385966239b_analysis.xml","ba06da6147e6c0b958ad2fca80910c68","10e7f438-f480-472d-adf9-226dc638ed32",2123,"2016-09-29T21:27:00.803671-05:00","10ad376b-bc4f-4bbf-a387-45385966239b_experiment.xml","1e28e70766a04e440ac48dcdd92e2867","92eab3d3-6bd0-4807-914d-4ffcc7a54fd8",2431,"2016-09-29T18:48:49.392743-05:00","10ad376b-bc4f-4bbf-a387-45385966239b_run.xml","69f2a654feac233c64eb5dd9cc2786a0","309c4cf5-0e74-4ce6-898a-050379e4dbad",354,"2016-09-08T11:20:07.653359-05:00","TCGA-AJ-A23N","2016-09-02T18:48:45.838078-05:00","female","TCGA-AJ-A23N_demographic",1941,"white","22f3b2a8-466f-59e5-a3f7-03c1a8beee4b","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A23N_diagnosis","not reported",25772,"dead","8441/3",439,33,"6c98a7d8-ead1-5662-9673-613cbaa8c99b","c54.1",-25772,"TCGA-AJ-A23N_treatment","172b4f09-46e1-5474-89df-c355b61adacf","01","false","TCGA-AJ-A23N-01A",NA,"4a5f2624-4f86-44cd-84a3-cd1403e093b6",FALSE,"38EB6233-9777-4640-A896-26D16A9DBD8E","Primary Tumor",NA,84,130,NA,1331510400,"11",30,"TCGA-AJ-A23N-01A-11",65,NA,1,NA,0,NA,0,NA,"2016-09-08T11:20:07.653359-05:00",NA,5,NA,1,NA,"TOP",NA,5,NA,"d723a1dd-17b6-463d-8349-748bbeb66e02",NA,"TCGA-AJ-A23N-01A-01-MS1",NA,95,NA,"65ac3881-f174-4b1a-9425-9fed22e06d0c","RNA","TCGA-AJ-A23N-01A-11R","5ca965ca-7f3e-411f-9e9e-1e33d86af762",1.82,0.16,"UV Spec","R","23","TCGA-AJ-A23N-01A-11R-A22K-07","fefa50dc-29a7-4c27-a735-ab6eb500a5d5",0.16,NA,NA,NA,NA,"40feab89-a434-504b-a7bb-f733ffb8153e","TCGA-AJ-A23N_exposure","UNCID_2173028.fefa50dc-29a7-4c27-a735-ab6eb500a5d5.130509_UNC10-SN254_0462_AC232JACXX_6_GTCCGC.tar.gz","2013-09-09T09:16:08.000Z","2013-09-09T09:33:02.000Z","10AD376B-BC4F-4BBF-A387-45385966239B","4A5F2624-4F86-44CD-84A3-CD1403E093B6","Unaligned reads",6829311030,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","FEFA50DC-29A7-4C27-A735-AB6EB500A5D5","University of North Carolina","564a3590e4b0ef121818921a","5D39E9A2-1073-4DB2-B02E-DB05D59563A7","Uterine Corpus Endometrial Carcinoma","TARGZ","65AC3881-F174-4B1A-9425-9FED22E06D0C","2013-09-09T09:33:02.000Z","5CA965CA-7F3E-411F-9E9E-1E33D86AF762","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",84,"65AC3881-F174-4B1A-9425-9FED22E06D0C",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6EDED36B-2F9E-460F-875B-21634AC908BA.txt",130,"TCGA-AJ-A23N-01A",NA,"6E45B1C4-453B-4EFB-82EB-0E2454D117C7","TCGA",2011,"TCGA-AJ-A23N_NTE-1",NA,"WITH TUMOR","9F0D3DEC-58EC-487C-BEEE-6A16D24150BE",70,"b578abf58a21b5f63a5d0c8b37140cc2.bam","Alive",NA,"TCGA-AJ-A23N",NA,"94CF2113-420A-4308-BE3B-9D01B5DA0448","NO",33,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"841B7E13-F74F-4A3D-B15D-4AA4A48E53E7","WHITE",NA,11,30,"D723A1DD-17B6-463D-8349-748BBEB66E02","5CA965CA-7F3E-411F-9E9E-1E33D86AF762","a4702c42061548a7e08366784194b513.bam.bai","TCGA-AJ-A23N-01A-11",65,0,1,5,0,"TOP",5,1,"TCGA-AJ-A23N-01A-01-MS1",95,"Taxol","Chemotherapy","TCGA-AJ-A23N-D47003","TCGA-AJ-A23N-R47001","External","Primary Tumor Field","TCGA-AJ-A23N-F47000_NTE-1","NO",NA,"WITH TUMOR","Dead",439,"TCGA-AJ-A23N-F47000","TCGA-AJ-A23N",1,"AJ","A23N","YES","C54.1","8441/3","C54.1","YES","NO",-25772,"FEMALE","WHITE",NA,"No","No","Alive",33,NA,NA,NA,"WITH TUMOR","YES",4,10,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,70,2011,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34258422,34057992,2570739991,"7E003476-C1CA-42BD-9BDF-E193B248D8C4.bw","5dd28537-d24f-4a6d-a454-6f64cf37e16a","7e003476-c1ca-42bd-9bdf-e193b248d8c4","2016-08-09T14:03:38.446131-05:00","UNCID_2194412.02302c44-fe54-4b39-9bef-c56db229c2ac.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_7.tar.gz","55f6ab25-b868-4afc-80dd-78ad0f90b90e",2133921981,"Illumina GA","ef1b12dfe5f1cd3e33cbac8c1c953ed9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:47:18.859050-05:00","2016-05-03T11:07:49.533431-05:00","55f6ab25-b868-4afc-80dd-78ad0f90b90e_analysis.xml","174e27a4590779a1a0ff48653bfe7fcc","09f805bf-6c9b-4237-8bff-58fcbe34ff97",2122,"2016-09-29T19:01:10.977410-05:00","55f6ab25-b868-4afc-80dd-78ad0f90b90e_experiment.xml","210826baf396128afdb1bd934464d767","3854529e-264b-46d3-a434-ad22a638003f",2258,"2016-09-29T22:42:24.630428-05:00","55f6ab25-b868-4afc-80dd-78ad0f90b90e_run.xml","b244825a2ad6553d6327a6ab5e6072a8","c174eb18-55bc-4640-b673-4681e8535262",349,"2016-09-08T11:04:38.551877-05:00","TCGA-EY-A1GU","2016-09-02T18:52:00.909895-05:00","female","TCGA-EY-A1GU_demographic",1944,"black or african american","fc12f5c0-916b-58cd-adf6-ffd5a2316196","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GU_diagnosis","not reported",24304,"dead","8380/3",997,378,"b9931a2c-2e4f-5dc9-a4b5-6d30be3fd97d","c54.1",-24304,"TCGA-EY-A1GU_treatment","81fcac9b-cdd5-51cf-be43-8e65f8cb3379","01","false","TCGA-EY-A1GU-01A",NA,"ef348984-8c78-46a3-8e76-d5d974819d1b",FALSE,"7A06A8F8-416F-41CD-B546-95DEA06996D0","Primary Tumor",NA,189,380,NA,1297728000,"11",30,"TCGA-EY-A1GU-01A-11",80,NA,10,NA,0,NA,15,NA,"2016-09-08T11:04:38.551877-05:00",NA,40,NA,40,NA,"TOP",NA,5,NA,"687bddc2-4ed6-4f56-bbad-84bf72ab618f",NA,"TCGA-EY-A1GU-01A-01-TSA",NA,80,NA,"6448a84b-23ec-4e59-9483-4aa94ebd059e","RNA","TCGA-EY-A1GU-01A-11R","f4dde49c-e9a2-465b-9be8-73177c9b21dd",1.67,0.15,"UV Spec","R","23","TCGA-EY-A1GU-01A-11R-A13S-07","02302c44-fe54-4b39-9bef-c56db229c2ac",0.15,NA,90,35.15625,160,"8af56266-28ad-56d8-a31a-6f75b263a63c","TCGA-EY-A1GU_exposure","UNCID_2194412.02302c44-fe54-4b39-9bef-c56db229c2ac.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_7.tar.gz","2013-09-22T23:06:07.000Z","2013-09-22T23:18:02.000Z","55F6AB25-B868-4AFC-80DD-78AD0F90B90E","EF348984-8C78-46A3-8E76-D5D974819D1B","Unaligned reads",2133921981,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","02302C44-FE54-4B39-9BEF-C56DB229C2AC","University of North Carolina","56607511e4b0b37b3d98f385","5DD28537-D24F-4A6D-A454-6F64CF37E16A","Uterine Corpus Endometrial Carcinoma","TARGZ","6448A84B-23EC-4E59-9483-4AA94EBD059E","2013-09-22T23:18:02.000Z","F4DDE49C-E9A2-465B-9BE8-73177C9B21DD","United States","NO",1,NA,"Primary Tumor","University of North Carolina",189,"6448A84B-23EC-4E59-9483-4AA94EBD059E",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.1B18AB0C-DC27-4B01-8E6A-7E890F1207DE.txt",380,"TCGA-EY-A1GU-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","EF348984-8C78-46A3-8E76-D5D974819D1B",66,"nationwidechildrens.org_clinical.TCGA-EY-A1GU.xml","Alive",NA,"TCGA-EY-A1GU","NOT HISPANIC OR LATINO","06869621-D1C9-4D1D-B0BA-EFDDBC81BF86",NA,259,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,"DDEA0192-8CDC-4CF5-AFE2-17C71378F888","BLACK OR AFRICAN AMERICAN",NA,11,30,"687BDDC2-4ED6-4F56-BBAD-84BF72AB618F","8E992A56-BFEA-4959-9C5D-82B464725A74","TCGA-EY-A1GU-01A-01D-YYYY-23.txt","TCGA-EY-A1GU-01A-11",80,0,10,40,15,"TOP",5,40,"TCGA-EY-A1GU-01A-01-TSA",80,NA,NA,NA,"TCGA-EY-A1GU-R19881","OTHER: SPECIFY IN NOTES","Regional site",NA,"NO",378,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GU-F19879","TCGA-EY-A1GU",1,"EY","A1GU","YES","C54.1","8380/3","C54.1","YES","NO",-24304,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",259,NA,NA,NA,"TUMOR FREE","NO",24,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,66,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31238446,30843042,2303323137,"93C284BA-155E-46C5-BF1F-3F98EDF1709C.bw","5dfdfcfc-72cc-4e33-aa3f-0d744eb94330","93c284ba-155e-46c5-bf1f-3f98edf1709c","2016-08-09T14:16:41.016685-05:00","UNCID_2214907.0d04e718-95ff-4eb9-b56f-99c0ee5970d2.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_3.tar.gz","5254b695-2382-4828-a12a-70e145366289",1864673854,"Illumina GA","3b0a6c682add3b9b3492c7f7e63df12e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:49:40.668211-05:00","2016-05-03T11:17:14.905409-05:00","5254b695-2382-4828-a12a-70e145366289_analysis.xml","3f23e9f86553a6cee80a1d08bbf912b9","311dae5d-d927-4a94-bc93-f0ea42e88f44",2120,"2016-08-28T05:54:52.015604-05:00","5254b695-2382-4828-a12a-70e145366289_experiment.xml","f00bbae92afbf69c4ba2a32a61da5146","a326de29-0b14-4b2e-b854-b3c05aaa7eca",2256,"2016-09-29T20:26:40.721091-05:00","5254b695-2382-4828-a12a-70e145366289_run.xml","ce66af373e2340f4c5029dcc6bb3e9cd","6d6821aa-d65e-43b3-a54b-3814dc92178b",345,"2016-09-08T11:33:37.269375-05:00","TCGA-AP-A0LV","2016-09-02T18:54:39.752873-05:00","female","TCGA-AP-A0LV_demographic",1970,"white","5b89e6af-bc94-5d29-9aae-508edc9f7ae2","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LV_diagnosis","not reported",14556,"alive","8380/3",NA,763,"3d9dedea-6420-562b-96e0-30befcd1d44f","c54.1",-14556,"TCGA-AP-A0LV_treatment","3344f8fb-070c-5e93-baaf-dd4901d6976d","01","true","TCGA-AP-A0LV-01A",NA,"f5c82191-3e5a-479a-b0e4-77f6ac14b3cc",FALSE,"75767B04-9FDF-4EE9-8DFF-350B60AF281C","Primary Tumor",NA,341,280,NA,1278547200,"11",30,"TCGA-AP-A0LV-01A-11",90,85,0,0,0,0,0,0,"2016-09-08T11:33:37.269375-05:00","2016-09-08T11:33:37.269375-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"07ca5dcb-d6d3-4142-9a8f-e791eedfb0a5","bcaf0eda-e74e-4575-81e6-58727b7f7c1d","TCGA-AP-A0LV-01A-01-BSA","TCGA-AP-A0LV-01A-01-TSA",100,100,"f507ccf5-9729-4679-87eb-e9f1cd21cd22","RNA","TCGA-AP-A0LV-01A-11R","9ae0d691-536f-4d92-8ec4-d2252c4a2928",1.91,0.13,"UV Spec","R","23","TCGA-AP-A0LV-01A-11R-A040-07","0d04e718-95ff-4eb9-b56f-99c0ee5970d2",0.13,NA,76,32.8947368421053,152,"e9f8bc3d-30f9-5857-9037-8a9943fe5747","TCGA-AP-A0LV_exposure","UNCID_2214907.0d04e718-95ff-4eb9-b56f-99c0ee5970d2.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_3.tar.gz","2013-10-03T22:16:04.000Z","2013-10-03T22:28:02.000Z","5254B695-2382-4828-A12A-70E145366289","F5C82191-3E5A-479A-B0E4-77F6AC14B3CC","Unaligned reads",1864673854,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0D04E718-95FF-4EB9-B56F-99C0EE5970D2","University of North Carolina","564a3c3ee4b0298dd2c8ad84","5DFDFCFC-72CC-4E33-AA3F-0D744EB94330","Uterine Corpus Endometrial Carcinoma","TARGZ","F507CCF5-9729-4679-87EB-E9F1CD21CD22","2013-10-03T22:28:02.000Z","9AE0D691-536F-4D92-8EC4-D2252C4A2928","None","NO",1,NA,"Primary Tumor","MSKCC",341,"F507CCF5-9729-4679-87EB-E9F1CD21CD22",NA,"AP","MODEM_p_TCGAb59_SNP_N_GenomeWideSNP_6_D09_680558.hg19.seg.txt",280,"TCGA-AP-A0LV-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","F5C82191-3E5A-479A-B0E4-77F6AC14B3CC",39,"US82800149_251976012243_S01_GE2_105_Dec08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","Alive",NA,"TCGA-AP-A0LV",NA,"A409FEE7-F916-4348-85C0-72FA0789A9BD",NA,385,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"BCAF0EDA-E74E-4575-81E6-58727B7F7C1D","DA21221C-82E6-4DA9-A166-DE2A9643C184","TCGA-AP-A0LV-01A-11W-A062-09_IlluminaGA-DNASeq_exome_1.bam.bai","TCGA-AP-A0LV-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-AP-A0LV-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,NA,385,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LV-F4048","TCGA-AP-A0LV",1,"AP","A0LV","YES","C54.1","8380/3","C54.1","NO","YES",-14556,"FEMALE","WHITE",NA,"No","No","Alive",385,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,39,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
35072993,33076692,2479240051,"EF59938B-A70B-44B9-AA7A-B46A566A8F79.bw","5e3b981e-73fe-4cc9-8c89-b420e8e2f426","ef59938b-a70b-44b9-aa7a-b46a566a8f79","2016-08-09T14:12:58.639990-05:00","UNCID_2207061.e1c80dfd-3db5-4005-9bb5-245124d4dc0f.110728_UNC2-RDR300275_00080_FC_63145AAXX_4.tar.gz","752ef0ce-b2b1-4351-a7fc-8bf674e965d4",2248330955,"Illumina GA","845d7efebe60b8f5b859f708a9ed9f17","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:29:11.600441-05:00","2016-05-03T11:13:42.364824-05:00","752ef0ce-b2b1-4351-a7fc-8bf674e965d4_analysis.xml","17a53c9aef68bac8e57c305b1bd208a9","944bf3cb-9c9e-4d86-a4b6-5fb82b4600c5",2121,"2016-10-07T17:21:14.092839-05:00","752ef0ce-b2b1-4351-a7fc-8bf674e965d4_experiment.xml","a51e1b6e2032bc24e7a7144b13e34950","4a2c3840-23ed-4223-be68-c5ebd609d95f",2257,"2016-09-29T20:07:42.255141-05:00","752ef0ce-b2b1-4351-a7fc-8bf674e965d4_run.xml","d0399177ca0eaeb111e79dbbdeb30f67","61c0ff3d-4ee7-4d64-8b64-2ab52e8d3b7a",347,"2016-09-08T10:35:07.678438-05:00","TCGA-A5-A0GV","2016-09-02T18:54:14.415420-05:00","female","TCGA-A5-A0GV_demographic",1942,"white","42b773b4-de7e-563d-b394-022955a80a1b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GV_diagnosis","not reported",24540,"alive","8380/3",NA,1643,"e71ae858-ef0c-5ca2-a931-dbf8abbb0e7b","c54.1",-24540,"TCGA-A5-A0GV_treatment","a20ab2ad-87d8-51ff-948f-ca3415f53cd6","01","true","TCGA-A5-A0GV-01A",NA,"339926e1-61e6-4256-a808-f931aa2c17d2",FALSE,"0E6417D3-6E95-4EEF-AE93-40D69D4F6525","Primary Tumor",NA,454,330,NA,1277856000,"31",30,"TCGA-A5-A0GV-01A-31",95,98,1,0,0,0,3,3,"2016-09-08T10:35:07.678438-05:00","2016-09-08T10:35:07.678438-05:00",1,0,0,0,"TOP","BOTTOM",5,5,"657bc432-8053-44f3-b484-357aa6901915","0130f61b-ff0a-48aa-b04f-36ddcb673a8e","TCGA-A5-A0GV-01A-03-TSC","TCGA-A5-A0GV-01A-03-BSC",92,92,"a76405f0-50c4-41e7-9690-70d304b3a579","RNA","TCGA-A5-A0GV-01A-31R","630eced3-4a14-4e3d-978d-f229a3e6edff",1.81,0.14,"UV Spec","R","23","TCGA-A5-A0GV-01A-31R-A16W-07","e1c80dfd-3db5-4005-9bb5-245124d4dc0f",0.14,NA,63,25.2363403300753,158,"63456843-86ba-5082-93e7-00bab5612ab1","TCGA-A5-A0GV_exposure","UNCID_2207061.e1c80dfd-3db5-4005-9bb5-245124d4dc0f.110728_UNC2-RDR300275_00080_FC_63145AAXX_4.tar.gz","2013-09-29T05:55:04.000Z","2013-09-29T06:08:01.000Z","752EF0CE-B2B1-4351-A7FC-8BF674E965D4","339926E1-61E6-4256-A808-F931AA2C17D2","Unaligned reads",2248330955,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E1C80DFD-3DB5-4005-9BB5-245124D4DC0F","University of North Carolina","564a3c87e4b0ef12181acc08","5E3B981E-73FE-4CC9-8C89-B420E8E2F426","Uterine Corpus Endometrial Carcinoma","TARGZ","A76405F0-50C4-41E7-9690-70D304B3A579","2013-09-29T06:08:01.000Z","630ECED3-4A14-4E3D-978D-F229A3E6EDFF","None","NO",1,NA,"Primary Tumor","Cedars Sinai",454,"A76405F0-50C4-41E7-9690-70D304B3A579",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C86E0866-3F2C-4364-91F3-BA8602F13866.txt",330,"TCGA-A5-A0GV-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","4A3E6225-7149-4AC4-B104-C133B00F1B6D",67,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C86E0866-3F2C-4364-91F3-BA8602F13866.txt","Alive",NA,"TCGA-A5-A0GV","NOT HISPANIC OR LATINO","578016D3-5E8F-4257-91CA-BEC9D29F7178",NA,486,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"ED0FD663-1E2B-43BD-B551-49839986AAD3","WHITE",NA,31,30,"657BC432-8053-44F3-B484-357AA6901915","5C63F5FA-8B0E-4229-A5BA-1CB71EE73DA4","TCGA-A5-A0GV-01A-31R-A041-13_mirna.bam.bai","TCGA-A5-A0GV-01A-31",95,0,1,1,3,"TOP",5,0,"TCGA-A5-A0GV-01A-03-TSC",92,NA,NA,NA,"TCGA-A5-A0GV-R3157","EXTERNAL BEAM","Primary Tumor Field",NA,NA,486,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GV-F3156","TCGA-A5-A0GV",1,"A5","A0GV","YES","C54.1","8380/3","C54.1","NO","YES",-24540,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",486,NA,NA,NA,"TUMOR FREE","NO",10,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
143177808,139504440,6653613103,"4BF75CF9-DA61-4A0B-940C-B09C7FE864F0.bw","5edaed6d-9914-4df2-a843-d6009c36cbcc","4bf75cf9-da61-4a0b-940c-b09c7fe864f0","2016-08-25T01:13:55.133119-05:00","UNCID_2581798.a9430dc8-38cf-4ef1-8442-e20582f6d893.140408_UNC11-SN627_0351_AC3KY3ACXX_5_CGATGT.tar.gz","603b2f7f-5875-4778-a7d2-557f188422e2",6187135124,"Illumina HiSeq","17a68d797d219545428e7183d688fee2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:32:45.515565-05:00","2016-05-03T11:55:56.226464-05:00","603b2f7f-5875-4778-a7d2-557f188422e2_analysis.xml","a5ae22357c9c9adc538e3cb4b5011897","966e2f42-796c-43b3-bcf7-ae06159c1f9f",2124,"2016-09-29T21:02:31.166946-05:00","603b2f7f-5875-4778-a7d2-557f188422e2_experiment.xml","39be7a2f120bd8598e37ab34a3e9576f","838369df-2a97-4339-9b8a-304512360d05",2628,"2016-09-29T20:19:34.071394-05:00","603b2f7f-5875-4778-a7d2-557f188422e2_run.xml","45ac7dfdcf4dca66d0c93ebb68e831c6","68f21e50-aa94-4891-83ed-5ae0d5b2db29",354,"2016-09-08T10:46:27.137653-05:00","TCGA-PG-A916","2016-09-02T18:52:01.315700-05:00","female","TCGA-PG-A916_demographic",1943,"black or african american","1b1c4e7b-2386-52da-929c-fc293a8cbad3","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","PG","69bd8326-4904-56a0-8230-1615a777173b","Montefiore Medical Center","not reported","c54.1","TCGA-PG-A916_diagnosis","not reported",25617,"alive","8380/3",NA,522,"09927097-08c2-5dde-b4c6-4e05005aca23","c54.1",-25617,"TCGA-PG-A916_treatment","f2410677-ed5a-5ee7-8abf-9cdebe514bdb","01","true","TCGA-PG-A916-01A",NA,"2004ff38-a2bf-43be-8b72-b2994a53d890",FALSE,"3E66FA38-0D87-47CA-A72D-63C0619A2182","Primary Tumor",NA,224,220,NA,1388361600,"11",30,"TCGA-PG-A916-01A-11",70,NA,0,NA,0,NA,30,NA,"2016-09-08T10:46:27.137653-05:00",NA,0,NA,0,NA,"TOP",NA,10,NA,"df6d6feb-bd09-4617-b95d-f8a0eab161b9",NA,"TCGA-PG-A916-01A-01-TSA",NA,60,NA,"6765da14-7335-416b-8964-b4200e7328b6","RNA","TCGA-PG-A916-01A-11R","19ced2a8-a358-4044-9b83-51506251f513",1.9,0.17,"UV Spec","R","23","TCGA-PG-A916-01A-11R-A37O-07","a9430dc8-38cf-4ef1-8442-e20582f6d893",0.17,NA,NA,NA,NA,"e81de8a8-6aa3-5bc9-b9e1-430bb5133be2","TCGA-PG-A916_exposure","UNCID_2581798.a9430dc8-38cf-4ef1-8442-e20582f6d893.140408_UNC11-SN627_0351_AC3KY3ACXX_5_CGATGT.tar.gz","2014-08-15T11:21:04.000Z","2014-08-15T11:41:58.000Z","603B2F7F-5875-4778-A7D2-557F188422E2","2004FF38-A2BF-43BE-8B72-B2994A53D890","Unaligned reads",6187135124,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","A9430DC8-38CF-4EF1-8442-E20582F6D893","University of North Carolina","564a3d3be4b08c5d869217d2","5EDAED6D-9914-4DF2-A843-D6009C36CBCC","Uterine Corpus Endometrial Carcinoma","TARGZ","6765DA14-7335-416B-8964-B4200E7328B6","2014-08-15T11:41:58.000Z","19CED2A8-A358-4044-9B83-51506251F513","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",224,"6765DA14-7335-416B-8964-B4200E7328B6",NA,"PG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.577759B3-B76A-445B-84C7-DCA24C120A56.txt",220,"TCGA-PG-A916-01A",NA,NA,"TCGA",2013,"TCGA-PG-A916_NTE-1","Complete Remission/Response","TUMOR FREE","AF053C48-40CD-46C4-A0AB-7A98EF0CFFD5",70,"TCGA-PG-A916-01A-11D_OPTIPLEX-XE_2015-01-16_012.fsa","Alive",NA,"TCGA-PG-A916","NOT HISPANIC OR LATINO","FC811706-4ADC-4E50-965A-C304212C6274","NO",342,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage I",NA,NA,NA,"8380/3","FEMALE","C54.1",381,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"DF6D6FEB-BD09-4617-B95D-F8A0EAB161B9","21373FEF-B438-4C69-A050-14F395A36BD5","TCGA-PG-A916-01A-11R-A37P-13_mirna.bam","TCGA-PG-A916-01A-11",70,0,0,0,30,"TOP",10,0,"TCGA-PG-A916-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,"TCGA-PG-A916-F71185_NTE-1","NO",522,"TUMOR FREE","Alive",NA,"TCGA-PG-A916-F71185","TCGA-PG-A916",1,"PG","A916","YES","C54.1","8380/3","C54.1","NO","YES",-25617,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",342,NA,"NO","NO","TUMOR FREE","YES",28,4,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,70,2013,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",1,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33054359,32380291,2420676433,"4F556BC6-3A10-4EB1-A835-DE1B9E64D292.bw","5f2f2e7a-8aec-4011-b261-0c5bc68da840","4f556bc6-3a10-4eb1-a835-de1b9e64d292","2016-08-09T14:08:18.448448-05:00","UNCID_2206485.fd13e02a-4bfb-4aaa-bbf7-488660106a31.110921_UNC6-RDR300211_00125_FC_634F4AAXX_3.tar.gz","e3d9bc86-e7fa-4f2e-bd98-252ad1640a9c",2167942344,"Illumina GA","eafdc811ee1e9cbacbb46292a5bca224","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:20:40.812061-05:00","2016-05-03T11:11:34.765256-05:00","e3d9bc86-e7fa-4f2e-bd98-252ad1640a9c_analysis.xml","a93ec5bea6090d21984b9d6735c8ad70","69a265b7-b494-4ed3-a001-4850445a556c",2121,"2016-08-28T19:13:25.414129-05:00","e3d9bc86-e7fa-4f2e-bd98-252ad1640a9c_experiment.xml","a86fdcde531dbdc861a183bb95fb6a40","5a219f63-8016-42ac-a727-8fbbf3b5c19b",2257,"2016-09-29T23:25:17.644115-05:00","e3d9bc86-e7fa-4f2e-bd98-252ad1640a9c_run.xml","199527494726e4ec57ce462a4f9ce296","dc01fd64-0dc1-43c5-963d-872896ea352d",347,"2016-09-08T10:43:47.477736-05:00","TCGA-EO-A1Y5","2016-09-02T18:52:40.037046-05:00","female","TCGA-EO-A1Y5_demographic",1947,"not reported","fd594d66-0c40-5b02-9262-afbc6549a207","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A1Y5_diagnosis","not reported",23251,"alive","8441/3",NA,327,"a52f4e96-efca-5354-ac1f-d5e4600af48f","c54.1",-23251,"TCGA-EO-A1Y5_treatment","e7870fa8-d744-59c3-97d4-6ea0b3f51420","01","false","TCGA-EO-A1Y5-01A",NA,"9bed3aea-1f78-4567-bb7b-016753a9bd0b",FALSE,"B3A96371-1CD6-4B08-BDA5-C8CD7C7DE81F","Primary Tumor",NA,223,110,NA,1303862400,"11",30,"TCGA-EO-A1Y5-01A-11",80,NA,0,NA,0,NA,20,NA,"2016-09-08T10:43:47.477736-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"bd409406-8451-4980-8914-e4df8fc23af3",NA,"TCGA-EO-A1Y5-01A-01-TSA",NA,80,NA,"8f22001a-6fe2-4a3f-9a6a-58048716145c","RNA","TCGA-EO-A1Y5-01A-11R","ec3154b2-15fa-4a62-a1ce-a46e522626a8",1.88,0.15,"UV Spec","R","23","TCGA-EO-A1Y5-01A-11R-A157-07","fd13e02a-4bfb-4aaa-bbf7-488660106a31",0.15,NA,79,30.4772192430848,161,"e95d407e-ec1d-5865-ad8d-f640f72f2363","TCGA-EO-A1Y5_exposure","UNCID_2206485.fd13e02a-4bfb-4aaa-bbf7-488660106a31.110921_UNC6-RDR300211_00125_FC_634F4AAXX_3.tar.gz","2013-09-27T04:07:05.000Z","2013-09-27T04:20:02.000Z","E3D9BC86-E7FA-4F2E-BD98-252AD1640A9C","9BED3AEA-1F78-4567-BB7B-016753A9BD0B","Unaligned reads",2167942344,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","FD13E02A-4BFB-4AAA-BBF7-488660106A31","University of North Carolina","56607ec5e4b018727fea384f","5F2F2E7A-8AEC-4011-B261-0C5BC68DA840","Uterine Corpus Endometrial Carcinoma","TARGZ","8F22001A-6FE2-4A3F-9A6A-58048716145C","2013-09-27T04:20:02.000Z","EC3154B2-15FA-4A62-A1CE-A46E522626A8","Canada","NO",1,NA,"Primary Tumor","University Health Network",223,"8F22001A-6FE2-4A3F-9A6A-58048716145C",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C19E3960-24A6-4C23-8543-E58F9FD8338B.txt",110,"TCGA-EO-A1Y5-01A",NA,"F1010094-972C-4393-8692-F13BF3DF4EA6","TCGA",2010,NA,NA,"TUMOR FREE","E4503920-A2D7-4D2E-82B9-E98EA37CA04B",63,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C19E3960-24A6-4C23-8543-E58F9FD8338B.txt","Alive",NA,"TCGA-EO-A1Y5",NA,"84CDBE89-ED65-4769-AD0E-B2CBCF903106",NA,332,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",137,NA,"FCCDFBD6-EBD4-4423-91F4-69C32FEAEAE7",NA,NA,11,30,"BD409406-8451-4980-8914-E4DF8FC23AF3","C8DFA5CD-3D2E-49C6-9C85-EA85DA01C6D9","UNCID_2206485.fd13e02a-4bfb-4aaa-bbf7-488660106a31.110921_UNC6-RDR300211_00125_FC_634F4AAXX_3.tar.gz","TCGA-EO-A1Y5-01A-11",80,0,0,0,20,"TOP",0,0,"TCGA-EO-A1Y5-01A-01-TSA",80,"Carboplatin","Chemotherapy","TCGA-EO-A1Y5-D56548","TCGA-EO-A1Y5-R56550","Internal","Regional site","TCGA-EO-A1Y5-F56547_NTE-1","NO",327,"TUMOR FREE","Alive",NA,"TCGA-EO-A1Y5-F56547","TCGA-EO-A1Y5",1,"EO","A1Y5","YES","C54.1","8441/3","C54.1","NO","YES",-23251,"FEMALE",NA,NA,"No","No","Alive",332,NA,NA,NA,"TUMOR FREE","NO",26,7,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,63,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
165196218,163051709,7703880645,"9E5162FF-4316-42B2-882F-9CDBE2193686.bw","5f764ac1-3de7-4cfd-a77a-d21baa418834","9e5162ff-4316-42b2-882f-9cdbe2193686","2016-08-09T13:15:27.142781-05:00","UNCID_2173000.eb279337-8251-4442-905c-8a4be743f057.130509_UNC10-SN254_0462_AC232JACXX_7_CGTACG.tar.gz","10f3a64a-149f-45ed-a38d-78a0413ad389",7628070660,"Illumina HiSeq","f227dbd1dd7d8222d437c70065d30f64","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:10:43.210091-05:00","2016-05-03T10:55:55.600288-05:00","10f3a64a-149f-45ed-a38d-78a0413ad389_analysis.xml","926d06a704fffe84f3f16fbfee507af1","d3151a4d-3dc9-4a0f-a3ec-75a8492c8a9b",2123,"2016-08-13T03:22:54.059180-05:00","10f3a64a-149f-45ed-a38d-78a0413ad389_experiment.xml","618bad741c55e10498e4219be41ccbf7","9272c486-76e2-4e97-95f4-20f6237f21f2",2431,"2016-09-29T21:00:32.420052-05:00","10f3a64a-149f-45ed-a38d-78a0413ad389_run.xml","b9e12dff353425f04bf60d107a6e722c","82505578-9618-46e8-9af0-d5758290aa20",354,"2016-09-08T10:47:11.779597-05:00","TCGA-EO-A3KW","2016-09-02T18:49:29.271011-05:00","female","TCGA-EO-A3KW_demographic",1939,"not reported","2892198e-6c40-564b-b111-52a3797e9f8c","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3KW_diagnosis","not reported",26492,"alive","8441/3",NA,497,"4d741fd5-b1bb-59fe-a569-74158159de1e","c54.1",-26492,"TCGA-EO-A3KW_treatment","ef755f5e-2676-5747-b307-7eb36c72e6fb","01","false","TCGA-EO-A3KW-01A",NA,"ac5073ea-51cf-466c-9b31-1d4fbb86f998",FALSE,"C1CFE3DE-628B-4C0F-881B-588C613498DA","Primary Tumor",NA,205,150,NA,1325721600,"11",30,"TCGA-EO-A3KW-01A-11",90,NA,0,NA,20,NA,0,NA,"2016-09-08T10:47:11.779597-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"8fcde58f-d538-46f2-9b5f-356c6a416c1e",NA,"TCGA-EO-A3KW-01A-01-TS1",NA,80,NA,"a017cef2-8567-4dd1-8851-bc10599ab8f3","RNA","TCGA-EO-A3KW-01A-11R","5721f4d8-b8d1-4d96-948a-1376a4036ece",1.8,0.17,"UV Spec","R","23","TCGA-EO-A3KW-01A-11R-A22K-07","eb279337-8251-4442-905c-8a4be743f057",0.17,NA,62,26.4855397496689,153,"4aadd2f4-c495-5ea3-a408-873fce16aa07","TCGA-EO-A3KW_exposure","UNCID_2173000.eb279337-8251-4442-905c-8a4be743f057.130509_UNC10-SN254_0462_AC232JACXX_7_CGTACG.tar.gz","2013-09-09T06:16:08.000Z","2013-09-09T06:45:02.000Z","10F3A64A-149F-45ED-A38D-78A0413AD389","AC5073EA-51CF-466C-9B31-1D4FBB86F998","Unaligned reads",7628070660,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","EB279337-8251-4442-905C-8A4BE743F057","University of North Carolina","564a3a0de4b093830b68d447","5F764AC1-3DE7-4CFD-A77A-D21BAA418834","Uterine Corpus Endometrial Carcinoma","TARGZ","A017CEF2-8567-4DD1-8851-BC10599AB8F3","2013-09-09T06:45:02.000Z","5721F4D8-B8D1-4D96-948A-1376A4036ECE","Canada","NO",1,NA,"Primary Tumor","University Health Network",205,"A017CEF2-8567-4DD1-8851-BC10599AB8F3",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E6BEBDFC-AE99-42FA-A673-C64C518F0EEA.txt",150,"TCGA-EO-A3KW-01A",NA,"0405EE3C-0A59-4252-B7EC-09B11D075D7A","TCGA",2011,NA,NA,"TUMOR FREE","C0E2D1F7-B529-4BF4-A644-E11BFA2AC9A5",72,"TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_E11_1151376.raw.copynumber.data.txt","Alive",NA,"TCGA-EO-A3KW",NA,"9A7BE8A1-675F-41FA-A59C-F293194E6F6E",NA,182,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"07E9B737-1DB7-4DF2-93AB-54BF56E18CB2",NA,NA,11,30,"8FCDE58F-D538-46F2-9B5F-356C6A416C1E","F088B2D4-6EC8-4532-823D-0EA2887B0C23","TCGA-EO-A3KW-01A-11R-A22I-13_mirna.bam.bai","TCGA-EO-A3KW-01A-11",90,20,0,1,0,"TOP",0,0,"TCGA-EO-A3KW-01A-01-TS1",80,NA,NA,"TCGA-EO-A3KW-D39970","TCGA-EO-A3KW-R39969",NA,NA,"TCGA-EO-A3KW-F39967_NTE-1","NO",497,"TUMOR FREE","Alive",NA,"TCGA-EO-A3KW-F39967","TCGA-EO-A3KW",1,"EO","A3KW","YES","C54.1","8441/3","C54.1","NO","YES",-26492,"FEMALE",NA,NA,"No","No","Alive",182,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,72,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29721209,29152283,2178786749,"1809618E-A051-4758-BC59-B04E23FB3A42.bw","5ffa2ec6-2d94-4b09-8fb9-3591cf38fa4f","1809618e-a051-4758-bc59-b04e23fb3a42","2016-08-09T14:16:58.425991-05:00","UNCID_2211848.b280c179-336d-4638-9309-0f51426f8054.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_2.tar.gz","8537c37f-39b7-4c1a-8cb7-a3cd6817b55b",1856472557,"Illumina GA","3ddfc863a9b3837172f5280c7856a237","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:58:41.499299-05:00","2016-05-03T11:16:29.240093-05:00","8537c37f-39b7-4c1a-8cb7-a3cd6817b55b_analysis.xml","134dd6ed59601e34e85992b3b158a331","36d89378-6a2c-4331-8d99-3a3b5cc294ac",2121,"2016-08-13T08:18:09.931764-05:00","8537c37f-39b7-4c1a-8cb7-a3cd6817b55b_experiment.xml","e88572a40fcce48c6b1c23ed8c3c0301","bd436686-258f-48e2-9081-da94f856c2fb",2257,"2016-09-29T18:12:10.465321-05:00","8537c37f-39b7-4c1a-8cb7-a3cd6817b55b_run.xml","2fe1e3904195e07e8829f7c4bf6dfbce","19980a2a-ef19-4964-b894-cb9ba41f7b25",347,"2016-09-08T11:34:37.605140-05:00","TCGA-BS-A0U9","2016-09-02T18:49:11.074574-05:00","female","TCGA-BS-A0U9_demographic",1947,"native hawaiian or other pacific islander","adc48981-fe38-5f10-b8d5-97a058523a5c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0U9_diagnosis","not reported",21580,"alive","8380/3",NA,2825,"97a94aa4-98f6-51d5-8f84-f33325cc9d45","c54.1",-21580,"TCGA-BS-A0U9_treatment","c983df28-1815-5382-8e67-b3967b6032c3","01","false","TCGA-BS-A0U9-01B",NA,"99d6d536-af2c-4c9b-9995-5b4032d54479",FALSE,"029B0BBB-D88D-4492-AC9A-9094E0DD101C","Primary Tumor",NA,1637,430,NA,1288051200,"21",30,"TCGA-BS-A0U9-01B-21",80,80,0,0,0,0,5,5,"2016-09-08T11:34:37.605140-05:00","2016-09-08T11:34:37.605140-05:00",1,2,1,1,"TOP","BOTTOM",15,15,"32ac844b-05c9-4a3d-b869-0e8a1f6362f5","850f5696-2fc8-4b63-be9d-dbdda77c3832","TCGA-BS-A0U9-01B-02-TSB","TCGA-BS-A0U9-01B-02-BSB",80,80,"1ac8b701-420f-4291-979e-03715687d2c9","RNA","TCGA-BS-A0U9-01B-21R","4092809f-5005-4f5d-a3a1-52fea1c5c013",1.79,0.15,"UV Spec","R","23","TCGA-BS-A0U9-01B-21R-A10J-07","b280c179-336d-4638-9309-0f51426f8054",0.15,NA,99,34.2560553633218,170,"fd0dab78-5e36-5e45-b3a7-94119c0bfb49","TCGA-BS-A0U9_exposure","UNCID_2211848.b280c179-336d-4638-9309-0f51426f8054.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_2.tar.gz","2013-10-03T03:16:03.000Z","2013-10-03T03:28:03.000Z","8537C37F-39B7-4C1A-8CB7-A3CD6817B55B","99D6D536-AF2C-4C9B-9995-5B4032D54479","Unaligned reads",1856472557,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B280C179-336D-4638-9309-0F51426F8054","University of North Carolina","566077bde4b0ec1099f8d093","5FFA2EC6-2D94-4B09-8FB9-3591CF38FA4F","Uterine Corpus Endometrial Carcinoma","TARGZ","1AC8B701-420F-4291-979E-03715687D2C9","2013-10-03T03:28:03.000Z","4092809F-5005-4F5D-A3A1-52FEA1C5C013","None","NO",1,NA,"Primary Tumor","University of Hawaii",1637,"1AC8B701-420F-4291-979E-03715687D2C9",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F2D7C005-5AB3-44EC-954F-D0CDFB98C51F.txt",430,"TCGA-BS-A0U9-01B",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","99D6D536-AF2C-4C9B-9995-5B4032D54479",59,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F2D7C005-5AB3-44EC-954F-D0CDFB98C51F.txt","Alive",NA,"TCGA-BS-A0U9","NOT HISPANIC OR LATINO","E8AAE683-BFC7-4F61-9116-A04A2D664B7D",NA,1749,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIA",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,21,30,"850F5696-2FC8-4B63-BE9D-DBDDA77C3832","DC3D3C76-6532-48C7-B1FE-437F564BF8C9","6f9e6813a75e86e0dd1890966a4457d9.bam","TCGA-BS-A0U9-01B-21",80,0,0,2,5,"BOTTOM",15,1,"TCGA-BS-A0U9-01B-02-BSB",80,NA,NA,NA,NA,NA,NA,"TCGA-BS-A0U9-F68986_NTE-1","NO",2825,"TUMOR FREE","Alive",NA,"TCGA-BS-A0U9-F68986","TCGA-BS-A0U9",1,"BS","A0U9","YES","C54.1","8380/3","C54.1","NO","YES",-21580,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","NOT HISPANIC OR LATINO","No","No","Alive",1749,NA,NA,NA,"TUMOR FREE","NO",28,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2006,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"1988",6,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30587593,29984845,2231790928,"B43F52DD-D081-4B9D-9E5B-F76FCCDB6E3A.bw","601734da-2d11-4745-a260-0965f58aadea","b43f52dd-d081-4b9d-9e5b-f76fccdb6e3a","2016-08-26T05:43:19.407113-05:00","UNCID_2206599.1b38dbc6-5830-4514-9317-9dcb23e36b98.110928_UNC6-RDR300211_00126_FC_6348UAAXX_8.tar.gz","a2ad1cf3-3e19-442d-b67f-83d615e40a0e",2011539621,"Illumina GA","acaa0a55b7a9d6cd8f5efe45efb888b8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:37:45.211104-05:00","2016-05-03T11:50:45.422885-05:00","a2ad1cf3-3e19-442d-b67f-83d615e40a0e_analysis.xml","ca3c31fa2980e8d77724b852f16688d5","7412cf6e-a549-4295-99f9-cf204e5be02b",2121,"2016-09-29T19:34:29.574286-05:00","a2ad1cf3-3e19-442d-b67f-83d615e40a0e_experiment.xml","ee4259d1958fdc24436b040a096be0c1","4d5031d9-5ebc-4c32-8ad8-6a53ecd731a0",2257,"2016-09-29T23:13:52.704341-05:00","a2ad1cf3-3e19-442d-b67f-83d615e40a0e_run.xml","23a4a6df33b984d38c20080f18352ac8","d513dbaf-d4b3-4763-af4b-d8abb0ca9625",347,"2016-09-08T10:25:55.358735-05:00","TCGA-FI-A2F8","2016-09-02T18:53:00.218480-05:00","female","TCGA-FI-A2F8_demographic",1945,"white","a4323184-d6f7-50dc-85ae-1b9adbf70349","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2F8_diagnosis","not reported",23649,"alive","8441/3",NA,933,"8e61edf0-cbe0-5a74-8ae9-1082dff20b6e","c54.1",-23649,"TCGA-FI-A2F8_treatment","9c78a99b-1815-50dd-83a8-07ae7223d2fd","01","true","TCGA-FI-A2F8-01A",NA,"500c427b-db2c-4ca4-8bad-9f573e99c32a",FALSE,"9445945A-A7AC-4C36-889B-68A50644D556","Primary Tumor",NA,679,70,NA,1308268800,"12",20,"TCGA-FI-A2F8-01A-12",70,NA,20,NA,0,NA,20,NA,"2016-09-08T10:25:55.358735-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"8e154304-4c97-44b3-88a2-b71e5cbb7900",NA,"TCGA-FI-A2F8-01A-01-TS1",NA,70,NA,"9f4a5b99-a326-4c55-a7b3-bcabf48f4abf","RNA","TCGA-FI-A2F8-01A-12R","50848127-ca56-41e4-bc07-1295d77aca3c",1.83,0.17,"UV Spec","R","23","TCGA-FI-A2F8-01A-12R-A17B-07","1b38dbc6-5830-4514-9317-9dcb23e36b98",0.17,NA,99,33.0782852751512,173,"1d0b0d91-9493-5718-9b0b-958305c1c0ed","TCGA-FI-A2F8_exposure","UNCID_2206599.1b38dbc6-5830-4514-9317-9dcb23e36b98.110928_UNC6-RDR300211_00126_FC_6348UAAXX_8.tar.gz","2013-09-27T12:07:05.000Z","2014-06-24T20:51:38.000Z","A2AD1CF3-3E19-442D-B67F-83D615E40A0E","500C427B-DB2C-4CA4-8BAD-9F573E99C32A","Unaligned reads",2011539621,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1B38DBC6-5830-4514-9317-9DCB23E36B98","University of North Carolina","564a368be4b0298dd2c6d8ca","601734DA-2D11-4745-A260-0965F58AADEA","Uterine Corpus Endometrial Carcinoma","TARGZ","9F4A5B99-A326-4C55-A7B3-BCABF48F4ABF","2014-06-24T20:51:38.000Z","50848127-CA56-41E4-BC07-1295D77ACA3C","United States","NO",1,NA,"Primary Tumor","Washington University",679,"9F4A5B99-A326-4C55-A7B3-BCABF48F4ABF",NA,"FI","4b8c0ebe362115aa8d7447764cd3cf00.bam.bai",70,"TCGA-FI-A2F8-01A",NA,"BFAD841D-D24F-4BFB-ABB1-429765A427E2","TCGA",2009,NA,NA,"TUMOR FREE","500C427B-DB2C-4CA4-8BAD-9F573E99C32A",64,"nationwidechildrens.org_clinical.TCGA-FI-A2F8.xml","Alive",NA,"TCGA-FI-A2F8","NOT HISPANIC OR LATINO","25C38AAB-2964-458A-A41B-FBB71882C91F",NA,761,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,12,20,"8E154304-4C97-44B3-88A2-B71E5CBB7900","F4AC25A3-9511-461A-8E63-4A143D41F2D6","4b8c0ebe362115aa8d7447764cd3cf00.bam.bai","TCGA-FI-A2F8-01A-12",70,0,20,40,20,"TOP",10,20,"TCGA-FI-A2F8-01A-01-TS1",70,"cisplatin","Chemotherapy","TCGA-FI-A2F8-D31810",NA,NA,NA,NA,"NO",933,"WITH TUMOR","Alive",NA,"TCGA-FI-A2F8-F31739","TCGA-FI-A2F8",1,"FI","A2F8","YES","C54.1","8441/3","C54.1","NO","YES",-23649,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",761,NA,NA,NA,"TUMOR FREE","NO",28,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,64,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30587593,29984647,2231772739,"7F209C48-3E3C-4710-8A9F-4C7B536D65C8.bw","601734da-2d11-4745-a260-0965f58aadea","7f209c48-3e3c-4710-8a9f-4c7b536d65c8","2016-08-05T10:56:48.078126-05:00","UNCID_2232063.1b38dbc6-5830-4514-9317-9dcb23e36b98.110928_UNC6-RDR300211_00126_FC_6348UAAXX_8.tar.gz","c88b15e3-db84-445a-9f55-715d9aa8098b",2011539621,"Illumina GA","94f8918caaf4318797438f0ab87b29d2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:27:06.788666-05:00","2016-05-03T11:20:13.161874-05:00","c88b15e3-db84-445a-9f55-715d9aa8098b_analysis.xml","dc1f68856516c61b7ea0c34dd991549f","b7e9e743-badb-4084-9faf-6f364f8f2185",2121,"2016-09-29T19:51:07.556707-05:00","c88b15e3-db84-445a-9f55-715d9aa8098b_experiment.xml","ee4259d1958fdc24436b040a096be0c1","57aeba47-e46e-40fd-8612-ee918d967503",2257,"2016-09-29T17:34:34.101024-05:00","c88b15e3-db84-445a-9f55-715d9aa8098b_run.xml","23a4a6df33b984d38c20080f18352ac8","01ca60d5-d388-428e-bebc-e8477aeebd62",347,"2016-09-08T10:25:55.358735-05:00","TCGA-FI-A2F8","2016-09-02T18:53:00.218480-05:00","female","TCGA-FI-A2F8_demographic",1945,"white","a4323184-d6f7-50dc-85ae-1b9adbf70349","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2F8_diagnosis","not reported",23649,"alive","8441/3",NA,933,"8e61edf0-cbe0-5a74-8ae9-1082dff20b6e","c54.1",-23649,"TCGA-FI-A2F8_treatment","9c78a99b-1815-50dd-83a8-07ae7223d2fd","01","true","TCGA-FI-A2F8-01A",NA,"500c427b-db2c-4ca4-8bad-9f573e99c32a",FALSE,"9445945A-A7AC-4C36-889B-68A50644D556","Primary Tumor",NA,679,70,NA,1308268800,"12",20,"TCGA-FI-A2F8-01A-12",70,NA,20,NA,0,NA,20,NA,"2016-09-08T10:25:55.358735-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"8e154304-4c97-44b3-88a2-b71e5cbb7900",NA,"TCGA-FI-A2F8-01A-01-TS1",NA,70,NA,"9f4a5b99-a326-4c55-a7b3-bcabf48f4abf","RNA","TCGA-FI-A2F8-01A-12R","50848127-ca56-41e4-bc07-1295d77aca3c",1.83,0.17,"UV Spec","R","23","TCGA-FI-A2F8-01A-12R-A17B-07","1b38dbc6-5830-4514-9317-9dcb23e36b98",0.17,NA,99,33.0782852751512,173,"1d0b0d91-9493-5718-9b0b-958305c1c0ed","TCGA-FI-A2F8_exposure","UNCID_2232063.1b38dbc6-5830-4514-9317-9dcb23e36b98.110928_UNC6-RDR300211_00126_FC_6348UAAXX_8.tar.gz","2013-10-17T23:28:41.000Z","2013-10-17T23:38:02.000Z","C88B15E3-DB84-445A-9F55-715D9AA8098B","500C427B-DB2C-4CA4-8BAD-9F573E99C32A","Unaligned reads",2011539621,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1B38DBC6-5830-4514-9317-9DCB23E36B98","University of North Carolina","564a368be4b0ef121818e287","601734DA-2D11-4745-A260-0965F58AADEA","Uterine Corpus Endometrial Carcinoma","TARGZ","9F4A5B99-A326-4C55-A7B3-BCABF48F4ABF","2013-10-17T23:38:02.000Z","50848127-CA56-41E4-BC07-1295D77ACA3C","United States","NO",1,NA,"Primary Tumor","Washington University",679,"9F4A5B99-A326-4C55-A7B3-BCABF48F4ABF",NA,"FI","4b8c0ebe362115aa8d7447764cd3cf00.bam.bai",70,"TCGA-FI-A2F8-01A",NA,"BFAD841D-D24F-4BFB-ABB1-429765A427E2","TCGA",2009,NA,NA,"TUMOR FREE","500C427B-DB2C-4CA4-8BAD-9F573E99C32A",64,"nationwidechildrens.org_clinical.TCGA-FI-A2F8.xml","Alive",NA,"TCGA-FI-A2F8","NOT HISPANIC OR LATINO","25C38AAB-2964-458A-A41B-FBB71882C91F",NA,761,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,12,20,"8E154304-4C97-44B3-88A2-B71E5CBB7900","F4AC25A3-9511-461A-8E63-4A143D41F2D6","4b8c0ebe362115aa8d7447764cd3cf00.bam.bai","TCGA-FI-A2F8-01A-12",70,0,20,40,20,"TOP",10,20,"TCGA-FI-A2F8-01A-01-TS1",70,"cisplatin","Chemotherapy","TCGA-FI-A2F8-D31810",NA,NA,NA,NA,"NO",933,"WITH TUMOR","Alive",NA,"TCGA-FI-A2F8-F31739","TCGA-FI-A2F8",1,"FI","A2F8","YES","C54.1","8441/3","C54.1","NO","YES",-23649,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",761,NA,NA,NA,"TUMOR FREE","NO",28,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,64,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33862507,33589184,2474975553,"06C726FC-E014-4401-9D9B-E4E8164E0FA6.bw","60c65e5e-57a4-4f15-8b95-30bd2dbd9010","06c726fc-e014-4401-9d9b-e4e8164e0fa6","2016-08-09T14:13:18.356445-05:00","UNCID_2208112.7eab3a7a-c66e-4289-8fb4-ae751b2103e6.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_4.tar.gz","4e88a0a6-f093-41e2-ae33-bdfa63af3ce0",2244594196,"Illumina GA","181b0fac4229b1ae4e0ca17ea5e21f64","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:16:39.787588-05:00","2016-05-03T11:14:23.412460-05:00","4e88a0a6-f093-41e2-ae33-bdfa63af3ce0_analysis.xml","0860eec842b8267c21c4b91f7bbc642a","b194900b-97cc-4763-a19f-7fd453ddf42c",2121,"2016-09-30T00:20:27.615022-05:00","4e88a0a6-f093-41e2-ae33-bdfa63af3ce0_experiment.xml","8f476d94475a75754fd369b641de745d","fe40e101-996e-4460-865e-053ec4d13353",2257,"2016-09-29T22:34:50.963502-05:00","4e88a0a6-f093-41e2-ae33-bdfa63af3ce0_run.xml","b486ad3ffbd273dd903bbb33b68ec009","bcc1d5ad-719f-41da-890d-33f6cafd6b18",347,"2016-09-08T10:40:16.427415-05:00","TCGA-D1-A16F","2016-09-02T18:50:14.656287-05:00","female","TCGA-D1-A16F_demographic",1948,"white","6ce087d0-d4e5-5568-a73d-d12df1aba4d9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16F_diagnosis","not reported",22242,"alive","8380/3",NA,80,"f14db50e-6bd3-55e2-9bc0-0a71a28eae56","c54.1",-22242,"TCGA-D1-A16F_treatment","37a24e06-4f5f-5676-8e4f-9c28fe0910f1","01","false","TCGA-D1-A16F-01A",NA,"25b73036-0cd7-43e1-b40e-b2e01c1b7247",FALSE,"E89C4CBF-45D5-405D-A673-F67186C206B3","Primary Tumor",NA,783,280,NA,1293494400,"11",30,"TCGA-D1-A16F-01A-11",66,NA,0,NA,0,NA,34,NA,"2016-09-08T10:40:16.427415-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"086af72a-e40c-4556-ba18-4e9d03959230",NA,"TCGA-D1-A16F-01A-01-TS1",NA,66,NA,"efe393cb-bd3a-40dc-9a3a-50568bcf9479","RNA","TCGA-D1-A16F-01A-11R","73b79b06-1325-44b2-90ff-f88538108f69",2.06,0.16,"UV Spec","R","23","TCGA-D1-A16F-01A-11R-A12I-07","7eab3a7a-c66e-4289-8fb4-ae751b2103e6",0.16,NA,90,36.5126374295103,157,"7a07d5ed-f44d-5740-ba0c-33040e723b46","TCGA-D1-A16F_exposure","UNCID_2208112.7eab3a7a-c66e-4289-8fb4-ae751b2103e6.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_4.tar.gz","2013-09-30T08:56:07.000Z","2013-09-30T09:09:02.000Z","4E88A0A6-F093-41E2-AE33-BDFA63AF3CE0","25B73036-0CD7-43E1-B40E-B2E01C1B7247","Unaligned reads",2244594196,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7EAB3A7A-C66E-4289-8FB4-AE751B2103E6","University of North Carolina","56607813e4b0ec1099f8d28f","60C65E5E-57A4-4F15-8B95-30BD2DBD9010","Uterine Corpus Endometrial Carcinoma","TARGZ","EFE393CB-BD3A-40DC-9A3A-50568BCF9479","2013-09-30T09:09:02.000Z","73B79B06-1325-44B2-90FF-F88538108F69","None","NO",1,NA,"Primary Tumor","Mayo Clinic",783,"EFE393CB-BD3A-40DC-9A3A-50568BCF9479",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2D4EB2C7-4E8D-4D10-B6D7-C6EE8965053E.txt",280,"TCGA-D1-A16F-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","F1E7DD8E-04AB-4A8E-A381-EF2808E40D12",60,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2D4EB2C7-4E8D-4D10-B6D7-C6EE8965053E.txt","Alive",NA,"TCGA-D1-A16F","NOT HISPANIC OR LATINO","A8508DCC-4084-426B-91E4-6EB70A5D0E05",NA,80,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"086AF72A-E40C-4556-BA18-4E9D03959230","73B79B06-1325-44B2-90FF-F88538108F69","UNCID_1626505.7eab3a7a-c66e-4289-8fb4-ae751b2103e6.sorted_genome_alignments.bam","TCGA-D1-A16F-01A-11",66,0,0,0,34,"TOP",0,0,"TCGA-D1-A16F-01A-01-TS1",66,NA,NA,NA,NA,NA,NA,NA,"NO",80,"TUMOR FREE","Alive",NA,"TCGA-D1-A16F-F18559","TCGA-D1-A16F",1,"D1","A16F","YES","C54.1","8380/3","C54.1","NO","YES",-22242,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",80,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2008,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
114478420,111657222,5325261998,"AE8B7695-DCB0-4E06-B407-FA4AF143B6F5.bw","60e307dd-e11e-40ba-93c1-7e8a1f669f60","ae8b7695-dcb0-4e06-b407-fa4af143b6f5","2016-08-09T13:15:20.168462-05:00","UNCID_2173734.af1f390e-abd4-4ed2-bc65-0b1080b786a9.130502_UNC12-SN629_0289_AC236KACXX_2_ACAGTG.tar.gz","51726071-cc64-4d8e-8735-e5c6efb7c7e2",5537315041,"Illumina HiSeq","768417f64857dcc09566ea070a914dd6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:50:39.931275-05:00","2016-05-03T10:56:47.870562-05:00","51726071-cc64-4d8e-8735-e5c6efb7c7e2_analysis.xml","e1670770670611965fb283e390f7a8c3","a179dbbb-438a-478c-a498-db8519c0f027",2123,"2016-09-29T19:54:36.347318-05:00","51726071-cc64-4d8e-8735-e5c6efb7c7e2_experiment.xml","849342dc7ed81dbb49494c0da2215516","59d71c84-34c5-488a-822f-8c8c711526d9",2431,"2016-09-29T19:30:42.159702-05:00","51726071-cc64-4d8e-8735-e5c6efb7c7e2_run.xml","c8a89e8115a680fcc53b78bb4d42a717","4b1097f6-4260-4b01-9066-11c143d4b6d1",354,"2016-09-08T10:44:26.956585-05:00","TCGA-FI-A3PV","2016-09-02T18:49:32.990273-05:00","female","TCGA-FI-A3PV_demographic",1935,"black or african american","587919ff-fbe2-59f6-8ffe-fe75b6f4f3a7","not hispanic or latino",2006,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A3PV_diagnosis","not reported",24898,"dead","8441/3",1249,NA,"fef8958c-b1db-5946-91a8-30531aa6f1b3","c54.1",-24898,"TCGA-FI-A3PV_treatment","22470e63-4901-58a1-bd91-d730bfb65ada","01","true","TCGA-FI-A3PV-01A",NA,"1d775e4c-dfb0-4db1-9495-13cea9aba532",FALSE,"0EBA5D54-65AC-4F79-ACE9-29FB1F924E3A","Primary Tumor",NA,3199,60,NA,1330473600,"11",30,"TCGA-FI-A3PV-01A-11",65,NA,0,NA,0,NA,35,NA,"2016-09-08T10:44:26.956585-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"44cfdf0b-147e-4057-8b59-1a4b43171e6c",NA,"TCGA-FI-A3PV-01A-01-TS1",NA,65,NA,"b4bb66cb-afd3-4b5b-b5dd-c98fed197bbf","RNA","TCGA-FI-A3PV-01A-11R","2c0044c9-506b-4ab4-9193-d7ef168b9923",1.85,0.16,"UV Spec","R","23","TCGA-FI-A3PV-01A-11R-A22K-07","af1f390e-abd4-4ed2-bc65-0b1080b786a9",0.16,NA,105,34.6809353943718,174,"3e3e577f-c6d3-5cb7-a1c0-8874e160eb8d","TCGA-FI-A3PV_exposure","UNCID_2173734.af1f390e-abd4-4ed2-bc65-0b1080b786a9.130502_UNC12-SN629_0289_AC236KACXX_2_ACAGTG.tar.gz","2013-09-09T23:06:04.000Z","2013-09-09T23:19:02.000Z","51726071-CC64-4D8E-8735-E5C6EFB7C7E2","1D775E4C-DFB0-4DB1-9495-13CEA9ABA532","Unaligned reads",5537315041,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","AF1F390E-ABD4-4ED2-BC65-0B1080B786A9","University of North Carolina","56607bcfe4b0ca319164fda0","60E307DD-E11E-40BA-93C1-7E8A1F669F60","Uterine Corpus Endometrial Carcinoma","TARGZ","B4BB66CB-AFD3-4B5B-B5DD-C98FED197BBF","2013-09-09T23:19:02.000Z","2C0044C9-506B-4AB4-9193-D7EF168B9923","United States","NO",1,NA,"Primary Tumor","Washington University",3199,"B4BB66CB-AFD3-4B5B-B5DD-C98FED197BBF",NA,"FI","TCGA-FI-A3PV-01A-11R-A22I-13_mirna.bam.bai",60,"TCGA-FI-A3PV-01A",NA,NA,"TCGA",2003,NA,NA,"WITH TUMOR","C608C20E-FCF8-4FE3-B16B-E5976098CC9D",68,"nationwidechildrens.org_clinical.TCGA-FI-A3PV.xml","Dead",1249,"TCGA-FI-A3PV","NOT HISPANIC OR LATINO","717D98B5-ECD4-4CEE-9623-4CB70683B8C4",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"44CFDF0B-147E-4057-8B59-1A4B43171E6C","A58F16EF-FBB0-4781-A99A-65C1C7992C92","TCGA-FI-A3PV-01A-11R-A22I-13_mirna.bam.bai","TCGA-FI-A3PV-01A-11",65,0,0,0,35,"TOP",0,0,"TCGA-FI-A3PV-01A-01-TS1",65,NA,NA,NA,NA,NA,NA,"TCGA-FI-A3PV-F71674_NTE-1",NA,NA,"WITH TUMOR","Dead",1264,"TCGA-FI-A3PV-F71674","TCGA-FI-A3PV",1,"FI","A3PV","YES","C54.1","8441/3","C54.1","NO","YES",-24898,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,1249,NA,NA,"WITH TUMOR","NO",15,6,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,68,2003,"Dilation and curettage procedure",NA,NA,NA,"High Grade","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
22831698,22575762,1640365362,"EE9D0C01-742E-49EB-8859-8A803D17E9F2.bw","60fcf50a-8598-475d-8dd0-6b3044661233","ee9d0c01-742e-49eb-8859-8a803d17e9f2","2016-08-09T14:16:42.752492-05:00","UNCID_2215122.cc57fe2e-2370-4697-828f-eee51aacbe0b.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_8.tar.gz","4cefaefc-898d-4613-bf78-38733a1e574b",1313980099,"Illumina GA","37903875e77ad3880ebb7dabeb01e314","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:26:35.209904-05:00","2016-05-03T11:17:59.899106-05:00","4cefaefc-898d-4613-bf78-38733a1e574b_analysis.xml","640a7c87e304e5f5e6468b5b66c6e1e1","dcd5bc59-8f02-4ac7-bc6c-7eaebbaafd78",2122,"2016-08-27T19:45:08.712887-05:00","4cefaefc-898d-4613-bf78-38733a1e574b_experiment.xml","8b3cb11d8b952909c00a5b98d88c87a2","00007bcb-cf79-484e-b044-a9d880b86f84",2256,"2016-09-29T19:06:55.201599-05:00","4cefaefc-898d-4613-bf78-38733a1e574b_run.xml","e532730c33f30e27db3b571f7a9a3310","3c160a8a-dc0a-49e5-af8e-d59fad0f984b",345,"2016-09-08T11:05:51.416807-05:00","TCGA-AP-A0LN","2016-09-02T18:54:38.035712-05:00","female","TCGA-AP-A0LN_demographic",1949,"black or african american","92af23e2-41c0-5f21-ad67-cd16091385df","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LN_diagnosis","not reported",20704,"alive","8380/3",NA,2510,"91604168-6c6c-50c3-bc78-d7ce70798015","c54.1",-20704,"TCGA-AP-A0LN_treatment","a1d28366-9d31-5e08-9b5a-b862b2421b63","01","true","TCGA-AP-A0LN-01A",NA,"90a221e7-8579-4af2-9b39-40de3c42f71c",FALSE,"D50C7207-D840-48A2-8D73-E1C71FFA73E1","Primary Tumor",NA,1907,250,NA,1278547200,"11",30,"TCGA-AP-A0LN-01A-11",80,85,0,0,0,0,0,0,"2016-09-08T11:05:51.416807-05:00","2016-09-08T11:05:51.416807-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"5ca4ebf0-16cb-46e8-867d-8e2e70b3e073","e71e2c5f-89b3-4f47-a609-fbe5a7b5f0bf","TCGA-AP-A0LN-01A-01-BS1","TCGA-AP-A0LN-01A-01-TS1",100,100,"0bf3b298-b2ef-4ad3-8324-195d73e2abe8","RNA","TCGA-AP-A0LN-01A-11R","fe4af4f2-7579-4b29-9e04-e7d4f8ab8ffc",2.17,0.16,"UV Spec","R","23","TCGA-AP-A0LN-01A-11R-A040-07","cc57fe2e-2370-4697-828f-eee51aacbe0b",0.16,NA,119,43.1847873421396,166,"ea1a28d9-bc6b-506d-b7e9-7dd02f708611","TCGA-AP-A0LN_exposure","UNCID_2215122.cc57fe2e-2370-4697-828f-eee51aacbe0b.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_8.tar.gz","2013-10-04T00:16:05.000Z","2013-10-04T00:28:03.000Z","4CEFAEFC-898D-4613-BF78-38733A1E574B","90A221E7-8579-4AF2-9B39-40DE3C42F71C","Unaligned reads",1313980099,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CC57FE2E-2370-4697-828F-EEE51AACBE0B","University of North Carolina","564a3839e4b08c5d86908067","60FCF50A-8598-475D-8DD0-6B3044661233","Uterine Corpus Endometrial Carcinoma","TARGZ","0BF3B298-B2EF-4AD3-8324-195D73E2ABE8","2013-10-04T00:28:03.000Z","FE4AF4F2-7579-4B29-9E04-E7D4F8AB8FFC","None","NO",1,NA,"Primary Tumor","MSKCC",1907,"0BF3B298-B2EF-4AD3-8324-195D73E2ABE8",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.DC2D620E-E811-473A-8780-61287FC2F992.txt",250,"TCGA-AP-A0LN-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","90A221E7-8579-4AF2-9B39-40DE3C42F71C",56,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.DC2D620E-E811-473A-8780-61287FC2F992.txt","Alive",NA,"TCGA-AP-A0LN",NA,"7E01C76E-8ACD-411B-88F2-6089B600EFB5",NA,1993,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"E71E2C5F-89B3-4F47-A609-FBE5A7B5F0BF","FE4AF4F2-7579-4B29-9E04-E7D4F8AB8FFC","UNCID_1609801.cc57fe2e-2370-4697-828f-eee51aacbe0b.sorted_genome_alignments.bam.bai","TCGA-AP-A0LN-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-AP-A0LN-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,NA,"NO",2510,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LN-F29048","TCGA-AP-A0LN",1,"AP","A0LN","YES","C54.1","8380/3","C54.1","NO","YES",-20704,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1993,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2005,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30766664,30537328,2286423989,"70C1A44A-40D3-4C59-920C-E0935EDBCA22.bw","615ea37d-6302-4d68-b253-d24efd947c3e","70c1a44a-40d3-4c59-920c-e0935edbca22","2016-08-10T21:38:00.189624-05:00","UNCID_2189209.e8d79b43-6ed3-40f4-854e-5fd23204381f.120531_UNC2-RDR300275_00125_FC_64VUHAAXX_2.tar.gz","6fa3dced-adb4-431b-80cb-dc1fa3475adb",2160907943,"Illumina GA","304522755e00360b03f9633502112a50","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:37:46.876626-05:00","2016-05-03T11:05:01.516668-05:00","6fa3dced-adb4-431b-80cb-dc1fa3475adb_analysis.xml","7b623e28bd38fa01768184967d9eb3af","e3e13dc9-e513-473b-9e46-55575a34c57f",2122,"2016-09-29T22:20:06.220865-05:00","6fa3dced-adb4-431b-80cb-dc1fa3475adb_experiment.xml","3cc7fa28ab6f1962fc9d548504c86051","b3909207-6740-42c6-a58d-814b763b5c33",2258,"2016-09-29T19:27:55.940250-05:00","6fa3dced-adb4-431b-80cb-dc1fa3475adb_run.xml","8ce908c80d1bda2556ebf787f79d679e","4948f4a4-dd53-4eb8-8fd0-36226c4ef0b9",349,"2016-09-08T11:18:39.042194-05:00","TCGA-EY-A1GF","2016-09-02T18:51:52.791809-05:00","female","TCGA-EY-A1GF_demographic",1934,"black or african american","0ecfa5bf-9458-5c6b-9ed8-3f37ef209fee","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GF_diagnosis","not reported",27450,"alive","8380/3",NA,826,"da1d2ce6-d1fa-59e2-bfc0-cf6ab085c864","c54.1",-27450,"TCGA-EY-A1GF_treatment","16dd6398-da72-5801-8dd2-007510d0c0f4","01","false","TCGA-EY-A1GF-01A",NA,"f6e156ad-3e24-4e44-94c0-bcf731ad7c80",FALSE,"0C63BAC2-FD3E-49CB-A352-0B1653B78BDD","Primary Tumor",NA,504,160,NA,1297900800,"11",30,"TCGA-EY-A1GF-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:18:39.042194-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"53943c4d-af3b-432f-9340-f8f4e79553bc",NA,"TCGA-EY-A1GF-01A-01-TSA",NA,100,NA,"2d718463-9edc-4007-ba74-969464ee826b","RNA","TCGA-EY-A1GF-01A-11R","e2c95738-efa2-4294-94ad-842b8b956ac5",1.83,0.15,"UV Spec","R","23","TCGA-EY-A1GF-01A-11R-A13S-07","e8d79b43-6ed3-40f4-854e-5fd23204381f",0.15,NA,71,26.078971533517,165,"531a14d1-e5f0-53bf-88fa-d648c4f4b453","TCGA-EY-A1GF_exposure","UNCID_2189209.e8d79b43-6ed3-40f4-854e-5fd23204381f.120531_UNC2-RDR300275_00125_FC_64VUHAAXX_2.tar.gz","2013-09-18T18:36:04.000Z","2013-09-18T18:49:02.000Z","6FA3DCED-ADB4-431B-80CB-DC1FA3475ADB","F6E156AD-3E24-4E44-94C0-BCF731AD7C80","Unaligned reads",2160907943,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E8D79B43-6ED3-40F4-854E-5FD23204381F","University of North Carolina","566078c6e4b018727fea1c8e","615EA37D-6302-4D68-B253-D24EFD947C3E","Uterine Corpus Endometrial Carcinoma","TARGZ","2D718463-9EDC-4007-BA74-969464EE826B","2013-09-18T18:49:02.000Z","E2C95738-EFA2-4294-94AD-842B8B956AC5","United States","NO",1,NA,"Primary Tumor","University of North Carolina",504,"2D718463-9EDC-4007-BA74-969464EE826B",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.EE015F30-256C-40B7-9FEF-3545593179BB.txt",160,"TCGA-EY-A1GF-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","F6E156AD-3E24-4E44-94C0-BCF731AD7C80",75,"nationwidechildrens.org_clinical.TCGA-EY-A1GF.xml","Alive",NA,"TCGA-EY-A1GF","NOT HISPANIC OR LATINO","54F54400-CE73-44D5-97BE-87A9351AF736",NA,532,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"53943C4D-AF3B-432F-9340-F8F4E79553BC","17FAB4C4-664C-43B2-BCA0-CC1345BF0D5A","UNCID_2189209.e8d79b43-6ed3-40f4-854e-5fd23204381f.120531_UNC2-RDR300275_00125_FC_64VUHAAXX_2.tar.gz","TCGA-EY-A1GF-01A-11",80,0,0,0,0,"TOP",0,0,"TCGA-EY-A1GF-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",826,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GF-F19725","TCGA-EY-A1GF",1,"EY","A1GF","YES","C54.1","8380/3","C54.1","NO","YES",-27450,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",532,NA,NA,NA,"TUMOR FREE","NO",11,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,75,2009,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31602914,30836225,2323853318,"655B32BE-AC22-4E6C-97D2-CC6B7F06B55E.bw","6164588a-d03a-46fc-82fb-a32cbaa54cac","655b32be-ac22-4e6c-97d2-cc6b7f06b55e","2016-08-06T10:37:51.245387-05:00","UNCID_2210337.34a66e0d-169f-4e39-89a2-78376bf741ae.110407_UNC6-RDR300211_00095_FC64GJRAAXX_3.tar.gz","1519bdfb-8a1c-4085-acb7-747e912edf08",2093532025,"Illumina GA","0ba5b354e35158d1c65dd4c7982b7394","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:47:07.304912-05:00","2016-05-03T11:15:47.420908-05:00","1519bdfb-8a1c-4085-acb7-747e912edf08_analysis.xml","6b48435a2cff79e2d2c6c658e6014a3a","e9bf420d-d00f-401e-a048-cc711686cadc",2119,"2016-10-07T16:21:47.463939-05:00","1519bdfb-8a1c-4085-acb7-747e912edf08_experiment.xml","414615f399f0ef914e368d28caff9caf","c57c09d1-b7ac-42f2-8710-69e7402bac4d",2257,"2016-09-29T18:06:29.885923-05:00","1519bdfb-8a1c-4085-acb7-747e912edf08_run.xml","b1a442b8ec51dd6e74ef90a59153a59e","16242cc7-d994-4271-a648-1e2bd8a26414",347,"2016-09-08T11:03:31.325644-05:00","TCGA-BG-A0VV","2016-09-02T18:49:38.134659-05:00","female","TCGA-BG-A0VV_demographic",1957,"white","92763274-a8e2-5612-a776-b334b6ae5dbe","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0VV_diagnosis","not reported",19581,"alive","8380/3",NA,1553,"753cacfd-1655-5069-814e-8960f01f0aca","c54.1",-19581,"TCGA-BG-A0VV_treatment","2105efad-c535-50fc-9b6c-1abc93a65c97","01","true","TCGA-BG-A0VV-01A",NA,"cf919557-13c9-4cf1-982c-a8d8ad3bf4ee",FALSE,"42E7D5FF-18CD-4DEA-9518-9B9732BCA635","Primary Tumor",NA,217,130,NA,1291334400,"21",10,"TCGA-BG-A0VV-01A-21",70,60,5,40,0,10,20,30,"2016-09-08T11:03:31.325644-05:00","2016-09-08T11:03:31.325644-05:00",60,40,30,20,"TOP","BOTTOM",10,0,"46ea817a-d652-4bef-b780-347f51e3a1c7","da84e6f7-3adb-4449-b1e9-737c37f2a7a4","TCGA-BG-A0VV-01A-02-TSB","TCGA-BG-A0VV-01A-02-BSB",70,60,"de79e1e7-299a-4925-b609-c7f4e7afc49a","RNA","TCGA-BG-A0VV-01A-21R","2c6e825f-7339-4865-8a12-14edebaf0fc7",1.87,0.16,"UV Spec","R","23","TCGA-BG-A0VV-01A-21R-A118-07","34a66e0d-169f-4e39-89a2-78376bf741ae",0.16,NA,147,56.0128029263832,162,"e249c7fa-9f08-5f06-bf03-faa6197fc198","TCGA-BG-A0VV_exposure","UNCID_2210337.34a66e0d-169f-4e39-89a2-78376bf741ae.110407_UNC6-RDR300211_00095_FC64GJRAAXX_3.tar.gz","2013-10-02T09:31:04.000Z","2013-10-02T09:45:03.000Z","1519BDFB-8A1C-4085-ACB7-747E912EDF08","CF919557-13C9-4CF1-982C-A8D8AD3BF4EE","Unaligned reads",2093532025,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","34A66E0D-169F-4E39-89A2-78376BF741AE","University of North Carolina","566075dde4b016715ab68834","6164588A-D03A-46FC-82FB-A32CBAA54CAC","Uterine Corpus Endometrial Carcinoma","TARGZ","DE79E1E7-299A-4925-B609-C7F4E7AFC49A","2013-10-02T09:45:03.000Z","2C6E825F-7339-4865-8A12-14EDEBAF0FC7","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",217,"DE79E1E7-299A-4925-B609-C7F4E7AFC49A",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B296BC3F-3E22-46FD-AD09-8C08D18CC239.txt",130,"TCGA-BG-A0VV-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","FC509EE7-0846-45FE-8889-745E39E6825D",53,"TCGA-BG-A0VV-01A-01D-YYYY-23.txt","Alive",NA,"TCGA-BG-A0VV","NOT HISPANIC OR LATINO","6E8F46B4-6E10-4288-B5A5-90F2F85E75A5",NA,272,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,21,10,"DA84E6F7-3ADB-4449-B1E9-737C37F2A7A4","FADECE77-B33E-4D6E-9CA8-92CC94299655","UNCID_2210337.34a66e0d-169f-4e39-89a2-78376bf741ae.110407_UNC6-RDR300211_00095_FC64GJRAAXX_3.tar.gz","TCGA-BG-A0VV-01A-21",60,10,40,40,30,"BOTTOM",0,20,"TCGA-BG-A0VV-01A-02-BSB",60,NA,NA,NA,NA,NA,NA,"TCGA-BG-A0VV-F34083_NTE-1","NO",811,"TUMOR FREE","Alive",NA,"TCGA-BG-A0VV-F34083","TCGA-BG-A0VV",1,"BG","A0VV","YES","C54.1","8380/3","C54.1","NO","YES",-19581,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",272,NA,NA,NA,"TUMOR FREE","NO",16,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
28352054,27938128,2099204607,"DC7CE58E-0EA8-4DDD-8AC4-DC5D5E8E7E3B.bw","61935424-44d0-4211-81c1-c925e436eac5","dc7ce58e-0ea8-4ddd-8ac4-dc5d5e8e7e3b","2016-08-09T14:17:51.353788-05:00","UNCID_2214568.bbc76639-b9f4-4e9f-afa2-e319eee91b48.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_8.tar.gz","0d076e91-323a-474e-8b6d-f02e16417319",1891305426,"Illumina GA","001caff604bf81d69fa006ca180b36ed","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:56:55.982844-05:00","2016-05-03T11:17:14.896869-05:00","0d076e91-323a-474e-8b6d-f02e16417319_analysis.xml","185556c03d0649198a0322bbf1f8acd3","a572e98a-2b40-4ed6-8a22-52508bd42279",2120,"2016-09-29T23:25:43.952279-05:00","0d076e91-323a-474e-8b6d-f02e16417319_experiment.xml","d0f629697b413d099710b06caa55ccdd","dc4c259b-263b-4140-afc9-268ffc0dde1c",2257,"2016-09-29T20:57:46.775404-05:00","0d076e91-323a-474e-8b6d-f02e16417319_run.xml","a6033fc23e57cbf0dadb0c456e58fb4d","8098b5bf-f002-44f0-bf50-c374b9f83c3c",347,"2016-09-08T11:10:47.540141-05:00","TCGA-B5-A0JY","2016-09-02T18:47:58.439113-05:00","female","TCGA-B5-A0JY_demographic",1958,"white","afd12a04-a61b-56c0-b7fc-bd90db975abb","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0JY_diagnosis","not reported",18475,"alive","8020/3",NA,2107,"2a69024b-1be6-586d-9895-f3cdc6062d14","c54.1",-18475,"TCGA-B5-A0JY_treatment","95c875fd-1ad1-59e8-8ae0-213498c177db","01","true","TCGA-B5-A0JY-01A",NA,"95f418ce-fcd9-4402-bc24-1520f45cb6b7",FALSE,"9708BE95-175D-458B-8BA1-02D9C488225D","Primary Tumor",NA,632,1170,NA,1277251200,"11",30,"TCGA-B5-A0JY-01A-11",70,80,0,0,30,20,0,0,"2016-09-08T11:10:47.540141-05:00","2016-09-08T11:10:47.540141-05:00",20,20,10,10,"TOP","BOTTOM",30,10,"702749b2-ce04-407d-980b-50b1260c87bb","71d96c32-bf0d-4f7e-bf8b-701e45ffbb5b","TCGA-B5-A0JY-01A-01-TSA","TCGA-B5-A0JY-01A-01-BSA",40,70,"76b12a32-9d3c-4cea-bff9-227cf1e79193","RNA","TCGA-B5-A0JY-01A-11R","eb058127-7cec-4744-8332-5e0c3fc5f346",1.6,0.15,"UV Spec","R","23","TCGA-B5-A0JY-01A-11R-A104-07","bbc76639-b9f4-4e9f-afa2-e319eee91b48",0.15,NA,67,23.7386621315193,168,"17350fb5-14c2-5152-9441-3f71c26a3ee9","TCGA-B5-A0JY_exposure","UNCID_2214568.bbc76639-b9f4-4e9f-afa2-e319eee91b48.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_8.tar.gz","2013-10-03T17:26:03.000Z","2013-10-03T17:38:03.000Z","0D076E91-323A-474E-8B6D-F02E16417319","95F418CE-FCD9-4402-BC24-1520F45CB6B7","Unaligned reads",1891305426,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","BBC76639-B9F4-4E9F-AFA2-E319EEE91B48","University of North Carolina","564a3aece4b093830b691d18","61935424-44D0-4211-81C1-C925E436EAC5","Uterine Corpus Endometrial Carcinoma","TARGZ","76B12A32-9D3C-4CEA-BFF9-227CF1E79193","2013-10-03T17:38:03.000Z","EB058127-7CEC-4744-8332-5E0C3FC5F346","United States","NO",1,NA,"Primary Tumor","Duke",632,"76B12A32-9D3C-4CEA-BFF9-227CF1E79193",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.67F7ACE8-BFC1-4162-B334-D70ADF7A75EF.txt",1170,"TCGA-B5-A0JY-01A",NA,"7D2E1735-E7DF-4EDC-85CB-04EB35E35D93","TCGA",2008,NA,NA,"TUMOR FREE","F3FF3E83-7B73-4243-BDAC-837D6AB60BF7",50,"nationwidechildrens.org_clinical.TCGA-B5-A0JY.xml","Alive",NA,"TCGA-B5-A0JY",NA,"F86E706B-BC2C-405E-ACE4-B56875D83B18",NA,809,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8020/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,11,30,"71D96C32-BF0D-4F7E-BF8B-701E45FFBB5B","EB058127-7CEC-4744-8332-5E0C3FC5F346","TCGA-B5-A0JY-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_6_rg.sorted.bam.bai","TCGA-B5-A0JY-01A-11",80,20,0,20,0,"BOTTOM",10,10,"TCGA-B5-A0JY-01A-01-BSA",70,"Doxorubicin","Chemotherapy","TCGA-B5-A0JY-D5688",NA,NA,NA,NA,"NO",990,"TUMOR FREE","Alive",NA,"TCGA-B5-A0JY-F12990","TCGA-B5-A0JY",1,"B5","A0JY","YES","C54.1","8020/3","C54.1","NO","YES",-18475,"FEMALE","WHITE",NA,"No","No","Alive",809,NA,NA,NA,"TUMOR FREE","NO",4,1,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,50,2008,"Dilation and curettage procedure",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33449974,32507900,2448015009,"A5162BC7-058E-419F-AAB6-9CFB02657D8D.bw","62ae3bb1-8102-4693-aee6-4d8d0d2bc515","a5162bc7-058e-419f-aab6-9cfb02657d8d","2016-08-09T14:13:55.723406-05:00","UNCID_2209576.5e981b2d-fef0-44c2-8228-8f5f7e9e3026.110509_UNC6-RDR300211_00102_FC_634VYAAXX_3.tar.gz","1db1fb90-1753-4c51-82d1-7e88f96e296b",2212735146,"Illumina GA","249530e46c145a0ee8a1eb01bca79c63","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:12:51.224774-05:00","2016-05-03T11:15:06.073526-05:00","1db1fb90-1753-4c51-82d1-7e88f96e296b_analysis.xml","23d59bf590428a7ab89467d095b6b261","d46f0cd3-cd9b-4fb3-9d70-1d8d026d09de",2121,"2016-09-29T21:26:14.930258-05:00","1db1fb90-1753-4c51-82d1-7e88f96e296b_experiment.xml","911f830cf44c497ddd1451880c1ca1f1","926686df-7f63-46f4-9400-29848492dcf5",2257,"2016-09-29T23:56:13.778137-05:00","1db1fb90-1753-4c51-82d1-7e88f96e296b_run.xml","69569aa1399f046a6d1bc9eb8c44b2a4","ef5ac6d8-721d-45cb-b4d9-e4a216c96b24",347,"2016-09-08T11:39:56.957683-05:00","TCGA-BG-A18B","2016-09-02T18:50:05.663777-05:00","female","TCGA-BG-A18B_demographic",1957,"white","5c40ea92-1293-5e14-96bf-5e39c5875c25","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A18B_diagnosis","not reported",19550,"alive","8380/3",NA,470,"4cb8a266-6605-5f34-95c2-b3dcee52e93e","c54.1",-19550,"TCGA-BG-A18B_treatment","a8f65561-fd60-50f9-876f-40b137c56808","01","true","TCGA-BG-A18B-01A",NA,"2a3bc803-54c4-4544-a72d-7077dbb0b93e",FALSE,"E7006FF4-33D9-4369-A4E0-42D124EAE1E0","Primary Tumor",NA,56,480,NA,1294358400,"11",30,"TCGA-BG-A18B-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T11:39:56.957683-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"5a681584-bbb6-4b8c-85e9-38b522cecd8e",NA,"TCGA-BG-A18B-01A-01-TSA",NA,100,NA,"994ce471-152f-4e18-8822-6fbf09b082b0","RNA","TCGA-BG-A18B-01A-11R","2ea67e75-a9d1-4b2f-a62f-d2e3d2c78a10",1.84,0.16,"UV Spec","R","23","TCGA-BG-A18B-01A-11R-A12I-07","5e981b2d-fef0-44c2-8228-8f5f7e9e3026",0.16,NA,116,43.6599043998645,163,"ebe78ab2-28eb-56d1-bb01-559c13d9b07d","TCGA-BG-A18B_exposure","UNCID_2209576.5e981b2d-fef0-44c2-8228-8f5f7e9e3026.110509_UNC6-RDR300211_00102_FC_634VYAAXX_3.tar.gz","2013-10-01T09:46:03.000Z","2013-10-01T09:59:01.000Z","1DB1FB90-1753-4C51-82D1-7E88F96E296B","2A3BC803-54C4-4544-A72D-7077DBB0B93E","Unaligned reads",2212735146,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","5E981B2D-FEF0-44C2-8228-8F5F7E9E3026","University of North Carolina","5660790de4b0b37b3d991766","62AE3BB1-8102-4693-AEE6-4D8D0D2BC515","Uterine Corpus Endometrial Carcinoma","TARGZ","994CE471-152F-4E18-8822-6FBF09B082B0","2013-10-01T09:59:01.000Z","2EA67E75-A9D1-4B2F-A62F-D2E3D2C78A10","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",56,"994CE471-152F-4E18-8822-6FBF09B082B0",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8A7E6C09-E5B7-4C2E-B645-C88DB29F8318.txt",480,"TCGA-BG-A18B-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","C6D5C577-812D-4CB6-8FA7-B3567058C58B",53,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8A7E6C09-E5B7-4C2E-B645-C88DB29F8318.txt","Alive",NA,"TCGA-BG-A18B","NOT HISPANIC OR LATINO","4738C947-FC1E-4BA6-9EFD-516C0FE64659",NA,155,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage I",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"5A681584-BBB6-4B8C-85E9-38B522CECD8E","2EA67E75-A9D1-4B2F-A62F-D2E3D2C78A10","UNCID_2209576.5e981b2d-fef0-44c2-8228-8f5f7e9e3026.110509_UNC6-RDR300211_00102_FC_634VYAAXX_3.tar.gz","TCGA-BG-A18B-01A-11",75,0,0,0,0,"TOP",0,0,"TCGA-BG-A18B-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",470,"TUMOR FREE","Alive",NA,"TCGA-BG-A18B-F28649","TCGA-BG-A18B",1,"BG","A18B","YES","C54.1","8380/3","C54.1","NO","YES",-19550,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",155,NA,NA,NA,"TUMOR FREE","NO",19,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","RX",NA,NA,NA,NA,NA,"2009",1,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
30853481,29023157,2187191947,"88BBA1BF-44E0-416E-A028-04F410A3FE5D.bw","62d71839-4fba-42e9-9929-8d937f0fe287","88bba1bf-44e0-416e-a028-04f410a3fe5d","2016-08-09T14:14:21.745547-05:00","UNCID_2210336.818368c5-a7b6-40d2-a24f-39604ea80303.110407_UNC6-RDR300211_00095_FC64GJRAAXX_4.tar.gz","5b475ba6-ac37-4fcf-97bd-23780c23e0c8",1997389065,"Illumina GA","29e5e678a5759be2aa100b83ed84d3a9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:26:48.104992-05:00","2016-05-03T11:15:47.420908-05:00","5b475ba6-ac37-4fcf-97bd-23780c23e0c8_analysis.xml","9ae5410b77826bf794236627bfc09718","b7b638b5-233e-428d-9288-d0312bd030fd",2119,"2016-08-13T04:03:40.560306-05:00","5b475ba6-ac37-4fcf-97bd-23780c23e0c8_experiment.xml","f8951352cc7b4a5c0d2d0eb899a7ae3d","f176e233-b4ea-43d0-9542-4793305324b9",2257,"2016-09-29T21:06:38.547851-05:00","5b475ba6-ac37-4fcf-97bd-23780c23e0c8_run.xml","3c9213aca6628c5df469ed1b536e5dc0","8639aae4-1ac5-4d54-87f6-e009329be7ac",347,"2016-09-08T12:06:57.972711-05:00","TCGA-BG-A0VW","2016-09-02T18:49:38.739804-05:00","female","TCGA-BG-A0VW_demographic",1933,"white","540f6a1a-88ee-5303-8612-f84ac47bc183","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0VW_diagnosis","not reported",28383,"alive","8380/3",NA,1582,"2c1907ca-c957-5798-9ce9-23fbcc276ab9","c54.1",-28383,"TCGA-BG-A0VW_treatment","e4c508a0-2edf-5f8b-974b-1652d00c1d88","01","true","TCGA-BG-A0VW-01A",NA,"e5e61331-4cca-4742-83ab-87e9dddafaca",FALSE,"7663D410-13EC-4A5B-B655-F7DCCC9C8E8D","Primary Tumor",NA,246,90,NA,1291334400,"11",30,"TCGA-BG-A0VW-01A-11",60,60,30,20,10,0,25,40,"2016-09-08T12:06:57.972711-05:00","2016-09-08T12:06:57.972711-05:00",40,40,30,30,"TOP","BOTTOM",5,0,"9f154f06-61ab-4645-8ec5-5a7ce1149f46","55ce56a0-b2e0-4625-9d75-e48b2f0d416f","TCGA-BG-A0VW-01A-01-TS1","TCGA-BG-A0VW-01A-01-BS1",60,60,"68fca334-a7ad-4e28-bf00-8754a40e1134","RNA","TCGA-BG-A0VW-01A-11R","b87ca17d-8a2c-439c-a71c-3e2a1dd84324",1.88,0.15,"UV Spec","R","23","TCGA-BG-A0VW-01A-11R-A118-07","818368c5-a7b6-40d2-a24f-39604ea80303",0.15,NA,93,37.7297253438273,157,"3a1bed2c-dce9-51f9-945b-872fb61ff4c6","TCGA-BG-A0VW_exposure","UNCID_2210336.818368c5-a7b6-40d2-a24f-39604ea80303.110407_UNC6-RDR300211_00095_FC64GJRAAXX_4.tar.gz","2013-10-02T09:26:03.000Z","2013-10-02T09:45:03.000Z","5B475BA6-AC37-4FCF-97BD-23780C23E0C8","E5E61331-4CCA-4742-83AB-87E9DDDAFACA","Unaligned reads",1997389065,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","818368C5-A7B6-40D2-A24F-39604EA80303","University of North Carolina","56607811e4b0ec1099f8d285","62D71839-4FBA-42E9-9929-8D937F0FE287","Uterine Corpus Endometrial Carcinoma","TARGZ","68FCA334-A7AD-4E28-BF00-8754A40E1134","2013-10-02T09:45:03.000Z","B87CA17D-8A2C-439C-A71C-3E2A1DD84324","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",246,"68FCA334-A7AD-4E28-BF00-8754A40E1134",NA,"BG","UNCID_2210336.818368c5-a7b6-40d2-a24f-39604ea80303.110407_UNC6-RDR300211_00095_FC64GJRAAXX_4.tar.gz",90,"TCGA-BG-A0VW-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","E5E61331-4CCA-4742-83AB-87E9DDDAFACA",77,"UNCID_218964.TCGA-BG-A0VW-01A-11R-A118-07.110407_UNC6-RDR300211_00095_FC64GJRAAXX.4.trimmed.annotated.translated_to_genomic.exon.quantification.txt","Alive",NA,"TCGA-BG-A0VW","NOT HISPANIC OR LATINO","615E6CDE-0DD4-4C7A-884C-5F5B76EFC4BA",NA,132,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"9F154F06-61AB-4645-8EC5-5A7CE1149F46","A5143D12-9348-4ACD-B08E-99AB2956B933","UNCID_2210336.818368c5-a7b6-40d2-a24f-39604ea80303.110407_UNC6-RDR300211_00095_FC64GJRAAXX_4.tar.gz","TCGA-BG-A0VW-01A-11",60,10,30,40,25,"TOP",5,30,"TCGA-BG-A0VW-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,"TCGA-BG-A0VW-F34084_NTE-1","NO",497,"TUMOR FREE","Alive",NA,"TCGA-BG-A0VW-F34084","TCGA-BG-A0VW",1,"BG","A0VW","YES","C54.1","8380/3","C54.1","NO","YES",-28383,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",132,NA,NA,NA,"TUMOR FREE","NO",16,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,77,2010,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
150203458,147670506,7049701875,"EC0B4E94-0FD0-4DBE-8E1A-14DBB0E63772.bw","62df1bd8-23a8-4e52-a483-6895b2f02494","ec0b4e94-0fd0-4dbe-8e1a-14dbb0e63772","2016-08-09T14:02:27.389622-05:00","UNCID_2167271.8488db37-440c-407d-a184-72ee19632c9f.130613_UNC9-SN296_0375_BD27CGACXX_3_ACTTGA.tar.gz","a664c7f2-819c-49db-813c-8f34a478f412",7362783994,"Illumina HiSeq","19b248dc7d2a8fffd8e9fe326a733e7d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:22:03.761645-05:00","2016-05-03T11:07:07.492763-05:00","a664c7f2-819c-49db-813c-8f34a478f412_analysis.xml","2c137cf147380ba6c948c4da2d0170d2","1f9a38c7-dc22-4c07-a7f6-abc897a6b8b8",2121,"2016-10-07T16:06:56.671799-05:00","a664c7f2-819c-49db-813c-8f34a478f412_experiment.xml","4cab0cae895d46701bf0408416a9f503","ab9af797-66ed-447b-9cde-2ba1e7496b97",2431,"2016-09-29T18:24:27.240358-05:00","a664c7f2-819c-49db-813c-8f34a478f412_run.xml","88b6355c1a7b00723cc73c9b8cfb6a15","212179b4-755e-4307-ab7c-a0c39b95895b",354,"2016-09-08T10:59:13.869280-05:00","TCGA-KP-A3W4","2016-09-02T18:49:39.464850-05:00","female","TCGA-KP-A3W4_demographic",1947,"white","a8449130-b9ad-5bf1-94ef-5855cf4613e5","not hispanic or latino",2011,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","KP","821aedb4-8788-5cb9-ae05-e670f0be1f9f","British Columbia Cancer Agency","not reported","c54.1","TCGA-KP-A3W4_diagnosis","not reported",23200,"dead","8441/3",554,NA,"a64b797a-6739-5be1-a4a8-9ee44b7570a5","c54.1",-23200,"TCGA-KP-A3W4_treatment","ed102a95-c140-572c-8132-cc949b135ae8","01","true","TCGA-KP-A3W4-01A",NA,"85363534-a7c9-481e-8d37-b961ce1ad7ae",FALSE,"5B8C1B60-7046-4A3A-9D65-ECCB91BF9847","Primary Tumor",NA,688,540,NA,1335398400,"11",20,"TCGA-KP-A3W4-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T10:59:13.869280-05:00",NA,60,NA,10,NA,"TOP",NA,10,NA,"65b33d84-956f-47aa-bd5f-80912f580e45",NA,"TCGA-KP-A3W4-01A-01-TSA",NA,70,NA,"bf924e74-bd28-4560-958d-1cfbcc3f9d57","RNA","TCGA-KP-A3W4-01A-11R","989b93ff-767b-4775-87ed-2607221add6a",1.85,0.15,"UV Spec","R","23","TCGA-KP-A3W4-01A-11R-A22K-07","8488db37-440c-407d-a184-72ee19632c9f",0.15,NA,61,26.7532125783957,151,"215ef57c-8150-582d-a45e-a3ce5e40f80d","TCGA-KP-A3W4_exposure","UNCID_2167271.8488db37-440c-407d-a184-72ee19632c9f.130613_UNC9-SN296_0375_BD27CGACXX_3_ACTTGA.tar.gz","2013-09-21T05:16:05.000Z","2013-09-21T05:37:02.000Z","A664C7F2-819C-49DB-813C-8F34A478F412","85363534-A7C9-481E-8D37-B961CE1AD7AE","Unaligned reads",7362783994,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8488DB37-440C-407D-A184-72EE19632C9F","University of North Carolina","564a404de4b0ef12181c03c5","62DF1BD8-23A8-4E52-A483-6895B2F02494","Uterine Corpus Endometrial Carcinoma","TARGZ","BF924E74-BD28-4560-958D-1CFBCC3F9D57","2013-09-21T05:37:02.000Z","989B93FF-767B-4775-87ED-2607221ADD6A","Canada","NO",1,NA,"Primary Tumor","British Columbia Cancer Agency",688,"BF924E74-BD28-4560-958D-1CFBCC3F9D57",NA,"KP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.EBA5622C-234D-4AA9-B586-10F48DC05A17.txt",540,"TCGA-KP-A3W4-01A",NA,NA,"TCGA",2010,"TCGA-KP-A3W4_NTE-2","Partial Remission/Response","WITH TUMOR","963F751F-6284-4F6A-909A-26A3F262D4EB",63,"nationwidechildrens.org_clinical.TCGA-KP-A3W4.xml","Dead",554,"TCGA-KP-A3W4","NOT HISPANIC OR LATINO",NA,"YES",NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,20,"65B33D84-956F-47AA-BD5F-80912F580E45","989B93FF-767B-4775-87ED-2607221ADD6A","262bbc2ede1dc3e069cb08c8c4e1f8ec.bam","TCGA-KP-A3W4-01A-11",70,0,20,60,20,"TOP",10,10,"TCGA-KP-A3W4-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-KP-A3W4",1,"KP","A3W4","YES","C54.1","8441/3","C54.1","NO","YES",-23200,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,554,"NO","YES","WITH TUMOR","YES",19,7,2012,"NO","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,63,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Partial Remission/Response","2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32860278,32671126,2445447988,"DD292494-92A2-43CB-B59B-726B2F429B29.bw","63170b0e-78cf-45d9-af9d-ce986ac66991","dd292494-92a2-43cb-b59b-726b2f429b29","2016-08-09T14:04:16.585369-05:00","UNCID_2196723.fe8a344f-fc0b-415c-b388-c71e82b64703.120216_UNC2-RDR300275_00113_FC_650PDAAXX_7.tar.gz","056f07e7-1662-4391-983f-9700df7e965e",2150433327,"Illumina GA","c2c8f46e4750bc9334b509407957bee3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:25:45.211696-05:00","2016-05-03T11:08:33.743897-05:00","056f07e7-1662-4391-983f-9700df7e965e_analysis.xml","cae416228b398e6618789f44f8e40a1d","6cd5ac05-0e1b-465f-aba1-f98fdc3f8223",2120,"2016-08-26T12:43:52.262192-05:00","056f07e7-1662-4391-983f-9700df7e965e_experiment.xml","1037a70991d45ba7502de924c2147dc1","8a2e3668-79b9-4040-8d85-31a405ecf5f8",2257,"2016-09-29T17:34:45.893246-05:00","056f07e7-1662-4391-983f-9700df7e965e_run.xml","150ae62da9bcda4821996bf55f7bc5f5","01e97132-d5c1-4a9c-ac3a-1f29f11f2bf8",347,"2016-09-08T10:54:43.593639-05:00","TCGA-EO-A22T","2016-09-02T18:54:20.075796-05:00","female","TCGA-EO-A22T_demographic",1952,"asian","255807e2-d413-5f0e-8244-0047a41ee5fe","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A22T_diagnosis","not reported",20608,"alive","8380/3",NA,2035,"ac541daa-1255-51ea-add1-8b6374d98e66","c54.1",-20608,"TCGA-EO-A22T_treatment","fb692730-85bf-5ac6-ad3e-318b0eb96063","01","false","TCGA-EO-A22T-01A",NA,"bf5a963a-4aa7-428b-acd6-606093a0ff2a",FALSE,"1D5567D9-3015-452E-9888-2E67F91D6B20","Primary Tumor",NA,916,140,NA,1304899200,"21",30,"TCGA-EO-A22T-01A-21",80,NA,20,NA,0,NA,15,NA,"2016-09-08T10:54:43.593639-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"fe0d201a-41b3-4d5f-94d5-c7fdc88a1c35",NA,"TCGA-EO-A22T-01A-02-TSB",NA,80,NA,"38170aa4-a0ac-4289-8d79-16cd25e52573","RNA","TCGA-EO-A22T-01A-21R","f43bf8d6-fb30-4001-bd67-bba1eb1d0a8f",1.92,0.16,"UV Spec","R","23","TCGA-EO-A22T-01A-21R-A18M-07","fe8a344f-fc0b-415c-b388-c71e82b64703",0.16,NA,53,22.9397506925208,152,"dca0fd6a-fbde-5f2b-a219-de2b89a0dc9c","TCGA-EO-A22T_exposure","UNCID_2196723.fe8a344f-fc0b-415c-b388-c71e82b64703.120216_UNC2-RDR300275_00113_FC_650PDAAXX_7.tar.gz","2013-09-23T20:16:06.000Z","2013-09-23T20:28:01.000Z","056F07E7-1662-4391-983F-9700DF7E965E","BF5A963A-4AA7-428B-ACD6-606093A0FF2A","Unaligned reads",2150433327,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","FE8A344F-FC0B-415C-B388-C71E82B64703","University of North Carolina","564a4021e4b0298dd2c9ed48","63170B0E-78CF-45D9-AF9D-CE986AC66991","Uterine Corpus Endometrial Carcinoma","TARGZ","38170AA4-A0AC-4289-8D79-16CD25E52573","2013-09-23T20:28:01.000Z","F43BF8D6-FB30-4001-BD67-BBA1EB1D0A8F","Canada","NO",1,NA,"Primary Tumor","University Health Network",916,"38170AA4-A0AC-4289-8D79-16CD25E52573",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.DFC6F069-E4BA-4BD0-BBB4-4A40A3C98A0E.txt",140,"TCGA-EO-A22T-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","BF5A963A-4AA7-428B-ACD6-606093A0FF2A",56,"nationwidechildrens.org_clinical.TCGA-EO-A22T.xml","Alive",NA,"TCGA-EO-A22T","NOT HISPANIC OR LATINO","5B31DE35-F1F8-4C48-A571-AC94C8FA1646",NA,1004,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,"EBE1AC89-6DEB-4042-BD22-E74CDA40B47A","ASIAN",NA,21,30,"FE0D201A-41B3-4D5F-94D5-C7FDC88A1C35","F43BF8D6-FB30-4001-BD67-BBA1EB1D0A8F","TCGA-EO-A22T-01A-21R-A18L-13_mirna.bam.bai","TCGA-EO-A22T-01A-21",80,0,20,40,15,"TOP",5,20,"TCGA-EO-A22T-01A-02-TSB",80,NA,NA,NA,"TCGA-EO-A22T-R62606","External","Regional site","TCGA-EO-A22T-F62605_NTE-1","NO",2035,"TUMOR FREE","Alive",NA,"TCGA-EO-A22T-F62605","TCGA-EO-A22T",1,"EO","A22T","YES","C54.1","8380/3","C54.1","NO","YES",-20608,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",1004,NA,NA,NA,"TUMOR FREE","NO",26,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
22061709,19616763,1478804650,"BB657D53-8FE7-46AA-918E-8BE6EB5B70AD.bw","633e6994-3e8b-4c0b-9b79-06cf4ab6f9bc","bb657d53-8fe7-46aa-918e-8be6eb5b70ad","2016-08-04T23:14:31.980377-05:00","UNCID_2216180.91340f00-f5e1-496d-b7d5-08c2ccf57292.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_6.tar.gz","72410247-5bb8-468c-9599-af4ea4112446",1313384985,"Illumina GA","41a8ee1580a36f395dab9b2fa3152dc2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:42:54.440852-05:00","2016-05-03T11:18:46.986610-05:00","72410247-5bb8-468c-9599-af4ea4112446_analysis.xml","6459885ab8b786cacf2488373e03a701","e718370a-4a8f-4f0d-a19d-83bb63182b4b",2122,"2016-09-29T20:22:07.240157-05:00","72410247-5bb8-468c-9599-af4ea4112446_experiment.xml","b1569d0cb87e45b2ccb005e4fc4e313c","6a8e4b0f-c7ba-4aee-aaf9-c5846e468810",2256,"2016-09-29T20:01:32.249721-05:00","72410247-5bb8-468c-9599-af4ea4112446_run.xml","a8995c4ee49084439a765bde3b2b7b86","5e0c7fea-785a-4747-a908-616b6fd946dd",345,"2016-09-08T10:52:10.540109-05:00","TCGA-AX-A064","2016-09-02T18:52:48.829634-05:00","female","TCGA-AX-A064_demographic",1926,"white","7a2e57b2-e19b-5407-967c-2f076d5ee7fc","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A064_diagnosis","not reported",29625,"alive","8380/3",NA,1517,"8d97aefb-5fe0-5a3b-a87e-d9d0f992ceab","c54.1",-29625,"TCGA-AX-A064_treatment","14fae94d-544a-58d6-8461-1f3aaf95ce41","01","false","TCGA-AX-A064-01A",NA,"3d85e546-d9f4-49ba-adbd-301118cd1307",FALSE,"F760DFF2-7A11-4465-8581-397ABAA76BE4","Primary Tumor",NA,1024,180,NA,1275868800,"11",30,"TCGA-AX-A064-01A-11",90,92,0,0,2,0,3,2,"2016-09-08T10:52:10.540109-05:00","2016-09-08T10:52:10.540109-05:00",0,0,4,4,"BOTTOM","TOP",15,15,"6967f3dd-eed4-450c-b565-c3d60ffcbd9f","5268bead-7f4c-4d38-89bc-5fa684c93806","TCGA-AX-A064-01A-01-BSA","TCGA-AX-A064-01A-01-TSA",80,83,"db5309a8-cb9a-487f-9186-a01bcb0d1dd5","RNA","TCGA-AX-A064-01A-11R","6a1a4913-a135-4d8e-9fc0-5f995e493813",1.84,0.14,"UV Spec","R","23","TCGA-AX-A064-01A-11R-A00V-07","91340f00-f5e1-496d-b7d5-08c2ccf57292",0.14,NA,48,20.2395007589813,154,"7df6a162-82bf-5784-978b-e5676c071072","TCGA-AX-A064_exposure","UNCID_2216180.91340f00-f5e1-496d-b7d5-08c2ccf57292.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_6.tar.gz","2013-10-04T07:26:05.000Z","2013-10-04T07:38:03.000Z","72410247-5BB8-468C-9599-AF4EA4112446","3D85E546-D9F4-49BA-ADBD-301118CD1307","Unaligned reads",1313384985,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","91340F00-F5E1-496D-B7D5-08C2CCF57292","University of North Carolina","564a3a6be4b093830b68f37e","633E6994-3E8B-4C0B-9B79-06CF4AB6F9BC","Uterine Corpus Endometrial Carcinoma","TARGZ","DB5309A8-CB9A-487F-9186-A01BCB0D1DD5","2013-10-04T07:38:03.000Z","6A1A4913-A135-4D8E-9FC0-5F995E493813","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1024,"DB5309A8-CB9A-487F-9186-A01BCB0D1DD5",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.146A3777-8123-40F5-91E7-117DD9CE360B.txt",180,"TCGA-AX-A064-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","96C862CD-1804-453E-A6BB-DDFBAD192E6C",81,"nationwidechildrens.org_clinical.TCGA-AX-A064.xml","Alive",NA,"TCGA-AX-A064",NA,"5F954748-4CE4-4546-BBAF-01A94B2BA53F",NA,1064,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIA",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"WHITE",NA,11,30,"5268BEAD-7F4C-4D38-89BC-5FA684C93806","6A1A4913-A135-4D8E-9FC0-5F995E493813","UNCID_1610655.91340f00-f5e1-496d-b7d5-08c2ccf57292.sorted_genome_alignments.bam","TCGA-AX-A064-01A-11",90,2,0,0,3,"BOTTOM",15,4,"TCGA-AX-A064-01A-01-BSA",80,NA,NA,NA,NA,NA,NA,NA,NA,1064,"TUMOR FREE","Alive",NA,"TCGA-AX-A064-F5498","TCGA-AX-A064",1,"AX","A064","YES","C54.1","8380/3","C54.1","NO","YES",-29625,"FEMALE","WHITE",NA,"No","No","Alive",1064,NA,NA,NA,"TUMOR FREE","NO",29,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,81,2007,"Office Endometrial Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",6,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34994218,34797428,2563782142,"CC03F1D9-C4C3-47B3-80D6-CFD1684757DA.bw","6397c4a1-0a29-4c2c-b8cb-ce73af93dd0b","cc03f1d9-c4c3-47b3-80d6-cfd1684757da","2016-08-31T10:38:42.326193-05:00","UNCID_2208037.07508c27-8f79-414e-af9d-e78240df5c48.110624_UNC2-RDR300275_00073_FC70KA5AAXX_7.tar.gz","0cc0e96a-51e8-417d-bf04-53a55568eabd",2220002986,"Illumina GA","a8505c444b530b7e454af3c5236f126d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:40:16.936676-05:00","2016-05-03T11:14:23.404443-05:00","0cc0e96a-51e8-417d-bf04-53a55568eabd_analysis.xml","cf0dc9fded7427022c2ca0cb93f4e7a1","c02aacf7-a211-4dbc-aa63-f6003b34aea9",2119,"2016-09-29T21:17:30.172290-05:00","0cc0e96a-51e8-417d-bf04-53a55568eabd_experiment.xml","947f7b74518438cc4fdcb03b97274e46","8cf9ee33-58a1-4da0-bc78-80c95076cf8f",2257,"2016-09-29T22:37:14.179391-05:00","0cc0e96a-51e8-417d-bf04-53a55568eabd_run.xml","dda57fb292948d7a7bbfea2729cfa60a","be3d8b89-14ea-449d-a964-b7120e6e9c55",347,"2016-09-08T12:14:57.132775-05:00","TCGA-D1-A17U","2016-09-02T18:50:46.220099-05:00","female","TCGA-D1-A17U_demographic",1957,"white","eada4ab5-d648-5c4f-9f46-ea31cebd6457","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17U_diagnosis","not reported",19544,"alive","8380/3",NA,697,"0e51088d-0e30-5949-82fe-36db6f57ac16","c54.1",-19544,"TCGA-D1-A17U_treatment","df41d07b-14db-5a29-bfa5-c1eaa22cb4aa","01","false","TCGA-D1-A17U-01A",NA,"1f1945ee-4cf3-43a3-9998-1c4528c7a511",FALSE,"A0A4164D-FD8D-4472-BAFA-A036469E22CC","Primary Tumor",NA,314,210,NA,1294358400,"21",20,"TCGA-D1-A17U-01A-21",65,NA,0,NA,0,NA,0,NA,"2016-09-08T12:14:57.132775-05:00",NA,0,NA,0,NA,"BOTTOM",NA,0,NA,"dde736f1-b204-43c9-b43f-52cd95e5fe7a",NA,"TCGA-D1-A17U-01A-02-TS2",NA,100,NA,"d0c9d545-e1e6-446a-b1b0-a7ae8dc5a2d4","RNA","TCGA-D1-A17U-01A-21R","f8554b65-fecf-4570-ac11-a52ca3a118c7",1.88,0.17,"UV Spec","R","23","TCGA-D1-A17U-01A-21R-A12I-07","07508c27-8f79-414e-af9d-e78240df5c48",0.17,NA,87,30.8248299319728,168,"918a068f-b3f6-5d96-9f0e-aa9fe0296146","TCGA-D1-A17U_exposure","UNCID_2208037.07508c27-8f79-414e-af9d-e78240df5c48.110624_UNC2-RDR300275_00073_FC70KA5AAXX_7.tar.gz","2013-09-30T07:55:04.000Z","2013-09-30T08:08:01.000Z","0CC0E96A-51E8-417D-BF04-53A55568EABD","1F1945EE-4CF3-43A3-9998-1C4528C7A511","Unaligned reads",2220002986,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","07508C27-8F79-414E-AF9D-E78240DF5C48","University of North Carolina","5660798ae4b018727fea2106","6397C4A1-0A29-4C2C-B8CB-CE73AF93DD0B","Uterine Corpus Endometrial Carcinoma","TARGZ","D0C9D545-E1E6-446A-B1B0-A7AE8DC5A2D4","2013-09-30T08:08:01.000Z","F8554B65-FECF-4570-AC11-A52CA3A118C7","None","NO",1,NA,"Primary Tumor","Mayo Clinic",314,"D0C9D545-E1E6-446A-B1B0-A7AE8DC5A2D4",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.0D4EB4B1-2250-4BFE-A2B0-CDC6AA7E7247.txt",210,"TCGA-D1-A17U-01A",NA,"FD64482C-545F-40F5-A539-428A2A1F1FBC","TCGA",2010,NA,NA,"TUMOR FREE","B0D7D8A8-D95E-48C0-A830-2C819403A91D",53,"D1-A17U-10A-01D_BCR3730_2011-09-20_025.fsa","Alive",NA,"TCGA-D1-A17U","NOT HISPANIC OR LATINO","CC0EB0EE-796C-45B3-9D2D-496121260AC7",NA,396,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"728DB748-AE90-4777-B8AD-A0C6C80A3F18","WHITE",NA,21,20,"DDE736F1-B204-43C9-B43F-52CD95E5FE7A","A6E22BDB-C55D-4482-9EBC-F30BE3F62D50","TCGA-D1-A17U-01A-21R-A12H-13_mirna.bam.bai","TCGA-D1-A17U-01A-21",65,0,0,0,0,"BOTTOM",0,0,"TCGA-D1-A17U-01A-02-TS2",100,"Paclitaxel","Chemotherapy","TCGA-D1-A17U-D20297","TCGA-D1-A17U-R20295","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",697,"TUMOR FREE","Alive",NA,"TCGA-D1-A17U-F20293","TCGA-D1-A17U",1,"D1","A17U","YES","C54.1","8380/3","C54.1","NO","YES",-19544,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",396,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
116971730,115473489,5504588669,"7D241B7B-E218-4F44-BE15-1B5A14A1550F.bw","6524a6d3-a9f0-4a46-ac0b-7beb0cd1b915","7d241b7b-e218-4f44-be15-1b5a14a1550f","2016-08-04T23:00:08.776480-05:00","UNCID_2177880.ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927.130402_UNC10-SN254_0447_BC22WAACXX_4_ACTTGA.tar.gz","a2188701-b730-442b-b554-eea93d411ddf",4943610246,"Illumina HiSeq","3625e0a61f397343f7c9657002897931","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:55:10.046880-05:00","2016-05-03T10:56:47.877475-05:00","a2188701-b730-442b-b554-eea93d411ddf_analysis.xml","b5608acc9c5fd11539ffa1c3d2710a8f","34a0d6a7-178e-4ff0-9f13-ab2cff355cb9",2123,"2016-10-07T16:10:09.013168-05:00","a2188701-b730-442b-b554-eea93d411ddf_experiment.xml","819dd983e1238c6028dc225174cee6ab","f356a013-4e24-4960-9bce-1a516e25303b",2431,"2016-09-29T22:54:50.260276-05:00","a2188701-b730-442b-b554-eea93d411ddf_run.xml","80e4fc95b098a0eca697d206f9cd10d9","c92a5598-800f-4d57-a759-bb0f3e5d84e3",354,"2016-09-08T10:36:33.807142-05:00","TCGA-DI-A2QY","2016-09-02T18:47:40.757892-05:00","female","TCGA-DI-A2QY_demographic",1939,"white","1bf3a85e-3bba-5f86-bdac-e4b82c02dbf6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A2QY_diagnosis","not reported",23398,"dead","8441/3",3349,2797,"16ba3979-eeba-5a99-a3e4-50daa96f30cd","c54.1",-23398,"TCGA-DI-A2QY_treatment","80c89912-4642-58ff-9420-bcf75d9bb5a7","01","false","TCGA-DI-A2QY-01A",NA,"e86df94d-784d-41e0-8610-46ded1032f00",FALSE,"C78D0C27-34C3-44C4-9814-94EEE8A8AB95","Primary Tumor",NA,2957,120,NA,1316563200,"12",20,"TCGA-DI-A2QY-01A-12",90,NA,20,NA,0,NA,5,NA,"2016-09-08T10:36:33.807142-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"62316960-36e9-4919-be3f-f89f3ce464ed",NA,"TCGA-DI-A2QY-01A-01-TS1",NA,90,NA,"e1c1aec2-ff42-410d-9d7a-634f58df802b","RNA","TCGA-DI-A2QY-01A-12R","322fd1e5-ff6a-477d-8f77-0dc6556b9e29",1.96,0.16,"UV Spec","R","23","TCGA-DI-A2QY-01A-12R-A19W-07","ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927",0.16,NA,85,33.203125,160,"03abc5eb-1514-5a39-8ba9-2b04141c412d","TCGA-DI-A2QY_exposure","UNCID_2177880.ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927.130402_UNC10-SN254_0447_BC22WAACXX_4_ACTTGA.tar.gz","2013-09-11T21:31:10.000Z","2013-09-11T21:47:02.000Z","A2188701-B730-442B-B554-EEA93D411DDF","E86DF94D-784D-41E0-8610-46DED1032F00","Unaligned reads",4943610246,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","EA5E5DCC-54E2-43A4-BCC6-AB7B81C87927","University of North Carolina","564a3668e4b0ef121818d77d","6524A6D3-A9F0-4A46-AC0B-7BEB0CD1B915","Uterine Corpus Endometrial Carcinoma","TARGZ","E1C1AEC2-FF42-410D-9D7A-634F58DF802B","2013-09-11T21:47:02.000Z","322FD1E5-FF6A-477D-8F77-0DC6556B9E29","United States","NO",1,NA,"Primary Tumor","MD Anderson",2957,"E1C1AEC2-FF42-410D-9D7A-634F58DF802B",NA,"DI","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3DD87696-1FE4-464E-8359-535C2AD8A78D.txt",120,"TCGA-DI-A2QY-01A",NA,"CA7FE5CE-C641-464F-AC82-7C12F0C3D39F","TCGA",2003,NA,NA,"TUMOR FREE","E86DF94D-784D-41E0-8610-46DED1032F00",64,"nationwidechildrens.org_clinical.TCGA-DI-A2QY.xml","Alive",NA,"TCGA-DI-A2QY","NOT HISPANIC OR LATINO","00517433-111A-4DCC-8826-C8FB55237638",NA,2797,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8441/3","FEMALE","C54.1",186,NA,"F7F81018-C1A1-4366-90CC-4037C8F155AD","WHITE",NA,12,20,"62316960-36E9-4919-BE3F-F89F3CE464ED","3BA36AEF-F863-4259-96B8-09F0290F4B02","UNCID_2035827.ea5e5dcc-54e2-43a4-bcc6-ab7b81c87927.sorted_genome_alignments.bam.bai","TCGA-DI-A2QY-01A-12",90,0,20,40,5,"TOP",5,20,"TCGA-DI-A2QY-01A-01-TS1",90,"Paclitaxel","Chemotherapy","TCGA-DI-A2QY-D60674","TCGA-DI-A2QY-R60670","External","Primary Tumor Field","TCGA-DI-A2QY-F60669_NTE-1","NO",NA,"TUMOR FREE","Dead",3349,"TCGA-DI-A2QY-F60669","TCGA-DI-A2QY",1,"DI","A2QY","YES","C54.1","8441/3","C54.1","NO","YES",-23398,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2797,NA,NA,NA,"TUMOR FREE","NO",29,8,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,64,2003,"Other method, specify:",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
97774502,95489078,4553767409,"D6BD2E37-B0ED-4351-8A9C-09C648A2DA9E.bw","6524a6d3-a9f0-4a46-ac0b-7beb0cd1b915","d6bd2e37-b0ed-4351-8a9c-09c648a2da9e","2016-08-09T13:15:47.839866-05:00","UNCID_2177867.9ba4d4d3-4640-40b7-8a67-72f384858b93.130402_UNC10-SN254_0447_BC22WAACXX_4_GTGGCC.tar.gz","e3ece9d1-d5a2-4994-8c50-41eedac59e75",4158212275,"Illumina HiSeq","6b2f7a59f5b85c4fdd1ad8e3563edb2c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:43:53.475550-05:00","2016-05-03T10:56:47.890899-05:00","e3ece9d1-d5a2-4994-8c50-41eedac59e75_analysis.xml","d4b6cf003d492cf8d9b0f3531db34e63","77e8a941-0539-4d67-8408-8fda927c2497",2123,"2016-09-29T22:37:09.863116-05:00","e3ece9d1-d5a2-4994-8c50-41eedac59e75_experiment.xml","4f2222595b8fae90e87852e7b9e8cd1c","be2fe42f-e9e5-4762-9ff4-d4764f796945",2431,"2016-09-30T00:21:16.532838-05:00","e3ece9d1-d5a2-4994-8c50-41eedac59e75_run.xml","007eb554abaaa93521f4db1a36269a73","fec9ca85-4de6-495c-8be8-49a3bb23be06",354,"2016-09-08T10:36:33.807142-05:00","TCGA-DI-A2QY","2016-09-02T18:47:40.757892-05:00","female","TCGA-DI-A2QY_demographic",1939,"white","1bf3a85e-3bba-5f86-bdac-e4b82c02dbf6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A2QY_diagnosis","not reported",23398,"dead","8441/3",3349,2797,"16ba3979-eeba-5a99-a3e4-50daa96f30cd","c54.1",-23398,"TCGA-DI-A2QY_treatment","80c89912-4642-58ff-9420-bcf75d9bb5a7","11","false","TCGA-DI-A2QY-11A",NA,"dd23fc95-047a-46eb-858f-c411bc337aa0",FALSE,NA,"Solid Tissue Normal",NA,2957,110,NA,1316563200,"11",30,"TCGA-DI-A2QY-11A-11",0,NA,30,NA,90,NA,10,NA,"2016-09-08T10:36:33.807142-05:00",NA,30,NA,10,NA,"TOP",NA,0,NA,"9dea9504-6cf4-4fd2-a919-638517991b3e",NA,"TCGA-DI-A2QY-11A-01-TS1",NA,0,NA,"35aacc90-3b62-471c-b650-6640a0a54c67","RNA","TCGA-DI-A2QY-11A-11R","9490e6b4-f208-4b4c-be44-0fc2ca58928c",1.81,0.16,"UV Spec","R","23","TCGA-DI-A2QY-11A-11R-A19W-07","9ba4d4d3-4640-40b7-8a67-72f384858b93",0.16,NA,85,33.203125,160,"03abc5eb-1514-5a39-8ba9-2b04141c412d","TCGA-DI-A2QY_exposure","UNCID_2177867.9ba4d4d3-4640-40b7-8a67-72f384858b93.130402_UNC10-SN254_0447_BC22WAACXX_4_GTGGCC.tar.gz","2013-09-11T07:36:04.000Z","2013-09-11T07:48:02.000Z","E3ECE9D1-D5A2-4994-8C50-41EEDAC59E75","DD23FC95-047A-46EB-858F-C411BC337AA0","Unaligned reads",4158212275,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","9BA4D4D3-4640-40B7-8A67-72F384858B93","University of North Carolina","56607aa7e4b0ca319164f816","6524A6D3-A9F0-4A46-AC0B-7BEB0CD1B915","Uterine Corpus Endometrial Carcinoma","TARGZ","35AACC90-3B62-471C-B650-6640A0A54C67","2013-09-11T07:48:02.000Z","9490E6B4-F208-4B4C-BE44-0FC2CA58928C","United States","NO",11,NA,"Solid Tissue Normal","MD Anderson",2957,"35AACC90-3B62-471C-B650-6640A0A54C67",NA,"DI","UNCID_2177867.9ba4d4d3-4640-40b7-8a67-72f384858b93.130402_UNC10-SN254_0447_BC22WAACXX_4_GTGGCC.tar.gz",110,"TCGA-DI-A2QY-11A",NA,"CA7FE5CE-C641-464F-AC82-7C12F0C3D39F","TCGA",2003,NA,NA,"TUMOR FREE","E86DF94D-784D-41E0-8610-46DED1032F00",64,"nationwidechildrens.org_clinical.TCGA-DI-A2QY.xml","Alive",NA,"TCGA-DI-A2QY","NOT HISPANIC OR LATINO","00517433-111A-4DCC-8826-C8FB55237638",NA,2797,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8441/3","FEMALE","C54.1",186,NA,"F7F81018-C1A1-4366-90CC-4037C8F155AD","WHITE",NA,11,30,"9DEA9504-6CF4-4FD2-A919-638517991B3E","F9A162D6-EFD2-485D-902D-B8235FA4F567","UNCID_2177867.9ba4d4d3-4640-40b7-8a67-72f384858b93.130402_UNC10-SN254_0447_BC22WAACXX_4_GTGGCC.tar.gz","TCGA-DI-A2QY-11A-11",0,90,30,30,10,"TOP",0,10,"TCGA-DI-A2QY-11A-01-TS1",0,"Paclitaxel","Chemotherapy","TCGA-DI-A2QY-D60674","TCGA-DI-A2QY-R60670","External","Primary Tumor Field","TCGA-DI-A2QY-F60669_NTE-1","NO",NA,"TUMOR FREE","Dead",3349,"TCGA-DI-A2QY-F60669","TCGA-DI-A2QY",1,"DI","A2QY","YES","C54.1","8441/3","C54.1","NO","YES",-23398,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2797,NA,NA,NA,"TUMOR FREE","NO",29,8,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,64,2003,"Other method, specify:",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35731169,35452211,2617983120,"A20D496F-29D4-4BBE-9300-5764A8AE4704.bw","65ef7168-69c6-4910-a141-d7558d0027c9","a20d496f-29d4-4bbe-9300-5764a8ae4704","2016-08-09T13:59:35.118719-05:00","UNCID_2189540.26ef4a16-ddf1-4585-949b-14057cc8a5bf.120524_UNC2-RDR300275_00121_FC_64KREAAXX_3.tar.gz","f89763cd-5794-4ceb-972a-7fe2419aac65",2250388487,"Illumina GA","457b9aeb20d0d831ea15b9c8964cc589","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:54:45.693123-05:00","2016-05-03T11:05:01.517061-05:00","f89763cd-5794-4ceb-972a-7fe2419aac65_analysis.xml","aa207b3a2bf884c6484a12da073dbe61","7eb58659-9adf-41d8-a025-aa74d5fb5776",2120,"2016-10-07T16:43:24.132637-05:00","f89763cd-5794-4ceb-972a-7fe2419aac65_experiment.xml","3fff5f4c44c5484309812427a5015094","e75d9306-18e1-4586-a0d4-5be652411fb4",2258,"2016-09-29T17:45:42.033089-05:00","f89763cd-5794-4ceb-972a-7fe2419aac65_run.xml","0fec7bc83956085fbe1c3bd22d6355b9","08f971ad-822e-445e-bc24-2b4bd09af597",349,"2016-09-08T12:15:13.207308-05:00","TCGA-B5-A0JU","2016-09-02T18:52:12.128656-05:00","female","TCGA-B5-A0JU_demographic",1950,"black or african american","152431b8-e214-5341-b373-68135dc22afb","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0JU_diagnosis","not reported",21159,"alive","8380/3",NA,1802,"49971867-9281-589f-86d7-068279f8956c","c54.1",-21159,"TCGA-B5-A0JU_treatment","fd84a4f0-a0dc-5c60-bcf0-e634d7bad2b4","01","true","TCGA-B5-A0JU-01B",NA,"a4e7601a-9828-453a-8616-17f19de6f997",FALSE,"1EB80878-50FF-4E79-AF16-E809E6EE7DEC","Primary Tumor",NA,1345,300,NA,1299801600,"11",30,"TCGA-B5-A0JU-01B-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T12:15:13.207308-05:00",NA,3,NA,0,NA,"TOP",NA,0,NA,"2dec1f0c-b7e9-42cb-b79e-61dd91df97fe",NA,"TCGA-B5-A0JU-01B-01-TS1",NA,90,NA,"3d113161-9475-4010-a378-41165550acfb","RNA","TCGA-B5-A0JU-01B-11R","ec132fe9-3aa9-4efc-915c-49367b808fec",1.8,0.16,"UV Spec","R","23","TCGA-B5-A0JU-01B-11R-A14D-07","26ef4a16-ddf1-4585-949b-14057cc8a5bf",0.16,NA,137,54.8790257971479,158,"dccacf7b-9f88-5460-bf11-62b44e59ffb6","TCGA-B5-A0JU_exposure","UNCID_2189540.26ef4a16-ddf1-4585-949b-14057cc8a5bf.120524_UNC2-RDR300275_00121_FC_64KREAAXX_3.tar.gz","2013-09-19T03:01:04.000Z","2013-09-19T03:49:02.000Z","F89763CD-5794-4CEB-972A-7FE2419AAC65","A4E7601A-9828-453A-8616-17F19DE6F997","Unaligned reads",2250388487,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","26EF4A16-DDF1-4585-949B-14057CC8A5BF","University of North Carolina","56607583e4b0b37b3d98f991","65EF7168-69C6-4910-A141-D7558D0027C9","Uterine Corpus Endometrial Carcinoma","TARGZ","3D113161-9475-4010-A378-41165550ACFB","2013-09-19T03:49:02.000Z","EC132FE9-3AA9-4EFC-915C-49367B808FEC","United States","NO",1,NA,"Primary Tumor","Duke",1345,"3D113161-9475-4010-A378-41165550ACFB",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7899C98B-FB71-4CE0-993B-FCBEA706104B.txt",300,"TCGA-B5-A0JU-01B",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","B06A4DDA-1A88-44B0-B28E-CBDDA545D7EC",57,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7899C98B-FB71-4CE0-993B-FCBEA706104B.txt","Alive",NA,"TCGA-B5-A0JU",NA,"02F9E4D5-BF91-449A-A587-8240F1CE9F33",NA,1483,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"2DEC1F0C-B7E9-42CB-B79E-61DD91DF97FE","61A669FA-AACF-410D-872C-F93D77D3ED30","TCGA-B5-A0JU-01B-11R-A14C-13_mirna.bam","TCGA-B5-A0JU-01B-11",90,0,0,3,10,"TOP",0,0,"TCGA-B5-A0JU-01B-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,"NO",1802,NA,"Alive",NA,"TCGA-B5-A0JU-F32684","TCGA-B5-A0JU",1,"B5","A0JU","YES","C54.1","8380/3","C54.1","NO","YES",-21159,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1483,NA,NA,NA,"TUMOR FREE","NO",5,8,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2007,"Office Endometrial Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
114817614,112559850,5365782087,"C8F2BAD0-7124-46BF-975C-4B44BE980F93.bw","6696cf88-3c43-482c-aabb-f1ea5cf565aa","c8f2bad0-7124-46bf-975c-4b44be980f93","2016-08-26T10:50:29.461708-05:00","UNCID_2316549.0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63.130909_UNC15-SN850_0326_AC2BWBACXX_2_GGCTAC.tar.gz","f485a793-04d5-4eef-a6ab-b1f42e4633ad",5209797831,"Illumina HiSeq","def76c20a6c318911458c747fef88808","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:35:20.744021-05:00","2016-05-03T11:28:50.207865-05:00","f485a793-04d5-4eef-a6ab-b1f42e4633ad_analysis.xml","3321745857e4af6a132a39c2cb2d6b9b","02420116-1f2c-4c8e-baf6-738e8a9683f3",2124,"2016-09-29T19:06:57.902812-05:00","f485a793-04d5-4eef-a6ab-b1f42e4633ad_experiment.xml","e817ebfc645ab77856c12942647609be","3c1edef1-46e2-4520-a3ad-64f1b00e5c52",2628,"2016-09-29T19:31:52.514029-05:00","f485a793-04d5-4eef-a6ab-b1f42e4633ad_run.xml","e96c10620a71c07e730c3ecf910d1f17","4bc74fd3-b4f6-46e4-8a03-df81c8470fa3",354,"2016-09-08T11:11:58.150380-05:00","TCGA-QS-A5YR","2016-09-02T18:51:26.243639-05:00","female","TCGA-QS-A5YR_demographic",1951,"black or african american","32525c21-d012-5d48-add2-322fb2132125","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","QS","c4c083cd-4644-53b2-9d7e-ca2ae833c525","Candler","not reported","c54.1","TCGA-QS-A5YR_diagnosis","not reported",22372,"alive","8380/3",NA,719,"933be2c9-e498-54b3-97d2-99f70124dba0","c54.1",-22372,"TCGA-QS-A5YR_treatment","73d3ee91-14e0-51ca-b7f3-fb82fb08309c","01","false","TCGA-QS-A5YR-01A",NA,"ff0189ba-f127-4093-b92c-5e37388c7a54",FALSE,"D9417AEE-FD30-42FA-986E-26C98E29C428","Primary Tumor",NA,118,280,NA,1363824000,"31",30,"TCGA-QS-A5YR-01A-31",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:11:58.150380-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"41a0f2d6-2866-4cea-9395-a33d327efdcb",NA,"TCGA-QS-A5YR-01A-03-TS3",NA,70,NA,"8a4788e4-00fb-4488-b50e-fd0a93b7f5c6","RNA","TCGA-QS-A5YR-01A-31R","8c31b35e-3c44-4b5c-85c4-7d5ca2887d85",1.82,0.16,"UV Spec","R","23","TCGA-QS-A5YR-01A-31R-A31O-07","0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63",0.16,NA,100,35.4308390022676,168,"8d8d7f0c-0274-540b-8131-721c30eb5b23","TCGA-QS-A5YR_exposure","UNCID_2316549.0c0e6adb-5f3b-429c-bbc4-5d3d74e9ef63.130909_UNC15-SN850_0326_AC2BWBACXX_2_GGCTAC.tar.gz","2014-01-07T02:21:21.000Z","2014-01-07T02:41:01.000Z","F485A793-04D5-4EEF-A6AB-B1F42E4633AD","FF0189BA-F127-4093-B92C-5E37388C7A54","Unaligned reads",5209797831,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0C0E6ADB-5F3B-429C-BBC4-5D3D74E9EF63","University of North Carolina","564a3aa1e4b093830b6904a6","6696CF88-3C43-482C-AABB-F1EA5CF565AA","Uterine Corpus Endometrial Carcinoma","TARGZ","8A4788E4-00FB-4488-B50E-FD0A93B7F5C6","2014-01-07T02:41:01.000Z","8C31B35E-3C44-4B5C-85C4-7D5CA2887D85","United States","NO",1,NA,"Primary Tumor","Candler",118,"8A4788E4-00FB-4488-B50E-FD0A93B7F5C6",NA,"QS","SWEDE_p_TCGAb322_23_24_25_26NSP_GenomeWideSNP_6_D05_1364958.tangent.copynumber.data.txt",280,"TCGA-QS-A5YR-01A",NA,NA,"TCGA",2012,"TCGA-QS-A5YR_NTE-1","Stable Disease","WITH TUMOR","FF0189BA-F127-4093-B92C-5E37388C7A54",61,"TCGA-QS-A5YR-01A-31D_OPTIPLEX-XE_2015-01-22_004.fsa","Alive",NA,"TCGA-QS-A5YR","NOT HISPANIC OR LATINO","8606517A-013F-412D-8CB8-270C7263397D","NO",168,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8380/3","FEMALE","C54.1",324,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,31,30,"41A0F2D6-2866-4CEA-9395-A33D327EFDCB","B0441638-B357-4A6A-8B7D-20B16FF22A46","SWEDE_p_TCGAb322_23_24_25_26NSP_GenomeWideSNP_6_D05_1364958.hg19.seg.txt","TCGA-QS-A5YR-01A-31",70,0,20,40,20,"TOP",10,20,"TCGA-QS-A5YR-01A-03-TS3",70,NA,NA,NA,NA,NA,NA,"TCGA-QS-A5YR-F58590_NTE-1","NO",719,"WITH TUMOR","Alive",NA,"TCGA-QS-A5YR-F58590","TCGA-QS-A5YR",1,"QS","A5YR","YES","C54.1","8380/3","C54.1","YES","NO",-22372,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",168,NA,"NO","NO","WITH TUMOR","YES",13,5,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2012,"Dilation and curettage procedure",NA,NA,NA,"G2","RX",NA,NA,NA,NA,"Stable Disease","2009",10,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33004916,31893964,2402407112,"24363857-9A33-40D4-8409-C17225570833.bw","66e305ca-8a16-44f0-b837-85e529b7ad55","24363857-9a33-40d4-8409-c17225570833","2016-08-09T14:15:28.180796-05:00","UNCID_2209573.484a9564-c6dd-4e54-a319-4d826f308d0c.110509_UNC6-RDR300211_00102_FC_634VYAAXX_4.tar.gz","c718dfe0-be49-411e-a4d7-c7cc3f063177",2178239482,"Illumina GA","694a82fe0720f4c28c61a9d6bb58c8a6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:40:08.843205-05:00","2016-05-03T11:15:06.073526-05:00","c718dfe0-be49-411e-a4d7-c7cc3f063177_analysis.xml","bde8692dff5a0e25aba0e1e98d3ed113","0546f1d2-dfe6-4f83-a737-a47f1ad17576",2121,"2016-08-30T02:16:08.092165-05:00","c718dfe0-be49-411e-a4d7-c7cc3f063177_experiment.xml","b7e9170c7fd1036f6454ede9ebe35a53","372c7f95-b481-4730-a05e-5b27461b8467",2257,"2016-09-29T18:13:17.159021-05:00","c718dfe0-be49-411e-a4d7-c7cc3f063177_run.xml","187ed5241c4715f414bf97430688b5d7","1a4bebe4-c277-4d99-9943-56b606c24d63",347,"2016-09-08T11:32:25.650559-05:00","TCGA-BG-A18C","2016-09-02T18:50:06.283843-05:00","female","TCGA-BG-A18C_demographic",1938,"white","06e72bfd-79e9-5aa2-a14c-1c4bb7c4bd57","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A18C_diagnosis","not reported",26602,"alive","8380/3",NA,470,"8337ee7b-e16c-5f14-93f5-f8730b9788c5","c54.1",-26602,"TCGA-BG-A18C_treatment","5b32ad9a-4607-583b-b0ae-f7534c108f8f","01","true","TCGA-BG-A18C-01A",NA,"37f209b1-c738-441c-b205-eaec4e2ade4e",FALSE,"2A6FB6E4-7FBF-45EA-B9B0-C4EDC78C35E2","Primary Tumor",NA,52,340,NA,1294617600,"11",30,"TCGA-BG-A18C-01A-11",60,NA,20,NA,0,NA,30,NA,"2016-09-08T11:32:25.650559-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"348cd7f6-57aa-40f6-b260-7ef53ff0f6bd",NA,"TCGA-BG-A18C-01A-01-TSA",NA,60,NA,"7906ba08-9b47-4c46-85fe-69658c62b8ff","RNA","TCGA-BG-A18C-01A-11R","11f5459c-6547-4523-92c6-e1ba313e27c6",1.86,0.16,"UV Spec","R","23","TCGA-BG-A18C-01A-11R-A12I-07","484a9564-c6dd-4e54-a319-4d826f308d0c",0.16,NA,96,36.1323346757499,163,"049ab97f-2226-57cc-b573-d154419bd09f","TCGA-BG-A18C_exposure","UNCID_2209573.484a9564-c6dd-4e54-a319-4d826f308d0c.110509_UNC6-RDR300211_00102_FC_634VYAAXX_4.tar.gz","2013-10-01T09:43:04.000Z","2013-10-01T09:56:02.000Z","C718DFE0-BE49-411E-A4D7-C7CC3F063177","37F209B1-C738-441C-B205-EAEC4E2ADE4E","Unaligned reads",2178239482,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","484A9564-C6DD-4E54-A319-4D826F308D0C","University of North Carolina","56607ca6e4b0ec1099f8ea08","66E305CA-8A16-44F0-B837-85E529B7AD55","Uterine Corpus Endometrial Carcinoma","TARGZ","7906BA08-9B47-4C46-85FE-69658C62B8FF","2013-10-01T09:56:02.000Z","11F5459C-6547-4523-92C6-E1BA313E27C6","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",52,"7906BA08-9B47-4C46-85FE-69658C62B8FF",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.42648EF0-3A6A-4CF2-9A7B-E3AA008D4BEE.txt",340,"TCGA-BG-A18C-01A",NA,NA,"TCGA",2010,NA,NA,NA,"9B300C20-4B43-4832-9746-F0401E0E7DDB",72,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.42648EF0-3A6A-4CF2-9A7B-E3AA008D4BEE.txt","Alive",NA,"TCGA-BG-A18C","NOT HISPANIC OR LATINO","8CAECF65-A756-4BB8-8000-3ACB94105F4E",NA,169,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"348CD7F6-57AA-40F6-B260-7EF53FF0F6BD","44BBBEBE-A717-4892-961F-0910C1F66082","UNCID_2209573.484a9564-c6dd-4e54-a319-4d826f308d0c.110509_UNC6-RDR300211_00102_FC_634VYAAXX_4.tar.gz","TCGA-BG-A18C-01A-11",60,0,20,40,30,"TOP",10,20,"TCGA-BG-A18C-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,NA,"NO",470,"TUMOR FREE","Alive",NA,"TCGA-BG-A18C-F28650","TCGA-BG-A18C",1,"BG","A18C","YES","C54.1","8380/3","C54.1","NO","YES",-26602,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",169,NA,NA,NA,NA,"NO",27,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,72,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","RX",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
94348362,93356384,4455432307,"0DE42FC5-00AF-4DA9-BD6A-3E0CF47CA89E.bw","672de064-3378-4004-a3ea-f79885e10d78","0de42fc5-00af-4da9-bd6a-3e0cf47ca89e","2016-08-09T13:15:44.708300-05:00","UNCID_2178360.6c10f0d4-fd7e-459e-af27-8cde9dc42860.130328_UNC10-SN254_0443_AD238RACXX_7_GGCTAC.tar.gz","5a44abe8-d518-435e-a3b4-ed391c0a1077",3928247139,"Illumina HiSeq","b86ad1f5b7be35bc226d7c34d3a2baf1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:54:49.448310-05:00","2016-05-03T10:56:47.878169-05:00","5a44abe8-d518-435e-a3b4-ed391c0a1077_analysis.xml","9106091bda2b61ba74f217225d3dc4a6","a4245739-a7c3-4581-b6d4-24ebf78b3e05",2123,"2016-08-28T17:35:33.668087-05:00","5a44abe8-d518-435e-a3b4-ed391c0a1077_experiment.xml","8f2c24c8f7f1a484d3c655f95c81b8e9","9a9b8b3f-3068-4583-b078-4551fc9e4503",2431,"2016-09-29T18:31:43.218314-05:00","5a44abe8-d518-435e-a3b4-ed391c0a1077_run.xml","beeca2eabaa68ff205074ab44d0e959c","25aa39df-55e5-47d0-9407-076313bd4abc",354,"2016-09-08T10:38:57.209629-05:00","TCGA-AJ-A3EJ","2016-09-02T18:47:34.778143-05:00","female","TCGA-AJ-A3EJ_demographic",1936,"white","651551b6-fc50-57b2-9072-7cb246435efc","not hispanic or latino",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3EJ_diagnosis","not reported",27317,"dead","8441/3",50,NA,"72e5ad38-31a5-51bb-9c1e-f7ed34b91622","c54.1",-27317,"TCGA-AJ-A3EJ_treatment","8674bbae-61f4-5e98-a29c-ce0ef3e9f93f","01","false","TCGA-AJ-A3EJ-01A",NA,"3960cc6d-3c1d-48c6-8ddb-4fc700060e1b",FALSE,"FB99D237-4583-4298-844F-43B2F99F83E3","Primary Tumor",NA,332,20,NA,1320105600,"11",20,"TCGA-AJ-A3EJ-01A-11",70,NA,0,NA,0,NA,15,NA,"2016-09-08T10:38:57.209629-05:00",NA,0,NA,0,NA,"TOP",NA,10,NA,"12f3130d-0ad2-46db-9479-90740047ca40",NA,"TCGA-AJ-A3EJ-01A-01-TS1",NA,75,NA,"6b88566b-97d0-49b7-9ace-1e35a6bc1893","RNA","TCGA-AJ-A3EJ-01A-11R","d9f6d143-3b91-468e-a4f5-a26163c642bf",1.86,0.16,"UV Spec","R","23","TCGA-AJ-A3EJ-01A-11R-A19W-07","6c10f0d4-fd7e-459e-af27-8cde9dc42860",0.16,NA,73,25.8645124716553,168,"2d20f317-ab79-5c32-92f3-1e76b49fc466","TCGA-AJ-A3EJ_exposure","UNCID_2178360.6c10f0d4-fd7e-459e-af27-8cde9dc42860.130328_UNC10-SN254_0443_AD238RACXX_7_GGCTAC.tar.gz","2013-09-12T01:16:10.000Z","2013-09-12T01:47:01.000Z","5A44ABE8-D518-435E-A3B4-ED391C0A1077","3960CC6D-3C1D-48C6-8DDB-4FC700060E1B","Unaligned reads",3928247139,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","6C10F0D4-FD7E-459E-AF27-8CDE9DC42860","University of North Carolina","564a3f0be4b08c5d8692abc7","672DE064-3378-4004-A3EA-F79885E10D78","Uterine Corpus Endometrial Carcinoma","TARGZ","6B88566B-97D0-49B7-9ACE-1E35A6BC1893","2013-09-12T01:47:01.000Z","D9F6D143-3B91-468E-A4F5-A26163C642BF","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",332,"6B88566B-97D0-49B7-9ACE-1E35A6BC1893",NA,"AJ","TCGA-AJ-A3EJ-01A-11R-A19V-13_mirna.bam",20,"TCGA-AJ-A3EJ-01A",NA,NA,"TCGA",2010,NA,NA,"WITH TUMOR","8E04ABCF-FB31-4A89-8086-5AC5220983F8",74,"nationwidechildrens.org_clinical.TCGA-AJ-A3EJ.xml","Dead",50,"TCGA-AJ-A3EJ","NOT HISPANIC OR LATINO","B8BF7F7C-4F0D-4E6A-9E9F-3E31015E513D",NA,NA,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",186,NA,NA,"WHITE",NA,11,20,"12F3130D-0AD2-46DB-9479-90740047CA40","D9F6D143-3B91-468E-A4F5-A26163C642BF","TCGA-AJ-A3EJ-01A-11R-A19V-13_mirna.bam","TCGA-AJ-A3EJ-01A-11",70,0,0,0,15,"TOP",10,0,"TCGA-AJ-A3EJ-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3EJ-F43201_NTE-1","NO",NA,"WITH TUMOR","Dead",50,"TCGA-AJ-A3EJ-F43201","TCGA-AJ-A3EJ",1,"AJ","A3EJ","YES","C54.1","8441/3","C54.1","YES","NO",-27317,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,50,NA,NA,"WITH TUMOR","NO",15,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,74,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34261419,33849631,2526311023,"739952C6-FF36-4E34-B881-E02FE17C4012.bw","67ccb182-3021-4621-bffb-6565574dbc58","739952c6-ff36-4e34-b881-e02fe17c4012","2016-08-07T17:27:31.290374-05:00","UNCID_2208051.1622de43-ddd8-4a57-a89c-70c427d0a9f6.110624_UNC2-RDR300275_00073_FC70KA5AAXX_5.tar.gz","488ae413-5ac6-463b-80c8-d4c7dcb62dcc",2144897521,"Illumina GA","b33391455194deee26383baa9457e3f7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:20:38.708521-05:00","2016-05-03T11:14:23.404443-05:00","488ae413-5ac6-463b-80c8-d4c7dcb62dcc_analysis.xml","1762cad39a61434c35970665fdc360a6","b3da39a0-dcec-4526-9297-41c3a3f22796",2119,"2016-09-29T18:08:30.890081-05:00","488ae413-5ac6-463b-80c8-d4c7dcb62dcc_experiment.xml","46af1a3cf4c792b7cfbd7aa01f7850f6","1762cea1-cf57-4254-b268-8f69a4cfed71",2257,"2016-09-29T23:01:09.805431-05:00","488ae413-5ac6-463b-80c8-d4c7dcb62dcc_run.xml","4e31258ef959115e5e719f9882e6c5f6","cced9286-8fd3-47d9-9889-132e09484b2d",347,"2016-09-08T11:03:22.716201-05:00","TCGA-D1-A17L","2016-09-02T18:50:41.519961-05:00","female","TCGA-D1-A17L_demographic",1928,"white","aa2b17e8-1a85-503a-b7ba-7847433aafaf","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17L_diagnosis","not reported",29899,"alive","8380/3",NA,802,"e3ac8e2c-44a2-5714-87e5-36a3a6ad7198","c54.1",-29899,"TCGA-D1-A17L_treatment","a36f788d-0a58-5518-9bff-1a14b262aec1","01","false","TCGA-D1-A17L-01A",NA,"5507cf56-068f-406e-aafd-8231f5943cbf",FALSE,"BCF17C02-8F6E-419F-AEDF-3AC03AA883E7","Primary Tumor",NA,493,210,NA,1294185600,"11",30,"TCGA-D1-A17L-01A-11",85,NA,0,NA,2,NA,15,NA,"2016-09-08T11:03:22.716201-05:00",NA,12,NA,2,NA,"TOP",NA,0,NA,"b6048e36-8cb0-4a8f-847b-71bd4bfb3187",NA,"TCGA-D1-A17L-01A-01-TS1",NA,83,NA,"a8d2d865-1a57-4906-8b7c-06a1d04b59e8","RNA","TCGA-D1-A17L-01A-11R","8d3fa01b-39be-4a92-ae19-86efe60b654d",1.84,0.15,"UV Spec","R","23","TCGA-D1-A17L-01A-11R-A12I-07","1622de43-ddd8-4a57-a89c-70c427d0a9f6",0.15,NA,123,41.5765278528935,172,"86d38bac-5945-5daf-b0b6-d219abc627cc","TCGA-D1-A17L_exposure","UNCID_2208051.1622de43-ddd8-4a57-a89c-70c427d0a9f6.110624_UNC2-RDR300275_00073_FC70KA5AAXX_5.tar.gz","2013-09-30T08:01:04.000Z","2013-09-30T08:16:02.000Z","488AE413-5AC6-463B-80C8-D4C7DCB62DCC","5507CF56-068F-406E-AAFD-8231F5943CBF","Unaligned reads",2144897521,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1622DE43-DDD8-4A57-A89C-70C427D0A9F6","University of North Carolina","564a3640e4b093830b679f39","67CCB182-3021-4621-BFFB-6565574DBC58","Uterine Corpus Endometrial Carcinoma","TARGZ","A8D2D865-1A57-4906-8B7C-06A1D04B59E8","2013-09-30T08:16:02.000Z","8D3FA01B-39BE-4A92-AE19-86EFE60B654D","None","NO",1,NA,"Primary Tumor","Mayo Clinic",493,"A8D2D865-1A57-4906-8B7C-06A1D04B59E8",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3D47AB97-2F85-4789-82B6-82268ABB08AC.txt",210,"TCGA-D1-A17L-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","7DAD3689-8668-4270-ADFB-4230B37EDD7B",81,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3D47AB97-2F85-4789-82B6-82268ABB08AC.txt","Alive",NA,"TCGA-D1-A17L","NOT HISPANIC OR LATINO","A8192EB8-5FFD-4B36-94C5-0A558E85CAD1",NA,459,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"B6048E36-8CB0-4A8F-847B-71BD4BFB3187","3003AB64-6067-465F-8F20-C4175C1CAA4F","TCGA-D1-A17L-01A-11R-A12H-13_mirna.bam","TCGA-D1-A17L-01A-11",85,2,0,12,15,"TOP",0,2,"TCGA-D1-A17L-01A-01-TS1",83,NA,NA,NA,NA,NA,NA,NA,"NO",802,"TUMOR FREE","Alive",NA,"TCGA-D1-A17L-F20271","TCGA-D1-A17L",1,"D1","A17L","YES","C54.1","8380/3","C54.1","NO","YES",-29899,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",459,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,81,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33444021,33064060,2471960894,"98E88BAB-4CE8-4A32-BBAC-7C6E711C4708.bw","68181bc9-aa8b-44ec-8601-564b30ea0561","98e88bab-4ce8-4a32-bbac-7c6e711c4708","2016-08-04T20:50:23.894255-05:00","UNCID_2206805.e91d204d-8790-4438-add0-52f520fa532b.110829_UNC2-RDR300275_00084_FC_634GCAAXX_7.tar.gz","56189845-fbe7-4108-9ebb-60dd8766e469",2140000120,"Illumina GA","0dbb9e3173a723a6651b0228027c1026","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:08:01.699673-05:00","2016-05-03T11:12:13.672306-05:00","56189845-fbe7-4108-9ebb-60dd8766e469_analysis.xml","8e96f8f781e1b1dfe2194e06a9596dce","17120abe-9cac-4fb5-99bb-024c3d4dac2b",2121,"2016-09-29T20:16:36.576468-05:00","56189845-fbe7-4108-9ebb-60dd8766e469_experiment.xml","e41e1acd5fa0a9d1f1c797fd7a1712ae","6724b725-f7fe-44fc-aded-af291e16bb6e",2257,"2016-09-29T23:44:28.370966-05:00","56189845-fbe7-4108-9ebb-60dd8766e469_run.xml","ec237697e44f8d3f6f84f9fbe474c331","e813bc7c-eb04-4e4e-b958-60740a4eb763",347,"2016-09-08T11:43:21.931878-05:00","TCGA-BG-A0LW","2016-09-02T18:54:46.103327-05:00","female","TCGA-BG-A0LW_demographic",1963,"white","d8c4248b-3e80-5a02-bf28-aff20c54f0dc","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0LW_diagnosis","not reported",17369,"alive","8380/3",NA,566,"565c2697-e6db-5c22-be88-bbc3f88f1424","c54.1",-17369,"TCGA-BG-A0LW_treatment","4278df68-abfe-558c-9aea-4848666f3327","01","true","TCGA-BG-A0LW-01A",NA,"6527ec31-1d41-49c2-93ff-11615a6cba8b",FALSE,"75A97BED-AB64-46CC-AE6B-59860673D53E","Primary Tumor",NA,107,190,NA,1278547200,"11",30,"TCGA-BG-A0LW-01A-11",90,90,0,0,0,0,0,0,"2016-09-08T11:43:21.931878-05:00","2016-09-08T11:43:21.931878-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"1cd44382-0c7e-4ab1-af3e-05e589cb33d9","095d6c24-e044-4e9e-a863-d0fde9d2dacd","TCGA-BG-A0LW-01A-01-TSA","TCGA-BG-A0LW-01A-01-BSA",100,100,"ccdaf387-f4b9-4a03-8fa6-dd29b1a62dfd","RNA","TCGA-BG-A0LW-01A-11R","784aa2a1-4074-4a61-9986-64f884e2044d",1.91,0.13,"UV Spec","R","23","TCGA-BG-A0LW-01A-11R-A16W-07","e91d204d-8790-4438-add0-52f520fa532b",0.13,NA,141,57.2031319728995,157,"c2adc86a-6fd1-56e1-bc7e-56e4d3581bca","TCGA-BG-A0LW_exposure","UNCID_2206805.e91d204d-8790-4438-add0-52f520fa532b.110829_UNC2-RDR300275_00084_FC_634GCAAXX_7.tar.gz","2013-09-28T07:36:06.000Z","2013-09-28T07:54:02.000Z","56189845-FBE7-4108-9EBB-60DD8766E469","6527EC31-1D41-49C2-93FF-11615A6CBA8B","Unaligned reads",2140000120,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E91D204D-8790-4438-ADD0-52F520FA532B","University of North Carolina","564a3848e4b0ef12181971e2","68181BC9-AA8B-44EC-8601-564B30EA0561","Uterine Corpus Endometrial Carcinoma","TARGZ","CCDAF387-F4B9-4A03-8FA6-DD29B1A62DFD","2013-09-28T07:54:02.000Z","784AA2A1-4074-4A61-9986-64F884E2044D","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",107,"CCDAF387-F4B9-4A03-8FA6-DD29B1A62DFD",NA,"BG","TCGA-BG-A0LW-01A-01D-YYYY-23.txt",190,"TCGA-BG-A0LW-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","ADDF5D6E-5C42-400B-98BC-B44E48336953",47,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.1AF915C6-7503-4190-9013-EA95D556D6D2.txt","Alive",NA,"TCGA-BG-A0LW","NOT HISPANIC OR LATINO","1DA9B00C-5FDD-479D-8632-B246711E2092",NA,195,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"1CD44382-0C7E-4AB1-AF3E-05E589CB33D9","F59B2F9E-C68C-4DD2-A518-52B877C72915","UNCID_1622192.e91d204d-8790-4438-add0-52f520fa532b.sorted_genome_alignments.bam.bai","TCGA-BG-A0LW-01A-11",90,0,0,0,0,"TOP",0,0,"TCGA-BG-A0LW-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",566,"TUMOR FREE","Alive",NA,"TCGA-BG-A0LW-F19329","TCGA-BG-A0LW",1,"BG","A0LW","YES","C54.1","8380/3","C54.1","NO","YES",-17369,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",195,NA,NA,NA,"TUMOR FREE","NO",1,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,47,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
135026966,131901279,6291898510,"0782D25A-3B14-499E-A40C-3852B3A15B8B.bw","69fc74bc-e961-40e2-9169-d7b51658eb10","0782d25a-3b14-499e-a40c-3852b3a15b8b","2016-08-05T15:43:34.884974-05:00","UNCID_2173174.6f0ffee6-d69f-459e-b401-f7dbcb17cb13.130509_UNC10-SN254_0462_AC232JACXX_1_CGATGT.tar.gz","877409e9-5d2a-45f8-98a7-7a87c54bb475",6378689706,"Illumina HiSeq","2ec7b5c2988915dec38f681789fe6ca0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:00:59.222585-05:00","2016-05-03T10:55:55.600288-05:00","877409e9-5d2a-45f8-98a7-7a87c54bb475_analysis.xml","a4c812efab91cb388dbb80feee93f635","ccceda30-ef21-4d2d-8834-1ed99a458151",2123,"2016-09-29T23:20:13.724429-05:00","877409e9-5d2a-45f8-98a7-7a87c54bb475_experiment.xml","24346c086d25ff1310a467c3710bfb52","d8c746ae-d390-4921-b551-32527f3c2222",2431,"2016-09-29T23:00:05.571738-05:00","877409e9-5d2a-45f8-98a7-7a87c54bb475_run.xml","cc0796c75218c27f4eac32a63567e9e9","cc42193f-c7ad-4d41-aa9d-689e6608bf36",354,"2016-09-08T10:43:10.194214-05:00","TCGA-AJ-A3QS","2016-09-02T18:49:08.156492-05:00","female","TCGA-AJ-A3QS_demographic",1954,"black or african american","4b4e030a-6c7f-5469-9180-3d974b5900d2","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3QS_diagnosis","not reported",21162,"alive","8441/3",NA,513,"9e06c1b9-f53c-574c-bcaf-9f3d6b0d778d","c54.1",-21162,"TCGA-AJ-A3QS_treatment","81ea6788-6a4d-594c-b016-93bb00b4cb44","01","true","TCGA-AJ-A3QS-01A",NA,"0d33f3bb-f849-4ffa-8192-c95bf69dd5cc",FALSE,"73D1F890-5799-4166-9F9A-F9852979FD29","Primary Tumor",NA,129,34,NA,1330992000,"11",34,"TCGA-AJ-A3QS-01A-11",40,60,0,0,0,0,60,5,"2016-09-08T10:43:10.194214-05:00","2016-09-08T10:43:10.194214-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"81f181fe-45db-417b-9267-1f7127d734d2","1228cf67-717b-4912-b3d3-c17ae38bf49b","TCGA-AJ-A3QS-01A-01-BS1","TCGA-AJ-A3QS-01A-01-TS1",40,95,"da9a0373-d011-4034-9329-44436b43596a","RNA","TCGA-AJ-A3QS-01A-11R","1a271df4-f21e-4ecc-886f-dc34043bbd2e",1.82,0.16,"UV Spec","R","23","TCGA-AJ-A3QS-01A-11R-A22K-07","6f0ffee6-d69f-459e-b401-f7dbcb17cb13",0.16,NA,71,26.078971533517,165,"d749b0cd-10ae-577e-9556-19b88bcc7014","TCGA-AJ-A3QS_exposure","UNCID_2173174.6f0ffee6-d69f-459e-b401-f7dbcb17cb13.130509_UNC10-SN254_0462_AC232JACXX_1_CGATGT.tar.gz","2013-09-09T12:36:08.000Z","2013-09-09T12:58:02.000Z","877409E9-5D2A-45F8-98A7-7A87C54BB475","0D33F3BB-F849-4FFA-8192-C95BF69DD5CC","Unaligned reads",6378689706,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","6F0FFEE6-D69F-459E-B401-F7DBCB17CB13","University of North Carolina","564a3c75e4b093830b699b51","69FC74BC-E961-40E2-9169-D7B51658EB10","Uterine Corpus Endometrial Carcinoma","TARGZ","DA9A0373-D011-4034-9329-44436B43596A","2013-09-09T12:58:02.000Z","1A271DF4-F21E-4ECC-886F-DC34043BBD2E","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",129,"DA9A0373-D011-4034-9329-44436B43596A",NA,"AJ","ac0814f41f419489b680cd75aba8fc84.bam",34,"TCGA-AJ-A3QS-01A",NA,"E8F22E51-4803-4AEB-BED5-17610F99AADB","TCGA",2011,"TCGA-AJ-A3QS_NTE-1",NA,"TUMOR FREE","A27EC64C-A817-4CB8-B8D0-B0871BEB9AFF",57,"nationwidechildrens.org_clinical.TCGA-AJ-A3QS.xml","Alive",NA,"TCGA-AJ-A3QS","NOT HISPANIC OR LATINO","705F6EBE-6120-43D1-9044-A1C1397BCF12","NO",56,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"F93DAFFF-A78E-4634-AA95-AE39869F8A24","BLACK OR AFRICAN AMERICAN",NA,11,34,"81F181FE-45DB-417B-9267-1F7127D734D2","A455EF01-9838-48DA-A9C0-360F6DCC0FBA","ac0814f41f419489b680cd75aba8fc84.bam","TCGA-AJ-A3QS-01A-11",60,0,0,0,5,"TOP",0,0,"TCGA-AJ-A3QS-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-AJ-A3QS-D47016","TCGA-AJ-A3QS-R47014","Internal","Primary Tumor Field","TCGA-AJ-A3QS-F47011_NTE-1","NO",513,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3QS-F47011","TCGA-AJ-A3QS",1,"AJ","A3QS","YES","C54.1","8441/3","C54.1","YES","NO",-21162,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",56,NA,NA,NA,"TUMOR FREE","YES",28,9,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,57,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30876937,30472721,2290141155,"2299CD19-BF08-404C-B1BF-B570F12CCEF8.bw","6b2e93b9-8271-4205-842e-0b7292b8115a","2299cd19-bf08-404c-b1bf-b570f12ccef8","2016-08-09T14:03:18.838386-05:00","UNCID_2194473.c3c8ccb3-db16-4cc6-b790-204473be0f25.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_3.tar.gz","97aa4e37-5486-48b1-be33-5e5f3e6d3111",1958896987,"Illumina GA","e56e21e3687f9319482c8d55126c4a3b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:55:32.026184-05:00","2016-05-03T11:07:49.533431-05:00","97aa4e37-5486-48b1-be33-5e5f3e6d3111_analysis.xml","6bc4b9056d0a18b3c44182638f61ccdf","34de8e19-2d50-4cd2-8844-0d9c87cd1236",2122,"2016-09-29T18:37:32.822330-05:00","97aa4e37-5486-48b1-be33-5e5f3e6d3111_experiment.xml","53e0c2e139285a3607b72099fa6da072","2973054b-e9f4-4faa-9b59-34f27ee0b6d3",2258,"2016-09-29T23:37:33.755703-05:00","97aa4e37-5486-48b1-be33-5e5f3e6d3111_run.xml","dfdb61dc02757b1e7baf865a960de8b3","e3c4c228-a18d-4893-abe4-c89cf520b0e9",349,"2016-09-08T11:00:24.180212-05:00","TCGA-EY-A1G7","2016-09-02T18:51:48.881398-05:00","female","TCGA-EY-A1G7_demographic",1922,"white","d186577b-35c7-5ccd-9d88-b083e445362f","not hispanic or latino",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1G7_diagnosis","not reported",31603,"dead","8380/3",189,NA,"f85591b5-ba91-59d8-9e44-7a4af2e80e25","c54.1",-31603,"TCGA-EY-A1G7_treatment","52864ae8-530f-537e-a9eb-04e7a720d395","01","false","TCGA-EY-A1G7-01A",NA,"730cb784-2266-4b5c-98b9-6cd7ebbe989d",FALSE,"2803014E-7E68-463F-BF3C-C5E4DF9FA421","Primary Tumor",NA,1002,140,NA,1297814400,"11",30,"TCGA-EY-A1G7-01A-11",70,NA,0,NA,20,NA,10,NA,"2016-09-08T11:00:24.180212-05:00",NA,20,NA,20,NA,"TOP",NA,20,NA,"1a8426f8-f491-44f9-9b60-773a7953e6ed",NA,"TCGA-EY-A1G7-01A-01-TSA",NA,50,NA,"d7447985-1171-41f1-b180-38029f36165c","RNA","TCGA-EY-A1G7-01A-11R","3c4b416f-49d2-4cf0-bdea-f41d5fee56f9",1.9,0.18,"UV Spec","R","23","TCGA-EY-A1G7-01A-11R-A13S-07","c3c8ccb3-db16-4cc6-b790-204473be0f25",0.18,NA,85,37.2790667076005,151,"03d8b791-b575-573e-aa4b-eec488297d28","TCGA-EY-A1G7_exposure","UNCID_2194473.c3c8ccb3-db16-4cc6-b790-204473be0f25.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_3.tar.gz","2013-09-22T23:26:04.000Z","2013-09-22T23:38:01.000Z","97AA4E37-5486-48B1-BE33-5E5F3E6D3111","730CB784-2266-4B5C-98B9-6CD7EBBE989D","Unaligned reads",1958896987,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C3C8CCB3-DB16-4CC6-B790-204473BE0F25","University of North Carolina","564a33cae4b0298dd2c5f7ba","6B2E93B9-8271-4205-842E-0B7292B8115A","Uterine Corpus Endometrial Carcinoma","TARGZ","D7447985-1171-41F1-B180-38029F36165C","2013-09-22T23:38:01.000Z","3C4B416F-49D2-4CF0-BDEA-F41D5FEE56F9","United States","NO",1,NA,"Primary Tumor","University of North Carolina",1002,"D7447985-1171-41F1-B180-38029F36165C",NA,"EY","HORNS_p_TCGA_b110_113_SNP_N_GenomeWideSNP_6_E08_772360.ismpolish.data.txt",140,"TCGA-EY-A1G7-01A",NA,NA,"TCGA",2008,NA,NA,"WITH TUMOR","730CB784-2266-4B5C-98B9-6CD7EBBE989D",86,"nationwidechildrens.org_clinical.TCGA-EY-A1G7.xml","Dead",189,"TCGA-EY-A1G7","NOT HISPANIC OR LATINO","314D80F2-830C-48B8-86FB-143E3CECE003",NA,NA,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,"83A35F60-1D1A-40CF-BB78-2314A0E66417","WHITE",NA,11,30,"1A8426F8-F491-44F9-9B60-773A7953E6ED","B5A5D593-0499-4C82-82BF-AD04CE4F89B0","UNCID_1604155.c3c8ccb3-db16-4cc6-b790-204473be0f25.sorted_genome_alignments.bam.bai","TCGA-EY-A1G7-01A-11",70,20,0,20,10,"TOP",20,20,"TCGA-EY-A1G7-01A-01-TSA",50,NA,NA,NA,"TCGA-EY-A1G7-R10979","IMPLANTS","Regional site",NA,NA,NA,"WITH TUMOR","Dead",189,"TCGA-EY-A1G7-F10982","TCGA-EY-A1G7",1,"EY","A1G7","YES","C54.1","8380/3","C54.1","NO","YES",-31603,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Dead",NA,189,NA,NA,"WITH TUMOR","NO",21,4,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,86,2008,"Tumor resection",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
132854238,126619886,6033147988,"19590D31-2415-4D46-8E50-494FC40BF639.bw","6b35a816-f9c4-44d4-9824-5dee4804b80d","19590d31-2415-4d46-8e50-494fc40bf639","2016-08-05T14:58:31.091444-05:00","UNCID_2173160.0f347f95-e4bc-480e-ab1a-84c9df4018c9.130509_UNC10-SN254_0462_AC232JACXX_1_TTAGGC.tar.gz","73396d90-6532-4944-b1fb-a41c8a52322f",6247839402,"Illumina HiSeq","8fae411b12fc4e57dd21999e2a28ab51","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:01:45.208606-05:00","2016-05-03T10:55:55.600288-05:00","73396d90-6532-4944-b1fb-a41c8a52322f_analysis.xml","d6cf876947e050c2b2b94a56b19b6894","5e33f847-33ee-4e95-a7e5-40ba690d1237",2123,"2016-10-07T16:04:01.228765-05:00","73396d90-6532-4944-b1fb-a41c8a52322f_experiment.xml","eb60fa9d6928571f4a73c83f6dceb087","eb494915-1697-4c51-b7a0-2e1f698b7310",2431,"2016-09-29T20:39:46.165257-05:00","73396d90-6532-4944-b1fb-a41c8a52322f_run.xml","ba30d09103ac04311b292fc41c4fc59a","7557d7ca-9063-45e3-9705-8a35c3b72465",354,"2016-09-08T10:39:49.236103-05:00","TCGA-KP-A3VZ","2016-09-02T18:49:37.030059-05:00","female","TCGA-KP-A3VZ_demographic",1941,"white","847fa83d-736f-5a87-a0db-2dfbe7973176","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","KP","821aedb4-8788-5cb9-ae05-e670f0be1f9f","British Columbia Cancer Agency","not reported","c54.1","TCGA-KP-A3VZ_diagnosis","not reported",25366,"alive","8441/3",NA,722,"15ac85f0-1a5c-5f57-8c36-8d0d94fb9c8c","c54.1",-25366,"TCGA-KP-A3VZ_treatment","7ee161da-2958-5ec8-b78d-b2204b1306cb","01","true","TCGA-KP-A3VZ-01A",NA,"f73c1ce5-2813-45b2-951f-8ab539b32988",FALSE,"FF834E31-78F7-4A56-8EC0-E026BE940FD4","Primary Tumor",NA,633,200,NA,1335398400,"11",30,"TCGA-KP-A3VZ-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T10:39:49.236103-05:00",NA,60,NA,10,NA,"TOP",NA,5,NA,"03e30840-a2f5-4309-97d1-8b6a3e2d7a7b",NA,"TCGA-KP-A3VZ-01A-01-TSA",NA,90,NA,"05af429d-e995-4941-9ccc-05ee82c41f6d","RNA","TCGA-KP-A3VZ-01A-11R","171ca5c0-9f8c-4e41-a517-cdf86dfafdcb",1.85,0.16,"UV Spec","R","23","TCGA-KP-A3VZ-01A-11R-A22K-07","0f347f95-e4bc-480e-ab1a-84c9df4018c9",0.16,NA,55,20.7008167413151,163,"5c932d84-d8f1-538a-82b3-a05938e364a1","TCGA-KP-A3VZ_exposure","UNCID_2173160.0f347f95-e4bc-480e-ab1a-84c9df4018c9.130509_UNC10-SN254_0462_AC232JACXX_1_TTAGGC.tar.gz","2013-09-09T11:56:08.000Z","2013-09-09T12:12:01.000Z","73396D90-6532-4944-B1FB-A41C8A52322F","F73C1CE5-2813-45B2-951F-8AB539B32988","Unaligned reads",6247839402,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0F347F95-E4BC-480E-AB1A-84C9DF4018C9","University of North Carolina","56607e72e4b0ca319165088c","6B35A816-F9C4-44D4-9824-5DEE4804B80D","Uterine Corpus Endometrial Carcinoma","TARGZ","05AF429D-E995-4941-9CCC-05EE82C41F6D","2013-09-09T12:12:01.000Z","171CA5C0-9F8C-4E41-A517-CDF86DFAFDCB","Canada","NO",1,NA,"Primary Tumor","British Columbia Cancer Agency",633,"05AF429D-E995-4941-9CCC-05EE82C41F6D",NA,"KP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F48CD35C-BA90-4686-97F7-DCB03EF55CC2.txt",200,"TCGA-KP-A3VZ-01A",NA,NA,"TCGA",2010,NA,NA,"WITH TUMOR","F73C1CE5-2813-45B2-951F-8AB539B32988",69,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F48CD35C-BA90-4686-97F7-DCB03EF55CC2.txt","Alive",NA,"TCGA-KP-A3VZ","NOT HISPANIC OR LATINO",NA,NA,722,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"03E30840-A2F5-4309-97D1-8B6A3E2D7A7B","D5F15C50-E80C-4141-A4DC-7F735385F98C","e048c313fecd53dbdc00f2c02af9accd.bam","TCGA-KP-A3VZ-01A-11",90,0,20,60,5,"TOP",5,10,"TCGA-KP-A3VZ-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-KP-A3VZ",1,"KP","A3VZ","YES","C54.1","8441/3","C54.1","NO","YES",-25366,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",722,NA,NA,NA,"WITH TUMOR","NO",16,7,2012,"NO","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,69,2010,"Office Endometrial Biopsy",NA,NA,NA,"High Grade","RX",NA,NA,NA,NA,NA,"2009",14,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
110402728,106602461,5081237890,"690AC831-7193-4552-91AD-4E157FEF661B.bw","6c2232b2-80ce-4156-a0b4-ffa411b0963e","690ac831-7193-4552-91ad-4e157fef661b","2016-08-25T12:13:38.733527-05:00","UNCID_2581802.4c56a6cc-f912-4b2f-b301-d6a64f211d31.140404_UNC11-SN627_0350_BC3K66ACXX_6_GAGTGG.tar.gz","b82a4799-6c1a-4715-910a-2ef4a21f8343",4899172573,"Illumina HiSeq","7d44f523b1375bee5a48ccd883757011","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:44:38.765384-05:00","2016-05-03T11:55:56.226464-05:00","b82a4799-6c1a-4715-910a-2ef4a21f8343_analysis.xml","6d1908af323a86aeec9f705c9e33fb84","c2dbf26a-d814-4296-af68-e1c10e149863",2124,"2016-08-29T15:02:19.785588-05:00","b82a4799-6c1a-4715-910a-2ef4a21f8343_experiment.xml","46cfbdb7b170900ea26f6335ebcc0da6","b76a2f9d-cf52-4a94-a69a-f798e752d3ce",2628,"2016-09-29T22:45:41.226297-05:00","b82a4799-6c1a-4715-910a-2ef4a21f8343_run.xml","ea01d25abfdafe132abbdea6aa00c283","c380f781-adb2-412f-9251-80d80fb42748",354,"2016-09-08T11:49:14.551030-05:00","TCGA-AJ-A8CT","2016-09-02T18:51:42.083067-05:00","female","TCGA-AJ-A8CT_demographic",1954,"black or african american","dac92b16-78e8-5599-94e2-bf73feae8378","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A8CT_diagnosis","not reported",21515,"alive","8380/3",NA,82,"2e7d9194-0cb7-5ba2-912c-90ac968c8b4d","c54.1",-21515,"TCGA-AJ-A8CT_treatment","b0ad9250-bf04-544e-9cd7-b662617d7bc3","01","false","TCGA-AJ-A8CT-01A",NA,"bfe80d89-f6e6-4ec9-9d0a-8a46ed80082c",FALSE,"67EF8128-8F99-4B19-9B64-9C5E5BD0786F","Primary Tumor",NA,587,60,NA,1384387200,"11",30,"TCGA-AJ-A8CT-01A-11",60,NA,5,NA,20,NA,20,NA,"2016-09-08T11:49:14.551030-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"8c79095b-35c3-40c8-a08a-c624290a3fd1",NA,"TCGA-AJ-A8CT-01A-01-TS1",NA,60,NA,"5ec40098-b09f-454b-9273-a827f433e048","RNA","TCGA-AJ-A8CT-01A-11R","8175c453-7d3c-40f7-b097-c8854e00a08a",1.86,0.18,"UV Spec","R","23","TCGA-AJ-A8CT-01A-11R-A37O-07","4c56a6cc-f912-4b2f-b301-d6a64f211d31",0.18,NA,115,42.2405876951332,165,"08099bbe-9e3f-56f9-923e-e5a72e2eca8c","TCGA-AJ-A8CT_exposure","UNCID_2581802.4c56a6cc-f912-4b2f-b301-d6a64f211d31.140404_UNC11-SN627_0350_BC3K66ACXX_6_GAGTGG.tar.gz","2014-08-15T12:37:04.000Z","2014-08-15T12:54:47.000Z","B82A4799-6C1A-4715-910A-2EF4A21F8343","BFE80D89-F6E6-4EC9-9D0A-8A46ED80082C","Unaligned reads",4899172573,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","4C56A6CC-F912-4B2F-B301-D6A64F211D31","University of North Carolina","56607df2e4b0b37b3d992e09","6C2232B2-80CE-4156-A0B4-FFA411B0963E","Uterine Corpus Endometrial Carcinoma","TARGZ","5EC40098-B09F-454B-9273-A827F433E048","2014-08-15T12:54:47.000Z","8175C453-7D3C-40F7-B097-C8854E00A08A","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",587,"5EC40098-B09F-454B-9273-A827F433E048",NA,"AJ","UNCID_2411619.4c56a6cc-f912-4b2f-b301-d6a64f211d31.sorted_genome_alignments.bam",60,"TCGA-AJ-A8CT-01A",NA,NA,"TCGA",2012,"TCGA-AJ-A8CT_NTE-1",NA,"TUMOR FREE","BFE80D89-F6E6-4EC9-9D0A-8A46ED80082C",58,"nationwidechildrens.org_clinical.TCGA-AJ-A8CT.xml","Alive",NA,"TCGA-AJ-A8CT",NA,"3CC0D211-D498-4548-AB2E-1FC6CE5E418D","NO",82,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",381,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"8C79095B-35C3-40C8-A08A-C624290A3FD1","8175C453-7D3C-40F7-B097-C8854E00A08A","UNCID_2411619.4c56a6cc-f912-4b2f-b301-d6a64f211d31.sorted_genome_alignments.bam","TCGA-AJ-A8CT-01A-11",60,20,5,5,20,"TOP",0,0,"TCGA-AJ-A8CT-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A8CT-F61504_NTE-1",NA,82,"TUMOR FREE","Alive",NA,"TCGA-AJ-A8CT-F61504","TCGA-AJ-A8CT",1,"AJ","A8CT","YES","C54.1","8380/3","C54.1","YES","NO",-21515,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",82,NA,NA,NA,"TUMOR FREE","YES",27,2,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2012,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31855353,31141195,2344022342,"DC01ED1E-6CD8-423D-BFF4-8DC6A657E5F8.bw","6c2a0f37-49cd-4fd0-b126-58b35f9121df","dc01ed1e-6cd8-423d-bff4-8dc6a657e5f8","2016-08-09T14:14:25.979109-05:00","UNCID_2210332.e6322f79-edd2-48f2-9712-82f7153b6e1e.110407_UNC6-RDR300211_00095_FC64GJRAAXX_5.tar.gz","77738a15-02b4-4df3-bdad-f6b11de732ab",2103932916,"Illumina GA","07ccd5da96ad7bc6716ac710535210de","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:03:03.827113-05:00","2016-05-03T11:15:47.420908-05:00","77738a15-02b4-4df3-bdad-f6b11de732ab_analysis.xml","1068b2a51696741269b065780e5ceb2f","13e85703-d585-4094-8df4-0d08b6e4c445",2119,"2016-09-29T20:05:57.146950-05:00","77738a15-02b4-4df3-bdad-f6b11de732ab_experiment.xml","e2446aa6c55311e7fa7094bce215ba38","60b99390-ec1f-498b-8f1b-c54db233d45d",2257,"2016-09-29T20:48:56.499040-05:00","77738a15-02b4-4df3-bdad-f6b11de732ab_run.xml","bfb69d396b98edc9ef9f1d0548e36707","7b10a42d-8321-44ee-9086-78985cbaa752",347,"2016-09-08T11:08:42.271851-05:00","TCGA-BG-A0VX","2016-09-02T18:49:39.353222-05:00","female","TCGA-BG-A0VX_demographic",1950,"white","3eafb5fd-b307-50ba-838d-d8a4921cce6d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0VX_diagnosis","not reported",21425,"alive","8380/3",NA,1043,"d48fb6b3-bc0c-54d1-8b6b-ddcf57e9798e","c54.1",-21425,"TCGA-BG-A0VX_treatment","647fc589-2820-52fb-a2d1-f38ccc26aa32","01","true","TCGA-BG-A0VX-01A",NA,"5797d32b-e482-4af3-b043-ad84c84e0296",FALSE,"D0131F13-2BA5-4B20-8D3D-25743A258C06","Primary Tumor",NA,729,90,NA,1291334400,"11",30,"TCGA-BG-A0VX-01A-11",70,50,25,15,0,10,20,35,"2016-09-08T11:08:42.271851-05:00","2016-09-08T11:08:42.271851-05:00",40,60,30,20,"BOTTOM","TOP",10,5,"7750c886-9e1f-4d9b-96f4-2e11d4297c41","a9f524cf-2ac3-40fb-8d24-61224aea7dc6","TCGA-BG-A0VX-01A-01-BS1","TCGA-BG-A0VX-01A-01-MS1",70,50,"fed382a9-bfab-467d-97e7-b190819f617c","RNA","TCGA-BG-A0VX-01A-11R","6233b0cd-2cb4-4950-90c9-d7daa89f5902",1.88,0.15,"UV Spec","R","23","TCGA-BG-A0VX-01A-11R-A118-07","e6322f79-edd2-48f2-9712-82f7153b6e1e",0.15,NA,157,67.9536011080332,152,"5c62e486-871b-59cb-95bf-a9c874aaee5e","TCGA-BG-A0VX_exposure","UNCID_2210332.e6322f79-edd2-48f2-9712-82f7153b6e1e.110407_UNC6-RDR300211_00095_FC64GJRAAXX_5.tar.gz","2013-10-02T09:26:04.000Z","2013-10-02T09:51:02.000Z","77738A15-02B4-4DF3-BDAD-F6B11DE732AB","5797D32B-E482-4AF3-B043-AD84C84E0296","Unaligned reads",2103932916,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E6322F79-EDD2-48F2-9712-82F7153B6E1E","University of North Carolina","564a3acde4b093830b691356","6C2A0F37-49CD-4FD0-B126-58B35F9121DF","Uterine Corpus Endometrial Carcinoma","TARGZ","FED382A9-BFAB-467D-97E7-B190819F617C","2013-10-02T09:51:02.000Z","6233B0CD-2CB4-4950-90C9-D7DAA89F5902","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",729,"FED382A9-BFAB-467D-97E7-B190819F617C",NA,"BG","22587b16bc331d966404d0216addd5d6.bam.bai",90,"TCGA-BG-A0VX-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","BF328ED4-17DB-45F0-83D5-6A07987D1CDF",58,"nationwidechildrens.org_clinical.TCGA-BG-A0VX.xml","Alive",NA,"TCGA-BG-A0VX","NOT HISPANIC OR LATINO","E11DD91E-F74A-4DB1-A44B-5B471A7CBE82",NA,490,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"CFF9FB17-9431-47B3-8E54-B5F3F26E484C","WHITE",NA,11,30,"A9F524CF-2AC3-40FB-8D24-61224AEA7DC6","F710326C-8A5C-456E-BC43-54552B3393BE","BG-A0VX-01A-11D_BCR3730_2011-09-20_044.fsa","TCGA-BG-A0VX-01A-11",50,10,15,60,35,"TOP",5,20,"TCGA-BG-A0VX-01A-01-MS1",50,NA,NA,NA,"TCGA-BG-A0VX-R34089","External","Primary Tumor Field","TCGA-BG-A0VX-F34087_NTE-1","NO",1043,"TUMOR FREE","Alive",NA,"TCGA-BG-A0VX-F34087","TCGA-BG-A0VX",1,"BG","A0VX","YES","C54.1","8380/3","C54.1","NO","YES",-21425,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",490,NA,NA,NA,"TUMOR FREE","NO",16,3,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2008,"Excisional Biopsy",NA,NA,NA,"G1","RX",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34465765,34130705,2531182837,"332B5EDB-2E8B-4D99-A58E-2DB147D08611.bw","6c526c42-2fb2-4dfa-8a3d-5651dd600ac7","332b5edb-2e8b-4d99-a58e-2db147d08611","2016-08-05T11:35:54.427084-05:00","UNCID_2208066.e9e9ace8-7686-48a6-9e1b-91899268bd11.110624_UNC2-RDR300275_00073_FC70KA5AAXX_3.tar.gz","4f4bea35-f56d-4a42-ad70-7d21430ae343",2158643718,"Illumina GA","404301afeded022857de0c3461aae973","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:49:16.821084-05:00","2016-05-03T11:14:23.404443-05:00","4f4bea35-f56d-4a42-ad70-7d21430ae343_analysis.xml","69340189f1142c7521cf8f8794401627","30e20c7e-2d6c-4e2d-a055-f1253c35bfd5",2119,"2016-08-28T17:43:10.119220-05:00","4f4bea35-f56d-4a42-ad70-7d21430ae343_experiment.xml","0bd2339b71d286e9675b47644d9989b4","15629da0-0847-4ede-9544-5153a1d7e889",2257,"2016-09-29T21:41:40.945933-05:00","4f4bea35-f56d-4a42-ad70-7d21430ae343_run.xml","1b9783db6718484205d097c0bc385864","9bd97961-657c-43c8-8e24-45278ea24869",347,"2016-09-08T11:44:04.151546-05:00","TCGA-D1-A17H","2016-09-02T18:50:39.927528-05:00","female","TCGA-D1-A17H_demographic",1948,"white","d6a3f6e0-9fcc-5add-a7b0-77050a978c56","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17H_diagnosis","not reported",22389,"alive","8380/3",NA,852,"b69f14a4-a7d5-5835-9968-652acdce5769","c54.1",-22389,"TCGA-D1-A17H_treatment","cc6b1ba9-a429-537b-ac64-afef83990274","01","false","TCGA-D1-A17H-01A",NA,"bf526d65-b323-418f-926a-6a0acd8f68e3",FALSE,"E2EBC803-BE77-4936-9B6A-9E6E7E6B8FA4","Primary Tumor",NA,531,230,NA,1294185600,"11",30,"TCGA-D1-A17H-01A-11",60,NA,0,NA,0,NA,40,NA,"2016-09-08T11:44:04.151546-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"41e683a7-63df-4fd4-8688-c3d4e61b9bcb",NA,"TCGA-D1-A17H-01A-01-TS1",NA,60,NA,"fd6a31e2-8218-4841-bb8c-d14e1a2d9b18","RNA","TCGA-D1-A17H-01A-11R","a7c5153f-6cb9-4c4d-8016-1fc451e58a39",1.85,0.16,"UV Spec","R","23","TCGA-D1-A17H-01A-11R-A12I-07","e9e9ace8-7686-48a6-9e1b-91899268bd11",0.16,NA,96,34.4221736168382,167,"bafb79de-8390-5e91-8b2f-4bf53575f0b2","TCGA-D1-A17H_exposure","UNCID_2208066.e9e9ace8-7686-48a6-9e1b-91899268bd11.110624_UNC2-RDR300275_00073_FC70KA5AAXX_3.tar.gz","2013-09-30T08:13:06.000Z","2013-09-30T08:25:01.000Z","4F4BEA35-F56D-4A42-AD70-7D21430AE343","BF526D65-B323-418F-926A-6A0ACD8F68E3","Unaligned reads",2158643718,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E9E9ACE8-7686-48A6-9E1B-91899268BD11","University of North Carolina","564a3eb3e4b093830b6a5204","6C526C42-2FB2-4DFA-8A3D-5651DD600AC7","Uterine Corpus Endometrial Carcinoma","TARGZ","FD6A31E2-8218-4841-BB8C-D14E1A2D9B18","2013-09-30T08:25:01.000Z","A7C5153F-6CB9-4C4D-8016-1FC451E58A39","None","NO",1,NA,"Primary Tumor","Mayo Clinic",531,"FD6A31E2-8218-4841-BB8C-D14E1A2D9B18",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E8A0F2A3-5323-48FE-BE8B-D1782EC2CB1E.txt",230,"TCGA-D1-A17H-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","BF526D65-B323-418F-926A-6A0ACD8F68E3",61,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E8A0F2A3-5323-48FE-BE8B-D1782EC2CB1E.txt","Alive",NA,"TCGA-D1-A17H","NOT HISPANIC OR LATINO","64CCA637-165D-4936-BD20-8819A8ED6DEC",NA,454,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"41E683A7-63DF-4FD4-8688-C3D4E61B9BCB","A7C5153F-6CB9-4C4D-8016-1FC451E58A39","TCGA-D1-A17H-01A-11R-A12H-13_mirna.bam","TCGA-D1-A17H-01A-11",60,0,0,5,40,"TOP",0,0,"TCGA-D1-A17H-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,NA,"NO",852,"TUMOR FREE","Alive",NA,"TCGA-D1-A17H-F20263","TCGA-D1-A17H",1,"D1","A17H","YES","C54.1","8380/3","C54.1","NO","YES",-22389,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",454,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2009,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31630507,31363903,2298706687,"78599DAC-E520-48F9-9B79-7929439DE4E7.bw","6d061ca9-ba7e-4b82-ab3c-34e33f244a54","78599dac-e520-48f9-9b79-7929439de4e7","2016-08-09T14:13:01.417740-05:00","UNCID_2208079.8e075c0e-43b4-48b0-9bdc-b27b6d6568b3.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_8.tar.gz","ab9d9a2a-e52a-4e03-bc86-323ae5511b85",2049693301,"Illumina GA","607f7e889003daad181ff951729dea5b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:50:44.898426-05:00","2016-05-03T11:14:23.412460-05:00","ab9d9a2a-e52a-4e03-bc86-323ae5511b85_analysis.xml","983d6c16823d42640b9253ec6966fbc8","57796578-8259-453a-b52c-d84621d059be",2119,"2016-09-29T18:16:10.660333-05:00","ab9d9a2a-e52a-4e03-bc86-323ae5511b85_experiment.xml","788ce9566fdc18b2571f4e4778ce9dd4","1c0a2663-1f67-4f3f-94e4-1b60e195e1a7",2257,"2016-09-29T19:37:49.068909-05:00","ab9d9a2a-e52a-4e03-bc86-323ae5511b85_run.xml","de486614521c24c239d38bd5be8f819c","4f5c31e8-5706-46d5-9a47-76bcb1ddfd5a",347,"2016-09-08T11:13:01.952994-05:00","TCGA-D1-A176","2016-09-02T18:50:34.181033-05:00","female","TCGA-D1-A176_demographic",1942,"white","93c550da-55b4-5bf1-be9c-bbc05ba86643","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A176_diagnosis","not reported",24521,"alive","8380/3",NA,917,"e673f6da-029d-577f-a452-0853e53851b4","c54.1",-24521,"TCGA-D1-A176_treatment","09de01e2-8c9c-5ffa-814c-be7c2f7fc5e2","01","false","TCGA-D1-A176-01A",NA,"b66b5979-62a1-4938-a655-aeff90d2d472",FALSE,"6F361A45-F13E-44F7-8F3C-00C8B30ACB7A","Primary Tumor",NA,555,100,NA,1294099200,"11",30,"TCGA-D1-A176-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:13:01.952994-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"f3b7fdbb-09f7-46c1-ae8f-6735c1ab0845",NA,"TCGA-D1-A176-01A-01-TSA",NA,70,NA,"db8fe441-8cfc-492e-a93d-51559a1dcf08","RNA","TCGA-D1-A176-01A-11R","58b04258-7308-43f8-a9b2-e0b49984d7dd",1.31,0.17,"UV Spec","R","23","TCGA-D1-A176-01A-11R-A12I-07","8e075c0e-43b4-48b0-9bdc-b27b6d6568b3",0.17,NA,94,33.7050449998207,167,"79e1cf85-12e8-5eed-8b69-d638f855ba0f","TCGA-D1-A176_exposure","UNCID_2208079.8e075c0e-43b4-48b0-9bdc-b27b6d6568b3.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_8.tar.gz","2013-09-30T08:26:04.000Z","2013-09-30T08:39:01.000Z","AB9D9A2A-E52A-4E03-BC86-323AE5511B85","B66B5979-62A1-4938-A655-AEFF90D2D472","Unaligned reads",2049693301,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8E075C0E-43B4-48B0-9BDC-B27B6D6568B3","University of North Carolina","56607732e4b0ec1099f8ccb4","6D061CA9-BA7E-4B82-AB3C-34E33F244A54","Uterine Corpus Endometrial Carcinoma","TARGZ","DB8FE441-8CFC-492E-A93D-51559A1DCF08","2013-09-30T08:39:01.000Z","58B04258-7308-43F8-A9B2-E0B49984D7DD","None","NO",1,NA,"Primary Tumor","Mayo Clinic",555,"DB8FE441-8CFC-492E-A93D-51559A1DCF08",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CF18931D-E2F9-4E89-A78D-93E5DE195854.txt",100,"TCGA-D1-A176-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","B66B5979-62A1-4938-A655-AEFF90D2D472",67,"nationwidechildrens.org_clinical.TCGA-D1-A176.xml","Alive",NA,"TCGA-D1-A176","NOT HISPANIC OR LATINO","90DAFB67-F207-4A10-9D18-832645A498E3",NA,506,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"F3B7FDBB-09F7-46C1-AE8F-6735C1AB0845","94035C7D-6997-4FDB-A460-A61909ECB75D","TCGA-D1-A176-01A-11R-A12H-13_mirna.bam.bai","TCGA-D1-A176-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-D1-A176-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,"NO",917,"TUMOR FREE","Alive",NA,"TCGA-D1-A176-F20248","TCGA-D1-A176",1,"D1","A176","YES","C54.1","8380/3","C54.1","NO","YES",-24521,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",506,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2009,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
111891752,109188588,5156177651,"ED687166-9F07-4BB4-8455-65E2D2F405F8.bw","6d3fdb58-fdc0-4937-ad38-3a455225ea51","ed687166-9f07-4bb4-8455-65e2d2f405f8","2016-08-09T13:14:57.200853-05:00","UNCID_2173001.9c949f30-455e-48a6-ae31-73f26c609ffd.130509_UNC10-SN254_0462_AC232JACXX_7_GTTTCG.tar.gz","27d4a6dd-13eb-4cd0-85d3-9af281d94c7f",5163057062,"Illumina HiSeq","8d46e96b52b4d78a794eb40abe00b078","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:41:07.215777-05:00","2016-05-03T10:55:55.600288-05:00","27d4a6dd-13eb-4cd0-85d3-9af281d94c7f_analysis.xml","4956e7a03cd26c68aef7b0c7d321eddc","7632dc54-a43b-45c9-ab50-4d41f95255f9",2123,"2016-08-13T09:06:17.663514-05:00","27d4a6dd-13eb-4cd0-85d3-9af281d94c7f_experiment.xml","0f79841a82ca0ac5cc3cf161b3404cdc","db9f9411-cd4b-4d1e-986c-c58e942fbd7b",2431,"2016-09-29T20:55:32.726975-05:00","27d4a6dd-13eb-4cd0-85d3-9af281d94c7f_run.xml","aa32d6a687c3b540c541b337f5c182b8","7f3619bd-1b61-4500-bf54-2bf24d0d2780",354,"2016-09-08T11:34:25.730870-05:00","TCGA-AX-A3G8","2016-09-02T18:49:13.429545-05:00","female","TCGA-AX-A3G8_demographic",1934,"white","9f6ec603-0186-5e86-bd95-3ae3fe32682b","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3G8_diagnosis","not reported",27899,"alive","8380/3",NA,30,"55334364-e942-507e-a788-e01c1651b279","c54.1",-27899,"TCGA-AX-A3G8_treatment","a244c19e-ccc7-5b22-a17c-57c6f4d3c426","01","false","TCGA-AX-A3G8-01A",NA,"dfe35835-d03e-4ce3-a76a-fdb15e601257",FALSE,"FD22A233-9333-4DA2-A913-4DBA90600247","Primary Tumor",NA,350,110,NA,1322784000,"11",20,"TCGA-AX-A3G8-01A-11",97,NA,0,NA,0,NA,2,NA,"2016-09-08T11:34:25.730870-05:00",NA,1,NA,0,NA,"TOP",NA,2,NA,"353f1c27-91b6-40bf-a5b3-e8b1abcc2d59",NA,"TCGA-AX-A3G8-01A-01-TS1",NA,96,NA,"bf25511d-d297-4fd3-badd-dd68bbce8c00","RNA","TCGA-AX-A3G8-01A-11R","7a87e942-615c-457e-9aaa-8c0ec070adf7",1.82,0.16,"UV Spec","R","23","TCGA-AX-A3G8-01A-11R-A22K-07","9c949f30-455e-48a6-ae31-73f26c609ffd",0.16,NA,62,25.1531502292182,157,"7d92eebf-0692-5756-bec1-00cd27226776","TCGA-AX-A3G8_exposure","UNCID_2173001.9c949f30-455e-48a6-ae31-73f26c609ffd.130509_UNC10-SN254_0462_AC232JACXX_7_GTTTCG.tar.gz","2013-09-09T05:56:09.000Z","2013-09-09T06:10:01.000Z","27D4A6DD-13EB-4CD0-85D3-9AF281D94C7F","DFE35835-D03E-4CE3-A76A-FDB15E601257","Unaligned reads",5163057062,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","9C949F30-455E-48A6-AE31-73F26C609FFD","University of North Carolina","56607cdee4b0b37b3d99298f","6D3FDB58-FDC0-4937-AD38-3A455225EA51","Uterine Corpus Endometrial Carcinoma","TARGZ","BF25511D-D297-4FD3-BADD-DD68BBCE8C00","2013-09-09T06:10:01.000Z","7A87E942-615C-457E-9AAA-8C0EC070ADF7","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",350,"BF25511D-D297-4FD3-BADD-DD68BBCE8C00",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.208B07DB-EF6D-4B9E-9E76-1F24126FFD67.txt",110,"TCGA-AX-A3G8-01A",NA,NA,"TCGA",2010,NA,NA,NA,"DFE35835-D03E-4CE3-A76A-FDB15E601257",76,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.208B07DB-EF6D-4B9E-9E76-1F24126FFD67.txt","Alive",NA,"TCGA-AX-A3G8",NA,"7CBDDCB5-1102-4C0C-BB1E-568274C96187",NA,36,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,20,"353F1C27-91B6-40BF-A5B3-E8B1ABCC2D59","A7860FAF-5ECB-42BA-A7E6-7FF942794F8C","UNCID_2173001.9c949f30-455e-48a6-ae31-73f26c609ffd.130509_UNC10-SN254_0462_AC232JACXX_7_GTTTCG.tar.gz","TCGA-AX-A3G8-01A-11",97,0,0,1,2,"TOP",2,0,"TCGA-AX-A3G8-01A-01-TS1",96,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3G8-F58291_NTE-1",NA,30,NA,"Alive",NA,"TCGA-AX-A3G8-F58291","TCGA-AX-A3G8",1,"AX","A3G8","YES","C54.1","8380/3","C54.1","NO","YES",-27899,"FEMALE","WHITE",NA,"No","No","Alive",36,NA,NA,NA,NA,"NO",7,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,76,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
114239400,111693932,5326593588,"6E704444-91A5-4DBC-8F7A-07BA3A3CFE61.bw","6f45a2e9-1ca5-438c-b06f-1cd8eb845465","6e704444-91a5-4dbc-8f7a-07ba3a3cfe61","2016-08-06T22:33:55.856732-05:00","UNCID_2173326.73d3142f-9060-488c-9108-3b1abd12f323.130502_UNC12-SN629_0289_AC236KACXX_8_GAGTGG.tar.gz","9b7381b2-a074-4339-bdbd-15ec61225881",5368263311,"Illumina HiSeq","76ebae405602aabdef6c5098d79e28ac","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:38:43.343566-05:00","2016-05-03T10:55:55.610281-05:00","9b7381b2-a074-4339-bdbd-15ec61225881_analysis.xml","88815ee5be716ef20c82c99e66c9f996","9a065c72-89c2-43a1-b57a-dfe9eb5fc7f4",2123,"2016-08-13T04:38:09.545182-05:00","9b7381b2-a074-4339-bdbd-15ec61225881_experiment.xml","ccfb1fd60394314913b6bd985e48f029","426bad3e-a3e1-42fb-a26e-9ef8d5b7fced",2431,"2016-09-29T18:02:51.191246-05:00","9b7381b2-a074-4339-bdbd-15ec61225881_run.xml","35abcaaa0cd9fe233388181e0c32da4d","13ca325d-5a6f-4c15-b084-7b42370ae97b",354,"2016-09-08T11:34:50.710364-05:00","TCGA-AX-A3FX","2016-09-02T18:49:11.556326-05:00","female","TCGA-AX-A3FX_demographic",1940,"white","42ecb87e-7e52-5296-aa28-bafa3f80d30a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3FX_diagnosis","not reported",25260,"dead","8380/3",1333,4,"a1c3f997-b0ef-589d-8be2-28d44d1e2a26","c54.1",-25260,"TCGA-AX-A3FX_treatment","c14178c7-2c26-5cc4-8279-a98e9aa27017","01","false","TCGA-AX-A3FX-01A",NA,"375bec4c-5e9b-4bc0-9f28-5854a159d655",FALSE,"B3326BA1-71E3-4207-9727-B157A3E195E7","Primary Tumor",NA,736,100,NA,1322784000,"11",30,"TCGA-AX-A3FX-01A-11",96,NA,1,NA,5,NA,1,NA,"2016-09-08T11:34:50.710364-05:00",NA,1,NA,0,NA,"TOP",NA,2,NA,"e1d48480-d8f9-461f-8243-68a123363bfc",NA,"TCGA-AX-A3FX-01A-01-TS1",NA,92,NA,"d49772ce-4577-43c4-977a-339b1b1c53e5","RNA","TCGA-AX-A3FX-01A-11R","8b55d7d6-b206-40c4-a7ca-1775e06f7477",1.87,0.17,"UV Spec","R","23","TCGA-AX-A3FX-01A-11R-A22K-07","73d3142f-9060-488c-9108-3b1abd12f323",0.17,NA,85,38.2865636683032,149,"83655193-bc62-51f5-b94d-cb045bb883e4","TCGA-AX-A3FX_exposure","UNCID_2173326.73d3142f-9060-488c-9108-3b1abd12f323.130502_UNC12-SN629_0289_AC236KACXX_8_GAGTGG.tar.gz","2013-09-09T16:36:08.000Z","2013-09-09T16:56:01.000Z","9B7381B2-A074-4339-BDBD-15EC61225881","375BEC4C-5E9B-4BC0-9F28-5854A159D655","Unaligned reads",5368263311,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","73D3142F-9060-488C-9108-3B1ABD12F323","University of North Carolina","564a409fe4b0298dd2ca14b1","6F45A2E9-1CA5-438C-B06F-1CD8EB845465","Uterine Corpus Endometrial Carcinoma","TARGZ","D49772CE-4577-43C4-977A-339B1B1C53E5","2013-09-09T16:56:01.000Z","8B55D7D6-B206-40C4-A7CA-1775E06F7477","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",736,"D49772CE-4577-43C4-977A-339B1B1C53E5",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8BB9A436-20C4-45D9-98BD-FFCAF66C9C8B.txt",100,"TCGA-AX-A3FX-01A",NA,"EA51A083-1FBD-4AB6-B35C-3F176DB5DD98","TCGA",2009,NA,NA,NA,"375BEC4C-5E9B-4BC0-9F28-5854A159D655",69,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8BB9A436-20C4-45D9-98BD-FFCAF66C9C8B.txt","Alive",NA,"TCGA-AX-A3FX","NOT HISPANIC OR LATINO","BFBD14F0-308A-48B9-A2FB-F29C521ED290",NA,4,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"E1D48480-D8F9-461F-8243-68A123363BFC","C8003A54-6023-4826-8BFE-0B85CFC95A91","de4dedead04a9831dcfc2b1affaa3750.bam.bai","TCGA-AX-A3FX-01A-11",96,5,1,1,1,"TOP",2,0,"TCGA-AX-A3FX-01A-01-TS1",92,"Carboplatin/Paclitaxel/Bevacizumab",NA,"TCGA-AX-A3FX-D58284",NA,NA,NA,"TCGA-AX-A3FX-F58283_NTE-2","YES",NA,NA,"Dead",1333,"TCGA-AX-A3FX-F58283","TCGA-AX-A3FX",1,"AX","A3FX","YES","C54.1","8380/3","C54.1","NO","YES",-25260,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",4,NA,NA,NA,NA,"NO",3,2,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2009,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33629438,32893168,2465114357,"ED949E81-873D-4331-A415-9334962C1CD4.bw","6f4f0cdd-8387-45d0-a9e8-efce6260159d","ed949e81-873d-4331-a415-9334962c1cd4","2016-08-06T22:32:14.499664-05:00","UNCID_2209931.1f3910ae-d1c0-4815-836b-25f2926f9258.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_4.tar.gz","0f2973e0-bb34-493e-bc2a-f757bce20496",2271408799,"Illumina GA","1d9fd91394f214d56a1c5dc5274407b7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:01:47.640577-05:00","2016-05-03T11:15:47.413267-05:00","0f2973e0-bb34-493e-bc2a-f757bce20496_analysis.xml","efd6771416929855bc7483ccccf910f6","13205f7f-b932-4680-b21b-2def1db8bac2",2121,"2016-09-29T18:14:43.350629-05:00","0f2973e0-bb34-493e-bc2a-f757bce20496_experiment.xml","7155573fa67e3c6607a61862e1bf727a","1b1ef4c4-cadf-4440-9560-4097ed9308c1",2257,"2016-09-29T19:01:29.152272-05:00","0f2973e0-bb34-493e-bc2a-f757bce20496_run.xml","d4615f50bdd0a291120611a8159bf62c","388999b7-d392-4c80-aea1-bb4bb488ab07",347,"2016-09-08T11:15:24.643885-05:00","TCGA-D1-A17C","2016-09-02T18:50:37.095535-05:00","female","TCGA-D1-A17C_demographic",1932,"white","7510a9b9-dfb5-55c4-98c3-cfbd60e2d6a9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17C_diagnosis","not reported",28571,"alive","8380/3",NA,30,"c37a7f86-46a7-5a73-b85e-db7612e0f0e4","c54.1",-28571,"TCGA-D1-A17C_treatment","2bf2e225-b089-5162-a321-f27fa348557f","01","false","TCGA-D1-A17C-01A",NA,"2d5ac7fc-bed4-4c7f-927d-9b44846324c4",FALSE,"213A073E-C5E1-4BA8-B4D5-23C92E539FA5","Primary Tumor",NA,249,130,NA,1294185600,"11",30,"TCGA-D1-A17C-01A-11",60,NA,3,NA,5,NA,40,NA,"2016-09-08T11:15:24.643885-05:00",NA,5,NA,5,NA,"TOP",NA,0,NA,"7377e706-2022-40a3-86e7-8d49a6a4219c",NA,"TCGA-D1-A17C-01A-01-TS1",NA,55,NA,"d5a30152-40d4-40bc-b90d-c0430bb643bf","RNA","TCGA-D1-A17C-01A-11R","1a664ff5-a753-4401-bb7b-4f0419e1d529",1.77,0.15,"UV Spec","R","23","TCGA-D1-A17C-01A-11R-A12I-07","1f3910ae-d1c0-4815-836b-25f2926f9258",0.15,NA,81,31.2487944137958,161,"7964cb46-e34f-5cbe-a801-52ce36710622","TCGA-D1-A17C_exposure","UNCID_2209931.1f3910ae-d1c0-4815-836b-25f2926f9258.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_4.tar.gz","2013-10-02T02:01:04.000Z","2013-10-02T02:14:02.000Z","0F2973E0-BB34-493E-BC2A-F757BCE20496","2D5AC7FC-BED4-4C7F-927D-9B44846324C4","Unaligned reads",2271408799,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1F3910AE-D1C0-4815-836B-25F2926F9258","University of North Carolina","564a3a47e4b0ef12181a15b1","6F4F0CDD-8387-45D0-A9E8-EFCE6260159D","Uterine Corpus Endometrial Carcinoma","TARGZ","D5A30152-40D4-40BC-B90D-C0430BB643BF","2013-10-02T02:14:02.000Z","1A664FF5-A753-4401-BB7B-4F0419E1D529","None","NO",1,NA,"Primary Tumor","Mayo Clinic",249,"D5A30152-40D4-40BC-B90D-C0430BB643BF",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.1EA520E6-0092-4DEB-992A-8CA0BB2B9B6C.txt",130,"TCGA-D1-A17C-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","2D5AC7FC-BED4-4C7F-927D-9B44846324C4",78,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.1EA520E6-0092-4DEB-992A-8CA0BB2B9B6C.txt","Alive",NA,"TCGA-D1-A17C","NOT HISPANIC OR LATINO","293B32F7-6417-4C7E-82E8-D79BF8F0220F",NA,1,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"7377E706-2022-40A3-86E7-8D49A6A4219C","F97409DC-B489-47C7-8DE8-162793D7C692","TCGA-D1-A17C-01A-11R-A12H-13_mirna.bam.bai","TCGA-D1-A17C-01A-11",60,5,3,5,40,"TOP",0,5,"TCGA-D1-A17C-01A-01-TS1",55,NA,NA,NA,NA,NA,NA,NA,"NO",30,"TUMOR FREE","Alive",NA,"TCGA-D1-A17C-F20302","TCGA-D1-A17C",1,"D1","A17C","YES","C54.1","8380/3","C54.1","NO","YES",-28571,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,78,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
101623310,99048736,4721458098,"009C6A5C-3F63-4925-A92B-2AF54F1A4852.bw","6f661f0d-f08b-486e-8bd7-4306e1593eb9","009c6a5c-3f63-4925-a92b-2af54f1a4852","2016-08-24T12:43:41.953368-05:00","UNCID_2327189.ca1b7ca7-5c8b-442d-ab3d-29bd16de1229.131118_UNC15-SN850_0339_AC347DACXX_4_TTAGGC.tar.gz","3707d40d-4cd1-446d-82b4-b4f2e68b3bc3",4841735686,"Illumina HiSeq","9cd21c7867c16307c8dc341d4fab7e69","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:18:50.881640-05:00","2016-05-03T11:34:55.532339-05:00","3707d40d-4cd1-446d-82b4-b4f2e68b3bc3_analysis.xml","0a2947787edf4c252d1a01023211b60c","fd3499c2-2b82-47d4-9680-6a93c0c4759e",2124,"2016-09-16T17:21:33.283650-05:00","3707d40d-4cd1-446d-82b4-b4f2e68b3bc3_experiment.xml","e1355e372bf5ccbdb9f07401ab5c5c4d","8a4cb1de-26ed-43d6-a208-ce342083e2ed",2628,"2016-09-29T18:32:25.068113-05:00","3707d40d-4cd1-446d-82b4-b4f2e68b3bc3_run.xml","d44565c6a699763ff967e8d2dacab90d","260df7ed-46fd-43e9-b2da-e48ef6edb111",354,"2016-09-08T12:16:04.629796-05:00","TCGA-D1-A2G0","2016-09-02T18:52:33.007755-05:00","female","TCGA-D1-A2G0_demographic",1937,"white","d45a801b-a1cd-51a8-abd6-5b5f4ad4f091","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A2G0_diagnosis","not reported",25573,"alive","8441/3",NA,1484,"3b9ea115-6fd4-5ead-91ad-38a0290e8a50","c54.1",-25573,"TCGA-D1-A2G0_treatment","02674f23-c7f6-5daf-818a-f167d8575e44","01","true","TCGA-D1-A2G0-01A",NA,"134cd317-cbeb-4633-b540-b639454615f7",FALSE,"02872006-6F7E-4FB7-B1C2-1C5DD3199FE3","Primary Tumor",NA,1416,90,NA,1308700800,"11",30,"TCGA-D1-A2G0-01A-11",90,NA,0,NA,10,NA,0,NA,"2016-09-08T12:16:04.629796-05:00",NA,20,NA,10,NA,"TOP",NA,20,NA,"597a1c04-57f6-499a-af5f-4b72214aff21",NA,"TCGA-D1-A2G0-01A-01-TSA",NA,70,NA,"b8209aee-0c7e-48bd-8936-3f1719c868cd","RNA","TCGA-D1-A2G0-01A-11R","a8b9f8ec-e248-4ab6-9bb4-6fd1d240d723",1.79,0.17,"UV Spec","R","23","TCGA-D1-A2G0-01A-11R-A32Y-07","ca1b7ca7-5c8b-442d-ab3d-29bd16de1229",0.17,NA,73,24.9649464792586,171,"a98c4a0a-1da4-5a07-a022-2e1bc468b73f","TCGA-D1-A2G0_exposure","UNCID_2327189.ca1b7ca7-5c8b-442d-ab3d-29bd16de1229.131118_UNC15-SN850_0339_AC347DACXX_4_TTAGGC.tar.gz","2014-01-25T06:12:27.000Z","2014-01-25T06:40:01.000Z","3707D40D-4CD1-446D-82B4-B4F2E68B3BC3","134CD317-CBEB-4633-B540-B639454615F7","Unaligned reads",4841735686,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","CA1B7CA7-5C8B-442D-AB3D-29BD16DE1229","University of North Carolina","564a4068e4b09c884b25db35","6F661F0D-F08B-486E-8BD7-4306E1593EB9","Uterine Corpus Endometrial Carcinoma","TARGZ","B8209AEE-0C7E-48BD-8936-3F1719C868CD","2014-01-25T06:40:01.000Z","A8B9F8EC-E248-4AB6-9BB4-6FD1D240D723","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",1416,"B8209AEE-0C7E-48BD-8936-3F1719C868CD",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.AF037631-DDA4-417C-9104-816BFE0B456F.txt",90,"TCGA-D1-A2G0-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","87CB512B-1C17-4C8C-93DB-7B7E62880924",70,"nationwidechildrens.org_clinical.TCGA-D1-A2G0.xml","Alive",NA,"TCGA-D1-A2G0","NOT HISPANIC OR LATINO","F3146266-2660-4FA3-9505-5B229158C326",NA,107,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"597A1C04-57F6-499A-AF5F-4B72214AFF21","A8B9F8EC-E248-4AB6-9BB4-6FD1D240D723","UNCID_2281141.ca1b7ca7-5c8b-442d-ab3d-29bd16de1229.sorted_genome_alignments.bam","TCGA-D1-A2G0-01A-11",90,10,0,20,0,"TOP",20,10,"TCGA-D1-A2G0-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-D1-A2G0-F41534_NTE-1",NA,1484,NA,"Alive",NA,"TCGA-D1-A2G0-F41534","TCGA-D1-A2G0",1,"D1","A2G0","YES","C54.1","8441/3","C54.1","NO","YES",-25573,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",107,NA,NA,NA,"TUMOR FREE","NO",2,6,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,70,2007,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
42187652,41174514,3071134346,"C3C9CF41-BD87-43B6-A064-E336ABB61CAF.bw","6fa99ae9-1d72-455e-938e-0ec0d240f5a3","c3c9cf41-bd87-43b6-a064-e336abb61caf","2016-08-09T14:10:38.161169-05:00","UNCID_2203676.28e3b0f0-29e2-4726-8e28-c6f5a2275fff.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_5.tar.gz","cc582975-5ed5-4ffe-b475-dcccf55e30fe",2707539897,"Illumina GA","54ef074b68772196eb803d07d1e2fcc4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:34:10.188512-05:00","2016-05-03T11:10:47.515830-05:00","cc582975-5ed5-4ffe-b475-dcccf55e30fe_analysis.xml","7e8a8bc8fd4237b071cdd96f9e0e20f7","4d1a3325-927d-48e7-b1bf-974473564b3b",2121,"2016-08-29T03:29:32.047729-05:00","cc582975-5ed5-4ffe-b475-dcccf55e30fe_experiment.xml","e9bde990fec7f71d622f7e99f707db85","99f947c7-4585-4b43-8d17-0cb05d1f52a8",2257,"2016-09-29T19:34:26.792857-05:00","cc582975-5ed5-4ffe-b475-dcccf55e30fe_run.xml","90babec3096e5b3d3920cc7a0d0e1bfd","4d48d93a-aa83-4a26-a62c-329f6021b2ca",347,"2016-09-08T11:03:40.768745-05:00","TCGA-AX-A2HK","2016-09-02T18:52:30.733342-05:00","female","TCGA-AX-A2HK_demographic",1928,"white","2966ded1-5d55-55d5-a8b6-385a79d36fba","not reported",2005,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HK_diagnosis","not reported",28316,"dead","8380/3",90,NA,"50428742-f7c1-581f-85b2-57306292200f","c54.1",-28316,"TCGA-AX-A2HK_treatment","dd94fa65-56d6-572e-9e15-35e4d93507d3","01","false","TCGA-AX-A2HK-01A",NA,"ebe937b7-b2bf-45b9-8517-009e6f67b6de",FALSE,"DBC5CE66-3BC0-4A86-A53C-06DEF90A752B","Primary Tumor",NA,2045,240,NA,1308182400,"11",30,"TCGA-AX-A2HK-01A-11",96,NA,0,NA,0,NA,2,NA,"2016-09-08T11:03:40.768745-05:00",NA,0,NA,0,NA,"TOP",NA,18,NA,"db601690-3f5a-4087-a921-f599914fdda6",NA,"TCGA-AX-A2HK-01A-01-TSA",NA,88,NA,"be2653dd-c013-4d02-bf20-7b07b37d66fb","RNA","TCGA-AX-A2HK-01A-11R","42783121-9dd8-415b-87e2-97e43b88710e",2.18,0.15,"UV Spec","R","23","TCGA-AX-A2HK-01A-11R-A17B-07","28e3b0f0-29e2-4726-8e28-c6f5a2275fff",0.15,NA,73,30.780907404284,154,"ba4dbc62-3783-5ff5-8a78-38219ff65f27","TCGA-AX-A2HK_exposure","UNCID_2203676.28e3b0f0-29e2-4726-8e28-c6f5a2275fff.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_5.tar.gz","2013-09-26T15:46:05.000Z","2013-09-26T16:00:02.000Z","CC582975-5ED5-4FFE-B475-DCCCF55E30FE","EBE937B7-B2BF-45B9-8517-009E6F67B6DE","Unaligned reads",2707539897,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","28E3B0F0-29E2-4726-8E28-C6F5A2275FFF","University of North Carolina","56607c97e4b0b37b3d992868","6FA99AE9-1D72-455E-938E-0EC0D240F5A3","Uterine Corpus Endometrial Carcinoma","TARGZ","BE2653DD-C013-4D02-BF20-7B07B37D66FB","2013-09-26T16:00:02.000Z","42783121-9DD8-415B-87E2-97E43B88710E","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",2045,"BE2653DD-C013-4D02-BF20-7B07B37D66FB",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.494C2E2E-C337-420E-BBBE-3981C02497AA.txt",240,"TCGA-AX-A2HK-01A",NA,NA,"TCGA",2005,NA,NA,NA,"EBE937B7-B2BF-45B9-8517-009E6F67B6DE",77,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.494C2E2E-C337-420E-BBBE-3981C02497AA.txt","Dead",90,"TCGA-AX-A2HK",NA,"4EFF5D58-632D-45BB-B106-554DDFB0479C",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"DB601690-3F5A-4087-A921-F599914FDDA6","5E6832E5-3ECD-4D29-9125-0BA00930D81D","AX-A2HK-01A-11D_BCR3730_2011-09-21_006.fsa","TCGA-AX-A2HK-01A-11",96,0,0,0,2,"TOP",18,0,"TCGA-AX-A2HK-01A-01-TSA",88,NA,NA,NA,NA,NA,NA,NA,"NO",NA,"WITH TUMOR","Dead",90,"TCGA-AX-A2HK-F31847","TCGA-AX-A2HK",1,"AX","A2HK","YES","C54.1","8380/3","C54.1","NO","YES",-28316,"FEMALE","WHITE",NA,"No","No","Dead",NA,90,NA,NA,NA,"NO",31,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,77,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33632603,32841946,2455817560,"4C2861D1-0E20-476D-B487-03F0712BA159.bw","70b4b353-10d4-49d0-bcc1-855616d8c8cc","4c2861d1-0e20-476d-b487-03f0712ba159","2016-08-09T14:08:07.045574-05:00","UNCID_2203913.aaece63d-8d6f-4048-81e3-d4e7e3706948.111018_UNC2-RDR300275_00092_FC_634BHAAXX_2.tar.gz","9e52ea6c-17a8-484b-b1d9-efac8cf219c8",2175881755,"Illumina GA","b8fe65c0eb365ff76e19416510079200","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:51:01.099923-05:00","2016-05-03T11:10:47.529133-05:00","9e52ea6c-17a8-484b-b1d9-efac8cf219c8_analysis.xml","88b0fba92a46ec83bb67e9be40e1ecdf","57a19c34-1472-4de0-8cc0-344f3af29b9a",2121,"2016-09-30T00:20:00.003007-05:00","9e52ea6c-17a8-484b-b1d9-efac8cf219c8_experiment.xml","8133bb48c002b23cbc5a1b717819d26e","fdf6e5a8-b818-4cc9-a021-9999498a3098",2257,"2016-09-29T18:07:55.321541-05:00","9e52ea6c-17a8-484b-b1d9-efac8cf219c8_run.xml","e8c5c7ac353e9abe9b65ab59cdb60fb0","1703fcf0-d2f1-40aa-a9b5-9ab77912680f",347,"2016-09-08T11:06:33.722288-05:00","TCGA-AJ-A23O","2016-09-02T18:52:36.636061-05:00","female","TCGA-AJ-A23O_demographic",1941,"white","b0f4f234-03f6-5629-b12d-ec4154d1c2b5","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A23O_diagnosis","not reported",25433,"dead","8380/3",312,60,"e017d64b-fd53-5fa0-8344-3a17671f49aa","c54.1",-25433,"TCGA-AJ-A23O_treatment","70502229-873b-5d58-bc64-a2e57732f9d1","01","false","TCGA-AJ-A23O-01A",NA,"b8e857f7-25b5-481d-b374-075138925fb8",FALSE,"4D477218-A4D1-4940-AEF5-D8F46931594C","Primary Tumor",NA,165,120,NA,1303862400,"11",30,"TCGA-AJ-A23O-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:06:33.722288-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"972cfefd-a013-47c2-a77e-661421b5059d",NA,"TCGA-AJ-A23O-01A-01-TSA",NA,70,NA,"c154364f-593f-444a-a485-1058043f9cec","RNA","TCGA-AJ-A23O-01A-11R","1aea1578-1b26-4f11-a832-b1f5a1fb9108",1.93,0.17,"UV Spec","R","23","TCGA-AJ-A23O-01A-11R-A157-07","aaece63d-8d6f-4048-81e3-d4e7e3706948",0.17,NA,60,24.3417582863402,157,"b982828e-e89f-575e-b18c-022a27010534","TCGA-AJ-A23O_exposure","UNCID_2203913.aaece63d-8d6f-4048-81e3-d4e7e3706948.111018_UNC2-RDR300275_00092_FC_634BHAAXX_2.tar.gz","2013-09-26T07:55:03.000Z","2013-09-26T20:08:01.000Z","9E52EA6C-17A8-484B-B1D9-EFAC8CF219C8","B8E857F7-25B5-481D-B374-075138925FB8","Unaligned reads",2175881755,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","AAECE63D-8D6F-4048-81E3-D4E7E3706948","University of North Carolina","56607cb5e4b0b37b3d9928f5","70B4B353-10D4-49D0-BCC1-855616D8C8CC","Uterine Corpus Endometrial Carcinoma","TARGZ","C154364F-593F-444A-A485-1058043F9CEC","2013-09-26T20:08:01.000Z","1AEA1578-1B26-4F11-A832-B1F5A1FB9108","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",165,"C154364F-593F-444A-A485-1058043F9CEC",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3CB29D8C-B588-480C-9C2E-DEA19BC85744.txt",120,"TCGA-AJ-A23O-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","FCC65348-BD3C-4075-911B-7FC893318733",69,"unc.edu.aaece63d-8d6f-4048-81e3-d4e7e3706948.1751989.bt.exon_quantification.txt","Alive",NA,"TCGA-AJ-A23O","NOT HISPANIC OR LATINO","D77F8099-3F04-4E5E-AC9D-D529FF0B62BD",NA,60,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,NA,"WHITE",NA,11,30,"972CFEFD-A013-47C2-A77E-661421B5059D","9C01A295-736C-4781-A3AD-B94EF45274A7","UNCID_2235715.aaece63d-8d6f-4048-81e3-d4e7e3706948.111018_UNC2-RDR300275_00092_FC_634BHAAXX_2.tar.gz","TCGA-AJ-A23O-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-AJ-A23O-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,"NO",NA,NA,"Dead",312,"TCGA-AJ-A23O-F22151","TCGA-AJ-A23O",1,"AJ","A23O","YES","C54.1","8380/3","C54.1","NO","YES",-25433,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",60,NA,NA,NA,"TUMOR FREE","NO",14,7,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33632603,32841875,2455796155,"9AC39CDD-4433-4055-8129-E83279E17451.bw","70b4b353-10d4-49d0-bcc1-855616d8c8cc","9ac39cdd-4433-4055-8129-e83279e17451","2016-08-09T14:18:27.196510-05:00","UNCID_2235715.aaece63d-8d6f-4048-81e3-d4e7e3706948.111018_UNC2-RDR300275_00092_FC_634BHAAXX_2.tar.gz","f50670c9-535c-45b6-8562-d1dda4dcb5b9",2175881755,"Illumina GA","040a4b45750d631009e36cc7bf91c77b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:13:33.579783-05:00","2016-05-03T11:20:13.148190-05:00","f50670c9-535c-45b6-8562-d1dda4dcb5b9_analysis.xml","5acd7bfebd5de1596d6ad42b58be33c4","6553f7d8-e59e-4570-99e4-9f41051ad6ae",2121,"2016-10-07T16:05:19.678905-05:00","f50670c9-535c-45b6-8562-d1dda4dcb5b9_experiment.xml","8133bb48c002b23cbc5a1b717819d26e","cba5d6cc-4fee-4548-a225-319213da631a",2257,"2016-09-29T22:18:19.471756-05:00","f50670c9-535c-45b6-8562-d1dda4dcb5b9_run.xml","e8c5c7ac353e9abe9b65ab59cdb60fb0","b28e3b67-d3ba-47de-8415-ec4e680e22fe",347,"2016-09-08T11:06:33.722288-05:00","TCGA-AJ-A23O","2016-09-02T18:52:36.636061-05:00","female","TCGA-AJ-A23O_demographic",1941,"white","b0f4f234-03f6-5629-b12d-ec4154d1c2b5","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A23O_diagnosis","not reported",25433,"dead","8380/3",312,60,"e017d64b-fd53-5fa0-8344-3a17671f49aa","c54.1",-25433,"TCGA-AJ-A23O_treatment","70502229-873b-5d58-bc64-a2e57732f9d1","01","false","TCGA-AJ-A23O-01A",NA,"b8e857f7-25b5-481d-b374-075138925fb8",FALSE,"4D477218-A4D1-4940-AEF5-D8F46931594C","Primary Tumor",NA,165,120,NA,1303862400,"11",30,"TCGA-AJ-A23O-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:06:33.722288-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"972cfefd-a013-47c2-a77e-661421b5059d",NA,"TCGA-AJ-A23O-01A-01-TSA",NA,70,NA,"c154364f-593f-444a-a485-1058043f9cec","RNA","TCGA-AJ-A23O-01A-11R","1aea1578-1b26-4f11-a832-b1f5a1fb9108",1.93,0.17,"UV Spec","R","23","TCGA-AJ-A23O-01A-11R-A157-07","aaece63d-8d6f-4048-81e3-d4e7e3706948",0.17,NA,60,24.3417582863402,157,"b982828e-e89f-575e-b18c-022a27010534","TCGA-AJ-A23O_exposure","UNCID_2235715.aaece63d-8d6f-4048-81e3-d4e7e3706948.111018_UNC2-RDR300275_00092_FC_634BHAAXX_2.tar.gz","2013-10-19T12:06:05.000Z","2013-10-19T12:19:02.000Z","F50670C9-535C-45B6-8562-D1DDA4DCB5B9","B8E857F7-25B5-481D-B374-075138925FB8","Unaligned reads",2175881755,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","AAECE63D-8D6F-4048-81E3-D4E7E3706948","University of North Carolina","56607cb9e4b0ec1099f8ea52","70B4B353-10D4-49D0-BCC1-855616D8C8CC","Uterine Corpus Endometrial Carcinoma","TARGZ","C154364F-593F-444A-A485-1058043F9CEC","2013-10-19T12:19:02.000Z","1AEA1578-1B26-4F11-A832-B1F5A1FB9108","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",165,"C154364F-593F-444A-A485-1058043F9CEC",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3CB29D8C-B588-480C-9C2E-DEA19BC85744.txt",120,"TCGA-AJ-A23O-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","FCC65348-BD3C-4075-911B-7FC893318733",69,"unc.edu.aaece63d-8d6f-4048-81e3-d4e7e3706948.1751989.bt.exon_quantification.txt","Alive",NA,"TCGA-AJ-A23O","NOT HISPANIC OR LATINO","D77F8099-3F04-4E5E-AC9D-D529FF0B62BD",NA,60,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,NA,"WHITE",NA,11,30,"972CFEFD-A013-47C2-A77E-661421B5059D","9C01A295-736C-4781-A3AD-B94EF45274A7","UNCID_2235715.aaece63d-8d6f-4048-81e3-d4e7e3706948.111018_UNC2-RDR300275_00092_FC_634BHAAXX_2.tar.gz","TCGA-AJ-A23O-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-AJ-A23O-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,"NO",NA,NA,"Dead",312,"TCGA-AJ-A23O-F22151","TCGA-AJ-A23O",1,"AJ","A23O","YES","C54.1","8380/3","C54.1","NO","YES",-25433,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",60,NA,NA,NA,"TUMOR FREE","NO",14,7,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36793931,36537975,2738833296,"3CC5C162-3D4F-46F2-BB1C-616CDF52E2F7.bw","70cdb758-26c9-4c11-a495-0c31cbc84949","3cc5c162-3d4f-46f2-bb1c-616cdf52e2f7","2016-08-09T14:05:05.814999-05:00","UNCID_2195163.64b366d1-dfb2-4488-9fd1-e6b26998bb9d.120307_UNC2-RDR300275_00118_FC_650V8AAXX_3.tar.gz","431573da-a6d8-445f-a741-f947d26ec67d",2369617414,"Illumina GA","b6dab13bf5fae57c24de106f218099f9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:09:57.002855-05:00","2016-05-03T11:07:49.539899-05:00","431573da-a6d8-445f-a741-f947d26ec67d_analysis.xml","7e8a4abbd740180434b9c18e8f8058b1","884ac86c-0e2b-417c-b2b4-a0d14bbb0d80",2121,"2016-08-30T08:24:31.393917-05:00","431573da-a6d8-445f-a741-f947d26ec67d_experiment.xml","100e6873416aa1f0ff5c28e4af3c1edb","22b2bd4e-b66c-4db7-bc9e-d081f10d68c6",2257,"2016-09-29T23:36:27.870197-05:00","431573da-a6d8-445f-a741-f947d26ec67d_run.xml","287abd15404ac9515cbca50f6ecb906c","e3092dd3-eb5e-4602-98a5-a3f5984d0548",347,"2016-09-08T11:14:23.029626-05:00","TCGA-EY-A1GR","2016-09-02T18:51:58.841590-05:00","female","TCGA-EY-A1GR_demographic",1943,"black or african american","eb77bd79-bd4a-5ef4-a359-c918b069e1a3","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GR_diagnosis","not reported",24784,"alive","8380/3",NA,536,"47653fc8-6a4d-5033-aa3d-abf73d9340a4","c54.1",-24784,"TCGA-EY-A1GR_treatment","3c2a2349-2808-5e89-92d7-101c61829ba2","01","false","TCGA-EY-A1GR-01A",NA,"1c1d49ed-4dea-4fd0-9952-393470502e81",FALSE,"1C53C957-1A0A-46AF-A53B-0287683D52F6","Primary Tumor",NA,263,410,NA,1297641600,"11",30,"TCGA-EY-A1GR-01A-11",80,NA,20,NA,0,NA,5,NA,"2016-09-08T11:14:23.029626-05:00",NA,20,NA,40,NA,"TOP",NA,15,NA,"55471289-016f-41e6-a80a-9ef9a4948679",NA,"TCGA-EY-A1GR-01A-01-TSA",NA,80,NA,"8b2737ab-0fd1-4cc4-9c85-c53eff3fcf13","RNA","TCGA-EY-A1GR-01A-11R","9f7bad46-bc95-4028-9ab4-96c89f0435b4",1.8,0.16,"UV Spec","R","23","TCGA-EY-A1GR-01A-11R-A13S-07","64b366d1-dfb2-4488-9fd1-e6b26998bb9d",0.16,NA,93,34.1597796143251,165,"3d762321-0bd7-5d90-89e5-c40873c5ba9f","TCGA-EY-A1GR_exposure","UNCID_2195163.64b366d1-dfb2-4488-9fd1-e6b26998bb9d.120307_UNC2-RDR300275_00118_FC_650V8AAXX_3.tar.gz","2013-09-23T06:36:07.000Z","2013-09-23T06:49:02.000Z","431573DA-A6D8-445F-A741-F947D26EC67D","1C1D49ED-4DEA-4FD0-9952-393470502E81","Unaligned reads",2369617414,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","64B366D1-DFB2-4488-9FD1-E6B26998BB9D","University of North Carolina","564a407ce4b093830b6ae6eb","70CDB758-26C9-4C11-A495-0C31CBC84949","Uterine Corpus Endometrial Carcinoma","TARGZ","8B2737AB-0FD1-4CC4-9C85-C53EFF3FCF13","2013-09-23T06:49:02.000Z","9F7BAD46-BC95-4028-9AB4-96C89F0435B4","United States","NO",1,NA,"Primary Tumor","University of North Carolina",263,"8B2737AB-0FD1-4CC4-9C85-C53EFF3FCF13",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8F1450F5-22BC-4D32-AB5E-5D64396EB05D.txt",410,"TCGA-EY-A1GR-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","1C1D49ED-4DEA-4FD0-9952-393470502E81",67,"HORNS_p_TCGA_b110_113_SNP_N_GenomeWideSNP_6_F10_772376.birdseed.data.txt","Alive",NA,"TCGA-EY-A1GR","NOT HISPANIC OR LATINO","ABDEA264-3027-4EEC-9E35-97C28F275369",NA,344,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"55471289-016F-41E6-A80A-9EF9A4948679","AF03BE9E-F9AE-458D-8EF1-9518E0B0FBC1","TCGA-EY-A1GR-01A-11R-A13R-13_mirna.bam.bai","TCGA-EY-A1GR-01A-11",80,0,20,20,5,"TOP",15,40,"TCGA-EY-A1GR-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,"NO",536,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GR-F19769","TCGA-EY-A1GR",1,"EY","A1GR","YES","C54.1","8380/3","C54.1","YES","NO",-24784,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",344,NA,NA,NA,"TUMOR FREE","NO",19,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
111629734,109341211,5215885554,"FFA5B992-AD5F-4527-B79B-B5EA62721684.bw","7186180a-688a-4fcc-9a67-166eff032e4b","ffa5b992-ad5f-4527-b79b-b5ea62721684","2016-08-05T05:17:40.696308-05:00","UNCID_2173169.1b2609b8-8c1f-4407-aba5-e47f9e83ebb1.130509_UNC10-SN254_0462_AC232JACXX_1_ATCACG.tar.gz","1e2455de-03be-45b5-bff0-a7e22f78d240",5284079739,"Illumina HiSeq","a34d6ada56d03f449adbda9815257ea5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:50:57.258798-05:00","2016-05-03T10:55:55.600288-05:00","1e2455de-03be-45b5-bff0-a7e22f78d240_analysis.xml","635685cb8b32cc669b0189e8dd1779d2","7c5301fe-c690-44d5-9b53-3590f33ecb9e",2123,"2016-08-29T21:15:20.674675-05:00","1e2455de-03be-45b5-bff0-a7e22f78d240_experiment.xml","3c1e950acde627cd65dfdfbd200f79e7","56f6f724-2235-4e92-bb1d-978eab1989a0",2431,"2016-09-29T17:48:39.937486-05:00","1e2455de-03be-45b5-bff0-a7e22f78d240_run.xml","03fc9b590c577b85f89c7872d6c22617","0ad47801-1291-46b7-aa2d-6813f0d3258d",354,"2016-09-08T10:38:18.201708-05:00","TCGA-AJ-A3NH","2016-09-02T18:49:05.490982-05:00","female","TCGA-AJ-A3NH_demographic",1921,"white","5260b2a3-c911-50eb-a9f3-7ab433a02860","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3NH_diagnosis","not reported",32871,"dead","8441/3",310,23,"05fae6e0-105f-517a-8fc6-bcc404aeb97a","c54.1",-32871,"TCGA-AJ-A3NH_treatment","6bd33564-ffec-5150-a2aa-74bb98c49f6f","11","false","TCGA-AJ-A3NH-11A",NA,"6985142f-a646-4b89-a60b-0801a3820bbd",FALSE,NA,"Solid Tissue Normal",NA,67,70,NA,1328054400,"11",30,"TCGA-AJ-A3NH-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T10:38:18.201708-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"c924e0fb-d565-4405-9f30-7e62a679003b",NA,"TCGA-AJ-A3NH-11A-01-TS1",NA,0,NA,"48ee9e7c-777d-4068-96ca-4a3d29d245ff","RNA","TCGA-AJ-A3NH-11A-11R","13646f9c-663b-425a-9ee4-6b98921a13f9",1.85,0.16,"UV Spec","R","23","TCGA-AJ-A3NH-11A-11R-A22K-07","1b2609b8-8c1f-4407-aba5-e47f9e83ebb1",0.16,NA,65,24.7675659198293,162,"c411984a-753e-5855-8855-2fbf4a442b32","TCGA-AJ-A3NH_exposure","UNCID_2173169.1b2609b8-8c1f-4407-aba5-e47f9e83ebb1.130509_UNC10-SN254_0462_AC232JACXX_1_ATCACG.tar.gz","2013-09-09T11:36:08.000Z","2013-09-09T11:57:02.000Z","1E2455DE-03BE-45B5-BFF0-A7E22F78D240","6985142F-A646-4B89-A60B-0801A3820BBD","Unaligned reads",5284079739,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","1B2609B8-8C1F-4407-ABA5-E47F9E83EBB1","University of North Carolina","566073c7e4b0ec1099f8a338","7186180A-688A-4FCC-9A67-166EFF032E4B","Uterine Corpus Endometrial Carcinoma","TARGZ","48EE9E7C-777D-4068-96CA-4A3D29D245FF","2013-09-09T11:57:02.000Z","13646F9C-663B-425A-9EE4-6B98921A13F9","United States","NO",11,NA,"Solid Tissue Normal","International Genomics Conosrtium",67,"48EE9E7C-777D-4068-96CA-4A3D29D245FF",NA,"AJ","2c6fb2fcef38e256722091e4011e7197.bam",70,"TCGA-AJ-A3NH-11A",NA,"1489C5E5-DCF2-4B32-8E18-000BD5A2A6D1","TCGA",2011,NA,NA,"TUMOR FREE","CF1CC9C5-2BEE-478F-A9BF-B786696697B3",90,"TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_G07_1151416.nocnv_hg18.seg.txt","Alive",NA,"TCGA-AJ-A3NH","NOT HISPANIC OR LATINO","AF305DF6-8B78-48C6-B0F4-BD84D5B80CE5",NA,23,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"C924E0FB-D565-4405-9F30-7E62A679003B","C639E0B4-48BB-492D-B1A9-E4ADE80C1C74","2c6fb2fcef38e256722091e4011e7197.bam","TCGA-AJ-A3NH-11A-11",0,100,0,0,0,"TOP",0,0,"TCGA-AJ-A3NH-11A-01-TS1",0,"Taxol","Chemotherapy","TCGA-AJ-A3NH-D46998",NA,NA,NA,"TCGA-AJ-A3NH-F46995_NTE-1","NO",NA,"TUMOR FREE","Dead",310,"TCGA-AJ-A3NH-F46995","TCGA-AJ-A3NH",1,"AJ","A3NH","YES","C54.1","8441/3","C54.1","YES","NO",-32871,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",23,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,90,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
139435642,137173330,6547960984,"966A3A03-3879-4816-A1E9-D805F6018836.bw","7186180a-688a-4fcc-9a67-166eff032e4b","966a3a03-3879-4816-a1e9-d805f6018836","2016-08-09T13:14:53.991747-05:00","UNCID_2173473.1b48e1cd-3c89-4508-9326-7fdd69841776.130502_UNC12-SN629_0289_AC236KACXX_6_GTGAAA.tar.gz","23e417a8-1eba-4862-8c12-5f5681cade0e",6708202697,"Illumina HiSeq","c3eca35c33a9c6be758531a85e23d796","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:20:38.290590-05:00","2016-05-03T10:55:55.610281-05:00","23e417a8-1eba-4862-8c12-5f5681cade0e_analysis.xml","40e4f224345125fb780112db28ddebfd","b3d89765-c308-4660-b353-61277bab2ef2",2123,"2016-09-29T22:46:00.262805-05:00","23e417a8-1eba-4862-8c12-5f5681cade0e_experiment.xml","67272bc822053460c3f836e335bae9ce","c3b6f1f6-30e7-4f9f-a741-2b268d3048a7",2431,"2016-09-29T23:14:26.363303-05:00","23e417a8-1eba-4862-8c12-5f5681cade0e_run.xml","5d9baebcb3ac8a13d1bca424d82a74d1","d56e968c-cfed-4110-8158-25fb352a4f59",354,"2016-09-08T10:38:18.201708-05:00","TCGA-AJ-A3NH","2016-09-02T18:49:05.490982-05:00","female","TCGA-AJ-A3NH_demographic",1921,"white","5260b2a3-c911-50eb-a9f3-7ab433a02860","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3NH_diagnosis","not reported",32871,"dead","8441/3",310,23,"05fae6e0-105f-517a-8fc6-bcc404aeb97a","c54.1",-32871,"TCGA-AJ-A3NH_treatment","6bd33564-ffec-5150-a2aa-74bb98c49f6f","01","false","TCGA-AJ-A3NH-01A",NA,"892763d2-7038-479e-a623-8f56eeab1a27",FALSE,"8FC0BB09-C917-4552-96A4-B4868FD33D27","Primary Tumor",NA,67,130,NA,1328054400,"11",30,"TCGA-AJ-A3NH-01A-11",90,NA,0,NA,10,NA,0,NA,"2016-09-08T10:38:18.201708-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"b274ee56-4edf-412e-85ef-b5a5fa38c32e",NA,"TCGA-AJ-A3NH-01A-01-TSA",NA,90,NA,"46fba282-a9d6-4c2f-ab53-66404b450128","RNA","TCGA-AJ-A3NH-01A-11R","20e95943-8b05-493e-b3b8-c46032de5416",1.86,0.16,"UV Spec","R","23","TCGA-AJ-A3NH-01A-11R-A22K-07","1b48e1cd-3c89-4508-9326-7fdd69841776",0.16,NA,65,24.7675659198293,162,"c411984a-753e-5855-8855-2fbf4a442b32","TCGA-AJ-A3NH_exposure","UNCID_2173473.1b48e1cd-3c89-4508-9326-7fdd69841776.130502_UNC12-SN629_0289_AC236KACXX_6_GTGAAA.tar.gz","2013-09-09T07:56:08.000Z","2013-09-09T20:17:01.000Z","23E417A8-1EBA-4862-8C12-5F5681CADE0E","892763D2-7038-479E-A623-8F56EEAB1A27","Unaligned reads",6708202697,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","1B48E1CD-3C89-4508-9326-7FDD69841776","University of North Carolina","564a3c59e4b093830b69921e","7186180A-688A-4FCC-9A67-166EFF032E4B","Uterine Corpus Endometrial Carcinoma","TARGZ","46FBA282-A9D6-4C2F-AB53-66404B450128","2013-09-09T20:17:01.000Z","20E95943-8B05-493E-B3B8-C46032DE5416","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",67,"46FBA282-A9D6-4C2F-AB53-66404B450128",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.DFCB26A6-1294-4CF4-AB1F-9D6F2773C04C.txt",130,"TCGA-AJ-A3NH-01A",NA,"1489C5E5-DCF2-4B32-8E18-000BD5A2A6D1","TCGA",2011,NA,NA,"TUMOR FREE","CF1CC9C5-2BEE-478F-A9BF-B786696697B3",90,"TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_G07_1151416.nocnv_hg18.seg.txt","Alive",NA,"TCGA-AJ-A3NH","NOT HISPANIC OR LATINO","AF305DF6-8B78-48C6-B0F4-BD84D5B80CE5",NA,23,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"B274EE56-4EDF-412E-85EF-B5A5FA38C32E","A30BD577-BE0A-4385-99CC-E47D77505996","e7e5f967b0649e651a982de624336378.bam.bai","TCGA-AJ-A3NH-01A-11",90,10,0,2,0,"TOP",0,0,"TCGA-AJ-A3NH-01A-01-TSA",90,"Taxol","Chemotherapy","TCGA-AJ-A3NH-D46998",NA,NA,NA,"TCGA-AJ-A3NH-F46995_NTE-1","NO",NA,"TUMOR FREE","Dead",310,"TCGA-AJ-A3NH-F46995","TCGA-AJ-A3NH",1,"AJ","A3NH","YES","C54.1","8441/3","C54.1","YES","NO",-32871,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",23,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,90,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
127871548,125102036,5966118937,"A30AEC39-BF91-4CEB-8B34-6DCAA775BAFA.bw","71ed2681-79bb-4ffb-985c-6d3cf18e9168","a30aec39-bf91-4ceb-8b34-6dcaa775bafa","2016-08-25T22:45:58.290587-05:00","UNCID_2316567.4da7543e-f58a-46f1-bf94-834d4ce4cbff.130909_UNC15-SN850_0327_BD2DT1ACXX_5_AGTTCC.tar.gz","aef1c7ff-ec8a-4716-bfcd-1f06c1e2f963",5862630678,"Illumina HiSeq","e3be5136a432149334219551294650f7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:47:09.940518-05:00","2016-05-03T11:28:50.231867-05:00","aef1c7ff-ec8a-4716-bfcd-1f06c1e2f963_analysis.xml","4e8771a0ce1c058c5a843f7475196c53","09df70cc-820b-40cd-b78c-af17303e5c78",2123,"2016-09-29T19:01:38.070926-05:00","aef1c7ff-ec8a-4716-bfcd-1f06c1e2f963_experiment.xml","2d3cff47f74a2876388be896ebc2ce70","389f8818-b7d2-4a9f-8c2e-57e7b635a23b",2628,"2016-09-29T22:58:55.291770-05:00","aef1c7ff-ec8a-4716-bfcd-1f06c1e2f963_run.xml","41ab013a8f731db8fac973e1cd2a0e41","cb9b2b38-4846-4ed4-a8dc-fe05e3c68dd3",354,"2016-09-08T12:10:59.296049-05:00","TCGA-EO-A1Y7","2016-09-02T18:52:40.740998-05:00","female","TCGA-EO-A1Y7_demographic",1945,"not reported","4197c40d-f4d9-5603-8712-f15525e88cf4","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A1Y7_diagnosis","not reported",24085,"alive","8380/3",NA,1495,"9120f880-1056-59e1-9717-b0e2a63d5702","c54.1",-24085,"TCGA-EO-A1Y7_treatment","43e17df0-a242-5798-bda2-2e6444e243d4","01","false","TCGA-EO-A1Y7-01A",NA,"c27f13ab-69dd-403c-b81e-fc4bc4bfa329",FALSE,"88AABD4B-ECB4-4748-B59F-BD4AE0621BFB","Primary Tumor",NA,196,140,NA,1303862400,"11",30,"TCGA-EO-A1Y7-01A-11",90,NA,8,NA,0,NA,10,NA,"2016-09-08T12:10:59.296049-05:00",NA,4,NA,0,NA,"TOP",NA,0,NA,"b656332d-c763-4425-84c7-a27ee6ebc9a9",NA,"TCGA-EO-A1Y7-01A-01-TSA",NA,90,NA,"62297bfd-57b6-46ef-8877-eadf2734abec","RNA","TCGA-EO-A1Y7-01A-11R","f073313a-a3d4-41f4-970c-9dabc16426c8",1.71,0.17,"UV Spec","R","23","TCGA-EO-A1Y7-01A-11R-A157-07","4da7543e-f58a-46f1-bf94-834d4ce4cbff",0.17,NA,95,34.8943985307622,165,"970213ff-4701-5f50-ab58-1f08c8f3acaa","TCGA-EO-A1Y7_exposure","UNCID_2316567.4da7543e-f58a-46f1-bf94-834d4ce4cbff.130909_UNC15-SN850_0327_BD2DT1ACXX_5_AGTTCC.tar.gz","2014-01-07T09:26:04.000Z","2014-01-07T09:45:03.000Z","AEF1C7FF-EC8A-4716-BFCD-1F06C1E2F963","C27F13AB-69DD-403C-B81E-FC4BC4BFA329","Unaligned reads",5862630678,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","4DA7543E-F58A-46F1-BF94-834D4CE4CBFF","University of North Carolina","564a373fe4b09c884b231771","71ED2681-79BB-4FFB-985C-6D3CF18E9168","Uterine Corpus Endometrial Carcinoma","TARGZ","62297BFD-57B6-46EF-8877-EADF2734ABEC","2014-01-07T09:45:03.000Z","F073313A-A3D4-41F4-970C-9DABC16426C8","Canada","NO",1,NA,"Primary Tumor","University Health Network",196,"62297BFD-57B6-46EF-8877-EADF2734ABEC",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F45FB2AE-1B5C-4470-8986-8E69124A46F2.txt",140,"TCGA-EO-A1Y7-01A",NA,"63F8D45C-03B7-4FC5-A46A-96C948E424A9","TCGA",2010,NA,NA,"TUMOR FREE","FCCB3282-2E43-4B1F-9041-65044A753FBD",65,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F45FB2AE-1B5C-4470-8986-8E69124A46F2.txt","Alive",NA,"TCGA-EO-A1Y7",NA,"CFD9F504-804B-448F-B591-940F2BFA214B",NA,243,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,"1372A0A7-6B53-46D2-BB13-53047695D68B",NA,NA,11,30,"B656332D-C763-4425-84C7-A27EE6EBC9A9","F2C6A783-8AA6-4477-9D5D-8674B8ECAF02","TCGA-EO-A1Y7-01A-11R-A156-13_mirna.bam","TCGA-EO-A1Y7-01A-11",90,0,8,4,10,"TOP",0,0,"TCGA-EO-A1Y7-01A-01-TSA",90,"PORTEC3-radiation alone","Chemotherapy","TCGA-EO-A1Y7-D68568","TCGA-EO-A1Y7-R56551",NA,"Primary Tumor Field",NA,"NO",572,"WITH TUMOR","Alive",NA,"TCGA-EO-A1Y7-F32594","TCGA-EO-A1Y7",1,"EO","A1Y7","YES","C54.1","8380/3","C54.1","NO","YES",-24085,"FEMALE",NA,NA,"No","No","Alive",243,NA,NA,NA,"TUMOR FREE","NO",26,7,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
99969728,96285232,4569710115,"EF184FFA-5DF2-4043-84A0-792C2AC15157.bw","71ed7d6d-8c44-4d37-a04a-7a78df21e514","ef184ffa-5df2-4043-84a0-792c2ac15157","2016-08-09T13:18:11.975415-05:00","UNCID_2177966.8d020165-5475-4257-87c3-c98fc2d201d2.130402_UNC10-SN254_0447_BC22WAACXX_1_GGCTAC.tar.gz","4b690822-eaf4-4121-94c7-6dd0b744e6ba",4159036267,"Illumina HiSeq","488ca0a152535d7fd99efb91dc6597a7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:52:31.336865-05:00","2016-05-03T10:56:47.877475-05:00","4b690822-eaf4-4121-94c7-6dd0b744e6ba_analysis.xml","82da9282dc911f26341e08a6f071670b","0d40061c-3678-4e86-895c-d014a09737bb",2123,"2016-09-29T18:36:18.208686-05:00","4b690822-eaf4-4121-94c7-6dd0b744e6ba_experiment.xml","5e2ee12388331e7b18d17ae1588a972e","2896a0ce-6e3d-4b04-93c1-359be1695792",2431,"2016-09-29T23:06:25.721793-05:00","4b690822-eaf4-4121-94c7-6dd0b744e6ba_run.xml","0f2953232bbdd4437c66680d7d26627b","d0571977-9502-4cc9-90d3-92ba0de37819",354,"2016-09-08T10:43:54.950250-05:00","TCGA-AX-A3G7","2016-09-02T18:48:40.667187-05:00","female","TCGA-AX-A3G7_demographic",1939,"white","ee9641f4-f36d-5742-be0c-130144f39240","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3G7_diagnosis","not reported",26187,"alive","8441/3",NA,9,"12e86155-3dc3-5b54-841e-8d6078c4c32c","c54.1",-26187,"TCGA-AX-A3G7_treatment","90e2a60c-42a3-578d-9176-ab514552434d","01","false","TCGA-AX-A3G7-01A",NA,"b44fab01-7ae7-4628-aea8-0be35ea93180",FALSE,"81608C78-6495-4FC7-9210-1132E9335D01","Primary Tumor",NA,520,50,NA,1322784000,"12",10,"TCGA-AX-A3G7-01A-12",90,NA,0,NA,0,NA,6,NA,"2016-09-08T10:43:54.950250-05:00",NA,6,NA,0,NA,"TOP",NA,5,NA,"2be00a94-4771-4979-ba22-13865aa93c6a",NA,"TCGA-AX-A3G7-01A-01-TS1",NA,89,NA,"9c3978be-6075-4408-a30a-98f2500d7fe4","RNA","TCGA-AX-A3G7-01A-12R","98f01332-1246-43c8-86c7-707d7c303d99",0.35,0.17,"UV Spec","R","23","TCGA-AX-A3G7-01A-12R-A213-07","8d020165-5475-4257-87c3-c98fc2d201d2",0.17,NA,74,31.2025636700961,154,"7bddfbda-b111-5219-a376-22a9d2efb71e","TCGA-AX-A3G7_exposure","UNCID_2177966.8d020165-5475-4257-87c3-c98fc2d201d2.130402_UNC10-SN254_0447_BC22WAACXX_1_GGCTAC.tar.gz","2013-09-11T20:46:08.000Z","2013-09-11T21:00:02.000Z","4B690822-EAF4-4121-94C7-6DD0B744E6BA","B44FAB01-7AE7-4628-AEA8-0BE35EA93180","Unaligned reads",4159036267,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8D020165-5475-4257-87C3-C98FC2D201D2","University of North Carolina","5660762ce4b016715ab68bc4","71ED7D6D-8C44-4D37-A04A-7A78DF21E514","Uterine Corpus Endometrial Carcinoma","TARGZ","9C3978BE-6075-4408-A30A-98F2500D7FE4","2013-09-11T21:00:02.000Z","98F01332-1246-43C8-86C7-707D7C303D99","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",520,"9C3978BE-6075-4408-A30A-98F2500D7FE4",NA,"AX","UNCID_2177966.8d020165-5475-4257-87c3-c98fc2d201d2.130402_UNC10-SN254_0447_BC22WAACXX_1_GGCTAC.tar.gz",50,"TCGA-AX-A3G7-01A",NA,NA,"TCGA",2010,NA,NA,NA,"B44FAB01-7AE7-4628-AEA8-0BE35EA93180",71,"jhu-usc.edu_UCEC.HumanMethylation450.16.lvl-3.TCGA-AX-A3G7-01A-12D-A212-05.txt","Alive",NA,"TCGA-AX-A3G7","NOT HISPANIC OR LATINO","B40EB527-CF0A-44A1-BEDA-1BC1677CB5C7",NA,7,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",201,NA,NA,"WHITE",NA,12,10,"2BE00A94-4771-4979-BA22-13865AA93C6A","C9BCA4F4-AEA9-4F96-8451-4F00BE937AF0","UNCID_2177966.8d020165-5475-4257-87c3-c98fc2d201d2.130402_UNC10-SN254_0447_BC22WAACXX_1_GGCTAC.tar.gz","TCGA-AX-A3G7-01A-12",90,0,0,6,6,"TOP",5,0,"TCGA-AX-A3G7-01A-01-TS1",89,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3G7-F58290_NTE-1",NA,9,NA,"Alive",NA,"TCGA-AX-A3G7-F58290","TCGA-AX-A3G7",1,"AX","A3G7","YES","C54.1","8441/3","C54.1","NO","YES",-26187,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",7,NA,NA,NA,NA,"NO",7,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,71,2010,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34480013,34055873,2530445668,"715C1406-D224-466D-968E-46889824CD3D.bw","71fed998-8fac-4e6b-b38a-22c83e05e958","715c1406-d224-466d-968e-46889824cd3d","2016-08-09T14:17:16.181806-05:00","UNCID_2215035.e2aee7fd-1c60-471a-931d-878805f4a443.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_1.tar.gz","f483b460-8be0-4e61-bfe2-afc041089da1",2189820969,"Illumina GA","88c35fe3112a7692b51af9555b96c93f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:54:28.549094-05:00","2016-05-03T11:17:14.878442-05:00","f483b460-8be0-4e61-bfe2-afc041089da1_analysis.xml","710c61ed8cfd925db3457c080238a1fb","59c1a808-ab27-47d6-aec5-e5438f1a1ab5",2122,"2016-09-29T20:21:46.196420-05:00","f483b460-8be0-4e61-bfe2-afc041089da1_experiment.xml","595d4d6993d7945377fccb3754810ef0","6a536d56-23fd-435e-88f6-4e211eec86cd",2256,"2016-09-29T21:19:29.079545-05:00","f483b460-8be0-4e61-bfe2-afc041089da1_run.xml","6c9a195b4abd20ce923b1d508389bbc3","8e37d3dc-3749-45a6-90e7-175595af263f",345,"2016-09-08T10:52:23.301678-05:00","TCGA-A5-A0GA","2016-09-02T18:53:59.095966-05:00","female","TCGA-A5-A0GA_demographic",1939,"white","e2c8cc50-bd74-513f-b812-c01b1b9600c2","not hispanic or latino",2007,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GA_diagnosis","not reported",24659,"dead","8380/3",543,NA,"7f059916-7f28-518d-b3d2-39ba89ce94e7","c54.1",-24659,"TCGA-A5-A0GA_treatment","ac03b65f-d0a6-58ea-94c5-b90bfb3cf6aa","01","true","TCGA-A5-A0GA-01A",NA,"5a40330f-9307-4584-9557-5d19f2357fcc",FALSE,"36A4F391-2F46-4896-8E53-223202E42A38","Primary Tumor",NA,1312,320,NA,1275955200,"11",30,"TCGA-A5-A0GA-01A-11",75,85,0,0,0,0,20,10,"2016-09-08T10:52:23.301678-05:00","2016-09-08T10:52:23.301678-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"ccc5cffb-765f-4598-9843-6888c43713ba","6074334a-089d-41ec-870e-99a99f7cf87b","TCGA-A5-A0GA-01A-01-TSA","TCGA-A5-A0GA-01A-01-BSA",80,90,"d9fd6b09-8433-4697-a016-df0dee27ee99","RNA","TCGA-A5-A0GA-01A-11R","7f1d06d7-0081-4aa7-a1b5-d0007ee6bde2",1.85,0.16,"UV Spec","R","23","TCGA-A5-A0GA-01A-11R-A040-07","e2aee7fd-1c60-471a-931d-878805f4a443",0.16,NA,90,31.1418685121107,170,"57c9a56a-67a1-5ab7-9982-2a578db11fdb","TCGA-A5-A0GA_exposure","UNCID_2215035.e2aee7fd-1c60-471a-931d-878805f4a443.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_1.tar.gz","2013-10-03T23:37:04.000Z","2013-10-03T23:50:02.000Z","F483B460-8BE0-4E61-BFE2-AFC041089DA1","5A40330F-9307-4584-9557-5D19F2357FCC","Unaligned reads",2189820969,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E2AEE7FD-1C60-471A-931D-878805F4A443","University of North Carolina","56607470e4b0ec1099f8ac5a","71FED998-8FAC-4E6B-B38A-22C83E05E958","Uterine Corpus Endometrial Carcinoma","TARGZ","D9FD6B09-8433-4697-A016-DF0DEE27EE99","2013-10-03T23:50:02.000Z","7F1D06D7-0081-4AA7-A1B5-D0007EE6BDE2","None","NO",1,NA,"Primary Tumor","Cedars Sinai",1312,"D9FD6B09-8433-4697-A016-DF0DEE27EE99",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.4FCEC56D-45CE-420A-868B-3726F1CC9347.txt",320,"TCGA-A5-A0GA-01A",NA,"9658C911-2106-4B8F-9441-E5CE11892CA0","TCGA",2006,NA,NA,"WITH TUMOR","FAE7E73A-D9EF-4A6F-807E-A46A46C29179",67,"nationwidechildrens.org_clinical.TCGA-A5-A0GA.xml","Dead",543,"TCGA-A5-A0GA","NOT HISPANIC OR LATINO","47343D22-1C53-46DE-AE33-14B5A65EF584",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"CCC5CFFB-765F-4598-9843-6888C43713BA","E8050DAE-A47D-4C8C-91EC-73DC299F0B8B","US82800149_251976012236_S01_GE2_105_Dec08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","TCGA-A5-A0GA-01A-11",85,0,0,0,10,"BOTTOM",0,0,"TCGA-A5-A0GA-01A-01-BSA",90,"Doxil","Chemotherapy","TCGA-A5-A0GA-D3152",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",543,"TCGA-A5-A0GA-F3146","TCGA-A5-A0GA",1,"A5","A0GA","YES","C54.1","8380/3","C54.1","NO","YES",-24659,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,543,NA,NA,"WITH TUMOR","NO",13,9,2010,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2006,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
27328673,26816231,2015900456,"0ADE6D62-9254-4D7C-84BD-2581B0F5524B.bw","734ef97f-807c-480e-8df9-feaf041032d2","0ade6d62-9254-4d7c-84bd-2581b0f5524b","2016-08-31T13:31:24.620286-05:00","UNCID_2214868.7fc96ce5-b529-4d89-8b27-5f8ba4e301e9.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_8.tar.gz","44aeff9f-71fd-4c49-9655-795860f4c30a",1704839608,"Illumina GA","4f4cae28653a6daf428c76bd515395e3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:26:42.851086-05:00","2016-05-03T11:17:14.905409-05:00","44aeff9f-71fd-4c49-9655-795860f4c30a_analysis.xml","448fb72cbaca7561f0de08bbface0dc9","22964069-dd01-410f-8b3a-3d5104673936",2120,"2016-09-29T20:19:57.734248-05:00","44aeff9f-71fd-4c49-9655-795860f4c30a_experiment.xml","4479716ede61a1917a8551edc505be42","692e015b-f642-4760-94d5-ddf4381c0e2f",2256,"2016-09-29T19:21:55.210574-05:00","44aeff9f-71fd-4c49-9655-795860f4c30a_run.xml","ca3878f818acdc63bc6262c765cac89a","4582c226-0f8d-4fcc-a691-4442a2884166",345,"2016-09-08T10:43:49.931913-05:00","TCGA-BG-A0MO","2016-09-02T18:54:49.447179-05:00","female","TCGA-BG-A0MO_demographic",1945,"white","ca39bf6f-6549-5d17-ae60-15dde3f5a32d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MO_diagnosis","not reported",23287,"alive","8380/3",NA,1309,"b05be386-4150-55a8-870e-6501f1517364","c54.1",-23287,"TCGA-BG-A0MO_treatment","1b233bee-34f2-552a-b0e1-5eb8ce1e039f","01","true","TCGA-BG-A0MO-01A",NA,"7582cbb9-42d3-496c-991d-d76bea4c434c",FALSE,"C120AC98-36D2-49AD-84A1-6EA168D2A2BA","Primary Tumor",NA,854,100,NA,1279065600,"11",30,"TCGA-BG-A0MO-01A-11",97,96,0,0,0,0,3,6,"2016-09-08T10:43:49.931913-05:00","2016-09-08T10:43:49.931913-05:00",1,2,0,0,"TOP","BOTTOM",1,4,"733bb672-8d01-40d9-acac-a6cffeef158c","933efb7e-8d38-4641-94a3-66af9061b625","TCGA-BG-A0MO-01A-01-TSA","TCGA-BG-A0MO-01A-01-BSA",96,90,"da7a3351-4324-49d7-95a2-c9cf0a47860d","RNA","TCGA-BG-A0MO-01A-11R","b3f6d7dc-2218-4458-876b-8e48478f438b",1.82,0.13,"UV Spec","R","23","TCGA-BG-A0MO-01A-11R-A040-07","7fc96ce5-b529-4d89-8b27-5f8ba4e301e9",0.13,NA,83,32.421875,160,"39b5cde9-6df1-52b6-b23b-f7226152baa2","TCGA-BG-A0MO_exposure","UNCID_2214868.7fc96ce5-b529-4d89-8b27-5f8ba4e301e9.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_8.tar.gz","2013-10-03T21:56:05.000Z","2013-10-03T22:08:03.000Z","44AEFF9F-71FD-4C49-9655-795860F4C30A","7582CBB9-42D3-496C-991D-D76BEA4C434C","Unaligned reads",1704839608,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7FC96CE5-B529-4D89-8B27-5F8BA4E301E9","University of North Carolina","5660749ae4b018727fe9f4dd","734EF97F-807C-480E-8DF9-FEAF041032D2","Uterine Corpus Endometrial Carcinoma","TARGZ","DA7A3351-4324-49D7-95A2-C9CF0A47860D","2013-10-03T22:08:03.000Z","B3F6D7DC-2218-4458-876B-8E48478F438B","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",854,"DA7A3351-4324-49D7-95A2-C9CF0A47860D",NA,"BG","UNCID_2214868.7fc96ce5-b529-4d89-8b27-5f8ba4e301e9.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_8.tar.gz",100,"TCGA-BG-A0MO-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","CA5DBD05-F91F-440B-B947-D0A060272E78",63,"nationwidechildrens.org_clinical.TCGA-BG-A0MO.xml","Alive",NA,"TCGA-BG-A0MO","NOT HISPANIC OR LATINO","E5CEE0F3-8BC4-46CE-864A-D2E320D6E8A8",NA,1021,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"973DB22E-D1A7-42E2-B4DE-2CD375EAB3D1","WHITE",NA,11,30,"733BB672-8D01-40D9-ACAC-A6CFFEEF158C","94A644D9-97A9-4F2A-BA1C-0BA73216B165","MODEM_p_TCGAb59_SNP_N_GenomeWideSNP_6_C02_680586.tangent.copynumber.data.txt","TCGA-BG-A0MO-01A-11",96,0,0,2,6,"BOTTOM",4,0,"TCGA-BG-A0MO-01A-01-BSA",90,NA,NA,NA,"TCGA-BG-A0MO-R4629","IMPLANTS","Primary Tumor Field",NA,"NO",1309,"TUMOR FREE","Alive",NA,"TCGA-BG-A0MO-F19273","TCGA-BG-A0MO",1,"BG","A0MO","YES","C54.1","8380/3","C54.1","NO","YES",-23287,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1021,NA,NA,NA,"TUMOR FREE","NO",9,12,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2008,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33808751,33451030,2503791658,"62E16838-7D5D-4B10-9599-0E2DF135B1CE.bw","73a0dd38-115d-48fb-b683-04aa5d612f2a","62e16838-7d5d-4b10-9599-0e2df135b1ce","2016-08-09T14:15:36.505834-05:00","UNCID_2209913.e500f620-089f-4e15-ba8c-25c91e88e7e2.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_8.tar.gz","974ce887-f6bf-4aa8-b69d-b9f6e5e3e5bc",2265872580,"Illumina GA","6df99ef856d35ef29bd440e050cf3e4d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:48:27.026040-05:00","2016-05-03T11:15:47.413267-05:00","974ce887-f6bf-4aa8-b69d-b9f6e5e3e5bc_analysis.xml","49157ff0599f2f7e984336d28047739f","ea8199b8-ad23-4422-a297-c285d087f2fe",2121,"2016-10-07T15:49:07.086310-05:00","974ce887-f6bf-4aa8-b69d-b9f6e5e3e5bc_experiment.xml","334a61bb812269b3e53506cdef3991c7","e9ee37c9-63ac-4f28-acae-27c8b6b9f72d",2257,"2016-09-29T21:30:53.777142-05:00","974ce887-f6bf-4aa8-b69d-b9f6e5e3e5bc_run.xml","fc06c6e01c84508fbd2c1f48faaddf1a","954ab29a-94a6-4a67-bda4-2b4aecff0141",347,"2016-09-08T11:04:26.559388-05:00","TCGA-D1-A17R","2016-09-02T18:50:44.145317-05:00","female","TCGA-D1-A17R_demographic",1951,"white","19d4a3c9-de61-5c42-b9fa-c1f83f34a08c","not hispanic or latino",2009,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17R_diagnosis","not reported",21382,"dead","8380/3",339,NA,"38409ad3-77ba-53f6-951c-92fc23d78067","c54.1",-21382,"TCGA-D1-A17R_treatment","5c57bd8f-8573-569b-81a6-b92af2efa9b8","01","false","TCGA-D1-A17R-01A",NA,"205de3e7-b078-4904-82c3-3d0f757d94a8",FALSE,"51598364-A609-4EBC-8500-53042C9E79E9","Primary Tumor",NA,443,150,NA,1294358400,"11",30,"TCGA-D1-A17R-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:04:26.559388-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"d292545c-33f3-4a6c-8733-9ad31ee5b43d",NA,"TCGA-D1-A17R-01A-01-TSA",NA,100,NA,"bbf8f7ac-bebb-4104-919e-c26b7afab238","RNA","TCGA-D1-A17R-01A-11R","718bd3a2-73ba-431b-8839-21ae908383d9",1.76,0.17,"UV Spec","R","23","TCGA-D1-A17R-01A-11R-A12I-07","e500f620-089f-4e15-ba8c-25c91e88e7e2",0.17,NA,126,46.2809917355372,165,"894c1492-59af-526b-9cdd-08fd4188f1b1","TCGA-D1-A17R_exposure","UNCID_2209913.e500f620-089f-4e15-ba8c-25c91e88e7e2.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_8.tar.gz","2013-10-02T01:43:03.000Z","2013-10-02T01:56:03.000Z","974CE887-F6BF-4AA8-B69D-B9F6E5E3E5BC","205DE3E7-B078-4904-82C3-3D0F757D94A8","Unaligned reads",2265872580,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E500F620-089F-4E15-BA8C-25C91E88E7E2","University of North Carolina","56607757e4b0ca319164e539","73A0DD38-115D-48FB-B683-04AA5D612F2A","Uterine Corpus Endometrial Carcinoma","TARGZ","BBF8F7AC-BEBB-4104-919E-C26B7AFAB238","2013-10-02T01:56:03.000Z","718BD3A2-73BA-431B-8839-21AE908383D9","None","NO",1,NA,"Primary Tumor","Mayo Clinic",443,"BBF8F7AC-BEBB-4104-919E-C26B7AFAB238",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B75B6784-2F5F-4900-8541-D7AD05DA5233.txt",150,"TCGA-D1-A17R-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","3F4549BD-550F-4E11-B0F0-D08C43DB73D9",58,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B75B6784-2F5F-4900-8541-D7AD05DA5233.txt","Dead",339,"TCGA-D1-A17R","NOT HISPANIC OR LATINO","0B835CB6-369E-40A1-A82A-7D0761CAED2A",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"D292545C-33F3-4A6C-8733-9AD31EE5B43D","718BD3A2-73BA-431B-8839-21AE908383D9","UNCID_2209913.e500f620-089f-4e15-ba8c-25c91e88e7e2.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_8.tar.gz","TCGA-D1-A17R-01A-11",80,0,0,0,0,"TOP",0,0,"TCGA-D1-A17R-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",NA,"TUMOR FREE","Dead",339,"TCGA-D1-A17R-F20285","TCGA-D1-A17R",1,"D1","A17R","YES","C54.1","8380/3","C54.1","NO","YES",-21382,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,339,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
22306608,22165254,1647903361,"DB0E8DA9-5249-4EB4-AB2A-78889B8CA9A8.bw","73e5310d-ba8c-4cbc-aa4f-e06206f898f4","db0e8da9-5249-4eb4-ab2a-78889b8ca9a8","2016-08-05T19:26:05.256511-05:00","UNCID_2214811.174acfe1-d3ab-4912-9d05-7aa598ae1add.101124_UNC4-RDR3001561_00054_FC_62FKEAAXX_8.tar.gz","de8a06e2-e610-44ba-96a3-80578046d7e3",1302220621,"Illumina GA","a6a82d87f80a87cd7092b4ff4fb3e869","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:48:15.212101-05:00","2016-05-03T11:17:14.905409-05:00","de8a06e2-e610-44ba-96a3-80578046d7e3_analysis.xml","ec30829778b1440c8bb177e979590d34","7aa1504d-c08b-4cd0-a920-3210b4a39ca1",2121,"2016-09-29T23:05:01.185101-05:00","de8a06e2-e610-44ba-96a3-80578046d7e3_experiment.xml","e4f8850422c6d4a0ca3d501306cdf007","cf67b546-dac9-4526-acb7-1af439beea19",2256,"2016-09-29T18:20:27.775213-05:00","de8a06e2-e610-44ba-96a3-80578046d7e3_run.xml","bd515cd3212a19eea10d336875b6ff87","1e9bbb32-a480-4614-9fc1-f55aa9e4dfcc",345,"2016-09-08T12:01:38.341716-05:00","TCGA-BG-A0M4","2016-09-02T18:48:03.930479-05:00","female","TCGA-BG-A0M4_demographic",1948,"white","ab7c810e-febe-5caa-a6c2-35ad0f421909","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0M4_diagnosis","not reported",22090,"alive","8380/3",NA,2167,"004d6366-8402-56fe-9858-7f1ba606f8af","c54.1",-22090,"TCGA-BG-A0M4_treatment","d44800d0-ae7d-5d29-bf22-b525a69afea8","01","true","TCGA-BG-A0M4-01A",NA,"e6e7e411-45cf-47a1-bcf0-7ae800a61a8d",FALSE,"95002D96-C9D8-43BE-ADD1-072E93994194","Primary Tumor",NA,643,240,NA,1280188800,"11",30,"TCGA-BG-A0M4-01A-11",90,75,0,0,0,0,0,0,"2016-09-08T12:01:38.341716-05:00","2016-09-08T12:01:38.341716-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"d55ae170-f484-4250-b370-8b3c870a3188","edd32c29-b009-4fb1-8d4d-03b66a7cb54a","TCGA-BG-A0M4-01A-01-BSA","TCGA-BG-A0M4-01A-01-TSA",100,100,"ad7e9453-5f1f-4ef1-94d4-d818b381427a","RNA","TCGA-BG-A0M4-01A-11R","6d44bf6f-167b-4e10-add1-0cf6454cc130",1.88,0.15,"UV Spec","R","23","TCGA-BG-A0M4-01A-11R-A104-07","174acfe1-d3ab-4912-9d05-7aa598ae1add",0.15,NA,97,30.6148213609393,178,"868a17f8-aa1e-5dd2-a482-4737c90005cb","TCGA-BG-A0M4_exposure","UNCID_2214811.174acfe1-d3ab-4912-9d05-7aa598ae1add.101124_UNC4-RDR3001561_00054_FC_62FKEAAXX_8.tar.gz","2013-10-03T21:31:04.000Z","2013-10-03T21:43:02.000Z","DE8A06E2-E610-44BA-96A3-80578046D7E3","E6E7E411-45CF-47A1-BCF0-7AE800A61A8D","Unaligned reads",1302220621,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","174ACFE1-D3AB-4912-9D05-7AA598AE1ADD","University of North Carolina","56607cd7e4b016715ab6b443","73E5310D-BA8C-4CBC-AA4F-E06206F898F4","Uterine Corpus Endometrial Carcinoma","TARGZ","AD7E9453-5F1F-4EF1-94D4-D818B381427A","2013-10-03T21:43:02.000Z","6D44BF6F-167B-4E10-ADD1-0CF6454CC130","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",643,"AD7E9453-5F1F-4EF1-94D4-D818B381427A",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.57311FA8-C83F-4B62-8310-BE9A12E10B2E.txt",240,"TCGA-BG-A0M4-01A",NA,"F2FE21B4-B4FE-4F9F-A5B8-80252A9A192F","TCGA",2008,NA,NA,"TUMOR FREE","E6E7E411-45CF-47A1-BCF0-7AE800A61A8D",60,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.57311FA8-C83F-4B62-8310-BE9A12E10B2E.txt","Alive",NA,"TCGA-BG-A0M4","NOT HISPANIC OR LATINO","7652B604-770C-4A91-B67E-B04DE9465AE9",NA,480,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,11,30,"EDD32C29-B009-4FB1-8D4D-03B66A7CB54A","F028CD8C-332F-4FAF-A45C-6B5392C7669B","TCGA-BG-A0M4-01A-11R-A103-13_mirna.bam.bai","TCGA-BG-A0M4-01A-11",90,0,0,0,0,"BOTTOM",0,0,"TCGA-BG-A0M4-01A-01-BSA",100,"TAXOL","Chemotherapy","TCGA-BG-A0M4-D4431",NA,NA,NA,"TCGA-BG-A0M4-F71768_NTE-1","NO",2167,"TUMOR FREE","Alive",NA,"TCGA-BG-A0M4-F71768","TCGA-BG-A0M4",1,"BG","A0M4","YES","C54.1","8380/3","C54.1","YES","NO",-22090,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",480,NA,NA,NA,"TUMOR FREE","NO",1,12,2010,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2008,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36479910,35730079,2675308277,"C4438C6E-8920-482D-A4A9-84FDB3EDBF21.bw","7427f9e8-1140-45fd-9613-78b72b13a7ba","c4438c6e-8920-482d-a4a9-84fdb3edbf21","2016-08-09T14:14:54.841993-05:00","UNCID_2211025.ba50902a-fcf9-4023-bdbc-3e7d61c7011b.110316_UNC2-RDR300275_00058_FC_62J26AAXX_8.tar.gz","b84beeac-cdda-48c9-92d7-5167da6a10c2",2298967734,"Illumina GA","480ee87b6abe40345cfa7382720edc9f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:07:35.228583-05:00","2016-05-03T11:15:47.420908-05:00","b84beeac-cdda-48c9-92d7-5167da6a10c2_analysis.xml","6b83877bae09e55123b47ad58a8774a9","d1170e24-31e8-436a-b1b7-783c1c63f3bd",2121,"2016-09-29T18:23:18.355780-05:00","b84beeac-cdda-48c9-92d7-5167da6a10c2_experiment.xml","885514b1097c83bbba67896a4c8b020f","20763a89-7e52-4fea-9795-41f0194b89a6",2257,"2016-09-29T18:23:16.345736-05:00","b84beeac-cdda-48c9-92d7-5167da6a10c2_run.xml","e0d2f65fa83c81fda71b1c2f711a25ea","206fdb6a-046a-41f1-b785-93a0e1e83667",347,"2016-09-08T10:46:05.413603-05:00","TCGA-D1-A103","2016-09-02T18:49:15.960322-05:00","female","TCGA-D1-A103_demographic",1922,"white","d93c3f44-61a7-53ce-9bd8-a934eb81d151","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A103_diagnosis","not reported",31841,"alive","8380/3",NA,669,"9667b64a-e27e-5ad8-8da6-b356444005ba","c54.1",-31841,"TCGA-D1-A103_treatment","1ec1ddde-d7ec-581b-9c2b-532e10d6cb8f","01","false","TCGA-D1-A103-01A",NA,"7430a6c2-758a-4a56-8168-865b3463c2db",FALSE,"AE2FAD3D-FA6A-4648-90A5-2D2C442796AF","Primary Tumor",NA,376,170,NA,1290384000,"11",30,"TCGA-D1-A103-01A-11",70,80,0,30,0,0,15,15,"2016-09-08T10:46:05.413603-05:00","2016-09-08T10:46:05.413603-05:00",0,40,0,20,"BOTTOM","TOP",0,5,"57f8c7b7-1aa4-4149-9ef4-4afc7a2b1f74","5138d46f-c062-4c3a-a189-7b405daa0956","TCGA-D1-A103-01A-01-BS1","TCGA-D1-A103-01A-01-MS1",85,80,"af6dd9d7-ef2b-453c-9bd2-58ae872b7249","RNA","TCGA-D1-A103-01A-11R","720759a9-4304-47dc-b34b-7e7178aca1e4",1.78,0.16,"UV Spec","R","23","TCGA-D1-A103-01A-11R-A10J-07","ba50902a-fcf9-4023-bdbc-3e7d61c7011b",0.16,NA,60,26.6666666666667,150,"a829be73-7cd9-5b5b-939d-4b3935060946","TCGA-D1-A103_exposure","UNCID_2211025.ba50902a-fcf9-4023-bdbc-3e7d61c7011b.110316_UNC2-RDR300275_00058_FC_62J26AAXX_8.tar.gz","2013-10-02T07:46:04.000Z","2013-10-02T07:59:02.000Z","B84BEEAC-CDDA-48C9-92D7-5167DA6A10C2","7430A6C2-758A-4A56-8168-865B3463C2DB","Unaligned reads",2298967734,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","BA50902A-FCF9-4023-BDBC-3E7D61C7011B","University of North Carolina","56607900e4b0ca319164ef20","7427F9E8-1140-45FD-9613-78B72B13A7BA","Uterine Corpus Endometrial Carcinoma","TARGZ","AF6DD9D7-EF2B-453C-9BD2-58AE872B7249","2013-10-02T07:59:02.000Z","720759A9-4304-47DC-B34B-7E7178ACA1E4","None","NO",1,NA,"Primary Tumor","Mayo Clinic",376,"AF6DD9D7-EF2B-453C-9BD2-58AE872B7249",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.93FD8223-7024-4A46-88F8-922B00C25EFA.txt",170,"TCGA-D1-A103-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","7ED77EA8-0E67-455D-A55A-F6A04B72E1BE",87,"UNCID_634949.TCGA-D1-A103-01A-11R-A10J-07.110316_UNC2-RDR300275_00058_FC_62J26AAXX.8.trimmed.annotated.translated_to_genomic.spljxn.quantification.txt","Alive",NA,"TCGA-D1-A103","NOT HISPANIC OR LATINO","ABE1C463-BBDD-4B8F-B731-426DBA0EEE37",NA,480,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,11,30,"57F8C7B7-1AA4-4149-9EF4-4AFC7A2B1F74","7E79A92E-298F-46B8-A122-1EDBAB8CE157","UNCID_2211025.ba50902a-fcf9-4023-bdbc-3e7d61c7011b.110316_UNC2-RDR300275_00058_FC_62J26AAXX_8.tar.gz","TCGA-D1-A103-01A-11",70,0,0,0,15,"BOTTOM",0,0,"TCGA-D1-A103-01A-01-BS1",85,NA,NA,NA,NA,NA,NA,NA,"NO",669,"TUMOR FREE","Alive",NA,"TCGA-D1-A103-F17751","TCGA-D1-A103",1,"D1","A103","YES","C54.1","8380/3","C54.1","NO","YES",-31841,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",480,NA,NA,NA,"TUMOR FREE","NO",8,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,87,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28055201,25919838,1947180281,"375C6EA2-4747-4959-9630-771FB8461BF1.bw","748e38b1-2ead-4a0a-8881-d640617b856b","375c6ea2-4747-4959-9630-771fb8461bf1","2016-08-05T02:31:55.758505-05:00","UNCID_2210404.2c5d86e0-2e3d-4259-97e9-023df54c8c56.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_1.tar.gz","775a7e2f-791b-4d8f-9af6-a9018b78b2a6",1837352964,"Illumina GA","41e7250fd2ce830ab93b358f9e15d3e1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:24:22.967841-05:00","2016-05-03T11:15:47.427352-05:00","775a7e2f-791b-4d8f-9af6-a9018b78b2a6_analysis.xml","a1ea38a2a8b84918508c5f2a88bdc6c4","6bf83c78-55c2-49bc-8fda-a8ebce8c4962",2121,"2016-08-13T02:35:08.135044-05:00","775a7e2f-791b-4d8f-9af6-a9018b78b2a6_experiment.xml","1f0ecb694ba63222af99b25e6c3f39f1","5cdabf0b-92dc-4105-85f2-6270433278ff",2257,"2016-09-29T22:45:36.786946-05:00","775a7e2f-791b-4d8f-9af6-a9018b78b2a6_run.xml","5f483ef0c9fb81880a60cd9296c25a95","c3763188-5179-4ab1-bfc2-1f4e62415a5c",347,"2016-09-08T10:43:59.972300-05:00","TCGA-AP-A0LF","2016-09-02T18:49:21.202660-05:00","female","TCGA-AP-A0LF_demographic",1920,"white","157a0de8-9a60-547a-92df-8b04e55b9482","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LF_diagnosis","not reported",30027,"alive","8380/3",NA,2859,"e09759b2-7f3c-5e76-b034-8b15aebd184d","c54.1",-30027,"TCGA-AP-A0LF_treatment","071b4f71-ac6c-510a-97c4-4fa5c83397a4","01","true","TCGA-AP-A0LF-01A",NA,"902e2dd8-81e5-4949-a57b-92b3efd86c63",FALSE,"7112CE75-9EFD-4989-9F2A-4D0F517B8EDE","Primary Tumor",NA,2891,240,NA,1291248000,"11",30,"TCGA-AP-A0LF-01A-11",60,60,0,0,0,0,0,0,"2016-09-08T10:43:59.972300-05:00","2016-09-08T10:43:59.972300-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"7e71c711-fc0e-4a85-b54d-3334a88ba5ed","8e902213-2e30-454a-ab73-99a4a4ece6e0","TCGA-AP-A0LF-01A-01-TSA","TCGA-AP-A0LF-01A-01-BSA",100,100,"900d67db-959b-4415-9680-c5eb717ae09d","RNA","TCGA-AP-A0LF-01A-11R","3b7a90dd-db50-4cec-9e96-5a2472fcddb0",1.86,0.17,"UV Spec","R","23","TCGA-AP-A0LF-01A-11R-A118-07","2c5d86e0-2e3d-4259-97e9-023df54c8c56",0.17,NA,72,27.7767061455962,161,"9181fcd6-8106-512e-a88e-498f332aa9d5","TCGA-AP-A0LF_exposure","UNCID_2210404.2c5d86e0-2e3d-4259-97e9-023df54c8c56.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_1.tar.gz","2013-10-02T10:16:03.000Z","2013-10-02T10:28:01.000Z","775A7E2F-791B-4D8F-9AF6-A9018B78B2A6","902E2DD8-81E5-4949-A57B-92B3EFD86C63","Unaligned reads",1837352964,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2C5D86E0-2E3D-4259-97E9-023DF54C8C56","University of North Carolina","564a3353e4b0298dd2c5d17a","748E38B1-2EAD-4A0A-8881-D640617B856B","Uterine Corpus Endometrial Carcinoma","TARGZ","900D67DB-959B-4415-9680-C5EB717AE09D","2013-10-02T10:28:01.000Z","3B7A90DD-DB50-4CEC-9E96-5A2472FCDDB0","None","NO",1,NA,"Primary Tumor","MSKCC",2891,"900D67DB-959B-4415-9680-C5EB717AE09D",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.4F747B8B-48BD-4672-AD42-B142645B56F5.txt",240,"TCGA-AP-A0LF-01A",NA,NA,"TCGA",2002,NA,NA,"WITH TUMOR","902E2DD8-81E5-4949-A57B-92B3EFD86C63",82,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.4F747B8B-48BD-4672-AD42-B142645B56F5.txt","Alive",NA,"TCGA-AP-A0LF","NOT HISPANIC OR LATINO","8DE60958-887B-4893-9AA8-0D9D8FAF5042",NA,2859,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"8E902213-2E30-454A-AB73-99A4A4ECE6E0","99C48014-7166-4DCE-8D5E-A2F43F3DD074","TCGA-AP-A0LF-01A-11R-A119-13_mirna.bam.bai","TCGA-AP-A0LF-01A-11",60,0,0,0,0,"TOP",0,0,"TCGA-AP-A0LF-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,NA,2859,"WITH TUMOR","Alive",NA,"TCGA-AP-A0LF-F6989","TCGA-AP-A0LF",1,"AP","A0LF","YES","C54.1","8380/3","C54.1","NO","YES",-30027,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",2859,NA,NA,NA,"WITH TUMOR","NO",1,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,82,2002,"Office Endometrial Biopsy",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
37261141,36398369,2741957933,"268EA4BE-77B2-4916-B1DE-4DB07C56DCA2.bw","755d7ab7-4563-408a-9135-f852048af975","268ea4be-77b2-4916-b1de-4db07c56dca2","2016-08-05T05:17:56.956508-05:00","UNCID_2194772.284f6163-92f2-4e21-8649-45dcfce6634f.120313_UNC6-RDR300211_00137_FC_650V5AAXX_5.tar.gz","be4eb2bb-ddea-47c9-b86d-8bbe9123ae43",2488168206,"Illumina GA","cec2b8a763c3124939d95e7694fe0c1c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:53:31.849532-05:00","2016-05-03T11:07:49.533775-05:00","be4eb2bb-ddea-47c9-b86d-8bbe9123ae43_analysis.xml","27dcabd774bc708550a70e5f3f47a4b9","0de6cc6f-9449-4144-b631-4403abdb9f98",2122,"2016-09-29T21:13:05.987488-05:00","be4eb2bb-ddea-47c9-b86d-8bbe9123ae43_experiment.xml","f6352c241b262a807a8bcce7450f93cf","8a444c1d-1135-4b97-a2d5-15100e5d16a7",2258,"2016-09-30T00:15:13.103757-05:00","be4eb2bb-ddea-47c9-b86d-8bbe9123ae43_run.xml","3bc18fe224947a5dcdf0614149affc6e","fafdf9b9-ae5d-402f-880e-d65bff99ff1c",349,"2016-09-08T10:36:35.196914-05:00","TCGA-AX-A1C7","2016-09-02T18:51:31.676976-05:00","female","TCGA-AX-A1C7_demographic",1932,"white","3814abc2-97c0-50d9-9f26-8ef2db2993f8","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1C7_diagnosis","not reported",28198,"alive","8441/3",NA,1054,"1ecfef7e-3108-57a3-a81c-4fa7f00ce512","c54.1",-28198,"TCGA-AX-A1C7_treatment","0827e0de-da65-50ef-b937-bf0d23a55873","01","false","TCGA-AX-A1C7-01A",NA,"a4b56935-7bb9-4c84-9176-e8d694f37faa",FALSE,"10458026-49D7-40EC-BC7B-0D6A381FB025","Primary Tumor",NA,423,90,NA,1295222400,"11",30,"TCGA-AX-A1C7-01A-11",94,NA,1,NA,0,NA,5,NA,"2016-09-08T10:36:35.196914-05:00",NA,1,NA,1,NA,"TOP",NA,2,NA,"3d218a2e-bb8b-4fec-88fd-68d22ba6f17b",NA,"TCGA-AX-A1C7-01A-01-TS1",NA,93,NA,"f883e003-d857-47f5-9d57-7e4d0b362b71","RNA","TCGA-AX-A1C7-01A-11R","26781bce-6b09-4427-8f97-78a34332cbd8",1.9,0.16,"UV Spec","R","23","TCGA-AX-A1C7-01A-11R-A137-07","284f6163-92f2-4e21-8649-45dcfce6634f",0.16,NA,60,25.9695290858726,152,"d6f5514f-d015-5f38-a9ce-96d40e52104d","TCGA-AX-A1C7_exposure","UNCID_2194772.284f6163-92f2-4e21-8649-45dcfce6634f.120313_UNC6-RDR300211_00137_FC_650V5AAXX_5.tar.gz","2013-09-23T03:07:04.000Z","2013-09-23T03:20:01.000Z","BE4EB2BB-DDEA-47C9-B86D-8BBE9123AE43","A4B56935-7BB9-4C84-9176-E8D694F37FAA","Unaligned reads",2488168206,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","284F6163-92F2-4E21-8649-45DCFCE6634F","University of North Carolina","564a3402e4b0298dd2c60914","755D7AB7-4563-408A-9135-F852048AF975","Uterine Corpus Endometrial Carcinoma","TARGZ","F883E003-D857-47F5-9D57-7E4D0B362B71","2013-09-23T03:20:01.000Z","26781BCE-6B09-4427-8F97-78A34332CBD8","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",423,"F883E003-D857-47F5-9D57-7E4D0B362B71",NA,"AX","TCGA-AX-A1C7-01A-11R-A136-13_mirna.bam",90,"TCGA-AX-A1C7-01A",NA,"7E25AA3C-5876-4354-9F92-66DF3C981FE0","TCGA",2009,NA,NA,NA,"1FCE2391-F0D7-421C-A0AE-BD5855FEAF83",77,"nationwidechildrens.org_clinical.TCGA-AX-A1C7.xml","Alive",NA,"TCGA-AX-A1C7","NOT HISPANIC OR LATINO","67905620-C7EF-4350-86AE-25222207C7BF",NA,516,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"3D218A2E-BB8B-4FEC-88FD-68D22BA6F17B","C71D5A56-850C-4B33-BDCA-A01DBE10FD22","TCGA-AX-A1C7-01A-11R-A136-13_mirna.bam","TCGA-AX-A1C7-01A-11",94,0,1,1,5,"TOP",2,1,"TCGA-AX-A1C7-01A-01-TS1",93,"Topotecan","Chemotherapy","TCGA-AX-A1C7-D12488",NA,NA,NA,NA,NA,516,NA,"Alive",NA,"TCGA-AX-A1C7-F10354","TCGA-AX-A1C7",1,"AX","A1C7","YES","C54.1","8441/3","C54.1","NO","YES",-28198,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",516,NA,NA,NA,NA,"NO",11,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,77,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
132440926,124333755,5918412857,"CB39F4AA-36F7-4FBD-9D98-A7B3F35A88D0.bw","755d7ab7-4563-408a-9135-f852048af975","cb39f4aa-36f7-4fbd-9d98-a7b3f35a88d0","2016-08-26T11:43:15.919450-05:00","UNCID_2364659.284f6163-92f2-4e21-8649-45dcfce6634f.130909_UNC15-SN850_0326_AC2BWBACXX_6_CGATGT.tar.gz","86928052-5779-4114-98f0-aea5fbfb8d8c",6062918865,"Illumina HiSeq","0b5040fe450631548dc19bb0f5c8bf1f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:04:59.884174-05:00","2016-05-03T11:38:50.208107-05:00","86928052-5779-4114-98f0-aea5fbfb8d8c_analysis.xml","5e8885d2f6dc66a91f309f64d325fcca","851ce7b7-c304-44dd-b179-7306f4b4c7af",2123,"2016-09-30T00:10:46.862256-05:00","86928052-5779-4114-98f0-aea5fbfb8d8c_experiment.xml","bb5888bf2c3ef1abf242c2b976ed7211","f82cf3cd-d1ee-4273-a5c8-dbe7b042f5b7",2628,"2016-09-29T23:55:04.945634-05:00","86928052-5779-4114-98f0-aea5fbfb8d8c_run.xml","12c7c06c2deefc167be8dc21d23741fd","eeb064ec-15fe-4cdf-b6e7-0dafbaf4b207",354,"2016-09-08T10:36:35.196914-05:00","TCGA-AX-A1C7","2016-09-02T18:51:31.676976-05:00","female","TCGA-AX-A1C7_demographic",1932,"white","3814abc2-97c0-50d9-9f26-8ef2db2993f8","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1C7_diagnosis","not reported",28198,"alive","8441/3",NA,1054,"1ecfef7e-3108-57a3-a81c-4fa7f00ce512","c54.1",-28198,"TCGA-AX-A1C7_treatment","0827e0de-da65-50ef-b937-bf0d23a55873","01","false","TCGA-AX-A1C7-01A",NA,"a4b56935-7bb9-4c84-9176-e8d694f37faa",FALSE,"10458026-49D7-40EC-BC7B-0D6A381FB025","Primary Tumor",NA,423,90,NA,1295222400,"11",30,"TCGA-AX-A1C7-01A-11",94,NA,1,NA,0,NA,5,NA,"2016-09-08T10:36:35.196914-05:00",NA,1,NA,1,NA,"TOP",NA,2,NA,"3d218a2e-bb8b-4fec-88fd-68d22ba6f17b",NA,"TCGA-AX-A1C7-01A-01-TS1",NA,93,NA,"f883e003-d857-47f5-9d57-7e4d0b362b71","RNA","TCGA-AX-A1C7-01A-11R","26781bce-6b09-4427-8f97-78a34332cbd8",1.9,0.16,"UV Spec","R","23","TCGA-AX-A1C7-01A-11R-A137-07","284f6163-92f2-4e21-8649-45dcfce6634f",0.16,NA,60,25.9695290858726,152,"d6f5514f-d015-5f38-a9ce-96d40e52104d","TCGA-AX-A1C7_exposure","UNCID_2364659.284f6163-92f2-4e21-8649-45dcfce6634f.130909_UNC15-SN850_0326_AC2BWBACXX_6_CGATGT.tar.gz","2014-02-28T18:33:04.000Z","2014-02-28T19:00:02.000Z","86928052-5779-4114-98F0-AEA5FBFB8D8C","A4B56935-7BB9-4C84-9176-E8D694F37FAA","Unaligned reads",6062918865,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","284F6163-92F2-4E21-8649-45DCFCE6634F","University of North Carolina","564a3402e4b093830b66e7a0","755D7AB7-4563-408A-9135-F852048AF975","Uterine Corpus Endometrial Carcinoma","TARGZ","F883E003-D857-47F5-9D57-7E4D0B362B71","2014-02-28T19:00:02.000Z","26781BCE-6B09-4427-8F97-78A34332CBD8","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",423,"F883E003-D857-47F5-9D57-7E4D0B362B71",NA,"AX","TCGA-AX-A1C7-01A-11R-A136-13_mirna.bam",90,"TCGA-AX-A1C7-01A",NA,"7E25AA3C-5876-4354-9F92-66DF3C981FE0","TCGA",2009,NA,NA,NA,"1FCE2391-F0D7-421C-A0AE-BD5855FEAF83",77,"nationwidechildrens.org_clinical.TCGA-AX-A1C7.xml","Alive",NA,"TCGA-AX-A1C7","NOT HISPANIC OR LATINO","67905620-C7EF-4350-86AE-25222207C7BF",NA,516,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"3D218A2E-BB8B-4FEC-88FD-68D22BA6F17B","C71D5A56-850C-4B33-BDCA-A01DBE10FD22","TCGA-AX-A1C7-01A-11R-A136-13_mirna.bam","TCGA-AX-A1C7-01A-11",94,0,1,1,5,"TOP",2,1,"TCGA-AX-A1C7-01A-01-TS1",93,"Topotecan","Chemotherapy","TCGA-AX-A1C7-D12488",NA,NA,NA,NA,NA,516,NA,"Alive",NA,"TCGA-AX-A1C7-F10354","TCGA-AX-A1C7",1,"AX","A1C7","YES","C54.1","8441/3","C54.1","NO","YES",-28198,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",516,NA,NA,NA,NA,"NO",11,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,77,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
125302094,124000687,5922069395,"D6A907FC-3A1B-4E3B-A440-1CE9BE9B334B.bw","75783dbe-e18c-4535-b9eb-2affd320e098","d6a907fc-3a1b-4e3b-a440-1ce9be9b334b","2016-08-09T13:15:14.879574-05:00","UNCID_2168983.a7c691a2-a91d-44d0-8e91-0234cddb1e92.130610_UNC14-SN744_0347_BD28NBACXX_3_CAGATC.tar.gz","a4d2dd69-3e85-477b-8cac-fa2433f21de8",5771470003,"Illumina HiSeq","8d3c2f26d66504f09724a772bd43dd74","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:46:28.781243-05:00","2016-05-03T10:55:55.601106-05:00","a4d2dd69-3e85-477b-8cac-fa2433f21de8_analysis.xml","c10c2fcfcb61c647edc4dfa4997d760f","097ab746-c32e-4337-b796-1e4ceb453cde",2128,"2016-09-29T19:04:58.092659-05:00","a4d2dd69-3e85-477b-8cac-fa2433f21de8_experiment.xml","d43c6dabfd4c2248f8e481118a847b9c","3ad1f111-e81e-4337-96e9-69edb94a38b3",2600,"2016-09-29T19:25:15.295651-05:00","a4d2dd69-3e85-477b-8cac-fa2433f21de8_run.xml","3229608072c63ccc9d8b7a8e92138880","47924e47-509f-4789-8719-3785b932e83b",343,"2016-09-09T16:02:10.941073-05:00","TCGA-EY-A54A","2016-09-02T18:50:05.752245-05:00","female","TCGA-EY-A54A_demographic",1945,"black or african american","be31e54c-a3d3-5eb6-8d3f-25c7b2e63f8c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.9","TCGA-EY-A54A_diagnosis","not reported",24822,"alive","8380/3",NA,447,"b0351059-8e11-5467-97c2-a451c3438893","c54.9",-24822,"TCGA-EY-A54A_treatment","71705968-3a24-5db0-8a48-2f04c84bc90c","01","false","TCGA-EY-A54A-01A",NA,"6d890026-4221-471a-afa6-1118ed804f08",FALSE,"E3C3D3B8-550A-4652-9B17-122BC64A437A","Primary Tumor",NA,105,500,NA,1355184000,"11",30,"TCGA-EY-A54A-01A-11",65,NA,3,NA,0,NA,0,NA,"2016-09-09T16:02:10.941073-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"3296f85a-b33f-4658-bf59-c9cb1e366030",NA,"TCGA-EY-A54A-01A-01-TS1",NA,100,NA,"67c3b59a-6690-4bf2-ac4e-a7dd63c04d01","RNA","TCGA-EY-A54A-01A-11R","e056a7b9-9392-498f-8b76-6772a72e2fec",1.88,0.17,"UV Spec","R","23","TCGA-EY-A54A-01A-11R-A27V-07","a7c691a2-a91d-44d0-8e91-0234cddb1e92",0.17,NA,70,27.0051309748852,161,"766d1f1d-8f0e-580b-a55a-3a9840139306","TCGA-EY-A54A_exposure","UNCID_2168983.a7c691a2-a91d-44d0-8e91-0234cddb1e92.130610_UNC14-SN744_0347_BD28NBACXX_3_CAGATC.tar.gz","2013-09-01T00:56:09.000Z","2013-09-01T01:29:02.000Z","A4D2DD69-3E85-477B-8CAC-FA2433F21DE8","6D890026-4221-471A-AFA6-1118ED804F08","Unaligned reads",5771470003,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","A7C691A2-A91D-44D0-8E91-0234CDDB1E92","University of North Carolina","564a3c93e4b0ef12181ad0c3","75783DBE-E18C-4535-B9EB-2AFFD320E098","Uterine Corpus Endometrial Carcinoma","TARGZ","67C3B59A-6690-4BF2-AC4E-A7DD63C04D01","2013-09-01T01:29:02.000Z","E056A7B9-9392-498F-8B76-6772A72E2FEC","United States","NO",1,NA,"Primary Tumor","University of North Carolina",105,"67C3B59A-6690-4BF2-AC4E-A7DD63C04D01",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2CD53475-9ADE-4981-95CF-286418DBBAF4.txt",500,"TCGA-EY-A54A-01A",NA,"A18E520C-8948-498F-A4AB-1E1F8A239299","TCGA",2012,"TCGA-EY-A54A_NTE-1","Complete Remission/Response","TUMOR FREE","6D890026-4221-471A-AFA6-1118ED804F08",67,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2CD53475-9ADE-4981-95CF-286418DBBAF4.txt","Alive",NA,"TCGA-EY-A54A","NOT HISPANIC OR LATINO","0620141A-0A16-4894-8171-9B57E014A234","NO",113,"No","Uterus","C54.9",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8380/3","FEMALE","C54.9",289,NA,"07930502-222C-4655-8BC6-79D214C60FA4","BLACK OR AFRICAN AMERICAN",NA,11,30,"3296F85A-B33F-4658-BF59-C9CB1E366030","E056A7B9-9392-498F-8B76-6772A72E2FEC","UNCID_2087912.a7c691a2-a91d-44d0-8e91-0234cddb1e92.sorted_genome_alignments.bam.bai","TCGA-EY-A54A-01A-11",65,0,3,5,0,"TOP",0,0,"TCGA-EY-A54A-01A-01-TS1",100,"Carboplatin","Chemotherapy","TCGA-EY-A54A-D44463","TCGA-EY-A54A-R44465","External","Primary Tumor Field","TCGA-EY-A54A-F57555_NTE-1","NO",447,NA,"Alive",NA,"TCGA-EY-A54A-F57555","TCGA-EY-A54A",1,"EY","A54A","YES","C54.9","8380/3","C54.9","YES","NO",-24822,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",113,NA,"YES","YES","TUMOR FREE","YES",27,2,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
135426964,132806436,6335932886,"7B8AB60E-77DA-48E4-9320-CC5595D12131.bw","75fb484d-cd12-4cf0-a99d-faf27aead118","7b8ab60e-77da-48e4-9320-cc5595d12131","2016-08-25T19:52:44.813252-05:00","UNCID_2316528.c3740105-aee5-42ef-94e9-50f6b242b7c8.131008_UNC11-SN627_0326_AC2KLPACXX_7_TGACCA.tar.gz","e9e5d257-53be-495b-a948-1a41827a1797",6157051534,"Illumina HiSeq","301e27fc148c3298bb055e8428f9dae9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:03:45.746747-05:00","2016-05-03T11:28:50.231867-05:00","e9e5d257-53be-495b-a948-1a41827a1797_analysis.xml","663abcb12df4aeaa4e29598f7115fc84","a9acdbec-8d4e-4263-a9d6-fe87144b4bbc",2123,"2016-08-28T04:15:10.166395-05:00","e9e5d257-53be-495b-a948-1a41827a1797_experiment.xml","128980ddebe8a18d92a04355a99a485c","6a786457-9cef-4966-b190-5976434dd46f",2628,"2016-09-29T21:16:22.886670-05:00","e9e5d257-53be-495b-a948-1a41827a1797_run.xml","8887774f3d5677e6e68afb1bdba88afd","8c494aa8-80f5-41cd-b3c3-2eb7bd91fa04",354,"2016-09-08T11:31:58.353168-05:00","TCGA-EY-A1GP","2016-09-02T18:51:57.489825-05:00","female","TCGA-EY-A1GP_demographic",1956,"black or african american","ce96d3e6-6f9d-54ec-8173-e7af52159c07","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GP_diagnosis","not reported",20011,"alive","8380/3",NA,573,"9d18e30f-2e1e-511a-8941-81743f8b9cf7","c54.1",-20011,"TCGA-EY-A1GP_treatment","2ac31c35-3472-5389-818d-f067f899b839","01","false","TCGA-EY-A1GP-01A",NA,"13c41beb-c86d-423f-97a4-8f18bff149be",FALSE,"D9933BA3-3D3B-4B93-AD6C-22ED47C4DBB1","Primary Tumor",NA,262,90,NA,1297641600,"11",30,"TCGA-EY-A1GP-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:31:58.353168-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"f44b05b6-51ee-474e-9baa-3a86cdf7e65f",NA,"TCGA-EY-A1GP-01A-01-TSA",NA,80,NA,"053730cc-968f-4936-a60b-407c3da2b988","RNA","TCGA-EY-A1GP-01A-11R","de8342ab-8fe5-42a2-aa7d-66e6afd11e13",1.78,0.15,"UV Spec","R","23","TCGA-EY-A1GP-01A-11R-A13S-07","c3740105-aee5-42ef-94e9-50f6b242b7c8",0.15,NA,72,28.8415318058004,158,"49e62e21-2c9d-5e2f-853f-5fca173db285","TCGA-EY-A1GP_exposure","UNCID_2316528.c3740105-aee5-42ef-94e9-50f6b242b7c8.131008_UNC11-SN627_0326_AC2KLPACXX_7_TGACCA.tar.gz","2014-01-07T02:16:53.000Z","2014-01-07T05:13:02.000Z","E9E5D257-53BE-495B-A948-1A41827A1797","13C41BEB-C86D-423F-97A4-8F18BFF149BE","Unaligned reads",6157051534,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","C3740105-AEE5-42EF-94E9-50F6B242B7C8","University of North Carolina","564a3887e4b09c884b237bd0","75FB484D-CD12-4CF0-A99D-FAF27AEAD118","Uterine Corpus Endometrial Carcinoma","TARGZ","053730CC-968F-4936-A60B-407C3DA2B988","2014-01-07T05:13:02.000Z","DE8342AB-8FE5-42A2-AA7D-66E6AFD11E13","United States","NO",1,NA,"Primary Tumor","University of North Carolina",262,"053730CC-968F-4936-A60B-407C3DA2B988",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.24AA478A-20A3-4B5D-BC07-A92892908608.txt",90,"TCGA-EY-A1GP-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","1771D3F8-390E-4607-BC57-92CA17529020",54,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.24AA478A-20A3-4B5D-BC07-A92892908608.txt","Alive",NA,"TCGA-EY-A1GP","NOT HISPANIC OR LATINO","D277372A-6EC1-4891-AD5E-84E26CFF55A9",NA,348,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"F44B05B6-51EE-474E-9BAA-3A86CDF7E65F","F404D051-D78A-4E91-9BA9-FE25340FE844","UNCID_2232898.c3740105-aee5-42ef-94e9-50f6b242b7c8.sorted_genome_alignments.bam","TCGA-EY-A1GP-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-EY-A1GP-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,"NO",573,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GP-F19766","TCGA-EY-A1GP",1,"EY","A1GP","YES","C54.1","8380/3","C54.1","YES","NO",-20011,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",348,NA,NA,NA,"TUMOR FREE","NO",19,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
102719838,100700352,4807907637,"62AE773F-A6EE-4704-A2C4-096A77C47DA7.bw","76f98002-e8df-4dfa-926e-8bb2d5114966","62ae773f-a6ee-4704-a2c4-096a77c47da7","2016-08-09T13:15:16.966523-05:00","UNCID_2173088.f141342e-fbed-4ccf-8e4a-7299397e6e77.130509_UNC10-SN254_0462_AC232JACXX_3_GATCAG.tar.gz","ac59ed2c-b74d-40be-a781-d00d2e159587",4767974309,"Illumina HiSeq","bcc178128803f4940847c193c069b37e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:20:52.423970-05:00","2016-05-03T10:55:55.600288-05:00","ac59ed2c-b74d-40be-a781-d00d2e159587_analysis.xml","1c8f1070c290513845777f490f6ca094","8f1f31e9-3e4c-4503-9071-a9f9cf254982",2123,"2016-09-29T23:47:55.462515-05:00","ac59ed2c-b74d-40be-a781-d00d2e159587_experiment.xml","5acc6a36b133849fe625b62cb8d4ce53","ea31a318-019e-4184-9008-10621c99c381",2431,"2016-09-29T18:08:37.381605-05:00","ac59ed2c-b74d-40be-a781-d00d2e159587_run.xml","8fd0c9db2ff4b4573b3af4e171a38dc2","1774f518-6c14-479e-b47e-d0c6808785b2",354,"2016-09-08T10:35:04.754573-05:00","TCGA-AJ-A3OJ","2016-09-02T18:49:06.007976-05:00","female","TCGA-AJ-A3OJ_demographic",1957,"white","2d640521-fd23-5176-bb37-d5e66cbca59a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3OJ_diagnosis","not reported",19826,"alive","8380/3",NA,467,"5588105e-6eed-5a1e-89c4-3a05d2f11428","c54.1",-19826,"TCGA-AJ-A3OJ_treatment","09a45c05-f663-5293-8e4f-066f0455b87c","01","false","TCGA-AJ-A3OJ-01A",NA,"654f67ed-7295-4360-ada6-830d4528b17d",FALSE,"89CAF35B-187A-499C-9E01-3992A0DEBCFD","Primary Tumor",NA,97,260,NA,1328572800,"11",30,"TCGA-AJ-A3OJ-01A-11",80,NA,1,NA,5,NA,0,NA,"2016-09-08T10:35:04.754573-05:00",NA,5,NA,2,NA,"TOP",NA,5,NA,"06d34766-621e-4778-a81f-b1836ab0f933",NA,"TCGA-AJ-A3OJ-01A-01-TS1",NA,90,NA,"af8e6134-a69f-443e-908d-22093d97f722","RNA","TCGA-AJ-A3OJ-01A-11R","36eb25d7-11a0-45e1-8dcb-e0ebb1529a5a",1.85,0.16,"UV Spec","R","23","TCGA-AJ-A3OJ-01A-11R-A22K-07","f141342e-fbed-4ccf-8e4a-7299397e6e77",0.16,NA,104,42.1923810296564,157,"75792d92-75af-5590-8d39-2f88ec1227c3","TCGA-AJ-A3OJ_exposure","UNCID_2173088.f141342e-fbed-4ccf-8e4a-7299397e6e77.130509_UNC10-SN254_0462_AC232JACXX_3_GATCAG.tar.gz","2013-09-09T09:36:08.000Z","2013-09-09T09:52:01.000Z","AC59ED2C-B74D-40BE-A781-D00D2E159587","654F67ED-7295-4360-ADA6-830D4528B17D","Unaligned reads",4767974309,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","F141342E-FBED-4CCF-8E4A-7299397E6E77","University of North Carolina","564a3f37e4b08c5d8692b9f9","76F98002-E8DF-4DFA-926E-8BB2D5114966","Uterine Corpus Endometrial Carcinoma","TARGZ","AF8E6134-A69F-443E-908D-22093D97F722","2013-09-09T09:52:01.000Z","36EB25D7-11A0-45E1-8DCB-E0EBB1529A5A","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",97,"AF8E6134-A69F-443E-908D-22093D97F722",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.81CF93AA-064D-43BA-AD1B-417F00852E28.txt",260,"TCGA-AJ-A3OJ-01A",NA,"8001C500-87B1-4669-B411-188C137EC1A4","TCGA",2011,NA,NA,"TUMOR FREE","DFA4B052-6286-4865-B645-917E4C6432F0",54,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.81CF93AA-064D-43BA-AD1B-417F00852E28.txt","Alive",NA,"TCGA-AJ-A3OJ","NOT HISPANIC OR LATINO","AEF04B6E-0D61-4C05-92DB-709E7F7A662C",NA,59,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"CDF03961-31C6-496D-9E8E-297738256783","WHITE",NA,11,30,"06D34766-621E-4778-A81F-B1836AB0F933","8C703E36-A8A4-4A24-8A1A-0550093124DA","UNCID_2090354.f141342e-fbed-4ccf-8e4a-7299397e6e77.sorted_genome_alignments.bam.bai","TCGA-AJ-A3OJ-01A-11",80,5,1,5,0,"TOP",5,2,"TCGA-AJ-A3OJ-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-AJ-A3OJ-D47052","TCGA-AJ-A3OJ-R47051","Internal","Regional site","TCGA-AJ-A3OJ-F47049_NTE-1","NO",467,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3OJ-F47049","TCGA-AJ-A3OJ",1,"AJ","A3OJ","YES","C54.1","8380/3","C54.1","YES","NO",-19826,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",59,NA,NA,NA,"TUMOR FREE","NO",19,4,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
102020994,100460006,4798082755,"E8A40DF2-019A-4EA8-BFCD-DA39A5942A45.bw","77ed36ad-222f-4693-8668-0ecf9073d6e8","e8a40df2-019a-4ea8-bfcd-da39a5942a45","2016-08-06T22:13:24.909150-05:00","UNCID_2178402.f3004f55-be95-4c2c-92f8-9ec3e96701cd.130328_UNC10-SN254_0443_AD238RACXX_6_GTTTCG.tar.gz","b94966c2-cc34-46cd-855d-b1a61c136bef",4230340115,"Illumina HiSeq","e002f27c07af4ab448287c94c8b617e8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:30:09.181484-05:00","2016-05-03T10:56:47.880266-05:00","b94966c2-cc34-46cd-855d-b1a61c136bef_analysis.xml","5237e7f71c9f108749f114b2e2e0d264","6f7e174f-0aa5-4046-b88a-fe813320089a",2123,"2016-09-30T00:16:10.007683-05:00","b94966c2-cc34-46cd-855d-b1a61c136bef_experiment.xml","a41879c1a25855e5045751e282a6667b","fb93ebef-9574-43d0-84bb-3f8ac90b65b5",2431,"2016-09-29T22:00:38.000423-05:00","b94966c2-cc34-46cd-855d-b1a61c136bef_run.xml","6a101d36681f363759c94ca23ec77025","a7c03898-14b6-441b-a4f8-7789b5039be0",354,"2016-09-08T10:30:33.870570-05:00","TCGA-AJ-A3BG","2016-09-02T18:54:50.061899-05:00","female","TCGA-AJ-A3BG_demographic",1946,"white","5b4a1e6c-e831-5826-949b-e548534065f8","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3BG_diagnosis","not reported",23861,"alive","8380/3",NA,550,"03aaa2cc-0cbd-5e47-b13d-c4fe8c4cb7b5","c54.1",-23861,"TCGA-AJ-A3BG_treatment","195855e6-4a3c-5a3b-897a-3b8b5bae8ecf","01","false","TCGA-AJ-A3BG-01A",NA,"0eeb2802-5276-4a2f-ae20-926a3feced91",FALSE,"3D42566F-92B2-4530-BF6A-624DA6E979B9","Primary Tumor",NA,137,24,NA,1317340800,"11",24,"TCGA-AJ-A3BG-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T10:30:33.870570-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"fdb1b2a0-9aad-460c-a874-aa69895c8cc8",NA,"TCGA-AJ-A3BG-01A-01-TS1",NA,95,NA,"9f8f6b9e-ce42-4f68-9bc2-093c3f6b3bf5","RNA","TCGA-AJ-A3BG-01A-11R","765c7fc8-313c-4291-8d32-b99eefdad90c",1.78,0.15,"UV Spec","R","23","TCGA-AJ-A3BG-01A-11R-A19W-07","f3004f55-be95-4c2c-92f8-9ec3e96701cd",0.15,NA,66,24.8409800895781,163,"a1946990-4d03-5c4f-8545-091a409c976b","TCGA-AJ-A3BG_exposure","UNCID_2178402.f3004f55-be95-4c2c-92f8-9ec3e96701cd.130328_UNC10-SN254_0443_AD238RACXX_6_GTTTCG.tar.gz","2013-09-12T02:01:12.000Z","2013-09-12T02:17:02.000Z","B94966C2-CC34-46CD-855D-B1A61C136BEF","0EEB2802-5276-4A2F-AE20-926A3FECED91","Unaligned reads",4230340115,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","F3004F55-BE95-4C2C-92F8-9EC3E96701CD","University of North Carolina","56607f30e4b016715ab6bcf4","77ED36AD-222F-4693-8668-0ECF9073D6E8","Uterine Corpus Endometrial Carcinoma","TARGZ","9F8F6B9E-CE42-4F68-9BC2-093C3F6B3BF5","2013-09-12T02:17:02.000Z","765C7FC8-313C-4291-8D32-B99EEFDAD90C","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",137,"9F8F6B9E-CE42-4F68-9BC2-093C3F6B3BF5",NA,"AJ","UNCID_2178402.f3004f55-be95-4c2c-92f8-9ec3e96701cd.130328_UNC10-SN254_0443_AD238RACXX_6_GTTTCG.tar.gz",24,"TCGA-AJ-A3BG-01A",NA,"F2FDEBDF-282C-4493-8453-1A68F22F1C22","TCGA",2011,NA,NA,"TUMOR FREE","19D89271-3133-4113-A25D-FB9BF388464F",65,"nationwidechildrens.org_clinical.TCGA-AJ-A3BG.xml","Alive",NA,"TCGA-AJ-A3BG","NOT HISPANIC OR LATINO","54422ED4-8DA9-43FA-A271-E8E88E2A07E5",NA,23,"Yes","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,"9CEF3365-5DD5-4284-AFEB-CC08DE2F1A8B","WHITE",NA,11,24,"FDB1B2A0-9AAD-460C-A874-AA69895C8CC8","9A515DFA-FA40-4B3B-9EE4-ED911D41E338","UNCID_2178402.f3004f55-be95-4c2c-92f8-9ec3e96701cd.130328_UNC10-SN254_0443_AD238RACXX_6_GTTTCG.tar.gz","TCGA-AJ-A3BG-01A-11",80,0,0,0,0,"TOP",5,0,"TCGA-AJ-A3BG-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-AJ-A3BG-D43758","TCGA-AJ-A3BG-R43757","External","Primary Tumor Field","TCGA-AJ-A3BG-F43755_NTE-1","YES",550,"WITH TUMOR","Alive",NA,"TCGA-AJ-A3BG-F43755","TCGA-AJ-A3BG",1,"AJ","A3BG","YES","C54.1","8380/3","C54.1","YES","NO",-23861,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",23,NA,NA,NA,"TUMOR FREE","NO",3,2,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,65,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
129788646,123128553,5871070170,"D5601721-19B1-4017-97F2-4CA697962C2B.bw","787c3e2f-a708-4985-a5b1-b2383c7bfc52","d5601721-19b1-4017-97f2-4ca697962c2b","2016-09-29T23:14:21.866251-05:00","UNCID_2316532.c23bc644-ff87-4c84-a156-686903524aaa.130930_UNC12-SN629_0331_BD2F2JACXX_3_ACAGTG.tar.gz","f1922653-c8b9-4aa8-8b7e-829b057918d5",5773268233,"Illumina HiSeq","bc4ac144dc7684007b551966f64334bc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:14:18.249748-05:00","2016-05-03T11:28:50.231867-05:00","f1922653-c8b9-4aa8-8b7e-829b057918d5_analysis.xml","1c223bf2d3ca7dee2b1a34df36c6f646","65c09bb8-53e9-40d0-bf83-3042cdcf6607",2124,"2016-09-29T21:18:29.831066-05:00","f1922653-c8b9-4aa8-8b7e-829b057918d5_experiment.xml","56f6938a44159a64ac064ce0a6b5a56a","8d9f399c-f984-4457-a7e4-9c673c24a5f3",2628,"2016-09-29T18:55:46.410919-05:00","f1922653-c8b9-4aa8-8b7e-829b057918d5_run.xml","d45ffa558f9bdc1ec62ebde16a013cb9","3502a58a-074a-4da5-a1d7-adfb280b8def",354,"2016-09-08T11:13:52.039341-05:00","TCGA-FI-A2EY","2016-09-02T18:54:21.924541-05:00","female","TCGA-FI-A2EY_demographic",1943,"white","631fe89e-04fb-56a0-ab68-80e604dfdaac","not hispanic or latino",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2EY_diagnosis","not reported",23042,"dead","8441/3",880,NA,"b7a3cfff-2bf8-5264-a606-25b3a131db3d","c54.1",-23042,"TCGA-FI-A2EY_treatment","a1f852b2-9aec-5d51-8222-6cd8c64a1822","01","true","TCGA-FI-A2EY-01A",NA,"8c8e5dd2-b8ef-4e5c-9cd6-7d3717e4cdef",FALSE,"D529A633-2FC9-4C28-BEA4-994BABD51A48","Primary Tumor",NA,1866,140,NA,1308268800,"12",30,"TCGA-FI-A2EY-01A-12",85,NA,20,NA,0,NA,5,NA,"2016-09-08T11:13:52.039341-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"45db3839-8439-4fa3-a540-7c977513df90",NA,"TCGA-FI-A2EY-01A-01-TSA",NA,85,NA,"830330fa-f309-4dd5-8ba9-1a377afcd59c","RNA","TCGA-FI-A2EY-01A-12R","8df98207-4ffe-4b93-b403-f304906494f9",1.83,0.17,"UV Spec","R","23","TCGA-FI-A2EY-01A-12R-A18M-07","c23bc644-ff87-4c84-a156-686903524aaa",0.17,NA,96,28.6661291767446,183,"dcfa66c8-8749-58ae-8f21-bf2507490949","TCGA-FI-A2EY_exposure","UNCID_2316532.c23bc644-ff87-4c84-a156-686903524aaa.130930_UNC12-SN629_0331_BD2F2JACXX_3_ACAGTG.tar.gz","2014-01-07T02:16:33.000Z","2014-01-07T04:27:02.000Z","F1922653-C8B9-4AA8-8B7E-829B057918D5","8C8E5DD2-B8EF-4E5C-9CD6-7D3717E4CDEF","Unaligned reads",5773268233,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","C23BC644-FF87-4C84-A156-686903524AAA","University of North Carolina","564a3318e4b09c884b21d1b7","787C3E2F-A708-4985-A5B1-B2383C7BFC52","Uterine Corpus Endometrial Carcinoma","TARGZ","830330FA-F309-4DD5-8BA9-1A377AFCD59C","2014-01-07T04:27:02.000Z","8DF98207-4FFE-4B93-B403-F304906494F9","United States","NO",1,NA,"Primary Tumor","Washington University",1866,"830330FA-F309-4DD5-8BA9-1A377AFCD59C",NA,"FI","CUTES_p_TCGA_172_176_178_SNP_N_GenomeWideSNP_6_H09_863572.raw.copynumber.data.txt",140,"TCGA-FI-A2EY-01A",NA,"97048882-64BE-4634-8361-2DCF7360D631","TCGA",2006,NA,NA,"TUMOR FREE","8C8E5DD2-B8EF-4E5C-9CD6-7D3717E4CDEF",63,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A57C3886-0CF2-40C1-9D4D-2F74B5D4F6F1.txt","Dead",880,"TCGA-FI-A2EY","NOT HISPANIC OR LATINO","8A6E1ECB-E6EA-4F43-9605-640E28B14CF8",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,12,30,"45DB3839-8439-4FA3-A540-7C977513DF90","FB75BFA9-0534-424A-B2E1-C3C4518896E3","UNCID_2223664.c23bc644-ff87-4c84-a156-686903524aaa.sorted_genome_alignments.bam","TCGA-FI-A2EY-01A-12",85,0,20,40,5,"TOP",10,20,"TCGA-FI-A2EY-01A-01-TSA",85,"Paclitaxel","Chemotherapy","TCGA-FI-A2EY-D31801",NA,NA,NA,NA,"YES",NA,"TUMOR FREE","Dead",880,"TCGA-FI-A2EY-F31521","TCGA-FI-A2EY",1,"FI","A2EY","YES","C54.1","8441/3","C54.1","NO","YES",-23042,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,880,NA,NA,"TUMOR FREE","NO",27,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,63,2006,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33338495,33149384,2466827446,"8879C57E-8876-462F-810E-EE07C2F541AD.bw","787d313f-9255-4b93-8ac2-0aa8febb7909","8879c57e-8876-462f-810e-ee07c2f541ad","2016-08-09T14:07:55.587777-05:00","UNCID_2203706.fffc5da3-ed33-4f8d-982e-e75b2d707c4b.111103_UNC6-RDR300211_00130_FC_638P5AAXX_6.tar.gz","5d14dc6d-db4a-4418-a536-c18585a40cad",2169521944,"Illumina GA","3223ab2a57bfac0241d1e7e982e5f864","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:09:34.253720-05:00","2016-05-03T11:10:47.515830-05:00","5d14dc6d-db4a-4418-a536-c18585a40cad_analysis.xml","ccf495f218634680f17af8184f8181be","880c67c3-0d8b-4417-84a2-3cf5b2db035b",2121,"2016-08-26T09:11:04.931122-05:00","5d14dc6d-db4a-4418-a536-c18585a40cad_experiment.xml","ae6f48f42aeff519d6919545722f41e1","46333078-35ea-4dce-bef4-4c5fd072fa8a",2257,"2016-09-29T21:38:28.377894-05:00","5d14dc6d-db4a-4418-a536-c18585a40cad_run.xml","2e273a2e2a9449e49987e5fa2df4bddb","99e0a44c-94e8-4f55-9af7-7c98d38d8be5",347,"2016-09-08T12:16:32.442650-05:00","TCGA-FI-A2D6","2016-09-02T18:52:57.193283-05:00","female","TCGA-FI-A2D6_demographic",1935,"white","64644953-9847-5512-ab46-7325c89519b5","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2D6_diagnosis","not reported",27060,"dead","8380/3",767,263,"a5b33358-e477-5003-a61b-918ef585c326","c54.1",-27060,"TCGA-FI-A2D6_treatment","032537d8-6aed-5929-a8c7-0d4baaf8e538","01","true","TCGA-FI-A2D6-01A",NA,"08f6f51f-9c99-4581-8cda-bec9a5208ee8",FALSE,"829C7791-3872-4EAC-BEC2-6B849056A4B7","Primary Tumor",NA,641,70,NA,1308700800,"11",30,"TCGA-FI-A2D6-01A-11",98,NA,5,NA,0,NA,2,NA,"2016-09-08T12:16:32.442650-05:00",NA,15,NA,3,NA,"TOP",NA,15,NA,"f53c9c47-0df9-4738-8ed0-a29cd1426224",NA,"TCGA-FI-A2D6-01A-01-TSA",NA,83,NA,"2330f1cf-fc65-417a-b7b2-1d9f4e75ec33","RNA","TCGA-FI-A2D6-01A-11R","70386def-6c18-45f1-b3c1-14670ada9293",2,0.17,"UV Spec","R","23","TCGA-FI-A2D6-01A-11R-A17B-07","fffc5da3-ed33-4f8d-982e-e75b2d707c4b",0.17,NA,95,34.8943985307622,165,"1f1e5e97-6e7f-5ca7-b2a8-cc847ef55f70","TCGA-FI-A2D6_exposure","UNCID_2203706.fffc5da3-ed33-4f8d-982e-e75b2d707c4b.111103_UNC6-RDR300211_00130_FC_638P5AAXX_6.tar.gz","2013-09-26T16:16:04.000Z","2013-09-26T16:29:01.000Z","5D14DC6D-DB4A-4418-A536-C18585A40CAD","08F6F51F-9C99-4581-8CDA-BEC9A5208EE8","Unaligned reads",2169521944,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","FFFC5DA3-ED33-4F8D-982E-E75B2D707C4B","University of North Carolina","56607479e4b0ca319164c478","787D313F-9255-4B93-8AC2-0AA8FEBB7909","Uterine Corpus Endometrial Carcinoma","TARGZ","2330F1CF-FC65-417A-B7B2-1D9F4E75EC33","2013-09-26T16:29:01.000Z","70386DEF-6C18-45F1-B3C1-14670ADA9293","United States","NO",1,NA,"Primary Tumor","Washington University",641,"2330F1CF-FC65-417A-B7B2-1D9F4E75EC33",NA,"FI","UNCID_2203706.fffc5da3-ed33-4f8d-982e-e75b2d707c4b.111103_UNC6-RDR300211_00130_FC_638P5AAXX_6.tar.gz",70,"TCGA-FI-A2D6-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","9958C25B-0D67-4C05-8D79-EC2497ACD89E",74,"nationwidechildrens.org_clinical.TCGA-FI-A2D6.xml","Alive",NA,"TCGA-FI-A2D6","NOT HISPANIC OR LATINO","8A3CE3F2-13FB-432A-A2FB-17DE24BAA7D9",NA,273,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"F53C9C47-0DF9-4738-8ED0-A29CD1426224","F85A6DF0-B826-4596-939D-B2B2A49EB0D2","UNCID_2203706.fffc5da3-ed33-4f8d-982e-e75b2d707c4b.111103_UNC6-RDR300211_00130_FC_638P5AAXX_6.tar.gz","TCGA-FI-A2D6-01A-11",98,0,5,15,2,"TOP",15,3,"TCGA-FI-A2D6-01A-01-TSA",83,NA,NA,NA,NA,NA,NA,NA,"NO",263,"TUMOR FREE","Alive",NA,"TCGA-FI-A2D6-F31746","TCGA-FI-A2D6",1,"FI","A2D6","YES","C54.1","8380/3","C54.1","NO","YES",-27060,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",273,NA,NA,NA,"TUMOR FREE","NO",28,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
102100226,100248921,4769021615,"1576BB97-F8EA-48FF-9494-EBC7A0C97312.bw","7890628d-7120-4dbc-85ae-1f895b6660c2","1576bb97-f8ea-48ff-9494-ebc7a0c97312","2016-08-09T13:15:12.732730-05:00","UNCID_2177892.11a0e295-f45e-4979-8317-10429d515d34.130402_UNC10-SN254_0447_BC22WAACXX_3_GGCTAC.tar.gz","aa3c8bbe-cdb5-4af8-8f07-dfb55ff1e4da",4321133340,"Illumina HiSeq","58988c8c0b70f4c43f2b6094ae33fe4a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:55:57.545534-05:00","2016-05-03T10:56:47.877475-05:00","aa3c8bbe-cdb5-4af8-8f07-dfb55ff1e4da_analysis.xml","d40814dfe34239e7e998ba8d9185a008","0f655851-2d2f-47ec-8ce8-79ccbe9839cd",2123,"2016-09-29T22:12:33.790108-05:00","aa3c8bbe-cdb5-4af8-8f07-dfb55ff1e4da_experiment.xml","f80181ba267651613bc20f484c785932","aef342ac-07a1-4126-a8e3-29a8f132f85f",2431,"2016-09-29T23:33:15.248250-05:00","aa3c8bbe-cdb5-4af8-8f07-dfb55ff1e4da_run.xml","49dacfe215eb69fdf518573f19b5d4e6","e115667f-8457-4b89-9d8f-63f2e5bb34f0",354,"2016-09-08T11:05:45.417030-05:00","TCGA-D1-A3DG","2016-09-02T18:47:38.911354-05:00","female","TCGA-D1-A3DG_demographic",1930,"white","4e318d3b-5faf-5302-b744-2aaf8d6fb33b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A3DG_diagnosis","not reported",29771,"dead","8380/3",130,130,"0f8d3a22-1d15-53f5-980b-63ebe2380b58","c54.1",-29771,"TCGA-D1-A3DG_treatment","b17f86ce-7b1c-5122-9bbb-c8055aba484e","01","true","TCGA-D1-A3DG-01A",NA,"ad26154d-5587-4af9-975f-367d712a5749",FALSE,"97C44FFC-8D88-43DC-BCC9-F634151C7098","Primary Tumor",NA,49,140,NA,1319068800,"11",30,"TCGA-D1-A3DG-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T11:05:45.417030-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"db67f64d-84c6-40ab-86fa-45fdad212016",NA,"TCGA-D1-A3DG-01A-01-TSA",NA,100,NA,"90ddb87c-d172-415c-9bb8-6188cddd8fef","RNA","TCGA-D1-A3DG-01A-11R","b4371fb2-dff3-452a-9ff4-4e228f426b51",1.79,0.18,"UV Spec","R","23","TCGA-D1-A3DG-01A-11R-A19W-07","11a0e295-f45e-4979-8317-10429d515d34",0.18,NA,86,30.4705215419501,168,"85cfee60-717d-5709-9abf-fcaa5892d786","TCGA-D1-A3DG_exposure","UNCID_2177892.11a0e295-f45e-4979-8317-10429d515d34.130402_UNC10-SN254_0447_BC22WAACXX_3_GGCTAC.tar.gz","2013-09-11T20:06:04.000Z","2013-09-11T20:20:02.000Z","AA3C8BBE-CDB5-4AF8-8F07-DFB55FF1E4DA","AD26154D-5587-4AF9-975F-367D712A5749","Unaligned reads",4321133340,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","11A0E295-F45E-4979-8317-10429D515D34","University of North Carolina","56607805e4b0b37b3d991167","7890628D-7120-4DBC-85AE-1F895B6660C2","Uterine Corpus Endometrial Carcinoma","TARGZ","90DDB87C-D172-415C-9BB8-6188CDDD8FEF","2013-09-11T20:20:02.000Z","B4371FB2-DFF3-452A-9FF4-4E228F426B51","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",49,"90DDB87C-D172-415C-9BB8-6188CDDD8FEF",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F12A529F-E468-486B-8B4E-A1EBC92C1A73.txt",140,"TCGA-D1-A3DG-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","AD26154D-5587-4AF9-975F-367D712A5749",81,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F12A529F-E468-486B-8B4E-A1EBC92C1A73.txt","Alive",NA,"TCGA-D1-A3DG","NOT HISPANIC OR LATINO","CCE3B5C5-701D-4132-87AE-0E4D535455C9",NA,130,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,"WHITE",NA,11,30,"DB67F64D-84C6-40AB-86FA-45FDAD212016","66DDDCD9-AF46-4A2B-99A7-030212612C90","TCGA-D1-A3DG-01A-11R-A19V-13_mirna.bam","TCGA-D1-A3DG-01A-11",75,0,0,0,0,"TOP",0,0,"TCGA-D1-A3DG-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,"TCGA-D1-A3DG-F41478_NTE-1","NO",NA,NA,"Dead",130,"TCGA-D1-A3DG-F41478","TCGA-D1-A3DG",1,"D1","A3DG","YES","C54.1","8380/3","C54.1","NO","YES",-29771,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",130,NA,NA,NA,"TUMOR FREE","NO",15,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,81,2011,"Excisional Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29553675,29102728,2108105309,"6C1FF3E9-0A8B-4B02-B0E9-EEF333E53592.bw","79ecc142-8f6e-4260-a7ce-c8e2a6212c35","6c1ff3e9-0a8b-4b02-b0e9-eef333e53592","2016-08-09T14:16:33.890051-05:00","UNCID_2215118.a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a.101014_UNC2-RDR300275_00039_FC_706C1AAXX_3.tar.gz","ee5ed9f0-8240-4b0b-b922-4dcef0a829bc",1785760008,"Illumina GA","715c51d4768c5128e0e221ea8cba9363","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:14:33.573728-05:00","2016-05-03T11:17:59.899725-05:00","ee5ed9f0-8240-4b0b-b922-4dcef0a829bc_analysis.xml","509ec26cc48b41075e24422a2b3c7529","b03d046b-8037-4ad0-af9b-b36960223434",2120,"2016-09-29T21:04:33.304420-05:00","ee5ed9f0-8240-4b0b-b922-4dcef0a829bc_experiment.xml","4d2013dbafb5c35dfff2e8dd65e94c75","84d609d6-7a38-403d-b872-d379ca2ceca2",2256,"2016-09-29T23:59:45.658949-05:00","ee5ed9f0-8240-4b0b-b922-4dcef0a829bc_run.xml","298eace3e2929fd8cfd715d761ab2025","f18604d1-89e3-47ce-8bea-877b991c234e",345,"2016-09-08T10:50:34.585840-05:00","TCGA-B5-A0K3","2016-09-02T18:54:44.042937-05:00","female","TCGA-B5-A0K3_demographic",1947,"black or african american","8827821d-7097-5450-b0fb-239fd48ffac4","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0K3_diagnosis","not reported",22664,"dead","8380/3",830,700,"cccb49d5-f5a6-516f-aa16-e4095ee4c579","c54.1",-22664,"TCGA-B5-A0K3_treatment","4ffa9f48-e839-5b6a-9cff-92d0321c588a","01","true","TCGA-B5-A0K3-01A",NA,"ed31ddc2-feda-496e-a642-0c4b5dce014d",FALSE,"2D78431C-7385-4BD3-B597-85E613D89BF6","Primary Tumor",NA,523,390,NA,1277769600,"11",30,"TCGA-B5-A0K3-01A-11",90,85,0,0,0,0,0,10,"2016-09-08T10:50:34.585840-05:00","2016-09-08T10:50:34.585840-05:00",0,0,0,0,"TOP","BOTTOM",5,5,"08df3c15-bb0b-46d3-9a1b-fcf18a8b39aa","109f079c-5142-4478-847a-955e9ae53da1","TCGA-B5-A0K3-01A-01-TSA","TCGA-B5-A0K3-01A-01-BSA",95,85,"430088ab-f5da-42af-a0a7-464e191bb47d","RNA","TCGA-B5-A0K3-01A-11R","1a4d6db6-a0d4-4d42-bf09-b433c6475743",1.85,0.15,"UV Spec","R","23","TCGA-B5-A0K3-01A-11R-A040-07","a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a",0.15,NA,88,32.7186198691255,164,"c903f959-8f20-5281-9212-00f005551ee8","TCGA-B5-A0K3_exposure","UNCID_2215118.a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a.101014_UNC2-RDR300275_00039_FC_706C1AAXX_3.tar.gz","2013-10-04T00:37:04.000Z","2013-10-04T00:49:03.000Z","EE5ED9F0-8240-4B0B-B922-4DCEF0A829BC","ED31DDC2-FEDA-496E-A642-0C4B5DCE014D","Unaligned reads",1785760008,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A2D46B53-D9BD-4C19-9A0A-FECB48D3C06A","University of North Carolina","56607e18e4b016715ab6b8f0","79ECC142-8F6E-4260-A7CE-C8E2A6212C35","Uterine Corpus Endometrial Carcinoma","TARGZ","430088AB-F5DA-42AF-A0A7-464E191BB47D","2013-10-04T00:49:03.000Z","1A4D6DB6-A0D4-4D42-BF09-B433C6475743","United States","NO",1,NA,"Primary Tumor","Duke",523,"430088AB-F5DA-42AF-A0A7-464E191BB47D",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.7854E580-34CD-4714-A5FF-58219FDC22BE.txt",390,"TCGA-B5-A0K3-01A",NA,"8CC53240-0467-4AC4-BD09-2AA75F382046","TCGA",2009,NA,NA,"WITH TUMOR","ED31DDC2-FEDA-496E-A642-0C4B5DCE014D",62,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.7854E580-34CD-4714-A5FF-58219FDC22BE.txt","Alive",NA,"TCGA-B5-A0K3",NA,"3BFDA979-1209-49BE-B1DE-D4361E9B72A3",NA,700,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"109F079C-5142-4478-847A-955E9AE53DA1","8075BEF8-634E-409E-A87B-055EA6AB1A98","UNCID_2215118.a2d46b53-d9bd-4c19-9a0a-fecb48d3c06a.101014_UNC2-RDR300275_00039_FC_706C1AAXX_3.tar.gz","TCGA-B5-A0K3-01A-11",85,0,0,0,10,"BOTTOM",5,0,"TCGA-B5-A0K3-01A-01-BSA",85,"Doxorubicin HCl Liposomal","Chemotherapy","TCGA-B5-A0K3-D10028",NA,NA,NA,NA,"YES",NA,NA,NA,NA,"TCGA-B5-A0K3-F13268","TCGA-B5-A0K3",1,"B5","A0K3","YES","C54.1","8380/3","C54.1","NO","YES",-22664,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",700,NA,NA,NA,"WITH TUMOR","NO",5,1,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36765299,36285134,2685576813,"90C991CD-412E-4318-96E3-EB84B868FE9F.bw","7a077812-f6ee-4820-a084-1a52c7ef062c","90c991cd-412e-4318-96e3-eb84b868fe9f","2016-08-04T23:15:44.941858-05:00","UNCID_2206675.2ffda10e-5941-4c80-9291-a5ebbe0d5a2a.111006_UNC2-RDR300275_00089_FC_634EEAAXX_4.tar.gz","f7655dca-de72-4bfc-bbc1-4ed3dcb80ad5",2430830894,"Illumina GA","e1711eb0e5b9c46fb3da60d566abc837","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:21:28.489537-05:00","2016-05-03T11:11:34.764500-05:00","f7655dca-de72-4bfc-bbc1-4ed3dcb80ad5_analysis.xml","d65cd1821e2f3c4eb10ef4ea6aab6c95","453ac6d3-7c26-45b6-9ec5-969b77441a4d",2121,"2016-10-07T16:54:39.507105-05:00","f7655dca-de72-4bfc-bbc1-4ed3dcb80ad5_experiment.xml","18d81aabe14c9ba4d44106e3edcb5449","d890c9bd-8002-473f-8e7f-0810dd7268e6",2257,"2016-09-29T18:51:41.466221-05:00","f7655dca-de72-4bfc-bbc1-4ed3dcb80ad5_run.xml","8a0491abfd086782507215c37bd498ef","326e06c3-576b-4d3d-bc1e-6d087d1390ed",347,"2016-09-08T11:04:50.730567-05:00","TCGA-AX-A2HF","2016-09-02T18:52:28.576515-05:00","female","TCGA-AX-A2HF_demographic",1943,"white","558de49a-8e14-51dd-8df2-fca36ddbcf3d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HF_diagnosis","not reported",24689,"alive","8441/3",NA,848,"24d572af-0dda-57d1-ba9d-9cb686340d6b","c54.1",-24689,"TCGA-AX-A2HF_treatment","c287c649-8af9-52d6-907d-483fbd5bbdb2","01","false","TCGA-AX-A2HF-01A",NA,"137e9776-ca5c-47f3-9ef7-8726d021fbb2",FALSE,"5454BF58-3D26-4D61-B0A8-30A06ECD0E60","Primary Tumor",NA,440,140,NA,1308182400,"11",30,"TCGA-AX-A2HF-01A-11",98,NA,0,NA,0,NA,2,NA,"2016-09-08T11:04:50.730567-05:00",NA,0,NA,0,NA,"TOP",NA,2,NA,"bbbb2b1a-2a3b-4583-bd26-5b46adcab7d6",NA,"TCGA-AX-A2HF-01A-01-TSA",NA,96,NA,"02490372-8dfd-4f56-860b-a93a901453c3","RNA","TCGA-AX-A2HF-01A-11R","68437c90-3f7d-4288-a8cc-94e5e058c3ef",2.17,0.16,"UV Spec","R","23","TCGA-AX-A2HF-01A-11R-A17B-07","2ffda10e-5941-4c80-9291-a5ebbe0d5a2a",0.16,NA,70,28.3987180007303,157,"240cbb46-8a03-5e1b-b1fd-6b3ae9041fb2","TCGA-AX-A2HF_exposure","UNCID_2206675.2ffda10e-5941-4c80-9291-a5ebbe0d5a2a.111006_UNC2-RDR300275_00089_FC_634EEAAXX_4.tar.gz","2013-09-27T18:56:06.000Z","2013-09-27T07:09:02.000Z","F7655DCA-DE72-4BFC-BBC1-4ED3DCB80AD5","137E9776-CA5C-47F3-9EF7-8726D021FBB2","Unaligned reads",2430830894,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2FFDA10E-5941-4C80-9291-A5EBBE0D5A2A","University of North Carolina","564a3bc5e4b0ef12181a8ec3","7A077812-F6EE-4820-A084-1A52C7EF062C","Uterine Corpus Endometrial Carcinoma","TARGZ","02490372-8DFD-4F56-860B-A93A901453C3","2013-09-27T07:09:02.000Z","68437C90-3F7D-4288-A8CC-94E5E058C3EF","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",440,"02490372-8DFD-4F56-860B-A93A901453C3",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.84A10878-AFC0-4880-A277-D06ACFDFCA8C.txt",140,"TCGA-AX-A2HF-01A",NA,"B9AC5C39-4A2A-4B0F-97E0-E5E78A9C6D83","TCGA",2010,NA,NA,"TUMOR FREE","537B6CC2-B617-4A5E-BE25-FE4AEE40BB4C",67,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.84A10878-AFC0-4880-A277-D06ACFDFCA8C.txt","Alive",NA,"TCGA-AX-A2HF","NOT HISPANIC OR LATINO","4E563268-CD36-46B5-95F9-5427F740BA2D",NA,489,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,"E86418E7-1971-479B-8220-F891199DFA6F","WHITE",NA,11,30,"BBBB2B1A-2A3B-4583-BD26-5B46ADCAB7D6","DC6A4181-7D7E-4277-8F0A-7A46BD9FD8BF","TATTY_p_TCGA_b52_156_SNP_N_GenomeWideSNP_6_G08_809044.ismpolish.data.txt","TCGA-AX-A2HF-01A-11",98,0,0,0,2,"TOP",2,0,"TCGA-AX-A2HF-01A-01-TSA",96,"Paclitaxel","Chemotherapy","TCGA-AX-A2HF-D31638","TCGA-AX-A2HF-R31639","IMPLANTS",NA,NA,"NO",589,"TUMOR FREE","Alive",NA,"TCGA-AX-A2HF-F31656","TCGA-AX-A2HF",1,"AX","A2HF","YES","C54.1","8441/3","C54.1","NO","YES",-24689,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",489,NA,NA,NA,"TUMOR FREE","NO",31,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32268151,31738290,2370360175,"251FD1E2-DA95-46F0-B95C-1AF74CCFCB21.bw","7a2cf5ce-8317-4fff-946e-b9937afab815","251fd1e2-da95-46f0-b95c-1af74ccfcb21","2016-08-09T14:07:37.032049-05:00","UNCID_2203683.8d2b2907-863e-4db9-8d4b-ce877e562531.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_3.tar.gz","093d4fd9-0c9d-4f37-9b78-4295e498d6de",2002308050,"Illumina GA","22eebe44a2e009b744fd0f7d60136931","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:41:56.220749-05:00","2016-05-03T11:10:47.515830-05:00","093d4fd9-0c9d-4f37-9b78-4295e498d6de_analysis.xml","0be7442c7e6723341391e323ac26b977","2c406215-22e9-48a2-b463-f98ab1a719e1",2121,"2016-09-29T19:25:06.922357-05:00","093d4fd9-0c9d-4f37-9b78-4295e498d6de_experiment.xml","92c69f53816e7aad784d5675eb4ce704","477f31e6-fd8f-4251-acf2-d96e35fdf3b3",2257,"2016-09-29T17:58:46.280842-05:00","093d4fd9-0c9d-4f37-9b78-4295e498d6de_run.xml","8c4c9fca5c8b5f39565fcc08f0564fec","112ea2f1-47a9-4c66-b498-4701b0ab3b20",347,"2016-09-08T10:30:36.936008-05:00","TCGA-AX-A2HG","2016-09-02T18:52:29.066176-05:00","female","TCGA-AX-A2HG_demographic",1953,"white","3505f603-e5fb-5a9e-8824-99e97c974956","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HG_diagnosis","not reported",20771,"alive","8380/3",NA,1163,"cb06baac-9e6b-5d41-984c-1ccfebb0f5b5","c54.1",-20771,"TCGA-AX-A2HG_treatment","be30cb19-8b77-5966-9d16-2acff402db61","01","false","TCGA-AX-A2HG-01A",NA,"5e3d8501-5e81-443f-8b64-e02a0e0b3d1f",FALSE,"EF863B73-4C80-42E6-8AAF-2EF72559212A","Primary Tumor",NA,582,150,NA,1308182400,"11",30,"TCGA-AX-A2HG-01A-11",70,NA,0,NA,20,NA,9,NA,"2016-09-08T10:30:36.936008-05:00",NA,20,NA,0,NA,"TOP",NA,1,NA,"1ac91f9c-428f-4f10-9e9b-1cba4364cf9b",NA,"TCGA-AX-A2HG-01A-01-TSA",NA,70,NA,"42327e89-76ea-4bc3-95c0-52824b430b03","RNA","TCGA-AX-A2HG-01A-11R","5456e03f-0375-4687-8e35-807b15e2633b",2.04,0.15,"UV Spec","R","23","TCGA-AX-A2HG-01A-11R-A17B-07","8d2b2907-863e-4db9-8d4b-ce877e562531",0.15,NA,115,46.6550367154854,157,"634e5fcb-f21d-50e4-8c7b-e396e082868e","TCGA-AX-A2HG_exposure","UNCID_2203683.8d2b2907-863e-4db9-8d4b-ce877e562531.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_3.tar.gz","2013-09-26T15:55:04.000Z","2013-09-26T16:08:01.000Z","093D4FD9-0C9D-4F37-9B78-4295E498D6DE","5E3D8501-5E81-443F-8B64-E02A0E0B3D1F","Unaligned reads",2002308050,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8D2B2907-863E-4DB9-8D4B-CE877E562531","University of North Carolina","5660779ce4b016715ab698be","7A2CF5CE-8317-4FFF-946E-B9937AFAB815","Uterine Corpus Endometrial Carcinoma","TARGZ","42327E89-76EA-4BC3-95C0-52824B430B03","2013-09-26T16:08:01.000Z","5456E03F-0375-4687-8E35-807B15E2633B","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",582,"42327E89-76EA-4BC3-95C0-52824B430B03",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C506AB11-CE52-4097-B686-C7962D68B9B5.txt",150,"TCGA-AX-A2HG-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","EF4B80EC-B453-48EC-8AD8-CCAC83E1E4DB",56,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C506AB11-CE52-4097-B686-C7962D68B9B5.txt","Alive",NA,"TCGA-AX-A2HG","HISPANIC OR LATINO","82381E0F-0AA4-4FA4-A40E-4A2CAA2E3AC7",NA,661,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,"44C2FA6C-8A70-4D3C-A7D6-607460A58F7E","WHITE",NA,11,30,"1AC91F9C-428F-4F10-9E9B-1CBA4364CF9B","D0EF1FB7-E1A3-49E4-AB18-C7C90B667E56","UNCID_2203683.8d2b2907-863e-4db9-8d4b-ce877e562531.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_3.tar.gz","TCGA-AX-A2HG-01A-11",70,20,0,20,9,"TOP",1,0,"TCGA-AX-A2HG-01A-01-TSA",70,NA,NA,NA,"TCGA-AX-A2HG-R31680","IMPLANTS",NA,NA,"NO",801,"TUMOR FREE","Alive",NA,"TCGA-AX-A2HG-F31657","TCGA-AX-A2HG",1,"AX","A2HG","YES","C54.1","8380/3","C54.1","NO","YES",-20771,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",661,NA,NA,NA,"TUMOR FREE","NO",31,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
101374216,90204623,4290280889,"8B5B3254-6861-404A-BB30-250486B85658.bw","7adaf608-19a5-4184-8b79-bbc6f9cf24ae","8b5b3254-6861-404a-bb30-250486b85658","2016-08-08T13:28:08.261289-05:00","UNCID_2167045.60fc2e50-f36c-4074-879b-b5773d75a466.130621_UNC14-SN744_0352_BC253TACXX_2_CGATGT.tar.gz","979ce7d0-e3db-4c92-9a38-032db9ba31b1",4396463852,"Illumina HiSeq","e29d02cf0ebda7095fd4cf981c1984d3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:53:56.373962-05:00","2016-05-03T11:07:07.492763-05:00","979ce7d0-e3db-4c92-9a38-032db9ba31b1_analysis.xml","4942608385f8a344e91622bd10a79277","33d78d61-d1df-4c3b-97b8-2deffd21eccb",2123,"2016-09-30T00:00:32.694031-05:00","979ce7d0-e3db-4c92-9a38-032db9ba31b1_experiment.xml","d5051298fcd62a566177ac5832eda63e","f1f9055a-a2ad-4393-bdd5-8715525e507a",2431,"2016-09-29T17:37:57.116465-05:00","979ce7d0-e3db-4c92-9a38-032db9ba31b1_run.xml","253722977400af1c96b1f17f16fa2288","03e0acba-1bf4-438b-8e2c-ef22327cd9ad",354,"2016-09-08T11:09:38.002531-05:00","TCGA-DF-A2L0","2016-09-02T18:53:55.773129-05:00","female","TCGA-DF-A2L0_demographic",NA,"not reported","e7e96bee-ac74-59ef-bb8f-80dcfcd1df95","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DF","bd439172-ab1d-57cc-a1ee-7282ceebd41a","Ontario Institute for Cancer Research","not reported","c54.1","TCGA-DF-A2L0_diagnosis","not reported",22200,"dead","8380/3",788,NA,"40f97b80-edac-5aea-ac69-928d372f2a80","c54.1",-22200,"TCGA-DF-A2L0_treatment","ca5efbea-4f5d-57b2-9571-57100bd95bc2","01","false","TCGA-DF-A2L0-01A",NA,"e3f9c326-544d-46e2-a58e-fc95e5ecd702",FALSE,"1679CA2C-86BF-41D1-96E1-62FC89D9AAA7","Primary Tumor",NA,NA,520,NA,1313452800,"11",30,"TCGA-DF-A2L0-01A-11",80,NA,5,NA,0,NA,20,NA,"2016-09-08T11:09:38.002531-05:00",NA,5,NA,10,NA,"TOP",NA,5,NA,"aa85eeaf-3a18-4572-b338-e33b4ec16fa8",NA,"TCGA-DF-A2L0-01A-01-TSA",NA,75,NA,"2a2156c8-e7e2-45ff-bae9-cbaeba3f48e1","RNA","TCGA-DF-A2L0-01A-11R","0ac14a36-d3d4-4157-89d8-bd808560cebe",1.76,0.17,"UV Spec","R","23","TCGA-DF-A2L0-01A-11R-A180-07","60fc2e50-f36c-4074-879b-b5773d75a466",0.17,NA,95,33.6592970521542,168,"577b8e08-5415-5aaf-b372-7c9e70c19c55","TCGA-DF-A2L0_exposure","UNCID_2167045.60fc2e50-f36c-4074-879b-b5773d75a466.130621_UNC14-SN744_0352_BC253TACXX_2_CGATGT.tar.gz","2013-09-21T07:01:04.000Z","2013-09-21T07:17:01.000Z","979CE7D0-E3DB-4C92-9A38-032DB9BA31B1","E3F9C326-544D-46E2-A58E-FC95E5ECD702","Unaligned reads",4396463852,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","60FC2E50-F36C-4074-879B-B5773D75A466","University of North Carolina","564a3a57e4b09c884b240953","7ADAF608-19A5-4184-8B79-BBC6F9CF24AE","Uterine Corpus Endometrial Carcinoma","TARGZ","2A2156C8-E7E2-45FF-BAE9-CBAEBA3F48E1","2013-09-21T07:17:01.000Z","0AC14A36-D3D4-4157-89D8-BD808560CEBE","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"2A2156C8-E7E2-45FF-BAE9-CBAEBA3F48E1",NA,"DF","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D58633C4-B72E-41B7-B8DC-2BBED3A4CD0C.txt",520,"TCGA-DF-A2L0-01A",NA,"7323A98C-6B53-4865-89D5-0144C3D6BA1C","TCGA",NA,"TCGA-DF-A2L0_NTE-1",NA,"WITH TUMOR","E3F9C326-544D-46E2-A58E-FC95E5ECD702",60,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D58633C4-B72E-41B7-B8DC-2BBED3A4CD0C.txt","Dead",788,"TCGA-DF-A2L0",NA,"2BA99092-A243-4143-ACF3-776A4A5387C2",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,"40994427-5F66-4186-A3A4-D57C44790EC0",NA,NA,11,30,"AA85EEAF-3A18-4572-B338-E33B4EC16FA8","79849D99-AAC1-412E-8CD1-2F7E44C31AE7","22f96758aa4589216639dc6eb87b67cb.bam.bai","TCGA-DF-A2L0-01A-11",80,0,5,5,20,"TOP",5,10,"TCGA-DF-A2L0-01A-01-TSA",75,"Carboplatin","Chemotherapy","TCGA-DF-A2L0-D49844","TCGA-DF-A2L0-R49846","External","Regional site","TCGA-DF-A2L0-F49841_NTE-1","YES",NA,"WITH TUMOR","Dead",788,"TCGA-DF-A2L0-F49841","TCGA-DF-A2L0",1,"DF","A2L0","YES","C54.1","8380/3","C54.1","NO","YES",-22200,"FEMALE",NA,NA,"No","No","Dead",NA,788,NA,NA,"WITH TUMOR","NO",11,10,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,NA,60,NA,"Other method, specify:",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33320326,32985250,2475521075,"B2639653-56F3-4992-9983-34F0142ED5E0.bw","7b7d2d2b-abe6-4f32-add0-3715096995d1","b2639653-56f3-4992-9983-34f0142ed5e0","2016-08-06T23:02:55.366118-05:00","UNCID_2214794.0b2aa3d5-f8cd-4047-91cf-295e6b4c8891.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_5.tar.gz","738e83f6-5fb9-4ef4-b46e-118438f22d24",2038895143,"Illumina GA","1dc3b2b079c9b456b9d5ba09107e0f81","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:15:27.146837-05:00","2016-05-03T11:17:14.905409-05:00","738e83f6-5fb9-4ef4-b46e-118438f22d24_analysis.xml","841d102993f571cf7d1dd3d7bbb1fbfe","d5f85aa4-5efc-4e6c-b54d-b464942da343",2119,"2016-09-29T23:14:53.832438-05:00","738e83f6-5fb9-4ef4-b46e-118438f22d24_experiment.xml","2c53724bcbe3bae866ade35585342f32","d5acfce7-b76b-496a-b286-3b3bf857ae67",2256,"2016-09-29T19:15:49.150620-05:00","738e83f6-5fb9-4ef4-b46e-118438f22d24_run.xml","a88fc7957277164cd78658145cb5b13d","41a2bf63-72eb-4683-8d49-76f7cee58fe1",345,"2016-09-08T10:37:28.991376-05:00","TCGA-BS-A0TC","2016-09-02T18:48:23.029542-05:00","female","TCGA-BS-A0TC_demographic",1935,"asian","9d386311-6715-5417-a3fb-06d248c6e813","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.3","TCGA-BS-A0TC_diagnosis","not reported",25560,"alive","8380/3",NA,2602,"6fb8ef5d-caed-5f93-8238-73f5291b6370","c54.3",-25560,"TCGA-BS-A0TC_treatment","94cbf165-19f0-56fc-908b-7050937cb943","01","false","TCGA-BS-A0TC-01A",NA,"c4c99327-b778-4e29-a111-75569ad38696",FALSE,"8AA64402-A062-410D-85B8-24DAD320916D","Primary Tumor",NA,2227,120,NA,1281484800,"11",30,"TCGA-BS-A0TC-01A-11",90,90,0,10,0,0,10,10,"2016-09-08T10:37:28.991376-05:00","2016-09-08T10:37:28.991376-05:00",20,50,5,20,"BOTTOM","TOP",0,0,"c6fe04a9-c77a-4820-9369-67cf2f30648b","9fe73928-2cfe-4398-8987-3dca33bd29ea","TCGA-BS-A0TC-01A-01-BS1","TCGA-BS-A0TC-01A-01-TS1",90,90,"f3ac605f-ff86-43df-8e7a-2400f2e4efdd","RNA","TCGA-BS-A0TC-01A-11R","df520c62-c310-4ae8-8f92-4b5a8fd54739",1.91,0.17,"UV Spec","R","23","TCGA-BS-A0TC-01A-11R-A104-07","0b2aa3d5-f8cd-4047-91cf-295e6b4c8891",0.17,NA,68,31.4683696607895,147,"3f8cb9ad-6613-5852-931b-3e63e383b4fd","TCGA-BS-A0TC_exposure","UNCID_2214794.0b2aa3d5-f8cd-4047-91cf-295e6b4c8891.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_5.tar.gz","2013-10-03T21:16:04.000Z","2013-10-03T21:28:02.000Z","738E83F6-5FB9-4EF4-B46E-118438F22D24","C4C99327-B778-4E29-A111-75569AD38696","Unaligned reads",2038895143,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0B2AA3D5-F8CD-4047-91CF-295E6B4C8891","University of North Carolina","56607db2e4b018727fea3419","7B7D2D2B-ABE6-4F32-ADD0-3715096995D1","Uterine Corpus Endometrial Carcinoma","TARGZ","F3AC605F-FF86-43DF-8E7A-2400F2E4EFDD","2013-10-03T21:28:02.000Z","DF520C62-C310-4AE8-8F92-4B5A8FD54739","None","NO",1,NA,"Primary Tumor","University of Hawaii",2227,"F3AC605F-FF86-43DF-8E7A-2400F2E4EFDD",NA,"BS","jhu-usc.edu_UCEC.HumanMethylation27.3.lvl-2.TCGA-BS-A0TC-01A-11D-A10Q-05.txt",120,"TCGA-BS-A0TC-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","C4C99327-B778-4E29-A111-75569AD38696",69,"nationwidechildrens.org_clinical.TCGA-BS-A0TC.xml","Alive",NA,"TCGA-BS-A0TC","NOT HISPANIC OR LATINO","E710452A-C98A-41E7-8028-BB72E1451FCB",NA,2260,"No","Uterus","C54.3",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.3",73,NA,NA,"ASIAN",NA,11,30,"9FE73928-2CFE-4398-8987-3DCA33BD29EA","8C7908C5-6EC4-4DF9-97EC-7B5EF792F83A","aa55b92d7a3d9eabf7f8c19d30f85566.bam.bai","TCGA-BS-A0TC-01A-11",90,0,0,20,10,"BOTTOM",0,5,"TCGA-BS-A0TC-01A-01-BS1",90,NA,NA,NA,NA,NA,NA,NA,NA,2602,"TUMOR FREE","Alive",NA,"TCGA-BS-A0TC-F4391","TCGA-BS-A0TC",1,"BS","A0TC","YES","C54.3","8380/3","C54.3","NO","YES",-25560,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",2260,NA,NA,NA,"TUMOR FREE","NO",19,11,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33413625,33097743,2461162338,"7A6BBBE6-2B3B-44EB-A101-C823739AB24F.bw","7b9947d5-e86b-4006-8890-ea5209584a88","7a6bbbe6-2b3b-44eb-a101-c823739ab24f","2016-08-08T03:32:33.340662-05:00","UNCID_2214968.43abe272-41cb-4b54-b6f6-50a27c670e46.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_7.tar.gz","a288ca34-1390-4217-844d-568b70e1f763",2040690726,"Illumina GA","7fb46be45973deedd2817be3c3e6f114","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:08:28.171445-05:00","2016-05-03T11:17:59.903755-05:00","a288ca34-1390-4217-844d-568b70e1f763_analysis.xml","333ad997c860ebde92464ce5abe0fabf","d1a396f4-297a-4384-9501-bf10cec0b2b1",2122,"2016-09-30T00:09:07.296820-05:00","a288ca34-1390-4217-844d-568b70e1f763_experiment.xml","0e33e6f7de8a42adc3a8e67ffa1f1b4e","f722146e-5269-41dd-8f8d-245f97346e23",2256,"2016-09-29T23:29:05.377587-05:00","a288ca34-1390-4217-844d-568b70e1f763_run.xml","91d76e92ea8534e052cabefbb96b41a6","de6add2e-e22f-4f13-8107-3c13303d28dd",345,"2016-09-08T10:44:06.859921-05:00","TCGA-AP-A0L9","2016-09-02T18:54:25.704661-05:00","female","TCGA-AP-A0L9_demographic",1930,"white","05c600f7-24d5-5768-9a0b-9c03dc374335","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0L9_diagnosis","not reported",26185,"alive","8441/3",NA,3815,"e04d0c32-8452-5a7c-b2f2-449dd19152c6","c54.1",-26185,"TCGA-AP-A0L9_treatment","4efab499-95b4-51eb-9c79-96e89696e61f","01","true","TCGA-AP-A0L9-01A",NA,"53d0521f-10d6-4f70-9277-d99025a6b963",FALSE,"62E44C56-838D-4318-B8F7-80476A148C03","Primary Tumor",NA,3402,140,NA,1278547200,"11",30,"TCGA-AP-A0L9-01A-11",100,100,0,0,0,0,0,0,"2016-09-08T10:44:06.859921-05:00","2016-09-08T10:44:06.859921-05:00",20,20,20,20,"TOP","BOTTOM",20,20,"f43521cb-85c1-4eda-90b7-c8dbe2af7b62","575ffdcb-b260-4848-80ab-36e3c6eb5429","TCGA-AP-A0L9-01A-01-TSA","TCGA-AP-A0L9-01A-01-BSA",80,80,"42cf146c-34bf-42bf-b095-8e689460dc07","RNA","TCGA-AP-A0L9-01A-11R","bf9e4a9b-b28e-4003-bde8-130cd6db65a4",1.72,0.14,"UV Spec","R","23","TCGA-AP-A0L9-01A-11R-A040-07","43abe272-41cb-4b54-b6f6-50a27c670e46",0.14,NA,60,25.9695290858726,152,"c1607987-3ecb-56d2-8a5e-0efa9ab26be3","TCGA-AP-A0L9_exposure","UNCID_2214968.43abe272-41cb-4b54-b6f6-50a27c670e46.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_7.tar.gz","2013-10-03T22:46:05.000Z","2013-10-04T00:19:02.000Z","A288CA34-1390-4217-844D-568B70E1F763","53D0521F-10D6-4F70-9277-D99025A6B963","Unaligned reads",2040690726,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","43ABE272-41CB-4B54-B6F6-50A27C670E46","University of North Carolina","564a4044e4b0ef12181c0180","7B9947D5-E86B-4006-8890-EA5209584A88","Uterine Corpus Endometrial Carcinoma","TARGZ","42CF146C-34BF-42BF-B095-8E689460DC07","2013-10-04T00:19:02.000Z","BF9E4A9B-B28E-4003-BDE8-130CD6DB65A4","None","NO",1,NA,"Primary Tumor","MSKCC",3402,"42CF146C-34BF-42BF-B095-8E689460DC07",NA,"AP","TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.bam",140,"TCGA-AP-A0L9-01A",NA,NA,"TCGA",2001,NA,NA,"TUMOR FREE","60EAC6D9-6404-4C11-A30C-3986D1CACAF2",71,"nationwidechildrens.org_clinical.TCGA-AP-A0L9.xml","Alive",NA,"TCGA-AP-A0L9",NA,"A98DDB9B-C512-4789-81B2-CD425E6C6054",NA,3444,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"F43521CB-85C1-4EDA-90B7-C8DBE2AF7B62","FC8F0F06-476E-49B8-A292-0A3CD3346DC5","TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.bam","TCGA-AP-A0L9-01A-11",100,0,0,20,0,"TOP",20,20,"TCGA-AP-A0L9-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,NA,3444,"TUMOR FREE","Alive",NA,"TCGA-AP-A0L9-F3836","TCGA-AP-A0L9",1,"AP","A0L9","YES","C54.1","8441/3","C54.1","NO","YES",-26185,"FEMALE","WHITE",NA,"No","No","Alive",3444,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,71,2001,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
98112980,96869746,4609523153,"C42DF19B-5558-46F3-B00B-A100F2ED9BEE.bw","7d22ff96-9249-46b3-9cfa-e40dc4ecebd6","c42df19b-5558-46f3-b00b-a100f2ed9bee","2016-08-09T13:17:42.157813-05:00","UNCID_2177891.8576f260-e8fb-4fbf-81ad-34fb4af302fd.130402_UNC10-SN254_0447_BC22WAACXX_3_ATCACG.tar.gz","464ad24d-aacd-41e6-a95a-7df56af88ea8",4142904701,"Illumina HiSeq","abe19f57c40f3b05c9d628521b05ad0b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:48:26.443223-05:00","2016-05-03T10:56:47.877475-05:00","464ad24d-aacd-41e6-a95a-7df56af88ea8_analysis.xml","eb6601201c41fa911e3f63b701d2f95c","ea80497d-ca54-46a0-9dab-5288dd4487a6",2123,"2016-10-07T17:19:52.896003-05:00","464ad24d-aacd-41e6-a95a-7df56af88ea8_experiment.xml","875355663185da2c86534259b1e0a0f6","59c6ebe5-d2c2-4463-81b0-2e2881de0cf1",2431,"2016-09-29T18:06:04.864216-05:00","464ad24d-aacd-41e6-a95a-7df56af88ea8_run.xml","7769e5fb1f927bca5c35280eb6fdd61c","15de7749-ad0a-4cf5-80f1-41e66c926b84",354,"2016-09-08T11:59:31.929422-05:00","TCGA-D1-A3DH","2016-09-02T18:47:39.677942-05:00","female","TCGA-D1-A3DH_demographic",1940,"white","0b11fb4d-52a2-56e1-9cef-35568e1a2c19","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A3DH_diagnosis","not reported",25935,"alive","8380/3",NA,573,"4016a029-9a7a-5557-9078-8876bf570a60","c54.1",-25935,"TCGA-D1-A3DH_treatment","2275e016-0860-5fd9-a236-4fe8d14ed7ea","01","true","TCGA-D1-A3DH-01A",NA,"5d130578-de0c-4336-92e6-02c6f11add92",FALSE,"C63CF985-CF78-42EE-A7A2-22083FED571D","Primary Tumor",NA,43,150,NA,1319068800,"11",30,"TCGA-D1-A3DH-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T11:59:31.929422-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"64be6a8f-6309-4492-b858-57c814070948",NA,"TCGA-D1-A3DH-01A-01-TSA",NA,100,NA,"46236498-c503-43d8-bda3-a32bac4cc5b9","RNA","TCGA-D1-A3DH-01A-11R","ed4c2af6-a12a-4741-8c1a-9c2b3c8f7501",1.78,0.17,"UV Spec","R","23","TCGA-D1-A3DH-01A-11R-A19W-07","8576f260-e8fb-4fbf-81ad-34fb4af302fd",0.17,NA,76,26.9274376417234,168,"0e3a954a-529c-5281-b836-51aea8bc1753","TCGA-D1-A3DH_exposure","UNCID_2177891.8576f260-e8fb-4fbf-81ad-34fb4af302fd.130402_UNC10-SN254_0447_BC22WAACXX_3_ATCACG.tar.gz","2013-09-11T20:01:09.000Z","2013-09-11T20:14:01.000Z","464AD24D-AACD-41E6-A95A-7DF56AF88EA8","5D130578-DE0C-4336-92E6-02C6F11ADD92","Unaligned reads",4142904701,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8576F260-E8FB-4FBF-81AD-34FB4AF302FD","University of North Carolina","56607e5be4b0ec1099f8f0d1","7D22FF96-9249-46B3-9CFA-E40DC4ECEBD6","Uterine Corpus Endometrial Carcinoma","TARGZ","46236498-C503-43D8-BDA3-A32BAC4CC5B9","2013-09-11T20:14:01.000Z","ED4C2AF6-A12A-4741-8C1A-9C2B3C8F7501","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",43,"46236498-C503-43D8-BDA3-A32BAC4CC5B9",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2EFDF91C-E96E-4A86-BF0C-A275A9FF2BA0.txt",150,"TCGA-D1-A3DH-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","FCCBB5BC-142A-40CA-9480-BCAAF9EA277E",71,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2EFDF91C-E96E-4A86-BF0C-A275A9FF2BA0.txt","Alive",NA,"TCGA-D1-A3DH","NOT HISPANIC OR LATINO","C344A92B-0BC2-4BA7-A619-034293449668",NA,125,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,"D1E489F4-B7F3-40E7-9DD4-79972F462568","WHITE",NA,11,30,"64BE6A8F-6309-4492-B858-57C814070948","ED4C2AF6-A12A-4741-8C1A-9C2B3C8F7501","TCGA-D1-A3DH-01A-11R-A19V-13_mirna.bam","TCGA-D1-A3DH-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-D1-A3DH-01A-01-TSA",100,NA,NA,NA,"TCGA-D1-A3DH-R72307","Internal","Primary Tumor Field","TCGA-D1-A3DH-F41531_NTE-1","NO",573,"TUMOR FREE","Alive",NA,"TCGA-D1-A3DH-F41531","TCGA-D1-A3DH",1,"D1","A3DH","YES","C54.1","8380/3","C54.1","NO","YES",-25935,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",125,NA,NA,NA,"TUMOR FREE","NO",15,2,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,71,2011,"Excisional Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
135242930,130833548,6239705009,"E013D176-4FCB-4DF5-93F0-72803590B677.bw","7d8e6965-51ea-4864-968e-5cecfb7da48a","e013d176-4fcb-4df5-93f0-72803590b677","2016-08-06T22:01:11.787411-05:00","UNCID_2173849.88802e34-7269-4b5e-b552-a969281ab241.130503_UNC9-SN296_0361_AC23VLACXX_3_ATCACG.tar.gz","0e5f416f-5114-4961-b45f-f9e019600894",6499985230,"Illumina HiSeq","f0d892c744a6e3ec03d6acd935bd149b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:39:14.513229-05:00","2016-05-03T10:56:47.870562-05:00","0e5f416f-5114-4961-b45f-f9e019600894_analysis.xml","bdce274ac0ec413ee1f606013c806199","bf8206f5-b3f2-48ba-883d-dbff42838695",2121,"2016-09-29T17:43:40.290873-05:00","0e5f416f-5114-4961-b45f-f9e019600894_experiment.xml","8ae872f9dd9f05c78e247d1841010de5","0796d90a-1e31-4dc1-822b-ddbae30ccf60",2431,"2016-09-29T23:08:06.978883-05:00","0e5f416f-5114-4961-b45f-f9e019600894_run.xml","f495e5730614738d3caeb90fcb4f2bc1","d16d2f98-347f-4435-af0d-f51ed8afcfa7",354,"2016-09-08T12:20:37.076109-05:00","TCGA-FL-A1YG",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YG-11A",NA,"7ce9c6ea-2d0b-448e-9d5f-3ab19714d979",FALSE,"5E88F0A0-6949-485D-89BA-9769A8847919","Solid Tissue Normal",NA,NA,170,NA,1302480000,"12",20,"TCGA-FL-A1YG-11A-12",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T12:20:37.076109-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"489186e6-19cf-4f65-859f-ac1b187a95af",NA,"TCGA-FL-A1YG-11A-01-TSA",NA,0,NA,"34cd9a5c-ed54-4945-9a31-c2db260c215c","RNA","TCGA-FL-A1YG-11A-12R","7e850466-b1a1-48e0-83de-2c7238103749",1.87,0.16,"UV Spec","R","23","TCGA-FL-A1YG-11A-12R-A16F-07","88802e34-7269-4b5e-b552-a969281ab241",0.16,NA,NA,NA,NA,NA,NA,"UNCID_2173849.88802e34-7269-4b5e-b552-a969281ab241.130503_UNC9-SN296_0361_AC23VLACXX_3_ATCACG.tar.gz","2013-09-10T02:16:10.000Z","2013-09-10T02:32:01.000Z","0E5F416F-5114-4961-B45F-F9E019600894","7CE9C6EA-2D0B-448E-9D5F-3AB19714D979","Unaligned reads",6499985230,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","88802E34-7269-4B5E-B552-A969281AB241","University of North Carolina","564a40a5e4b09c884b25eeac","7D8E6965-51EA-4864-968E-5CECFB7DA48A","Uterine Corpus Endometrial Carcinoma","TARGZ","34CD9A5C-ED54-4945-9A31-C2DB260C215C","2013-09-10T02:32:01.000Z","7E850466-B1A1-48E0-83DE-2C7238103749","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"34CD9A5C-ED54-4945-9A31-C2DB260C215C",NA,"FL","TCGA-FL-A1YG-11A-12R-A16E-13_mirna.bam",170,"TCGA-FL-A1YG-11A",NA,NA,"TCGA",NA,NA,NA,NA,"7CE9C6EA-2D0B-448E-9D5F-3AB19714D979",NA,"TCGA-FL-A1YG-11A-12R-A16E-13_mirna.bam",NA,NA,"TCGA-FL-A1YG",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,143,NA,NA,NA,NA,12,20,"489186E6-19CF-4F65-859F-AC1B187A95AF","D2907114-C18F-4592-84D8-A682A54EB48E","TCGA-FL-A1YG-11A-12R-A16E-13_mirna.bam","TCGA-FL-A1YG-11A-12",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YG-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
31550499,30567176,2263305386,"334A56B0-2251-4640-A52A-3923F93797D0.bw","7dce4215-01f6-43e9-9378-9e22c26c23a2","334a56b0-2251-4640-a52a-3923f93797d0","2016-08-09T14:13:36.616311-05:00","UNCID_2206800.39dbc57b-dd7d-4ebe-a905-47b500adef88.110829_UNC2-RDR300275_00084_FC_634GCAAXX_4.tar.gz","2348a31b-b7f3-4e0e-bc3b-c1d892d8426c",1961991169,"Illumina GA","ec9c002859df1feae5635c43b4a199e4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:43:48.033414-05:00","2016-05-03T11:12:13.672306-05:00","2348a31b-b7f3-4e0e-bc3b-c1d892d8426c_analysis.xml","610663c05e140b34c77397339628b83c","c2520819-89cf-4efc-80d0-19c0db1604e1",2121,"2016-09-29T23:37:21.996287-05:00","2348a31b-b7f3-4e0e-bc3b-c1d892d8426c_experiment.xml","b62674549f6bda17a5b316f1411fc9c7","e3a592a6-e3d2-4a59-85d8-7b56d79f9451",2257,"2016-09-29T20:07:10.127606-05:00","2348a31b-b7f3-4e0e-bc3b-c1d892d8426c_run.xml","91f7781dab342cedf7402512a2e07016","616ec34f-c670-4acc-9f96-ca884263c591",347,"2016-09-09T16:42:55.956240-05:00","TCGA-AP-A0LH","2016-09-02T18:54:30.660152-05:00","female","TCGA-AP-A0LH_demographic",1942,"white","8bd4e246-74c0-5a87-a680-0a9764a0bde5","not hispanic or latino",2005,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LH_diagnosis","not reported",22169,"dead","8441/3",1106,NA,"8061a94b-839c-5815-b4d5-18d8f4bf6ad1","c54.1",-22169,"TCGA-AP-A0LH_treatment","c4bec7c6-bab7-5e5e-9c9c-a9f1156b0705","01","true","TCGA-AP-A0LH-01A",NA,"4c657ad4-2c53-4ea9-82b5-52996e74e3ff",FALSE,"78E73020-1173-45DA-BDBA-DFB1CF7BCB41","Primary Tumor",NA,2772,210,NA,1278547200,"11",30,"TCGA-AP-A0LH-01A-11",90,60,0,0,5,30,0,0,"2016-09-09T16:42:55.956240-05:00","2016-09-09T16:42:55.956240-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"c2c91aea-c449-491e-adae-de47b6b24737","83ab6f02-cfa0-4107-8fd8-255f537c42ea","TCGA-AP-A0LH-01A-01-TS1","TCGA-AP-A0LH-01A-01-BS1",95,70,"ee9b20e6-318e-455a-9a0c-ae8d3bfd7db5","RNA","TCGA-AP-A0LH-01A-11R","d45b6175-442c-41ea-b72e-05401dc99527",1.94,0.15,"UV Spec","R","23","TCGA-AP-A0LH-01A-11R-A16W-07","39dbc57b-dd7d-4ebe-a905-47b500adef88",0.15,NA,83,30.8596073765616,164,"6f5bf2e8-acee-552e-9c10-7c07f01af7bc","TCGA-AP-A0LH_exposure","UNCID_2206800.39dbc57b-dd7d-4ebe-a905-47b500adef88.110829_UNC2-RDR300275_00084_FC_634GCAAXX_4.tar.gz","2013-09-28T07:13:07.000Z","2013-09-28T07:24:03.000Z","2348A31B-B7F3-4E0E-BC3B-C1D892D8426C","4C657AD4-2C53-4EA9-82B5-52996E74E3FF","Unaligned reads",1961991169,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","39DBC57B-DD7D-4EBE-A905-47B500ADEF88","University of North Carolina","564a3a11e4b0ef12181a054f","7DCE4215-01F6-43E9-9378-9E22C26C23A2","Uterine Corpus Endometrial Carcinoma","TARGZ","EE9B20E6-318E-455A-9A0C-AE8D3BFD7DB5","2013-09-28T07:24:03.000Z","D45B6175-442C-41EA-B72E-05401DC99527","None","NO",1,NA,"Primary Tumor","MSKCC",2772,"EE9B20E6-318E-455A-9A0C-AE8D3BFD7DB5",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.186CD641-E906-4F42-B3CE-8CF9B361AE3A.txt",210,"TCGA-AP-A0LH-01A",NA,"D55838A0-6C0A-4A7A-8C9C-E14D2B45859B","TCGA",2002,NA,NA,"WITH TUMOR","6E5515FB-6252-4703-B7F4-B57E38121C5B",60,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.186CD641-E906-4F42-B3CE-8CF9B361AE3A.txt","Dead",1106,"TCGA-AP-A0LH","NOT HISPANIC OR LATINO","6FFFA15E-1A22-4087-8A5E-8DC253051665",NA,NA,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",59,NA,"D96B83C6-C810-44EA-82B5-1F1BC1C37949","WHITE",NA,11,30,"C2C91AEA-C449-491E-ADAE-DE47B6B24737","D45B6175-442C-41EA-B72E-05401DC99527","TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.bam.bai","TCGA-AP-A0LH-01A-11",90,5,0,0,0,"TOP",0,0,"TCGA-AP-A0LH-01A-01-TS1",95,"IXABEPILONE","Chemotherapy","TCGA-AP-A0LH-D3957","TCGA-AP-A0LH-R3963","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,NA,NA,"WITH TUMOR","Dead",1106,"TCGA-AP-A0LH-F3950","TCGA-AP-A0LH",1,"AP","A0LH","YES","C54.1","8441/3","C54.1","NO","YES",-22169,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,1106,NA,NA,"WITH TUMOR","NO",23,9,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,60,2002,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32931261,31959635,2399768343,"50F69785-8B7A-4933-85B1-8DC539ACC72A.bw","7ddeddd1-b2ad-425f-94a2-9c476b959f2a","50f69785-8b7a-4933-85b1-8dc539acc72a","2016-08-09T14:14:45.307227-05:00","UNCID_2209930.ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_5.tar.gz","3455e2cf-6d32-404e-a90d-1e9372bb5532",2214333428,"Illumina GA","37946a3d169789e4467dab1aa69ec906","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:07:15.177841-05:00","2016-05-03T11:15:47.413267-05:00","3455e2cf-6d32-404e-a90d-1e9372bb5532_analysis.xml","9bd6d3b840af34924ef003fdcde7d95b","f6008683-37ff-4e21-a4de-26b04e3690a1",2121,"2016-08-29T13:14:43.571428-05:00","3455e2cf-6d32-404e-a90d-1e9372bb5532_experiment.xml","712e5848b966df1614112419952d0447","9834c985-7aa9-42c8-97d3-90de15ad19cd",2257,"2016-09-29T23:13:42.337228-05:00","3455e2cf-6d32-404e-a90d-1e9372bb5532_run.xml","e2f93fba1e3d5d2577ae97319b512d6c","d4f606b7-3c92-4864-9e1f-169b8ce32580",347,"2016-09-08T11:25:44.781028-05:00","TCGA-D1-A17D","2016-09-02T18:50:37.654178-05:00","female","TCGA-D1-A17D_demographic",1951,"white","b13e3c60-a675-5a8c-a335-12e65a23a310","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17D_diagnosis","not reported",21441,"alive","8380/3",NA,926,"ada11ac6-b450-5feb-ad99-5631e0845094","c54.1",-21441,"TCGA-D1-A17D_treatment","8935759e-cc41-5b31-8138-5db438299830","01","false","TCGA-D1-A17D-01A",NA,"9ec5a25b-9ce1-4fde-9341-13da39bc74b0",FALSE,"1042404C-E963-4620-BC02-E33751FDB96C","Primary Tumor",NA,541,160,NA,1294185600,"12",30,"TCGA-D1-A17D-01A-12",80,NA,5,NA,0,NA,20,NA,"2016-09-08T11:25:44.781028-05:00",NA,5,NA,5,NA,"TOP",NA,10,NA,"3cddfd25-9705-4dd7-9666-ae5092c5d9f7",NA,"TCGA-D1-A17D-01A-01-TSA",NA,70,NA,"357beb71-520f-4bc8-b446-2fd553d3ee21","RNA","TCGA-D1-A17D-01A-12R","37aeb0a7-aba6-4e3b-b81b-b3ca4a6ee062",1.82,0.16,"UV Spec","R","23","TCGA-D1-A17D-01A-12R-A12I-07","ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9",0.16,NA,68,28.3038501560874,155,"0354a4b5-baff-5e7c-97af-b8803b3aa158","TCGA-D1-A17D_exposure","UNCID_2209930.ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_5.tar.gz","2013-10-02T02:07:03.000Z","2013-10-02T02:20:02.000Z","3455E2CF-6D32-404E-A90D-1E9372BB5532","9EC5A25B-9CE1-4FDE-9341-13DA39BC74B0","Unaligned reads",2214333428,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CEAAF6E4-8F99-4FE0-8D2E-8D5AEE22EBB9","University of North Carolina","56607b73e4b016715ab6addd","7DDEDDD1-B2AD-425F-94A2-9C476B959F2A","Uterine Corpus Endometrial Carcinoma","TARGZ","357BEB71-520F-4BC8-B446-2FD553D3EE21","2013-10-02T02:20:02.000Z","37AEB0A7-ABA6-4E3B-B81B-B3CA4A6EE062","None","NO",1,NA,"Primary Tumor","Mayo Clinic",541,"357BEB71-520F-4BC8-B446-2FD553D3EE21",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.AD75151C-839F-4245-9F2C-94BF67FC993D.txt",160,"TCGA-D1-A17D-01A",NA,"599ED21D-AC9B-4B32-A4C4-F956E7CAC160","TCGA",2009,NA,NA,"TUMOR FREE","E1C4F986-0667-4B47-9BEE-2C6BF81A45EE",58,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.AD75151C-839F-4245-9F2C-94BF67FC993D.txt","Alive",NA,"TCGA-D1-A17D","NOT HISPANIC OR LATINO","E8A3CD74-D523-4119-A7AD-B240645174E9",NA,160,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"F905CE7A-C8C9-42EC-B08F-F16B520C175E","WHITE",NA,12,30,"3CDDFD25-9705-4DD7-9666-AE5092C5D9F7","85F429F7-D6A0-4C40-8265-10B63A522EFA","UNCID_2209930.ceaaf6e4-8f99-4fe0-8d2e-8d5aee22ebb9.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_5.tar.gz","TCGA-D1-A17D-01A-12",80,0,5,5,20,"TOP",10,5,"TCGA-D1-A17D-01A-01-TSA",70,"Paclitaxel","Chemotherapy","TCGA-D1-A17D-D20257","TCGA-D1-A17D-R20255","IMPLANTS","Regional site",NA,"NO",926,"TUMOR FREE","Alive",NA,"TCGA-D1-A17D-F20254","TCGA-D1-A17D",1,"D1","A17D","YES","C54.1","8380/3","C54.1","NO","YES",-21441,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",160,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31515522,31076512,2290295853,"E4488C31-B5C1-4CD9-A200-ED941DA3B73F.bw","7e64ea6c-a3db-48eb-91be-131361510a92","e4488c31-b5c1-4cd9-a200-ed941da3b73f","2016-08-09T14:11:05.692393-05:00","UNCID_2207050.fb355c45-282b-4eff-8d06-074d9acf1ea5.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_3.tar.gz","019cce43-61a7-4c3a-aecd-00a3fb93f747",2036157248,"Illumina GA","50280ae2e774be434cb5ec86ce7886a9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:19:03.444741-05:00","2016-05-03T11:13:42.364824-05:00","019cce43-61a7-4c3a-aecd-00a3fb93f747_analysis.xml","a3c34d81cb90cd7448ce3da13d125a09","fd5c4234-eee1-4594-bab4-e55edeac9ee6",2121,"2016-09-29T17:50:10.962354-05:00","019cce43-61a7-4c3a-aecd-00a3fb93f747_experiment.xml","b65af55ba5cf24132f8926f5debe56f6","0bc7fd2e-814a-4d04-acbb-1a5b842b92cf",2257,"2016-09-30T00:15:12.499289-05:00","019cce43-61a7-4c3a-aecd-00a3fb93f747_run.xml","1faf2aeb63b1f81735fdf3bfb5c7b5cb","fafc5660-21e4-491d-b72c-94df913648ea",347,"2016-09-08T10:50:20.953789-05:00","TCGA-AX-A0IU","2016-09-02T18:47:56.105142-05:00","female","TCGA-AX-A0IU_demographic",1929,"black or african american","337f449f-972e-5bc5-a434-fe6dfca3d407","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A0IU_diagnosis","not reported",29063,"alive","8441/3",NA,1087,"cd91da4b-9f1c-590c-9b86-ae8be6b80640","c54.1",-29063,"TCGA-AX-A0IU_treatment","6a29e81c-0eaf-5629-82e9-8cc5da7b1f46","01","false","TCGA-AX-A0IU-01A",NA,"dc4b3695-ce62-48d5-9f1d-7dd70d049c97",FALSE,"454539FB-7B1B-43DF-87D1-E7E47C1776E7","Primary Tumor",NA,636,240,NA,1276560000,"11",30,"TCGA-AX-A0IU-01A-11",85,60,0,4,0,0,15,45,"2016-09-08T10:50:20.953789-05:00","2016-09-08T10:50:20.953789-05:00",7,10,1,2,"BOTTOM","TOP",30,10,"ea8dcc0a-2081-43b5-a21b-fbf7dc1c275d","50434b51-2b9b-46f1-929e-5679835479b6","TCGA-AX-A0IU-01A-01-BS1","TCGA-AX-A0IU-01A-01-MS1",55,45,"65212f6f-ee67-41ad-afa6-0a9d3550907b","RNA","TCGA-AX-A0IU-01A-11R","53904cdf-ecfa-4a1b-a41b-ed2666936ff3",1.85,0.14,"UV Spec","R","23","TCGA-AX-A0IU-01A-11R-A16W-07","fb355c45-282b-4eff-8d06-074d9acf1ea5",0.14,NA,76,30.4438391283448,158,"aae18b61-0a6d-51fb-b2c5-ab11fa22cc0b","TCGA-AX-A0IU_exposure","UNCID_2207050.fb355c45-282b-4eff-8d06-074d9acf1ea5.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_3.tar.gz","2013-09-29T04:26:07.000Z","2013-09-29T04:44:01.000Z","019CCE43-61A7-4C3A-AECD-00A3FB93F747","DC4B3695-CE62-48D5-9F1D-7DD70D049C97","Unaligned reads",2036157248,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","FB355C45-282B-4EFF-8D06-074D9ACF1EA5","University of North Carolina","566075d7e4b016715ab687fd","7E64EA6C-A3DB-48EB-91BE-131361510A92","Uterine Corpus Endometrial Carcinoma","TARGZ","65212F6F-EE67-41AD-AFA6-0A9D3550907B","2013-09-29T04:44:01.000Z","53904CDF-ECFA-4A1B-A41B-ED2666936FF3","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",636,"65212F6F-EE67-41AD-AFA6-0A9D3550907B",NA,"AX","UNCID_2207050.fb355c45-282b-4eff-8d06-074d9acf1ea5.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_3.tar.gz",240,"TCGA-AX-A0IU-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","DC4B3695-CE62-48D5-9F1D-7DD70D049C97",79,"nationwidechildrens.org_clinical.TCGA-AX-A0IU.xml","Alive",NA,"TCGA-AX-A0IU","NOT HISPANIC OR LATINO","780B4F07-796D-429E-A012-D033202AA726",NA,868,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",73,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"EA8DCC0A-2081-43B5-A21B-FBF7DC1C275D","E89F8470-B13B-4321-9D38-3977B133209B","UNCID_2207050.fb355c45-282b-4eff-8d06-074d9acf1ea5.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_3.tar.gz","TCGA-AX-A0IU-01A-11",60,0,4,10,45,"TOP",10,2,"TCGA-AX-A0IU-01A-01-MS1",45,NA,NA,NA,NA,NA,NA,NA,NA,868,"TUMOR FREE","Alive",NA,"TCGA-AX-A0IU-F5533","TCGA-AX-A0IU",1,"AX","A0IU","YES","C54.1","8441/3","C54.1","NO","YES",-29063,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",868,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,79,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31107665,30541381,2278107440,"235D18D4-E859-4FE9-8B09-AA8DEE3CF2E8.bw","7f4f3aed-69af-421e-817b-b258dcc0bac5","235d18d4-e859-4fe9-8b09-aa8dee3cf2e8","2016-08-09T14:12:09.580156-05:00","UNCID_2208092.6f456a65-f075-469d-a0f9-365cae129564.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_5.tar.gz","fb39af7b-b73e-437b-83fc-a760895a834d",2028327912,"Illumina GA","65c4a738a5771fe7b1035d688a6b2e44","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:57:24.249053-05:00","2016-05-03T11:14:23.412460-05:00","fb39af7b-b73e-437b-83fc-a760895a834d_analysis.xml","a79a1ccc370a250100690aee541d16d6","80589cae-2d70-46c0-818c-6a3e8e51e8e8",2120,"2016-08-30T03:58:44.095882-05:00","fb39af7b-b73e-437b-83fc-a760895a834d_experiment.xml","98bc944a5bb820a9d8a118b7fb5ffc14","de80e01d-2aa1-4117-bab6-97263287457c",2257,"2016-09-29T18:10:52.239303-05:00","fb39af7b-b73e-437b-83fc-a760895a834d_run.xml","499368a66bf7e87b618c7556f64046f3","18cad3ce-391a-441d-84a8-a84e2d307f7b",347,"2016-09-08T10:56:42.500430-05:00","TCGA-D1-A16Q","2016-09-02T18:50:28.352822-05:00","female","TCGA-D1-A16Q_demographic",1956,"white","fe1bd1e0-1b8f-5c74-bb5d-f068ea6327ed","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16Q_diagnosis","not reported",19873,"alive","8380/3",NA,324,"52a2d92b-2ab7-5fcd-b853-58703bf7770b","c54.1",-19873,"TCGA-D1-A16Q_treatment","98a34762-ec10-51e9-b12b-489454074c15","01","false","TCGA-D1-A16Q-01A",NA,"bfe3da05-506e-4837-ac72-a285fe079c58",FALSE,"60635568-D27E-4C72-BFF2-238CF2992925","Primary Tumor",NA,136,240,NA,1293062400,"12",30,"TCGA-D1-A16Q-01A-12",90,NA,0,NA,0,NA,10,NA,"2016-09-08T10:56:42.500430-05:00",NA,30,NA,10,NA,"TOP",NA,20,NA,"c4b05cd8-ae6f-4a51-b9d1-311f988d90ca",NA,"TCGA-D1-A16Q-01A-01-TS1",NA,70,NA,"a88d4fe8-7f4b-4f71-9854-1c6ea35121ee","RNA","TCGA-D1-A16Q-01A-12R","034225cd-16c7-451b-aa78-142cff2b1c5e",1.83,0.17,"UV Spec","R","23","TCGA-D1-A16Q-01A-12R-A12I-07","6f456a65-f075-469d-a0f9-365cae129564",0.17,NA,117,39.5484045429962,172,"81f96f20-5e90-50c2-9d70-4ea6b23b10df","TCGA-D1-A16Q_exposure","UNCID_2208092.6f456a65-f075-469d-a0f9-365cae129564.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_5.tar.gz","2013-09-30T08:43:06.000Z","2013-09-30T08:55:02.000Z","FB39AF7B-B73E-437B-83FC-A760895A834D","BFE3DA05-506E-4837-AC72-A285FE079C58","Unaligned reads",2028327912,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","6F456A65-F075-469D-A0F9-365CAE129564","University of North Carolina","564a397de4b093830b68a6cf","7F4F3AED-69AF-421E-817B-B258DCC0BAC5","Uterine Corpus Endometrial Carcinoma","TARGZ","A88D4FE8-7F4B-4F71-9854-1C6EA35121EE","2013-09-30T08:55:02.000Z","034225CD-16C7-451B-AA78-142CFF2B1C5E","None","NO",1,NA,"Primary Tumor","Mayo Clinic",136,"A88D4FE8-7F4B-4F71-9854-1C6EA35121EE",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.088C67D6-5A80-407A-BA4A-2F02C25C7A65.txt",240,"TCGA-D1-A16Q-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","BFE3DA05-506E-4837-AC72-A285FE079C58",54,"nationwidechildrens.org_clinical.TCGA-D1-A16Q.xml","Alive",NA,"TCGA-D1-A16Q","NOT HISPANIC OR LATINO","2D15B698-33AF-4C31-BC3D-5C2494F69038",NA,221,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,12,30,"C4B05CD8-AE6F-4A51-B9D1-311F988D90CA","DFFA0FA8-FEF1-41DB-96E5-0CE79BE8B321","TCGA-D1-A16Q-01A-12D-A12J-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-D1-A16Q-01A-12",90,0,0,30,10,"TOP",20,10,"TCGA-D1-A16Q-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,NA,"NO",324,"TUMOR FREE","Alive",NA,"TCGA-D1-A16Q-F18653","TCGA-D1-A16Q",1,"D1","A16Q","YES","C54.1","8380/3","C54.1","NO","YES",-19873,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",221,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
119180894,117213167,5536708017,"026B4F22-FD28-4DE6-8C80-0AC3DF950F1C.bw","7f91a0c5-d639-48ea-b3f7-b6f385e047ed","026b4f22-fd28-4de6-8c80-0ac3df950f1c","2016-08-09T13:15:03.303452-05:00","UNCID_2173013.69fbadaa-5a9f-4fc6-b676-e938179ee830.130509_UNC10-SN254_0462_AC232JACXX_6_CCGTCC.tar.gz","b8cc9bd3-a926-43ce-9c7c-eefc561cd94d",5614218628,"Illumina HiSeq","05966c506708cfafbacd9079557e0146","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:31:10.949310-05:00","2016-05-03T10:55:55.600288-05:00","b8cc9bd3-a926-43ce-9c7c-eefc561cd94d_analysis.xml","2312aff0a7c3414a66c6b83969aef11f","70213cfc-53b8-41cd-98d4-f505d18d7774",2123,"2016-09-29T20:38:47.421985-05:00","b8cc9bd3-a926-43ce-9c7c-eefc561cd94d_experiment.xml","543c02046c786684e8de19bdf33b710f","74bb9f6f-2604-4158-b66a-f59852567507",2431,"2016-09-29T18:55:06.409173-05:00","b8cc9bd3-a926-43ce-9c7c-eefc561cd94d_run.xml","d1cd7e7af117b7de6d448f936a12150d","3497b2b1-26a7-4b2b-8c62-256861ff10dd",354,"2016-09-08T11:13:03.729692-05:00","TCGA-AJ-A3OL","2016-09-02T18:49:07.154552-05:00","female","TCGA-AJ-A3OL_demographic",1956,"white","5c564e9c-9baa-58fe-8dce-62768d9cc0dd","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3OL_diagnosis","not reported",20115,"dead","8380/3",449,57,"5b300041-47a8-558a-8468-6db414bd9ff9","c54.1",-20115,"TCGA-AJ-A3OL_treatment","eab6425a-3109-512d-a77c-afc947890f66","01","false","TCGA-AJ-A3OL-01A",NA,"029e5e0d-9f4e-4031-a5f2-0187c2b70879",FALSE,"B42FF342-34F0-4611-A275-B979D7658510","Primary Tumor",NA,81,190,NA,1328572800,"11",30,"TCGA-AJ-A3OL-01A-11",90,NA,0,NA,0,NA,0,NA,"2016-09-08T11:13:03.729692-05:00",NA,3,NA,0,NA,"TOP",NA,3,NA,"0f63b35f-5939-4489-b523-dee4e02b7bc5",NA,"TCGA-AJ-A3OL-01A-01-TSA",NA,97,NA,"ba74969d-be87-4bd8-a178-e66169af1ae8","RNA","TCGA-AJ-A3OL-01A-11R","9adeea61-6977-455f-8c72-0509202f909d",1.8,0.15,"UV Spec","R","23","TCGA-AJ-A3OL-01A-11R-A22K-07","69fbadaa-5a9f-4fc6-b676-e938179ee830",0.15,NA,64,25,160,"65d04a27-4442-5a70-bc86-80258bf56184","TCGA-AJ-A3OL_exposure","UNCID_2173013.69fbadaa-5a9f-4fc6-b676-e938179ee830.130509_UNC10-SN254_0462_AC232JACXX_6_CCGTCC.tar.gz","2013-09-09T06:56:08.000Z","2013-09-09T07:18:01.000Z","B8CC9BD3-A926-43CE-9C7C-EEFC561CD94D","029E5E0D-9F4E-4031-A5F2-0187C2B70879","Unaligned reads",5614218628,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","69FBADAA-5A9F-4FC6-B676-E938179EE830","University of North Carolina","56607808e4b0b37b3d99117b","7F91A0C5-D639-48EA-B3F7-B6F385E047ED","Uterine Corpus Endometrial Carcinoma","TARGZ","BA74969D-BE87-4BD8-A178-E66169AF1AE8","2013-09-09T07:18:01.000Z","9ADEEA61-6977-455F-8C72-0509202F909D","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",81,"BA74969D-BE87-4BD8-A178-E66169AF1AE8",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.956AEB98-315D-492E-AFD1-F3C590EE790C.txt",190,"TCGA-AJ-A3OL-01A",NA,"F43F3E37-E6BD-46CB-B2F4-39211DF04578","TCGA",2011,NA,NA,"TUMOR FREE","52C40D39-DA51-4148-ADC9-30DB34B98831",55,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.956AEB98-315D-492E-AFD1-F3C590EE790C.txt","Alive",NA,"TCGA-AJ-A3OL","NOT HISPANIC OR LATINO","49B67618-7D5E-4268-9A3B-EE68E0953BD0",NA,57,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"0F63B35F-5939-4489-B523-DEE4E02B7BC5","B92C9E7E-AF6F-4753-A6A1-8D4A31011188","UNCID_2089988.69fbadaa-5a9f-4fc6-b676-e938179ee830.sorted_genome_alignments.bam","TCGA-AJ-A3OL-01A-11",90,0,0,3,0,"TOP",3,0,"TCGA-AJ-A3OL-01A-01-TSA",97,"Taxol","Chemotherapy","TCGA-AJ-A3OL-D47009",NA,NA,NA,"TCGA-AJ-A3OL-F47006_NTE-1","YES",NA,"WITH TUMOR","Dead",449,"TCGA-AJ-A3OL-F47006","TCGA-AJ-A3OL",1,"AJ","A3OL","YES","C54.1","8380/3","C54.1","YES","NO",-20115,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",57,NA,NA,NA,"TUMOR FREE","NO",19,4,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33779240,32931582,2486135060,"09565F89-3CBA-4FE4-9DF1-3EFA35A570B6.bw","80105773-372e-4552-a10b-5df188b15b16","09565f89-3cba-4fe4-9df1-3efa35a570b6","2016-08-09T14:14:57.351133-05:00","UNCID_2210226.f35db751-0250-4045-9faf-2c0f1158b354.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_5.tar.gz","c802cde4-58e4-4e8c-bb63-da5298f4acbc",2127941180,"Illumina GA","0e3a59803c4b7c5f2571dd169aa6970f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:51:13.986025-05:00","2016-05-03T11:15:47.407128-05:00","c802cde4-58e4-4e8c-bb63-da5298f4acbc_analysis.xml","12495822bca58d957b749c4da53705f2","0c701db6-e3c4-4c30-8850-4201810e9dd9",2121,"2016-10-07T15:59:20.744132-05:00","c802cde4-58e4-4e8c-bb63-da5298f4acbc_experiment.xml","10f82a76c624e4cae9f8ec699bc16582","2af8fb80-24a9-431c-8e61-493f8d79a48f",2257,"2016-09-29T21:36:16.976826-05:00","c802cde4-58e4-4e8c-bb63-da5298f4acbc_run.xml","952c15249a33c44ad0410fca6f09975f","988d87e3-417d-41e4-833f-2a12c3545c65",347,"2016-09-08T10:55:54.842431-05:00","TCGA-D1-A0ZS","2016-09-02T18:49:52.972166-05:00","female","TCGA-D1-A0ZS_demographic",1955,"white","7e3c3954-9e54-5294-be2e-0761ef69da77","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A0ZS_diagnosis","not reported",19821,"alive","8380/3",NA,148,"61c62350-18f6-5bdd-9eb5-447cef6c4df1","c54.1",-19821,"TCGA-D1-A0ZS_treatment","92545594-0cb0-5a9f-9019-a716304b9586","01","false","TCGA-D1-A0ZS-01A",NA,"e914e3db-e907-495a-9b59-43e07132052a",FALSE,"313BCAEC-965D-4FF4-BAAA-3CAF48C739C6","Primary Tumor",NA,308,120,NA,1290384000,"11",30,"TCGA-D1-A0ZS-01A-11",90,70,0,20,10,0,0,20,"2016-09-08T10:55:54.842431-05:00","2016-09-08T10:55:54.842431-05:00",10,40,10,30,"TOP","BOTTOM",10,10,"3bc66ffb-b6ce-478f-ac39-597260a1aa3c","28d10901-23db-4a0e-884b-ff838e408be2","TCGA-D1-A0ZS-01A-01-TS1","TCGA-D1-A0ZS-01A-01-MS1",80,70,"cbf235bb-55a4-4f58-b5a2-845f23cec37c","RNA","TCGA-D1-A0ZS-01A-11R","e62c8400-2b45-4adc-98ba-aa83cdbbb05a",1.89,0.16,"UV Spec","R","23","TCGA-D1-A0ZS-01A-11R-A118-07","f35db751-0250-4045-9faf-2c0f1158b354",0.16,NA,62,23.051754907793,164,"a0f30146-c20d-5164-917d-5fac4c9ab7c3","TCGA-D1-A0ZS_exposure","UNCID_2210226.f35db751-0250-4045-9faf-2c0f1158b354.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_5.tar.gz","2013-10-02T07:31:04.000Z","2013-10-02T07:44:02.000Z","C802CDE4-58E4-4E8C-BB63-DA5298F4ACBC","E914E3DB-E907-495A-9B59-43E07132052A","Unaligned reads",2127941180,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","F35DB751-0250-4045-9FAF-2C0F1158B354","University of North Carolina","56607d72e4b018727fea3321","80105773-372E-4552-A10B-5DF188B15B16","Uterine Corpus Endometrial Carcinoma","TARGZ","CBF235BB-55A4-4F58-B5A2-845F23CEC37C","2013-10-02T07:44:03.000Z","E62C8400-2B45-4ADC-98BA-AA83CDBBB05A","None","NO",1,NA,"Primary Tumor","Mayo Clinic",308,"CBF235BB-55A4-4F58-B5A2-845F23CEC37C",NA,"D1","UNCID_2210226.f35db751-0250-4045-9faf-2c0f1158b354.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_5.tar.gz",120,"TCGA-D1-A0ZS-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","E914E3DB-E907-495A-9B59-43E07132052A",54,"UNCID_1630837.f35db751-0250-4045-9faf-2c0f1158b354.sorted_genome_alignments.bam","Alive",NA,"TCGA-D1-A0ZS","NOT HISPANIC OR LATINO","6485B3F2-ABAA-4A93-8BBD-F6CA6EAF18FD",NA,148,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"BFCAF3F3-1D8C-4B85-9E77-AF0389331E3F","WHITE",NA,11,30,"3BC66FFB-B6CE-478F-AC39-597260A1AA3C","E62C8400-2B45-4ADC-98BA-AA83CDBBB05A","UNCID_2210226.f35db751-0250-4045-9faf-2c0f1158b354.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_5.tar.gz","TCGA-D1-A0ZS-01A-11",70,0,20,40,20,"BOTTOM",10,30,"TCGA-D1-A0ZS-01A-01-MS1",70,NA,NA,NA,"TCGA-D1-A0ZS-R17756","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"NO",148,"TUMOR FREE","Alive",NA,"TCGA-D1-A0ZS-F17755","TCGA-D1-A0ZS",1,"D1","A0ZS","YES","C54.1","8380/3","C54.1","NO","YES",-19821,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",148,NA,NA,NA,"TUMOR FREE","NO",8,3,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30645554,28544316,2126226910,"3B02D2AE-6DBB-4439-A976-A3B186DFA3AD.bw","82c51af5-4ba2-48fe-b5e2-a0f1c9d68f34","3b02d2ae-6dbb-4439-a976-a3b186dfa3ad","2016-08-09T14:15:15.626868-05:00","UNCID_2210476.10b2b797-1ddd-4ef8-b0e7-38f96fb06f57.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_1.tar.gz","55a08c5a-88d4-4598-bf37-0dd6702b007e",1890613899,"Illumina GA","a0dd69ea1c1b9dc2c80c63374679cc01","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:15:38.294698-05:00","2016-05-03T11:15:47.427352-05:00","55a08c5a-88d4-4598-bf37-0dd6702b007e_analysis.xml","72d01de4c9e3c4e53fc0b732511629eb","b0ec66d2-d782-4d3b-9abc-83e58bdc2756",2121,"2016-09-29T19:52:24.598155-05:00","55a08c5a-88d4-4598-bf37-0dd6702b007e_experiment.xml","d406aa87763a8039f0642c92ad6a89a9","587d05e4-f179-4dc2-8a02-5a295e6ac58c",2257,"2016-09-29T20:45:02.496932-05:00","55a08c5a-88d4-4598-bf37-0dd6702b007e_run.xml","9282693adc9c7e1d99f6629d8869eb9a","78a8fd0c-a5fa-4185-9bde-555a26c0548b",347,"2016-09-08T11:37:08.704711-05:00","TCGA-A5-A0GR","2016-09-02T18:49:18.484342-05:00","female","TCGA-A5-A0GR_demographic",1939,"black or african american","4507d83f-2738-5679-abb2-92367a2ac213","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GR_diagnosis","not reported",25353,"alive","8380/3",NA,1120,"4a331b84-3e37-57fc-b8ba-74480f256522","c54.1",-25353,"TCGA-A5-A0GR_treatment","302c22c2-e905-5abb-8d21-80b12d60607c","01","true","TCGA-A5-A0GR-01A",NA,"1c8de102-85f6-47d5-87ce-50b6fe24bb7a",FALSE,"009B5049-74B7-49B8-8B64-28184A3ACA2B","Primary Tumor",NA,632,160,NA,1291334400,"11",30,"TCGA-A5-A0GR-01A-11",8,70,2,20,0,0,75,30,"2016-09-08T11:37:08.704711-05:00","2016-09-08T11:37:08.704711-05:00",40,35,2,25,"BOTTOM","TOP",10,10,"ac22b37c-7c54-4055-b3c6-52e332ec9dfe","4701ffe6-35eb-4376-a141-a7b34dc982e9","TCGA-A5-A0GR-01A-01-MSA","TCGA-A5-A0GR-01A-01-TSA",15,60,"6abb44a2-aaa9-4a50-a228-9e09c23530a8","RNA","TCGA-A5-A0GR-01A-11R","0500da3c-ce40-4f0b-a7e9-9a3f46b6c9fb",2,0.16,"UV Spec","R","23","TCGA-A5-A0GR-01A-11R-A118-07","10b2b797-1ddd-4ef8-b0e7-38f96fb06f57",0.16,NA,88,28.0889910306745,177,"f9744e32-0223-5afe-b0db-69bd117b6916","TCGA-A5-A0GR_exposure","UNCID_2210476.10b2b797-1ddd-4ef8-b0e7-38f96fb06f57.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_1.tar.gz","2013-10-02T11:43:05.000Z","2013-10-02T11:56:02.000Z","55A08C5A-88D4-4598-BF37-0DD6702B007E","1C8DE102-85F6-47D5-87CE-50B6FE24BB7A","Unaligned reads",1890613899,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","10B2B797-1DDD-4EF8-B0E7-38F96FB06F57","University of North Carolina","56607742e4b016715ab69638","82C51AF5-4BA2-48FE-B5E2-A0F1C9D68F34","Uterine Corpus Endometrial Carcinoma","TARGZ","6ABB44A2-AAA9-4A50-A228-9E09C23530A8","2013-10-02T11:56:03.000Z","0500DA3C-CE40-4F0B-A7E9-9A3F46B6C9FB","None","NO",1,NA,"Primary Tumor","Cedars Sinai",632,"6ABB44A2-AAA9-4A50-A228-9E09C23530A8",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2F6C92AF-8F69-4F30-B8DD-D752A11DF831.txt",160,"TCGA-A5-A0GR-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","C4E2E58A-A958-49ED-AEC7-926A49F1F79E",69,"CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_G07_735612.nocnv_hg18.seg.txt","Alive",NA,"TCGA-A5-A0GR","NOT HISPANIC OR LATINO","F1B17C1D-A944-480D-97FD-B25C0858FCF8",NA,780,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"AC22B37C-7C54-4055-B3C6-52E332EC9DFE","E37F4F3B-273B-49ED-A87B-FD23F3DC58FD","TCGA-A5-A0GR-01A-11R-A119-13_mirna.bam","TCGA-A5-A0GR-01A-11",8,0,2,40,75,"BOTTOM",10,2,"TCGA-A5-A0GR-01A-01-MSA",15,NA,NA,NA,NA,NA,NA,NA,"NO",1120,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GR-F17155","TCGA-A5-A0GR",1,"A5","A0GR","YES","C54.1","8380/3","C54.1","NO","YES",-25353,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",780,NA,NA,NA,"TUMOR FREE","NO",7,1,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2008,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31469347,30061335,2224502002,"F6F85277-BE41-4534-A0D6-F654F4263094.bw","838fcc2b-48b4-49dd-b8fc-ff27bbd16b17","f6f85277-be41-4534-a0d6-f654f4263094","2016-08-05T11:52:44.841322-05:00","UNCID_2188994.770fd2b7-24cf-432b-829d-39364a11277d.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_3.tar.gz","c55ac9d4-8d49-43c0-8cb1-eb2fac5306a7",1983517684,"Illumina GA","7a64dd070fdcbf173a39fc35ccd04462","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:34:38.179014-05:00","2016-05-03T11:05:01.518052-05:00","c55ac9d4-8d49-43c0-8cb1-eb2fac5306a7_analysis.xml","9448d6979f1f5fb66d708ec541acd7c8","e1e1fde6-622b-49aa-bee2-7fe3cb64747e",2122,"2016-08-27T07:37:24.306799-05:00","c55ac9d4-8d49-43c0-8cb1-eb2fac5306a7_experiment.xml","0dd655298de598f44f73645f2fe2818a","3fb9ff65-c7bd-46fb-83ed-4e1678b2a50f",2258,"2016-09-29T18:26:59.805920-05:00","c55ac9d4-8d49-43c0-8cb1-eb2fac5306a7_run.xml","bf76bab77a67de0e9e716e68fa342cd2","22c71e3f-3018-4549-8317-e0a6adefb977",349,"2016-09-08T10:27:04.672971-05:00","TCGA-B5-A1MZ","2016-09-02T18:52:05.086991-05:00","female","TCGA-B5-A1MZ_demographic",1956,"white","d0725cda-50ff-56dc-a9bd-64f4ae186931","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A1MZ_diagnosis","not reported",19955,"alive","8380/3",NA,1598,"474dca13-43a1-5c7a-8fa9-21dfd1a79d7b","c54.1",-19955,"TCGA-B5-A1MZ_treatment","b187910f-eff1-59c2-ad9a-0b9551241194","01","true","TCGA-B5-A1MZ-01A",NA,"cba2dcfb-5988-435c-99c1-445a36c6082f",FALSE,"071A53F9-6E40-4402-8353-BB963AFE5C33","Primary Tumor",NA,114,130,NA,1300406400,"11",30,"TCGA-B5-A1MZ-01A-11",85,NA,3,NA,0,NA,15,NA,"2016-09-08T10:27:04.672971-05:00",NA,20,NA,5,NA,"TOP",NA,0,NA,"0bfcc6bd-5d49-476b-9866-b342d9f2574a",NA,"TCGA-B5-A1MZ-01A-01-TSA",NA,85,NA,"08baddd1-51b6-4800-b5f7-30ca4acc22bc","RNA","TCGA-B5-A1MZ-01A-11R","242f3c70-da92-464d-ad32-ee0b248326f7",1.85,0.15,"UV Spec","R","23","TCGA-B5-A1MZ-01A-11R-A144-07","770fd2b7-24cf-432b-829d-39364a11277d",0.15,NA,114,41.3703004790245,166,"dcd65c55-1006-55e9-a1f7-b0fdd38403a9","TCGA-B5-A1MZ_exposure","UNCID_2188994.770fd2b7-24cf-432b-829d-39364a11277d.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_3.tar.gz","2013-09-18T13:43:04.000Z","2013-09-18T13:55:01.000Z","C55AC9D4-8D49-43C0-8CB1-EB2FAC5306A7","CBA2DCFB-5988-435C-99C1-445A36C6082F","Unaligned reads",1983517684,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","770FD2B7-24CF-432B-829D-39364A11277D","University of North Carolina","566074d9e4b0b37b3d98f0c6","838FCC2B-48B4-49DD-B8FC-FF27BBD16B17","Uterine Corpus Endometrial Carcinoma","TARGZ","08BADDD1-51B6-4800-B5F7-30CA4ACC22BC","2013-09-18T13:55:01.000Z","242F3C70-DA92-464D-AD32-EE0B248326F7","United States","NO",1,NA,"Primary Tumor","Duke",114,"08BADDD1-51B6-4800-B5F7-30CA4ACC22BC",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.96829880-88C7-4AC5-B779-1C3E985309FD.txt",130,"TCGA-B5-A1MZ-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","CBA2DCFB-5988-435C-99C1-445A36C6082F",54,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.96829880-88C7-4AC5-B779-1C3E985309FD.txt","Alive",NA,"TCGA-B5-A1MZ",NA,"EBD74C72-1DC2-489E-B7E5-CB4D951D7C89",NA,465,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",118,NA,NA,"WHITE",NA,11,30,"0BFCC6BD-5D49-476B-9866-B342D9F2574A","05B86B48-F749-416B-90A8-2E7355C653B0","UNCID_2188994.770fd2b7-24cf-432b-829d-39364a11277d.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_3.tar.gz","TCGA-B5-A1MZ-01A-11",85,0,3,20,15,"TOP",0,5,"TCGA-B5-A1MZ-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,NA,"NO",465,"TUMOR FREE","Alive",NA,"TCGA-B5-A1MZ-F22099","TCGA-B5-A1MZ",1,"B5","A1MZ","YES","C54.1","8380/3","C54.1","NO","YES",-19955,"FEMALE","WHITE",NA,"No","No","Alive",465,NA,NA,NA,"TUMOR FREE","NO",22,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2010,"Dilation and curettage procedure",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
111697288,109913063,5248252715,"C49078E1-E730-4E81-8EAE-5AAAB9FA1BF5.bw","83f2cd11-0dd7-47a6-b4b3-8212faac94bb","c49078e1-e730-4e81-8eae-5aaab9fa1bf5","2016-08-09T13:15:51.154656-05:00","UNCID_2178361.a598aef0-10a2-41bb-b755-4b2788b32e10.130328_UNC10-SN254_0443_AD238RACXX_8_TTAGGC.tar.gz","acab9489-1a18-4866-bd6f-d603dbbd36e1",4639083792,"Illumina HiSeq","c7965f8af3fb1c52d8c3acf6bdc3e944","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:02:32.679987-05:00","2016-05-03T10:56:47.878169-05:00","acab9489-1a18-4866-bd6f-d603dbbd36e1_analysis.xml","98e0ffd5b127c345d4daf5f344a9e1ad","5ea9fab5-c545-4dcc-b4e3-8acb13c5f416",2123,"2016-09-29T23:36:30.916013-05:00","acab9489-1a18-4866-bd6f-d603dbbd36e1_experiment.xml","20377965955dcbea8d7a8fd69925b6f2","e31366dd-31f5-4ac6-9d71-300db0f561f7",2431,"2016-09-29T20:55:31.366592-05:00","acab9489-1a18-4866-bd6f-d603dbbd36e1_run.xml","724c88c0a21c65946a0ef7452806de82","7f32ac5f-efa8-42d0-9f56-3c1555613e7e",354,"2016-09-08T10:42:07.669680-05:00","TCGA-AX-A3G4","2016-09-02T18:48:39.293619-05:00","female","TCGA-AX-A3G4_demographic",1950,"native hawaiian or other pacific islander","f3e4184b-0452-5930-98c5-ac8023f647f4","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3G4_diagnosis","not reported",22099,"alive","8441/3",NA,9,"72611320-df20-5a36-8dde-6c5856557583","c54.1",-22099,"TCGA-AX-A3G4_treatment","1633b899-ede4-541a-978e-6ff2d595cb9f","01","false","TCGA-AX-A3G4-01A",NA,"bb0d2369-9133-4189-a386-25feaa78c6e9",FALSE,"7E8857D6-4347-4BC5-8655-40AAD7197789","Primary Tumor",NA,463,130,NA,1322784000,"11",30,"TCGA-AX-A3G4-01A-11",94,NA,0,NA,3,NA,3,NA,"2016-09-08T10:42:07.669680-05:00",NA,1,NA,1,NA,"TOP",NA,4,NA,"db36c5ff-d254-406d-8d8e-4f73817ce863",NA,"TCGA-AX-A3G4-01A-01-TS1",NA,90,NA,"c75328a8-3829-4468-a282-502a37d68331","RNA","TCGA-AX-A3G4-01A-11R","6406235e-cbd9-479e-851f-a8de5eedb05d",1.84,0.16,"UV Spec","R","23","TCGA-AX-A3G4-01A-11R-A213-07","a598aef0-10a2-41bb-b755-4b2788b32e10",0.16,NA,107,38.3663810104342,167,"77e80186-716e-5804-ba31-8375b7e1eaeb","TCGA-AX-A3G4_exposure","UNCID_2178361.a598aef0-10a2-41bb-b755-4b2788b32e10.130328_UNC10-SN254_0443_AD238RACXX_8_TTAGGC.tar.gz","2013-09-12T01:21:04.000Z","2013-09-12T01:48:01.000Z","ACAB9489-1A18-4866-BD6F-D603DBBD36E1","BB0D2369-9133-4189-A386-25FEAA78C6E9","Unaligned reads",4639083792,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","A598AEF0-10A2-41BB-B755-4B2788B32E10","University of North Carolina","56607e32e4b016715ab6b952","83F2CD11-0DD7-47A6-B4B3-8212FAAC94BB","Uterine Corpus Endometrial Carcinoma","TARGZ","C75328A8-3829-4468-A282-502A37D68331","2013-09-12T01:48:01.000Z","6406235E-CBD9-479E-851F-A8DE5EEDB05D","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",463,"C75328A8-3829-4468-A282-502A37D68331",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.AC600CA3-2BAC-46B1-A370-C17D6BB200DE.txt",130,"TCGA-AX-A3G4-01A",NA,NA,"TCGA",2010,NA,NA,NA,"E5798C6C-5187-4D90-88BB-F17F2973D641",60,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.AC600CA3-2BAC-46B1-A370-C17D6BB200DE.txt","Alive",NA,"TCGA-AX-A3G4","NOT HISPANIC OR LATINO","B1329CFB-0CD4-4037-B682-15C94C0BAC5A",NA,4,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",201,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,11,30,"DB36C5FF-D254-406D-8D8E-4F73817CE863","9B1E685C-57E0-4761-9E92-D5042AA9B967","UNCID_2178361.a598aef0-10a2-41bb-b755-4b2788b32e10.130328_UNC10-SN254_0443_AD238RACXX_8_TTAGGC.tar.gz","TCGA-AX-A3G4-01A-11",94,3,0,1,3,"TOP",4,1,"TCGA-AX-A3G4-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3G4-F58288_NTE-1",NA,9,NA,"Alive",NA,"TCGA-AX-A3G4-F58288","TCGA-AX-A3G4",1,"AX","A3G4","YES","C54.1","8441/3","C54.1","NO","YES",-22099,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","NOT HISPANIC OR LATINO","No","No","Alive",4,NA,NA,NA,NA,"NO",6,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,60,2010,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
103452726,101757178,4854471040,"B9EF0525-8B4A-4306-B06B-35AC457F5F48.bw","840ff11f-f991-4e1b-861b-98d236d573d3","b9ef0525-8b4a-4306-b06b-35ac457f5f48","2016-08-05T02:14:40.649457-05:00","UNCID_2167109.4341d180-bcb4-47e5-83b4-df5ecc4f7eec.130620_UNC15-SN850_0314_BD2AC0ACXX_8_CTTGTA.tar.gz","73a4465d-fd9f-4ebd-9862-7a92b3535f29",4372560959,"Illumina HiSeq","6e701e7581540fb61bbfaa77fb9b4c47","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:00:52.623479-05:00","2016-05-03T11:07:07.492763-05:00","73a4465d-fd9f-4ebd-9862-7a92b3535f29_analysis.xml","b7fbc05990bd6765b9067d9a093c8b76","a7dfe5a4-611c-4694-b5ac-5a90fae78ee1",2123,"2016-09-29T22:14:49.492266-05:00","73a4465d-fd9f-4ebd-9862-7a92b3535f29_experiment.xml","c7f399132227098d52332f75bdd86836","b06b3368-3394-4d28-8da5-897d49ae9868",2431,"2016-09-29T18:17:09.081252-05:00","73a4465d-fd9f-4ebd-9862-7a92b3535f29_run.xml","7fc0be500046f28306173c14039f6a40","1cab0188-d530-464d-a42a-66d30f039552",354,"2016-09-08T10:25:18.645064-05:00","TCGA-A5-A2K2","2016-09-02T18:54:00.158231-05:00","female","TCGA-A5-A2K2_demographic",1926,"white","d090c047-cf0d-569c-beb8-c5a933d12d42","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A2K2_diagnosis","not reported",28456,"alive","8441/3",NA,3595,"ca7e77ce-472f-5fe6-9e5a-50bf9e5b3fca","c54.1",-28456,"TCGA-A5-A2K2_treatment","8beedc0b-23ac-57da-8692-ff5b07799c86","01","true","TCGA-A5-A2K2-01A",NA,"8494b10e-a989-49fa-860c-2b8f0e4f93d9",FALSE,"D8065FA8-DC0E-4F1C-8FA4-5D8A567AC24C","Primary Tumor",NA,2812,70,NA,1315958400,"11",30,"TCGA-A5-A2K2-01A-11",80,NA,1,NA,0,NA,15,NA,"2016-09-08T10:25:18.645064-05:00",NA,1,NA,3,NA,"TOP",NA,5,NA,"3d8a11a8-40be-4314-99ef-39103d658ed4",NA,"TCGA-A5-A2K2-01A-01-TSA",NA,80,NA,"d5840454-5f3f-45ae-86ed-3ce48932e7a1","RNA","TCGA-A5-A2K2-01A-11R","d90e2657-c847-4fca-8010-cf6426cd0597",1.85,0.17,"UV Spec","R","23","TCGA-A5-A2K2-01A-11R-A18M-07","4341d180-bcb4-47e5-83b4-df5ecc4f7eec",0.17,NA,50,20.8116545265349,155,"c008c0eb-2267-58ca-8b65-27e16679d50b","TCGA-A5-A2K2_exposure","UNCID_2167109.4341d180-bcb4-47e5-83b4-df5ecc4f7eec.130620_UNC15-SN850_0314_BD2AC0ACXX_8_CTTGTA.tar.gz","2013-09-21T06:43:05.000Z","2013-09-21T06:57:01.000Z","73A4465D-FD9F-4EBD-9862-7A92B3535F29","8494B10E-A989-49FA-860C-2B8F0E4F93D9","Unaligned reads",4372560959,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","4341D180-BCB4-47E5-83B4-DF5ECC4F7EEC","University of North Carolina","564a39fce4b09c884b23eea7","840FF11F-F991-4E1B-861B-98D236D573D3","Uterine Corpus Endometrial Carcinoma","TARGZ","D5840454-5F3F-45AE-86ED-3CE48932E7A1","2013-09-21T06:57:01.000Z","D90E2657-C847-4FCA-8010-CF6426CD0597","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",2812,"D5840454-5F3F-45AE-86ED-3CE48932E7A1",NA,"A5","f44db5b7db4154ad8bbae60ae4371204.bam.bai",70,"TCGA-A5-A2K2-01A",NA,"C1DAC380-74A5-4888-8621-F4F181B86ECF","TCGA",2003,NA,NA,"TUMOR FREE","A469FE54-599F-4AF6-BB24-4E759B5A4CA8",77,"nationwidechildrens.org_clinical.TCGA-A5-A2K2.xml","Alive",NA,"TCGA-A5-A2K2","NOT HISPANIC OR LATINO","E1F599A5-34CE-4EE4-A5FD-709AE6D8D9B4",NA,2769,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,30,"3D8A11A8-40BE-4314-99EF-39103D658ED4","D90E2657-C847-4FCA-8010-CF6426CD0597","f44db5b7db4154ad8bbae60ae4371204.bam.bai","TCGA-A5-A2K2-01A-11",80,0,1,1,15,"TOP",5,3,"TCGA-A5-A2K2-01A-01-TSA",80,"Carboplatin","Chemotherapy","TCGA-A5-A2K2-D17194",NA,NA,NA,NA,"NO",2769,"TUMOR FREE","Alive",NA,"TCGA-A5-A2K2-F17191","TCGA-A5-A2K2",1,"A5","A2K2","YES","C54.1","8441/3","C54.1","NO","YES",-28456,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2769,NA,NA,NA,"TUMOR FREE","NO",4,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,77,2003,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
22997784,22639137,1649135073,"36765D6C-D93E-46A0-A8C6-1FC776AC9FEB.bw","8432401d-799f-4f2f-b536-e79e1e8be064","36765d6c-d93e-46a0-a8c6-1fc776ac9feb","2016-08-09T14:16:23.801526-05:00","UNCID_2215237.cf384574-5895-4708-b29c-6906de020406.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_1.tar.gz","aca9702a-4856-42db-855c-00967de54130",1339416363,"Illumina GA","4ff189f6386b29e8b123fad657363814","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:08:13.733751-05:00","2016-05-03T11:17:59.903873-05:00","aca9702a-4856-42db-855c-00967de54130_analysis.xml","6e187fb1dad87efe55239b6c684a3b4a","f698aa52-69e5-446c-ac4f-fadd7c7de720",2121,"2016-09-29T19:53:27.916056-05:00","aca9702a-4856-42db-855c-00967de54130_experiment.xml","378c3f702ba0ffa3fb43dca584203174","592147e8-9566-444c-a5a1-28672cdfdd9e",2256,"2016-09-29T22:59:32.044592-05:00","aca9702a-4856-42db-855c-00967de54130_run.xml","e0419cfabfadb174388ff453f1a21daf","cbf5a87b-1b07-4299-b3a8-43d7110be2ba",345,"2016-09-08T11:35:04.497168-05:00","TCGA-A5-A0G3","2016-09-02T18:53:55.520367-05:00","female","TCGA-A5-A0G3_demographic",1946,"black or african american","1919a3a7-a04e-5f06-bbe2-d190bee937e0","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0G3_diagnosis","not reported",22421,"alive","8441/3",NA,1428,"4acaf19b-207d-54a9-942c-57da493776cb","c54.1",-22421,"TCGA-A5-A0G3_treatment","c73162f8-a544-5db3-9016-966af22d8bd8","01","true","TCGA-A5-A0G3-01A",NA,"e462c0f0-4a2e-4571-af18-879e41d01aad",FALSE,"66DEDB33-CA2C-4967-8074-1EFC1FC3CF29","Primary Tumor",NA,987,230,NA,1275955200,"11",30,"TCGA-A5-A0G3-01A-11",90,90,0,0,0,0,0,0,"2016-09-08T11:35:04.497168-05:00","2016-09-08T11:35:04.497168-05:00",0,0,0,0,"TOP","BOTTOM",20,5,"cd672fbe-b1d5-4279-be11-eb92d6da3f97","37e944fa-afd3-46f8-a08c-6d29ff5fe1c2","TCGA-A5-A0G3-01A-01-TS1","TCGA-A5-A0G3-01A-01-BS1",80,95,"4f9edecc-6156-462e-84ef-22cb31d8c41b","RNA","TCGA-A5-A0G3-01A-11R","7760750a-676b-416c-a870-e38a4ab4c636",1.93,0.16,"UV Spec","R","23","TCGA-A5-A0G3-01A-11R-A040-07","cf384574-5895-4708-b29c-6906de020406",0.16,NA,64,23.5078053259871,165,"15021f1c-1ffb-5a84-8ab4-15a96aba214b","TCGA-A5-A0G3_exposure","UNCID_2215237.cf384574-5895-4708-b29c-6906de020406.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_1.tar.gz","2013-10-04T01:37:05.000Z","2013-10-04T01:49:04.000Z","ACA9702A-4856-42DB-855C-00967DE54130","E462C0F0-4A2E-4571-AF18-879E41D01AAD","Unaligned reads",1339416363,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CF384574-5895-4708-B29C-6906DE020406","University of North Carolina","564a3dece4b0298dd2c935d4","8432401D-799F-4F2F-B536-E79E1E8BE064","Uterine Corpus Endometrial Carcinoma","TARGZ","4F9EDECC-6156-462E-84EF-22CB31D8C41B","2013-10-04T01:49:04.000Z","7760750A-676B-416C-A870-E38A4AB4C636","None","NO",1,NA,"Primary Tumor","Cedars Sinai",987,"4F9EDECC-6156-462E-84EF-22CB31D8C41B",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.86CC5EF9-0D7D-4187-8002-CC774C70EEB1.txt",230,"TCGA-A5-A0G3-01A",NA,"E4BA8C1B-C01D-4897-925F-D10B42B29F28","TCGA",2007,NA,NA,"WITH TUMOR","E462C0F0-4A2E-4571-AF18-879E41D01AAD",61,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.86CC5EF9-0D7D-4187-8002-CC774C70EEB1.txt","Alive",NA,"TCGA-A5-A0G3",NA,"F0894149-18AD-4B9C-946B-09C451E6E507",NA,1079,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",59,NA,"9B613400-F3A1-4EAC-9BDE-C5A37DF2F359","BLACK OR AFRICAN AMERICAN",NA,11,30,"CD672FBE-B1D5-4279-BE11-EB92D6DA3F97","F81F8396-6548-4D21-BF2F-76FEB2E25C5E","UNCID_257502.TCGA-A5-A0G3-01A-11R-A040-07.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX.1.trimmed.annotated.translated_to_genomic.bam","TCGA-A5-A0G3-01A-11",90,0,0,0,0,"TOP",20,0,"TCGA-A5-A0G3-01A-01-TS1",80,"Taxotere","Chemotherapy","TCGA-A5-A0G3-D3064","TCGA-A5-A0G3-R3071","IMPLANTS","Primary Tumor Field",NA,NA,1079,"WITH TUMOR","Alive",NA,"TCGA-A5-A0G3-F3063","TCGA-A5-A0G3",1,"A5","A0G3","YES","C54.1","8441/3","C54.1","NO","YES",-22421,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1079,NA,NA,NA,"WITH TUMOR","NO",10,9,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,61,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35720341,35371146,2666019948,"F6AE36EB-9A9C-4327-8FBA-DC122A5C942C.bw","84b96f93-6273-4101-a259-9602000ae491","f6ae36eb-9a9c-4327-8fba-dc122a5c942c","2016-08-06T12:51:49.812845-05:00","UNCID_2194791.d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61.120313_UNC6-RDR300211_00137_FC_650V5AAXX_3.tar.gz","7c6d2981-8d48-4b45-b62b-26a379e87705",2389382906,"Illumina GA","12b932940846e56537a4e2844a6d5ab3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:36:32.340650-05:00","2016-05-03T11:07:49.533775-05:00","7c6d2981-8d48-4b45-b62b-26a379e87705_analysis.xml","446bb35f9462434e507c16eb8dd79071","02fdf741-9b1d-46a0-a8c8-e5951817624f",2122,"2016-09-29T20:02:37.404734-05:00","7c6d2981-8d48-4b45-b62b-26a379e87705_experiment.xml","4ae9c385be3e315e40999d0321087be4","5eb71a5f-82df-4ab0-9052-627785f56011",2258,"2016-09-29T23:11:26.124378-05:00","7c6d2981-8d48-4b45-b62b-26a379e87705_run.xml","5c005eda2ab017a7c5010afc318ca507","d3897990-77d5-4b7c-adc3-e14c55695e41",349,"2016-09-08T11:35:26.874331-05:00","TCGA-AP-A1E0","2016-09-02T18:51:28.265103-05:00","female","TCGA-AP-A1E0_demographic",1969,"white","27868555-f3af-59fb-ba00-4da9c14176e1","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1E0_diagnosis","not reported",14653,"alive","8380/3",NA,1832,"bcaeab42-ac51-534a-8007-c4de65e6c3d8","c54.1",-14653,"TCGA-AP-A1E0_treatment","38b3b145-82e2-53a0-945e-553cb6414e36","01","true","TCGA-AP-A1E0-01A",NA,"9862bae4-6ad0-4607-ab28-cc6bf73d77d0",FALSE,"700FD29A-69DC-4B34-B841-FFFA7E76A5AF","Primary Tumor",NA,582,110,NA,1295913600,"11",30,"TCGA-AP-A1E0-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T11:35:26.874331-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"de8bfae6-cc2e-4b96-8794-60fb878957d1",NA,"TCGA-AP-A1E0-01A-01-TSA",NA,100,NA,"4f644467-1a7b-4598-aaa0-0f6382305644","RNA","TCGA-AP-A1E0-01A-11R","6a4278f3-47bd-4b4c-84c5-ce766ae1c587",1.8,0.16,"UV Spec","R","23","TCGA-AP-A1E0-01A-11R-A137-07","d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61",0.16,NA,59,23.6340330075308,158,"6686ea8c-0df1-5815-a294-b1a8ab449db5","TCGA-AP-A1E0_exposure","UNCID_2194791.d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61.120313_UNC6-RDR300211_00137_FC_650V5AAXX_3.tar.gz","2013-09-23T03:16:04.000Z","2013-09-23T03:29:01.000Z","7C6D2981-8D48-4B45-B62B-26A379E87705","9862BAE4-6AD0-4607-AB28-CC6BF73D77D0","Unaligned reads",2389382906,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","D2B4E23B-6CFA-4831-B0EA-8D15F2A55E61","University of North Carolina","56607baae4b0ca319164fcfd","84B96F93-6273-4101-A259-9602000AE491","Uterine Corpus Endometrial Carcinoma","TARGZ","4F644467-1A7B-4598-AAA0-0F6382305644","2013-09-23T03:29:01.000Z","6A4278F3-47BD-4B4C-84C5-CE766AE1C587","None","NO",1,NA,"Primary Tumor","MSKCC",582,"4F644467-1A7B-4598-AAA0-0F6382305644",NA,"AP","UNCID_1011938.TCGA-AP-A1E0-01A-11R-A137-07.120313_UNC6-RDR300211_00137_FC_650V5AAXX.3.trimmed.annotated.translated_to_genomic.exon.quantification.txt",110,"TCGA-AP-A1E0-01A",NA,"B71376C6-4A68-4B3F-A066-9480DC9051C9","TCGA",2009,NA,NA,"TUMOR FREE","A74926C6-CF6D-4C57-AB01-F8C40A9E85D6",40,"jhu-usc.edu_UCEC.HumanMethylation450.5.lvl-3.TCGA-AP-A1E0-01A-11D-A138-05.txt","Alive",NA,"TCGA-AP-A1E0",NA,"5091DA35-13AC-4CB8-9C6B-CE05E6D25C76",NA,691,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"DE8BFAE6-CC2E-4B96-8794-60FB878957D1","6A4278F3-47BD-4B4C-84C5-CE766AE1C587","UNCID_2194791.d2b4e23b-6cfa-4831-b0ea-8d15f2a55e61.120313_UNC6-RDR300211_00137_FC_650V5AAXX_3.tar.gz","TCGA-AP-A1E0-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-AP-A1E0-01A-01-TSA",100,"Carboplatin","Chemotherapy","TCGA-AP-A1E0-D13638",NA,NA,NA,"TCGA-AP-A1E0-F68436_NTE-1","NO",1832,"TUMOR FREE","Alive",NA,"TCGA-AP-A1E0-F68436","TCGA-AP-A1E0",1,"AP","A1E0","YES","C54.1","8380/3","C54.1","NO","YES",-14653,"FEMALE","WHITE",NA,"No","No","Alive",691,NA,NA,NA,"TUMOR FREE","NO",9,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,40,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
33187909,32899670,2474180725,"93A66EA0-0C74-4342-8140-72ECB01F99A1.bw","8636db4d-a67b-4d8a-b02f-15fce553cf17","93a66ea0-0c74-4342-8140-72ecb01f99a1","2016-08-09T14:04:27.842512-05:00","UNCID_2194829.afceaea6-337b-4ac4-a7fb-773c98d95547.120307_UNC2-RDR300275_00118_FC_650V8AAXX_6.tar.gz","65bac55b-d46f-4143-a07b-b788cb652c8b",2064363502,"Illumina GA","78a073303244778a2828ccd0dc1eb64a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:38:26.126062-05:00","2016-05-03T11:07:49.533775-05:00","65bac55b-d46f-4143-a07b-b788cb652c8b_analysis.xml","974e086d7071e0cdb56621ec10f60f2f","042e1ae9-78a3-4176-af6d-176ae094b7e7",2121,"2016-09-29T18:19:16.984770-05:00","65bac55b-d46f-4143-a07b-b788cb652c8b_experiment.xml","369cbbdfadcc24c6292c913b78103983","1de8c1fd-6006-4d91-ad98-494eb947b173",2257,"2016-09-29T18:18:17.035837-05:00","65bac55b-d46f-4143-a07b-b788cb652c8b_run.xml","053fcc4274775eef67c5650762070298","1d576467-8e43-4513-b9eb-a4e8ed6532fa",347,"2016-09-08T10:56:31.638675-05:00","TCGA-EY-A1GQ","2016-09-02T18:51:58.206471-05:00","female","TCGA-EY-A1GQ_demographic",1934,"white","823c38c3-da83-5448-a724-54b825439b21","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GQ_diagnosis","not reported",27905,"alive","8380/3",NA,544,"26cd1b0f-a731-52ee-b6f8-1b4d226a267d","c54.1",-27905,"TCGA-EY-A1GQ_treatment","dd963ed0-4dbe-591b-9106-f46e58b4808e","01","false","TCGA-EY-A1GQ-01A",NA,"2ce5197d-0239-4df1-85fc-47ae27324028",FALSE,"9A8D1D19-18D8-483B-BD87-B686D25C617F","Primary Tumor",NA,274,160,NA,1297641600,"21",30,"TCGA-EY-A1GQ-01A-21",60,NA,20,NA,0,NA,30,NA,"2016-09-08T10:56:31.638675-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"9b72acda-452c-42e1-931d-ff3165be1358",NA,"TCGA-EY-A1GQ-01A-02-TSB",NA,60,NA,"3b92755b-913e-4828-b0ad-49aa7622c3a5","RNA","TCGA-EY-A1GQ-01A-21R","c8725946-e4b3-4439-8fca-bc37cd7c9f17",1.9,0.15,"UV Spec","R","23","TCGA-EY-A1GQ-01A-21R-A13S-07","afceaea6-337b-4ac4-a7fb-773c98d95547",0.15,NA,81,29.7520661157025,165,"98946abd-7fdd-5947-b44d-1e9a2e9699ce","TCGA-EY-A1GQ_exposure","UNCID_2194829.afceaea6-337b-4ac4-a7fb-773c98d95547.120307_UNC2-RDR300275_00118_FC_650V8AAXX_6.tar.gz","2013-09-23T03:56:04.000Z","2013-09-23T04:08:01.000Z","65BAC55B-D46F-4143-A07B-B788CB652C8B","2CE5197D-0239-4DF1-85FC-47AE27324028","Unaligned reads",2064363502,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","AFCEAEA6-337B-4AC4-A7FB-773C98D95547","University of North Carolina","56607b59e4b0b37b3d9922d8","8636DB4D-A67B-4D8A-B02F-15FCE553CF17","Uterine Corpus Endometrial Carcinoma","TARGZ","3B92755B-913E-4828-B0AD-49AA7622C3A5","2013-09-23T04:08:01.000Z","C8725946-E4B3-4439-8FCA-BC37CD7C9F17","United States","NO",1,NA,"Primary Tumor","University of North Carolina",274,"3B92755B-913E-4828-B0AD-49AA7622C3A5",NA,"EY","HORNS_p_TCGA_b110_113_SNP_N_GenomeWideSNP_6_F08_772370.hg19.seg.txt",160,"TCGA-EY-A1GQ-01A",NA,"CDF252A5-E73A-4267-8CF5-047C3262933E","TCGA",2010,NA,NA,"WITH TUMOR","FCA08D10-7FAB-478C-AB32-4CCAD4850C1D",76,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9901D7A2-131B-47A0-A143-80885513AFF8.txt","Alive",NA,"TCGA-EY-A1GQ","NOT HISPANIC OR LATINO","E3B09ACC-2004-4463-AD16-198BC6A6EA0B",NA,340,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,"C8141BF2-6FAA-4927-A990-89FCF4638293","WHITE",NA,21,30,"9B72ACDA-452C-42E1-931D-FF3165BE1358","D1EB52CD-85EA-479D-8A08-D20062648DA2","UNCID_1605781.afceaea6-337b-4ac4-a7fb-773c98d95547.sorted_genome_alignments.bam.bai","TCGA-EY-A1GQ-01A-21",60,0,20,40,30,"TOP",10,20,"TCGA-EY-A1GQ-01A-02-TSB",60,"Carboplatin","Chemotherapy","TCGA-EY-A1GQ-D13195","TCGA-EY-A1GQ-R11974","OTHER: SPECIFY IN NOTES","Regional site",NA,"YES",544,"WITH TUMOR","Alive",NA,"TCGA-EY-A1GQ-F13192","TCGA-EY-A1GQ",1,"EY","A1GQ","YES","C54.1","8380/3","C54.1","YES","NO",-27905,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",340,NA,NA,NA,"WITH TUMOR","NO",19,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,76,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
60761850,36743896,1739162609,"E070D6ED-3B18-4D12-ABB4-2B62FF6033FC.bw","8751429b-4a11-451e-b978-dc9e9db0eb36","e070d6ed-3b18-4d12-abb4-2b62ff6033fc","2016-08-09T14:42:42.055127-05:00","UNCID_2661007.5eb217b7-bf79-475d-8476-a66670ad9ed2.140711_UNC12-SN629_0381_AC4M54ACXX_3_TGACCA.tar.gz","b5012bbb-ae49-4b78-a17b-d34d9883e43e",2412804444,"Illumina HiSeq","54523e527059eeb9315e0ce90bf620d6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:45:59.513661-05:00","2016-06-22T11:15:44.245302-05:00","b5012bbb-ae49-4b78-a17b-d34d9883e43e_analysis.xml","eea336cb347777c0e5d1364661dee1d1","2ed4c14d-bb34-4da2-ae97-cf29521dd690",2123,"2016-09-29T20:40:50.127124-05:00","b5012bbb-ae49-4b78-a17b-d34d9883e43e_experiment.xml","b86de67d431ea03803c89e56560d41c9","7606f8eb-b98f-4d5c-8ab8-cb385ad2774f",2628,"2016-09-29T18:39:18.671326-05:00","b5012bbb-ae49-4b78-a17b-d34d9883e43e_run.xml","3a5d970abd779c91c675d9ef50aaf5f5","2a8ab4b2-e21e-4572-867b-b5b567da39f4",354,"2016-09-08T10:39:19.979488-05:00","TCGA-5S-A9Q8","2016-09-02T18:52:14.736869-05:00","female","TCGA-5S-A9Q8_demographic",1962,"black or african american","9bc7569c-897a-5443-a8f7-f160ecba3605","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","5S","9f66a0e0-7425-5bdd-bf78-3952a44d6328","Holy Cross","not reported","c54.1","TCGA-5S-A9Q8_diagnosis","not reported",18785,"alive","8380/3",NA,313,"d3102afa-c8e9-5eae-997f-1bf246a5b819","c54.1",-18785,"TCGA-5S-A9Q8_treatment","610bbc3f-3888-5d71-b2ed-29af76ac3d7b","01","true","TCGA-5S-A9Q8-01A",NA,"e5004b9a-a75d-4908-924f-d46e53d33e6b",FALSE,"3F89A501-BE16-4E08-9846-41B4BBDDFCF9","Primary Tumor",NA,103,690,NA,1395964800,"11",30,"TCGA-5S-A9Q8-01A-11",90,NA,0,NA,2,NA,5,NA,"2016-09-08T10:39:19.979488-05:00",NA,2,NA,0,NA,"TOP",NA,3,NA,"4ca0d921-5924-4033-b405-086190bfd54d",NA,"TCGA-5S-A9Q8-01A-01-TSA",NA,90,NA,"a49c848b-486d-493e-b46b-2de7fa1e8681","RNA","TCGA-5S-A9Q8-01A-11R","b671c387-5261-4a64-a59d-dbe384971953",1.9,0.16,"UV Spec","R","23","TCGA-5S-A9Q8-01A-11R-A40A-07","5eb217b7-bf79-475d-8476-a66670ad9ed2",0.16,NA,86,32.7693949093126,162,"194023da-444b-5e6b-865d-34e67defa169","TCGA-5S-A9Q8_exposure","UNCID_2661007.5eb217b7-bf79-475d-8476-a66670ad9ed2.140711_UNC12-SN629_0381_AC4M54ACXX_3_TGACCA.tar.gz","2014-11-14T21:27:03.000Z","2014-11-14T21:40:21.000Z","B5012BBB-AE49-4B78-A17B-D34D9883E43E","E5004B9A-A75D-4908-924F-D46E53D33E6B","Unaligned reads",2412804444,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","5EB217B7-BF79-475D-8476-A66670AD9ED2","University of North Carolina","56607608e4b0b37b3d99000c","8751429B-4A11-451E-B978-DC9E9DB0EB36","Uterine Corpus Endometrial Carcinoma","TARGZ","A49C848B-486D-493E-B46B-2DE7FA1E8681","2014-11-14T21:40:21.000Z","B671C387-5261-4A64-A59D-DBE384971953","United States","NO",1,NA,"Primary Tumor","Holy Cross",103,"A49C848B-486D-493E-B46B-2DE7FA1E8681",NA,"5S","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BABFB88E-883C-4766-BBBA-9EE3781212F0.txt",690,"TCGA-5S-A9Q8-01A",NA,"C3D2C1D7-A802-4380-AE62-B29E2614F2BB","TCGA",2013,"TCGA-5S-A9Q8_NTE-1",NA,NA,"E5004B9A-A75D-4908-924F-D46E53D33E6B",51,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BABFB88E-883C-4766-BBBA-9EE3781212F0.txt","Alive",NA,"TCGA-5S-A9Q8","NOT HISPANIC OR LATINO","433FEF2F-84D8-4FAE-8488-7CF6B761AE60","NO",33,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",421,NA,"60E7A516-F631-4679-8948-E1FA2ECDD428","BLACK OR AFRICAN AMERICAN",NA,11,30,"4CA0D921-5924-4033-B405-086190BFD54D","B671C387-5261-4A64-A59D-DBE384971953","UNCID_2661007.5eb217b7-bf79-475d-8476-a66670ad9ed2.140711_UNC12-SN629_0381_AC4M54ACXX_3_TGACCA.tar.gz","TCGA-5S-A9Q8-01A-11",90,2,0,2,5,"TOP",3,0,"TCGA-5S-A9Q8-01A-01-TSA",90,"Carboplatin","Chemotherapy","TCGA-5S-A9Q8-D64498","TCGA-5S-A9Q8-R64501","Internal","Primary Tumor Field","TCGA-5S-A9Q8-F64486_NTE-1","NO",313,NA,"Alive",NA,"TCGA-5S-A9Q8-F64486","TCGA-5S-A9Q8",1,"5S","A9Q8","YES","C54.1","8380/3","C54.1","YES","NO",-18785,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",33,NA,"NO","YES",NA,"YES",23,12,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,51,2013,"Excisional Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
106401428,104250343,4983070110,"F006335D-4815-4E3A-9761-722302DA6930.bw","87e44856-eb9a-475f-96b1-047b7f77b0da","f006335d-4815-4e3a-9761-722302da6930","2016-08-09T14:43:00.800087-05:00","UNCID_2668048.ceba19ee-6da0-4917-a4ba-e9bd20ad7f10.150108_UNC15-SN850_0402_AC5FTHACXX_1_ACAGTG.tar.gz","aa8d1dcd-d79e-4049-8e0d-df926673e07d",4394870888,"Illumina HiSeq","5d741434b405a376f82225ca31739788","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:14:11.248163-05:00","2016-06-22T11:18:40.518409-05:00","aa8d1dcd-d79e-4049-8e0d-df926673e07d_analysis.xml","baf48f11e973acde95732fa48b97a94f","b0037fc3-36d1-4fee-a883-0e5094a75b29",2123,"2016-09-30T00:21:15.922617-05:00","aa8d1dcd-d79e-4049-8e0d-df926673e07d_experiment.xml","bfb743626b773773d7046ccee2be6cea","fec7c696-19cc-4664-8f03-a5a2ffc3feef",2628,"2016-09-29T21:39:57.311550-05:00","aa8d1dcd-d79e-4049-8e0d-df926673e07d_run.xml","c1aed0f8b565e51cb6d21ab2d0a9c689","9ac019b1-404c-4c9a-86bd-876ad0102b58",354,"2016-09-08T10:38:49.074451-05:00","TCGA-AX-A05W","2016-09-02T18:52:44.460255-05:00","female","TCGA-AX-A05W_demographic",1944,"white","2a3c98a5-a5b9-56cc-9247-093e90862409","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A05W_diagnosis","not reported",22200,"alive","8380/3",NA,2450,"b7d4f74c-12af-5445-b73d-84769ca2e86c","c54.1",-22200,"TCGA-AX-A05W_treatment","be3c981b-54f6-5287-9e05-aad09e92a735","01","false","TCGA-AX-A05W-01A",NA,"dbdf67e1-e4c2-499c-b701-f1f322242e84",FALSE,"4C960E79-D109-4C4C-B99F-F73D4DD73B40","Primary Tumor",NA,1935,210,NA,1275868800,"21",30,"TCGA-AX-A05W-01A-21",95,90,0,0,3,6,2,4,"2016-09-08T10:38:49.074451-05:00","2016-09-08T10:38:49.074451-05:00",3,3,0,2,"TOP","BOTTOM",10,5,"7504484a-e663-47da-845b-a7aa648a4717","8073e8ab-2786-472c-944b-e92ce36e7bc5","TCGA-AX-A05W-01A-02-TSB","TCGA-AX-A05W-01A-02-BSB",85,85,"91549966-8c2f-448f-898c-56bbc6000b1c","RNA","TCGA-AX-A05W-01A-21R","4c7b6670-9aa1-46b9-a6a1-bb90d58d3ba2",1.8,0.16,"UV Spec","R","23","TCGA-AX-A05W-01A-21R-A466-07","ceba19ee-6da0-4917-a4ba-e9bd20ad7f10",0.16,NA,74,28.5482813163072,161,"a536f19d-3e30-5535-becc-cd43aa95d393","TCGA-AX-A05W_exposure","UNCID_2668048.ceba19ee-6da0-4917-a4ba-e9bd20ad7f10.150108_UNC15-SN850_0402_AC5FTHACXX_1_ACAGTG.tar.gz","2015-02-02T00:06:04.000Z","2015-02-02T00:26:44.000Z","AA8D1DCD-D79E-4049-8E0D-DF926673E07D","DBDF67E1-E4C2-499C-B701-F1F322242E84","Unaligned reads",4394870888,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","CEBA19EE-6DA0-4917-A4BA-E9BD20AD7F10","University of North Carolina","56607bcce4b0ca319164fd90","87E44856-EB9A-475F-96B1-047B7F77B0DA","Uterine Corpus Endometrial Carcinoma","TARGZ","91549966-8C2F-448F-898C-56BBC6000B1C","2015-02-02T00:26:44.000Z","4C7B6670-9AA1-46B9-A6A1-BB90D58D3BA2","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1935,"91549966-8C2F-448F-898C-56BBC6000B1C",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2DDFA76D-9935-4B66-BAC4-051E44960A93.txt",210,"TCGA-AX-A05W-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","DBDF67E1-E4C2-499C-B701-F1F322242E84",60,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2DDFA76D-9935-4B66-BAC4-051E44960A93.txt","Alive",NA,"TCGA-AX-A05W","NOT HISPANIC OR LATINO","D7F1CF3E-41AE-4570-88A3-1A5074156979",NA,2079,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"WHITE",NA,21,30,"7504484A-E663-47DA-845B-A7AA648A4717","A7E46C5B-B526-4CA7-97AA-51F5E01BBFA4","UNCID_2668048.ceba19ee-6da0-4917-a4ba-e9bd20ad7f10.150108_UNC15-SN850_0402_AC5FTHACXX_1_ACAGTG.tar.gz","TCGA-AX-A05W-01A-21",90,6,0,3,4,"BOTTOM",5,2,"TCGA-AX-A05W-01A-02-BSB",85,NA,NA,NA,NA,NA,NA,NA,NA,2079,"TUMOR FREE","Alive",NA,"TCGA-AX-A05W-F5572","TCGA-AX-A05W",1,"AX","A05W","YES","C54.1","8380/3","C54.1","NO","YES",-22200,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2079,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2004,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
22823000,22189453,1639545168,"E4EFC6A1-F139-42AD-ACE3-79CB66804595.bw","884fd57d-bd8e-40e7-82f6-0ba1c71101a9","e4efc6a1-f139-42ad-ace3-79cb66804595","2016-08-05T06:09:30.698014-05:00","UNCID_2215049.1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9.101014_UNC2-RDR300275_00039_FC_706C1AAXX_7.tar.gz","1ae3b589-a3fb-4084-8ce7-ca04f3cb39c1",1372759148,"Illumina GA","aad4e8709dc992144e4fc7d34e309adf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:39:08.614062-05:00","2016-05-03T11:17:14.878442-05:00","1ae3b589-a3fb-4084-8ce7-ca04f3cb39c1_analysis.xml","d549e2caec78a39941bb3c096288cd31","e4b13aa9-f2db-488d-b088-48d2d8b4e762",2120,"2016-09-29T22:27:55.905458-05:00","1ae3b589-a3fb-4084-8ce7-ca04f3cb39c1_experiment.xml","1b6da135e5fc16fa7f32bd8020d3b564","b8743e4e-ada2-4423-a7cd-1e7334560a23",2256,"2016-09-29T20:31:04.887941-05:00","1ae3b589-a3fb-4084-8ce7-ca04f3cb39c1_run.xml","25aaa52baf8667825ffd6a211296b14f","70104b4a-a6be-4699-9983-b53d6ec14045",345,"2016-09-08T10:39:33.479314-05:00","TCGA-BG-A0MC","2016-09-02T18:54:48.165506-05:00","female","TCGA-BG-A0MC_demographic",1934,"white","42b3c01b-def5-5cb2-be54-586665f83089","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MC_diagnosis","not reported",27136,"alive","8380/3",NA,1263,"6489843e-939f-5f39-badf-ccab378a3ad6","c54.1",-27136,"TCGA-BG-A0MC_treatment","6d91b950-ac08-5e7e-95f1-27820d5c7083","01","true","TCGA-BG-A0MC-01A",NA,"46b48bf8-346b-4f25-916e-26a3cddfa00d",FALSE,"100F4900-491A-438B-9704-51D4E016B325","Primary Tumor",NA,779,630,NA,1279584000,"21",30,"TCGA-BG-A0MC-01A-21",75,80,0,0,0,0,0,0,"2016-09-08T10:39:33.479314-05:00","2016-09-08T10:39:33.479314-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"a62cbfb6-1ee0-4f71-93bd-ba89a3329b81","1da708b6-4e12-4d86-8c15-6e768f2103c8","TCGA-BG-A0MC-01A-02-TSB","TCGA-BG-A0MC-01A-02-BSB",100,100,"7a317648-c8d5-4996-8322-717b17f27ed9","RNA","TCGA-BG-A0MC-01A-21R","f084272e-7a5d-42ef-ba7a-950ad591e5d8",1.94,0.15,"UV Spec","R","23","TCGA-BG-A0MC-01A-21R-A040-07","1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9",0.15,NA,135,56.1914672216441,155,"afc80ae7-c13d-5667-9466-39c1c6aba358","TCGA-BG-A0MC_exposure","UNCID_2215049.1ad1a4dc-b34a-4f34-990b-05c2c14fb4c9.101014_UNC2-RDR300275_00039_FC_706C1AAXX_7.tar.gz","2013-10-03T23:36:04.000Z","2013-10-03T23:48:02.000Z","1AE3B589-A3FB-4084-8CE7-CA04F3CB39C1","46B48BF8-346B-4F25-916E-26A3CDDFA00D","Unaligned reads",1372759148,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1AD1A4DC-B34A-4F34-990B-05C2C14FB4C9","University of North Carolina","56607891e4b018727fea1b64","884FD57D-BD8E-40E7-82F6-0BA1C71101A9","Uterine Corpus Endometrial Carcinoma","TARGZ","7A317648-C8D5-4996-8322-717B17F27ED9","2013-10-03T23:48:02.000Z","F084272E-7A5D-42EF-BA7A-950AD591E5D8","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",779,"7A317648-C8D5-4996-8322-717B17F27ED9",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.27EBFA46-C09D-471B-A9D5-B3BA90EE832E.txt",630,"TCGA-BG-A0MC-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","E9B69826-4669-4C37-BD74-1192C9660A22",74,"TCGA-BG-A0MC-01A-21W-A062-09_IlluminaGA-DNASeq_exome.bam","Alive",NA,"TCGA-BG-A0MC","NOT HISPANIC OR LATINO","42382E50-2066-4FD9-BCD3-70C666D7A19C",NA,827,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,21,30,"A62CBFB6-1EE0-4F71-93BD-BA89A3329B81","F084272E-7A5D-42EF-BA7A-950AD591E5D8","TCGA-BG-A0MC-01A-21R-A041-13_mirna.bam.bai","TCGA-BG-A0MC-01A-21",75,0,0,0,0,"TOP",0,0,"TCGA-BG-A0MC-01A-02-TSB",100,NA,NA,NA,NA,NA,NA,NA,"NO",1263,"TUMOR FREE","Alive",NA,"TCGA-BG-A0MC-F19280","TCGA-BG-A0MC",1,"BG","A0MC","YES","C54.1","8380/3","C54.1","NO","YES",-27136,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",827,NA,NA,NA,"TUMOR FREE","NO",8,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2008,"Tumor resection",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
150728760,147484277,7036065164,"27A91CA1-26B8-4317-A640-353DE0AF3013.bw","8a0a58a0-5c12-4366-af43-4fd25f8ff454","27a91ca1-26b8-4317-a640-353de0af3013","2016-08-05T06:00:57.040331-05:00","UNCID_2178337.c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf.130404_UNC12-SN629_0271_AC24VNACXX_7_ACTTGA.tar.gz","675c35d5-f45e-4cf8-a754-83897685d9d2",7057847432,"Illumina HiSeq","96429c8853e2544ede780e1950e05ba0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:51:04.931227-05:00","2016-05-03T10:56:47.880266-05:00","675c35d5-f45e-4cf8-a754-83897685d9d2_analysis.xml","0675e1b3507878a2b45449c7cf1254f6","ec204c26-929f-4113-9994-032469e3acdb",2123,"2016-09-30T00:11:39.972056-05:00","675c35d5-f45e-4cf8-a754-83897685d9d2_experiment.xml","0dc01101b8db4895e778811946175fd1","f8bb1a71-b1db-4126-a79e-1323953aa9e8",2431,"2016-09-29T23:45:53.392789-05:00","675c35d5-f45e-4cf8-a754-83897685d9d2_run.xml","23b2cd9bd6b804187d1235f9e6251c16","e8f6bbee-b85a-4108-840d-b587b0e304e2",354,"2016-09-08T10:31:18.073493-05:00","TCGA-AJ-A3IA","2016-09-02T18:48:18.678325-05:00","female","TCGA-AJ-A3IA_demographic",1934,"white","7d424c52-15ea-5d54-9fc8-3bdfb035d686","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3IA_diagnosis","not reported",28470,"alive","8380/3",NA,633,"15536478-e5fd-539a-9ce0-3beb75abd69f","c54.1",-28470,"TCGA-AJ-A3IA_treatment","b774bff9-6bb0-5134-8bbe-161997a63981","01","false","TCGA-AJ-A3IA-01A",NA,"0fb7ceae-cf5d-4e98-8ad8-114947b6e7e3",FALSE,"883486F6-0EDF-4BBC-8412-67F31351427B","Primary Tumor",NA,66,35,NA,1325548800,"11",35,"TCGA-AJ-A3IA-01A-11",75,NA,0,NA,0,NA,10,NA,"2016-09-08T10:31:18.073493-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"58b1e9f4-4ccf-4590-a481-eceefd0541b3",NA,"TCGA-AJ-A3IA-01A-01-TS1",NA,90,NA,"bcd1928a-1b55-4eab-aae7-6c243db67778","RNA","TCGA-AJ-A3IA-01A-11R","1cb03957-b716-4d6f-9190-ebea2edbe3ec",1.73,0.15,"UV Spec","R","23","TCGA-AJ-A3IA-01A-11R-A213-07","c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf",0.15,NA,58,23.5303663434622,157,"96f1dafe-b560-5350-8c4e-e6a36276b72c","TCGA-AJ-A3IA_exposure","UNCID_2178337.c32dabac-90ce-4b8c-b08c-85a1a2fe8ccf.130404_UNC12-SN629_0271_AC24VNACXX_7_ACTTGA.tar.gz","2013-09-12T01:31:10.000Z","2013-09-12T02:05:01.000Z","675C35D5-F45E-4CF8-A754-83897685D9D2","0FB7CEAE-CF5D-4E98-8AD8-114947B6E7E3","Unaligned reads",7057847432,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","C32DABAC-90CE-4B8C-B08C-85A1A2FE8CCF","University of North Carolina","5660783ae4b016715ab69c70","8A0A58A0-5C12-4366-AF43-4FD25F8FF454","Uterine Corpus Endometrial Carcinoma","TARGZ","BCD1928A-1B55-4EAB-AAE7-6C243DB67778","2013-09-12T02:05:01.000Z","1CB03957-B716-4D6F-9190-EBEA2EDBE3EC","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",66,"BCD1928A-1B55-4EAB-AAE7-6C243DB67778",NA,"AJ","COAPT_p_TCGASNP_197_201_204_N_GenomeWideSNP_6_H11_1051400.hg19.seg.txt",35,"TCGA-AJ-A3IA-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","84E04039-9DF7-42A9-A133-E14D166DCA4F",77,"nationwidechildrens.org_clinical.TCGA-AJ-A3IA.xml","Alive",NA,"TCGA-AJ-A3IA","NOT HISPANIC OR LATINO","EF0D71C1-22CD-4802-9133-C4ACF10EB8D0",NA,28,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",201,NA,NA,"WHITE",NA,11,35,"58B1E9F4-4CCF-4590-A481-ECEEFD0541B3","1CB03957-B716-4D6F-9190-EBEA2EDBE3EC","c6d391bc546e303bad12bc7f2e8149a8.bam","TCGA-AJ-A3IA-01A-11",75,0,0,0,10,"TOP",0,0,"TCGA-AJ-A3IA-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3IA-F48781_NTE-1","NO",633,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3IA-F48781","TCGA-AJ-A3IA",1,"AJ","A3IA","YES","C54.1","8380/3","C54.1","YES","NO",-28470,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",28,NA,NA,NA,"TUMOR FREE","NO",13,4,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,77,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33488267,33164796,2474462605,"B90A0E6D-D667-4AC5-8F4C-0B5198E4716F.bw","8a235d4d-5ee1-4d6b-839e-e71cadcd8c39","b90a0e6d-d667-4ac5-8f4c-0b5198e4716f","2016-08-05T04:40:53.181821-05:00","UNCID_2206672.e216a53d-5300-45af-985d-9d397e990acf.111006_UNC2-RDR300275_00089_FC_634EEAAXX_5.tar.gz","63ac8b7a-84f6-4200-adef-db7df2822192",2165417724,"Illumina GA","436487bf1106960820dd0f88b40033a7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:56:29.567825-05:00","2016-05-03T11:12:13.642315-05:00","63ac8b7a-84f6-4200-adef-db7df2822192_analysis.xml","02c2446b29a353ac6450089353f081c9","a529761f-4f35-4c85-b30c-7e97a02876dd",2121,"2016-08-13T04:21:39.649920-05:00","63ac8b7a-84f6-4200-adef-db7df2822192_experiment.xml","e92272d72ced6814f208556c451ca626","9e428bbb-0aa3-4e72-93df-b6996531813c",2257,"2016-09-29T18:41:25.551296-05:00","63ac8b7a-84f6-4200-adef-db7df2822192_run.xml","88b81109d842d424915786376505e3fc","2be5e416-7e1b-4eb5-b168-ce0389f79ddd",347,"2016-09-08T10:33:53.278509-05:00","TCGA-AX-A2IO","2016-09-02T18:53:14.535727-05:00","female","TCGA-AX-A2IO_demographic",1925,"white","a3d8b15e-c949-5b84-8dfa-e04e6ef92814","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2IO_diagnosis","not reported",30539,"alive","8441/3",NA,1975,"f9192a59-62b1-59d0-8feb-bf2e9ec37371","c54.1",-30539,"TCGA-AX-A2IO_treatment","bced907c-b54c-570b-9717-e6de5a6a3360","01","false","TCGA-AX-A2IO-01A",NA,"4873bdca-1153-4187-95b8-30ee31880ddf",FALSE,"5482CC06-7854-459E-8A23-81ABC45DD076","Primary Tumor",NA,1262,40,NA,1310515200,"11",30,"TCGA-AX-A2IO-01A-11",60,NA,0,NA,38,NA,10,NA,"2016-09-08T10:33:53.278509-05:00",NA,10,NA,0,NA,"TOP",NA,2,NA,"b934d163-edd2-4fa6-a6a7-b9ba833f327e",NA,"TCGA-AX-A2IO-01A-01-TSA",NA,50,NA,"0b4c6c0f-c31c-47aa-b8e4-f03b90eeed6a","RNA","TCGA-AX-A2IO-01A-11R","8a136768-0928-41c4-a0b9-e90f32d1989c",1.68,0.16,"UV Spec","R","23","TCGA-AX-A2IO-01A-11R-A180-07","e216a53d-5300-45af-985d-9d397e990acf",0.16,NA,64,24.3865264441396,162,"6f497245-c25e-59a8-af38-b53f81cd2e37","TCGA-AX-A2IO_exposure","UNCID_2206672.e216a53d-5300-45af-985d-9d397e990acf.111006_UNC2-RDR300275_00089_FC_634EEAAXX_5.tar.gz","2013-09-27T18:43:09.000Z","2013-09-27T18:56:02.000Z","63AC8B7A-84F6-4200-ADEF-DB7DF2822192","4873BDCA-1153-4187-95B8-30EE31880DDF","Unaligned reads",2165417724,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E216A53D-5300-45AF-985D-9D397E990ACF","University of North Carolina","564a3850e4b08c5d869087fe","8A235D4D-5EE1-4D6B-839E-E71CADCD8C39","Uterine Corpus Endometrial Carcinoma","TARGZ","0B4C6C0F-C31C-47AA-B8E4-F03B90EEED6A","2013-09-27T18:56:02.000Z","8A136768-0928-41C4-A0B9-E90F32D1989C","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1262,"0B4C6C0F-C31C-47AA-B8E4-F03B90EEED6A",NA,"AX","a477e5620f4bce913a09e47d3f3407d5.bam",40,"TCGA-AX-A2IO-01A",NA,"D6ADB87E-DFE5-4059-8FD0-C350D8558938","TCGA",2008,NA,NA,"TUMOR FREE","CF7A1D44-3752-47CA-ACB6-298024680E99",83,"nationwidechildrens.org_clinical.TCGA-AX-A2IO.xml","Alive",NA,"TCGA-AX-A2IO",NA,"50718218-DB5E-4254-B224-1D328172D40C",NA,1177,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIA",NA,NA,NA,"8441/3","FEMALE","C54.1",168,NA,"D3AEE75F-4C1A-46D1-B0C2-E8A8FC3156C1","WHITE",NA,11,30,"B934D163-EDD2-4FA6-A6A7-B9BA833F327E","EAF15637-E03B-4023-B37D-223B749E909A","TCGA-AX-A2IO-01A-11R-A17X-13_mirna.bam.bai","TCGA-AX-A2IO-01A-11",60,38,0,10,10,"TOP",2,0,"TCGA-AX-A2IO-01A-01-TSA",50,"Carboplatin, Taxol",NA,"TCGA-AX-A2IO-D58278","TCGA-AX-A2IO-R58277","Internal","Primary Tumor Field","TCGA-AX-A2IO-F58276_NTE-1","NO",1975,NA,"Alive",NA,"TCGA-AX-A2IO-F58276","TCGA-AX-A2IO",1,"AX","A2IO","YES","C54.1","8441/3","C54.1","NO","YES",-30539,"FEMALE","WHITE",NA,"No","No","Alive",1177,NA,NA,NA,"TUMOR FREE","NO",1,11,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,83,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",6,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
138294604,132394729,6318087030,"368CFCA3-7BAB-4D6D-9AE1-55713A9965C1.bw","8a67ed86-156f-4b45-b460-000fe33da26b","368cfca3-7bab-4d6d-9ae1-55713a9965c1","2016-08-05T19:21:37.230872-05:00","UNCID_2661008.8cda2390-3a6c-422e-b827-5c62c015f020.140711_UNC12-SN629_0381_AC4M54ACXX_1_GCCAAT.tar.gz","4b09e15a-6393-4cad-8d8b-c153d416019a",6083489639,"Illumina HiSeq","802b88f85f3cb7fa2192621af0efe836","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:56:33.220957-05:00","2016-06-22T11:15:44.245302-05:00","4b09e15a-6393-4cad-8d8b-c153d416019a_analysis.xml","29b6d4f33c763986d241924421ae0d99","a537052f-62b5-4169-9949-4da060ff7b66",2124,"2016-09-29T19:10:56.906988-05:00","4b09e15a-6393-4cad-8d8b-c153d416019a_experiment.xml","b5d22b2591c87cb5a333672b5cce0068","3e8ffb67-daa5-484d-bbbf-816dd8fb8716",2628,"2016-09-29T18:07:17.231361-05:00","4b09e15a-6393-4cad-8d8b-c153d416019a_run.xml","aa0e3a408f73c74cc594385cd88ccf57","16a3787a-6099-427e-9c00-79ddda54092f",354,"2016-09-08T11:02:37.327367-05:00","TCGA-A5-AB3J","2016-09-02T18:52:15.234069-05:00","female","TCGA-A5-AB3J_demographic",1961,"black or african american","a4c89303-0bac-562f-bd1a-207d4fd60680","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-AB3J_diagnosis","not reported",19020,"alive","8380/3",NA,512,"81c22851-9367-5247-96b9-934f8a458523","c54.1",-19020,"TCGA-A5-AB3J_treatment","5cffb7dc-c095-5a07-a445-89bceb62fcf2","01","true","TCGA-A5-AB3J-01A",NA,"396753d3-fae0-4a1a-b193-4121a47746d2",FALSE,"41CDFB48-33A6-4FCD-97CA-30C73A9E6FED","Primary Tumor",NA,126,210,NA,1397001600,"11",30,"TCGA-A5-AB3J-01A-11",60,NA,0,NA,30,NA,10,NA,"2016-09-08T11:02:37.327367-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"a55d457e-1df1-4007-8f97-4a849f453371",NA,"TCGA-A5-AB3J-01A-01-TS1",NA,60,NA,"2b7f26c0-60c9-4b32-b03b-e88001ba6102","RNA","TCGA-A5-AB3J-01A-11R","56d7021e-21e7-45ec-a626-5ce001005b3b",1.86,0.17,"UV Spec","R","23","TCGA-A5-AB3J-01A-11R-A40A-07","8cda2390-3a6c-422e-b827-5c62c015f020",0.17,NA,59,23.046875,160,"b08b910e-0926-518c-9c2a-40c832005267","TCGA-A5-AB3J_exposure","UNCID_2661008.8cda2390-3a6c-422e-b827-5c62c015f020.140711_UNC12-SN629_0381_AC4M54ACXX_1_GCCAAT.tar.gz","2014-11-14T23:06:04.000Z","2014-11-14T23:30:23.000Z","4B09E15A-6393-4CAD-8D8B-C153D416019A","396753D3-FAE0-4A1A-B193-4121A47746D2","Unaligned reads",6083489639,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8CDA2390-3A6C-422E-B827-5C62C015F020","University of North Carolina","5660791ae4b0ca319164efb7","8A67ED86-156F-4B45-B460-000FE33DA26B","Uterine Corpus Endometrial Carcinoma","TARGZ","2B7F26C0-60C9-4B32-B03B-E88001BA6102","2014-11-14T23:30:23.000Z","56D7021E-21E7-45EC-A626-5CE001005B3B","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",126,"2B7F26C0-60C9-4B32-B03B-E88001BA6102",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.10735EAE-8427-4413-BF92-D9A29F5A3796.txt",210,"TCGA-A5-AB3J-01A",NA,"B947E618-F799-4297-A396-8D9B78606682","TCGA",2013,"TCGA-A5-AB3J_NTE-1","Complete Remission/Response","TUMOR FREE","396753D3-FAE0-4A1A-B193-4121A47746D2",52,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.10735EAE-8427-4413-BF92-D9A29F5A3796.txt","Alive",NA,"TCGA-A5-AB3J","NOT HISPANIC OR LATINO","BB282865-03D9-4C27-A39F-2F6B5FE515F3","NO",251,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",421,NA,"E45BB3C2-19B8-4159-864E-B08C06ABD03D","BLACK OR AFRICAN AMERICAN",NA,11,30,"A55D457E-1DF1-4007-8F97-4A849F453371","56D7021E-21E7-45EC-A626-5CE001005B3B","UNCID_2661008.8cda2390-3a6c-422e-b827-5c62c015f020.140711_UNC12-SN629_0381_AC4M54ACXX_1_GCCAAT.tar.gz","TCGA-A5-AB3J-01A-11",60,30,0,5,10,"TOP",0,0,"TCGA-A5-AB3J-01A-01-TS1",60,"Paclitaxel","Chemotherapy","TCGA-A5-AB3J-D64510","TCGA-A5-AB3J-R64511","Internal","Primary Tumor Field","TCGA-A5-AB3J-F65030_NTE-1","NO",329,"TUMOR FREE","Alive",NA,"TCGA-A5-AB3J-F65030","TCGA-A5-AB3J",1,"A5","AB3J","YES","C54.1","8380/3","C54.1","YES","NO",-19020,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes","No","Alive",251,NA,"YES","YES","TUMOR FREE","YES",8,10,2014,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,52,2013,"Other method, specify:",NA,NA,NA,"G2","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",5,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
32437634,32108104,2392900332,"2635B074-43E4-4731-AE5E-86BBFA30809D.bw","8b19c8ac-68e6-4dc8-aec9-1556e62ca20f","2635b074-43e4-4731-ae5e-86bbfa30809d","2016-08-06T23:19:18.979221-05:00","UNCID_2207444.860613bc-72b2-47bb-90ac-2b272e549860.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_6.tar.gz","0328de31-723e-4940-81b8-5d32b7f56c45",2100909625,"Illumina GA","5a5a1f08c974d31639791eb5f01d45ee","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:52:38.601245-05:00","2016-05-03T11:13:42.378529-05:00","0328de31-723e-4940-81b8-5d32b7f56c45_analysis.xml","dba83e38b2b950f3e7ea2196e0bfe7df","c7df4d8c-1dec-4409-942d-5b5110aa932b",2121,"2016-09-29T23:51:27.793783-05:00","0328de31-723e-4940-81b8-5d32b7f56c45_experiment.xml","37e88711aefb57da7e14a8a71d4d4033","ec5c8291-944a-4f48-9d5e-bf3d0e7fde17",2257,"2016-09-29T21:23:28.279792-05:00","0328de31-723e-4940-81b8-5d32b7f56c45_run.xml","d4a48443fce37fef35271af325cd84da","90b3a541-eddb-4427-8502-55f3ab3bd60d",347,"2016-09-08T11:54:51.265339-05:00","TCGA-D1-A16V","2016-09-02T18:50:30.911607-05:00","female","TCGA-D1-A16V_demographic",1931,"white","c70e4bfa-e599-54ca-91a6-d9088fab9f05","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16V_diagnosis","not reported",28635,"dead","8380/3",120,43,"6f7e7f7a-d0fd-52fb-b263-c8678cbdfcbe","c54.1",-28635,"TCGA-D1-A16V_treatment","0b5906f7-d802-5f84-813c-0e371f8ace82","01","false","TCGA-D1-A16V-01A",NA,"67d0886e-54be-4771-aee7-63adf4a475b7",FALSE,"92EA83B6-8041-4449-BAE6-5060C32966D0","Primary Tumor",NA,609,410,NA,1294617600,"11",30,"TCGA-D1-A16V-01A-11",90,NA,2,NA,2,NA,10,NA,"2016-09-08T11:54:51.265339-05:00",NA,15,NA,3,NA,"TOP",NA,6,NA,"87b4a379-4103-4fdf-a182-5aa53bcf5bc0",NA,"TCGA-D1-A16V-01A-01-TS1",NA,82,NA,"cc688a6d-95de-4869-9b4d-55137caa6475","RNA","TCGA-D1-A16V-01A-11R","aaa6975f-c829-40a6-bc87-469c7676cf4c",1.85,0.17,"UV Spec","R","23","TCGA-D1-A16V-01A-11R-A12I-07","860613bc-72b2-47bb-90ac-2b272e549860",0.17,NA,105,35.0830298372816,173,"cc4cd264-a016-5827-81fb-14e0d849ddf6","TCGA-D1-A16V_exposure","UNCID_2207444.860613bc-72b2-47bb-90ac-2b272e549860.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_6.tar.gz","2013-09-30T01:01:04.000Z","2013-09-30T01:13:02.000Z","0328DE31-723E-4940-81B8-5D32B7F56C45","67D0886E-54BE-4771-AEE7-63ADF4A475B7","Unaligned reads",2100909625,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","860613BC-72B2-47BB-90AC-2B272E549860","University of North Carolina","56607eafe4b0b37b3d9930f9","8B19C8AC-68E6-4DC8-AEC9-1556E62CA20F","Uterine Corpus Endometrial Carcinoma","TARGZ","CC688A6D-95DE-4869-9B4D-55137CAA6475","2013-09-30T01:13:02.000Z","AAA6975F-C829-40A6-BC87-469C7676CF4C","None","NO",1,NA,"Primary Tumor","Mayo Clinic",609,"CC688A6D-95DE-4869-9B4D-55137CAA6475",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C3D27B98-8016-4388-9F04-B07D6389F0EF.txt",410,"TCGA-D1-A16V-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","839BBA92-F758-42AE-A64B-F8049F712C51",78,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C3D27B98-8016-4388-9F04-B07D6389F0EF.txt","Alive",NA,"TCGA-D1-A16V","NOT HISPANIC OR LATINO","D610C06B-3D5F-4C46-9AC2-3F67F006014F",NA,43,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"87B4A379-4103-4FDF-A182-5AA53BCF5BC0","AAA6975F-C829-40A6-BC87-469C7676CF4C","SCAUR_p_TCGA_b94_SNP_N_GenomeWideSNP_6_H03_755372.hg19.seg.txt","TCGA-D1-A16V-01A-11",90,2,2,15,10,"TOP",6,3,"TCGA-D1-A16V-01A-01-TS1",82,NA,NA,NA,NA,NA,NA,NA,"NO",NA,NA,"Dead",120,"TCGA-D1-A16V-F20230","TCGA-D1-A16V",1,"D1","A16V","YES","C54.1","8380/3","C54.1","NO","YES",-28635,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",43,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,78,2009,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
130282392,127608647,6027416891,"26C57D13-F2BB-4DAB-8342-D706708DCDE3.bw","8b4cf993-1e16-4009-a37f-a629528b7d7e","26c57d13-f2bb-4dab-8342-d706708dcde3","2016-08-05T09:44:31.899973-05:00","UNCID_2173011.9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b.130509_UNC10-SN254_0462_AC232JACXX_7_GTGGCC.tar.gz","0d9b9844-8365-4f99-9006-f6a52a58b24b",6015833498,"Illumina HiSeq","310b9ab129f928d6d427eb4ce8b5642a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:05:20.594065-05:00","2016-05-03T10:55:55.600288-05:00","0d9b9844-8365-4f99-9006-f6a52a58b24b_analysis.xml","a55c2fed72d8c9f9f701c01478cc3d89","3b0c7589-ef20-4b07-bbb5-33c3c1fccd43",2122,"2016-10-07T16:49:47.354241-05:00","0d9b9844-8365-4f99-9006-f6a52a58b24b_experiment.xml","db4bdc39adebc48537cb873011e1a3ab","a05c6a50-b449-4668-b5e9-a86b5925d9dc",2431,"2016-09-29T18:20:16.825733-05:00","0d9b9844-8365-4f99-9006-f6a52a58b24b_run.xml","c3e2f732cbc32fa13912a0e91c4b2c05","1e7eaf05-7363-41fc-af7a-f509e518865b",354,"2016-09-08T10:54:52.769609-05:00","TCGA-AX-A3FT","2016-09-02T18:49:09.737859-05:00","female","TCGA-AX-A3FT_demographic",1946,"white","a0b12635-e4b8-5c98-8598-5d12f61f0f2a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3FT_diagnosis","not reported",23543,"alive","8380/3",NA,6,"87f6a4eb-1096-5d7a-8994-9394e567c502","c54.1",-23543,"TCGA-AX-A3FT_treatment","a813bcfb-5f99-5ff2-8f53-8f6842292720","01","false","TCGA-AX-A3FT-01A",NA,"6176a2e7-9c0b-4a9c-b8d6-cf669419959d",FALSE,"EF16D53F-14A2-4127-B5F7-F318EC60C5C0","Primary Tumor",NA,524,110,NA,1322784000,"11",30,"TCGA-AX-A3FT-01A-11",80,NA,0,NA,8,NA,20,NA,"2016-09-08T10:54:52.769609-05:00",NA,10,NA,0,NA,"TOP",NA,2,NA,"a7e05063-a1f2-449a-bb2e-11aaa9d0985d",NA,"TCGA-AX-A3FT-01A-01-TS1",NA,70,NA,"29302b27-6ee9-4a64-b0cf-165b15bbafe4","RNA","TCGA-AX-A3FT-01A-11R","e09b063d-3b22-4dbb-8039-39b8e83d440d",1.84,0.15,"UV Spec","R","23","TCGA-AX-A3FT-01A-11R-A22K-07","9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b",0.15,NA,82,31.6345819991513,161,"fb974c37-14e9-5fc3-a9e4-ed99220d857f","TCGA-AX-A3FT_exposure","UNCID_2173011.9c9dcb46-e9c5-4a85-9bf5-00d7cd9e871b.130509_UNC10-SN254_0462_AC232JACXX_7_GTGGCC.tar.gz","2013-09-09T06:36:10.000Z","2013-09-09T06:57:01.000Z","0D9B9844-8365-4F99-9006-F6A52A58B24B","6176A2E7-9C0B-4A9C-B8D6-CF669419959D","Unaligned reads",6015833498,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","9C9DCB46-E9C5-4A85-9BF5-00D7CD9E871B","University of North Carolina","564a3c16e4b093830b697c97","8B4CF993-1E16-4009-A37F-A629528B7D7E","Uterine Corpus Endometrial Carcinoma","TARGZ","29302B27-6EE9-4A64-B0CF-165B15BBAFE4","2013-09-09T06:57:01.000Z","E09B063D-3B22-4DBB-8039-39B8E83D440D","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",524,"29302B27-6EE9-4A64-B0CF-165B15BBAFE4",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3F2A36E1-DC43-4EB6-B0C0-F7D255496FB0.txt",110,"TCGA-AX-A3FT-01A",NA,NA,"TCGA",2010,NA,NA,NA,"E1B6B09E-B7E8-4A21-9977-5140E4ABE1B0",64,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3F2A36E1-DC43-4EB6-B0C0-F7D255496FB0.txt","Alive",NA,"TCGA-AX-A3FT","NOT HISPANIC OR LATINO","09DE90F5-988C-41B9-AA42-66E2A7141C1F",NA,3,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"A7E05063-A1F2-449A-BB2E-11AAA9D0985D","E09B063D-3B22-4DBB-8039-39B8E83D440D","TCGA-AX-A3FT-01A-11R-A22I-13_mirna.bam.bai","TCGA-AX-A3FT-01A-11",80,8,0,10,20,"TOP",2,0,"TCGA-AX-A3FT-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3FT-F58280_NTE-1",NA,6,NA,"Alive",NA,"TCGA-AX-A3FT-F58280","TCGA-AX-A3FT",1,"AX","A3FT","YES","C54.1","8380/3","C54.1","NO","YES",-23543,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",3,NA,NA,NA,NA,"NO",6,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2010,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
155691660,154299152,7368300888,"52AA2072-540B-4026-B10A-934EA2572A2E.bw","8bb89c0f-0f04-485e-8e08-801042dfcba9","52aa2072-540b-4026-b10a-934ea2572a2e","2016-08-09T13:15:11.007937-05:00","UNCID_2171223.cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3.130509_UNC10-SN254_0462_AC232JACXX_8_ATTCCT.tar.gz","afd64ee8-ca44-45ab-b0cc-7d02e4bf5eb8",7085912887,"Illumina HiSeq","4636971c565388b2866507cba915dcda","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:12:24.853438-05:00","2016-05-03T10:55:55.600288-05:00","afd64ee8-ca44-45ab-b0cc-7d02e4bf5eb8_analysis.xml","b8306cac9a84f52510e9d5144d0c50a1","f92e8322-c0b0-43f5-8f07-534494e69126",2123,"2016-09-29T18:46:14.662850-05:00","afd64ee8-ca44-45ab-b0cc-7d02e4bf5eb8_experiment.xml","90e42006fa8a5405ab23eb7520580db6","2efd2e70-108a-4211-868f-5be94a47ed70",2431,"2016-09-29T18:34:19.540340-05:00","afd64ee8-ca44-45ab-b0cc-7d02e4bf5eb8_run.xml","dd6853635a3be346c1a01c0a9328b239","2740fe28-f93e-48b7-8520-4545ccba0d6c",354,"2016-09-08T10:39:49.870203-05:00","TCGA-EY-A3QX","2016-09-02T18:49:32.329313-05:00","female","TCGA-EY-A3QX_demographic",1947,"white","02f9c51a-865f-5292-9165-f7d4c7de2cd1","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A3QX_diagnosis","not reported",23663,"dead","8441/3",989,421,"848350aa-eb1a-54e2-9b71-f9584248ad9d","c54.1",-23663,"TCGA-EY-A3QX_treatment","2af2ea6f-38c3-5a69-93d1-349a4598bb99","01","false","TCGA-EY-A3QX-01A",NA,"8d1365a7-c67c-4073-8483-8693d4683ccd",FALSE,"8AED036E-FB86-42D1-B840-FB4AD6E8D0EF","Primary Tumor",NA,112,659,NA,1332979200,"11",30,"TCGA-EY-A3QX-01A-11",75,NA,1,NA,0,NA,0,NA,"2016-09-08T10:39:49.870203-05:00",NA,5,NA,0,NA,"TOP",NA,10,NA,"d77f35e6-7b7a-4a9e-9c31-acf9395a356e",NA,"TCGA-EY-A3QX-01A-01-TS1",NA,90,NA,"a5d18bd4-0f54-4fd1-b2d6-09230a57836c","RNA","TCGA-EY-A3QX-01A-11R","aafb0027-06fa-4d0a-8177-29fd04ddb7dd",1.84,0.16,"UV Spec","R","23","TCGA-EY-A3QX-01A-11R-A22K-07","cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3",0.16,NA,63,22.3214285714286,168,"c3a523e8-bbb4-550a-a627-09cbd5ddb198","TCGA-EY-A3QX_exposure","UNCID_2171223.cdb9c4a5-81e3-4718-bb7e-ace2bc04b7c3.130509_UNC10-SN254_0462_AC232JACXX_8_ATTCCT.tar.gz","2013-09-09T03:08:44.000Z","2013-09-09T03:42:01.000Z","AFD64EE8-CA44-45AB-B0CC-7D02E4BF5EB8","8D1365A7-C67C-4073-8483-8693D4683CCD","Unaligned reads",7085912887,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","CDB9C4A5-81E3-4718-BB7E-ACE2BC04B7C3","University of North Carolina","56607f5ee4b016715ab6bd5c","8BB89C0F-0F04-485E-8E08-801042DFCBA9","Uterine Corpus Endometrial Carcinoma","TARGZ","A5D18BD4-0F54-4FD1-B2D6-09230A57836C","2013-09-09T03:42:01.000Z","AAFB0027-06FA-4D0A-8177-29FD04DDB7DD","United States","NO",1,NA,"Primary Tumor","University of North Carolina",112,"A5D18BD4-0F54-4FD1-B2D6-09230A57836C",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FCB39116-72F7-4722-B691-A8D39DC71BFE.txt",659,"TCGA-EY-A3QX-01A",NA,"A93B97A0-7966-4862-9959-9799991D54BE","TCGA",2011,NA,NA,"WITH TUMOR","A1C62B14-A065-4A4F-9D3B-C9D68103D1F2",64,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FCB39116-72F7-4722-B691-A8D39DC71BFE.txt","Alive",NA,"TCGA-EY-A3QX","NOT HISPANIC OR LATINO","E5713F22-B517-4177-B526-3FDC08F3972B",NA,162,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"D77F35E6-7B7A-4A9E-9C31-ACF9395A356E","AAFB0027-06FA-4D0A-8177-29FD04DDB7DD","1f21df6a2807d205025d4019d19a2fb2.bam","TCGA-EY-A3QX-01A-11",75,0,1,5,0,"TOP",10,0,"TCGA-EY-A3QX-01A-01-TS1",90,"Taxol","Chemotherapy","TCGA-EY-A3QX-D40909",NA,NA,NA,"TCGA-EY-A3QX-F40907_NTE-1","NO",421,"TUMOR FREE","Alive",NA,"TCGA-EY-A3QX-F40907","TCGA-EY-A3QX",1,"EY","A3QX","YES","C54.1","8441/3","C54.1","YES","NO",-23663,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",162,NA,NA,NA,"WITH TUMOR","NO",10,5,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,64,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31188354,29194079,2193342926,"1E221CC6-319B-4B53-8836-80FDFC99FD72.bw","8bdd4e0e-5bec-43f2-b9fa-d6e94a72fe05","1e221cc6-319b-4b53-8836-80fdfc99fd72","2016-08-09T14:16:09.330054-05:00","UNCID_2214494.e5b97796-bf64-458e-8ed8-246c2b303ce7.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_8.tar.gz","25542129-1615-4002-afcb-8aa5926b8f82",1915983249,"Illumina GA","66fab9726e2cbae4f7212b52e65feb2b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:32:47.814742-05:00","2016-05-03T11:17:14.896869-05:00","25542129-1615-4002-afcb-8aa5926b8f82_analysis.xml","54fa20e6db7378631f340d1ca74c994d","e0cddddc-92a8-4f0a-83c4-76789cb3342e",2121,"2016-09-29T19:28:47.132402-05:00","25542129-1615-4002-afcb-8aa5926b8f82_experiment.xml","b91507f97a631b81dc2e849c14d95f1e","49d104a5-f3cd-451b-9004-a4f300ffaf4e",2257,"2016-09-29T20:29:14.370312-05:00","25542129-1615-4002-afcb-8aa5926b8f82_run.xml","42777dda1a1030cf7ce0ea10360bd767","6eebed59-fd92-41dd-b566-b129c9906b00",347,"2016-09-08T10:38:00.924692-05:00","TCGA-BG-A0M3","2016-09-02T18:48:03.385499-05:00","female","TCGA-BG-A0M3_demographic",1934,"white","fc98d37b-3159-5080-92f4-829f488879b6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0M3_diagnosis","not reported",27183,"alive","8380/3",NA,1071,"1df0ea26-2081-5b79-a3dc-bbed3d057699","c54.1",-27183,"TCGA-BG-A0M3_treatment","8da9a0a6-d51c-513f-8ad2-4828fa6efb5e","01","true","TCGA-BG-A0M3-01A",NA,"1802cd6b-4d4a-45fa-b839-7450071e41ee",FALSE,"19AABBD8-3DC5-418E-9B62-37CF7500F174","Primary Tumor",NA,597,100,NA,1280188800,"11",30,"TCGA-BG-A0M3-01A-11",90,90,0,0,0,0,0,0,"2016-09-08T10:38:00.924692-05:00","2016-09-08T10:38:00.924692-05:00",0,0,0,0,"BOTTOM","TOP",0,5,"9255500f-76e1-4055-b698-b1c858a00f24","42bb9b1f-f16b-4a2b-b1ed-4bb317e5cc9e","TCGA-BG-A0M3-01A-01-BSA","TCGA-BG-A0M3-01A-01-TSA",100,95,"762cb09b-ad1e-4df5-8955-09d0a6e364ea","RNA","TCGA-BG-A0M3-01A-11R","3e652242-e504-458f-b385-008245431dbb",1.81,0.16,"UV Spec","R","23","TCGA-BG-A0M3-01A-11R-A104-07","e5b97796-bf64-458e-8ed8-246c2b303ce7",0.16,NA,75,29.296875,160,"bfa7b4c2-6ef2-57fa-97bb-2c72a03a0727","TCGA-BG-A0M3_exposure","UNCID_2214494.e5b97796-bf64-458e-8ed8-246c2b303ce7.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_8.tar.gz","2013-10-03T16:26:03.000Z","2013-10-03T16:37:01.000Z","25542129-1615-4002-AFCB-8AA5926B8F82","1802CD6B-4D4A-45FA-B839-7450071E41EE","Unaligned reads",1915983249,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E5B97796-BF64-458E-8ED8-246C2B303CE7","University of North Carolina","56607713e4b0ec1099f8cb94","8BDD4E0E-5BEC-43F2-B9FA-D6E94A72FE05","Uterine Corpus Endometrial Carcinoma","TARGZ","762CB09B-AD1E-4DF5-8955-09D0A6E364EA","2013-10-03T16:37:01.000Z","3E652242-E504-458F-B385-008245431DBB","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",597,"762CB09B-AD1E-4DF5-8955-09D0A6E364EA",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.00F34C1B-8B1B-47D2-9D64-12591734FAA1.txt",100,"TCGA-BG-A0M3-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","1802CD6B-4D4A-45FA-B839-7450071E41EE",74,"nationwidechildrens.org_clinical.TCGA-BG-A0M3.xml","Alive",NA,"TCGA-BG-A0M3","NOT HISPANIC OR LATINO","47EBC600-9BF0-4242-B22F-64C2F9BABE2E",NA,742,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"9FC468AC-2F61-4DAD-BE8B-C5F571EF0ED8","WHITE",NA,11,30,"9255500F-76E1-4055-B698-B1C858A00F24","A9A9990B-3696-4DA0-B5E2-F4AB24BC59F8","UNCID_2214494.e5b97796-bf64-458e-8ed8-246c2b303ce7.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_8.tar.gz","TCGA-BG-A0M3-01A-11",90,0,0,0,0,"BOTTOM",0,0,"TCGA-BG-A0M3-01A-01-BSA",100,NA,NA,NA,"TCGA-BG-A0M3-R4430","IMPLANTS","Primary Tumor Field",NA,"NO",1071,"TUMOR FREE","Alive",NA,"TCGA-BG-A0M3-F19332","TCGA-BG-A0M3",1,"BG","A0M3","YES","C54.1","8380/3","C54.1","NO","YES",-27183,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",742,NA,NA,NA,"TUMOR FREE","NO",1,12,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2008,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33690189,32350406,2424683645,"7CC19F15-9662-4D82-A1E5-788415F98781.bw","8bf0b156-6eb4-45e8-9cbb-0979efbea898","7cc19f15-9662-4d82-a1e5-788415f98781","2016-08-05T11:01:36.528737-05:00","UNCID_2214519.5343a292-c0ee-4764-8051-ee24716cf79d.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_6.tar.gz","59569792-7d36-4c03-aba5-2a026a5ab70a",2103388053,"Illumina GA","37ce525911fe8d25506af605e2d513ab","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:59:54.368884-05:00","2016-05-03T11:17:14.896869-05:00","59569792-7d36-4c03-aba5-2a026a5ab70a_analysis.xml","4bb16755e06fd20ae40a5fcfe46f7f39","11e3154b-cc84-46b9-b89d-a8286db9319e",2121,"2016-09-29T21:56:47.345812-05:00","59569792-7d36-4c03-aba5-2a026a5ab70a_experiment.xml","70055fd69566c51915a80835920c64ce","a55d5ed4-7999-4b26-9bd0-f9dfd1fbf232",2257,"2016-09-29T23:11:12.380916-05:00","59569792-7d36-4c03-aba5-2a026a5ab70a_run.xml","cd69ab926a5acf8fc03bea531598b73f","d363636d-d97f-48f2-ae45-a6731b95c5d7",347,"2016-09-08T10:46:00.627140-05:00","TCGA-BG-A0M0","2016-09-02T18:48:01.349542-05:00","female","TCGA-BG-A0M0_demographic",1944,"white","253415bb-94cc-5a4a-8235-d20cb0ee900e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0M0_diagnosis","not reported",24427,"alive","8380/3",NA,588,"3232eb69-feda-59db-907e-136c7f3f6721","c54.1",-24427,"TCGA-BG-A0M0_treatment","001809bd-11a9-5bdc-8abd-682e42f4297a","01","true","TCGA-BG-A0M0-01A",NA,"e3f599db-19cf-4086-8e5d-d3527119120f",FALSE,"BDDACDFC-E3D4-4EA7-9591-DB6371713E8E","Primary Tumor",NA,147,800,NA,1280188800,"11",20,"TCGA-BG-A0M0-01A-11",95,95,2,2,0,0,0,0,"2016-09-08T10:46:00.627140-05:00","2016-09-08T10:46:00.627140-05:00",0,0,2,2,"BOTTOM","TOP",0,0,"aaddcd61-b4d4-4271-9a01-6cb2bf8a8afb","1455a3e3-be65-45ab-af05-3be56eb85166","TCGA-BG-A0M0-01A-01-BSA","TCGA-BG-A0M0-01A-01-TSA",100,100,"b471fbcc-c7c9-4cec-a762-27d3d37398df","RNA","TCGA-BG-A0M0-01A-11R","e1d74a2b-175a-49c0-ad63-1e49092f2ef1",1.78,0.14,"UV Spec","R","23","TCGA-BG-A0M0-01A-11R-A104-07","5343a292-c0ee-4764-8051-ee24716cf79d",0.14,NA,117,42.9752066115702,165,"03b98b05-5ddf-5e81-83d5-3eff846b9d5f","TCGA-BG-A0M0_exposure","UNCID_2214519.5343a292-c0ee-4764-8051-ee24716cf79d.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_6.tar.gz","2013-10-03T16:36:07.000Z","2013-10-03T16:49:01.000Z","59569792-7D36-4C03-ABA5-2A026A5AB70A","E3F599DB-19CF-4086-8E5D-D3527119120F","Unaligned reads",2103388053,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","5343A292-C0EE-4764-8051-EE24716CF79D","University of North Carolina","564a3a78e4b09c884b24142f","8BF0B156-6EB4-45E8-9CBB-0979EFBEA898","Uterine Corpus Endometrial Carcinoma","TARGZ","B471FBCC-C7C9-4CEC-A762-27D3D37398DF","2013-10-03T16:49:01.000Z","E1D74A2B-175A-49C0-AD63-1E49092F2EF1","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",147,"B471FBCC-C7C9-4CEC-A762-27D3D37398DF",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5007B1AB-8651-4B64-8777-885393A6A284.txt",800,"TCGA-BG-A0M0-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","E3F599DB-19CF-4086-8E5D-D3527119120F",66,"nationwidechildrens.org_clinical.TCGA-BG-A0M0.xml","Alive",NA,"TCGA-BG-A0M0","NOT HISPANIC OR LATINO","8FBD037F-0BAD-4227-82C4-D1BF62D9FA6D",NA,238,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,11,20,"AADDCD61-B4D4-4271-9A01-6CB2BF8A8AFB","E1D74A2B-175A-49C0-AD63-1E49092F2EF1","UNCID_1636702.5343a292-c0ee-4764-8051-ee24716cf79d.sorted_genome_alignments.bam.bai","TCGA-BG-A0M0-01A-11",95,0,2,0,0,"BOTTOM",0,2,"TCGA-BG-A0M0-01A-01-BSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",588,"TUMOR FREE","Alive",NA,"TCGA-BG-A0M0-F19320","TCGA-BG-A0M0",1,"BG","A0M0","YES","C54.1","8380/3","C54.1","NO","YES",-24427,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",238,NA,NA,NA,"TUMOR FREE","NO",1,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,66,2010,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
136302056,134428854,6420642086,"1F871CAC-44B4-4DBC-8B00-013A92AF56F0.bw","8c6b9b54-58eb-4d5f-b8a9-8007163db457","1f871cac-44b4-4dbc-8b00-013a92af56f0","2016-08-09T14:02:36.041916-05:00","UNCID_2167302.2db9f19e-4614-44f9-a9f5-7541d6a20369.130613_UNC9-SN296_0375_BD27CGACXX_1_CGATGT.tar.gz","275b0968-8e2b-4a2f-a9b0-480904865f10",6672789596,"Illumina HiSeq","d5ecc8c4d3b0c8c568c830b5556e097c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:02:24.426181-05:00","2016-05-03T11:07:07.492763-05:00","275b0968-8e2b-4a2f-a9b0-480904865f10_analysis.xml","9be08bbcc9ac657513cd98a89d992ec3","cdbb439c-1142-4e64-b0ba-cdb3793d44f2",2121,"2016-08-29T01:53:46.729905-05:00","275b0968-8e2b-4a2f-a9b0-480904865f10_experiment.xml","18da19110784f397ff42f20d4683c82d","c0a087c8-a703-46b0-8524-1ba358c9817a",2431,"2016-09-29T18:49:02.746689-05:00","275b0968-8e2b-4a2f-a9b0-480904865f10_run.xml","8030d6397767844b6f6d11058d68f61d","30c338f3-aa2c-4c63-9383-9b78bc9b465d",354,"2016-09-08T10:40:49.372275-05:00","TCGA-AX-A3FS","2016-09-02T18:49:09.108746-05:00","female","TCGA-AX-A3FS_demographic",1928,"white","75c88efc-df2b-5dc9-8f26-0a8826fc80c5","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3FS_diagnosis","not reported",30102,"alive","8380/3",NA,1,"aab6e5c3-dc5a-5f48-9bc6-9ab2ea1b7235","c54.1",-30102,"TCGA-AX-A3FS_treatment","0bbc2e25-f483-5390-9aec-edd9531f8305","01","false","TCGA-AX-A3FS-01A",NA,"272d64f9-0b4b-4136-adff-66c5401fc1d2",FALSE,"1AEA9AC0-3B22-4819-9542-1F6A6AD474BC","Primary Tumor",NA,609,80,NA,1322784000,"11",20,"TCGA-AX-A3FS-01A-11",95,NA,0,NA,10,NA,5,NA,"2016-09-08T10:40:49.372275-05:00",NA,1,NA,0,NA,"TOP",NA,10,NA,"27ae39d9-679d-42d4-ad3a-2e4342d5243f",NA,"TCGA-AX-A3FS-01A-01-TS1",NA,75,NA,"b6acf7ab-b2d4-4e33-9755-338900ad0415","RNA","TCGA-AX-A3FS-01A-11R","1a352048-fd56-4559-bc97-0705454937c9",1.8,0.16,"UV Spec","R","23","TCGA-AX-A3FS-01A-11R-A22K-07","2db9f19e-4614-44f9-a9f5-7541d6a20369",0.16,NA,98,50.722012318203,139,"485ba7d5-fb8a-5a33-bbc9-8f1d9c9022b3","TCGA-AX-A3FS_exposure","UNCID_2167302.2db9f19e-4614-44f9-a9f5-7541d6a20369.130613_UNC9-SN296_0375_BD27CGACXX_1_CGATGT.tar.gz","2013-09-21T04:56:06.000Z","2013-09-21T05:17:01.000Z","275B0968-8E2B-4A2F-A9B0-480904865F10","272D64F9-0B4B-4136-ADFF-66C5401FC1D2","Unaligned reads",6672789596,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","2DB9F19E-4614-44F9-A9F5-7541D6A20369","University of North Carolina","5660779ee4b018727fea15be","8C6B9B54-58EB-4D5F-B8A9-8007163DB457","Uterine Corpus Endometrial Carcinoma","TARGZ","B6ACF7AB-B2D4-4E33-9755-338900AD0415","2013-09-21T05:17:01.000Z","1A352048-FD56-4559-BC97-0705454937C9","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",609,"B6ACF7AB-B2D4-4E33-9755-338900AD0415",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.07244A31-9016-4B5E-B95C-E2EC48438634.txt",80,"TCGA-AX-A3FS-01A",NA,NA,"TCGA",2010,NA,NA,NA,"5CB11F30-BFFA-4A05-91F1-F4D71B04B7B6",82,"nationwidechildrens.org_clinical.TCGA-AX-A3FS.xml","Alive",NA,"TCGA-AX-A3FS","NOT HISPANIC OR LATINO","12DD7679-10B4-4097-9241-C1AC14C1136B",NA,7,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,20,"27AE39D9-679D-42D4-AD3A-2E4342D5243F","60C32F7E-E225-4751-81AA-F98A2E913568","TCGA-AX-A3FS-01A-11R-A22I-13_mirna.bam.bai","TCGA-AX-A3FS-01A-11",95,10,0,1,5,"TOP",10,0,"TCGA-AX-A3FS-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3FS-F58279_NTE-1",NA,1,NA,"Alive",NA,"TCGA-AX-A3FS-F58279","TCGA-AX-A3FS",1,"AX","A3FS","YES","C54.1","8380/3","C54.1","NO","YES",-30102,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",7,NA,NA,NA,NA,"NO",3,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,82,2010,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32328217,31766633,2383133592,"1329E1C1-743E-4541-9081-165572D4BF47.bw","8d9e4917-334b-4c76-aee1-1e22be772db0","1329e1c1-743e-4541-9081-165572d4bf47","2016-08-06T22:34:03.916598-05:00","UNCID_2210159.4b398b99-8916-440b-9ed5-9ed67db19b9b.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_8.tar.gz","27629399-18f2-421c-b0b0-f0201d542189",2069024313,"Illumina GA","7170084d3e804e0330818060377baeb8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:37:02.423129-05:00","2016-05-03T11:15:47.407128-05:00","27629399-18f2-421c-b0b0-f0201d542189_analysis.xml","d6df9fc960d18c744f648941b4a037b6","990b20fb-67ac-4ed9-804d-50054ef97104",2123,"2016-08-28T00:45:34.774318-05:00","27629399-18f2-421c-b0b0-f0201d542189_experiment.xml","d581cf1abba0c8cc3c4a30038f47e4e0","62f7bec2-3b91-4f2c-aa36-6b6f8202b612",2257,"2016-09-29T19:39:59.269572-05:00","27629399-18f2-421c-b0b0-f0201d542189_run.xml","a4aa13c0420b18b842deaf456567a816","50b38983-0f8f-43f9-94df-8102f9ed87c0",347,"2016-09-08T10:38:13.135007-05:00","TCGA-BK-A139","2016-09-02T18:49:40.809632-05:00","female","TCGA-BK-A139_demographic",1936,"white","283a931a-a653-50c4-992a-c69e21c6af1c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A139_diagnosis","not reported",27077,"dead","8380/3",943,309,"fff68755-ed35-52d0-9a4f-86a4b19bc82e","c54.1",-27077,"TCGA-BK-A139_treatment","6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e","01","false","TCGA-BK-A139-01A",NA,"d777e49b-cb47-44f3-ad42-4d23af7e296c",FALSE,"5F8C376B-31F8-4566-8EBF-21E7F4E6499D","Primary Tumor",NA,175,770,NA,1291680000,"11",30,"TCGA-BK-A139-01A-11",80,90,10,20,0,0,20,10,"2016-09-08T10:38:13.135007-05:00","2016-09-08T10:38:13.135007-05:00",20,50,20,50,"TOP","BOTTOM",20,60,"18724d00-97cf-48c0-b7bb-638a80ef5e39","08b415f6-1a0a-4b55-96a1-3a26b26e7c0b","TCGA-BK-A139-01A-01-TSA","TCGA-BK-A139-01A-01-BSA",60,30,"4e7f7eeb-0b1c-4f53-842c-229ea461c6d8","RNA","TCGA-BK-A139-01A-11R","e8da3efa-c60c-43a1-af72-3772da62d2b2",1.84,0.15,"UV Spec","R","23","TCGA-BK-A139-01A-11R-A118-07","4b398b99-8916-440b-9ed5-9ed67db19b9b",0.15,NA,59,24.8777196829145,154,"8155bfc1-1c5f-5642-9a14-8b020eeb7bf3","TCGA-BK-A139_exposure","UNCID_2210159.4b398b99-8916-440b-9ed5-9ed67db19b9b.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_8.tar.gz","2013-10-02T06:46:03.000Z","2013-10-02T06:58:03.000Z","27629399-18F2-421C-B0B0-F0201D542189","D777E49B-CB47-44F3-AD42-4D23AF7E296C","Unaligned reads",2069024313,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4B398B99-8916-440B-9ED5-9ED67DB19B9B","University of North Carolina","566074b8e4b0ca319164c7d3","8D9E4917-334B-4C76-AEE1-1E22BE772DB0","Uterine Corpus Endometrial Carcinoma","TARGZ","4E7F7EEB-0B1C-4F53-842C-229EA461C6D8","2013-10-02T06:58:03.000Z","E8DA3EFA-C60C-43A1-AF72-3772DA62D2B2","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",175,"4E7F7EEB-0B1C-4F53-842C-229EA461C6D8",NA,"BK","TCGA-BK-A139-01A-11R-A119-13_mirna.bam.bai",770,"TCGA-BK-A139-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","DC183CCA-CF96-4DF3-87DB-BFCFF58DC273",74,"nationwidechildrens.org_clinical.TCGA-BK-A139.xml","Alive",NA,"TCGA-BK-A139","NOT HISPANIC OR LATINO","0D847F64-12FE-44E8-AC38-62DEB09D9670",NA,239,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"18724D00-97CF-48C0-B7BB-638A80EF5E39","FA73F975-D155-4FCD-B6DB-955B23D0320D","UNCID_2210159.4b398b99-8916-440b-9ed5-9ed67db19b9b.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_8.tar.gz","TCGA-BK-A139-01A-11",80,0,10,20,20,"TOP",20,20,"TCGA-BK-A139-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,NA,"NO",309,"TUMOR FREE","Alive",NA,"TCGA-BK-A139-F13253","TCGA-BK-A139",2,"BK","A139","YES","C54.1","8380/3","C54.1","YES","NO",-27077,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",239,NA,NA,NA,"TUMOR FREE","NO",23,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
146253332,144012258,6876077717,"80379304-DD5D-49A3-8DE7-376FD06AEE17.bw","8d9e4917-334b-4c76-aee1-1e22be772db0","80379304-dd5d-49a3-8de7-376fd06aee17","2016-08-09T14:03:16.076419-05:00","UNCID_2167248.923217e0-602c-4cf7-b17a-37269d9371c4.130613_UNC9-SN296_0375_BD27CGACXX_4_CTTGTA.tar.gz","e8cbdd5d-516f-47c4-a234-7493130800eb",7148187008,"Illumina HiSeq","56f7e93e71ef8b0a73c684b5e433b7f3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:07:03.036623-05:00","2016-05-03T11:07:07.492763-05:00","e8cbdd5d-516f-47c4-a234-7493130800eb_analysis.xml","e3ebf7410d0b8dc0033e2032ae506691","d0c1f022-6c66-4d31-b9a8-ce0b5e559576",2121,"2016-10-07T16:38:06.927065-05:00","e8cbdd5d-516f-47c4-a234-7493130800eb_experiment.xml","d06c3244c8139d83c9751c25016cbea2","debe9bf6-2170-4963-b0ab-8bc5ebb8dfa1",2431,"2016-09-29T20:32:48.628925-05:00","e8cbdd5d-516f-47c4-a234-7493130800eb_run.xml","e1ab48f60cb38aac9e13ff7d2920af95","710eb7f6-0ca0-461d-a7f4-41f983da89a9",354,"2016-09-08T10:38:13.135007-05:00","TCGA-BK-A139","2016-09-02T18:49:40.809632-05:00","female","TCGA-BK-A139_demographic",1936,"white","283a931a-a653-50c4-992a-c69e21c6af1c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A139_diagnosis","not reported",27077,"dead","8380/3",943,309,"fff68755-ed35-52d0-9a4f-86a4b19bc82e","c54.1",-27077,"TCGA-BK-A139_treatment","6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e","02","false","TCGA-BK-A139-02A",NA,"a4ee1cc7-9cac-4e7e-96db-d38981e5f506",FALSE,"FE6C557C-6F28-4F5C-B48C-E2A3BB7EF14F","Recurrent Tumor",NA,874,430,NA,1352419200,"11",30,"TCGA-BK-A139-02A-11",65,NA,0,NA,40,NA,0,NA,"2016-09-08T10:38:13.135007-05:00",NA,3,NA,0,NA,"TOP",NA,20,NA,"66e7ece0-48d6-4ea3-b99f-7e58840414f8",NA,"TCGA-BK-A139-02A-01-TS1",NA,40,NA,"f874d219-2ba9-4d3e-b660-064ba1403994","RNA","TCGA-BK-A139-02A-11R","c322fb81-31c9-4591-aa88-d1aff9a03e32",1.98,0.18,"UV Spec","R","23","TCGA-BK-A139-02A-11R-A27V-07","923217e0-602c-4cf7-b17a-37269d9371c4",0.18,NA,59,24.8777196829145,154,"8155bfc1-1c5f-5642-9a14-8b020eeb7bf3","TCGA-BK-A139_exposure","UNCID_2167248.923217e0-602c-4cf7-b17a-37269d9371c4.130613_UNC9-SN296_0375_BD27CGACXX_4_CTTGTA.tar.gz","2013-09-21T05:36:05.000Z","2013-09-21T05:57:02.000Z","E8CBDD5D-516F-47C4-A234-7493130800EB","A4EE1CC7-9CAC-4E7E-96DB-D38981E5F506","Unaligned reads",7148187008,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","923217E0-602C-4CF7-B17A-37269D9371C4","University of North Carolina","564a34e9e4b0298dd2c65203","8D9E4917-334B-4C76-AEE1-1E22BE772DB0","Uterine Corpus Endometrial Carcinoma","TARGZ","F874D219-2BA9-4D3E-B660-064BA1403994","2013-09-21T05:57:02.000Z","C322FB81-31C9-4591-AA88-D1AFF9A03E32","None","NO",2,NA,"Recurrent Tumor","Christiana Healthcare",874,"F874D219-2BA9-4D3E-B660-064BA1403994",NA,"BK","2be00dec5467a58bac72ea37dc4aa75d.bam.bai",430,"TCGA-BK-A139-02A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","DC183CCA-CF96-4DF3-87DB-BFCFF58DC273",74,"nationwidechildrens.org_clinical.TCGA-BK-A139.xml","Alive",NA,"TCGA-BK-A139","NOT HISPANIC OR LATINO","0D847F64-12FE-44E8-AC38-62DEB09D9670",NA,239,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"66E7ECE0-48D6-4EA3-B99F-7E58840414F8","F0279604-D2ED-4DC4-99E7-9120F006D8B2","2be00dec5467a58bac72ea37dc4aa75d.bam.bai","TCGA-BK-A139-02A-11",65,40,0,3,0,"TOP",20,0,"TCGA-BK-A139-02A-01-TS1",40,NA,NA,NA,NA,NA,NA,NA,"NO",309,"TUMOR FREE","Alive",NA,"TCGA-BK-A139-F13253","TCGA-BK-A139",2,"BK","A139","YES","C54.1","8380/3","C54.1","YES","NO",-27077,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",239,NA,NA,NA,"TUMOR FREE","NO",23,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
167426738,163360888,7817547457,"586BE6FC-AA70-43AA-8550-975C8B069CF9.bw","8d9e4917-334b-4c76-aee1-1e22be772db0","586be6fc-aa70-43aa-8550-975c8b069cf9","2016-08-25T05:34:37.276947-05:00","UNCID_2332617.8e901591-a236-4208-899b-f1bde1e5f841.130718_UNC12-SN629_0321_AC2E6WACXX_4_ACTTGA.tar.gz","8ef4db37-221f-480c-aa8c-dbb284a4d6a1",6871954014,"Illumina HiSeq","3efc7d7216dc38778fd9e276007cf2e1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:20:27.759356-05:00","2016-05-03T11:35:41.339088-05:00","8ef4db37-221f-480c-aa8c-dbb284a4d6a1_analysis.xml","81399fe10ff232bdb7be98ec13595d7c","d8f13617-d2e0-4742-a504-50d1499f5055",2123,"2016-09-29T20:42:24.245272-05:00","8ef4db37-221f-480c-aa8c-dbb284a4d6a1_experiment.xml","04b4df0f90906b9d5d700573e5adf393","76fdf0a7-1b63-4629-aece-407672fe5abc",2884,"2016-09-30T00:10:25.792344-05:00","8ef4db37-221f-480c-aa8c-dbb284a4d6a1_run.xml","f2fe65a4c5882576b2142559408a34e7","f7f0fa15-56a8-493f-9bb7-13845d634230",355,"2016-09-08T10:38:13.135007-05:00","TCGA-BK-A139","2016-09-02T18:49:40.809632-05:00","female","TCGA-BK-A139_demographic",1936,"white","283a931a-a653-50c4-992a-c69e21c6af1c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A139_diagnosis","not reported",27077,"dead","8380/3",943,309,"fff68755-ed35-52d0-9a4f-86a4b19bc82e","c54.1",-27077,"TCGA-BK-A139_treatment","6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e","01","false","TCGA-BK-A139-01A",NA,"d777e49b-cb47-44f3-ad42-4d23af7e296c",FALSE,"5F8C376B-31F8-4566-8EBF-21E7F4E6499D","Primary Tumor",NA,175,770,NA,1291680000,"11",30,"TCGA-BK-A139-01A-11",80,90,10,20,0,0,20,10,"2016-09-08T10:38:13.135007-05:00","2016-09-08T10:38:13.135007-05:00",20,50,20,50,"TOP","BOTTOM",20,60,"18724d00-97cf-48c0-b7bb-638a80ef5e39","08b415f6-1a0a-4b55-96a1-3a26b26e7c0b","TCGA-BK-A139-01A-01-TSA","TCGA-BK-A139-01A-01-BSA",60,30,"4e7f7eeb-0b1c-4f53-842c-229ea461c6d8","RNA","TCGA-BK-A139-01A-11R","e8da3efa-c60c-43a1-af72-3772da62d2b2",1.84,0.15,"UV Spec","R","23","TCGA-BK-A139-01A-11R-A277-07","8e901591-a236-4208-899b-f1bde1e5f841",0.15,NA,59,24.8777196829145,154,"8155bfc1-1c5f-5642-9a14-8b020eeb7bf3","TCGA-BK-A139_exposure","UNCID_2332617.8e901591-a236-4208-899b-f1bde1e5f841.130718_UNC12-SN629_0321_AC2E6WACXX_4_ACTTGA.tar.gz","2014-01-29T11:07:04.000Z","2014-01-29T11:28:02.000Z","8EF4DB37-221F-480C-AA8C-DBB284A4D6A1","D777E49B-CB47-44F3-AD42-4D23AF7E296C","Unaligned reads",6871954014,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8E901591-A236-4208-899B-F1BDE1E5F841","University of North Carolina","566074b4e4b0ec1099f8b018","8D9E4917-334B-4C76-AEE1-1E22BE772DB0","Uterine Corpus Endometrial Carcinoma","TARGZ","4E7F7EEB-0B1C-4F53-842C-229EA461C6D8","2014-01-29T11:28:02.000Z","E8DA3EFA-C60C-43A1-AF72-3772DA62D2B2","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",175,"4E7F7EEB-0B1C-4F53-842C-229EA461C6D8",NA,"BK","TCGA-BK-A139-01A-11R-A119-13_mirna.bam.bai",770,"TCGA-BK-A139-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","DC183CCA-CF96-4DF3-87DB-BFCFF58DC273",74,"nationwidechildrens.org_clinical.TCGA-BK-A139.xml","Alive",NA,"TCGA-BK-A139","NOT HISPANIC OR LATINO","0D847F64-12FE-44E8-AC38-62DEB09D9670",NA,239,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"18724D00-97CF-48C0-B7BB-638A80EF5E39","FA73F975-D155-4FCD-B6DB-955B23D0320D","UNCID_2210159.4b398b99-8916-440b-9ed5-9ed67db19b9b.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_8.tar.gz","TCGA-BK-A139-01A-11",80,0,10,20,20,"TOP",20,20,"TCGA-BK-A139-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,NA,"NO",309,"TUMOR FREE","Alive",NA,"TCGA-BK-A139-F13253","TCGA-BK-A139",2,"BK","A139","YES","C54.1","8380/3","C54.1","YES","NO",-27077,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",239,NA,NA,NA,"TUMOR FREE","NO",23,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
180019444,177800250,8500172128,"0038E71C-CAA3-417D-8C16-2986863A4D9A.bw","8d9e4917-334b-4c76-aee1-1e22be772db0","0038e71c-caa3-417d-8c16-2986863a4d9a","2016-08-24T12:50:32.204500-05:00","UNCID_2337801.470f2bb9-1dd8-4e57-a8a5-e6b7c8de78dd.130702_UNC12-SN629_0317_AD29BFACXX_5_TAGCTT.tar.gz","3b0c52b5-46a5-4df1-84c0-efa7dc4d8182",7526043473,"Illumina HiSeq","d0dc4b54c4b43b369408495ae837896b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:05:11.678696-05:00","2016-05-03T11:35:41.364651-05:00","3b0c52b5-46a5-4df1-84c0-efa7dc4d8182_analysis.xml","65921bcf5d658a6edb557ea463bf27e2","8542c399-a689-419f-9b7a-88ba0228b3ff",2124,"2016-10-07T16:24:55.581372-05:00","3b0c52b5-46a5-4df1-84c0-efa7dc4d8182_experiment.xml","216c2f2ad691c28532952360ffa5e1dd","3553bcad-68b9-4d32-aa06-416439485ba8",2882,"2016-09-29T20:17:13.632600-05:00","3b0c52b5-46a5-4df1-84c0-efa7dc4d8182_run.xml","66bf2b272627f78bd1a338b9e8957f66","6781a990-7a87-46a0-bf8e-e3a9f2afd5db",355,"2016-09-08T10:38:13.135007-05:00","TCGA-BK-A139","2016-09-02T18:49:40.809632-05:00","female","TCGA-BK-A139_demographic",1936,"white","283a931a-a653-50c4-992a-c69e21c6af1c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A139_diagnosis","not reported",27077,"dead","8380/3",943,309,"fff68755-ed35-52d0-9a4f-86a4b19bc82e","c54.1",-27077,"TCGA-BK-A139_treatment","6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e","01","false","TCGA-BK-A139-01C",NA,"0c2e9ba3-0e50-41e0-bfcd-9c221383df4c",TRUE,"5F8C376B-31F8-4566-8EBF-21E7F4E6499D","Primary Tumor",NA,551,NA,NA,1360886400,"08",1,"TCGA-BK-A139-01C-08",70,60,40,40,0,0,30,40,"2016-09-08T10:38:13.135007-05:00","2016-09-08T10:38:13.135007-05:00",2,20,20,20,"BOTTOM","TOP",0,0,"a52ed78b-2752-43d5-a185-c329b9b38b74","ca999e4a-352f-4af7-bc49-71c9fea4c18c","TCGA-BK-A139-01C-08-BS8","TCGA-BK-A139-01C-07-BS7",70,60,"a0e08019-4220-470f-b3b9-4e556f1d6bf8","RNA","TCGA-BK-A139-01C-08R","1645eb95-adb9-419d-961f-0039936d6ad5",1.83,0.15,"UV Spec","R","23","TCGA-BK-A139-01C-08R-A277-07","470f2bb9-1dd8-4e57-a8a5-e6b7c8de78dd",0.15,NA,59,24.8777196829145,154,"8155bfc1-1c5f-5642-9a14-8b020eeb7bf3","TCGA-BK-A139_exposure","UNCID_2337801.470f2bb9-1dd8-4e57-a8a5-e6b7c8de78dd.130702_UNC12-SN629_0317_AD29BFACXX_5_TAGCTT.tar.gz","2014-02-04T07:37:05.000Z","2014-02-04T08:00:01.000Z","3B0C52B5-46A5-4DF1-84C0-EFA7DC4D8182","0C2E9BA3-0E50-41E0-BFCD-9C221383DF4C","Unaligned reads",7526043473,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","470F2BB9-1DD8-4E57-A8A5-E6B7C8DE78DD","University of North Carolina","566074b7e4b0ca319164c7cb","8D9E4917-334B-4C76-AEE1-1E22BE772DB0","Uterine Corpus Endometrial Carcinoma","TARGZ","A0E08019-4220-470F-B3B9-4E556F1D6BF8","2014-02-04T08:00:01.000Z","1645EB95-ADB9-419D-961F-0039936D6AD5","None","YES",1,NA,"Primary Tumor","Christiana Healthcare",551,"A0E08019-4220-470F-B3B9-4E556F1D6BF8",NA,"BK","UNCID_2337801.470f2bb9-1dd8-4e57-a8a5-e6b7c8de78dd.130702_UNC12-SN629_0317_AD29BFACXX_5_TAGCTT.tar.gz",NA,"TCGA-BK-A139-01C",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","DC183CCA-CF96-4DF3-87DB-BFCFF58DC273",74,"nationwidechildrens.org_clinical.TCGA-BK-A139.xml","Alive",NA,"TCGA-BK-A139","NOT HISPANIC OR LATINO","0D847F64-12FE-44E8-AC38-62DEB09D9670",NA,239,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,8,1,"CA999E4A-352F-4AF7-BC49-71C9FEA4C18C","1645EB95-ADB9-419D-961F-0039936D6AD5","UNCID_2337801.470f2bb9-1dd8-4e57-a8a5-e6b7c8de78dd.130702_UNC12-SN629_0317_AD29BFACXX_5_TAGCTT.tar.gz","TCGA-BK-A139-01C-08",70,0,40,2,30,"BOTTOM",0,20,"TCGA-BK-A139-01C-08-BS8",70,NA,NA,NA,NA,NA,NA,NA,"NO",309,"TUMOR FREE","Alive",NA,"TCGA-BK-A139-F13253","TCGA-BK-A139",2,"BK","A139","YES","C54.1","8380/3","C54.1","YES","NO",-27077,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",239,NA,NA,NA,"TUMOR FREE","NO",23,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
110425208,108895130,5194515721,"0CEC1E8C-E80C-415C-8A7F-229D45CC67A1.bw","8e225f5f-49c1-4a39-a8b5-41fea6a79819","0cec1e8c-e80c-415c-8a7f-229d45cc67a1","2016-08-09T13:15:11.937206-05:00","UNCID_2177860.f6c13e4d-5a10-48cc-8ce1-a535565b6006.130402_UNC10-SN254_0447_BC22WAACXX_6_TTAGGC.tar.gz","2282c48a-08e8-4512-a07d-ed5bb1b6051d",4677040190,"Illumina HiSeq","6ee5e7c40a36822fbb81ea6cb56bc4e2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:48:27.151947-05:00","2016-05-03T10:56:47.877475-05:00","2282c48a-08e8-4512-a07d-ed5bb1b6051d_analysis.xml","ce529137120980b7d4666d4ae4a03be5","0ab147b4-47d2-446c-8c88-a7c88419b3ad",2123,"2016-09-29T21:09:52.455843-05:00","2282c48a-08e8-4512-a07d-ed5bb1b6051d_experiment.xml","9c773a9df700dbea32828293b2c2cd3e","883dca38-2947-4a4c-9902-e90384fd2b12",2431,"2016-09-29T22:33:16.950823-05:00","2282c48a-08e8-4512-a07d-ed5bb1b6051d_run.xml","14adc6f227a31ffa13ef6358d8e8d039","bbcb372f-5d65-4dc7-b76f-c0e3dda251e2",354,"2016-09-08T10:38:34.640329-05:00","TCGA-EO-A3AU","2016-09-02T18:47:55.883352-05:00","female","TCGA-EO-A3AU_demographic",1938,"not reported","71e171de-4fbc-5396-8a52-e362331a8fd9","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3AU_diagnosis","not reported",26406,"alive","8380/3",NA,1543,"742571f6-a445-57d3-bf47-4142abe4f1bf","c54.1",-26406,"TCGA-EO-A3AU_treatment","a93700a8-f34c-5c2d-88c8-7920e2cf7d45","01","false","TCGA-EO-A3AU-01A",NA,"c9d250d6-ab13-4feb-a747-aa3ebfa43503",FALSE,"B1D13355-6346-4FA4-950A-84114901515C","Primary Tumor",NA,393,130,NA,1317600000,"21",30,"TCGA-EO-A3AU-01A-21",80,NA,20,NA,0,NA,10,NA,"2016-09-08T10:38:34.640329-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"291f563b-da6e-4ea9-8475-94ff45903fed",NA,"TCGA-EO-A3AU-01A-02-TSB",NA,80,NA,"3d66cc1b-a57c-4b92-a8fd-9c8d6e35f8ba","RNA","TCGA-EO-A3AU-01A-21R","363393d7-c2e0-4ac7-ac54-e4695acb1f12",1.87,0.17,"UV Spec","R","23","TCGA-EO-A3AU-01A-21R-A19W-07","f6c13e4d-5a10-48cc-8ce1-a535565b6006",0.17,NA,78,34.6666666666667,150,"9e414817-ff98-51ec-bd86-c640277e870e","TCGA-EO-A3AU_exposure","UNCID_2177860.f6c13e4d-5a10-48cc-8ce1-a535565b6006.130402_UNC10-SN254_0447_BC22WAACXX_6_TTAGGC.tar.gz","2013-09-11T07:46:09.000Z","2013-09-11T20:01:01.000Z","2282C48A-08E8-4512-A07D-ED5BB1B6051D","C9D250D6-AB13-4FEB-A747-AA3EBFA43503","Unaligned reads",4677040190,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","F6C13E4D-5A10-48CC-8CE1-A535565B6006","University of North Carolina","564a3528e4b0ef1218187073","8E225F5F-49C1-4A39-A8B5-41FEA6A79819","Uterine Corpus Endometrial Carcinoma","TARGZ","3D66CC1B-A57C-4B92-A8FD-9C8D6E35F8BA","2013-09-11T20:01:01.000Z","363393D7-C2E0-4AC7-AC54-E4695ACB1F12","Canada","NO",1,NA,"Primary Tumor","University Health Network",393,"3D66CC1B-A57C-4B92-A8FD-9C8D6E35F8BA",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6DB1614D-F39D-4DF2-9293-232B3CA6A975.txt",130,"TCGA-EO-A3AU-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","C9D250D6-AB13-4FEB-A747-AA3EBFA43503",72,"nationwidechildrens.org_clinical.TCGA-EO-A3AU.xml","Alive",NA,"TCGA-EO-A3AU",NA,"694ADC28-D62C-4E81-929F-BF10739136D7",NA,589,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,NA,NA,21,30,"291F563B-DA6E-4EA9-8475-94FF45903FED","C4AE8692-B99B-4F85-BD94-9AB4CC692384","3b8aab4f2ac1daa5065d727a99945a8f.bam.bai","TCGA-EO-A3AU-01A-21",80,0,20,40,10,"TOP",10,20,"TCGA-EO-A3AU-01A-02-TSB",80,NA,NA,NA,NA,NA,NA,"TCGA-EO-A3AU-F38256_NTE-1","NO",804,"TUMOR FREE","Alive",NA,"TCGA-EO-A3AU-F38256","TCGA-EO-A3AU",1,"EO","A3AU","YES","C54.1","8380/3","C54.1",NA,"YES",-26406,"FEMALE",NA,NA,"No","No","Alive",589,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,72,2010,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
132045306,118498238,5636203150,"CC211FB2-6FE7-4FE5-A571-0715C7E5395E.bw","8e7792b3-2b6c-47ac-acbe-3da7462a8321","cc211fb2-6fe7-4fe5-a571-0715c7e5395e","2016-08-26T12:01:53.999203-05:00","UNCID_2365319.1073a603-5546-48b8-b6aa-9a16f909547b.140124_UNC12-SN629_0346_BC375JACXX_2_TGACCA.tar.gz","44661276-2cc3-40f0-977b-961e2e143821",5775324986,"Illumina HiSeq","4e5970a3dd15e9d707998304b3987356","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:01:25.364345-05:00","2016-05-03T11:39:34.521514-05:00","44661276-2cc3-40f0-977b-961e2e143821_analysis.xml","d230cb0706c6bb32ae0033ae17a74baf","387d45a4-6172-4e38-b853-116f24872d81",2124,"2016-10-07T15:43:47.460686-05:00","44661276-2cc3-40f0-977b-961e2e143821_experiment.xml","feb35a89ddff220447d00bdc686ae313","21613799-3d65-4866-9f35-ab88cf66458b",2628,"2016-09-29T23:55:48.325360-05:00","44661276-2cc3-40f0-977b-961e2e143821_run.xml","327c9766e301fa5d584d2f18ab5a7547","ef16cb54-e8b8-4de7-a858-230b95205653",354,"2016-09-08T10:29:26.454619-05:00","TCGA-BK-A6W4","2016-09-02T18:51:31.048089-05:00","female","TCGA-BK-A6W4_demographic",1951,"black or african american","13527a4f-c30d-54d3-87c3-f2e6883445da","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A6W4_diagnosis","not reported",22766,"alive","8380/3",NA,300,"796e258f-42f2-5fdb-8f39-750511699f03","c54.1",-22766,"TCGA-BK-A6W4_treatment","728d30c7-200c-50c1-85c6-d80f08642e0c","01","false","TCGA-BK-A6W4-01A",NA,"780bb0ac-d5dd-447f-a280-3ff49d7849f2",FALSE,"5F25185F-4F80-4137-A07C-230FB3ACE3AE","Primary Tumor",NA,118,180,NA,1374537600,"12",30,"TCGA-BK-A6W4-01A-12",75,NA,2,NA,15,NA,10,NA,"2016-09-08T10:29:26.454619-05:00",NA,5,NA,2,NA,"TOP",NA,0,NA,"9e10af3c-0004-4315-bf06-e9f05f613a2b",NA,"TCGA-BK-A6W4-01A-01-TS1",NA,75,NA,"519a54df-c5dc-4a43-80f6-72fff1e0b814","RNA","TCGA-BK-A6W4-01A-12R","2737de9e-1ed5-43ae-8177-d11fe850a49f",1.89,0.15,"UV Spec","R","23","TCGA-BK-A6W4-01A-12R-A34R-07","1073a603-5546-48b8-b6aa-9a16f909547b",0.15,NA,107,43.4094689439734,157,"63ba4be2-1e1c-5661-ab87-525f4b944b56","TCGA-BK-A6W4_exposure","UNCID_2365319.1073a603-5546-48b8-b6aa-9a16f909547b.140124_UNC12-SN629_0346_BC375JACXX_2_TGACCA.tar.gz","2014-03-05T14:33:03.000Z","2014-03-05T14:50:01.000Z","44661276-2CC3-40F0-977B-961E2E143821","780BB0AC-D5DD-447F-A280-3FF49D7849F2","Unaligned reads",5775324986,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","1073A603-5546-48B8-B6AA-9A16F909547B","University of North Carolina","56607f42e4b0b37b3d9932b7","8E7792B3-2B6C-47AC-ACBE-3DA7462A8321","Uterine Corpus Endometrial Carcinoma","TARGZ","519A54DF-C5DC-4A43-80F6-72FFF1E0B814","2014-03-05T14:50:01.000Z","2737DE9E-1ED5-43AE-8177-D11FE850A49F","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",118,"519A54DF-C5DC-4A43-80F6-72FFF1E0B814",NA,"BK","791e522a496355351b6e9a7569f72b85.bam.bai",180,"TCGA-BK-A6W4-01A",NA,NA,"TCGA",2013,"TCGA-BK-A6W4_NTE-1","Complete Remission/Response","TUMOR FREE","FD42F1F4-4EB3-4912-BAF1-775BEF2C8D50",62,"UNDID_p_TCGA_353_354_355_37_NSP_GenomeWideSNP_6_D10_1376954.hg19.seg.txt","Alive",NA,"TCGA-BK-A6W4","NOT HISPANIC OR LATINO","60385628-E2A3-4217-AD16-F99B21815806","NO",158,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",354,NA,"B067F75A-BAAA-42A3-9338-133ECFED0082","BLACK OR AFRICAN AMERICAN",NA,12,30,"9E10AF3C-0004-4315-BF06-E9F05F613A2B","5C10915A-5B76-4F95-9B10-728BD88ABCF2","791e522a496355351b6e9a7569f72b85.bam.bai","TCGA-BK-A6W4-01A-12",75,15,2,5,10,"TOP",0,2,"TCGA-BK-A6W4-01A-01-TS1",75,NA,NA,NA,"TCGA-BK-A6W4-R52415","Internal","Primary Tumor Field","TCGA-BK-A6W4-F57489_NTE-1","NO",300,"TUMOR FREE","Alive",NA,"TCGA-BK-A6W4-F57489","TCGA-BK-A6W4",1,"BK","A6W4","YES","C54.1","8380/3","C54.1","YES","NO",-22766,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",158,NA,"YES","NO","TUMOR FREE","YES",5,12,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2013,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
171500038,165251545,7880353506,"C12206E3-0D85-44AA-864F-97B833FA1F0A.bw","8e8f19bd-dbaa-4738-bad2-207f634cd63d","c12206e3-0d85-44aa-864f-97b833fa1f0a","2016-08-26T10:56:13.149784-05:00","UNCID_2364782.2eede096-06aa-4026-9c23-2a2d1d9015c1.140205_UNC13-SN749_0329_BC3K12ACXX_6_GTGGCC.tar.gz","b20dfedb-aec5-44ea-afaa-e54544b898d7",8260210395,"Illumina HiSeq","31caffc29ab2caefba6e5a9e331ac047","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:46:58.155566-05:00","2016-05-03T11:39:34.500988-05:00","b20dfedb-aec5-44ea-afaa-e54544b898d7_analysis.xml","bc76df0079bb2cc547f9840b3b024702","79d5f0d6-7295-4c10-a18b-6fdd2c605d8b",2124,"2016-09-29T18:50:45.876164-05:00","b20dfedb-aec5-44ea-afaa-e54544b898d7_experiment.xml","415276897933854165b652d90cf430f3","31d40835-27c6-4b7e-ace2-fc0a6a5a542b",2628,"2016-09-29T17:34:18.573051-05:00","b20dfedb-aec5-44ea-afaa-e54544b898d7_run.xml","2c5ba8f405b2837249462a7891244eb4","01a31992-fd65-422a-9551-db3455c693b6",354,"2016-09-08T11:39:17.271982-05:00","TCGA-QS-A744","2016-09-02T18:51:33.749100-05:00","female","TCGA-QS-A744_demographic",1927,"black or african american","4bb8f00c-d398-5777-8070-31fa84085acd","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","QS","c4c083cd-4644-53b2-9d7e-ca2ae833c525","Candler","not reported","c54.0","TCGA-QS-A744_diagnosis","not reported",31520,"alive","8380/3",NA,451,"6da0b164-4420-596e-8f3f-26edad13cbba","c54.0",-31520,"TCGA-QS-A744_treatment","12a33213-0967-53c4-baf7-90d174f101ae","01","false","TCGA-QS-A744-01A",NA,"100f19f6-f2c6-456b-8a54-e6ed68b1fb05",FALSE,"F37C9C5C-8AAA-47FB-8BAD-AE2EB0F70B4F","Primary Tumor",NA,44,310,NA,1376006400,"11",30,"TCGA-QS-A744-01A-11",80,NA,20,NA,0,NA,15,NA,"2016-09-08T11:39:17.271982-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"1caf4bea-3f5b-4a72-9aef-5124a848ca82",NA,"TCGA-QS-A744-01A-01-TS1",NA,80,NA,"c878c12b-6faa-44a8-b519-96fc8a3349ff","RNA","TCGA-QS-A744-01A-11R","25ba155c-5347-44fd-aa52-2a7ce51dbe8e",1.89,0.17,"UV Spec","R","23","TCGA-QS-A744-01A-11R-A34R-07","2eede096-06aa-4026-9c23-2a2d1d9015c1",0.17,NA,76,28.6047649516354,163,"e707809f-cb22-55dd-a206-99464982bd3e","TCGA-QS-A744_exposure","UNCID_2364782.2eede096-06aa-4026-9c23-2a2d1d9015c1.140205_UNC13-SN749_0329_BC3K12ACXX_6_GTGGCC.tar.gz","2014-03-04T17:33:04.000Z","2014-03-04T17:58:02.000Z","B20DFEDB-AEC5-44EA-AFAA-E54544B898D7","100F19F6-F2C6-456B-8A54-E6ED68B1FB05","Unaligned reads",8260210395,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","2EEDE096-06AA-4026-9C23-2A2D1D9015C1","University of North Carolina","564a4134e4b0ef12181c4f27","8E8F19BD-DBAA-4738-BAD2-207F634CD63D","Uterine Corpus Endometrial Carcinoma","TARGZ","C878C12B-6FAA-44A8-B519-96FC8A3349FF","2014-03-04T17:58:02.000Z","25BA155C-5347-44FD-AA52-2A7CE51DBE8E","United States","NO",1,NA,"Primary Tumor","Candler",44,"C878C12B-6FAA-44A8-B519-96FC8A3349FF",NA,"QS","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.59780BBC-3B71-437F-9C0F-2FD11DA2AA92.txt",310,"TCGA-QS-A744-01A",NA,"79CBB4E7-B1A5-4C8A-936B-8BFFD0E2CEE8","TCGA",2013,"TCGA-QS-A744_NTE-1",NA,"TUMOR FREE","100F19F6-F2C6-456B-8A54-E6ED68B1FB05",86,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.59780BBC-3B71-437F-9C0F-2FD11DA2AA92.txt","Alive",NA,"TCGA-QS-A744","NOT HISPANIC OR LATINO","B57A982D-4B8B-421C-96BA-2B1E76632435","NO",143,"No","Uterus","C54.0",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8380/3","FEMALE","C54.0",354,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"1CAF4BEA-3F5B-4A72-9AEF-5124A848CA82","C8648D1F-876C-4E70-BA78-E29D6A05A656","UNCID_2354440.2eede096-06aa-4026-9c23-2a2d1d9015c1.sorted_genome_alignments.bam","TCGA-QS-A744-01A-11",80,0,20,40,15,"TOP",5,20,"TCGA-QS-A744-01A-01-TS1",80,"PACLITAXEL","Chemotherapy","TCGA-QS-A744-D51192",NA,NA,NA,"TCGA-QS-A744-F64971_NTE-1","NO",451,NA,"Alive",NA,"TCGA-QS-A744-F64971","TCGA-QS-A744",1,"QS","A744","YES","C54.0","8380/3","C54.0","YES","NO",-31520,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",143,NA,"NO","YES","TUMOR FREE","YES",12,11,2013,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,86,2013,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",10,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
27532709,25967777,1919921650,"70E33AD4-D800-4983-A451-1802880DBC2B.bw","8f2d3495-8ce7-4f6e-a41d-8cfae5750937","70e33ad4-d800-4983-a451-1802880dbc2b","2016-08-09T14:04:32.015009-05:00","UNCID_2196777.b8177a01-9ec3-47dc-a776-1794f693d9e7.120208_UNC2-RDR300275_00112_FC_64V42AAXX_8.tar.gz","65b694d6-5c5c-4c21-90e6-994935afd948",1732469328,"Illumina GA","a7036636b6490cd8e6b8d7bbc530015d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:43:47.956127-05:00","2016-05-03T11:08:33.752363-05:00","65b694d6-5c5c-4c21-90e6-994935afd948_analysis.xml","13b822292b20f7770a5a5fb13b7c2f3a","77d6be1a-92a5-4ed3-89ca-ed66e0f9e535",2121,"2016-09-29T22:06:43.738721-05:00","65b694d6-5c5c-4c21-90e6-994935afd948_experiment.xml","7299742c300648d5ab81929f9350fdf2","ab789217-a3df-4d13-b86d-a44a885daab7",2257,"2016-09-30T00:10:32.208015-05:00","65b694d6-5c5c-4c21-90e6-994935afd948_run.xml","4a69e261aef927f25c5a08e22550ebbd","f8061df9-ff06-4369-b629-70d91fecc63c",347,"2016-09-08T10:35:42.596730-05:00","TCGA-EO-A22S","2016-09-02T18:54:19.388936-05:00","female","TCGA-EO-A22S_demographic",1950,"not reported","3d97f2b9-778a-5826-8aa7-ddc7402c36c2","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A22S_diagnosis","not reported",21328,"alive","8380/3",NA,1872,"dde5c9f9-6cd7-5b32-b160-a711fc93b1f7","c54.1",-21328,"TCGA-EO-A22S_treatment","6c44fbd4-5976-5484-9e81-2817197df8de","01","false","TCGA-EO-A22S-01A",NA,"745f2cc5-f0f1-49d1-899e-72b823802b08",FALSE,"DB26485C-BE5C-4874-B79D-7FCFFFF70C4E","Primary Tumor",NA,919,100,NA,1304899200,"11",30,"TCGA-EO-A22S-01A-11",80,NA,20,NA,0,NA,15,NA,"2016-09-08T10:35:42.596730-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"5324ea1e-59de-4d69-9441-f39244beda3b",NA,"TCGA-EO-A22S-01A-01-TSA",NA,80,NA,"251b7a17-25c6-4a31-8f94-1d58562565ef","RNA","TCGA-EO-A22S-01A-11R","bdad030a-3a89-4e4b-9462-304de7608b75",1.93,0.17,"UV Spec","R","23","TCGA-EO-A22S-01A-11R-A18M-07","b8177a01-9ec3-47dc-a776-1794f693d9e7",0.17,NA,84,34.5167652859961,156,"9ec07980-e64c-5cc6-99d0-e75b54a9d57d","TCGA-EO-A22S_exposure","UNCID_2196777.b8177a01-9ec3-47dc-a776-1794f693d9e7.120208_UNC2-RDR300275_00112_FC_64V42AAXX_8.tar.gz","2013-09-23T22:06:03.000Z","2013-09-23T22:18:01.000Z","65B694D6-5C5C-4C21-90E6-994935AFD948","745F2CC5-F0F1-49D1-899E-72B823802B08","Unaligned reads",1732469328,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B8177A01-9EC3-47DC-A776-1794F693D9E7","University of North Carolina","564a3b11e4b093830b6929ec","8F2D3495-8CE7-4F6E-A41D-8CFAE5750937","Uterine Corpus Endometrial Carcinoma","TARGZ","251B7A17-25C6-4A31-8F94-1D58562565EF","2013-09-23T22:18:01.000Z","BDAD030A-3A89-4E4B-9462-304DE7608B75","Canada","NO",1,NA,"Primary Tumor","University Health Network",919,"251B7A17-25C6-4A31-8F94-1D58562565EF",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.A71C8254-A31B-460C-8920-65EA0E6BE583.txt",100,"TCGA-EO-A22S-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","745F2CC5-F0F1-49D1-899E-72B823802B08",58,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.A71C8254-A31B-460C-8920-65EA0E6BE583.txt","Alive",NA,"TCGA-EO-A22S",NA,"BFB8F5C7-2E7B-4D50-8FD1-077F12F86B7E",NA,1066,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,"35030533-DDA8-4E7A-8A45-7F10FF4820E7",NA,NA,11,30,"5324EA1E-59DE-4D69-9441-F39244BEDA3B","BDAD030A-3A89-4E4B-9462-304DE7608B75","TCGA-EO-A22S-01A-11R-A18L-13_mirna.bam.bai","TCGA-EO-A22S-01A-11",80,0,20,40,15,"TOP",5,20,"TCGA-EO-A22S-01A-01-TSA",80,NA,NA,NA,"TCGA-EO-A22S-R62596","External","Regional site","TCGA-EO-A22S-F62595_NTE-1","NO",1872,"TUMOR FREE","Alive",NA,"TCGA-EO-A22S-F62595","TCGA-EO-A22S",1,"EO","A22S","YES","C54.1","8380/3","C54.1","NO","YES",-21328,"FEMALE",NA,NA,"No","No","Alive",1066,NA,NA,NA,"TUMOR FREE","NO",26,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32708849,31503033,2372058947,"F75BDF1D-A6DD-4DA2-A8C9-430086A0FD6E.bw","8f508b78-cdc6-4a3d-b86e-520746d78653","f75bdf1d-a6dd-4da2-a8c9-430086a0fd6e","2016-08-09T14:13:56.406776-05:00","UNCID_2209570.3581b34d-0e76-4feb-a872-b510effff12a.110509_UNC6-RDR300211_00102_FC_634VYAAXX_7.tar.gz","f4a0c30f-e7db-47d1-9522-01f0578141a6",2188149157,"Illumina GA","56bbcb72c26371aab9ba1b48d9535d91","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:28:10.042413-05:00","2016-05-03T11:15:06.073526-05:00","f4a0c30f-e7db-47d1-9522-01f0578141a6_analysis.xml","e662a5ad06b8ce57c019c4b468be20ac","ddd2ada7-73fe-4684-ad97-f0fde3b38a9a",2121,"2016-09-29T23:15:18.167428-05:00","f4a0c30f-e7db-47d1-9522-01f0578141a6_experiment.xml","f4c6e7192c5dc9d9f4e9847edb86dc00","d5e2dba7-0471-4f1d-b987-6a9f2b1dff47",2257,"2016-09-29T18:41:11.473773-05:00","f4a0c30f-e7db-47d1-9522-01f0578141a6_run.xml","53acec9abe090a65c31ee09dbe36ac55","2bc0ff3f-1ea2-4500-8352-5ae9f2f0a4b8",347,"2016-09-08T10:52:16.781154-05:00","TCGA-D1-A16O","2016-09-02T18:50:27.655015-05:00","female","TCGA-D1-A16O_demographic",1964,"white","992e1ed5-04f1-53ff-9084-e6594408070b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16O_diagnosis","not reported",16114,"alive","8380/3",NA,1023,"ee91774f-4d7a-537f-89de-fb5655fa7819","c54.1",-16114,"TCGA-D1-A16O_treatment","a2438fdc-5246-5b10-8e25-58542cb1c948","01","false","TCGA-D1-A16O-01A",NA,"a2befa03-27ec-4d5a-bf12-6ded95a4dd18",FALSE,"B4EFFDB8-CB4C-46D7-96AD-9D33DF7163C0","Primary Tumor",NA,756,120,NA,1293062400,"11",30,"TCGA-D1-A16O-01A-11",80,NA,0,NA,10,NA,10,NA,"2016-09-08T10:52:16.781154-05:00",NA,10,NA,0,NA,"TOP",NA,20,NA,"4cae4d24-d0c5-48d0-820b-947f5c1ed0f8",NA,"TCGA-D1-A16O-01A-01-TS1",NA,60,NA,"3eaaed5c-3d51-4109-a61b-974655194b6d","RNA","TCGA-D1-A16O-01A-11R","ed08d1d1-9a8a-46bf-828d-5ceaaee815fc",2.13,0.15,"UV Spec","R","23","TCGA-D1-A16O-01A-11R-A12I-07","3581b34d-0e76-4feb-a872-b510effff12a",0.15,NA,102,35.7130352578691,169,"1e54903b-19d3-55b7-b511-a417f21ad6e2","TCGA-D1-A16O_exposure","UNCID_2209570.3581b34d-0e76-4feb-a872-b510effff12a.110509_UNC6-RDR300211_00102_FC_634VYAAXX_7.tar.gz","2013-10-01T09:36:04.000Z","2013-10-01T09:49:02.000Z","F4A0C30F-E7DB-47D1-9522-01F0578141A6","A2BEFA03-27EC-4D5A-BF12-6DED95A4DD18","Unaligned reads",2188149157,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3581B34D-0E76-4FEB-A872-B510EFFFF12A","University of North Carolina","566073bae4b0ec1099f8a265","8F508B78-CDC6-4A3D-B86E-520746D78653","Uterine Corpus Endometrial Carcinoma","TARGZ","3EAAED5C-3D51-4109-A61B-974655194B6D","2013-10-01T09:49:02.000Z","ED08D1D1-9A8A-46BF-828D-5CEAAEE815FC","None","NO",1,NA,"Primary Tumor","Mayo Clinic",756,"3EAAED5C-3D51-4109-A61B-974655194B6D",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.641D2D76-4BC1-4A7F-8F59-87BF90319D4F.txt",120,"TCGA-D1-A16O-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","A73ACF84-503F-4624-B0DC-5437C26094C4",44,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.641D2D76-4BC1-4A7F-8F59-87BF90319D4F.txt","Alive",NA,"TCGA-D1-A16O","NOT HISPANIC OR LATINO","DCCFF20F-414C-4A27-A1DF-42EEFB8C4DAD",NA,865,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"4CAE4D24-D0C5-48D0-820B-947F5C1ED0F8","ED08D1D1-9A8A-46BF-828D-5CEAAEE815FC","UNCID_1626608.3581b34d-0e76-4feb-a872-b510effff12a.sorted_genome_alignments.bam.bai","TCGA-D1-A16O-01A-11",80,10,0,10,10,"TOP",20,0,"TCGA-D1-A16O-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,NA,"NO",1023,"TUMOR FREE","Alive",NA,"TCGA-D1-A16O-F18652","TCGA-D1-A16O",1,"D1","A16O","YES","C54.1","8380/3","C54.1","NO","YES",-16114,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",865,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,44,2008,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
25495104,24740225,1840461313,"37B86425-204C-40FC-995E-EBD0E797B1DB.bw","9002fc6c-26de-4b8f-8985-a4814cd3daf7","37b86425-204c-40fc-995e-ebd0e797b1db","2016-08-09T14:05:43.260396-05:00","UNCID_2196808.575c927a-b846-4ef3-9644-7879d522a2cb.120208_UNC2-RDR300275_00112_FC_64V42AAXX_1.tar.gz","365a74f7-e6bc-4164-9131-db75e81280dd",1695534111,"Illumina GA","a0190afe361db17c1fb471cf8ac0bf72","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:22:08.500254-05:00","2016-05-03T11:08:33.752363-05:00","365a74f7-e6bc-4164-9131-db75e81280dd_analysis.xml","04d9fa2354addfed5d3648de3db68a69","6a926d52-0249-4b57-b7a5-ec8c464288fb",2121,"2016-09-29T18:06:54.384197-05:00","365a74f7-e6bc-4164-9131-db75e81280dd_experiment.xml","aa46f7df4dd5d5d4281bc46eedbd2796","1662c7a8-55c7-44f4-b63f-fbef2600e26e",2257,"2016-09-29T23:34:13.252814-05:00","365a74f7-e6bc-4164-9131-db75e81280dd_run.xml","65768a3d380678805609d7cd2fb2548c","e1a160d9-a55e-46a9-9ca3-d6c319cc1bb6",347,"2016-09-08T11:12:38.516314-05:00","TCGA-AJ-A2QL","2016-09-02T18:54:01.856640-05:00","female","TCGA-AJ-A2QL_demographic",1951,"white","ea1129e7-d64f-5806-8611-03a0818e92fc","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A2QL_diagnosis","not reported",22057,"alive","8380/3",NA,602,"7b4cfed7-6fbc-51b1-8b33-e05317244f31","c54.1",-22057,"TCGA-AJ-A2QL_treatment","4f97ab32-906a-5607-a8e1-30b37a12a264","01","false","TCGA-AJ-A2QL-01A",NA,"9884f8d6-3a49-4613-aa45-855be115e01b",FALSE,"4AD4E8D1-5DA7-4134-A0C0-0AF1C3A8BCD4","Primary Tumor",NA,138,170,NA,1315958400,"11",30,"TCGA-AJ-A2QL-01A-11",80,NA,5,NA,0,NA,20,NA,"2016-09-08T11:12:38.516314-05:00",NA,8,NA,3,NA,"TOP",NA,0,NA,"0fa67bbc-0a8e-4173-b314-6e3797b5421e",NA,"TCGA-AJ-A2QL-01A-01-TSA",NA,80,NA,"20201732-98eb-4f63-a1d0-94926f27c834","RNA","TCGA-AJ-A2QL-01A-11R","8517610f-c48e-4c88-9189-f216f898d8af",1.82,0.16,"UV Spec","R","23","TCGA-AJ-A2QL-01A-11R-A18M-07","575c927a-b846-4ef3-9644-7879d522a2cb",0.16,NA,112,42.1543904550416,163,"4251ca27-a376-5d7e-825a-9b693b335278","TCGA-AJ-A2QL_exposure","UNCID_2196808.575c927a-b846-4ef3-9644-7879d522a2cb.120208_UNC2-RDR300275_00112_FC_64V42AAXX_1.tar.gz","2013-09-23T22:36:04.000Z","2013-09-23T22:48:02.000Z","365A74F7-E6BC-4164-9131-DB75E81280DD","9884F8D6-3A49-4613-AA45-855BE115E01B","Unaligned reads",1695534111,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","575C927A-B846-4EF3-9644-7879D522A2CB","University of North Carolina","564a3296e4b0298dd2c59670","9002FC6C-26DE-4B8F-8985-A4814CD3DAF7","Uterine Corpus Endometrial Carcinoma","TARGZ","20201732-98EB-4F63-A1D0-94926F27C834","2013-09-23T22:48:02.000Z","8517610F-C48E-4C88-9189-F216F898D8AF","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",138,"20201732-98EB-4F63-A1D0-94926F27C834",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A02B4058-B864-489A-9FAE-360F60438D12.txt",170,"TCGA-AJ-A2QL-01A",NA,"E275FAC3-0AC4-4928-8021-B420F563DDE0","TCGA",2011,NA,NA,"WITH TUMOR","9884F8D6-3A49-4613-AA45-855BE115E01B",60,"6929718105_R02C01_Grn.idat","Alive",NA,"TCGA-AJ-A2QL","NOT HISPANIC OR LATINO","3F6B2A53-7C84-49E6-B358-D2291674235B",NA,49,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,30,"0FA67BBC-0A8E-4173-B314-6E3797B5421E","8517610F-C48E-4C88-9189-F216F898D8AF","0798263e354473ed502818df7b973439.bam.bai","TCGA-AJ-A2QL-01A-11",80,0,5,8,20,"TOP",0,3,"TCGA-AJ-A2QL-01A-01-TSA",80,"Paclitaxel","Chemotherapy","TCGA-AJ-A2QL-D43205",NA,NA,NA,"TCGA-AJ-A2QL-F43202_NTE-1","NO",602,"TUMOR FREE","Alive",NA,"TCGA-AJ-A2QL-F43202","TCGA-AJ-A2QL",1,"AJ","A2QL","YES","C54.1","8380/3","C54.1","YES","NO",-22057,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",49,NA,NA,NA,"WITH TUMOR","NO",18,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
26223908,25697161,1907409445,"252C3486-FBA8-4A82-AA02-480A88E0C508.bw","9002fc6c-26de-4b8f-8985-a4814cd3daf7","252c3486-fba8-4a82-aa02-480a88e0c508","2016-08-05T07:47:42.633829-05:00","UNCID_2196805.59022898-5d0a-4109-90fa-9f8ad89b9758.120208_UNC2-RDR300275_00112_FC_64V42AAXX_2.tar.gz","8d1e43f7-dd24-4081-a9fc-a3a8769cb806",1761298368,"Illumina GA","5537ea548163f0675fe5f8d085650b06","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:47:11.687045-05:00","2016-05-03T11:08:33.752363-05:00","8d1e43f7-dd24-4081-a9fc-a3a8769cb806_analysis.xml","992b52248ce585fcdcb285bd3cae741d","552c54d3-c561-495a-ba89-af340661098b",2121,"2016-10-07T17:27:42.910537-05:00","8d1e43f7-dd24-4081-a9fc-a3a8769cb806_experiment.xml","29eaa8acaf05567090aec38f48bd57e9","431266f7-0e60-4426-84b8-4d02ece2480b",2257,"2016-09-29T18:48:11.285829-05:00","8d1e43f7-dd24-4081-a9fc-a3a8769cb806_run.xml","1614fe55077a0cf09fa51af19040a76f","303baf90-a0fc-46c7-be89-89bc5e7883ba",347,"2016-09-08T11:12:38.516314-05:00","TCGA-AJ-A2QL","2016-09-02T18:54:01.856640-05:00","female","TCGA-AJ-A2QL_demographic",1951,"white","ea1129e7-d64f-5806-8611-03a0818e92fc","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A2QL_diagnosis","not reported",22057,"alive","8380/3",NA,602,"7b4cfed7-6fbc-51b1-8b33-e05317244f31","c54.1",-22057,"TCGA-AJ-A2QL_treatment","4f97ab32-906a-5607-a8e1-30b37a12a264","11","false","TCGA-AJ-A2QL-11A",NA,"635f5364-1934-4130-9641-a1a6caff2e59",FALSE,NA,"Solid Tissue Normal",NA,138,100,NA,1315958400,"11",30,"TCGA-AJ-A2QL-11A-11",0,NA,0,NA,5,NA,95,NA,"2016-09-08T11:12:38.516314-05:00",NA,8,NA,0,NA,"TOP",NA,0,NA,"48e63c18-6022-48fd-8a19-9f0a6b45481b",NA,"TCGA-AJ-A2QL-11A-01-TSA",NA,0,NA,"b7bd7cd8-7f60-4791-8446-d86dba36201e","RNA","TCGA-AJ-A2QL-11A-11R","f232cadd-4774-4e2a-94ae-ed87240a9f25",1.82,0.17,"UV Spec","R","23","TCGA-AJ-A2QL-11A-11R-A18M-07","59022898-5d0a-4109-90fa-9f8ad89b9758",0.17,NA,112,42.1543904550416,163,"4251ca27-a376-5d7e-825a-9b693b335278","TCGA-AJ-A2QL_exposure","UNCID_2196805.59022898-5d0a-4109-90fa-9f8ad89b9758.120208_UNC2-RDR300275_00112_FC_64V42AAXX_2.tar.gz","2013-09-23T22:26:03.000Z","2013-09-23T22:38:02.000Z","8D1E43F7-DD24-4081-A9FC-A3A8769CB806","635F5364-1934-4130-9641-A1A6CAFF2E59","Unaligned reads",1761298368,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","59022898-5D0A-4109-90FA-9F8AD89B9758","University of North Carolina","564a3296e4b093830b667348","9002FC6C-26DE-4B8F-8985-A4814CD3DAF7","Uterine Corpus Endometrial Carcinoma","TARGZ","B7BD7CD8-7F60-4791-8446-D86DBA36201E","2013-09-23T22:38:02.000Z","F232CADD-4774-4E2A-94AE-ED87240A9F25","United States","NO",11,NA,"Solid Tissue Normal","International Genomics Conosrtium",138,"B7BD7CD8-7F60-4791-8446-D86DBA36201E",NA,"AJ","TCGA-AJ-A2QL-11A-11R-A18L-13_mirna.bam.bai",100,"TCGA-AJ-A2QL-11A",NA,"E275FAC3-0AC4-4928-8021-B420F563DDE0","TCGA",2011,NA,NA,"WITH TUMOR","9884F8D6-3A49-4613-AA45-855BE115E01B",60,"6929718105_R02C01_Grn.idat","Alive",NA,"TCGA-AJ-A2QL","NOT HISPANIC OR LATINO","3F6B2A53-7C84-49E6-B358-D2291674235B",NA,49,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,30,"48E63C18-6022-48FD-8A19-9F0A6B45481B","F232CADD-4774-4E2A-94AE-ED87240A9F25","TCGA-AJ-A2QL-11A-11R-A18L-13_mirna.bam.bai","TCGA-AJ-A2QL-11A-11",0,5,0,8,95,"TOP",0,0,"TCGA-AJ-A2QL-11A-01-TSA",0,"Paclitaxel","Chemotherapy","TCGA-AJ-A2QL-D43205",NA,NA,NA,"TCGA-AJ-A2QL-F43202_NTE-1","NO",602,"TUMOR FREE","Alive",NA,"TCGA-AJ-A2QL-F43202","TCGA-AJ-A2QL",1,"AJ","A2QL","YES","C54.1","8380/3","C54.1","YES","NO",-22057,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",49,NA,NA,NA,"WITH TUMOR","NO",18,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31120601,29229503,2180165841,"55CE136A-D378-4F33-8EDF-FA35AEF90523.bw","905291b0-f077-48f7-9c14-5cfa9d8a3e6e","55ce136a-d378-4f33-8edf-fa35aef90523","2016-09-03T08:17:52.872136-05:00","UNCID_2210456.f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_3.tar.gz","ba5506ce-3b03-4147-9d2a-1e544f457558",1939781519,"Illumina GA","8928a433e9f7d5c6a14346b36fb73b2d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:50:26.837899-05:00","2016-05-03T11:15:47.427352-05:00","ba5506ce-3b03-4147-9d2a-1e544f457558_analysis.xml","8a16c852c095d6d28dd5377e751c6bd7","5745d69c-191d-4716-80c2-6aefc4706fe6",2121,"2016-08-13T02:31:47.271638-05:00","ba5506ce-3b03-4147-9d2a-1e544f457558_experiment.xml","d59dba8ae2ba62b326b47772e0009d2f","a802e2fc-4993-4102-b135-5f8c57514d2b",2257,"2016-09-29T22:48:40.268273-05:00","ba5506ce-3b03-4147-9d2a-1e544f457558_run.xml","2edae494966de76bbc74492a2e86f036","c560cbda-c5bb-476a-9e05-eb5ba50e4f53",347,"2016-09-08T10:56:22.534401-05:00","TCGA-AX-A06D","2016-09-02T18:49:22.687473-05:00","female","TCGA-AX-A06D_demographic",1925,"white","0ba9baaa-8ead-50b7-a9e2-669532e9a138","not reported",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A06D_diagnosis","not reported",30024,"dead","8380/3",373,NA,"0eafcbcd-deec-577e-a9bb-31bfdb6a3b2b","c54.1",-30024,"TCGA-AX-A06D_treatment","d9dad5fc-bea9-5b35-bb49-ebd3974f9f05","01","false","TCGA-AX-A06D-01A",NA,"f97bb30a-759e-44b9-889a-b5bde9855b29",FALSE,"B523C3E8-6FE7-4D6A-B6CE-7DEA1C32D33F","Primary Tumor",NA,1066,190,NA,1291161600,"11",30,"TCGA-AX-A06D-01A-11",60,60,0,0,30,15,10,5,"2016-09-08T10:56:22.534401-05:00","2016-09-08T10:56:22.534401-05:00",1,3,0,0,"BOTTOM","TOP",10,25,"f1cbae87-7c7d-449e-adb0-5359fc0ff3e4","1612207f-d9f1-4f39-812c-5b6f3e3ac570","TCGA-AX-A06D-01A-01-BSA","TCGA-AX-A06D-01A-01-TSA",50,55,"dab01b45-bcac-4ff0-bc00-62313a267f92","RNA","TCGA-AX-A06D-01A-11R","b8775f7d-2b20-4a32-b024-cf9fab019252",1.85,0.16,"UV Spec","R","23","TCGA-AX-A06D-01A-11R-A118-07","f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9",0.16,NA,91,35.546875,160,"99f35939-f252-562a-a5c1-9642339d4d53","TCGA-AX-A06D_exposure","UNCID_2210456.f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_3.tar.gz","2013-10-02T11:13:06.000Z","2013-10-02T11:25:01.000Z","BA5506CE-3B03-4147-9D2A-1E544F457558","F97BB30A-759E-44B9-889A-B5BDE9855B29","Unaligned reads",1939781519,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","F29CD33B-C1EB-4C17-B2B0-5CF553BEB2A9","University of North Carolina","566074e3e4b018727fe9f8b4","905291B0-F077-48F7-9C14-5CFA9D8A3E6E","Uterine Corpus Endometrial Carcinoma","TARGZ","DAB01B45-BCAC-4FF0-BC00-62313A267F92","2013-10-02T11:25:01.000Z","B8775F7D-2B20-4A32-B024-CF9FAB019252","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1066,"DAB01B45-BCAC-4FF0-BC00-62313A267F92",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5269E40A-C8F6-4F21-BAEF-CD506B1D8493.txt",190,"TCGA-AX-A06D-01A",NA,"B3FB8411-8425-4300-ADD3-FBA4F6CC6747","TCGA",2007,NA,NA,"WITH TUMOR","F97BB30A-759E-44B9-889A-B5BDE9855B29",82,"CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_H12_735670.hg19.seg.txt","Dead",373,"TCGA-AX-A06D",NA,"D14654D6-1C14-4539-AFBF-0AA7C08933D4",NA,NA,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"F1CBAE87-7C7D-449E-ADB0-5359FC0FF3E4","F590FF12-1B6D-4A89-99FF-E059D5ECC56B","UNCID_2210456.f29cd33b-c1eb-4c17-b2b0-5cf553beb2a9.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_3.tar.gz","TCGA-AX-A06D-01A-11",60,15,0,3,5,"TOP",25,0,"TCGA-AX-A06D-01A-01-TSA",55,"Carboplatin & Paclitaxel","Chemotherapy","TCGA-AX-A06D-D9719",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",373,"TCGA-AX-A06D-F9718","TCGA-AX-A06D",1,"AX","A06D","YES","C54.1","8380/3","C54.1","NO","YES",-30024,"FEMALE","WHITE",NA,"Yes","No","Dead",NA,373,NA,NA,"WITH TUMOR","NO",13,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,82,2007,"Office Endometrial Biopsy",NA,NA,NA,"G2","R1",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30911468,30530086,2298775823,"739BEBEA-F6CC-4827-81D4-28102A8B774B.bw","916ccf0d-02ef-4ccb-824b-6b4294095a08","739bebea-f6cc-4827-81d4-28102a8b774b","2016-08-05T01:08:00.295808-05:00","UNCID_2210053.2d12622b-f828-43b0-a63f-fc542af894db.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_4.tar.gz","c4727930-551e-4284-b826-68b6545c4e9e",1980912512,"Illumina GA","efcd0da2354ff075f6af2e18ad942ccc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:17:53.018646-05:00","2016-05-03T11:15:47.403263-05:00","c4727930-551e-4284-b826-68b6545c4e9e_analysis.xml","dfbfe1e1b1271458089511bdd917d1d6","42f1a20b-e995-4b8d-919b-d4a4587f2ac5",2121,"2016-10-07T17:24:22.382043-05:00","c4727930-551e-4284-b826-68b6545c4e9e_experiment.xml","2c03fa50d1c880687d5d9125ccf018ca","42792969-d0c4-437a-8d71-74e56354c614",2257,"2016-09-29T20:51:15.688159-05:00","c4727930-551e-4284-b826-68b6545c4e9e_run.xml","e6973b04b69988221799d24e0a6e0917","7c832034-79df-4eef-a0bc-3d9accb91f4d",347,"2016-09-08T11:03:34.478646-05:00","TCGA-D1-A0ZN","2016-09-02T18:49:51.268768-05:00","female","TCGA-D1-A0ZN_demographic",1949,"white","820573ea-7bc9-59dd-aca0-e4e712597461","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A0ZN_diagnosis","not reported",22026,"alive","8380/3",NA,512,"ca0a7de2-265c-56df-8221-83cdff52a52c","c54.1",-22026,"TCGA-D1-A0ZN_treatment","8126ce2b-b1e3-51db-a428-e1152951871c","01","false","TCGA-D1-A0ZN-01A",NA,"87d4a16c-1a19-4234-b946-aea11d70169b",FALSE,"53DB2270-9308-47F5-BD1F-4D4C737F98AC","Primary Tumor",NA,567,120,NA,1291334400,"11",30,"TCGA-D1-A0ZN-01A-11",70,60,0,0,20,2,10,38,"2016-09-08T11:03:34.478646-05:00","2016-09-08T11:03:34.478646-05:00",20,8,10,1,"TOP","BOTTOM",10,0,"3cdc79ef-c829-472e-b22e-01174ed0e21c","a3f086e1-a55b-43ae-a442-3698c43b3a97","TCGA-D1-A0ZN-01A-01-TS1","TCGA-D1-A0ZN-01A-01-MS1",60,60,"744b50cd-f41d-4c05-a1c1-2f2eda8c2783","RNA","TCGA-D1-A0ZN-01A-11R","7b3ec4a1-850c-4a29-89d8-e3dfb3bd58fd",1.87,0.14,"UV Spec","R","23","TCGA-D1-A0ZN-01A-11R-A118-07","2d12622b-f828-43b0-a63f-fc542af894db",0.14,NA,82,29.0532879818594,168,"73e7bdbb-7c14-5e83-b300-06ace5938d5b","TCGA-D1-A0ZN_exposure","UNCID_2210053.2d12622b-f828-43b0-a63f-fc542af894db.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_4.tar.gz","2013-10-02T05:01:03.000Z","2013-10-02T05:13:02.000Z","C4727930-551E-4284-B826-68B6545C4E9E","87D4A16C-1A19-4234-B946-AEA11D70169B","Unaligned reads",1980912512,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2D12622B-F828-43B0-A63F-FC542AF894DB","University of North Carolina","564a3918e4b0ef121819b478","916CCF0D-02EF-4CCB-824B-6B4294095A08","Uterine Corpus Endometrial Carcinoma","TARGZ","744B50CD-F41D-4C05-A1C1-2F2EDA8C2783","2013-10-02T05:13:02.000Z","7B3EC4A1-850C-4A29-89D8-E3DFB3BD58FD","None","NO",1,NA,"Primary Tumor","Mayo Clinic",567,"744B50CD-F41D-4C05-A1C1-2F2EDA8C2783",NA,"D1","UNCID_215565.TCGA-D1-A0ZN-01A-11R-A118-07.110412_UNC2-RDR300275_00062_FC_64GKPAAXX.4.trimmed.annotated.translated_to_genomic.bam",120,"TCGA-D1-A0ZN-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","87D4A16C-1A19-4234-B946-AEA11D70169B",60,"nationwidechildrens.org_clinical.TCGA-D1-A0ZN.xml","Alive",NA,"TCGA-D1-A0ZN","NOT HISPANIC OR LATINO","B4453AF1-93F2-4B74-982E-F3F59FD121AD",NA,512,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"A9B608CA-532A-46B2-8631-1047CE01F176","WHITE",NA,11,30,"A3F086E1-A55B-43AE-A442-3698C43B3A97","7B3EC4A1-850C-4A29-89D8-E3DFB3BD58FD","UNCID_215565.TCGA-D1-A0ZN-01A-11R-A118-07.110412_UNC2-RDR300275_00062_FC_64GKPAAXX.4.trimmed.annotated.translated_to_genomic.bam","TCGA-D1-A0ZN-01A-11",60,2,0,8,38,"BOTTOM",0,1,"TCGA-D1-A0ZN-01A-01-MS1",60,NA,NA,NA,"TCGA-D1-A0ZN-R17738","EXTERNAL BEAM","Regional site",NA,"YES",512,"TUMOR FREE","Alive",NA,"TCGA-D1-A0ZN-F17736","TCGA-D1-A0ZN",1,"D1","A0ZN","YES","C54.1","8380/3","C54.1","NO","YES",-22026,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",512,NA,NA,NA,"TUMOR FREE","NO",4,3,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2009,"Tumor resection",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
34126601,33420720,2494517955,"B939F186-F96D-4F4D-A19F-27A9DCACEF6B.bw","9205c164-7975-421a-90c3-edfe8def595c","b939f186-f96d-4f4d-a19f-27a9dcacef6b","2016-08-09T14:08:07.614574-05:00","UNCID_2206486.4f4a8bd9-c07f-4930-8600-349ab60a37a7.110921_UNC6-RDR300211_00125_FC_634F4AAXX_2.tar.gz","53aa9b59-66e4-433d-8405-87432424b560",2246773731,"Illumina GA","03ddb39d1efbf41175d613a85eec0d78","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:04:26.296992-05:00","2016-05-03T11:11:34.765256-05:00","53aa9b59-66e4-433d-8405-87432424b560_analysis.xml","08dc7dfd180f40f5d998a26ff51c2658","aa148c43-ae84-4796-b264-94d518f7fc65",2121,"2016-09-29T20:55:48.673672-05:00","53aa9b59-66e4-433d-8405-87432424b560_experiment.xml","e126cfd8ed7b8f8c1f65d4d8620ea884","7f612273-540e-4956-ab5b-f38f022ed269",2257,"2016-09-29T23:43:01.028299-05:00","53aa9b59-66e4-433d-8405-87432424b560_run.xml","ba034334c758b12ea0cd1d9b8dba089b","e7276620-dc0e-49a9-9a1a-586e8ac65e69",347,"2016-09-08T11:08:30.407822-05:00","TCGA-E6-A1LZ","2016-09-02T18:52:06.492665-05:00","female","TCGA-E6-A1LZ_demographic",1931,"black or african american","f4785965-fb92-5876-80dc-48eba5d1a988","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","E6","39aa3c67-c7d9-5001-8ed1-3bf83eac7872","Roswell Park","not reported","c54.1","TCGA-E6-A1LZ_diagnosis","not reported",28054,"alive","8441/3",NA,2406,"1f0bef4b-abd9-5bee-a57b-7fc404c4eada","c54.1",-28054,"TCGA-E6-A1LZ_treatment","9d915d6b-aef4-59a9-bdc2-39c576c543bc","01","false","TCGA-E6-A1LZ-01A",NA,"62bff77e-4fe6-4a9f-a867-345584608e7d",FALSE,"55F7B7D0-D30A-4E78-B91A-CE794784CA3C","Primary Tumor",NA,1233,350,NA,1300233600,"11",30,"TCGA-E6-A1LZ-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:08:30.407822-05:00",NA,0,NA,0,NA,"TOP",NA,20,NA,"280462b7-50a4-40c4-be46-aeb2ef958183",NA,"TCGA-E6-A1LZ-01A-01-TSA",NA,80,NA,"def1d8ac-59e6-450e-8421-e6567d12da7f","RNA","TCGA-E6-A1LZ-01A-11R","6dec1819-bf4a-458d-8459-ae7152d43635",1.83,0.17,"UV Spec","R","23","TCGA-E6-A1LZ-01A-11R-A144-07","4f4a8bd9-c07f-4930-8600-349ab60a37a7",0.17,NA,65,NA,NA,"f1ac91e5-0fc9-53ed-bbf5-de4bf4c1726d","TCGA-E6-A1LZ_exposure","UNCID_2206486.4f4a8bd9-c07f-4930-8600-349ab60a37a7.110921_UNC6-RDR300211_00125_FC_634F4AAXX_2.tar.gz","2013-09-27T04:06:07.000Z","2013-09-27T04:19:01.000Z","53AA9B59-66E4-433D-8405-87432424B560","62BFF77E-4FE6-4A9F-A867-345584608E7D","Unaligned reads",2246773731,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4F4A8BD9-C07F-4930-8600-349AB60A37A7","University of North Carolina","564a3bf7e4b0298dd2c8961a","9205C164-7975-421A-90C3-EDFE8DEF595C","Uterine Corpus Endometrial Carcinoma","TARGZ","DEF1D8AC-59E6-450E-8421-E6567D12DA7F","2013-09-27T04:19:01.000Z","6DEC1819-BF4A-458D-8459-AE7152D43635","United States","NO",1,NA,"Primary Tumor","Roswell Park",1233,"DEF1D8AC-59E6-450E-8421-E6567D12DA7F",NA,"E6","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.89C5BBA0-431E-4A89-9FC5-A03ABB721615.txt",350,"TCGA-E6-A1LZ-01A",NA,"F9CDDFAE-6B75-4345-9786-426AA6419657","TCGA",2007,NA,NA,"TUMOR FREE","7DABF2C0-BB56-4FB5-AA33-FD37D600096C",76,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.89C5BBA0-431E-4A89-9FC5-A03ABB721615.txt","Alive",NA,"TCGA-E6-A1LZ","NOT HISPANIC OR LATINO","D278C24B-1C95-45F6-89DE-91602B7C6F36",NA,1289,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",118,NA,"4D7C686B-7C92-4697-8556-D0817AAA93BB","BLACK OR AFRICAN AMERICAN",NA,11,30,"280462B7-50A4-40C4-BE46-AEB2EF958183","5CC427C4-7CCC-4ACF-8D05-F7CEDC69255B","UNCID_1620101.4f4a8bd9-c07f-4930-8600-349ab60a37a7.sorted_genome_alignments.bam.bai","TCGA-E6-A1LZ-01A-11",80,0,0,0,0,"TOP",20,0,"TCGA-E6-A1LZ-01A-01-TSA",80,"taxol","Chemotherapy","TCGA-E6-A1LZ-D20256","TCGA-E6-A1LZ-R20259","IMPLANTS","Primary Tumor Field","TCGA-E6-A1LZ-F69830_NTE-1","NO",2406,"TUMOR FREE","Alive",NA,"TCGA-E6-A1LZ-F69830","TCGA-E6-A1LZ",1,"E6","A1LZ","YES","C54.1","8441/3","C54.1","NO","YES",-28054,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",1289,NA,NA,NA,"TUMOR FREE","NO",7,6,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,76,2007,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
25980308,25840348,1932455451,"5CCDB21B-5BA9-4F3D-8554-A5F90326133F.bw","92a2cae3-b8ee-4ebb-ac5c-01e58749448f","5ccdb21b-5ba9-4f3d-8554-a5f90326133f","2016-08-09T14:17:57.009134-05:00","UNCID_2215539.71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_8.tar.gz","624124dc-0428-4eda-a297-ae725546efc3",1524505736,"Illumina GA","198d107a3272afc86f967a70d07be74b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:12:47.339974-05:00","2016-05-03T11:18:46.976827-05:00","624124dc-0428-4eda-a297-ae725546efc3_analysis.xml","dfcc327ebc3250b65e026d35f7cbaba6","19fed46a-4746-436f-ae18-d87b37bab52d",2122,"2016-09-29T22:38:52.009926-05:00","624124dc-0428-4eda-a297-ae725546efc3_experiment.xml","df4eb5461ecd750637dfd249c37c54fc","bf44bdda-b65b-41f5-9b52-9b378a1c1679",2256,"2016-09-30T00:13:46.757229-05:00","624124dc-0428-4eda-a297-ae725546efc3_run.xml","5a4a98d569ef2533786f7cf75cc9178e","fa125eb0-20a9-49bc-98d2-b9ed903d2a3a",345,"2016-09-08T11:18:08.836614-05:00","TCGA-BK-A0C9","2016-09-02T18:52:52.537521-05:00","female","TCGA-BK-A0C9_demographic",1952,"white","dbc9ef72-8377-52a7-b0cc-6a29c0c1c174","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A0C9_diagnosis","not reported",20876,"alive","8380/3",NA,1092,"69aaab7d-9b61-55a8-b617-f1ed370f06c3","c54.1",-20876,"TCGA-BK-A0C9_treatment","fbf028c5-5bd5-503a-8f53-a097d431b239","01","false","TCGA-BK-A0C9-01A",NA,"155181e3-7733-44be-8ef8-7e24cebb59a4",FALSE,"3E14F5F3-2C40-403F-A499-BE64857E8559","Primary Tumor",NA,192,490,NA,1275955200,"11",30,"TCGA-BK-A0C9-01A-11",75,85,0,0,0,0,25,15,"2016-09-08T11:18:08.836614-05:00","2016-09-08T11:18:08.836614-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"beca33f8-0591-4830-800f-0713f8278648","a3e6d573-95d8-470a-9fd5-303bbb08a40f","TCGA-BK-A0C9-01A-01-TS1","TCGA-BK-A0C9-01A-01-BS1",75,85,"2333f095-4d71-45ed-9778-9b1c14faa5b4","RNA","TCGA-BK-A0C9-01A-11R","25abd606-1648-4d4a-b302-631809546623",1.8,0.14,"UV Spec","R","23","TCGA-BK-A0C9-01A-11R-A00V-07","71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7",0.14,NA,127,44.9971655328798,168,"ee2e38b8-a7a3-5129-861c-989087ff4f2a","TCGA-BK-A0C9_exposure","UNCID_2215539.71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_8.tar.gz","2013-10-04T03:26:03.000Z","2013-10-04T03:44:01.000Z","624124DC-0428-4EDA-A297-AE725546EFC3","155181E3-7733-44BE-8EF8-7E24CEBB59A4","Unaligned reads",1524505736,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","71EF8BCE-4B04-4FBA-9AE6-8C8F2B18B2C7","University of North Carolina","56607c6ee4b0ca319165007c","92A2CAE3-B8EE-4EBB-AC5C-01E58749448F","Uterine Corpus Endometrial Carcinoma","TARGZ","2333F095-4D71-45ED-9778-9B1C14FAA5B4","2013-10-04T03:44:01.000Z","25ABD606-1648-4D4A-B302-631809546623","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",192,"2333F095-4D71-45ED-9778-9B1C14FAA5B4",NA,"BK","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FC84BD3F-BCE6-41AF-98D4-A4586B56F810.txt",490,"TCGA-BK-A0C9-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","A4C5A791-5CD5-4A60-8368-69517B4DC131",57,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FC84BD3F-BCE6-41AF-98D4-A4586B56F810.txt","Alive",NA,"TCGA-BK-A0C9","NOT HISPANIC OR LATINO","B57C3C41-DFFB-4707-9C37-C245CE111682",NA,289,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"WHITE",NA,11,30,"BECA33F8-0591-4830-800F-0713F8278648","25ABD606-1648-4D4A-B302-631809546623","UNCID_2215539.71ef8bce-4b04-4fba-9ae6-8c8f2b18b2c7.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_8.tar.gz","TCGA-BK-A0C9-01A-11",75,0,0,0,25,"TOP",0,0,"TCGA-BK-A0C9-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,NA,NA,386,"TUMOR FREE","Alive",NA,"TCGA-BK-A0C9-F4006","TCGA-BK-A0C9",1,"BK","A0C9","YES","C54.1","8380/3","C54.1","YES","NO",-20876,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",289,NA,NA,NA,"TUMOR FREE","NO",8,10,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
91061686,90051109,4299982086,"A74F4B43-909C-4429-ABDF-AA1F9DDE86F9.bw","9370e189-8fb7-4bfa-8ef9-2220f3557188","a74f4b43-909c-4429-abdf-aa1f9dde86f9","2016-08-26T00:51:11.436416-05:00","UNCID_2316534.8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7.130924_UNC9-SN296_0403_AC2BR8ACXX_2_CAGATC.tar.gz","a4ba7ef2-9f72-428c-adb5-684bb863c037",4448638522,"Illumina HiSeq","9f8abeb70e1081adbce7a4df2e1c1c01","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:58:23.196013-05:00","2016-05-03T11:28:50.207865-05:00","a4ba7ef2-9f72-428c-adb5-684bb863c037_analysis.xml","5999f1d78be64ae81f82d5ffaac55eed","80ff13ce-f26b-4ca5-b488-fb8fce72c626",2122,"2016-09-29T23:16:08.670448-05:00","a4ba7ef2-9f72-428c-adb5-684bb863c037_experiment.xml","4bba561a838663d80a946f668d431d8f","d6610fbc-30ee-4e74-a405-e6ff6642599b",2628,"2016-09-29T23:56:24.336840-05:00","a4ba7ef2-9f72-428c-adb5-684bb863c037_run.xml","5775a42c9af678a8fe131453ba2968a4","ef75ed7c-60e1-42ed-98bb-2460b18067e1",354,"2016-09-08T11:12:30.418607-05:00","TCGA-EY-A1GO","2016-09-02T18:52:27.090523-05:00","female","TCGA-EY-A1GO_demographic",1945,"white","bffaa34a-37f1-5822-ab31-7d17a1aca9e4","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GO_diagnosis","not reported",23853,"alive","8380/3",NA,586,"75a373fb-25bb-52a0-b7c5-a59f7de4a641","c54.1",-23853,"TCGA-EY-A1GO_treatment","1bf9e4d5-faeb-5ff7-8742-47defac8fd1c","01","false","TCGA-EY-A1GO-01A",NA,"84c460ba-e8a0-43ea-a4c3-c838d5587f99",FALSE,"82216372-E1EF-47F2-B57A-25C1DCB24E5E","Primary Tumor",NA,259,100,NA,1297641600,"11",30,"TCGA-EY-A1GO-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:12:30.418607-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"a56e1e97-9298-4131-8c25-41fb19926214",NA,"TCGA-EY-A1GO-01A-01-TSA",NA,80,NA,"125682f6-1757-49ce-b371-7807d71a7093","RNA","TCGA-EY-A1GO-01A-11R","60b02e7b-db9d-4e40-abd3-9d4d71067c45",1.8,0.16,"UV Spec","R","23","TCGA-EY-A1GO-01A-11R-A14D-07","8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7",0.16,NA,76,31.2294543063774,156,"a4f0ecef-c3c3-5e1c-9088-f506048dbe89","TCGA-EY-A1GO_exposure","UNCID_2316534.8bf59d5d-e4e0-48c3-9ae7-16feeb2675e7.130924_UNC9-SN296_0403_AC2BR8ACXX_2_CAGATC.tar.gz","2014-01-07T02:16:25.000Z","2014-01-07T03:46:01.000Z","A4BA7EF2-9F72-428C-ADB5-684BB863C037","84C460BA-E8A0-43EA-A4C3-C838D5587F99","Unaligned reads",4448638522,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8BF59D5D-E4E0-48C3-9AE7-16FEEB2675E7","University of North Carolina","5660795de4b0ec1099f8da36","9370E189-8FB7-4BFA-8EF9-2220F3557188","Uterine Corpus Endometrial Carcinoma","TARGZ","125682F6-1757-49CE-B371-7807D71A7093","2014-01-07T03:46:01.000Z","60B02E7B-DB9D-4E40-ABD3-9D4D71067C45","United States","NO",1,NA,"Primary Tumor","University of North Carolina",259,"125682F6-1757-49CE-B371-7807D71A7093",NA,"EY","FISTS_p_TCGA_b107_121_SNP_N_GenomeWideSNP_6_H01_777790.ismpolish.data.txt",100,"TCGA-EY-A1GO-01A",NA,"729A7E33-FEBC-46AD-B80D-AE5DD18B6140","TCGA",2010,NA,NA,"TUMOR FREE","A59BADE9-93B8-4049-9331-03682EA926B0",65,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.DFCAEDA6-D463-4CE3-B9BD-66CC4B3F2C82.txt","Alive",NA,"TCGA-EY-A1GO","NOT HISPANIC OR LATINO","A2885D9B-0AE9-45D5-82E6-449FEEAD6E57",NA,360,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,"61D69E3D-879A-44D1-BE51-939A027F63F8","WHITE",NA,11,30,"A56E1E97-9298-4131-8C25-41FB19926214","FE0CF068-C124-48D8-9096-844DFC38D19A","TCGA-EY-A1GO-01A-11R-A14C-13_mirna.bam.bai","TCGA-EY-A1GO-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-EY-A1GO-01A-01-TSA",80,"Carboplatin","Chemotherapy","TCGA-EY-A1GO-D11907","TCGA-EY-A1GO-R12180","EXTERNAL BEAM","Regional site",NA,"YES",586,"WITH TUMOR","Alive",NA,"TCGA-EY-A1GO-F19759","TCGA-EY-A1GO",1,"EY","A1GO","YES","C54.1","8380/3","C54.1","YES","NO",-23853,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",360,NA,NA,NA,"TUMOR FREE","NO",18,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2010,"Tumor resection",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32715410,31908036,2367872048,"D259B183-3FEB-45BD-80E5-9E13D08F272D.bw","93d6df4a-aea2-48c2-8b6a-4b3eca0bf26f","d259b183-3feb-45bd-80e5-9e13d08f272d","2016-08-09T14:09:22.791517-05:00","UNCID_2206602.e3abb7cf-945d-496f-8bf0-828ddfef6538.110928_UNC6-RDR300211_00126_FC_6348UAAXX_6.tar.gz","f33c3dc3-574b-431c-8255-04fde3336a46",2140711503,"Illumina GA","6a32170308cdf1a7723fa00d10ffdf96","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:32:10.461831-05:00","2016-05-03T11:11:34.779998-05:00","f33c3dc3-574b-431c-8255-04fde3336a46_analysis.xml","e981ac2199da089522d9c6a4ae499947","70addc7a-1e84-42a3-9ddd-011912b443d2",2121,"2016-08-30T05:26:18.243288-05:00","f33c3dc3-574b-431c-8255-04fde3336a46_experiment.xml","df665580d59c643b11058057ec865f57","9a94f7e6-2b03-4c0b-ae2f-b153e4a78f6b",2257,"2016-09-29T17:40:36.303653-05:00","f33c3dc3-574b-431c-8255-04fde3336a46_run.xml","7463af80c6d8e351acb245f2252ec408","05997247-0b87-44c5-9e83-730404f60ead",347,"2016-09-08T10:32:44.060195-05:00","TCGA-FI-A2EW","2016-09-02T18:52:58.310473-05:00","female","TCGA-FI-A2EW_demographic",1934,"black or african american","6576c375-63ee-5f39-8eba-d41859b9dc27","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2EW_diagnosis","not reported",26267,"alive","8441/3",NA,1462,"be321182-f652-5312-9819-ffd9509fa760","c54.1",-26267,"TCGA-FI-A2EW_treatment","3dc0ea35-e22f-5639-b0e4-5fb7fbc8e19d","01","true","TCGA-FI-A2EW-01A",NA,"c10f91bf-385f-4e50-a9ef-67cf43b279b1",FALSE,"3DED6690-5A21-4EDC-B9D4-5E1F2F5A9CC1","Primary Tumor",NA,2321,120,NA,1308268800,"11",30,"TCGA-FI-A2EW-01A-11",85,NA,20,NA,0,NA,10,NA,"2016-09-08T10:32:44.060195-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"3c90e1b7-c496-4c98-b729-0173657f4488",NA,"TCGA-FI-A2EW-01A-01-TSA",NA,85,NA,"ac6bb6fd-d3bc-41fb-ae56-d4f1a841f7f6","RNA","TCGA-FI-A2EW-01A-11R","6a20e426-b5fa-4c88-8220-8fcf569b2b1d",1.79,0.15,"UV Spec","R","23","TCGA-FI-A2EW-01A-11R-A17B-07","e3abb7cf-945d-496f-8bf0-828ddfef6538",0.15,NA,83,32.421875,160,"9ee99747-d0f7-5b74-a5f1-0c7dd2e0726e","TCGA-FI-A2EW_exposure","UNCID_2206602.e3abb7cf-945d-496f-8bf0-828ddfef6538.110928_UNC6-RDR300211_00126_FC_6348UAAXX_6.tar.gz","2013-09-27T12:26:04.000Z","2013-09-27T12:39:02.000Z","F33C3DC3-574B-431C-8255-04FDE3336A46","C10F91BF-385F-4E50-A9EF-67CF43B279B1","Unaligned reads",2140711503,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E3ABB7CF-945D-496F-8BF0-828DDFEF6538","University of North Carolina","564a3d07e4b08c5d86920817","93D6DF4A-AEA2-48C2-8B6A-4B3ECA0BF26F","Uterine Corpus Endometrial Carcinoma","TARGZ","AC6BB6FD-D3BC-41FB-AE56-D4F1A841F7F6","2013-09-27T12:39:02.000Z","6A20E426-B5FA-4C88-8220-8FCF569B2B1D","United States","NO",1,NA,"Primary Tumor","Washington University",2321,"AC6BB6FD-D3BC-41FB-AE56-D4F1A841F7F6",NA,"FI","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2C665CF4-C3ED-4579-9050-4064E3AE281C.txt",120,"TCGA-FI-A2EW-01A",NA,"AF6163E1-112C-4EC7-8224-1446635F13AC","TCGA",2005,NA,NA,"WITH TUMOR","C10F91BF-385F-4E50-A9EF-67CF43B279B1",71,"TCGA-FI-A2EW-01A-11R-A17A-13_mirna.bam","Alive",NA,"TCGA-FI-A2EW",NA,NA,NA,1795,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"3C90E1B7-C496-4C98-B729-0173657F4488","C9BCF91B-0D90-46D8-AD0C-557612C22538","jhu-usc.edu_UCEC.HumanMethylation450.12.lvl-2.TCGA-FI-A2EW-01A-11D-A17F-05.txt","TCGA-FI-A2EW-01A-11",85,0,20,40,10,"TOP",5,20,"TCGA-FI-A2EW-01A-01-TSA",85,"Paclitaxel","Chemotherapy","TCGA-FI-A2EW-D31790",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-FI-A2EW",1,"FI","A2EW","YES","C54.1","8441/3","C54.1","NO","YES",-26267,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1795,NA,NA,NA,"WITH TUMOR","NO",27,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,71,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32303217,31793283,2348176014,"0A3E0A3D-D396-4340-8D98-4B79DBFC312C.bw","944a102f-3475-45aa-9e30-4b92d1449f00","0a3e0a3d-d396-4340-8d98-4b79dbfc312c","2016-08-06T05:17:38.039069-05:00","UNCID_2206600.1857cddd-76d1-403b-a14e-f14d0781f68b.110928_UNC6-RDR300211_00126_FC_6348UAAXX_1.tar.gz","de11bbf7-23d0-4327-804f-0a6a31a7a225",2106558509,"Illumina GA","5620b159f177088cc61ddaf5916c5138","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:06:07.328632-05:00","2016-05-03T11:11:34.779998-05:00","de11bbf7-23d0-4327-804f-0a6a31a7a225_analysis.xml","aeab2551ca72326830b647ef2f2a4284","85e07674-437e-4ab7-8782-b47036d3d776",2121,"2016-08-13T11:34:48.787572-05:00","de11bbf7-23d0-4327-804f-0a6a31a7a225_experiment.xml","d100f1d7ca1c193df80276bc7b5622a7","48e3afc9-4c38-4bcd-b378-c6f0b950b766",2257,"2016-09-29T21:10:56.145816-05:00","de11bbf7-23d0-4327-804f-0a6a31a7a225_run.xml","d46223be5aeab287e583ef36ae768c04","88e7ee0b-8130-4d3c-9582-e41eb4086ee7",347,"2016-09-08T11:35:10.547656-05:00","TCGA-DI-A1NN","2016-09-02T18:52:46.215612-05:00","female","TCGA-DI-A1NN_demographic",1945,"white","603ef2c1-6a1b-5889-926a-2cb5e9eaaba8","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A1NN_diagnosis","not reported",23026,"alive","8441/3",NA,1076,"3747482b-b1d6-5c36-9a94-1ab52a2ab851","c54.1",-23026,"TCGA-DI-A1NN_treatment","f0d98b6f-8a12-5fa4-b2ff-bae5a61774fb","01","false","TCGA-DI-A1NN-01A",NA,"5fabce9c-0dfb-4b0d-8478-599fd181a84f",FALSE,"EBBDE504-29C9-4662-8D06-44E8CBAD0741","Primary Tumor",NA,813,300,NA,1302220800,"11",30,"TCGA-DI-A1NN-01A-11",80,NA,10,NA,0,NA,10,NA,"2016-09-08T11:35:10.547656-05:00",NA,40,NA,30,NA,"TOP",NA,10,NA,"3b1b22bc-b0b7-4b19-a597-ada548ed1063",NA,"TCGA-DI-A1NN-01A-01-TSA",NA,80,NA,"741adcaa-6173-4250-9c93-b67ffc59cd7d","RNA","TCGA-DI-A1NN-01A-11R","6c5afeee-d8cb-4170-809f-a4563f8381e7",1.62,0.16,"UV Spec","R","23","TCGA-DI-A1NN-01A-11R-A16F-07","1857cddd-76d1-403b-a14e-f14d0781f68b",0.16,NA,71,23.7228106518761,173,"1c3f6dc1-9e72-5928-82eb-c87a4166b5fc","TCGA-DI-A1NN_exposure","UNCID_2206600.1857cddd-76d1-403b-a14e-f14d0781f68b.110928_UNC6-RDR300211_00126_FC_6348UAAXX_1.tar.gz","2013-09-27T12:16:04.000Z","2013-09-27T12:29:01.000Z","DE11BBF7-23D0-4327-804F-0A6A31A7A225","5FABCE9C-0DFB-4B0D-8478-599FD181A84F","Unaligned reads",2106558509,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1857CDDD-76D1-403B-A14E-F14D0781F68B","University of North Carolina","5660741be4b018727fe9edd1","944A102F-3475-45AA-9E30-4B92D1449F00","Uterine Corpus Endometrial Carcinoma","TARGZ","741ADCAA-6173-4250-9C93-B67FFC59CD7D","2013-09-27T12:29:01.000Z","6C5AFEEE-D8CB-4170-809F-A4563F8381E7","United States","NO",1,NA,"Primary Tumor","MD Anderson",813,"741ADCAA-6173-4250-9C93-B67FFC59CD7D",NA,"DI","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CF1A7C5B-632B-4792-AA34-E10E967EC882.txt",300,"TCGA-DI-A1NN-01A",NA,"E4429CA4-7B7D-44CB-A374-CFEBF5051355","TCGA",2008,NA,NA,"TUMOR FREE","5FABCE9C-0DFB-4B0D-8478-599FD181A84F",63,"jhu-usc.edu_UCEC.HumanMethylation450.11.lvl-3.TCGA-DI-A1NN-01A-11D-A16G-05.txt","Alive",NA,"TCGA-DI-A1NN","NOT HISPANIC OR LATINO","3E979129-A6F4-4AA4-BC80-D88CEB386807",NA,944,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",143,NA,NA,"WHITE",NA,11,30,"3B1B22BC-B0B7-4B19-A597-ADA548ED1063","841EF897-5B15-4079-AD52-348108288C63","TCGA-DI-A1NN-01A-11R-A16E-13_mirna.bam","TCGA-DI-A1NN-01A-11",80,0,10,40,10,"TOP",10,30,"TCGA-DI-A1NN-01A-01-TSA",80,"AZD6244","Chemotherapy","TCGA-DI-A1NN-D20800",NA,NA,NA,NA,"YES",1076,"WITH TUMOR","Alive",NA,"TCGA-DI-A1NN-F19104","TCGA-DI-A1NN",1,"DI","A1NN","YES","C54.1","8441/3","C54.1","NO","YES",-23026,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",944,NA,NA,NA,"TUMOR FREE","NO",1,8,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,63,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
23073613,22485322,1663167003,"2366BE81-7B98-4293-8ABC-D80D49092E24.bw","94817e78-78f5-4556-9394-610df65605e2","2366be81-7b98-4293-8abc-d80d49092e24","2016-08-07T21:59:45.590541-05:00","UNCID_2215160.2b483617-1fc6-4809-b15c-d48d687ca3b8.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_5.tar.gz","7615cef8-9f41-49ac-8a67-e3ddd0fef72d",1353897189,"Illumina GA","f995ff40edc5155c0867334d1e888047","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:38:34.423069-05:00","2016-05-03T11:17:59.899725-05:00","7615cef8-9f41-49ac-8a67-e3ddd0fef72d_analysis.xml","f6ee21838390c712cb12898704f8a32c","4fd2f727-36c4-4c79-86b0-c9c94847ed8f",2122,"2016-09-29T19:07:23.333548-05:00","7615cef8-9f41-49ac-8a67-e3ddd0fef72d_experiment.xml","c77b49b5cb95d3cdb3e13472f8c0d63c","3c56362e-c100-4187-82d1-75c2b704584b",2256,"2016-09-29T23:11:39.006329-05:00","7615cef8-9f41-49ac-8a67-e3ddd0fef72d_run.xml","8f1ea2d7b9363ed8904a55b3dbb69984","d3affdfb-dc25-4359-a8cf-38e8bd18348b",345,"2016-09-08T12:11:24.466996-05:00","TCGA-A5-A0GJ","2016-09-02T18:54:10.775902-05:00","female","TCGA-A5-A0GJ_demographic",1961,"white","bb77659e-237f-5a94-8538-2fb5d2a1797f","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GJ_diagnosis","not reported",16421,"alive","8380/3",NA,2000,"b6fb24ef-56f2-58fe-9500-478b07397a71","c54.1",-16421,"TCGA-A5-A0GJ_treatment","aea681f6-5801-52ce-b126-a79682dce318","01","true","TCGA-A5-A0GJ-01A",NA,"48fa5b7d-e488-4743-a7ce-aceb9945f00b",FALSE,"83743C19-A9FF-42F0-947E-5697709151C5","Primary Tumor",NA,1708,220,NA,1276041600,"11",30,"TCGA-A5-A0GJ-01A-11",70,100,0,0,30,0,0,0,"2016-09-08T12:11:24.466996-05:00","2016-09-08T12:11:24.466996-05:00",10,10,5,15,"TOP","BOTTOM",10,30,"2f2d238d-1607-4d7a-98a1-76e995cf8bc2","514abe88-06d3-4c49-9426-9e5cf3ab0858","TCGA-A5-A0GJ-01A-01-TS1","TCGA-A5-A0GJ-01A-01-BS1",60,70,"1ab2ed43-67ab-4cd7-8fc6-94e8aa7b08b8","RNA","TCGA-A5-A0GJ-01A-11R","3667ad27-d2f4-4322-bf7e-8670e7514314",2.04,0.16,"UV Spec","R","23","TCGA-A5-A0GJ-01A-11R-A040-07","2b483617-1fc6-4809-b15c-d48d687ca3b8",0.16,NA,115,43.2835259136588,163,"d551f2d8-155a-5ff2-8a7a-bb3036b01c25","TCGA-A5-A0GJ_exposure","UNCID_2215160.2b483617-1fc6-4809-b15c-d48d687ca3b8.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_5.tar.gz","2013-10-04T00:36:04.000Z","2013-10-04T00:48:02.000Z","7615CEF8-9F41-49AC-8A67-E3DDD0FEF72D","48FA5B7D-E488-4743-A7CE-ACEB9945F00B","Unaligned reads",1353897189,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2B483617-1FC6-4809-B15C-D48D687CA3B8","University of North Carolina","564a3302e4b0ef121817c0c4","94817E78-78F5-4556-9394-610DF65605E2","Uterine Corpus Endometrial Carcinoma","TARGZ","1AB2ED43-67AB-4CD7-8FC6-94E8AA7B08B8","2013-10-04T00:48:02.000Z","3667AD27-D2F4-4322-BF7E-8670E7514314","None","NO",1,NA,"Primary Tumor","Cedars Sinai",1708,"1AB2ED43-67AB-4CD7-8FC6-94E8AA7B08B8",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.AE211CF8-6F17-463C-9F5F-DC177FA3C373.txt",220,"TCGA-A5-A0GJ-01A",NA,"C438C2AA-2888-4F3E-AD69-01526619697E","TCGA",2005,NA,NA,"TUMOR FREE","81C5B859-DB07-4FA5-90D8-B0C36E913743",44,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.AE211CF8-6F17-463C-9F5F-DC177FA3C373.txt","Alive",NA,"TCGA-A5-A0GJ","NOT HISPANIC OR LATINO","B65DC8EB-61A3-4EC2-AFEF-653AABF86405",NA,1447,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"514ABE88-06D3-4C49-9426-9E5CF3AB0858","7C978FAD-6F43-4882-9D59-D2C7FF732992","TCGA-A5-A0GJ-01A-01D-YYYY-23.txt","TCGA-A5-A0GJ-01A-11",100,0,0,10,0,"BOTTOM",30,15,"TCGA-A5-A0GJ-01A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-A5-A0GJ-D5084",NA,NA,NA,NA,"NO",2000,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GJ-F17144","TCGA-A5-A0GJ",1,"A5","A0GJ","YES","C54.1","8380/3","C54.1","NO","YES",-16421,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1447,NA,NA,NA,"TUMOR FREE","NO",17,12,2010,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,44,2005,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32357519,31396056,2353650552,"A395841E-1974-4EBE-A456-CCC1B870B65F.bw","957ac10a-7365-47b1-bbed-47e5d42fbfdf","a395841e-1974-4ebe-a456-ccc1b870b65f","2016-08-06T22:28:54.595690-05:00","UNCID_2212070.6e00c57a-69e5-4b00-9e5e-97aa1d4933c7.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_1.tar.gz","b3a6dc97-c3ca-4de9-a506-8f58f9168885",2020329543,"Illumina GA","c7dd86bd7c6521e30b94bd2137adb068","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:48:44.827327-05:00","2016-05-03T11:16:29.242391-05:00","b3a6dc97-c3ca-4de9-a506-8f58f9168885_analysis.xml","a1a0284cca33a6f2b9bf3cace78e2e8a","5627ff18-6936-42c7-b0ca-f5f4c66297d0",2121,"2016-10-07T16:35:02.765566-05:00","b3a6dc97-c3ca-4de9-a506-8f58f9168885_experiment.xml","070644d29d760bd3b2de5513a652456b","a6982ac4-3d94-47d2-b74f-4e72b3aa8fa4",2257,"2016-09-29T22:11:54.514337-05:00","b3a6dc97-c3ca-4de9-a506-8f58f9168885_run.xml","eeeddf85a701db11dade172ffdfc2284","ae8a20a0-ba66-48df-85a9-2f13cc7b4c25",347,"2016-09-08T11:09:08.324816-05:00","TCGA-BG-A0YU","2016-09-02T18:49:09.962023-05:00","female","TCGA-BG-A0YU_demographic",1973,"white","33a85b3a-5efc-559a-958b-e7cc12adaff4","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0YU_diagnosis","not reported",13644,"alive","8380/3",NA,451,"fb3780be-6dfa-56b2-981a-762ea0de6733","c54.1",-13644,"TCGA-BG-A0YU_treatment","b1082cf6-f173-5473-8cbf-f4b7931b6341","01","true","TCGA-BG-A0YU-01A",NA,"61a80dcf-f83b-4b4f-806f-8ad3882ecfe4",FALSE,"5E3AA4BA-20F6-4241-AD70-8E5DEDA9D129","Primary Tumor",NA,166,310,NA,1287705600,"21",30,"TCGA-BG-A0YU-01A-21",90,80,0,0,0,0,10,20,"2016-09-08T11:09:08.324816-05:00","2016-09-08T11:09:08.324816-05:00",20,20,10,10,"TOP","BOTTOM",10,20,"532f2d2b-50e6-421a-9001-10d5e0f35f43","8d1f9efc-9ddc-4a6f-a53c-464c157d8bd0","TCGA-BG-A0YU-01A-02-TSB","TCGA-BG-A0YU-01A-02-BSB",80,60,"7e3aebd5-9384-467f-83e1-851784773e14","RNA","TCGA-BG-A0YU-01A-21R","149495ad-fcf4-4d18-977e-3ca11db7f326",1.89,0.17,"UV Spec","R","23","TCGA-BG-A0YU-01A-21R-A10J-07","6e00c57a-69e5-4b00-9e5e-97aa1d4933c7",0.17,NA,107,43.4094689439734,157,"eff04177-e895-599d-874b-b37a31de3d82","TCGA-BG-A0YU_exposure","UNCID_2212070.6e00c57a-69e5-4b00-9e5e-97aa1d4933c7.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_1.tar.gz","2013-10-03T05:13:04.000Z","2013-10-03T05:25:02.000Z","B3A6DC97-C3CA-4DE9-A506-8F58F9168885","61A80DCF-F83B-4B4F-806F-8AD3882ECFE4","Unaligned reads",2020329543,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","6E00C57A-69E5-4B00-9E5E-97AA1D4933C7","University of North Carolina","564a3b83e4b08c5d86918b67","957AC10A-7365-47B1-BBED-47E5D42FBFDF","Uterine Corpus Endometrial Carcinoma","TARGZ","7E3AEBD5-9384-467F-83E1-851784773E14","2013-10-03T05:25:02.000Z","149495AD-FCF4-4D18-977E-3CA11DB7F326","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",166,"7E3AEBD5-9384-467F-83E1-851784773E14",NA,"BG","DEBUT_p_TCGAb45_81_wRedosSNP_N_GenomeWideSNP_6_E07_729534.hg19.seg.txt",310,"TCGA-BG-A0YU-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","61A80DCF-F83B-4B4F-806F-8AD3882ECFE4",37,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3F6A7393-8558-4803-BC69-541FBB713CF3.txt","Alive",NA,"TCGA-BG-A0YU","NOT HISPANIC OR LATINO","B2408F86-A0D5-45E2-847F-4950189C2199",NA,279,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,21,30,"8D1F9EFC-9DDC-4A6F-A53C-464C157D8BD0","149495AD-FCF4-4D18-977E-3CA11DB7F326","UNCID_1635932.6e00c57a-69e5-4b00-9e5e-97aa1d4933c7.sorted_genome_alignments.bam","TCGA-BG-A0YU-01A-21",90,0,0,20,10,"TOP",10,10,"TCGA-BG-A0YU-01A-02-TSB",80,NA,NA,NA,NA,NA,NA,NA,"NO",451,"TUMOR FREE","Alive",NA,"TCGA-BG-A0YU-F19334","TCGA-BG-A0YU",1,"BG","A0YU","YES","C54.1","8380/3","C54.1","NO","YES",-13644,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",279,NA,NA,NA,"TUMOR FREE","NO",16,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,37,2010,"Other method, specify:",NA,NA,NA,"G1","RX",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
111599596,109792909,5239537538,"9B9A845C-B1CC-43AD-A356-E33EA99FBB9B.bw","9583c10b-b21a-4863-98fa-61e735e64ea5","9b9a845c-b1cc-43ad-a356-e33ea99fbb9b","2016-08-09T14:41:20.352425-05:00","UNCID_2661009.8e9f2a41-dddc-4761-8883-ca58f5934d5f.140715_UNC11-SN627_0367_BC4KEPACXX_8_GGCTAC.tar.gz","94ec40b5-348e-4db8-95ac-54f5e248a9ba",4818927694,"Illumina HiSeq","75d0f694af69d01964cca6b20c5c1e11","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:24:14.558952-05:00","2016-06-22T11:15:44.245302-05:00","94ec40b5-348e-4db8-95ac-54f5e248a9ba_analysis.xml","08bffef69efc3d734afe7a546b44da22","2104e8cf-f16f-4c7a-8ec3-74c14b72af60",2124,"2016-09-29T20:22:26.052567-05:00","94ec40b5-348e-4db8-95ac-54f5e248a9ba_experiment.xml","3c08a9b9c7108541f6e103bf2c45a60a","6ac1849a-2b69-443a-a60e-eb4e32e944b6",2628,"2016-09-29T19:34:08.957824-05:00","94ec40b5-348e-4db8-95ac-54f5e248a9ba_run.xml","a2900aca8164631973c961aba90597c1","4d1736aa-740a-4b7f-9dcc-396ffac45436",354,"2016-09-08T11:03:56.754687-05:00","TCGA-2E-A9G8","2016-09-02T18:52:14.201787-05:00","female","TCGA-2E-A9G8_demographic",1952,"black or african american","a0452fbc-d834-54b0-a7af-54217646f706","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","2E","436d9f32-46d2-5742-8f24-4108512a84e1","University of Kansas Medical Center","not reported","c54.3","TCGA-2E-A9G8_diagnosis","not reported",NA,"alive","8380/3",NA,1249,"138c08ab-6469-5248-abf2-818fc309f839","c54.3",NA,"TCGA-2E-A9G8_treatment","b9ef309c-d76b-5d51-ac45-633e7da24e3f","01","false","TCGA-2E-A9G8-01A",NA,"792e23a2-aed7-40f6-966b-281697eb7c85",FALSE,"921E6140-A03E-4FBD-9FB8-554AE96FD16C","Primary Tumor",NA,957,90,NA,1390176000,"11",30,"TCGA-2E-A9G8-01A-11",80,NA,0,NA,0,NA,15,NA,"2016-09-08T11:03:56.754687-05:00",NA,10,NA,0,NA,"TOP",NA,5,NA,"ac7602cc-7407-42e8-bbf1-19068d8a9df6",NA,"TCGA-2E-A9G8-01A-01-TS1",NA,80,NA,"38148658-9a4e-479c-99a5-f10b9bfe3f25","RNA","TCGA-2E-A9G8-01A-11R","93d951f6-1c95-41eb-b969-bf8c168aa420",1.84,0.16,"UV Spec","R","23","TCGA-2E-A9G8-01A-11R-A40A-07","8e9f2a41-dddc-4761-8883-ca58f5934d5f",0.16,NA,71,28.8044139721693,157,"551105cd-8da0-5696-b291-f9fb0ad036c7","TCGA-2E-A9G8_exposure","UNCID_2661009.8e9f2a41-dddc-4761-8883-ca58f5934d5f.140715_UNC11-SN627_0367_BC4KEPACXX_8_GGCTAC.tar.gz","2014-11-14T22:27:03.000Z","2014-11-14T22:42:39.000Z","94EC40B5-348E-4DB8-95AC-54F5E248A9BA","792E23A2-AED7-40F6-966B-281697EB7C85","Unaligned reads",4818927694,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8E9F2A41-DDDC-4761-8883-CA58F5934D5F","University of North Carolina","5660768de4b0ec1099f8c68d","9583C10B-B21A-4863-98FA-61E735E64EA5","Uterine Corpus Endometrial Carcinoma","TARGZ","38148658-9A4E-479C-99A5-F10B9BFE3F25","2014-11-14T22:42:39.000Z","93D951F6-1C95-41EB-B969-BF8C168AA420","United States","NO",1,NA,"Primary Tumor","University of Kansas Medical Center",957,"38148658-9A4E-479C-99A5-F10B9BFE3F25",NA,"2E","UNCID_2661009.8e9f2a41-dddc-4761-8883-ca58f5934d5f.140715_UNC11-SN627_0367_BC4KEPACXX_8_GGCTAC.tar.gz",90,"TCGA-2E-A9G8-01A",NA,"B2A9F3C5-EC2F-4E11-A5C9-B9CD9C7BE1FA","TCGA",2011,"TCGA-2E-A9G8_NTE-1","Progressive Disease","TUMOR FREE","D6640FA4-AAD5-4BD0-B326-FF5F18F28473",59,"9934398135_R01C01_Red.idat","Alive",NA,"TCGA-2E-A9G8","NOT HISPANIC OR LATINO","016726CE-E55C-4B6C-BB00-D44C75C8205D","YES",1065,"Yes","Uterus","C54.3",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage III",NA,NA,NA,"8380/3","FEMALE","C54.3",421,NA,"6F880611-5715-4CE9-8077-A6560CF66E58","BLACK OR AFRICAN AMERICAN",NA,11,30,"AC7602CC-7407-42E8-BBF1-19068D8A9DF6","93D951F6-1C95-41EB-B969-BF8C168AA420","UNCID_2661009.8e9f2a41-dddc-4761-8883-ca58f5934d5f.140715_UNC11-SN627_0367_BC4KEPACXX_8_GGCTAC.tar.gz","TCGA-2E-A9G8-01A-11",80,0,0,10,15,"TOP",5,0,"TCGA-2E-A9G8-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-2E-A9G8-D59816","TCGA-2E-A9G8-R59813","Internal","Primary Tumor Field","TCGA-2E-A9G8-F66642_NTE-1","YES",1249,"TUMOR FREE","Alive",NA,"TCGA-2E-A9G8-F66642","TCGA-2E-A9G8",1,"2E","A9G8","YES","C54.3","8380/3","C54.3","NO","YES",NA,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes","No","Alive",1065,NA,"YES","NO","TUMOR FREE","YES",21,5,2014,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2011,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,"Progressive Disease","2009",8,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35912734,34866331,2631523062,"638A0BBA-E2BE-449C-8BF5-EC07F765200C.bw","95e6d327-9ab7-45de-9527-f5634b3995c3","638a0bba-e2be-449c-8bf5-ec07f765200c","2016-08-05T02:08:52.666451-05:00","UNCID_2215668.e62793b0-8fb2-4c91-9f64-c0eae21571a7.100916_UNC4-RDR3001561_00024_FC_62HW7AAXX_8.tar.gz","28fd3732-f152-46c4-bedf-4c9ebf0f566a",2265734253,"Illumina GA","f74ac9e7cdd3421ce82ab72bfaf942a3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:01:41.372812-05:00","2016-05-03T11:18:46.988754-05:00","28fd3732-f152-46c4-bedf-4c9ebf0f566a_analysis.xml","9fac63b4135fce124b9680ed39be0c1e","13102b60-441a-4238-b3af-11d72f372f22",2122,"2016-09-29T23:33:34.528877-05:00","28fd3732-f152-46c4-bedf-4c9ebf0f566a_experiment.xml","b267a9de6652cb2cd14a5cfdc85cb710","e1450723-c6b6-4a6c-8e44-3b16ada51a7d",2256,"2016-09-29T18:50:41.236014-05:00","28fd3732-f152-46c4-bedf-4c9ebf0f566a_run.xml","6ce2c8973160e2b9bd7dc0ea8ade21a2","31c604ba-649d-477e-8205-50eb5576fe2f",345,"2016-09-09T16:40:48.103557-05:00","TCGA-AX-A06B","2016-09-02T18:52:49.472024-05:00","female","TCGA-AX-A06B_demographic",1933,"white","26a37a66-829e-5cad-b2d4-c18ad2b5d28f","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A06B_diagnosis","not reported",26348,"alive","8380/3",NA,2058,"181824f3-502b-50d8-a5a6-1308d7c7fed1","c54.1",-26348,"TCGA-AX-A06B_treatment","2c0edc5d-dd45-5c1f-b9e1-854580e3588c","01","false","TCGA-AX-A06B-01A",NA,"a43f90b7-4a6c-423c-82de-ad2c330ae0fb",FALSE,"394E8BCD-1BE6-44C4-BDAC-D251A6C08E2B","Primary Tumor",NA,1563,210,NA,1275868800,"11",30,"TCGA-AX-A06B-01A-11",72,85,0,0,36,18,2,2,"2016-09-09T16:40:48.103557-05:00","2016-09-09T16:40:48.103557-05:00",5,7,0,0,"BOTTOM","TOP",2,2,"3f60ba31-1a26-4eff-8b2d-5e35f6802f40","088c195d-ea53-4630-a24b-07aa8d975e1b","TCGA-AX-A06B-01A-01-BS1","TCGA-AX-A06B-01A-01-TS1",60,78,"5ad4b637-9b81-4885-91b7-b6647e5f3feb","RNA","TCGA-AX-A06B-01A-11R","a970fd10-ff56-4b1c-8847-a9b78596241a",1.76,0.16,"UV Spec","R","23","TCGA-AX-A06B-01A-11R-A00V-07","e62793b0-8fb2-4c91-9f64-c0eae21571a7",0.16,NA,93,40.7876847506688,151,"f49ae067-0c1b-5f64-9e09-3bcc404c8411","TCGA-AX-A06B_exposure","UNCID_2215668.e62793b0-8fb2-4c91-9f64-c0eae21571a7.100916_UNC4-RDR3001561_00024_FC_62HW7AAXX_8.tar.gz","2013-10-04T04:37:07.000Z","2013-10-04T04:51:03.000Z","28FD3732-F152-46C4-BEDF-4C9EBF0F566A","A43F90B7-4A6C-423C-82DE-AD2C330AE0FB","Unaligned reads",2265734253,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E62793B0-8FB2-4C91-9F64-C0EAE21571A7","University of North Carolina","564a3bfee4b093830b697567","95E6D327-9AB7-45DE-9527-F5634B3995C3","Uterine Corpus Endometrial Carcinoma","TARGZ","5AD4B637-9B81-4885-91B7-B6647E5F3FEB","2013-10-04T04:51:03.000Z","A970FD10-FF56-4B1C-8847-A9B78596241A","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1563,"5AD4B637-9B81-4885-91B7-B6647E5F3FEB",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.3A631688-46E7-40E7-BABA-DAA439DA508D.txt",210,"TCGA-AX-A06B-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","EB746A8F-14ED-47E4-8B29-D75F675A4C9D",72,"TCGA-AX-A06B-01A-11R-A00W-13.isoform.quantification.txt","Alive",NA,"TCGA-AX-A06B","NOT HISPANIC OR LATINO","FEF4A520-C31D-4DF1-919C-F1D99B87B1E9",NA,1640,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIA",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,"A15CDE05-60B4-4A69-9851-7E703947030F","WHITE",NA,11,30,"3F60BA31-1A26-4EFF-8B2D-5E35F6802F40","DC41220C-0344-473E-8462-F7591296283C","TCGA-AX-A06B-01A-11R-A00W_mirna.bam","TCGA-AX-A06B-01A-11",72,36,0,5,2,"BOTTOM",2,0,"TCGA-AX-A06B-01A-01-BS1",60,NA,NA,NA,"TCGA-AX-A06B-R12754","IMPLANTS","Primary Tumor Field",NA,NA,1640,"TUMOR FREE","Alive",NA,"TCGA-AX-A06B-F5473","TCGA-AX-A06B",1,"AX","A06B","YES","C54.1","8380/3","C54.1","NO","YES",-26348,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",1640,NA,NA,NA,"TUMOR FREE","NO",25,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,72,2005,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",6,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
109241338,104348891,4969385767,"F38DF975-5D95-4993-9CEF-B775C6851B3E.bw","95eefb47-3f96-4a6d-8773-4d22843f0a6a","f38df975-5d95-4993-9cef-b775c6851b3e","2016-08-09T14:01:28.496958-05:00","UNCID_2167015.ee0873f1-b89d-44ef-9aad-d40c5a8999f1.130621_UNC14-SN744_0352_BC253TACXX_2_CAGATC.tar.gz","9d749d7c-4659-4c69-ad24-c57053fd8d56",4782385530,"Illumina HiSeq","ab9fd7d66948ed1686301d47cf226840","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:30:09.293135-05:00","2016-05-03T11:07:07.492763-05:00","9d749d7c-4659-4c69-ad24-c57053fd8d56_analysis.xml","0f6d494b3f241384e35443f22ef2cad5","94e0dbb0-7a00-49fa-9818-09c46bce88a1",2123,"2016-09-29T23:27:17.894516-05:00","9d749d7c-4659-4c69-ad24-c57053fd8d56_experiment.xml","98ad797cbd7a44ba8b33be8ce586aa51","dd49af2d-9618-4640-939b-a38e6c5d4afd",2431,"2016-09-29T21:25:06.044213-05:00","9d749d7c-4659-4c69-ad24-c57053fd8d56_run.xml","41ff2d46722ea969101131e563692d5a","91aedc03-e61d-4a05-b23c-ca8bd12fc365",354,"2016-09-08T10:52:48.816862-05:00","TCGA-DF-A2KU","2016-09-02T18:53:54.168777-05:00","female","TCGA-DF-A2KU_demographic",NA,"not reported","a1f289cf-dd76-53da-85d7-8289e9f6d3fa","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DF","bd439172-ab1d-57cc-a1ee-7282ceebd41a","Ontario Institute for Cancer Research","not reported","c54.1","TCGA-DF-A2KU_diagnosis","not reported",NA,"alive","8380/3",NA,3067,"d8d39996-51aa-594d-a4df-fbeebce320eb","c54.1",NA,"TCGA-DF-A2KU_treatment","e4f76860-c1f8-5f10-b979-503d75caba06","01","false","TCGA-DF-A2KU-01A",NA,"341b9ad3-2aa4-4e8c-9a41-1915ab6cdba8",FALSE,"6F425E9F-E02A-4EFB-A0DE-00BF09D9BB98","Primary Tumor",NA,NA,380,NA,1313452800,"11",30,"TCGA-DF-A2KU-01A-11",90,NA,3,NA,0,NA,10,NA,"2016-09-08T10:52:48.816862-05:00",NA,15,NA,3,NA,"TOP",NA,0,NA,"10aa0e57-2087-4983-8ed3-be95e7151f58",NA,"TCGA-DF-A2KU-01A-01-TSA",NA,90,NA,"18d99902-ab35-41e8-a39f-690a4adde898","RNA","TCGA-DF-A2KU-01A-11R","b7973f3c-1a43-4466-83a5-2fe1aa45783d",1.79,0.18,"UV Spec","R","23","TCGA-DF-A2KU-01A-11R-A180-07","ee0873f1-b89d-44ef-9aad-d40c5a8999f1",0.18,NA,NA,NA,NA,"62a45313-ac77-54e5-8c01-0b7b63da04ff","TCGA-DF-A2KU_exposure","UNCID_2167015.ee0873f1-b89d-44ef-9aad-d40c5a8999f1.130621_UNC14-SN744_0352_BC253TACXX_2_CAGATC.tar.gz","2013-09-21T07:06:05.000Z","2013-09-21T07:20:01.000Z","9D749D7C-4659-4C69-AD24-C57053FD8D56","341B9AD3-2AA4-4E8C-9A41-1915AB6CDBA8","Unaligned reads",4782385530,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","EE0873F1-B89D-44EF-9AAD-D40C5A8999F1","University of North Carolina","56607d53e4b0ec1099f8ecbd","95EEFB47-3F96-4A6D-8773-4D22843F0A6A","Uterine Corpus Endometrial Carcinoma","TARGZ","18D99902-AB35-41E8-A39F-690A4ADDE898","2013-09-21T07:20:01.000Z","B7973F3C-1A43-4466-83A5-2FE1AA45783D","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"18D99902-AB35-41E8-A39F-690A4ADDE898",NA,"DF","WHIRR_p_TCGA_168_169_170_redo_N_GenomeWideSNP_6_D07_845250.nocnv_hg19.seg.txt",380,"TCGA-DF-A2KU-01A",NA,NA,"TCGA",NA,NA,NA,NA,"A71AF23A-94CB-41F2-928C-268B2C67C8B2",NA,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E3626449-4A3F-4515-972E-CBCB111BE320.txt",NA,NA,"TCGA-DF-A2KU",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,168,NA,NA,NA,NA,11,30,"10AA0E57-2087-4983-8ED3-BE95E7151F58","D4269FBA-075E-4470-ADE5-F977752CD75B","TCGA-DF-A2KU-01A-11R-A17X-13.isoform.quantification.txt","TCGA-DF-A2KU-01A-11",90,0,3,15,10,"TOP",0,3,"TCGA-DF-A2KU-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-DF-A2KU",1,"DF","A2KU","YES","C54.1","8380/3","C54.1","NO","YES",NA,"FEMALE",NA,NA,"No","No","Alive",1983,NA,"YES","NO","TUMOR FREE","NO",15,10,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,NA,NA,NA,"Dilation and curettage procedure",NA,NA,NA,"G3","RX",NA,NA,NA,NA,"Complete Remission/Response",NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34253098,33204201,2489010748,"C3FDCD45-2013-4BA2-BEAF-5ED6A3393783.bw","972db411-9744-46f0-89c7-efe14135f1b4","c3fdcd45-2013-4ba2-beaf-5ed6a3393783","2016-08-09T14:03:31.050828-05:00","UNCID_2194875.bfbb3c82-87b0-44b2-bf2c-5c9bdc318460.120307_UNC2-RDR300275_00118_FC_650V8AAXX_1.tar.gz","459bb24a-be96-4438-8cf9-1f6634602657",2121367324,"Illumina GA","8d5099cef3feb86a4b6fc24d7faae24e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:53:43.142519-05:00","2016-05-03T11:07:49.533775-05:00","459bb24a-be96-4438-8cf9-1f6634602657_analysis.xml","02d5b8f4087a2a13b417ccf05c7a98e4","a36d021d-58c4-4be2-b68d-8e8ddb485df5",2121,"2016-09-29T19:05:52.872646-05:00","459bb24a-be96-4438-8cf9-1f6634602657_experiment.xml","d06683eb6e1d1f7637c6c4d03a157f99","3b68d052-9640-4df7-8bae-59b75753c92e",2257,"2016-09-29T19:17:22.104587-05:00","459bb24a-be96-4438-8cf9-1f6634602657_run.xml","36c93dd1a90bdbd6e0b0b12b3dfe0286","4299ec57-7c57-496c-ba80-cc688dc33687",347,"2016-09-08T10:38:47.979597-05:00","TCGA-EY-A1GK","2016-09-02T18:51:54.478173-05:00","female","TCGA-EY-A1GK_demographic",1935,"white","524b3bcd-5407-5806-9e56-c91529f85f1e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GK_diagnosis","not reported",27127,"alive","8380/3",NA,693,"4bcfe1ca-121f-5b5f-bfb9-4f8586ae8672","c54.1",-27127,"TCGA-EY-A1GK_treatment","801a2fc9-6ecf-5e3f-9b60-e4e48e544179","01","false","TCGA-EY-A1GK-01A",NA,"d4e702a9-8e4a-4ad7-8b45-691c95dcf298",FALSE,"B5024D10-E23D-4B3B-8C54-13EBAA423A04","Primary Tumor",NA,409,120,NA,1297641600,"11",30,"TCGA-EY-A1GK-01A-11",80,NA,30,NA,0,NA,15,NA,"2016-09-08T10:38:47.979597-05:00",NA,30,NA,30,NA,"TOP",NA,5,NA,"10e5129b-b84e-4471-a90c-6dd02ae4fc47",NA,"TCGA-EY-A1GK-01A-01-TSA",NA,80,NA,"0332136b-8393-4afd-a2f1-706593ac8813","RNA","TCGA-EY-A1GK-01A-11R","705fc6ca-af31-4586-9fdd-2b0060126d79",1.75,0.17,"UV Spec","R","23","TCGA-EY-A1GK-01A-11R-A13S-07","bfbb3c82-87b0-44b2-bf2c-5c9bdc318460",0.17,NA,105,41.015625,160,"dba2b620-6c48-5f97-a199-fff7d5bb2533","TCGA-EY-A1GK_exposure","UNCID_2194875.bfbb3c82-87b0-44b2-bf2c-5c9bdc318460.120307_UNC2-RDR300275_00118_FC_650V8AAXX_1.tar.gz","2013-09-23T04:26:05.000Z","2013-09-23T04:45:01.000Z","459BB24A-BE96-4438-8CF9-1F6634602657","D4E702A9-8E4A-4AD7-8B45-691C95DCF298","Unaligned reads",2121367324,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","BFBB3C82-87B0-44B2-BF2C-5C9BDC318460","University of North Carolina","564a31ede4b0298dd2c56018","972DB411-9744-46F0-89C7-EFE14135F1B4","Uterine Corpus Endometrial Carcinoma","TARGZ","0332136B-8393-4AFD-A2F1-706593AC8813","2013-09-23T04:45:01.000Z","705FC6CA-AF31-4586-9FDD-2B0060126D79","United States","NO",1,NA,"Primary Tumor","University of North Carolina",409,"0332136B-8393-4AFD-A2F1-706593AC8813",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.FE0AC1DE-B750-4B82-9B56-EE722A7064F0.txt",120,"TCGA-EY-A1GK-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","D4E702A9-8E4A-4AD7-8B45-691C95DCF298",74,"UNCID_1017771.bfbb3c82-87b0-44b2-bf2c-5c9bdc318460.120307_UNC2-RDR300275_00118_FC_650V8AAXX.1.trimmed.annotated.translated_to_genomic.bam","Alive",NA,"TCGA-EY-A1GK","NOT HISPANIC OR LATINO","67312EF9-72B5-4721-AE05-83AAAEEA77AD",NA,504,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,"CA1B5B43-8249-42C9-BBCA-AF1A9AFFAA87","WHITE",NA,11,30,"10E5129B-B84E-4471-A90C-6DD02AE4FC47","705FC6CA-AF31-4586-9FDD-2B0060126D79","TCGA-EY-A1GK-01A-11R-A13R-13_mirna.bam.bai","TCGA-EY-A1GK-01A-11",80,0,30,30,15,"TOP",5,30,"TCGA-EY-A1GK-01A-01-TSA",80,NA,NA,NA,"TCGA-EY-A1GK-R11877","OTHER: SPECIFY IN NOTES","Regional site",NA,"NO",693,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GK-F19756","TCGA-EY-A1GK",1,"EY","A1GK","YES","C54.1","8380/3","C54.1","YES","NO",-27127,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",504,NA,NA,NA,"TUMOR FREE","NO",18,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29888625,27672775,2074979052,"9F0EAB4C-BC1A-4646-9BC5-8597C8EA6887.bw","9731e0b3-c62d-43cb-8ae7-8f973d69ab19","9f0eab4c-bc1a-4646-9bc5-8597c8ea6887","2016-08-09T14:17:16.158157-05:00","UNCID_2214498.4487eb24-a67d-4406-9a1f-b2c2fde39787.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_7.tar.gz","6b07a8fa-a458-4687-b11f-1c8ea03578a4",1815313142,"Illumina GA","8fb9227289152fe54a92fbcddf62fd67","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:40:57.024685-05:00","2016-05-03T11:17:14.896869-05:00","6b07a8fa-a458-4687-b11f-1c8ea03578a4_analysis.xml","ea21edb70a8bd7bfc2f28145768e9411","2b96da8a-ce3c-49bd-a2da-456f9939d77e",2121,"2016-08-13T02:15:43.098908-05:00","6b07a8fa-a458-4687-b11f-1c8ea03578a4_experiment.xml","c113a67caed31a16fb0a3c19a3666a87","0373b826-e2dc-43e5-ad0a-11ed710cd8df",2257,"2016-09-29T18:02:02.778970-05:00","6b07a8fa-a458-4687-b11f-1c8ea03578a4_run.xml","9011b16a1a704363b46ba0968e29d31a","13483fcb-ed25-4d12-9064-9866b07287bf",347,"2016-09-08T12:39:30.725795-05:00","TCGA-BG-A0M2","2016-09-02T18:48:02.824787-05:00","female","TCGA-BG-A0M2_demographic",1947,"white","e46162a7-b38d-5473-ba17-81b4e62c5c17","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0M2_diagnosis","not reported",22822,"alive","8380/3",NA,637,"be22f33f-6622-5a48-842b-2176fd309799","c54.1",-22822,"TCGA-BG-A0M2_treatment","9fc5b4dd-f556-55a2-adb3-a32ab6ee1233","01","true","TCGA-BG-A0M2-01A",NA,"2af18345-2a71-4574-ac8e-83ddeed3ad57",FALSE,"A0087300-81E9-4733-8497-95E0F95575B4","Primary Tumor",NA,185,510,NA,1280188800,"11",30,"TCGA-BG-A0M2-01A-11",90,90,0,0,0,0,2,0,"2016-09-08T12:39:30.725795-05:00","2016-09-08T12:39:30.725795-05:00",0,0,0,0,"TOP","BOTTOM",1,0,"4551b683-c871-4a60-bdcf-d8ca86e7ddea","811f4cc3-8e9d-4375-8dc0-0b328866e3d9","TCGA-BG-A0M2-01A-01-TSA","TCGA-BG-A0M2-01A-01-BSA",97,100,"a069f5a0-84c7-43ad-8294-0c7c5ca6b85f","RNA","TCGA-BG-A0M2-01A-11R","63041125-20e3-49d6-a1e9-7899fc2367e1",1.81,0.14,"UV Spec","R","23","TCGA-BG-A0M2-01A-11R-A104-07","4487eb24-a67d-4406-9a1f-b2c2fde39787",0.14,NA,76,26.9274376417234,168,"23ddc56a-99e1-5b23-96d9-e002d7796205","TCGA-BG-A0M2_exposure","UNCID_2214498.4487eb24-a67d-4406-9a1f-b2c2fde39787.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_7.tar.gz","2013-10-03T16:31:04.000Z","2013-10-03T16:43:01.000Z","6B07A8FA-A458-4687-B11F-1C8EA03578A4","2AF18345-2A71-4574-AC8E-83DDEED3AD57","Unaligned reads",1815313142,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4487EB24-A67D-4406-9A1F-B2C2FDE39787","University of North Carolina","56607c1ae4b016715ab6b0c7","9731E0B3-C62D-43CB-8AE7-8F973D69AB19","Uterine Corpus Endometrial Carcinoma","TARGZ","A069F5A0-84C7-43AD-8294-0C7C5CA6B85F","2013-10-03T16:43:01.000Z","63041125-20E3-49D6-A1E9-7899FC2367E1","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",185,"A069F5A0-84C7-43AD-8294-0C7C5CA6B85F",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.DD52C56D-2806-4F0F-906C-7518B5CC058F.txt",510,"TCGA-BG-A0M2-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","2AF18345-2A71-4574-AC8E-83DDEED3AD57",62,"nationwidechildrens.org_clinical.TCGA-BG-A0M2.xml","Alive",NA,"TCGA-BG-A0M2","NOT HISPANIC OR LATINO","AED94BD9-9C01-4694-987B-62B322CA9530",NA,317,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"8803DEAD-58B0-4BA9-BF28-87819D0ECAF1","WHITE",NA,11,30,"811F4CC3-8E9D-4375-8DC0-0B328866E3D9","7B1F7D40-2893-499E-AE79-A1129F83F104","UNCID_2214498.4487eb24-a67d-4406-9a1f-b2c2fde39787.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_7.tar.gz","TCGA-BG-A0M2-01A-11",90,0,0,0,2,"TOP",1,0,"TCGA-BG-A0M2-01A-01-TSA",97,NA,NA,NA,"TCGA-BG-A0M2-R4433","IMPLANTS","Primary Tumor Field",NA,"NO",637,"TUMOR FREE","Alive",NA,"TCGA-BG-A0M2-F19319","TCGA-BG-A0M2",1,"BG","A0M2","YES","C54.1","8380/3","C54.1","NO","YES",-22822,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",317,NA,NA,NA,"TUMOR FREE","NO",1,12,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33141545,31924155,2391708309,"764E2C89-1DEC-4E30-AED5-1A29B743B1B9.bw","976bb47a-d999-4e24-ad08-452fea73c846","764e2c89-1dec-4e30-aed5-1a29b743b1b9","2016-08-05T08:43:28.568393-05:00","UNCID_2215016.75da1901-49d7-4a96-b195-6e38625898e5.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_3.tar.gz","eb7b11f7-3ffa-4d58-af10-e066e4f13806",2030672978,"Illumina GA","2030a7aecf3eb75e0d883fdda921bce5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:35:31.035373-05:00","2016-05-03T11:17:14.882251-05:00","eb7b11f7-3ffa-4d58-af10-e066e4f13806_analysis.xml","b49813150f3462e308fc01cb6e24e023","4df2cf04-8de4-4bcb-bd63-919d8889be66",2122,"2016-09-29T23:45:14.769551-05:00","eb7b11f7-3ffa-4d58-af10-e066e4f13806_experiment.xml","24ac386337ac7a64bead64a5967a48a4","e895d545-d684-4047-a5ee-c359b62002cd",2256,"2016-09-29T20:03:36.980969-05:00","eb7b11f7-3ffa-4d58-af10-e066e4f13806_run.xml","a456f7facd5e3b3b0b3c0dcc2d419b00","5f4898ec-c09e-46d8-9ff2-4b458a911894",345,"2016-09-08T11:11:30.089891-05:00","TCGA-A5-A0GM","2016-09-02T18:54:11.979238-05:00","female","TCGA-A5-A0GM_demographic",1953,"white","2bb9d677-ca90-5a3c-a8d6-6962e1ecaa7e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GM_diagnosis","not reported",19452,"alive","8380/3",NA,1841,"582dc06e-79d4-52fb-b0a2-11597a992790","c54.1",-19452,"TCGA-A5-A0GM_treatment","84cd1149-7f47-5e2c-a7b9-0d3946c006e8","01","true","TCGA-A5-A0GM-01A",NA,"a0eccb29-0485-459a-a881-9bb5c59f4371",FALSE,"4AAFF034-45D3-4F4F-A283-262BA641D03A","Primary Tumor",NA,1518,360,NA,1275609600,"11",30,"TCGA-A5-A0GM-01A-11",85,90,0,0,10,5,0,0,"2016-09-08T11:11:30.089891-05:00","2016-09-08T11:11:30.089891-05:00",1,1,0,0,"TOP","BOTTOM",0,0,"a5b795a0-0503-4fb6-af85-c632897dd867","b94b737c-2623-4a9b-9fa0-d8d2aa5c337d","TCGA-A5-A0GM-01A-01-TSA","TCGA-A5-A0GM-01A-01-BSA",90,95,"a390c44f-ea7b-474b-a2cc-5e8e90161856","RNA","TCGA-A5-A0GM-01A-11R","f30238a6-ff6b-4800-98f7-019a4eb596c0",1.79,0.16,"UV Spec","R","23","TCGA-A5-A0GM-01A-11R-A040-07","75da1901-49d7-4a96-b195-6e38625898e5",0.16,NA,97,37.890625,160,"ec2c4d69-801b-5580-adab-94284a87cacc","TCGA-A5-A0GM_exposure","UNCID_2215016.75da1901-49d7-4a96-b195-6e38625898e5.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_3.tar.gz","2013-10-03T23:06:04.000Z","2013-10-03T23:18:02.000Z","EB7B11F7-3FFA-4D58-AF10-E066E4F13806","A0ECCB29-0485-459A-A881-9BB5C59F4371","Unaligned reads",2030672978,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","75DA1901-49D7-4A96-B195-6E38625898E5","University of North Carolina","5660747be4b0ec1099f8acf3","976BB47A-D999-4E24-AD08-452FEA73C846","Uterine Corpus Endometrial Carcinoma","TARGZ","A390C44F-EA7B-474B-A2CC-5E8E90161856","2013-10-03T23:18:02.000Z","F30238A6-FF6B-4800-98F7-019A4EB596C0","None","NO",1,NA,"Primary Tumor","Cedars Sinai",1518,"A390C44F-EA7B-474B-A2CC-5E8E90161856",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2245E2D9-A240-4577-A231-7034D705CF82.txt",360,"TCGA-A5-A0GM-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","A0ECCB29-0485-459A-A881-9BB5C59F4371",53,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2245E2D9-A240-4577-A231-7034D705CF82.txt","Alive",NA,"TCGA-A5-A0GM","NOT HISPANIC OR LATINO","7EFF3711-FC41-4273-B68F-C678C0D5A534",NA,1448,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"B94B737C-2623-4A9B-9FA0-D8D2AA5C337D","F30238A6-FF6B-4800-98F7-019A4EB596C0","TCGA-A5-A0GM-01A-11R-A041-13_mirna.bam","TCGA-A5-A0GM-01A-11",85,10,0,1,0,"TOP",0,0,"TCGA-A5-A0GM-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,NA,1448,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GM-F4928","TCGA-A5-A0GM",1,"A5","A0GM","YES","C54.1","8380/3","C54.1","NO","YES",-19452,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",1448,NA,NA,NA,"TUMOR FREE","NO",15,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2006,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33754602,32995770,2474534153,"47F6E197-7164-4289-95B5-8FD305A13B4C.bw","9a599f57-0e8d-4e1f-a181-791f5fdeadb7","47f6e197-7164-4289-95b5-8fd305a13b4c","2016-08-06T23:32:03.762287-05:00","UNCID_2209887.7a487d4e-9e11-4adc-86a1-cf6a7bde4f67.110420_UNC6-RDR300211_00096_FC_634WMAAXX_4.tar.gz","c8ea33c2-2523-4c78-980f-e6da616c4553",2250111264,"Illumina GA","81b6a3e88c2ad5131a39a738045b1d2f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:38:11.042084-05:00","2016-05-03T11:15:47.414649-05:00","c8ea33c2-2523-4c78-980f-e6da616c4553_analysis.xml","fa917c284ef0cb456a8fe6144b01417d","7458e601-2568-4582-a397-f91678152ad2",2121,"2016-10-07T16:38:21.209958-05:00","c8ea33c2-2523-4c78-980f-e6da616c4553_experiment.xml","c502d3fbffd1cd99521d2bed9ba75a4e","aeb406df-804a-49de-934f-22686eb240c9",2257,"2016-09-29T21:47:26.940976-05:00","c8ea33c2-2523-4c78-980f-e6da616c4553_run.xml","1f5ea87e0a442a2a2b9f4d651556f252","9f6e5578-eed1-4e32-ad30-4bc63067f293",347,"2016-09-08T11:03:13.866881-05:00","TCGA-D1-A169","2016-09-02T18:50:11.575416-05:00","female","TCGA-D1-A169_demographic",1945,"white","32f9bc7f-6bbe-55fb-8c70-28e7cd114d27","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A169_diagnosis","not reported",23238,"alive","8380/3",NA,1135,"6475596b-d57b-55b5-add0-768e2e451294","c54.1",-23238,"TCGA-D1-A169_treatment","a4461901-15be-5e89-932b-23db942c34f5","01","false","TCGA-D1-A169-01A",NA,"9b36f264-55c3-4e08-a151-4b356871520c",FALSE,"F7B4C0DC-2259-4A0A-81D3-E145EFA91279","Primary Tumor",NA,800,180,NA,1293062400,"11",30,"TCGA-D1-A169-01A-11",70,NA,6,NA,0,NA,30,NA,"2016-09-08T11:03:13.866881-05:00",NA,4,NA,2,NA,"TOP",NA,20,NA,"9764e8c0-c8a3-4d29-b8a2-44beaf1a2734",NA,"TCGA-D1-A169-01A-01-TS1",NA,50,NA,"6f3936d6-069a-4fdd-9595-6028f9857de7","RNA","TCGA-D1-A169-01A-11R","191032f1-b4a7-4cf5-b7c1-df53d0d39278",1.83,0.16,"UV Spec","R","23","TCGA-D1-A169-01A-11R-A12I-07","7a487d4e-9e11-4adc-86a1-cf6a7bde4f67",0.16,NA,102,35.2941176470588,170,"084bdc25-0423-5828-921a-b697e2467bea","TCGA-D1-A169_exposure","UNCID_2209887.7a487d4e-9e11-4adc-86a1-cf6a7bde4f67.110420_UNC6-RDR300211_00096_FC_634WMAAXX_4.tar.gz","2013-10-02T00:01:03.000Z","2013-10-02T00:14:03.000Z","C8EA33C2-2523-4C78-980F-E6DA616C4553","9B36F264-55C3-4E08-A151-4B356871520C","Unaligned reads",2250111264,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7A487D4E-9E11-4ADC-86A1-CF6A7BDE4F67","University of North Carolina","56607533e4b018727fe9fcd5","9A599F57-0E8D-4E1F-A181-791F5FDEADB7","Uterine Corpus Endometrial Carcinoma","TARGZ","6F3936D6-069A-4FDD-9595-6028F9857DE7","2013-10-02T00:14:03.000Z","191032F1-B4A7-4CF5-B7C1-DF53D0D39278","None","NO",1,NA,"Primary Tumor","Mayo Clinic",800,"6F3936D6-069A-4FDD-9595-6028F9857DE7",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.EED70D33-031C-4464-A665-1E4B090ECAE8.txt",180,"TCGA-D1-A169-01A",NA,"A64EB640-7430-4051-8C26-6BE57A93DDE5","TCGA",2008,NA,NA,"WITH TUMOR","9B36F264-55C3-4E08-A151-4B356871520C",63,"SCAUR_p_TCGA_b94_SNP_N_GenomeWideSNP_6_B02_755300.byallele.copynumber.data.txt","Alive",NA,"TCGA-D1-A169","NOT HISPANIC OR LATINO","FC03FCC6-C924-417C-A0B9-13E94813215D",NA,905,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"9764E8C0-C8A3-4D29-B8A2-44BEAF1A2734","4A8C393F-AC30-4110-8AD4-6334B222E555","TCGA-D1-A169-01A-11R-A12H-13_mirna.bam","TCGA-D1-A169-01A-11",70,0,6,4,30,"TOP",20,2,"TCGA-D1-A169-01A-01-TS1",50,"Taxol","Chemotherapy","TCGA-D1-A169-D18506",NA,NA,NA,NA,"YES",1135,"WITH TUMOR","Alive",NA,"TCGA-D1-A169-F18503","TCGA-D1-A169",1,"D1","A169","YES","C54.1","8380/3","C54.1","NO","YES",-23238,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",905,NA,NA,NA,"WITH TUMOR","NO",13,4,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2008,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1995",14,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32800439,32576713,2422389349,"57633DCE-DC21-42AE-82EB-81F532CE9840.bw","9aa8c2b4-db32-4899-bf0c-d578cb175e90","57633dce-dc21-42ae-82eb-81f532ce9840","2016-08-09T14:17:38.885134-05:00","UNCID_2214987.ca1e32b0-7daf-403e-a3b2-7cfd3948cedf.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_6.tar.gz","bfd4ba58-7a29-42fe-bbd2-6ebf90bd5347",2003501060,"Illumina GA","0b901e8cd4805e25b12ab7c2c4d49f94","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:39:41.756644-05:00","2016-05-03T11:17:14.882251-05:00","bfd4ba58-7a29-42fe-bbd2-6ebf90bd5347_analysis.xml","edd8054ecf1b098b68149aa40cf3b5de","754a9270-db83-4bcc-99ef-603ded991a2b",2122,"2016-09-29T22:48:45.189549-05:00","bfd4ba58-7a29-42fe-bbd2-6ebf90bd5347_experiment.xml","da09b714aa293f525ada8a101911bd7b","c56caf2b-8c87-4d9f-9b62-7a358b7a9343",2256,"2016-09-29T23:26:08.317211-05:00","bfd4ba58-7a29-42fe-bbd2-6ebf90bd5347_run.xml","8bbcb467a0b9ad2ddeb0a3c219cf7b47","dc8fc208-7b25-4dba-91ab-dce1252e001e",345,"2016-09-08T10:38:35.313011-05:00","TCGA-AP-A0L8","2016-09-02T18:54:25.007132-05:00","female","TCGA-AP-A0L8_demographic",1930,"black or african american","dc7a4a86-4e5d-5763-939f-1ef9f9df5bf5","not reported",2004,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0L8_diagnosis","not reported",25733,"dead","8441/3",1484,NA,"45d8de3a-d52a-5566-8697-68775330fbba","c54.1",-25733,"TCGA-AP-A0L8_treatment","d602a5df-060d-5d39-b2af-cd35f774b133","01","true","TCGA-AP-A0L8-01A",NA,"d1a7a58f-7a35-4a94-a337-051ae56ded00",FALSE,"A708C154-A635-4423-A1A0-BB1FC23D3613","Primary Tumor",NA,3510,110,NA,1278547200,"11",30,"TCGA-AP-A0L8-01A-11",70,70,0,0,30,30,0,0,"2016-09-08T10:38:35.313011-05:00","2016-09-08T10:38:35.313011-05:00",10,10,10,10,"TOP","BOTTOM",10,10,"e7ff33de-2622-4476-a2df-4240b06b8342","3bd0b305-fc91-4904-bb40-dc57f95ee394","TCGA-AP-A0L8-01A-01-TSA","TCGA-AP-A0L8-01A-01-BSA",60,60,"f6a521ef-9222-4b0b-8362-5412cf98d788","RNA","TCGA-AP-A0L8-01A-11R","ac56ffa1-aacf-4ca5-97eb-6a7b7834ae55",1.7,0.14,"UV Spec","R","23","TCGA-AP-A0L8-01A-11R-A040-07","ca1e32b0-7daf-403e-a3b2-7cfd3948cedf",0.14,NA,61,NA,NA,"183b7693-81b6-5a19-b7df-4f681073eff7","TCGA-AP-A0L8_exposure","UNCID_2214987.ca1e32b0-7daf-403e-a3b2-7cfd3948cedf.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_6.tar.gz","2013-10-03T22:46:05.000Z","2013-10-03T22:58:02.000Z","BFD4BA58-7A29-42FE-BBD2-6EBF90BD5347","D1A7A58F-7A35-4A94-A337-051AE56DED00","Unaligned reads",2003501060,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CA1E32B0-7DAF-403E-A3B2-7CFD3948CEDF","University of North Carolina","564a32eee4b0ef121817b9f0","9AA8C2B4-DB32-4899-BF0C-D578CB175E90","Uterine Corpus Endometrial Carcinoma","TARGZ","F6A521EF-9222-4B0B-8362-5412CF98D788","2013-10-03T22:58:02.000Z","AC56FFA1-AACF-4CA5-97EB-6A7B7834AE55","None","NO",1,NA,"Primary Tumor","MSKCC",3510,"F6A521EF-9222-4B0B-8362-5412CF98D788",NA,"AP","TCGA-AP-A0L8-01A-11R-A041-13_mirna.bam.bai",110,"TCGA-AP-A0L8-01A",NA,NA,"TCGA",2000,NA,NA,"WITH TUMOR","D1A7A58F-7A35-4A94-A337-051AE56DED00",70,"nationwidechildrens.org_clinical.TCGA-AP-A0L8.xml","Dead",1484,"TCGA-AP-A0L8",NA,"9C548905-00B0-4178-AA92-BD0F8A53016A",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",59,NA,"F166F1A1-7F35-4C2B-BEF6-4A0D55653B4A","BLACK OR AFRICAN AMERICAN",NA,11,30,"E7FF33DE-2622-4476-A2DF-4240B06B8342","AC56FFA1-AACF-4CA5-97EB-6A7B7834AE55","TCGA-AP-A0L8-01A-11R-A041-13_mirna.bam.bai","TCGA-AP-A0L8-01A-11",70,30,0,10,0,"BOTTOM",10,10,"TCGA-AP-A0L8-01A-01-BSA",60,NA,NA,NA,"TCGA-AP-A0L8-R3830","EXTERNAL BEAM","Distant Recurrence",NA,NA,NA,"WITH TUMOR","Dead",1484,"TCGA-AP-A0L8-F3824","TCGA-AP-A0L8",1,"AP","A0L8","YES","C54.1","8441/3","C54.1","NO","YES",-25733,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Dead",NA,1484,NA,NA,"WITH TUMOR","NO",23,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,70,2000,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32512721,32280800,2408656276,"F03405F8-125E-4B72-A3E0-5E1134322DDD.bw","9bc2f33f-3067-4000-bc8a-1c5bb671d101","f03405f8-125e-4b72-a3e0-5e1134322ddd","2016-08-09T14:12:45.687309-05:00","UNCID_2207448.6d1d9284-004e-4ed7-91dd-71f4fa919632.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_4.tar.gz","317427b6-f596-46c2-bbb9-77b6598d9363",2095531517,"Illumina GA","bc90156545887fab9bd4c34ac430de48","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:28:31.058856-05:00","2016-05-03T11:13:42.378529-05:00","317427b6-f596-46c2-bbb9-77b6598d9363_analysis.xml","e9b2affb713a712bfb58eb7833eef619","49a63c8a-13ef-4a03-bcbe-fbf63df93bd5",2121,"2016-08-13T06:03:18.348705-05:00","317427b6-f596-46c2-bbb9-77b6598d9363_experiment.xml","11669a49be3d1a4653f6b38391841deb","efb627b1-3d6c-4b38-ab11-d62bacbd3d6b",2257,"2016-09-29T22:31:44.137179-05:00","317427b6-f596-46c2-bbb9-77b6598d9363_run.xml","6dbbf88f0c1f8e26491d124fe742e275","bacfb6ac-06fd-4fd1-a37f-56473a687e52",347,"2016-09-08T11:04:35.500416-05:00","TCGA-D1-A165","2016-09-02T18:50:08.684553-05:00","female","TCGA-D1-A165_demographic",1944,"white","23755925-6968-50a9-b660-040e517fa61c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A165_diagnosis","not reported",23526,"alive","8380/3",NA,20,"faceeab7-76af-541e-a04d-6cfdbfa8b23f","c54.1",-23526,"TCGA-D1-A165_treatment","302c56de-3836-5d29-9e73-f4532f4af26d","01","false","TCGA-D1-A165-01A",NA,"ba3d9cb2-0d1c-4f3b-b1b8-a6dd4ac9adef",FALSE,"476F8219-DAAE-4DB3-BA31-C64AC24ACF65","Primary Tumor",NA,848,90,NA,1292976000,"11",30,"TCGA-D1-A165-01A-11",60,NA,1,NA,0,NA,40,NA,"2016-09-08T11:04:35.500416-05:00",NA,4,NA,0,NA,"TOP",NA,0,NA,"8d25db67-52cf-429e-9559-7753348377a0",NA,"TCGA-D1-A165-01A-01-TS1",NA,60,NA,"2ac57c15-170f-4001-8e25-24e2cd12d578","RNA","TCGA-D1-A165-01A-11R","569484fe-f7d0-47a9-babe-821255c84e9a",1.83,0.16,"UV Spec","R","23","TCGA-D1-A165-01A-11R-A12I-07","6d1d9284-004e-4ed7-91dd-71f4fa919632",0.16,NA,87,26.5559659351058,181,"9f540e38-64dd-56bb-8055-6d0aa6644ec9","TCGA-D1-A165_exposure","UNCID_2207448.6d1d9284-004e-4ed7-91dd-71f4fa919632.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_4.tar.gz","2013-09-30T01:13:08.000Z","2013-09-30T01:25:01.000Z","317427B6-F596-46C2-BBB9-77B6598D9363","BA3D9CB2-0D1C-4F3B-B1B8-A6DD4AC9ADEF","Unaligned reads",2095531517,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","6D1D9284-004E-4ED7-91DD-71F4FA919632","University of North Carolina","564a390be4b093830b688155","9BC2F33F-3067-4000-BC8A-1C5BB671D101","Uterine Corpus Endometrial Carcinoma","TARGZ","2AC57C15-170F-4001-8E25-24E2CD12D578","2013-09-30T01:25:01.000Z","569484FE-F7D0-47A9-BABE-821255C84E9A","None","NO",1,NA,"Primary Tumor","Mayo Clinic",848,"2AC57C15-170F-4001-8E25-24E2CD12D578",NA,"D1","6164647036_R03C02_Grn.idat",90,"TCGA-D1-A165-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","BA3D9CB2-0D1C-4F3B-B1B8-A6DD4AC9ADEF",64,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2DC14A00-8265-4379-A0FD-EB8E9E199B59.txt","Alive",NA,"TCGA-D1-A165","NOT HISPANIC OR LATINO","E602CF0E-5E4E-446E-AD9E-14721AAA587D",NA,20,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"8D25DB67-52CF-429E-9559-7753348377A0","75B52182-368F-4E25-B250-F68087466C7D","TCGA-D1-A165-01A-11D-A12J-09_IlluminaGA-DNASeq_exome.bam","TCGA-D1-A165-01A-11",60,0,1,4,40,"TOP",0,0,"TCGA-D1-A165-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,NA,"NO",20,"TUMOR FREE","Alive",NA,"TCGA-D1-A165-F18493","TCGA-D1-A165",1,"D1","A165","YES","C54.1","8380/3","C54.1","NO","YES",-23526,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",20,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1995",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
149584778,147900888,7064140016,"B80A74AB-A264-4396-93F8-FD976DBC1456.bw","9bce44a2-dcee-4d1a-a522-c2bcb9a8e025","b80a74ab-a264-4396-93f8-fd976dbc1456","2016-08-09T13:15:13.524328-05:00","UNCID_2173087.303036f4-8c7a-484d-8458-8db4803ad6b5.130509_UNC10-SN254_0462_AC232JACXX_4_TAGCTT.tar.gz","d93d3cc0-54aa-4f91-be51-9c933ad1b4a8",6816053773,"Illumina HiSeq","dfc9a36b085182930dfd156af5364f94","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:55:03.697344-05:00","2016-05-03T10:55:55.600288-05:00","d93d3cc0-54aa-4f91-be51-9c933ad1b4a8_analysis.xml","63d5a9c136925afd37b1940eb96b1204","5a1f4074-0c02-4d18-bc23-dd6da2b2406f",2122,"2016-08-28T12:31:01.767497-05:00","d93d3cc0-54aa-4f91-be51-9c933ad1b4a8_experiment.xml","b0a590b14a16b7f8b150c4f7b42a9460","6c1130aa-bd96-4d50-92b1-813ff8dd79b5",2431,"2016-09-29T23:07:15.360343-05:00","d93d3cc0-54aa-4f91-be51-9c933ad1b4a8_run.xml","4293ca1e10eb33fac95f64a85790557f","d0e33d7b-aec7-433d-8779-f2fadbbd94ad",354,"2016-09-08T11:41:00.651577-05:00","TCGA-A5-A1OH","2016-09-02T18:48:43.948851-05:00","female","TCGA-A5-A1OH_demographic",1924,"white","fa79ab3e-3e6a-53f8-8f85-fe4c34052427","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A1OH_diagnosis","not reported",31451,"alive","8441/3",NA,1105,"bf3d0dd5-2dd5-5d34-b02c-d776a26745ec","c54.1",-31451,"TCGA-A5-A1OH_treatment","3c9754da-2a89-52e4-bf33-cd1610f9c400","01","true","TCGA-A5-A1OH-01A",NA,"8bf78dab-9910-48eb-ab6a-fc92502a71a3",FALSE,"AAF1B591-1A0D-48D2-BF59-95B0D605950A","Primary Tumor",NA,358,200,NA,1331510400,"21",30,"TCGA-A5-A1OH-01A-21",95,NA,1,NA,0,NA,0,NA,"2016-09-08T11:41:00.651577-05:00",NA,1,NA,0,NA,"TOP",NA,10,NA,"04cdda6d-14a0-4d93-91f0-0f22fad9d006",NA,"TCGA-A5-A1OH-01A-02-MSB",NA,90,NA,"541448d3-09b6-415b-b37a-c5ce1d52aa89","RNA","TCGA-A5-A1OH-01A-21R","8b489c1e-4f51-4915-bae3-0c21171ad69c",1.86,0.16,"UV Spec","R","23","TCGA-A5-A1OH-01A-21R-A22K-07","303036f4-8c7a-484d-8458-8db4803ad6b5",0.16,NA,59,24.5577523413111,155,"0e1b9cf2-08f2-5a07-ae12-4286ce860f30","TCGA-A5-A1OH_exposure","UNCID_2173087.303036f4-8c7a-484d-8458-8db4803ad6b5.130509_UNC10-SN254_0462_AC232JACXX_4_TAGCTT.tar.gz","2013-09-09T09:56:09.000Z","2013-09-09T10:14:02.000Z","D93D3CC0-54AA-4F91-BE51-9C933AD1B4A8","8BF78DAB-9910-48EB-AB6A-FC92502A71A3","Unaligned reads",6816053773,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","303036F4-8C7A-484D-8458-8DB4803AD6B5","University of North Carolina","5660782be4b016715ab69c1c","9BCE44A2-DCEE-4D1A-A522-C2BCB9A8E025","Uterine Corpus Endometrial Carcinoma","TARGZ","541448D3-09B6-415B-B37A-C5CE1D52AA89","2013-09-09T10:14:02.000Z","8B489C1E-4F51-4915-BAE3-0C21171AD69C","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",358,"541448D3-09B6-415B-B37A-C5CE1D52AA89",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CCB3C579-1FC7-43B1-8DAB-85F26E151F35.txt",200,"TCGA-A5-A1OH-01A",NA,"F76236DB-DF2C-4184-B035-5CFE33C5FE59","TCGA",2010,"TCGA-A5-A1OH_NTE-1","Complete Remission/Response","TUMOR FREE","8BF78DAB-9910-48EB-AB6A-FC92502A71A3",86,"nationwidechildrens.org_clinical.TCGA-A5-A1OH.xml","Alive",NA,"TCGA-A5-A1OH",NA,"8B4D95DB-4858-44AF-A4F4-C0EE6D2B7903","NO",539,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"7723A336-3F31-47A0-A453-9065B6C5378C","WHITE",NA,21,30,"04CDDA6D-14A0-4D93-91F0-0F22FAD9D006","DE2D9D0C-2647-4A73-BE3D-F7AB3F1294D5","UNCID_2173087.303036f4-8c7a-484d-8458-8db4803ad6b5.130509_UNC10-SN254_0462_AC232JACXX_4_TAGCTT.tar.gz","TCGA-A5-A1OH-01A-21",95,0,1,1,0,"TOP",10,0,"TCGA-A5-A1OH-01A-02-MSB",90,"Carboplatin","Chemotherapy","TCGA-A5-A1OH-D34162","TCGA-A5-A1OH-R34163","Internal","Primary Tumor Field","TCGA-A5-A1OH-F41438_NTE-1","NO",1105,"TUMOR FREE","Alive",NA,"TCGA-A5-A1OH-F41438","TCGA-A5-A1OH",1,"A5","A1OH","YES","C54.1","8441/3","C54.1","NO","YES",-31451,"FEMALE","WHITE",NA,"No","No","Alive",539,NA,"YES","YES","TUMOR FREE","YES",3,8,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,86,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
129174480,126919047,6058325088,"0E1705B5-F5D0-421B-9E6B-FAAA4CFEB386.bw","9becf65d-01f2-4e84-a256-106002e22526","0e1705b5-f5d0-421b-9e6b-faaa4cfeb386","2016-08-09T13:14:29.874968-05:00","UNCID_2173606.5359ca45-0d86-43b9-b318-adbee53c7381.130502_UNC12-SN629_0289_AC236KACXX_4_TAGCTT.tar.gz","48a7b730-053a-4891-b520-c47236afbdf5",6115184814,"Illumina HiSeq","b22f6471f1cdd34ffa95765c74d962d1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:35:55.794493-05:00","2016-05-03T10:55:55.610281-05:00","48a7b730-053a-4891-b520-c47236afbdf5_analysis.xml","c20a921f5ee932e86314d37a9e251364","bd683aab-88cf-45d6-8b52-13313f83760e",2123,"2016-09-29T19:45:47.396469-05:00","48a7b730-053a-4891-b520-c47236afbdf5_experiment.xml","aeb49ecffc082a1c842d829e7b98f1f6","54507215-8fff-40f5-9a9f-a0223762655e",2431,"2016-09-29T17:43:03.226434-05:00","48a7b730-053a-4891-b520-c47236afbdf5_run.xml","f8b002ee9e796e3a9f6d56b33299a405","07301db5-1850-469f-ad66-f64b04f95445",354,"2016-09-08T10:57:04.056688-05:00","TCGA-A5-A3LP","2016-09-02T18:48:45.272153-05:00","female","TCGA-A5-A3LP_demographic",1937,"white","ce8a91da-f81d-51b6-a2e5-82541798e6b9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A3LP_diagnosis","not reported",27131,"alive","8441/3",NA,455,"64e2a390-b639-56d8-89e6-dd4dadc1c92f","c54.1",-27131,"TCGA-A5-A3LP_treatment","63fe62b7-1e26-5fc5-a9cb-becaeac66d7b","01","true","TCGA-A5-A3LP-01A",NA,"6d328d5d-7225-437a-afb1-d293d2d45866",FALSE,"A20CDB07-D90C-42B7-AE0A-254E27C6153B","Primary Tumor",NA,111,150,NA,1326758400,"11",30,"TCGA-A5-A3LP-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T10:57:04.056688-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"6d75cf4c-8e78-40f4-ac55-ae210686d686",NA,"TCGA-A5-A3LP-01A-01-TSA",NA,100,NA,"82eb8e9a-e0f2-449e-b73a-25bfead99809","RNA","TCGA-A5-A3LP-01A-11R","4017dc76-46c6-4e5d-b024-aae649d1bd54",1.77,0.16,"UV Spec","R","23","TCGA-A5-A3LP-01A-11R-A22K-07","5359ca45-0d86-43b9-b318-adbee53c7381",0.16,NA,46,18.1954827736245,159,"6f5d8c98-d10d-586d-8959-eb9b0a49adbd","TCGA-A5-A3LP_exposure","UNCID_2173606.5359ca45-0d86-43b9-b318-adbee53c7381.130502_UNC12-SN629_0289_AC236KACXX_4_TAGCTT.tar.gz","2013-09-09T21:36:10.000Z","2013-09-09T21:57:02.000Z","48A7B730-053A-4891-B520-C47236AFBDF5","6D328D5D-7225-437A-AFB1-D293D2D45866","Unaligned reads",6115184814,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","5359CA45-0D86-43B9-B318-ADBEE53C7381","University of North Carolina","56607db8e4b018727fea3439","9BECF65D-01F2-4E84-A256-106002E22526","Uterine Corpus Endometrial Carcinoma","TARGZ","82EB8E9A-E0F2-449E-B73A-25BFEAD99809","2013-09-09T21:57:02.000Z","4017DC76-46C6-4E5D-B024-AAE649D1BD54","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",111,"82EB8E9A-E0F2-449E-B73A-25BFEAD99809",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.90E488D4-EABB-4A2B-9BA4-B669167D24A6.txt",150,"TCGA-A5-A3LP-01A",NA,"7628FE0F-F9AC-4382-B6F0-32D4DDA643CC","TCGA",2011,NA,NA,"TUMOR FREE","6D328D5D-7225-437A-AFB1-D293D2D45866",74,"nationwidechildrens.org_clinical.TCGA-A5-A3LP.xml","Alive",NA,"TCGA-A5-A3LP","NOT HISPANIC OR LATINO","B1A58CCB-837A-4F6F-BF95-B3CF6D7062B2",NA,230,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"6D75CF4C-8E78-40F4-AC55-AE210686D686","4017DC76-46C6-4E5D-B024-AAE649D1BD54","UNCID_2035011.5359ca45-0d86-43b9-b318-adbee53c7381.sorted_genome_alignments.bam","TCGA-A5-A3LP-01A-11",75,0,0,0,0,"TOP",0,0,"TCGA-A5-A3LP-01A-01-TSA",100,"Carboplatin","Chemotherapy","TCGA-A5-A3LP-D32261",NA,NA,NA,NA,"NO",230,"TUMOR FREE","Alive",NA,"TCGA-A5-A3LP-F32260","TCGA-A5-A3LP",1,"A5","A3LP","YES","C54.1","8441/3","C54.1","YES","NO",-27131,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",230,NA,NA,NA,"TUMOR FREE","NO",15,3,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,74,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
99835464,96941408,4573960679,"81A2D108-72B9-4397-AADE-80FB5DC2354E.bw","9cc1b44a-ac26-408d-b12b-084e982ccadf","81a2d108-72b9-4397-aade-80fb5dc2354e","2016-08-09T13:14:51.730301-05:00","UNCID_2173032.b774f929-57f2-4f5a-9080-82b390a7a7f9.130509_UNC10-SN254_0462_AC232JACXX_5_AGTCAA.tar.gz","12623220-d313-4bff-8015-5e5bd87ced32",4630970734,"Illumina HiSeq","ba5c7efe572aa74be69dcc3205c177ce","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:49:17.466968-05:00","2016-05-03T10:55:55.600288-05:00","12623220-d313-4bff-8015-5e5bd87ced32_analysis.xml","99504824065edf914ad9fb00c4595f67","eb04aabc-843c-412c-9639-3dbe1b9715ff",2123,"2016-09-29T22:58:17.473341-05:00","12623220-d313-4bff-8015-5e5bd87ced32_experiment.xml","47661f3118983fd97305b7b96a7b2f6d","cb416da5-28a5-4cdf-8db4-287aa18d6caf",2431,"2016-09-29T20:38:02.229692-05:00","12623220-d313-4bff-8015-5e5bd87ced32_run.xml","ae4cd368ab40387145b8c5e96cfbdaba","743f3ede-37c5-4fbc-a392-c8dd48ab1ea5",354,"2016-09-08T10:46:30.826255-05:00","TCGA-AX-A3G1","2016-09-02T18:49:12.777629-05:00","female","TCGA-AX-A3G1_demographic",1925,"white","1991506f-07bc-5bae-9fb7-10ef9fb7c2e4","not hispanic or latino",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3G1_diagnosis","not reported",31037,"dead","8380/3",624,NA,"96f53917-5907-5e68-b0b1-aee826e436dc","c54.1",-31037,"TCGA-AX-A3G1_treatment","c2cf532f-34f5-5000-8181-a48f52295b59","01","false","TCGA-AX-A3G1-01A",NA,"582513c5-474c-484e-ad98-811f0d4e07c6",FALSE,"AEAB9EBE-7BDA-45E4-B2D8-82680BE9B4D4","Primary Tumor",NA,765,40,NA,1322784000,"11",20,"TCGA-AX-A3G1-01A-11",92,NA,1,NA,0,NA,5,NA,"2016-09-08T10:46:30.826255-05:00",NA,3,NA,0,NA,"TOP",NA,2,NA,"0b0d8597-b264-488f-8532-f005dd88efd5",NA,"TCGA-AX-A3G1-01A-01-TS1",NA,93,NA,"d1c66cba-e954-4c86-83d2-1c0332e8ace3","RNA","TCGA-AX-A3G1-01A-11R","1b6b0c76-931e-4999-8faa-7269202a4cb5",1.77,0.16,"UV Spec","R","23","TCGA-AX-A3G1-01A-11R-A22K-07","b774f929-57f2-4f5a-9080-82b390a7a7f9",0.16,NA,61,23.828125,160,"c6e5d35f-8aa4-5eb4-80d7-d9b8f69b1aab","TCGA-AX-A3G1_exposure","UNCID_2173032.b774f929-57f2-4f5a-9080-82b390a7a7f9.130509_UNC10-SN254_0462_AC232JACXX_5_AGTCAA.tar.gz","2013-09-09T07:56:09.000Z","2013-09-09T08:10:01.000Z","12623220-D313-4BFF-8015-5E5BD87CED32","582513C5-474C-484E-AD98-811F0D4E07C6","Unaligned reads",4630970734,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","B774F929-57F2-4F5A-9080-82B390A7A7F9","University of North Carolina","564a403ee4b0298dd2c9f5d9","9CC1B44A-AC26-408D-B12B-084E982CCADF","Uterine Corpus Endometrial Carcinoma","TARGZ","D1C66CBA-E954-4C86-83D2-1C0332E8ACE3","2013-09-09T08:10:01.000Z","1B6B0C76-931E-4999-8FAA-7269202A4CB5","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",765,"D1C66CBA-E954-4C86-83D2-1C0332E8ACE3",NA,"AX","TCGA-AX-A3G1-01A-11R-A22I-13_mirna.bam",40,"TCGA-AX-A3G1-01A",NA,NA,"TCGA",2009,NA,NA,NA,"582513C5-474C-484E-AD98-811F0D4E07C6",84,"jhu-usc.edu_UCEC.HumanMethylation450.17.lvl-2.TCGA-AX-A3G1-01A-11D-A22B-05.txt","Dead",624,"TCGA-AX-A3G1","NOT HISPANIC OR LATINO","C24447E4-61EB-4C69-9453-F51ECC66AE54",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,20,"0B0D8597-B264-488F-8532-F005DD88EFD5","90DC6182-2494-4693-81A7-36C38773A2E3","TCGA-AX-A3G1-01A-11R-A22I-13_mirna.bam","TCGA-AX-A3G1-01A-11",92,0,1,3,5,"TOP",2,0,"TCGA-AX-A3G1-01A-01-TS1",93,NA,NA,NA,NA,NA,NA,NA,"NO",NA,NA,"Dead",624,"TCGA-AX-A3G1-F21258","TCGA-AX-A3G1",1,"AX","A3G1","YES","C54.1","8380/3","C54.1","NO","YES",-31037,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,624,NA,NA,NA,"NO",3,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,84,2009,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
23111402,22602845,1695699739,"B1608A00-9B83-4F1C-873E-EA0B99E453A4.bw","9cde90c8-2be0-4328-a032-ff1dc19e66fd","b1608a00-9b83-4f1c-873e-ea0b99e453a4","2016-08-09T14:15:53.295350-05:00","UNCID_2211139.a21894d9-a459-4dbd-b9de-6c39f6fc61c2.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_2.tar.gz","ea1e01a3-bdda-4009-9f28-99233c7101ef",1419487652,"Illumina GA","e50c5a4fce77a78a039c9b434bcca967","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:40:25.453535-05:00","2016-05-03T11:16:29.221188-05:00","ea1e01a3-bdda-4009-9f28-99233c7101ef_analysis.xml","a56102ac7866e3109cbab16684d9e169","75c1b0a6-a400-4cf6-aaeb-6a1e7043e2f8",2121,"2016-09-29T20:07:04.002422-05:00","ea1e01a3-bdda-4009-9f28-99233c7101ef_experiment.xml","4246813702401c34f3431803d7c3727c","615ce7e4-cabb-4ea0-a18f-e1ca67459bc0",2257,"2016-09-29T20:19:41.322865-05:00","ea1e01a3-bdda-4009-9f28-99233c7101ef_run.xml","7a73db4d24653e4915cba0dc532bbd31","69029631-fec2-40e4-9428-f51abc9b9ff3",347,"2016-09-08T10:58:43.541109-05:00","TCGA-BG-A0MG","2016-09-02T18:48:06.774017-05:00","female","TCGA-BG-A0MG_demographic",1934,"white","d8ac2c9f-ad6c-5280-8b9b-2851dbd4af1c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MG_diagnosis","not reported",26957,"alive","8380/3",NA,1477,"c8e5a50b-7533-55fc-b7f9-c9d246d65b2a","c54.1",-26957,"TCGA-BG-A0MG_treatment","72656f0e-d49d-5f08-82b1-99989496ddbe","01","true","TCGA-BG-A0MG-01A",NA,"96b6826d-8a4c-45f5-8cd3-b5988aa5fd0e",FALSE,"65A0B84A-72AD-42E2-B0DB-DA8D2BD54E9B","Primary Tumor",NA,980,240,NA,1279065600,"21",30,"TCGA-BG-A0MG-01A-21",65,85,1,1,10,0,10,5,"2016-09-08T10:58:43.541109-05:00","2016-09-08T10:58:43.541109-05:00",1,2,20,7,"BOTTOM","TOP",3,10,"37a03d5d-afc5-43a0-a6ab-132f9afc2e08","b8cadd5d-2b2d-479f-ba56-36dddbc6786b","TCGA-BG-A0MG-01A-02-BSB","TCGA-BG-A0MG-01A-02-TSB",77,85,"0115cd29-20f1-4f38-ac10-5238f6f0cf8d","RNA","TCGA-BG-A0MG-01A-21R","0c97c8b8-a458-4423-8111-b2b3f64111d0",1.94,0.15,"UV Spec","R","23","TCGA-BG-A0MG-01A-21R-A104-07","a21894d9-a459-4dbd-b9de-6c39f6fc61c2",0.15,NA,61,23.828125,160,"a32bd207-a734-54b7-b7f4-a3ceeb6f8ff6","TCGA-BG-A0MG_exposure","UNCID_2211139.a21894d9-a459-4dbd-b9de-6c39f6fc61c2.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_2.tar.gz","2013-10-02T21:01:03.000Z","2013-10-02T21:48:01.000Z","EA1E01A3-BDDA-4009-9F28-99233C7101EF","96B6826D-8A4C-45F5-8CD3-B5988AA5FD0E","Unaligned reads",1419487652,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A21894D9-A459-4DBD-B9DE-6C39F6FC61C2","University of North Carolina","56607a1ce4b0ec1099f8de62","9CDE90C8-2BE0-4328-A032-FF1DC19E66FD","Uterine Corpus Endometrial Carcinoma","TARGZ","0115CD29-20F1-4F38-AC10-5238F6F0CF8D","2013-10-02T21:48:01.000Z","0C97C8B8-A458-4423-8111-B2B3F64111D0","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",980,"0115CD29-20F1-4F38-AC10-5238F6F0CF8D",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.107D6429-EC36-4D65-9820-23FF2EACE5E9.txt",240,"TCGA-BG-A0MG-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","96B6826D-8A4C-45F5-8CD3-B5988AA5FD0E",73,"nationwidechildrens.org_clinical.TCGA-BG-A0MG.xml","Alive",NA,"TCGA-BG-A0MG","NOT HISPANIC OR LATINO","F0501075-109C-4D7D-A3ED-9E4233626110",NA,896,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,21,30,"B8CADD5D-2B2D-479F-BA56-36DDDBC6786B","EAD7074C-BAC1-4A40-82C2-B200265C24AD","TCGA-BG-A0MG-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_5_rg.sorted.bam","TCGA-BG-A0MG-01A-21",65,10,1,1,10,"BOTTOM",3,20,"TCGA-BG-A0MG-01A-02-BSB",77,NA,NA,NA,NA,NA,NA,NA,"NO",1477,"TUMOR FREE","Alive",NA,"TCGA-BG-A0MG-F19272","TCGA-BG-A0MG",1,"BG","A0MG","YES","C54.1","8380/3","C54.1","NO","YES",-26957,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",896,NA,NA,NA,"TUMOR FREE","NO",8,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2007,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
19097268,18455911,1380975694,"C4C7C112-555F-46D5-8D5D-411C7737A4C9.bw","9d84dff8-6c19-4881-93c6-56c98a3049b5","c4c7c112-555f-46d5-8d5d-411c7737a4c9","2016-08-09T14:03:57.989916-05:00","UNCID_2196801.0f659732-62d9-4b13-b4c4-cd6b231bdedb.120208_UNC2-RDR300275_00112_FC_64V42AAXX_5.tar.gz","e80800ea-5470-4c1f-bf7a-edd9a0e9d285",1284902990,"Illumina GA","1e134700fd4d0914016eec5cf11f3117","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:45:57.522867-05:00","2016-05-03T11:08:33.752363-05:00","e80800ea-5470-4c1f-bf7a-edd9a0e9d285_analysis.xml","941343bb3f975b3c3b838412c5b8bebd","793acd33-cfc4-4709-8fda-0fc49a145a4f",2121,"2016-09-29T18:19:58.909959-05:00","e80800ea-5470-4c1f-bf7a-edd9a0e9d285_experiment.xml","7b0fc2ae5a8f0fcd7e107e57c5605136","1e537c02-1cef-4317-b3b9-df7c10bba139",2257,"2016-09-30T00:19:27.521157-05:00","e80800ea-5470-4c1f-bf7a-edd9a0e9d285_run.xml","02706ea75111609f804d3a822938486e","fd9d7094-dd32-4d38-8197-a60e19a02027",347,"2016-09-08T10:47:46.479199-05:00","TCGA-AX-A2HA","2016-09-02T18:54:16.175787-05:00","female","TCGA-AX-A2HA_demographic",1970,"white","dbd03450-1805-5569-9589-3d0455324e64","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HA_diagnosis","not reported",13142,"alive","8380/3",NA,2475,"daae28ec-ef21-5f4d-9d8f-201866caca25","c54.1",-13142,"TCGA-AX-A2HA_treatment","9fc2141a-cb1f-52c6-a705-83396cfe0c7b","11","false","TCGA-AX-A2HA-11A",NA,"94bc7e3c-bfae-4148-8995-8ab104370a8f",FALSE,NA,"Solid Tissue Normal",NA,2188,100,NA,1308182400,"11",30,"TCGA-AX-A2HA-11A-11",0,NA,0,NA,99,NA,0,NA,"2016-09-08T10:47:46.479199-05:00",NA,1,NA,0,NA,"TOP",NA,1,NA,"39fd9b44-cd7d-42ab-ae80-90fa4b1402ab",NA,"TCGA-AX-A2HA-11A-01-TSA",NA,0,NA,"59e667ec-493b-4863-99ba-b44b0dfe757b","RNA","TCGA-AX-A2HA-11A-11R","01b3f072-daab-4c91-9bc3-f04e02ae90eb",2,0.18,"UV Spec","R","23","TCGA-AX-A2HA-11A-11R-A18M-07","0f659732-62d9-4b13-b4c4-cd6b231bdedb",0.18,NA,60,21.5138585105239,167,"6b0affe5-8f9e-57cc-814d-5edb7d7d1245","TCGA-AX-A2HA_exposure","UNCID_2196801.0f659732-62d9-4b13-b4c4-cd6b231bdedb.120208_UNC2-RDR300275_00112_FC_64V42AAXX_5.tar.gz","2013-09-23T22:31:04.000Z","2013-09-23T22:42:02.000Z","E80800EA-5470-4C1F-BF7A-EDD9A0E9D285","94BC7E3C-BFAE-4148-8995-8AB104370A8F","Unaligned reads",1284902990,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0F659732-62D9-4B13-B4C4-CD6B231BDEDB","University of North Carolina","566078cbe4b0ca319164edee","9D84DFF8-6C19-4881-93C6-56C98A3049B5","Uterine Corpus Endometrial Carcinoma","TARGZ","59E667EC-493B-4863-99BA-B44B0DFE757B","2013-09-23T22:42:02.000Z","01B3F072-DAAB-4C91-9BC3-F04E02AE90EB","United States","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",2188,"59E667EC-493B-4863-99BA-B44B0DFE757B",NA,"AX","TCGA-AX-A2HA-11A-11R-A18L-13_mirna.bam",100,"TCGA-AX-A2HA-11A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","94BC7E3C-BFAE-4148-8995-8AB104370A8F",35,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.91D657B3-74C5-4978-81F8-249127F92199.txt","Alive",NA,"TCGA-AX-A2HA",NA,"2D96E740-4342-4BB4-803C-1C54DD6DD2B9",NA,2090,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,30,"39FD9B44-CD7D-42AB-AE80-90FA4B1402AB","E0E1F4CA-8E41-40ED-A82A-0292290D591D","TCGA-AX-A2HA-11A-11R-A18L-13_mirna.bam","TCGA-AX-A2HA-11A-11",0,99,0,1,0,"TOP",1,0,"TCGA-AX-A2HA-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,"NO",2475,"TUMOR FREE","Alive",NA,"TCGA-AX-A2HA-F31721","TCGA-AX-A2HA",1,"AX","A2HA","YES","C54.1","8380/3","C54.1","NO","YES",-13142,"FEMALE","WHITE",NA,"No","No","Alive",2090,NA,NA,NA,"TUMOR FREE","NO",31,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,35,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32312199,30601583,2295114799,"805D5473-BF65-4BF0-B5C4-4A0335FA0B92.bw","9d84dff8-6c19-4881-93c6-56c98a3049b5","805d5473-bf65-4bf0-b5c4-4a0335fa0b92","2016-08-06T21:41:23.229484-05:00","UNCID_2196694.3df718d2-9089-4055-8190-adc218fd3216.120216_UNC2-RDR300275_00113_FC_650PDAAXX_3.tar.gz","e62109ae-fd07-49a4-b9f8-02dad61a9c07",2001838945,"Illumina GA","ecec383ffee892a0f5d1491d64665192","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:45:37.016655-05:00","2016-05-03T11:08:33.743897-05:00","e62109ae-fd07-49a4-b9f8-02dad61a9c07_analysis.xml","82c7894fa2472b6f17717ced13528d62","790a1534-139f-4c19-97aa-d44c2e433bb7",2121,"2016-09-29T20:29:02.099912-05:00","e62109ae-fd07-49a4-b9f8-02dad61a9c07_experiment.xml","1e23e7eb7f49fcfbf5e7e954b23a9edb","6ed30ec3-bccb-4b5f-959a-31f4251de9d4",2257,"2016-09-29T23:39:48.097533-05:00","e62109ae-fd07-49a4-b9f8-02dad61a9c07_run.xml","244cb4a6ae09c2fc8e4b85a72c398239","e5199ff5-7ac7-4747-834a-a89971de07d4",347,"2016-09-08T10:47:46.479199-05:00","TCGA-AX-A2HA","2016-09-02T18:54:16.175787-05:00","female","TCGA-AX-A2HA_demographic",1970,"white","dbd03450-1805-5569-9589-3d0455324e64","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HA_diagnosis","not reported",13142,"alive","8380/3",NA,2475,"daae28ec-ef21-5f4d-9d8f-201866caca25","c54.1",-13142,"TCGA-AX-A2HA_treatment","9fc2141a-cb1f-52c6-a705-83396cfe0c7b","01","false","TCGA-AX-A2HA-01A",NA,"76742cf8-a932-47bd-acf9-c507184e02c3",FALSE,"E44408C9-53DE-4FF7-8D8E-6BFAB24302C3","Primary Tumor",NA,2188,100,NA,1308182400,"12",20,"TCGA-AX-A2HA-01A-12",85,NA,0,NA,10,NA,7,NA,"2016-09-08T10:47:46.479199-05:00",NA,6,NA,0,NA,"TOP",NA,3,NA,"a2f0b4e7-4910-4be1-863e-32340ba709a0",NA,"TCGA-AX-A2HA-01A-01-TSA",NA,80,NA,"5ac36dca-91c2-4259-aa72-2c34be3e056a","RNA","TCGA-AX-A2HA-01A-12R","c06ffb0f-4e7b-405b-beca-d44c8ebd5f55",1.84,0.16,"UV Spec","R","23","TCGA-AX-A2HA-01A-12R-A18M-07","3df718d2-9089-4055-8190-adc218fd3216",0.16,NA,60,21.5138585105239,167,"6b0affe5-8f9e-57cc-814d-5edb7d7d1245","TCGA-AX-A2HA_exposure","UNCID_2196694.3df718d2-9089-4055-8190-adc218fd3216.120216_UNC2-RDR300275_00113_FC_650PDAAXX_3.tar.gz","2013-09-23T07:56:05.000Z","2013-09-23T20:08:01.000Z","E62109AE-FD07-49A4-B9F8-02DAD61A9C07","76742CF8-A932-47BD-ACF9-C507184E02C3","Unaligned reads",2001838945,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3DF718D2-9089-4055-8190-ADC218FD3216","University of North Carolina","564a3572e4b093830b675d4e","9D84DFF8-6C19-4881-93C6-56C98A3049B5","Uterine Corpus Endometrial Carcinoma","TARGZ","5AC36DCA-91C2-4259-AA72-2C34BE3E056A","2013-09-23T20:08:01.000Z","C06FFB0F-4E7B-405B-BECA-D44C8EBD5F55","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",2188,"5AC36DCA-91C2-4259-AA72-2C34BE3E056A",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.91D657B3-74C5-4978-81F8-249127F92199.txt",100,"TCGA-AX-A2HA-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","94BC7E3C-BFAE-4148-8995-8AB104370A8F",35,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.91D657B3-74C5-4978-81F8-249127F92199.txt","Alive",NA,"TCGA-AX-A2HA",NA,"2D96E740-4342-4BB4-803C-1C54DD6DD2B9",NA,2090,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,12,20,"A2F0B4E7-4910-4BE1-863E-32340BA709A0","CD7A20D5-BE29-480E-A8B1-FA7F31182C55","UNCID_1613764.3df718d2-9089-4055-8190-adc218fd3216.sorted_genome_alignments.bam.bai","TCGA-AX-A2HA-01A-12",85,10,0,6,7,"TOP",3,0,"TCGA-AX-A2HA-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,"NO",2475,"TUMOR FREE","Alive",NA,"TCGA-AX-A2HA-F31721","TCGA-AX-A2HA",1,"AX","A2HA","YES","C54.1","8380/3","C54.1","NO","YES",-13142,"FEMALE","WHITE",NA,"No","No","Alive",2090,NA,NA,NA,"TUMOR FREE","NO",31,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,35,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
30976159,29639938,2220245497,"9CD9103A-214F-4C29-B766-97FACDEC946F.bw","9da5ecd0-a287-4e67-84b6-af9077a98009","9cd9103a-214f-4c29-b766-97facdec946f","2016-08-09T14:15:46.073484-05:00","UNCID_2211976.df97f5e0-e49a-4f34-911c-92502e7df570.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_8.tar.gz","fb84c64c-5a4f-419b-b824-6b2cebc2fc03",1947805236,"Illumina GA","3f8b37b1ab3c5ff288855848d581ee33","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:54:04.359648-05:00","2016-05-03T11:16:29.242391-05:00","fb84c64c-5a4f-419b-b824-6b2cebc2fc03_analysis.xml","512ab842638501c4a7636dbf3474d7d8","c8b918f3-9f18-469f-b196-3a1df01752ef",2120,"2016-08-27T18:05:42.853479-05:00","fb84c64c-5a4f-419b-b824-6b2cebc2fc03_experiment.xml","318b9457272bbfafa3fd6148a5ec5148","6f23361e-79a8-4a47-bb89-f271efe23ee2",2257,"2016-09-29T19:19:48.766681-05:00","fb84c64c-5a4f-419b-b824-6b2cebc2fc03_run.xml","de2f49ae3d494d7dfda4ee29ca541da1","4429fbf5-8719-4d59-a254-e60d5e7e37f4",347,"2016-09-08T11:37:18.642725-05:00","TCGA-D1-A101","2016-09-02T18:49:14.724755-05:00","female","TCGA-D1-A101_demographic",1949,"white","c049a25f-94b1-5f01-a13c-0ec35b371750","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A101_diagnosis","not reported",22078,"alive","8380/3",NA,53,"af7710fa-9154-5b82-bcfb-9c50c2290f88","c54.1",-22078,"TCGA-D1-A101_treatment","1a69ff9e-1d7b-5c93-9646-47a367eb1a29","01","false","TCGA-D1-A101-01A",NA,"34fcec04-7c8f-4964-83eb-c7f81c475c79",FALSE,"2D6287C8-9C22-4046-8F14-3886DDE62695","Primary Tumor",NA,349,150,NA,1288656000,"12",20,"TCGA-D1-A101-01A-12",80,60,0,0,0,35,0,0,"2016-09-08T11:37:18.642725-05:00","2016-09-08T11:37:18.642725-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"cef0d641-1d2e-4914-a704-58f70d356496","ce0d439c-7005-40d5-805e-b93f56928476","TCGA-D1-A101-01A-01-BSA","TCGA-D1-A101-01A-01-TSA",100,65,"bde9be50-18a3-48dc-a629-bb211c78af4c","RNA","TCGA-D1-A101-01A-12R","8b140cc5-5406-48b1-9520-8a63c6e3efdf",1.86,0.17,"UV Spec","R","23","TCGA-D1-A101-01A-12R-A10J-07","df97f5e0-e49a-4f34-911c-92502e7df570",0.17,NA,82,36.4444444444444,150,"b1a86196-2237-5995-9e8d-17da4b4c8765","TCGA-D1-A101_exposure","UNCID_2211976.df97f5e0-e49a-4f34-911c-92502e7df570.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_8.tar.gz","2013-10-03T04:31:04.000Z","2013-10-03T04:44:03.000Z","FB84C64C-5A4F-419B-B824-6B2CEBC2FC03","34FCEC04-7C8F-4964-83EB-C7F81C475C79","Unaligned reads",1947805236,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","DF97F5E0-E49A-4F34-911C-92502E7DF570","University of North Carolina","56607e3de4b0b37b3d992f4f","9DA5ECD0-A287-4E67-84B6-AF9077A98009","Uterine Corpus Endometrial Carcinoma","TARGZ","BDE9BE50-18A3-48DC-A629-BB211C78AF4C","2013-10-03T04:44:03.000Z","8B140CC5-5406-48B1-9520-8A63C6E3EFDF","None","NO",1,NA,"Primary Tumor","Mayo Clinic",349,"BDE9BE50-18A3-48DC-A629-BB211C78AF4C",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.AF6EEC20-46D9-4B44-989E-B36509847182.txt",150,"TCGA-D1-A101-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","72992899-8BCF-4F65-8E40-FBE7FA2CD3EE",60,"nationwidechildrens.org_clinical.TCGA-D1-A101.xml","Alive",NA,"TCGA-D1-A101","NOT HISPANIC OR LATINO","EB146824-102A-40B1-977D-05DD35E34109",NA,53,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,12,20,"CE0D439C-7005-40D5-805E-B93F56928476","8A3DC21A-EA0C-4F1C-B635-BA54F2777CC9","UNCID_340084.TCGA-D1-A101-01A-12R-A10J-07.110303_UNC3-RDR300156_00077_FC_62J3HAAXX.8.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-D1-A101-01A-12",80,0,0,0,0,"BOTTOM",0,0,"TCGA-D1-A101-01A-01-BSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",53,"TUMOR FREE","Alive",NA,"TCGA-D1-A101-F17752","TCGA-D1-A101",1,"D1","A101","YES","C54.1","8380/3","C54.1","NO","YES",-22078,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",53,NA,NA,NA,"TUMOR FREE","NO",8,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","RX",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
129323410,126559874,6038135625,"42CA7C91-F962-42B8-BF63-87DC50211EBC.bw","9ee944ef-4293-4228-b750-cc34ab388eb3","42ca7c91-f962-42b8-bf63-87dc50211ebc","2016-08-09T13:14:50.713047-05:00","UNCID_2173735.a1ba7666-0fb4-4fa6-8530-242d32ca3708.130502_UNC12-SN629_0289_AC236KACXX_2_GCCAAT.tar.gz","ffa235a0-928f-48ce-b657-25d12a3c8106",6269152064,"Illumina HiSeq","05b66f746734cdcd160462022f66191b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:18:48.753248-05:00","2016-05-03T10:56:47.870562-05:00","ffa235a0-928f-48ce-b657-25d12a3c8106_analysis.xml","08c25571bfefd1880f434f1ac3e10777","8dd5d06f-91f1-45d1-b601-e7ed8a9b1004",2123,"2016-09-29T20:17:29.145760-05:00","ffa235a0-928f-48ce-b657-25d12a3c8106_experiment.xml","1193e008bc6040a6235b9d9321436b41","67a9a811-f87c-4df3-9fd4-d4303bbd6881",2431,"2016-09-29T19:11:05.426078-05:00","ffa235a0-928f-48ce-b657-25d12a3c8106_run.xml","66d0a2f9ac268d48bc6a8ac302d103c1","3ea5f0e3-8b54-451d-88d8-e6ec4368245b",354,"2016-09-08T11:28:07.562795-05:00","TCGA-AJ-A3TW","2016-09-02T18:49:08.630888-05:00","female","TCGA-AJ-A3TW_demographic",1934,"white","561d660f-959e-5ee1-8989-14eebe9c71a9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3TW_diagnosis","not reported",28559,"alive","8441/3",NA,513,"2c526212-4581-593b-b288-6315a6fdab8f","c54.1",-28559,"TCGA-AJ-A3TW_treatment","23229ee4-af8d-5d34-8678-19aeb85322f8","01","false","TCGA-AJ-A3TW-01A",NA,"25c226fa-c084-4128-8b49-62f1d5538aa0",FALSE,"1271A645-AF29-453E-BEA8-420ECCD0DFDC","Primary Tumor",NA,71,230,NA,1334102400,"11",20,"TCGA-AJ-A3TW-01A-11",90,NA,1,NA,0,NA,0,NA,"2016-09-08T11:28:07.562795-05:00",NA,3,NA,0,NA,"TOP",NA,5,NA,"6e3b83cf-8516-46bf-a922-2b9a0bb5308f",NA,"TCGA-AJ-A3TW-01A-01-TS1",NA,95,NA,"0112d354-393a-47bb-8a41-1b0e944cea94","RNA","TCGA-AJ-A3TW-01A-11R","a3998157-26d8-4a18-818f-861694cd3ffb",2.02,0.17,"UV Spec","R","23","TCGA-AJ-A3TW-01A-11R-A22K-07","a1ba7666-0fb4-4fa6-8530-242d32ca3708",0.17,NA,55,21.484375,160,"d35d8a96-7e57-5400-a455-a2f5e91b03cf","TCGA-AJ-A3TW_exposure","UNCID_2173735.a1ba7666-0fb4-4fa6-8530-242d32ca3708.130502_UNC12-SN629_0289_AC236KACXX_2_GCCAAT.tar.gz","2013-09-09T22:56:10.000Z","2013-09-09T23:13:02.000Z","FFA235A0-928F-48CE-B657-25D12A3C8106","25C226FA-C084-4128-8B49-62F1D5538AA0","Unaligned reads",6269152064,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","A1BA7666-0FB4-4FA6-8530-242D32CA3708","University of North Carolina","56607ecbe4b0ec1099f8f27d","9EE944EF-4293-4228-B750-CC34AB388EB3","Uterine Corpus Endometrial Carcinoma","TARGZ","0112D354-393A-47BB-8A41-1B0E944CEA94","2013-09-09T23:13:02.000Z","A3998157-26D8-4A18-818F-861694CD3FFB","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",71,"0112D354-393A-47BB-8A41-1B0E944CEA94",NA,"AJ","TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_E10_1151440.ismpolish.data.txt",230,"TCGA-AJ-A3TW-01A",NA,NA,"TCGA",2012,"TCGA-AJ-A3TW_NTE-1",NA,"TUMOR FREE","9250E029-CD6F-4B4F-9CFA-62EC45FA8BF8",78,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B25EC080-F61A-41EB-85CE-40820BDCE279.txt","Alive",NA,"TCGA-AJ-A3TW","NOT HISPANIC OR LATINO","8B15887D-4BC4-4A0B-B4FE-504AA36ADB08","NO",52,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"A2D2ECEE-8029-4A7F-A73C-C028AF8E1388","WHITE",NA,11,20,"6E3B83CF-8516-46BF-A922-2B9A0BB5308F","A3998157-26D8-4A18-818F-861694CD3FFB","UNCID_2035342.a1ba7666-0fb4-4fa6-8530-242d32ca3708.sorted_genome_alignments.bam","TCGA-AJ-A3TW-01A-11",90,0,1,3,0,"TOP",5,0,"TCGA-AJ-A3TW-01A-01-TS1",95,NA,NA,NA,"TCGA-AJ-A3TW-R48780","External","Primary Tumor Field","TCGA-AJ-A3TW-F48779_NTE-1","NO",513,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3TW-F48779","TCGA-AJ-A3TW",1,"AJ","A3TW","YES","C54.1","8441/3","C54.1","YES","NO",-28559,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",52,NA,NA,NA,"TUMOR FREE","YES",6,8,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,78,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
130941462,128595904,6139354322,"4E8288D6-E7E7-42F2-9090-9F5EC2E52C44.bw","9f92080f-f6e0-42db-a02b-b3069664f6d0","4e8288d6-e7e7-42f2-9090-9f5ec2e52c44","2016-08-09T13:14:19.434516-05:00","UNCID_2173395.02446b95-1e3f-474b-8123-f49117f58893.130502_UNC12-SN629_0289_AC236KACXX_7_GTGGCC.tar.gz","89f35e16-b6b9-45d7-b9bf-e1949c655de1",6271903528,"Illumina HiSeq","ca573db7689098b4662748f75dcc3e11","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:19:25.194418-05:00","2016-05-03T10:55:55.610281-05:00","89f35e16-b6b9-45d7-b9bf-e1949c655de1_analysis.xml","f8a7677103c2cfdb197ea4eb1726a1cc","8e2fa592-277c-4ce5-ac67-d1de0dde3a70",2123,"2016-09-29T19:36:13.988362-05:00","89f35e16-b6b9-45d7-b9bf-e1949c655de1_experiment.xml","f992184baefc7f1f6f0da64025326cc3","4e60476d-6bb1-42d9-b574-b3f0f7b775ed",2431,"2016-09-29T23:28:38.069370-05:00","89f35e16-b6b9-45d7-b9bf-e1949c655de1_run.xml","591f270b01fd5c79638bec4032cfb086","de19baba-15ff-49b6-9e81-8c39ba54fdad",354,"2016-09-08T10:41:33.311551-05:00","TCGA-BG-A3PP","2016-09-02T18:49:22.603921-05:00","female","TCGA-BG-A3PP_demographic",1929,"white","190653c3-b629-5caf-8cad-8a6dfc4b62f9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A3PP_diagnosis","not reported",30227,"alive","8441/3",NA,681,"0facab6a-307d-5b57-af33-9afebf96a986","c54.1",-30227,"TCGA-BG-A3PP_treatment","b7e48094-6fa6-509e-b289-82ec1f865547","11","true","TCGA-BG-A3PP-11A",NA,"65b6c8b0-ae4a-410a-8e35-f7d8abeecfc6",FALSE,NA,"Solid Tissue Normal",NA,143,190,NA,1330905600,"11",30,"TCGA-BG-A3PP-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T10:41:33.311551-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"d8c90564-c3a9-4505-89f8-dbfde985884d",NA,"TCGA-BG-A3PP-11A-01-TSA",NA,0,NA,"8af9fefa-90ba-414c-a77f-eb3ffeb7caa7","RNA","TCGA-BG-A3PP-11A-11R","9216a218-3da2-469d-b2c0-7f18fc97ef1b",2.04,0.16,"UV Spec","R","23","TCGA-BG-A3PP-11A-11R-A22K-07","02446b95-1e3f-474b-8123-f49117f58893",0.16,NA,NA,NA,NA,"bbd5e0eb-5769-510a-ba7f-0a38d9fea1da","TCGA-BG-A3PP_exposure","UNCID_2173395.02446b95-1e3f-474b-8123-f49117f58893.130502_UNC12-SN629_0289_AC236KACXX_7_GTGGCC.tar.gz","2013-09-09T18:16:11.000Z","2013-09-09T18:31:01.000Z","89F35E16-B6B9-45D7-B9BF-E1949C655DE1","65B6C8B0-AE4A-410A-8E35-F7D8ABEECFC6","Unaligned reads",6271903528,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","02446B95-1E3F-474B-8123-F49117F58893","University of North Carolina","564a3b1be4b0ef12181a5945","9F92080F-F6E0-42DB-A02B-B3069664F6D0","Uterine Corpus Endometrial Carcinoma","TARGZ","8AF9FEFA-90BA-414C-A77F-EB3FFEB7CAA7","2013-09-09T18:31:01.000Z","9216A218-3DA2-469D-B2C0-7F18FC97EF1B","United States","NO",11,NA,"Solid Tissue Normal","University of Pittsburgh",143,"8AF9FEFA-90BA-414C-A77F-EB3FFEB7CAA7",NA,"BG","TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_C03_1151298.CEL",190,"TCGA-BG-A3PP-11A",NA,"A9469417-2AD1-4220-92EB-AEAEC9FCA5A0","TCGA",2011,NA,NA,"TUMOR FREE","B3533E99-9A5D-46A5-8D7E-D1B6192D5EDD",82,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.1EFCFA38-5D77-420A-A635-9657E138099C.txt","Alive",NA,"TCGA-BG-A3PP","NOT HISPANIC OR LATINO","1D733009-2D5B-408F-954E-B08633C7260D",NA,207,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"46647FD3-32DB-4B36-946C-57F7B3469596","WHITE",NA,11,30,"D8C90564-C3A9-4505-89F8-DBFDE985884D","4C1B255F-051F-4657-B1D6-226A4A99913F","TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_C03_1151298.CEL","TCGA-BG-A3PP-11A-11",0,100,0,1,0,"TOP",0,0,"TCGA-BG-A3PP-11A-01-TSA",0,"Taxol","Chemotherapy","TCGA-BG-A3PP-D33394","TCGA-BG-A3PP-R57828","External","Primary Tumor Field","TCGA-BG-A3PP-F57825_NTE-1","YES",681,"WITH TUMOR","Alive",NA,"TCGA-BG-A3PP-F57825","TCGA-BG-A3PP",1,"BG","A3PP","YES","C54.1","8441/3","C54.1","YES","NO",-30227,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",207,NA,NA,NA,"TUMOR FREE","NO",2,7,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,82,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
108013644,105934021,5055893278,"4DCEC4AC-4B50-4AA9-AD1B-FFE04C70EBE7.bw","9f92080f-f6e0-42db-a02b-b3069664f6d0","4dcec4ac-4b50-4aa9-ad1b-ffe04c70ebe7","2016-08-04T19:47:29.831375-05:00","UNCID_2173576.5ece050b-b22d-44b9-b920-257a351b5602.130502_UNC12-SN629_0289_AC236KACXX_4_CTTGTA.tar.gz","176a52c8-30d8-4fbb-a41d-9a706474eeb0",5112949267,"Illumina HiSeq","ac4315bc62d96a5770c1035d513fe633","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:23:40.303928-05:00","2016-05-03T10:55:55.610281-05:00","176a52c8-30d8-4fbb-a41d-9a706474eeb0_analysis.xml","59c871bc3fe76cb662a9097dfce57e86","20b02b16-5f1d-499e-83d7-77c9e709e55f",2123,"2016-09-29T22:48:44.371876-05:00","176a52c8-30d8-4fbb-a41d-9a706474eeb0_experiment.xml","5c3d131b2950437d4182013ac295328a","c56ab9d4-caac-4f52-98bb-dc25930f2aa4",2431,"2016-09-29T19:53:30.257056-05:00","176a52c8-30d8-4fbb-a41d-9a706474eeb0_run.xml","35ec4d3e7e6a1099bf05ef58e97b948a","5927512c-c192-4b9b-9821-dee045818960",354,"2016-09-08T10:41:33.311551-05:00","TCGA-BG-A3PP","2016-09-02T18:49:22.603921-05:00","female","TCGA-BG-A3PP_demographic",1929,"white","190653c3-b629-5caf-8cad-8a6dfc4b62f9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A3PP_diagnosis","not reported",30227,"alive","8441/3",NA,681,"0facab6a-307d-5b57-af33-9afebf96a986","c54.1",-30227,"TCGA-BG-A3PP_treatment","b7e48094-6fa6-509e-b289-82ec1f865547","01","true","TCGA-BG-A3PP-01A",NA,"b3533e99-9a5d-46a5-8d7e-d1b6192d5edd",FALSE,"728D12CF-B846-49B7-8B16-463460CAD5C0","Primary Tumor",NA,143,320,NA,1330905600,"11",30,"TCGA-BG-A3PP-01A-11",70,NA,0,NA,15,NA,0,NA,"2016-09-08T10:41:33.311551-05:00",NA,2,NA,0,NA,"TOP",NA,5,NA,"2e4ac653-5b8b-4fc1-ae25-82542db00b02",NA,"TCGA-BG-A3PP-01A-01-TSA",NA,80,NA,"40ee0b33-13ad-41e2-a083-174ce0ecd125","RNA","TCGA-BG-A3PP-01A-11R","4ec9612e-dcdf-4613-becc-162daaac0756",2.07,0.17,"UV Spec","R","23","TCGA-BG-A3PP-01A-11R-A22K-07","5ece050b-b22d-44b9-b920-257a351b5602",0.17,NA,NA,NA,NA,"bbd5e0eb-5769-510a-ba7f-0a38d9fea1da","TCGA-BG-A3PP_exposure","UNCID_2173576.5ece050b-b22d-44b9-b920-257a351b5602.130502_UNC12-SN629_0289_AC236KACXX_4_CTTGTA.tar.gz","2013-09-09T20:16:09.000Z","2013-09-09T20:30:01.000Z","176A52C8-30D8-4FBB-A41D-9A706474EEB0","B3533E99-9A5D-46A5-8D7E-D1B6192D5EDD","Unaligned reads",5112949267,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","5ECE050B-B22D-44B9-B920-257A351B5602","University of North Carolina","564a3b1ae4b0298dd2c84fa0","9F92080F-F6E0-42DB-A02B-B3069664F6D0","Uterine Corpus Endometrial Carcinoma","TARGZ","40EE0B33-13AD-41E2-A083-174CE0ECD125","2013-09-09T20:30:01.000Z","4EC9612E-DCDF-4613-BECC-162DAAAC0756","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",143,"40EE0B33-13AD-41E2-A083-174CE0ECD125",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.1EFCFA38-5D77-420A-A635-9657E138099C.txt",320,"TCGA-BG-A3PP-01A",NA,"A9469417-2AD1-4220-92EB-AEAEC9FCA5A0","TCGA",2011,NA,NA,"TUMOR FREE","B3533E99-9A5D-46A5-8D7E-D1B6192D5EDD",82,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.1EFCFA38-5D77-420A-A635-9657E138099C.txt","Alive",NA,"TCGA-BG-A3PP","NOT HISPANIC OR LATINO","1D733009-2D5B-408F-954E-B08633C7260D",NA,207,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"46647FD3-32DB-4B36-946C-57F7B3469596","WHITE",NA,11,30,"2E4AC653-5B8B-4FC1-AE25-82542DB00B02","31EFEE09-A5CF-4F83-A2D9-7E416FA4C3CA","UNCID_2034978.5ece050b-b22d-44b9-b920-257a351b5602.sorted_genome_alignments.bam","TCGA-BG-A3PP-01A-11",70,15,0,2,0,"TOP",5,0,"TCGA-BG-A3PP-01A-01-TSA",80,"Taxol","Chemotherapy","TCGA-BG-A3PP-D33394","TCGA-BG-A3PP-R57828","External","Primary Tumor Field","TCGA-BG-A3PP-F57825_NTE-1","YES",681,"WITH TUMOR","Alive",NA,"TCGA-BG-A3PP-F57825","TCGA-BG-A3PP",1,"BG","A3PP","YES","C54.1","8441/3","C54.1","YES","NO",-30227,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",207,NA,NA,NA,"TUMOR FREE","NO",2,7,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,82,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
146800664,144762735,6912967883,"227776D9-56FD-49EC-8D5B-841433C0D2E4.bw","9fcbef9e-2cca-4033-b574-daab2a42198b","227776d9-56fd-49ec-8d5b-841433c0d2e4","2016-08-09T13:14:12.782006-05:00","UNCID_2173342.5ab8bc7b-9e70-426f-8f84-d8c691440e98.130502_UNC12-SN629_0289_AC236KACXX_8_ATTCCT.tar.gz","381048de-fba0-4a49-a7e7-1dea887d9c9f",6920202947,"Illumina HiSeq","20fb92c96c78e889606d3aba57c57b8e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:39:20.932364-05:00","2016-05-03T10:55:55.610281-05:00","381048de-fba0-4a49-a7e7-1dea887d9c9f_analysis.xml","950b2e3a4d57a1ee4bff19552aa1527c","e4d0e361-c30b-49d4-8008-dd76b7096f7f",2123,"2016-09-29T18:04:44.431990-05:00","381048de-fba0-4a49-a7e7-1dea887d9c9f_experiment.xml","453c306da712c448c4a08ce71ee65dd5","15026881-b2e2-414e-a020-e4ee6f1eff48",2431,"2016-09-30T00:03:46.266741-05:00","381048de-fba0-4a49-a7e7-1dea887d9c9f_run.xml","1be573ada5111cded41c5058f836ecb0","f3ef6337-38a3-4d2c-a076-b08e7ad70eee",354,"2016-09-08T10:44:10.319230-05:00","TCGA-AJ-A3NF","2016-09-02T18:49:03.226865-05:00","female","TCGA-AJ-A3NF_demographic",1951,"white","606473b1-aaf5-50b5-9b3f-fd2fe9945ded","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3NF_diagnosis","not reported",22210,"alive","8441/3",NA,645,"369db65e-496b-506f-a46f-f41fc34ef5f8","c54.1",-22210,"TCGA-AJ-A3NF_treatment","14770bb3-5de0-5295-ab7f-e37a3314024e","01","false","TCGA-AJ-A3NF-01A",NA,"964ffd81-4b84-4045-abdc-63e79975158e",FALSE,"7003815D-F09A-46A0-8A8E-E0685A765788","Primary Tumor",NA,85,22,NA,1327449600,"11",22,"TCGA-AJ-A3NF-01A-11",60,NA,0,NA,0,NA,20,NA,"2016-09-08T10:44:10.319230-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"a33fc984-62b1-4ed7-b246-86b1e378ade9",NA,"TCGA-AJ-A3NF-01A-01-TS1",NA,80,NA,"11bd5099-7925-4a36-ae85-d32f4513efda","RNA","TCGA-AJ-A3NF-01A-11R","87b28814-67d5-4a0c-9997-881e28bf5b50",1.76,0.17,"UV Spec","R","23","TCGA-AJ-A3NF-01A-11R-A22K-07","5ab8bc7b-9e70-426f-8f84-d8c691440e98",0.17,NA,117,45.703125,160,"46caaf66-66d0-5206-9dfd-d6dbe99934ed","TCGA-AJ-A3NF_exposure","UNCID_2173342.5ab8bc7b-9e70-426f-8f84-d8c691440e98.130502_UNC12-SN629_0289_AC236KACXX_8_ATTCCT.tar.gz","2013-09-09T17:16:08.000Z","2013-09-09T17:38:01.000Z","381048DE-FBA0-4A49-A7E7-1DEA887D9C9F","964FFD81-4B84-4045-ABDC-63E79975158E","Unaligned reads",6920202947,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","5AB8BC7B-9E70-426F-8F84-D8C691440E98","University of North Carolina","564a3bc5e4b0ef12181a8f03","9FCBEF9E-2CCA-4033-B574-DAAB2A42198B","Uterine Corpus Endometrial Carcinoma","TARGZ","11BD5099-7925-4A36-AE85-D32F4513EFDA","2013-09-09T17:38:01.000Z","87B28814-67D5-4A0C-9997-881E28BF5B50","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",85,"11BD5099-7925-4A36-AE85-D32F4513EFDA",NA,"AJ","9450e24bf1fed1c0fc272ff7647722cd.bam.bai",22,"TCGA-AJ-A3NF-01A",NA,"AFBEC5F6-6F1D-4F21-A2B6-329845104DE5","TCGA",2011,NA,NA,NA,"964FFD81-4B84-4045-ABDC-63E79975158E",60,"nationwidechildrens.org_clinical.TCGA-AJ-A3NF.xml","Alive",NA,"TCGA-AJ-A3NF","NOT HISPANIC OR LATINO","44BCA84A-32FC-4C20-8393-CFB6E9B63FA3",NA,41,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"F5AD86C1-E9F2-4F55-873C-11CFECC39B25","WHITE",NA,11,22,"A33FC984-62B1-4ED7-B246-86B1E378ADE9","87B28814-67D5-4A0C-9997-881E28BF5B50","9450e24bf1fed1c0fc272ff7647722cd.bam.bai","TCGA-AJ-A3NF-01A-11",60,0,0,0,20,"TOP",0,0,"TCGA-AJ-A3NF-01A-01-TS1",80,"Chemo, NOS","Chemotherapy","TCGA-AJ-A3NF-D58991","TCGA-AJ-A3NF-R58990","Internal","Primary Tumor Field","TCGA-AJ-A3NF-F58988_NTE-1","NO",645,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3NF-F58988","TCGA-AJ-A3NF",1,"AJ","A3NF","YES","C54.1","8441/3","C54.1","YES","NO",-22210,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",41,NA,NA,NA,NA,"NO",17,4,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,60,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
146006120,143846130,6866366233,"9F4AAF98-06AC-480E-95DB-EC475663AF10.bw","a033fbea-7cd0-4e65-94c4-b54f2f80b895","9f4aaf98-06ac-480e-95db-ec475663af10","2016-08-05T11:02:08.324100-05:00","UNCID_2173729.3f24dcf1-9ec6-4ec4-9379-f9051151c639.130502_UNC12-SN629_0289_AC236KACXX_3_ACTTGA.tar.gz","0bd80ed4-0bd1-4029-b675-5d3cfd14e2f4",6920618190,"Illumina HiSeq","46850ee1c9ca14bc4404cee1de0f9ef7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:49:43.415338-05:00","2016-05-03T10:56:47.870562-05:00","0bd80ed4-0bd1-4029-b675-5d3cfd14e2f4_analysis.xml","7c40bbfb8ed17d4123e6f15eed440857","a0d95cd3-b007-47bf-9ce3-b6a38adcf5a3",2123,"2016-10-07T16:09:22.152605-05:00","0bd80ed4-0bd1-4029-b675-5d3cfd14e2f4_experiment.xml","8740598d90bafbadb03053a695f40769","fb2da276-a83c-4d3f-a04e-46c05a97841a",2431,"2016-09-29T18:43:20.401277-05:00","0bd80ed4-0bd1-4029-b675-5d3cfd14e2f4_run.xml","512f5c35e21eeb64f6aabf30cfce90d1","2d26012b-f846-4b9f-9e39-eba7ca54f6c5",354,"2016-09-08T10:44:18.805052-05:00","TCGA-AX-A3FV","2016-09-02T18:49:10.361816-05:00","female","TCGA-AX-A3FV_demographic",1947,"white","68eeb680-0c16-5cd2-ad66-077e1551696c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3FV_diagnosis","not reported",22752,"alive","8380/3",NA,-6,"29e797a7-4a65-573e-b3a7-8650ffca6ed2","c54.1",-22752,"TCGA-AX-A3FV_treatment","521523e4-353b-5e8d-bf02-62daef0086d1","01","false","TCGA-AX-A3FV-01A",NA,"1661922c-cd0a-4b1e-a9bf-4aefe10654a6",FALSE,"0D1601D0-E0F4-4DBA-91EA-62092FE8621F","Primary Tumor",NA,799,100,NA,1322784000,"11",30,"TCGA-AX-A3FV-01A-11",97,NA,0,NA,0,NA,5,NA,"2016-09-08T10:44:18.805052-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"ab1337a9-1fa9-433a-9b1a-73963cf61f32",NA,"TCGA-AX-A3FV-01A-01-TS1",NA,90,NA,"d5d650d9-74f9-409d-882d-3697b716be27","RNA","TCGA-AX-A3FV-01A-11R","15a8b76e-17b4-4d5a-9602-1f5b7bd806dd",1.86,0.17,"UV Spec","R","23","TCGA-AX-A3FV-01A-11R-A22K-07","3f24dcf1-9ec6-4ec4-9379-f9051151c639",0.17,NA,113,48.9092797783934,152,"a405c9ed-a2fe-52ee-9dd3-fe6c3c7fbeb8","TCGA-AX-A3FV_exposure","UNCID_2173729.3f24dcf1-9ec6-4ec4-9379-f9051151c639.130502_UNC12-SN629_0289_AC236KACXX_3_ACTTGA.tar.gz","2013-09-09T22:51:07.000Z","2013-09-09T23:06:02.000Z","0BD80ED4-0BD1-4029-B675-5D3CFD14E2F4","1661922C-CD0A-4B1E-A9BF-4AEFE10654A6","Unaligned reads",6920618190,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","3F24DCF1-9EC6-4EC4-9379-F9051151C639","University of North Carolina","564a3a4fe4b08c5d8691291c","A033FBEA-7CD0-4E65-94C4-B54F2F80B895","Uterine Corpus Endometrial Carcinoma","TARGZ","D5D650D9-74F9-409D-882D-3697B716BE27","2013-09-09T23:06:02.000Z","15A8B76E-17B4-4D5A-9602-1F5B7BD806DD","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",799,"D5D650D9-74F9-409D-882D-3697B716BE27",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C39A1125-5A35-4983-B5F7-290CBA28EE1A.txt",100,"TCGA-AX-A3FV-01A",NA,NA,"TCGA",2009,NA,NA,NA,"C240B255-BC26-40FB-863D-71BBC7613B97",62,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C39A1125-5A35-4983-B5F7-290CBA28EE1A.txt","Alive",NA,"TCGA-AX-A3FV","NOT HISPANIC OR LATINO","DF6F0906-85D3-4AE0-9A94-A1790EB95873",NA,-13,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"AB1337A9-1FA9-433A-9B1A-73963CF61F32","9C294FD4-3793-43E6-9036-0B6AD0920224","UNCID_2035751.3f24dcf1-9ec6-4ec4-9379-f9051151c639.sorted_genome_alignments.bam.bai","TCGA-AX-A3FV-01A-11",97,0,0,0,5,"TOP",5,0,"TCGA-AX-A3FV-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3FV-F58281_NTE-1",NA,-6,NA,"Alive",NA,"TCGA-AX-A3FV-F58281","TCGA-AX-A3FV",1,"AX","A3FV","YES","C54.1","8380/3","C54.1","NO","YES",-22752,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",-13,NA,NA,NA,NA,"NO",3,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
28869898,27972819,2089910658,"681D8638-84E1-43B9-93A9-3189560D8611.bw","a081da6f-51f3-4555-a6b8-736f8c6cda39","681d8638-84e1-43b9-93a9-3189560d8611","2016-08-05T00:19:53.627272-05:00","UNCID_2214932.e563cfb5-6904-45c6-acbb-ac96bfb9770b.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_1.tar.gz","b0f67163-9244-4a7f-860d-bcfd1292d665",1702561225,"Illumina GA","a39ff6331ab2ac65c5cd5e8dabd00676","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:51:38.318888-05:00","2016-05-03T11:17:14.905409-05:00","b0f67163-9244-4a7f-860d-bcfd1292d665_analysis.xml","6d85ea4327966e4b76b78a7f851c52db","c733adc7-22c4-4104-ab67-1d3e4b8aad2c",2120,"2016-08-28T22:26:34.637614-05:00","b0f67163-9244-4a7f-860d-bcfd1292d665_experiment.xml","c50915539c16fae2131e8831be8fba75","d659ca01-1a7a-4eb0-8fbf-a762a5c9a56b",2256,"2016-09-29T22:16:49.923216-05:00","b0f67163-9244-4a7f-860d-bcfd1292d665_run.xml","7af1fe9f1fd0d2a3a862d19b97500109","b1a8a207-632e-4ea1-84b4-5c67a9000d4b",345,"2016-09-08T11:14:46.306822-05:00","TCGA-AP-A0LO","2016-09-02T18:54:38.496277-05:00","female","TCGA-AP-A0LO_demographic",1960,"white","d07b1e85-ccc7-5cd4-9a87-b38f8ae021bb","not hispanic or latino",2007,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LO_diagnosis","not reported",16493,"dead","8380/3",1016,NA,"91213600-3f58-58a5-a12c-e90f4f1c9f90","c54.1",-16493,"TCGA-AP-A0LO_treatment","55c9dfc2-0933-5e78-9e9d-e719a12cafb9","01","true","TCGA-AP-A0LO-01A",NA,"9846d8f3-5b22-48e9-b972-a0fe9f509fb4",FALSE,"DC0116C2-788E-46F5-A4AC-115D857C1F85","Primary Tumor",NA,1894,140,NA,1278547200,"11",30,"TCGA-AP-A0LO-01A-11",90,80,0,0,0,0,0,0,"2016-09-08T11:14:46.306822-05:00","2016-09-08T11:14:46.306822-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"6075d8de-0bbb-491f-aff0-27bcd61f9ee1","a6b2e6d7-e482-4aa7-8084-5e1f043412cf","TCGA-AP-A0LO-01A-01-TSA","TCGA-AP-A0LO-01A-01-BSA",100,100,"b14abbed-fbac-4a91-a2ee-6fc4391a91b1","RNA","TCGA-AP-A0LO-01A-11R","5caa3eb1-f9f7-42ee-b8e8-d36f3349a0ac",2.02,0.14,"UV Spec","R","23","TCGA-AP-A0LO-01A-11R-A040-07","e563cfb5-6904-45c6-acbb-ac96bfb9770b",0.14,NA,67,26.171875,160,"b26ac3c8-78a3-5358-8dfb-d59ec0b6b9c7","TCGA-AP-A0LO_exposure","UNCID_2214932.e563cfb5-6904-45c6-acbb-ac96bfb9770b.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_1.tar.gz","2013-10-03T22:26:05.000Z","2013-10-03T22:38:03.000Z","B0F67163-9244-4A7F-860D-BCFD1292D665","9846D8F3-5B22-48E9-B972-A0FE9F509FB4","Unaligned reads",1702561225,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E563CFB5-6904-45C6-ACBB-AC96BFB9770B","University of North Carolina","56607b45e4b0ca319164faf5","A081DA6F-51F3-4555-A6B8-736F8C6CDA39","Uterine Corpus Endometrial Carcinoma","TARGZ","B14ABBED-FBAC-4A91-A2EE-6FC4391A91B1","2013-10-03T22:38:03.000Z","5CAA3EB1-F9F7-42EE-B8E8-D36F3349A0AC","None","NO",1,NA,"Primary Tumor","MSKCC",1894,"B14ABBED-FBAC-4A91-A2EE-6FC4391A91B1",NA,"AP","UNCID_2214932.e563cfb5-6904-45c6-acbb-ac96bfb9770b.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_1.tar.gz",140,"TCGA-AP-A0LO-01A",NA,NA,"TCGA",2005,NA,NA,"WITH TUMOR","FBFCB809-4EE6-4402-9FB8-F435BA7B43A1",45,"nationwidechildrens.org_clinical.TCGA-AP-A0LO.xml","Dead",1016,"TCGA-AP-A0LO","NOT HISPANIC OR LATINO","B4AD7DDD-80E7-4392-9632-C6FB87770EA2",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"C3D64425-6B52-4811-9D80-7415F7CECE73","WHITE",NA,11,30,"A6B2E6D7-E482-4AA7-8084-5E1F043412CF","7B714F0D-49E7-4740-9C0A-7337108EB73B","UNCID_2214932.e563cfb5-6904-45c6-acbb-ac96bfb9770b.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_1.tar.gz","TCGA-AP-A0LO-01A-11",90,0,0,0,0,"TOP",0,0,"TCGA-AP-A0LO-01A-01-TSA",100,NA,NA,NA,"TCGA-AP-A0LO-R4027","EXTERNAL BEAM","Local Recurrence",NA,NA,NA,"WITH TUMOR","Dead",1016,"TCGA-AP-A0LO-F4021","TCGA-AP-A0LO",1,"AP","A0LO","YES","C54.1","8380/3","C54.1","NO","YES",-16493,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,1016,NA,NA,"WITH TUMOR","NO",23,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,45,2005,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
142044858,139373350,6649539863,"1897D384-012E-4A19-A294-FE11EF21EFA3.bw","a12df3d7-c560-4e7d-a482-1025a6e5b465","1897d384-012e-4a19-a294-fe11ef21efa3","2016-08-25T03:39:17.881587-05:00","UNCID_2365068.051469db-cfa9-4907-ae54-13c060ad2958.140124_UNC12-SN629_0346_BC375JACXX_7_AGTTCC.tar.gz","08ee7277-9f52-49fe-a150-91031d5843dc",6487263763,"Illumina HiSeq","b3142ac8f37b4f31d1648f7a556cc06a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:41:53.047485-05:00","2016-05-03T11:39:34.521514-05:00","08ee7277-9f52-49fe-a150-91031d5843dc_analysis.xml","60f39b07e4e21d350ede44ee0c7cf714","0667e99b-9cd2-40c4-95c8-af4d007ca862",2124,"2016-09-29T18:37:43.187086-05:00","08ee7277-9f52-49fe-a150-91031d5843dc_experiment.xml","37b2401797964411a792c1fd65239e04","298bfb4a-bf35-4314-b762-9d5b15693c6b",2628,"2016-09-29T22:47:30.502331-05:00","08ee7277-9f52-49fe-a150-91031d5843dc_run.xml","09335615692cabe3f0fb270b5c624a19","c4a55206-2487-427d-9a86-84ec029ae17f",354,"2016-09-08T11:01:06.155650-05:00","TCGA-EY-A72D","2016-09-02T18:51:31.734014-05:00","female","TCGA-EY-A72D_demographic",1926,"black or african american","c8b4918b-961a-55ee-930c-51304d95033f","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A72D_diagnosis","not reported",31818,"alive","8380/3",NA,179,"c584ec2e-e218-50e5-845f-eb874468128a","c54.1",-31818,"TCGA-EY-A72D_treatment","49732276-e5ab-5fea-98fe-dfc0c5f4d4cc","01","false","TCGA-EY-A72D-01A",NA,"f661c070-cff5-4fdc-bb26-9f1a3ef2592a",FALSE,"6F2C081B-8D36-4DB4-9846-67DC1D3964E0","Primary Tumor",NA,120,340,NA,1375747200,"12",30,"TCGA-EY-A72D-01A-12",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:01:06.155650-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"6290a65c-ceca-4c42-879f-a11519e88993",NA,"TCGA-EY-A72D-01A-01-TS1",NA,80,NA,"77033bbb-7b69-45c4-8488-76657dba00eb","RNA","TCGA-EY-A72D-01A-12R","4ea9fa37-e9c5-4f7b-a0e1-dbf4ade86bc5",1.9,0.17,"UV Spec","R","23","TCGA-EY-A72D-01A-12R-A34R-07","051469db-cfa9-4907-ae54-13c060ad2958",0.17,NA,106,40.3901844231062,162,"1efc26d0-50e5-5bb4-9d83-bc80d36cf7df","TCGA-EY-A72D_exposure","UNCID_2365068.051469db-cfa9-4907-ae54-13c060ad2958.140124_UNC12-SN629_0346_BC375JACXX_7_AGTTCC.tar.gz","2014-03-05T13:33:04.000Z","2014-03-05T13:52:02.000Z","08EE7277-9F52-49FE-A150-91031D5843DC","F661C070-CFF5-4FDC-BB26-9F1A3EF2592A","Unaligned reads",6487263763,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","051469DB-CFA9-4907-AE54-13C060AD2958","University of North Carolina","56607efee4b016715ab6bc6c","A12DF3D7-C560-4E7D-A482-1025A6E5B465","Uterine Corpus Endometrial Carcinoma","TARGZ","77033BBB-7B69-45C4-8488-76657DBA00EB","2014-03-05T13:52:02.000Z","4EA9FA37-E9C5-4F7B-A0E1-DBF4ADE86BC5","United States","NO",1,NA,"Primary Tumor","University of North Carolina",120,"77033BBB-7B69-45C4-8488-76657DBA00EB",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C1F2DA4B-8F02-437C-9A58-E1E9E3362666.txt",340,"TCGA-EY-A72D-01A",NA,NA,"TCGA",2013,"TCGA-EY-A72D_NTE-1","Complete Remission/Response","TUMOR FREE","F661C070-CFF5-4FDC-BB26-9F1A3EF2592A",87,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C1F2DA4B-8F02-437C-9A58-E1E9E3362666.txt","Alive",NA,"TCGA-EY-A72D","NOT HISPANIC OR LATINO","BC505585-D076-4760-B4C7-DE0A326A95C1","NO",179,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",354,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,12,30,"6290A65C-CECA-4C42-879F-A11519E88993","60BEC394-CC15-488E-961C-6732EA820A6F","TCGA-EY-A72D-01A-12R-A34O-13_mirna.bam.bai","TCGA-EY-A72D-01A-12",80,0,20,40,10,"TOP",10,20,"TCGA-EY-A72D-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-EY-A72D-F63789_NTE-1","NO",179,NA,"Alive",NA,"TCGA-EY-A72D-F63789","TCGA-EY-A72D",1,"EY","A72D","YES","C54.1","8380/3","C54.1","YES","NO",-31818,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes","No","Alive",179,NA,"NO","NO","TUMOR FREE","YES",9,12,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,87,2013,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32307386,31570181,2355890021,"8772FB9B-8621-4693-8C35-63A39CA05955.bw","a1780432-860e-4bff-9b66-a1e25c0076fe","8772fb9b-8621-4693-8c35-63a39ca05955","2016-08-09T14:03:52.469642-05:00","UNCID_2196702.25dd0765-735c-4146-9551-cdfdd9213593.120216_UNC2-RDR300275_00113_FC_650PDAAXX_2.tar.gz","e80aa0a9-bc61-4bbf-bf02-ecb38f0b5c12",2018179610,"Illumina GA","8de2e6f3513babd755b15ef9f57d44a2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:57:49.270780-05:00","2016-05-03T11:08:33.743897-05:00","e80aa0a9-bc61-4bbf-bf02-ecb38f0b5c12_analysis.xml","ce8a1657f2c99d1fc2520ce9993b92b0","3651bb50-3c26-449a-bc08-f5b8dce199d5",2121,"2016-10-07T15:38:59.432848-05:00","e80aa0a9-bc61-4bbf-bf02-ecb38f0b5c12_experiment.xml","9d413f04a89c9b03f4055595a703c1e5","a9066277-1fee-4361-8ea9-8ac48e4a18c7",2257,"2016-09-29T21:39:25.694987-05:00","e80aa0a9-bc61-4bbf-bf02-ecb38f0b5c12_run.xml","0442bd810fe88496f4bbbe6d859b6892","9a707fb6-d590-4739-ba77-71e051d2dbd9",347,"2016-09-08T11:39:28.470731-05:00","TCGA-AX-A2H7","2016-09-02T18:54:15.529583-05:00","female","TCGA-AX-A2H7_demographic",1921,"white","c44cf1de-5a77-5fad-b61a-6878e3bdb55c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2H7_diagnosis","not reported",32100,"dead","8380/3",1241,1020,"bebfb9f5-f3ef-5aa7-a11f-2616dfdee4a0","c54.1",-32100,"TCGA-AX-A2H7_treatment","315b14aa-f4e7-5df3-9968-9be063f71479","01","false","TCGA-AX-A2H7-01A",NA,"7077ce1b-d224-4313-9d71-1a3eee54ffaf",FALSE,"76630DF8-2D08-4CF8-8B07-ACCE872B3ED1","Primary Tumor",NA,951,160,NA,1308182400,"12",30,"TCGA-AX-A2H7-01A-12",97,NA,1,NA,0,NA,5,NA,"2016-09-08T11:39:28.470731-05:00",NA,0,NA,0,NA,"TOP",NA,2,NA,"d5b7be92-43c9-408e-a25c-3aa2d9d5c4e0",NA,"TCGA-AX-A2H7-01A-01-TSA",NA,93,NA,"873200a2-04af-4fc5-a386-389aee4092ad","RNA","TCGA-AX-A2H7-01A-12R","b7857b18-8f2d-457b-b1c0-058c9c987b17",1.8,0.15,"UV Spec","R","23","TCGA-AX-A2H7-01A-12R-A18M-07","25dd0765-735c-4146-9551-cdfdd9213593",0.15,NA,60,26.3146353230121,151,"f3a96c85-baf7-5004-a921-1030ea0f6e49","TCGA-AX-A2H7_exposure","UNCID_2196702.25dd0765-735c-4146-9551-cdfdd9213593.120216_UNC2-RDR300275_00113_FC_650PDAAXX_2.tar.gz","2013-09-23T20:07:05.000Z","2013-09-23T20:20:02.000Z","E80AA0A9-BC61-4BBF-BF02-ECB38F0B5C12","7077CE1B-D224-4313-9D71-1A3EEE54FFAF","Unaligned reads",2018179610,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","25DD0765-735C-4146-9551-CDFDD9213593","University of North Carolina","5660755be4b0ec1099f8b87e","A1780432-860E-4BFF-9B66-A1E25C0076FE","Uterine Corpus Endometrial Carcinoma","TARGZ","873200A2-04AF-4FC5-A386-389AEE4092AD","2013-09-23T20:20:02.000Z","B7857B18-8F2D-457B-B1C0-058C9C987B17","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",951,"873200A2-04AF-4FC5-A386-389AEE4092AD",NA,"AX","UNCID_1613706.25dd0765-735c-4146-9551-cdfdd9213593.sorted_genome_alignments.bam.bai",160,"TCGA-AX-A2H7-01A",NA,NA,"TCGA",2008,NA,NA,NA,"E8858E3A-F7E0-4E71-875F-6273E5CB169D",87,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.808DF04C-E181-48B1-A9C5-0EB8617CC26F.txt","Alive",NA,"TCGA-AX-A2H7","NOT HISPANIC OR LATINO","F246F9DE-BDEA-4D1C-9A40-53472AA1DD2B",NA,1020,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,"8F5622F8-0B28-4F61-BB27-24C0E56D6055","WHITE",NA,12,30,"D5B7BE92-43C9-408E-A25C-3AA2D9D5C4E0","C274A178-EF8B-46E5-A751-0BF4CEB358F4","TCGA-AX-A2H7-01A-12R-A18L-13_mirna.bam","TCGA-AX-A2H7-01A-12",97,0,1,0,5,"TOP",2,0,"TCGA-AX-A2H7-01A-01-TSA",93,NA,NA,NA,"TCGA-AX-A2H7-R31706","IMPLANTS","Regional site",NA,"YES",NA,"WITH TUMOR","Dead",1241,"TCGA-AX-A2H7-F31704","TCGA-AX-A2H7",1,"AX","A2H7","YES","C54.1","8380/3","C54.1","NO","YES",-32100,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1020,NA,NA,NA,NA,"NO",28,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,87,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
26975183,26432786,1968506249,"563D8B4D-F2E5-4E81-87F3-9FAB655D4185.bw","a1a0177d-e670-4f2f-a99d-6f668a2f9e8a","563d8b4d-f2e5-4e81-87f3-9fab655d4185","2016-08-09T14:15:06.794192-05:00","UNCID_2210063.97ffaeb2-3ff9-41ff-9552-27f622469460.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_3.tar.gz","e84cae05-26fc-4611-8bf8-c8a9e757e135",1652273562,"Illumina GA","636e4f5d0f1652b3d9e3b5695d63272c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:09:10.593774-05:00","2016-05-03T11:15:47.403263-05:00","e84cae05-26fc-4611-8bf8-c8a9e757e135_analysis.xml","e9069f32555baa2c6198070d3cc98558","acefee9f-0c6d-4cee-baaf-0a16be61d6e6",2121,"2016-08-28T17:43:43.648361-05:00","e84cae05-26fc-4611-8bf8-c8a9e757e135_experiment.xml","a7e46a24a9711db8d275e3e5285cb250","8da52b66-a900-445c-bb69-cdc30d1caf0c",2257,"2016-09-29T19:02:06.457249-05:00","e84cae05-26fc-4611-8bf8-c8a9e757e135_run.xml","3e84105a6d5ab2603615876407772ea5","38f5c1e6-a95b-49d8-a7fe-8389fe5b93ea",347,"2016-09-08T10:39:25.765838-05:00","TCGA-BS-A0UA","2016-09-02T18:49:42.216195-05:00","female","TCGA-BS-A0UA_demographic",1936,"white","344d426f-68fd-5ffe-8808-4716cab3c3c5","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0UA_diagnosis","not reported",24872,"alive","8380/3",NA,3495,"2f04a3a1-b00b-5cfc-87b4-d4bd9b401c23","c54.1",-24872,"TCGA-BS-A0UA_treatment","223ec108-3a8d-593c-9628-338927ee526d","01","false","TCGA-BS-A0UA-01A",NA,"c72da85c-c6dc-4567-9db6-f15b044328dc",FALSE,"58DC7332-5100-408B-9A1E-F0282B013648","Primary Tumor",NA,2361,50,NA,1291334400,"11",30,"TCGA-BS-A0UA-01A-11",50,100,0,20,10,0,40,10,"2016-09-08T10:39:25.765838-05:00","2016-09-08T10:39:25.765838-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"8b842815-0a31-444f-84af-44ba42fd2488","612653f3-1d4d-4ec1-873a-750e661f3e49","TCGA-BS-A0UA-01A-01-MS1","TCGA-BS-A0UA-01A-01-TS1",50,90,"0f8eeb71-7011-4e42-8d70-cb0d10fd6688","RNA","TCGA-BS-A0UA-01A-11R","0d7b5a13-853e-41d0-a0dc-a43a4f78c0a3",1.82,0.14,"UV Spec","R","23","TCGA-BS-A0UA-01A-11R-A118-07","97ffaeb2-3ff9-41ff-9552-27f622469460",0.14,NA,64,27.7008310249307,152,"0b21253a-2093-5bec-beb4-b04f3a37a2f8","TCGA-BS-A0UA_exposure","UNCID_2210063.97ffaeb2-3ff9-41ff-9552-27f622469460.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_3.tar.gz","2013-10-02T05:07:04.000Z","2013-10-02T05:19:02.000Z","E84CAE05-26FC-4611-8BF8-C8A9E757E135","C72DA85C-C6DC-4567-9DB6-F15B044328DC","Unaligned reads",1652273562,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","97FFAEB2-3FF9-41FF-9552-27F622469460","University of North Carolina","564a3a4fe4b093830b68ea8c","A1A0177D-E670-4F2F-A99D-6F668A2F9E8A","Uterine Corpus Endometrial Carcinoma","TARGZ","0F8EEB71-7011-4E42-8D70-CB0D10FD6688","2013-10-02T05:19:02.000Z","0D7B5A13-853E-41D0-A0DC-A43A4F78C0A3","None","NO",1,NA,"Primary Tumor","University of Hawaii",2361,"0F8EEB71-7011-4E42-8D70-CB0D10FD6688",NA,"BS","CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_B07_735718.hg18.seg.txt",50,"TCGA-BS-A0UA-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","C72DA85C-C6DC-4567-9DB6-F15B044328DC",68,"nationwidechildrens.org_clinical.TCGA-BS-A0UA.xml","Alive",NA,"TCGA-BS-A0UA","NOT HISPANIC OR LATINO","5F0911D4-CF37-4194-8781-F329198E0D95",NA,2540,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"7637DB50-DFF0-443A-AAB2-3612786C8335","WHITE",NA,11,30,"8B842815-0A31-444F-84AF-44BA42FD2488","C8860BC6-4A93-4EE2-AB7D-19A1DD97CBA9","TCGA-BS-A0UA-01A-11R-A119-13_mirna.bam.bai","TCGA-BS-A0UA-01A-11",50,10,0,0,40,"BOTTOM",0,0,"TCGA-BS-A0UA-01A-01-MS1",50,NA,NA,NA,"TCGA-BS-A0UA-R16709","EXTERNAL BEAM","Local Recurrence",NA,"YES",2687,NA,"Alive",NA,"TCGA-BS-A0UA-F16708","TCGA-BS-A0UA",1,"BS","A0UA","YES","C54.1","8380/3","C54.1","NO","YES",-24872,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2540,NA,NA,NA,"TUMOR FREE","NO",25,3,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34264134,33884541,2557017417,"BD6DAD3D-2D5F-4560-9A4C-70D8A1D49732.bw","a28beb70-d309-45b8-a2ba-40558f3c8f4f","bd6dad3d-2d5f-4560-9a4c-70d8a1d49732","2016-08-09T14:02:28.031433-05:00","UNCID_2194419.d2a5585a-76fe-4e69-bf8a-36553bf282fb.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_5.tar.gz","bbc9e9b9-77e7-42de-b707-ba768bf33eee",2162330120,"Illumina GA","51469aec932f6a7e59c7b0e64541080c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:54:41.163015-05:00","2016-05-03T11:07:49.533431-05:00","bbc9e9b9-77e7-42de-b707-ba768bf33eee_analysis.xml","cbd968b381c3791bef3ec9a48e00e96e","7eabefa2-1ce5-40e8-a8e3-fa8d1cda45a1",2122,"2016-10-07T17:16:34.623728-05:00","bbc9e9b9-77e7-42de-b707-ba768bf33eee_experiment.xml","3cbcec55794b0f14f7c997213130a61f","6157c411-ad96-4ab6-8604-dcbf043de8d4",2258,"2016-09-29T23:22:25.988416-05:00","bbc9e9b9-77e7-42de-b707-ba768bf33eee_run.xml","3e9382d03d71eb5707b2f9f1bdc082ef","da3508e8-6b88-4a15-bb28-9c62d72d4be9",349,"2016-09-08T11:23:40.498426-05:00","TCGA-EY-A1GE","2016-09-02T18:51:52.278140-05:00","female","TCGA-EY-A1GE_demographic",1942,"white","06154713-6fc5-589b-8799-e904a7d3ebd6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GE_diagnosis","not reported",24667,"alive","8380/3",NA,741,"d67270f5-331a-59d8-bb5d-52d08dd818b2","c54.1",-24667,"TCGA-EY-A1GE_treatment","db85fdb2-ef42-5d45-9d98-f3bb3ffccbb5","01","false","TCGA-EY-A1GE-01A",NA,"8673d69f-530e-4c33-ba96-25cd44adea7b",FALSE,"432813D0-4B52-4941-940C-5725BCE4211A","Primary Tumor",NA,506,410,NA,1297900800,"11",30,"TCGA-EY-A1GE-01A-11",65,NA,0,NA,0,NA,0,NA,"2016-09-08T11:23:40.498426-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"dccc2cec-5058-49ab-ab08-1f05534b3682",NA,"TCGA-EY-A1GE-01A-01-TSA",NA,100,NA,"c989af12-0f87-4ee7-bbfa-05c465ed48e2","RNA","TCGA-EY-A1GE-01A-11R","0aa8a6be-52f8-46d9-b241-ac8c1037c541",1.83,0.15,"UV Spec","R","23","TCGA-EY-A1GE-01A-11R-A13S-07","d2a5585a-76fe-4e69-bf8a-36553bf282fb",0.15,NA,103,37.8328741965106,165,"f7e83fbd-79bb-568a-a87e-a013b168994d","TCGA-EY-A1GE_exposure","UNCID_2194419.d2a5585a-76fe-4e69-bf8a-36553bf282fb.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_5.tar.gz","2013-09-22T23:16:06.000Z","2013-09-22T23:30:01.000Z","BBC9E9B9-77E7-42DE-B707-BA768BF33EEE","8673D69F-530E-4C33-BA96-25CD44ADEA7B","Unaligned reads",2162330120,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","D2A5585A-76FE-4E69-BF8A-36553BF282FB","University of North Carolina","564a581be4b09c884b26c47a","A28BEB70-D309-45B8-A2BA-40558F3C8F4F","Uterine Corpus Endometrial Carcinoma","TARGZ","C989AF12-0F87-4EE7-BBFA-05C465ED48E2","2013-09-22T23:30:01.000Z","0AA8A6BE-52F8-46D9-B241-AC8C1037C541","United States","NO",1,NA,"Primary Tumor","University of North Carolina",506,"C989AF12-0F87-4EE7-BBFA-05C465ED48E2",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D3FF0165-3783-4EA1-83CF-9A312E3A8EC0.txt",410,"TCGA-EY-A1GE-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","995CE20E-A06E-4AA6-8778-DD7A7E55BD6D",67,"TCGA-EY-A1GE-01A-11R-A13R-13_mirna.bam.bai","Alive",NA,"TCGA-EY-A1GE","NOT HISPANIC OR LATINO","B83F6C93-CC5B-43EF-BFBD-8FDE8C04A342",NA,552,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"WHITE",NA,11,30,"DCCC2CEC-5058-49AB-AB08-1F05534B3682","DC68B977-D4C1-4A84-A3F3-E73064DA5A6A","TCGA-EY-A1GE-01A-11R-A13R-13_mirna.bam","TCGA-EY-A1GE-01A-11",65,0,0,0,0,"TOP",0,0,"TCGA-EY-A1GE-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",741,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GE-F19724","TCGA-EY-A1GE",1,"EY","A1GE","YES","C54.1","8380/3","C54.1","NO","YES",-24667,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",552,NA,NA,NA,"TUMOR FREE","NO",2,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31629982,27085799,2029836886,"9DD73399-620E-472C-8360-5565F91BBD3A.bw","a2a2dbda-d10c-49c4-86a8-61baf6160cda","9dd73399-620e-472c-8360-5565f91bbd3a","2016-08-05T07:47:55.145060-05:00","UNCID_2215005.53a3dd36-866d-4c44-9b79-b9f9564996b3.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_4.tar.gz","9de2b21a-e1bf-4f6e-b344-daa369490795",1915734552,"Illumina GA","acc33d224673312e558e9e1c74ffe293","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:43:04.598675-05:00","2016-05-03T11:17:14.882251-05:00","9de2b21a-e1bf-4f6e-b344-daa369490795_analysis.xml","35d309d8661f48803a5279a4331ce3c5","0732339e-21be-4540-b1fb-99169a7ee3bb",2122,"2016-10-07T16:15:28.952498-05:00","9de2b21a-e1bf-4f6e-b344-daa369490795_experiment.xml","791f19880daaf3299065ca14958d4506","b4d06a1b-8d43-4103-93e3-70cf16ea0437",2256,"2016-09-29T19:26:48.881359-05:00","9de2b21a-e1bf-4f6e-b344-daa369490795_run.xml","e81ae64c20ccd250058fb378336b7506","48945b91-88ad-4a85-ad0b-80fb57722ec8",345,"2016-09-09T16:07:47.188298-05:00","TCGA-A5-A0GN","2016-09-02T18:54:12.595852-05:00","female","TCGA-A5-A0GN_demographic",1941,"white","8dc88809-3a23-5cdf-8f5a-97e7747200b9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GN_diagnosis","not reported",24020,"alive","8380/3",NA,1841,"03e39652-cda1-5257-a00c-b2959370daf1","c54.1",-24020,"TCGA-A5-A0GN_treatment","ca7cd085-c216-51aa-b48b-5ade175dccfa","01","true","TCGA-A5-A0GN-01A",NA,"f6f9c40b-1e58-47a3-b518-9694fb5ff2cf",FALSE,"7A76BDC7-62D9-4A8D-AAEF-CECF9F819D58","Primary Tumor",NA,1354,340,NA,1275609600,"11",30,"TCGA-A5-A0GN-01A-11",80,80,0,0,0,0,0,0,"2016-09-09T16:07:47.188298-05:00","2016-09-09T16:07:47.188298-05:00",1,1,0,0,"TOP","BOTTOM",0,0,"0319e94a-cd9b-43b9-9426-9a7d1e647d7a","89bcb918-f801-44cd-a89c-aeeb7ccd3d92","TCGA-A5-A0GN-01A-01-TS1","TCGA-A5-A0GN-01A-01-BS1",100,100,"e15cd12c-7af8-429e-a042-368ad2350fed","RNA","TCGA-A5-A0GN-01A-11R","d8eed631-0535-4111-8bb3-5463b7229941",1.82,0.16,"UV Spec","R","23","TCGA-A5-A0GN-01A-11R-A040-07","53a3dd36-866d-4c44-9b79-b9f9564996b3",0.16,NA,68,25.2825698988697,164,"8fbb5109-7518-55ef-9c99-7edf90cf42be","TCGA-A5-A0GN_exposure","UNCID_2215005.53a3dd36-866d-4c44-9b79-b9f9564996b3.101103_UNC4-RDR3001561_00045_FC_62JATAAXX_4.tar.gz","2013-10-03T23:07:04.000Z","2013-10-03T23:19:03.000Z","9DE2B21A-E1BF-4F6E-B344-DAA369490795","F6F9C40B-1E58-47A3-B518-9694FB5FF2CF","Unaligned reads",1915734552,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","53A3DD36-866D-4C44-9B79-B9F9564996B3","University of North Carolina","564a3d99e4b0ef12181b23c6","A2A2DBDA-D10C-49C4-86A8-61BAF6160CDA","Uterine Corpus Endometrial Carcinoma","TARGZ","E15CD12C-7AF8-429E-A042-368AD2350FED","2013-10-03T23:19:03.000Z","D8EED631-0535-4111-8BB3-5463B7229941","None","NO",1,NA,"Primary Tumor","Cedars Sinai",1354,"E15CD12C-7AF8-429E-A042-368AD2350FED",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5622D6D1-DC8D-41EC-9088-6ADA060749C4.txt",340,"TCGA-A5-A0GN-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","F6F9C40B-1E58-47A3-B518-9694FB5FF2CF",65,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5622D6D1-DC8D-41EC-9088-6ADA060749C4.txt","Alive",NA,"TCGA-A5-A0GN","NOT HISPANIC OR LATINO","B320C129-6407-4F01-9E25-61C9336B5B7E",NA,1477,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"5582EC98-5525-41F6-8E13-2DA1ADD2BCB8","WHITE",NA,11,30,"89BCB918-F801-44CD-A89C-AEEB7CCD3D92","D8EED631-0535-4111-8BB3-5463B7229941","TCGA-A5-A0GN-01A-11R-A041-13_mirna.bam.bai","TCGA-A5-A0GN-01A-11",80,0,0,1,0,"BOTTOM",0,0,"TCGA-A5-A0GN-01A-01-BS1",100,NA,NA,NA,"TCGA-A5-A0GN-R3465","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",1841,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GN-F17151","TCGA-A5-A0GN",1,"A5","A0GN","YES","C54.1","8380/3","C54.1","NO","YES",-24020,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1477,NA,NA,NA,"TUMOR FREE","NO",13,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2006,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
158101290,155083839,7400190537,"767FE89E-E19F-4F56-A744-CB3C5CCC085B.bw","a31554af-d77a-4862-8aed-4581fb2bd877","767fe89e-e19f-4f56-a744-cb3c5ccc085b","2016-08-09T02:36:06.152507-05:00","UNCID_2173764.8b8048b4-fe60-45f4-97c5-662c45169334.130502_UNC12-SN629_0289_AC236KACXX_1_ATCACG.tar.gz","a8d5ebc3-0bf3-4a86-81b1-d1e049732146",7628516314,"Illumina HiSeq","d2849bc6443082b1e6a6641fe8c0de10","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:33:39.523184-05:00","2016-05-03T10:56:47.870562-05:00","a8d5ebc3-0bf3-4a86-81b1-d1e049732146_analysis.xml","36438200736ba16ba77aaa94e33a65db","e14f6cce-7430-4658-bf42-3c609119f4f5",2123,"2016-09-29T19:37:15.060403-05:00","a8d5ebc3-0bf3-4a86-81b1-d1e049732146_experiment.xml","574eb441d66207f1debddef8ce6f09ab","4f06b9dc-60c9-48fd-8b84-64351e07faac",2431,"2016-09-30T00:21:41.444366-05:00","a8d5ebc3-0bf3-4a86-81b1-d1e049732146_run.xml","b7d40828b30387f97bae18418e564436","ff0cf044-bef3-4e57-9376-48629bc7b5d7",354,"2016-09-08T11:04:16.829044-05:00","TCGA-BG-A3EW","2016-09-02T18:49:21.398718-05:00","female","TCGA-BG-A3EW_demographic",1949,"white","d1af4708-62fe-5624-9a61-f1542621ba4b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A3EW_diagnosis","not reported",22705,"alive","8380/3",NA,344,"e43255c0-7939-5711-9902-2c989fe7a847","c54.1",-22705,"TCGA-BG-A3EW_treatment","5a52d132-8e17-587a-adba-b3fa180144f6","01","true","TCGA-BG-A3EW-01A",NA,"be387236-f691-4303-aa47-be1d67cbdd5e",FALSE,"0463CA05-339C-4AB9-A236-CEAE733AD5F6","Primary Tumor",NA,24,130,NA,1321401600,"11",30,"TCGA-BG-A3EW-01A-11",85,NA,0,NA,5,NA,15,NA,"2016-09-08T11:04:16.829044-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"5f8074f6-b42b-4ecf-a051-a37f9b9be555",NA,"TCGA-BG-A3EW-01A-01-TSA",NA,80,NA,"d31adce8-de3a-4259-99ed-bd4b668d69d2","RNA","TCGA-BG-A3EW-01A-11R","fb87078d-e3f6-4310-a47b-1843a9896163",1.82,0.16,"UV Spec","R","23","TCGA-BG-A3EW-01A-11R-A22K-07","8b8048b4-fe60-45f4-97c5-662c45169334",0.16,NA,126,45.7250689505008,166,"fce2e002-ab7f-5878-b97e-cab6552407b6","TCGA-BG-A3EW_exposure","UNCID_2173764.8b8048b4-fe60-45f4-97c5-662c45169334.130502_UNC12-SN629_0289_AC236KACXX_1_ATCACG.tar.gz","2013-09-09T23:51:05.000Z","2013-09-10T00:19:01.000Z","A8D5EBC3-0BF3-4A86-81B1-D1E049732146","BE387236-F691-4303-AA47-BE1D67CBDD5E","Unaligned reads",7628516314,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8B8048B4-FE60-45F4-97C5-662C45169334","University of North Carolina","564a3383e4b093830b66bea0","A31554AF-D77A-4862-8AED-4581FB2BD877","Uterine Corpus Endometrial Carcinoma","TARGZ","D31ADCE8-DE3A-4259-99ED-BD4B668D69D2","2013-09-10T00:19:01.000Z","FB87078D-E3F6-4310-A47B-1843A9896163","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",24,"D31ADCE8-DE3A-4259-99ED-BD4B668D69D2",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.918C09B1-BCFE-4194-A61C-90B4A30DB902.txt",130,"TCGA-BG-A3EW-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","BE387236-F691-4303-AA47-BE1D67CBDD5E",62,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.918C09B1-BCFE-4194-A61C-90B4A30DB902.txt","Alive",NA,"TCGA-BG-A3EW","NOT HISPANIC OR LATINO","A133029A-A4B1-4509-9E92-BD093F922CAD",NA,5,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage III",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"ED9DFA9F-49CC-4AD1-AEEC-D024A790585B","WHITE",NA,11,30,"5F8074F6-B42B-4ECF-A051-A37F9B9BE555","FB87078D-E3F6-4310-A47B-1843A9896163","TCGA-BG-A3EW-01A-11R-A22I-13_mirna.bam","TCGA-BG-A3EW-01A-11",85,5,0,2,15,"TOP",0,0,"TCGA-BG-A3EW-01A-01-TSA",80,NA,NA,NA,"TCGA-BG-A3EW-R43330","External","Primary Tumor Field","TCGA-BG-A3EW-F39618_NTE-1","NO",344,"TUMOR FREE","Alive",NA,"TCGA-BG-A3EW-F39618","TCGA-BG-A3EW",1,"BG","A3EW","YES","C54.1","8380/3","C54.1","YES","NO",-22705,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",5,NA,NA,NA,"TUMOR FREE","NO",28,3,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",8,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
112572880,110439641,5270720875,"B7D18227-6A93-4E18-9BC4-28CA5502AE4E.bw","a31554af-d77a-4862-8aed-4581fb2bd877","b7d18227-6a93-4e18-9bc4-28ca5502ae4e","2016-08-05T08:32:17.052912-05:00","UNCID_2173690.a75c4597-041a-44ad-88e1-0466278f621c.130502_UNC12-SN629_0289_AC236KACXX_3_GATCAG.tar.gz","5bd35f38-2789-495f-afbd-89db80590ecb",5343805450,"Illumina HiSeq","20314e77ac7016802e2106c752494289","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:40:41.758132-05:00","2016-05-03T10:56:47.870562-05:00","5bd35f38-2789-495f-afbd-89db80590ecb_analysis.xml","ddda2c84112d2cf097d0c2856f0fa85b","75eea63a-8b24-43b8-ab7e-8ed69c5b2778",2123,"2016-08-27T23:04:00.337438-05:00","5bd35f38-2789-495f-afbd-89db80590ecb_experiment.xml","cee3020cb2c5378f75632d3cc76d9edd","0878ac4d-5b41-458a-b173-19120b1e9b05",2431,"2016-09-29T22:02:16.974339-05:00","5bd35f38-2789-495f-afbd-89db80590ecb_run.xml","fdb1e31e9a3b6ab7a0ddd61feb6adfc3","a8c47386-d7ed-4b39-8daf-0fcfa5e71f6c",354,"2016-09-08T11:04:16.829044-05:00","TCGA-BG-A3EW","2016-09-02T18:49:21.398718-05:00","female","TCGA-BG-A3EW_demographic",1949,"white","d1af4708-62fe-5624-9a61-f1542621ba4b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A3EW_diagnosis","not reported",22705,"alive","8380/3",NA,344,"e43255c0-7939-5711-9902-2c989fe7a847","c54.1",-22705,"TCGA-BG-A3EW_treatment","5a52d132-8e17-587a-adba-b3fa180144f6","11","true","TCGA-BG-A3EW-11A",NA,"44dcbef9-4ff8-425d-895e-127f7f5c4d4d",FALSE,NA,"Solid Tissue Normal",NA,24,220,NA,1324944000,"22",20,"TCGA-BG-A3EW-11A-22",0,NA,0,NA,100,NA,0,NA,"2016-09-08T11:04:16.829044-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"5d0cf041-bd1c-416a-aaa5-035b622d3c2e",NA,"TCGA-BG-A3EW-11A-02-TSB",NA,0,NA,"ad6bebd4-14ec-4657-900a-4e5da79c8046","RNA","TCGA-BG-A3EW-11A-22R","74b0d078-8d4c-449d-adb7-09385b3d79dc",1.76,0.18,"UV Spec","R","23","TCGA-BG-A3EW-11A-22R-A22K-07","a75c4597-041a-44ad-88e1-0466278f621c",0.18,NA,126,45.7250689505008,166,"fce2e002-ab7f-5878-b97e-cab6552407b6","TCGA-BG-A3EW_exposure","UNCID_2173690.a75c4597-041a-44ad-88e1-0466278f621c.130502_UNC12-SN629_0289_AC236KACXX_3_GATCAG.tar.gz","2013-09-09T22:16:09.000Z","2013-09-09T22:36:02.000Z","5BD35F38-2789-495F-AFBD-89DB80590ECB","44DCBEF9-4FF8-425D-895E-127F7F5C4D4D","Unaligned reads",5343805450,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","A75C4597-041A-44AD-88E1-0466278F621C","University of North Carolina","564a3383e4b08c5d868eff0f","A31554AF-D77A-4862-8AED-4581FB2BD877","Uterine Corpus Endometrial Carcinoma","TARGZ","AD6BEBD4-14EC-4657-900A-4E5DA79C8046","2013-09-09T22:36:02.000Z","74B0D078-8D4C-449D-ADB7-09385B3D79DC","United States","NO",11,NA,"Solid Tissue Normal","University of Pittsburgh",24,"AD6BEBD4-14EC-4657-900A-4E5DA79C8046",NA,"BG","UNCID_2035002.a75c4597-041a-44ad-88e1-0466278f621c.sorted_genome_alignments.bam",220,"TCGA-BG-A3EW-11A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","BE387236-F691-4303-AA47-BE1D67CBDD5E",62,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.918C09B1-BCFE-4194-A61C-90B4A30DB902.txt","Alive",NA,"TCGA-BG-A3EW","NOT HISPANIC OR LATINO","A133029A-A4B1-4509-9E92-BD093F922CAD",NA,5,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage III",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"ED9DFA9F-49CC-4AD1-AEEC-D024A790585B","WHITE",NA,22,20,"5D0CF041-BD1C-416A-AAA5-035B622D3C2E","C6006159-4E28-44C7-B5FE-8D25BF616ACA","UNCID_2035002.a75c4597-041a-44ad-88e1-0466278f621c.sorted_genome_alignments.bam","TCGA-BG-A3EW-11A-22",0,100,0,1,0,"TOP",0,0,"TCGA-BG-A3EW-11A-02-TSB",0,NA,NA,NA,"TCGA-BG-A3EW-R43330","External","Primary Tumor Field","TCGA-BG-A3EW-F39618_NTE-1","NO",344,"TUMOR FREE","Alive",NA,"TCGA-BG-A3EW-F39618","TCGA-BG-A3EW",1,"BG","A3EW","YES","C54.1","8380/3","C54.1","YES","NO",-22705,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",5,NA,NA,NA,"TUMOR FREE","NO",28,3,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",8,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
169375838,166596842,7947215346,"BA95F2DB-3378-428C-8757-AC61AE6C4FAE.bw","a3e728ce-0874-4f4b-a83d-8c679f4bd938","ba95f2db-3378-428c-8757-ac61ae6c4fae","2016-08-26T08:24:25.515651-05:00","UNCID_2365630.382f8e3e-6414-4bfd-81de-fa4260be7ede.140114_UNC13-SN749_0325_AC339CACXX_8_TGACCA.tar.gz","c1a64d21-1012-411c-ad77-c611870f3c4d",7886186120,"Illumina HiSeq","05ae13b2888992b73c397d3219d55998","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:09:05.201836-05:00","2016-05-03T11:39:34.521514-05:00","c1a64d21-1012-411c-ad77-c611870f3c4d_analysis.xml","57b0f85a50270d7f0da0efacbf62e297","629c35ec-fdd1-4868-9239-cdf41aaafa16",2124,"2016-09-29T21:41:16.831926-05:00","c1a64d21-1012-411c-ad77-c611870f3c4d_experiment.xml","fb094f9929b0de7d08b17c84c66434af","9b9d368f-f002-4fb4-83c3-d97b2f19f695",2628,"2016-09-29T21:04:15.205944-05:00","c1a64d21-1012-411c-ad77-c611870f3c4d_run.xml","e67d9ff2e2d295baeae4a507b85220fd","849eea86-80cf-4ead-a8a4-4eba091c3d54",354,"2016-09-08T11:06:11.949140-05:00","TCGA-A5-A7WJ","2016-09-02T18:51:28.268994-05:00","female","TCGA-A5-A7WJ_demographic",1948,"black or african american","9251d9f1-be21-5e38-9822-eede8d5cc51c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A7WJ_diagnosis","not reported",23723,"alive","8380/3",NA,341,"b66be01d-91aa-5e6d-91a2-76c1c5729a52","c54.1",-23723,"TCGA-A5-A7WJ_treatment","cca169e6-85f5-5896-a2b2-1a7fa4f8b2ae","01","true","TCGA-A5-A7WJ-01A",NA,"6595c691-70d1-4b5f-a8c3-ed0167e07249",FALSE,"402A6ED4-B9EC-43A0-B47C-A0B95282678D","Primary Tumor",NA,439,140,NA,1381449600,"12",10,"TCGA-A5-A7WJ-01A-12",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:06:11.949140-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"bc04c484-4974-4f86-b084-260a5ed2cffd",NA,"TCGA-A5-A7WJ-01A-01-TSA",NA,70,NA,"3ae83a34-ee45-47d9-bf8c-cdbe2e9db75f","RNA","TCGA-A5-A7WJ-01A-12R","86e90f23-0549-4bd2-8061-2e01fa5c7941",1.82,0.18,"UV Spec","R","23","TCGA-A5-A7WJ-01A-12R-A34R-07","382f8e3e-6414-4bfd-81de-fa4260be7ede",0.18,NA,64,22.1453287197232,170,"edefd70e-3f10-5f74-b0d4-a2627bae7b7a","TCGA-A5-A7WJ_exposure","UNCID_2365630.382f8e3e-6414-4bfd-81de-fa4260be7ede.140114_UNC13-SN749_0325_AC339CACXX_8_TGACCA.tar.gz","2014-03-05T17:33:04.000Z","2014-03-05T17:57:02.000Z","C1A64D21-1012-411C-AD77-C611870F3C4D","6595C691-70D1-4B5F-A8C3-ED0167E07249","Unaligned reads",7886186120,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","382F8E3E-6414-4BFD-81DE-FA4260BE7EDE","University of North Carolina","56607cb0e4b0b37b3d9928df","A3E728CE-0874-4F4B-A83D-8C679F4BD938","Uterine Corpus Endometrial Carcinoma","TARGZ","3AE83A34-EE45-47D9-BF8C-CDBE2E9DB75F","2014-03-05T17:57:02.000Z","86E90F23-0549-4BD2-8061-2E01FA5C7941","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",439,"3AE83A34-EE45-47D9-BF8C-CDBE2E9DB75F",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E76A6335-F295-4BB2-B04E-4B69A461837C.txt",140,"TCGA-A5-A7WJ-01A",NA,NA,"TCGA",2012,"TCGA-A5-A7WJ_NTE-1","Complete Remission/Response","TUMOR FREE","A6832A66-9F19-4225-91F0-CA65AE871644",64,"nationwidechildrens.org_clinical.TCGA-A5-A7WJ.xml","Alive",NA,"TCGA-A5-A7WJ","NOT HISPANIC OR LATINO","28DD6E24-163A-4115-8544-F1974A194704","NO",341,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",354,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,12,10,"BC04C484-4974-4F86-B084-260A5ED2CFFD","A216F81A-1521-4D84-973D-B5A6701997C1","UNCID_2330898.382f8e3e-6414-4bfd-81de-fa4260be7ede.sorted_genome_alignments.bam.bai","TCGA-A5-A7WJ-01A-12",70,0,20,40,20,"TOP",10,20,"TCGA-A5-A7WJ-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-A5-A7WJ-F64296_NTE-1","NO",341,"TUMOR FREE","Alive",NA,"TCGA-A5-A7WJ-F64296","TCGA-A5-A7WJ",1,"A5","A7WJ","YES","C54.1","8380/3","C54.1","YES","NO",-23723,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",341,NA,"NO","NO","TUMOR FREE","YES",22,4,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2012,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33034740,32722548,2425838709,"E73BCFCB-C5FE-4BF2-A236-B9E69711C121.bw","a438dce7-6592-4ea6-a401-57f5a8fe8ba6","e73bcfcb-c5fe-4bf2-a236-b9e69711c121","2016-08-09T14:13:41.000218-05:00","UNCID_2208117.b9d45e58-d758-4aa0-a282-1366dc00f833.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_2.tar.gz","34b18a3f-2955-4b91-a6e9-07d60e0ef943",2201765452,"Illumina GA","60a68477b9ca0a931835b4a1d269c949","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:38:29.738225-05:00","2016-05-03T11:14:23.412460-05:00","34b18a3f-2955-4b91-a6e9-07d60e0ef943_analysis.xml","b7d706357f60e1f21f080f8aaa55e5e2","2a09043c-e9c7-43d7-8201-5aa12847655a",2121,"2016-09-29T22:45:23.612031-05:00","34b18a3f-2955-4b91-a6e9-07d60e0ef943_experiment.xml","5837543ccbb0106faabdf6fc7755d1d8","c350100f-d124-411f-9d0d-7cfe9e136b57",2257,"2016-09-29T19:18:19.122580-05:00","34b18a3f-2955-4b91-a6e9-07d60e0ef943_run.xml","a12c815ff5cdcacaf513ca9116bd9940","4338c4df-6d16-40b7-86b4-0d1e3a0a02b7",347,"2016-09-08T10:44:29.532389-05:00","TCGA-D1-A163","2016-09-02T18:50:07.440936-05:00","female","TCGA-D1-A163_demographic",1958,"white","3706c952-17d0-5829-9624-26ed35ce61c6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A163_diagnosis","not reported",18604,"alive","8380/3",NA,991,"76162bb9-f138-5dde-9b50-b697cd6328cb","c54.1",-18604,"TCGA-D1-A163_treatment","7281bfd0-c3df-5071-9c27-4df40e1b39cc","01","false","TCGA-D1-A163-01A",NA,"8e3afec6-eb01-404f-ae76-08590b3c0ad0",FALSE,"993B9CE9-7D25-4B2B-B246-F642550C70CD","Primary Tumor",NA,854,170,NA,1292976000,"11",30,"TCGA-D1-A163-01A-11",60,NA,0,NA,10,NA,0,NA,"2016-09-08T10:44:29.532389-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"bd20600a-f798-4fa0-bb32-f78be6a5f29c",NA,"TCGA-D1-A163-01A-01-TSA",NA,90,NA,"39121036-acf8-487f-8989-9f7f5082efc6","RNA","TCGA-D1-A163-01A-11R","ecc53abc-b0a2-4e44-b95d-57c9b97cf7c4",1.89,0.16,"UV Spec","R","23","TCGA-D1-A163-01A-11R-A12I-07","b9d45e58-d758-4aa0-a282-1366dc00f833",0.16,NA,109,38.1639298343895,169,"8736d299-95aa-5149-92c9-31aa172bf96c","TCGA-D1-A163_exposure","UNCID_2208117.b9d45e58-d758-4aa0-a282-1366dc00f833.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_2.tar.gz","2013-09-30T09:06:04.000Z","2013-09-30T09:19:02.000Z","34B18A3F-2955-4B91-A6E9-07D60E0EF943","8E3AFEC6-EB01-404F-AE76-08590B3C0AD0","Unaligned reads",2201765452,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B9D45E58-D758-4AA0-A282-1366DC00F833","University of North Carolina","564a38f7e4b0ef121819aa52","A438DCE7-6592-4EA6-A401-57F5A8FE8BA6","Uterine Corpus Endometrial Carcinoma","TARGZ","39121036-ACF8-487F-8989-9F7F5082EFC6","2013-09-30T09:19:02.000Z","ECC53ABC-B0A2-4E44-B95D-57C9B97CF7C4","None","NO",1,NA,"Primary Tumor","Mayo Clinic",854,"39121036-ACF8-487F-8989-9F7F5082EFC6",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.78CB9680-D489-4ED4-BFDF-56CF4E9B2C9C.txt",170,"TCGA-D1-A163-01A",NA,"AF0313ED-CB28-462D-9B55-221511D98B16","TCGA",2008,NA,NA,"TUMOR FREE","FE3D63F7-7BE6-44BE-898A-36916DA1C54A",50,"nationwidechildrens.org_clinical.TCGA-D1-A163.xml","Alive",NA,"TCGA-D1-A163","NOT HISPANIC OR LATINO","44F34C31-AC61-4765-86E2-EDC289C3CD59",NA,938,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"D105E30A-AA40-4A21-94A7-7D52A0A92494","WHITE",NA,11,30,"BD20600A-F798-4FA0-BB32-F78BE6A5F29C","20CAB43E-B776-40EA-ADB7-FEBA4B869FBE","UNCID_364301.TCGA-D1-A163-01A-11R-A12I-07.110624_UNC6-RDR300211_00108_FC_634Y6AAXX.2.trimmed.annotated.translated_to_genomic.bam","TCGA-D1-A163-01A-11",60,10,0,0,0,"TOP",0,0,"TCGA-D1-A163-01A-01-TSA",90,"Taxol","Chemotherapy","TCGA-D1-A163-D18491","TCGA-D1-A163-R18488","IMPLANTS","Regional site",NA,"YES",991,"TUMOR FREE","Alive",NA,"TCGA-D1-A163-F18485","TCGA-D1-A163",1,"D1","A163","YES","C54.1","8380/3","C54.1","NO","YES",-18604,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",938,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,50,2008,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1995",11,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
34054256,33851716,2540092844,"9F3CF556-9E7A-4EE4-86C9-5BB453DF86C1.bw","a45a2343-f425-4e62-9049-7782733b6234","9f3cf556-9e7a-4ee4-86c9-5bb453df86c1","2016-08-09T13:58:52.164322-05:00","UNCID_2189211.55f89e0e-bb6b-40e0-bc85-602a011c764b.120531_UNC2-RDR300275_00125_FC_64VUHAAXX_3.tar.gz","b0709bfa-b57a-449a-8f2e-b9c853e0a1cb",2372735500,"Illumina GA","f815d10fdfd64e67b10f5596c8be6644","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:38:00.583709-05:00","2016-05-03T11:05:01.516668-05:00","b0709bfa-b57a-449a-8f2e-b9c853e0a1cb_analysis.xml","8e38f560e218cb25d71443a45c3b9217","743bcedf-3ff7-4a47-841f-235b4a5a41dd",2122,"2016-09-29T22:51:10.779091-05:00","b0709bfa-b57a-449a-8f2e-b9c853e0a1cb_experiment.xml","5ff53e79c19e1915de92a7c6c9bbade5","c6e6b86e-2549-4f6f-9faf-1eabd85de758",2258,"2016-09-29T23:40:55.615726-05:00","b0709bfa-b57a-449a-8f2e-b9c853e0a1cb_run.xml","7fef4389b44fbc38bcfcb8aac527e96e","e5caaf94-198f-4077-8984-a258311f0594",349,"2016-09-08T10:58:56.114230-05:00","TCGA-EY-A1GH","2016-09-02T18:51:53.309919-05:00","female","TCGA-EY-A1GH_demographic",1939,"white","ea34983c-8abf-5e0e-b795-731c3baf565e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GH_diagnosis","not reported",25802,"alive","8380/3",NA,710,"989578c6-378e-573e-9073-63846c0150e4","c54.1",-25802,"TCGA-EY-A1GH_treatment","f5d65e17-9e74-5109-b5a8-16f07cafdc9a","01","false","TCGA-EY-A1GH-01A",NA,"b32b07ac-a84d-4b1d-89c9-ffe2e91ee037",FALSE,"29D738E9-2F8D-4909-A427-7C056859B89A","Primary Tumor",NA,452,280,NA,1297900800,"11",30,"TCGA-EY-A1GH-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T10:58:56.114230-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"37a2f139-dd85-4660-9712-11fd5a006507",NA,"TCGA-EY-A1GH-01A-01-TSA",NA,100,NA,"cdb787bf-b97c-44d0-8be3-0fd4677e95f2","RNA","TCGA-EY-A1GH-01A-11R","ef84c144-3d07-471b-88cb-2a2ecf61c67c",1.82,0.15,"UV Spec","R","23","TCGA-EY-A1GH-01A-11R-A13S-07","55f89e0e-bb6b-40e0-bc85-602a011c764b",0.15,NA,117,40.4844290657439,170,"9ef75f65-f805-509d-9a48-cd1a25a72a50","TCGA-EY-A1GH_exposure","UNCID_2189211.55f89e0e-bb6b-40e0-bc85-602a011c764b.120531_UNC2-RDR300275_00125_FC_64VUHAAXX_3.tar.gz","2013-09-18T18:37:04.000Z","2013-09-18T18:49:02.000Z","B0709BFA-B57A-449A-8F2E-B9C853E0A1CB","B32B07AC-A84D-4B1D-89C9-FFE2E91EE037","Unaligned reads",2372735500,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","55F89E0E-BB6B-40E0-BC85-602A011C764B","University of North Carolina","56607c0fe4b0ca319164febb","A45A2343-F425-4E62-9049-7782733B6234","Uterine Corpus Endometrial Carcinoma","TARGZ","CDB787BF-B97C-44D0-8BE3-0FD4677E95F2","2013-09-18T18:49:02.000Z","EF84C144-3D07-471B-88CB-2A2ECF61C67C","United States","NO",1,NA,"Primary Tumor","University of North Carolina",452,"CDB787BF-B97C-44D0-8BE3-0FD4677E95F2",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.18E9DF4D-A21E-449E-8EE8-C2AD19BD4491.txt",280,"TCGA-EY-A1GH-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","B32B07AC-A84D-4B1D-89C9-FFE2E91EE037",70,"nationwidechildrens.org_clinical.TCGA-EY-A1GH.xml","Alive",NA,"TCGA-EY-A1GH","NOT HISPANIC OR LATINO","3C7A2C97-FB03-4FBE-82ED-FEEB10B05380",NA,528,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,"3AA5752F-B9F9-4AE8-A127-7EB1C3575769","WHITE",NA,11,30,"37A2F139-DD85-4660-9712-11FD5A006507","F6892FEB-379C-4286-9324-D6B316E80F23","unc.edu.55f89e0e-bb6b-40e0-bc85-602a011c764b.1748366.bt.exon_quantification.txt","TCGA-EY-A1GH-01A-11",75,0,0,0,0,"TOP",0,0,"TCGA-EY-A1GH-01A-01-TSA",100,NA,NA,NA,"TCGA-EY-A1GH-R11869","OTHER: SPECIFY IN NOTES","Regional site",NA,"NO",710,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GH-F19726","TCGA-EY-A1GH",1,"EY","A1GH","YES","C54.1","8380/3","C54.1","NO","YES",-25802,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",528,NA,NA,NA,"TUMOR FREE","NO",11,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,70,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34189394,33400972,2505609793,"F1037B9A-1497-4338-908B-35DEEF1EE894.bw","a587e62e-430e-4f1b-82b7-6fbe856fdaf1","f1037b9a-1497-4338-908b-35deef1ee894","2016-08-09T14:12:10.045027-05:00","UNCID_2207062.34294f7a-7f80-443c-854e-5fe22b4391e0.110728_UNC2-RDR300275_00080_FC_63145AAXX_2.tar.gz","cdb5fc10-a798-48e4-b2e5-8a562bf30f63",2204045895,"Illumina GA","0ed5af609acfea2e56e5533efbd717f6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:36:25.856312-05:00","2016-05-03T11:13:42.364824-05:00","cdb5fc10-a798-48e4-b2e5-8a562bf30f63_analysis.xml","03fb9bccc0bb21defa016851aed2eeef","733d3965-fb23-4e43-9bea-8b08f71f113d",2121,"2016-09-29T21:56:47.770254-05:00","cdb5fc10-a798-48e4-b2e5-8a562bf30f63_experiment.xml","1028c14573252102972c0d81d36718ca","a55e9279-3e76-4ba9-b80e-19f33e8706bd",2257,"2016-09-29T18:49:21.421994-05:00","cdb5fc10-a798-48e4-b2e5-8a562bf30f63_run.xml","69e7d02cfd1a54faeb14503c32874375","30edec80-1a37-4266-807d-da27bcb789c1",347,"2016-09-08T11:09:48.885165-05:00","TCGA-A5-A0GE","2016-09-02T18:54:08.427245-05:00","female","TCGA-A5-A0GE_demographic",1964,"asian","909e5384-bc65-57da-a325-b3e37696288a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GE_diagnosis","not reported",14170,"alive","8380/3",NA,3205,"0fa4bc83-ddc7-5bf3-9d0f-dbe6998d1497","c54.1",-14170,"TCGA-A5-A0GE_treatment","b1de703e-7e57-509d-bcd7-73fc90e95140","01","true","TCGA-A5-A0GE-01A",NA,"20c3f64d-acf6-45b3-9ace-2f93b3a951c8",FALSE,"7686A445-554F-43EF-BE79-6EA5E5C4DB21","Primary Tumor",NA,2941,200,NA,1275868800,"11",30,"TCGA-A5-A0GE-01A-11",85,85,0,0,10,10,5,5,"2016-09-08T11:09:48.885165-05:00","2016-09-08T11:09:48.885165-05:00",60,60,30,30,"TOP","BOTTOM",5,10,"6ee44933-f37b-4b7d-86c7-25fdee432127","a4462306-50b6-4c77-8f52-59ebb6e9d4f7","TCGA-A5-A0GE-01A-01-TSA","TCGA-A5-A0GE-01A-01-BSA",80,75,"0e996dbf-881f-414c-8cf7-8897d8c44361","RNA","TCGA-A5-A0GE-01A-11R","99d2fcda-411b-4a3b-ae2b-1ae8a3d61e0e",1.93,0.16,"UV Spec","R","23","TCGA-A5-A0GE-01A-11R-A16W-07","34294f7a-7f80-443c-854e-5fe22b4391e0",0.16,NA,57,23.7252861602497,155,"5ee45cb2-4ad6-5b2c-be4d-e5b9779be8b7","TCGA-A5-A0GE_exposure","UNCID_2207062.34294f7a-7f80-443c-854e-5fe22b4391e0.110728_UNC2-RDR300275_00080_FC_63145AAXX_2.tar.gz","2013-09-29T06:01:03.000Z","2013-09-29T06:14:02.000Z","CDB5FC10-A798-48E4-B2E5-8A562BF30F63","20C3F64D-ACF6-45B3-9ACE-2F93B3A951C8","Unaligned reads",2204045895,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","34294F7A-7F80-443C-854E-5FE22B4391E0","University of North Carolina","566076dce4b016715ab692a4","A587E62E-430E-4F1B-82B7-6FBE856FDAF1","Uterine Corpus Endometrial Carcinoma","TARGZ","0E996DBF-881F-414C-8CF7-8897D8C44361","2013-09-29T06:14:02.000Z","99D2FCDA-411B-4A3B-AE2B-1AE8A3D61E0E","None","NO",1,NA,"Primary Tumor","Cedars Sinai",2941,"0E996DBF-881F-414C-8CF7-8897D8C44361",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CFFA7BD4-5310-4035-8ADA-943D90FC2344.txt",200,"TCGA-A5-A0GE-01A",NA,NA,"TCGA",2002,NA,NA,"TUMOR FREE","FC6580A8-FFE8-4F16-A19D-DB65F2789369",38,"jhu-usc.edu_UCEC.HumanMethylation27.2.lvl-3.TCGA-A5-A0GE-01A-11D-A039-05.txt","Alive",NA,"TCGA-A5-A0GE","NOT HISPANIC OR LATINO","6A30AED4-B8F5-4FB0-A107-7BEC2CAEF592",NA,2717,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"4B37C527-A0B0-4B84-A458-13F84DEE4ED0","ASIAN",NA,11,30,"A4462306-50B6-4C77-8F52-59EBB6E9D4F7","99D2FCDA-411B-4A3B-AE2B-1AE8A3D61E0E","UNCID_2207062.34294f7a-7f80-443c-854e-5fe22b4391e0.110728_UNC2-RDR300275_00080_FC_63145AAXX_2.tar.gz","TCGA-A5-A0GE-01A-11",85,10,0,60,5,"BOTTOM",10,30,"TCGA-A5-A0GE-01A-01-BSA",75,NA,NA,NA,"TCGA-A5-A0GE-R3080","IMPLANTS","Primary Tumor Field",NA,"NO",3205,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GE-F17140","TCGA-A5-A0GE",1,"A5","A0GE","YES","C54.1","8380/3","C54.1","NO","YES",-14170,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",2717,NA,NA,NA,"TUMOR FREE","NO",10,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,38,2002,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
33130218,32133653,2417847739,"56DA9453-26CD-4682-9970-8D8F55152BB1.bw","a59a79fd-433d-44dc-9601-4c63d599ab28","56da9453-26cd-4682-9970-8d8f55152bb1","2016-08-09T14:14:32.908177-05:00","UNCID_2210186.7e3666db-df81-4413-b742-c475e786772e.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_4.tar.gz","4ce1817d-a745-47c4-b18c-0a6d62c7af5e",2103638389,"Illumina GA","2a921ebf93193491a62b62a867d7ccc3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:52:58.590296-05:00","2016-05-03T11:15:47.407128-05:00","4ce1817d-a745-47c4-b18c-0a6d62c7af5e_analysis.xml","2c3827572b4002368820432551348cc0","58d76a23-212c-4703-9b36-86190af6d6d2",2123,"2016-09-30T00:06:36.792960-05:00","4ce1817d-a745-47c4-b18c-0a6d62c7af5e_experiment.xml","bbf38f45b30baac94633d8f13e9ae421","f59e9614-aecc-4af9-9faa-64d625b76914",2257,"2016-09-29T19:05:37.722307-05:00","4ce1817d-a745-47c4-b18c-0a6d62c7af5e_run.xml","092f58dbd901234b4f4538dc5dbf7219","3b3f335d-0a1d-4b2b-96e8-4d8b0c16ec69",347,"2016-09-08T10:46:13.015131-05:00","TCGA-B5-A11O","2016-09-02T18:49:28.760834-05:00","female","TCGA-B5-A11O_demographic",1946,"white","b0e6de39-ab28-5b60-90a2-2ae8485c99d9","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11O_diagnosis","not reported",22720,"alive","8380/3",NA,2609,"4528c73f-e558-5634-8ad1-76154e43a209","c54.1",-22720,"TCGA-B5-A11O_treatment","f166c518-fa80-528e-9ad3-a9bb7367e827","01","true","TCGA-B5-A11O-01A",NA,"f3d85f05-bd2c-46fc-ac6a-0e2a7248c630",FALSE,"078AA8A2-E812-4603-9084-8414937B88E1","Primary Tumor",NA,993,130,NA,1291593600,"11",30,"TCGA-B5-A11O-01A-11",95,90,8,8,0,0,5,10,"2016-09-08T10:46:13.015131-05:00","2016-09-08T10:46:13.015131-05:00",20,20,8,5,"BOTTOM","TOP",10,8,"164cda41-b90e-42d0-9851-8c98137d09d0","4f87ebf7-49e5-4f9d-bfd0-c8bf651be2ce","TCGA-B5-A11O-01A-01-BS1","TCGA-B5-A11O-01A-01-TS1",85,82,"cd5fc1b5-09ba-4394-a718-f2289ea5abfb","RNA","TCGA-B5-A11O-01A-11R","dec99650-a2c8-4ece-b9b2-9ca33d77c155",1.8,0.14,"UV Spec","R","23","TCGA-B5-A11O-01A-11R-A118-07","7e3666db-df81-4413-b742-c475e786772e",0.14,NA,114,36.3880111079192,177,"5e0f52ff-49b2-597e-9637-680d466885dd","TCGA-B5-A11O_exposure","UNCID_2210186.7e3666db-df81-4413-b742-c475e786772e.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_4.tar.gz","2013-10-02T07:07:05.000Z","2013-10-02T07:19:03.000Z","4CE1817D-A745-47C4-B18C-0A6D62C7AF5E","F3D85F05-BD2C-46FC-AC6A-0E2A7248C630","Unaligned reads",2103638389,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7E3666DB-DF81-4413-B742-C475E786772E","University of North Carolina","564a39b0e4b08c5d8690f69a","A59A79FD-433D-44DC-9601-4C63D599AB28","Uterine Corpus Endometrial Carcinoma","TARGZ","CD5FC1B5-09BA-4394-A718-F2289EA5ABFB","2013-10-02T07:19:03.000Z","DEC99650-A2C8-4ECE-B9B2-9CA33D77C155","United States","NO",1,NA,"Primary Tumor","Duke",993,"CD5FC1B5-09BA-4394-A718-F2289EA5ABFB",NA,"B5","UNCID_193751.TCGA-B5-A11O-01A-11R-A118-07.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX.4.trimmed.annotated.translated_to_genomic.bam.bai",130,"TCGA-B5-A11O-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","F3D85F05-BD2C-46FC-AC6A-0E2A7248C630",62,"nationwidechildrens.org_clinical.TCGA-B5-A11O.xml","Alive",NA,"TCGA-B5-A11O",NA,"169CD704-9B32-4908-A83D-FAE243406DAF",NA,1042,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"4F87EBF7-49E5-4F9D-BFD0-C8BF651BE2CE","DEC99650-A2C8-4ECE-B9B2-9CA33D77C155","UNCID_193751.TCGA-B5-A11O-01A-11R-A118-07.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX.4.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-B5-A11O-01A-11",95,0,8,20,5,"BOTTOM",10,8,"TCGA-B5-A11O-01A-01-BS1",85,NA,NA,NA,NA,NA,NA,NA,"NO",1232,"TUMOR FREE","Alive",NA,"TCGA-B5-A11O-F17769","TCGA-B5-A11O",1,"B5","A11O","YES","C54.1","8380/3","C54.1","NO","YES",-22720,"FEMALE","WHITE",NA,"No","No","Alive",1042,NA,NA,NA,"TUMOR FREE","NO",11,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
104150528,102028258,4870087891,"E98D364C-C1F8-4C51-A68F-87294AE6D922.bw","a633d316-59a4-45ae-8bf8-135cfbd27656","e98d364c-c1f8-4c51-a68f-87294ae6d922","2016-08-05T11:15:36.302371-05:00","UNCID_2169055.e55857c5-0581-471c-ba7a-cd9b83afbc14.130610_UNC14-SN744_0347_BD28NBACXX_5_ATGTCA.tar.gz","07ddd39f-0aae-4e99-bf79-2b5bdd8a561d",4758653071,"Illumina HiSeq","d9c61798d5ec6ab012c1c8e6e9a22ecb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:25:57.879224-05:00","2016-05-03T11:05:42.738267-05:00","07ddd39f-0aae-4e99-bf79-2b5bdd8a561d_analysis.xml","b9a6410b10800bdc9b65b32c5ac845af","4808bb14-67d0-4f2e-8214-6846e99e81ea",2123,"2016-09-29T18:50:49.023940-05:00","07ddd39f-0aae-4e99-bf79-2b5bdd8a561d_experiment.xml","dc7ed8eb903da513c0e51b6233987ca1","31dacec4-1cf7-45f9-acd3-4e52b433e4e1",2431,"2016-09-29T22:12:20.703348-05:00","07ddd39f-0aae-4e99-bf79-2b5bdd8a561d_run.xml","05d6154532dff1f0a8bf291c6053d3c6","aed17e97-9854-43c0-a154-6501019ca433",354,"2016-09-08T10:46:54.048586-05:00","TCGA-AP-A5FX","2016-09-02T18:50:00.640851-05:00","female","TCGA-AP-A5FX_demographic",1942,"black or african american","c54df739-8b8f-53d4-be3f-4bb048131e5d","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A5FX_diagnosis","not reported",25063,"dead","8255/3",1099,1026,"0dcdbef2-95f1-5dbe-b7ed-98f7bacfe3e8","c54.1",-25063,"TCGA-AP-A5FX_treatment","59d9ccb0-1130-5204-8080-95ad631ca47a","01","true","TCGA-AP-A5FX-01A",NA,"b37ba34a-5f2e-46a9-9334-79e6782d40dc",FALSE,"AF38CD86-2F5A-46A3-903A-81A8067F2456","Primary Tumor",NA,878,300,NA,1358726400,"11",30,"TCGA-AP-A5FX-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T10:46:54.048586-05:00",NA,1,NA,0,NA,"TOP",NA,2,NA,"7ea0b9d7-ac2e-4ba6-ab92-304bc4f0be2b",NA,"TCGA-AP-A5FX-01A-01-TSA",NA,98,NA,"24df9d5e-20ba-4825-b90f-cf118928e8f6","RNA","TCGA-AP-A5FX-01A-11R","c8c70b18-c574-4152-b883-a5387924aeab",1.91,0.18,"UV Spec","R","23","TCGA-AP-A5FX-01A-11R-A27V-07","e55857c5-0581-471c-ba7a-cd9b83afbc14",0.18,NA,80,28.3446712018141,168,"bb55f4d4-d6d1-5709-84b1-e4c1066d56e8","TCGA-AP-A5FX_exposure","UNCID_2169055.e55857c5-0581-471c-ba7a-cd9b83afbc14.130610_UNC14-SN744_0347_BD28NBACXX_5_ATGTCA.tar.gz","2013-09-20T01:07:04.000Z","2013-09-20T01:21:01.000Z","07DDD39F-0AAE-4E99-BF79-2B5BDD8A561D","B37BA34A-5F2E-46A9-9334-79E6782D40DC","Unaligned reads",4758653071,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","E55857C5-0581-471C-BA7A-CD9B83AFBC14","University of North Carolina","566074c3e4b0ca319164c868","A633D316-59A4-45AE-8BF8-135CFBD27656","Uterine Corpus Endometrial Carcinoma","TARGZ","24DF9D5E-20BA-4825-B90F-CF118928E8F6","2013-09-20T01:21:01.000Z","C8C70B18-C574-4152-B883-A5387924AEAB","United States","NO",1,NA,"Primary Tumor","MSKCC",878,"24DF9D5E-20BA-4825-B90F-CF118928E8F6",NA,"AP","TCGA-AP-A5FX-01A-11R-A27R-13_mirna.bam",300,"TCGA-AP-A5FX-01A",NA,"9FF793C4-98A5-48F8-95C6-43756F12F395","TCGA",2010,"TCGA-AP-A5FX_NTE-1","Complete Remission/Response","WITH TUMOR","B37BA34A-5F2E-46A9-9334-79E6782D40DC",68,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.383E90E4-0DD9-4887-B3F5-B7FF175F3A99.txt","Alive",NA,"TCGA-AP-A5FX",NA,"092A5779-9882-457B-B04B-7EC2863D4BFC","YES",1026,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIIC1",NA,NA,NA,"8255/3","FEMALE","C54.1",289,NA,"0C835115-DE81-491D-8768-4837AB4C97F0","BLACK OR AFRICAN AMERICAN",NA,11,30,"7EA0B9D7-AC2E-4BA6-AB92-304BC4F0BE2B","C8C70B18-C574-4152-B883-A5387924AEAB","UNCID_2169055.e55857c5-0581-471c-ba7a-cd9b83afbc14.130610_UNC14-SN744_0347_BD28NBACXX_5_ATGTCA.tar.gz","TCGA-AP-A5FX-01A-11",80,0,0,1,0,"TOP",2,0,"TCGA-AP-A5FX-01A-01-TSA",98,"Carboplatin","Chemotherapy","TCGA-AP-A5FX-D43566","TCGA-AP-A5FX-R43568","External","Primary Tumor Field","TCGA-AP-A5FX-F58067_NTE-1","NO",NA,"WITH TUMOR","Dead",1099,"TCGA-AP-A5FX-F58067","TCGA-AP-A5FX",1,"AP","A5FX","YES","C54.1","8255/3","C54.1","NO","YES",-25063,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1026,NA,"YES","YES","WITH TUMOR","YES",26,5,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,68,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","RX",NA,NA,NA,NA,"Complete Remission/Response","2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32528995,31963505,2395575098,"5BE4D8E9-DA18-426F-8AE6-075B15010390.bw","a7329910-b1c7-4a18-b28e-8fad79121339","5be4d8e9-da18-426f-8ae6-075b15010390","2016-08-09T14:16:36.427614-05:00","UNCID_2214801.06c39fc6-9167-4913-bf84-4fde036869a2.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_3.tar.gz","fa3b2b0a-4ac6-4b74-82b0-64149a19cb20",1975284722,"Illumina GA","6882027f4d3027188dada5ab5dc18cd0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:44:56.397716-05:00","2016-05-03T11:17:14.905409-05:00","fa3b2b0a-4ac6-4b74-82b0-64149a19cb20_analysis.xml","cc9bfc859f86bc1c7534274b3ac5f18b","2e24da42-3a43-471a-9903-b104ae2b3b56",2120,"2016-08-13T02:05:16.208514-05:00","fa3b2b0a-4ac6-4b74-82b0-64149a19cb20_experiment.xml","605185da965646d7787e96bcf0dfc33b","6cc238b8-cd56-43b1-9f99-126f4491a503",2256,"2016-09-29T19:42:21.597136-05:00","fa3b2b0a-4ac6-4b74-82b0-64149a19cb20_run.xml","f8ffbbbc09e9a41d6caeface61cf61a7","52313983-69b6-4811-97f9-9115bdc078b8",345,"2016-09-08T11:18:11.687029-05:00","TCGA-BG-A0MU","2016-09-02T18:48:20.284453-05:00","female","TCGA-BG-A0MU_demographic",1932,"white","ad41e1ef-c12d-539c-936a-66be05ef82b6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MU_diagnosis","not reported",28621,"alive","8380/3",NA,617,"a87f99dd-5401-5644-83c3-bd101864d91b","c54.1",-28621,"TCGA-BG-A0MU_treatment","f920c410-cea7-5309-970b-8bc5adb439a5","01","true","TCGA-BG-A0MU-01A",NA,"f0af3f30-3d64-4bd8-9a8f-7ff7ab9bb7b0",FALSE,"7162F7A7-7295-4736-B721-B13DAE006092","Primary Tumor",NA,121,860,NA,1279065600,"11",30,"TCGA-BG-A0MU-01A-11",94,94,1,1,0,0,7,6,"2016-09-08T11:18:11.687029-05:00","2016-09-08T11:18:11.687029-05:00",1,2,1,1,"BOTTOM","TOP",3,2,"84f88171-4dfe-4ef7-920d-79674fbf8b55","93aeefe4-33bd-42e5-a05b-891899da1ed7","TCGA-BG-A0MU-01A-01-BSA","TCGA-BG-A0MU-01A-01-TSA",90,92,"05f82e60-6b95-4ea4-b035-7122eb450141","RNA","TCGA-BG-A0MU-01A-11R","8a2bd51a-13ae-43b6-94e4-9fb6e5bd2997",1.78,0.15,"UV Spec","R","23","TCGA-BG-A0MU-01A-11R-A104-07","06c39fc6-9167-4913-bf84-4fde036869a2",0.15,NA,68,29.4321329639889,152,"0a471f35-4e1d-5c94-9dca-3d9e81a87bb8","TCGA-BG-A0MU_exposure","UNCID_2214801.06c39fc6-9167-4913-bf84-4fde036869a2.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_3.tar.gz","2013-10-03T21:26:04.000Z","2013-10-03T21:38:02.000Z","FA3B2B0A-4AC6-4B74-82B0-64149A19CB20","F0AF3F30-3D64-4BD8-9A8F-7FF7AB9BB7B0","Unaligned reads",1975284722,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","06C39FC6-9167-4913-BF84-4FDE036869A2","University of North Carolina","564a380ce4b08c5d86907211","A7329910-B1C7-4A18-B28E-8FAD79121339","Uterine Corpus Endometrial Carcinoma","TARGZ","05F82E60-6B95-4EA4-B035-7122EB450141","2013-10-03T21:38:02.000Z","8A2BD51A-13AE-43B6-94E4-9FB6E5BD2997","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",121,"05F82E60-6B95-4EA4-B035-7122EB450141",NA,"BG","unc.edu.06c39fc6-9167-4913-bf84-4fde036869a2.1754884.bt.exon_quantification.txt",860,"TCGA-BG-A0MU-01A",NA,"F2348BE2-8D4E-4785-9289-5230F91BD122","TCGA",2010,NA,NA,"TUMOR FREE","F0AF3F30-3D64-4BD8-9A8F-7FF7AB9BB7B0",78,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2220B369-D1D5-48E1-8F1D-2BF17726A5C9.txt","Alive",NA,"TCGA-BG-A0MU","NOT HISPANIC OR LATINO","5A63B66E-FA8F-4464-9B02-248ADC81A0D4",NA,232,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"D5E88477-CCFB-41A8-BB5C-5D9931F23751","WHITE",NA,11,30,"93AEEFE4-33BD-42E5-A05B-891899DA1ED7","F00BBA55-A395-4E55-89A1-FDC58742ACE2","TCGA-BG-A0MU-01A-11R-A103-13_mirna.bam.bai","TCGA-BG-A0MU-01A-11",94,0,1,2,6,"TOP",2,1,"TCGA-BG-A0MU-01A-01-TSA",92,"MEGACE","Hormone Therapy","TCGA-BG-A0MU-D4661","TCGA-BG-A0MU-R4663","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",617,"TUMOR FREE","Alive",NA,"TCGA-BG-A0MU-F19322","TCGA-BG-A0MU",1,"BG","A0MU","YES","C54.1","8380/3","C54.1","NO","YES",-28621,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",232,NA,NA,NA,"TUMOR FREE","NO",9,12,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,78,2010,"Tumor resection",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
106609298,104753672,5007020174,"C6F4EDA3-DD75-4C38-8CA9-BFF8EEEFE182.bw","a766d113-bc3f-4448-a4e5-f391fb0c0e22","c6f4eda3-dd75-4c38-8ca9-bff8eeefe182","2016-08-09T14:43:26.895764-05:00","UNCID_2668043.a67adcd5-7f63-44f2-a127-568569c9a357.150108_UNC15-SN850_0402_AC5FTHACXX_8_TGACCA.tar.gz","2d44e4f2-afea-4ae4-8d39-db7f7a6d7249",4383898003,"Illumina HiSeq","52e6061b08ea9afa33638e9a02830e1e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:59:22.417459-05:00","2016-06-22T11:18:40.518409-05:00","2d44e4f2-afea-4ae4-8d39-db7f7a6d7249_analysis.xml","fd75deb2c5a9bce4207b0d3af0168deb","8199cbf6-68b7-49cc-a61b-0a9a23331ca0",2124,"2016-09-29T22:49:03.064749-05:00","2d44e4f2-afea-4ae4-8d39-db7f7a6d7249_experiment.xml","53222d4958a63b8c3d7a28892820fbf7","c599c132-0102-4873-a6ef-cb36bd0c2a98",2628,"2016-09-29T22:49:43.443379-05:00","2d44e4f2-afea-4ae4-8d39-db7f7a6d7249_run.xml","0b735647eefaf43d8b1b4f64608bd85a","c6015d17-8e0e-4c8c-9cd3-941288397814",354,"2016-09-08T11:27:03.863434-05:00","TCGA-B5-A0JR","2016-09-02T18:54:41.510318-05:00","female","TCGA-B5-A0JR_demographic",1933,"white","ac45a829-3a9a-5711-953f-829b2fec2583","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0JR_diagnosis","not reported",26814,"alive","8380/3",NA,1731,"938f9cea-823b-5d31-be57-89661c35ca40","c54.1",-26814,"TCGA-B5-A0JR_treatment","d525ff07-ba20-515e-a548-eba05bd605cc","01","true","TCGA-B5-A0JR-01A",NA,"07381a09-5cbd-4744-86ec-41a81e470204",FALSE,"B3CF4DE2-8755-4585-92C5-F8EE350C1C50","Primary Tumor",NA,1407,100,NA,1279670400,"13",20,"TCGA-B5-A0JR-01A-13",80,65,0,0,0,0,15,50,"2016-09-08T11:27:03.863434-05:00","2016-09-08T11:27:03.863434-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"973f9b75-2d49-4be1-9b46-4e1857d0f33e","a1c2fa30-471a-42c5-91fc-f4d9430153e2","TCGA-B5-A0JR-01A-01-TSA","TCGA-B5-A0JR-01A-01-BSA",85,50,"fe5c1a15-4677-4f53-9475-79dacea622f5","RNA","TCGA-B5-A0JR-01A-13R","8ee063d2-aa96-4631-8bfe-af66a43eba15",1.98,0.17,"UV Spec","R","23","TCGA-B5-A0JR-01A-13R-A466-07","a67adcd5-7f63-44f2-a127-568569c9a357",0.17,NA,105,40.5076964623278,161,"5cdf5e5c-f91a-5d80-8ef7-ef253e62de2d","TCGA-B5-A0JR_exposure","UNCID_2668043.a67adcd5-7f63-44f2-a127-568569c9a357.150108_UNC15-SN850_0402_AC5FTHACXX_8_TGACCA.tar.gz","2015-02-01T22:27:03.000Z","2015-02-01T22:46:39.000Z","2D44E4F2-AFEA-4AE4-8D39-DB7F7A6D7249","07381A09-5CBD-4744-86EC-41A81E470204","Unaligned reads",4383898003,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","A67ADCD5-7F63-44F2-A127-568569C9A357","University of North Carolina","56607922e4b0b37b3d9917d1","A766D113-BC3F-4448-A4E5-F391FB0C0E22","Uterine Corpus Endometrial Carcinoma","TARGZ","FE5C1A15-4677-4F53-9475-79DACEA622F5","2015-02-01T22:46:39.000Z","8EE063D2-AA96-4631-8BFE-AF66A43EBA15","United States","NO",1,NA,"Primary Tumor","Duke",1407,"FE5C1A15-4677-4F53-9475-79DACEA622F5",NA,"B5","UNCID_2667298.a67adcd5-7f63-44f2-a127-568569c9a357.sorted_genome_alignments.bam.bai",100,"TCGA-B5-A0JR-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","CA5FD93A-6951-451A-B41E-5B2A1C522B5E",73,"nationwidechildrens.org_clinical.TCGA-B5-A0JR.xml","Alive",NA,"TCGA-B5-A0JR",NA,"99C50A49-CFF6-4437-98A3-4890ED24EC1A",NA,1465,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,13,20,"A1C2FA30-471A-42C5-91FC-F4D9430153E2","D538E86A-ACB4-47CA-B48E-152F706C5231","UNCID_2667298.a67adcd5-7f63-44f2-a127-568569c9a357.sorted_genome_alignments.bam.bai","TCGA-B5-A0JR-01A-13",80,0,0,0,15,"TOP",0,0,"TCGA-B5-A0JR-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,NA,"NO",1731,"TUMOR FREE","Alive",NA,"TCGA-B5-A0JR-F12807","TCGA-B5-A0JR",1,"B5","A0JR","YES","C54.1","8380/3","C54.1","NO","YES",-26814,"FEMALE","WHITE",NA,"No","No","Alive",1465,NA,NA,NA,"TUMOR FREE","NO",7,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2006,"Dilation and curettage procedure",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29839293,29382501,2188371270,"90C2DE9B-904B-4206-A31A-B682239FD8A8.bw","a798a8cc-4e72-4a8c-9e20-74a14deafd12","90c2de9b-904b-4206-a31a-b682239fd8a8","2016-08-09T14:16:40.679222-05:00","UNCID_2214396.09b4aa83-d8e7-4615-bfad-da877df4fe7d.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_2.tar.gz","5592f5b9-8ca1-4f96-9d02-c06a96436a51",1859145158,"Illumina GA","3d8e913b8e8216dd9589c88aa95d2284","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:15:23.650921-05:00","2016-05-03T11:17:14.896869-05:00","5592f5b9-8ca1-4f96-9d02-c06a96436a51_analysis.xml","ac6caf2ed30e50a5906332ca9545751a","415cb07e-b1d2-4ce8-9248-b06ea45b93fb",2121,"2016-09-30T00:23:01.448544-05:00","5592f5b9-8ca1-4f96-9d02-c06a96436a51_experiment.xml","47dc2347add53eabe9a2c294a7d7aecc","ffe1749d-b651-4d98-8423-de5235dc5bd6",2257,"2016-09-29T19:09:11.287034-05:00","5592f5b9-8ca1-4f96-9d02-c06a96436a51_run.xml","694117b8c4d99583f64ff24c97050df4","3d748f84-a08b-44b1-a3ac-5cbdb021f787",347,"2016-09-08T10:30:16.988054-05:00","TCGA-BG-A0MS","2016-09-02T18:48:08.079627-05:00","female","TCGA-BG-A0MS_demographic",1956,"white","eb111509-466e-5511-a767-c881fb9375e6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MS_diagnosis","not reported",19547,"alive","8380/3",NA,1882,"439da3e5-75e8-5825-a748-010655b6fe25","c54.1",-19547,"TCGA-BG-A0MS_treatment","9314546a-c286-59b2-970d-7b55c7672991","01","true","TCGA-BG-A0MS-01A",NA,"ef7f78eb-314b-4cf2-b45b-810c84c6aa7b",FALSE,"7BE89F2D-74E5-4D9E-8270-A216D79ADCD7","Primary Tumor",NA,420,560,NA,1279065600,"11",30,"TCGA-BG-A0MS-01A-11",60,85,1,0,30,0,5,10,"2016-09-08T10:30:16.988054-05:00","2016-09-08T10:30:16.988054-05:00",15,7,3,0,"TOP","BOTTOM",1,1,"7c5e3a35-55f3-445b-83aa-f19d6b99e672","a2fb1a5e-885f-4eea-9753-77d2afc91b19","TCGA-BG-A0MS-01A-01-TSA","TCGA-BG-A0MS-01A-01-BSA",64,89,"49245adc-3fe1-419b-b757-fc0e091a26a0","RNA","TCGA-BG-A0MS-01A-11R","711a4927-ba06-47ff-b56e-fd3ffb1ece5d",1.95,0.13,"UV Spec","R","23","TCGA-BG-A0MS-01A-11R-A104-07","09b4aa83-d8e7-4615-bfad-da877df4fe7d",0.13,NA,65,25.390625,160,"315d1c24-b925-5ebd-842c-dfe6958b2d68","TCGA-BG-A0MS_exposure","UNCID_2214396.09b4aa83-d8e7-4615-bfad-da877df4fe7d.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_2.tar.gz","2013-10-03T15:16:04.000Z","2013-10-03T15:35:01.000Z","5592F5B9-8CA1-4F96-9D02-C06A96436A51","EF7F78EB-314B-4CF2-B45B-810C84C6AA7B","Unaligned reads",1859145158,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","09B4AA83-D8E7-4615-BFAD-DA877DF4FE7D","University of North Carolina","564a3364e4b0ef121817e09e","A798A8CC-4E72-4A8C-9E20-74A14DEAFD12","Uterine Corpus Endometrial Carcinoma","TARGZ","49245ADC-3FE1-419B-B757-FC0E091A26A0","2013-10-03T15:35:01.000Z","711A4927-BA06-47FF-B56E-FD3FFB1ECE5D","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",420,"49245ADC-3FE1-419B-B757-FC0E091A26A0",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C7A57035-FAC8-466B-B969-37A70C4D246F.txt",560,"TCGA-BG-A0MS-01A",NA,"5160EB08-ACF6-4632-90F7-162CE68A365E","TCGA",2009,NA,NA,"TUMOR FREE","EF7F78EB-314B-4CF2-B45B-810C84C6AA7B",53,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C7A57035-FAC8-466B-B969-37A70C4D246F.txt","Alive",NA,"TCGA-BG-A0MS","NOT HISPANIC OR LATINO","C367243D-2423-4376-8A9A-5F6EE89094F0",NA,553,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"D90979AA-5294-4BE4-8654-5E45D23FF70F","WHITE",NA,11,30,"A2FB1A5E-885F-4EEA-9753-77D2AFC91B19","711A4927-BA06-47FF-B56E-FD3FFB1ECE5D","TCGA-BG-A0MS-01A-11D-A10B-09_IlluminaGA-DNASeq_exome.bam","TCGA-BG-A0MS-01A-11",60,30,1,15,5,"TOP",1,3,"TCGA-BG-A0MS-01A-01-TSA",64,"PACLITAXEL","Chemotherapy","TCGA-BG-A0MS-D4643","TCGA-BG-A0MS-R4641","IMPLANTS","Primary Tumor Field",NA,"NO",937,"TUMOR FREE","Alive",NA,"TCGA-BG-A0MS-F19317","TCGA-BG-A0MS",1,"BG","A0MS","YES","C54.1","8380/3","C54.1","NO","YES",-19547,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",553,NA,NA,NA,"TUMOR FREE","NO",9,12,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34488814,34138180,2562143069,"EF6CF746-EDAC-47D9-BF0C-50C57D4E4322.bw","a79a4e56-09bf-4691-b7e0-81a9c2620d0f","ef6cf746-edac-47d9-bf0c-50c57d4e4322","2016-08-05T04:58:56.330875-05:00","UNCID_2189520.48ade293-84c9-41cf-97aa-c28bb4ac4ca6.120524_UNC2-RDR300275_00121_FC_64KREAAXX_5.tar.gz","e4fb845e-9225-4cf7-b6b4-f4641990990d",2194645544,"Illumina GA","9997ee24d59b02461cc9475436eaece0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:28:30.084973-05:00","2016-05-03T11:05:01.523277-05:00","e4fb845e-9225-4cf7-b6b4-f4641990990d_analysis.xml","0e352bee8538ddcf52749a4447cb626e","de06d6b4-34c3-4e50-ac0a-f0bee31b8c10",2122,"2016-09-29T22:24:21.429357-05:00","e4fb845e-9225-4cf7-b6b4-f4641990990d_experiment.xml","258a9a3122a9c2f769bc6a6cd09fb64d","b62f620e-7427-4a8c-9a97-ee676dd5e669",2258,"2016-09-29T22:39:45.579413-05:00","e4fb845e-9225-4cf7-b6b4-f4641990990d_run.xml","9ed5407bceab8a6043ec696880e084aa","bfd85c26-0690-4297-b428-f9ff036a2954",349,"2016-09-08T11:39:34.085225-05:00","TCGA-D1-A1NS","2016-09-02T18:52:17.402450-05:00","female","TCGA-D1-A1NS_demographic",1957,"white","9c7ebc91-28c8-5947-adb5-8a59ce7a93c4","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1NS_diagnosis","not reported",19638,"alive","8380/3",NA,43,"aab4e05f-3644-56c4-b7f7-af9d5e1b8adc","c54.1",-19638,"TCGA-D1-A1NS_treatment","10cd44cc-c7cc-5dff-b589-04115adc19a0","01","false","TCGA-D1-A1NS-01A",NA,"88b09e18-049d-4cbe-b7cb-42f0add220bb",FALSE,"FE397385-B600-4450-AE73-3CB62D5FEA3B","Primary Tumor",NA,92,220,NA,1301875200,"11",30,"TCGA-D1-A1NS-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:39:34.085225-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"c94d0f93-0e68-4149-9c0f-86311c5d0d39",NA,"TCGA-D1-A1NS-01A-01-TSA",NA,70,NA,"dd430f7d-8cab-440d-9481-de8d5c04bbd5","RNA","TCGA-D1-A1NS-01A-11R","e6704de6-897e-4594-bda2-fedbe9b99c2f",1.81,0.17,"UV Spec","R","23","TCGA-D1-A1NS-01A-11R-A14D-07","48ade293-84c9-41cf-97aa-c28bb4ac4ca6",0.17,NA,126,39.7677060977149,178,"5fc51d01-4ac8-53c6-885d-fe3101fae088","TCGA-D1-A1NS_exposure","UNCID_2189520.48ade293-84c9-41cf-97aa-c28bb4ac4ca6.120524_UNC2-RDR300275_00121_FC_64KREAAXX_5.tar.gz","2013-09-19T00:37:06.000Z","2013-09-19T00:50:02.000Z","E4FB845E-9225-4CF7-B6B4-F4641990990D","88B09E18-049D-4CBE-B7CB-42F0ADD220BB","Unaligned reads",2194645544,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","48ADE293-84C9-41CF-97AA-C28BB4AC4CA6","University of North Carolina","56607f15e4b0ca3191650b2a","A79A4E56-09BF-4691-B7E0-81A9C2620D0F","Uterine Corpus Endometrial Carcinoma","TARGZ","DD430F7D-8CAB-440D-9481-DE8D5C04BBD5","2013-09-19T00:50:02.000Z","E6704DE6-897E-4594-BDA2-FEDBE9B99C2F","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",92,"DD430F7D-8CAB-440D-9481-DE8D5C04BBD5",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.00339539-4450-4AD5-90AC-FDFE11DD167B.txt",220,"TCGA-D1-A1NS-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","E1FE6462-A80B-412B-98C8-091B24D58739",53,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.00339539-4450-4AD5-90AC-FDFE11DD167B.txt","Alive",NA,"TCGA-D1-A1NS","NOT HISPANIC OR LATINO","8CF73B8A-A70B-4B3C-856B-7CD025B95EF3",NA,43,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,11,30,"C94D0F93-0E68-4149-9C0F-86311C5D0D39","F14C6F32-5DBD-4D4C-A758-0F72B964D67A","TCGA-D1-A1NS-01A-11R-A14C-13_mirna.bam.bai","TCGA-D1-A1NS-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-D1-A1NS-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,"NO",43,"TUMOR FREE","Alive",NA,"TCGA-D1-A1NS-F21633","TCGA-D1-A1NS",1,"D1","A1NS","YES","C54.1","8380/3","C54.1","NO","YES",-19638,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",43,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
16631548,16386279,1223890574,"44E0B86A-690F-4AE9-9EA8-FDCC3C826B4F.bw","a7c565fc-c711-4b63-9549-4cd74d1f57c2","44e0b86a-690f-4ae9-9ea8-fdcc3c826b4f","2016-08-09T14:15:58.032372-05:00","UNCID_2211765.40c2c93a-81a9-4baa-91b3-3c950042475a.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_6.tar.gz","b3c0a6f4-4afe-4624-b123-b461eb560b4a",1010084170,"Illumina GA","af4e3f490f0e2a436115c96de3baf94b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:25:04.607014-05:00","2016-05-03T11:16:29.238681-05:00","b3c0a6f4-4afe-4624-b123-b461eb560b4a_analysis.xml","ce554a1951a2a35b732c385c600c8252","dbdc82c3-a77f-4767-b7e4-d0065ac654c7",2121,"2016-09-29T19:09:21.565793-05:00","b3c0a6f4-4afe-4624-b123-b461eb560b4a_experiment.xml","74904f8b863febabaf158abbc9b4dea5","3d943ece-2a6f-497b-a207-1f5dff277b9d",2257,"2016-09-29T21:27:02.001612-05:00","b3c0a6f4-4afe-4624-b123-b461eb560b4a_run.xml","81fa6ae24113c66fa384ac5b14d9bf2b","92ee3d0d-d499-424a-bc91-d5c9e46dee8f",347,"2016-09-08T10:31:23.930154-05:00","TCGA-BS-A0UM","2016-09-02T18:48:29.090369-05:00","female","TCGA-BS-A0UM_demographic",1941,"white","ee82158d-3054-55ab-a9f7-25cc3d32151e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0UM_diagnosis","not reported",23400,"alive","8380/3",NA,2644,"46329a92-6677-51db-ab6e-891dca8b0683","c54.1",-23400,"TCGA-BS-A0UM_treatment","f86d765a-e914-554f-8902-7c44d38b72c0","01","false","TCGA-BS-A0UM-01A",NA,"6f70f18e-5c53-4f1f-a63d-62bd27039b8d",FALSE,"97354B28-9E9A-4DBD-B0C7-79C1165AD1CA","Primary Tumor",NA,2072,90,NA,1285545600,"11",30,"TCGA-BS-A0UM-01A-11",75,70,0,0,0,0,0,10,"2016-09-08T10:31:23.930154-05:00","2016-09-08T10:31:23.930154-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"46f4a264-659e-4f14-b663-4bdedb899e44","09c675dc-fc1b-46d0-994b-2112d909fcec","TCGA-BS-A0UM-01A-01-TS1","TCGA-BS-A0UM-01A-01-BS1",100,90,"be6309d2-1155-4ecb-8a48-e7d02ecd82d8","RNA","TCGA-BS-A0UM-01A-11R","6b1a07ed-0468-4034-a319-44f1ca87b058",1.71,0.16,"UV Spec","R","23","TCGA-BS-A0UM-01A-11R-A104-07","40c2c93a-81a9-4baa-91b3-3c950042475a",0.16,NA,90,35.15625,160,"b8e10fe8-86da-5348-ba4a-85c03f9505b6","TCGA-BS-A0UM_exposure","UNCID_2211765.40c2c93a-81a9-4baa-91b3-3c950042475a.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_6.tar.gz","2013-10-03T01:43:04.000Z","2013-10-03T01:55:02.000Z","B3C0A6F4-4AFE-4624-B123-B461EB560B4A","6F70F18E-5C53-4F1F-A63D-62BD27039B8D","Unaligned reads",1010084170,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","40C2C93A-81A9-4BAA-91B3-3C950042475A","University of North Carolina","566076c7e4b0ca319164e03b","A7C565FC-C711-4B63-9549-4CD74D1F57C2","Uterine Corpus Endometrial Carcinoma","TARGZ","BE6309D2-1155-4ECB-8A48-E7D02ECD82D8","2013-10-03T01:55:02.000Z","6B1A07ED-0468-4034-A319-44F1CA87B058","None","NO",1,NA,"Primary Tumor","University of Hawaii",2072,"BE6309D2-1155-4ECB-8A48-E7D02ECD82D8",NA,"BS","UNCID_362266.TCGA-BS-A0UM-01A-11R-A104-07.110216_UNC6-RDR300211_00060_FC_62J5DAAXX.6.trimmed.annotated.translated_to_genomic.bam.bai",90,"TCGA-BS-A0UM-01A",NA,"ED9501A7-633C-45DC-9123-F634D931B33E","TCGA",2005,NA,NA,"WITH TUMOR","D5EF6EF5-A2E1-49A9-BFCB-C6BB41424676",64,"nationwidechildrens.org_clinical.TCGA-BS-A0UM.xml","Alive",NA,"TCGA-BS-A0UM","NOT HISPANIC OR LATINO","2EF3D9E3-28FD-4685-B47E-6E00A2710E92",NA,2191,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"9C79915C-E3CF-48DB-8E97-E8688AE81584","WHITE",NA,11,30,"46F4A264-659E-4F14-B663-4BDEDB899E44","A0869E60-1CC6-4857-AF6A-7C6A275DADA9","UNCID_2211765.40c2c93a-81a9-4baa-91b3-3c950042475a.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_6.tar.gz","TCGA-BS-A0UM-01A-11",75,0,0,0,0,"TOP",0,0,"TCGA-BS-A0UM-01A-01-TS1",100,"Carboplatin","Chemotherapy","TCGA-BS-A0UM-D17020","TCGA-BS-A0UM-R17024","OTHER: SPECIFY IN NOTES","Distant Recurrence",NA,"YES",2644,"WITH TUMOR","Alive",NA,"TCGA-BS-A0UM-F17016","TCGA-BS-A0UM",1,"BS","A0UM","YES","C54.1","8380/3","C54.1","NO","YES",-23400,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2191,NA,NA,NA,"WITH TUMOR","NO",25,3,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2005,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
94759006,93847034,4482539953,"67A90465-7774-43DD-A5AE-1F7B13757803.bw","a7d07151-5fc8-4c2a-a1cd-e7c7a2a9a7a7","67a90465-7774-43dd-a5ae-1f7b13757803","2016-08-09T13:15:46.420720-05:00","UNCID_2178399.9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e.130328_UNC10-SN254_0443_AD238RACXX_6_ATCACG.tar.gz","3a0cf042-21b2-4af3-9743-daf4e735f198",3933049700,"Illumina HiSeq","c6dc9a5f64928fa7bf2d3e1625021034","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:02:17.364421-05:00","2016-05-03T10:56:47.880266-05:00","3a0cf042-21b2-4af3-9743-daf4e735f198_analysis.xml","9fd79c0c1f72c49ae5569f3bd4520010","5e849295-9ab8-4771-af69-1f6283e7f33b",2122,"2016-09-29T21:03:57.498469-05:00","3a0cf042-21b2-4af3-9743-daf4e735f198_experiment.xml","f2aec6743ac51fce65a607fffc654589","846eeaf8-f1f3-4f3f-ae7f-2dfc01c8d041",2431,"2016-09-29T17:43:51.651282-05:00","3a0cf042-21b2-4af3-9743-daf4e735f198_run.xml","e0634f4ce9385c5cf5b76225f7b2bbcd","07b62506-5094-4df4-8562-9550db0dbbeb",354,"2016-09-08T10:26:00.751514-05:00","TCGA-AJ-A3BH","2016-09-02T18:54:51.050366-05:00","female","TCGA-AJ-A3BH_demographic",NA,"white","1974fb64-2bf1-5ae4-a1d3-549373310899","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3BH_diagnosis","not reported",NA,"alive","8380/3",NA,NA,"42feafc4-47c7-5f07-938b-cab59277e396","c54.1",NA,"TCGA-AJ-A3BH_treatment","712d6c72-03e3-563c-a608-66fac6735f30","01","false","TCGA-AJ-A3BH-01A",NA,"5f692f2b-3736-4b1f-8ffe-a0ee085975df",FALSE,"469A2D52-09E6-4B67-B8D0-D6292AC22285","Primary Tumor",NA,NA,100,NA,1317859200,"11",30,"TCGA-AJ-A3BH-01A-11",90,NA,1,NA,6,NA,2,NA,"2016-09-08T10:26:00.751514-05:00",NA,2,NA,0,NA,"TOP",NA,2,NA,"13a3c30d-32ac-4982-859a-4100a29dbbe2",NA,"TCGA-AJ-A3BH-01A-01-TSA",NA,90,NA,"069f69f8-f9b9-4861-a7a7-4968e748205e","RNA","TCGA-AJ-A3BH-01A-11R","b994deb3-938c-493d-8f80-f8fc6cc6f558",1.34,0.18,"UV Spec","R","23","TCGA-AJ-A3BH-01A-11R-A19W-07","9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e",0.18,NA,71,28.8044139721693,157,"3f9f336f-1876-5ebf-b865-9bdfaefb2be4","TCGA-AJ-A3BH_exposure","UNCID_2178399.9f7b98f9-86c1-4c0c-8727-b8ecfb7b5e4e.130328_UNC10-SN254_0443_AD238RACXX_6_ATCACG.tar.gz","2013-09-12T01:51:03.000Z","2013-09-12T02:08:01.000Z","3A0CF042-21B2-4AF3-9743-DAF4E735F198","5F692F2B-3736-4B1F-8FFE-A0EE085975DF","Unaligned reads",3933049700,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","9F7B98F9-86C1-4C0C-8727-B8ECFB7B5E4E","University of North Carolina","564a4073e4b0298dd2ca0756","A7D07151-5FC8-4C2A-A1CD-E7C7A2A9A7A7","Uterine Corpus Endometrial Carcinoma","TARGZ","069F69F8-F9B9-4861-A7A7-4968E748205E","2013-09-12T02:08:01.000Z","B994DEB3-938C-493D-8F80-F8FC6CC6F558","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",NA,"069F69F8-F9B9-4861-A7A7-4968E748205E",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.44F1F9B9-348C-45D3-9E94-E3FC9BCFE9F6.txt",100,"TCGA-AJ-A3BH-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","5F692F2B-3736-4B1F-8FFE-A0EE085975DF",81,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.44F1F9B9-348C-45D3-9E94-E3FC9BCFE9F6.txt","Alive",NA,"TCGA-AJ-A3BH","NOT HISPANIC OR LATINO",NA,NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,"WHITE",NA,11,30,"13A3C30D-32AC-4982-859A-4100A29DBBE2","DA6C1E99-DC0B-4FF8-9211-C9268B60AA1B","TCGA-AJ-A3BH-01A-11R-A19V-13_mirna.bam.bai","TCGA-AJ-A3BH-01A-11",90,6,1,2,2,"TOP",2,0,"TCGA-AJ-A3BH-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3BH",1,"AJ","A3BH","YES","C54.1","8380/3","C54.1","YES","NO",NA,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",NA,NA,NA,NA,"TUMOR FREE","NO",3,2,2012,"NO","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,NA,NA,2011,NA,NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
133840254,131853036,6294270362,"A73A2348-FC50-42A5-ADF0-6647E5ECF0EA.bw","a7fd6522-8953-461f-9e5f-fdeb7d180d46","a73a2348-fc50-42a5-adf0-6647e5ecf0ea","2016-09-29T21:59:47.023527-05:00","UNCID_2316529.253d79e4-6505-4704-8cd4-aafa5d36b4a4.131008_UNC11-SN627_0326_AC2KLPACXX_7_ACAGTG.tar.gz","1eaaa6ae-61a8-47ff-b93b-e73c230853b0",6077760107,"Illumina HiSeq","8b2816d3a136e1f4457136a0b0b1e2dd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:57:55.994286-05:00","2016-05-03T11:28:50.231867-05:00","1eaaa6ae-61a8-47ff-b93b-e73c230853b0_analysis.xml","bd8783fd3da3c3fb74c644ddc72a6780","80b0d394-b327-4a13-bd2c-10f060d99f8b",2124,"2016-09-29T21:16:27.454940-05:00","1eaaa6ae-61a8-47ff-b93b-e73c230853b0_experiment.xml","337d724f08569ddddbe8f82766d9604e","8c56e09c-78bd-4dac-9b92-c06db79e442c",2628,"2016-09-29T18:44:53.210410-05:00","1eaaa6ae-61a8-47ff-b93b-e73c230853b0_run.xml","8be0dd77c1c8d3afb2679daab81b4d2e","2e207894-f237-4894-a29a-543ad80fc8f6",354,"2016-09-08T10:27:12.782724-05:00","TCGA-EY-A1GX","2016-09-02T18:52:02.594180-05:00","female","TCGA-EY-A1GX_demographic",1934,"white","f1aab7a0-5038-57c0-bbcd-a20644b292c6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GX_diagnosis","not reported",27962,"dead","8380/3",1127,197,"51442c7f-83e1-5dee-b60b-d7393a63ebf6","c54.1",-27962,"TCGA-EY-A1GX_treatment","2e803209-934e-5057-ac22-b2e4f59b52c9","01","false","TCGA-EY-A1GX-01A",NA,"a6a446ff-6dcf-4311-ac05-afb34fcb19a7",FALSE,"4AD600AE-7CE0-4BBA-B4FC-0EB8C460502B","Primary Tumor",NA,172,370,NA,1297728000,"12",20,"TCGA-EY-A1GX-01A-12",60,NA,20,NA,0,NA,30,NA,"2016-09-08T10:27:12.782724-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"ea199ce8-d342-4084-89be-818eedd0a4ab",NA,"TCGA-EY-A1GX-01A-01-TSA",NA,60,NA,"6676b287-4309-4924-a5e7-f45e598d8e03","RNA","TCGA-EY-A1GX-01A-12R","cf6a97de-ef94-4dea-aa94-1cc026e86039",1.89,0.15,"UV Spec","R","23","TCGA-EY-A1GX-01A-12R-A13S-07","253d79e4-6505-4704-8cd4-aafa5d36b4a4",0.15,NA,69,26.953125,160,"ac42e896-1a9c-5755-8a71-a1b9714f3795","TCGA-EY-A1GX_exposure","UNCID_2316529.253d79e4-6505-4704-8cd4-aafa5d36b4a4.131008_UNC11-SN627_0326_AC2KLPACXX_7_ACAGTG.tar.gz","2014-01-07T02:16:48.000Z","2014-01-07T05:00:01.000Z","1EAAA6AE-61A8-47FF-B93B-E73C230853B0","A6A446FF-6DCF-4311-AC05-AFB34FCB19A7","Unaligned reads",6077760107,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","253D79E4-6505-4704-8CD4-AAFA5D36B4A4","University of North Carolina","56607b98e4b0ca319164fc9d","A7FD6522-8953-461F-9E5F-FDEB7D180D46","Uterine Corpus Endometrial Carcinoma","TARGZ","6676B287-4309-4924-A5E7-F45E598D8E03","2014-01-07T05:00:01.000Z","CF6A97DE-EF94-4DEA-AA94-1CC026E86039","United States","NO",1,NA,"Primary Tumor","University of North Carolina",172,"6676B287-4309-4924-A5E7-F45E598D8E03",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E64F4415-7FA9-481E-8BD3-89FE5AB640D9.txt",370,"TCGA-EY-A1GX-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","A6A446FF-6DCF-4311-AC05-AFB34FCB19A7",76,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E64F4415-7FA9-481E-8BD3-89FE5AB640D9.txt","Alive",NA,"TCGA-EY-A1GX","NOT HISPANIC OR LATINO","CC86F068-B581-457F-AB04-BE8D1BBFDB1E",NA,166,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"WHITE",NA,12,20,"EA199CE8-D342-4084-89BE-818EEDD0A4AB","2ACF6357-E8BC-4DBD-87A5-DCE79728A24A","TCGA-EY-A1GX-01A-12R-A13R-13_mirna.bam","TCGA-EY-A1GX-01A-12",60,0,20,40,30,"TOP",10,20,"TCGA-EY-A1GX-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,"TCGA-EY-A1GX-F70244_NTE-3","YES",NA,NA,"Dead",1127,"TCGA-EY-A1GX-F70244","TCGA-EY-A1GX",1,"EY","A1GX","YES","C54.1","8380/3","C54.1","YES","NO",-27962,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",166,NA,NA,NA,"TUMOR FREE","NO",24,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,76,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33436054,28175054,2113125487,"E3D18696-51D7-4BE3-A32B-3196E5F80438.bw","a8079ea5-c37b-4f77-aca0-b043bf420675","e3d18696-51d7-4be3-a32b-3196e5f80438","2016-08-09T14:17:21.498349-05:00","UNCID_2214425.c30924bd-cb0b-43ee-832e-1b470ec39d21.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_4.tar.gz","0c6dc2cd-c559-418b-a3ec-a0bd3b2fa76d",2090762361,"Illumina GA","47302b6e04de50ba585dba9395d813dc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:47:11.720675-05:00","2016-05-03T11:17:14.896869-05:00","0c6dc2cd-c559-418b-a3ec-a0bd3b2fa76d_analysis.xml","07bb9a9d91a75f0a86b40e4f075df7d4","552cb365-eb22-4aaf-972c-ba0aae2548f9",2121,"2016-08-29T09:59:52.653238-05:00","0c6dc2cd-c559-418b-a3ec-a0bd3b2fa76d_experiment.xml","5d416844cb0b92977d2eab0b12c322ce","b1fb83d1-c2ad-4832-a391-b5fbb4b79c25",2257,"2016-09-29T20:07:27.345636-05:00","0c6dc2cd-c559-418b-a3ec-a0bd3b2fa76d_run.xml","d5d9ac16cd497a11869f5a3e29c0c1f9","619bfa9e-bb6b-479d-9c4d-5689cc0fd847",347,"2016-09-08T10:33:42.819207-05:00","TCGA-B5-A0K2","2016-09-02T18:47:59.527921-05:00","female","TCGA-B5-A0K2_demographic",1954,"white","8edb6f51-93e3-5ff9-88f6-e970cb486bb6","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0K2_diagnosis","not reported",20080,"alive","8380/3",NA,2209,"3b479bf2-eb91-5790-bda7-bf6c64a89476","c54.1",-20080,"TCGA-B5-A0K2_treatment","1e1191a3-0b25-5019-82c7-0b995e1ccd88","01","true","TCGA-B5-A0K2-01A",NA,"17122498-71c0-4094-a86e-863da3116463",FALSE,"5D780459-F4E6-4BB8-939D-5FDFD9BF7073","Primary Tumor",NA,534,270,NA,1277769600,"12",30,"TCGA-B5-A0K2-01A-12",75,90,0,0,0,0,0,0,"2016-09-08T10:33:42.819207-05:00","2016-09-08T10:33:42.819207-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"cc6ea95a-e461-4e34-ab1b-d3fc81614c96","810ef419-1871-4afb-ae27-f5533c377a4a","TCGA-B5-A0K2-01A-01-BS1","TCGA-B5-A0K2-01A-01-TS1",100,100,"0713ffc5-ae56-4661-be30-78c3eb7c4d60","RNA","TCGA-B5-A0K2-01A-12R","381a446a-c911-4f1c-bbb8-2aa35e688fdc",1.79,0.15,"UV Spec","R","23","TCGA-B5-A0K2-01A-12R-A104-07","c30924bd-cb0b-43ee-832e-1b470ec39d21",0.15,NA,84,33.2265337605316,159,"d420e1e5-a13a-5011-8450-e23c06dc8a65","TCGA-B5-A0K2_exposure","UNCID_2214425.c30924bd-cb0b-43ee-832e-1b470ec39d21.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_4.tar.gz","2013-10-03T15:46:04.000Z","2013-10-03T15:59:01.000Z","0C6DC2CD-C559-418B-A3EC-A0BD3B2FA76D","17122498-71C0-4094-A86E-863DA3116463","Unaligned reads",2090762361,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C30924BD-CB0B-43EE-832E-1B470EC39D21","University of North Carolina","5660769fe4b0ec1099f8c746","A8079EA5-C37B-4F77-ACA0-B043BF420675","Uterine Corpus Endometrial Carcinoma","TARGZ","0713FFC5-AE56-4661-BE30-78C3EB7C4D60","2013-10-03T15:59:01.000Z","381A446A-C911-4F1C-BBB8-2AA35E688FDC","United States","NO",1,NA,"Primary Tumor","Duke",534,"0713FFC5-AE56-4661-BE30-78C3EB7C4D60",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A0DA1E80-290C-4AF2-AE26-9492B418C580.txt",270,"TCGA-B5-A0K2-01A",NA,"F06CA5D1-8240-44DF-B610-AFD56691F3EA","TCGA",2008,NA,NA,"TUMOR FREE","D71B2497-59F7-41AC-8814-8A9556E96BEB",54,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A0DA1E80-290C-4AF2-AE26-9492B418C580.txt","Alive",NA,"TCGA-B5-A0K2",NA,"52E88D34-0A29-418A-90A8-66431D85B992",NA,683,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,12,30,"CC6EA95A-E461-4E34-AB1B-D3FC81614C96","BA1C6854-4450-411D-A7F6-047209249B5E","UNCID_362787.TCGA-B5-A0K2-01A-12R-A104-07.110209_UNC1-RDR301647_00038_FC_62J3UAAXX.4.trimmed.annotated.translated_to_genomic.bam","TCGA-B5-A0K2-01A-12",75,0,0,0,0,"BOTTOM",0,0,"TCGA-B5-A0K2-01A-01-BS1",100,"Megace","Hormone Therapy","TCGA-B5-A0K2-D13264",NA,NA,NA,NA,"NO",788,"TUMOR FREE","Alive",NA,"TCGA-B5-A0K2-F13261","TCGA-B5-A0K2",1,"B5","A0K2","YES","C54.1","8380/3","C54.1","NO","YES",-20080,"FEMALE","WHITE",NA,"No","No","Alive",683,NA,NA,NA,"TUMOR FREE","NO",5,1,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
32257887,31692952,2377449249,"86A9A426-4B69-4572-9AFF-103C2724E5EA.bw","a8614c49-c7f1-4de9-bd2f-4764b094d604","86a9a426-4b69-4572-9aff-103c2724e5ea","2016-08-09T14:14:36.228884-05:00","UNCID_2210189.88e9cdc4-bcf1-49e9-8965-7dc6b3688585.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_2.tar.gz","f1d8a363-3071-4740-a20b-63f0729d07cd",2041328509,"Illumina GA","fba2bb070d836409022ac811599c7fe6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:37:15.005922-05:00","2016-05-03T11:15:47.407128-05:00","f1d8a363-3071-4740-a20b-63f0729d07cd_analysis.xml","a585ee50d7ccf611096b90ad13993e69","293f2ff0-7f64-477c-a0c4-437f891e053b",2123,"2016-08-13T02:51:08.284955-05:00","f1d8a363-3071-4740-a20b-63f0729d07cd_experiment.xml","549ca9c8048474018ae6b4d0b15f3e1c","445b9c19-f1c9-4ca8-8a3c-3f1e03d9eeab",2257,"2016-09-29T19:40:58.578478-05:00","f1d8a363-3071-4740-a20b-63f0729d07cd_run.xml","f5f9c9bcb5300ea792712c18ae37e4b9","5150e56a-c4ae-4fc9-ba37-c84b4246fd97",347,"2016-09-08T10:54:59.951659-05:00","TCGA-A5-A0GG","2016-09-02T18:49:17.172104-05:00","female","TCGA-A5-A0GG_demographic",1927,"black or african american","ffaff7f1-1d96-5720-9231-587e03833f53","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GG_diagnosis","not reported",27809,"alive","8380/3",NA,3762,"1e3e2d09-526a-5154-a63e-32946e37e91b","c54.1",-27809,"TCGA-A5-A0GG_treatment","80b36487-b93d-5818-b76c-37a327462440","01","true","TCGA-A5-A0GG-01A",NA,"b5b941e3-f828-4091-b9b1-6b38d1493847",FALSE,"6867E576-1020-41D7-BC18-25160FE17F81","Primary Tumor",NA,2369,220,NA,1291248000,"11",30,"TCGA-A5-A0GG-01A-11",70,50,0,0,20,30,0,10,"2016-09-08T10:54:59.951659-05:00","2016-09-08T10:54:59.951659-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"129ee9f0-ade1-4f92-800c-9be7c2500b78","6e03d58b-727d-4a60-a7ab-726183eae29d","TCGA-A5-A0GG-01A-01-TSA","TCGA-A5-A0GG-01A-01-BSA",80,60,"f704fb02-9c9a-46ff-9291-4112433333e4","RNA","TCGA-A5-A0GG-01A-11R","a0e9b3f2-70cc-40ab-b39f-637d50f8347e",1.81,0.15,"UV Spec","R","23","TCGA-A5-A0GG-01A-11R-A118-07","88e9cdc4-bcf1-49e9-8965-7dc6b3688585",0.15,NA,64,25,160,"4e2f60a6-7e94-5a2f-982d-8ecf3caf95f7","TCGA-A5-A0GG_exposure","UNCID_2210189.88e9cdc4-bcf1-49e9-8965-7dc6b3688585.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_2.tar.gz","2013-10-02T07:06:04.000Z","2013-10-02T07:25:02.000Z","F1D8A363-3071-4740-A20B-63F0729D07CD","B5B941E3-F828-4091-B9B1-6B38D1493847","Unaligned reads",2041328509,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","88E9CDC4-BCF1-49E9-8965-7DC6B3688585","University of North Carolina","566075f2e4b016715ab68923","A8614C49-C7F1-4DE9-BD2F-4764B094D604","Uterine Corpus Endometrial Carcinoma","TARGZ","F704FB02-9C9A-46FF-9291-4112433333E4","2013-10-02T07:25:02.000Z","A0E9B3F2-70CC-40AB-B39F-637D50F8347E","None","NO",1,NA,"Primary Tumor","Cedars Sinai",2369,"F704FB02-9C9A-46FF-9291-4112433333E4",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B9DA4BE2-52B2-4824-A299-8E0D9B3E91E4.txt",220,"TCGA-A5-A0GG-01A",NA,NA,"TCGA",2003,NA,NA,"TUMOR FREE","B5B941E3-F828-4091-B9B1-6B38D1493847",76,"438b5b6ed07bc9f1ed70deb246ba9ab5.bam","Alive",NA,"TCGA-A5-A0GG","NOT HISPANIC OR LATINO","E49D7085-44FE-4B71-94DD-F26879F496CE",NA,2517,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"59DDEB88-4276-4E39-BD90-1B7A7E9DBB52","BLACK OR AFRICAN AMERICAN",NA,11,30,"6E03D58B-727D-4A60-A7AB-726183EAE29D","F4A5CCFA-0580-4E70-B4A8-EA1618F721A1","730dac4f2b9e3f7bc83f758dbd514583.bam","TCGA-A5-A0GG-01A-11",70,20,0,0,0,"TOP",0,0,"TCGA-A5-A0GG-01A-01-TSA",80,NA,NA,NA,"TCGA-A5-A0GG-R5831","IMPLANTS","Primary Tumor Field",NA,"NO",2656,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GG-F17141","TCGA-A5-A0GG",1,"A5","A0GG","YES","C54.1","8380/3","C54.1","NO","YES",-27809,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",2517,NA,NA,NA,"TUMOR FREE","NO",7,1,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,76,2003,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
133802498,126713259,6037789412,"9293F2BB-99B2-45DF-AEDD-83F734641FFD.bw","a8def1a0-a136-47f4-9ad9-60ebcf9b726b","9293f2bb-99b2-45df-aedd-83f734641ffd","2016-08-25T14:57:12.312168-05:00","UNCID_2327182.773d237c-995c-4e0b-aaf1-3b78763ae704.131118_UNC15-SN850_0339_AC347DACXX_8_TGACCA.tar.gz","60b6293b-651b-4418-b27d-17915cc99f7c",5995576893,"Illumina HiSeq","102383383186f02d72b8fd250df21815","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:57:07.523660-05:00","2016-05-03T11:34:55.532339-05:00","60b6293b-651b-4418-b27d-17915cc99f7c_analysis.xml","480933ccb4d91c32860ed21565900b63","a59391d3-608d-45fb-b00a-6cf12c9008d3",2124,"2016-09-29T19:26:23.999964-05:00","60b6293b-651b-4418-b27d-17915cc99f7c_experiment.xml","be7dbe3e71b38eb3961190f3af91dab0","484e87ab-f8dd-4112-af78-6102965125a5",2628,"2016-09-29T19:35:28.748171-05:00","60b6293b-651b-4418-b27d-17915cc99f7c_run.xml","70dbf88aa3b838cab163fdff5f350ed9","4decbeb3-3125-43e1-a15b-2e0a5256f885",354,"2016-09-08T11:14:14.413834-05:00","TCGA-AX-A2HD","2016-09-02T18:52:27.880050-05:00","female","TCGA-AX-A2HD_demographic",1939,"white","0cbf6c30-6909-56ac-9390-67b1bba5eaac","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HD_diagnosis","not reported",25499,"alive","8380/3",NA,1414,"c3080851-f81c-5b94-b205-562399603585","c54.1",-25499,"TCGA-AX-A2HD_treatment","61f8a04d-cded-5f19-aa28-ea114d0f140d","11","false","TCGA-AX-A2HD-11A",NA,"26bc3b4c-b0bc-4d05-9dbf-334f27f1cb89",FALSE,NA,"Solid Tissue Normal",NA,1175,110,NA,1308182400,"11",30,"TCGA-AX-A2HD-11A-11",0,NA,0,NA,97,NA,0,NA,"2016-09-08T11:14:14.413834-05:00",NA,0,NA,0,NA,"TOP",NA,3,NA,"04eec40c-697e-4d90-bfe1-ecd5e80ea5a8",NA,"TCGA-AX-A2HD-11A-01-TSA",NA,0,NA,"416b6377-b861-4b1d-8b4e-2e106c14b8c8","RNA","TCGA-AX-A2HD-11A-11R","eb6ac8cd-ae49-499d-9b29-0782610f884f",1.75,0.18,"UV Spec","R","23","TCGA-AX-A2HD-11A-11R-A32Y-07","773d237c-995c-4e0b-aaf1-3b78763ae704",0.18,NA,51,22.9719382009819,149,"9c6b1c0f-6943-5a5f-be42-039f5d5fb4ee","TCGA-AX-A2HD_exposure","UNCID_2327182.773d237c-995c-4e0b-aaf1-3b78763ae704.131118_UNC15-SN850_0339_AC347DACXX_8_TGACCA.tar.gz","2014-01-25T00:52:09.000Z","2014-01-25T01:08:03.000Z","60B6293B-651B-4418-B27D-17915CC99F7C","26BC3B4C-B0BC-4D05-9DBF-334F27F1CB89","Unaligned reads",5995576893,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","773D237C-995C-4E0B-AAF1-3B78763AE704","University of North Carolina","56607720e4b018727fea11cf","A8DEF1A0-A136-47F4-9AD9-60EBCF9B726B","Uterine Corpus Endometrial Carcinoma","TARGZ","416B6377-B861-4B1D-8B4E-2E106C14B8C8","2014-01-25T01:08:03.000Z","EB6AC8CD-AE49-499D-9B29-0782610F884F","United States","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",1175,"416B6377-B861-4B1D-8B4E-2E106C14B8C8",NA,"AX","UNCID_2281343.773d237c-995c-4e0b-aaf1-3b78763ae704.sorted_genome_alignments.bam.bai",110,"TCGA-AX-A2HD-11A",NA,NA,"TCGA",2008,NA,NA,"WITH TUMOR","5A2EDE97-0CF7-44D7-A789-92EE9BDA3D6C",69,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.6BD35FAB-31F7-42F9-BD81-F8083DF351AC.txt","Alive",NA,"TCGA-AX-A2HD","NOT HISPANIC OR LATINO","52ED148B-1AD5-45C2-A450-1CE9AAD1B2E8",NA,1232,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"04EEC40C-697E-4D90-BFE1-ECD5E80EA5A8","EB6AC8CD-AE49-499D-9B29-0782610F884F","UNCID_2281343.773d237c-995c-4e0b-aaf1-3b78763ae704.sorted_genome_alignments.bam.bai","TCGA-AX-A2HD-11A-11",0,97,0,0,0,"TOP",3,0,"TCGA-AX-A2HD-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,"NO",1414,"WITH TUMOR","Alive",NA,"TCGA-AX-A2HD-F31844","TCGA-AX-A2HD",1,"AX","A2HD","YES","C54.1","8380/3","C54.1","NO","YES",-25499,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1232,NA,NA,NA,"WITH TUMOR","NO",26,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33373136,33170289,2465402682,"3113CB55-0CB8-4C63-9308-AFF20B6A7452.bw","a8def1a0-a136-47f4-9ad9-60ebcf9b726b","3113cb55-0cb8-4c63-9308-aff20b6a7452","2016-08-05T07:36:34.072023-05:00","UNCID_2203685.03141105-bc66-4e89-ad97-c54fcf189468.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_2.tar.gz","6a80a9f6-c7f5-4ff8-9377-f911646999c0",2119408727,"Illumina GA","87950988a49f6f922cf7a76a86018107","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:01:42.055095-05:00","2016-05-03T11:10:47.515830-05:00","6a80a9f6-c7f5-4ff8-9377-f911646999c0_analysis.xml","9efec0742598180b0cc3ddd8522c95ef","5e26ef5b-4c5d-451f-99d4-3e3e1fb0f4ca",2121,"2016-08-13T01:55:13.556314-05:00","6a80a9f6-c7f5-4ff8-9377-f911646999c0_experiment.xml","6eacc0da0eac153dcc5f5baf60531bbf","d7315873-aedf-432a-8d9b-1fc4e4c0e88c",2257,"2016-09-29T20:03:04.938850-05:00","6a80a9f6-c7f5-4ff8-9377-f911646999c0_run.xml","6e0191dd29cf7876f8f18d9927091cb0","5efa3e47-e9c3-4762-a087-4518aabc22c6",347,"2016-09-08T11:14:14.413834-05:00","TCGA-AX-A2HD","2016-09-02T18:52:27.880050-05:00","female","TCGA-AX-A2HD_demographic",1939,"white","0cbf6c30-6909-56ac-9390-67b1bba5eaac","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2HD_diagnosis","not reported",25499,"alive","8380/3",NA,1414,"c3080851-f81c-5b94-b205-562399603585","c54.1",-25499,"TCGA-AX-A2HD_treatment","61f8a04d-cded-5f19-aa28-ea114d0f140d","01","false","TCGA-AX-A2HD-01A",NA,"5a2ede97-0cf7-44d7-a789-92ee9bda3d6c",FALSE,"83BDA3FE-254F-4F99-B41E-FC1F8C128906","Primary Tumor",NA,1175,100,NA,1308182400,"21",30,"TCGA-AX-A2HD-01A-21",96,NA,0,NA,0,NA,2,NA,"2016-09-08T11:14:14.413834-05:00",NA,1,NA,0,NA,"TOP",NA,2,NA,"e8562f08-560d-4bd2-8c4e-015837b6bc91",NA,"TCGA-AX-A2HD-01A-02-TSB",NA,96,NA,"f15a4f70-8cc3-4b21-b5f3-37a46fd9ac21","RNA","TCGA-AX-A2HD-01A-21R","0cb9da84-99d2-4e46-a1a4-57520616a55c",1.85,0.17,"UV Spec","R","23","TCGA-AX-A2HD-01A-21R-A17B-07","03141105-bc66-4e89-ad97-c54fcf189468",0.17,NA,51,22.9719382009819,149,"9c6b1c0f-6943-5a5f-be42-039f5d5fb4ee","TCGA-AX-A2HD_exposure","UNCID_2203685.03141105-bc66-4e89-ad97-c54fcf189468.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_2.tar.gz","2013-09-26T16:07:05.000Z","2013-09-26T16:20:01.000Z","6A80A9F6-C7F5-4FF8-9377-F911646999C0","5A2EDE97-0CF7-44D7-A789-92EE9BDA3D6C","Unaligned reads",2119408727,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","03141105-BC66-4E89-AD97-C54FCF189468","University of North Carolina","56607723e4b0ec1099f8cc2d","A8DEF1A0-A136-47F4-9AD9-60EBCF9B726B","Uterine Corpus Endometrial Carcinoma","TARGZ","F15A4F70-8CC3-4B21-B5F3-37A46FD9AC21","2013-09-26T16:20:01.000Z","0CB9DA84-99D2-4E46-A1A4-57520616A55C","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1175,"F15A4F70-8CC3-4B21-B5F3-37A46FD9AC21",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.6BD35FAB-31F7-42F9-BD81-F8083DF351AC.txt",100,"TCGA-AX-A2HD-01A",NA,NA,"TCGA",2008,NA,NA,"WITH TUMOR","5A2EDE97-0CF7-44D7-A789-92EE9BDA3D6C",69,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.6BD35FAB-31F7-42F9-BD81-F8083DF351AC.txt","Alive",NA,"TCGA-AX-A2HD","NOT HISPANIC OR LATINO","52ED148B-1AD5-45C2-A450-1CE9AAD1B2E8",NA,1232,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,21,30,"E8562F08-560D-4BD2-8C4E-015837B6BC91","A2F51D5C-25BB-45A6-AF51-CE16E5B14118","TATTY_p_TCGA_b52_156_SNP_N_GenomeWideSNP_6_E08_809046.tangent.copynumber.data.txt","TCGA-AX-A2HD-01A-21",96,0,0,1,2,"TOP",2,0,"TCGA-AX-A2HD-01A-02-TSB",96,NA,NA,NA,NA,NA,NA,NA,"NO",1414,"WITH TUMOR","Alive",NA,"TCGA-AX-A2HD-F31844","TCGA-AX-A2HD",1,"AX","A2HD","YES","C54.1","8380/3","C54.1","NO","YES",-25499,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1232,NA,NA,NA,"WITH TUMOR","NO",26,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
26374707,25815728,1886290870,"C76988D4-E96A-4708-8320-399E9C880BC3.bw","a8f38e37-978b-4435-b676-e8d4c34da909","c76988d4-e96a-4708-8320-399e9c880bc3","2016-08-05T00:23:43.971729-05:00","UNCID_2215090.73e01a38-164c-44ce-ab36-ed429af8af44.101014_UNC2-RDR300275_00039_FC_706C1AAXX_4.tar.gz","c558edf2-590c-4e43-9aff-8a46686605d7",1542269153,"Illumina GA","6091e81de12f432f9a38fdb6ee9fae09","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:09:31.181452-05:00","2016-05-03T11:17:59.903755-05:00","c558edf2-590c-4e43-9aff-8a46686605d7_analysis.xml","a6439ba8806871e614ef096ca5a05e25","ad2561d7-76b6-4d7b-9f00-c66966f110ca",2120,"2016-10-07T15:57:16.019924-05:00","c558edf2-590c-4e43-9aff-8a46686605d7_experiment.xml","d2333804bd00a3174223ab4876742619","0aae586a-b533-466b-abbc-f335c95307b5",2256,"2016-09-30T00:01:45.151518-05:00","c558edf2-590c-4e43-9aff-8a46686605d7_run.xml","d0b2ec4b9b77e88310c9a51d034945d3","f2b70d41-c9bd-4b43-8db0-11c682d00020",345,"2016-09-08T10:44:15.133645-05:00","TCGA-B5-A0K4","2016-09-02T18:54:44.789837-05:00","female","TCGA-B5-A0K4_demographic",1958,"not reported","9234f877-58d0-540d-89b1-9666a42bbfc4","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0K4_diagnosis","not reported",18631,"alive","8380/3",NA,1757,"d54c375d-f9ef-5698-8f4d-af8872247cee","c54.1",-18631,"TCGA-B5-A0K4_treatment","a93d1176-b083-536f-b90c-0b99e4578474","01","true","TCGA-B5-A0K4-01A",NA,"a4ac1f6e-3411-47ae-9592-513b3d32223f",FALSE,"80DE2981-089A-47A2-B221-F7C28ECAF3F2","Primary Tumor",NA,264,280,NA,1277769600,"11",30,"TCGA-B5-A0K4-01A-11",70,80,0,0,0,0,20,15,"2016-09-08T10:44:15.133645-05:00","2016-09-08T10:44:15.133645-05:00",0,0,0,0,"TOP","BOTTOM",20,15,"7d5daf5a-f9d5-43ec-b4a0-1c935d7af49a","c716946c-3e2e-4d05-b569-770d6f5023a5","TCGA-B5-A0K4-01A-01-TS1","TCGA-B5-A0K4-01A-01-BS1",60,70,"4fd4eaec-f023-4f55-95e0-baa21436a3a3","RNA","TCGA-B5-A0K4-01A-11R","8c76c396-a566-4a1f-b8a3-5b64ded3e20d",1.77,0.14,"UV Spec","R","23","TCGA-B5-A0K4-01A-11R-A040-07","73e01a38-164c-44ce-ab36-ed429af8af44",0.14,NA,75,28.5779606767261,162,"2da882ba-e841-5e22-abdc-806a990c0209","TCGA-B5-A0K4_exposure","UNCID_2215090.73e01a38-164c-44ce-ab36-ed429af8af44.101014_UNC2-RDR300275_00039_FC_706C1AAXX_4.tar.gz","2013-10-03T23:55:04.000Z","2013-10-04T00:07:02.000Z","C558EDF2-590C-4E43-9AFF-8A46686605D7","A4AC1F6E-3411-47AE-9592-513B3D32223F","Unaligned reads",1542269153,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","73E01A38-164C-44CE-AB36-ED429AF8AF44","University of North Carolina","566077cae4b018727fea16d0","A8F38E37-978B-4435-B676-E8D4C34DA909","Uterine Corpus Endometrial Carcinoma","TARGZ","4FD4EAEC-F023-4F55-95E0-BAA21436A3A3","2013-10-04T00:07:02.000Z","8C76C396-A566-4A1F-B8A3-5B64DED3E20D","United States","NO",1,NA,"Primary Tumor","Duke",264,"4FD4EAEC-F023-4F55-95E0-BAA21436A3A3",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.AB1E33D6-97E4-43CA-BAC8-612E767BE9EF.txt",280,"TCGA-B5-A0K4-01A",NA,"039FE74C-6161-481C-A8C8-CE504F906BAB","TCGA",2009,NA,NA,"TUMOR FREE","A4AC1F6E-3411-47AE-9592-513B3D32223F",51,"nationwidechildrens.org_clinical.TCGA-B5-A0K4.xml","Alive",NA,"TCGA-B5-A0K4",NA,"B3BA716F-720B-4F83-9392-A1013B2DA348",NA,466,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"E9B33E2F-8E20-45E5-8B3B-EE27A1FB7D40",NA,NA,11,30,"C716946C-3E2E-4D05-B569-770D6F5023A5","A4398569-BC13-42BB-A7A4-25961070C4A9","UNCID_257746.TCGA-B5-A0K4-01A-11R-A040-07.101014_UNC2-RDR300275_00039_FC_706C1AAXX.4.trimmed.annotated.translated_to_genomic.bam","TCGA-B5-A0K4-01A-11",70,0,0,0,20,"TOP",20,0,"TCGA-B5-A0K4-01A-01-TS1",60,"Carboplatin","Chemotherapy","TCGA-B5-A0K4-D10033","TCGA-B5-A0K4-R10034","OTHER: SPECIFY IN NOTES","Regional site","TCGA-B5-A0K4-F72223_NTE-1","NO",1757,"TUMOR FREE","Alive",NA,"TCGA-B5-A0K4-F72223","TCGA-B5-A0K4",1,"B5","A0K4","YES","C54.1","8380/3","C54.1","NO","YES",-18631,"FEMALE",NA,NA,"No","No","Alive",466,NA,NA,NA,"TUMOR FREE","NO",5,1,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,51,2009,"Dilation and curettage procedure",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
26070545,25222207,1898065937,"AE8E3884-06AA-439D-9DEF-B7D7699DCCD4.bw","a93c47a9-65b5-4785-af4f-a2078db4514e","ae8e3884-06aa-439d-9def-b7d7699dccd4","2016-08-07T10:50:59.814952-05:00","UNCID_2194795.97b9cac2-2c23-4759-b558-24f7b90fe787.120313_UNC6-RDR300211_00137_FC_650V5AAXX_1.tar.gz","fded6c56-737e-43d2-8162-dc6144f9afc7",1756324866,"Illumina GA","45f4b77e473171108ac23cf558a47b1f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:41:04.870443-05:00","2016-05-03T11:07:49.533775-05:00","fded6c56-737e-43d2-8162-dc6144f9afc7_analysis.xml","f50a45b1d394555ef4ee0c2f7ac48a3f","05e7128c-8af2-4b70-be85-49f1acc8f0fe",2122,"2016-09-29T19:24:11.706367-05:00","fded6c56-737e-43d2-8162-dc6144f9afc7_experiment.xml","ef387ea99f5b5f65ebc66f361c9c1417","46e8ef6d-bb28-4217-86c9-2dbc979a767a",2258,"2016-09-29T22:10:44.009768-05:00","fded6c56-737e-43d2-8162-dc6144f9afc7_run.xml","794ba6857a6e38053a64f7df762c4aa3","add91140-6ddf-4e2f-8070-12efa9aa23de",349,"2016-09-08T12:09:20.726240-05:00","TCGA-AP-A1DP","2016-09-02T18:51:25.555238-05:00","female","TCGA-AP-A1DP_demographic",1938,"white","4a9cbf57-5459-5e8b-8fda-2a5dd5a9e2f5","not reported",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1DP_diagnosis","not reported",25601,"dead","8441/3",1081,NA,"c96495d3-47a4-5cd1-8e8b-cc70f395057c","c54.1",-25601,"TCGA-AP-A1DP_treatment","fd8f072a-5782-5bf8-bf2e-dc5f6faebb5f","01","true","TCGA-AP-A1DP-01A",NA,"b5206087-88de-4963-9239-189d159f7b35",FALSE,"20EEB047-0185-4B65-9A6A-43D6C97307C8","Primary Tumor",NA,1105,230,NA,1295395200,"11",30,"TCGA-AP-A1DP-01A-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T12:09:20.726240-05:00",NA,5,NA,2,NA,"TOP",NA,0,NA,"50c3ed02-e9b5-4e2a-a210-b422ceecdb2b",NA,"TCGA-AP-A1DP-01A-01-TSA",NA,90,NA,"93c2da90-ed4e-408d-bfb9-1aec33bf06d5","RNA","TCGA-AP-A1DP-01A-11R","01010c21-8a0c-4b39-9501-5e866f1ec03c",1.79,0.16,"UV Spec","R","23","TCGA-AP-A1DP-01A-11R-A137-07","97b9cac2-2c23-4759-b558-24f7b90fe787",0.16,NA,83,33.2478769427976,158,"77875cc2-334a-55c0-8d2c-e72c8b15e127","TCGA-AP-A1DP_exposure","UNCID_2194795.97b9cac2-2c23-4759-b558-24f7b90fe787.120313_UNC6-RDR300211_00137_FC_650V5AAXX_1.tar.gz","2013-09-23T03:26:04.000Z","2013-09-23T03:38:01.000Z","FDED6C56-737E-43D2-8162-DC6144F9AFC7","B5206087-88DE-4963-9239-189D159F7B35","Unaligned reads",1756324866,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","97B9CAC2-2C23-4759-B558-24F7B90FE787","University of North Carolina","564a3de3e4b0ef12181b3ac8","A93C47A9-65B5-4785-AF4F-A2078DB4514E","Uterine Corpus Endometrial Carcinoma","TARGZ","93C2DA90-ED4E-408D-BFB9-1AEC33BF06D5","2013-09-23T03:38:01.000Z","01010C21-8A0C-4B39-9501-5E866F1EC03C","None","NO",1,NA,"Primary Tumor","MSKCC",1105,"93C2DA90-ED4E-408D-BFB9-1AEC33BF06D5",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.4F1CABB5-0907-49C7-80CC-AE14712D3DCA.txt",230,"TCGA-AP-A1DP-01A",NA,"38988CFE-99F6-45EC-A32D-6B32C87377CC","TCGA",2008,NA,NA,"WITH TUMOR","B5206087-88DE-4963-9239-189D159F7B35",70,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.4F1CABB5-0907-49C7-80CC-AE14712D3DCA.txt","Dead",1081,"TCGA-AP-A1DP",NA,"81D54C76-9F8F-454F-9A77-42A7CDE86F7F",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",104,NA,"121A148C-E429-4C06-8CF9-3096ED1461D4","WHITE",NA,11,30,"50C3ED02-E9B5-4E2A-A210-B422CEECDB2B","70E26A40-A5AF-444E-93A2-A2DD643F981A","e9c79b884ccbd20a028af2ca8dd730e6.bam.bai","TCGA-AP-A1DP-01A-11",90,0,0,5,10,"TOP",0,2,"TCGA-AP-A1DP-01A-01-TSA",90,"Paclitaxel","Chemotherapy","TCGA-AP-A1DP-D13650","TCGA-AP-A1DP-R16676","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",1081,"TCGA-AP-A1DP-F13648","TCGA-AP-A1DP",1,"AP","A1DP","YES","C54.1","8441/3","C54.1","NO","YES",-25601,"FEMALE","WHITE",NA,"No","No","Dead",NA,1081,NA,NA,"WITH TUMOR","NO",9,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,70,2008,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
154239610,150307775,7167529466,"AFA4FB45-C83D-411B-B8D8-79C736BE56F1.bw","a94de778-9c21-410d-8b9d-0f9240036bb8","afa4fb45-c83d-411b-b8d8-79c736be56f1","2016-08-26T04:10:36.759830-05:00","UNCID_2327181.f0d6b561-bfd2-41b7-a43c-1006370eec8f.131118_UNC15-SN850_0339_AC347DACXX_8_TTAGGC.tar.gz","64d096da-354a-429c-9096-5c1f334a96f7",6942305190,"Illumina HiSeq","2b5e27f735eeb6c26159dd9113fbde81","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:10:05.638097-05:00","2016-05-03T11:34:55.532339-05:00","64d096da-354a-429c-9096-5c1f334a96f7_analysis.xml","a85bdf35512bd77d52f30a4e9e2d60a7","ad7e7888-9fd5-4d5e-8b73-ab8131c26dfa",2124,"2016-09-29T23:59:57.377912-05:00","64d096da-354a-429c-9096-5c1f334a96f7_experiment.xml","4a4f28e2ea1f1c9f0db5fe58ef128ab3","f19d829b-7653-46d0-bbab-d5994a17e2a7",2628,"2016-09-29T19:56:47.055231-05:00","64d096da-354a-429c-9096-5c1f334a96f7_run.xml","27fa9359d90834f2f30efecce8aca586","5b310f99-7dc7-4e6f-a521-b90a0ad1f709",354,"2016-09-08T10:45:13.169961-05:00","TCGA-FL-A1YU",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YU-11A",NA,"b28c3b96-d5a6-4209-831f-5e1f0277d825",FALSE,"50EB1015-2B54-4B28-B581-1F0707604595","Solid Tissue Normal",NA,NA,50,NA,1302480000,"11",20,"TCGA-FL-A1YU-11A-11",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T10:45:13.169961-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"2c88512b-6a11-47f8-9904-6ce354bcf8e4",NA,"TCGA-FL-A1YU-11A-01-TSA",NA,0,NA,"f5b0baf6-c7b1-4dda-846c-6f7a885169f7","RNA","TCGA-FL-A1YU-11A-11R","7ea5bfa4-fc82-42cc-905e-4cc6eed54332",1.6,0.16,"UV Spec","R","23","TCGA-FL-A1YU-11A-11R-A32Y-07","f0d6b561-bfd2-41b7-a43c-1006370eec8f",0.16,NA,NA,NA,NA,NA,NA,"UNCID_2327181.f0d6b561-bfd2-41b7-a43c-1006370eec8f.131118_UNC15-SN850_0339_AC347DACXX_8_TTAGGC.tar.gz","2014-01-25T00:22:14.000Z","2014-01-25T00:52:02.000Z","64D096DA-354A-429C-9096-5C1F334A96F7","B28C3B96-D5A6-4209-831F-5E1F0277D825","Unaligned reads",6942305190,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","F0D6B561-BFD2-41B7-A43C-1006370EEC8F","University of North Carolina","56607ce6e4b016715ab6b480","A94DE778-9C21-410D-8B9D-0F9240036BB8","Uterine Corpus Endometrial Carcinoma","TARGZ","F5B0BAF6-C7B1-4DDA-846C-6F7A885169F7","2014-01-25T00:52:02.000Z","7EA5BFA4-FC82-42CC-905E-4CC6EED54332","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"F5B0BAF6-C7B1-4DDA-846C-6F7A885169F7",NA,"FL","UNCID_2327181.f0d6b561-bfd2-41b7-a43c-1006370eec8f.131118_UNC15-SN850_0339_AC347DACXX_8_TTAGGC.tar.gz",50,"TCGA-FL-A1YU-11A",NA,NA,"TCGA",NA,NA,NA,NA,"B28C3B96-D5A6-4209-831F-5E1F0277D825",NA,"UNCID_2327181.f0d6b561-bfd2-41b7-a43c-1006370eec8f.131118_UNC15-SN850_0339_AC347DACXX_8_TTAGGC.tar.gz",NA,NA,"TCGA-FL-A1YU",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,156,NA,NA,NA,NA,11,20,"2C88512B-6A11-47F8-9904-6CE354BCF8E4","7EA5BFA4-FC82-42CC-905E-4CC6EED54332","UNCID_2327181.f0d6b561-bfd2-41b7-a43c-1006370eec8f.131118_UNC15-SN850_0339_AC347DACXX_8_TTAGGC.tar.gz","TCGA-FL-A1YU-11A-11",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YU-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
35234496,34908764,2613802917,"94E26CD5-238B-4D8C-B8E8-A62C44EB2B41.bw","a98bbe29-8817-4380-a738-3c1bf9f8e0cc","94e26cd5-238b-4d8c-b8e8-a62c44eb2b41","2016-08-09T14:10:18.389418-05:00","UNCID_2203657.6eefe77a-d312-44fc-9b9e-7c3b439a7e23.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_7.tar.gz","7c9272b1-9603-4517-9267-50fa3c0fb4fe",2181154287,"Illumina GA","ffc431692b88cff85f86a89be4a75928","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:46:12.528014-05:00","2016-05-03T11:10:47.526878-05:00","7c9272b1-9603-4517-9267-50fa3c0fb4fe_analysis.xml","dc5976af2578e8e0451fd51b12ca834e","549607e8-8756-4c02-a985-9b8493ad6950",2121,"2016-10-07T16:32:53.854405-05:00","7c9272b1-9603-4517-9267-50fa3c0fb4fe_experiment.xml","8adef68299142c35d56bfdea0184194c","0e04bc5f-7d30-448b-b644-7c9b5fd04692",2257,"2016-09-29T20:00:37.316290-05:00","7c9272b1-9603-4517-9267-50fa3c0fb4fe_run.xml","bd5371dd69476b1e00fb55e3e2a8e0fe","5d83a1de-be80-4bf0-b0f5-73a0e69321f9",347,"2016-09-08T10:41:55.543402-05:00","TCGA-D1-A1O0","2016-09-02T18:52:32.530373-05:00","female","TCGA-D1-A1O0_demographic",1933,"white","d4ecc93c-481d-5d2e-a1be-cadcc9a73cb8","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1O0_diagnosis","not reported",28162,"alive","8380/3",NA,63,"f4d89a7e-b70c-5e08-9a4b-b87165d3122a","c54.1",-28162,"TCGA-D1-A1O0_treatment","83988d55-554c-54bc-b133-4faa168d9592","01","false","TCGA-D1-A1O0-01A",NA,"e113e0f0-3ae5-48a3-a226-ad920f41259e",FALSE,"2F5CADA5-176C-4B9D-9660-53BE86B1CD39","Primary Tumor",NA,195,50,NA,1306368000,"11",30,"TCGA-D1-A1O0-01A-11",95,NA,8,NA,0,NA,5,NA,"2016-09-08T10:41:55.543402-05:00",NA,5,NA,1,NA,"TOP",NA,5,NA,"8e429057-8273-4ea4-bf0c-fcf04d60d448",NA,"TCGA-D1-A1O0-01A-01-TS1",NA,90,NA,"8846d84c-364a-4541-aa90-3eac33807648","RNA","TCGA-D1-A1O0-01A-11R","7c7f29c1-2d3e-4052-8e16-b73dd13b5b0c",1.89,0.17,"UV Spec","R","23","TCGA-D1-A1O0-01A-11R-A17B-07","6eefe77a-d312-44fc-9b9e-7c3b439a7e23",0.17,NA,117,47.4664286583634,157,"956583d0-2cda-594e-8ccd-45e0b5193435","TCGA-D1-A1O0_exposure","UNCID_2203657.6eefe77a-d312-44fc-9b9e-7c3b439a7e23.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_7.tar.gz","2013-09-26T15:31:05.000Z","2013-09-26T15:44:02.000Z","7C9272B1-9603-4517-9267-50FA3C0FB4FE","E113E0F0-3AE5-48A3-A226-AD920F41259E","Unaligned reads",2181154287,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","6EEFE77A-D312-44FC-9B9E-7C3B439A7E23","University of North Carolina","56607575e4b0ca319164d196","A98BBE29-8817-4380-A738-3C1BF9F8E0CC","Uterine Corpus Endometrial Carcinoma","TARGZ","8846D84C-364A-4541-AA90-3EAC33807648","2013-09-26T15:44:02.000Z","7C7F29C1-2D3E-4052-8E16-B73DD13B5B0C","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",195,"8846D84C-364A-4541-AA90-3EAC33807648",NA,"D1","UNCID_1614801.6eefe77a-d312-44fc-9b9e-7c3b439a7e23.sorted_genome_alignments.bam",50,"TCGA-D1-A1O0-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","E113E0F0-3AE5-48A3-A226-AD920F41259E",77,"0d3f6680cef818e78692fa5469f1d466.bam","Alive",NA,"TCGA-D1-A1O0","NOT HISPANIC OR LATINO","08285D30-AD33-497A-9C36-C6EB6BB4EF37",NA,2,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"8E429057-8273-4EA4-BF0C-FCF04D60D448","7C7F29C1-2D3E-4052-8E16-B73DD13B5B0C","UNCID_1614801.6eefe77a-d312-44fc-9b9e-7c3b439a7e23.sorted_genome_alignments.bam","TCGA-D1-A1O0-01A-11",95,0,8,5,5,"TOP",5,1,"TCGA-D1-A1O0-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,"NO",63,"TUMOR FREE","Alive",NA,"TCGA-D1-A1O0-F21636","TCGA-D1-A1O0",1,"D1","A1O0","YES","C54.1","8380/3","C54.1","NO","YES",-28162,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,77,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33952701,31326787,2349703488,"AE082A2F-39BF-4BFD-8BC3-35B8CE45D53A.bw","a9b6cd65-f042-4073-9000-4143a2c55373","ae082a2f-39bf-4bfd-8bc3-35b8ce45d53a","2016-08-09T14:15:46.519876-05:00","UNCID_2210920.a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a.110316_UNC2-RDR300275_00058_FC_62J26AAXX_5.tar.gz","1058349a-5186-452a-bb1e-38c8fc0cabed",2126642391,"Illumina GA","22335072baebb9d28441df96d8708727","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:55:59.767265-05:00","2016-05-03T11:16:29.236069-05:00","1058349a-5186-452a-bb1e-38c8fc0cabed_analysis.xml","5a02303f4f3529444cc1f392f24ce195","c9da0805-7490-4132-9408-3fde9d0fc5db",2121,"2016-09-30T00:14:33.579491-05:00","1058349a-5186-452a-bb1e-38c8fc0cabed_experiment.xml","9fd66027d5e5663969b1dbcb700dc171","fa968b37-98d3-40fa-92d0-e07527e9a9de",2257,"2016-09-30T00:16:02.626127-05:00","1058349a-5186-452a-bb1e-38c8fc0cabed_run.xml","100ca1678245c64b6bea52fc7715ea49","fb7dff8c-8ff7-4a44-bf72-6eccdfa47ebe",347,"2016-09-08T10:25:33.639590-05:00","TCGA-BS-A0V6","2016-09-02T18:49:42.808518-05:00","female","TCGA-BS-A0V6_demographic",1951,"asian","118bb2cb-a544-5ce7-9eba-f989bd4f48f0","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0V6_diagnosis","not reported",20369,"alive","8380/3",NA,2725,"f9e16061-74b2-560a-844c-561de6ed91ab","c54.1",-20369,"TCGA-BS-A0V6_treatment","a29ed7c9-472f-5e82-aa48-b3ce4b8057bd","01","false","TCGA-BS-A0V6-01A",NA,"1c337d11-f2ac-48cf-9c8f-ec27550876ea",FALSE,"657466BC-3CA2-4568-BF64-2905571C3666","Primary Tumor",NA,1462,80,NA,1291334400,"11",20,"TCGA-BS-A0V6-01A-11",30,90,2,0,25,0,30,10,"2016-09-08T10:25:33.639590-05:00","2016-09-08T10:25:33.639590-05:00",40,30,2,20,"BOTTOM","TOP",5,20,"2ed39e1a-3670-47f2-bafb-7f87ed4da19d","935ddf91-06b4-4553-930a-41605aa2548f","TCGA-BS-A0V6-01A-01-MS1","TCGA-BS-A0V6-01A-01-TS1",40,70,"64c2137a-10e4-4cd7-b7e4-efecd09702b3","RNA","TCGA-BS-A0V6-01A-11R","76d9d53a-f046-4d2e-87b8-6e3b4e3423c2",1.84,0.16,"UV Spec","R","23","TCGA-BS-A0V6-01A-11R-A118-07","a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a",0.16,NA,83,33.6727656294373,157,"30700f2f-dec9-5942-9ef2-88c96f520b82","TCGA-BS-A0V6_exposure","UNCID_2210920.a7efbfc2-48f4-44ec-a8a6-7e565cfe2b6a.110316_UNC2-RDR300275_00058_FC_62J26AAXX_5.tar.gz","2013-10-02T18:36:05.000Z","2013-10-02T18:48:02.000Z","1058349A-5186-452A-BB1E-38C8FC0CABED","1C337D11-F2AC-48CF-9C8F-EC27550876EA","Unaligned reads",2126642391,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A7EFBFC2-48F4-44EC-A8A6-7E565CFE2B6A","University of North Carolina","564a3a91e4b0ef12181a2d8a","A9B6CD65-F042-4073-9000-4143A2C55373","Uterine Corpus Endometrial Carcinoma","TARGZ","64C2137A-10E4-4CD7-B7E4-EFECD09702B3","2013-10-02T18:48:02.000Z","76D9D53A-F046-4D2E-87B8-6E3B4E3423C2","None","NO",1,NA,"Primary Tumor","University of Hawaii",1462,"64C2137A-10E4-4CD7-B7E4-EFECD09702B3",NA,"BS","CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_B10_735756.hg18.seg.txt",80,"TCGA-BS-A0V6-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","A0CC0A3C-77D9-4DB4-A91E-DE516E73381A",55,"nationwidechildrens.org_clinical.TCGA-BS-A0V6.xml","Alive",NA,"TCGA-BS-A0V6","NOT HISPANIC OR LATINO","8171C424-665E-48FD-A943-3D1567ABDDA2",NA,1650,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"ASIAN",NA,11,20,"935DDF91-06B4-4553-930A-41605AA2548F","76D9D53A-F046-4D2E-87B8-6E3B4E3423C2","d3a903334662bc738afc89ac90426c0d.bam.bai","TCGA-BS-A0V6-01A-11",90,0,0,30,10,"TOP",20,20,"TCGA-BS-A0V6-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,NA,"NO",1910,"TUMOR FREE","Alive",NA,"TCGA-BS-A0V6-F17013","TCGA-BS-A0V6",1,"BS","A0V6","YES","C54.1","8380/3","C54.1","NO","YES",-20369,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",1650,NA,NA,NA,"TUMOR FREE","NO",28,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2006,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
104730938,102019127,4865171393,"DEAB79F5-336A-49B4-8046-AEE2F567FE46.bw","aa3ad7c0-37cf-4337-945e-cefeee801bbb","deab79f5-336a-49b4-8046-aee2f567fe46","2016-08-09T13:14:45.169416-05:00","UNCID_2173752.ba01a4cb-d7cd-4a9a-ae28-978262154683.130502_UNC12-SN629_0289_AC236KACXX_1_CGATGT.tar.gz","f7481744-7749-490e-956e-5dd4a389efe3",5042295184,"Illumina HiSeq","21d78f89c7eee4be0a09327f4a4bd8ff","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:39:23.494891-05:00","2016-05-03T10:56:47.870562-05:00","f7481744-7749-490e-956e-5dd4a389efe3_analysis.xml","ef8b377a05ae3f980d8a89f36ad1d496","9a69a8d6-5af7-49ee-88ff-fa137a7dabe7",2123,"2016-09-29T22:17:38.781929-05:00","f7481744-7749-490e-956e-5dd4a389efe3_experiment.xml","7d372b7e06fc48a337812242d1b97a88","b2272a6c-1824-4b7a-8777-3a3344f04f8d",2431,"2016-09-29T23:55:27.816735-05:00","f7481744-7749-490e-956e-5dd4a389efe3_run.xml","810176b8c7dec3536e693c1a81a52033","eee546f0-f1a9-482a-abdb-bde1e938c1c4",354,"2016-09-08T10:41:21.938690-05:00","TCGA-AX-A3GB","2016-09-02T18:49:14.636593-05:00","female","TCGA-AX-A3GB_demographic",1937,"white","c24bb733-c129-5932-bba5-c197ac5b1bef","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3GB_diagnosis","not reported",26724,"alive","8380/3",NA,440,"a3becdfe-4514-5c7a-9363-0d079ffb5f25","c54.1",-26724,"TCGA-AX-A3GB_treatment","06f55a96-ffcd-55c9-8436-f28ab96a839c","01","false","TCGA-AX-A3GB-01A",NA,"b473b052-e1f3-40d2-bf32-7873263973c9",FALSE,"50C8217A-6834-46E9-9727-5B6B3D37347D","Primary Tumor",NA,469,80,NA,1323043200,"11",30,"TCGA-AX-A3GB-01A-11",90,NA,1,NA,0,NA,20,NA,"2016-09-08T10:41:21.938690-05:00",NA,2,NA,0,NA,"TOP",NA,2,NA,"c4ecaa83-86a6-478c-8a8a-977cbdf9755f",NA,"TCGA-AX-A3GB-01A-01-TSA",NA,78,NA,"4a34ae7c-2422-4008-92e9-1a1d90c4dc29","RNA","TCGA-AX-A3GB-01A-11R","79cae173-220d-4cd5-bef0-caa6be95668b",1.78,0.16,"UV Spec","R","23","TCGA-AX-A3GB-01A-11R-A22K-07","ba01a4cb-d7cd-4a9a-ae28-978262154683",0.16,NA,87,34.8501842653421,158,"efeec016-4cad-504d-a436-f5726627c171","TCGA-AX-A3GB_exposure","UNCID_2173752.ba01a4cb-d7cd-4a9a-ae28-978262154683.130502_UNC12-SN629_0289_AC236KACXX_1_CGATGT.tar.gz","2013-09-09T23:36:04.000Z","2013-09-10T00:02:01.000Z","F7481744-7749-490E-956E-5DD4A389EFE3","B473B052-E1F3-40D2-BF32-7873263973C9","Unaligned reads",5042295184,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","BA01A4CB-D7CD-4A9A-AE28-978262154683","University of North Carolina","56607a61e4b0ec1099f8dfd9","AA3AD7C0-37CF-4337-945E-CEFEEE801BBB","Uterine Corpus Endometrial Carcinoma","TARGZ","4A34AE7C-2422-4008-92E9-1A1D90C4DC29","2013-09-10T00:02:01.000Z","79CAE173-220D-4CD5-BEF0-CAA6BE95668B","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",469,"4A34AE7C-2422-4008-92E9-1A1D90C4DC29",NA,"AX","UNCID_2173752.ba01a4cb-d7cd-4a9a-ae28-978262154683.130502_UNC12-SN629_0289_AC236KACXX_1_CGATGT.tar.gz",80,"TCGA-AX-A3GB-01A",NA,"3B825A9D-4B06-44FF-9000-C02FA665379E","TCGA",2010,NA,NA,NA,"B473B052-E1F3-40D2-BF32-7873263973C9",73,"nationwidechildrens.org_clinical.TCGA-AX-A3GB.xml","Alive",NA,"TCGA-AX-A3GB","NOT HISPANIC OR LATINO","973C919F-A77F-42AF-9FAC-A13E1DE7E2C8",NA,440,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"C4ECAA83-86A6-478C-8A8A-977CBDF9755F","3808D220-A417-4273-9F8C-F719EFBAD32C","UNCID_2173752.ba01a4cb-d7cd-4a9a-ae28-978262154683.130502_UNC12-SN629_0289_AC236KACXX_1_CGATGT.tar.gz","TCGA-AX-A3GB-01A-11",90,0,1,2,20,"TOP",2,0,"TCGA-AX-A3GB-01A-01-TSA",78,"Carboplatin and Paclitaxel","Chemotherapy","TCGA-AX-A3GB-D21267",NA,NA,NA,NA,"NO",440,NA,"Alive",NA,"TCGA-AX-A3GB-F21266","TCGA-AX-A3GB",1,"AX","A3GB","YES","C54.1","8380/3","C54.1","NO","YES",-26724,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",440,NA,NA,NA,NA,"NO",7,2,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2010,"Other method, specify:",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
101422156,100151078,4781150552,"3B8267C3-6FCC-4753-BA84-96950B342E39.bw","ab68cd1b-5075-4b30-a829-d6d0f95871cb","3b8267c3-6fcc-4753-ba84-96950b342e39","2016-08-09T13:15:54.151928-05:00","UNCID_2178407.b38f9ed4-266f-4b44-b42f-48396fb0be68.130328_UNC10-SN254_0443_AD238RACXX_5_TAGCTT.tar.gz","ca69d4be-5bed-44e1-8182-f4d95de8fbaa",4163972146,"Illumina HiSeq","b6373d49fd1cdf7a7afad00cfe826a00","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:09:35.727933-05:00","2016-05-03T10:56:47.880266-05:00","ca69d4be-5bed-44e1-8182-f4d95de8fbaa_analysis.xml","dcf5a4e26ea29965142a7617247f1793","3dbb08c2-8fa1-4906-b34b-9717a2a0d294",2123,"2016-08-28T09:13:41.632566-05:00","ca69d4be-5bed-44e1-8182-f4d95de8fbaa_experiment.xml","d4badd557ae97a7e0f8ddb61c58d3211","00777360-fea8-422a-a120-c4e29205e840",2431,"2016-09-29T19:57:03.697722-05:00","ca69d4be-5bed-44e1-8182-f4d95de8fbaa_run.xml","1a1cdd013605f208caa350e7ae76c05f","5b5b2fee-e6b1-4d04-9672-0df130db353b",354,"2016-09-08T11:09:33.084875-05:00","TCGA-AJ-A3BD","2016-09-02T18:54:32.043809-05:00","female","TCGA-AJ-A3BD_demographic",1954,"white","8c2d24f1-cb1d-5b13-84a0-dcccefd1655c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3BD_diagnosis","not reported",20998,"alive","8460/3",NA,1039,"a1b1c6cb-6499-5b68-a141-e465b688c84f","c54.1",-20998,"TCGA-AJ-A3BD_treatment","0f11beca-c742-5020-8e34-25c01a756d48","01","false","TCGA-AJ-A3BD-01A",NA,"a41beebe-3c3a-41fc-a611-0e9b322f638b",FALSE,"8B7CB7C6-86B5-41EA-A6CB-FC496C311888","Primary Tumor",NA,170,200,NA,1317859200,"11",30,"TCGA-AJ-A3BD-01A-11",95,NA,0,NA,5,NA,2,NA,"2016-09-08T11:09:33.084875-05:00",NA,2,NA,0,NA,"TOP",NA,3,NA,"34c01987-fbf9-4d64-bacf-1281380926c0",NA,"TCGA-AJ-A3BD-01A-01-TSA",NA,90,NA,"686d429b-667c-4fa6-800b-d6b9641fe1b1","RNA","TCGA-AJ-A3BD-01A-11R","792a6656-0729-47c1-ba48-df0e22ddb575",1.86,0.17,"UV Spec","R","23","TCGA-AJ-A3BD-01A-11R-A19W-07","b38f9ed4-266f-4b44-b42f-48396fb0be68",0.17,NA,85,36.7901662049861,152,"4e9a5fbc-2830-535c-bfb4-413693b6e698","TCGA-AJ-A3BD_exposure","UNCID_2178407.b38f9ed4-266f-4b44-b42f-48396fb0be68.130328_UNC10-SN254_0443_AD238RACXX_5_TAGCTT.tar.gz","2013-09-12T02:11:05.000Z","2013-09-12T02:24:01.000Z","CA69D4BE-5BED-44E1-8182-F4D95DE8FBAA","A41BEEBE-3C3A-41FC-A611-0E9B322F638B","Unaligned reads",4163972146,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","B38F9ED4-266F-4B44-B42F-48396FB0BE68","University of North Carolina","5660763be4b016715ab68c52","AB68CD1B-5075-4B30-A829-D6D0F95871CB","Uterine Corpus Endometrial Carcinoma","TARGZ","686D429B-667C-4FA6-800B-D6B9641FE1B1","2013-09-12T02:24:01.000Z","792A6656-0729-47C1-BA48-DF0E22DDB575","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",170,"686D429B-667C-4FA6-800B-D6B9641FE1B1",NA,"AJ","CLUBS_p_TCGA_186_188_SNP_N_GenomeWideSNP_6_A10_914116.tangent.copynumber.data.txt",200,"TCGA-AJ-A3BD-01A",NA,"F722F671-C70C-4C1B-92C2-7BBF3C0AA1B4","TCGA",2011,NA,NA,"TUMOR FREE","FE8211B9-2B2F-482E-BA7F-358945C64C47",57,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.EAB8433C-32F7-48FF-98B7-3DFB2D5E7E87.txt","Alive",NA,"TCGA-AJ-A3BD","NOT HISPANIC OR LATINO","050243E5-333E-44AA-881F-3702912C812C",NA,15,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8460/3","FEMALE","C54.1",186,NA,"327B96EC-E1D8-4AA4-8C43-4EBC60D73586","WHITE",NA,11,30,"34C01987-FBF9-4D64-BACF-1281380926C0","A31DE860-054D-4EC7-B28B-DAB3B9761FA1","CLUBS_p_TCGA_186_188_SNP_N_GenomeWideSNP_6_A10_914116.hg18.seg.txt","TCGA-AJ-A3BD-01A-11",95,5,0,2,2,"TOP",3,0,"TCGA-AJ-A3BD-01A-01-TSA",90,"Carboplatin","Chemotherapy","TCGA-AJ-A3BD-D58986","TCGA-AJ-A3BD-R58985","Internal","Primary Tumor Field","TCGA-AJ-A3BD-F58983_NTE-1","NO",1039,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3BD-F58983","TCGA-AJ-A3BD",1,"AJ","A3BD","YES","C54.1","8460/3","C54.1","YES","NO",-20998,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",15,NA,NA,NA,"TUMOR FREE","NO",3,2,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,57,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
86532148,82631392,3951272044,"6129063A-E329-4242-AD80-51AE66C50593.bw","ab7adf74-6e87-4117-9742-54e323348e06","6129063a-e329-4242-ad80-51ae66c50593","2016-08-25T08:53:37.058074-05:00","UNCID_2332541.ff504261-6803-4f5f-920c-7e82fa5ac9e3.130822_UNC11-SN627_0320_AC2B3YACXX_3_ACAGTG.tar.gz","3889ffe0-a7a0-4186-9eb5-8cb31383c4dc",3291800882,"Illumina HiSeq","a1d3b99cd19c455c33884bee2c70bee3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:50:24.681015-05:00","2016-05-03T11:35:41.346304-05:00","3889ffe0-a7a0-4186-9eb5-8cb31383c4dc_analysis.xml","686a825ddeaa72213895ffbec422f01f","573fff94-4b51-4216-acca-e2e4e589a6cd",2124,"2016-10-07T15:58:53.426469-05:00","3889ffe0-a7a0-4186-9eb5-8cb31383c4dc_experiment.xml","ceccc21be22d518844fd23d94240d38b","fa1a532f-730b-490d-a746-eb55c1a8f4e2",2884,"2016-09-29T22:09:42.500427-05:00","3889ffe0-a7a0-4186-9eb5-8cb31383c4dc_run.xml","879978271060a2812bb95dfadb582de9","ad4417ba-9bbd-4476-a12c-1732081fdbbc",355,"2016-09-08T11:31:10.092014-05:00","TCGA-BK-A26L","2016-09-02T18:52:44.553785-05:00","female","TCGA-BK-A26L_demographic",1939,"white","cd6ec347-4caf-5ff7-a22e-34c0c62a99b3","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A26L_diagnosis","not reported",26002,"alive","8441/3",NA,734,"d2b10490-3a90-5a92-bf52-ee5faaa52852","c54.1",-26002,"TCGA-BK-A26L_treatment","a800f1f1-88f2-5f57-be1e-c504f5f2d832","01","false","TCGA-BK-A26L-01A",NA,"cfde53b1-a992-4180-b747-b4c1d3ed2e2b",FALSE,"979388A8-CC61-4C03-BADC-BEF9EC50C40A","Primary Tumor",NA,131,320,NA,1307318400,"11",30,"TCGA-BK-A26L-01A-11",70,NA,20,NA,0,NA,25,NA,"2016-09-08T11:31:10.092014-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"fbc3731f-ad7b-4b2d-85f1-d09f9caa666a",NA,"TCGA-BK-A26L-01A-01-TS1",NA,70,NA,"adeae27b-9627-4ac2-bc0c-e3a52c293084","RNA","TCGA-BK-A26L-01A-11R","5802796b-ea96-497c-b6bd-619d7f1c0f40",1.95,0.18,"UV Spec","R","23","TCGA-BK-A26L-01A-11R-A277-07","ff504261-6803-4f5f-920c-7e82fa5ac9e3",0.18,NA,75,32.4619113573407,152,"457ac974-3e7b-5b32-ad48-70007f173b72","TCGA-BK-A26L_exposure","UNCID_2332541.ff504261-6803-4f5f-920c-7e82fa5ac9e3.130822_UNC11-SN627_0320_AC2B3YACXX_3_ACAGTG.tar.gz","2014-01-29T03:07:04.000Z","2014-01-29T03:20:01.000Z","3889FFE0-A7A0-4186-9EB5-8CB31383C4DC","CFDE53B1-A992-4180-B747-B4C1D3ED2E2B","Unaligned reads",3291800882,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","FF504261-6803-4F5F-920C-7E82FA5AC9E3","University of North Carolina","56607975e4b018727fea208b","AB7ADF74-6E87-4117-9742-54E323348E06","Uterine Corpus Endometrial Carcinoma","TARGZ","ADEAE27B-9627-4AC2-BC0C-E3A52C293084","2014-01-29T03:20:02.000Z","5802796B-EA96-497C-B6BD-619D7F1C0F40","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",131,"ADEAE27B-9627-4AC2-BC0C-E3A52C293084",NA,"BK","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E78FD774-2F02-41DA-BE47-D049CACC8560.txt",320,"TCGA-BK-A26L-01A",NA,"F01F265D-9735-45F5-BD86-FED282F0CE51","TCGA",2010,NA,NA,NA,"CFDE53B1-A992-4180-B747-B4C1D3ED2E2B",71,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E78FD774-2F02-41DA-BE47-D049CACC8560.txt","Alive",NA,"TCGA-BK-A26L","NOT HISPANIC OR LATINO","A9C4C29A-32D3-4234-BE2E-74BD64F966EE",NA,234,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8441/3","FEMALE","C54.1",143,NA,"68758F4E-11D6-437F-A057-33C391965EF2","WHITE",NA,11,30,"FBC3731F-AD7B-4B2D-85F1-D09F9CAA666A","5802796B-EA96-497C-B6BD-619D7F1C0F40","UNCID_603001.80b16496-74bd-4fe7-967c-31058b2c022b.111006_UNC2-RDR300275_00089_FC_634EEAAXX.6.trimmed.annotated.translated_to_genomic.bam","TCGA-BK-A26L-01A-11",70,0,20,40,25,"TOP",5,20,"TCGA-BK-A26L-01A-01-TS1",70,"Carboplatin","Chemotherapy","TCGA-BK-A26L-D21627","TCGA-BK-A26L-R21621","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",363,"TUMOR FREE","Alive",NA,"TCGA-BK-A26L-F21626","TCGA-BK-A26L",2,"BK","A26L","YES","C54.1","8441/3","C54.1","YES","NO",-26002,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",234,NA,NA,NA,NA,"NO",8,8,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,71,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35781622,35599541,2632969745,"B7E14E69-007A-4F04-8C8F-B424F73AD883.bw","ab7adf74-6e87-4117-9742-54e323348e06","b7e14e69-007a-4f04-8c8f-b424f73ad883","2016-08-09T14:09:26.488894-05:00","UNCID_2206671.80b16496-74bd-4fe7-967c-31058b2c022b.111006_UNC2-RDR300275_00089_FC_634EEAAXX_6.tar.gz","027e7b3c-189d-4e1e-9658-9d66c0254ded",2358723138,"Illumina GA","d1131fcc90da295f850e9801e39fc8db","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:58:14.585410-05:00","2016-05-03T11:12:13.642315-05:00","027e7b3c-189d-4e1e-9658-9d66c0254ded_analysis.xml","cb994bba33799b9841693a729eea3142","10d4551b-a6e3-460b-b5c3-351d77fdcc87",2121,"2016-10-07T16:38:59.204746-05:00","027e7b3c-189d-4e1e-9658-9d66c0254ded_experiment.xml","3c719b2ca7d7b34907a03f13e198dd97","ee6110dd-a2a4-443a-81fb-6dd623805c4e",2257,"2016-09-29T23:50:50.014708-05:00","027e7b3c-189d-4e1e-9658-9d66c0254ded_run.xml","e0dda61163dc1944b2c78528ce3194a7","ebf6e0c0-d0da-45a3-8665-990a7d3eef5d",347,"2016-09-08T11:31:10.092014-05:00","TCGA-BK-A26L","2016-09-02T18:52:44.553785-05:00","female","TCGA-BK-A26L_demographic",1939,"white","cd6ec347-4caf-5ff7-a22e-34c0c62a99b3","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A26L_diagnosis","not reported",26002,"alive","8441/3",NA,734,"d2b10490-3a90-5a92-bf52-ee5faaa52852","c54.1",-26002,"TCGA-BK-A26L_treatment","a800f1f1-88f2-5f57-be1e-c504f5f2d832","01","false","TCGA-BK-A26L-01A",NA,"cfde53b1-a992-4180-b747-b4c1d3ed2e2b",FALSE,"979388A8-CC61-4C03-BADC-BEF9EC50C40A","Primary Tumor",NA,131,320,NA,1307318400,"11",30,"TCGA-BK-A26L-01A-11",70,NA,20,NA,0,NA,25,NA,"2016-09-08T11:31:10.092014-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"fbc3731f-ad7b-4b2d-85f1-d09f9caa666a",NA,"TCGA-BK-A26L-01A-01-TS1",NA,70,NA,"adeae27b-9627-4ac2-bc0c-e3a52c293084","RNA","TCGA-BK-A26L-01A-11R","5802796b-ea96-497c-b6bd-619d7f1c0f40",1.95,0.18,"UV Spec","R","23","TCGA-BK-A26L-01A-11R-A16F-07","80b16496-74bd-4fe7-967c-31058b2c022b",0.18,NA,75,32.4619113573407,152,"457ac974-3e7b-5b32-ad48-70007f173b72","TCGA-BK-A26L_exposure","UNCID_2206671.80b16496-74bd-4fe7-967c-31058b2c022b.111006_UNC2-RDR300275_00089_FC_634EEAAXX_6.tar.gz","2013-09-27T18:46:03.000Z","2013-09-27T18:59:02.000Z","027E7B3C-189D-4E1E-9658-9D66C0254DED","CFDE53B1-A992-4180-B747-B4C1D3ED2E2B","Unaligned reads",2358723138,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","80B16496-74BD-4FE7-967C-31058B2C022B","University of North Carolina","56607972e4b0b37b3d9919b4","AB7ADF74-6E87-4117-9742-54E323348E06","Uterine Corpus Endometrial Carcinoma","TARGZ","ADEAE27B-9627-4AC2-BC0C-E3A52C293084","2013-09-27T18:59:02.000Z","5802796B-EA96-497C-B6BD-619D7F1C0F40","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",131,"ADEAE27B-9627-4AC2-BC0C-E3A52C293084",NA,"BK","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E78FD774-2F02-41DA-BE47-D049CACC8560.txt",320,"TCGA-BK-A26L-01A",NA,"F01F265D-9735-45F5-BD86-FED282F0CE51","TCGA",2010,NA,NA,NA,"CFDE53B1-A992-4180-B747-B4C1D3ED2E2B",71,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E78FD774-2F02-41DA-BE47-D049CACC8560.txt","Alive",NA,"TCGA-BK-A26L","NOT HISPANIC OR LATINO","A9C4C29A-32D3-4234-BE2E-74BD64F966EE",NA,234,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8441/3","FEMALE","C54.1",143,NA,"68758F4E-11D6-437F-A057-33C391965EF2","WHITE",NA,11,30,"FBC3731F-AD7B-4B2D-85F1-D09F9CAA666A","5802796B-EA96-497C-B6BD-619D7F1C0F40","UNCID_603001.80b16496-74bd-4fe7-967c-31058b2c022b.111006_UNC2-RDR300275_00089_FC_634EEAAXX.6.trimmed.annotated.translated_to_genomic.bam","TCGA-BK-A26L-01A-11",70,0,20,40,25,"TOP",5,20,"TCGA-BK-A26L-01A-01-TS1",70,"Carboplatin","Chemotherapy","TCGA-BK-A26L-D21627","TCGA-BK-A26L-R21621","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",363,"TUMOR FREE","Alive",NA,"TCGA-BK-A26L-F21626","TCGA-BK-A26L",2,"BK","A26L","YES","C54.1","8441/3","C54.1","YES","NO",-26002,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",234,NA,NA,NA,NA,"NO",8,8,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,71,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
189887576,188246395,9002071448,"933DB910-2728-4DC4-840E-B0CD1F13A421.bw","ab7adf74-6e87-4117-9742-54e323348e06","933db910-2728-4dc4-840e-b0cd1f13a421","2016-08-25T15:19:14.178518-05:00","UNCID_2337792.a36f18b0-3978-4a46-bb1c-7c0839f492e9.130702_UNC12-SN629_0317_AD29BFACXX_7_ATGTCA.tar.gz","31a5f2a9-23fa-4cde-b387-41cf9053cd88",8148938629,"Illumina HiSeq","ffc3fa6265e8f46d7dbd53ab037ba192","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:21:41.218928-05:00","2016-05-03T11:35:41.364651-05:00","31a5f2a9-23fa-4cde-b387-41cf9053cd88_analysis.xml","f9335d86884a91f8d55d8274e0c36365","6a48d081-9778-46fe-a411-d2c80430baf8",2124,"2016-10-07T17:57:16.241094-05:00","31a5f2a9-23fa-4cde-b387-41cf9053cd88_experiment.xml","1929834fe574b605e05aaa910abe3c17","718bda3c-e904-47bd-bc4c-31a7bf66993f",2882,"2016-09-29T19:03:47.175072-05:00","31a5f2a9-23fa-4cde-b387-41cf9053cd88_run.xml","2df932b6d2d1b867e7cd9fd89fbd3dfd","3a14aab0-5372-4155-bbfc-bfbd900f69fd",355,"2016-09-08T11:31:10.092014-05:00","TCGA-BK-A26L","2016-09-02T18:52:44.553785-05:00","female","TCGA-BK-A26L_demographic",1939,"white","cd6ec347-4caf-5ff7-a22e-34c0c62a99b3","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A26L_diagnosis","not reported",26002,"alive","8441/3",NA,734,"d2b10490-3a90-5a92-bf52-ee5faaa52852","c54.1",-26002,"TCGA-BK-A26L_treatment","a800f1f1-88f2-5f57-be1e-c504f5f2d832","01","false","TCGA-BK-A26L-01C",NA,"7ac409d7-3f50-4228-9767-6bbf38a8d767",TRUE,"979388A8-CC61-4C03-BADC-BEF9EC50C40A","Primary Tumor",NA,347,NA,NA,1360627200,"04",400,"TCGA-BK-A26L-01C-04",75,75,0,0,0,0,0,0,"2016-09-08T11:31:10.092014-05:00","2016-09-08T11:31:10.092014-05:00",4,4,0,0,"TOP","BOTTOM",2,2,"4600bfd5-9f3d-4d3c-9328-26668f3f3b1a","eb427800-6af1-48b8-8321-5a6a7d2e6154","TCGA-BK-A26L-01C-03-BS3","TCGA-BK-A26L-01C-04-BS4",98,98,"cd5aa9f7-d96c-42fc-b031-bb1426555c7e","RNA","TCGA-BK-A26L-01C-04R","802cd7f9-43fc-455a-b342-32bc3bbb8fec",1.92,0.16,"UV Spec","R","23","TCGA-BK-A26L-01C-04R-A277-07","a36f18b0-3978-4a46-bb1c-7c0839f492e9",0.16,NA,75,32.4619113573407,152,"457ac974-3e7b-5b32-ad48-70007f173b72","TCGA-BK-A26L_exposure","UNCID_2337792.a36f18b0-3978-4a46-bb1c-7c0839f492e9.130702_UNC12-SN629_0317_AD29BFACXX_7_ATGTCA.tar.gz","2014-02-04T05:37:06.000Z","2014-02-04T06:00:01.000Z","31A5F2A9-23FA-4CDE-B387-41CF9053CD88","7AC409D7-3F50-4228-9767-6BBF38A8D767","Unaligned reads",8148938629,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","A36F18B0-3978-4A46-BB1C-7C0839F492E9","University of North Carolina","564a39e1e4b0298dd2c7eae8","AB7ADF74-6E87-4117-9742-54E323348E06","Uterine Corpus Endometrial Carcinoma","TARGZ","CD5AA9F7-D96C-42FC-B031-BB1426555C7E","2014-02-04T06:00:01.000Z","802CD7F9-43FC-455A-B342-32BC3BBB8FEC","United States","YES",1,NA,"Primary Tumor","Christiana Healthcare",347,"CD5AA9F7-D96C-42FC-B031-BB1426555C7E",NA,"BK","UNCID_2251816.a36f18b0-3978-4a46-bb1c-7c0839f492e9.sorted_genome_alignments.bam",NA,"TCGA-BK-A26L-01C",NA,"F01F265D-9735-45F5-BD86-FED282F0CE51","TCGA",2010,NA,NA,NA,"CFDE53B1-A992-4180-B747-B4C1D3ED2E2B",71,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E78FD774-2F02-41DA-BE47-D049CACC8560.txt","Alive",NA,"TCGA-BK-A26L","NOT HISPANIC OR LATINO","A9C4C29A-32D3-4234-BE2E-74BD64F966EE",NA,234,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8441/3","FEMALE","C54.1",143,NA,"68758F4E-11D6-437F-A057-33C391965EF2","WHITE",NA,4,400,"EB427800-6AF1-48B8-8321-5A6A7D2E6154","802CD7F9-43FC-455A-B342-32BC3BBB8FEC","UNCID_2251816.a36f18b0-3978-4a46-bb1c-7c0839f492e9.sorted_genome_alignments.bam","TCGA-BK-A26L-01C-04",75,0,0,4,0,"BOTTOM",2,0,"TCGA-BK-A26L-01C-04-BS4",98,"Carboplatin","Chemotherapy","TCGA-BK-A26L-D21627","TCGA-BK-A26L-R21621","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",363,"TUMOR FREE","Alive",NA,"TCGA-BK-A26L-F21626","TCGA-BK-A26L",2,"BK","A26L","YES","C54.1","8441/3","C54.1","YES","NO",-26002,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",234,NA,NA,NA,NA,"NO",8,8,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,71,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29929773,28918407,2162173109,"1CF552FF-CF95-475F-AE0B-63BDBF753FD1.bw","abaf757b-f79f-40bd-96e3-e2c0f63061f0","1cf552ff-cf95-475f-ae0b-63bdbf753fd1","2016-08-25T15:50:56.040049-05:00","UNCID_2207450.87d95a5d-174b-4f13-a00f-85a28bfd1fb7.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_1.tar.gz","b1a25e67-e040-4c5f-9a66-672c6ba0b7cb",1901215554,"Illumina GA","10e4a8b2760a3ce941071006dc80629f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:01:11.057685-05:00","2016-05-03T11:13:42.378529-05:00","b1a25e67-e040-4c5f-9a66-672c6ba0b7cb_analysis.xml","1ac1cb579e40fd862f0611dac27d5f67","82ba0d83-3db2-46a2-aad0-77c9f7000446",2120,"2016-09-29T22:40:01.891273-05:00","b1a25e67-e040-4c5f-9a66-672c6ba0b7cb_experiment.xml","0a85591a48ce33689b92eafa5cfa95b6","c003eb11-3c07-4f46-a71c-0c483923b625",2257,"2016-09-29T21:35:56.302560-05:00","b1a25e67-e040-4c5f-9a66-672c6ba0b7cb_run.xml","c8a6783deaba5c4c16a7b52e8c8572d5","9852fb01-3f37-4063-93d6-37881d33f2fc",347,"2016-09-08T10:25:13.712228-05:00","TCGA-AX-A1CJ","2016-09-02T18:51:42.773224-05:00","female","TCGA-AX-A1CJ_demographic",1947,"black or african american","dde39d8c-7e4a-5965-852b-cd6904b2e99e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CJ_diagnosis","not reported",21655,"alive","8380/3",NA,2233,"9255f42f-4135-576d-a2eb-8e25a8a9263d","c54.1",-21655,"TCGA-AX-A1CJ_treatment","f2e18f7d-746c-54ee-ba50-e6d17e039c4b","01","false","TCGA-AX-A1CJ-01A",NA,"72d06ddf-9fb2-4577-bfdb-b0e463105b4a",FALSE,"AC9C3BB1-9B41-4B1F-BCEA-F6A0C68921B3","Primary Tumor",NA,1758,90,NA,1295222400,"11",30,"TCGA-AX-A1CJ-01A-11",90,NA,2,NA,0,NA,7,NA,"2016-09-08T10:25:13.712228-05:00",NA,8,NA,2,NA,"TOP",NA,2,NA,"a8895109-97c6-445b-8f1c-da2852c3e822",NA,"TCGA-AX-A1CJ-01A-01-TS1",NA,91,NA,"7c84466e-5926-47f0-b1d5-35fa9fbd8cc3","RNA","TCGA-AX-A1CJ-01A-11R","9dcee026-f258-47ac-be55-c2dae9fb2ac6",1.89,0.16,"UV Spec","R","23","TCGA-AX-A1CJ-01A-11R-A137-07","87d95a5d-174b-4f13-a00f-85a28bfd1fb7",0.16,NA,115,43.2835259136588,163,"bfd739a6-aa39-520f-80b9-152d4d88c434","TCGA-AX-A1CJ_exposure","UNCID_2207450.87d95a5d-174b-4f13-a00f-85a28bfd1fb7.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_1.tar.gz","2013-09-30T01:26:03.000Z","2013-09-30T01:38:02.000Z","B1A25E67-E040-4C5F-9A66-672C6BA0B7CB","72D06DDF-9FB2-4577-BFDB-B0E463105B4A","Unaligned reads",1901215554,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","87D95A5D-174B-4F13-A00F-85A28BFD1FB7","University of North Carolina","564a3655e4b0ef121818d1a9","ABAF757B-F79F-40BD-96E3-E2C0F63061F0","Uterine Corpus Endometrial Carcinoma","TARGZ","7C84466E-5926-47F0-B1D5-35FA9FBD8CC3","2013-09-30T01:38:02.000Z","9DCEE026-F258-47AC-BE55-C2DAE9FB2AC6","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1758,"7C84466E-5926-47F0-B1D5-35FA9FBD8CC3",NA,"AX","jhu-usc.edu_UCEC.HumanMethylation450.5.lvl-2.TCGA-AX-A1CJ-01A-11D-A138-05.txt",90,"TCGA-AX-A1CJ-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","72D06DDF-9FB2-4577-BFDB-B0E463105B4A",59,"nationwidechildrens.org_clinical.TCGA-AX-A1CJ.xml","Alive",NA,"TCGA-AX-A1CJ","NOT HISPANIC OR LATINO","64EAA365-4095-4720-9782-182CABFD593C",NA,1646,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"07F2DC14-3A63-40A2-9103-FB97DEFF210F","BLACK OR AFRICAN AMERICAN",NA,11,30,"A8895109-97C6-445B-8F1C-DA2852C3E822","C41D7A8D-6A2D-4237-8905-E2B0D2430552","TCGA-AX-A1CJ-01A-11R-A136-13_mirna.bam.bai","TCGA-AX-A1CJ-01A-11",90,0,2,8,7,"TOP",2,2,"TCGA-AX-A1CJ-01A-01-TS1",91,NA,NA,NA,"TCGA-AX-A1CJ-R12318","IMPLANTS","Primary Tumor Field","TCGA-AX-A1CJ-F65232_NTE-1","NO",2233,NA,"Alive",NA,"TCGA-AX-A1CJ-F65232","TCGA-AX-A1CJ",1,"AX","A1CJ","YES","C54.1","8380/3","C54.1","NO","YES",-21655,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",1646,NA,NA,NA,"TUMOR FREE","NO",10,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2006,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
34772416,34307313,2575207170,"BE0FF70F-61AB-48F4-B883-FDB77EE262FE.bw","ac1d3946-fe6c-4bd8-b02c-638799cb0f67","be0ff70f-61ab-48f4-b883-fdb77ee262fe","2016-08-09T14:10:21.018609-05:00","UNCID_2206803.7961370a-641d-4dc9-a530-99789e7d0036.110829_UNC2-RDR300275_00084_FC_634GCAAXX_8.tar.gz","125f4994-febe-4fe6-9d07-d6365cc67d0a",2219957924,"Illumina GA","5619931ff798a82069ba7d3d9c3c58df","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:21:29.188651-05:00","2016-05-03T11:12:13.672306-05:00","125f4994-febe-4fe6-9d07-d6365cc67d0a_analysis.xml","baac08f0ce34e8201f21914edc2e8161","d993383a-5f85-4e02-ac7f-bdbc87c7c858",2121,"2016-09-29T18:07:54.826593-05:00","125f4994-febe-4fe6-9d07-d6365cc67d0a_experiment.xml","6fa8ca2f582ae32e90ef5d6483861b90","1701ab8f-f092-45e3-9736-b94fe0cdd125",2257,"2016-09-29T17:41:34.273939-05:00","125f4994-febe-4fe6-9d07-d6365cc67d0a_run.xml","ef83ceb4fe758d69db048f7ec5cdeb6f","06330f68-7e82-4f7d-bd8e-216decef16d1",347,"2016-09-08T10:26:23.212836-05:00","TCGA-BG-A0LX","2016-09-02T18:54:47.014937-05:00","female","TCGA-BG-A0LX_demographic",1953,"white","1bcc5a0d-6671-5861-b26d-b67afa80d667","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0LX_diagnosis","not reported",20928,"alive","8380/3",NA,614,"64f9d868-5fb4-5a05-b777-196a4c569488","c54.1",-20928,"TCGA-BG-A0LX_treatment","29470147-1ea9-5cf9-b1d5-a422a62d321c","01","true","TCGA-BG-A0LX-01A",NA,"99cdf3a0-90dc-4992-b75a-11dd41928d43",FALSE,"4306E592-FA36-4AB9-BF84-7232CC599A64","Primary Tumor",NA,120,250,NA,1278547200,"11",30,"TCGA-BG-A0LX-01A-11",90,85,0,0,0,0,0,0,"2016-09-08T10:26:23.212836-05:00","2016-09-08T10:26:23.212836-05:00",0,0,0,0,"BOTTOM","TOP",30,10,"10ccc5d8-9f9a-4905-9302-bfb34cebc861","040f601d-497b-49c7-afb3-86e8aee102e2","TCGA-BG-A0LX-01A-01-BSA","TCGA-BG-A0LX-01A-01-TSA",70,90,"27a12dec-2c9d-4404-bb84-00632f0e187f","RNA","TCGA-BG-A0LX-01A-11R","bc892b57-8222-49ad-9354-89be22e7139a",1.74,0.14,"UV Spec","R","23","TCGA-BG-A0LX-01A-11R-A16W-07","7961370a-641d-4dc9-a530-99789e7d0036",0.14,NA,96,33.2179930795848,170,"5d4cdf8a-e235-556e-8dcd-0bc4e5ae7172","TCGA-BG-A0LX_exposure","UNCID_2206803.7961370a-641d-4dc9-a530-99789e7d0036.110829_UNC2-RDR300275_00084_FC_634GCAAXX_8.tar.gz","2013-09-28T07:26:05.000Z","2013-09-28T07:41:01.000Z","125F4994-FEBE-4FE6-9D07-D6365CC67D0A","99CDF3A0-90DC-4992-B75A-11DD41928D43","Unaligned reads",2219957924,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7961370A-641D-4DC9-A530-99789E7D0036","University of North Carolina","566079b8e4b0ec1099f8dc49","AC1D3946-FE6C-4BD8-B02C-638799CB0F67","Uterine Corpus Endometrial Carcinoma","TARGZ","27A12DEC-2C9D-4404-BB84-00632F0E187F","2013-09-28T07:41:01.000Z","BC892B57-8222-49AD-9354-89BE22E7139A","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",120,"27A12DEC-2C9D-4404-BB84-00632F0E187F",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5F4E9178-6219-44BF-A4A2-D02F0AB33AD8.txt",250,"TCGA-BG-A0LX-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","BB935FAB-8B12-4FDC-8A49-A03FD67CC014",57,"nationwidechildrens.org_clinical.TCGA-BG-A0LX.xml","Alive",NA,"TCGA-BG-A0LX","NOT HISPANIC OR LATINO","6F5BFE95-EA7F-40CF-8D0F-F52FB28F6490",NA,253,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"7AE9CB2E-0AB9-419A-B1AB-0E48B555953B","WHITE",NA,11,30,"10CCC5D8-9F9A-4905-9302-BFB34CEBC861","BC892B57-8222-49AD-9354-89BE22E7139A","TCGA-BG-A0LX-01A-11R-A041-13_mirna.bam.bai","TCGA-BG-A0LX-01A-11",85,0,0,0,0,"TOP",10,0,"TCGA-BG-A0LX-01A-01-TSA",90,NA,NA,NA,"TCGA-BG-A0LX-R4338","IMPLANTS","Primary Tumor Field",NA,"NO",614,"TUMOR FREE","Alive",NA,"TCGA-BG-A0LX-F19323","TCGA-BG-A0LX",1,"BG","A0LX","YES","C54.1","8380/3","C54.1","NO","YES",-20928,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",253,NA,NA,NA,"TUMOR FREE","NO",1,12,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34483242,33956533,2529958840,"0CC397C4-80BE-48CE-A1C9-7AC62547979E.bw","ac216bb5-15e4-4462-955e-8a522380690e","0cc397c4-80be-48ce-a1c9-7ac62547979e","2016-08-07T01:12:03.660586-05:00","UNCID_2211830.2188d23d-209d-4d3c-b737-f48892e08d31.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_3.tar.gz","23c6eeda-31d5-4efd-87d6-a7429e9a3043",2188072233,"Illumina GA","2e0850a26ba231ac716aa2c5aa60191e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:44:06.058637-05:00","2016-05-03T11:16:29.240093-05:00","23c6eeda-31d5-4efd-87d6-a7429e9a3043_analysis.xml","101ec691133102a38df82c1cbcb17e8a","c27cc02a-5af9-473d-9e57-39cd75b7c70f",2121,"2016-10-07T16:40:34.226449-05:00","23c6eeda-31d5-4efd-87d6-a7429e9a3043_experiment.xml","5b14712a1cdcec55914b5f0c47230888","9084d26c-7938-486f-93d4-fc79b3e2c5a4",2257,"2016-09-29T20:57:33.755527-05:00","23c6eeda-31d5-4efd-87d6-a7429e9a3043_run.xml","42b1145db76611525e58b4da96eb92ad","807598c6-220f-4cb2-b5ca-bd86379968de",347,"2016-09-08T10:37:58.708043-05:00","TCGA-D1-A0ZP","2016-09-02T18:49:11.601333-05:00","female","TCGA-D1-A0ZP_demographic",1950,"white","0ecef8f0-f148-5b31-8f6d-ea0e4f2440da","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A0ZP_diagnosis","not reported",21581,"alive","8441/3",NA,911,"a50ec4a3-5106-583e-a55c-bd33dfc9c68e","c54.1",-21581,"TCGA-D1-A0ZP_treatment","f1b231a6-bbdb-5a33-8a1a-4e9fc0585b84","01","false","TCGA-D1-A0ZP-01A",NA,"41a4ef51-9560-4089-a08a-624a64a168d5",FALSE,"FD46BB74-914F-4B4E-819A-5AD5F4548672","Primary Tumor",NA,552,180,NA,1288828800,"21",30,"TCGA-D1-A0ZP-01A-21",75,90,0,0,2,0,23,10,"2016-09-08T10:37:58.708043-05:00","2016-09-08T10:37:58.708043-05:00",8,10,1,10,"TOP","BOTTOM",0,10,"83a2289d-0752-4cc5-8127-05c2e7d4b2d1","3dd0e2a4-ec53-4cfa-8935-6e4b7c087167","TCGA-D1-A0ZP-01A-02-MS2","TCGA-D1-A0ZP-01A-02-BS2",75,80,"b7ff3f0a-22eb-4700-bf14-8bb70511afa0","RNA","TCGA-D1-A0ZP-01A-21R","9fd0bb5a-3130-49c4-8f79-d538deb7462d",1.85,0.17,"UV Spec","R","23","TCGA-D1-A0ZP-01A-21R-A10J-07","2188d23d-209d-4d3c-b737-f48892e08d31",0.17,NA,58,22.3756799506192,161,"c4ab6cbc-7064-52ec-8ad1-a23820dbebcd","TCGA-D1-A0ZP_exposure","UNCID_2211830.2188d23d-209d-4d3c-b737-f48892e08d31.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_3.tar.gz","2013-10-03T02:43:04.000Z","2013-10-03T02:55:02.000Z","23C6EEDA-31D5-4EFD-87D6-A7429E9A3043","41A4EF51-9560-4089-A08A-624A64A168D5","Unaligned reads",2188072233,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2188D23D-209D-4D3C-B737-F48892E08D31","University of North Carolina","566079cce4b018727fea2266","AC216BB5-15E4-4462-955E-8A522380690E","Uterine Corpus Endometrial Carcinoma","TARGZ","B7FF3F0A-22EB-4700-BF14-8BB70511AFA0","2013-10-03T02:55:02.000Z","9FD0BB5A-3130-49C4-8F79-D538DEB7462D","None","NO",1,NA,"Primary Tumor","Mayo Clinic",552,"B7FF3F0A-22EB-4700-BF14-8BB70511AFA0",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.A0FF554C-EDC0-4E64-B073-E447DB25593B.txt",180,"TCGA-D1-A0ZP-01A",NA,"E5E62438-A5E6-46EE-BE4B-F5502C224D88","TCGA",2009,NA,NA,"WITH TUMOR","41A4EF51-9560-4089-A08A-624A64A168D5",59,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.A0FF554C-EDC0-4E64-B073-E447DB25593B.txt","Alive",NA,"TCGA-D1-A0ZP","NOT HISPANIC OR LATINO","4A46C461-2F02-4EC2-8E81-5C30116E7A36",NA,690,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVA",NA,NA,NA,"8441/3","FEMALE","C54.1",81,NA,"1943E51D-3F80-4374-802D-4CBF3DF9ED2C","WHITE",NA,21,30,"83A2289D-0752-4CC5-8127-05C2E7D4B2D1","66A6B5B1-C3E3-4CFF-8387-1092E03B16C3","TCGA-D1-A0ZP-01A-21R-A10I-13_mirna.bam","TCGA-D1-A0ZP-01A-21",75,2,0,8,23,"TOP",0,1,"TCGA-D1-A0ZP-01A-02-MS2",75,"Paclitaxel","Chemotherapy","TCGA-D1-A0ZP-D17765","TCGA-D1-A0ZP-R17757","EXTERNAL BEAM","Regional site",NA,"YES",911,"TUMOR FREE","Alive",NA,"TCGA-D1-A0ZP-F17745","TCGA-D1-A0ZP",1,"D1","A0ZP","YES","C54.1","8441/3","C54.1","NO","YES",-21581,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",690,NA,NA,NA,"WITH TUMOR","NO",7,3,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,59,2009,"Tumor resection",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,15,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
100488428,97374969,4623690076,"9F59F086-C9D1-4624-8023-DB2EB9377743.bw","ac9ec63a-c3b6-4d0c-b1a9-7c72dbad456c","9f59f086-c9d1-4624-8023-db2eb9377743","2016-08-06T11:07:27.254894-05:00","UNCID_2178001.ae424bbe-6970-4afc-aa3b-7ae842f9a9d9.130402_UNC10-SN254_0447_BC22WAACXX_1_GATCAG.tar.gz","1d6a3a20-3797-41a1-b3fe-32120289579c",4216583411,"Illumina HiSeq","71527cfd5848514bffe2323d66bbab87","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:01:19.984065-05:00","2016-05-03T10:56:47.877475-05:00","1d6a3a20-3797-41a1-b3fe-32120289579c_analysis.xml","42d6f5845009407f9b3a229faa4a46d3","5de8dc25-1038-4d29-a2c1-62723955e10d",2123,"2016-09-29T18:59:35.159842-05:00","1d6a3a20-3797-41a1-b3fe-32120289579c_experiment.xml","c742db122d12e66d5aac642c86881e0c","3766f895-f1d4-4021-aaa0-d8f12ced4fea",2431,"2016-09-30T00:15:10.159242-05:00","1d6a3a20-3797-41a1-b3fe-32120289579c_run.xml","c963316b92915bd759c233bb0003592e","faf72db3-e452-4467-9979-98b81e0316d5",354,"2016-09-08T10:37:10.657713-05:00","TCGA-B5-A3FA","2016-09-02T18:47:36.016894-05:00","female","TCGA-B5-A3FA_demographic",1931,"white","03dbbfce-a850-50b1-a52b-10a4bda28aaa","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A3FA_diagnosis","not reported",26850,"alive","8380/3",NA,2929,"c99b7ccb-7e94-5dc8-9192-5d3d7a6f8708","c54.1",-26850,"TCGA-B5-A3FA_treatment","8352456b-9961-58af-a2df-092254af1008","01","true","TCGA-B5-A3FA-01A",NA,"6ba7181f-0fd1-4158-ad8d-2ce4513ab53f",FALSE,"1CA1DEC3-AD70-40F7-859B-24A27F47C904","Primary Tumor",NA,2679,510,NA,1321574400,"11",30,"TCGA-B5-A3FA-01A-11",75,NA,2,NA,30,NA,0,NA,"2016-09-08T10:37:10.657713-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"4047ce05-c5cd-4141-9d7f-5770e2d70270",NA,"TCGA-B5-A3FA-01A-01-TSA",NA,70,NA,"f1640f9c-4947-4efc-8eed-b1b1778759f7","RNA","TCGA-B5-A3FA-01A-11R","038b647b-2287-4f46-bc49-05f90f06277a",1.82,0.16,"UV Spec","R","23","TCGA-B5-A3FA-01A-11R-A19W-07","ae424bbe-6970-4afc-aa3b-7ae842f9a9d9",0.16,NA,74,29.6426854670726,158,"4852fa36-e90a-559f-939e-89648ab2ef78","TCGA-B5-A3FA_exposure","UNCID_2178001.ae424bbe-6970-4afc-aa3b-7ae842f9a9d9.130402_UNC10-SN254_0447_BC22WAACXX_1_GATCAG.tar.gz","2013-09-11T21:06:05.000Z","2013-09-11T21:20:01.000Z","1D6A3A20-3797-41A1-B3FE-32120289579C","6BA7181F-0FD1-4158-AD8D-2CE4513AB53F","Unaligned reads",4216583411,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","AE424BBE-6970-4AFC-AA3B-7AE842F9A9D9","University of North Carolina","564a355be4b09c884b228310","AC9EC63A-C3B6-4D0C-B1A9-7C72DBAD456C","Uterine Corpus Endometrial Carcinoma","TARGZ","F1640F9C-4947-4EFC-8EED-B1B1778759F7","2013-09-11T21:20:01.000Z","038B647B-2287-4F46-BC49-05F90F06277A","United States","NO",1,NA,"Primary Tumor","Duke",2679,"F1640F9C-4947-4EFC-8EED-B1B1778759F7",NA,"B5","TCGA-B5-A3FA-01A-11R-A19V-13_mirna.bam",510,"TCGA-B5-A3FA-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","E7B59508-807C-4CFE-A22D-148B6E2005BF",73,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B51FC044-B48F-43F6-B592-04C89D59A355.txt","Alive",NA,"TCGA-B5-A3FA",NA,"C493F1AA-008A-4465-8550-56CB308DBBB0",NA,2565,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,"WHITE",NA,11,30,"4047CE05-C5CD-4141-9D7F-5770E2D70270","14B1FE1E-8829-4F98-85D9-35B015C0031C","TCGA-B5-A3FA-01A-11R-A19V-13_mirna.bam.bai","TCGA-B5-A3FA-01A-11",75,30,2,1,0,"TOP",0,0,"TCGA-B5-A3FA-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-B5-A3FA-F37049_NTE-1","NO",2929,"TUMOR FREE","Alive",NA,"TCGA-B5-A3FA-F37049","TCGA-B5-A3FA",1,"B5","A3FA","YES","C54.1","8380/3","C54.1","NO","YES",-26850,"FEMALE","WHITE",NA,"No","No","Alive",2565,NA,NA,NA,"TUMOR FREE","NO",19,3,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2004,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33141050,32661953,2446143288,"0BA0302E-63B8-469F-B729-899E12AE8809.bw","ad0806a5-df9e-48ea-bc8b-d4a3c9ea7ea0","0ba0302e-63b8-469f-b729-899e12ae8809","2016-08-09T14:12:39.932984-05:00","UNCID_2207205.19d3602e-79e6-467f-b49d-c2fa216418ed.110719_UNC2-RDR300275_00077_FC_70KATAAXX_3.tar.gz","58ab865c-bc5d-4756-a890-dec9801f1d33",2050817155,"Illumina GA","ba48ef1144dd7a961f75af791bb88daf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:47:17.553206-05:00","2016-05-03T11:13:42.375045-05:00","58ab865c-bc5d-4756-a890-dec9801f1d33_analysis.xml","fb4a7df61cb3e7dc49989166b32e8df4","7a0375d9-b9b1-40a7-ae1d-8c1d14d82783",2121,"2016-09-29T20:39:24.952488-05:00","58ab865c-bc5d-4756-a890-dec9801f1d33_experiment.xml","e8ce5622a98bb9029fea9e8eb201a3f3","751f8b24-2ae3-462b-93a5-b4cadb6b50d3",2257,"2016-09-29T18:48:19.468966-05:00","58ab865c-bc5d-4756-a890-dec9801f1d33_run.xml","c075053dc11806824a890d05435857bd","304f5c9d-ef80-4e22-bf12-932918a20cab",347,"2016-09-08T11:08:36.135167-05:00","TCGA-AP-A1DQ","2016-09-02T18:51:26.387488-05:00","female","TCGA-AP-A1DQ_demographic",1932,"white","306dab98-cd1e-50f5-989a-70e8f5e5da76","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1DQ_diagnosis","not reported",27815,"dead","8380/3",1423,1276,"42051a2d-4aa0-53ce-b7ec-e9dc8ba5aab3","c54.1",-27815,"TCGA-AP-A1DQ_treatment","bc799570-1022-5ad9-9c7d-96f05e735efe","01","true","TCGA-AP-A1DQ-01A",NA,"812485e9-fbb8-431b-8c49-d2f1a9391457",FALSE,"F5983E58-F466-42CF-8905-B942D2BDF702","Primary Tumor",NA,1074,100,NA,1295395200,"11",30,"TCGA-AP-A1DQ-01A-11",70,NA,4,NA,0,NA,30,NA,"2016-09-08T11:08:36.135167-05:00",NA,3,NA,3,NA,"TOP",NA,0,NA,"08c20bf9-6de9-4841-be39-f93381fc1cf1",NA,"TCGA-AP-A1DQ-01A-01-TSA",NA,70,NA,"0e2e0154-c083-406c-a8f7-fdad10e371ef","RNA","TCGA-AP-A1DQ-01A-11R","67bb6dd0-e058-4d6a-a632-e15c82991849",1.88,0.18,"UV Spec","R","23","TCGA-AP-A1DQ-01A-11R-A137-07","19d3602e-79e6-467f-b49d-c2fa216418ed",0.18,NA,60,22.5827091723437,163,"73a3d5ce-3b08-52c5-bfd0-90e3029ecd0c","TCGA-AP-A1DQ_exposure","UNCID_2207205.19d3602e-79e6-467f-b49d-c2fa216418ed.110719_UNC2-RDR300275_00077_FC_70KATAAXX_3.tar.gz","2013-09-29T18:06:04.000Z","2013-09-29T18:19:01.000Z","58AB865C-BC5D-4756-A890-DEC9801F1D33","812485E9-FBB8-431B-8C49-D2F1A9391457","Unaligned reads",2050817155,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","19D3602E-79E6-467F-B49D-C2FA216418ED","University of North Carolina","56607adae4b0b37b3d9920bb","AD0806A5-DF9E-48EA-BC8B-D4A3C9EA7EA0","Uterine Corpus Endometrial Carcinoma","TARGZ","0E2E0154-C083-406C-A8F7-FDAD10E371EF","2013-09-29T18:19:01.000Z","67BB6DD0-E058-4D6A-A632-E15C82991849","None","NO",1,NA,"Primary Tumor","MSKCC",1074,"0E2E0154-C083-406C-A8F7-FDAD10E371EF",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.903A7E22-F05E-40BC-A40B-7833FC342F07.txt",100,"TCGA-AP-A1DQ-01A",NA,"F8281007-6733-4F30-B706-3581CE0AAAB5","TCGA",2008,NA,NA,"WITH TUMOR","812485E9-FBB8-431B-8C49-D2F1A9391457",76,"nationwidechildrens.org_clinical.TCGA-AP-A1DQ.xml","Alive",NA,"TCGA-AP-A1DQ",NA,"C15903E7-34A0-4CB8-9EB2-EC3FFFEA265B",NA,1185,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"31528D28-E6A0-4BCE-8DBE-8681C9EFA3FA","WHITE",NA,11,30,"08C20BF9-6DE9-4841-BE39-F93381FC1CF1","E7A3CB02-A7F6-4428-AECE-2C36FC70718C","GAMMA_p_TCGA_b103_104_SNP_N_GenomeWideSNP_6_G09_755942.CEL","TCGA-AP-A1DQ-01A-11",70,0,4,3,30,"TOP",0,3,"TCGA-AP-A1DQ-01A-01-TSA",70,"Anastrozole","Hormone Therapy","TCGA-AP-A1DQ-D13654","TCGA-AP-A1DQ-R13652","EXTERNAL BEAM","Distant Recurrence",NA,"NO",NA,"WITH TUMOR","Dead",1423,"TCGA-AP-A1DQ-F29057","TCGA-AP-A1DQ",1,"AP","A1DQ","YES","C54.1","8380/3","C54.1","NO","YES",-27815,"FEMALE","WHITE",NA,"No","No","Alive",1185,NA,NA,NA,"WITH TUMOR","NO",9,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,76,2008,"Office Endometrial Biopsy",NA,NA,NA,"High Grade","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31562842,30609232,2296120528,"9D121938-C7DA-45BD-8EC0-126C8A93A7FE.bw","ad3d8420-f562-4cbe-ac82-c968bd4f782d","9d121938-c7da-45bd-8ec0-126c8a93a7fe","2016-08-05T08:20:36.444681-05:00","UNCID_2214559.c1621135-fa9b-4043-8168-356402d45f01.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_5.tar.gz","b79295d6-d489-418f-8024-d2cababe733a",1968844444,"Illumina GA","cc05195b314d3d069d5f830cdc10d498","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:28:07.399194-05:00","2016-05-03T11:17:14.896869-05:00","b79295d6-d489-418f-8024-d2cababe733a_analysis.xml","2c143f37431b4d679c1993216cecf4ce","6e4599e2-5404-4332-a0d7-89c7422dc3de",2121,"2016-09-29T21:10:15.254855-05:00","b79295d6-d489-418f-8024-d2cababe733a_experiment.xml","4cc928bf6e68bc302286bb4cea9e365e","887a320e-ed0e-4fbf-9f84-6347ec49b509",2257,"2016-09-29T18:01:18.870421-05:00","b79295d6-d489-418f-8024-d2cababe733a_run.xml","c989678b0abfc701d9e6d391a75dc4b2","12cef141-4748-45e6-be34-72af31a9e7e3",347,"2016-09-08T10:46:07.789161-05:00","TCGA-BS-A0TA","2016-09-02T18:48:22.140121-05:00","female","TCGA-BS-A0TA_demographic",1947,"native hawaiian or other pacific islander","55d1f392-d699-5dd4-9831-47cdcdf35006","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0TA_diagnosis","not reported",21505,"dead","8380/3",740,714,"fae06394-6c46-5ec5-8f41-1b53fbb65203","c54.1",-21505,"TCGA-BS-A0TA_treatment","f85e4c69-fc08-5296-a038-1a34c2b7569c","01","false","TCGA-BS-A0TA-01A",NA,"b6a042b6-f94a-4acc-98cb-a1a2fe72b9ad",FALSE,"5F009A9A-549F-4EEB-BB6D-C67353C7A292","Primary Tumor",NA,1788,300,NA,1281484800,"11",30,"TCGA-BS-A0TA-01A-11",85,90,30,20,0,0,10,5,"2016-09-08T10:46:07.789161-05:00","2016-09-08T10:46:07.789161-05:00",50,40,40,30,"TOP","BOTTOM",5,5,"97560966-7c77-4e09-9cf8-294de46441cf","96942cd0-80f0-40e3-803f-656755cb1a47","TCGA-BS-A0TA-01A-01-TS1","TCGA-BS-A0TA-01A-01-BS1",85,90,"2dda202d-5041-4019-9b1e-acb3d4e1c63d","RNA","TCGA-BS-A0TA-01A-11R","63586f5a-7f6a-4ec5-b03d-bb707f2dfbf3",1.77,0.16,"UV Spec","R","23","TCGA-BS-A0TA-01A-11R-A104-07","c1621135-fa9b-4043-8168-356402d45f01",0.16,NA,90,38.9542936288089,152,"d7a28285-1d52-5eaf-a4bb-6a9ffbb2d7b8","TCGA-BS-A0TA_exposure","UNCID_2214559.c1621135-fa9b-4043-8168-356402d45f01.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_5.tar.gz","2013-10-03T17:26:04.000Z","2013-10-03T17:44:02.000Z","B79295D6-D489-418F-8024-D2CABABE733A","B6A042B6-F94A-4ACC-98CB-A1A2FE72B9AD","Unaligned reads",1968844444,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C1621135-FA9B-4043-8168-356402D45F01","University of North Carolina","566078fbe4b0ca319164ef05","AD3D8420-F562-4CBE-AC82-C968BD4F782D","Uterine Corpus Endometrial Carcinoma","TARGZ","2DDA202D-5041-4019-9B1E-ACB3D4E1C63D","2013-10-03T17:44:02.000Z","63586F5A-7F6A-4EC5-B03D-BB707F2DFBF3","None","NO",1,NA,"Primary Tumor","University of Hawaii",1788,"2DDA202D-5041-4019-9B1E-ACB3D4E1C63D",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9553C69B-1FB7-4D93-9B62-19E9A7AE9C62.txt",300,"TCGA-BS-A0TA-01A",NA,"C2C27C9F-7696-4311-AAF0-FCF3E21AD592","TCGA",2005,NA,NA,"WITH TUMOR","B6A042B6-F94A-4ACC-98CB-A1A2FE72B9AD",58,"TCGA-BS-A0TA-01A-11D-A101-02_BD0UKBACXX---TCGA-BS-A0TA-10A-01D-A101-02_BD0UK4ACXX---VariantCalling.vcf","Alive",NA,"TCGA-BS-A0TA","HISPANIC OR LATINO","789C4AFB-2D2B-4270-BF9C-0DE36521A3F0",NA,714,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"CBDB6D7C-18C4-4506-A5DA-A412693D6AD3","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,11,30,"97560966-7C77-4E09-9CF8-294DE46441CF","A88234A4-C1B8-45BC-BDC3-231E44C62E07","UNCID_2214559.c1621135-fa9b-4043-8168-356402d45f01.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_5.tar.gz","TCGA-BS-A0TA-01A-11",85,0,30,50,10,"TOP",5,40,"TCGA-BS-A0TA-01A-01-TS1",85,"Adriamycin","Chemotherapy","TCGA-BS-A0TA-D4429","TCGA-BS-A0TA-R4424","EXTERNAL BEAM","Distant Recurrence","TCGA-BS-A0TA-F68985_NTE-1","YES",NA,"WITH TUMOR","Dead",740,"TCGA-BS-A0TA-F68985","TCGA-BS-A0TA",1,"BS","A0TA","YES","C54.1","8380/3","C54.1","NO","YES",-21505,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","HISPANIC OR LATINO","No","No","Alive",714,NA,NA,NA,"WITH TUMOR","NO",19,11,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2005,"Fine needle aspiration biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
37555802,37260223,2766915125,"E89AC323-326B-4511-AFEF-9ABEFF9D3BDA.bw","adc22472-e31d-419f-aeae-cb01b9423343","e89ac323-326b-4511-afef-9abeff9d3bda","2016-08-09T14:11:47.691391-05:00","UNCID_2207037.95ea81fa-025d-4338-94db-ec7024562d8f.110728_UNC2-RDR300275_00080_FC_63145AAXX_3.tar.gz","145e69d6-99d4-4d01-9e7c-5aacd18c568f",2435794558,"Illumina GA","2d72261a77cb04568d24d467dc885b43","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:18:58.658364-05:00","2016-05-03T11:13:02.646906-05:00","145e69d6-99d4-4d01-9e7c-5aacd18c568f_analysis.xml","afa8e2c914a20cc2a92098b1d64345c1","8df0c6f8-4291-4262-a7ce-ddf11c89c2c3",2121,"2016-09-29T23:51:36.087320-05:00","145e69d6-99d4-4d01-9e7c-5aacd18c568f_experiment.xml","40db49e4585b77becdbc5671b320f2cf","ec74f5c8-c06f-4197-a91e-126731687f2b",2257,"2016-09-29T23:27:43.846829-05:00","145e69d6-99d4-4d01-9e7c-5aacd18c568f_run.xml","3b93089db8550eeb91ff2fe233ce3a4b","dd91b580-8c77-46d4-a237-ed073e40c1d2",347,"2016-09-08T10:57:01.099980-05:00","TCGA-A5-A0GU","2016-09-02T18:54:13.720330-05:00","female","TCGA-A5-A0GU_demographic",1951,"white","33d6af45-80b9-546f-a040-7441d66a34d7","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GU_diagnosis","not reported",21192,"alive","8380/3",NA,860,"ac66ac8a-c4c4-5b6b-8b90-daf06b5f6af7","c54.1",-21192,"TCGA-A5-A0GU_treatment","a8734643-9e1d-5435-8295-b23b0ece4ff1","01","true","TCGA-A5-A0GU-01A",NA,"074d4466-e072-42cd-9a6c-a595dc9363e7",FALSE,"B284E409-4AC1-45E5-9133-39659987D7F9","Primary Tumor",NA,471,190,NA,1277856000,"11",30,"TCGA-A5-A0GU-01A-11",70,90,20,3,0,0,30,8,"2016-09-08T10:57:01.099980-05:00","2016-09-08T10:57:01.099980-05:00",25,4,20,1,"TOP","BOTTOM",10,10,"f44447b5-e30f-42a5-8221-e55d35666d48","af20265b-8332-42ea-b34c-3373bfbb6ed9","TCGA-A5-A0GU-01A-01-TS1","TCGA-A5-A0GU-01A-01-MS1",60,82,"1342abbf-84bb-4c59-b8e2-df49f307d900","RNA","TCGA-A5-A0GU-01A-11R","adc0e204-cf17-4e26-89b2-53e3886e6dd1",1.85,0.14,"UV Spec","R","23","TCGA-A5-A0GU-01A-11R-A16W-07","95ea81fa-025d-4338-94db-ec7024562d8f",0.14,NA,95,37.109375,160,"da9439f1-81da-56a7-be45-69bfaae2b48e","TCGA-A5-A0GU_exposure","UNCID_2207037.95ea81fa-025d-4338-94db-ec7024562d8f.110728_UNC2-RDR300275_00080_FC_63145AAXX_3.tar.gz","2013-09-29T03:26:03.000Z","2013-09-29T03:39:01.000Z","145E69D6-99D4-4D01-9E7C-5AACD18C568F","074D4466-E072-42CD-9A6C-A595DC9363E7","Unaligned reads",2435794558,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","95EA81FA-025D-4338-94DB-EC7024562D8F","University of North Carolina","564a3c7ee4b093830b699e27","ADC22472-E31D-419F-AEAE-CB01B9423343","Uterine Corpus Endometrial Carcinoma","TARGZ","1342ABBF-84BB-4C59-B8E2-DF49F307D900","2013-09-29T03:39:01.000Z","ADC0E204-CF17-4E26-89B2-53E3886E6DD1","None","NO",1,NA,"Primary Tumor","Cedars Sinai",471,"1342ABBF-84BB-4C59-B8E2-DF49F307D900",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5BD1CBD7-EF39-4774-8A6A-3BADD82989F0.txt",190,"TCGA-A5-A0GU-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","14A66466-7AC3-48D7-B39F-5353E27D370F",58,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5BD1CBD7-EF39-4774-8A6A-3BADD82989F0.txt","Alive",NA,"TCGA-A5-A0GU",NA,"C92855F0-7DB1-4883-A23E-C2419E125012",NA,496,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"F44447B5-E30F-42A5-8221-E55D35666D48","ADC0E204-CF17-4E26-89B2-53E3886E6DD1","MODEM_p_TCGAb59_SNP_N_GenomeWideSNP_6_D07_680424.nocnv_hg19.seg.txt","TCGA-A5-A0GU-01A-11",90,0,3,4,8,"BOTTOM",10,1,"TCGA-A5-A0GU-01A-01-MS1",82,NA,NA,NA,NA,NA,NA,NA,NA,496,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GU-F3075","TCGA-A5-A0GU",1,"A5","A0GU","YES","C54.1","8380/3","C54.1","NO","YES",-21192,"FEMALE","WHITE",NA,"No","No","Alive",496,NA,NA,NA,"TUMOR FREE","NO",10,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2009,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
122368380,121153486,5785448691,"25A9EC4A-F646-4B58-A565-14E9AE3C5944.bw","ae8a4958-5407-4c01-93c3-8090862533ae","25a9ec4a-f646-4b58-a565-14e9ae3c5944","2016-08-09T14:01:32.571496-05:00","UNCID_2168492.12be39a5-bbae-439a-84a9-28b790e89aa9.130610_UNC14-SN744_0347_BD28NBACXX_2_GCCAAT.tar.gz","2a96b91a-228e-4fe9-8f0b-1fc3898bb6b4",5648956366,"Illumina HiSeq","effc42ce30c4c271f55f5784e228845c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:35:22.702786-05:00","2016-05-03T11:06:28.634121-05:00","2a96b91a-228e-4fe9-8f0b-1fc3898bb6b4_analysis.xml","135cbcd5857be5ec8610d33c4d66f90c","e25c2790-1543-4d70-b172-23f790f3b987",2123,"2016-09-29T23:48:22.902919-05:00","2a96b91a-228e-4fe9-8f0b-1fc3898bb6b4_experiment.xml","0e0532f7acab4f4fc7f9147c0711b7a0","ea7643d4-7e21-43b5-95d7-50c052498873",2431,"2016-09-29T18:51:18.982008-05:00","2a96b91a-228e-4fe9-8f0b-1fc3898bb6b4_run.xml","1b4bda0562f0808963e131c9a54a121d","3231bbba-4a9e-4dd7-9c39-8b633510a5c7",354,"2016-09-09T16:00:36.010222-05:00","TCGA-B5-A5OC","2016-09-02T18:50:01.756267-05:00","female","TCGA-B5-A5OC_demographic",1940,"black or african american","7d93421a-71dc-502a-9c1a-8d3d30104edf","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A5OC_diagnosis","not reported",26109,"alive","8380/3",NA,1249,"d0efbe59-a540-5d2d-83db-f1e2c8d18b8e","c54.1",-26109,"TCGA-B5-A5OC_treatment","480b91ab-910b-5bac-ad43-dca37c364126","01","true","TCGA-B5-A5OC-01A",NA,"69ac12c0-a986-44ac-8687-134ccb12ac21",FALSE,"2B1515A6-001A-46AF-952C-D393944DE57F","Primary Tumor",NA,732,750,NA,1361232000,"21",30,"TCGA-B5-A5OC-01A-21",60,NA,40,NA,0,NA,40,NA,"2016-09-09T16:00:36.010222-05:00",NA,20,NA,20,NA,"TOP",NA,0,NA,"15d25a6a-f0e7-4ad1-8b42-10faa46ed62e",NA,"TCGA-B5-A5OC-01A-02-TSB",NA,60,NA,"280dbbfb-b37e-4ec0-a892-e79d50296c7e","RNA","TCGA-B5-A5OC-01A-21R","f274d7ac-057a-4053-8881-0d25b299b5fc",1.88,0.16,"UV Spec","R","23","TCGA-B5-A5OC-01A-21R-A27V-07","12be39a5-bbae-439a-84a9-28b790e89aa9",0.16,NA,NA,NA,NA,"d1f77a82-9999-537c-b1bb-50128a7ef8ee","TCGA-B5-A5OC_exposure","UNCID_2168492.12be39a5-bbae-439a-84a9-28b790e89aa9.130610_UNC14-SN744_0347_BD28NBACXX_2_GCCAAT.tar.gz","2013-09-20T07:37:05.000Z","2013-09-20T07:51:02.000Z","2A96B91A-228E-4FE9-8F0B-1FC3898BB6B4","69AC12C0-A986-44AC-8687-134CCB12AC21","Unaligned reads",5648956366,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","12BE39A5-BBAE-439A-84A9-28B790E89AA9","University of North Carolina","564a4102e4b0298dd2ca3477","AE8A4958-5407-4C01-93C3-8090862533AE","Uterine Corpus Endometrial Carcinoma","TARGZ","280DBBFB-B37E-4EC0-A892-E79D50296C7E","2013-09-20T07:51:02.000Z","F274D7AC-057A-4053-8881-0D25B299B5FC","United States","NO",1,NA,"Primary Tumor","Duke",732,"280DBBFB-B37E-4EC0-A892-E79D50296C7E",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.22D396FC-0D94-4E2A-AFD0-4D2CCFB3872F.txt",750,"TCGA-B5-A5OC-01A",NA,"707CBBF9-1168-471B-B062-BD3EE6D6EFC4","TCGA",2011,"TCGA-B5-A5OC_NTE-1",NA,NA,"69AC12C0-A986-44AC-8687-134CCB12AC21",71,"nationwidechildrens.org_clinical.TCGA-B5-A5OC.xml","Alive",NA,"TCGA-B5-A5OC",NA,"8FF1AF67-8DEA-40EF-8AC9-04C39F0B8DA9","NO",841,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8380/3","FEMALE","C54.1",289,NA,"740287BB-76E4-4C69-AE43-F22DEE2C4A15","BLACK OR AFRICAN AMERICAN",NA,21,30,"15D25A6A-F0E7-4AD1-8B42-10FAA46ED62E","2F3ECD21-A029-4619-ABB4-A1B906AB02A6","e3e156ccdf4491d4ca5ca75b57011a75.bam.bai","TCGA-B5-A5OC-01A-21",60,0,40,20,40,"TOP",0,20,"TCGA-B5-A5OC-01A-02-TSB",60,"Cisplatin",NA,"TCGA-B5-A5OC-D57491","TCGA-B5-A5OC-R57490","External","Primary Tumor Field","TCGA-B5-A5OC-F59471_NTE-1","NO",1249,"TUMOR FREE","Alive",NA,"TCGA-B5-A5OC-F59471","TCGA-B5-A5OC",1,"B5","A5OC","YES","C54.1","8380/3","C54.1","YES","NO",-26109,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",841,NA,"YES","YES",NA,"YES",20,8,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,71,2011,NA,NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"2009",10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33490169,32691671,2443066202,"ACAD59E0-B2BD-4D91-93AB-227A4C55E410.bw","af363cec-bec9-4de3-8cc2-e98b0eed2858","acad59e0-b2bd-4d91-93ab-227a4c55e410","2016-08-09T14:08:58.770961-05:00","UNCID_2206603.5f65a8b5-2460-4544-be71-5e7b7347b0fa.110928_UNC6-RDR300211_00126_FC_6348UAAXX_2.tar.gz","1a07e303-bcf7-499c-b41c-02a99de78678",2195787447,"Illumina GA","f6fe4d08f4f2a9c1a8c3ccd973c8cf44","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:34:08.350248-05:00","2016-05-03T11:11:34.786211-05:00","1a07e303-bcf7-499c-b41c-02a99de78678_analysis.xml","eab163918cdc99919ac926a28361e7d9","71ce1809-7d20-453c-84b3-140db6b8cc61",2121,"2016-10-07T16:57:59.122486-05:00","1a07e303-bcf7-499c-b41c-02a99de78678_experiment.xml","0527e9b7a0b4e4cd3130295d058cf55b","30676555-6e74-4fbb-b2c5-7d2d031f8138",2257,"2016-09-29T23:13:33.919207-05:00","1a07e303-bcf7-499c-b41c-02a99de78678_run.xml","71e898093fccda80cffb828ea186b20d","d4e49724-04b8-4c4a-a7ac-d8283172e1d9",347,"2016-09-08T10:33:39.265841-05:00","TCGA-EO-A2CG","2016-09-02T18:53:57.872849-05:00","female","TCGA-EO-A2CG_demographic",1940,"asian","07c36ef4-9831-5e46-a1af-0458dd1703c6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A2CG_diagnosis","not reported",25279,"alive","8441/3",NA,1564,"8f4ffe4f-967f-5d0a-876b-1bc00c13b80d","c54.1",-25279,"TCGA-EO-A2CG_treatment","1488e994-e459-5daf-ba2e-e37bba5831c0","01","false","TCGA-EO-A2CG-01A",NA,"cf894594-77cc-471e-b112-5eae1829c415",FALSE,"CAF671DB-2DD1-43D5-99C8-185253775B37","Primary Tumor",NA,643,60,NA,1309305600,"12",30,"TCGA-EO-A2CG-01A-12",75,NA,0,NA,20,NA,0,NA,"2016-09-08T10:33:39.265841-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"8fdad480-24ea-485a-8087-877cd5143349",NA,"TCGA-EO-A2CG-01A-01-TS1",NA,80,NA,"9510c1d0-3512-4080-b667-face7e065147","RNA","TCGA-EO-A2CG-01A-12R","07881191-f7a0-4275-800c-2c855b50af02",1.87,0.16,"UV Spec","R","23","TCGA-EO-A2CG-01A-12R-A180-07","5f65a8b5-2460-4544-be71-5e7b7347b0fa",0.16,NA,68,29.4321329639889,152,"10ada757-7957-52ba-9d8a-23d6fa925270","TCGA-EO-A2CG_exposure","UNCID_2206603.5f65a8b5-2460-4544-be71-5e7b7347b0fa.110928_UNC6-RDR300211_00126_FC_6348UAAXX_2.tar.gz","2013-09-27T12:31:03.000Z","2013-09-27T12:44:02.000Z","1A07E303-BCF7-499C-B41C-02A99DE78678","CF894594-77CC-471E-B112-5EAE1829C415","Unaligned reads",2195787447,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","5F65A8B5-2460-4544-BE71-5E7B7347B0FA","University of North Carolina","56607f03e4b0ec1099f8f345","AF363CEC-BEC9-4DE3-8CC2-E98B0EED2858","Uterine Corpus Endometrial Carcinoma","TARGZ","9510C1D0-3512-4080-B667-FACE7E065147","2013-09-27T12:44:02.000Z","07881191-F7A0-4275-800C-2C855B50AF02","Canada","NO",1,NA,"Primary Tumor","University Health Network",643,"9510C1D0-3512-4080-B667-FACE7E065147",NA,"EO","UNCID_2206603.5f65a8b5-2460-4544-be71-5e7b7347b0fa.110928_UNC6-RDR300211_00126_FC_6348UAAXX_2.tar.gz",60,"TCGA-EO-A2CG-01A",NA,"9100F8AD-3D0F-433E-A172-B739230B7817","TCGA",2009,NA,NA,"TUMOR FREE","FDF547E6-FB89-4F0B-AAA9-55460DD0A5A4",69,"nationwidechildrens.org_clinical.TCGA-EO-A2CG.xml","Alive",NA,"TCGA-EO-A2CG","NOT HISPANIC OR LATINO","6AE0763F-C789-4721-9705-77DB38E52043",NA,752,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",168,NA,"A58A91DE-C073-4C51-81BA-2CADE3C4BEC4","ASIAN",NA,12,30,"8FDAD480-24EA-485A-8087-877CD5143349","098FA0A6-CD9F-460C-8252-4E2289918D43","UNCID_2206603.5f65a8b5-2460-4544-be71-5e7b7347b0fa.110928_UNC6-RDR300211_00126_FC_6348UAAXX_2.tar.gz","TCGA-EO-A2CG-01A-12",75,20,0,0,0,"TOP",0,0,"TCGA-EO-A2CG-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-EO-A2CG-D56881","TCGA-EO-A2CG-R56887","External","Primary Tumor Field",NA,"NO",985,NA,"Alive",NA,"TCGA-EO-A2CG-F32589","TCGA-EO-A2CG",1,"EO","A2CG","YES","C54.1","8441/3","C54.1",NA,"YES",-25279,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",752,NA,NA,NA,"TUMOR FREE","NO",26,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,69,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28688560,28322978,2123499878,"EE564C1C-E383-4E04-9B0D-1DD97E48EA1C.bw","af37d8f0-fea0-47f6-be0a-2fb55a5da5c4","ee564c1c-e383-4e04-9b0d-1dd97e48ea1c","2016-08-09T14:18:59.072750-05:00","UNCID_2216424.bd558781-2e3b-4fb0-aeb8-a8cefbf3272d.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_3.tar.gz","41effb80-4dc0-4ef1-9926-42ee73b14c92",1799093081,"Illumina GA","106bd6f4915200fe094427d146414698","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:33:40.366423-05:00","2016-05-03T11:18:47.010651-05:00","41effb80-4dc0-4ef1-9926-42ee73b14c92_analysis.xml","607175383c0ad27b8217ccffa887bd55","e150ba53-69ea-4fd6-9e59-2a9798fbde42",2120,"2016-09-29T21:36:49.270562-05:00","41effb80-4dc0-4ef1-9926-42ee73b14c92_experiment.xml","96c842c10e508b1e645687d4bd088347","98e5648d-34fc-4e8e-8c58-f26089316a73",2256,"2016-09-29T18:06:57.392486-05:00","41effb80-4dc0-4ef1-9926-42ee73b14c92_run.xml","d800eec1f9609761be6750f4a497da07","166e863d-9120-426f-98cb-d2f1a9799d72",345,"2016-09-08T11:01:58.523606-05:00","TCGA-AP-A053","2016-09-02T18:52:37.799147-05:00","female","TCGA-AP-A053_demographic",1914,"white","75602116-9f85-5987-8850-77008a821b05","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A053_diagnosis","not reported",32872,"dead","8380/3",3365,18,"2e148196-8012-5792-9d48-74c104ac12a8","c54.1",-32872,"TCGA-AP-A053_treatment","f2c07f84-a8ab-57ee-bbc9-3c579efeb595","01","true","TCGA-AP-A053-01A",NA,"e1121a9e-bc27-44eb-a1ad-eb0ab10b7c3a",FALSE,"6179478F-93BE-4C03-9F65-D74E66AFE449","Primary Tumor",NA,2163,220,NA,1275868800,"21",30,"TCGA-AP-A053-01A-21",98,70,0,0,0,30,2,2,"2016-09-08T11:01:58.523606-05:00","2016-09-08T11:01:58.523606-05:00",0,0,0,0,"BOTTOM","TOP",15,8,"9770d67d-7a80-42c2-a9a8-9f23d9a881e1","0317dafc-0b86-43ac-847d-f1500ced3cd2","TCGA-AP-A053-01A-02-BS2","TCGA-AP-A053-01A-01-BS1",83,60,"de85d9af-d956-4856-be0f-769bf80dbf16","RNA","TCGA-AP-A053-01A-21R","28ebda4e-94e7-45e1-8a67-d91afa0e979e",1.79,0.16,"UV Spec","R","23","TCGA-AP-A053-01A-21R-A00V-07","bd558781-2e3b-4fb0-aeb8-a8cefbf3272d",0.16,NA,48,19.723865877712,156,"c6cc757c-e7b9-57c1-8be5-523e21d7a022","TCGA-AP-A053_exposure","UNCID_2216424.bd558781-2e3b-4fb0-aeb8-a8cefbf3272d.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_3.tar.gz","2013-10-04T08:16:04.000Z","2013-10-04T08:28:02.000Z","41EFFB80-4DC0-4EF1-9926-42EE73B14C92","E1121A9E-BC27-44EB-A1AD-EB0AB10B7C3A","Unaligned reads",1799093081,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","BD558781-2E3B-4FB0-AEB8-A8CEFBF3272D","University of North Carolina","56607cc6e4b016715ab6b401","AF37D8F0-FEA0-47F6-BE0A-2FB55A5DA5C4","Uterine Corpus Endometrial Carcinoma","TARGZ","DE85D9AF-D956-4856-BE0F-769BF80DBF16","2013-10-04T08:28:02.000Z","28EBDA4E-94E7-45E1-8A67-D91AFA0E979E","None","NO",1,NA,"Primary Tumor","MSKCC",2163,"DE85D9AF-D956-4856-BE0F-769BF80DBF16",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C6D00B82-9791-4C99-AC08-263A2BC2E33E.txt",220,"TCGA-AP-A053-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","E1121A9E-BC27-44EB-A1AD-EB0AB10B7C3A",90,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C6D00B82-9791-4C99-AC08-263A2BC2E33E.txt","Alive",NA,"TCGA-AP-A053","NOT HISPANIC OR LATINO","A354E0A4-479D-49B6-BA5A-5E56DFD2688F",NA,18,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,"11DE469C-2872-4711-8CC1-B0B45CED55B6","WHITE",NA,21,30,"9770D67D-7A80-42C2-A9A8-9F23D9A881E1","C26BEEB6-5FF9-4C04-988B-B7B8E1C70DB9","TCGA-AP-A053-01A-21W-A027-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-AP-A053-01A-21",70,30,0,0,2,"TOP",8,0,"TCGA-AP-A053-01A-01-BS1",60,NA,NA,NA,"TCGA-AP-A053-R6993","IMPLANTS","Primary Tumor Field",NA,NA,18,"TUMOR FREE","Alive",NA,"TCGA-AP-A053-F6983","TCGA-AP-A053",1,"AP","A053","YES","C54.1","8380/3","C54.1","NO","YES",-32872,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",18,NA,NA,NA,"TUMOR FREE","NO",1,2,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,90,2004,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30911040,26279084,1964087037,"B409D7F1-47F0-467A-96F9-BB2CE3AA0E67.bw","af852215-5a4b-44b4-8e8e-b887dcb3cf8c","b409d7f1-47f0-467a-96f9-bb2ce3aa0e67","2016-08-09T14:16:24.611289-05:00","UNCID_2210469.3b8301c9-646f-43e7-9b8c-7690294d0356.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_7.tar.gz","bdbecc2c-3e29-47ed-9222-190fd3366b0f",1898012541,"Illumina GA","1592a9137eeb393c9d8cb5a9c4bb94a1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:28:23.343411-05:00","2016-05-03T11:15:47.427352-05:00","bdbecc2c-3e29-47ed-9222-190fd3366b0f_analysis.xml","f0fdf37635b8329d999fb6208ef41a8f","b8bc9e64-541d-40e9-9b9c-2b31afde840f",2121,"2016-09-29T18:51:33.932498-05:00","bdbecc2c-3e29-47ed-9222-190fd3366b0f_experiment.xml","cdca91947f64bcc51fb96cc973d09485","3258cb6c-e17a-43be-8372-a55c8e6e6a7c",2257,"2016-09-29T22:30:03.876212-05:00","bdbecc2c-3e29-47ed-9222-190fd3366b0f_run.xml","bb524d4761d04b0fe3e98e42224fcb41","b9c4f90c-c492-4182-be82-178ef6f21ab8",347,"2016-09-08T12:03:15.066135-05:00","TCGA-B5-A11Q","2016-09-02T18:49:33.905302-05:00","female","TCGA-B5-A11Q_demographic",1944,"white","78723c73-98b3-5130-8a7b-d983311f213b","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11Q_diagnosis","not reported",23538,"alive","8380/3",NA,976,"4dd34623-3977-5703-a403-b19e465e46ab","c54.1",-23538,"TCGA-B5-A11Q_treatment","9bc0ffaa-75f6-5a59-9284-3fb18baee886","01","true","TCGA-B5-A11Q-01A",NA,"c9b18c70-4d2b-4cd8-b0a8-a4226edab816",FALSE,"5117F490-9CE1-465F-BDF7-7B545B314703","Primary Tumor",NA,702,120,NA,1291680000,"11",30,"TCGA-B5-A11Q-01A-11",75,70,5,1,0,0,25,30,"2016-09-08T12:03:15.066135-05:00","2016-09-08T12:03:15.066135-05:00",8,1,6,0,"BOTTOM","TOP",15,2,"792af7c6-c6c8-4e0d-af98-3bd9be86b1d5","45ec2811-42b4-4c1c-b370-085935633563","TCGA-B5-A11Q-01A-01-BS1","TCGA-B5-A11Q-01A-01-TS1",60,68,"c74c3dad-9483-4f7c-9533-46149f99178d","RNA","TCGA-B5-A11Q-01A-11R","89f82d06-03d9-4321-bce7-d34c70fe2c28",1.82,0.16,"UV Spec","R","23","TCGA-B5-A11Q-01A-11R-A118-07","3b8301c9-646f-43e7-9b8c-7690294d0356",0.16,NA,88,33.9493075112843,161,"462ffbb6-c888-5fa9-a8ca-68abba7c96e6","TCGA-B5-A11Q_exposure","UNCID_2210469.3b8301c9-646f-43e7-9b8c-7690294d0356.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_7.tar.gz","2013-10-02T11:36:05.000Z","2013-10-02T11:54:03.000Z","BDBECC2C-3E29-47ED-9222-190FD3366B0F","C9B18C70-4D2B-4CD8-B0A8-A4226EDAB816","Unaligned reads",1898012541,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3B8301C9-646F-43E7-9B8C-7690294D0356","University of North Carolina","56607822e4b016715ab69bf5","AF852215-5A4B-44B4-8E8E-B887DCB3CF8C","Uterine Corpus Endometrial Carcinoma","TARGZ","C74C3DAD-9483-4F7C-9533-46149F99178D","2013-10-02T11:54:03.000Z","89F82D06-03D9-4321-BCE7-D34C70FE2C28","United States","NO",1,NA,"Primary Tumor","Duke",702,"C74C3DAD-9483-4F7C-9533-46149F99178D",NA,"B5","CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_A01_735754.ismpolish.data.txt",120,"TCGA-B5-A11Q-01A",NA,"E86BFFDF-5626-45C4-B9D3-75293E2B2B63","TCGA",2008,NA,NA,"TUMOR FREE","C9B18C70-4D2B-4CD8-B0A8-A4226EDAB816",64,"6055424121_R04C01_Grn.idat","Alive",NA,"TCGA-B5-A11Q",NA,"6649419A-CB55-4A08-8EDC-43E013471C33",NA,703,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"704BB24E-3168-4A09-94F5-3B255601EDB2","WHITE",NA,11,30,"45EC2811-42B4-4C1C-B370-085935633563","B67C8ED1-2006-4196-8FA4-7302A9610ECB","TCGA-B5-A11Q-01A-11R-A119-13_mirna.bam.bai","TCGA-B5-A11Q-01A-11",75,0,5,8,25,"BOTTOM",15,6,"TCGA-B5-A11Q-01A-01-BS1",60,"Megace","Hormone Therapy","TCGA-B5-A11Q-D10457","TCGA-B5-A11Q-R10456","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",976,"TUMOR FREE","Alive",NA,"TCGA-B5-A11Q-F17770","TCGA-B5-A11Q",1,"B5","A11Q","YES","C54.1","8380/3","C54.1","NO","YES",-23538,"FEMALE","WHITE",NA,"No","No","Alive",703,NA,NA,NA,"TUMOR FREE","NO",11,2,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
108445620,102152091,4871494351,"3CA49BB1-30F6-47F3-A751-D5601E16BDBA.bw","afa79b18-2ac6-4179-9c8c-5fa4d1d09a7e","3ca49bb1-30f6-47f3-a751-d5601e16bdba","2016-08-02T19:46:27.858822-05:00","UNCID_2160274.46eaeac0-bacb-4c76-b86d-5bd912229f69.130619_UNC13-SN749_0277_BC293YACXX_2_AGTTCC.tar.gz","3e2c6ea6-fa2e-4139-b899-19184b2098f6",4564449242,"Illumina HiSeq","fe74fb4fc14deab40ceb38ef3121d474","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:32:42.060717-05:00","2016-05-03T11:07:07.511815-05:00","3e2c6ea6-fa2e-4139-b899-19184b2098f6_analysis.xml","df5f586f9eec79a4e158ad26214c5831","e0bcbcea-13d8-481d-acc1-43250ea4f7b1",2123,"2016-08-29T21:16:50.878114-05:00","3e2c6ea6-fa2e-4139-b899-19184b2098f6_experiment.xml","814968cbeee152cc311506dfb44b15e3","3c6a8530-a7aa-437e-8c9e-41f3abbcc47f",2431,"2016-09-29T19:28:38.925485-05:00","3e2c6ea6-fa2e-4139-b899-19184b2098f6_run.xml","e063088f5da377fc0896f1cb78218e82","49bc7863-85aa-44d8-b06e-abcd23a33aee",354,"2016-09-08T10:45:36.905670-05:00","TCGA-AX-A2H4","2016-09-02T18:54:14.982797-05:00","female","TCGA-AX-A2H4_demographic",1940,"white","aa0c0ecd-e82a-5798-b1a4-a40911eaf464","not hispanic or latino",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2H4_diagnosis","not reported",24234,"dead","8441/3",916,NA,"e1162466-e10b-58a1-96ac-2399188c61ef","c54.1",-24234,"TCGA-AX-A2H4_treatment","034af59b-5a06-55d2-b842-413567ec649a","01","false","TCGA-AX-A2H4-01A",NA,"47b7fd2a-3437-4991-8c7c-7ff6ba88ef86",FALSE,"5230A27B-4AA6-4ED9-90BB-98C6671E0B2E","Primary Tumor",NA,1981,120,NA,1314662400,"21",30,"TCGA-AX-A2H4-01A-21",80,NA,1,NA,0,NA,35,NA,"2016-09-08T10:45:36.905670-05:00",NA,10,NA,2,NA,"TOP",NA,5,NA,"e4077e33-365f-46b0-8382-ea1ace6d6f5d",NA,"TCGA-AX-A2H4-01A-02-TSB",NA,60,NA,"d7e5d226-69a5-4bfd-9336-64bd0573f9f7","RNA","TCGA-AX-A2H4-01A-21R","f2c21d96-39be-4a61-ad82-fd353552458a",1.82,0.17,"UV Spec","R","23","TCGA-AX-A2H4-01A-21R-A18M-07","46eaeac0-bacb-4c76-b86d-5bd912229f69",0.17,NA,84,34.0784616008763,157,"ece868ed-1099-5d09-8441-bb49dd7341c8","TCGA-AX-A2H4_exposure","UNCID_2160274.46eaeac0-bacb-4c76-b86d-5bd912229f69.130619_UNC13-SN749_0277_BC293YACXX_2_AGTTCC.tar.gz","2013-09-21T07:16:08.000Z","2013-09-21T07:30:01.000Z","3E2C6EA6-FA2E-4139-B899-19184B2098F6","47B7FD2A-3437-4991-8C7C-7FF6BA88EF86","Unaligned reads",4564449242,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","46EAEAC0-BACB-4C76-B86D-5BD912229F69","University of North Carolina","566075b3e4b0b37b3d98fc02","AFA79B18-2AC6-4179-9C8C-5FA4D1D09A7E","Uterine Corpus Endometrial Carcinoma","TARGZ","D7E5D226-69A5-4BFD-9336-64BD0573F9F7","2013-09-21T07:30:01.000Z","F2C21D96-39BE-4A61-AD82-FD353552458A","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1981,"D7E5D226-69A5-4BFD-9336-64BD0573F9F7",NA,"AX","TCGA-AX-A2H4-01A-21R-A18L-13_mirna.bam.bai",120,"TCGA-AX-A2H4-01A",NA,NA,"TCGA",2006,NA,NA,"WITH TUMOR","47B7FD2A-3437-4991-8C7C-7FF6BA88EF86",66,"nationwidechildrens.org_clinical.TCGA-AX-A2H4.xml","Dead",916,"TCGA-AX-A2H4","NOT HISPANIC OR LATINO","6766E5E3-3C2B-4CB8-8F42-6B62D5162DEF",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,21,30,"E4077E33-365F-46B0-8382-EA1ACE6D6F5D","F2C21D96-39BE-4A61-AD82-FD353552458A","TCGA-AX-A2H4-01A-21R-A18L-13_mirna.bam.bai","TCGA-AX-A2H4-01A-21",80,0,1,10,35,"TOP",5,2,"TCGA-AX-A2H4-01A-02-TSB",60,NA,NA,NA,NA,NA,NA,NA,"YES",NA,"WITH TUMOR","Dead",916,"TCGA-AX-A2H4-F31597","TCGA-AX-A2H4",1,"AX","A2H4","YES","C54.1","8441/3","C54.1","NO","YES",-24234,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,916,NA,NA,"WITH TUMOR","NO",28,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,66,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
10614278,10143774,756545171,"653C0A98-1A7B-435D-837F-5F866E8496C0.bw","afd710b8-d172-4ac4-9973-e969db1ed231","653c0a98-1a7b-435d-837f-5f866e8496c0","2016-08-05T10:31:37.418911-05:00","UNCID_2214422.7a051ecb-ad2d-4c98-8b91-96b66110a46e.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_1.tar.gz","755d4c86-e16a-498f-85ff-db8902807d5a",614190781,"Illumina GA","b7e6c3dcf26a5e664d63a068129b2028","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:49:46.273022-05:00","2016-05-03T11:17:14.896869-05:00","755d4c86-e16a-498f-85ff-db8902807d5a_analysis.xml","d75fbfbd6558961bc323825f7e8f2a63","7b926b00-31bf-40af-9590-b0adb069fb80",2121,"2016-10-07T16:42:01.299666-05:00","755d4c86-e16a-498f-85ff-db8902807d5a_experiment.xml","fb412c9e08b702a38f901b5a4ad3d5c7","b76c7e53-e770-493d-9a80-34bdbfcfe0a2",2257,"2016-09-29T21:22:23.786392-05:00","755d4c86-e16a-498f-85ff-db8902807d5a_run.xml","e7e416dadbd2d69990aa907d6659e408","9007c662-69dc-487e-9f47-2b246179aa04",347,"2016-09-08T10:53:13.058386-05:00","TCGA-A5-A0RA","2016-09-02T18:47:50.106353-05:00","female","TCGA-A5-A0RA_demographic",1941,"white","0c86e026-26be-5c46-b41c-fa8aaaf5668b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0RA_diagnosis","not reported",25060,"alive","8380/3",NA,884,"b4cac064-3445-58c8-8349-dbf25cf9fe3d","c54.1",-25060,"TCGA-A5-A0RA_treatment","778d9f52-fdff-5736-b77a-bd0338744023","01","true","TCGA-A5-A0RA-01A",NA,"4ed231ee-0e54-4ac5-8278-1061ad3972a2",FALSE,"EB6E4309-9CE1-468A-A94B-907874BDE9DE","Primary Tumor",NA,492,270,NA,1280275200,"21",30,"TCGA-A5-A0RA-01A-21",80,70,20,20,0,5,5,20,"2016-09-08T10:53:13.058386-05:00","2016-09-08T10:53:13.058386-05:00",20,30,40,30,"BOTTOM","TOP",10,5,"39e37d9a-6328-4504-985d-52199e42f1fb","da7de47e-22bd-4c64-9141-0c0c18bd5188","TCGA-A5-A0RA-01A-02-BS2","TCGA-A5-A0RA-01A-01-BS1",85,70,"7257e875-f62e-4a96-b706-08d202267e81","RNA","TCGA-A5-A0RA-01A-21R","f02c5538-7df2-450e-9ca9-6e4f486b3a33",1.87,0.14,"UV Spec","R","23","TCGA-A5-A0RA-01A-21R-A104-07","7a051ecb-ad2d-4c98-8b91-96b66110a46e",0.14,NA,113,47.0343392299688,155,"aaaca63f-90b0-5526-88c9-b08163906748","TCGA-A5-A0RA_exposure","UNCID_2214422.7a051ecb-ad2d-4c98-8b91-96b66110a46e.110209_UNC1-RDR301647_00038_FC_62J3UAAXX_1.tar.gz","2013-10-03T15:36:04.000Z","2013-10-03T15:43:02.000Z","755D4C86-E16A-498F-85FF-DB8902807D5A","4ED231EE-0E54-4AC5-8278-1061AD3972A2","Unaligned reads",614190781,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7A051ECB-AD2D-4C98-8B91-96B66110A46E","University of North Carolina","564a3edfe4b0298dd2c9842d","AFD710B8-D172-4AC4-9973-E969DB1ED231","Uterine Corpus Endometrial Carcinoma","TARGZ","7257E875-F62E-4A96-B706-08D202267E81","2013-10-03T15:43:02.000Z","F02C5538-7DF2-450E-9CA9-6E4F486B3A33","None","NO",1,NA,"Primary Tumor","Cedars Sinai",492,"7257E875-F62E-4A96-B706-08D202267E81",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.83A77885-4D57-487B-AE02-BB38572E0E44.txt",270,"TCGA-A5-A0RA-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","55E3C47B-0A82-4347-98BD-F4F3B6D0C7C7",68,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.83A77885-4D57-487B-AE02-BB38572E0E44.txt","Alive",NA,"TCGA-A5-A0RA","NOT HISPANIC OR LATINO","3D455F01-CDEA-4BBC-9861-20AB29AFD7AD",NA,556,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"0251E037-27A0-4B3A-80A4-E28EA4D6C58F","WHITE",NA,21,30,"DA7DE47E-22BD-4C64-9141-0C0C18BD5188","F02C5538-7DF2-450E-9CA9-6E4F486B3A33","TCGA-A5-A0RA-01A-21D-A10B-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-A5-A0RA-01A-21",80,0,20,20,5,"BOTTOM",10,40,"TCGA-A5-A0RA-01A-02-BS2",85,NA,NA,NA,"TCGA-A5-A0RA-R3595","EXTERNAL BEAM","Primary Tumor Field",NA,NA,556,"TUMOR FREE","Alive",NA,"TCGA-A5-A0RA-F3592","TCGA-A5-A0RA",1,"A5","A0RA","YES","C54.1","8380/3","C54.1","NO","YES",-25060,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",556,NA,NA,NA,"TUMOR FREE","NO",15,11,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2009,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30975529,30590322,2302233509,"0A1391EA-5B15-4D28-B6AE-2732FCA49897.bw","b045f24b-f822-4df9-9ffa-47308edcec8c","0a1391ea-5b15-4d28-b6ae-2732fca49897","2016-08-09T14:18:33.602031-05:00","UNCID_2216446.520ac0a0-a49f-4990-8a49-dfe312361e30.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_1.tar.gz","500831f0-ab5f-4a7f-b2ce-02ffae25afc7",2004271411,"Illumina GA","7b6ff245491d1c1a3678340212c37cff","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:26:04.509629-05:00","2016-05-03T11:18:47.010651-05:00","500831f0-ab5f-4a7f-b2ce-02ffae25afc7_analysis.xml","b73bfb1193a3a73297660e6087254d26","222aa4d2-4098-4d9e-a4a1-00f74307424e",2120,"2016-09-29T21:09:56.236935-05:00","500831f0-ab5f-4a7f-b2ce-02ffae25afc7_experiment.xml","7c7cc12aa97d4747744b3d6ba8913f8f","8848736a-89d0-461a-b9df-994ae1abfbde",2256,"2016-09-29T21:54:33.444390-05:00","500831f0-ab5f-4a7f-b2ce-02ffae25afc7_run.xml","0981977329897bc09afb9d2be62cd16f","a3f531d9-44b2-41a6-9df7-92f17d1b0ced",345,"2016-09-08T11:11:12.777180-05:00","TCGA-AP-A051","2016-09-02T18:52:36.627950-05:00","female","TCGA-AP-A051_demographic",1934,"white","ce7f54a2-f817-5fdc-8f8e-56e5ea202cc7","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A051_diagnosis","not reported",25269,"alive","8380/3",NA,3948,"04b7b6ca-6e8a-5702-b1e2-0bdd145d546c","c54.1",-25269,"TCGA-AP-A051_treatment","dcefc2e5-fa75-54a4-b60f-34b5b44f0ee1","01","true","TCGA-AP-A051-01A",NA,"417cff62-b034-4197-9cfd-e640d55f3094",FALSE,"2146A2FC-99EE-4939-AD9F-086BB77D2B21","Primary Tumor",NA,2475,430,NA,1275868800,"21",30,"TCGA-AP-A051-01A-21",98,98,0,0,0,0,6,4,"2016-09-08T11:11:12.777180-05:00","2016-09-08T11:11:12.777180-05:00",0,0,0,0,"BOTTOM","TOP",4,4,"a0ef9cff-0cba-4cd7-aa0e-380626f0eae6","8a6c5124-ceeb-4199-a1ff-0d6bb3d1d7f9","TCGA-AP-A051-01A-02-BSB","TCGA-AP-A051-01A-02-TSB",90,92,"30ba55bb-39ae-405e-9efc-6d76b9f00c3d","RNA","TCGA-AP-A051-01A-21R","104303d4-3dfe-478d-95ca-d664b69c3881",1.83,0.14,"UV Spec","R","23","TCGA-AP-A051-01A-21R-A00V-07","520ac0a0-a49f-4990-8a49-dfe312361e30",0.14,NA,97,38.3687354139472,159,"0e777688-64df-53c3-8e2e-37c2261c2d9a","TCGA-AP-A051_exposure","UNCID_2216446.520ac0a0-a49f-4990-8a49-dfe312361e30.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_1.tar.gz","2013-10-04T08:37:04.000Z","2013-10-04T08:48:02.000Z","500831F0-AB5F-4A7F-B2CE-02FFAE25AFC7","417CFF62-B034-4197-9CFD-E640D55F3094","Unaligned reads",2004271411,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","520AC0A0-A49F-4990-8A49-DFE312361E30","University of North Carolina","564a3bcfe4b08c5d8691a42c","B045F24B-F822-4DF9-9FFA-47308EDCEC8C","Uterine Corpus Endometrial Carcinoma","TARGZ","30BA55BB-39AE-405E-9EFC-6D76B9F00C3D","2013-10-04T08:48:02.000Z","104303D4-3DFE-478D-95CA-D664B69C3881","None","NO",1,NA,"Primary Tumor","MSKCC",2475,"30BA55BB-39AE-405E-9EFC-6D76B9F00C3D",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E1F9F4C1-CBB9-49FB-BBAC-E1CA174F5FCB.txt",430,"TCGA-AP-A051-01A",NA,NA,"TCGA",2003,NA,NA,"TUMOR FREE","F75CD7D6-DC83-4636-BB88-C181C0A7834E",69,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E1F9F4C1-CBB9-49FB-BBAC-E1CA174F5FCB.txt","Alive",NA,"TCGA-AP-A051",NA,"577C7F26-6031-40B6-8DD9-68299AEB3639",NA,2545,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,"6E4976E1-B594-41D1-B848-4AC8D29A8A80","WHITE",NA,21,30,"A0EF9CFF-0CBA-4CD7-AA0E-380626F0EAE6","104303D4-3DFE-478D-95CA-D664B69C3881","UNCID_251958.TCGA-AP-A051-01A-21R-A00V-07.100903_UNC3-RDR300156_00028_FC_62ELKAAXX.1.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-AP-A051-01A-21",98,0,0,0,4,"TOP",4,0,"TCGA-AP-A051-01A-02-TSB",92,NA,NA,NA,"TCGA-AP-A051-R3387","EXTERNAL BEAM","Primary Tumor Field","TCGA-AP-A051-F68440_NTE-1","NO",3948,"TUMOR FREE","Alive",NA,"TCGA-AP-A051-F68440","TCGA-AP-A051",1,"AP","A051","YES","C54.1","8380/3","C54.1","NO","YES",-25269,"FEMALE","WHITE",NA,"No","No","Alive",2545,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2003,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
26346947,25774889,1928873316,"38D2BE9E-15D4-47BC-8FEB-55310F23825B.bw","b19425ab-a82f-4c2a-bf58-d1bd30511d74","38d2be9e-15d4-47bc-8feb-55310f23825b","2016-08-09T14:11:29.696263-05:00","UNCID_2207039.08890bb3-7ad1-41c2-8774-b10bf86ee047.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_7.tar.gz","bfb38329-f17e-442b-89d6-938d30a58a6e",1662645216,"Illumina GA","d8a9a241fb2f784c51f57e0f4b399fa9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:56:43.241580-05:00","2016-05-03T11:13:02.646906-05:00","bfb38329-f17e-442b-89d6-938d30a58a6e_analysis.xml","a53b4be49124309858a2236dc7bebcb7","5b251dfc-2f2a-4abc-b972-6a5228209ba6",2121,"2016-09-29T23:19:19.010599-05:00","bfb38329-f17e-442b-89d6-938d30a58a6e_experiment.xml","87599f62fd31cf941e69a780575e56b3","d832d858-cc26-4ad2-a35a-27b3ac892a0b",2257,"2016-09-29T20:40:13.263252-05:00","bfb38329-f17e-442b-89d6-938d30a58a6e_run.xml","c7e7086cf1699038d73e9d14853993cb","75a3c175-a04f-4fe5-92f5-d5554346657f",347,"2016-09-08T11:09:19.811892-05:00","TCGA-BS-A0UV","2016-09-02T18:48:30.809982-05:00","female","TCGA-BS-A0UV_demographic",1950,"native hawaiian or other pacific islander","04f8eb46-e4c3-5074-ae25-c74e2facb1df","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0UV_diagnosis","not reported",20266,"alive","8380/3",NA,2228,"299e7afb-cff2-535a-ad6f-7a13d7a1bd44","c54.1",-20266,"TCGA-BS-A0UV_treatment","9cb639e3-877c-5a07-a5a9-95b265b15172","01","false","TCGA-BS-A0UV-01A",NA,"30945527-528a-448e-8db4-2e0c31c9016d",FALSE,"9414D0B9-3126-42E9-8189-7C1EC38B2AAB","Primary Tumor",NA,1902,80,NA,1285200000,"11",30,"TCGA-BS-A0UV-01A-11",90,90,0,0,0,0,10,10,"2016-09-08T11:09:19.811892-05:00","2016-09-08T11:09:19.811892-05:00",40,40,57,57,"TOP","BOTTOM",20,15,"0dfa1eda-9c93-4df0-86ec-124acff65398","10d845c3-8b4f-4caf-8619-c4d7193afc35","TCGA-BS-A0UV-01A-01-TS1","TCGA-BS-A0UV-01A-01-BS1",70,75,"c1037aad-376b-4776-b6c2-b7ccb591a1ec","RNA","TCGA-BS-A0UV-01A-11R","28200f72-f54e-4f2d-832c-4ba6bfb7ef8e",1.72,0.15,"UV Spec","R","23","TCGA-BS-A0UV-01A-11R-A16W-07","08890bb3-7ad1-41c2-8774-b10bf86ee047",0.15,NA,112,39.6825396825397,168,"ea8a1054-64e3-5cf9-85e0-abafaee6e9ce","TCGA-BS-A0UV_exposure","UNCID_2207039.08890bb3-7ad1-41c2-8774-b10bf86ee047.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_7.tar.gz","2013-09-29T03:46:06.000Z","2013-09-29T03:58:02.000Z","BFB38329-F17E-442B-89D6-938D30A58A6E","30945527-528A-448E-8DB4-2E0C31C9016D","Unaligned reads",1662645216,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","08890BB3-7AD1-41C2-8774-B10BF86EE047","University of North Carolina","5660797be4b0b37b3d9919e0","B19425AB-A82F-4C2A-BF58-D1BD30511D74","Uterine Corpus Endometrial Carcinoma","TARGZ","C1037AAD-376B-4776-B6C2-B7CCB591A1EC","2013-09-29T03:58:02.000Z","28200F72-F54E-4F2D-832C-4BA6BFB7EF8E","None","NO",1,NA,"Primary Tumor","University of Hawaii",1902,"C1037AAD-376B-4776-B6C2-B7CCB591A1EC",NA,"BS","TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.bam.bai",80,"TCGA-BS-A0UV-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","C1DB0188-CBB7-4202-B8CF-65D4DB60F512",55,"UNCID_400399.08890bb3-7ad1-41c2-8774-b10bf86ee047.110728_UNC6-RDR300211_00118_FC_70KA8AAXX.7.trimmed.annotated.translated_to_genomic.bam","Alive",NA,"TCGA-BS-A0UV","NOT HISPANIC OR LATINO","DDF7C1D2-DA8F-4BF2-B77A-6278287F027C",NA,149,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,11,30,"0DFA1EDA-9C93-4DF0-86EC-124ACFF65398","F766460F-17ED-4052-A770-9EADF441183F","CAUSE_p_TCGAb73_SNP_N_GenomeWideSNP_6_C08_698356.nocnv_hg18.seg.txt","TCGA-BS-A0UV-01A-11",90,0,0,40,10,"BOTTOM",15,57,"TCGA-BS-A0UV-01A-01-BS1",75,NA,NA,NA,NA,NA,NA,NA,"NO",2228,"TUMOR FREE","Alive",NA,"TCGA-BS-A0UV-F16696","TCGA-BS-A0UV",1,"BS","A0UV","YES","C54.1","8380/3","C54.1","NO","YES",-20266,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","NOT HISPANIC OR LATINO","No","No","Alive",149,NA,NA,NA,"TUMOR FREE","NO",28,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
102962760,100072026,4773224151,"3808C3A9-22DA-4DC5-9F51-884A7EF574E6.bw","b1b9173c-b370-4fe5-a263-c807e8a9709c","3808c3a9-22da-4dc5-9f51-884a7ef574e6","2016-08-25T15:50:08.297103-05:00","UNCID_2581806.2dc0d41b-72fa-4514-889f-3c46507fd5e8.140403_UNC15-SN850_0359_BC41CEACXX_1_CGATGT.tar.gz","63703da7-3dec-4353-92ff-ab317f95f621",4791508910,"Illumina HiSeq","314f110b5060f0762b2267fcb8eb32bf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:16:38.254079-05:00","2016-05-03T11:55:56.231757-05:00","63703da7-3dec-4353-92ff-ab317f95f621_analysis.xml","7fdbabff4137367a5c09ca0341f8fd34","fbd7f86e-bd1c-433b-83fb-93960adc2c92",2124,"2016-09-29T19:55:24.992754-05:00","63703da7-3dec-4353-92ff-ab317f95f621_experiment.xml","d592c97736439ead90b6cd5f0ca88130","5a56f033-0587-422e-b95a-5f9ece5bae6d",2628,"2016-09-29T19:40:51.372028-05:00","63703da7-3dec-4353-92ff-ab317f95f621_run.xml","a6e5489ea32c5b0278079f2d74bb5355","513dd422-9e2d-4ccd-839a-a8f280a0c2b2",354,"2016-09-08T10:56:44.637178-05:00","TCGA-PG-A917","2016-09-02T18:52:06.678792-05:00","female","TCGA-PG-A917_demographic",1938,"black or african american","6a5c27c8-b7e0-5ef7-8113-fd24e5e1a494","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","PG","69bd8326-4904-56a0-8230-1615a777173b","Montefiore Medical Center","not reported","c54.1","TCGA-PG-A917_diagnosis","not reported",27104,"alive","8380/3",NA,212,"b57f13c5-0feb-5c26-b363-ea4811c9f398","c54.1",-27104,"TCGA-PG-A917_treatment","1a4bcd82-3c46-554a-a446-15b5ff91cec3","01","true","TCGA-PG-A917-01A",NA,"4f849148-48bb-4e89-b0b9-f7ec6e85e0b9",FALSE,"9836008F-81F7-4029-9A28-10AB6021DFEA","Primary Tumor",NA,583,390,NA,1388620800,"31",30,"TCGA-PG-A917-01A-31",80,NA,0,NA,20,NA,10,NA,"2016-09-08T10:56:44.637178-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"6a473512-d381-4bad-a7b0-7cd23065649a",NA,"TCGA-PG-A917-01A-03-TSC",NA,70,NA,"aa03eb18-162f-45cc-a93e-1b1b7aa82636","RNA","TCGA-PG-A917-01A-31R","026139a8-b3ea-4cb3-932a-74b3e7b4956b",1.91,0.18,"UV Spec","R","23","TCGA-PG-A917-01A-31R-A37O-07","2dc0d41b-72fa-4514-889f-3c46507fd5e8",0.18,NA,NA,NA,NA,"4f720239-2d8e-54fd-a678-659a332953b9","TCGA-PG-A917_exposure","UNCID_2581806.2dc0d41b-72fa-4514-889f-3c46507fd5e8.140403_UNC15-SN850_0359_BC41CEACXX_1_CGATGT.tar.gz","2014-08-15T13:06:05.000Z","2014-08-15T13:31:22.000Z","63703DA7-3DEC-4353-92FF-AB317F95F621","4F849148-48BB-4E89-B0B9-F7EC6E85E0B9","Unaligned reads",4791508910,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","2DC0D41B-72FA-4514-889F-3C46507FD5E8","University of North Carolina","56607d1fe4b018727fea31cf","B1B9173C-B370-4FE5-A263-C807E8A9709C","Uterine Corpus Endometrial Carcinoma","TARGZ","AA03EB18-162F-45CC-A93E-1B1B7AA82636","2014-08-15T13:31:22.000Z","026139A8-B3EA-4CB3-932A-74B3E7B4956B","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",583,"AA03EB18-162F-45CC-A93E-1B1B7AA82636",NA,"PG","UNCID_2581806.2dc0d41b-72fa-4514-889f-3c46507fd5e8.140403_UNC15-SN850_0359_BC41CEACXX_1_CGATGT.tar.gz",390,"TCGA-PG-A917-01A",NA,NA,"TCGA",2012,"TCGA-PG-A917_NTE-1","Complete Remission/Response","TUMOR FREE","4F849148-48BB-4E89-B0B9-F7EC6E85E0B9",74,"nationwidechildrens.org_clinical.TCGA-PG-A917.xml","Alive",NA,"TCGA-PG-A917","NOT HISPANIC OR LATINO","41689F92-DDD0-4058-9FB3-057F03A72958","NO",212,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",381,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,31,30,"6A473512-D381-4BAD-A7B0-7CD23065649A","2A5DBBF9-22B9-4442-A892-3304A8DDADB9","unc.edu.2dc0d41b-72fa-4514-889f-3c46507fd5e8.2408665.bt.exon_quantification.txt","TCGA-PG-A917-01A-31",80,20,0,0,10,"TOP",0,0,"TCGA-PG-A917-01A-03-TSC",70,NA,NA,NA,NA,NA,NA,"TCGA-PG-A917-F67180_NTE-1","NO",212,"TUMOR FREE","Alive",NA,"TCGA-PG-A917-F67180","TCGA-PG-A917",1,"PG","A917","YES","C54.1","8380/3","C54.1","NO","YES",-27104,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",212,NA,"NO","NO","TUMOR FREE","YES",28,4,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2012,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G2","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
161829332,158825213,7580157796,"EE5E3F5F-3712-46AF-85EC-6F84CA553912.bw","b2aa0220-6387-4eea-b6d4-a4fa0f15b2d9","ee5e3f5f-3712-46af-85ec-6f84ca553912","2016-08-09T13:15:45.758789-05:00","UNCID_2173569.6acf7672-ec9d-4765-85db-43c311d5f124.130502_UNC12-SN629_0289_AC236KACXX_5_AGTCAA.tar.gz","29101a1a-de1b-409b-968b-1a5b98c98cf8",7605678054,"Illumina HiSeq","a84288a4b8775e2355474e8f331708dc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:51:16.707066-05:00","2016-05-03T10:55:55.610281-05:00","29101a1a-de1b-409b-968b-1a5b98c98cf8_analysis.xml","63b25b86df01cd0f0ed832f443ac7a04","7c87b7c4-a639-4001-a136-5a40f6d02a75",2123,"2016-10-07T17:54:20.719821-05:00","29101a1a-de1b-409b-968b-1a5b98c98cf8_experiment.xml","7389a2a8c81c77f531d27f0c786fd9a7","5071e319-a7f2-4fd2-85c2-736cbeeaff72",2431,"2016-09-29T22:02:12.514820-05:00","29101a1a-de1b-409b-968b-1a5b98c98cf8_run.xml","470ca39f0b45ee5070795a4a9e643305","a8b9f7c9-2aa2-4d80-9ccd-8485b7f05358",354,"2016-09-08T10:58:31.607188-05:00","TCGA-B5-A1MS","2016-09-02T18:49:15.455986-05:00","female","TCGA-B5-A1MS_demographic",1943,"white","2f5073c6-d784-534d-8170-ca24a733d556","not hispanic or latino",2011,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A1MS_diagnosis","not reported",22068,"dead","8441/3",3112,NA,"ff1c9ded-fbef-52e6-ba9d-e89ba8446649","c54.1",-22068,"TCGA-B5-A1MS_treatment","9e5b530f-ec1e-5c73-8e79-d35b98157eed","01","true","TCGA-B5-A1MS-01B",NA,"077a804e-8053-4319-80be-65d33bc2cf41",FALSE,"5FF9FC65-FBCD-40E8-8382-DDD0B8EFD22B","Primary Tumor",NA,3117,440,NA,1333411200,"11",30,"TCGA-B5-A1MS-01B-11",90,NA,2,NA,0,NA,0,NA,"2016-09-08T10:58:31.607188-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"aa633dd8-5291-40fe-9d8b-f2dd9abb2e89",NA,"TCGA-B5-A1MS-01B-01-TSA",NA,95,NA,"65aac6a8-71c6-45f3-8858-3569635cf6f2","RNA","TCGA-B5-A1MS-01B-11R","e247a723-eefe-4451-80f4-763bb53cc102",1.82,0.18,"UV Spec","R","23","TCGA-B5-A1MS-01B-11R-A22K-07","6acf7672-ec9d-4765-85db-43c311d5f124",0.18,NA,74,26.8544055741036,166,"bf8ce5c1-b920-5ec6-b2fd-368f1a0d679c","TCGA-B5-A1MS_exposure","UNCID_2173569.6acf7672-ec9d-4765-85db-43c311d5f124.130502_UNC12-SN629_0289_AC236KACXX_5_AGTCAA.tar.gz","2013-09-09T20:36:09.000Z","2013-09-09T20:58:01.000Z","29101A1A-DE1B-409B-968B-1A5B98C98CF8","077A804E-8053-4319-80BE-65D33BC2CF41","Unaligned reads",7605678054,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","6ACF7672-EC9D-4765-85DB-43C311D5F124","University of North Carolina","566074cbe4b0ca319164c8de","B2AA0220-6387-4EEA-B6D4-A4FA0F15B2D9","Uterine Corpus Endometrial Carcinoma","TARGZ","65AAC6A8-71C6-45F3-8858-3569635CF6F2","2013-09-09T20:58:01.000Z","E247A723-EEFE-4451-80F4-763BB53CC102","United States","NO",1,NA,"Primary Tumor","Duke",3117,"65AAC6A8-71C6-45F3-8858-3569635CF6F2",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.02AB5130-5982-4EFB-9CA0-BE933CB5D453.txt",440,"TCGA-B5-A1MS-01B",NA,"43FEFFD9-3BED-4A56-9EB1-455708EAC22A","TCGA",2003,NA,NA,"WITH TUMOR","36E6A16B-8980-471E-9A29-4F5B1B4FC8F2",60,"B5-A1MS-01B-11D_BCR3730_2012-06-15_031.fsa","Dead",3112,"TCGA-B5-A1MS","NOT HISPANIC OR LATINO","342163B7-CE7F-442B-B30E-256C7E55D088",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"FD6D4008-3BB4-4781-B3A3-84EC1AADA3E8","WHITE",NA,11,30,"AA633DD8-5291-40FE-9D8B-F2DD9ABB2E89","E247A723-EEFE-4451-80F4-763BB53CC102","UNCID_2035278.6acf7672-ec9d-4765-85db-43c311d5f124.sorted_genome_alignments.bam.bai","TCGA-B5-A1MS-01B-11",90,0,2,1,0,"TOP",5,0,"TCGA-B5-A1MS-01B-01-TSA",95,"Paclitaxel","Chemotherapy","TCGA-B5-A1MS-D31884","TCGA-B5-A1MS-R31879","EXTERNAL BEAM","Local Recurrence","TCGA-B5-A1MS-F44649_NTE-1","YES",NA,"WITH TUMOR","Dead",3112,"TCGA-B5-A1MS-F44649","TCGA-B5-A1MS",1,"B5","A1MS","YES","C54.1","8441/3","C54.1","NO","YES",-22068,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,3112,NA,NA,"WITH TUMOR","NO",10,5,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,60,2003,"Dilation and curettage procedure",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32496047,32001069,2403450759,"21A31B3E-254C-4311-AF9A-4F500E711729.bw","b3aa16d6-1677-445d-a8d3-46657d4f8b43","21a31b3e-254c-4311-af9a-4f500e711729","2016-08-05T05:52:20.739926-05:00","UNCID_2189215.838b151f-4608-4981-89f3-0cba9ec540fb.120531_UNC2-RDR300275_00125_FC_64VUHAAXX_1.tar.gz","ca128815-c055-4033-9660-651112a23c5b",2279105661,"Illumina GA","dbc27c0f35a656d481aecb68584ae5fd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:30:39.097034-05:00","2016-05-03T11:05:01.516668-05:00","ca128815-c055-4033-9660-651112a23c5b_analysis.xml","800732c5c506a24afb8da3b57bba534c","4b0602e7-04ab-400c-a67f-2fdb9939f0ba",2122,"2016-09-29T20:43:50.879064-05:00","ca128815-c055-4033-9660-651112a23c5b_experiment.xml","834e4381590da8d4c29e24d445ba713e","77e04965-4b08-4ce7-80f4-1b8f4f4b3b52",2258,"2016-09-29T17:49:43.412336-05:00","ca128815-c055-4033-9660-651112a23c5b_run.xml","164ea7c3c641364018b302c91cdfedb3","0b816351-991e-4632-855c-c3a7adfbddf6",349,"2016-09-08T11:40:24.846849-05:00","TCGA-EC-A1NJ","2016-09-02T18:52:25.887760-05:00","female","TCGA-EC-A1NJ_demographic",1937,"white","83619ed1-a7ed-5029-ae2d-608ce3dcbf3f","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EC","acc43e64-d63e-554c-a488-8bf6b93bec91","Asterand","not reported","c54.1","TCGA-EC-A1NJ_diagnosis","not reported",27002,"alive","8380/3",NA,488,"b4211663-bd7a-593e-8805-1813d9dee70c","c54.1",-27002,"TCGA-EC-A1NJ_treatment","583f8f48-82b6-5360-93af-73f4090473f6","01","true","TCGA-EC-A1NJ-01A",NA,"0a6212d0-cb90-4e24-add2-6ef723d2a701",FALSE,"8E02F7D6-EBE4-46CB-B05C-B41FDCDC1141","Primary Tumor",NA,60,620,NA,1301270400,"31",30,"TCGA-EC-A1NJ-01A-31",60,NA,0,NA,20,NA,20,NA,"2016-09-08T11:40:24.846849-05:00",NA,20,NA,10,NA,"TOP",NA,10,NA,"d0e12aae-7a65-46f1-bd29-1f7be1cef73a",NA,"TCGA-EC-A1NJ-01A-03-TSC",NA,50,NA,"5de4a15e-cd0c-481a-a334-961639de2434","RNA","TCGA-EC-A1NJ-01A-31R","541fc5b5-43b2-4243-acef-0346d04edab2",1.79,0.17,"UV Spec","R","23","TCGA-EC-A1NJ-01A-31R-A14D-07","838b151f-4608-4981-89f3-0cba9ec540fb",0.17,NA,62,26.4855397496689,153,"113ac322-49d4-5f5c-85ec-78277c9ece14","TCGA-EC-A1NJ_exposure","UNCID_2189215.838b151f-4608-4981-89f3-0cba9ec540fb.120531_UNC2-RDR300275_00125_FC_64VUHAAXX_1.tar.gz","2013-09-18T18:43:04.000Z","2013-09-18T18:57:02.000Z","CA128815-C055-4033-9660-651112A23C5B","0A6212D0-CB90-4E24-ADD2-6EF723D2A701","Unaligned reads",2279105661,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","838B151F-4608-4981-89F3-0CBA9EC540FB","University of North Carolina","56607843e4b0b37b3d9912ec","B3AA16D6-1677-445D-A8D3-46657D4F8B43","Uterine Corpus Endometrial Carcinoma","TARGZ","5DE4A15E-CD0C-481A-A334-961639DE2434","2013-09-18T18:57:02.000Z","541FC5B5-43B2-4243-ACEF-0346D04EDAB2","Russia","NO",1,NA,"Primary Tumor","Asterand",60,"5DE4A15E-CD0C-481A-A334-961639DE2434",NA,"EC","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.42820F72-E240-43CF-B375-31A1021BB55A.txt",620,"TCGA-EC-A1NJ-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","52C24DA6-DC30-42DE-AFEF-D5B655340D6F",73,"FISTS_p_TCGA_b107_121_SNP_N_GenomeWideSNP_6_F07_777908.hg18.seg.txt","Alive",NA,"TCGA-EC-A1NJ","NOT HISPANIC OR LATINO","55239565-EFB7-4E03-8E0A-9FCBC3516001",NA,0,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,31,30,"D0E12AAE-7A65-46F1-BD29-1F7BE1CEF73A","541FC5B5-43B2-4243-ACEF-0346D04EDAB2","FISTS_p_TCGA_b107_121_SNP_N_GenomeWideSNP_6_F07_777908.CEL","TCGA-EC-A1NJ-01A-31",60,20,0,20,20,"TOP",10,10,"TCGA-EC-A1NJ-01A-03-TSC",50,NA,NA,NA,NA,NA,NA,NA,"NO",488,"TUMOR FREE","Alive",NA,"TCGA-EC-A1NJ-F21077","TCGA-EC-A1NJ",1,"EC","A1NJ","YES","C54.1","8380/3","C54.1","YES","NO",-27002,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,"TUMOR FREE","NO",23,6,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2010,"Tumor resection",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29784104,29359054,2210581275,"5A147DAD-7390-4C90-9921-45CB05066827.bw","b3d635b3-d7ac-4cf8-a318-0a9dd0073e89","5a147dad-7390-4c90-9921-45cb05066827","2016-08-09T14:15:29.578429-05:00","UNCID_2210049.0e70ff34-799d-4e88-9911-85357f2bb0a2.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_5.tar.gz","3739e3cb-b1ee-4183-a562-5e6bd52de52c",1891031400,"Illumina GA","fc68104fe107354f64cec3b0976dda8e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:47:28.056917-05:00","2016-05-03T11:15:47.403263-05:00","3739e3cb-b1ee-4183-a562-5e6bd52de52c_analysis.xml","e12188640bee991bed0aa57ea3e8ae8c","c4a226b7-48cb-4816-8007-e9dc43428f30",2121,"2016-10-07T16:23:13.950744-05:00","3739e3cb-b1ee-4183-a562-5e6bd52de52c_experiment.xml","b703da2127704d5d825327c969af9922","d57cd452-3071-4a1c-a160-8e2724164309",2257,"2016-09-29T19:04:59.284078-05:00","3739e3cb-b1ee-4183-a562-5e6bd52de52c_run.xml","599f1e52fe31ea11e6f256f864824d5f","3ad4c7bb-fce6-40ea-ae4d-f8fb4b023840",347,"2016-09-08T10:58:43.015126-05:00","TCGA-D1-A0ZO","2016-09-02T18:49:51.791618-05:00","female","TCGA-D1-A0ZO_demographic",1934,"white","58b46677-323d-533b-980b-5a724af621af","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A0ZO_diagnosis","not reported",27482,"alive","8380/3",NA,602,"63e70dd2-1a97-5c6d-a4cd-e5fb9d25e179","c54.1",-27482,"TCGA-D1-A0ZO_treatment","86376fa5-b08c-5bba-b265-e6d30d562a90","01","false","TCGA-D1-A0ZO-01A",NA,"9c617822-c9a8-42c5-aab7-d6f22887c325",FALSE,"13826E23-2184-4D03-B67C-B312BF4FA87E","Primary Tumor",NA,586,50,NA,1291334400,"11",30,"TCGA-D1-A0ZO-01A-11",30,60,0,0,70,30,0,10,"2016-09-08T10:58:43.015126-05:00","2016-09-08T10:58:43.015126-05:00",20,20,10,10,"BOTTOM","TOP",10,10,"5c9ccd64-fe4d-4053-9764-482baf585cde","71fdc8a6-2b4d-4309-902c-6541baa3e82b","TCGA-D1-A0ZO-01A-01-BS1","TCGA-D1-A0ZO-01A-01-TS1",20,50,"ea8bc9c8-b07e-4f32-8ad4-87080b4806e3","RNA","TCGA-D1-A0ZO-01A-11R","71dc862f-5b93-4f1d-8250-8e05e357d2e9",1.9,0.15,"UV Spec","R","23","TCGA-D1-A0ZO-01A-11R-A118-07","0e70ff34-799d-4e88-9911-85357f2bb0a2",0.15,NA,110,40.4040404040404,165,"4a4a2990-9fd5-56c3-a9b4-8f4acf5eb8f0","TCGA-D1-A0ZO_exposure","UNCID_2210049.0e70ff34-799d-4e88-9911-85357f2bb0a2.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_5.tar.gz","2013-10-02T04:55:03.000Z","2013-10-02T05:07:02.000Z","3739E3CB-B1EE-4183-A562-5E6BD52DE52C","9C617822-C9A8-42C5-AAB7-D6F22887C325","Unaligned reads",1891031400,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0E70FF34-799D-4E88-9911-85357F2BB0A2","University of North Carolina","566077e6e4b018727fea177c","B3D635B3-D7AC-4CF8-A318-0A9DD0073E89","Uterine Corpus Endometrial Carcinoma","TARGZ","EA8BC9C8-B07E-4F32-8AD4-87080B4806E3","2013-10-02T05:07:02.000Z","71DC862F-5B93-4F1D-8250-8E05E357D2E9","None","NO",1,NA,"Primary Tumor","Mayo Clinic",586,"EA8BC9C8-B07E-4F32-8AD4-87080B4806E3",NA,"D1","d4368872d92003db40aaddb85e0c4972.bam.bai",50,"TCGA-D1-A0ZO-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","9C617822-C9A8-42C5-AAB7-D6F22887C325",75,"nationwidechildrens.org_clinical.TCGA-D1-A0ZO.xml","Alive",NA,"TCGA-D1-A0ZO","NOT HISPANIC OR LATINO","7D4EFFA0-A409-4C83-A409-1479AA928EE0",NA,69,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"71FDC8A6-2B4D-4309-902C-6541BAA3E82B","7DCAC1C1-D849-4249-8858-A2B345837738","d4368872d92003db40aaddb85e0c4972.bam.bai","TCGA-D1-A0ZO-01A-11",60,30,0,20,10,"TOP",10,10,"TCGA-D1-A0ZO-01A-01-TS1",50,NA,NA,NA,NA,NA,NA,NA,"NO",602,"TUMOR FREE","Alive",NA,"TCGA-D1-A0ZO-F17744","TCGA-D1-A0ZO",1,"D1","A0ZO","YES","C54.1","8380/3","C54.1","NO","YES",-27482,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",69,NA,NA,NA,"TUMOR FREE","NO",4,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,75,2009,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
114335120,111979841,5338567574,"5E10DA5D-9542-4B4A-9388-12D7BE89B688.bw","b43de98d-4bb1-41a1-91f2-ce4e7ea4d0ca","5e10da5d-9542-4b4a-9388-12d7be89b688","2016-08-25T07:41:33.161499-05:00","UNCID_2581742.87087b2e-a589-4a75-a005-2c61cb44b414.140416_UNC11-SN627_0352_AC3M6RACXX_5_GTGAAA.tar.gz","25dae980-07e5-4092-9ea7-71205f95222f",4938202016,"Illumina HiSeq","063e4493905eeffc018be248f246079a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:04:10.369093-05:00","2016-05-03T11:55:56.226464-05:00","25dae980-07e5-4092-9ea7-71205f95222f_analysis.xml","f2139d0fab98a7b20c3e79fba020d56f","3a52c9f8-e9a7-4cab-b2f1-f8a29bc533d6",2124,"2016-10-07T16:32:37.202285-05:00","25dae980-07e5-4092-9ea7-71205f95222f_experiment.xml","a2b90143899230e7d370a6e6d50c0d23","25f2bcec-3096-44c3-a762-68184a6fff88",2628,"2016-09-29T23:19:19.750455-05:00","25dae980-07e5-4092-9ea7-71205f95222f_run.xml","dcce48db0a7ed16c4f43d2c673b19370","d835adce-9d6f-4b89-8728-9688d81f16e7",354,"2016-09-08T10:55:47.302467-05:00","TCGA-4E-A92E","2016-09-02T18:51:40.861449-05:00","female","TCGA-4E-A92E_demographic",1959,"black or african american","0599478f-7f76-560c-a1c0-93972e0d41da","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","4E","268087d4-78ec-52c3-accc-ca0dfea08954","Molecular Response","not reported","c54.1","TCGA-4E-A92E_diagnosis","not reported",19818,"alive","8380/3",NA,13,"2db9e566-967e-5b4b-8b14-9ecb2d7ee2ab","c54.1",-19818,"TCGA-4E-A92E_treatment","05b9fb1e-52f1-5acd-9b36-559e012d02de","01","false","TCGA-4E-A92E-01A",NA,"3043a6c9-3dce-4a5b-bbb1-9ad5a07f21e8",FALSE,"BC43D6CA-235C-4217-BF72-F33B089C532B","Primary Tumor",NA,90,140,NA,1388448000,"11",30,"TCGA-4E-A92E-01A-11",80,NA,20,NA,0,NA,15,NA,"2016-09-08T10:55:47.302467-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"54bd2abd-0a11-4c82-8d1e-dfe242bda516",NA,"TCGA-4E-A92E-01A-01-TS1",NA,80,NA,"4b3123cc-488f-46b3-97e6-30317ab76e87","RNA","TCGA-4E-A92E-01A-11R","49ffad67-4577-498d-ba56-e19f16ce1038",1.84,0.16,"UV Spec","R","23","TCGA-4E-A92E-01A-11R-A37O-07","87087b2e-a589-4a75-a005-2c61cb44b414",0.16,NA,76,28.9590001524158,162,"d5c4d745-ae0a-5a59-a4f3-74b051e6322a","TCGA-4E-A92E_exposure","UNCID_2581742.87087b2e-a589-4a75-a005-2c61cb44b414.140416_UNC11-SN627_0352_AC3M6RACXX_5_GTGAAA.tar.gz","2014-08-15T08:21:05.000Z","2014-08-15T08:36:48.000Z","25DAE980-07E5-4092-9EA7-71205F95222F","3043A6C9-3DCE-4A5B-BBB1-9AD5A07F21E8","Unaligned reads",4938202016,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","87087B2E-A589-4A75-A005-2C61CB44B414","University of North Carolina","564a3e7ce4b0298dd2c965a8","B43DE98D-4BB1-41A1-91F2-CE4E7EA4D0CA","Uterine Corpus Endometrial Carcinoma","TARGZ","4B3123CC-488F-46B3-97E6-30317AB76E87","2014-08-15T08:36:48.000Z","49FFAD67-4577-498D-BA56-E19F16CE1038","United States","NO",1,NA,"Primary Tumor","Molecular Response",90,"4B3123CC-488F-46B3-97E6-30317AB76E87",NA,"4E","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9117161E-9271-495E-BC8F-26EBC10D661B.txt",140,"TCGA-4E-A92E-01A",NA,NA,"TCGA",2013,"TCGA-4E-A92E_NTE-1","Complete Remission/Response","TUMOR FREE","8A6495E0-306C-4FAB-A66C-20534CF95AA4",54,"nationwidechildrens.org_clinical.TCGA-4E-A92E.xml","Alive",NA,"TCGA-4E-A92E","NOT HISPANIC OR LATINO","33217D11-3447-4EE9-9092-CC33E574D68E",NA,0,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage I",NA,NA,NA,"8380/3","FEMALE","C54.1",381,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"54BD2ABD-0A11-4C82-8D1E-DFE242BDA516","2C837892-840E-4C1F-8136-D08612B81998","UNCID_2442622.87087b2e-a589-4a75-a005-2c61cb44b414.sorted_genome_alignments.bam.bai","TCGA-4E-A92E-01A-11",80,0,20,40,15,"TOP",5,20,"TCGA-4E-A92E-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-4E-A92E-F69233_NTE-1","NO",13,"TUMOR FREE","Alive",NA,"TCGA-4E-A92E-F69233","TCGA-4E-A92E",1,"4E","A92E","YES","C54.1","8380/3","C54.1","YES","NO",-19818,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,"TUMOR FREE","NO",20,8,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2013,"Tumor resection",NA,NA,NA,"G1","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",1,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29893430,29629113,2139184795,"5902FA3E-0EF9-47C7-96DC-BFB9DCB41BEB.bw","b4a520ae-f259-48c8-823e-c10b9b8a133a","5902fa3e-0ef9-47c7-96dc-bfb9dcb41beb","2016-08-05T09:21:50.037709-05:00","UNCID_2215148.db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_7.tar.gz","8c25b5d0-ff95-4946-9868-b18c2a5373a9",1782774616,"Illumina GA","b3957d836335bd318095e1bf26516283","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:12:02.913357-05:00","2016-05-03T11:17:59.899725-05:00","8c25b5d0-ff95-4946-9868-b18c2a5373a9_analysis.xml","d1a0e04fd59b30a52faee90cdf3941c0","3f41692d-93ee-4939-8647-311ee6d0aec8",2122,"2016-09-29T20:43:04.663970-05:00","8c25b5d0-ff95-4946-9868-b18c2a5373a9_experiment.xml","e4fb11139ac681722218a6f22e764435","7768e6cc-a112-4ffb-a704-e3df6d8e5660",2256,"2016-09-29T22:50:26.824435-05:00","8c25b5d0-ff95-4946-9868-b18c2a5373a9_run.xml","372ba76b2d59fe02d4392dcd31e1d9b9","c672751d-5fa1-4753-8875-1045e081a1aa",345,"2016-09-08T10:33:58.436408-05:00","TCGA-AP-A0LJ","2016-09-02T18:54:37.564074-05:00","female","TCGA-AP-A0LJ_demographic",1962,"white","f8f23111-a666-52f4-aab4-9640dcf8e425","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LJ_diagnosis","not reported",15577,"alive","8380/3",NA,1421,"4b5538b8-395b-5c6f-aad4-0cca187eccf8","c54.1",-15577,"TCGA-AP-A0LJ_treatment","0aedb67e-1ddf-58bf-9679-462d6162fcf9","01","true","TCGA-AP-A0LJ-01A",NA,"be3ed392-4d9f-4eaf-8a56-d251846df4da",FALSE,"859CBF70-D72E-4843-B3AA-6226B707AA2B","Primary Tumor",NA,2290,680,NA,1278547200,"11",30,"TCGA-AP-A0LJ-01A-11",75,75,0,0,0,0,0,0,"2016-09-08T10:33:58.436408-05:00","2016-09-08T10:33:58.436408-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"952c6eef-4b26-4d1a-9d74-cfbe45c44df0","610d5a0b-dfe0-4641-8681-3c7f871b728e","TCGA-AP-A0LJ-01A-01-BSA","TCGA-AP-A0LJ-01A-01-TSA",100,100,"331b9dd8-b4fb-429f-b744-cbb412f8dbd5","RNA","TCGA-AP-A0LJ-01A-11R","e179ce6f-dc2b-4e58-9e34-d38dd13d96b3",2.02,0.15,"UV Spec","R","23","TCGA-AP-A0LJ-01A-11R-A040-07","db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6",0.15,NA,80,34.6260387811634,152,"bd0aa32d-5cfb-554f-b5a0-119b095f4dce","TCGA-AP-A0LJ_exposure","UNCID_2215148.db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_7.tar.gz","2013-10-04T00:26:03.000Z","2013-10-04T00:38:03.000Z","8C25B5D0-FF95-4946-9868-B18C2A5373A9","BE3ED392-4D9F-4EAF-8A56-D251846DF4DA","Unaligned reads",1782774616,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","DB3D4B8A-6EF3-4BB9-ACCA-2CBC4CF5F8C6","University of North Carolina","566078dbe4b0ec1099f8d73d","B4A520AE-F259-48C8-823E-C10B9B8A133A","Uterine Corpus Endometrial Carcinoma","TARGZ","331B9DD8-B4FB-429F-B744-CBB412F8DBD5","2013-10-04T00:38:03.000Z","E179CE6F-DC2B-4E58-9E34-D38DD13D96B3","None","NO",1,NA,"Primary Tumor","MSKCC",2290,"331B9DD8-B4FB-429F-B744-CBB412F8DBD5",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.FE469D1C-3900-4649-A36E-562F8047F8E0.txt",680,"TCGA-AP-A0LJ-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","BE3ED392-4D9F-4EAF-8A56-D251846DF4DA",42,"nationwidechildrens.org_clinical.TCGA-AP-A0LJ.xml","Alive",NA,"TCGA-AP-A0LJ",NA,"A8D90AC1-00D1-4AC9-8989-B82D32048872",NA,1421,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"952C6EEF-4B26-4D1A-9D74-CFBE45C44DF0","ED89F419-9AE6-43BA-B0DC-3BC41624E789","UNCID_2215148.db3d4b8a-6ef3-4bb9-acca-2cbc4cf5f8c6.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_7.tar.gz","TCGA-AP-A0LJ-01A-11",75,0,0,0,0,"BOTTOM",0,0,"TCGA-AP-A0LJ-01A-01-BSA",100,NA,NA,NA,NA,NA,NA,NA,NA,1421,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LJ-F3979","TCGA-AP-A0LJ",1,"AP","A0LJ","YES","C54.1","8380/3","C54.1","NO","YES",-15577,"FEMALE","WHITE",NA,"No","No","Alive",1421,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,42,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
33116360,32769213,2440257666,"1383A856-992F-4A6B-A80F-28DA8598CB79.bw","b5c1e511-baf2-45b3-9919-110e8941e3c2","1383a856-992f-4a6b-a80f-28da8598cb79","2016-08-09T14:19:44.704121-05:00","UNCID_2203929.92f1d13e-3dbb-4a41-aac4-5887b50bc19f.111020_UNC6-RDR300211_00129_FC_62EA9AAXX_7.tar.gz","664d90ec-f92d-438f-961b-33d4285ba945",2209968276,"Illumina GA","4ab0a25e8d54aee708a2cdaf0613e3fa","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:20:34.548141-05:00","2016-05-03T11:19:30.078749-05:00","664d90ec-f92d-438f-961b-33d4285ba945_analysis.xml","17af12bb9dac6b3ed78116c892943382","69922b68-fc7c-4e24-8c1d-cc3eefb526e1",2121,"2016-09-29T18:32:47.660199-05:00","664d90ec-f92d-438f-961b-33d4285ba945_experiment.xml","fab41ab882fe4c1ffe122ab3939d2e98","264a60e4-a4c0-44a1-8ec3-e2bc15047fb4",2257,"2016-09-29T22:38:00.542607-05:00","664d90ec-f92d-438f-961b-33d4285ba945_run.xml","d77598a2e157eac27f341c545c361b12","bebb5d84-2288-4e03-93d2-db945b0f3b97",347,"2016-09-08T10:40:31.549428-05:00","TCGA-EC-A24G","2016-09-02T18:52:47.909867-05:00","female","TCGA-EC-A24G_demographic",1954,"white","93b52e42-bee1-5a84-973a-5dec59c6e5ed","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EC","acc43e64-d63e-554c-a488-8bf6b93bec91","Asterand","not reported","c54.1","TCGA-EC-A24G_diagnosis","not reported",20857,"alive","8380/3",NA,511,"647de959-f4f7-552e-b46f-a335e3ee30d7","c54.1",-20857,"TCGA-EC-A24G_treatment","002afe07-a1a0-5d19-babf-29c713364fa6","01","true","TCGA-EC-A24G-01A",NA,"2fea9b96-3434-4a38-bd69-a5fec3d8f960",FALSE,"5DE142C5-7A0D-4C5E-8EF6-2809B10378C4","Primary Tumor",NA,78,410,NA,1306281600,"11",30,"TCGA-EC-A24G-01A-11",85,NA,3,NA,0,NA,15,NA,"2016-09-08T10:40:31.549428-05:00",NA,10,NA,3,NA,"TOP",NA,0,NA,"e313a49e-2b27-465d-b504-5ba0bdea0703",NA,"TCGA-EC-A24G-01A-01-TSA",NA,85,NA,"75f34509-2881-497c-8bd5-868ef657487d","RNA","TCGA-EC-A24G-01A-11R","27566bae-72dd-4257-bc03-513d61846b31",1.78,0.18,"UV Spec","R","23","TCGA-EC-A24G-01A-11R-A16F-07","92f1d13e-3dbb-4a41-aac4-5887b50bc19f",0.18,NA,93,42.4579985390796,148,"4da33fd8-7da3-5be0-8c1a-1030f257b863","TCGA-EC-A24G_exposure","UNCID_2203929.92f1d13e-3dbb-4a41-aac4-5887b50bc19f.111020_UNC6-RDR300211_00129_FC_62EA9AAXX_7.tar.gz","2013-10-04T16:16:03.000Z","2013-10-04T16:56:02.000Z","664D90EC-F92D-438F-961B-33D4285BA945","2FEA9B96-3434-4A38-BD69-A5FEC3D8F960","Unaligned reads",2209968276,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","92F1D13E-3DBB-4A41-AAC4-5887B50BC19F","University of North Carolina","564a3fd8e4b093830b6ab18c","B5C1E511-BAF2-45B3-9919-110E8941E3C2","Uterine Corpus Endometrial Carcinoma","TARGZ","75F34509-2881-497C-8BD5-868EF657487D","2013-10-04T16:56:02.000Z","27566BAE-72DD-4257-BC03-513D61846B31","Ukraine","NO",1,NA,"Primary Tumor","Asterand",78,"75F34509-2881-497C-8BD5-868EF657487D",NA,"EC","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.98AB1F54-6633-42A9-B751-785CD6E9260C.txt",410,"TCGA-EC-A24G-01A",NA,"F9F2DE02-F608-409B-BD34-6E43FFFC76C6","TCGA",2011,NA,NA,"TUMOR FREE","61CF2E54-1B8D-40A0-9C73-A7449CBD570A",57,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.98AB1F54-6633-42A9-B751-785CD6E9260C.txt","Alive",NA,"TCGA-EC-A24G","NOT HISPANIC OR LATINO","9EF43B3B-AA5C-4AAC-BC4C-0A4C023A71FB",NA,47,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",143,NA,"DFD6643C-9E4D-4ED6-83D1-057EE6C2ADF2","WHITE",NA,11,30,"E313A49E-2B27-465D-B504-5BA0BDEA0703","BC74039E-7EBD-4F63-8485-1627E9B520FF","6223e0272516d97b21ef1014c53cd608.bam.bai","TCGA-EC-A24G-01A-11",85,0,3,10,15,"TOP",0,3,"TCGA-EC-A24G-01A-01-TSA",85,"Carboplatin","Chemotherapy","TCGA-EC-A24G-D31233","TCGA-EC-A24G-R31236","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",440,"TUMOR FREE","Alive",NA,"TCGA-EC-A24G-F31225","TCGA-EC-A24G",1,"EC","A24G","YES","C54.1","8380/3","C54.1","YES","NO",-20857,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",47,NA,NA,NA,"TUMOR FREE","NO",21,3,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
163907028,161378272,7698274302,"938B793F-7821-41B6-8ADB-A78089628F65.bw","b60f22ac-a659-4f33-b01d-820e86a9a5c9","938b793f-7821-41b6-8adb-a78089628f65","2016-08-25T15:27:47.740599-05:00","UNCID_2364660.cbd18c2a-4544-4a90-904e-533c3f776f32.130909_UNC15-SN850_0327_BD2DT1ACXX_1_ACAGTG.tar.gz","492080a3-5f90-4f63-b474-c3596dbd4aed",7555108926,"Illumina HiSeq","dc6c6ed3d03c441fda1e4b86af2cc59f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:55:14.652234-05:00","2016-05-03T11:38:50.208107-05:00","492080a3-5f90-4f63-b474-c3596dbd4aed_analysis.xml","8827009b810c85dcab631eeb7c2179f5","a4664cac-1dc0-45bc-bcbf-897fd98b166c",2124,"2016-09-29T21:30:44.241814-05:00","492080a3-5f90-4f63-b474-c3596dbd4aed_experiment.xml","329c6f329ae318701f58009c02614df7","95331725-a5f0-476f-8c49-68ed3974bb83",2628,"2016-09-29T21:30:26.790814-05:00","492080a3-5f90-4f63-b474-c3596dbd4aed_run.xml","b1108fe9924c9e187958396c10a6d794","95071ce9-56bf-4fcb-9ffe-e6f6b5307b74",354,"2016-09-08T12:09:51.021188-05:00","TCGA-B5-A0JN","2016-09-02T18:47:56.727659-05:00","female","TCGA-B5-A0JN_demographic",1920,"black or african american","803b97ad-544f-5652-a79b-7dc4f1df6e1c","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0JN_diagnosis","not reported",30933,"alive","8441/3",NA,2445,"4c735ac3-31b0-59a6-9214-c58a003e4c8f","c54.1",-30933,"TCGA-B5-A0JN_treatment","03baf715-289a-5971-9525-3be0eca9a7f5","01","true","TCGA-B5-A0JN-01A",NA,"684c6894-fd49-4934-8962-9628ece734fb",FALSE,"A22F4C33-7630-4595-8415-24C87949B211","Primary Tumor",NA,2164,440,NA,1276732800,"11",30,"TCGA-B5-A0JN-01A-11",90,90,0,0,0,0,0,0,"2016-09-08T12:09:51.021188-05:00","2016-09-08T12:09:51.021188-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"19bbff7a-2913-4963-8bbe-2a632dc04e82","1ada5fe5-accb-4872-a5b9-19545a359e21","TCGA-B5-A0JN-01A-01-BS1","TCGA-B5-A0JN-01A-01-TS1",100,100,"13ce4847-064c-4e9a-9d49-6ce705d67d0f","RNA","TCGA-B5-A0JN-01A-11R","a09e5a77-fa03-474d-925d-6b6e491430be",1.7,0.15,"UV Spec","R","23","TCGA-B5-A0JN-01A-11R-A104-07","cbd18c2a-4544-4a90-904e-533c3f776f32",0.15,NA,58,24.4560634171024,154,"54349de0-3234-5aa9-bd95-5e4700382947","TCGA-B5-A0JN_exposure","UNCID_2364660.cbd18c2a-4544-4a90-904e-533c3f776f32.130909_UNC15-SN850_0327_BD2DT1ACXX_1_ACAGTG.tar.gz","2014-02-28T19:03:04.000Z","2014-02-28T19:28:02.000Z","492080A3-5F90-4F63-B474-C3596DBD4AED","684C6894-FD49-4934-8962-9628ECE734FB","Unaligned reads",7555108926,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","CBD18C2A-4544-4A90-904E-533C3F776F32","University of North Carolina","56607b07e4b018727fea2888","B60F22AC-A659-4F33-B01D-820E86A9A5C9","Uterine Corpus Endometrial Carcinoma","TARGZ","13CE4847-064C-4E9A-9D49-6CE705D67D0F","2014-02-28T19:28:02.000Z","A09E5A77-FA03-474D-925D-6B6E491430BE","United States","NO",1,NA,"Primary Tumor","Duke",2164,"13CE4847-064C-4E9A-9D49-6CE705D67D0F",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.90FFCFFB-C276-438C-AD00-0DA5CABA8596.txt",440,"TCGA-B5-A0JN-01A",NA,"BA6F77A1-FC03-4924-9EDC-5198AFBB6A77","TCGA",2004,NA,NA,"TUMOR FREE","684C6894-FD49-4934-8962-9628ECE734FB",84,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.90FFCFFB-C276-438C-AD00-0DA5CABA8596.txt","Alive",NA,"TCGA-B5-A0JN",NA,"ADF9261A-3B70-4B7D-A8F8-E13CC48C4298",NA,2068,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",73,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"1ADA5FE5-ACCB-4872-A5B9-19545A359E21","273730BC-C9BC-4294-A4A6-D8564F8BF49F","UNCID_2364660.cbd18c2a-4544-4a90-904e-533c3f776f32.130909_UNC15-SN850_0327_BD2DT1ACXX_1_ACAGTG.tar.gz","TCGA-B5-A0JN-01A-11",90,0,0,0,0,"BOTTOM",0,0,"TCGA-B5-A0JN-01A-01-BS1",100,"Carboplatin","Chemotherapy","TCGA-B5-A0JN-D9968",NA,NA,NA,NA,NA,2445,"TUMOR FREE","Alive",NA,"TCGA-B5-A0JN-F11873","TCGA-B5-A0JN",1,"B5","A0JN","YES","C54.1","8441/3","C54.1","NO","YES",-30933,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"Yes","Yes","Alive",2068,NA,NA,NA,"TUMOR FREE","NO",23,2,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,84,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29841923,29682565,2207237963,"AE8BD116-5550-4A0F-BEBE-F092675A1F45.bw","b6819b52-6f01-4011-9bd3-a1a00397e0c9","ae8bd116-5550-4a0f-bebe-f092675a1f45","2016-08-09T14:16:33.656624-05:00","UNCID_2215534.3d4e6413-b717-45c2-8531-118ed3a593a0.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_7.tar.gz","c8f1bba2-b6b8-4a72-97a1-2ef50ad3296a",1777922995,"Illumina GA","ccd62c69702235cf0a7a266071e9ff91","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:36:08.989842-05:00","2016-05-03T11:18:46.976827-05:00","c8f1bba2-b6b8-4a72-97a1-2ef50ad3296a_analysis.xml","526e0aed69662d84515a158d9f717eb7","98755127-e631-4092-bc48-eb7cc377390f",2122,"2016-08-27T07:40:41.415375-05:00","c8f1bba2-b6b8-4a72-97a1-2ef50ad3296a_experiment.xml","439f8ff82dc6174c2e3de14db13c7784","556e5cba-2b0c-49fc-b686-229beb54cbc3",2256,"2016-09-29T23:44:33.461171-05:00","c8f1bba2-b6b8-4a72-97a1-2ef50ad3296a_run.xml","86cc470654babec5a9429306b2c54383","e823bfcd-4f27-4b7b-93cf-0c556c8664d5",345,"2016-09-08T10:41:18.089235-05:00","TCGA-AX-A06J","2016-09-02T18:52:51.566571-05:00","female","TCGA-AX-A06J_demographic",1937,"white","96e572fd-b222-549c-969e-fd4cc8e894d3","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A06J_diagnosis","not reported",26000,"alive","8380/3",NA,913,"86f02a51-8598-52f5-9385-2039491b5c30","c54.1",-26000,"TCGA-AX-A06J_treatment","3d47647b-b5ab-5673-832f-36582f08741d","01","false","TCGA-AX-A06J-01A",NA,"fa750459-78d8-4dd7-890b-45729bad112a",FALSE,"553324CE-44B8-416F-B965-074CE5FF9834","Primary Tumor",NA,662,200,NA,1275868800,"11",30,"TCGA-AX-A06J-01A-11",95,95,1,4,3,3,8,2,"2016-09-08T10:41:18.089235-05:00","2016-09-08T10:41:18.089235-05:00",0,0,1,0,"TOP","BOTTOM",1,20,"9c92618f-0e02-4ce8-a288-946f96276883","ae5db9f1-f67c-4989-817a-1325ebff6d96","TCGA-AX-A06J-01A-01-TS1","TCGA-AX-A06J-01A-01-BS1",88,75,"7ab839b8-df38-4cf5-b67d-7f32ccec757a","RNA","TCGA-AX-A06J-01A-11R","a8ef6e23-1fe3-425c-869f-ee3996ad0a67",1.78,0.14,"UV Spec","R","23","TCGA-AX-A06J-01A-11R-A00V-07","3d4e6413-b717-45c2-8531-118ed3a593a0",0.14,NA,119,45.9087226573049,161,"53d69ff1-e5a9-576d-81e1-6bec9f4a5422","TCGA-AX-A06J_exposure","UNCID_2215534.3d4e6413-b717-45c2-8531-118ed3a593a0.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_7.tar.gz","2013-10-04T03:16:04.000Z","2013-10-04T03:34:01.000Z","C8F1BBA2-B6B8-4A72-97A1-2EF50AD3296A","FA750459-78D8-4DD7-890B-45729BAD112A","Unaligned reads",1777922995,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3D4E6413-B717-45C2-8531-118ED3A593A0","University of North Carolina","564a3cafe4b08c5d8691eb47","B6819B52-6F01-4011-9BD3-A1A00397E0C9","Uterine Corpus Endometrial Carcinoma","TARGZ","7AB839B8-DF38-4CF5-B67D-7F32CCEC757A","2013-10-04T03:34:01.000Z","A8EF6E23-1FE3-425C-869F-EE3996AD0A67","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",662,"7AB839B8-DF38-4CF5-B67D-7F32CCEC757A",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.06500A95-B79C-47B8-8777-34E5DB32AB3C.txt",200,"TCGA-AX-A06J-01A",NA,"9E8A69C1-C059-4825-852B-BB1425EBE778","TCGA",2008,NA,NA,"TUMOR FREE","FA750459-78D8-4DD7-890B-45729BAD112A",71,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.06500A95-B79C-47B8-8777-34E5DB32AB3C.txt","Alive",NA,"TCGA-AX-A06J","NOT HISPANIC OR LATINO","05FAEAA0-3BA5-4C15-8E61-9352235BECD6",NA,913,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,"ADBCF923-1B99-4485-B7A0-037C71747736","WHITE",NA,11,30,"9C92618F-0E02-4CE8-A288-946F96276883","F7A085F0-4C45-4571-8DCA-ED4017C65D7E","TCGA-AX-A06J-01A-11R-A00W-13_mirna.bam.bai","TCGA-AX-A06J-01A-11",95,3,4,0,2,"BOTTOM",20,0,"TCGA-AX-A06J-01A-01-BS1",75,"Carboplatin & Paclitaxel","Chemotherapy","TCGA-AX-A06J-D12764","TCGA-AX-A06J-R12765","IMPLANTS","Primary Tumor Field",NA,NA,913,"TUMOR FREE","Alive",NA,"TCGA-AX-A06J-F5542","TCGA-AX-A06J",1,"AX","A06J","YES","C54.1","8380/3","C54.1","NO","YES",-26000,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",913,NA,NA,NA,"TUMOR FREE","NO",26,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,71,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
15538287,15358113,1095815951,"84B08BFD-C015-4B18-B2F4-4E00F98DF058.bw","b8588e0f-aad6-4ded-845e-3cff67a48d8f","84b08bfd-c015-4b18-b2f4-4e00f98df058","2016-08-09T14:16:37.134384-05:00","UNCID_2215036.c199bab3-c6e3-4123-811c-2c50e8d44fae.101014_UNC2-RDR300275_00039_FC_706C1AAXX_8.tar.gz","72859b2e-15b1-4767-9dd0-f4f1138a6851",902851233,"Illumina GA","a788988a651d3ff64bd4e8e0809e71cb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:00:05.528982-05:00","2016-05-03T11:17:14.882251-05:00","72859b2e-15b1-4767-9dd0-f4f1138a6851_analysis.xml","36430e574628769f7d09c8a8f8f67c47","cc421364-df4e-4eaa-b5f4-d4ef16c73d21",2119,"2016-09-29T18:09:42.684171-05:00","72859b2e-15b1-4767-9dd0-f4f1138a6851_experiment.xml","aee83c028fe45109829ca8aa77452201","181f9e3a-4a62-4d1d-bf3a-8b8c1aaf70d9",2256,"2016-09-29T22:53:54.158135-05:00","72859b2e-15b1-4767-9dd0-f4f1138a6851_run.xml","6dfbfca8179139beb33fe95f1dae6cbd","c8a5e0bb-4297-4cde-829a-88f326357c81",345,"2016-09-09T16:21:02.795190-05:00","TCGA-BG-A0MI","2016-09-02T18:54:48.708899-05:00","female","TCGA-BG-A0MI_demographic",1924,"white","0fb4bc67-19f3-5554-b4f5-9cdc29776597","not hispanic or latino",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MI_diagnosis","not reported",30334,"dead","8380/3",714,NA,"0269ec13-6288-5b21-91f1-82f13a57ecd0","c54.1",-30334,"TCGA-BG-A0MI_treatment","6122e669-a6d0-5f9b-89ab-8a52e1128891","01","true","TCGA-BG-A0MI-01A",NA,"f030dae4-bd6f-4d0d-96e0-12b299057338",FALSE,"1A0F6DD8-22A2-4A00-8AAD-04710DBBDFED","Primary Tumor",NA,1014,100,NA,1279065600,"11",30,"TCGA-BG-A0MI-01A-11",85,88,2,2,0,0,15,8,"2016-09-09T16:21:02.795190-05:00","2016-09-09T16:21:02.795190-05:00",5,5,1,1,"TOP","BOTTOM",10,12,"53f3aeb0-fd8e-45af-a669-3ffab0acaece","aa4484c2-ec55-4801-aea2-06f2b378dfcb","TCGA-BG-A0MI-01A-01-TSA","TCGA-BG-A0MI-01A-01-BSA",75,80,"d0fa4ea2-7ca9-4bf0-96a1-ca6b08eee49a","RNA","TCGA-BG-A0MI-01A-11R","f869c047-4aaf-49bd-9b39-4a213396c321",2.05,0.13,"UV Spec","R","23","TCGA-BG-A0MI-01A-11R-A040-07","c199bab3-c6e3-4123-811c-2c50e8d44fae",0.13,NA,101,37.0982552800735,165,"7f4d8eec-0390-502c-b7d9-ef6a77b60acb","TCGA-BG-A0MI_exposure","UNCID_2215036.c199bab3-c6e3-4123-811c-2c50e8d44fae.101014_UNC2-RDR300275_00039_FC_706C1AAXX_8.tar.gz","2013-10-03T23:25:04.000Z","2013-10-03T23:37:03.000Z","72859B2E-15B1-4767-9DD0-F4F1138A6851","F030DAE4-BD6F-4D0D-96E0-12B299057338","Unaligned reads",902851233,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C199BAB3-C6E3-4123-811C-2C50E8D44FAE","University of North Carolina","56607d36e4b018727fea3235","B8588E0F-AAD6-4DED-845E-3CFF67A48D8F","Uterine Corpus Endometrial Carcinoma","TARGZ","D0FA4EA2-7CA9-4BF0-96A1-CA6B08EEE49A","2013-10-03T23:37:03.000Z","F869C047-4AAF-49BD-9B39-4A213396C321","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",1014,"D0FA4EA2-7CA9-4BF0-96A1-CA6B08EEE49A",NA,"BG","MODEM_p_TCGAb59_SNP_N_GenomeWideSNP_6_G04_680472.hg19.seg.txt",100,"TCGA-BG-A0MI-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","F030DAE4-BD6F-4D0D-96E0-12B299057338",83,"nationwidechildrens.org_clinical.TCGA-BG-A0MI.xml","Dead",714,"TCGA-BG-A0MI","NOT HISPANIC OR LATINO","897AFA88-B519-48C9-BD94-E08AAAEA9754",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"AA4484C2-EC55-4801-AEA2-06F2B378DFCB","F869C047-4AAF-49BD-9B39-4A213396C321","UNCID_257309.TCGA-BG-A0MI-01A-11R-A040-07.101014_UNC2-RDR300275_00039_FC_706C1AAXX.8.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-BG-A0MI-01A-11",85,0,2,5,15,"TOP",10,1,"TCGA-BG-A0MI-01A-01-TSA",75,NA,NA,NA,NA,NA,NA,NA,"NO",NA,"TUMOR FREE","Dead",714,"TCGA-BG-A0MI-F17205","TCGA-BG-A0MI",1,"BG","A0MI","YES","C54.1","8380/3","C54.1","NO","YES",-30334,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,714,NA,NA,"TUMOR FREE","NO",8,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,83,2007,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
38265616,38130213,2820622614,"76040542-6D1B-4A0F-9F2E-43E4AA33FE21.bw","b9ab4ab9-ba9c-4a01-9f61-55c82b924936","76040542-6d1b-4a0f-9f2e-43e4aa33fe21","2016-08-06T23:32:20.368240-05:00","UNCID_2203752.4bcff10b-20ad-4635-bbcd-855826277b8a.111103_UNC6-RDR300211_00130_FC_638P5AAXX_2.tar.gz","bcac572d-cff9-4e0e-ac84-2a28d0c5df5b",2533569112,"Illumina GA","0384ce7b1601cfb614e5c583fc399e87","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:47:47.496656-05:00","2016-05-03T11:10:47.515830-05:00","bcac572d-cff9-4e0e-ac84-2a28d0c5df5b_analysis.xml","4b8785c5d0d8a75b10ccf3a3460f0945","9fa4006a-3e20-420f-a376-0ded3d96f3de",2121,"2016-08-13T02:56:36.744738-05:00","bcac572d-cff9-4e0e-ac84-2a28d0c5df5b_experiment.xml","917f7672d1d2e5543817cd55479a577e","3b59ea46-aabe-4d4e-95d6-a9ae1a314918",2257,"2016-09-29T23:08:42.489137-05:00","bcac572d-cff9-4e0e-ac84-2a28d0c5df5b_run.xml","e6c8395adcc1eefc8053498d461e7e4c","d1c9f211-13db-4513-bf57-14ff92dd6a48",347,"2016-09-08T10:45:26.755367-05:00","TCGA-FI-A2CY","2016-09-02T18:52:53.631665-05:00","female","TCGA-FI-A2CY_demographic",1948,"black or african american","fe1253ff-6372-59d4-95d5-b7799dd58660","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2CY_diagnosis","not reported",22098,"alive","8441/3",NA,2080,"bf7ef25c-4fee-555f-a5ba-4f5029f881f0","c54.1",-22098,"TCGA-FI-A2CY_treatment","da046201-0637-5609-998e-7b8f436ca222","01","true","TCGA-FI-A2CY-01A",NA,"047b688c-aa29-4a63-b555-9275af4b0cee",FALSE,"2C4CE5F5-AD46-427E-A787-529DF9FA891A","Primary Tumor",NA,1067,110,NA,1308700800,"11",30,"TCGA-FI-A2CY-01A-11",98,NA,8,NA,0,NA,2,NA,"2016-09-08T10:45:26.755367-05:00",NA,5,NA,2,NA,"TOP",NA,2,NA,"f893b64a-d23a-423b-9474-1371d91a30be",NA,"TCGA-FI-A2CY-01A-01-TS1",NA,96,NA,"f5ab21cf-3560-49ee-9659-0022765a8088","RNA","TCGA-FI-A2CY-01A-11R","25458bc2-0601-468e-be09-a1fb2595612c",1.91,0.18,"UV Spec","R","23","TCGA-FI-A2CY-01A-11R-A17B-07","4bcff10b-20ad-4635-bbcd-855826277b8a",0.18,NA,100,47.5624256837099,145,"d5dfd0ca-a27d-5859-a8a4-b315f9f4d065","TCGA-FI-A2CY_exposure","UNCID_2203752.4bcff10b-20ad-4635-bbcd-855826277b8a.111103_UNC6-RDR300211_00130_FC_638P5AAXX_2.tar.gz","2013-09-26T16:46:04.000Z","2013-09-26T17:00:02.000Z","BCAC572D-CFF9-4E0E-AC84-2A28D0C5DF5B","047B688C-AA29-4A63-B555-9275AF4B0CEE","Unaligned reads",2533569112,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4BCFF10B-20AD-4635-BBCD-855826277B8A","University of North Carolina","564a38fce4b093830b687c7f","B9AB4AB9-BA9C-4A01-9F61-55C82B924936","Uterine Corpus Endometrial Carcinoma","TARGZ","F5AB21CF-3560-49EE-9659-0022765A8088","2013-09-26T17:00:02.000Z","25458BC2-0601-468E-BE09-A1FB2595612C","United States","NO",1,NA,"Primary Tumor","Washington University",1067,"F5AB21CF-3560-49EE-9659-0022765A8088",NA,"FI","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.40294F1C-B9EC-4486-87DB-8973840F9238.txt",110,"TCGA-FI-A2CY-01A",NA,"AB47B1E1-C904-4EF0-BCF5-0EC7EE6FA257","TCGA",2008,NA,NA,"TUMOR FREE","B09A76E3-73B7-4192-B3DD-E37C42C8D271",60,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.40294F1C-B9EC-4486-87DB-8973840F9238.txt","Alive",NA,"TCGA-FI-A2CY","NOT HISPANIC OR LATINO","A8828E4D-6C9C-4A61-A239-4D129717C90C",NA,1064,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"F893B64A-D23A-423B-9474-1371D91A30BE","AEF65430-35A9-4644-80AF-30D3A6F3D159","TCGA-FI-A2CY-01A-11R-A17A-13_mirna.bam","TCGA-FI-A2CY-01A-11",98,0,8,5,2,"TOP",2,2,"TCGA-FI-A2CY-01A-01-TS1",96,"Carboplatinum","Chemotherapy","TCGA-FI-A2CY-D31802",NA,NA,NA,"TCGA-FI-A2CY-F71663_NTE-1","NO",2080,"TUMOR FREE","Alive",NA,"TCGA-FI-A2CY-F71663","TCGA-FI-A2CY",1,"FI","A2CY","YES","C54.1","8441/3","C54.1","NO","YES",-22098,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",1064,NA,NA,NA,"TUMOR FREE","NO",27,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,60,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32436081,32119029,2408977307,"1A8B7020-31DF-44DA-8253-9A12C33982A2.bw","bad34c92-1e64-4187-a0b4-061105fd13ba","1a8b7020-31df-44da-8253-9a12c33982a2","2016-08-09T14:12:14.468292-05:00","UNCID_2207209.34149234-2d6a-46ac-b7e0-52787cf2c49a.110719_UNC2-RDR300275_00077_FC_70KATAAXX_7.tar.gz","1828ef15-79e4-47d3-8e8e-f777ede8c278",1997909554,"Illumina GA","c29436b17edbc5a8e3ebfdda860c66c0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:47:54.057517-05:00","2016-05-03T11:13:42.375045-05:00","1828ef15-79e4-47d3-8e8e-f777ede8c278_analysis.xml","2fb600a26943213b0309dbffc06e8ab9","3011c7c3-d74b-400d-a1ad-b7dfae243780",2120,"2016-09-29T19:09:30.818457-05:00","1828ef15-79e4-47d3-8e8e-f777ede8c278_experiment.xml","de095b7079479f781dbea923bc3e9949","3daaebdb-9905-4080-a1f3-42914c30e8bf",2257,"2016-09-29T22:01:33.797246-05:00","1828ef15-79e4-47d3-8e8e-f777ede8c278_run.xml","7a74db41a641b938a5a18bb1d1faa14d","a84a1ef8-e8df-47ad-873d-448c66055fa1",347,"2016-09-08T10:54:27.242982-05:00","TCGA-AX-A1C8","2016-09-02T18:51:38.361265-05:00","female","TCGA-AX-A1C8_demographic",1932,"white","46ee949e-91ac-585a-b287-023dda00ab3d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1C8_diagnosis","not reported",28452,"alive","8441/3",NA,776,"2409cab7-cad6-57d6-8b56-732c17c0e990","c54.1",-28452,"TCGA-AX-A1C8_treatment","0ed6b81a-29d4-591c-b16f-8c0a2196310d","01","false","TCGA-AX-A1C8-01A",NA,"83e4dfb0-f240-476b-bc25-f9f52c960af5",FALSE,"5F0E78BA-B827-4DB6-99EB-5FA3D3598793","Primary Tumor",NA,475,100,NA,1295222400,"11",30,"TCGA-AX-A1C8-01A-11",80,NA,1,NA,0,NA,20,NA,"2016-09-08T10:54:27.242982-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"61e0c69d-6a8d-4674-a03d-217c5ea965aa",NA,"TCGA-AX-A1C8-01A-01-TS1",NA,75,NA,"ba4b4047-b61a-46eb-9018-bd4564770192","RNA","TCGA-AX-A1C8-01A-11R","47c776c6-58b0-4ff2-9505-b529230c2fb0",1.89,0.17,"UV Spec","R","23","TCGA-AX-A1C8-01A-11R-A137-07","34149234-2d6a-46ac-b7e0-52787cf2c49a",0.17,NA,66,27.120315581854,156,"da890de9-6fd6-5967-80f4-50fa4012fcd0","TCGA-AX-A1C8_exposure","UNCID_2207209.34149234-2d6a-46ac-b7e0-52787cf2c49a.110719_UNC2-RDR300275_00077_FC_70KATAAXX_7.tar.gz","2013-09-29T18:16:04.000Z","2013-09-29T18:28:03.000Z","1828EF15-79E4-47D3-8E8E-F777EDE8C278","83E4DFB0-F240-476B-BC25-F9F52C960AF5","Unaligned reads",1997909554,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","34149234-2D6A-46AC-B7E0-52787CF2C49A","University of North Carolina","566078bae4b016715ab69f51","BAD34C92-1E64-4187-A0B4-061105FD13BA","Uterine Corpus Endometrial Carcinoma","TARGZ","BA4B4047-B61A-46EB-9018-BD4564770192","2013-09-29T18:28:03.000Z","47C776C6-58B0-4FF2-9505-B529230C2FB0","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",475,"BA4B4047-B61A-46EB-9018-BD4564770192",NA,"AX","UNCID_2207209.34149234-2d6a-46ac-b7e0-52787cf2c49a.110719_UNC2-RDR300275_00077_FC_70KATAAXX_7.tar.gz",100,"TCGA-AX-A1C8-01A",NA,NA,"TCGA",2009,NA,NA,NA,"B06ABBDA-60D6-4E45-8FF0-11F555D42F14",77,"nationwidechildrens.org_clinical.TCGA-AX-A1C8.xml","Alive",NA,"TCGA-AX-A1C8","NOT HISPANIC OR LATINO","B1E95410-B7BF-4BA2-AFB8-89953880180B",NA,412,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"61E0C69D-6A8D-4674-A03D-217C5EA965AA","47C776C6-58B0-4FF2-9505-B529230C2FB0","UNCID_2207209.34149234-2d6a-46ac-b7e0-52787cf2c49a.110719_UNC2-RDR300275_00077_FC_70KATAAXX_7.tar.gz","TCGA-AX-A1C8-01A-11",80,0,1,1,20,"TOP",5,0,"TCGA-AX-A1C8-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,NA,NA,412,NA,"Alive",NA,"TCGA-AX-A1C8-F10361","TCGA-AX-A1C8",1,"AX","A1C8","YES","C54.1","8441/3","C54.1","NO","YES",-28452,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",412,NA,NA,NA,NA,"NO",11,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,77,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
21568656,21279144,1601101295,"4FCF75A0-D0E4-4418-988F-2241B1C33DBF.bw","bc02493a-0296-4329-939a-bf91a4d0c16a","4fcf75a0-d0e4-4418-988f-2241b1c33dbf","2016-08-09T14:11:52.330763-05:00","UNCID_2207057.ac3b86dc-2dd8-41e8-832a-5625f5cd5a27.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_8.tar.gz","5d47013e-4566-4e30-94f7-e07e441628be",1336807547,"Illumina GA","0a2c84e7779273aaddc9dfb6f5d53bce","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:05:33.702979-05:00","2016-05-03T11:13:42.364824-05:00","5d47013e-4566-4e30-94f7-e07e441628be_analysis.xml","619a82f2098c5822ac1c6d10f93e30f2","15862601-70cf-4a0d-a72c-7bac00861c67",2121,"2016-09-29T23:50:12.334958-05:00","5d47013e-4566-4e30-94f7-e07e441628be_experiment.xml","26d1627ac8a4065eccc1bf2a485697c4","eb9149f9-80e4-4aa4-a174-f8283565463d",2257,"2016-09-30T00:05:48.645144-05:00","5d47013e-4566-4e30-94f7-e07e441628be_run.xml","ad88acae31628866c4eaf795130692a1","f51b65bc-2ede-4a36-ada6-3725c05a1bb1",347,"2016-09-08T10:32:27.331582-05:00","TCGA-AX-A1CC","2016-09-02T18:51:40.137707-05:00","female","TCGA-AX-A1CC_demographic",1945,"white","7c2e2f5f-ce78-504d-817b-73a479cd09f9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CC_diagnosis","not reported",23795,"alive","8441/3",NA,788,"272ec012-fe88-5946-b590-5fd2f36587aa","c54.1",-23795,"TCGA-AX-A1CC_treatment","9eea8624-2472-5365-a62f-6678bea3b959","01","false","TCGA-AX-A1CC-01A",NA,"86f051d5-f4a3-47e2-b377-88a516c29bc3",FALSE,"C621C7A6-FF3F-453E-94A2-9789F66750E3","Primary Tumor",NA,356,90,NA,1295222400,"11",30,"TCGA-AX-A1CC-01A-11",65,NA,1,NA,10,NA,20,NA,"2016-09-08T10:32:27.331582-05:00",NA,20,NA,1,NA,"TOP",NA,2,NA,"8c38ebd9-f0ef-425d-bd2a-e4c52604045f",NA,"TCGA-AX-A1CC-01A-01-TS1",NA,68,NA,"7f8d443d-a801-4ecf-9392-42dd72db9180","RNA","TCGA-AX-A1CC-01A-11R","18b0b7d1-3330-4253-be4e-7a883f647091",1.8,0.16,"UV Spec","R","23","TCGA-AX-A1CC-01A-11R-A137-07","ac3b86dc-2dd8-41e8-832a-5625f5cd5a27",0.16,NA,99,40.6804733727811,156,"9805d128-680a-5d92-b356-960c05dc9e03","TCGA-AX-A1CC_exposure","UNCID_2207057.ac3b86dc-2dd8-41e8-832a-5625f5cd5a27.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_8.tar.gz","2013-09-29T05:36:05.000Z","2013-09-29T05:48:02.000Z","5D47013E-4566-4E30-94F7-E07E441628BE","86F051D5-F4A3-47E2-B377-88A516C29BC3","Unaligned reads",1336807547,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","AC3B86DC-2DD8-41E8-832A-5625F5CD5A27","University of North Carolina","56607a3ce4b0ec1099f8df01","BC02493A-0296-4329-939A-BF91A4D0C16A","Uterine Corpus Endometrial Carcinoma","TARGZ","7F8D443D-A801-4ECF-9392-42DD72DB9180","2013-09-29T05:48:02.000Z","18B0B7D1-3330-4253-BE4E-7A883F647091","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",356,"7F8D443D-A801-4ECF-9392-42DD72DB9180",NA,"AX","UNCID_2207057.ac3b86dc-2dd8-41e8-832a-5625f5cd5a27.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_8.tar.gz",90,"TCGA-AX-A1CC-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","86F051D5-F4A3-47E2-B377-88A516C29BC3",65,"nationwidechildrens.org_clinical.TCGA-AX-A1CC.xml","Alive",NA,"TCGA-AX-A1CC","NOT HISPANIC OR LATINO",NA,NA,378,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8441/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"8C38EBD9-F0EF-425D-BD2A-E4C52604045F","D518A168-7BDA-4986-BBCC-6A8280D80241","UNCID_2207057.ac3b86dc-2dd8-41e8-832a-5625f5cd5a27.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_8.tar.gz","TCGA-AX-A1CC-01A-11",65,10,1,20,20,"TOP",2,1,"TCGA-AX-A1CC-01A-01-TS1",68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-AX-A1CC",1,"AX","A1CC","YES","C54.1","8441/3","C54.1","NO","YES",-23795,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",378,NA,NA,NA,"TUMOR FREE","NO",11,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,65,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33800191,32815679,2470964877,"EDDCFDBA-B3E7-4E3F-97CB-D017C9DC9EF7.bw","bca1057a-1e96-404d-8a37-5a8dc1944ee7","eddcfdba-b3e7-4e3f-97cb-d017c9dc9ef7","2016-08-09T14:13:48.859172-05:00","UNCID_2209574.90250b43-5a36-42c0-886f-32a0ed39bea6.110509_UNC6-RDR300211_00102_FC_634VYAAXX_5.tar.gz","bcabdde3-ad1e-440d-a987-f64bae75bc42",2250884999,"Illumina GA","b4244046fcf6d56bf4ef236ef4cfa588","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:56:49.399099-05:00","2016-05-03T11:15:06.073526-05:00","bcabdde3-ad1e-440d-a987-f64bae75bc42_analysis.xml","bc2763bfd554e802c891eb197f417a35","ca67338f-153d-4e4d-8f8b-30fe0ca668cd",2121,"2016-09-29T20:05:21.432448-05:00","bcabdde3-ad1e-440d-a987-f64bae75bc42_experiment.xml","54720bb4c227470ed9f06817492cc44a","605b4c11-060a-4339-a39a-ac8f104e9807",2257,"2016-09-29T21:44:43.784966-05:00","bcabdde3-ad1e-440d-a987-f64bae75bc42_run.xml","2e3be114942dc9d4006431f34aec8552","9dc0b6f2-ed95-4bfe-aa12-e8c26b9857c3",347,"2016-09-08T10:43:52.486550-05:00","TCGA-D1-A16B","2016-09-02T18:50:12.066866-05:00","female","TCGA-D1-A16B_demographic",1944,"white","75adb354-65dc-56e8-a9bb-d01ff7b9ec15","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16B_diagnosis","not reported",23450,"alive","8380/3",NA,1106,"8fc243ef-6ae1-505d-9afb-c0e9901a5020","c54.1",-23450,"TCGA-D1-A16B_treatment","ac7adcc2-9cb6-51c6-ac77-bd02d4346d48","01","false","TCGA-D1-A16B-01A",NA,"6a59ff6e-7cc6-4d46-8983-7d9e6a48cc19",FALSE,"1B9ED459-4046-4DD9-ABA5-E815A90601A3","Primary Tumor",NA,793,150,NA,1293062400,"11",30,"TCGA-D1-A16B-01A-11",70,NA,2,NA,0,NA,30,NA,"2016-09-08T10:43:52.486550-05:00",NA,2,NA,6,NA,"TOP",NA,5,NA,"fc500705-7f9a-4126-b7af-99e123de3042",NA,"TCGA-D1-A16B-01A-01-TSA",NA,65,NA,"2cce53e2-e1aa-49f8-960a-af1112950723","RNA","TCGA-D1-A16B-01A-11R","6c1f4d06-072a-438f-9e8d-b611ed3066ee",1.84,0.16,"UV Spec","R","23","TCGA-D1-A16B-01A-11R-A12I-07","90250b43-5a36-42c0-886f-32a0ed39bea6",0.16,NA,86,34.0176417072109,159,"600f37fc-9483-576a-bf64-05cef7be398e","TCGA-D1-A16B_exposure","UNCID_2209574.90250b43-5a36-42c0-886f-32a0ed39bea6.110509_UNC6-RDR300211_00102_FC_634VYAAXX_5.tar.gz","2013-10-01T09:46:07.000Z","2013-10-01T09:59:01.000Z","BCABDDE3-AD1E-440D-A987-F64BAE75BC42","6A59FF6E-7CC6-4D46-8983-7D9E6A48CC19","Unaligned reads",2250884999,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","90250B43-5A36-42C0-886F-32A0ED39BEA6","University of North Carolina","564a38e9e4b093830b687676","BCA1057A-1E96-404D-8A37-5A8DC1944EE7","Uterine Corpus Endometrial Carcinoma","TARGZ","2CCE53E2-E1AA-49F8-960A-AF1112950723","2013-10-01T09:59:01.000Z","6C1F4D06-072A-438F-9E8D-B611ED3066EE","None","NO",1,NA,"Primary Tumor","Mayo Clinic",793,"2CCE53E2-E1AA-49F8-960A-AF1112950723",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FAAC5466-A988-4DF3-8098-C4208C4D0453.txt",150,"TCGA-D1-A16B-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","AECBCF95-6D7A-401D-999E-D2169479D50B",64,"jhu-usc.edu_UCEC.HumanMethylation450.4.lvl-2.TCGA-D1-A16B-01A-11D-A12K-05.txt","Alive",NA,"TCGA-D1-A16B","NOT HISPANIC OR LATINO","8E35EB0A-E47B-4FBA-889B-A386E8E80C18",NA,744,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"FC500705-7F9A-4126-B7AF-99E123DE3042","A4737E83-23C1-4111-BD71-E3863E394420","TCGA-D1-A16B-01A-11D-A12J-09_IlluminaGA-DNASeq_exome.bam","TCGA-D1-A16B-01A-11",70,0,2,2,30,"TOP",5,6,"TCGA-D1-A16B-01A-01-TSA",65,NA,NA,NA,NA,NA,NA,NA,"NO",1106,"TUMOR FREE","Alive",NA,"TCGA-D1-A16B-F18508","TCGA-D1-A16B",1,"D1","A16B","YES","C54.1","8380/3","C54.1","NO","YES",-23450,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",744,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2008,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1995",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
23177225,22389759,1686863449,"575CE889-DD6F-43B0-BA1A-326A1DE34E37.bw","bd4284a7-260d-48b3-9b48-a1c578c30d27","575ce889-dd6f-43b0-ba1a-326a1de34e37","2016-08-09T14:19:16.234502-05:00","UNCID_2216443.2b64fee1-6e95-417d-b9b7-25bad9db4dc3.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_2.tar.gz","cf4a7b25-42a8-4e95-a1af-f9736e7a87e5",1450938930,"Illumina GA","5844e8cf6e04ad47b89449835a846991","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:45:49.703801-05:00","2016-05-03T11:18:47.010651-05:00","cf4a7b25-42a8-4e95-a1af-f9736e7a87e5_analysis.xml","b66c2cd86d18093bab39e13576cfcfb7","2eb788e4-8673-47e8-a3c0-10f5553c0002",2120,"2016-08-29T01:59:40.246858-05:00","cf4a7b25-42a8-4e95-a1af-f9736e7a87e5_experiment.xml","ad4c52db58e764526762ae922a982e09","2336d3e8-6a36-4384-8dc3-c766698698c3",2256,"2016-09-29T19:32:02.377264-05:00","cf4a7b25-42a8-4e95-a1af-f9736e7a87e5_run.xml","089592bddbd6374eccb2b51693e446c6","4be3a056-26f3-4fb7-a0bb-5d7890564806",345,"2016-09-08T10:38:13.251976-05:00","TCGA-AP-A052","2016-09-02T18:52:37.200443-05:00","female","TCGA-AP-A052_demographic",1945,"black or african american","85eec076-18a5-5b0e-a276-1c95815c60c8","not reported",2005,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A052_diagnosis","not reported",21721,"dead","8441/3",669,NA,"38131fdb-27ab-55c1-96eb-d8d1577b4764","c54.1",-21721,"TCGA-AP-A052_treatment","4c91f2d1-dbf7-58dd-95ca-6db6c735f694","01","true","TCGA-AP-A052-01A",NA,"33c21dca-f3b3-48cd-9fc5-ad316598f23e",FALSE,"830EF496-4672-4E9A-B662-DCB4678E99B0","Primary Tumor",NA,2211,500,NA,1275868800,"11",30,"TCGA-AP-A052-01A-11",85,90,1,1,0,0,15,20,"2016-09-08T10:38:13.251976-05:00","2016-09-08T10:38:13.251976-05:00",3,1,0,0,"TOP","BOTTOM",2,5,"8355f3c9-6aff-4f3b-8ac5-ab0684156bbe","e0d3e061-5fac-4c79-9cc7-d456b1f5933b","TCGA-AP-A052-01A-01-TSA","TCGA-AP-A052-01A-01-BSA",83,75,"6acc7044-e1f7-4d28-a785-70cb588e0112","RNA","TCGA-AP-A052-01A-11R","367368c4-c762-4d02-a7ee-b25d1fdd7dd5",1.76,0.15,"UV Spec","R","23","TCGA-AP-A052-01A-11R-A00V-07","2b64fee1-6e95-417d-b9b7-25bad9db4dc3",0.15,NA,126,46.2809917355372,165,"b8538893-9082-5a20-95b5-5eed462ec69d","TCGA-AP-A052_exposure","UNCID_2216443.2b64fee1-6e95-417d-b9b7-25bad9db4dc3.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_2.tar.gz","2013-10-04T08:25:04.000Z","2013-10-04T08:37:03.000Z","CF4A7B25-42A8-4E95-A1AF-F9736E7A87E5","33C21DCA-F3B3-48CD-9FC5-AD316598F23E","Unaligned reads",1450938930,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2B64FEE1-6E95-417D-B9B7-25BAD9DB4DC3","University of North Carolina","564a370be4b0ef1218190ca7","BD4284A7-260D-48B3-9B48-A1C578C30D27","Uterine Corpus Endometrial Carcinoma","TARGZ","6ACC7044-E1F7-4D28-A785-70CB588E0112","2013-10-04T08:37:03.000Z","367368C4-C762-4D02-A7EE-B25D1FDD7DD5","None","NO",1,NA,"Primary Tumor","MSKCC",2211,"6ACC7044-E1F7-4D28-A785-70CB588E0112",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.48950750-AF24-4930-A739-4D029A0D5B2D.txt",500,"TCGA-AP-A052-01A",NA,"C8F72A13-F527-4B75-BBD3-41DF2188EC10","TCGA",2004,NA,NA,"WITH TUMOR","BBE82112-697D-4494-9D9C-39C702C98759",59,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.48950750-AF24-4930-A739-4D029A0D5B2D.txt","Dead",669,"TCGA-AP-A052",NA,"7A26422D-AD5D-4F07-A0FF-44D22F4A72FE",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",49,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"E0D3E061-5FAC-4C79-9CC7-D456B1F5933B","36CB2A15-F297-4FA6-BEFF-CF24CE666AF9","TCGA-AP-A052-01A-11W-A027-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-AP-A052-01A-11",90,0,1,1,20,"BOTTOM",5,0,"TCGA-AP-A052-01A-01-BSA",75,"Paclitaxel","Chemotherapy","TCGA-AP-A052-D3396",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",669,"TCGA-AP-A052-F3393","TCGA-AP-A052",1,"AP","A052","YES","C54.1","8441/3","C54.1","NO","YES",-21721,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Dead",NA,669,NA,NA,"WITH TUMOR","NO",23,9,2010,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,59,2004,"Dilation and curettage procedure",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,NA,16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
108427956,100025740,4754875680,"A9177246-FC38-42BC-9C57-86F739D02309.bw","bee58be0-c2b0-4cdc-adf6-b99243da586a","a9177246-fc38-42bc-9c57-86f739d02309","2016-08-09T14:01:48.145150-05:00","UNCID_2160275.10a6bc01-f811-400f-a205-caf7879008fe.130621_UNC14-SN744_0352_BC253TACXX_4_TGACCA.tar.gz","24cec50a-6e75-475a-9d9b-8b77d06e92cc",4921345181,"Illumina HiSeq","747239ab68ef293a8548bf0247b3d8a3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:48:39.410749-05:00","2016-05-03T11:07:07.511815-05:00","24cec50a-6e75-475a-9d9b-8b77d06e92cc_analysis.xml","98c1138d772e62d5b58c522898e94726","a0358087-5105-4723-8727-d767e48974d1",2123,"2016-09-29T19:00:43.294188-05:00","24cec50a-6e75-475a-9d9b-8b77d06e92cc_experiment.xml","4f48511b3ec1bf90aba388f18bd3ed30","38085bd0-cf50-4711-a193-f9d8fa6a8fc0",2431,"2016-09-29T18:38:57.585386-05:00","24cec50a-6e75-475a-9d9b-8b77d06e92cc_run.xml","50ca2d0b0b342db0549b8d43e6e87f67","2a561cc0-5b2d-46ed-94d3-37b1cfb9d738",354,"2016-09-08T10:37:25.861077-05:00","TCGA-EY-A2ON","2016-09-02T18:54:21.217078-05:00","female","TCGA-EY-A2ON_demographic",1950,"black or african american","0f0b8383-5c08-5e28-93eb-571ce71c030e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A2ON_diagnosis","not reported",22624,"dead","8441/3",610,409,"c98972bf-f5fa-5a9e-9e88-1125fc8fb704","c54.1",-22624,"TCGA-EY-A2ON_treatment","ee98f21c-ff70-5cab-a7e2-4bca9e5979eb","01","false","TCGA-EY-A2ON-01A",NA,"d7090a2c-648a-43dc-a639-a78dfda2a0ec",FALSE,"AB1B272C-E1ED-4E7B-AAD2-F6B7E741E134","Primary Tumor",NA,80,650,NA,1314662400,"21",30,"TCGA-EY-A2ON-01A-21",80,NA,10,NA,0,NA,5,NA,"2016-09-08T10:37:25.861077-05:00",NA,40,NA,30,NA,"TOP",NA,15,NA,"636d15e8-e56e-4cb7-8e12-ad38efabbd32",NA,"TCGA-EY-A2ON-01A-02-TSB",NA,80,NA,"91012b27-cc2c-4fbc-9f61-4606734c636e","RNA","TCGA-EY-A2ON-01A-21R","a6fc0794-0b64-4970-afb6-9200bc86ee24",1.8,0.18,"UV Spec","R","23","TCGA-EY-A2ON-01A-21R-A18M-07","10a6bc01-f811-400f-a205-caf7879008fe",0.18,NA,100,36.7309458218549,165,"900e258e-3fe8-55c8-beb8-db3956070ca5","TCGA-EY-A2ON_exposure","UNCID_2160275.10a6bc01-f811-400f-a205-caf7879008fe.130621_UNC14-SN744_0352_BC253TACXX_4_TGACCA.tar.gz","2013-09-21T07:16:05.000Z","2013-09-21T07:31:01.000Z","24CEC50A-6E75-475A-9D9B-8B77D06E92CC","D7090A2C-648A-43DC-A639-A78DFDA2A0EC","Unaligned reads",4921345181,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","10A6BC01-F811-400F-A205-CAF7879008FE","University of North Carolina","56607879e4b0ec1099f8d4ed","BEE58BE0-C2B0-4CDC-ADF6-B99243DA586A","Uterine Corpus Endometrial Carcinoma","TARGZ","91012B27-CC2C-4FBC-9F61-4606734C636E","2013-09-21T07:31:01.000Z","A6FC0794-0B64-4970-AFB6-9200BC86EE24","United States","NO",1,NA,"Primary Tumor","University of North Carolina",80,"91012B27-CC2C-4FBC-9F61-4606734C636E",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D85F0679-8CFA-4EA3-B9DA-02CC32C4E01B.txt",650,"TCGA-EY-A2ON-01A",NA,"FC059943-BA02-4E02-B2C9-3A8222FB859F","TCGA",2011,NA,NA,"WITH TUMOR","F5E1C96E-EA17-4B35-9792-EE6556C23984",61,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D85F0679-8CFA-4EA3-B9DA-02CC32C4E01B.txt","Alive",NA,"TCGA-EY-A2ON","NOT HISPANIC OR LATINO","7BD4A821-7D36-445C-B5E1-A709FA11DF66",NA,171,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",178,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,21,30,"636D15E8-E56E-4CB7-8E12-AD38EFABBD32","A6FC0794-0B64-4970-AFB6-9200BC86EE24","TCGA-EY-A2ON-01A-01D-YYYY-23.txt","TCGA-EY-A2ON-01A-21",80,0,10,40,5,"TOP",15,30,"TCGA-EY-A2ON-01A-02-TSB",80,"Carboplatin","Chemotherapy","TCGA-EY-A2ON-D34166",NA,NA,NA,"TCGA-EY-A2ON-F44442_NTE-1",NA,NA,"WITH TUMOR","Dead",610,"TCGA-EY-A2ON-F44442","TCGA-EY-A2ON",1,"EY","A2ON","YES","C54.1","8441/3","C54.1","YES","NO",-22624,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",171,NA,NA,NA,"WITH TUMOR","NO",15,11,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,61,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36008736,35467003,2581412870,"5852071B-50C4-4016-B48C-3CC2E43EEF87.bw","bf632368-8ce7-4b4b-8842-d1b1801e62ef","5852071b-50c4-4016-b48c-3cc2e43eef87","2016-08-09T14:16:04.458245-05:00","UNCID_2215596.5e6246e7-35a3-4ce5-b234-b4dec034a6a8.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_5.tar.gz","7cc2e670-de33-4851-921b-7db713b9601a",2210644858,"Illumina GA","d226ad875e12ef9e4f3d13d911b3fcf2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:44:05.335194-05:00","2016-05-03T11:18:46.977159-05:00","7cc2e670-de33-4851-921b-7db713b9601a_analysis.xml","57826e18c22a0f8a3f0b0e6f0ac5a55f","07e00bbd-0ad8-449f-b496-5223baea916e",2122,"2016-10-07T15:56:14.335516-05:00","7cc2e670-de33-4851-921b-7db713b9601a_experiment.xml","e5a14e0f66adb49e63145552acabd6eb","c2d6f0fc-12c9-4348-a915-d4454f57e76e",2256,"2016-09-29T22:32:38.915303-05:00","7cc2e670-de33-4851-921b-7db713b9601a_run.xml","d27a3c3543e66f5722ab9d0e28062bb9","bb631cf5-3dd9-4119-a0d7-ee8e9fb4435e",345,"2016-09-08T10:30:13.320445-05:00","TCGA-AX-A05Z","2016-09-02T18:52:45.974660-05:00","female","TCGA-AX-A05Z_demographic",1969,"not reported","8a10a03b-4e16-529a-9ea8-d36aa532aad9","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A05Z_diagnosis","not reported",13529,"alive","8380/3",NA,2175,"ac0b991f-ff86-5331-a54d-5a8367993517","c54.1",-13529,"TCGA-AX-A05Z_treatment","5109d5e8-9ef2-5e9e-914e-287c53658681","01","false","TCGA-AX-A05Z-01A",NA,"acda9261-6c73-4b31-aab3-97a40eddb9bd",FALSE,"5938A010-17E7-41FB-9F4D-8B4F1A3C0F2F","Primary Tumor",NA,1416,180,NA,1275868800,"11",30,"TCGA-AX-A05Z-01A-11",80,80,0,0,0,0,10,10,"2016-09-08T10:30:13.320445-05:00","2016-09-08T10:30:13.320445-05:00",10,5,0,0,"TOP","BOTTOM",10,10,"ab503d7c-a2bf-4e96-82e1-71ef8e07b83e","2da68cb9-e919-4478-8d2b-b38fdfef8ac8","TCGA-AX-A05Z-01A-01-TS1","TCGA-AX-A05Z-01A-01-BS1",80,80,"d8640447-590d-4a31-ae1b-909adf87d6e7","RNA","TCGA-AX-A05Z-01A-11R","edc86c96-114c-4cde-b6c8-95478ce3ede8",1.78,0.15,"UV Spec","R","23","TCGA-AX-A05Z-01A-11R-A00V-07","5e6246e7-35a3-4ce5-b234-b4dec034a6a8",0.15,NA,66,29.3333333333333,150,"8fef4403-b6e9-527d-8549-997005b91b4d","TCGA-AX-A05Z_exposure","UNCID_2215596.5e6246e7-35a3-4ce5-b234-b4dec034a6a8.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_5.tar.gz","2013-10-04T03:37:04.000Z","2013-10-04T03:49:03.000Z","7CC2E670-DE33-4851-921B-7DB713B9601A","ACDA9261-6C73-4B31-AAB3-97A40EDDB9BD","Unaligned reads",2210644858,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","5E6246E7-35A3-4CE5-B234-B4DEC034A6A8","University of North Carolina","564a3ca5e4b09c884b24bd91","BF632368-8CE7-4B4B-8842-D1B1801E62EF","Uterine Corpus Endometrial Carcinoma","TARGZ","D8640447-590D-4A31-AE1B-909ADF87D6E7","2013-10-04T03:49:03.000Z","EDC86C96-114C-4CDE-B6C8-95478CE3EDE8","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1416,"D8640447-590D-4A31-AE1B-909ADF87D6E7",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5ADB0EFC-74E1-4C20-8516-88D70CB851A0.txt",180,"TCGA-AX-A05Z-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","E51E4F67-17CF-46AC-8180-DE2E2CF90734",37,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5ADB0EFC-74E1-4C20-8516-88D70CB851A0.txt","Alive",NA,"TCGA-AX-A05Z","HISPANIC OR LATINO","88C8022C-E1AC-4F6C-8F4E-B7F37B816953",NA,1413,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,NA,NA,11,30,"AB503D7C-A2BF-4E96-82E1-71EF8E07B83E","EDC86C96-114C-4CDE-B6C8-95478CE3EDE8","UNCID_1610496.5e6246e7-35a3-4ce5-b234-b4dec034a6a8.sorted_genome_alignments.bam.bai","TCGA-AX-A05Z-01A-11",80,0,0,10,10,"TOP",10,0,"TCGA-AX-A05Z-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,NA,1413,"TUMOR FREE","Alive",NA,"TCGA-AX-A05Z-F5560","TCGA-AX-A05Z",1,"AX","A05Z","YES","C54.1","8380/3","C54.1","NO","YES",-13529,"FEMALE",NA,"HISPANIC OR LATINO","No","No","Alive",1413,NA,NA,NA,"TUMOR FREE","NO",24,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,37,2006,"Office Endometrial Biopsy",NA,NA,NA,"G2","R1",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
32778320,31478566,2367660491,"8D4335F6-6ACB-4E38-B9F2-A2B5B647AE90.bw","bfac45a6-fa01-4edb-9807-6898ea82e80e","8d4335f6-6acb-4e38-b9f2-a2b5b647ae90","2016-08-09T14:15:07.041901-05:00","UNCID_2210169.f73e7e5b-239b-4ac9-861e-c8f42e68188e.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_5.tar.gz","ac3a4a2d-d273-41ef-a788-a49a4a098d7c",2085536230,"Illumina GA","a0c23b6f1f11dc377ebe848c5c6ffc0a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:50:32.071290-05:00","2016-05-03T11:15:47.407128-05:00","ac3a4a2d-d273-41ef-a788-a49a4a098d7c_analysis.xml","f67ba8b1c1cee72af6e410314dd9330e","5755ae88-4068-4071-b203-4b17c71e5789",2123,"2016-09-29T23:06:56.805200-05:00","ac3a4a2d-d273-41ef-a788-a49a4a098d7c_experiment.xml","b5fc206f7c14f3e4623129bc9bbc802c","d0b04474-90b8-42ae-bab4-2ca5524a1195",2257,"2016-09-29T20:45:18.486104-05:00","ac3a4a2d-d273-41ef-a788-a49a4a098d7c_run.xml","10f48b0839fda0f0b61c40a62b12dce1","78d5cf39-bf79-4194-b168-ce017e5c23c5",347,"2016-09-08T11:17:32.767428-05:00","TCGA-BG-A0MH","2016-09-02T18:49:37.604667-05:00","female","TCGA-BG-A0MH_demographic",1946,"white","b42bdb93-a0ce-5f19-9aba-f7c50bdd8f5e","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MH_diagnosis","not reported",22475,"alive","8380/3",NA,1930,"1c708c57-cbf9-589f-85c1-c9979ed11899","c54.1",-22475,"TCGA-BG-A0MH_treatment","f7509265-bfe3-5212-ab86-ea1e3f36b03b","01","true","TCGA-BG-A0MH-01A",NA,"8ad77275-6034-4d01-832f-d8bf3668e6bb",FALSE,"F641C526-7A0D-46C3-92EE-CD9CB0D13960","Primary Tumor",NA,1000,790,NA,1291334400,"11",30,"TCGA-BG-A0MH-01A-11",80,20,3,0,0,30,20,50,"2016-09-08T11:17:32.767428-05:00","2016-09-08T11:17:32.767428-05:00",2,20,8,20,"TOP","BOTTOM",2,20,"1d841b27-12f3-462c-96be-feeb72f4b477","312fdc18-104e-464f-9e32-043e43fb86b0","TCGA-BG-A0MH-01A-01-TSA","TCGA-BG-A0MH-01A-01-MSA",78,20,"d51efcd6-2f8a-417e-ac86-1907f5f14f45","RNA","TCGA-BG-A0MH-01A-11R","810dcff2-4428-4ba7-a1b0-3c12f9442956",1.85,0.13,"UV Spec","R","23","TCGA-BG-A0MH-01A-11R-A118-07","f73e7e5b-239b-4ac9-861e-c8f42e68188e",0.13,NA,136,57.345252150447,154,"a1b951b1-4c7f-55e8-9173-a3068b174deb","TCGA-BG-A0MH_exposure","UNCID_2210169.f73e7e5b-239b-4ac9-861e-c8f42e68188e.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_5.tar.gz","2013-10-02T06:55:03.000Z","2013-10-02T07:08:03.000Z","AC3A4A2D-D273-41EF-A788-A49A4A098D7C","8AD77275-6034-4D01-832F-D8BF3668E6BB","Unaligned reads",2085536230,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","F73E7E5B-239B-4AC9-861E-C8F42E68188E","University of North Carolina","56607b22e4b018727fea290a","BFAC45A6-FA01-4EDB-9807-6898EA82E80E","Uterine Corpus Endometrial Carcinoma","TARGZ","D51EFCD6-2F8A-417E-AC86-1907F5F14F45","2013-10-02T07:08:03.000Z","810DCFF2-4428-4BA7-A1B0-3C12F9442956","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",1000,"D51EFCD6-2F8A-417E-AC86-1907F5F14F45",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.61CC9B5C-C646-4D6C-92FF-CEC57CD68FB7.txt",790,"TCGA-BG-A0MH-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","9AB847BD-B108-4323-9E75-8698EA694018",61,"nationwidechildrens.org_clinical.TCGA-BG-A0MH.xml","Alive",NA,"TCGA-BG-A0MH",NA,"0CDEF11E-D0DB-461B-BAB6-E6A8F390E78E",NA,1341,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"529A0367-E35E-4197-BB75-5CC4BB5ECD4A","WHITE",NA,11,30,"312FDC18-104E-464F-9E32-043E43FB86B0","8A717CA9-EC98-40D6-A079-C02E9ADCD3C7","UNCID_194030.TCGA-BG-A0MH-01A-11R-A118-07.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX.5.trimmed.annotated.translated_to_genomic.bam","TCGA-BG-A0MH-01A-11",20,30,0,20,50,"BOTTOM",20,20,"TCGA-BG-A0MH-01A-01-MSA",20,NA,NA,NA,"TCGA-BG-A0MH-R56531","External","Primary Tumor Field","TCGA-BG-A0MH-F49548_NTE-1","NO",1930,"TUMOR FREE","Alive",NA,"TCGA-BG-A0MH-F49548","TCGA-BG-A0MH",1,"BG","A0MH","YES","C54.1","8380/3","C54.1","NO","YES",-22475,"FEMALE","WHITE",NA,"No","No","Alive",1341,NA,NA,NA,"TUMOR FREE","NO",8,9,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2007,"Office Endometrial Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
119821586,118760684,5672943196,"BBA00038-09B1-461D-9F8E-484890B0D130.bw","c0b684d1-b96c-4420-9285-172402b7b123","bba00038-09b1-461d-9f8e-484890b0d130","2016-08-09T14:00:00.243739-05:00","UNCID_2169071.25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd.130610_UNC14-SN744_0347_BD28NBACXX_5_AGTCAA.tar.gz","495c02e0-cffd-4c14-935e-4c548e5d02d4",5491698944,"Illumina HiSeq","f45e87ea384bdeb09b70175fff13c49b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:46:55.961300-05:00","2016-05-03T11:05:42.738267-05:00","495c02e0-cffd-4c14-935e-4c548e5d02d4_analysis.xml","3666ef310a05ea2e96b2a62b4aa9d585","79ce6bc7-bf54-4d69-b913-de4341f448c2",2123,"2016-09-29T18:28:22.847890-05:00","495c02e0-cffd-4c14-935e-4c548e5d02d4_experiment.xml","74b56b9bf89951e4d793aa7f8979d730","23ad6302-3b7c-4f37-b5fe-0e3ea87e9d32",2431,"2016-09-29T22:46:44.782790-05:00","495c02e0-cffd-4c14-935e-4c548e5d02d4_run.xml","3a4ce3528d768a70d3c9cf7666c0d7fb","c42e6606-219d-4a61-9578-c4a4e9928c64",354,"2016-09-08T11:07:56.408588-05:00","TCGA-AJ-A5DW","2016-09-02T18:49:59.107902-05:00","female","TCGA-AJ-A5DW_demographic",1956,"black or african american","e0c51d2e-2739-5a27-ad54-25d14c00f90a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A5DW_diagnosis","not reported",20711,"alive","8380/3",NA,390,"0f80c564-ea46-5654-a562-53c10686392d","c54.1",-20711,"TCGA-AJ-A5DW_treatment","d2bfeef2-549f-5886-ad2a-5761a5d1f908","01","false","TCGA-AJ-A5DW-01A",NA,"ae83512d-3739-4e4d-9f27-8b01e6400479",FALSE,"8B641F9B-ACF5-448B-9AC3-8C8E6B1F0724","Primary Tumor",NA,133,80,NA,1358208000,"11",30,"TCGA-AJ-A5DW-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:07:56.408588-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"d3be5fb2-efde-44da-8b73-8147588f0bde",NA,"TCGA-AJ-A5DW-01A-01-TS1",NA,100,NA,"9cc40a73-24f5-45e8-960e-8df749e0c3f9","RNA","TCGA-AJ-A5DW-01A-11R","649fc253-aae2-40f5-b91d-0accfbbc155c",1.89,0.18,"UV Spec","R","23","TCGA-AJ-A5DW-01A-11R-A27V-07","25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd",0.18,NA,109,39.0835096274517,167,"adc55366-0db9-55ca-a01f-b1cf55917a6d","TCGA-AJ-A5DW_exposure","UNCID_2169071.25b2c2d1-38b6-4fa7-ab1c-c2de3b6fb2fd.130610_UNC14-SN744_0347_BD28NBACXX_5_AGTCAA.tar.gz","2013-09-20T00:01:03.000Z","2013-09-20T00:17:02.000Z","495C02E0-CFFD-4C14-935E-4C548E5D02D4","AE83512D-3739-4E4D-9F27-8B01E6400479","Unaligned reads",5491698944,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","25B2C2D1-38B6-4FA7-AB1C-C2DE3B6FB2FD","University of North Carolina","56607acee4b018727fea277e","C0B684D1-B96C-4420-9285-172402B7B123","Uterine Corpus Endometrial Carcinoma","TARGZ","9CC40A73-24F5-45E8-960E-8DF749E0C3F9","2013-09-20T00:17:02.000Z","649FC253-AAE2-40F5-B91D-0ACCFBBC155C","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",133,"9CC40A73-24F5-45E8-960E-8DF749E0C3F9",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.D9A34298-570F-49D3-9252-7ECFA9059DB8.txt",80,"TCGA-AJ-A5DW-01A",NA,NA,"TCGA",2012,"TCGA-AJ-A5DW_NTE-1",NA,"TUMOR FREE","E44C3B16-DA69-4877-A3A1-EDB828251EE1",56,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.D9A34298-570F-49D3-9252-7ECFA9059DB8.txt","Alive",NA,"TCGA-AJ-A5DW","NOT HISPANIC OR LATINO","EA306C4B-1E81-45C4-9150-1D24F9EF2254","NO",71,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",289,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"D3BE5FB2-EFDE-44DA-8B73-8147588F0BDE","2978EB5D-B5CB-449E-B636-BCA3B46644AE","b3b339670c1817ed8425f8bdf8356041.bam","TCGA-AJ-A5DW-01A-11",80,0,0,2,0,"TOP",0,0,"TCGA-AJ-A5DW-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A5DW-F66007_NTE-1","NO",390,"TUMOR FREE","Alive",NA,"TCGA-AJ-A5DW-F66007","TCGA-AJ-A5DW",1,"AJ","A5DW","YES","C54.1","8380/3","C54.1","YES","NO",-20711,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",71,NA,NA,NA,"TUMOR FREE","YES",12,7,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2012,"Other method, specify:",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32753742,32135779,2408652644,"841E2203-5B7F-4306-BD38-4BD68E79F9C8.bw","c0db966b-1024-4ee3-899a-f12e3c71a42c","841e2203-5b7f-4306-bd38-4bd68e79f9c8","2016-08-09T14:15:33.202531-05:00","UNCID_2212073.f192adcd-d613-400e-9737-725083638ee4.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_7.tar.gz","1b027b48-45ad-478e-b818-e1d4f7244be7",1964356641,"Illumina GA","ee23d15ddeb59a863a26a9770c93dde3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:00:55.741309-05:00","2016-05-03T11:16:29.242391-05:00","1b027b48-45ad-478e-b818-e1d4f7244be7_analysis.xml","bf96e0bf24aaa4d868f5ff2f87d84632","ccc4620f-fffd-4c27-be5a-71b216ca8a22",2121,"2016-09-29T19:09:05.463330-05:00","1b027b48-45ad-478e-b818-e1d4f7244be7_experiment.xml","519317799f696d4cafb6d962d936a700","3d65fd44-6dfa-4b88-9c0c-d867062012e6",2257,"2016-09-29T22:48:52.583574-05:00","1b027b48-45ad-478e-b818-e1d4f7244be7_run.xml","ad3b119ad1fde4a62d8c8ee4995d3ecd","c57db197-1e7c-44be-920c-699a73ef6eda",347,"2016-09-08T11:27:53.632509-05:00","TCGA-B5-A11Y","2016-09-02T18:49:08.352509-05:00","female","TCGA-B5-A11Y_demographic",1951,"white","0ac0360f-5df5-52b5-a219-49f145a7e2ba","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11Y_diagnosis","not reported",21860,"alive","8382/3",NA,560,"f93b188b-6244-59fe-9580-e068f8f319dd","c54.1",-21860,"TCGA-B5-A11Y_treatment","beed18da-4b8e-51ce-af0a-eb8102903543","01","true","TCGA-B5-A11Y-01A",NA,"24ddff8e-237c-47a0-acde-ce602cd70739",FALSE,"4FA7876E-EF1B-4EBA-99F9-1D26099B2CA1","Primary Tumor",NA,244,580,NA,1290556800,"21",30,"TCGA-B5-A11Y-01A-21",70,75,0,0,0,0,0,0,"2016-09-08T11:27:53.632509-05:00","2016-09-08T11:27:53.632509-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"947a3803-7406-4234-ba7c-ca6a17a2d6de","3fa72e73-ebf0-43f3-8673-5fddc1fa8855","TCGA-B5-A11Y-01A-02-BSB","TCGA-B5-A11Y-01A-02-TSB",100,100,"7ce830c4-8738-4f44-98bc-86d6cc5e9762","RNA","TCGA-B5-A11Y-01A-21R","1f402838-540c-4bb1-9164-af68a76823e5",1.8,0.16,"UV Spec","R","23","TCGA-B5-A11Y-01A-21R-A10J-07","f192adcd-d613-400e-9737-725083638ee4",0.16,NA,63,24.0054869684499,162,"dee837c1-5a9a-5b76-be3b-8c5da8965adf","TCGA-B5-A11Y_exposure","UNCID_2212073.f192adcd-d613-400e-9737-725083638ee4.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_7.tar.gz","2013-10-03T05:16:04.000Z","2013-10-03T05:28:02.000Z","1B027B48-45AD-478E-B818-E1D4F7244BE7","24DDFF8E-237C-47A0-ACDE-CE602CD70739","Unaligned reads",1964356641,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","F192ADCD-D613-400E-9737-725083638EE4","University of North Carolina","564a3686e4b093830b67b5c2","C0DB966B-1024-4EE3-899A-F12E3C71A42C","Uterine Corpus Endometrial Carcinoma","TARGZ","7CE830C4-8738-4F44-98BC-86D6CC5E9762","2013-10-03T05:28:02.000Z","1F402838-540C-4BB1-9164-AF68A76823E5","United States","NO",1,NA,"Primary Tumor","Duke",244,"7CE830C4-8738-4F44-98BC-86D6CC5E9762",NA,"B5","unc.edu.f192adcd-d613-400e-9737-725083638ee4.1646525.junction_quantification.txt",580,"TCGA-B5-A11Y-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","BEA62E5A-500C-403A-BF74-383D20D33908",59,"DEBUT_p_TCGAb45_81_wRedosSNP_N_GenomeWideSNP_6_A03_729518.birdseed.data.txt","Alive",NA,"TCGA-B5-A11Y",NA,"5795D1FE-9983-4C05-B8BA-339D8ED5BCE3",NA,315,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8382/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,21,30,"947A3803-7406-4234-BA7C-CA6A17A2D6DE","E671F431-E7D9-4F90-8E63-0CBD88C152CE","UNCID_344728.TCGA-B5-A11Y-01A-21R-A10J-07.110302_UNC1-RDR301647_00045_FC_62J5FAAXX.7.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-B5-A11Y-01A-21",75,0,0,0,0,"TOP",0,0,"TCGA-B5-A11Y-01A-02-TSB",100,NA,NA,NA,NA,NA,NA,NA,"NO",560,"TUMOR FREE","Alive",NA,"TCGA-B5-A11Y-F17795","TCGA-B5-A11Y",1,"B5","A11Y","YES","C54.1","8382/3","C54.1","NO","YES",-21860,"FEMALE","WHITE",NA,"No","No","Alive",315,NA,NA,NA,"TUMOR FREE","NO",11,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32865398,32129561,2406428965,"D181D0D8-FD8C-4259-9B34-97224CF27E1B.bw","c10b2885-70ea-4d32-bc48-8b85530df702","d181d0d8-fd8c-4259-9b34-97224cf27e1b","2016-08-09T14:09:02.301333-05:00","UNCID_2206483.7348f1f9-8bcf-41e2-bcb0-743823cac926.110921_UNC6-RDR300211_00125_FC_634F4AAXX_6.tar.gz","dc6cfa31-4b89-4a16-b1a0-8600f7b1a79f",2121363800,"Illumina GA","44bd96efd92f79497c552d866a61a5de","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:48:41.825561-05:00","2016-05-03T11:11:34.765256-05:00","dc6cfa31-4b89-4a16-b1a0-8600f7b1a79f_analysis.xml","52c06eaecfae1d0ec5b1e42f255b6689","308a7499-64ac-40ef-ae28-0dc4e0ef48f0",2121,"2016-09-29T18:22:59.567814-05:00","dc6cfa31-4b89-4a16-b1a0-8600f7b1a79f_experiment.xml","ca378f58833bef92bfe6f4e530a220e5","203dc684-2155-412d-85d1-185537ce711e",2257,"2016-09-29T19:02:35.597577-05:00","dc6cfa31-4b89-4a16-b1a0-8600f7b1a79f_run.xml","298f7914a49d18206d78acef2a53a3a2","394efbfa-5558-405d-8c0c-52d841c2dd74",347,"2016-09-08T11:13:21.760840-05:00","TCGA-EY-A1GS","2016-09-02T18:51:59.427063-05:00","female","TCGA-EY-A1GS_demographic",1939,"black or african american","d4070e0f-bae1-5bbc-920e-4c67a15f4736","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GS_diagnosis","not reported",26012,"dead","8441/3",670,459,"884471a7-e889-56f7-a090-97fcb66320df","c54.1",-26012,"TCGA-EY-A1GS_treatment","a7576901-6053-541e-b0b6-b53150db5aa8","01","false","TCGA-EY-A1GS-01A",NA,"99540910-61a1-434b-9937-216dfac5f719",FALSE,"3F953015-45DC-4678-A8B3-DC55339DE717","Primary Tumor",NA,211,270,NA,1297728000,"11",30,"TCGA-EY-A1GS-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:13:21.760840-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"89f78eaa-1840-432a-a384-53efc4e21889",NA,"TCGA-EY-A1GS-01A-01-TSA",NA,80,NA,"d52fffaa-5c45-4a46-a1e2-d6f68bfabcfc","RNA","TCGA-EY-A1GS-01A-11R","ef6ba5c4-6376-4c27-ba92-379df193e68c",1.98,0.15,"UV Spec","R","23","TCGA-EY-A1GS-01A-11R-A13S-07","7348f1f9-8bcf-41e2-bcb0-743823cac926",0.15,NA,62,23.9188302920412,161,"e352b332-b45f-58b2-a355-4343af2f0585","TCGA-EY-A1GS_exposure","UNCID_2206483.7348f1f9-8bcf-41e2-bcb0-743823cac926.110921_UNC6-RDR300211_00125_FC_634F4AAXX_6.tar.gz","2013-09-27T03:46:06.000Z","2013-09-27T04:05:02.000Z","DC6CFA31-4B89-4A16-B1A0-8600F7B1A79F","99540910-61A1-434B-9937-216DFAC5F719","Unaligned reads",2121363800,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7348F1F9-8BCF-41E2-BCB0-743823CAC926","University of North Carolina","564a3927e4b093830b688b40","C10B2885-70EA-4D32-BC48-8B85530DF702","Uterine Corpus Endometrial Carcinoma","TARGZ","D52FFFAA-5C45-4A46-A1E2-D6F68BFABCFC","2013-09-27T04:05:02.000Z","EF6BA5C4-6376-4C27-BA92-379DF193E68C","United States","NO",1,NA,"Primary Tumor","University of North Carolina",211,"D52FFFAA-5C45-4A46-A1E2-D6F68BFABCFC",NA,"EY","TCGA-EY-A1GS-01A-11R-A13R-13_mirna.bam.bai",270,"TCGA-EY-A1GS-01A",NA,"7F532712-D88D-4245-82A5-26D24B6A4155","TCGA",2010,NA,NA,"WITH TUMOR","D9A0C0DB-DAEB-484B-822F-CE9686094054",71,"nationwidechildrens.org_clinical.TCGA-EY-A1GS.xml","Alive",NA,"TCGA-EY-A1GS","NOT HISPANIC OR LATINO","59532F7E-F00E-4F32-8B32-AF9C917D6B0C",NA,284,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",110,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"89F78EAA-1840-432A-A384-53EFC4E21889","EF6BA5C4-6376-4C27-BA92-379DF193E68C","TCGA-EY-A1GS-01A-11R-A13R-13_mirna.bam.bai","TCGA-EY-A1GS-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-EY-A1GS-01A-01-TSA",80,"Megace","Hormone Therapy","TCGA-EY-A1GS-D12000",NA,NA,NA,"TCGA-EY-A1GS-F70247_NTE-1","NO",NA,"WITH TUMOR","Dead",670,"TCGA-EY-A1GS-F70247","TCGA-EY-A1GS",1,"EY","A1GS","YES","C54.1","8441/3","C54.1","YES","NO",-26012,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",284,NA,NA,NA,"WITH TUMOR","NO",19,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,71,2010,"Tumor resection",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
173457468,170172532,8114209804,"9A281EDE-FF96-4E66-AEF4-692BDFA8E99D.bw","c1f1dc90-2c67-4862-9e5f-078b861ffc6e","9a281ede-ff96-4e66-aef4-692bdfa8e99d","2016-08-25T18:13:49.972861-05:00","UNCID_2316551.55477806-1928-4281-8ee4-69da5b60c6a8.130909_UNC15-SN850_0326_AC2BWBACXX_2_GTGGCC.tar.gz","54ff52d7-5224-4e22-a596-0ffae294ac84",7845263092,"Illumina HiSeq","adb292e981fddeb0cae35790e38ec502","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:21:17.780324-05:00","2016-05-03T11:28:50.207865-05:00","54ff52d7-5224-4e22-a596-0ffae294ac84_analysis.xml","94e2eae25e37eb7878f555f8b3dc086a","feccd55e-994a-4285-b140-491441e9eda2",2124,"2016-08-13T06:48:50.991152-05:00","54ff52d7-5224-4e22-a596-0ffae294ac84_experiment.xml","f0ac1264f011d8864c1fdaa380bb49a6","0fe3b827-be94-47e9-a91d-90c898be1994",2628,"2016-09-29T23:55:52.817481-05:00","54ff52d7-5224-4e22-a596-0ffae294ac84_run.xml","49a565313f9be82f3a4379077144e438","ef23a6f0-1da6-4200-99d3-b827be034a6a",354,"2016-09-08T11:21:02.729629-05:00","TCGA-SL-A6J9","2016-09-02T18:51:27.072432-05:00","female","TCGA-SL-A6J9_demographic",1940,"black or african american","3171801b-ead8-54fc-a7b9-481100dfe39d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","SL","54704c4f-95dd-5a29-a680-878bb1a36612","St. Joseph's Hospital AZ","not reported","c54.1","TCGA-SL-A6J9_diagnosis","not reported",26701,"alive","8380/3",NA,2,"41c082af-250a-57a1-bdf3-11be4f195d17","c54.1",-26701,"TCGA-SL-A6J9_treatment","dc003f42-69b7-5ac8-bdd4-931f31c0559f","01","true","TCGA-SL-A6J9-01A",NA,"8a93e942-ee48-421a-a696-2b367c6c3867",FALSE,"DFD43EFD-E91F-487F-A737-93C57C065A49","Primary Tumor",NA,86,280,NA,1372636800,"11",30,"TCGA-SL-A6J9-01A-11",90,NA,5,NA,0,NA,10,NA,"2016-09-08T11:21:02.729629-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"45f298fc-0e92-439f-82f3-4c45f7ddccaf",NA,"TCGA-SL-A6J9-01A-01-TS1",NA,90,NA,"646a3099-adc7-4fe5-a0d6-193e9fbdc799","RNA","TCGA-SL-A6J9-01A-11R","977ca27f-e44b-4d1d-ac66-74e63608f6bd",1.96,0.17,"UV Spec","R","23","TCGA-SL-A6J9-01A-11R-A31O-07","55477806-1928-4281-8ee4-69da5b60c6a8",0.17,NA,88,31.5536591487683,167,"bb3cc5e5-c20c-509b-b802-18938fe25163","TCGA-SL-A6J9_exposure","UNCID_2316551.55477806-1928-4281-8ee4-69da5b60c6a8.130909_UNC15-SN850_0326_AC2BWBACXX_2_GTGGCC.tar.gz","2014-01-07T02:24:13.000Z","2014-01-07T02:56:02.000Z","54FF52D7-5224-4E22-A596-0FFAE294AC84","8A93E942-EE48-421A-A696-2B367C6C3867","Unaligned reads",7845263092,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","55477806-1928-4281-8EE4-69DA5B60C6A8","University of North Carolina","56607ed6e4b018727fea38a7","C1F1DC90-2C67-4862-9E5F-078B861FFC6E","Uterine Corpus Endometrial Carcinoma","TARGZ","646A3099-ADC7-4FE5-A0D6-193E9FBDC799","2014-01-07T02:56:02.000Z","977CA27F-E44B-4D1D-AC66-74E63608F6BD","United States","NO",1,NA,"Primary Tumor","St. Joseph's Hospital AZ",86,"646A3099-ADC7-4FE5-A0D6-193E9FBDC799",NA,"SL","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D703CF4D-5D96-4B15-8944-2EDD5BECA5A0.txt",280,"TCGA-SL-A6J9-01A",NA,NA,"TCGA",2013,"TCGA-SL-A6J9_NTE-1",NA,NA,"D5D72D40-7E20-4891-A0F1-AC34B22E7F6A",73,"nationwidechildrens.org_clinical.TCGA-SL-A6J9.xml","Alive",NA,"TCGA-SL-A6J9","NOT HISPANIC OR LATINO","73C6928E-4431-4651-9C6D-DD4717FAA06C",NA,2,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",324,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"45F298FC-0E92-439F-82F3-4C45F7DDCCAF","6BB68C0A-D811-4D2B-842B-8B8F61437B04","1c8c1bbe7ef84338608f418d2f266991.bam.bai","TCGA-SL-A6J9-01A-11",90,0,5,0,10,"TOP",0,0,"TCGA-SL-A6J9-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-SL-A6J9-F68332_NTE-1",NA,2,NA,"Alive",NA,"TCGA-SL-A6J9-F68332","TCGA-SL-A6J9",1,"SL","A6J9","YES","C54.1","8380/3","C54.1","NO","YES",-26701,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",2,NA,NA,NA,NA,"NO",12,11,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2013,"Tumor resection",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33723209,32444358,2429752545,"2DF22867-7FDF-4066-8CC8-2E6706BB0BEA.bw","c306d7e8-5486-41d3-84dd-9311ce3e2069","2df22867-7fdf-4066-8cc8-2e6706bb0bea","2016-08-09T14:16:11.895656-05:00","UNCID_2210925.2bb7d230-0982-4ce5-908a-a04064cb7665.110316_UNC2-RDR300275_00058_FC_62J26AAXX_3.tar.gz","177553b3-6999-49aa-a05c-f49380892b62",2140227440,"Illumina GA","35ab018f5a55c4943055cf9a50b8dcf8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:04:59.612307-05:00","2016-05-03T11:16:29.236069-05:00","177553b3-6999-49aa-a05c-f49380892b62_analysis.xml","6298eb8cc60393a176a3cb9903c0ada6","15294244-b5d1-41cd-a3f5-ad4fe1f0ad02",2121,"2016-09-29T22:58:02.023200-05:00","177553b3-6999-49aa-a05c-f49380892b62_experiment.xml","df62c01f71062a4956b01ca015328a94","cb1bde26-fa06-4ca2-a7ca-272d5ffab85f",2257,"2016-09-29T22:14:00.465462-05:00","177553b3-6999-49aa-a05c-f49380892b62_run.xml","7f9c0d90a607d545c62b248188d55bca","afe3aa32-7101-4e43-ae0f-4a7dccf6cf95",347,"2016-09-08T10:27:45.921282-05:00","TCGA-BS-A0U5","2016-09-02T18:49:02.612914-05:00","female","TCGA-BS-A0U5_demographic",1927,"white","ba99ed39-a94d-592d-ac4a-1ad8c93ba4d6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0U5_diagnosis","not reported",27945,"alive","8380/3",NA,2935,"1500a430-392c-5459-bbb2-de07e77900cb","c54.1",-27945,"TCGA-BS-A0U5_treatment","c8a1090d-555b-5b20-8083-3467e950f28d","01","false","TCGA-BS-A0U5-01A",NA,"48a5e048-b35d-4207-b45b-e72ac51e041d",FALSE,"8024498D-449C-45C6-B57D-846DDBA3FF30","Primary Tumor",NA,2525,110,NA,1286841600,"11",30,"TCGA-BS-A0U5-01A-11",80,70,0,40,0,0,10,30,"2016-09-08T10:27:45.921282-05:00","2016-09-08T10:27:45.921282-05:00",0,30,0,20,"TOP","BOTTOM",0,0,"57d20a48-afb8-4130-a4a2-351c51729c26","dece34dc-5192-4142-968e-06be2bde0faf","TCGA-BS-A0U5-01A-01-MS1","TCGA-BS-A0U5-01A-01-BS1",90,70,"6a17ee30-84ce-457c-97d4-6adc8bcbc86c","RNA","TCGA-BS-A0U5-01A-11R","150721ea-0b2f-45e8-92d5-52190be5047d",1.84,0.16,"UV Spec","R","23","TCGA-BS-A0U5-01A-11R-A109-07","2bb7d230-0982-4ce5-908a-a04064cb7665",0.16,NA,59,21.6712580348944,165,"e78cd5cb-a45c-56b9-b63b-a59c84358444","TCGA-BS-A0U5_exposure","UNCID_2210925.2bb7d230-0982-4ce5-908a-a04064cb7665.110316_UNC2-RDR300275_00058_FC_62J26AAXX_3.tar.gz","2013-10-02T18:31:04.000Z","2013-10-02T18:43:03.000Z","177553B3-6999-49AA-A05C-F49380892B62","48A5E048-B35D-4207-B45B-E72AC51E041D","Unaligned reads",2140227440,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2BB7D230-0982-4CE5-908A-A04064CB7665","University of North Carolina","564a3c35e4b093830b698659","C306D7E8-5486-41D3-84DD-9311CE3E2069","Uterine Corpus Endometrial Carcinoma","TARGZ","6A17EE30-84CE-457C-97D4-6ADC8BCBC86C","2013-10-02T18:43:03.000Z","150721EA-0B2F-45E8-92D5-52190BE5047D","None","NO",1,NA,"Primary Tumor","University of Hawaii",2525,"6A17EE30-84CE-457C-97D4-6ADC8BCBC86C",NA,"BS","UNCID_634948.TCGA-BS-A0U5-01A-11R-A109-07.110316_UNC2-RDR300275_00058_FC_62J26AAXX.3.trimmed.annotated.translated_to_genomic.exon.quantification.txt",110,"TCGA-BS-A0U5-01A",NA,NA,"TCGA",2003,NA,NA,"TUMOR FREE","A9B9C958-A34D-457C-89C5-5AA96E8E0D3D",76,"nationwidechildrens.org_clinical.TCGA-BS-A0U5.xml","Alive",NA,"TCGA-BS-A0U5","NOT HISPANIC OR LATINO","9FD12112-A5A5-46B3-AF1A-5D02B00B3D89",NA,2204,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",75,NA,NA,"WHITE",NA,11,30,"DECE34DC-5192-4142-968E-06BE2BDE0FAF","F84C332A-9790-45B5-8CDE-FA5EE54845C9","TCGA-BS-A0U5-01A-11R-A108-13_mirna.bam","TCGA-BS-A0U5-01A-11",70,0,40,30,30,"BOTTOM",0,20,"TCGA-BS-A0U5-01A-01-BS1",70,NA,NA,NA,NA,NA,NA,NA,"NO",2935,"TUMOR FREE","Alive",NA,"TCGA-BS-A0U5-F16697","TCGA-BS-A0U5",1,"BS","A0U5","YES","C54.1","8380/3","C54.1","NO","YES",-27945,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2204,NA,NA,NA,"TUMOR FREE","NO",25,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,76,2003,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
109143790,106498927,5067241225,"329665BC-B959-47C5-B831-5546F94EDAC1.bw","c3096984-bd11-44a0-8ee0-47f07ad04d81","329665bc-b959-47c5-b831-5546f94edac1","2016-08-25T13:40:22.262597-05:00","UNCID_2316527.ef76bd16-f313-4d92-8040-44e7068958a7.131016_UNC15-SN850_0333_AC2MBAACXX_5_TAGCTT.tar.gz","e6d54a74-1ccf-4de0-8e6f-ea9a30b27938",4910087245,"Illumina HiSeq","4629e7a8c6b2ec4487623e1ed97d6f10","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:53:33.697370-05:00","2016-05-03T11:34:55.533546-05:00","e6d54a74-1ccf-4de0-8e6f-ea9a30b27938_analysis.xml","c8a0b2d7728de8a050322d2a0cb91df1","a352ecde-77e5-4a1c-ab6e-ae12c9d9e58e",2124,"2016-08-30T04:00:54.825970-05:00","e6d54a74-1ccf-4de0-8e6f-ea9a30b27938_experiment.xml","2d85a7749b3f4d241008685ca891e72d","03a9efa7-cdba-48c6-99d3-29af9838d289",2628,"2016-09-29T22:52:56.083187-05:00","e6d54a74-1ccf-4de0-8e6f-ea9a30b27938_run.xml","8ee907789ab7c362ec478de15afc9520","c80c7277-7553-4e31-95a5-5ca63a59dc06",354,"2016-09-08T10:34:56.555995-05:00","TCGA-A5-A2K3","2016-09-02T18:53:11.472150-05:00","female","TCGA-A5-A2K3_demographic",1939,"white","018043c6-bd82-5183-8d98-7b422d6d321c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A2K3_diagnosis","not reported",24907,"alive","8441/3",NA,2012,"18dc7277-755f-57f0-adad-d98b47ecb6d1","c54.1",-24907,"TCGA-A5-A2K3_treatment","3accfced-92be-5249-8170-f255470aad79","01","true","TCGA-A5-A2K3-01A",NA,"b6e6722f-cefe-4eb7-8545-94383659db9a",FALSE,"D38D2FD4-78EF-4F49-976E-529055A6D9A9","Primary Tumor",NA,1431,120,NA,1312848000,"11",30,"TCGA-A5-A2K3-01A-11",85,NA,1,NA,0,NA,5,NA,"2016-09-08T10:34:56.555995-05:00",NA,3,NA,0,NA,"TOP",NA,5,NA,"3955dfaf-9ccf-4946-b662-bfbb11f7089d",NA,"TCGA-A5-A2K3-01A-01-TSA",NA,90,NA,"f1fe2759-7cc4-494e-8b91-546f78e42f74","RNA","TCGA-A5-A2K3-01A-11R","dd3794f2-4bea-49de-8286-86760c291d2c",1.79,0.17,"UV Spec","R","23","TCGA-A5-A2K3-01A-11R-A32Y-07","ef76bd16-f313-4d92-8040-44e7068958a7",0.17,NA,80,31.25,160,"d7b1c567-84eb-57ac-ba1d-fc5be9dc4c1e","TCGA-A5-A2K3_exposure","UNCID_2316527.ef76bd16-f313-4d92-8040-44e7068958a7.131016_UNC15-SN850_0333_AC2MBAACXX_5_TAGCTT.tar.gz","2014-01-26T19:07:04.000Z","2014-01-26T08:37:01.000Z","E6D54A74-1CCF-4DE0-8E6F-EA9A30B27938","B6E6722F-CEFE-4EB7-8545-94383659DB9A","Unaligned reads",4910087245,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","EF76BD16-F313-4D92-8040-44E7068958A7","University of North Carolina","564a410ce4b093830b6b1663","C3096984-BD11-44A0-8EE0-47F07AD04D81","Uterine Corpus Endometrial Carcinoma","TARGZ","F1FE2759-7CC4-494E-8B91-546F78E42F74","2014-01-26T08:37:01.000Z","DD3794F2-4BEA-49DE-8286-86760C291D2C","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",1431,"F1FE2759-7CC4-494E-8B91-546F78E42F74",NA,"A5","WHIRR_p_TCGA_168_169_170_redo_N_GenomeWideSNP_6_D11_845102.tangent.copynumber.data.txt",120,"TCGA-A5-A2K3-01A",NA,"85B34B9C-7511-4D6B-A1D7-E86CA3D8AD29","TCGA",2007,NA,NA,"TUMOR FREE","B6E6722F-CEFE-4EB7-8545-94383659DB9A",68,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5DC692F2-49FA-4E7A-95C8-81D47EE698F1.txt","Alive",NA,"TCGA-A5-A2K3","NOT HISPANIC OR LATINO","7E0714DD-B087-437F-AA22-1CA875AF0A4A",NA,1409,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",168,NA,NA,"WHITE",NA,11,30,"3955DFAF-9CCF-4946-B662-BFBB11F7089D","DD3794F2-4BEA-49DE-8286-86760C291D2C","13cae68292518cedd65049465123631a.bam","TCGA-A5-A2K3-01A-11",85,0,1,3,5,"TOP",5,0,"TCGA-A5-A2K3-01A-01-TSA",90,"Taxol","Chemotherapy","TCGA-A5-A2K3-D17200",NA,NA,NA,"TCGA-A5-A2K3-F51572_NTE-1","NO",2012,"TUMOR FREE","Alive",NA,"TCGA-A5-A2K3-F51572","TCGA-A5-A2K3",1,"A5","A2K3","YES","C54.1","8441/3","C54.1","NO","YES",-24907,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1409,NA,NA,NA,"TUMOR FREE","NO",4,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,68,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
14932148,13995111,1051268591,"726497B7-C557-4D5C-A926-6DDA6136C899.bw","c350b53b-3c27-4b9e-8b57-d7b6a1205a1f","726497b7-c557-4d5c-a926-6dda6136c899","2016-08-09T14:18:10.337927-05:00","UNCID_2216349.02528092-3a7a-4ddf-8801-e47a48fdeafe.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_5.tar.gz","d3af5e60-871d-4838-9df4-0498c32fd5c0",880415887,"Illumina GA","dc55e814e3c415ec11a93f4dc38b45e8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:04:51.710533-05:00","2016-05-03T11:18:47.010651-05:00","d3af5e60-871d-4838-9df4-0498c32fd5c0_analysis.xml","8ccf68c01b506c42b6be964c98752ae9","aa5cbdda-1d79-4859-9a4c-508b89e739f9",2120,"2016-09-29T23:31:54.707771-05:00","d3af5e60-871d-4838-9df4-0498c32fd5c0_experiment.xml","dbd04299f4d70306fcb7cee989d738cf","e03ce354-0af6-4bd3-858c-f82a63242142",2256,"2016-09-30T00:19:10.835706-05:00","d3af5e60-871d-4838-9df4-0498c32fd5c0_run.xml","81370772d10515252aee828e95250144","fd6e1e7a-0203-4c29-87f7-5374ecef7839",345,"2016-09-08T12:14:11.159826-05:00","TCGA-AP-A05A","2016-09-02T18:52:38.947262-05:00","female","TCGA-AP-A05A_demographic",1925,"white","e2c969a6-33f1-5950-af29-6b93725ec9c0","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A05A_diagnosis","not reported",29914,"dead","8441/3",1944,1199,"96c1048b-6aae-5406-9ec5-44b1e2b5807b","c54.1",-29914,"TCGA-AP-A05A_treatment","2ef259b3-b982-5425-9c29-aed7393b1800","01","true","TCGA-AP-A05A-01A",NA,"482153fb-e69d-4748-9cf4-e281ec141518",FALSE,"1DAE9968-7D20-45A9-B2BC-5F32F6EC7A08","Primary Tumor",NA,1479,260,NA,1275868800,"11",30,"TCGA-AP-A05A-01A-11",90,96,0,0,10,0,5,5,"2016-09-08T12:14:11.159826-05:00","2016-09-08T12:14:11.159826-05:00",2,0,0,0,"BOTTOM","TOP",3,2,"4f7e22ff-a721-45dd-bc3a-ebd416ad6349","4fbf18dc-8d25-4cd6-af8c-8447642d1d0c","TCGA-AP-A05A-01A-01-BSA","TCGA-AP-A05A-01A-01-TSA",82,93,"5620503a-d61f-482b-859f-72adb0085101","RNA","TCGA-AP-A05A-01A-11R","1ac07cb7-088c-4366-baf7-4c08657d2c97",1.75,0.16,"UV Spec","R","23","TCGA-AP-A05A-01A-11R-A00V-07","02528092-3a7a-4ddf-8801-e47a48fdeafe",0.16,NA,NA,NA,NA,"13477ffa-4243-5520-a3df-b488c413436a","TCGA-AP-A05A_exposure","UNCID_2216349.02528092-3a7a-4ddf-8801-e47a48fdeafe.100903_UNC3-RDR300156_00028_FC_62ELKAAXX_5.tar.gz","2013-10-04T08:07:04.000Z","2013-10-04T08:19:03.000Z","D3AF5E60-871D-4838-9DF4-0498C32FD5C0","482153FB-E69D-4748-9CF4-E281EC141518","Unaligned reads",880415887,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","02528092-3A7A-4DDF-8801-E47A48FDEAFE","University of North Carolina","564a3e33e4b0298dd2c94ced","C350B53B-3C27-4B9E-8B57-D7B6A1205A1F","Uterine Corpus Endometrial Carcinoma","TARGZ","5620503A-D61F-482B-859F-72ADB0085101","2013-10-04T08:19:03.000Z","1AC07CB7-088C-4366-BAF7-4C08657D2C97","None","NO",1,NA,"Primary Tumor","MSKCC",1479,"5620503A-D61F-482B-859F-72ADB0085101",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.4DB12D27-16C1-4BE7-B060-977F3F5CAA30.txt",260,"TCGA-AP-A05A-01A",NA,"8F102C10-660C-4AE2-B4B1-7B42079DC933","TCGA",2006,NA,NA,"TUMOR FREE","482153FB-E69D-4748-9CF4-E281EC141518",81,"nationwidechildrens.org_clinical.TCGA-AP-A05A.xml","Alive",NA,"TCGA-AP-A05A",NA,"D1F8F390-4792-4675-A812-4097528444BD",NA,1199,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",49,NA,"1911ED43-2E93-4B50-B1E7-C0F9EF75B169","WHITE",NA,11,30,"4FBF18DC-8D25-4CD6-AF8C-8447642D1D0C","87282BD0-0316-4C5D-95B1-CA0E2CE9B8C7","0efe658adac35f9288ebc6e59891a34b.bam.bai","TCGA-AP-A05A-01A-11",90,10,0,2,5,"BOTTOM",3,0,"TCGA-AP-A05A-01A-01-BSA",82,"Anastrozole","Hormone Therapy","TCGA-AP-A05A-D3429","TCGA-AP-A05A-R3433","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"NO",NA,"TUMOR FREE","Dead",1944,"TCGA-AP-A05A-F29051","TCGA-AP-A05A",1,"AP","A05A","YES","C54.1","8441/3","C54.1","NO","YES",-29914,"FEMALE","WHITE",NA,"No","No","Alive",1199,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,81,2006,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
100814778,98575462,4678376469,"21FB1823-0E28-4F50-8546-D0F0847B1733.bw","c4f8f33f-a07c-4dfb-be24-c52d577bd640","21fb1823-0e28-4f50-8546-d0f0847b1733","2016-08-09T14:18:52.320239-05:00","UNCID_2234463.586c18a6-7278-4200-9d64-20b2c7ccbc60.130619_UNC13-SN749_0277_BC293YACXX_1_CGATGT.tar.gz","070c6f85-0e1f-433a-81fc-44f7f259e5c2",4312698515,"Illumina HiSeq","55d6215ec5a6a3e67698ba9c038f84f3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:39:57.510845-05:00","2016-05-03T11:20:13.161874-05:00","070c6f85-0e1f-433a-81fc-44f7f259e5c2_analysis.xml","ad7d2c7afbbcbad626ed8aca18e95002","0529f06a-7e8f-4a14-8cf6-f1a929f92c83",2124,"2016-08-28T02:30:53.405280-05:00","070c6f85-0e1f-433a-81fc-44f7f259e5c2_experiment.xml","395157e2c66b6194a79bf7c419bcebac","fa87d059-2e44-4f0b-aa78-3e4ee3af2310",2431,"2016-09-29T21:04:49.739151-05:00","070c6f85-0e1f-433a-81fc-44f7f259e5c2_run.xml","cfeea059dced4c3ce0cac0ec20b98ebe","8501a16d-c338-47e2-9a1c-7c3bb3bc3e07",354,"2016-09-08T11:57:02.593004-05:00","TCGA-A5-A2K4","2016-09-02T18:54:00.654797-05:00","female","TCGA-A5-A2K4_demographic",1940,"white","50869b7a-55b7-59d1-913e-a177d11580ff","not reported",2011,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A2K4_diagnosis","not reported",25270,"dead","8441/3",871,NA,"2b092884-4975-5b4f-a839-d6fe0ff71e1f","c54.1",-25270,"TCGA-A5-A2K4_treatment","40491dc3-a7da-5038-8cfd-206a8a5cb312","01","true","TCGA-A5-A2K4-01A",NA,"825524a8-ede8-44b2-9c4a-8375ac14387a",FALSE,"CB29CD1C-584B-42EA-BF1D-11B6DF8EA756","Primary Tumor",NA,849,140,NA,1312416000,"11",30,"TCGA-A5-A2K4-01A-11",75,NA,4,NA,0,NA,10,NA,"2016-09-08T11:57:02.593004-05:00",NA,10,NA,1,NA,"TOP",NA,5,NA,"09eeb44b-5743-47c4-9453-d4635b2b663a",NA,"TCGA-A5-A2K4-01A-01-TSA",NA,85,NA,"b4591d03-7d0a-4ff9-a780-b31ab13e34f9","RNA","TCGA-A5-A2K4-01A-11R","4ff86eeb-1be8-4519-8815-dbecbb2523f8",1.79,0.17,"UV Spec","R","23","TCGA-A5-A2K4-01A-11R-A18M-07","586c18a6-7278-4200-9d64-20b2c7ccbc60",0.17,NA,51,18.0697278911565,168,"44a2d83e-bcb9-593a-a47c-71a694219d2c","TCGA-A5-A2K4_exposure","UNCID_2234463.586c18a6-7278-4200-9d64-20b2c7ccbc60.130619_UNC13-SN749_0277_BC293YACXX_1_CGATGT.tar.gz","2013-10-18T20:36:04.000Z","2013-10-18T20:51:02.000Z","070C6F85-0E1F-433A-81FC-44F7F259E5C2","825524A8-EDE8-44B2-9C4A-8375AC14387A","Unaligned reads",4312698515,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","586C18A6-7278-4200-9D64-20B2C7CCBC60","University of North Carolina","564a32bde4b0298dd2c5a27c","C4F8F33F-A07C-4DFB-BE24-C52D577BD640","Uterine Corpus Endometrial Carcinoma","TARGZ","B4591D03-7D0A-4FF9-A780-B31AB13E34F9","2013-10-18T20:51:02.000Z","4FF86EEB-1BE8-4519-8815-DBECBB2523F8","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",849,"B4591D03-7D0A-4FF9-A780-B31AB13E34F9",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.D61371B8-56B1-44A5-85CD-EF1E560E4C1D.txt",140,"TCGA-A5-A2K4-01A",NA,"FA98A5D6-0367-46E9-A147-3B8D42262AB1","TCGA",2009,NA,NA,"WITH TUMOR","C11313EC-83D9-4DB0-B1E3-63139935ABA0",69,"nationwidechildrens.org_clinical.TCGA-A5-A2K4.xml","Dead",871,"TCGA-A5-A2K4",NA,"099FB4AB-9375-43BF-98E9-5DEE3207C7D0",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,30,"09EEB44B-5743-47C4-9453-D4635B2B663A","1FCAECB6-45B7-4F41-A36B-64362C6517D5","nationwidechildrens.org_biospecimen.TCGA-A5-A2K4.xml","TCGA-A5-A2K4-01A-11",75,0,4,10,10,"TOP",5,1,"TCGA-A5-A2K4-01A-01-TSA",85,"Doxil","Chemotherapy","TCGA-A5-A2K4-D17272",NA,NA,NA,NA,"YES",NA,"WITH TUMOR","Dead",871,"TCGA-A5-A2K4-F17269","TCGA-A5-A2K4",1,"A5","A2K4","YES","C54.1","8441/3","C54.1","NO","YES",-25270,"FEMALE","WHITE",NA,"No","No","Dead",NA,871,NA,NA,"WITH TUMOR","NO",6,10,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,69,2009,"Tumor resection",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34358077,33897050,2541572206,"6CDE5D5E-F4C1-4C8C-B216-CDB5CA1413DB.bw","c5a797d3-82ae-49dc-b2fe-0da64da271a2","6cde5d5e-f4c1-4c8c-b216-cdb5ca1413db","2016-08-09T14:00:03.520293-05:00","UNCID_2189522.929006f8-5f5c-4215-80a9-0ff6a91ef1d6.120524_UNC2-RDR300275_00121_FC_64KREAAXX_2.tar.gz","09128986-decd-4dda-8315-75cdb3f9db13",2183245034,"Illumina GA","c4ff0bf8180d50fcec1ec38d2cabc606","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:38:58.244423-05:00","2016-05-03T11:05:01.523277-05:00","09128986-decd-4dda-8315-75cdb3f9db13_analysis.xml","502e67d6bd925fa58a96ec3c847ecb2b","e4908336-d013-4e53-9bbc-cd334077f37d",2122,"2016-10-07T15:37:36.600601-05:00","09128986-decd-4dda-8315-75cdb3f9db13_experiment.xml","edf48347ece8545336e5891b3bbd3b41","9946a3a1-34bf-4c77-aa54-8381e202639c",2258,"2016-09-29T21:37:34.469487-05:00","09128986-decd-4dda-8315-75cdb3f9db13_run.xml","ea834689e17f331db1f0490a6734ae06","995d05cf-c122-4a3b-93f5-acb880b40f04",349,"2016-09-08T12:00:27.843571-05:00","TCGA-AP-A0LS","2016-09-02T18:52:11.358791-05:00","female","TCGA-AP-A0LS_demographic",1943,"white","ce0d78ee-e0db-55d8-88b5-227de3fbf4d2","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LS_diagnosis","not reported",23126,"alive","8380/3",NA,2904,"19e6b67b-cc43-5b42-9709-aa36599dc30b","c54.1",-23126,"TCGA-AP-A0LS_treatment","1c5375dd-4ad4-5ae0-9598-b653026cff01","01","true","TCGA-AP-A0LS-01A",NA,"c6f914f3-0888-4890-9323-6386f1035d81",FALSE,"E802CEF6-BC3F-4C35-85E8-2B37531571CD","Primary Tumor",NA,1421,200,NA,1278547200,"11",30,"TCGA-AP-A0LS-01A-11",80,65,0,0,0,0,0,20,"2016-09-08T12:00:27.843571-05:00","2016-09-08T12:00:27.843571-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"7ce21d5c-6c2d-4162-bd76-a5c440d42f24","88b6ae2b-b318-4698-a3ba-fc41257fe0c0","TCGA-AP-A0LS-01A-01-BSA","TCGA-AP-A0LS-01A-01-TSA",100,80,"863f3d5e-b28b-45c0-8dc9-2fbc4b95a7d4","RNA","TCGA-AP-A0LS-01A-11R","574934e1-dedd-4e17-abe2-c3c699718486",1.87,0.14,"UV Spec","R","23","TCGA-AP-A0LS-01A-11R-A14D-07","929006f8-5f5c-4215-80a9-0ff6a91ef1d6",0.14,NA,81,28.3603515283078,169,"822a0b4a-7ec6-592c-8999-64d61abf03b3","TCGA-AP-A0LS_exposure","UNCID_2189522.929006f8-5f5c-4215-80a9-0ff6a91ef1d6.120524_UNC2-RDR300275_00121_FC_64KREAAXX_2.tar.gz","2013-09-19T00:46:05.000Z","2013-09-19T00:58:01.000Z","09128986-DECD-4DDA-8315-75CDB3F9DB13","C6F914F3-0888-4890-9323-6386F1035D81","Unaligned reads",2183245034,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","929006F8-5F5C-4215-80A9-0FF6A91EF1D6","University of North Carolina","564a3b53e4b093830b693f8e","C5A797D3-82AE-49DC-B2FE-0DA64DA271A2","Uterine Corpus Endometrial Carcinoma","TARGZ","863F3D5E-B28B-45C0-8DC9-2FBC4B95A7D4","2013-09-19T00:58:01.000Z","574934E1-DEDD-4E17-ABE2-C3C699718486","None","NO",1,NA,"Primary Tumor","MSKCC",1421,"863F3D5E-B28B-45C0-8DC9-2FBC4B95A7D4",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.86FD0DBA-0947-4AC8-B145-E8799F8C335C.txt",200,"TCGA-AP-A0LS-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","C6F914F3-0888-4890-9323-6386F1035D81",63,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.86FD0DBA-0947-4AC8-B145-E8799F8C335C.txt","Alive",NA,"TCGA-AP-A0LS",NA,"FA5B0FAA-3F19-46F6-929B-15189F886682",NA,1668,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,"04F022ED-E2D6-4B90-B62C-65E5B052D20E","WHITE",NA,11,30,"88B6AE2B-B318-4698-A3BA-FC41257FE0C0","715C6D93-8DA6-4808-B0B5-DDF983C2C8C4","TCGA-AP-A0LS-01A-11R-A14C-13_mirna.bam.bai","TCGA-AP-A0LS-01A-11",65,0,0,0,20,"TOP",0,0,"TCGA-AP-A0LS-01A-01-TSA",80,NA,NA,NA,"TCGA-AP-A0LS-R14432","IMPLANTS","Primary Tumor Field",NA,"NO",1668,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LS-F14429","TCGA-AP-A0LS",1,"AP","A0LS","YES","C54.1","8380/3","C54.1","NO","YES",-23126,"FEMALE","WHITE",NA,"Yes","No","Alive",1668,NA,NA,NA,"TUMOR FREE","NO",22,6,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2006,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32233922,31515134,2369332101,"5FC43C88-E667-4566-9115-4DE1B18F8FCC.bw","c5df9142-27f6-4d97-933e-c79ea9199362","5fc43c88-e667-4566-9115-4de1b18f8fcc","2016-08-06T23:23:24.208282-05:00","UNCID_2210320.0ca45a1d-6cdc-48f5-8bde-633cfd15d687.110407_UNC6-RDR300211_00095_FC64GJRAAXX_7.tar.gz","0ced8cfd-cc1a-44d5-a860-40b1a7a5ce55",2130782756,"Illumina GA","45623d7705eca87ac1520033a2dd82fe","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:43:27.883442-05:00","2016-05-03T11:15:47.420908-05:00","0ced8cfd-cc1a-44d5-a860-40b1a7a5ce55_analysis.xml","464ca41f6b8dfa7adea84cd18ffa841f","77a80417-2ec3-4197-a58c-75c9da77a5da",2119,"2016-09-29T18:31:17.629603-05:00","0ced8cfd-cc1a-44d5-a860-40b1a7a5ce55_experiment.xml","7e54829577779c5dd6d88e38f8c0e438","256e852b-faee-44c9-a894-e56fc7507e12",2257,"2016-09-29T18:02:02.154501-05:00","0ced8cfd-cc1a-44d5-a860-40b1a7a5ce55_run.xml","6cb552bc322028c08eeb4379927db00d","1345fb3a-7a53-4181-a48f-160f61ebe150",347,"2016-09-08T11:24:43.827489-05:00","TCGA-D1-A15Z","2016-09-02T18:49:55.066074-05:00","female","TCGA-D1-A15Z_demographic",1936,"white","69387b62-2c68-5b85-a959-7200561ef196","not hispanic or latino",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A15Z_diagnosis","not reported",26638,"dead","8380/3",58,NA,"66e7281a-e104-5a39-9ca1-9645b46f893c","c54.1",-26638,"TCGA-D1-A15Z_treatment","4022dab4-2357-5bbd-a965-817f18876ff1","01","false","TCGA-D1-A15Z-01A",NA,"7a961c2f-2e7f-4eb0-945b-9f0d59923962",FALSE,"280F86BF-4834-4FA9-B153-DE7BE312E619","Primary Tumor",NA,884,160,NA,1292976000,"11",30,"TCGA-D1-A15Z-01A-11",85,NA,0,NA,5,NA,0,NA,"2016-09-08T11:24:43.827489-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"daa0e373-defd-48f0-844f-61cc55851fc8",NA,"TCGA-D1-A15Z-01A-01-TS1",NA,95,NA,"87d40644-23c6-4ad1-8540-d66e9cdad1a8","RNA","TCGA-D1-A15Z-01A-11R","4c3063cf-1675-47f3-a500-c93c81a8404a",1.85,0.17,"UV Spec","R","23","TCGA-D1-A15Z-01A-11R-A118-07","0ca45a1d-6cdc-48f5-8bde-633cfd15d687",0.17,NA,125,48.828125,160,"0d4b3cbd-bc59-50ad-be08-34f4e95ab20f","TCGA-D1-A15Z_exposure","UNCID_2210320.0ca45a1d-6cdc-48f5-8bde-633cfd15d687.110407_UNC6-RDR300211_00095_FC64GJRAAXX_7.tar.gz","2013-10-02T09:13:06.000Z","2013-10-02T09:45:03.000Z","0CED8CFD-CC1A-44D5-A860-40B1A7A5CE55","7A961C2F-2E7F-4EB0-945B-9F0D59923962","Unaligned reads",2130782756,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0CA45A1D-6CDC-48F5-8BDE-633CFD15D687","University of North Carolina","564a335fe4b093830b66b380","C5DF9142-27F6-4D97-933E-C79EA9199362","Uterine Corpus Endometrial Carcinoma","TARGZ","87D40644-23C6-4AD1-8540-D66E9CDAD1A8","2013-10-02T09:45:03.000Z","4C3063CF-1675-47F3-A500-C93C81A8404A","None","NO",1,NA,"Primary Tumor","Mayo Clinic",884,"87D40644-23C6-4AD1-8540-D66E9CDAD1A8",NA,"D1","UNCID_1632192.0ca45a1d-6cdc-48f5-8bde-633cfd15d687.sorted_genome_alignments.bam.bai",160,"TCGA-D1-A15Z-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","7A961C2F-2E7F-4EB0-945B-9F0D59923962",72,"CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_G12_735720.hg19.seg.txt","Dead",58,"TCGA-D1-A15Z","NOT HISPANIC OR LATINO","D813FDEA-C6E0-403D-A12C-0E73186C72C4",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"DAA0E373-DEFD-48F0-844F-61CC55851FC8","C9D946CA-8CF7-4CF0-9274-DF0FE48589FE","97684bbe8bd38667655650b45f28dd4f.bam","TCGA-D1-A15Z-01A-11",85,5,0,0,0,"TOP",0,0,"TCGA-D1-A15Z-01A-01-TS1",95,NA,NA,NA,NA,NA,NA,NA,"NO",NA,"TUMOR FREE","Dead",58,"TCGA-D1-A15Z-F18475","TCGA-D1-A15Z",1,"D1","A15Z","YES","C54.1","8380/3","C54.1","NO","YES",-26638,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,58,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,72,2008,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31227439,30756738,2293751952,"70060D21-4E80-4273-B12C-E3BC6B365DB3.bw","c68dd983-b199-4f53-ac0c-b2d8dd6a7931","70060d21-4e80-4273-b12c-e3bc6b365db3","2016-08-06T05:44:22.182995-05:00","UNCID_2207441.88aec124-1462-4fd5-b209-b0dadf1138bc.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_7.tar.gz","be1f834a-fabb-4e01-aceb-8d6e8f949dae",2014781871,"Illumina GA","ad03e913fc5010aa82abe8bd98aa5d11","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:31:53.313111-05:00","2016-05-03T11:13:42.378529-05:00","be1f834a-fabb-4e01-aceb-8d6e8f949dae_analysis.xml","ace744ac7876a4a406a0a57c2930074f","bae98db9-7208-474d-aa8d-93f6377784fe",2121,"2016-08-13T03:52:41.482656-05:00","be1f834a-fabb-4e01-aceb-8d6e8f949dae_experiment.xml","7381fa95fe0a229c33e840f4dac56a95","bed9092b-8135-4753-900c-7909f15e7c1b",2257,"2016-09-29T17:38:33.033964-05:00","be1f834a-fabb-4e01-aceb-8d6e8f949dae_run.xml","fbb9f8945500ce7c2500f0bb507baf97","044434ea-f3b1-4dd4-9de7-e51919d73e31",347,"2016-09-08T10:27:06.720322-05:00","TCGA-D1-A17A","2016-09-02T18:50:36.062518-05:00","female","TCGA-D1-A17A_demographic",1950,"white","34a4b0c0-cafa-5ade-9250-9a33891abdf0","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17A_diagnosis","not reported",21560,"alive","8380/3",NA,48,"65afd97d-49f3-57ce-aef3-e0393aa0b85d","c54.1",-21560,"TCGA-D1-A17A_treatment","9522a52c-1ca1-5b97-b212-33b0b26519fe","01","false","TCGA-D1-A17A-01A",NA,"a0083336-5187-4969-85bb-993fa72fbd75",FALSE,"9E0E5CDA-AE46-4ABC-8AF7-C89FE86B7472","Primary Tumor",NA,553,60,NA,1294099200,"11",30,"TCGA-D1-A17A-01A-11",80,NA,10,NA,0,NA,10,NA,"2016-09-08T10:27:06.720322-05:00",NA,30,NA,50,NA,"TOP",NA,10,NA,"602734e5-9cc2-4682-b4db-903744434568",NA,"TCGA-D1-A17A-01A-01-TS1",NA,80,NA,"7afc9762-1860-4ae7-abc3-9dd5a8898431","RNA","TCGA-D1-A17A-01A-11R","504aebe6-7441-4d44-a625-3dd6b8db2e26",1.86,0.17,"UV Spec","R","23","TCGA-D1-A17A-01A-11R-A12I-07","88aec124-1462-4fd5-b209-b0dadf1138bc",0.17,NA,102,32.9287190082645,176,"126788c8-8bea-584c-ad9c-43c050709f55","TCGA-D1-A17A_exposure","UNCID_2207441.88aec124-1462-4fd5-b209-b0dadf1138bc.110628_UNC2-RDR300275_00075_FC_70K9LAAXX_7.tar.gz","2013-09-30T00:55:03.000Z","2013-09-30T01:09:01.000Z","BE1F834A-FABB-4E01-ACEB-8D6E8F949DAE","A0083336-5187-4969-85BB-993FA72FBD75","Unaligned reads",2014781871,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","88AEC124-1462-4FD5-B209-B0DADF1138BC","University of North Carolina","564a3ef1e4b0ef12181b92a4","C68DD983-B199-4F53-AC0C-B2D8DD6A7931","Uterine Corpus Endometrial Carcinoma","TARGZ","7AFC9762-1860-4AE7-ABC3-9DD5A8898431","2013-09-30T01:09:01.000Z","504AEBE6-7441-4D44-A625-3DD6B8DB2E26","None","NO",1,NA,"Primary Tumor","Mayo Clinic",553,"7AFC9762-1860-4AE7-ABC3-9DD5A8898431",NA,"D1","TCGA-D1-A17A-01A-11R-A12H-13_mirna.bam",60,"TCGA-D1-A17A-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","C40B8BDB-A4F4-4C29-B5D0-5788E07E45E4",59,"nationwidechildrens.org_clinical.TCGA-D1-A17A.xml","Alive",NA,"TCGA-D1-A17A","NOT HISPANIC OR LATINO","EFF8FF1D-E837-414F-AF2C-680020420ECD",NA,19,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"602734E5-9CC2-4682-B4DB-903744434568","B2D347FD-43EA-4BB0-880E-FE49E4CDC25C","TCGA-D1-A17A-01A-11R-A12H-13_mirna.bam","TCGA-D1-A17A-01A-11",80,0,10,30,10,"TOP",10,50,"TCGA-D1-A17A-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,"NO",48,"TUMOR FREE","Alive",NA,"TCGA-D1-A17A-F20250","TCGA-D1-A17A",1,"D1","A17A","YES","C54.1","8380/3","C54.1","NO","YES",-21560,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",19,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",6,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35817247,35419483,2672909071,"989C4444-1DAE-4EA2-8D1C-3E845C501FEB.bw","c71e0986-56c0-45f4-be8d-2236e4418604","989c4444-1dae-4ea2-8d1c-3e845c501feb","2016-08-09T14:02:53.397253-05:00","UNCID_2194406.8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_8.tar.gz","49425660-ef69-4609-b2c2-8d28d63e4d1b",2240312633,"Illumina GA","a726a1c0d8b003079f0576274000ea5b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:53:00.174631-05:00","2016-05-03T11:07:49.533431-05:00","49425660-ef69-4609-b2c2-8d28d63e4d1b_analysis.xml","aa18737ea5d787e4d66419ff4c05216b","ed5a96bc-7d21-4c42-a5e4-78c6d9fec2fd",2122,"2016-08-30T05:25:22.561236-05:00","49425660-ef69-4609-b2c2-8d28d63e4d1b_experiment.xml","c2a268584febff3a774ac559cf9e9f85","ec0d42ed-ce87-4280-8499-81b2d4d7a95f",2258,"2016-09-30T00:16:39.233587-05:00","49425660-ef69-4609-b2c2-8d28d63e4d1b_run.xml","2c4989ed6bf138d27f3dd47052258f3d","fbd9e27f-0363-4e8e-81a6-1bd8f882ec7d",349,"2016-09-08T12:14:09.008979-05:00","TCGA-EY-A1H0","2016-09-02T18:52:03.174045-05:00","female","TCGA-EY-A1H0_demographic",1953,"black or african american","0fe639d2-e36c-5dd9-bed0-8e11e1d36a61","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1H0_diagnosis","not reported",20937,"alive","8380/3",NA,588,"850391fc-3536-5ce9-b8ad-2fc1b06b5eab","c54.1",-20937,"TCGA-EY-A1H0_treatment","6106b9c8-845e-5722-aa46-0c0a637644a2","01","false","TCGA-EY-A1H0-01A",NA,"3e1472fb-a882-4bb1-b4c0-c0ff3c9e6e25",FALSE,"CE7F1184-9FFC-4A30-926B-0008915893F2","Primary Tumor",NA,262,330,NA,1297728000,"11",30,"TCGA-EY-A1H0-01A-11",70,NA,20,NA,0,NA,25,NA,"2016-09-08T12:14:09.008979-05:00",NA,30,NA,30,NA,"TOP",NA,5,NA,"0600e93e-8c34-4173-9158-6fe3bf6a2dd6",NA,"TCGA-EY-A1H0-01A-01-TSA",NA,70,NA,"92fda1b6-fe02-417d-82a9-06600885d055","RNA","TCGA-EY-A1H0-01A-11R","543da982-d5cb-4452-a6bf-e2939b5b7084",1.81,0.15,"UV Spec","R","23","TCGA-EY-A1H0-01A-11R-A13S-07","8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01",0.15,NA,90,33.8740637585156,163,"77377d91-2f23-502d-a2fd-dfe6d944c6de","TCGA-EY-A1H0_exposure","UNCID_2194406.8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_8.tar.gz","2013-09-22T23:07:04.000Z","2013-09-22T23:19:01.000Z","49425660-EF69-4609-B2C2-8D28D63E4D1B","3E1472FB-A882-4BB1-B4C0-C0FF3C9E6E25","Unaligned reads",2240312633,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8B72E6E7-CAC5-4B7F-8F6A-7ABEF8B24E01","University of North Carolina","56607f38e4b016715ab6bd0a","C71E0986-56C0-45F4-BE8D-2236E4418604","Uterine Corpus Endometrial Carcinoma","TARGZ","92FDA1B6-FE02-417D-82A9-06600885D055","2013-09-22T23:19:01.000Z","543DA982-D5CB-4452-A6BF-E2939B5B7084","United States","NO",1,NA,"Primary Tumor","University of North Carolina",262,"92FDA1B6-FE02-417D-82A9-06600885D055",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.690B02E6-1CAD-4909-B674-32A3843EE797.txt",330,"TCGA-EY-A1H0-01A",NA,"6E8C5668-6E62-4E1F-9DA3-0D93AFD8010F","TCGA",2010,NA,NA,"TUMOR FREE","F6B3DB2B-40D9-49D8-8D24-5BFC777E4E15",57,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.690B02E6-1CAD-4909-B674-32A3843EE797.txt","Alive",NA,"TCGA-EY-A1H0","NOT HISPANIC OR LATINO","B31EB6B0-F9F6-4D2F-995C-0E76CA42B903",NA,339,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,"EE62CEF1-92D8-4D89-8B5C-394B4CAA4DA7","BLACK OR AFRICAN AMERICAN",NA,11,30,"0600E93E-8C34-4173-9158-6FE3BF6A2DD6","543DA982-D5CB-4452-A6BF-E2939B5B7084","UNCID_2194406.8b72e6e7-cac5-4b7f-8f6a-7abef8b24e01.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_8.tar.gz","TCGA-EY-A1H0-01A-11",70,0,20,30,25,"TOP",5,30,"TCGA-EY-A1H0-01A-01-TSA",70,"Carboplatin","Chemotherapy","TCGA-EY-A1H0-D11987","TCGA-EY-A1H0-R12185","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",588,"WITH TUMOR","Alive",NA,"TCGA-EY-A1H0-F19894","TCGA-EY-A1H0",1,"EY","A1H0","YES","C54.1","8380/3","C54.1","YES","NO",-20937,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",339,NA,NA,NA,"TUMOR FREE","NO",19,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
113211998,112135129,5356161175,"2D448C52-038B-4A02-B3FC-8F1A7DB515DE.bw","c7b3ac87-5260-4042-895a-279cd8cda620","2d448c52-038b-4a02-b3fc-8f1a7db515de","2016-08-05T08:39:13.488682-05:00","UNCID_2168173.f9cc97ae-9b1a-46fa-ab38-c46bccf84380.130610_UNC14-SN744_0347_BD28NBACXX_4_GGCTAC.tar.gz","e68a0af3-a392-4aae-86d8-a02006437007",5002442438,"Illumina HiSeq","7748dbb38248720b40b496e5648cabeb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:42:18.912339-05:00","2016-05-03T11:06:28.634121-05:00","e68a0af3-a392-4aae-86d8-a02006437007_analysis.xml","20068a108a4ad16139496ce8ccefd371","e6b54731-ed1c-48a6-9d33-4028c7eb532b",2123,"2016-09-29T19:36:44.030055-05:00","e68a0af3-a392-4aae-86d8-a02006437007_experiment.xml","7d68f367b4e219db1dd02e86b00e504b","4eafaa01-1710-490b-abfe-78e8729c4c92",2431,"2016-09-29T22:40:44.451938-05:00","e68a0af3-a392-4aae-86d8-a02006437007_run.xml","ec63d14c50fe8bde3a7440f6a48e001d","c0747d06-082b-460a-b549-33947b0509d6",354,"2016-09-08T10:44:08.526760-05:00","TCGA-AJ-A5DV","2016-09-02T18:49:57.676815-05:00","female","TCGA-AJ-A5DV_demographic",1947,"black or african american","f51e0306-5841-5740-83d5-43755b0b9f1e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A5DV_diagnosis","not reported",23892,"alive","8380/3",NA,679,"96dfad91-dccc-59e3-9879-0bfd79b07218","c54.1",-23892,"TCGA-AJ-A5DV_treatment","a87dbe9b-af61-5eec-b2f4-f6d40bb908fa","01","false","TCGA-AJ-A5DV-01A",NA,"0e933a81-858a-4a82-9ece-b56af448a510",FALSE,"049C45D6-6FC6-42EE-BD51-AC344D1E3CD9","Primary Tumor",NA,220,70,NA,1358208000,"11",30,"TCGA-AJ-A5DV-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T10:44:08.526760-05:00",NA,5,NA,0,NA,"TOP",NA,10,NA,"eb6105ef-8c73-4159-9125-72cb6ef88715",NA,"TCGA-AJ-A5DV-01A-01-TS1",NA,90,NA,"ece80489-896e-41f4-a008-74b560037260","RNA","TCGA-AJ-A5DV-01A-11R","52707cc5-9e8d-47ad-aab8-74522ddde533",1.81,0.17,"UV Spec","R","23","TCGA-AJ-A5DV-01A-11R-A27V-07","f9cc97ae-9b1a-46fa-ab38-c46bccf84380",0.17,NA,147,57.421875,160,"4ac76f76-706a-5226-b0f8-d6c990278671","TCGA-AJ-A5DV_exposure","UNCID_2168173.f9cc97ae-9b1a-46fa-ab38-c46bccf84380.130610_UNC14-SN744_0347_BD28NBACXX_4_GGCTAC.tar.gz","2013-09-20T07:56:03.000Z","2013-09-20T08:10:02.000Z","E68A0AF3-A392-4AAE-86D8-A02006437007","0E933A81-858A-4A82-9ECE-B56AF448A510","Unaligned reads",5002442438,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","F9CC97AE-9B1A-46FA-AB38-C46BCCF84380","University of North Carolina","56607e92e4b0ec1099f8f1b1","C7B3AC87-5260-4042-895A-279CD8CDA620","Uterine Corpus Endometrial Carcinoma","TARGZ","ECE80489-896E-41F4-A008-74B560037260","2013-09-20T08:10:02.000Z","52707CC5-9E8D-47AD-AAB8-74522DDDE533","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",220,"ECE80489-896E-41F4-A008-74B560037260",NA,"AJ","06de4e93fcb5181e256b4e92e08fcaca.bam.bai",70,"TCGA-AJ-A5DV-01A",NA,NA,"TCGA",2012,"TCGA-AJ-A5DV_NTE-1","Complete Remission/Response","TUMOR FREE","0E933A81-858A-4A82-9ECE-B56AF448A510",65,"nationwidechildrens.org_clinical.TCGA-AJ-A5DV.xml","Alive",NA,"TCGA-AJ-A5DV","NOT HISPANIC OR LATINO","27FA47F0-8223-40F1-8512-251A898E1195","NO",148,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",289,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"EB6105EF-8C73-4159-9125-72CB6EF88715","DD33DA3D-56C8-41CC-8E8A-06A5767C5F7D","06de4e93fcb5181e256b4e92e08fcaca.bam.bai","TCGA-AJ-A5DV-01A-11",75,0,0,5,0,"TOP",10,0,"TCGA-AJ-A5DV-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A5DV-F64110_NTE-1","NO",679,"TUMOR FREE","Alive",NA,"TCGA-AJ-A5DV-F64110","TCGA-AJ-A5DV",1,"AJ","A5DV","YES","C54.1","8380/3","C54.1","YES","NO",-23892,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",148,NA,NA,NA,"TUMOR FREE","YES",12,7,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2012,"Other method, specify:",NA,NA,NA,"G3","RX",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
127791774,125277356,5978401269,"83A761F1-F59F-4D81-B673-C5DF37FBE172.bw","c856e031-bbd0-431f-b44f-b3ad9b39af7b","83a761f1-f59f-4d81-b673-c5df37fbe172","2016-08-05T01:09:11.619506-05:00","UNCID_2178322.4835dbe5-983f-458a-91d2-8e1d754259c3.130404_UNC12-SN629_0271_AC24VNACXX_7_ATCACG.tar.gz","ce0a2fed-ed38-4771-b35e-163b1a012189",6002561941,"Illumina HiSeq","52ec12708c75ffdff8f74d3fa8609411","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:02:24.347732-05:00","2016-05-03T10:56:47.878169-05:00","ce0a2fed-ed38-4771-b35e-163b1a012189_analysis.xml","047be18ae174e0f216b1bef0c70675f9","392cdad2-65ec-4456-867a-59bf030f34bd",2123,"2016-09-29T18:41:09.722303-05:00","ce0a2fed-ed38-4771-b35e-163b1a012189_experiment.xml","591291370cd8e044f4b9c806d71517c0","2bbb321d-a344-49a6-8a4d-c8ed44c927db",2431,"2016-09-29T21:09:22.301159-05:00","ce0a2fed-ed38-4771-b35e-163b1a012189_run.xml","80584f43369f44d2a1f847336a1ea47d","87eda338-d25e-483e-8c01-231fa9df4957",354,"2016-09-09T16:37:42.640636-05:00","TCGA-AJ-A3EM","2016-09-02T18:48:17.391162-05:00","female","TCGA-AJ-A3EM_demographic",1942,"white","93778d19-dd7a-5e27-8b67-4fba294de047","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3EM_diagnosis","not reported",25557,"alive","8380/3",NA,677,"701ef023-6d22-59d1-8dd7-d94dc341ee5a","c54.1",-25557,"TCGA-AJ-A3EM_treatment","4ad72b2f-f4ce-537b-a4fa-23b78f5f0992","01","false","TCGA-AJ-A3EM-01A",NA,"7dc99437-730f-44f3-88e8-ea6d7e9dbcc1",FALSE,"E5CE38FD-DB53-49D9-92B3-BA075BDDC5CF","Primary Tumor",NA,296,9,NA,1320105600,"11",10,"TCGA-AJ-A3EM-01A-11",80,NA,0,NA,0,NA,5,NA,"2016-09-09T16:37:42.640636-05:00",NA,0,NA,0,NA,"TOP",NA,20,NA,"4d36461a-2a3f-48be-9f4f-6875ff623bc3",NA,"TCGA-AJ-A3EM-01A-01-TS1",NA,75,NA,"12209cb2-44d1-4802-9f1d-f26e073b2995","RNA","TCGA-AJ-A3EM-01A-11R","fe1b1a44-c385-448a-8d2f-b58b0e60e172",1.85,0.15,"UV Spec","R","23","TCGA-AJ-A3EM-01A-11R-A213-07","4835dbe5-983f-458a-91d2-8e1d754259c3",0.15,NA,82,30.119375573921,165,"82871e59-7d9f-5d51-9047-73fc4ea7c86f","TCGA-AJ-A3EM_exposure","UNCID_2178322.4835dbe5-983f-458a-91d2-8e1d754259c3.130404_UNC12-SN629_0271_AC24VNACXX_7_ATCACG.tar.gz","2013-09-12T00:31:10.000Z","2013-09-12T01:06:01.000Z","CE0A2FED-ED38-4771-B35E-163B1A012189","7DC99437-730F-44F3-88E8-EA6D7E9DBCC1","Unaligned reads",6002561941,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","4835DBE5-983F-458A-91D2-8E1D754259C3","University of North Carolina","56607b31e4b0ca319164faa0","C856E031-BBD0-431F-B44F-B3AD9B39AF7B","Uterine Corpus Endometrial Carcinoma","TARGZ","12209CB2-44D1-4802-9F1D-F26E073B2995","2013-09-12T01:06:01.000Z","FE1B1A44-C385-448A-8D2F-B58B0E60E172","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",296,"12209CB2-44D1-4802-9F1D-F26E073B2995",NA,"AJ","UNCID_2178322.4835dbe5-983f-458a-91d2-8e1d754259c3.130404_UNC12-SN629_0271_AC24VNACXX_7_ATCACG.tar.gz",9,"TCGA-AJ-A3EM-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","7DC99437-730F-44F3-88E8-EA6D7E9DBCC1",69,"nationwidechildrens.org_clinical.TCGA-AJ-A3EM.xml","Alive",NA,"TCGA-AJ-A3EM",NA,"B88985E3-8E33-4928-B219-06677BEE5D37",NA,50,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",201,NA,NA,"WHITE",NA,11,10,"4D36461A-2A3F-48BE-9F4F-6875FF623BC3","FE1B1A44-C385-448A-8D2F-B58B0E60E172","UNCID_2178322.4835dbe5-983f-458a-91d2-8e1d754259c3.130404_UNC12-SN629_0271_AC24VNACXX_7_ATCACG.tar.gz","TCGA-AJ-A3EM-01A-11",80,0,0,0,5,"TOP",20,0,"TCGA-AJ-A3EM-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3EM-F46680_NTE-1","NO",677,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3EM-F46680","TCGA-AJ-A3EM",1,"AJ","A3EM","YES","C54.1","8380/3","C54.1","YES","NO",-25557,"FEMALE","WHITE",NA,"No","No","Alive",50,NA,NA,NA,"TUMOR FREE","NO",15,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36916669,36670365,2718627026,"D9349C09-2AFC-4D21-92FB-63A65DE3ADEC.bw","c88e3901-f3ee-436a-ba80-143c8eab7d69","d9349c09-2afc-4d21-92fb-63a65de3adec","2016-08-05T09:20:30.081565-05:00","UNCID_2206676.2f712e62-f400-4922-bdc5-d5d06276101d.111006_UNC2-RDR300275_00089_FC_634EEAAXX_3.tar.gz","165efa6b-5c3d-4a42-99e3-3b915f2977f4",2448263976,"Illumina GA","399592d25605af67f23451a7ac8c0964","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:15:09.749680-05:00","2016-05-03T11:11:34.764500-05:00","165efa6b-5c3d-4a42-99e3-3b915f2977f4_analysis.xml","7c6c1760d22303b35152844215d22f19","d5d1384d-084e-4672-9606-cd3046f01827",2121,"2016-08-27T11:06:04.635015-05:00","165efa6b-5c3d-4a42-99e3-3b915f2977f4_experiment.xml","159dcead1840c6cd424dfd434df5b20f","cd740f04-f661-4abb-a846-94ce2c9af36c",2257,"2016-09-29T21:45:08.821237-05:00","165efa6b-5c3d-4a42-99e3-3b915f2977f4_run.xml","707465b6d48c77ef500d1615c11df3bb","9dff82dd-d6c5-4aa5-baa3-ba7c88429441",347,"2016-09-08T11:01:09.814615-05:00","TCGA-AX-A2H5","2016-09-02T18:52:26.096211-05:00","female","TCGA-AX-A2H5_demographic",1938,"black or african american","e0765893-2c2e-50ce-a4c7-ac3526a8746e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2H5_diagnosis","not reported",24757,"alive","8441/3",NA,2167,"a2c8a8c5-431a-528b-b5d2-e077796b783d","c54.1",-24757,"TCGA-AX-A2H5_treatment","95a7a730-476b-5069-9f63-3652c25c345f","01","false","TCGA-AX-A2H5-01A",NA,"44eb96b4-5e4f-460b-bc51-add38cbc76a1",FALSE,"BF4BE7F8-7D37-4CB2-B340-FAE14155F257","Primary Tumor",NA,2206,100,NA,1308182400,"11",30,"TCGA-AX-A2H5-01A-11",97,NA,1,NA,0,NA,4,NA,"2016-09-08T11:01:09.814615-05:00",NA,1,NA,0,NA,"TOP",NA,2,NA,"d840ca6e-8c30-4292-8b89-035e3a72788d",NA,"TCGA-AX-A2H5-01A-01-TSA",NA,94,NA,"18c05333-77bc-4488-a35c-9cbb2ea842a5","RNA","TCGA-AX-A2H5-01A-11R","901ff01d-4e37-44af-b3fd-ed4d1b4226e6",2.08,0.17,"UV Spec","R","23","TCGA-AX-A2H5-01A-11R-A17B-07","2f712e62-f400-4922-bdc5-d5d06276101d",0.17,NA,87,33.5635199259288,161,"53f71c9b-db2a-52d3-9637-6e9637de8750","TCGA-AX-A2H5_exposure","UNCID_2206676.2f712e62-f400-4922-bdc5-d5d06276101d.111006_UNC2-RDR300275_00089_FC_634EEAAXX_3.tar.gz","2013-09-27T18:55:04.000Z","2013-09-27T07:08:02.000Z","165EFA6B-5C3D-4A42-99E3-3B915F2977F4","44EB96B4-5E4F-460B-BC51-ADD38CBC76A1","Unaligned reads",2448263976,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2F712E62-F400-4922-BDC5-D5D06276101D","University of North Carolina","564a3b2be4b093830b69319e","C88E3901-F3EE-436A-BA80-143C8EAB7D69","Uterine Corpus Endometrial Carcinoma","TARGZ","18C05333-77BC-4488-A35C-9CBB2EA842A5","2013-09-27T07:08:02.000Z","901FF01D-4E37-44AF-B3FD-ED4D1B4226E6","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",2206,"18C05333-77BC-4488-A35C-9CBB2EA842A5",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5298E5E5-5AAF-46F4-8D91-AA10FAB8F2B2.txt",100,"TCGA-AX-A2H5-01A",NA,"C0052967-B2FB-43B6-A100-E42026C41CDE","TCGA",2005,NA,NA,NA,"9793E609-348F-4AA6-9705-EC236604F085",67,"nationwidechildrens.org_clinical.TCGA-AX-A2H5.xml","Alive",NA,"TCGA-AX-A2H5","NOT HISPANIC OR LATINO","6A69BD72-F643-48C8-9F37-FF5D4B6DA2C7",NA,2167,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",156,NA,"170664CD-F21E-4F82-8E6B-BAC82FFCF42F","BLACK OR AFRICAN AMERICAN",NA,11,30,"D840CA6E-8C30-4292-8B89-035E3A72788D","901FF01D-4E37-44AF-B3FD-ED4D1B4226E6","e52c300fcc024e8d3a3b64ad3ab79eb8.bam","TCGA-AX-A2H5-01A-11",97,0,1,1,4,"TOP",2,0,"TCGA-AX-A2H5-01A-01-TSA",94,"Carboplatin","Chemotherapy","TCGA-AX-A2H5-D31627","TCGA-AX-A2H5-R31630",NA,"Primary Tumor Field",NA,"NO",2167,"TUMOR FREE","Alive",NA,"TCGA-AX-A2H5-F31616","TCGA-AX-A2H5",1,"AX","A2H5","YES","C54.1","8441/3","C54.1","NO","YES",-24757,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",2167,NA,NA,NA,NA,"NO",28,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32426335,30958762,2330052446,"29DE9C1A-36DC-44E0-84A4-67BF57CF6FAF.bw","c8d672ed-9910-4f80-b222-38c833f55850","29de9c1a-36dc-44e0-84a4-67bf57cf6faf","2016-08-09T14:16:02.831791-05:00","UNCID_2210719.2386cca4-1d9d-490e-b188-c0e266952a5f.110323_UNC3-RDR300156_00085_FC_706FWAAXX_2.tar.gz","045c1754-f105-4aa8-9658-28d4a8948f4a",2111504424,"Illumina GA","865cbbe42c98c00e27b1eb19b08937d3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:34:51.202985-05:00","2016-05-03T11:15:47.421196-05:00","045c1754-f105-4aa8-9658-28d4a8948f4a_analysis.xml","2da95b449b229d087b0d3dc909c01843","279e3764-b4cb-4212-aada-d95b0acc6273",2121,"2016-10-07T15:53:57.146228-05:00","045c1754-f105-4aa8-9658-28d4a8948f4a_experiment.xml","e2e300cd272092c9087f03a3f3d42532","8b9fa20f-c7ed-4cec-afdc-d4d03956ffa8",2257,"2016-09-29T18:03:04.318073-05:00","045c1754-f105-4aa8-9658-28d4a8948f4a_run.xml","a3690d444b9585af7e52d01838a3bc36","13e9a563-2a9b-49b7-8552-a40d49e95227",347,"2016-09-08T10:44:46.192787-05:00","TCGA-A5-A0GQ","2016-09-02T18:49:17.726963-05:00","female","TCGA-A5-A0GQ_demographic",1931,"white","7847ae82-f710-579e-a09d-765bec5e27a0","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A0GQ_diagnosis","not reported",28078,"alive","8380/3",NA,2247,"eb9b510d-cb05-581d-a51b-fc771c65913e","c54.1",-28078,"TCGA-A5-A0GQ_treatment","c687623c-9fb3-5af2-9b9c-2efcfab2413f","01","true","TCGA-A5-A0GQ-01A",NA,"4805287e-cd6d-48ff-ac6d-19d01052bf8b",FALSE,"7B57FD81-AA42-4C76-BF65-0BA2B3451065","Primary Tumor",NA,1022,140,NA,1291334400,"11",30,"TCGA-A5-A0GQ-01A-11",2,70,5,20,0,0,92,25,"2016-09-08T10:44:46.192787-05:00","2016-09-08T10:44:46.192787-05:00",20,35,30,25,"BOTTOM","TOP",3,5,"c12ddd4b-5306-4fd7-9d6d-8bb3179f3fc3","d2a2d47c-b218-402b-a89b-d1fcb79d0f5f","TCGA-A5-A0GQ-01A-01-MSA","TCGA-A5-A0GQ-01A-01-TSA",5,70,"d8141644-6ed7-4506-982e-831bb096b7b7","RNA","TCGA-A5-A0GQ-01A-11R","cb1bf2ec-3fd1-4559-abe8-c1cf92668a80",1.81,0.16,"UV Spec","R","23","TCGA-A5-A0GQ-01A-11R-A118-07","2386cca4-1d9d-490e-b188-c0e266952a5f",0.16,NA,57,25.3333333333333,150,"255e30c6-58da-5872-aff3-36b8b8bd365e","TCGA-A5-A0GQ_exposure","UNCID_2210719.2386cca4-1d9d-490e-b188-c0e266952a5f.110323_UNC3-RDR300156_00085_FC_706FWAAXX_2.tar.gz","2013-10-02T15:16:04.000Z","2013-10-02T15:29:03.000Z","045C1754-F105-4AA8-9658-28D4A8948F4A","4805287E-CD6D-48FF-AC6D-19D01052BF8B","Unaligned reads",2111504424,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2386CCA4-1D9D-490E-B188-C0E266952A5F","University of North Carolina","56607ad6e4b018727fea279e","C8D672ED-9910-4F80-B222-38C833F55850","Uterine Corpus Endometrial Carcinoma","TARGZ","D8141644-6ED7-4506-982E-831BB096B7B7","2013-10-02T15:29:03.000Z","CB1BF2EC-3FD1-4559-ABE8-C1CF92668A80","None","NO",1,NA,"Primary Tumor","Cedars Sinai",1022,"D8141644-6ED7-4506-982E-831BB096B7B7",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.35256B27-92B1-4905-9571-7269212E85A6.txt",140,"TCGA-A5-A0GQ-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","4805287E-CD6D-48FF-AC6D-19D01052BF8B",76,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.35256B27-92B1-4905-9571-7269212E85A6.txt","Alive",NA,"TCGA-A5-A0GQ","NOT HISPANIC OR LATINO","9ACF5909-80CA-457D-B15B-EEA7EEC4AAF9",NA,1167,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"D2A2D47C-B218-402B-A89B-D1FCB79D0F5F","9B05BD38-7D8E-4D13-BAC0-36FBD821BFC7","d9ade9f37bcac3a5dbed190bcc2fd690.bam.bai","TCGA-A5-A0GQ-01A-11",2,0,5,20,92,"BOTTOM",3,30,"TCGA-A5-A0GQ-01A-01-MSA",5,NA,NA,NA,NA,NA,NA,NA,NA,1167,"TUMOR FREE","Alive",NA,"TCGA-A5-A0GQ-F5826","TCGA-A5-A0GQ",1,"A5","A0GQ","YES","C54.1","8380/3","C54.1","NO","YES",-28078,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1167,NA,NA,NA,"TUMOR FREE","NO",7,1,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,76,2007,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
123018112,121462247,5799876041,"433CED6F-A9DE-444E-9A11-8929A3EFEC9B.bw","c8fb94dd-c535-48f4-9419-aac2bf47bbb4","433ced6f-a9de-444e-9a11-8929a3efec9b","2016-08-06T13:28:28.846771-05:00","UNCID_2172983.e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53.130509_UNC10-SN254_0462_AC232JACXX_8_GAGTGG.tar.gz","f8ce86d7-bdcd-4cf1-9cea-c5e074b71b76",5578646564,"Illumina HiSeq","b4284581ec09e93ac80d035210f92406","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:15:33.574147-05:00","2016-05-03T10:55:55.600288-05:00","f8ce86d7-bdcd-4cf1-9cea-c5e074b71b76_analysis.xml","67998a9ef5f26ef35d4af927f296be04","8bc5783e-ad3f-4615-b2db-6f4ec16a59a6",2123,"2016-10-07T16:23:32.496102-05:00","f8ce86d7-bdcd-4cf1-9cea-c5e074b71b76_experiment.xml","ee26ab69d59f9d5f0065a2e4029e79ba","c5b21e1c-d6f8-437d-b8b9-34c5f5caa447",2431,"2016-09-29T21:33:32.978545-05:00","f8ce86d7-bdcd-4cf1-9cea-c5e074b71b76_run.xml","1c14805a8fcd00ec5ebb677b47ea61cf","96e30dd6-1c9f-487e-98c1-c41ac74a27eb",354,"2016-09-08T10:39:23.376446-05:00","TCGA-AJ-A3NC","2016-09-02T18:49:02.192083-05:00","female","TCGA-AJ-A3NC_demographic",1948,"white","af950860-01d9-57e3-a223-7ae401b8c798","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3NC_diagnosis","not reported",23353,"alive","8380/3",NA,1125,"53218018-d835-5878-a24c-d303aede851f","c54.1",-23353,"TCGA-AJ-A3NC_treatment","0bfff125-be0b-51b9-a1b6-c3be59e73898","01","false","TCGA-AJ-A3NC-01A",NA,"2398c565-2432-4fe9-bf9a-13ed877badea",FALSE,"B6DB87F4-E88A-4209-92E2-75ADB364FB28","Primary Tumor",NA,282,300,NA,1328054400,"11",30,"TCGA-AJ-A3NC-01A-11",95,NA,1,NA,0,NA,0,NA,"2016-09-08T10:39:23.376446-05:00",NA,1,NA,1,NA,"TOP",NA,5,NA,"cdb70b96-0425-4593-8052-1c5a87a855ec",NA,"TCGA-AJ-A3NC-01A-01-TSA",NA,95,NA,"04bd1e8a-6fb5-49f2-814a-8b1d87e71d06","RNA","TCGA-AJ-A3NC-01A-11R","5508fe64-f4b7-4d5b-b0e2-0f9265ec237a",1.8,0.16,"UV Spec","R","23","TCGA-AJ-A3NC-01A-11R-A22K-07","e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53",0.16,NA,110,38.9739229024943,168,"aaeea8bd-b083-526c-9941-e37eb1f1508c","TCGA-AJ-A3NC_exposure","UNCID_2172983.e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53.130509_UNC10-SN254_0462_AC232JACXX_8_GAGTGG.tar.gz","2013-09-09T04:56:16.000Z","2013-09-09T05:12:01.000Z","F8CE86D7-BDCD-4CF1-9CEA-C5E074B71B76","2398C565-2432-4FE9-BF9A-13ED877BADEA","Unaligned reads",5578646564,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","E6DBC0A5-B610-406A-9C7A-43EB8B6B6B53","University of North Carolina","564a37d9e4b09c884b234595","C8FB94DD-C535-48F4-9419-AAC2BF47BBB4","Uterine Corpus Endometrial Carcinoma","TARGZ","04BD1E8A-6FB5-49F2-814A-8B1D87E71D06","2013-09-09T05:12:01.000Z","5508FE64-F4B7-4D5B-B0E2-0F9265EC237A","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",282,"04BD1E8A-6FB5-49F2-814A-8B1D87E71D06",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C156B816-181C-4A58-B620-01C7A857C8A1.txt",300,"TCGA-AJ-A3NC-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","DF404299-C2EB-4EDD-9A9A-C20619B0F7C6",63,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C156B816-181C-4A58-B620-01C7A857C8A1.txt","Alive",NA,"TCGA-AJ-A3NC",NA,"CE07D52F-48FF-4FC0-81DA-287C5E25484B",NA,210,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"CDB70B96-0425-4593-8052-1C5A87A855EC","EC018B29-6F9A-4513-A5E4-FA980E6671F8","UNCID_2031628.e6dbc0a5-b610-406a-9c7a-43eb8b6b6b53.sorted_genome_alignments.bam.bai","TCGA-AJ-A3NC-01A-11",95,0,1,1,0,"TOP",5,1,"TCGA-AJ-A3NC-01A-01-TSA",95,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3NC-F46679_NTE-1","NO",616,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3NC-F46679","TCGA-AJ-A3NC",1,"AJ","A3NC","YES","C54.1","8380/3","C54.1","YES","NO",-23353,"FEMALE","WHITE",NA,"No","No","Alive",210,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
140792454,138305416,6603453543,"34D8CE1D-7376-4212-A775-56FD25C7D678.bw","c8fb94dd-c535-48f4-9419-aac2bf47bbb4","34d8ce1d-7376-4212-a775-56fd25c7d678","2016-08-04T22:26:30.120199-05:00","UNCID_2167300.cd0ccc13-2ce8-408e-aceb-1b363e98584f.130613_UNC9-SN296_0375_BD27CGACXX_2_ACAGTG.tar.gz","eb4e90b9-66c7-4f21-af68-725a91cdc186",6988170435,"Illumina HiSeq","c93cf17a07b9d0a4a35ba3e062a57a0b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:31:19.427539-05:00","2016-05-03T11:07:07.492763-05:00","eb4e90b9-66c7-4f21-af68-725a91cdc186_analysis.xml","f71e3330074534fb97800861fd49b51f","4b7321f2-dd0c-4172-9c80-c0649f6e7e1d",2121,"2016-09-29T17:31:42.360617-05:00","eb4e90b9-66c7-4f21-af68-725a91cdc186_experiment.xml","8f7921cecc45b5d83b3f4cffc3d6e5f7","00021216-d38c-49f3-8e80-fbfed68be8d3",2431,"2016-09-29T19:18:03.440610-05:00","eb4e90b9-66c7-4f21-af68-725a91cdc186_run.xml","1cecd0bda150ed69e7214b68b3fde694","4311393f-fd16-4e75-84ec-04100f0e6510",354,"2016-09-08T10:39:23.376446-05:00","TCGA-AJ-A3NC","2016-09-02T18:49:02.192083-05:00","female","TCGA-AJ-A3NC_demographic",1948,"white","af950860-01d9-57e3-a223-7ae401b8c798","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3NC_diagnosis","not reported",23353,"alive","8380/3",NA,1125,"53218018-d835-5878-a24c-d303aede851f","c54.1",-23353,"TCGA-AJ-A3NC_treatment","0bfff125-be0b-51b9-a1b6-c3be59e73898","11","false","TCGA-AJ-A3NC-11A",NA,"df404299-c2eb-4edd-9a9a-c20619b0f7c6",FALSE,NA,"Solid Tissue Normal",NA,282,70,NA,1328054400,"11",30,"TCGA-AJ-A3NC-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T10:39:23.376446-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"3af0e14c-7ce0-448a-9de4-ae154f299c7f",NA,"TCGA-AJ-A3NC-11A-01-TS1",NA,0,NA,"43e24494-ce16-4816-9abf-f6687c53bfd8","RNA","TCGA-AJ-A3NC-11A-11R","511e9231-c091-4bb6-8630-6a563f93c7c9",1.8,0.16,"UV Spec","R","23","TCGA-AJ-A3NC-11A-11R-A22K-07","cd0ccc13-2ce8-408e-aceb-1b363e98584f",0.16,NA,110,38.9739229024943,168,"aaeea8bd-b083-526c-9941-e37eb1f1508c","TCGA-AJ-A3NC_exposure","UNCID_2167300.cd0ccc13-2ce8-408e-aceb-1b363e98584f.130613_UNC9-SN296_0375_BD27CGACXX_2_ACAGTG.tar.gz","2013-09-21T05:06:04.000Z","2013-09-21T05:27:01.000Z","EB4E90B9-66C7-4F21-AF68-725A91CDC186","DF404299-C2EB-4EDD-9A9A-C20619B0F7C6","Unaligned reads",6988170435,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","CD0CCC13-2CE8-408E-ACEB-1B363E98584F","University of North Carolina","564a37d4e4b093830b68207f","C8FB94DD-C535-48F4-9419-AAC2BF47BBB4","Uterine Corpus Endometrial Carcinoma","TARGZ","43E24494-CE16-4816-9ABF-F6687C53BFD8","2013-09-21T05:27:01.000Z","511E9231-C091-4BB6-8630-6A563F93C7C9","United States","NO",11,NA,"Solid Tissue Normal","International Genomics Conosrtium",282,"43E24494-CE16-4816-9ABF-F6687C53BFD8",NA,"AJ","TCGA-AJ-A3NC-11A-11R-A22I-13_mirna.bam.bai",70,"TCGA-AJ-A3NC-11A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","DF404299-C2EB-4EDD-9A9A-C20619B0F7C6",63,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C156B816-181C-4A58-B620-01C7A857C8A1.txt","Alive",NA,"TCGA-AJ-A3NC",NA,"CE07D52F-48FF-4FC0-81DA-287C5E25484B",NA,210,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"WHITE",NA,11,30,"3AF0E14C-7CE0-448A-9DE4-AE154F299C7F","C4E1447A-6CE4-4A67-82F0-8C64A5B5AFD6","TCGA-AJ-A3NC-11A-11R-A22I-13_mirna.bam.bai","TCGA-AJ-A3NC-11A-11",0,100,0,1,0,"TOP",0,0,"TCGA-AJ-A3NC-11A-01-TS1",0,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A3NC-F46679_NTE-1","NO",616,"TUMOR FREE","Alive",NA,"TCGA-AJ-A3NC-F46679","TCGA-AJ-A3NC",1,"AJ","A3NC","YES","C54.1","8380/3","C54.1","YES","NO",-23353,"FEMALE","WHITE",NA,"No","No","Alive",210,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
127803350,126654963,6048971820,"3A0EEC57-FD97-484D-8844-C2F090340EB5.bw","c9ebaeff-6a27-4a6c-a34c-5337a3508a52","3a0eec57-fd97-484d-8844-c2f090340eb5","2016-08-06T02:38:48.270180-05:00","UNCID_2173048.0ed2207e-47d3-47aa-804f-abffb6f42e64.130509_UNC10-SN254_0462_AC232JACXX_4_GGCTAC.tar.gz","e0d84bfb-89c8-42fc-b489-a5b6de98e452",5844039153,"Illumina HiSeq","4729a56d944d00477bb666a3f9d202eb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:38:12.580904-05:00","2016-05-03T10:55:55.600288-05:00","e0d84bfb-89c8-42fc-b489-a5b6de98e452_analysis.xml","ad0f291639d88ba3fcc78de1d3b7dc6c","99ba7256-4138-42d1-885c-8a528cebcb8e",2123,"2016-08-13T05:16:30.808340-05:00","e0d84bfb-89c8-42fc-b489-a5b6de98e452_experiment.xml","9afcbe0a02fb489159ee9ca1209d5769","40e36600-aaac-4997-9967-529bd69b6691",2431,"2016-09-29T17:40:14.339061-05:00","e0d84bfb-89c8-42fc-b489-a5b6de98e452_run.xml","6a9ae8d7df1bbffa472954f78639064f","05582d0d-6fe1-42e6-98d5-1cf88f2f9c1b",354,"2016-09-09T16:28:38.397578-05:00","TCGA-KP-A3W0","2016-09-02T18:49:37.759179-05:00","female","TCGA-KP-A3W0_demographic",1939,"not reported","59388de5-fd85-5e5e-9f59-87345330429b","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","KP","821aedb4-8788-5cb9-ae05-e670f0be1f9f","British Columbia Cancer Agency","not reported","c54.1","TCGA-KP-A3W0_diagnosis","not reported",26378,"alive","8441/3",NA,404,"27fb4d70-b5fe-515f-8dc1-b4d461322f31","c54.1",-26378,"TCGA-KP-A3W0_treatment","267ad052-a47f-566c-b65b-bf25b5550753","01","true","TCGA-KP-A3W0-01A",NA,"570bb596-bad8-4a83-a7d7-e9fa8c9e16aa",FALSE,"8623B627-C3E3-469B-A640-2F8BCFC0B711","Primary Tumor",NA,351,90,NA,1335398400,"21",30,"TCGA-KP-A3W0-01A-21",60,NA,20,NA,0,NA,30,NA,"2016-09-09T16:28:38.397578-05:00",NA,60,NA,10,NA,"TOP",NA,10,NA,"e56865fe-8c27-4dbb-8c65-4f35e433cb5f",NA,"TCGA-KP-A3W0-01A-02-TSB",NA,60,NA,"246029f0-0e22-4f73-baa5-eb80d889d8e7","RNA","TCGA-KP-A3W0-01A-21R","e5e443b8-031d-4fa6-b66f-d1dd86ac152f",1.85,0.17,"UV Spec","R","23","TCGA-KP-A3W0-01A-21R-A22K-07","0ed2207e-47d3-47aa-804f-abffb6f42e64",0.17,NA,94,35.8177107148301,162,"84ca83c3-7077-535c-9fc3-7fe95c1049ea","TCGA-KP-A3W0_exposure","UNCID_2173048.0ed2207e-47d3-47aa-804f-abffb6f42e64.130509_UNC10-SN254_0462_AC232JACXX_4_GGCTAC.tar.gz","2013-09-09T08:36:08.000Z","2013-09-09T08:50:01.000Z","E0D84BFB-89C8-42FC-B489-A5B6DE98E452","570BB596-BAD8-4A83-A7D7-E9FA8C9E16AA","Unaligned reads",5844039153,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0ED2207E-47D3-47AA-804F-ABFFB6F42E64","University of North Carolina","564a34d5e4b0298dd2c64c3e","C9EBAEFF-6A27-4A6C-A34C-5337A3508A52","Uterine Corpus Endometrial Carcinoma","TARGZ","246029F0-0E22-4F73-BAA5-EB80D889D8E7","2013-09-09T08:50:01.000Z","E5E443B8-031D-4FA6-B66F-D1DD86AC152F","Canada","NO",1,NA,"Primary Tumor","British Columbia Cancer Agency",351,"246029F0-0E22-4F73-BAA5-EB80D889D8E7",NA,"KP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.516DD408-6008-4824-852D-77384BAD6142.txt",90,"TCGA-KP-A3W0-01A",NA,NA,"TCGA",2011,"TCGA-KP-A3W0_NTE-1","Complete Remission/Response","TUMOR FREE","570BB596-BAD8-4A83-A7D7-E9FA8C9E16AA",72,"nationwidechildrens.org_clinical.TCGA-KP-A3W0.xml","Alive",NA,"TCGA-KP-A3W0",NA,NA,"NO",404,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,NA,NA,NA,21,30,"E56865FE-8C27-4DBB-8C65-4F35E433CB5F","9A306B77-E460-4310-B14B-49EB82F647A0","TCGA-KP-A3W0-01A-21R-A22I-13_mirna.bam.bai","TCGA-KP-A3W0-01A-21",60,0,20,60,30,"TOP",10,10,"TCGA-KP-A3W0-01A-02-TSB",60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-KP-A3W0",1,"KP","A3W0","YES","C54.1","8441/3","C54.1","NO","YES",-26378,"FEMALE",NA,NA,"No","No","Alive",404,NA,"YES","YES","TUMOR FREE","YES",19,7,2012,"NO","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,72,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32346949,31870409,2380282948,"9ECE4E94-28D5-4692-82D4-5B7FA882543C.bw","ca594f56-9c68-4b7e-84b2-669f1004e3a4","9ece4e94-28d5-4692-82d4-5b7fa882543c","2016-08-09T14:17:40.649283-05:00","UNCID_2210187.823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_3.tar.gz","83ed6ca5-d0cb-42ba-b665-c0fa9d548ad3",2028091642,"Illumina GA","496f268c7d0e415385dd8bb791fe7f2d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:56:05.357303-05:00","2016-05-03T11:15:47.407128-05:00","83ed6ca5-d0cb-42ba-b665-c0fa9d548ad3_analysis.xml","9df6e614db01b1e3e29bd4f78dc06bcd","ef4304aa-915b-48c7-b42c-349a0b18cc80",2123,"2016-09-29T23:51:09.966844-05:00","83ed6ca5-d0cb-42ba-b665-c0fa9d548ad3_experiment.xml","c5d028ac55aa19aa162d7a51610c4dd8","ec2d3361-83d2-44ef-8775-994381af8761",2257,"2016-09-29T19:58:55.832760-05:00","83ed6ca5-d0cb-42ba-b665-c0fa9d548ad3_run.xml","5359d1e6ebd87e0599ef9955d85b521d","5c7a29e5-89ac-4201-a494-64a1c8774dc1",347,"2016-09-08T11:38:45.590705-05:00","TCGA-B5-A11N","2016-09-02T18:49:28.219030-05:00","female","TCGA-B5-A11N_demographic",1938,"white","ef38b762-6e65-5a5f-985e-ae40bec376aa","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11N_diagnosis","not reported",25442,"alive","8380/3",NA,1876,"d6158568-3774-5c50-aaa7-671bf85d5032","c54.1",-25442,"TCGA-B5-A11N_treatment","b573c252-049a-5aa8-9ba9-258f89313a21","01","true","TCGA-B5-A11N-01A",NA,"d3222a2c-6715-4eea-88b0-4006f61c736b",FALSE,"A4C1DE15-A45A-4D31-B363-C6652370C09C","Primary Tumor",NA,1140,370,NA,1291593600,"11",30,"TCGA-B5-A11N-01A-11",75,70,2,0,0,0,25,30,"2016-09-08T11:38:45.590705-05:00","2016-09-08T11:38:45.590705-05:00",30,35,0,0,"BOTTOM","TOP",5,5,"3742add6-0e00-4b8e-a5bf-7465f034496c","235c492f-dc54-413f-b00b-9651aca15076","TCGA-B5-A11N-01A-01-BSA","TCGA-B5-A11N-01A-01-TSA",70,65,"32b044a9-06bb-4194-a05a-5895942e7800","RNA","TCGA-B5-A11N-01A-11R","fbcaeda7-ec48-4a6a-a304-50c1e89171fa",1.83,0.16,"UV Spec","R","23","TCGA-B5-A11N-01A-11R-A118-07","823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f",0.16,NA,90,29.7265160523187,174,"276d0a4b-0086-5139-ba87-11369514f219","TCGA-B5-A11N_exposure","UNCID_2210187.823aed7c-3bf3-4ace-b17d-dc4f8a4e0e2f.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_3.tar.gz","2013-10-02T07:01:04.000Z","2013-10-02T07:13:02.000Z","83ED6CA5-D0CB-42BA-B665-C0FA9D548AD3","D3222A2C-6715-4EEA-88B0-4006F61C736B","Unaligned reads",2028091642,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","823AED7C-3BF3-4ACE-B17D-DC4F8A4E0E2F","University of North Carolina","564a37b5e4b0298dd2c73992","CA594F56-9C68-4B7E-84B2-669F1004E3A4","Uterine Corpus Endometrial Carcinoma","TARGZ","32B044A9-06BB-4194-A05A-5895942E7800","2013-10-02T07:13:02.000Z","FBCAEDA7-EC48-4A6A-A304-50C1E89171FA","United States","NO",1,NA,"Primary Tumor","Duke",1140,"32B044A9-06BB-4194-A05A-5895942E7800",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.0DA12AA8-1686-4705-90CD-B50DB7F41C24.txt",370,"TCGA-B5-A11N-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","D3222A2C-6715-4EEA-88B0-4006F61C736B",69,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.0DA12AA8-1686-4705-90CD-B50DB7F41C24.txt","Alive",NA,"TCGA-B5-A11N",NA,"D2EE1850-DAF5-4481-9C1E-33FEBF6C9824",NA,1147,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"3742ADD6-0E00-4B8E-A5BF-7465F034496C","FBCAEDA7-EC48-4A6A-A304-50C1E89171FA","87a35a63959aa8c3b3d8a64c48df1f71.bam","TCGA-B5-A11N-01A-11",70,0,0,35,30,"TOP",5,0,"TCGA-B5-A11N-01A-01-TSA",65,NA,NA,NA,NA,NA,NA,"TCGA-B5-A11N-F72227_NTE-1","NO",1876,"TUMOR FREE","Alive",NA,"TCGA-B5-A11N-F72227","TCGA-B5-A11N",1,"B5","A11N","YES","C54.1","8380/3","C54.1","NO","YES",-25442,"FEMALE","WHITE",NA,"No","No","Alive",1147,NA,NA,NA,"TUMOR FREE","NO",10,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2007,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32569642,32033980,2395387794,"55E9BC6F-3123-4444-BC23-33FBA5F84BD7.bw","ca7f9d8b-2abc-4606-bf95-4c42791b38bd","55e9bc6f-3123-4444-bc23-33fba5f84bd7","2016-08-09T14:13:46.440361-05:00","UNCID_2207676.631c96e1-7e11-4c0f-a6ea-49cd942f4390.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_2.tar.gz","61e2e26d-8729-4f3b-9b1c-335ad78c9120",2111247097,"Illumina GA","76e8c33a54b22b9930f34922944be4f0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:09:05.697662-05:00","2016-05-03T11:14:23.401440-05:00","61e2e26d-8729-4f3b-9b1c-335ad78c9120_analysis.xml","96b34d607c5fbb023e7dabb5449597c7","3d668e88-78bf-4783-a811-402d46ee1700",2121,"2016-08-26T11:03:30.139383-05:00","61e2e26d-8729-4f3b-9b1c-335ad78c9120_experiment.xml","658f91ada64abf124080f8894e358cc7","e96b7fed-c30a-4f75-a9bc-7ba30202dac8",2257,"2016-09-29T23:34:05.876742-05:00","61e2e26d-8729-4f3b-9b1c-335ad78c9120_run.xml","594d00dbe98260af80a0adc829a36e5a","e190ba8e-81a7-469b-8767-89e5f7e84b95",347,"2016-09-08T10:58:34.092187-05:00","TCGA-AP-A1DM","2016-09-02T18:51:24.400098-05:00","female","TCGA-AP-A1DM_demographic",1947,"white","eb14ffb2-f120-5873-8146-038dadc0fba8","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A1DM_diagnosis","not reported",22239,"alive","8380/3",NA,1700,"313fd825-764e-5f76-a974-459faf3c2800","c54.1",-22239,"TCGA-AP-A1DM_treatment","83c24cd8-ff03-58dc-8f63-07839c3f1456","01","true","TCGA-AP-A1DM-01A",NA,"7f4344cf-a5d7-4623-abe8-9f046723ea0a",FALSE,"E25BA7AD-5C24-4953-B9C3-7509AE6E9F4C","Primary Tumor",NA,1309,110,NA,1295827200,"21",30,"TCGA-AP-A1DM-01A-21",60,NA,20,NA,20,NA,20,NA,"2016-09-08T10:58:34.092187-05:00",NA,20,NA,20,NA,"TOP",NA,20,NA,"ccdf9dc0-1bbf-4fbd-a23d-d2aba12fb625",NA,"TCGA-AP-A1DM-01A-02-TSB",NA,40,NA,"6ad8ea8a-a726-4145-a64c-ae6091a121e1","RNA","TCGA-AP-A1DM-01A-21R","4eb59733-f8e8-4e49-aab3-75fa1a2f73bf",1.93,0.18,"UV Spec","R","23","TCGA-AP-A1DM-01A-21R-A137-07","631c96e1-7e11-4c0f-a6ea-49cd942f4390",0.18,NA,92,36.3909655472489,159,"24f87471-9ef6-57e4-8417-a67113179a95","TCGA-AP-A1DM_exposure","UNCID_2207676.631c96e1-7e11-4c0f-a6ea-49cd942f4390.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_2.tar.gz","2013-09-30T04:31:04.000Z","2013-09-30T04:44:01.000Z","61E2E26D-8729-4F3B-9B1C-335AD78C9120","7F4344CF-A5D7-4623-ABE8-9F046723EA0A","Unaligned reads",2111247097,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","631C96E1-7E11-4C0F-A6EA-49CD942F4390","University of North Carolina","566077fee4b018727fea1807","CA7F9D8B-2ABC-4606-BF95-4C42791B38BD","Uterine Corpus Endometrial Carcinoma","TARGZ","6AD8EA8A-A726-4145-A64C-AE6091A121E1","2013-09-30T04:44:01.000Z","4EB59733-F8E8-4E49-AAB3-75FA1A2F73BF","None","NO",1,NA,"Primary Tumor","MSKCC",1309,"6AD8EA8A-A726-4145-A64C-AE6091A121E1",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2DA765F6-6546-491B-A2A8-07FCB86B94D0.txt",110,"TCGA-AP-A1DM-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","7F4344CF-A5D7-4623-ABE8-9F046723EA0A",60,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2DA765F6-6546-491B-A2A8-07FCB86B94D0.txt","Alive",NA,"TCGA-AP-A1DM",NA,"E3583008-C51F-4CD4-9F56-D86D9F4A890F",NA,1329,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"E79143F0-2BB8-4F39-9F9C-13364502C953","WHITE",NA,21,30,"CCDF9DC0-1BBF-4FBD-A23D-D2ABA12FB625","B045F9C8-F831-45BB-8F0B-1A242C787315","UNCID_1626935.631c96e1-7e11-4c0f-a6ea-49cd942f4390.sorted_genome_alignments.bam.bai","TCGA-AP-A1DM-01A-21",60,20,20,20,20,"TOP",20,20,"TCGA-AP-A1DM-01A-02-TSB",40,NA,NA,NA,"TCGA-AP-A1DM-R13620","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"NO",1700,"TUMOR FREE","Alive",NA,"TCGA-AP-A1DM-F29056","TCGA-AP-A1DM",1,"AP","A1DM","YES","C54.1","8380/3","C54.1","NO","YES",-22239,"FEMALE","WHITE",NA,"No","No","Alive",1329,NA,NA,NA,"TUMOR FREE","NO",9,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2007,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
96965044,62329081,2932888292,"70622A15-FDD9-45F4-8EEB-784A77235AC2.bw","ca858743-1f06-40e3-accf-395d08375b63","70622a15-fdd9-45f4-8eeb-784a77235ac2","2016-08-25T15:16:19.734762-05:00","UNCID_2316573.0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c.130909_UNC15-SN850_0327_BD2DT1ACXX_3_CTTGTA.tar.gz","7f3cdabb-b9c5-46b2-a0df-bf74ca3b346c",4037840535,"Illumina HiSeq","bff2bf1204b4becd1ef4cc443694f37a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:01:15.542384-05:00","2016-05-03T11:28:50.231867-05:00","7f3cdabb-b9c5-46b2-a0df-bf74ca3b346c_analysis.xml","993018e323fc0f3a3dcf26d0faf9f082","12c34142-7ee6-4e8d-942d-28e257c20034",2124,"2016-09-29T20:32:11.837984-05:00","7f3cdabb-b9c5-46b2-a0df-bf74ca3b346c_experiment.xml","bf2b8f184f19749b41fbd8823300e376","70b1950b-d678-4d9f-b3f4-acf8e14a5175",2628,"2016-09-29T23:22:18.175915-05:00","7f3cdabb-b9c5-46b2-a0df-bf74ca3b346c_run.xml","7ee5b56c67099592c725ff403f272ec4","da19f404-3480-419a-ad95-43b8d9573922",354,"2016-09-08T10:43:41.205354-05:00","TCGA-BS-A0V7","2016-09-02T18:49:43.411749-05:00","female","TCGA-BS-A0V7_demographic",1958,"native hawaiian or other pacific islander","358c1776-769f-553f-9b5b-edaa92da5a9a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0V7_diagnosis","not reported",17810,"alive","8380/3",NA,1934,"c33af881-6611-57b2-a417-aa419c4974d7","c54.1",-17810,"TCGA-BS-A0V7_treatment","615da570-874a-5d63-b27b-a5b5d7f92d9e","01","false","TCGA-BS-A0V7-01A",NA,"a772ab94-cb06-464c-9a5a-fa4978510f9b",FALSE,"A4515806-9888-48E8-8F9E-491527FFC29C","Primary Tumor",NA,1455,130,NA,1291334400,"21",30,"TCGA-BS-A0V7-01A-21",80,35,0,2,20,15,0,47,"2016-09-08T10:43:41.205354-05:00","2016-09-08T10:43:41.205354-05:00",10,20,10,1,"TOP","BOTTOM",20,2,"9d67b83e-9c43-4820-a480-1ca0e7f15afd","442ecb7f-6800-419e-9cdd-e79ee1426201","TCGA-BS-A0V7-01A-01-BS1","TCGA-BS-A0V7-01A-02-MS2",60,30,"a6eb1a45-9bdf-4250-a5aa-347e9721b4ec","RNA","TCGA-BS-A0V7-01A-21R","d6499dd3-2a20-475f-bb04-74486725ac56",1.84,0.16,"UV Spec","R","23","TCGA-BS-A0V7-01A-21R-A118-07","0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c",0.16,NA,102,35.2941176470588,170,"1d9f3764-9fc4-5ddf-b399-f81330512ce6","TCGA-BS-A0V7_exposure","UNCID_2316573.0fcc0aec-5ef8-4284-a7b5-eb8b328ef02c.130909_UNC15-SN850_0327_BD2DT1ACXX_3_CTTGTA.tar.gz","2014-01-07T09:01:04.000Z","2014-01-07T09:29:03.000Z","7F3CDABB-B9C5-46B2-A0DF-BF74CA3B346C","A772AB94-CB06-464C-9A5A-FA4978510F9B","Unaligned reads",4037840535,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0FCC0AEC-5EF8-4284-A7B5-EB8B328EF02C","University of North Carolina","564a36c5e4b08c5d869007ca","CA858743-1F06-40E3-ACCF-395D08375B63","Uterine Corpus Endometrial Carcinoma","TARGZ","A6EB1A45-9BDF-4250-A5AA-347E9721B4EC","2014-01-07T09:29:03.000Z","D6499DD3-2A20-475F-BB04-74486725AC56","None","NO",1,NA,"Primary Tumor","University of Hawaii",1455,"A6EB1A45-9BDF-4250-A5AA-347E9721B4EC",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E32601C9-C3CF-4923-93AA-40DDFA630978.txt",130,"TCGA-BS-A0V7-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","E1495551-C35F-41A7-B341-54AAF23FA8D8",48,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E32601C9-C3CF-4923-93AA-40DDFA630978.txt","Alive",NA,"TCGA-BS-A0V7","NOT HISPANIC OR LATINO","CC8D8A16-3D6C-46C5-A68A-D419745D41FC",NA,1429,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,21,30,"9D67B83E-9C43-4820-A480-1CA0E7F15AFD","DD4B7740-573E-4298-B4C7-8DFF83708431","TCGA-BS-A0V7-01A-21R-A119-13_mirna.bam.bai","TCGA-BS-A0V7-01A-21",35,15,2,20,47,"BOTTOM",2,1,"TCGA-BS-A0V7-01A-02-MS2",30,NA,NA,NA,NA,NA,NA,NA,"NO",1934,"TUMOR FREE","Alive",NA,"TCGA-BS-A0V7-F17014","TCGA-BS-A0V7",1,"BS","A0V7","YES","C54.1","8380/3","C54.1","NO","YES",-17810,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","NOT HISPANIC OR LATINO","No","No","Alive",1429,NA,NA,NA,"TUMOR FREE","NO",28,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,48,2006,"Other method, specify:",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
34121834,33638568,2504438011,"63F4281A-4D90-4589-879E-549097FB3459.bw","ca8dbbfd-8928-4e25-94c6-b875de631bbd","63f4281a-4d90-4589-879e-549097fb3459","2016-08-05T10:10:53.105100-05:00","UNCID_2209917.85b22bad-9b11-474f-9c87-5ddb98c76ccb.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_7.tar.gz","8415a561-4ff2-4336-a8e7-daf830cefac0",2305632023,"Illumina GA","2155335c66e8239b984c177dc8eeca47","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:09:20.281337-05:00","2016-05-03T11:15:47.413267-05:00","8415a561-4ff2-4336-a8e7-daf830cefac0_analysis.xml","f7e8bcafe8494de0ca7975b00a3e4208","3d913f0a-d5c6-4ff2-9c24-1e1a086d7a1c",2121,"2016-09-29T18:24:03.775395-05:00","8415a561-4ff2-4336-a8e7-daf830cefac0_experiment.xml","1d681618080dd162bd192799bbeb7253","20eee081-5648-467a-a0ef-96c6f5fc0ec5",2257,"2016-09-29T20:15:54.719735-05:00","8415a561-4ff2-4336-a8e7-daf830cefac0_run.xml","c5edad842c98a9980730168968fa97e4","66c1a5d9-b5c7-4ad5-9e5e-c1dcc340ba94",347,"2016-09-08T10:42:54.420322-05:00","TCGA-D1-A17Q","2016-09-02T18:50:43.485038-05:00","female","TCGA-D1-A17Q_demographic",1955,"white","105fd313-edc4-545d-b653-07fd87c0f017","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17Q_diagnosis","not reported",20015,"alive","8380/3",NA,54,"3f107814-8eeb-5e24-9e5a-5a9abc94546f","c54.1",-20015,"TCGA-D1-A17Q_treatment","e38e41c4-7639-565f-b930-b00d395a01d6","01","false","TCGA-D1-A17Q-01A",NA,"b6abeb01-b6ea-4ab4-aa00-ae16cfc88b7c",FALSE,"698079B6-EB07-4491-9672-4BDE4E5DAC49","Primary Tumor",NA,434,130,NA,1294358400,"11",30,"TCGA-D1-A17Q-01A-11",65,NA,0,NA,0,NA,0,NA,"2016-09-08T10:42:54.420322-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"08b233d1-b90a-401a-b29f-b500f62168af",NA,"TCGA-D1-A17Q-01A-01-TSA",NA,100,NA,"bfde1087-8a1a-4341-a1f2-48a0c7ff7b8c","RNA","TCGA-D1-A17Q-01A-11R","504a935f-44c6-4fe7-8f62-cd94276e103c",1.8,0.17,"UV Spec","R","23","TCGA-D1-A17Q-01A-11R-A12I-07","85b22bad-9b11-474f-9c87-5ddb98c76ccb",0.17,NA,68,23.8086901719127,169,"78c2c0a9-6fd1-52d4-ae83-eb3a32f07b75","TCGA-D1-A17Q_exposure","UNCID_2209917.85b22bad-9b11-474f-9c87-5ddb98c76ccb.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_7.tar.gz","2013-10-02T01:56:04.000Z","2013-10-02T02:09:03.000Z","8415A561-4FF2-4336-A8E7-DAF830CEFAC0","B6ABEB01-B6EA-4AB4-AA00-AE16CFC88B7C","Unaligned reads",2305632023,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","85B22BAD-9B11-474F-9C87-5DDB98C76CCB","University of North Carolina","56607a7ce4b0ec1099f8e086","CA8DBBFD-8928-4E25-94C6-B875DE631BBD","Uterine Corpus Endometrial Carcinoma","TARGZ","BFDE1087-8A1A-4341-A1F2-48A0C7FF7B8C","2013-10-02T02:09:03.000Z","504A935F-44C6-4FE7-8F62-CD94276E103C","None","NO",1,NA,"Primary Tumor","Mayo Clinic",434,"BFDE1087-8A1A-4341-A1F2-48A0C7FF7B8C",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5518E1C8-0CB5-4944-B0CD-C80DE1E1B87F.txt",130,"TCGA-D1-A17Q-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","B6ABEB01-B6EA-4AB4-AA00-AE16CFC88B7C",54,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.5518E1C8-0CB5-4944-B0CD-C80DE1E1B87F.txt","Alive",NA,"TCGA-D1-A17Q","NOT HISPANIC OR LATINO","F5A047DC-9EFC-4CBB-9FAC-F6FC4CB59DA3",NA,54,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"08B233D1-B90A-401A-B29F-B500F62168AF","EF6763F0-FC73-4ABD-9537-0CD278DD1BE1","UNCID_2209917.85b22bad-9b11-474f-9c87-5ddb98c76ccb.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_7.tar.gz","TCGA-D1-A17Q-01A-11",65,0,0,0,0,"TOP",0,0,"TCGA-D1-A17Q-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",54,"TUMOR FREE","Alive",NA,"TCGA-D1-A17Q-F20277","TCGA-D1-A17Q",1,"D1","A17Q","YES","C54.1","8380/3","C54.1","NO","YES",-20015,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",54,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
31338537,31063158,2312796357,"2232577D-C1E7-49DB-A0F9-DA3FEDCB1331.bw","caebdce0-f954-471a-ac63-5daaa2e76d97","2232577d-c1e7-49db-a0f9-da3fedcb1331","2016-08-09T14:12:51.868848-05:00","UNCID_2207670.1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_5.tar.gz","f5f2c1dd-cebc-4074-986f-19b3877c6c1f",2018156939,"Illumina GA","476c47072a296a8aebae2549ad973d6c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:42:47.731745-05:00","2016-05-03T11:14:23.412796-05:00","f5f2c1dd-cebc-4074-986f-19b3877c6c1f_analysis.xml","87f803f4bd9ed092c57976954df2c777","070310d7-4bf1-4abb-8915-1c4da872ba46",2121,"2016-09-29T22:13:08.065318-05:00","f5f2c1dd-cebc-4074-986f-19b3877c6c1f_experiment.xml","8a8e060b7f47e7207c1706fa9313141b","af5b3fcd-68fd-4761-9486-370f3351df02",2257,"2016-09-29T20:30:51.354623-05:00","f5f2c1dd-cebc-4074-986f-19b3877c6c1f_run.xml","07562ec518a5249994e05f1d07b74b53","6feaf4d2-511c-460e-80ff-229aebfd72a8",347,"2016-09-08T10:39:52.450266-05:00","TCGA-AX-A1C5","2016-09-02T18:51:31.102574-05:00","female","TCGA-AX-A1C5_demographic",1962,"white","94140e88-a9fa-5519-947c-1960dd16a2cd","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1C5_diagnosis","not reported",17383,"alive","8380/3",NA,1001,"523b2dd3-21d7-51f5-840a-98c0c584d53b","c54.1",-17383,"TCGA-AX-A1C5_treatment","7c8a22d1-d380-5319-9440-b69bdc7d9fa5","01","false","TCGA-AX-A1C5-01A",NA,"cb8bc1f7-c7a2-4378-9f91-a4d76a70435b",FALSE,"6F79B83A-90B4-45DF-8542-A6BC2F93470D","Primary Tumor",NA,517,130,NA,1295308800,"11",30,"TCGA-AX-A1C5-01A-11",70,NA,1,NA,5,NA,34,NA,"2016-09-08T10:39:52.450266-05:00",NA,5,NA,1,NA,"TOP",NA,1,NA,"80d815c6-0f04-40a6-838c-71cec774532a",NA,"TCGA-AX-A1C5-01A-01-TS1",NA,60,NA,"882dd5b9-7138-4a09-a312-9f973f600d48","RNA","TCGA-AX-A1C5-01A-11R","24909727-4d69-44ef-ba40-a40a2be492f6",2.23,0.18,"UV Spec","R","23","TCGA-AX-A1C5-01A-11R-A137-07","1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1",0.18,NA,107,41.796875,160,"17c87eaf-e16b-55de-9f9c-c3ae4f383fb9","TCGA-AX-A1C5_exposure","UNCID_2207670.1bce2d6c-cbe9-4191-b23c-a3bb815ec5e1.110628_UNC6-RDR300211_00110_FC_70K9TAAXX_5.tar.gz","2013-09-30T04:26:04.000Z","2013-09-30T04:38:02.000Z","F5F2C1DD-CEBC-4074-986F-19B3877C6C1F","CB8BC1F7-C7A2-4378-9F91-A4D76A70435B","Unaligned reads",2018156939,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1BCE2D6C-CBE9-4191-B23C-A3BB815EC5E1","University of North Carolina","56607f46e4b016715ab6bd2e","CAEBDCE0-F954-471A-AC63-5DAAA2E76D97","Uterine Corpus Endometrial Carcinoma","TARGZ","882DD5B9-7138-4A09-A312-9F973F600D48","2013-09-30T04:38:02.000Z","24909727-4D69-44EF-BA40-A40A2BE492F6","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",517,"882DD5B9-7138-4A09-A312-9F973F600D48",NA,"AX","b67944fe62fcbe73d4e854f57a9a9782.bam",130,"TCGA-AX-A1C5-01A",NA,"495F644C-3B05-487A-8800-7FEFA6A369A2","TCGA",2009,NA,NA,NA,"CB8BC1F7-C7A2-4378-9F91-A4D76A70435B",47,"nationwidechildrens.org_clinical.TCGA-AX-A1C5.xml","Alive",NA,"TCGA-AX-A1C5","NOT HISPANIC OR LATINO","30A69568-BCA3-4A3A-9823-2502F0B503A9",NA,584,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"1740136A-4E57-41ED-8439-8EF5A9C4C490","WHITE",NA,11,30,"80D815C6-0F04-40A6-838C-71CEC774532A","D662B529-D3DA-41C4-93C5-E96756308858","b67944fe62fcbe73d4e854f57a9a9782.bam","TCGA-AX-A1C5-01A-11",70,5,1,5,34,"TOP",1,1,"TCGA-AX-A1C5-01A-01-TS1",60,"Carboplatin & Paclitaxel","Chemotherapy","TCGA-AX-A1C5-D10398","TCGA-AX-A1C5-R12543","COMBINATION","Primary Tumor Field",NA,NA,584,NA,"Alive",NA,"TCGA-AX-A1C5-F10397","TCGA-AX-A1C5",1,"AX","A1C5","YES","C54.1","8380/3","C54.1","NO","YES",-17383,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",584,NA,NA,NA,"WITH TUMOR","NO",12,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,47,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
115974912,114199224,5454131546,"ACA8E16D-0BA5-4267-8483-13E1A077022B.bw","cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf","aca8e16d-0ba5-4267-8483-13e1a077022b","2016-08-09T14:02:17.957538-05:00","UNCID_2167253.1011cb92-17a6-48b0-95ab-da22acddfb5a.130613_UNC9-SN296_0375_BD27CGACXX_4_TAGCTT.tar.gz","2a7ace9f-65b3-4884-8d40-ebb57613f117",5677765919,"Illumina HiSeq","bf24d1527c8ada1a890be3d26ced219b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:41:07.782515-05:00","2016-05-03T11:07:07.492763-05:00","2a7ace9f-65b3-4884-8d40-ebb57613f117_analysis.xml","397e9d6ac00f51102240aa52413253e3","2bb6f042-cb0f-410c-a47a-d1a969dfd043",2121,"2016-08-26T00:14:44.098528-05:00","2a7ace9f-65b3-4884-8d40-ebb57613f117_experiment.xml","1eb907a5f53947e9dd7d95c6802475e4","95d996e2-9f32-4e06-bf91-425cada4660b",2431,"2016-09-29T21:04:01.791170-05:00","2a7ace9f-65b3-4884-8d40-ebb57613f117_run.xml","e7e84c80cd17d22ca0508bfb6c5db1fb","847befdb-e3f6-4eeb-a1a2-6170fc879831",354,"2016-09-08T11:03:24.399269-05:00","TCGA-AX-A05Y","2016-09-02T18:52:45.367733-05:00","female","TCGA-AX-A05Y_demographic",1947,"white","d62cdfef-4a5d-51b3-90a0-369c60216423","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A05Y_diagnosis","not reported",20904,"alive","8380/3",NA,2684,"a122877f-69ee-5e1e-975d-3ece1c4e4684","c54.1",-20904,"TCGA-AX-A05Y_treatment","722a709c-684a-5209-9163-28a3e8b6d946","11","false","TCGA-AX-A05Y-11A",NA,"82790b63-1c88-49b8-b09f-8b42f0a93c2b",FALSE,NA,"Solid Tissue Normal",NA,2391,140,NA,1308182400,"11",30,"TCGA-AX-A05Y-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T11:03:24.399269-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"0c20881c-9561-4130-816d-bb28e3d48ec7",NA,"TCGA-AX-A05Y-11A-01-TSA",NA,0,NA,"7f488fea-22f5-4c9e-9b73-348c67d1b7ba","RNA","TCGA-AX-A05Y-11A-11R","e14e2802-fcda-444e-9857-8644033f0014",1.89,0.15,"UV Spec","R","23","TCGA-AX-A05Y-11A-11R-A27V-07","1011cb92-17a6-48b0-95ab-da22acddfb5a",0.15,NA,92,33.386558281318,166,"693d99bb-5af1-5412-915b-467c061fe43c","TCGA-AX-A05Y_exposure","UNCID_2167253.1011cb92-17a6-48b0-95ab-da22acddfb5a.130613_UNC9-SN296_0375_BD27CGACXX_4_TAGCTT.tar.gz","2013-09-21T05:26:08.000Z","2013-09-21T05:40:02.000Z","2A7ACE9F-65B3-4884-8D40-EBB57613F117","82790B63-1C88-49B8-B09F-8B42F0A93C2B","Unaligned reads",5677765919,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","1011CB92-17A6-48B0-95AB-DA22ACDDFB5A","University of North Carolina","56607414e4b0ec1099f8a76f","CBE0BD4A-02B7-43E7-B08E-2B0F13560EAF","Uterine Corpus Endometrial Carcinoma","TARGZ","7F488FEA-22F5-4C9E-9B73-348C67D1B7BA","2013-09-21T05:40:02.000Z","E14E2802-FCDA-444E-9857-8644033F0014","None","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",2391,"7F488FEA-22F5-4C9E-9B73-348C67D1B7BA",NA,"AX","5d521848428077a9ec692e25d5dda762.bam",140,"TCGA-AX-A05Y-11A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","BF5BF36E-2C08-4187-801B-A2AECB163383",57,"US82800149_251976011924_S01_GE2_105_Dec08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","Alive",NA,"TCGA-AX-A05Y","NOT HISPANIC OR LATINO","567E05AA-284F-4805-B106-808B26EE1009",NA,2191,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"WHITE",NA,11,30,"0C20881C-9561-4130-816D-BB28E3D48EC7","27192044-0F9A-40F3-9FF8-B11470C6E6E0","5d521848428077a9ec692e25d5dda762.bam","TCGA-AX-A05Y-11A-11",0,100,0,0,0,"TOP",0,0,"TCGA-AX-A05Y-11A-01-TSA",0,NA,NA,NA,NA,NA,NA,NA,NA,2191,"TUMOR FREE","Alive",NA,"TCGA-AX-A05Y-F5568","TCGA-AX-A05Y",1,"AX","A05Y","YES","C54.1","8380/3","C54.1","NO","YES",-20904,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2191,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
37184021,36967334,2719472369,"A6DCB76D-40D2-4A7C-81C9-E9E0229D88B1.bw","cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf","a6dcb76d-40d2-4a7c-81c9-e9e0229d88b1","2016-08-09T14:16:33.085419-05:00","UNCID_2215610.153cecfe-8963-4b96-8cc3-d2870ce8e584.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_4.tar.gz","6b53feda-b3ae-4a42-8b83-f119c14d0285",2308249124,"Illumina GA","0b2b5c77265ee1c68c64d4e56fa26dd3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:47:55.475593-05:00","2016-05-03T11:18:46.977159-05:00","6b53feda-b3ae-4a42-8b83-f119c14d0285_analysis.xml","3a92066194fd819b5689c043949c08df","0a57fe3e-36c7-4536-8217-669884b999a4",2122,"2016-09-29T17:59:57.533686-05:00","6b53feda-b3ae-4a42-8b83-f119c14d0285_experiment.xml","38715e2dae045e9a037c8640b6b33cf8","11edf71f-8e0c-49cd-9eac-fc04a087c844",2256,"2016-09-29T23:46:44.069436-05:00","6b53feda-b3ae-4a42-8b83-f119c14d0285_run.xml","ac11661c8c2ba897be7523da895b6cf3","e988df86-d865-4a45-80ef-d4042fc060cf",345,"2016-09-08T11:03:24.399269-05:00","TCGA-AX-A05Y","2016-09-02T18:52:45.367733-05:00","female","TCGA-AX-A05Y_demographic",1947,"white","d62cdfef-4a5d-51b3-90a0-369c60216423","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A05Y_diagnosis","not reported",20904,"alive","8380/3",NA,2684,"a122877f-69ee-5e1e-975d-3ece1c4e4684","c54.1",-20904,"TCGA-AX-A05Y_treatment","722a709c-684a-5209-9163-28a3e8b6d946","01","false","TCGA-AX-A05Y-01A",NA,"60e1de46-8c8f-4fa9-bc51-ce975d02d5ac",FALSE,"7E7D9403-AA77-4F14-9017-3B69F66D8EBC","Primary Tumor",NA,1967,230,NA,1275868800,"11",30,"TCGA-AX-A05Y-01A-11",92,96,0,0,0,0,5,2,"2016-09-08T11:03:24.399269-05:00","2016-09-08T11:03:24.399269-05:00",0,0,5,2,"TOP","BOTTOM",3,2,"9a336ebb-191b-408d-be0a-901386e9c59b","3d803842-442e-4429-9669-f6e405eb3cb7","TCGA-AX-A05Y-01A-01-TS1","TCGA-AX-A05Y-01A-01-BS1",92,96,"f31f3dcf-ab1a-4a11-a9d2-e950d4774efb","RNA","TCGA-AX-A05Y-01A-11R","f11f0bc6-a6fd-4bee-97ce-8b067a16fbfa",1.83,0.15,"UV Spec","R","23","TCGA-AX-A05Y-01A-11R-A00V-07","153cecfe-8963-4b96-8cc3-d2870ce8e584",0.15,NA,92,33.386558281318,166,"693d99bb-5af1-5412-915b-467c061fe43c","TCGA-AX-A05Y_exposure","UNCID_2215610.153cecfe-8963-4b96-8cc3-d2870ce8e584.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_4.tar.gz","2013-10-04T03:36:04.000Z","2013-10-04T03:49:04.000Z","6B53FEDA-B3AE-4A42-8B83-F119C14D0285","60E1DE46-8C8F-4FA9-BC51-CE975D02D5AC","Unaligned reads",2308249124,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","153CECFE-8963-4B96-8CC3-D2870CE8E584","University of North Carolina","564a3858e4b093830b684902","CBE0BD4A-02B7-43E7-B08E-2B0F13560EAF","Uterine Corpus Endometrial Carcinoma","TARGZ","F31F3DCF-AB1A-4A11-A9D2-E950D4774EFB","2013-10-04T03:49:04.000Z","F11F0BC6-A6FD-4BEE-97CE-8B067A16FBFA","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1967,"F31F3DCF-AB1A-4A11-A9D2-E950D4774EFB",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.52EF3E35-2A73-4880-91BE-E768E8DD7D08.txt",230,"TCGA-AX-A05Y-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","BF5BF36E-2C08-4187-801B-A2AECB163383",57,"US82800149_251976011924_S01_GE2_105_Dec08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","Alive",NA,"TCGA-AX-A05Y","NOT HISPANIC OR LATINO","567E05AA-284F-4805-B106-808B26EE1009",NA,2191,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"WHITE",NA,11,30,"9A336EBB-191B-408D-BE0A-901386E9C59B","82A64C81-DE6D-4087-92AF-A5B873793CA0","TCGA-AX-A05Y-01A-11R-A00W_mirna.bam.bai","TCGA-AX-A05Y-01A-11",96,0,0,0,2,"BOTTOM",2,2,"TCGA-AX-A05Y-01A-01-BS1",96,NA,NA,NA,NA,NA,NA,NA,NA,2191,"TUMOR FREE","Alive",NA,"TCGA-AX-A05Y-F5568","TCGA-AX-A05Y",1,"AX","A05Y","YES","C54.1","8380/3","C54.1","NO","YES",-20904,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2191,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34377278,32262895,2417413131,"6C8E7334-2E64-4611-9857-3BD4B3C9EA69.bw","cc058b8c-df40-4f9e-88e3-3d1131b22b41","6c8e7334-2e64-4611-9857-3bd4b3c9ea69","2016-08-05T07:46:19.396387-05:00","UNCID_2211934.666ecfed-75d2-412a-bd7f-24b9775db969.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_8.tar.gz","79302c51-8426-4c89-8b4b-2e28bf1d837e",2138351651,"Illumina GA","7ac7b5a5d48ff4ad9b5210490ca2e894","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:22:09.341153-05:00","2016-05-03T11:16:29.242391-05:00","79302c51-8426-4c89-8b4b-2e28bf1d837e_analysis.xml","d34667dc8a68a88fda04df36a5188b2d","6a94e253-706a-4581-9d0d-ae9719710dbd",2121,"2016-08-13T09:32:14.741530-05:00","79302c51-8426-4c89-8b4b-2e28bf1d837e_experiment.xml","eece17c4353948c9d2f7a7d0699c778e","3488b1a8-d7d2-4ee9-960a-2e5f935566cb",2257,"2016-09-29T17:56:26.060445-05:00","79302c51-8426-4c89-8b4b-2e28bf1d837e_run.xml","318c39bff3e5c87fb44cb176e86631c5","0faec182-2016-41d7-8e73-6564f49ae563",347,"2016-09-08T10:34:25.149398-05:00","TCGA-BG-A0VT","2016-09-02T18:49:09.413121-05:00","female","TCGA-BG-A0VT_demographic",1954,"white","e994a2fd-e48e-59d3-8f79-518983164bf1","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0VT_diagnosis","not reported",20602,"alive","8380/3",NA,1568,"3d11de4e-227e-54c3-a47f-a4bd36c33697","c54.1",-20602,"TCGA-BG-A0VT_treatment","56e89139-ad72-5a22-961d-c5865816bc0c","01","true","TCGA-BG-A0VT-01A",NA,"0cfbcb61-c5e2-47f7-beb6-504f3cd4605b",FALSE,"0BC38740-A7B9-4086-9F03-A139287B33CC","Primary Tumor",NA,87,70,NA,1287705600,"11",30,"TCGA-BG-A0VT-01A-11",70,70,0,20,30,0,0,20,"2016-09-08T10:34:25.149398-05:00","2016-09-08T10:34:25.149398-05:00",1,30,0,40,"TOP","BOTTOM",10,10,"7425fe9f-c4ba-4867-8ca5-b921ca5e3138","152b81ef-e8ed-446a-b00f-776ba3df3bec","TCGA-BG-A0VT-01A-01-MSA","TCGA-BG-A0VT-01A-01-BSA",60,70,"47159fec-afa8-4a67-b36c-8b826e392d82","RNA","TCGA-BG-A0VT-01A-11R","0994329c-a931-40b4-9477-fb9a051d8dc8",1.84,0.16,"UV Spec","R","23","TCGA-BG-A0VT-01A-11R-A10J-07","666ecfed-75d2-412a-bd7f-24b9775db969",0.16,NA,144,49.8269896193772,170,"9bdc9340-4e96-5c13-aba3-3daa119ab453","TCGA-BG-A0VT_exposure","UNCID_2211934.666ecfed-75d2-412a-bd7f-24b9775db969.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_8.tar.gz","2013-10-03T04:13:04.000Z","2013-10-03T04:26:03.000Z","79302C51-8426-4C89-8B4B-2E28BF1D837E","0CFBCB61-C5E2-47F7-BEB6-504F3CD4605B","Unaligned reads",2138351651,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","666ECFED-75D2-412A-BD7F-24B9775DB969","University of North Carolina","564a353be4b093830b674baa","CC058B8C-DF40-4F9E-88E3-3D1131B22B41","Uterine Corpus Endometrial Carcinoma","TARGZ","47159FEC-AFA8-4A67-B36C-8B826E392D82","2013-10-03T04:26:03.000Z","0994329C-A931-40B4-9477-FB9A051D8DC8","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",87,"47159FEC-AFA8-4A67-B36C-8B826E392D82",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.EA1D2D67-9237-433D-A6B5-D3918D8BF59A.txt",70,"TCGA-BG-A0VT-01A",NA,"D3FA983D-287C-4BC0-A71D-B0A408AA2406","TCGA",2010,NA,NA,"TUMOR FREE","FC406E6A-7C7B-4917-997A-1D9FE8B92970",56,"unc.edu.666ecfed-75d2-412a-bd7f-24b9775db969.1647245.junction_quantification.txt","Alive",NA,"TCGA-BG-A0VT","NOT HISPANIC OR LATINO","50A40C8C-C734-4802-B81B-E4E30101504B",NA,224,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,11,30,"7425FE9F-C4BA-4867-8CA5-B921CA5E3138","50F648FC-AEF5-443A-A3AB-22323A2491E2","DEBUT_p_TCGAb45_81_wRedosSNP_N_GenomeWideSNP_6_A01_729542.nocnv_hg18.seg.txt","TCGA-BG-A0VT-01A-11",70,0,20,30,20,"BOTTOM",10,40,"TCGA-BG-A0VT-01A-01-BSA",70,"Taxol","Chemotherapy","TCGA-BG-A0VT-D55548",NA,NA,NA,"TCGA-BG-A0VT-F34081_NTE-1","NO",742,"TUMOR FREE","Alive",NA,"TCGA-BG-A0VT-F34081","TCGA-BG-A0VT",1,"BG","A0VT","YES","C54.1","8380/3","C54.1","NO","YES",-20602,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",224,NA,NA,NA,"TUMOR FREE","NO",16,3,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
32056400,31574950,2367461820,"77A27A5A-7DE7-4D82-BD76-6C073F0A2E8F.bw","cc141997-edab-4aae-a056-0c079eaa7362","77a27a5a-7de7-4d82-bd76-6c073f0a2e8f","2016-08-09T14:15:40.684296-05:00","UNCID_2210694.640190cd-cd16-4a1a-8e63-9e41db6c3f89.110323_UNC3-RDR300156_00085_FC_706FWAAXX_6.tar.gz","a3458984-98b4-4f2d-8d47-c1e9a31ec480",2068067120,"Illumina GA","8cdd49796c4113333005dc13daf2ff11","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:03:48.325918-05:00","2016-05-03T11:15:47.421196-05:00","a3458984-98b4-4f2d-8d47-c1e9a31ec480_analysis.xml","e40070e1e3aa2038016f649780ec0333","a9b37712-d1cf-4330-887b-91948ea5f2d8",2121,"2016-10-07T16:29:25.234796-05:00","a3458984-98b4-4f2d-8d47-c1e9a31ec480_experiment.xml","52c8a7e1c1b638b3841632725d0a289b","8f568578-e4fb-459b-a8df-1887281dcda8",2257,"2016-09-29T20:21:50.185386-05:00","a3458984-98b4-4f2d-8d47-c1e9a31ec480_run.xml","8a231db6787bebe2d406556caf8b4ad0","6a5e4dad-6496-450f-92f7-07d67f52e6f6",347,"2016-09-08T11:34:29.840133-05:00","TCGA-B5-A11Z","2016-09-02T18:49:08.850547-05:00","female","TCGA-B5-A11Z_demographic",1949,"white","e62a79ee-848d-50f1-a4e5-e32f4eb1605b","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11Z_diagnosis","not reported",22505,"alive","8380/3",NA,528,"d6c19cf3-0ae9-5911-ae67-1e2664af27a8","c54.1",-22505,"TCGA-B5-A11Z_treatment","5f3f631b-6729-5489-a9ab-cfaa34c91631","01","true","TCGA-B5-A11Z-01A",NA,"2a8af07b-b514-4cd0-bf20-03a5f5abdb38",FALSE,"62C170A9-710F-45C0-B6BB-3F491A86A7E4","Primary Tumor",NA,213,340,NA,1290556800,"11",30,"TCGA-B5-A11Z-01A-11",85,90,0,0,0,0,0,0,"2016-09-08T11:34:29.840133-05:00","2016-09-08T11:34:29.840133-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"579feafb-e8e2-41f8-a0c2-b7c8679f0ac7","f410f4c3-60ec-45bb-bf5c-7dfc75e4da5c","TCGA-B5-A11Z-01A-01-BSA","TCGA-B5-A11Z-01A-01-TSA",100,100,"1c8862af-aab1-48ad-b10c-009d488b1d05","RNA","TCGA-B5-A11Z-01A-11R","e072b5c0-c2f7-4ebc-a2ad-e48ca0edc4e3",1.78,0.15,"UV Spec","R","23","TCGA-B5-A11Z-01A-11R-A10J-07","640190cd-cd16-4a1a-8e63-9e41db6c3f89",0.15,NA,84,28.3937263385614,172,"145cb85d-d954-587e-b314-620843e2bbc6","TCGA-B5-A11Z_exposure","UNCID_2210694.640190cd-cd16-4a1a-8e63-9e41db6c3f89.110323_UNC3-RDR300156_00085_FC_706FWAAXX_6.tar.gz","2013-10-02T15:01:03.000Z","2013-10-02T15:14:02.000Z","A3458984-98B4-4F2D-8D47-C1E9A31EC480","2A8AF07B-B514-4CD0-BF20-03A5F5ABDB38","Unaligned reads",2068067120,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","640190CD-CD16-4A1A-8E63-9E41DB6C3F89","University of North Carolina","564a3288e4b09c884b21a4ef","CC141997-EDAB-4AAE-A056-0C079EAA7362","Uterine Corpus Endometrial Carcinoma","TARGZ","1C8862AF-AAB1-48AD-B10C-009D488B1D05","2013-10-02T15:14:02.000Z","E072B5C0-C2F7-4EBC-A2AD-E48CA0EDC4E3","United States","NO",1,NA,"Primary Tumor","Duke",213,"1C8862AF-AAB1-48AD-B10C-009D488B1D05",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.6CEE54D4-5FA9-4D01-82BF-C5B6A6341AB3.txt",340,"TCGA-B5-A11Z-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","C90E88AC-361F-4449-B841-FD6052613ECB",61,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.6CEE54D4-5FA9-4D01-82BF-C5B6A6341AB3.txt","Alive",NA,"TCGA-B5-A11Z",NA,"92307D89-9FBF-430A-A4BB-4C650D284B1D",NA,291,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,11,30,"F410F4C3-60EC-45BB-BF5C-7DFC75E4DA5C","E072B5C0-C2F7-4EBC-A2AD-E48CA0EDC4E3","DEBUT_p_TCGAb45_81_wRedosSNP_N_GenomeWideSNP_6_E08_729550.nocnv_hg18.seg.txt","TCGA-B5-A11Z-01A-11",85,0,0,0,0,"BOTTOM",0,0,"TCGA-B5-A11Z-01A-01-BSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",528,"TUMOR FREE","Alive",NA,"TCGA-B5-A11Z-F17833","TCGA-B5-A11Z",1,"B5","A11Z","YES","C54.1","8380/3","C54.1","NO","YES",-22505,"FEMALE","WHITE",NA,"No","No","Alive",291,NA,NA,NA,"TUMOR FREE","NO",22,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28844393,28444297,2126753696,"CAD6E491-88FB-4221-90E9-AC9C68AECCB0.bw","cca5717d-226d-4390-a99b-c7aed6d9d70e","cad6e491-88fb-4221-90e9-ac9c68aeccb0","2016-08-09T14:11:33.692353-05:00","UNCID_2207045.e4db21b5-9a76-47c1-b838-10f49d2696d0.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_1.tar.gz","5083b54f-8143-4c43-9397-c0327a772f7c",1867868715,"Illumina GA","5e59de26a1a9f5025da3d17dd5e23891","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:49:55.897401-05:00","2016-05-03T11:13:42.364824-05:00","5083b54f-8143-4c43-9397-c0327a772f7c_analysis.xml","061e3e560abbbcb333ce314e0b0ad1ae","314c664e-4bc0-44d9-b0b2-4df90ea7fe99",2121,"2016-10-07T16:26:29.156417-05:00","5083b54f-8143-4c43-9397-c0327a772f7c_experiment.xml","505315e650d2bbfb6c30c6f21c318d7e","fd061841-0905-4124-8b78-7b23de3812fc",2257,"2016-09-29T19:54:05.535006-05:00","5083b54f-8143-4c43-9397-c0327a772f7c_run.xml","4888dffdb426a39b9340d678d6fc1e80","59835265-a5ef-465a-a869-7a3ac0c3cff9",347,"2016-09-08T10:35:14.861466-05:00","TCGA-AP-A0LG","2016-09-02T18:54:26.932980-05:00","female","TCGA-AP-A0LG_demographic",1948,"white","dc97087e-e474-5a4a-ae55-9df2cd584547","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LG_diagnosis","not reported",20047,"alive","8380/3",NA,2015,"6ce71ba2-cd75-57ee-af14-db1e0b405777","c54.1",-20047,"TCGA-AP-A0LG_treatment","695886f4-309d-58ac-aefc-e2c3eb137fae","01","true","TCGA-AP-A0LG-01A",NA,"031667f8-38d9-4df3-a18e-32cc426d234b",FALSE,"7343A9B5-276E-4EE1-AC06-27835D63B0E2","Primary Tumor",NA,2833,360,NA,1278547200,"11",30,"TCGA-AP-A0LG-01A-11",90,90,0,0,0,0,0,0,"2016-09-08T10:35:14.861466-05:00","2016-09-08T10:35:14.861466-05:00",0,0,0,0,"TOP","BOTTOM",0,20,"baf8495c-f210-4bd6-99bd-3f6d558aea44","a7e14a9a-8172-4e41-b6bd-de60f3c1330d","TCGA-AP-A0LG-01A-01-TSA","TCGA-AP-A0LG-01A-01-BSA",100,80,"0435bafb-f1e8-4413-b25a-9af52e9f88c7","RNA","TCGA-AP-A0LG-01A-11R","dae0c39d-947b-4c11-b518-dfefe267661a",1.81,0.17,"UV Spec","R","23","TCGA-AP-A0LG-01A-11R-A16W-07","e4db21b5-9a76-47c1-b838-10f49d2696d0",0.17,NA,76,28.6047649516354,163,"416c1d18-dfc9-582b-b5e9-69aa3615deef","TCGA-AP-A0LG_exposure","UNCID_2207045.e4db21b5-9a76-47c1-b838-10f49d2696d0.110728_UNC6-RDR300211_00118_FC_70KA8AAXX_1.tar.gz","2013-09-29T04:13:10.000Z","2013-09-29T04:25:02.000Z","5083B54F-8143-4C43-9397-C0327A772F7C","031667F8-38D9-4DF3-A18E-32CC426D234B","Unaligned reads",1867868715,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E4DB21B5-9A76-47C1-B838-10F49D2696D0","University of North Carolina","564a3a26e4b08c5d86911c43","CCA5717D-226D-4390-A99B-C7AED6D9D70E","Uterine Corpus Endometrial Carcinoma","TARGZ","0435BAFB-F1E8-4413-B25A-9AF52E9F88C7","2013-09-29T04:25:02.000Z","DAE0C39D-947B-4C11-B518-DFEFE267661A","None","NO",1,NA,"Primary Tumor","MSKCC",2833,"0435BAFB-F1E8-4413-B25A-9AF52E9F88C7",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7058B69A-0F87-471D-A36D-E355BC950F3E.txt",360,"TCGA-AP-A0LG-01A",NA,NA,"TCGA",2002,NA,NA,"TUMOR FREE","9319DFAF-A180-4375-A7E6-5D988E6C8E56",54,"US82800149_251976012220_S01_GE2_105_Dec08.txt","Alive",NA,"TCGA-AP-A0LG",NA,"ED4BAEF7-FA2B-47AC-979E-718E9E41A5F4",NA,2015,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"A2083B4A-37EB-4ACE-AED1-E32C1A54757F","WHITE",NA,11,30,"BAF8495C-F210-4BD6-99BD-3F6D558AEA44","2B4DAF78-3687-4043-A3DA-E6926CBD0BEE","nationwidechildrens.org_biospecimen.TCGA-AP-A0LG.xml","TCGA-AP-A0LG-01A-11",90,0,0,0,0,"BOTTOM",20,0,"TCGA-AP-A0LG-01A-01-BSA",80,NA,NA,NA,"TCGA-AP-A0LG-R3849","IMPLANTS","Primary Tumor Field",NA,NA,2015,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LG-F3848","TCGA-AP-A0LG",1,"AP","A0LG","YES","C54.1","8380/3","C54.1","NO","YES",-20047,"FEMALE","WHITE",NA,"No","No","Alive",2015,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2002,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28763624,28296196,2121732381,"4CD103C8-2FD7-4550-90D1-21B4B7DA86A9.bw","ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38","4cd103c8-2fd7-4550-90d1-21b4b7da86a9","2016-08-05T11:13:11.046515-05:00","UNCID_2210064.a6ba27cf-7e06-4a44-a948-8575593272cb.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_2.tar.gz","63ca4e2a-30b9-4010-bf40-70af25dbb9de",1827206161,"Illumina GA","c6a7cbe8c55fca8246b18f174385c2e2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:33:07.980076-05:00","2016-05-03T11:15:47.403263-05:00","63ca4e2a-30b9-4010-bf40-70af25dbb9de_analysis.xml","910f8bc9402feb57c2c4bd39de55a390","96a3b251-7f70-4521-8326-937c9b503d25",2120,"2016-10-07T17:23:48.691006-05:00","63ca4e2a-30b9-4010-bf40-70af25dbb9de_experiment.xml","ec157888785ef17574a6d11e35295237","730713b4-7a4d-4b42-ad43-5bc07269ed1b",2257,"2016-09-29T21:25:46.120311-05:00","63ca4e2a-30b9-4010-bf40-70af25dbb9de_run.xml","8b5c7fc592755fad1bbda52d6faf7c9d","92165306-73e9-4321-9201-041121e50e84",347,"2016-09-08T11:36:09.045222-05:00","TCGA-BK-A13C","2016-09-02T18:49:41.447518-05:00","female","TCGA-BK-A13C_demographic",1963,"black or african american","51289bbf-8cc2-5022-bfdd-b1377b17ce22","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A13C_diagnosis","not reported",17317,"alive","8380/3",NA,760,"609011ba-d2fd-5a6c-a353-3959ab108622","c54.1",-17317,"TCGA-BK-A13C_treatment","ae363043-0668-5e9f-82b7-125cf2d2d6cc","11","false","TCGA-BK-A13C-11A",NA,"badde2a2-91b8-4f92-9993-a854f408c887",FALSE,NA,"Solid Tissue Normal",NA,146,270,NA,1291852800,"11",30,"TCGA-BK-A13C-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T11:36:09.045222-05:00",NA,10,NA,0,NA,"TOP",NA,0,NA,"d2bde2c5-6261-41c4-8d13-60cd839647f2",NA,"TCGA-BK-A13C-11A-01-TS1",NA,0,NA,"a5a694f1-916c-4332-8e88-a1711886867e","RNA","TCGA-BK-A13C-11A-11R","5e832945-e5ab-4021-9ea1-40fcc2f71f48",1.8,0.16,"UV Spec","R","23","TCGA-BK-A13C-11A-11R-A118-07","a6ba27cf-7e06-4a44-a948-8575593272cb",0.16,NA,93,33.7494556539411,166,"cc6f1bed-847c-5811-a3bc-2e3f40b3ba70","TCGA-BK-A13C_exposure","UNCID_2210064.a6ba27cf-7e06-4a44-a948-8575593272cb.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_2.tar.gz","2013-10-02T05:06:05.000Z","2013-10-02T05:18:03.000Z","63CA4E2A-30B9-4010-BF40-70AF25DBB9DE","BADDE2A2-91B8-4F92-9993-A854F408C887","Unaligned reads",1827206161,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A6BA27CF-7E06-4A44-A948-8575593272CB","University of North Carolina","56607da0e4b018727fea33cb","CE73D0AA-BB3D-4AA3-8ED3-E9912CF25D38","Uterine Corpus Endometrial Carcinoma","TARGZ","A5A694F1-916C-4332-8E88-A1711886867E","2013-10-02T05:18:03.000Z","5E832945-E5AB-4021-9EA1-40FCC2F71F48","None","NO",11,NA,"Solid Tissue Normal","Christiana Healthcare",146,"A5A694F1-916C-4332-8E88-A1711886867E",NA,"BK","UNCID_215478.TCGA-BK-A13C-11A-11R-A118-07.110412_UNC2-RDR300275_00062_FC_64GKPAAXX.2.trimmed.annotated.translated_to_genomic.bam.bai",270,"TCGA-BK-A13C-11A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","BADDE2A2-91B8-4F92-9993-A854F408C887",47,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C833D378-9B97-4808-806E-A9DEE1298AE3.txt","Alive",NA,"TCGA-BK-A13C","NOT HISPANIC OR LATINO","409A6F8F-B26A-4594-8719-AFCF0AEF7181",NA,202,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"D2BDE2C5-6261-41C4-8D13-60CD839647F2","BC9159BD-3DEA-47BA-AFB6-79CB463AAA54","UNCID_215478.TCGA-BK-A13C-11A-11R-A118-07.110412_UNC2-RDR300275_00062_FC_64GKPAAXX.2.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-BK-A13C-11A-11",0,100,0,10,0,"TOP",0,0,"TCGA-BK-A13C-11A-01-TS1",0,NA,NA,NA,NA,NA,NA,"TCGA-BK-A13C-F40813_NTE-1","NO",760,"TUMOR FREE","Alive",NA,"TCGA-BK-A13C-F40813","TCGA-BK-A13C",1,"BK","A13C","YES","C54.1","8380/3","C54.1","YES","NO",-17317,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",202,NA,NA,NA,"TUMOR FREE","NO",17,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,47,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
29637267,28335932,2116340230,"A129599B-81EC-4AF0-B74A-4FB9483A3A7E.bw","ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38","a129599b-81ec-4af0-b74a-4fb9483a3a7e","2016-08-05T05:26:14.360591-05:00","UNCID_2210075.a7dc4fdb-a62d-4d84-b351-16d84ab202e3.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_1.tar.gz","5ae65eff-f185-48dd-a59d-aae994b51eb7",1855928225,"Illumina GA","c5254a95b89c41d0bf28a1cab5678568","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:54:44.009039-05:00","2016-05-03T11:15:47.403263-05:00","5ae65eff-f185-48dd-a59d-aae994b51eb7_analysis.xml","c31076fa4f22823b4dd2b9316c8bb3cd","59ed809c-732d-44f1-9fb4-5f04a0e9d81d",2121,"2016-10-07T16:25:22.096260-05:00","5ae65eff-f185-48dd-a59d-aae994b51eb7_experiment.xml","2aeb42ffd419a822bf997ddd2857ecfd","b5b9e6f2-e63e-4a74-9f35-74f606303eb1",2257,"2016-09-29T23:39:36.645175-05:00","5ae65eff-f185-48dd-a59d-aae994b51eb7_run.xml","56d0fa02ef991170f4a2e8ef18cf6d25","e4f8bd92-4524-47d9-b602-5cd1e3c94cd6",347,"2016-09-08T11:36:09.045222-05:00","TCGA-BK-A13C","2016-09-02T18:49:41.447518-05:00","female","TCGA-BK-A13C_demographic",1963,"black or african american","51289bbf-8cc2-5022-bfdd-b1377b17ce22","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A13C_diagnosis","not reported",17317,"alive","8380/3",NA,760,"609011ba-d2fd-5a6c-a353-3959ab108622","c54.1",-17317,"TCGA-BK-A13C_treatment","ae363043-0668-5e9f-82b7-125cf2d2d6cc","01","false","TCGA-BK-A13C-01A",NA,"7cc1bcb4-63a2-4585-b936-30a9e23caccc",FALSE,"2043D579-6785-4775-8A28-CDE3F1400BA2","Primary Tumor",NA,146,310,NA,1291852800,"11",30,"TCGA-BK-A13C-01A-11",80,90,10,0,10,10,10,0,"2016-09-08T11:36:09.045222-05:00","2016-09-08T11:36:09.045222-05:00",20,10,20,0,"TOP","BOTTOM",20,10,"db0344ee-6f00-4f53-85f8-734fc308f98a","b97e487f-7343-4f67-946a-0c25cfedc5b1","TCGA-BK-A13C-01A-01-TS1","TCGA-BK-A13C-01A-01-BS1",60,80,"f11c024d-4b65-4e46-ad47-1b103fd2e8de","RNA","TCGA-BK-A13C-01A-11R","fbdd40ae-0a2e-4404-a0ec-babe3db426b2",1.87,0.16,"UV Spec","R","23","TCGA-BK-A13C-01A-11R-A118-07","a7dc4fdb-a62d-4d84-b351-16d84ab202e3",0.16,NA,93,33.7494556539411,166,"cc6f1bed-847c-5811-a3bc-2e3f40b3ba70","TCGA-BK-A13C_exposure","UNCID_2210075.a7dc4fdb-a62d-4d84-b351-16d84ab202e3.110412_UNC2-RDR300275_00062_FC_64GKPAAXX_1.tar.gz","2013-10-02T05:16:04.000Z","2013-10-02T05:28:03.000Z","5AE65EFF-F185-48DD-A59D-AAE994B51EB7","7CC1BCB4-63A2-4585-B936-30A9E23CACCC","Unaligned reads",1855928225,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A7DC4FDB-A62D-4D84-B351-16D84AB202E3","University of North Carolina","56607d9be4b0b37b3d992ca9","CE73D0AA-BB3D-4AA3-8ED3-E9912CF25D38","Uterine Corpus Endometrial Carcinoma","TARGZ","F11C024D-4B65-4E46-AD47-1B103FD2E8DE","2013-10-02T05:28:03.000Z","FBDD40AE-0A2E-4404-A0EC-BABE3DB426B2","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",146,"F11C024D-4B65-4E46-AD47-1B103FD2E8DE",NA,"BK","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C833D378-9B97-4808-806E-A9DEE1298AE3.txt",310,"TCGA-BK-A13C-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","BADDE2A2-91B8-4F92-9993-A854F408C887",47,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C833D378-9B97-4808-806E-A9DEE1298AE3.txt","Alive",NA,"TCGA-BK-A13C","NOT HISPANIC OR LATINO","409A6F8F-B26A-4594-8719-AFCF0AEF7181",NA,202,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"DB0344EE-6F00-4F53-85F8-734FC308F98A","D4030218-C9FB-43D2-9AAA-744C7EAA9894","UNCID_1630516.a7dc4fdb-a62d-4d84-b351-16d84ab202e3.sorted_genome_alignments.bam","TCGA-BK-A13C-01A-11",90,10,0,10,0,"BOTTOM",10,0,"TCGA-BK-A13C-01A-01-BS1",80,NA,NA,NA,NA,NA,NA,"TCGA-BK-A13C-F40813_NTE-1","NO",760,"TUMOR FREE","Alive",NA,"TCGA-BK-A13C-F40813","TCGA-BK-A13C",1,"BK","A13C","YES","C54.1","8380/3","C54.1","YES","NO",-17317,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",202,NA,NA,NA,"TUMOR FREE","NO",17,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,47,2010,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
116268506,109180732,5178071810,"412F9B5E-324D-40CC-A8F3-FA9C1FCC83C0.bw","cf77afe9-3785-45d4-ba2a-61c9cb706225","412f9b5e-324d-40cc-a8f3-fa9c1fcc83c0","2016-08-09T14:19:07.704798-05:00","UNCID_2234454.98327e51-9e30-4d72-a4b1-19b62b4d3cd2.130619_UNC13-SN749_0277_BC293YACXX_1_CTTGTA.tar.gz","440f64d1-7fc7-4f07-a57e-c2f8fef84473",4954069437,"Illumina HiSeq","7c08fc3099dbc80a78f1c35550c522bc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:58:51.683531-05:00","2016-05-03T11:20:13.161874-05:00","440f64d1-7fc7-4f07-a57e-c2f8fef84473_analysis.xml","411c2c6a0be3690e782537d8f3465404","814969cc-5470-44be-925b-8cdc42d18b13",2124,"2016-09-29T18:15:53.153401-05:00","440f64d1-7fc7-4f07-a57e-c2f8fef84473_experiment.xml","ea05fd3c5dadab4f9ebce76d60926b38","1bd8c2b3-dff7-4922-9e14-4d4dfdd4db37",2431,"2016-09-29T23:39:48.208295-05:00","440f64d1-7fc7-4f07-a57e-c2f8fef84473_run.xml","e0626154241072368396d1c137d474f2","e519f599-bae2-4036-8844-7ec1a50f6e68",354,"2016-09-08T12:06:14.533959-05:00","TCGA-A5-A2K5","2016-09-02T18:53:12.236610-05:00","female","TCGA-A5-A2K5_demographic",1935,"white","90e1163b-6080-5f74-b548-83420da90baf","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A2K5_diagnosis","not reported",28057,"alive","8380/3",NA,752,"2a714244-9f8e-5acd-b228-19563cf28716","c54.1",-28057,"TCGA-A5-A2K5_treatment","db2b6dff-7eba-530d-8b9f-5d5db50d1ff3","01","true","TCGA-A5-A2K5-01A",NA,"eca91844-e767-4045-a87f-e43dafbcc17a",FALSE,"FF305857-5814-4815-90D3-B54BAA0DACB4","Primary Tumor",NA,171,290,NA,1313452800,"11",30,"TCGA-A5-A2K5-01A-11",90,NA,3,NA,0,NA,20,NA,"2016-09-08T12:06:14.533959-05:00",NA,5,NA,0,NA,"TOP",NA,5,NA,"5bf478ca-f1e0-4fd6-86f0-e4a3daa48dfb",NA,"TCGA-A5-A2K5-01A-01-TS1",NA,75,NA,"aef3b317-4622-41ba-b2eb-9cd94d7ba187","RNA","TCGA-A5-A2K5-01A-11R","2d484caa-07b5-489e-af1d-acf36441e7f6",1.78,0.17,"UV Spec","R","23","TCGA-A5-A2K5-01A-11R-A180-07","98327e51-9e30-4d72-a4b1-19b62b4d3cd2",0.17,NA,127,47.8000677481275,163,"0135d838-a478-587b-802a-d3cd8984b8e4","TCGA-A5-A2K5_exposure","UNCID_2234454.98327e51-9e30-4d72-a4b1-19b62b4d3cd2.130619_UNC13-SN749_0277_BC293YACXX_1_CTTGTA.tar.gz","2013-10-18T20:21:05.000Z","2013-10-18T20:35:01.000Z","440F64D1-7FC7-4F07-A57E-C2F8FEF84473","ECA91844-E767-4045-A87F-E43DAFBCC17A","Unaligned reads",4954069437,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","98327E51-9E30-4D72-A4B1-19B62B4D3CD2","University of North Carolina","564a35eee4b093830b6784f0","CF77AFE9-3785-45D4-BA2A-61C9CB706225","Uterine Corpus Endometrial Carcinoma","TARGZ","AEF3B317-4622-41BA-B2EB-9CD94D7BA187","2013-10-18T20:35:01.000Z","2D484CAA-07B5-489E-AF1D-ACF36441E7F6","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",171,"AEF3B317-4622-41BA-B2EB-9CD94D7BA187",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6074A3B3-E5D0-48BD-9877-8435B1314590.txt",290,"TCGA-A5-A2K5-01A",NA,NA,"TCGA",2011,NA,NA,NA,"ECA91844-E767-4045-A87F-E43DAFBCC17A",76,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6074A3B3-E5D0-48BD-9877-8435B1314590.txt","Alive",NA,"TCGA-A5-A2K5","NOT HISPANIC OR LATINO","6AFF6648-3083-4BC5-9B2F-3E3170CA3C46",NA,162,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,"F6A7FC47-0F85-4E43-9D65-ED6AAEF7587C","WHITE",NA,11,30,"5BF478CA-F1E0-4FD6-86F0-E4A3DAA48DFB","2D484CAA-07B5-489E-AF1D-ACF36441E7F6","WHIRR_p_TCGA_168_169_170_redo_N_GenomeWideSNP_6_G07_845200.hg18.seg.txt","TCGA-A5-A2K5-01A-11",90,0,3,5,20,"TOP",5,0,"TCGA-A5-A2K5-01A-01-TS1",75,NA,NA,NA,"TCGA-A5-A2K5-R17197","EXTERNAL BEAM","Primary Tumor Field","TCGA-A5-A2K5-F51589_NTE-1","NO",752,"TUMOR FREE","Alive",NA,"TCGA-A5-A2K5-F51589","TCGA-A5-A2K5",1,"A5","A2K5","YES","C54.1","8380/3","C54.1","YES","NO",-28057,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",162,NA,NA,NA,NA,"NO",4,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,76,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31344355,30488852,2272095923,"40E73C40-97CA-44BC-BAF1-5933C0B0709A.bw","cfd096ac-4d0f-4b89-8822-00656bc7f516","40e73c40-97ca-44bc-baf1-5933c0b0709a","2016-08-09T14:16:34.798419-05:00","UNCID_2210236.eb6cac23-997e-4d0b-82cf-f74fd5fb57d2.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_1.tar.gz","7f5455a3-96b2-4df0-87f2-9133adf6ceb6",2104405690,"Illumina GA","7c29dc332ca32bf03cbeb75c73ce0bb6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:15:35.266430-05:00","2016-05-03T11:15:47.420908-05:00","7f5455a3-96b2-4df0-87f2-9133adf6ceb6_analysis.xml","4d690ba3a7bcd7a35a516b140a67da93","8bca7e63-87a8-4f77-8c15-70847e2262a2",2121,"2016-10-07T16:15:49.894387-05:00","7f5455a3-96b2-4df0-87f2-9133adf6ceb6_experiment.xml","968b9e412cd01fa04e55a1fce0e92095","0c49f435-befb-4f03-a21e-e9532bb20477",2257,"2016-09-29T19:23:30.875382-05:00","7f5455a3-96b2-4df0-87f2-9133adf6ceb6_run.xml","ca5fd727b1ec9f8f0730e0a158937108","4681dc4c-2359-420c-9fdc-c2823deeecd8",347,"2016-09-08T11:36:37.256777-05:00","TCGA-B5-A11S","2016-09-02T18:49:35.184657-05:00","female","TCGA-B5-A11S_demographic",1946,"white","d2b3ab8b-b070-588b-b574-8ee86e7eff94","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11S_diagnosis","not reported",23085,"alive","8380/3",NA,2229,"10aae23f-e099-59e4-b255-22ec38998415","c54.1",-23085,"TCGA-B5-A11S_treatment","24083fb0-14bf-5abf-bcbe-d0911ba93b0f","01","true","TCGA-B5-A11S-01A",NA,"f36e52ee-22b3-4e9a-aacd-d74e7f7d4a51",FALSE,"A1E96BA3-7DFB-4E3C-A6CF-B0B99D4C44FA","Primary Tumor",NA,615,200,NA,1291680000,"11",30,"TCGA-B5-A11S-01A-11",95,60,6,6,5,10,5,40,"2016-09-08T11:36:37.256777-05:00","2016-09-08T11:36:37.256777-05:00",35,30,3,10,"TOP","BOTTOM",0,0,"59901d18-1da8-43f8-9b33-957ff230b7d9","26021e2d-0be7-4b9c-b96b-8fee71cf9cb5","TCGA-B5-A11S-01A-01-TSA","TCGA-B5-A11S-01A-01-BSA",90,50,"2c34c90e-332d-43d7-9788-0d96490de04a","RNA","TCGA-B5-A11S-01A-11R","a6e4e527-868d-420c-b0c4-50512eea3797",1.84,0.15,"UV Spec","R","23","TCGA-B5-A11S-01A-11R-A118-07","eb6cac23-997e-4d0b-82cf-f74fd5fb57d2",0.15,NA,118,47.8721246298024,157,"9ecfb6ee-1a69-5b38-a4f5-bff63e473e15","TCGA-B5-A11S_exposure","UNCID_2210236.eb6cac23-997e-4d0b-82cf-f74fd5fb57d2.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_1.tar.gz","2013-10-02T07:46:03.000Z","2013-10-02T07:59:02.000Z","7F5455A3-96B2-4DF0-87F2-9133ADF6CEB6","F36E52EE-22B3-4E9A-AACD-D74E7F7D4A51","Unaligned reads",2104405690,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","EB6CAC23-997E-4D0B-82CF-F74FD5FB57D2","University of North Carolina","56607e79e4b018727fea372d","CFD096AC-4D0F-4B89-8822-00656BC7F516","Uterine Corpus Endometrial Carcinoma","TARGZ","2C34C90E-332D-43D7-9788-0D96490DE04A","2013-10-02T07:59:02.000Z","A6E4E527-868D-420C-B0C4-50512EEA3797","United States","NO",1,NA,"Primary Tumor","Duke",615,"2C34C90E-332D-43D7-9788-0D96490DE04A",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.69621795-517F-4376-81BC-4450BE17F9EF.txt",200,"TCGA-B5-A11S-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","F36E52EE-22B3-4E9A-AACD-D74E7F7D4A51",63,"nationwidechildrens.org_clinical.TCGA-B5-A11S.xml","Alive",NA,"TCGA-B5-A11S",NA,"E8625C04-EFEC-4576-8901-048B1051CB72",NA,650,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"59901D18-1DA8-43F8-9B33-957FF230B7D9","CD0500DD-0CEC-4EED-B35A-0998C761CF19","UNCID_2210236.eb6cac23-997e-4d0b-82cf-f74fd5fb57d2.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_1.tar.gz","TCGA-B5-A11S-01A-11",95,5,6,35,5,"TOP",0,3,"TCGA-B5-A11S-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,"TCGA-B5-A11S-F72230_NTE-1","NO",2229,"TUMOR FREE","Alive",NA,"TCGA-B5-A11S-F72230","TCGA-B5-A11S",1,"B5","A11S","YES","C54.1","8380/3","C54.1","NO","YES",-23085,"FEMALE","WHITE",NA,"No","No","Alive",650,NA,NA,NA,"TUMOR FREE","NO",22,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2009,"Dilation and curettage procedure",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32796152,31763771,2383600640,"F02829BE-B45A-48AA-AA97-7E6298B9F8A7.bw","d129ebb4-db21-4342-8d9b-318a67aefa56","f02829be-b45a-48aa-aa97-7e6298b9f8a7","2016-08-05T07:03:15.635530-05:00","UNCID_2214890.3bc43656-d16a-4ec6-9fde-aab0446c6e50.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_7.tar.gz","35161b7d-c854-4e5c-b96a-768dc7a6f925",2021803676,"Illumina GA","bced2223246961d3b42c2e91b1618fc4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:06:04.995407-05:00","2016-05-03T11:17:14.905409-05:00","35161b7d-c854-4e5c-b96a-768dc7a6f925_analysis.xml","53eb3883bc6c2bef5b4a9edd2655d82f","ab1dfe83-7ad9-4378-bdb7-882874fada85",2120,"2016-09-29T19:23:41.959640-05:00","35161b7d-c854-4e5c-b96a-768dc7a6f925_experiment.xml","5c0aaafffee2f347e9f05699f322d1ee","469cd969-efcb-4a50-b95d-dd10d037149a",2256,"2016-09-29T22:09:56.738672-05:00","35161b7d-c854-4e5c-b96a-768dc7a6f925_run.xml","abec6e74cb97dc49c8af7b4a567df656","ad69182a-ece1-4e33-99d1-58a45a15cda1",345,"2016-09-08T11:16:09.655097-05:00","TCGA-B5-A0JZ","2016-09-02T18:54:42.158127-05:00","female","TCGA-B5-A0JZ_demographic",1948,"white","3fccce6d-e7af-5ff7-9246-31b7c387040d","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0JZ_diagnosis","not reported",22106,"alive","8380/3",NA,2173,"8cc6e20a-f170-5433-bbca-2537c70c226f","c54.1",-22106,"TCGA-B5-A0JZ_treatment","52942e59-628b-5748-a05a-4cbe3aea5d2b","01","true","TCGA-B5-A0JZ-01A",NA,"5e55ac8b-23b4-4cde-825a-753ed8c9208c",FALSE,"B275A085-067D-42ED-8E41-8461D5183A6E","Primary Tumor",NA,642,400,NA,1277424000,"11",30,"TCGA-B5-A0JZ-01A-11",70,70,0,0,0,0,30,30,"2016-09-08T11:16:09.655097-05:00","2016-09-08T11:16:09.655097-05:00",20,20,10,10,"TOP","BOTTOM",10,10,"02beb8b3-2a16-443c-a321-9bd0e2971ecc","2f69e130-1709-486b-9a69-83b920a9fbd6","TCGA-B5-A0JZ-01A-01-TSA","TCGA-B5-A0JZ-01A-01-BSA",60,60,"5dd9a30a-9e06-4585-9437-e273064a409c","RNA","TCGA-B5-A0JZ-01A-11R","573ca4a5-9a80-4dbf-b2ea-1af6c39c0261",1.89,0.13,"UV Spec","R","23","TCGA-B5-A0JZ-01A-11R-A040-07","3bc43656-d16a-4ec6-9fde-aab0446c6e50",0.13,NA,87,33.1504343850023,162,"8b83e1ec-a0be-557a-8fc0-3aa3a49688ae","TCGA-B5-A0JZ_exposure","UNCID_2214890.3bc43656-d16a-4ec6-9fde-aab0446c6e50.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_7.tar.gz","2013-10-03T22:06:03.000Z","2013-10-03T22:18:03.000Z","35161B7D-C854-4E5C-B96A-768DC7A6F925","5E55AC8B-23B4-4CDE-825A-753ED8C9208C","Unaligned reads",2021803676,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3BC43656-D16A-4EC6-9FDE-AAB0446C6E50","University of North Carolina","56607ccfe4b0ca319165020f","D129EBB4-DB21-4342-8D9B-318A67AEFA56","Uterine Corpus Endometrial Carcinoma","TARGZ","5DD9A30A-9E06-4585-9437-E273064A409C","2013-10-03T22:18:03.000Z","573CA4A5-9A80-4DBF-B2EA-1AF6C39C0261","United States","NO",1,NA,"Primary Tumor","Duke",642,"5DD9A30A-9E06-4585-9437-E273064A409C",NA,"B5","TCGA-B5-A0JZ-01A-11R-A041-13_mirna.bam",400,"TCGA-B5-A0JZ-01A",NA,"E7F62D0F-F14B-4894-89D1-A13ECFB1B6BA","TCGA",2008,NA,NA,"TUMOR FREE","5E55AC8B-23B4-4CDE-825A-753ED8C9208C",60,"nationwidechildrens.org_clinical.TCGA-B5-A0JZ.xml","Alive",NA,"TCGA-B5-A0JZ",NA,"5752388D-7B03-4D49-9484-B20AE962463F",NA,689,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,"39EA3DEE-0CC1-4DAA-87B2-E80AD91A31F7","WHITE",NA,11,30,"2F69E130-1709-486B-9A69-83B920A9FBD6","D6765D0E-E627-4C5D-A87F-2976DD9BB330","UNCID_2214890.3bc43656-d16a-4ec6-9fde-aab0446c6e50.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_7.tar.gz","TCGA-B5-A0JZ-01A-11",70,0,0,20,30,"TOP",10,10,"TCGA-B5-A0JZ-01A-01-TSA",60,"Carboplatin","Chemotherapy","TCGA-B5-A0JZ-D9978","TCGA-B5-A0JZ-R9985","EXTERNAL BEAM","Regional site","TCGA-B5-A0JZ-F72219_NTE-1","NO",2173,"TUMOR FREE","Alive",NA,"TCGA-B5-A0JZ-F72219","TCGA-B5-A0JZ",1,"B5","A0JZ","YES","C54.1","8380/3","C54.1","NO","YES",-22106,"FEMALE","WHITE",NA,"No","No","Alive",689,NA,NA,NA,"TUMOR FREE","NO",5,1,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2008,"Dilation and curettage procedure",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28889500,27407453,2063278164,"869B62A4-5B6F-41DC-8113-C2CA9ECB681C.bw","d17668c4-5d66-4e16-8b70-b54616581aae","869b62a4-5b6f-41dc-8113-c2ca9ecb681c","2016-08-09T14:19:19.849444-05:00","UNCID_2239961.96756b4d-0e43-404d-a819-dc6da126eef8.101124_UNC4-RDR3001561_00054_FC_62FKEAAXX_3.tar.gz","9d926891-cfc1-4ecc-b6a0-1d98bb49f9e1",1719086982,"Illumina GA","7222d8229cd3727a0039e9b27a4b57a4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:41:22.402804-05:00","2016-05-03T11:20:13.162117-05:00","9d926891-cfc1-4ecc-b6a0-1d98bb49f9e1_analysis.xml","26beb5197b0c9a0a21da8c3d6d7fada3","061226c1-427d-4f3b-94b4-ae5b3265c187",2122,"2016-09-29T23:29:11.794756-05:00","9d926891-cfc1-4ecc-b6a0-1d98bb49f9e1_experiment.xml","d271ffdf6e91ca6dbe4f31fe5791838e","de79f883-76bc-4470-93d1-7c8789828857",2256,"2016-09-29T19:40:20.731385-05:00","9d926891-cfc1-4ecc-b6a0-1d98bb49f9e1_run.xml","3f93c2aaefad6fd231296ea5c55f5157","50e93469-f4b2-479c-abb9-5f62e5593c91",345,"2016-09-08T10:38:15.821410-05:00","TCGA-AP-A0LL","2016-09-02T18:47:53.438758-05:00","female","TCGA-AP-A0LL_demographic",1948,"white","08c435d5-dcc2-53eb-b1bc-64e9ff9fdb60","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LL_diagnosis","not reported",20700,"alive","8380/3",NA,2554,"f06b7f7a-a842-5716-a603-cc32d3f20ba4","c54.1",-20700,"TCGA-AP-A0LL_treatment","897e754a-2682-5790-952a-90ecf5096aef","01","true","TCGA-AP-A0LL-01A",NA,"488a7462-8348-422c-91d3-7d9f0c39d25e",FALSE,"B4A6F5DE-E477-48FD-ADA1-EAE436FBC576","Primary Tumor",NA,2066,160,NA,1278547200,"12",30,"TCGA-AP-A0LL-01A-12",95,90,0,0,0,0,0,0,"2016-09-08T10:38:15.821410-05:00","2016-09-08T10:38:15.821410-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"0c989325-952b-43bd-9c5e-685a04daf2b7","78948b84-4b2f-4898-9697-628e3dbd4a5d","TCGA-AP-A0LL-01A-01-TSA","TCGA-AP-A0LL-01A-01-BSA",100,100,"76353c8d-9d97-48c7-ad8f-0fe2470c0c09","RNA","TCGA-AP-A0LL-01A-12R","4a218ecf-5cbf-46fa-a06e-dbfca03b612e",1.86,0.17,"UV Spec","R","23","TCGA-AP-A0LL-01A-12R-A104-07","96756b4d-0e43-404d-a819-dc6da126eef8",0.17,NA,72,27.7767061455962,161,"9101d280-d44f-544e-91bb-ea775ca37dc1","TCGA-AP-A0LL_exposure","UNCID_2239961.96756b4d-0e43-404d-a819-dc6da126eef8.101124_UNC4-RDR3001561_00054_FC_62FKEAAXX_3.tar.gz","2013-10-22T07:36:03.000Z","2013-10-22T07:49:02.000Z","9D926891-CFC1-4ECC-B6A0-1D98BB49F9E1","488A7462-8348-422C-91D3-7D9F0C39D25E","Unaligned reads",1719086982,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","96756B4D-0E43-404D-A819-DC6DA126EEF8","University of North Carolina","56607eebe4b018727fea38f5","D17668C4-5D66-4E16-8B70-B54616581AAE","Uterine Corpus Endometrial Carcinoma","TARGZ","76353C8D-9D97-48C7-AD8F-0FE2470C0C09","2013-10-22T07:49:02.000Z","4A218ECF-5CBF-46FA-A06E-DBFCA03B612E","None","NO",1,NA,"Primary Tumor","MSKCC",2066,"76353C8D-9D97-48C7-AD8F-0FE2470C0C09",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5B026F34-12B6-4DCC-838A-E65120AED9C7.txt",160,"TCGA-AP-A0LL-01A",NA,"BFF43EF5-4738-48BE-AE83-B47BBC5AE094","TCGA",2004,NA,NA,"WITH TUMOR","ACC43C62-1C62-4BA1-ABFA-D8F4872E8D8B",56,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5B026F34-12B6-4DCC-838A-E65120AED9C7.txt","Alive",NA,"TCGA-AP-A0LL",NA,"E0DD2923-6BB0-4C97-9632-7EC3C2BB6A22",NA,2141,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"DF9E861E-D0E8-4C2D-808B-352783005D25","WHITE",NA,12,30,"78948B84-4B2F-4898-9697-628E3DBD4A5D","B9239508-1862-4D06-9CDE-DF1A6BAAED82","CAUSE_p_TCGAb73_SNP_N_GenomeWideSNP_6_C04_698286.CEL","TCGA-AP-A0LL-01A-12",95,0,0,0,0,"TOP",0,0,"TCGA-AP-A0LL-01A-01-TSA",100,"MEGACE","Hormone Therapy","TCGA-AP-A0LL-D4011","TCGA-AP-A0LL-R4012","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"NO",2554,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LL-F29047","TCGA-AP-A0LL",1,"AP","A0LL","YES","C54.1","8380/3","C54.1","NO","YES",-20700,"FEMALE","WHITE",NA,"No","No","Alive",2141,NA,NA,NA,"WITH TUMOR","NO",23,9,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
38764474,38440949,2840939834,"7C5B3EDD-640B-4A0C-B40C-02764C738D6C.bw","d1b615f4-50c9-497b-8a69-8de78aa17e09","7c5b3edd-640b-4a0c-b40c-02764c738d6c","2016-08-09T14:16:14.431610-05:00","UNCID_2215578.3289fb8a-7268-4669-8d0c-471fc24a8607.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_6.tar.gz","5c3175a3-a757-4dd2-bf0f-2eb6cbce0a6c",2438242493,"Illumina GA","4d1df06acc39a3099e595db8277fa421","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:18:07.952289-05:00","2016-05-03T11:18:46.976827-05:00","5c3175a3-a757-4dd2-bf0f-2eb6cbce0a6c_analysis.xml","00f23755220e1c333810ed331a297720","6807dc45-34df-444d-98bb-8822b4d8ade2",2122,"2016-08-26T03:58:53.842855-05:00","5c3175a3-a757-4dd2-bf0f-2eb6cbce0a6c_experiment.xml","caef56cadb299d38a428bc4999224b89","0515aebf-e80a-4865-87e1-e012b904499e",2256,"2016-09-29T18:42:20.026194-05:00","5c3175a3-a757-4dd2-bf0f-2eb6cbce0a6c_run.xml","aff2fe734c6a8f1268f3e966225b32d9","2c80515d-928f-49cc-8fe2-32db3c737ce2",345,"2016-09-08T10:39:12.511586-05:00","TCGA-AX-A060","2016-09-02T18:52:46.804762-05:00","female","TCGA-AX-A060_demographic",1930,"american indian or alaska native","19a24b4b-1b54-5c06-ae56-8d3dde47aadd","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A060_diagnosis","not reported",28472,"alive","8380/3",NA,1075,"f7ad81f2-cea4-5e5f-8da3-33ec4c74256b","c54.1",-28472,"TCGA-AX-A060_treatment","8d747551-451b-5b61-8052-319604eba5dd","01","false","TCGA-AX-A060-01A",NA,"7b7fd42b-451a-40d8-8b00-cbf745493115",FALSE,"9086A79B-F764-42D4-BD9A-4C4F9F65C92B","Primary Tumor",NA,1033,170,NA,1275868800,"11",20,"TCGA-AX-A060-01A-11",95,96,0,0,3,4,2,4,"2016-09-08T10:39:12.511586-05:00","2016-09-08T10:39:12.511586-05:00",1,0,0,2,"TOP","BOTTOM",15,11,"ec8525f0-2d81-426e-8fc8-814988e22a70","0bb77d77-b5c6-43d2-a2ad-c57ea2effd11","TCGA-AX-A060-01A-01-TS1","TCGA-AX-A060-01A-01-BS1",80,81,"c594df1d-ac4c-40a5-9561-fe3fe4110033","RNA","TCGA-AX-A060-01A-11R","04853f6b-883a-44de-aa34-f3a40f3ab02e",1.77,0.15,"UV Spec","R","23","TCGA-AX-A060-01A-11R-A00V-07","3289fb8a-7268-4669-8d0c-471fc24a8607",0.15,NA,87,32.7449282998984,163,"e6432995-20a1-527d-89a5-87927bc855ae","TCGA-AX-A060_exposure","UNCID_2215578.3289fb8a-7268-4669-8d0c-471fc24a8607.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_6.tar.gz","2013-10-04T03:25:04.000Z","2013-10-04T03:38:02.000Z","5C3175A3-A757-4DD2-BF0F-2EB6CBCE0A6C","7B7FD42B-451A-40D8-8B00-CBF745493115","Unaligned reads",2438242493,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3289FB8A-7268-4669-8D0C-471FC24A8607","University of North Carolina","56607d25e4b018727fea31df","D1B615F4-50C9-497B-8A69-8DE78AA17E09","Uterine Corpus Endometrial Carcinoma","TARGZ","C594DF1D-AC4C-40A5-9561-FE3FE4110033","2013-10-04T03:38:02.000Z","04853F6B-883A-44DE-AA34-F3A40F3AB02E","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1033,"C594DF1D-AC4C-40A5-9561-FE3FE4110033",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.97D25271-925A-4D51-95D3-AE0C5B584BB3.txt",170,"TCGA-AX-A060-01A",NA,"1108B4C7-D534-4AD3-B751-FBCB294365CF","TCGA",2007,NA,NA,"TUMOR FREE","7B7FD42B-451A-40D8-8B00-CBF745493115",77,"nationwidechildrens.org_clinical.TCGA-AX-A060.xml","Alive",NA,"TCGA-AX-A060","NOT HISPANIC OR LATINO","2402E6C9-BED8-43E4-B729-58944100595E",NA,1075,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,"51F83E23-C50C-470F-BF79-A85D9082D5DC","AMERICAN INDIAN OR ALASKA NATIVE",NA,11,20,"EC8525F0-2D81-426E-8FC8-814988E22A70","67AF3830-D580-4FCD-A641-E3C4F4178435","UNCID_1610642.3289fb8a-7268-4669-8d0c-471fc24a8607.sorted_genome_alignments.bam","TCGA-AX-A060-01A-11",96,4,0,0,4,"BOTTOM",11,2,"TCGA-AX-A060-01A-01-BS1",81,"Cisplatin","Chemotherapy","TCGA-AX-A060-D12750","TCGA-AX-A060-R12751",NA,NA,NA,NA,1075,"TUMOR FREE","Alive",NA,"TCGA-AX-A060-F5558","TCGA-AX-A060",1,"AX","A060","YES","C54.1","8380/3","C54.1","NO","YES",-28472,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","NOT HISPANIC OR LATINO","No","No","Alive",1075,NA,NA,NA,"TUMOR FREE","NO",24,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,77,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33414159,33133625,2349157994,"58F11B66-AE40-417E-B465-811C6CF7311C.bw","d1c65e6a-098e-4c10-9183-c303ba66015a","58f11b66-ae40-417e-b465-811c6cf7311c","2016-08-09T14:03:24.501064-05:00","UNCID_2195231.2d49f9b3-88bc-4e99-a2ea-ba900713563d.120306_UNC6-RDR300211_00136_FC_650PFAAXX_3.tar.gz","b58adb18-a0d5-458b-acd7-b565b6abf647",2126256921,"Illumina GA","2360201633ea5fe17aeda98e40a880ea","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:54:18.352466-05:00","2016-05-03T11:07:49.539899-05:00","b58adb18-a0d5-458b-acd7-b565b6abf647_analysis.xml","4505b83839e91632e29a06ddbf89dc3b","ee293fa5-513f-4684-8860-b9084fbb972f",2121,"2016-09-29T23:58:51.730620-05:00","b58adb18-a0d5-458b-acd7-b565b6abf647_experiment.xml","149982001868e3bc2856199b330083c9","f0f3423d-1805-4184-bacc-4b60ce472fbe",2257,"2016-09-29T20:54:03.888625-05:00","b58adb18-a0d5-458b-acd7-b565b6abf647_run.xml","a430ebf8e4c7f31132d2e46636045c4f","7e49b589-1c61-43f8-bb3d-c3a1e32caacb",347,"2016-09-08T10:29:12.810075-05:00","TCGA-B5-A11P","2016-09-02T18:52:13.317646-05:00","female","TCGA-B5-A11P_demographic",1921,"white","55b042ff-89d8-5610-8f99-d3f469e6edd4","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11P_diagnosis","not reported",32047,"alive","8380/3",NA,1583,"33bb6f27-9eb6-5d4f-a83f-e3c89193ad47","c54.1",-32047,"TCGA-B5-A11P_treatment","0ab65933-70af-536b-8007-a1b053b63419","01","true","TCGA-B5-A11P-01B",NA,"64bf25f8-67bb-4f32-bad5-e879d1ad7736",FALSE,"77639636-9C18-4C81-9FCF-04BA2D92110E","Primary Tumor",NA,979,120,NA,1300060800,"11",30,"TCGA-B5-A11P-01B-11",95,NA,2,NA,0,NA,5,NA,"2016-09-08T10:29:12.810075-05:00",NA,8,NA,4,NA,"TOP",NA,5,NA,"5ec7f65a-5202-4d4c-a850-2aeb95df7314",NA,"TCGA-B5-A11P-01B-01-TS1",NA,90,NA,"2b8fb9b7-78c7-4dd5-a5b8-de26eb221264","RNA","TCGA-B5-A11P-01B-11R","621c2063-0b1f-4185-abc1-52e9640defee",2.04,0.16,"UV Spec","R","23","TCGA-B5-A11P-01B-11R-A14D-07","2d49f9b3-88bc-4e99-a2ea-ba900713563d",0.16,NA,74,NA,NA,"ed8724e5-89c3-5128-94fc-b5cb0f9782b4","TCGA-B5-A11P_exposure","UNCID_2195231.2d49f9b3-88bc-4e99-a2ea-ba900713563d.120306_UNC6-RDR300211_00136_FC_650PFAAXX_3.tar.gz","2013-09-23T07:07:07.000Z","2013-09-23T07:20:01.000Z","B58ADB18-A0D5-458B-ACD7-B565B6ABF647","64BF25F8-67BB-4F32-BAD5-E879D1AD7736","Unaligned reads",2126256921,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2D49F9B3-88BC-4E99-A2EA-BA900713563D","University of North Carolina","564a34ffe4b0298dd2c658e9","D1C65E6A-098E-4C10-9183-C303BA66015A","Uterine Corpus Endometrial Carcinoma","TARGZ","2B8FB9B7-78C7-4DD5-A5B8-DE26EB221264","2013-09-23T07:20:01.000Z","621C2063-0B1F-4185-ABC1-52E9640DEFEE","United States","NO",1,NA,"Primary Tumor","Duke",979,"2B8FB9B7-78C7-4DD5-A5B8-DE26EB221264",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.4DB77D5F-8FE5-4079-B786-AC15D556A530.txt",120,"TCGA-B5-A11P-01B",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","7F6F564D-C2C2-4BEE-A3E0-5A56E2F4DF2C",87,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.4DB77D5F-8FE5-4079-B786-AC15D556A530.txt","Alive",NA,"TCGA-B5-A11P",NA,"D488D35E-2E32-49EC-9357-8F6876C64A46",NA,1120,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,11,30,"5EC7F65A-5202-4D4C-A850-2AEB95DF7314","C28FD669-535C-4BEB-BE2A-B7C975FFB3C5","TCGA-B5-A11P-01B-11R-A14C-13_mirna.bam","TCGA-B5-A11P-01B-11",95,0,2,8,5,"TOP",5,4,"TCGA-B5-A11P-01B-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-B5-A11P-F37003_NTE-1","NO",1583,"TUMOR FREE","Alive",NA,"TCGA-B5-A11P-F37003","TCGA-B5-A11P",1,"B5","A11P","YES","C54.1","8380/3","C54.1","NO","YES",-32047,"FEMALE","WHITE",NA,"No","No","Alive",1120,NA,NA,NA,"TUMOR FREE","NO",9,8,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,87,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
104749314,101032942,4807309284,"4C02B5A8-A87E-4AEF-9451-C4B9EEA6B60D.bw","d213da3a-ff1c-4fbd-8d4e-7f9e6a2318d0","4c02b5a8-a87e-4aef-9451-c4b9eea6b60d","2016-08-09T13:15:35.092830-05:00","UNCID_2177895.db3429ba-32b0-40ef-bc81-ad0a8b097610.130402_UNC10-SN254_0447_BC22WAACXX_2_GTGGCC.tar.gz","336e55a4-1afb-46c3-8892-78a938c1e2c8",4452793312,"Illumina HiSeq","f5521f3046435096d7e1173763bfba4d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:18:48.151320-05:00","2016-05-03T10:56:47.877475-05:00","336e55a4-1afb-46c3-8892-78a938c1e2c8_analysis.xml","3691eb06667c3e119b8c7adf448b753c","1da4525b-02cd-4a9b-8dfe-b5c833ca12bc",2123,"2016-09-29T21:05:15.372819-05:00","336e55a4-1afb-46c3-8892-78a938c1e2c8_experiment.xml","9cb2c6d63006629458004379c5b70062","854da4c5-9688-4144-ac00-92ce4c51684b",2431,"2016-09-29T21:43:16.992387-05:00","336e55a4-1afb-46c3-8892-78a938c1e2c8_run.xml","c1cb6fae328f991e0282dd9e7b40f509","9cd5c1f1-172e-46f5-ba4d-384055e79185",354,"2016-09-08T11:17:48.956797-05:00","TCGA-E6-A2P8","2016-09-02T18:47:53.614347-05:00","female","TCGA-E6-A2P8_demographic",1957,"black or african american","a51a6a0a-d4c4-54ec-97a9-ce55baea0d0f","not hispanic or latino",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","E6","39aa3c67-c7d9-5001-8ed1-3bf83eac7872","Roswell Park","not reported","c54.1","TCGA-E6-A2P8_diagnosis","not reported",19448,"dead","8441/3",72,NA,"ac55b2e9-7e56-5d7f-acd8-d576ae60066c","c54.1",-19448,"TCGA-E6-A2P8_treatment","1ace1606-ee88-5554-8696-63819b2606aa","01","true","TCGA-E6-A2P8-01A",NA,"04dea046-32c8-4bd8-a5b2-944957072bdc",FALSE,"B67CD692-73B4-4A61-A65B-65964AA3ACF4","Primary Tumor",NA,254,100,NA,1314316800,"11",30,"TCGA-E6-A2P8-01A-11",85,NA,0,NA,0,NA,10,NA,"2016-09-08T11:17:48.956797-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"754e84db-2c31-438f-87ee-751524443e21",NA,"TCGA-E6-A2P8-01A-01-TSA",NA,90,NA,"4876b99c-9727-4afa-a8ca-91af844500ef","RNA","TCGA-E6-A2P8-01A-11R","58f151ce-20b0-4b1d-a86b-e7b7cf934c93",1.86,0.16,"UV Spec","R","23","TCGA-E6-A2P8-01A-11R-A19W-07","db3429ba-32b0-40ef-bc81-ad0a8b097610",0.16,NA,76,31.2294543063774,156,"a53cd3d2-3db2-58a3-9c64-14b93b8ac606","TCGA-E6-A2P8_exposure","UNCID_2177895.db3429ba-32b0-40ef-bc81-ad0a8b097610.130402_UNC10-SN254_0447_BC22WAACXX_2_GTGGCC.tar.gz","2013-09-11T20:21:05.000Z","2013-09-11T20:35:01.000Z","336E55A4-1AFB-46C3-8892-78A938C1E2C8","04DEA046-32C8-4BD8-A5B2-944957072BDC","Unaligned reads",4452793312,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","DB3429BA-32B0-40EF-BC81-AD0A8B097610","University of North Carolina","564a5876e4b0298dd2cb30b6","D213DA3A-FF1C-4FBD-8D4E-7F9E6A2318D0","Uterine Corpus Endometrial Carcinoma","TARGZ","4876B99C-9727-4AFA-A8CA-91AF844500EF","2013-09-11T20:35:01.000Z","58F151CE-20B0-4B1D-A86B-E7B7CF934C93","United States","NO",1,NA,"Primary Tumor","Roswell Park",254,"4876B99C-9727-4AFA-A8CA-91AF844500EF",NA,"E6","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.10DEABF1-C72A-400C-9CDF-E2CE69F8E2CA.txt",100,"TCGA-E6-A2P8-01A",NA,NA,"TCGA",2010,NA,NA,"WITH TUMOR","0513264F-FAF2-43E9-8308-4CDDC5AC8541",53,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.10DEABF1-C72A-400C-9CDF-E2CE69F8E2CA.txt","Dead",72,"TCGA-E6-A2P8","NOT HISPANIC OR LATINO","49FBAF21-FBE8-44AC-977F-24E326630B9C",NA,NA,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C54.1",186,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"754E84DB-2C31-438F-87EE-751524443E21","B9479D97-7CC7-4D25-BAF8-1A2D386C8228","UNCID_2110089.db3429ba-32b0-40ef-bc81-ad0a8b097610.sorted_genome_alignments.bam.bai","TCGA-E6-A2P8-01A-11",85,0,0,1,10,"TOP",0,0,"TCGA-E6-A2P8-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,"YES",NA,"WITH TUMOR","Dead",72,"TCGA-E6-A2P8-F33518","TCGA-E6-A2P8",1,"E6","A2P8","YES","C54.1","8441/3","C54.1","NO","YES",-19448,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,72,NA,NA,"WITH TUMOR","NO",22,12,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,53,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",14,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31782726,28257317,2117838646,"B55F6F72-FE83-41E1-AE4C-EF279B173583.bw","d2aa7d70-a25f-4a9e-9d52-37e372461824","b55f6f72-fe83-41e1-ae4c-ef279b173583","2016-08-09T14:15:42.760392-05:00","UNCID_2210457.b213f9e2-4253-41db-9a05-e91791f4ec7e.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_6.tar.gz","42c020aa-93fc-433f-bcae-9b0eeca7d49f",1955100043,"Illumina GA","03454bcaa38407ed4c0ec103513c5122","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:16:24.396597-05:00","2016-05-03T11:15:47.427352-05:00","42c020aa-93fc-433f-bcae-9b0eeca7d49f_analysis.xml","c180a3719f9faca03e92d699d30121d3","b169ce8b-fd20-4b28-8df1-1102d74bf4b7",2121,"2016-09-29T21:13:23.057561-05:00","42c020aa-93fc-433f-bcae-9b0eeca7d49f_experiment.xml","ccc069ace40a168690c4e3db318a33c6","8a6d10b6-db9a-47f6-9d6d-f16b76b13d88",2257,"2016-09-29T18:38:53.428859-05:00","42c020aa-93fc-433f-bcae-9b0eeca7d49f_run.xml","3d5803267f788a6596adb7df30875dbc","2a482df7-0c1a-4af9-a36c-65e4590d3d23",347,"2016-09-08T10:43:22.994164-05:00","TCGA-B5-A11G","2016-09-02T18:49:25.808258-05:00","female","TCGA-B5-A11G_demographic",1930,"black or african american","f42df73b-0462-5a66-b2da-39969fa1bcb0","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11G_diagnosis","not reported",25995,"alive","8380/3",NA,3448,"69dd2f41-a209-50cc-88a1-5baa38da839e","c54.1",-25995,"TCGA-B5-A11G_treatment","3c9f4783-73f1-5b34-abbd-878387de2a34","01","true","TCGA-B5-A11G-01A",NA,"fe5d8e64-98b1-4ea7-adda-f28d12349a7e",FALSE,"7021DC28-67C3-4BB6-9C8B-0FE7EFBCA1E1","Primary Tumor",NA,3248,180,NA,1289865600,"13",20,"TCGA-B5-A11G-01A-13",95,95,4,4,0,0,4,5,"2016-09-08T10:43:22.994164-05:00","2016-09-08T10:43:22.994164-05:00",4,4,0,0,"TOP","BOTTOM",1,0,"a0533411-2cfa-4f6b-9971-b380beaea8c2","8ffb147a-8145-435d-83ff-d630fd0bbc15","TCGA-B5-A11G-01A-01-TSA","TCGA-B5-A11G-01A-01-BSA",95,95,"44a18c8c-f485-4ada-8702-b6a8966de960","RNA","TCGA-B5-A11G-01A-13R","0ed4029a-d942-45f7-993e-d787200e483a",1.88,0.17,"UV Spec","R","23","TCGA-B5-A11G-01A-13R-A118-07","b213f9e2-4253-41db-9a05-e91791f4ec7e",0.17,NA,77,30.078125,160,"9f7acdeb-54fd-5ec8-ba42-72fc6f01bbda","TCGA-B5-A11G_exposure","UNCID_2210457.b213f9e2-4253-41db-9a05-e91791f4ec7e.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_6.tar.gz","2013-10-02T11:16:03.000Z","2013-10-02T11:28:03.000Z","42C020AA-93FC-433F-BCAE-9B0EECA7D49F","FE5D8E64-98B1-4EA7-ADDA-F28D12349A7E","Unaligned reads",1955100043,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B213F9E2-4253-41DB-9A05-E91791F4EC7E","University of North Carolina","56607998e4b0ec1099f8db99","D2AA7D70-A25F-4A9E-9D52-37E372461824","Uterine Corpus Endometrial Carcinoma","TARGZ","44A18C8C-F485-4ADA-8702-B6A8966DE960","2013-10-02T11:28:03.000Z","0ED4029A-D942-45F7-993E-D787200E483A","United States","NO",1,NA,"Primary Tumor","Duke",3248,"44A18C8C-F485-4ADA-8702-B6A8966DE960",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A166DDC1-C6D9-4125-81AE-7CA62778D347.txt",180,"TCGA-B5-A11G-01A",NA,NA,"TCGA",2001,NA,NA,"TUMOR FREE","FE5D8E64-98B1-4EA7-ADDA-F28D12349A7E",71,"nationwidechildrens.org_clinical.TCGA-B5-A11G.xml","Alive",NA,"TCGA-B5-A11G",NA,"49CD7436-99D8-4CC7-94EE-38EE4F67A3C2",NA,3077,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,13,20,"A0533411-2CFA-4F6B-9971-B380BEAEA8C2","0ED4029A-D942-45F7-993E-D787200E483A","TCGA-B5-A11G-01A-13R-A119-13_mirna.bam","TCGA-B5-A11G-01A-13",95,0,4,4,4,"TOP",1,0,"TCGA-B5-A11G-01A-01-TSA",95,NA,NA,NA,NA,NA,NA,NA,"NO",3448,"TUMOR FREE","Alive",NA,"TCGA-B5-A11G-F17657","TCGA-B5-A11G",1,"B5","A11G","YES","C54.1","8380/3","C54.1","NO","YES",-25995,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",3077,NA,NA,NA,"TUMOR FREE","NO",27,1,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,71,2001,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
104037806,101815843,4851870913,"A29E97C5-27A2-4113-B215-0ED606E64F7A.bw","d383008a-a1bf-4689-b243-3c464c79b818","a29e97c5-27a2-4113-b215-0ed606e64f7a","2016-08-09T13:16:04.024004-05:00","UNCID_2177829.ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f.130402_UNC10-SN254_0447_BC22WAACXX_6_ATCACG.tar.gz","ca4b0657-e5aa-462e-b04b-6cf78d488c53",4383992097,"Illumina HiSeq","560903b24a567f854ed23b3c3c674a5c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:42:38.066368-05:00","2016-05-03T10:56:47.890899-05:00","ca4b0657-e5aa-462e-b04b-6cf78d488c53_analysis.xml","3e2f0797ee7e8633fd1d5bd16bde0015","c19df033-46e7-44b3-bdab-1ad6270a9ef6",2123,"2016-09-30T00:03:44.457489-05:00","ca4b0657-e5aa-462e-b04b-6cf78d488c53_experiment.xml","22a2bbe9c61a581383e90813aa6522c9","f3ebcf73-3975-4d9b-a916-ce9b2d15ef6f",2431,"2016-09-29T21:36:10.211883-05:00","ca4b0657-e5aa-462e-b04b-6cf78d488c53_run.xml","651e7fcac3268b43b3835e9ace882f31","98783415-4e6d-459a-9743-a23555b3709a",354,"2016-09-08T10:45:06.756040-05:00","TCGA-EO-A3AV","2016-09-02T18:47:56.397461-05:00","female","TCGA-EO-A3AV_demographic",1959,"not reported","f558be12-2a1f-5506-b7a5-39ae58109415","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3AV_diagnosis","not reported",18713,"alive","8380/3",NA,1069,"b4428283-5286-527f-97ff-74c7988b7d01","c54.1",-18713,"TCGA-EO-A3AV_treatment","c6b3a35f-f5c9-5c8e-8e97-baca09dd2367","01","false","TCGA-EO-A3AV-01A",NA,"c3beeb0b-07f7-44e6-ab4b-8015472b0dd1",FALSE,"9FF6FADC-4F38-41A2-8B96-24CB1EB2010E","Primary Tumor",NA,407,130,NA,1317600000,"12",20,"TCGA-EO-A3AV-01A-12",90,NA,10,NA,0,NA,5,NA,"2016-09-08T10:45:06.756040-05:00",NA,70,NA,10,NA,"TOP",NA,5,NA,"c65920a1-68cb-4b9d-8f39-7e20cdf5eadf",NA,"TCGA-EO-A3AV-01A-01-TSA",NA,90,NA,"c9e15897-713c-4989-b6d5-8a82af76317b","RNA","TCGA-EO-A3AV-01A-12R","25eb8a73-bf84-468d-a760-ba96391c5b05",1.82,0.16,"UV Spec","R","23","TCGA-EO-A3AV-01A-12R-A19W-07","ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f",0.16,NA,45,18.0259573786252,158,"bbf781ad-2708-57a1-a541-93eb65d01bd7","TCGA-EO-A3AV_exposure","UNCID_2177829.ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f.130402_UNC10-SN254_0447_BC22WAACXX_6_ATCACG.tar.gz","2013-09-11T07:06:04.000Z","2013-09-11T07:20:02.000Z","CA4B0657-E5AA-462E-B04B-6CF78D488C53","C3BEEB0B-07F7-44E6-AB4B-8015472B0DD1","Unaligned reads",4383992097,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","EC7693CF-C6EC-4FFF-9D18-D1FD165A1A6F","University of North Carolina","56607debe4b0ec1099f8ef21","D383008A-A1BF-4689-B243-3C464C79B818","Uterine Corpus Endometrial Carcinoma","TARGZ","C9E15897-713C-4989-B6D5-8A82AF76317B","2013-09-11T07:20:02.000Z","25EB8A73-BF84-468D-A760-BA96391C5B05","Canada","NO",1,NA,"Primary Tumor","University Health Network",407,"C9E15897-713C-4989-B6D5-8A82AF76317B",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CAEF23A5-BEC8-4033-9A45-A2620497D282.txt",130,"TCGA-EO-A3AV-01A",NA,"F45A33D2-7384-4E99-BE4A-28059BE1EC37","TCGA",2010,NA,NA,"TUMOR FREE","C3BEEB0B-07F7-44E6-AB4B-8015472B0DD1",51,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CAEF23A5-BEC8-4033-9A45-A2620497D282.txt","Alive",NA,"TCGA-EO-A3AV",NA,"146DEC9F-1887-486D-A439-9EB292999467",NA,573,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,"47FE6850-4455-477F-B74A-AA9DFB76FBD0",NA,NA,12,20,"C65920A1-68CB-4B9D-8F39-7E20CDF5EADF","DC4BE124-385C-444C-A906-DC5714056E8C","UNCID_2177829.ec7693cf-c6ec-4fff-9d18-d1fd165a1a6f.130402_UNC10-SN254_0447_BC22WAACXX_6_ATCACG.tar.gz","TCGA-EO-A3AV-01A-12",90,0,10,70,5,"TOP",5,10,"TCGA-EO-A3AV-01A-01-TSA",90,"taxol","Chemotherapy","TCGA-EO-A3AV-D56829","TCGA-EO-A3AV-R48632","External","Primary Tumor Field","TCGA-EO-A3AV-F38255_NTE-1","NO",762,"TUMOR FREE","Alive",NA,"TCGA-EO-A3AV-F38255","TCGA-EO-A3AV",1,"EO","A3AV","YES","C54.1","8380/3","C54.1","NO","YES",-18713,"FEMALE",NA,NA,"No","No","Alive",573,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,51,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
31326480,31194431,2322244468,"F4CFA6BD-7516-4A58-BDA7-2CAC24ACAEF7.bw","d39df936-4bc6-404d-9e1d-f6416cc5a34c","f4cfa6bd-7516-4a58-bda7-2cac24acaef7","2016-08-09T14:10:11.487663-05:00","UNCID_2206478.9cde3009-e59c-4a08-bd85-e3f5ab521d41.110921_UNC2-RDR300275_00086_FC634HAAAXX_2.tar.gz","59624b28-a3d4-40d5-b75a-cd0c4bc2d45f",1965730784,"Illumina GA","c6f18ab8fe2b14a89f0df08270eb7d95","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:44:22.119310-05:00","2016-05-03T11:11:34.768699-05:00","59624b28-a3d4-40d5-b75a-cd0c4bc2d45f_analysis.xml","844d8e818a9b5d9091373884888b30f9","c2ac8652-2a8c-49c1-b797-93b2d38dbf4e",2119,"2016-08-26T16:19:42.362878-05:00","59624b28-a3d4-40d5-b75a-cd0c4bc2d45f_experiment.xml","113c4f97805583de75fbc8f3b4f5cf3c","652dd7d1-fdf3-4cde-a7e4-822ef878e58f",2257,"2016-09-29T18:15:33.302614-05:00","59624b28-a3d4-40d5-b75a-cd0c4bc2d45f_run.xml","fad6442acfad6778a0a692ffb5f7ff1f","1ba00784-1f7b-4af8-a625-959129ee6df6",347,"2016-09-08T11:05:59.457135-05:00","TCGA-AJ-A23M","2016-09-02T18:52:36.084511-05:00","female","TCGA-AJ-A23M_demographic",1949,"white","f103f7be-085d-52f8-a650-31b9e2c0bc56","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A23M_diagnosis","not reported",22430,"dead","8441/3",616,36,"d8cefeb1-6fae-59ae-ba9f-8421609c52e9","c54.1",-22430,"TCGA-AJ-A23M_treatment","a161dcb0-d222-5abf-ba4e-669ad3d80968","01","false","TCGA-AJ-A23M-01A",NA,"acbbc556-4e4e-4ebc-b408-55d69720a87d",FALSE,"B9651546-290B-405B-8275-24C8A53A10A3","Primary Tumor",NA,274,90,NA,1303862400,"11",30,"TCGA-AJ-A23M-01A-11",60,NA,10,NA,0,NA,30,NA,"2016-09-08T11:05:59.457135-05:00",NA,60,NA,20,NA,"TOP",NA,10,NA,"6682b6d5-0289-490f-aa12-fab5c3518233",NA,"TCGA-AJ-A23M-01A-01-TSA",NA,60,NA,"db67a2bf-fc00-4316-87fa-06453d67f602","RNA","TCGA-AJ-A23M-01A-11R","5e58a5fc-fccd-48ec-bb91-abd3f0f5a6d5",1.87,0.16,"UV Spec","R","23","TCGA-AJ-A23M-01A-11R-A157-07","9cde3009-e59c-4a08-bd85-e3f5ab521d41",0.16,NA,141,61.0283933518006,152,"b7e4b16f-56e0-57e8-9071-474eeb25cca6","TCGA-AJ-A23M_exposure","UNCID_2206478.9cde3009-e59c-4a08-bd85-e3f5ab521d41.110921_UNC2-RDR300275_00086_FC634HAAAXX_2.tar.gz","2013-09-27T03:26:06.000Z","2013-09-27T03:38:02.000Z","59624B28-A3D4-40D5-B75A-CD0C4BC2D45F","ACBBC556-4E4E-4EBC-B408-55D69720A87D","Unaligned reads",1965730784,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","9CDE3009-E59C-4A08-BD85-E3F5AB521D41","University of North Carolina","564a4124e4b093830b6b1e14","D39DF936-4BC6-404D-9E1D-F6416CC5A34C","Uterine Corpus Endometrial Carcinoma","TARGZ","DB67A2BF-FC00-4316-87FA-06453D67F602","2013-09-27T03:38:02.000Z","5E58A5FC-FCCD-48EC-BB91-ABD3F0F5A6D5","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",274,"DB67A2BF-FC00-4316-87FA-06453D67F602",NA,"AJ","unc.edu.9cde3009-e59c-4a08-bd85-e3f5ab521d41.1752026.bt.exon_quantification.txt",90,"TCGA-AJ-A23M-01A",NA,"35730238-4EC2-42B2-95A0-8EA45CDB68A3","TCGA",2010,NA,NA,"WITH TUMOR","ACBBC556-4E4E-4EBC-B408-55D69720A87D",61,"nationwidechildrens.org_clinical.TCGA-AJ-A23M.xml","Alive",NA,"TCGA-AJ-A23M",NA,"A2E523B1-BEFD-46CF-81CA-6FCEEE919513",NA,36,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",137,NA,"BD673B9C-742C-4CAC-A45B-8DEC2D7C8180","WHITE",NA,11,30,"6682B6D5-0289-490F-AA12-FAB5C3518233","B5FD1B0C-40B7-4838-AAAD-2900A54E07F0","c79ef19f6bece7192970ba8a6fab373e.bam","TCGA-AJ-A23M-01A-11",60,0,10,60,30,"TOP",10,20,"TCGA-AJ-A23M-01A-01-TSA",60,NA,"Chemotherapy","TCGA-AJ-A23M-D56160","TCGA-AJ-A23M-R56157","Internal","Primary Tumor Field","TCGA-AJ-A23M-F56158_NTE-1","YES",NA,"WITH TUMOR","Dead",616,"TCGA-AJ-A23M-F56158","TCGA-AJ-A23M",1,"AJ","A23M","YES","C54.1","8441/3","C54.1","NO","YES",-22430,"FEMALE","WHITE",NA,"No","No","Alive",36,NA,NA,NA,"WITH TUMOR","NO",14,7,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,61,2010,NA,NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33923880,33409568,2505799405,"11099BC1-1BCD-405B-91B0-4DDAD1DAEF3D.bw","d3c83c5e-acb1-4cb0-8f56-96341822582f","11099bc1-1bcd-405b-91b0-4ddad1daef3d","2016-08-09T14:16:09.088092-05:00","UNCID_2211858.986bddf6-4dde-4bfb-94c3-123674a4ca45.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_5.tar.gz","8a998a6c-19c0-49f6-8cb3-5c78156de8de",2087785437,"Illumina GA","145bc8142baadbbacd4456f784837cf5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:19:31.934106-05:00","2016-05-03T11:16:29.240093-05:00","8a998a6c-19c0-49f6-8cb3-5c78156de8de_analysis.xml","89d98791b636c9b9d9290855377f0cf8","1e0e7d7b-e9d1-4869-b99b-deced885d387",2121,"2016-09-29T21:34:25.242578-05:00","8a998a6c-19c0-49f6-8cb3-5c78156de8de_experiment.xml","3e53a4f84cb28d70209b372ea9783195","9767f02d-9d5b-4971-a3a4-d2b0d797677d",2257,"2016-09-29T22:14:32.307571-05:00","8a998a6c-19c0-49f6-8cb3-5c78156de8de_run.xml","b3898575a0a13813537211576fe39c74","b0388e29-416b-471f-b549-d06f61f86ef0",347,"2016-09-08T11:30:25.279215-05:00","TCGA-B5-A11V","2016-09-02T18:49:07.313686-05:00","female","TCGA-B5-A11V_demographic",1946,"black or african american","a0d7577a-1868-535e-b229-e0ea205cd267","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11V_diagnosis","not reported",23630,"alive","8380/3",NA,595,"09b79b21-54c9-57a2-a6bc-fb02f236f79a","c54.1",-23630,"TCGA-B5-A11V_treatment","45d01c6b-7ac8-58e1-b687-b2d440fac32b","01","true","TCGA-B5-A11V-01A",NA,"1eb9c43a-17d8-4fa7-b779-9277ff828cb1",FALSE,"E1B5A941-5EEB-4207-84DC-F3BF22D5FC29","Primary Tumor",NA,294,760,NA,1290556800,"11",30,"TCGA-B5-A11V-01A-11",80,70,0,0,10,0,10,30,"2016-09-08T11:30:25.279215-05:00","2016-09-08T11:30:25.279215-05:00",10,10,0,0,"TOP","BOTTOM",10,10,"53cda3f8-4272-4447-93b4-5a2b72c4466d","c0a9546e-6a4e-487a-844c-ed11acf1ab7e","TCGA-B5-A11V-01A-01-TS1","TCGA-B5-A11V-01A-01-BS1",70,60,"bed44600-2d48-46f8-ab6f-515987008f18","RNA","TCGA-B5-A11V-01A-11R","18d36986-b058-47d9-83bc-2f7213dbc9ee",1.86,0.15,"UV Spec","R","23","TCGA-B5-A11V-01A-11R-A10J-07","986bddf6-4dde-4bfb-94c3-123674a4ca45",0.15,NA,71,28.8044139721693,157,"8e526b43-7688-57d1-a8c1-33587061fa59","TCGA-B5-A11V_exposure","UNCID_2211858.986bddf6-4dde-4bfb-94c3-123674a4ca45.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_5.tar.gz","2013-10-03T03:26:03.000Z","2013-10-03T03:38:02.000Z","8A998A6C-19C0-49F6-8CB3-5C78156DE8DE","1EB9C43A-17D8-4FA7-B779-9277FF828CB1","Unaligned reads",2087785437,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","986BDDF6-4DDE-4BFB-94C3-123674A4CA45","University of North Carolina","56607a73e4b0b37b3d991eeb","D3C83C5E-ACB1-4CB0-8F56-96341822582F","Uterine Corpus Endometrial Carcinoma","TARGZ","BED44600-2D48-46F8-AB6F-515987008F18","2013-10-03T03:38:02.000Z","18D36986-B058-47D9-83BC-2F7213DBC9EE","United States","NO",1,NA,"Primary Tumor","Duke",294,"BED44600-2D48-46F8-AB6F-515987008F18",NA,"B5","UNCID_344769.TCGA-B5-A11V-01A-11R-A10J-07.110302_UNC1-RDR301647_00045_FC_62J5FAAXX.5.trimmed.annotated.translated_to_genomic.bam.bai",760,"TCGA-B5-A11V-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","A4C6FF2C-4E04-442B-860D-0F29DF59235E",64,"DEBUT_p_TCGAb45_81_wRedosSNP_N_GenomeWideSNP_6_A08_729436.nocnv_hg19.seg.txt","Alive",NA,"TCGA-B5-A11V",NA,"D181BC97-DDA8-49B1-BB1F-75DDFEA601BC",NA,232,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"C0A9546E-6A4E-487A-844C-ED11ACF1AB7E","FA96D080-A587-4B90-9DCA-D6CF7B630AE3","UNCID_2211858.986bddf6-4dde-4bfb-94c3-123674a4ca45.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_5.tar.gz","TCGA-B5-A11V-01A-11",80,10,0,10,10,"TOP",10,0,"TCGA-B5-A11V-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,NA,"NO",595,"TUMOR FREE","Alive",NA,"TCGA-B5-A11V-F17776","TCGA-B5-A11V",1,"B5","A11V","YES","C54.1","8380/3","C54.1","NO","YES",-23630,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",232,NA,NA,NA,"TUMOR FREE","NO",4,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32995071,32483981,2424860142,"0E4AD9E3-52AB-4BA5-9A46-CC60EF0A28E4.bw","d3e93d76-6565-454a-a085-4492024350e9","0e4ad9e3-52ab-4ba5-9a46-cc60ef0a28e4","2016-08-04T23:37:00.365011-05:00","UNCID_2203957.272f94bc-ce8b-46ff-b13f-827bba6071d5.111020_UNC6-RDR300211_00129_FC_62EA9AAXX_2.tar.gz","4aaa43e2-2ab2-408d-87bc-18bcc5a834e6",2198524646,"Illumina GA","4ea27b61e94c012e8cb861a6b5f0f9de","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:47:53.335646-05:00","2016-05-03T11:19:30.078695-05:00","4aaa43e2-2ab2-408d-87bc-18bcc5a834e6_analysis.xml","d4d6f6c77220bbb7e85cad79f19129b6","ea2abdb8-3c56-4775-bd57-cb37824add5c",2121,"2016-10-07T16:34:59.275683-05:00","4aaa43e2-2ab2-408d-87bc-18bcc5a834e6_experiment.xml","55b1fc7704f1d2b7ca72b5d61d6a94ca","b6e43057-f846-4024-9bd1-b0199800310d",2257,"2016-09-29T17:46:44.788430-05:00","4aaa43e2-2ab2-408d-87bc-18bcc5a834e6_run.xml","3c5d59860013540e737947ac3145b232","09a1a74d-116f-419d-9149-81914e64a241",347,"2016-09-08T11:27:37.355064-05:00","TCGA-DI-A1NO","2016-09-02T18:52:39.423329-05:00","female","TCGA-DI-A1NO_demographic",1941,"black or african american","c538c930-b7ad-54d7-a79e-15aa04e38237","not hispanic or latino",2009,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A1NO_diagnosis","not reported",24996,"dead","8380/3",285,NA,"ab76fd83-0688-509b-a2f7-164e59ade853","c54.1",-24996,"TCGA-DI-A1NO_treatment","fd99f745-6d70-5394-a9c0-be334264d4ff","01","false","TCGA-DI-A1NO-01A",NA,"002a3a28-71c7-4a8c-960a-14a239ffb433",FALSE,"11CEAAB6-3853-48EB-94CE-1B11FEF45B4C","Primary Tumor",NA,688,270,NA,1302739200,"31",30,"TCGA-DI-A1NO-01A-31",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:27:37.355064-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"6555461b-cb50-4f06-a64a-49f6ba9fcccb",NA,"TCGA-DI-A1NO-01A-03-TSC",NA,80,NA,"e268a235-d038-4d1f-b655-2add842d1cf4","RNA","TCGA-DI-A1NO-01A-31R","932e56c1-931e-412f-a13f-6a4fd99204a2",1.88,0.18,"UV Spec","R","23","TCGA-DI-A1NO-01A-31R-A157-07","272f94bc-ce8b-46ff-b13f-827bba6071d5",0.18,NA,122,44.2734794600087,166,"b9c36527-91a9-53fd-9cc3-cbf25e0bfcfa","TCGA-DI-A1NO_exposure","UNCID_2203957.272f94bc-ce8b-46ff-b13f-827bba6071d5.111020_UNC6-RDR300211_00129_FC_62EA9AAXX_2.tar.gz","2013-10-04T15:43:04.000Z","2013-10-04T16:20:02.000Z","4AAA43E2-2AB2-408D-87BC-18BCC5A834E6","002A3A28-71C7-4A8C-960A-14A239FFB433","Unaligned reads",2198524646,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","272F94BC-CE8B-46FF-B13F-827BBA6071D5","University of North Carolina","564a3660e4b0298dd2c6cb89","D3E93D76-6565-454A-A085-4492024350E9","Uterine Corpus Endometrial Carcinoma","TARGZ","E268A235-D038-4D1F-B655-2ADD842D1CF4","2013-10-04T16:20:02.000Z","932E56C1-931E-412F-A13F-6A4FD99204A2","United States","NO",1,NA,"Primary Tumor","MD Anderson",688,"E268A235-D038-4D1F-B655-2ADD842D1CF4",NA,"DI","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.6DFFF5AA-3B22-4F41-9A2F-4F6E84237EF6.txt",270,"TCGA-DI-A1NO-01A",NA,NA,"TCGA",2009,NA,NA,"WITH TUMOR","7AAF991A-6CF7-4A53-9235-D0BC73208152",68,"nationwidechildrens.org_clinical.TCGA-DI-A1NO.xml","Dead",285,"TCGA-DI-A1NO","NOT HISPANIC OR LATINO","8A7777DB-6F54-4869-8664-DF27CFE2AEA1",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,31,30,"6555461B-CB50-4F06-A64A-49F6BA9FCCCB","C3B95479-4726-46E4-9D6B-8880393794B6","TCGA-DI-A1NO-01A-31R-A156-13_mirna.bam.bai","TCGA-DI-A1NO-01A-31",80,0,20,40,10,"TOP",10,20,"TCGA-DI-A1NO-01A-03-TSC",80,NA,NA,NA,NA,NA,NA,NA,"NO",NA,"WITH TUMOR","Dead",285,"TCGA-DI-A1NO-F20801","TCGA-DI-A1NO",1,"DI","A1NO","YES","C54.1","8380/3","C54.1","NO","YES",-24996,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,285,NA,NA,"WITH TUMOR","NO",1,8,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
118015310,116068202,5544072742,"CDB44ECD-3F01-4865-B4CC-5190E0FB64DC.bw","d438c58e-f038-47a3-8e62-485a5aca9695","cdb44ecd-3f01-4865-b4cc-5190e0fb64dc","2016-08-07T01:04:58.408086-05:00","UNCID_2167104.291167cc-8f00-47e1-abe2-72388c98170d.130621_UNC14-SN744_0352_BC253TACXX_1_GCCAAT.tar.gz","aca6ea2e-d676-4f40-8668-fc682bf80506",5179722224,"Illumina HiSeq","cd74da0da33c1f893e55be4bcc10da50","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:14:24.295289-05:00","2016-05-03T11:07:07.492763-05:00","aca6ea2e-d676-4f40-8668-fc682bf80506_analysis.xml","9522a72de3747323c7e952a149c11b16","40c4fffe-8505-473b-b292-30163c84a83e",2123,"2016-09-29T23:14:25.856698-05:00","aca6ea2e-d676-4f40-8668-fc682bf80506_experiment.xml","aa6c6726bcdba476f9a743f7ef2364e7","d56d05d4-0f5d-4ede-91dd-18a22562352f",2431,"2016-09-29T22:27:13.522996-05:00","aca6ea2e-d676-4f40-8668-fc682bf80506_run.xml","767feefc056ecde5294d2e224d7d4d6e","b7fcf413-1cd9-46a9-8df4-b7a5bbb29de6",354,"2016-09-08T10:40:39.190406-05:00","TCGA-DF-A2KN","2016-09-02T18:53:15.655453-05:00","female","TCGA-DF-A2KN_demographic",NA,"not reported","9e21e02c-b227-5e1f-8ed6-c145c7713145","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DF","bd439172-ab1d-57cc-a1ee-7282ceebd41a","Ontario Institute for Cancer Research","not reported","c54.1","TCGA-DF-A2KN_diagnosis","not reported",NA,"alive","8380/3",NA,67,"f0c22945-90d0-568d-a3ab-dfed57db05fc","c54.1",NA,"TCGA-DF-A2KN_treatment","bd3d7d6a-606f-5bcc-83d2-9de0d36e2971","01","false","TCGA-DF-A2KN-01A",NA,"4ad23a52-bceb-4b12-88aa-272153e01b01",FALSE,"A61CE064-B18B-429E-93F1-BA0FC06AB310","Primary Tumor",NA,NA,200,NA,1313452800,"11",30,"TCGA-DF-A2KN-01A-11",90,NA,6,NA,0,NA,10,NA,"2016-09-08T10:40:39.190406-05:00",NA,20,NA,3,NA,"TOP",NA,0,NA,"29d8a8b6-0104-4756-986d-2ef7e3d18da8",NA,"TCGA-DF-A2KN-01A-01-TS1",NA,90,NA,"37c58b0c-175e-4328-b400-b322d1894362","RNA","TCGA-DF-A2KN-01A-11R","d19e8fb1-142e-4ca6-a109-08be2e20b21b",1.8,0.18,"UV Spec","R","23","TCGA-DF-A2KN-01A-11R-A180-07","291167cc-8f00-47e1-abe2-72388c98170d",0.18,NA,77,33.3275623268698,152,"2826093c-4900-5aa8-9338-8effb5b12e0d","TCGA-DF-A2KN_exposure","UNCID_2167104.291167cc-8f00-47e1-abe2-72388c98170d.130621_UNC14-SN744_0352_BC253TACXX_1_GCCAAT.tar.gz","2013-09-21T06:46:03.000Z","2013-09-21T07:09:01.000Z","ACA6EA2E-D676-4F40-8668-FC682BF80506","4AD23A52-BCEB-4B12-88AA-272153E01B01","Unaligned reads",5179722224,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","291167CC-8F00-47E1-ABE2-72388C98170D","University of North Carolina","564a39a6e4b0ef121819e251","D438C58E-F038-47A3-8E62-485A5ACA9695","Uterine Corpus Endometrial Carcinoma","TARGZ","37C58B0C-175E-4328-B400-B322D1894362","2013-09-21T07:09:01.000Z","D19E8FB1-142E-4CA6-A109-08BE2E20B21B","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"37C58B0C-175E-4328-B400-B322D1894362",NA,"DF","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B215AA1E-6DD0-48DE-BFED-181FC2612DBD.txt",200,"TCGA-DF-A2KN-01A",NA,NA,"TCGA",NA,NA,NA,NA,"4AD23A52-BCEB-4B12-88AA-272153E01B01",NA,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B215AA1E-6DD0-48DE-BFED-181FC2612DBD.txt",NA,NA,"TCGA-DF-A2KN",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,168,NA,NA,NA,NA,11,30,"29D8A8B6-0104-4756-986D-2EF7E3D18DA8","839CFC3E-4E84-42F0-8535-194415B0D954","010cfdb67758c1a430c2588eb29fd8bd.bam.bai","TCGA-DF-A2KN-01A-11",90,0,6,20,10,"TOP",0,3,"TCGA-DF-A2KN-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-DF-A2KN",1,"DF","A2KN","YES","C54.1","8380/3","C54.1","NO","YES",NA,"FEMALE",NA,NA,"No","No","Alive",67,NA,NA,NA,"TUMOR FREE","NO",7,11,2013,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,NA,NA,NA,"Tumor resection",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,NA,4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
122409990,121508600,5801266789,"99406416-1F47-4791-B186-C2F0FBC67532.bw","d46d5af5-62ae-43eb-a885-4c078e0c956e","99406416-1f47-4791-b186-c2f0fbc67532","2016-08-25T17:48:44.316099-05:00","UNCID_2316530.94120972-002e-4dbd-8bb1-7f41f05f2b0f.131008_UNC15-SN850_0331_AC2KJ8ACXX_7_GCCAAT.tar.gz","6750f063-aa7e-49b4-a798-c140e317dde6",5475512918,"Illumina HiSeq","be257303800f5db50d246757e3e7f0fc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:50:13.112049-05:00","2016-05-03T11:28:50.231867-05:00","6750f063-aa7e-49b4-a798-c140e317dde6_analysis.xml","f5869c506a034073b146fb7e62389bd7","3179c64b-dce7-444b-9ef2-27d321f914a7",2124,"2016-09-29T18:47:36.936746-05:00","6750f063-aa7e-49b4-a798-c140e317dde6_experiment.xml","088e1a9a6eca4c2745bd57f06546843e","2fe10ef6-b13c-4957-ba7e-fa7a2a8f8029",2628,"2016-09-29T20:17:37.893545-05:00","6750f063-aa7e-49b4-a798-c140e317dde6_run.xml","47f9434927af9ac5a046ae60c25463c4","67bc3c34-c007-4d66-9911-9ab8a9e95091",354,"2016-09-08T11:30:13.494036-05:00","TCGA-EY-A1GL","2016-09-02T18:51:56.748611-05:00","female","TCGA-EY-A1GL_demographic",1959,"white","51e0a502-6a75-5175-89d6-43421041fff7","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GL_diagnosis","not reported",18761,"alive","8380/3",NA,1014,"12d48312-efdd-529e-abdf-822efda92984","c54.1",-18761,"TCGA-EY-A1GL_treatment","40f1eca8-b298-578e-81fa-6f9d0e263ce7","01","false","TCGA-EY-A1GL-01A",NA,"4032607d-6cf1-4b53-941e-0c50cb3d0f10",FALSE,"449C1D9F-6A1F-4523-8C86-AFED911D95D4","Primary Tumor",NA,366,300,NA,1297641600,"11",30,"TCGA-EY-A1GL-01A-11",70,NA,20,NA,0,NA,25,NA,"2016-09-08T11:30:13.494036-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"0c4ab12b-f8d8-4e51-b815-284720767ad1",NA,"TCGA-EY-A1GL-01A-01-TSA",NA,70,NA,"16200664-274a-4d51-b1f1-0c28290d2778","RNA","TCGA-EY-A1GL-01A-11R","09f8fc57-db83-4fcb-8b0c-42639e9f5311",1.9,0.16,"UV Spec","R","23","TCGA-EY-A1GL-01A-11R-A13S-07","94120972-002e-4dbd-8bb1-7f41f05f2b0f",0.16,NA,73,24.3910588392529,173,"e24c7895-fd05-50a1-b458-a8c80e68686a","TCGA-EY-A1GL_exposure","UNCID_2316530.94120972-002e-4dbd-8bb1-7f41f05f2b0f.131008_UNC15-SN850_0331_AC2KJ8ACXX_7_GCCAAT.tar.gz","2014-01-07T02:16:43.000Z","2014-01-07T04:55:02.000Z","6750F063-AA7E-49B4-A798-C140E317DDE6","4032607D-6CF1-4B53-941E-0C50CB3D0F10","Unaligned reads",5475512918,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","94120972-002E-4DBD-8BB1-7F41F05F2B0F","University of North Carolina","564a3608e4b0298dd2c6af8d","D46D5AF5-62AE-43EB-A885-4C078E0C956E","Uterine Corpus Endometrial Carcinoma","TARGZ","16200664-274A-4D51-B1F1-0C28290D2778","2014-01-07T04:55:02.000Z","09F8FC57-DB83-4FCB-8B0C-42639E9F5311","United States","NO",1,NA,"Primary Tumor","University of North Carolina",366,"16200664-274A-4D51-B1F1-0C28290D2778",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C3D4EF49-BDA0-4723-90CB-311EDDE0C900.txt",300,"TCGA-EY-A1GL-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","4032607D-6CF1-4B53-941E-0C50CB3D0F10",51,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C3D4EF49-BDA0-4723-90CB-311EDDE0C900.txt","Alive",NA,"TCGA-EY-A1GL",NA,"B9B0DD46-8DD9-41DA-B3E8-6CC4837CD35A",NA,425,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,"24A8F1FC-8F19-4637-B476-B686F48B7893","WHITE",NA,11,30,"0C4AB12B-F8D8-4E51-B815-284720767AD1","F284D3FC-FAEC-4128-BE61-13DBCCAB037E","TCGA-EY-A1GL-01A-11R-A13R-13_mirna.bam","TCGA-EY-A1GL-01A-11",70,0,20,40,25,"TOP",5,20,"TCGA-EY-A1GL-01A-01-TSA",70,NA,NA,NA,"TCGA-EY-A1GL-R11883","EXTERNAL BEAM","Primary Tumor Field","TCGA-EY-A1GL-F70250_NTE-1","NO",1014,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GL-F70250","TCGA-EY-A1GL",1,"EY","A1GL","YES","C54.1","8380/3","C54.1","YES","NO",-18761,"FEMALE","WHITE",NA,"No","No","Alive",425,NA,NA,NA,"TUMOR FREE","NO",18,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,51,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
174116296,172254236,8221707991,"3E8264FA-EB76-46E8-9601-D627BB28642C.bw","d5ee39e8-a1d2-4244-9c38-07d7c5c1baba","3e8264fa-eb76-46e8-9601-d627bb28642c","2016-08-25T19:01:50.083306-05:00","UNCID_2316583.0595a9e2-f382-4f97-8d0e-69af86b9fb78.130827_UNC15-SN850_0324_AC2B28ACXX_4_ATCACG.tar.gz","78c89099-fe78-492b-8ef7-28d7622cb6d5",7982901982,"Illumina HiSeq","83124adc6307384d4201d2242b0a1283","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:25:31.201903-05:00","2016-05-03T11:28:50.231867-05:00","78c89099-fe78-492b-8ef7-28d7622cb6d5_analysis.xml","03488da0a4da402236e5b3b8a259286e","6cb29ace-911e-4be4-a36c-5390ecd9d8b9",2124,"2016-09-29T22:16:29.257021-05:00","78c89099-fe78-492b-8ef7-28d7622cb6d5_experiment.xml","9bfb71f008c3cb2e632a1e923774e256","b176956c-8284-4e99-999e-0b53eb2995b8",2628,"2016-09-29T19:25:32.224295-05:00","78c89099-fe78-492b-8ef7-28d7622cb6d5_run.xml","7c0366d8629a57b410f2dd80048f72b8","47c2ef30-a759-401d-84ff-75ec848fb475",354,"2016-09-08T10:26:04.122396-05:00","TCGA-B5-A5OE","2016-09-02T18:50:38.213731-05:00","female","TCGA-B5-A5OE_demographic",1943,"black or african american","efdecf34-f346-53d8-9aab-eefc419d4463","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A5OE_diagnosis","not reported",24905,"alive","8441/3",NA,1063,"4c34818d-6290-52a5-a4d4-29ab9ec64c52","c54.1",-24905,"TCGA-B5-A5OE_treatment","a1de606d-210d-5d88-ab82-eff7e6b4ab75","01","true","TCGA-B5-A5OE-01A",NA,"df9184ec-0a56-4227-a0f7-ce92e5e6203e",FALSE,"82A668E5-6B89-4C94-BEED-F4FF227BD0B1","Primary Tumor",NA,609,1540,NA,1360800000,"11",30,"TCGA-B5-A5OE-01A-11",80,NA,2,NA,0,NA,10,NA,"2016-09-08T10:26:04.122396-05:00",NA,2,NA,2,NA,"TOP",NA,10,NA,"88d0713a-7553-405a-958b-d234a21bb537",NA,"TCGA-B5-A5OE-01A-01-TSA",NA,80,NA,"e723f328-5597-4606-9ce8-fba9bf987501","RNA","TCGA-B5-A5OE-01A-11R","10335946-6ec2-45cd-bf6d-93788ed8341b",1.9,0.16,"UV Spec","R","23","TCGA-B5-A5OE-01A-11R-A31O-07","0595a9e2-f382-4f97-8d0e-69af86b9fb78",0.16,NA,NA,NA,NA,"73048860-d819-5808-80e1-461490925fb0","TCGA-B5-A5OE_exposure","UNCID_2316583.0595a9e2-f382-4f97-8d0e-69af86b9fb78.130827_UNC15-SN850_0324_AC2B28ACXX_4_ATCACG.tar.gz","2014-01-07T08:01:03.000Z","2014-01-07T08:39:03.000Z","78C89099-FE78-492B-8EF7-28D7622CB6D5","DF9184EC-0A56-4227-A0F7-CE92E5E6203E","Unaligned reads",7982901982,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0595A9E2-F382-4F97-8D0E-69AF86B9FB78","University of North Carolina","56607ce1e4b016715ab6b469","D5EE39E8-A1D2-4244-9C38-07D7C5C1BABA","Uterine Corpus Endometrial Carcinoma","TARGZ","E723F328-5597-4606-9CE8-FBA9BF987501","2014-01-07T08:39:03.000Z","10335946-6EC2-45CD-BF6D-93788ED8341B","United States","NO",1,NA,"Primary Tumor","Duke",609,"E723F328-5597-4606-9CE8-FBA9BF987501",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.300974AA-5FA7-4658-A7BD-95F64E650DCC.txt",1540,"TCGA-B5-A5OE-01A",NA,"F3F82874-CC18-43CC-971E-8ED77CA14042","TCGA",2011,"TCGA-B5-A5OE_NTE-1",NA,NA,"DF9184EC-0A56-4227-A0F7-CE92E5E6203E",68,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.300974AA-5FA7-4658-A7BD-95F64E650DCC.txt","Alive",NA,"TCGA-B5-A5OE",NA,"D6834E81-BD6E-4A83-A8B2-E84156DD1864","NO",734,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",324,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"88D0713A-7553-405A-958B-D234A21BB537","EF116E49-B352-436F-B689-B89EC7E3732F","2dcd74959153734e5a56a61da181521c.bam","TCGA-B5-A5OE-01A-11",80,0,2,2,10,"TOP",10,2,"TCGA-B5-A5OE-01A-01-TSA",80,"Bevacizumab",NA,"TCGA-B5-A5OE-D57500",NA,NA,NA,"TCGA-B5-A5OE-F59473_NTE-1","NO",1063,"TUMOR FREE","Alive",NA,"TCGA-B5-A5OE-F59473","TCGA-B5-A5OE",1,"B5","A5OE","YES","C54.1","8441/3","C54.1","YES","NO",-24905,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",734,NA,"NO","YES",NA,"YES",20,8,2013,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,68,2011,NA,NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33065753,32335385,2426177383,"4C2829F9-2672-4C6C-9901-778B3721ACAF.bw","d5f2bae1-7cd1-49bf-ae41-12d2aa44408e","4c2829f9-2672-4c6c-9901-778b3721acaf","2016-08-09T14:16:38.115553-05:00","UNCID_2210398.b3e039bf-945c-4974-a4ec-8e3b177aef8d.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_4.tar.gz","560a817e-440f-4a45-979d-281b0caff006",2222506102,"Illumina GA","7ebdd03694042136f91bfbc21018ecbe","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:19:13.028342-05:00","2016-05-03T11:15:47.427352-05:00","560a817e-440f-4a45-979d-281b0caff006_analysis.xml","08665bd56fa48ef332fe05d14587a07d","68b934cd-a4d6-4290-a5a2-ecfb7c76cf3f",2121,"2016-09-29T23:25:20.415115-05:00","560a817e-440f-4a45-979d-281b0caff006_experiment.xml","391034f188d116e46cf40bfd18687c26","dc072c9d-370e-40cb-bfe0-07a83833f58d",2257,"2016-09-29T22:01:08.748088-05:00","560a817e-440f-4a45-979d-281b0caff006_run.xml","169104028f89e793953acfc0c90da7a3","a805494e-124e-44f9-ade5-457649f62aa9",347,"2016-09-08T11:09:56.726769-05:00","TCGA-B5-A0JT","2016-09-02T18:49:25.241706-05:00","female","TCGA-B5-A0JT_demographic",1944,"white","d5d00d70-77b9-5443-bd30-112211cf1f36","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0JT_diagnosis","not reported",23041,"alive","8380/3",NA,1682,"1f791e55-9d7d-5124-93cb-f158cbaf8e8e","c54.1",-23041,"TCGA-B5-A0JT_treatment","45c03b7b-783e-5995-9fdb-aeaf67737262","01","true","TCGA-B5-A0JT-01A",NA,"4188c8ea-fe84-4c30-a390-0bd9a6b10c7b",FALSE,"CC6EE5B1-5548-4DE7-873F-332DBF81710F","Primary Tumor",NA,1128,750,NA,1291334400,"21",30,"TCGA-B5-A0JT-01A-21",40,65,0,0,50,20,0,0,"2016-09-08T11:09:56.726769-05:00","2016-09-08T11:09:56.726769-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"c4c62b77-f331-4101-8fe5-5794ef695407","f3f9c95a-a557-469d-8521-8d2705976f89","TCGA-B5-A0JT-01A-02-TSB","TCGA-B5-A0JT-01A-02-BSB",50,80,"f0663ac1-9d86-4576-ac94-aa1f66b554ac","RNA","TCGA-B5-A0JT-01A-21R","05903202-0bf3-41e0-8132-cb79843b50f8",1.73,0.17,"UV Spec","R","23","TCGA-B5-A0JT-01A-21R-A118-07","b3e039bf-945c-4974-a4ec-8e3b177aef8d",0.17,NA,119,42.1626984126984,168,"c7f8aa1d-a411-5467-ab5c-ae89e4953919","TCGA-B5-A0JT_exposure","UNCID_2210398.b3e039bf-945c-4974-a4ec-8e3b177aef8d.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_4.tar.gz","2013-10-02T10:16:04.000Z","2013-10-02T10:35:03.000Z","560A817E-440F-4A45-979D-281B0CAFF006","4188C8EA-FE84-4C30-A390-0BD9A6B10C7B","Unaligned reads",2222506102,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B3E039BF-945C-4974-A4EC-8E3B177AEF8D","University of North Carolina","564a393be4b0ef121819bf49","D5F2BAE1-7CD1-49BF-AE41-12D2AA44408E","Uterine Corpus Endometrial Carcinoma","TARGZ","F0663AC1-9D86-4576-AC94-AA1F66B554AC","2013-10-02T10:35:03.000Z","05903202-0BF3-41E0-8132-CB79843B50F8","United States","NO",1,NA,"Primary Tumor","Duke",1128,"F0663AC1-9D86-4576-AC94-AA1F66B554AC",NA,"B5","UNCID_2210398.b3e039bf-945c-4974-a4ec-8e3b177aef8d.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_4.tar.gz",750,"TCGA-B5-A0JT-01A",NA,"C1D3DD4E-523F-4056-B92E-14A764EB235E","TCGA",2007,NA,NA,"TUMOR FREE","4188C8EA-FE84-4C30-A390-0BD9A6B10C7B",63,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4E93B9DF-D389-4EDB-B2D5-CFD48CEBB426.txt","Alive",NA,"TCGA-B5-A0JT",NA,"D653822A-6447-4510-BCDA-35AD022F72A2",NA,1312,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,21,30,"F3F9C95A-A557-469D-8521-8D2705976F89","98D8581C-6DAE-4764-80ED-91E7FC53DF89","1adbaaead03b2d02a20245823cf7c282.bam.bai","TCGA-B5-A0JT-01A-21",65,20,0,0,0,"BOTTOM",0,0,"TCGA-B5-A0JT-01A-02-BSB",80,"Megace","Hormone Therapy","TCGA-B5-A0JT-D10042",NA,NA,NA,NA,"NO",1312,"TUMOR FREE","Alive",NA,"TCGA-B5-A0JT-F13514","TCGA-B5-A0JT",1,"B5","A0JT","YES","C54.1","8380/3","C54.1","NO","YES",-23041,"FEMALE","WHITE",NA,"No","No","Alive",1312,NA,NA,NA,"TUMOR FREE","NO",25,1,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2007,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
119123154,116074942,5536853033,"B9D71C22-6662-484C-B21E-0CA305E0B16E.bw","d6303a05-f705-4413-8860-506a105d5b08","b9d71c22-6662-484c-b21e-0ca305e0b16e","2016-08-05T10:42:59.679674-05:00","UNCID_2173486.8fac215c-7172-42ed-af07-00b27c05d3a6.130502_UNC12-SN629_0289_AC236KACXX_5_AGTTCC.tar.gz","0fff10c1-940f-4550-9ba2-c8a474a35854",5606155100,"Illumina HiSeq","b469047307ea1ef326d3c6c048ae2fcb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:28:02.742931-05:00","2016-05-03T10:55:55.600288-05:00","0fff10c1-940f-4550-9ba2-c8a474a35854_analysis.xml","3121c5488594066d527bc1612349cb13","b88812e4-978e-4bf1-8885-4fc75d383053",2123,"2016-08-27T17:57:24.481555-05:00","0fff10c1-940f-4550-9ba2-c8a474a35854_experiment.xml","6b037fd8ad43a3f5da5333d95f3ce62d","c1bff283-cdfb-477e-bcd8-bce9ba244d6f",2431,"2016-09-29T21:44:30.940627-05:00","0fff10c1-940f-4550-9ba2-c8a474a35854_run.xml","26fa805ca7afbf302fb894c3c907194b","9d9eeeda-413c-403a-b724-0e6d87254092",354,"2016-09-08T11:06:14.967348-05:00","TCGA-K6-A3WQ","2016-09-02T18:49:34.254126-05:00","female","TCGA-K6-A3WQ_demographic",1952,"white","66209a4f-b667-5200-a6b9-4b39cfdb6f72","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","K6","8eacce23-33fb-500d-8d6f-5fc1794664f1","ABS - Lahey Clinic","not reported","c54.1","TCGA-K6-A3WQ_diagnosis","not reported",22092,"dead","8441/3",427,400,"9542a14c-2521-575a-8430-31ef6aa00d50","c54.1",-22092,"TCGA-K6-A3WQ_treatment","97826b3a-bd76-5325-8bf3-1c89eaf34e26","01","true","TCGA-K6-A3WQ-01A",NA,"702c78d1-352a-4050-a17e-501bbfd0317a",FALSE,"16F848AA-C14C-45F7-A756-414615853761","Primary Tumor",NA,63,440,NA,1336953600,"11",30,"TCGA-K6-A3WQ-01A-11",95,NA,10,NA,0,NA,3,NA,"2016-09-08T11:06:14.967348-05:00",NA,50,NA,20,NA,"TOP",NA,2,NA,"330ac99f-8b36-416f-a76e-f62e10746cb1",NA,"TCGA-K6-A3WQ-01A-01-TS1",NA,95,NA,"dd37e24e-85de-4b6f-ba70-bfd4946d9f60","RNA","TCGA-K6-A3WQ-01A-11R","ea9731be-3699-4de3-bb76-21de1e6ded99",1.82,0.16,"UV Spec","R","23","TCGA-K6-A3WQ-01A-11R-A22K-07","8fac215c-7172-42ed-af07-00b27c05d3a6",0.16,NA,99,33.8565712526931,171,"3b0a3a0a-066e-5645-8e83-f4790a90fc2d","TCGA-K6-A3WQ_exposure","UNCID_2173486.8fac215c-7172-42ed-af07-00b27c05d3a6.130502_UNC12-SN629_0289_AC236KACXX_5_AGTTCC.tar.gz","2013-09-09T07:16:09.000Z","2013-09-09T07:32:01.000Z","0FFF10C1-940F-4550-9BA2-C8A474A35854","702C78D1-352A-4050-A17E-501BBFD0317A","Unaligned reads",5606155100,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8FAC215C-7172-42ED-AF07-00B27C05D3A6","University of North Carolina","564a3a3ee4b0ef12181a12f5","D6303A05-F705-4413-8860-506A105D5B08","Uterine Corpus Endometrial Carcinoma","TARGZ","DD37E24E-85DE-4B6F-BA70-BFD4946D9F60","2013-09-09T07:32:01.000Z","EA9731BE-3699-4DE3-BB76-21DE1E6DED99","United States","NO",1,NA,"Primary Tumor","ABS - Lahey Clinic",63,"DD37E24E-85DE-4B6F-BA70-BFD4946D9F60",NA,"K6","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.2F07DA77-7FFB-44F5-A741-FEFC6577AEDE.txt",440,"TCGA-K6-A3WQ-01A",NA,"D9AF43C7-3058-413B-B3FB-1A84F061BAAD","TCGA",2012,NA,NA,"TUMOR FREE","702C78D1-352A-4050-A17E-501BBFD0317A",60,"nationwidechildrens.org_clinical.TCGA-K6-A3WQ.xml","Alive",NA,"TCGA-K6-A3WQ","NOT HISPANIC OR LATINO","540A6555-576B-48C8-A471-78EAD16276F8",NA,204,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"45E7296D-1661-4D9D-B7EC-ABB1687F14E0","WHITE",NA,11,30,"330AC99F-8B36-416F-A76E-F62E10746CB1","6696C20F-7957-4507-BE15-F16616E538B6","UNCID_2034926.8fac215c-7172-42ed-af07-00b27c05d3a6.sorted_genome_alignments.bam.bai","TCGA-K6-A3WQ-01A-11",95,0,10,50,3,"TOP",2,20,"TCGA-K6-A3WQ-01A-01-TS1",95,"Taxol","Chemotherapy","TCGA-K6-A3WQ-D55416","TCGA-K6-A3WQ-R55414","Internal","Regional site","TCGA-K6-A3WQ-F59157_NTE-1","YES",400,"WITH TUMOR","Dead",427,"TCGA-K6-A3WQ-F59157","TCGA-K6-A3WQ",1,"K6","A3WQ","YES","C54.1","8441/3","C54.1","YES","NO",-22092,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",204,NA,NA,NA,"TUMOR FREE","NO",26,9,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,60,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35820011,34588647,2595312229,"D20402E2-E3CC-4535-922D-3D7BBFA48AD7.bw","d6562acf-6d82-4f08-a779-82cdc5df16f9","d20402e2-e3cc-4535-922d-3d7bbfa48ad7","2016-08-06T17:08:39.565102-05:00","UNCID_2210209.9def1496-a891-431c-b5c2-75d258e7ec29.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_7.tar.gz","e6ab73b2-70f1-42fc-a899-a5d388984010",2310481533,"Illumina GA","5a7374f170317d3e52ccf28caaa02541","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:18:37.813904-05:00","2016-05-03T11:15:47.407128-05:00","e6ab73b2-70f1-42fc-a899-a5d388984010_analysis.xml","66a589342993bb57e4833293677d0eb1","68597452-867b-4d11-9692-efd8d4634db7",2121,"2016-10-07T16:26:45.497142-05:00","e6ab73b2-70f1-42fc-a899-a5d388984010_experiment.xml","08ec22b5ec70a0e2fff25a9b782d3be6","9e2bc513-07c7-4084-b08c-baf3af075d61",2257,"2016-09-29T22:39:10.325766-05:00","e6ab73b2-70f1-42fc-a899-a5d388984010_run.xml","69e7bd42da0e76ff32c87a5f56350715","bf75a423-00d3-4ce0-8174-83795bd31e81",347,"2016-09-08T12:03:26.182104-05:00","TCGA-D1-A15W","2016-09-02T18:49:54.070319-05:00","female","TCGA-D1-A15W_demographic",1950,"white","5e8f2da5-7f61-5140-9364-25325bf20cad","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A15W_diagnosis","not reported",21545,"alive","8380/3",NA,915,"54ec6618-ae60-5df8-9a0e-32da9a95aeb4","c54.1",-21545,"TCGA-D1-A15W_treatment","6ea57f75-1f3e-5422-b62a-ba1a9e573765","01","false","TCGA-D1-A15W-01A",NA,"1ac48153-0577-4bc0-ab8c-f77453ebfbb0",FALSE,"1C938760-9492-4F4E-87CE-85CE3C15BBCA","Primary Tumor",NA,906,190,NA,1292976000,"11",30,"TCGA-D1-A15W-01A-11",80,NA,0,NA,5,NA,0,NA,"2016-09-08T12:03:26.182104-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"94afb8d6-ecdb-43e0-b844-8dc2fc4c6f22",NA,"TCGA-D1-A15W-01A-01-TS1",NA,95,NA,"99856b4b-6116-4aad-a15c-80732f1d869f","RNA","TCGA-D1-A15W-01A-11R","f9877fe4-fad6-4f5b-b41f-c03479b7c0b2",1.87,0.16,"UV Spec","R","23","TCGA-D1-A15W-01A-11R-A118-07","9def1496-a891-431c-b5c2-75d258e7ec29",0.16,NA,126,46.2809917355372,165,"025d48e7-661f-506e-809a-b68b9ebf186d","TCGA-D1-A15W_exposure","UNCID_2210209.9def1496-a891-431c-b5c2-75d258e7ec29.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_7.tar.gz","2013-10-02T07:26:04.000Z","2013-10-02T07:38:03.000Z","E6AB73B2-70F1-42FC-A899-A5D388984010","1AC48153-0577-4BC0-AB8C-F77453EBFBB0","Unaligned reads",2310481533,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","9DEF1496-A891-431C-B5C2-75D258E7EC29","University of North Carolina","566074bae4b016715ab67943","D6562ACF-6D82-4F08-A779-82CDC5DF16F9","Uterine Corpus Endometrial Carcinoma","TARGZ","99856B4B-6116-4AAD-A15C-80732F1D869F","2013-10-02T07:38:03.000Z","F9877FE4-FAD6-4F5B-B41F-C03479B7C0B2","None","NO",1,NA,"Primary Tumor","Mayo Clinic",906,"99856B4B-6116-4AAD-A15C-80732F1D869F",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CAFD3FC6-B826-40D0-BDA1-E66AB5BFA073.txt",190,"TCGA-D1-A15W-01A",NA,"3D92959A-B80D-40AE-9876-AEAA751BF22B","TCGA",2008,NA,NA,"TUMOR FREE","6F25B610-527F-4DA2-A6F4-3202475E5D5A",58,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CAFD3FC6-B826-40D0-BDA1-E66AB5BFA073.txt","Alive",NA,"TCGA-D1-A15W","NOT HISPANIC OR LATINO","E1B82A9E-925E-43DC-BF07-935BC0BB97C1",NA,915,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"C0BFFBD3-D84E-4373-86C0-FDDEA7082C80","WHITE",NA,11,30,"94AFB8D6-ECDB-43E0-B844-8DC2FC4C6F22","F9877FE4-FAD6-4F5B-B41F-C03479B7C0B2","UNCID_2210209.9def1496-a891-431c-b5c2-75d258e7ec29.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_7.tar.gz","TCGA-D1-A15W-01A-11",80,5,0,0,0,"TOP",0,0,"TCGA-D1-A15W-01A-01-TS1",95,"Taxol","Chemotherapy","TCGA-D1-A15W-D18471","TCGA-D1-A15W-R18464","EXTERNAL BEAM","Regional site",NA,"NO",915,"TUMOR FREE","Alive",NA,"TCGA-D1-A15W-F18462","TCGA-D1-A15W",1,"D1","A15W","YES","C54.1","8380/3","C54.1","NO","YES",-21545,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",915,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1","RX",NA,NA,NA,NA,NA,"1995",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32931865,32788445,2465535783,"6F9405E7-9279-42E1-99B1-DEC727D9EC1A.bw","d70b3c6e-04da-4abc-a832-a461e4cfcc94","6f9405e7-9279-42e1-99b1-dec727d9ec1a","2016-08-09T14:11:36.296382-05:00","UNCID_2206906.222512dc-7088-4c86-a82c-99c2e4cd427c.110817_UNC6-RDR300211_00122_FC_6315AAXX_3.tar.gz","115a4acc-fd2a-453b-8f0b-164a48301366",2146937882,"Illumina GA","f66bae6bae39ab4ef72d7ae223e8f157","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:26:28.468275-05:00","2016-05-03T11:13:02.652554-05:00","115a4acc-fd2a-453b-8f0b-164a48301366_analysis.xml","35f5c0bc08989242115e100938b3a4b2","dcc60138-05ff-4915-827b-9120e80bb839",2118,"2016-09-29T22:03:58.016667-05:00","115a4acc-fd2a-453b-8f0b-164a48301366_experiment.xml","6d29ca0f55622aedf39b97de325dc9c3","a9ca5e8e-79c6-4a55-9e6c-0edfd84b3aef",2257,"2016-09-29T20:28:18.184827-05:00","115a4acc-fd2a-453b-8f0b-164a48301366_run.xml","887a0a68d5467189dcd4b1e1b6d109b3","6e5f4dbd-619a-445c-8a73-9c70e65570c7",347,"2016-09-08T10:39:16.964972-05:00","TCGA-AX-A1CN","2016-09-02T18:51:43.780636-05:00","female","TCGA-AX-A1CN_demographic",1955,"white","5f17d402-31f5-519a-8045-d4092aead279","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CN_diagnosis","not reported",19860,"alive","8380/3",NA,1143,"05e7f7c9-ee29-5096-97c2-f5f08b948f5f","c54.1",-19860,"TCGA-AX-A1CN_treatment","ff0adede-d697-563d-b250-3b60006fddbc","01","false","TCGA-AX-A1CN-01A",NA,"785a9c46-0629-4e15-90c0-9437644ff9bf",FALSE,"D0FB2179-60D4-4B3C-9D88-B07D802F772E","Primary Tumor",NA,701,110,NA,1295308800,"11",30,"TCGA-AX-A1CN-01A-11",90,NA,0,NA,13,NA,2,NA,"2016-09-08T10:39:16.964972-05:00",NA,1,NA,1,NA,"TOP",NA,10,NA,"5940e78d-9fa5-436e-bb23-b4db5e9c415d",NA,"TCGA-AX-A1CN-01A-01-TS1",NA,75,NA,"0756884a-ae2e-41e8-8abb-4fc9b40055f9","RNA","TCGA-AX-A1CN-01A-11R","82bb7a35-4c00-446e-a0fb-576b4eaa6348",1.88,0.17,"UV Spec","R","23","TCGA-AX-A1CN-01A-11R-A137-07","222512dc-7088-4c86-a82c-99c2e4cd427c",0.17,NA,146,47.6734693877551,175,"6f684f0d-f908-5d53-8e69-293851d178cc","TCGA-AX-A1CN_exposure","UNCID_2206906.222512dc-7088-4c86-a82c-99c2e4cd427c.110817_UNC6-RDR300211_00122_FC_6315AAXX_3.tar.gz","2013-09-28T16:36:04.000Z","2013-09-28T16:50:02.000Z","115A4ACC-FD2A-453B-8F0B-164A48301366","785A9C46-0629-4E15-90C0-9437644FF9BF","Unaligned reads",2146937882,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","222512DC-7088-4C86-A82C-99C2E4CD427C","University of North Carolina","56607ee9e4b018727fea38ef","D70B3C6E-04DA-4ABC-A832-A461E4CFCC94","Uterine Corpus Endometrial Carcinoma","TARGZ","0756884A-AE2E-41E8-8ABB-4FC9B40055F9","2013-09-28T16:50:02.000Z","82BB7A35-4C00-446E-A0FB-576B4EAA6348","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",701,"0756884A-AE2E-41E8-8ABB-4FC9B40055F9",NA,"AX","TCGA-AX-A1CN-01A-11R-A136-13_mirna.bam.bai",110,"TCGA-AX-A1CN-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","785A9C46-0629-4E15-90C0-9437644FF9BF",54,"nationwidechildrens.org_clinical.TCGA-AX-A1CN.xml","Alive",NA,"TCGA-AX-A1CN","NOT HISPANIC OR LATINO","68C2F832-2DEA-4DED-AFC1-D47659626B93",NA,764,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"5940E78D-9FA5-436E-BB23-B4DB5E9C415D","D9262759-9247-40FE-8C9D-432A0236C8C2","TCGA-AX-A1CN-01A-11R-A136-13_mirna.bam.bai","TCGA-AX-A1CN-01A-11",90,13,0,1,2,"TOP",10,1,"TCGA-AX-A1CN-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,NA,NA,764,"TUMOR FREE","Alive",NA,"TCGA-AX-A1CN-F10301","TCGA-AX-A1CN",1,"AX","A1CN","YES","C54.1","8380/3","C54.1","NO","YES",-19860,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",764,NA,NA,NA,"TUMOR FREE","NO",10,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,54,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
111135864,110001752,5247537957,"1B33A2A7-2FF8-48ED-AD7E-499B4847FBC5.bw","d72264ec-d4d7-423a-9216-ae4485f81aba","1b33a2a7-2ff8-48ed-ad7e-499b4847fbc5","2016-08-25T04:35:37.735099-05:00","UNCID_2327188.331785a5-59ba-441f-81dc-384d7f80905b.131016_UNC10-SN254_0498_BC2KTUACXX_6_TAGCTT.tar.gz","40d528dd-3b71-485b-83bf-298a281da168",5265785535,"Illumina HiSeq","6babf4ecbb9302c8aedde8696970a445","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:51:57.435273-05:00","2016-05-03T11:34:55.532339-05:00","40d528dd-3b71-485b-83bf-298a281da168_analysis.xml","7c21750c1633f8f845ae85486db271c7","a2517250-338b-4bf3-8ec7-c907ee10348f",2124,"2016-08-27T06:04:18.568006-05:00","40d528dd-3b71-485b-83bf-298a281da168_experiment.xml","45f70535179c18984b17905e09629c7e","48abbc04-c43d-4b17-bbaf-eefebc5981af",2628,"2016-09-29T18:47:57.974355-05:00","40d528dd-3b71-485b-83bf-298a281da168_run.xml","773f713024e30a0269ba752db5910aed","30189d1c-bc63-443f-86f2-ee0d29d6c0d1",354,"2016-09-08T11:04:25.473336-05:00","TCGA-FL-A1YN",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YN-11A",NA,"ec811767-6af1-485a-967d-231764ef6797",FALSE,"BA22BA6E-3DEF-4354-A52C-19B405A349FB","Solid Tissue Normal",NA,NA,60,NA,1302480000,"11",30,"TCGA-FL-A1YN-11A-11",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T11:04:25.473336-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"f81e300c-262d-4000-b85d-bcaf01258372",NA,"TCGA-FL-A1YN-11A-01-TS1",NA,0,NA,"fa1bd542-e49c-4ee8-a9e4-d9bfafa5d7e0","RNA","TCGA-FL-A1YN-11A-11R","f8bace8b-dc5c-4e39-868f-e1ca45eacd95",2.12,0.17,"UV Spec","R","23","TCGA-FL-A1YN-11A-11R-A32Y-07","331785a5-59ba-441f-81dc-384d7f80905b",0.17,NA,NA,NA,NA,NA,NA,"UNCID_2327188.331785a5-59ba-441f-81dc-384d7f80905b.131016_UNC10-SN254_0498_BC2KTUACXX_6_TAGCTT.tar.gz","2014-01-25T04:52:40.000Z","2014-01-25T05:15:02.000Z","40D528DD-3B71-485B-83BF-298A281DA168","EC811767-6AF1-485A-967D-231764EF6797","Unaligned reads",5265785535,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","331785A5-59BA-441F-81DC-384D7F80905B","University of North Carolina","56607b19e4b018727fea28da","D72264EC-D4D7-423A-9216-AE4485F81ABA","Uterine Corpus Endometrial Carcinoma","TARGZ","FA1BD542-E49C-4EE8-A9E4-D9BFAFA5D7E0","2014-01-25T05:15:02.000Z","F8BACE8B-DC5C-4E39-868F-E1CA45EACD95","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"FA1BD542-E49C-4EE8-A9E4-D9BFAFA5D7E0",NA,"FL","2ad27bb643c41c8408a413b31a243a51.bam",60,"TCGA-FL-A1YN-11A",NA,NA,"TCGA",NA,NA,NA,NA,"EC811767-6AF1-485A-967D-231764EF6797",NA,"2ad27bb643c41c8408a413b31a243a51.bam",NA,NA,"TCGA-FL-A1YN",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,156,NA,NA,NA,NA,11,30,"F81E300C-262D-4000-B85D-BCAF01258372","F8BACE8B-DC5C-4E39-868F-E1CA45EACD95","2ad27bb643c41c8408a413b31a243a51.bam","TCGA-FL-A1YN-11A-11",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YN-11A-01-TS1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
32954544,32268484,2409446704,"2CB06CA6-8D1F-4BC7-99BE-66921805B8FD.bw","d7258a64-3ea0-40fc-b3f4-b581a1725fff","2cb06ca6-8d1f-4bc7-99be-66921805b8fd","2016-08-09T14:08:32.701995-05:00","UNCID_2206487.35759844-0020-4b37-bd5a-ede870b7f0ab.110921_UNC6-RDR300211_00125_FC_634F4AAXX_1.tar.gz","d34216c6-c730-407e-a9bd-27780575e6d0",2155247376,"Illumina GA","4dca5ec02f7115e9ac08f2d7f44d3f76","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:21:52.020116-05:00","2016-05-03T11:11:34.765256-05:00","d34216c6-c730-407e-a9bd-27780575e6d0_analysis.xml","aa648b7fab705643344511fdee938fc1","1f78c1c9-678c-4cb8-b7d0-f760536bc7cb",2121,"2016-09-29T17:56:51.931766-05:00","d34216c6-c730-407e-a9bd-27780575e6d0_experiment.xml","5db5a0ffa33529e24b9dfb9a138d1493","0ff6966a-a64a-459e-8040-19a33fda4545",2257,"2016-09-30T00:04:43.221697-05:00","d34216c6-c730-407e-a9bd-27780575e6d0_run.xml","ed487070a808db31bf12bf57b1373f46","f476d7ae-3710-4403-8e34-4b7952f16fac",347,"2016-09-08T11:07:46.212879-05:00","TCGA-D1-A1NW","2016-09-02T18:52:34.201942-05:00","female","TCGA-D1-A1NW_demographic",1938,"white","694e78fe-7a46-5958-8551-9345298fe4ba","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1NW_diagnosis","not reported",26556,"alive","8441/3",NA,22,"5d5d849c-052c-5063-ade9-20bd9e3e4943","c54.1",-26556,"TCGA-D1-A1NW_treatment","683c480b-caa4-509d-9f18-23dbd20d4781","01","false","TCGA-D1-A1NW-01A",NA,"b79a1d9c-02ef-4192-beb3-bca8b362eb2e",FALSE,"10E1E872-408C-458D-9438-00F5ECA3083A","Primary Tumor",NA,199,80,NA,1301875200,"11",30,"TCGA-D1-A1NW-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T11:07:46.212879-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"6c1e3c0a-2c0e-4ca4-a088-8f6c6d2715d8",NA,"TCGA-D1-A1NW-01A-01-TS1",NA,90,NA,"4840796f-9972-48d4-84d7-97c431d81a09","RNA","TCGA-D1-A1NW-01A-11R","476109fe-9d56-4162-bbc2-f8aafc17e3e9",1.82,0.16,"UV Spec","R","23","TCGA-D1-A1NW-01A-11R-A14M-07","35759844-0020-4b37-bd5a-ede870b7f0ab",0.16,NA,98,38.28125,160,"248a0f69-967e-5d4c-acbb-715c3c04cc74","TCGA-D1-A1NW_exposure","UNCID_2206487.35759844-0020-4b37-bd5a-ede870b7f0ab.110921_UNC6-RDR300211_00125_FC_634F4AAXX_1.tar.gz","2013-09-27T04:16:04.000Z","2013-09-27T04:35:02.000Z","D34216C6-C730-407E-A9BD-27780575E6D0","B79A1D9C-02EF-4192-BEB3-BCA8B362EB2E","Unaligned reads",2155247376,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","35759844-0020-4B37-BD5A-EDE870B7F0AB","University of North Carolina","564a3ebee4b0298dd2c97aaf","D7258A64-3EA0-40FC-B3F4-B581A1725FFF","Uterine Corpus Endometrial Carcinoma","TARGZ","4840796F-9972-48D4-84D7-97C431D81A09","2013-09-27T04:35:02.000Z","476109FE-9D56-4162-BBC2-F8AAFC17E3E9","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",199,"4840796F-9972-48D4-84D7-97C431D81A09",NA,"D1","UNCID_1620065.35759844-0020-4b37-bd5a-ede870b7f0ab.sorted_genome_alignments.bam.bai",80,"TCGA-D1-A1NW-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","C62BEAEC-9EBC-418C-8980-83835858FDA6",72,"nationwidechildrens.org_clinical.TCGA-D1-A1NW.xml","Alive",NA,"TCGA-D1-A1NW","NOT HISPANIC OR LATINO","BE8A5DA3-EAFF-461F-880D-6ADB3F84B95C",NA,22,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",125,NA,NA,"WHITE",NA,11,30,"6C1E3C0A-2C0E-4CA4-A088-8F6C6D2715D8","67F21826-F986-4708-AA32-E45DB513B9F9","CABAL_p_TCGA_b112_125_SNP_N_GenomeWideSNP_6_E08_780584.hg19.seg.txt","TCGA-D1-A1NW-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-D1-A1NW-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,"NO",22,"TUMOR FREE","Alive",NA,"TCGA-D1-A1NW-F21642","TCGA-D1-A1NW",1,"D1","A1NW","YES","C54.1","8441/3","C54.1","NO","YES",-26556,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",22,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,72,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33497748,32846271,2465952998,"D237B5BC-852B-4C51-B4B8-A7DAA55F03E0.bw","d74bc72e-8103-4aed-8958-5f40953d48eb","d237b5bc-852b-4c51-b4b8-a7daa55f03e0","2016-08-05T06:34:11.527643-05:00","UNCID_2212126.8708462d-d090-4fa2-95a6-f6021ce0489b.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_5.tar.gz","5d636335-2495-4aaf-9932-955d060076f0",2110115943,"Illumina GA","61321b3a16d9f6d4c68bf1edf3b185c2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:02:46.620982-05:00","2016-05-03T11:16:29.242391-05:00","5d636335-2495-4aaf-9932-955d060076f0_analysis.xml","6223319b23440695d7e7ed5fa906bc28","5ed26dbe-6d28-4b7a-be05-38fff2be2d0d",2121,"2016-09-29T19:10:38.264083-05:00","5d636335-2495-4aaf-9932-955d060076f0_experiment.xml","74f73762511e94f00e7325e628246d42","3e60591d-01e8-4a55-9dcc-c8e6cb96624a",2257,"2016-09-29T18:29:43.574603-05:00","5d636335-2495-4aaf-9932-955d060076f0_run.xml","322e4d1313a86c0cffe4b3889cca3007","247f593a-2830-4893-b999-35450888ba40",347,"2016-09-08T10:27:10.724925-05:00","TCGA-D1-A0ZU","2016-09-02T18:49:12.916023-05:00","female","TCGA-D1-A0ZU_demographic",1975,"white","ee1002c1-689a-5594-a725-effa8b8af1dc","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A0ZU_diagnosis","not reported",12458,"alive","8382/3",NA,872,"b4a356da-fe64-55c9-af8e-cfb83379916a","c54.1",-12458,"TCGA-D1-A0ZU_treatment","6e8af011-3c03-57b3-8a0b-40bdfc7655c3","01","false","TCGA-D1-A0ZU-01A",NA,"7b90b0fe-1088-48e9-8903-6102f27e4485",FALSE,"D0BC0903-390B-4344-A613-48ABF71CF08D","Primary Tumor",NA,508,180,NA,1288656000,"11",30,"TCGA-D1-A0ZU-01A-11",80,80,0,0,10,20,10,0,"2016-09-08T10:27:10.724925-05:00","2016-09-08T10:27:10.724925-05:00",10,10,10,10,"TOP","BOTTOM",10,10,"24650b19-645b-476f-91cf-85a8c0db5dc3","19f8bd4c-f8ae-4f5c-9560-f92839226651","TCGA-D1-A0ZU-01A-01-TS1","TCGA-D1-A0ZU-01A-01-BS1",70,70,"d39d7dc6-8782-41f1-b3e4-457337b288b4","RNA","TCGA-D1-A0ZU-01A-11R","a476f599-ab31-4ddf-ba35-fb7626bb419e",1.86,0.16,"UV Spec","R","23","TCGA-D1-A0ZU-01A-11R-A10J-07","8708462d-d090-4fa2-95a6-f6021ce0489b",0.16,NA,94,32.5259515570934,170,"4f987bcb-1e39-5e41-86c3-d8b25429138c","TCGA-D1-A0ZU_exposure","UNCID_2212126.8708462d-d090-4fa2-95a6-f6021ce0489b.110303_UNC3-RDR300156_00077_FC_62J3HAAXX_5.tar.gz","2013-10-03T05:43:05.000Z","2013-10-03T05:55:02.000Z","5D636335-2495-4AAF-9932-955D060076F0","7B90B0FE-1088-48E9-8903-6102F27E4485","Unaligned reads",2110115943,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8708462D-D090-4FA2-95A6-F6021CE0489B","University of North Carolina","564a3df0e4b0298dd2c9380c","D74BC72E-8103-4AED-8958-5F40953D48EB","Uterine Corpus Endometrial Carcinoma","TARGZ","D39D7DC6-8782-41F1-B3E4-457337B288B4","2013-10-03T05:55:02.000Z","A476F599-AB31-4DDF-BA35-FB7626BB419E","None","NO",1,NA,"Primary Tumor","Mayo Clinic",508,"D39D7DC6-8782-41F1-B3E4-457337B288B4",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8C9B9C6B-D8EB-4609-AAF6-8C92BA431FEF.txt",180,"TCGA-D1-A0ZU-01A",NA,"CC7B2E87-3F9D-4964-A803-4E0FE36DA4FC","TCGA",2009,NA,NA,"TUMOR FREE","7B90B0FE-1088-48E9-8903-6102F27E4485",34,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8C9B9C6B-D8EB-4609-AAF6-8C92BA431FEF.txt","Alive",NA,"TCGA-D1-A0ZU","NOT HISPANIC OR LATINO","01F3B150-428B-4E8A-858E-459A87B66329",NA,578,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8382/3","FEMALE","C54.1",81,NA,"B2A5B170-C75A-4DCB-A51E-C43B146FB2E0","WHITE",NA,11,30,"19F8BD4C-F8AE-4F5C-9560-F92839226651","D2EDB165-FD77-48DE-9394-91B0F649C891","TCGA-D1-A0ZU-01A-11R-A10I-13_mirna.bam","TCGA-D1-A0ZU-01A-11",80,10,0,10,10,"TOP",10,10,"TCGA-D1-A0ZU-01A-01-TS1",70,"Paclitaxel","Chemotherapy","TCGA-D1-A0ZU-D17777","TCGA-D1-A0ZU-R17816","EXTERNAL BEAM","Regional site",NA,"NO",872,"TUMOR FREE","Alive",NA,"TCGA-D1-A0ZU-F17749","TCGA-D1-A0ZU",1,"D1","A0ZU","YES","C54.1","8382/3","C54.1","NO","YES",-12458,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",578,NA,NA,NA,"TUMOR FREE","NO",8,3,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,34,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
36915764,36348841,2729411928,"74DDE13E-88AD-47C3-8824-5AE0C2B969D6.bw","d77e4dbc-b239-4742-8cb7-efd427010d13","74dde13e-88ad-47c3-8824-5ae0c2b969d6","2016-08-06T12:54:00.119577-05:00","UNCID_2207036.2fc92e79-f56f-46b9-b378-a242dd7642d6.110728_UNC2-RDR300275_00080_FC_63145AAXX_7.tar.gz","af75668b-22d4-4660-9044-9197b07893db",2386107772,"Illumina GA","7bf6b5ab64e028f5ecc1c82e3c12a197","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:38:01.014932-05:00","2016-05-03T11:13:02.646906-05:00","af75668b-22d4-4660-9044-9197b07893db_analysis.xml","5d91f00351733e53bf430f8e35b44209","bebc381d-249b-4137-a48f-6dc75ab8b473",2121,"2016-09-29T20:10:16.469696-05:00","af75668b-22d4-4660-9044-9197b07893db_experiment.xml","eddcf54eb1eb60da1bbb2ab22205dc04","63543df6-7e60-4e91-815a-67579b687003",2257,"2016-09-29T19:34:45.032573-05:00","af75668b-22d4-4660-9044-9197b07893db_run.xml","a9bf5b9ab5fd3d22571b8713b87efd91","4d769b12-81f7-4a77-b08d-ec4f0ba179f5",347,"2016-09-08T11:24:14.201931-05:00","TCGA-AP-A054","2016-09-02T18:54:16.231196-05:00","female","TCGA-AP-A054_demographic",1940,"white","d6f05fb4-474c-5dc6-af92-61624f0f0d4c","not hispanic or latino",2005,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A054_diagnosis","not reported",23404,"dead","8380/3",709,NA,"2b7347af-8dcf-51f7-a56d-c994d6a4fc35","c54.1",-23404,"TCGA-AP-A054_treatment","f4e752ef-f88e-5b9b-8a14-31201292e799","01","true","TCGA-AP-A054-01A",NA,"ddffb9c7-185f-402f-99b8-8058b40086d9",FALSE,"72028DF7-DAD0-487E-914B-C3AA69A1E6C4","Primary Tumor",NA,2086,410,NA,1275868800,"11",30,"TCGA-AP-A054-01A-11",94,88,0,0,8,23,2,2,"2016-09-08T11:24:14.201931-05:00","2016-09-08T11:24:14.201931-05:00",0,0,0,0,"BOTTOM","TOP",20,8,"d296e33e-f6e6-488f-9582-d4a94c63eeda","cf06e2fb-c9bf-4161-87dd-152deb208062","TCGA-AP-A054-01A-01-BS1","TCGA-AP-A054-01A-01-TS1",70,67,"f213819b-662c-4ee1-a038-f4330a31d118","RNA","TCGA-AP-A054-01A-11R","2f3d66d7-03de-4230-936a-542e8f8d333d",1.86,0.15,"UV Spec","R","23","TCGA-AP-A054-01A-11R-A16W-07","2fc92e79-f56f-46b9-b378-a242dd7642d6",0.15,NA,75,26.8923231381548,167,"c6d729f9-018a-5cb9-a133-6c1c1eb4ace8","TCGA-AP-A054_exposure","UNCID_2207036.2fc92e79-f56f-46b9-b378-a242dd7642d6.110728_UNC2-RDR300275_00080_FC_63145AAXX_7.tar.gz","2013-09-29T03:16:04.000Z","2013-09-29T03:35:02.000Z","AF75668B-22D4-4660-9044-9197B07893DB","DDFFB9C7-185F-402F-99B8-8058B40086D9","Unaligned reads",2386107772,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2FC92E79-F56F-46B9-B378-A242DD7642D6","University of North Carolina","564a3c94e4b093830b69a567","D77E4DBC-B239-4742-8CB7-EFD427010D13","Uterine Corpus Endometrial Carcinoma","TARGZ","F213819B-662C-4EE1-A038-F4330A31D118","2013-09-29T03:35:02.000Z","2F3D66D7-03DE-4230-936A-542E8F8D333D","None","NO",1,NA,"Primary Tumor","MSKCC",2086,"F213819B-662C-4EE1-A038-F4330A31D118",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.566C65B2-4775-4AC8-B63D-21ED246B0523.txt",410,"TCGA-AP-A054-01A",NA,"EEE7E85B-987A-42E9-BD83-21800963AB15","TCGA",2004,NA,NA,"WITH TUMOR","DDFFB9C7-185F-402F-99B8-8058B40086D9",64,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.566C65B2-4775-4AC8-B63D-21ED246B0523.txt","Dead",709,"TCGA-AP-A054","NOT HISPANIC OR LATINO","AAFAE529-AAAF-435C-98B0-D2997006D7A8",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"D296E33E-F6E6-488F-9582-D4A94C63EEDA","733CE2CC-F9A1-4438-ADC0-B970038A8662","TCGA-AP-A054-01A-11R-A041-13_mirna.bam.bai","TCGA-AP-A054-01A-11",88,23,0,0,2,"TOP",8,0,"TCGA-AP-A054-01A-01-TS1",67,"Paclitaxel","Chemotherapy","TCGA-AP-A054-D3411",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",709,"TCGA-AP-A054-F3409","TCGA-AP-A054",1,"AP","A054","YES","C54.1","8380/3","C54.1","NO","YES",-23404,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,709,NA,NA,"WITH TUMOR","NO",23,9,2010,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2004,"Dilation and curettage procedure",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,NA,12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35442713,35272664,2625727194,"33DE9BAA-3B78-4026-96C5-A1A82FB61274.bw","d79e692c-5053-4484-a180-01a094c5ff45","33de9baa-3b78-4026-96c5-a1a82fb61274","2016-08-09T14:08:28.532943-05:00","UNCID_2206475.c45110ae-6ba6-44d7-8bff-5fa16c45d962.110921_UNC2-RDR300275_00086_FC634HAAAXX_6.tar.gz","cd761798-f8f2-4736-a4ec-c415ff76c2c1",2259643564,"Illumina GA","33e5db0b66f22770e1f4255340e0d9aa","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:53:52.912651-05:00","2016-05-03T11:11:34.768699-05:00","cd761798-f8f2-4736-a4ec-c415ff76c2c1_analysis.xml","d316c673a5d8f343f5bdc7c7c1a49d60","c8a2219f-68b7-4375-8bc2-db252befa7bf",2119,"2016-09-30T00:08:00.451494-05:00","cd761798-f8f2-4736-a4ec-c415ff76c2c1_experiment.xml","d3ce7e6150c53a6a007dddfe43cad508","f6750579-5a40-4a0e-ac40-f6ceb89ab4f0",2257,"2016-09-29T21:44:59.699665-05:00","cd761798-f8f2-4736-a4ec-c415ff76c2c1_run.xml","28ac937d05b918d71f8a1286151a080a","9de78eb4-0861-402b-9bad-38a5be567b19",347,"2016-09-08T11:16:27.708982-05:00","TCGA-B5-A1N2","2016-09-02T18:52:05.846316-05:00","female","TCGA-B5-A1N2_demographic",1940,"black or african american","da3707f8-f6ee-513d-b165-45858db4dcd1","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A1N2_diagnosis","not reported",25612,"dead","8441/3",954,389,"327134b5-089b-59d7-8f74-1504576e9298","c54.1",-25612,"TCGA-B5-A1N2_treatment","1df98583-271a-521f-b524-eff3f9bb7f06","01","true","TCGA-B5-A1N2-01A",NA,"a5058d90-cea2-4886-9823-501ff2262e13",FALSE,"CB8D6955-D74A-4A05-ACC3-F0DE49CC60A9","Primary Tumor",NA,93,540,NA,1300406400,"21",30,"TCGA-B5-A1N2-01A-21",70,NA,5,NA,0,NA,30,NA,"2016-09-08T11:16:27.708982-05:00",NA,30,NA,3,NA,"TOP",NA,0,NA,"0b277d6f-d369-4821-b068-e57a4eeafaa4",NA,"TCGA-B5-A1N2-01A-02-TSB",NA,70,NA,"7253e0cb-4f5f-4e2c-b410-9588d68466cf","RNA","TCGA-B5-A1N2-01A-21R","82790ce6-3c46-44d8-a25b-d69fd48d7ee4",1.85,0.15,"UV Spec","R","23","TCGA-B5-A1N2-01A-21R-A144-07","c45110ae-6ba6-44d7-8bff-5fa16c45d962",0.15,NA,114,40.391156462585,168,"81e769ca-859d-5821-a1e6-15e71d3aa235","TCGA-B5-A1N2_exposure","UNCID_2206475.c45110ae-6ba6-44d7-8bff-5fa16c45d962.110921_UNC2-RDR300275_00086_FC634HAAAXX_6.tar.gz","2013-09-27T03:01:09.000Z","2013-09-27T03:15:01.000Z","CD761798-F8F2-4736-A4EC-C415FF76C2C1","A5058D90-CEA2-4886-9823-501FF2262E13","Unaligned reads",2259643564,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C45110AE-6BA6-44D7-8BFF-5FA16C45D962","University of North Carolina","56607e07e4b0ca31916506e2","D79E692C-5053-4484-A180-01A094C5FF45","Uterine Corpus Endometrial Carcinoma","TARGZ","7253E0CB-4F5F-4E2C-B410-9588D68466CF","2013-09-27T03:15:01.000Z","82790CE6-3C46-44D8-A25B-D69FD48D7EE4","United States","NO",1,NA,"Primary Tumor","Duke",93,"7253E0CB-4F5F-4E2C-B410-9588D68466CF",NA,"B5","GOOFS_p_TCGA_b117_118_SNP_N_GenomeWideSNP_6_H06_778010.byallele.copynumber.data.txt",540,"TCGA-B5-A1N2-01A",NA,"41CBE845-6D3F-4CB6-B530-20210A51FAE3","TCGA",2010,NA,NA,"TUMOR FREE","D8A90CC9-D96D-478D-B1C2-135266D98E15",70,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C3866F58-D26C-4DF1-A522-125C0A4D12CE.txt","Alive",NA,"TCGA-B5-A1N2",NA,"BE87B1A8-2BDC-41DD-AA78-15C8973163A1",NA,389,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8441/3","FEMALE","C54.1",118,NA,"79AFB4D2-1201-4800-8735-9312D6DF546E","BLACK OR AFRICAN AMERICAN",NA,21,30,"0B277D6F-D369-4821-B068-E57A4EEAFAA4","82790CE6-3C46-44D8-A25B-D69FD48D7EE4","UNCID_2206475.c45110ae-6ba6-44d7-8bff-5fa16c45d962.110921_UNC2-RDR300275_00086_FC634HAAAXX_6.tar.gz","TCGA-B5-A1N2-01A-21",70,0,5,30,30,"TOP",0,3,"TCGA-B5-A1N2-01A-02-TSB",70,"Carboplatin","Chemotherapy","TCGA-B5-A1N2-D21945","TCGA-B5-A1N2-R21951","EXTERNAL BEAM","Regional site",NA,"NO",389,NA,"Alive",NA,"TCGA-B5-A1N2-F22136","TCGA-B5-A1N2",1,"B5","A1N2","YES","C54.1","8441/3","C54.1","NO","YES",-25612,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",389,NA,NA,NA,"TUMOR FREE","NO",22,2,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,70,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32561734,31350333,2355366531,"29294D9A-434B-4581-9591-63D16107C7B1.bw","d8e57746-37a1-482a-a3d3-a11bd00cdc11","29294d9a-434b-4581-9591-63d16107c7b1","2016-08-04T18:45:02.536084-05:00","UNCID_2210951.9b120d0b-5e47-4428-8116-557fcb7edf8a.110316_UNC2-RDR300275_00058_FC_62J26AAXX_2.tar.gz","7abd05ee-b563-4cfb-93cc-eb9dcecd34ff",2071338762,"Illumina GA","30c762e4f17f6c1050eac605546b436f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:49:38.912756-05:00","2016-05-03T11:15:47.407128-05:00","7abd05ee-b563-4cfb-93cc-eb9dcecd34ff_analysis.xml","d1b0b9945bf4c6f5ba23313c0dd6522f","7b7e820a-6c87-43cb-a43d-6af70fe35a29",2121,"2016-10-07T17:38:02.111277-05:00","7abd05ee-b563-4cfb-93cc-eb9dcecd34ff_experiment.xml","944ac20ae82786cfbe3ef810c0a1c803","5d481d18-dd5b-438b-8c77-0b727ab5068e",2257,"2016-09-29T21:18:09.609728-05:00","7abd05ee-b563-4cfb-93cc-eb9dcecd34ff_run.xml","1e8dabece331fa75c088201364601d43","8d5fac8e-761b-4916-b6c1-a6dac30a3bb7",347,"2016-09-08T11:03:59.344998-05:00","TCGA-BG-A0YV","2016-09-02T18:49:10.503171-05:00","female","TCGA-BG-A0YV_demographic",1943,"white","a725b8c8-1661-5ee3-8187-e4cb2286b6ed","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0YV_diagnosis","not reported",24567,"alive","8441/3",NA,382,"6e2eb9bb-87c9-5622-99ea-211fba71718e","c54.1",-24567,"TCGA-BG-A0YV_treatment","1c1cda1f-b8d3-5f9b-9eb2-ef8ebed93596","01","true","TCGA-BG-A0YV-01A",NA,"13db3af5-5f71-49b8-95f6-d452062c7ea4",FALSE,"D037EFD1-22CB-43FE-BE0A-F2189C5FB202","Primary Tumor",NA,62,330,NA,1287705600,"11",30,"TCGA-BG-A0YV-01A-11",80,80,10,10,0,0,20,20,"2016-09-08T11:03:59.344998-05:00","2016-09-08T11:03:59.344998-05:00",10,10,20,10,"BOTTOM","TOP",20,20,"381aa5ac-a1d2-4ddf-893d-3f32a07817fa","00b115d7-c396-41dd-ae34-05f0eccd40b6","TCGA-BG-A0YV-01A-01-BSA","TCGA-BG-A0YV-01A-01-TSA",60,60,"eaabf134-57bc-4073-8c6d-62097ba34336","RNA","TCGA-BG-A0YV-01A-11R","301f3fff-5315-4749-bf76-f180d5716b70",1.9,0.16,"UV Spec","R","23","TCGA-BG-A0YV-01A-11R-A10J-07","9b120d0b-5e47-4428-8116-557fcb7edf8a",0.16,NA,54,22.4765868886576,155,"2ac0cf15-c3cb-5c1c-af00-6dfcffd580ed","TCGA-BG-A0YV_exposure","UNCID_2210951.9b120d0b-5e47-4428-8116-557fcb7edf8a.110316_UNC2-RDR300275_00058_FC_62J26AAXX_2.tar.gz","2013-10-02T07:06:06.000Z","2013-10-02T07:19:02.000Z","7ABD05EE-B563-4CFB-93CC-EB9DCECD34FF","13DB3AF5-5F71-49B8-95F6-D452062C7EA4","Unaligned reads",2071338762,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","9B120D0B-5E47-4428-8116-557FCB7EDF8A","University of North Carolina","566074dee4b016715ab67afd","D8E57746-37A1-482A-A3D3-A11BD00CDC11","Uterine Corpus Endometrial Carcinoma","TARGZ","EAABF134-57BC-4073-8C6D-62097BA34336","2013-10-02T07:19:02.000Z","301F3FFF-5315-4749-BF76-F180D5716B70","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",62,"EAABF134-57BC-4073-8C6D-62097BA34336",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5F0A557D-F6A8-4FFA-93C5-0236054DB568.txt",330,"TCGA-BG-A0YV-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","B1C14A9D-5B6C-415E-9AEB-578FE2B962DF",67,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.5F0A557D-F6A8-4FFA-93C5-0236054DB568.txt","Alive",NA,"TCGA-BG-A0YV","NOT HISPANIC OR LATINO","2E320782-EF51-4625-93EE-337667D357EA",NA,186,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,11,30,"381AA5AC-A1D2-4DDF-893D-3F32A07817FA","9B0E9CD5-554F-4204-8D2C-BD3C41CC7148","UNCID_2210951.9b120d0b-5e47-4428-8116-557fcb7edf8a.110316_UNC2-RDR300275_00058_FC_62J26AAXX_2.tar.gz","TCGA-BG-A0YV-01A-11",80,0,10,10,20,"BOTTOM",20,20,"TCGA-BG-A0YV-01A-01-BSA",60,NA,NA,NA,NA,NA,NA,NA,"NO",382,"TUMOR FREE","Alive",NA,"TCGA-BG-A0YV-F19335","TCGA-BG-A0YV",1,"BG","A0YV","YES","C54.1","8441/3","C54.1","NO","YES",-24567,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",186,NA,NA,NA,"TUMOR FREE","NO",16,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,2010,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
107104866,105775947,5050372633,"E6ECEA27-510A-46F2-9AF0-1E0286ABD9B5.bw","d9f4a2c1-ac6d-48c6-95fe-ffbc2fa08268","e6ecea27-510a-46f2-9af0-1e0286abd9b5","2016-08-04T19:08:05.273399-05:00","UNCID_2160272.2bd4aa66-5a09-4bac-bfd0-fc3519d398a1.130619_UNC13-SN749_0277_BC293YACXX_2_CAGATC.tar.gz","b0daf86e-e020-4a06-b5f4-8fd2fb0658ab",4552332888,"Illumina HiSeq","ef05e6111b55aaba04ce302c1006b062","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:59:49.034685-05:00","2016-05-03T11:07:07.511815-05:00","b0daf86e-e020-4a06-b5f4-8fd2fb0658ab_analysis.xml","d3a45e1e3e46cea021d4385eed95436b","11da8f1a-081e-4433-93b6-a1b6ad135d46",2123,"2016-09-30T00:21:59.944672-05:00","b0daf86e-e020-4a06-b5f4-8fd2fb0658ab_experiment.xml","df98d9e856cbc6f041533c2adbe3651f","ff415f5e-5bff-4716-8fe6-dfe748be4fe2",2431,"2016-09-29T19:35:18.121975-05:00","b0daf86e-e020-4a06-b5f4-8fd2fb0658ab_run.xml","b297a07d2d624b130308fc957eda35f2","4dd029dc-6d15-44da-9f7c-b2dd69d03868",354,"2016-09-08T10:27:09.518612-05:00","TCGA-AJ-A2QM","2016-09-02T18:54:02.572987-05:00","female","TCGA-AJ-A2QM_demographic",1944,"white","e636331b-e748-57b6-8d24-32106af64cdf","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A2QM_diagnosis","not reported",24776,"alive","8441/3",NA,894,"dde0f5b7-2211-5416-ac11-5766a2b0cf8d","c54.1",-24776,"TCGA-AJ-A2QM_treatment","4df372b1-60ba-52b0-93b7-48970232bb46","01","false","TCGA-AJ-A2QM-01A",NA,"f2748bad-0575-4258-9186-118bbd471325",FALSE,"282D10FF-370D-4252-B1CB-3410A43C8F82","Primary Tumor",NA,108,210,NA,1315958400,"11",30,"TCGA-AJ-A2QM-01A-11",90,NA,8,NA,0,NA,10,NA,"2016-09-08T10:27:09.518612-05:00",NA,3,NA,5,NA,"TOP",NA,4,NA,"a7357359-de36-4ab7-991c-8a0a08feb731",NA,"TCGA-AJ-A2QM-01A-01-TSA",NA,86,NA,"3f996f67-17d3-489e-9611-7557c74a0837","RNA","TCGA-AJ-A2QM-01A-11R","12fe7b63-34a5-4674-ab2a-bee8371594d9",1.81,0.18,"UV Spec","R","23","TCGA-AJ-A2QM-01A-11R-A18M-07","2bd4aa66-5a09-4bac-bfd0-fc3519d398a1",0.18,NA,74,25.6055363321799,170,"280ff0e1-7698-53b7-8443-e8d26cac5bba","TCGA-AJ-A2QM_exposure","UNCID_2160272.2bd4aa66-5a09-4bac-bfd0-fc3519d398a1.130619_UNC13-SN749_0277_BC293YACXX_2_CAGATC.tar.gz","2013-09-21T07:31:04.000Z","2013-09-21T07:48:01.000Z","B0DAF86E-E020-4A06-B5F4-8FD2FB0658AB","F2748BAD-0575-4258-9186-118BBD471325","Unaligned reads",4552332888,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","2BD4AA66-5A09-4BAC-BFD0-FC3519D398A1","University of North Carolina","564a33a2e4b0ef121817f3cc","D9F4A2C1-AC6D-48C6-95FE-FFBC2FA08268","Uterine Corpus Endometrial Carcinoma","TARGZ","3F996F67-17D3-489E-9611-7557C74A0837","2013-09-21T07:48:01.000Z","12FE7B63-34A5-4674-AB2A-BEE8371594D9","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",108,"3F996F67-17D3-489E-9611-7557C74A0837",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E6999DEA-FA88-4C3E-8DE5-C2DDCE73F606.txt",210,"TCGA-AJ-A2QM-01A",NA,"FB5BCEB7-9935-4037-B737-E80CEF6F34D8","TCGA",2011,NA,NA,"TUMOR FREE","F2748BAD-0575-4258-9186-118BBD471325",67,"nationwidechildrens.org_clinical.TCGA-AJ-A2QM.xml","Alive",NA,"TCGA-AJ-A2QM","NOT HISPANIC OR LATINO","15913BAD-2D76-460D-841E-3AE824DC3B90",NA,26,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",178,NA,"E212FFD1-C204-4788-B530-ED8382411DFB","WHITE",NA,11,30,"A7357359-DE36-4AB7-991C-8A0A08FEB731","2E387700-88E8-4AA8-B33D-DD433D4EAACC","aa97b8aa93288da4f3ad57912e2a08d9.bam.bai","TCGA-AJ-A2QM-01A-11",90,0,8,3,10,"TOP",4,5,"TCGA-AJ-A2QM-01A-01-TSA",86,"Taxol","Chemotherapy","TCGA-AJ-A2QM-D60109","TCGA-AJ-A2QM-R60106","Internal","Primary Tumor Field","TCGA-AJ-A2QM-F60105_NTE-1","NO",894,"TUMOR FREE","Alive",NA,"TCGA-AJ-A2QM-F60105","TCGA-AJ-A2QM",1,"AJ","A2QM","YES","C54.1","8441/3","C54.1","YES","NO",-24776,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",26,NA,NA,NA,"TUMOR FREE","NO",18,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32691188,31623093,2333402435,"383B2B19-3610-4649-B97B-AC9D80BBBB43.bw","da0474b3-48ab-4398-ae4b-f15e27e99b2d","383b2b19-3610-4649-b97b-ac9d80bbbb43","2016-08-05T22:36:26.661043-05:00","UNCID_2189025.8e59d005-8361-457f-9316-04c989d0b74f.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_2.tar.gz","c1910c71-4676-4f8c-a807-66df97d93980",2076343116,"Illumina GA","e7b66510d6a98d85aa349b1abfc146c9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:10:42.604317-05:00","2016-05-03T11:05:01.516314-05:00","c1910c71-4676-4f8c-a807-66df97d93980_analysis.xml","091b669b5c8c4fdbfb59b269b6e17eee","18ae15d6-e507-42dd-8392-01a60d285480",2122,"2016-09-29T19:10:16.003832-05:00","c1910c71-4676-4f8c-a807-66df97d93980_experiment.xml","127414452e43c108406f4750bf9c951e","3e22c748-2f1a-4807-a07c-72fa25180812",2258,"2016-09-29T19:32:50.974455-05:00","c1910c71-4676-4f8c-a807-66df97d93980_run.xml","5ee94a5af12a973604fcfe6335a6b25e","4c550595-30f6-4de0-b05a-746f4049b330",349,"2016-09-08T11:00:52.019484-05:00","TCGA-AX-A2H8","2016-09-02T18:52:26.740033-05:00","female","TCGA-AX-A2H8_demographic",1942,"white","abe07506-82c6-5605-8235-f6792943c654","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2H8_diagnosis","not reported",23448,"alive","8380/3",NA,1861,"f34ddcc1-6f19-596f-ac77-2fdf5ddf1507","c54.1",-23448,"TCGA-AX-A2H8_treatment","a405c0db-a0a9-5eb9-a91d-da06b48951d4","11","false","TCGA-AX-A2H8-11A",NA,"98d62bf5-889b-40f9-b4da-fc29313acf9e",FALSE,NA,"Solid Tissue Normal",NA,1974,140,NA,1308182400,"11",30,"TCGA-AX-A2H8-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T11:00:52.019484-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"33194e61-d0e6-46c0-8050-081050d68e57",NA,"TCGA-AX-A2H8-11A-01-TSA",NA,0,NA,"f6fd31e8-7e4e-4796-85b3-8f3b5c3c8ced","RNA","TCGA-AX-A2H8-11A-11R","0aba10e2-2c23-4dee-bc90-9dbfe87f9270",1.96,0.17,"UV Spec","R","23","TCGA-AX-A2H8-11A-11R-A17B-07","8e59d005-8361-457f-9316-04c989d0b74f",0.17,NA,113,44.140625,160,"c1b39e28-562f-5b2b-a6d4-e20bfcfe5d27","TCGA-AX-A2H8_exposure","UNCID_2189025.8e59d005-8361-457f-9316-04c989d0b74f.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_2.tar.gz","2013-09-18T14:37:05.000Z","2013-09-18T14:49:01.000Z","C1910C71-4676-4F8C-A807-66DF97D93980","98D62BF5-889B-40F9-B4DA-FC29313ACF9E","Unaligned reads",2076343116,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8E59D005-8361-457F-9316-04C989D0B74F","University of North Carolina","5660785be4b016715ab69d28","DA0474B3-48AB-4398-AE4B-F15E27E99B2D","Uterine Corpus Endometrial Carcinoma","TARGZ","F6FD31E8-7E4E-4796-85B3-8F3B5C3C8CED","2013-09-18T14:49:01.000Z","0ABA10E2-2C23-4DEE-BC90-9DBFE87F9270","United States","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",1974,"F6FD31E8-7E4E-4796-85B3-8F3B5C3C8CED",NA,"AX","UNCID_2189025.8e59d005-8361-457f-9316-04c989d0b74f.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_2.tar.gz",140,"TCGA-AX-A2H8-11A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","98D62BF5-889B-40F9-B4DA-FC29313ACF9E",64,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.EB4C8FF0-F085-401B-A1D7-B37B1DEEE592.txt","Alive",NA,"TCGA-AX-A2H8","NOT HISPANIC OR LATINO","E5083E6B-C604-45A9-A422-11D88BEEB5FB",NA,1861,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,"CF29EFA8-AECE-4746-861B-513EADF06E98","WHITE",NA,11,30,"33194E61-D0E6-46C0-8050-081050D68E57","E3D72029-0EA0-4C91-8E14-135E42B966C8","UNCID_2189025.8e59d005-8361-457f-9316-04c989d0b74f.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_2.tar.gz","TCGA-AX-A2H8-11A-11",0,100,0,0,0,"TOP",0,0,"TCGA-AX-A2H8-11A-01-TSA",0,NA,NA,NA,"TCGA-AX-A2H8-R31716",NA,"Primary Tumor Field",NA,"NO",1861,"TUMOR FREE","Alive",NA,"TCGA-AX-A2H8-F31709","TCGA-AX-A2H8",1,"AX","A2H8","YES","C54.1","8380/3","C54.1","NO","YES",-23448,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",1861,NA,NA,NA,"TUMOR FREE","NO",31,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31978950,31549947,2340788825,"E961CCAF-2324-4209-92A0-D13C83DE8752.bw","da0474b3-48ab-4398-ae4b-f15e27e99b2d","e961ccaf-2324-4209-92a0-d13c83de8752","2016-08-09T13:58:46.539074-05:00","UNCID_2189005.99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_1.tar.gz","c5428638-b6aa-44f9-863f-7083dbc789b6",2025014872,"Illumina GA","c0dfd9d794b3c7b14d46629f2f39bbc1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:09:46.002550-05:00","2016-05-03T11:05:01.518052-05:00","c5428638-b6aa-44f9-863f-7083dbc789b6_analysis.xml","06d7b9c9835e65a481ef6ed231e7fbfc","18255a75-0936-4e02-a61c-9c288e276861",2122,"2016-08-30T08:23:39.948281-05:00","c5428638-b6aa-44f9-863f-7083dbc789b6_experiment.xml","156a92501dbc1b1a8b1078878ff6c626","066d7d05-53dc-465b-9a08-e987798d244b",2258,"2016-09-29T19:34:24.043250-05:00","c5428638-b6aa-44f9-863f-7083dbc789b6_run.xml","31c33617438fc5051da263888388e4c5","4d41612c-63bb-4e5d-bd2d-5d55b01b6b34",349,"2016-09-08T11:00:52.019484-05:00","TCGA-AX-A2H8","2016-09-02T18:52:26.740033-05:00","female","TCGA-AX-A2H8_demographic",1942,"white","abe07506-82c6-5605-8235-f6792943c654","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2H8_diagnosis","not reported",23448,"alive","8380/3",NA,1861,"f34ddcc1-6f19-596f-ac77-2fdf5ddf1507","c54.1",-23448,"TCGA-AX-A2H8_treatment","a405c0db-a0a9-5eb9-a91d-da06b48951d4","01","false","TCGA-AX-A2H8-01A",NA,"5b39cf2f-3ada-4c86-aab1-05734e817664",FALSE,"1D1AF737-8A5A-4274-B9AD-2F4BA3127DDD","Primary Tumor",NA,1974,150,NA,1308182400,"11",30,"TCGA-AX-A2H8-01A-11",96,NA,0,NA,0,NA,5,NA,"2016-09-08T11:00:52.019484-05:00",NA,1,NA,0,NA,"TOP",NA,1,NA,"2aed6dc8-ed88-4ebb-922f-aa0cb71ea818",NA,"TCGA-AX-A2H8-01A-01-TSA",NA,94,NA,"27a77645-6138-4c3e-84f1-4066b2175846","RNA","TCGA-AX-A2H8-01A-11R","0f829573-c934-4fe7-97a7-7dc236811a6c",2.02,0.16,"UV Spec","R","23","TCGA-AX-A2H8-01A-11R-A17B-07","99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda",0.16,NA,113,44.140625,160,"c1b39e28-562f-5b2b-a6d4-e20bfcfe5d27","TCGA-AX-A2H8_exposure","UNCID_2189005.99d5ea34-d803-41f1-a7bc-3d9e0fb3dbda.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_1.tar.gz","2013-09-18T13:56:11.000Z","2013-09-18T14:08:01.000Z","C5428638-B6AA-44F9-863F-7083DBC789B6","5B39CF2F-3ADA-4C86-AAB1-05734E817664","Unaligned reads",2025014872,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","99D5EA34-D803-41F1-A7BC-3D9E0FB3DBDA","University of North Carolina","564a3d88e4b093830b69f319","DA0474B3-48AB-4398-AE4B-F15E27E99B2D","Uterine Corpus Endometrial Carcinoma","TARGZ","27A77645-6138-4C3E-84F1-4066B2175846","2013-09-18T14:08:01.000Z","0F829573-C934-4FE7-97A7-7DC236811A6C","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1974,"27A77645-6138-4C3E-84F1-4066B2175846",NA,"AX","66ee839c39be57871b3247d0db315b43.bam",150,"TCGA-AX-A2H8-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","98D62BF5-889B-40F9-B4DA-FC29313ACF9E",64,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.EB4C8FF0-F085-401B-A1D7-B37B1DEEE592.txt","Alive",NA,"TCGA-AX-A2H8","NOT HISPANIC OR LATINO","E5083E6B-C604-45A9-A422-11D88BEEB5FB",NA,1861,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,"CF29EFA8-AECE-4746-861B-513EADF06E98","WHITE",NA,11,30,"2AED6DC8-ED88-4EBB-922F-AA0CB71EA818","7A39F821-0305-44D7-A2FC-2A61D238D6B8","TCGA-AX-A2H8-01A-11R-A17A-13_mirna.bam.bai","TCGA-AX-A2H8-01A-11",96,0,0,1,5,"TOP",1,0,"TCGA-AX-A2H8-01A-01-TSA",94,NA,NA,NA,"TCGA-AX-A2H8-R31716",NA,"Primary Tumor Field",NA,"NO",1861,"TUMOR FREE","Alive",NA,"TCGA-AX-A2H8-F31709","TCGA-AX-A2H8",1,"AX","A2H8","YES","C54.1","8380/3","C54.1","NO","YES",-23448,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",1861,NA,NA,NA,"TUMOR FREE","NO",31,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
26926742,26212942,1919938439,"D1C0E70B-B2BB-4FE7-8DEC-B50659739BAA.bw","db21fccf-40cb-4235-a34d-336a03b8c8f4","d1c0e70b-b2bb-4fe7-8dec-b50659739baa","2016-08-09T14:18:03.613673-05:00","UNCID_2215109.60bb00e3-9ac9-4c61-bb38-b85b27bff865.101014_UNC2-RDR300275_00039_FC_706C1AAXX_2.tar.gz","3a4cb2fc-7cfe-4fff-82b5-a43af00abfad",1623372091,"Illumina GA","38fdd14fabd776643b9bf264c7eda95d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:10:26.486525-05:00","2016-05-03T11:17:59.903755-05:00","3a4cb2fc-7cfe-4fff-82b5-a43af00abfad_analysis.xml","67036a34193fb2f4aa66cf4be0ac8523","18841ac5-7c58-48ea-bb24-87d4143da3f8",2120,"2016-09-29T22:29:33.982184-05:00","3a4cb2fc-7cfe-4fff-82b5-a43af00abfad_experiment.xml","33989877768de95930588b2efd8b3a6f","b97586fd-84da-4ced-8f5c-4567dafacf6a",2256,"2016-09-29T21:30:27.770942-05:00","3a4cb2fc-7cfe-4fff-82b5-a43af00abfad_run.xml","5bed5e8dcc2523ca2a842e230ecf7161","95098da4-d354-4497-9fe4-26b6e8956f64",345,"2016-09-08T10:43:00.886370-05:00","TCGA-AX-A0IW","2016-09-02T18:54:40.234832-05:00","female","TCGA-AX-A0IW_demographic",1941,"white","c3177194-2df1-5361-a8c2-9a181bc27742","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A0IW_diagnosis","not reported",24488,"alive","8441/3",NA,1149,"0bbc5122-2673-5345-9e8f-9129e7abfd59","c54.1",-24488,"TCGA-AX-A0IW_treatment","7fee2d3c-3619-51b0-8c3a-a734219ca77e","01","false","TCGA-AX-A0IW-01A",NA,"874a1c5c-229b-4bce-b612-55eff238d533",FALSE,"DE971C2D-31E8-42AC-A943-29E76FCD8F68","Primary Tumor",NA,854,190,NA,1275609600,"11",30,"TCGA-AX-A0IW-01A-11",95,75,0,0,0,0,5,25,"2016-09-08T10:43:00.886370-05:00","2016-09-08T10:43:00.886370-05:00",0,15,0,0,"BOTTOM","TOP",5,5,"335d64f4-dc2d-4f86-9aef-458707175d39","8520b124-6364-434c-ad6e-725bf7b20ed1","TCGA-AX-A0IW-01A-01-BSA","TCGA-AX-A0IW-01A-01-TSA",90,70,"e7082b6b-de6e-4675-b255-0f153055a596","RNA","TCGA-AX-A0IW-01A-11R","1e0aac91-e3ec-405f-8a1b-638255e5f02d",1.85,0.16,"UV Spec","R","23","TCGA-AX-A0IW-01A-11R-A040-07","60bb00e3-9ac9-4c61-bb38-b85b27bff865",0.16,NA,61,22.9590876585494,163,"b8e04e16-6bb3-5e78-9d80-aab67b3d1b71","TCGA-AX-A0IW_exposure","UNCID_2215109.60bb00e3-9ac9-4c61-bb38-b85b27bff865.101014_UNC2-RDR300275_00039_FC_706C1AAXX_2.tar.gz","2013-10-04T00:06:05.000Z","2013-10-04T00:18:03.000Z","3A4CB2FC-7CFE-4FFF-82B5-A43AF00ABFAD","874A1C5C-229B-4BCE-B612-55EFF238D533","Unaligned reads",1623372091,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","60BB00E3-9AC9-4C61-BB38-B85B27BFF865","University of North Carolina","566074fce4b0ca319164cb7b","DB21FCCF-40CB-4235-A34D-336A03B8C8F4","Uterine Corpus Endometrial Carcinoma","TARGZ","E7082B6B-DE6E-4675-B255-0F153055A596","2013-10-04T00:18:03.000Z","1E0AAC91-E3EC-405F-8A1B-638255E5F02D","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",854,"E7082B6B-DE6E-4675-B255-0F153055A596",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.1619E238-C173-4981-A0BD-8F7138F26FDD.txt",190,"TCGA-AX-A0IW-01A",NA,"506B4C7E-1E72-4FAD-AC06-63DC04CA606B","TCGA",2008,NA,NA,"TUMOR FREE","874A1C5C-229B-4BCE-B612-55EFF238D533",67,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.1619E238-C173-4981-A0BD-8F7138F26FDD.txt","Alive",NA,"TCGA-AX-A0IW","NOT HISPANIC OR LATINO","C7C2C80E-B89E-4D0B-8627-DE64E8825C4E",NA,1149,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"8520B124-6364-434C-AD6E-725BF7B20ED1","4FBFE2A0-FE74-4DBC-9A01-527C991D24D5","jhu-usc.edu_UCEC.HumanMethylation27.2.lvl-3.TCGA-AX-A0IW-01A-11D-A039-05.txt","TCGA-AX-A0IW-01A-11",95,0,0,0,5,"BOTTOM",5,0,"TCGA-AX-A0IW-01A-01-BSA",90,"Carboplatin & Paclitaxel","Chemotherapy","TCGA-AX-A0IW-D12240",NA,NA,NA,NA,NA,1149,"TUMOR FREE","Alive",NA,"TCGA-AX-A0IW-F5518","TCGA-AX-A0IW",1,"AX","A0IW","YES","C54.1","8441/3","C54.1","NO","YES",-24488,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1149,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
24505136,23846659,1786570730,"946A06A0-1A8B-430B-A8FD-5165A3FEE5DB.bw","db3a4986-55d5-4ecc-be73-59725dce3c33","946a06a0-1a8b-430b-a8fd-5165a3fee5db","2016-08-05T00:03:14.043547-05:00","UNCID_2194841.d653b50c-d568-48a1-bbed-5e36fbf525ac.120307_UNC2-RDR300275_00118_FC_650V8AAXX_2.tar.gz","8ac86960-2a0b-4410-aee7-602640fd4e36",1467895999,"Illumina GA","ad1cc9eecde3ac43f89189422aea4786","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:25:45.543112-05:00","2016-05-03T11:07:49.533775-05:00","8ac86960-2a0b-4410-aee7-602640fd4e36_analysis.xml","e85ea69b474ad3ea8a9c57c92a6bdf55","dc50a7de-f804-4b39-839b-aa19d8765c83",2120,"2016-09-29T18:06:38.759327-05:00","8ac86960-2a0b-4410-aee7-602640fd4e36_experiment.xml","0890e3a6e582a87d77365ff60ad8a58b","163b8bc9-df82-4a5f-aaeb-7fa263c8c9e0",2257,"2016-09-29T23:53:01.655550-05:00","8ac86960-2a0b-4410-aee7-602640fd4e36_run.xml","e906bf1fd6142054e95dd141e6932caa","ed5efa1a-4ac9-4fbd-88ce-6bebbd20fb1b",347,"2016-09-08T11:10:17.529510-05:00","TCGA-EY-A1G8","2016-09-02T18:51:50.017976-05:00","female","TCGA-EY-A1G8_demographic",1925,"white","76d2f9cb-ddcb-59c4-9316-1df7c9f3062d","not hispanic or latino",2009,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1G8_diagnosis","not reported",30517,"dead","8380/3",456,NA,"09ebfe76-e226-502d-ab70-4d55a5b86d6a","c54.1",-30517,"TCGA-EY-A1G8_treatment","ca239b3c-a104-5101-be77-1425fac0c419","01","false","TCGA-EY-A1G8-01A",NA,"e95dde06-f397-4b0c-a854-dc91aa3c6f31",FALSE,"2454950F-8B3D-4690-98CA-B94C79F99552","Primary Tumor",NA,771,100,NA,1297814400,"11",30,"TCGA-EY-A1G8-01A-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T11:10:17.529510-05:00",NA,10,NA,10,NA,"TOP",NA,20,NA,"5334f4e4-c14d-4842-969c-1d55678b209a",NA,"TCGA-EY-A1G8-01A-01-TSA",NA,70,NA,"333ff5da-6c4c-43a4-9f9a-89fe8f8a7e85","RNA","TCGA-EY-A1G8-01A-11R","e5325844-25be-4fc6-bed7-7bf517a5108d",1.8,0.16,"UV Spec","R","23","TCGA-EY-A1G8-01A-11R-A13S-07","d653b50c-d568-48a1-bbed-5e36fbf525ac",0.16,NA,49,19.140625,160,"c9dd5123-bad8-505b-822d-eb6fc0edd68e","TCGA-EY-A1G8_exposure","UNCID_2194841.d653b50c-d568-48a1-bbed-5e36fbf525ac.120307_UNC2-RDR300275_00118_FC_650V8AAXX_2.tar.gz","2013-09-23T04:06:04.000Z","2013-09-23T04:18:02.000Z","8AC86960-2A0B-4410-AEE7-602640FD4E36","E95DDE06-F397-4B0C-A854-DC91AA3C6F31","Unaligned reads",1467895999,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","D653B50C-D568-48A1-BBED-5E36FBF525AC","University of North Carolina","564a3fa4e4b09c884b25a2e0","DB3A4986-55D5-4ECC-BE73-59725DCE3C33","Uterine Corpus Endometrial Carcinoma","TARGZ","333FF5DA-6C4C-43A4-9F9A-89FE8F8A7E85","2013-09-23T04:18:02.000Z","E5325844-25BE-4FC6-BED7-7BF517A5108D","United States","NO",1,NA,"Primary Tumor","University of North Carolina",771,"333FF5DA-6C4C-43A4-9F9A-89FE8F8A7E85",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.70FDD3EE-9591-401A-8AE0-EACA0BDE0FFA.txt",100,"TCGA-EY-A1G8-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","E95DDE06-F397-4B0C-A854-DC91AA3C6F31",83,"nationwidechildrens.org_clinical.TCGA-EY-A1G8.xml","Dead",456,"TCGA-EY-A1G8","NOT HISPANIC OR LATINO","98DC9646-C209-4D7A-89B4-FB2BEC89DC3D",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"WHITE",NA,11,30,"5334F4E4-C14D-4842-969C-1D55678B209A","E5325844-25BE-4FC6-BED7-7BF517A5108D","UNCID_1011436.d653b50c-d568-48a1-bbed-5e36fbf525ac.120307_UNC2-RDR300275_00118_FC_650V8AAXX.2.trimmed.annotated.translated_to_genomic.bam","TCGA-EY-A1G8-01A-11",90,0,0,10,10,"TOP",20,10,"TCGA-EY-A1G8-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TUMOR FREE","Dead",456,"TCGA-EY-A1G8-F10562","TCGA-EY-A1G8",1,"EY","A1G8","YES","C54.1","8380/3","C54.1","NO","YES",-30517,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,456,NA,NA,"TUMOR FREE","NO",21,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,83,2008,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
97610088,94667830,4471004634,"294F1DC6-4610-4DC3-8879-2FB7E4AB30CA.bw","db67a9cd-65ba-4d6f-a799-031b6b3df599","294f1dc6-4610-4dc3-8879-2fb7e4ab30ca","2016-08-09T13:14:23.178071-05:00","UNCID_2173037.91238210-9f8d-4c09-8016-fd0a7d135023.130509_UNC10-SN254_0462_AC232JACXX_5_ATGTCA.tar.gz","ebd9c5af-ff84-4eb4-9208-7afea78f0a4c",4521329860,"Illumina HiSeq","e9ce843cc5cb0a943c5b3e7c1ce7182c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:47:15.067787-05:00","2016-05-03T10:55:55.600288-05:00","ebd9c5af-ff84-4eb4-9208-7afea78f0a4c_analysis.xml","e9f65a386b61ed68fe4267bfd7b9f437","e9d332d6-169d-4c8e-91fd-2e79d6701150",2123,"2016-09-29T22:27:14.894604-05:00","ebd9c5af-ff84-4eb4-9208-7afea78f0a4c_experiment.xml","f0b61cee8cd55a5315b62749be7d1071","b8000562-cd39-4b94-aca1-87479ac8c63e",2431,"2016-09-29T22:11:37.982387-05:00","ebd9c5af-ff84-4eb4-9208-7afea78f0a4c_run.xml","86cf7cc33b3e531782d85647a1ec6fa0","ae5e2b99-4205-4259-a664-d649d99ad00b",354,"2016-09-08T10:34:45.157383-05:00","TCGA-EO-A3KU","2016-09-02T18:49:27.552181-05:00","female","TCGA-EO-A3KU_demographic",1943,"not reported","97fe2fbf-2085-5ffe-a6f9-5133af42f12d","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3KU_diagnosis","not reported",25116,"alive","8441/3",NA,677,"4075524a-4217-50e3-b313-06ebf63c29c8","c54.1",-25116,"TCGA-EO-A3KU_treatment","1f18a7e3-3945-5bf9-8943-3437b951df50","01","false","TCGA-EO-A3KU-01A",NA,"72940768-0848-4134-8d1d-c81a02f92134",FALSE,"B6945BE4-FA4A-4ED4-9233-B32123F41C95","Primary Tumor",NA,93,110,NA,1327881600,"11",30,"TCGA-EO-A3KU-01A-11",90,NA,5,NA,0,NA,10,NA,"2016-09-08T10:34:45.157383-05:00",NA,5,NA,15,NA,"TOP",NA,10,NA,"e86bfdf1-6ab9-49be-afa4-006b9387a535",NA,"TCGA-EO-A3KU-01A-01-TSA",NA,80,NA,"74bc7ff6-6d75-4f37-b09a-8537e7b14cde","RNA","TCGA-EO-A3KU-01A-11R","4024a437-2b78-4b23-8f90-c42535e744e2",1.87,0.18,"UV Spec","R","23","TCGA-EO-A3KU-01A-11R-A22K-07","91238210-9f8d-4c09-8016-fd0a7d135023",0.18,NA,65,24.4646016033723,163,"cb5c7ff4-e5b4-51b8-9b86-399cdb98aa99","TCGA-EO-A3KU_exposure","UNCID_2173037.91238210-9f8d-4c09-8016-fd0a7d135023.130509_UNC10-SN254_0462_AC232JACXX_5_ATGTCA.tar.gz","2013-09-09T08:16:08.000Z","2013-09-09T08:36:02.000Z","EBD9C5AF-FF84-4EB4-9208-7AFEA78F0A4C","72940768-0848-4134-8D1D-C81A02F92134","Unaligned reads",4521329860,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","91238210-9F8D-4C09-8016-FD0A7D135023","University of North Carolina","566073f1e4b018727fe9eb6a","DB67A9CD-65BA-4D6F-A799-031B6B3DF599","Uterine Corpus Endometrial Carcinoma","TARGZ","74BC7FF6-6D75-4F37-B09A-8537E7B14CDE","2013-09-09T08:36:02.000Z","4024A437-2B78-4B23-8F90-C42535E744E2","Canada","NO",1,NA,"Primary Tumor","University Health Network",93,"74BC7FF6-6D75-4F37-B09A-8537E7B14CDE",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9615A8B1-9358-4C26-A89B-10112848D993.txt",110,"TCGA-EO-A3KU-01A",NA,"F06DA8DF-9A22-473F-8E07-72C9FCD5E3AE","TCGA",2011,NA,NA,"TUMOR FREE","A777D478-47F6-490C-B321-3AA3C5C3EDB0",68,"unc.edu.91238210-9f8d-4c09-8016-fd0a7d135023.2041336.bt.exon_quantification.txt","Alive",NA,"TCGA-EO-A3KU",NA,"BC60B704-0FF1-4A88-BA00-41955C62AD10",NA,254,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8441/3","FEMALE","C54.1",228,NA,"63A7A318-7D7B-439E-B107-60CA5407A69F",NA,NA,11,30,"E86BFDF1-6AB9-49BE-AFA4-006B9387A535","B0083956-DA02-40BE-8561-C3683EB876A6","TCGA-EO-A3KU-01A-11R-A22I-13_mirna.bam.bai","TCGA-EO-A3KU-01A-11",90,0,5,5,10,"TOP",10,15,"TCGA-EO-A3KU-01A-01-TSA",80,"Carboplatin",NA,"TCGA-EO-A3KU-D48716","TCGA-EO-A3KU-R48654","External","Primary Tumor Field","TCGA-EO-A3KU-F39921_NTE-1","NO",427,"TUMOR FREE","Alive",NA,"TCGA-EO-A3KU-F39921","TCGA-EO-A3KU",1,"EO","A3KU","YES","C54.1","8441/3","C54.1","NO","YES",-25116,"FEMALE",NA,NA,"No","No","Alive",254,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,68,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33418238,32808228,2446350813,"281247B3-F314-4938-87EB-42BA5857486C.bw","dbbbddae-d711-40f5-bd10-863735885b1f","281247b3-f314-4938-87eb-42ba5857486c","2016-08-09T14:15:01.982096-05:00","UNCID_2209885.55b006ca-aacf-4ed5-a0bc-7238eacfb23e.110420_UNC6-RDR300211_00096_FC_634WMAAXX_7.tar.gz","80d22c8e-fd37-4fba-b2d3-943bbdce430f",2246463973,"Illumina GA","f8b5be856c551a65c66a019299ae150b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:56:58.290779-05:00","2016-05-03T11:15:47.414649-05:00","80d22c8e-fd37-4fba-b2d3-943bbdce430f_analysis.xml","4c7e187ab44e013d01b0eacc5f34c4f8","8020d6fd-ba8f-435d-9883-c9e552c21ed7",2121,"2016-09-29T20:16:20.709025-05:00","80d22c8e-fd37-4fba-b2d3-943bbdce430f_experiment.xml","ba1993fd289a7b75183a85d9c0fe077f","6702e9ff-029f-4f58-ad7d-5fbd0257e31b",2257,"2016-09-29T18:36:18.862218-05:00","80d22c8e-fd37-4fba-b2d3-943bbdce430f_run.xml","534969e5e3c53fb49419a3eeceb013f3","28991627-0b46-4b06-b201-cb9be5ee43eb",347,"2016-09-08T11:08:58.029877-05:00","TCGA-D1-A16N","2016-09-02T18:50:27.052060-05:00","female","TCGA-D1-A16N_demographic",1958,"white","f0036ae7-4205-5040-8e3e-a693f85e34ec","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16N_diagnosis","not reported",18787,"alive","8380/3",NA,945,"5fd69136-43be-59b2-8e31-a625adbfba40","c54.1",-18787,"TCGA-D1-A16N_treatment","b957ae85-6a97-54ff-85af-bf337f8f225f","01","false","TCGA-D1-A16N-01A",NA,"6d916a47-dcff-4c98-9e88-348aaa353f98",FALSE,"81CFA07C-5FCE-41F3-88D1-FFD17840B293","Primary Tumor",NA,629,240,NA,1293667200,"11",30,"TCGA-D1-A16N-01A-11",95,NA,0,NA,0,NA,2,NA,"2016-09-08T11:08:58.029877-05:00",NA,0,NA,0,NA,"TOP",NA,3,NA,"a74c1a37-d6a5-4eb8-9917-ebf450457805",NA,"TCGA-D1-A16N-01A-01-TS1",NA,95,NA,"33c64495-a359-4b09-9c5a-6e1c7bcb5061","RNA","TCGA-D1-A16N-01A-11R","54cb48d0-0449-4248-8861-33d47c18a205",1.91,0.16,"UV Spec","R","23","TCGA-D1-A16N-01A-11R-A12I-07","55b006ca-aacf-4ed5-a0bc-7238eacfb23e",0.16,NA,89,37.044745057232,155,"c93fb777-88bb-5c1c-8e8a-57d2cbdf7467","TCGA-D1-A16N_exposure","UNCID_2209885.55b006ca-aacf-4ed5-a0bc-7238eacfb23e.110420_UNC6-RDR300211_00096_FC_634WMAAXX_7.tar.gz","2013-10-01T23:56:04.000Z","2013-10-02T00:15:02.000Z","80D22C8E-FD37-4FBA-B2D3-943BBDCE430F","6D916A47-DCFF-4C98-9E88-348AAA353F98","Unaligned reads",2246463973,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","55B006CA-AACF-4ED5-A0BC-7238EACFB23E","University of North Carolina","566078dfe4b0ec1099f8d758","DBBBDDAE-D711-40F5-BD10-863735885B1F","Uterine Corpus Endometrial Carcinoma","TARGZ","33C64495-A359-4B09-9C5A-6E1C7BCB5061","2013-10-02T00:15:02.000Z","54CB48D0-0449-4248-8861-33D47C18A205","None","NO",1,NA,"Primary Tumor","Mayo Clinic",629,"33C64495-A359-4B09-9C5A-6E1C7BCB5061",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4C1FD9BC-7AE2-4325-B08F-56075E677662.txt",240,"TCGA-D1-A16N-01A",NA,"E4E94708-5281-4C69-AAC1-95FCD8302533","TCGA",2009,NA,NA,"TUMOR FREE","6D916A47-DCFF-4C98-9E88-348AAA353F98",51,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4C1FD9BC-7AE2-4325-B08F-56075E677662.txt","Alive",NA,"TCGA-D1-A16N","NOT HISPANIC OR LATINO","C8138BB8-F495-4B41-87B0-298CBBE2AF6B",NA,640,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"1D53F8C6-D6AD-4C01-B6FF-49FB86F44148","WHITE",NA,11,30,"A74C1A37-D6A5-4EB8-9917-EBF450457805","54CB48D0-0449-4248-8861-33D47C18A205","TCGA-D1-A16N-01A-11D-A12J-09_IlluminaGA-DNASeq_exome.bam","TCGA-D1-A16N-01A-11",95,0,0,0,2,"TOP",3,0,"TCGA-D1-A16N-01A-01-TS1",95,"Taxol","Chemotherapy","TCGA-D1-A16N-D18601","TCGA-D1-A16N-R18600","IMPLANTS","Regional site",NA,"NO",945,"TUMOR FREE","Alive",NA,"TCGA-D1-A16N-F18584","TCGA-D1-A16N",1,"D1","A16N","YES","C54.1","8380/3","C54.1","NO","YES",-18787,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",640,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,51,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1995",9,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
149209816,138576359,6605523776,"8606CA64-EA89-48DA-B8F3-9F244737CB0E.bw","dcf1beb9-bce4-4f4c-98dd-1226d8e0c125","8606ca64-ea89-48da-b8f3-9f244737cb0e","2016-08-25T23:48:02.453885-05:00","UNCID_2327166.0ebc7d28-128d-4842-9e10-28abb1953b72.131118_UNC12-SN629_0336_AC31D0ACXX_8_ATCACG.tar.gz","07454d93-cc51-44dd-98d7-ff39184cfb79",6871700552,"Illumina HiSeq","c5e1b574c8f5fa60b33b4b5c077e83cf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:43:25.881323-05:00","2016-05-03T11:34:55.532339-05:00","07454d93-cc51-44dd-98d7-ff39184cfb79_analysis.xml","e811a86c3b36bfaeb3d2052c0b0a3bd1","076cdbed-c249-4405-8114-2a8b4d418dd1",2124,"2016-08-13T04:59:54.637987-05:00","07454d93-cc51-44dd-98d7-ff39184cfb79_experiment.xml","d6abbd01ca333a679d1325e4f2595a28","3aac953a-9fc2-441c-a675-11372c701435",2628,"2016-09-29T20:12:40.369264-05:00","07454d93-cc51-44dd-98d7-ff39184cfb79_run.xml","f626e905e0598fd0e3f7e61d2b0dbaea","64cb824f-3385-40d9-a5bb-6819c717fd77",354,"2016-09-08T10:37:27.097084-05:00","TCGA-AJ-A2QO","2016-09-02T18:54:03.834692-05:00","female","TCGA-AJ-A2QO_demographic",1926,"white","150c9f58-1fa3-59d5-af58-ec8e150277bc","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A2QO_diagnosis","not reported",31222,"dead","8380/3",1045,92,"7e286786-b8d5-50d7-9097-a9ef232702c7","c54.1",-31222,"TCGA-AJ-A2QO_treatment","967034e4-bd02-5092-a7f2-609080272db0","01","false","TCGA-AJ-A2QO-01A",NA,"32be3043-2dce-42c7-bb5c-a313f2c5e3a1",FALSE,"5351BF98-9E1D-4F4D-A3EE-26A83B867D58","Primary Tumor",NA,174,16,NA,1315526400,"11",16,"TCGA-AJ-A2QO-01A-11",65,NA,0,NA,0,NA,30,NA,"2016-09-08T10:37:27.097084-05:00",NA,0,NA,0,NA,"TOP",NA,15,NA,"e73d0cb9-cea6-4259-ab8e-872f32736127",NA,"TCGA-AJ-A2QO-01A-01-TS1",NA,55,NA,"69d6d366-e620-4449-9175-36a57de9812a","RNA","TCGA-AJ-A2QO-01A-11R","61b06cde-28d3-4e22-9bf6-5310e11cab78",1.75,0.17,"UV Spec","R","23","TCGA-AJ-A2QO-01A-11R-A32Y-07","0ebc7d28-128d-4842-9e10-28abb1953b72",0.17,NA,67,24.6097337006428,165,"fe3ebe52-7649-5f46-9136-abe20ee1fba3","TCGA-AJ-A2QO_exposure","UNCID_2327166.0ebc7d28-128d-4842-9e10-28abb1953b72.131118_UNC12-SN629_0336_AC31D0ACXX_8_ATCACG.tar.gz","2014-01-25T01:22:13.000Z","2014-01-25T01:53:01.000Z","07454D93-CC51-44DD-98D7-FF39184CFB79","32BE3043-2DCE-42C7-BB5C-A313F2C5E3A1","Unaligned reads",6871700552,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","0EBC7D28-128D-4842-9E10-28ABB1953B72","University of North Carolina","56607405e4b0ec1099f8a693","DCF1BEB9-BCE4-4F4C-98DD-1226D8E0C125","Uterine Corpus Endometrial Carcinoma","TARGZ","69D6D366-E620-4449-9175-36A57DE9812A","2014-01-25T01:53:01.000Z","61B06CDE-28D3-4E22-9BF6-5310E11CAB78","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",174,"69D6D366-E620-4449-9175-36A57DE9812A",NA,"AJ","1363cbc5654cfe76f7dcfc73e23d82f8.bam",16,"TCGA-AJ-A2QO-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","E9C4BA8A-B2AD-40EF-9EFE-7BC20D610E35",85,"nationwidechildrens.org_clinical.TCGA-AJ-A2QO.xml","Alive",NA,"TCGA-AJ-A2QO",NA,"744474F7-008B-43AC-A1B2-231D5B6ADF2F",NA,92,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,16,"E73D0CB9-CEA6-4259-AB8E-872F32736127","0E602D55-A190-4DE6-9A57-83EBB209D653","CUTES_p_TCGA_172_176_178_SNP_N_GenomeWideSNP_6_C03_863452.nocnv_hg19.seg.txt","TCGA-AJ-A2QO-01A-11",65,0,0,0,30,"TOP",15,0,"TCGA-AJ-A2QO-01A-01-TS1",55,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A2QO-F58978_NTE-1","NO",NA,"TUMOR FREE","Dead",1045,"TCGA-AJ-A2QO-F58978","TCGA-AJ-A2QO",1,"AJ","A2QO","YES","C54.1","8380/3","C54.1","YES","NO",-31222,"FEMALE","WHITE",NA,"No","No","Alive",92,NA,NA,NA,"TUMOR FREE","NO",18,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,85,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31063941,30919541,2302217588,"AFF029D8-FFC9-4AA9-8049-F1E27C743F6F.bw","dcfbe781-a92a-45b5-b80a-e3bb3bdc0d9a","aff029d8-ffc9-4aa9-8049-f1e27c743f6f","2016-08-09T14:09:38.925993-05:00","UNCID_2203709.33655926-ef2e-4e77-8be7-3f9c921db77c.111103_UNC6-RDR300211_00130_FC_638P5AAXX_5.tar.gz","4c60987a-b18d-434b-91b6-52cf7173639b",2000991872,"Illumina GA","bd4fce5cd03bf39cccaa19d188afd164","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:18:18.613366-05:00","2016-05-03T11:10:47.515830-05:00","4c60987a-b18d-434b-91b6-52cf7173639b_analysis.xml","bc9a1c4e484fa07d2d041b4837d176a8","d79e3d34-ac3d-4f13-b255-beb912aff808",2121,"2016-09-29T19:28:16.376217-05:00","4c60987a-b18d-434b-91b6-52cf7173639b_experiment.xml","6a4f3be2e2671330f868dd35951520b6","497c623e-2c56-4461-abcd-58d3d87876b7",2257,"2016-09-29T18:59:02.799664-05:00","4c60987a-b18d-434b-91b6-52cf7173639b_run.xml","6ccfe7d22c578d60a0af0bebe53cce39","370f7251-58b1-4ced-ac5e-b972183b5759",347,"2016-09-08T10:38:31.408549-05:00","TCGA-FI-A2D5","2016-09-02T18:52:56.026513-05:00","female","TCGA-FI-A2D5_demographic",1953,"white","e289b51f-d0b4-53a0-b413-30c24ce2f776","not hispanic or latino",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2D5_diagnosis","not reported",20666,"dead","8380/3",421,NA,"c3f99001-ee1d-5f72-b8f7-416690803ed2","c54.1",-20666,"TCGA-FI-A2D5_treatment","04c3a52f-064d-5e78-9d54-dbcacd9140c7","01","true","TCGA-FI-A2D5-01A",NA,"d5f6444e-c388-42e9-8b20-7b3a4db8e0db",FALSE,"A8F4B3DC-7B7D-4F1F-A909-E23DAE23E52C","Primary Tumor",NA,702,60,NA,1308700800,"11",30,"TCGA-FI-A2D5-01A-11",98,NA,5,NA,0,NA,2,NA,"2016-09-08T10:38:31.408549-05:00",NA,15,NA,3,NA,"TOP",NA,15,NA,"0176e005-01be-44da-81fa-8dbe508526be",NA,"TCGA-FI-A2D5-01A-01-TSA",NA,83,NA,"507f2c98-1aeb-4fcc-bfc9-764fe7722b0d","RNA","TCGA-FI-A2D5-01A-11R","14aaeb65-a0cf-4d2b-9f69-b89def63dff0",1.95,0.18,"UV Spec","R","23","TCGA-FI-A2D5-01A-11R-A17B-07","33655926-ef2e-4e77-8be7-3f9c921db77c",0.18,NA,92,35.9375,160,"8913283d-14b2-5ca1-87e7-f9c907ba689e","TCGA-FI-A2D5_exposure","UNCID_2203709.33655926-ef2e-4e77-8be7-3f9c921db77c.111103_UNC6-RDR300211_00130_FC_638P5AAXX_5.tar.gz","2013-09-26T16:26:04.000Z","2013-09-26T16:38:02.000Z","4C60987A-B18D-434B-91B6-52CF7173639B","D5F6444E-C388-42E9-8B20-7B3A4DB8E0DB","Unaligned reads",2000991872,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","33655926-EF2E-4E77-8BE7-3F9C921DB77C","University of North Carolina","564a3e38e4b09c884b2536e0","DCFBE781-A92A-45B5-B80A-E3BB3BDC0D9A","Uterine Corpus Endometrial Carcinoma","TARGZ","507F2C98-1AEB-4FCC-BFC9-764FE7722B0D","2013-09-26T16:38:02.000Z","14AAEB65-A0CF-4D2B-9F69-B89DEF63DFF0","United States","NO",1,NA,"Primary Tumor","Washington University",702,"507F2C98-1AEB-4FCC-BFC9-764FE7722B0D",NA,"FI","c017080444a8f5549bf9758753292be1.bam",60,"TCGA-FI-A2D5-01A",NA,"D94E793F-5F81-4E18-8650-783FE58AEEBC","TCGA",2009,NA,NA,"WITH TUMOR","D5F6444E-C388-42E9-8B20-7B3A4DB8E0DB",56,"nationwidechildrens.org_clinical.TCGA-FI-A2D5.xml","Dead",421,"TCGA-FI-A2D5","NOT HISPANIC OR LATINO","63C5272D-EDE5-40DF-87C0-F1AE38B0B315",NA,NA,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,"CF09F25F-6475-4CCB-9032-CDBDBB2B597B","WHITE",NA,11,30,"0176E005-01BE-44DA-81FA-8DBE508526BE","BC1EE12A-EFEA-4B11-B65D-1F2FEFFF9280","c017080444a8f5549bf9758753292be1.bam","TCGA-FI-A2D5-01A-11",98,0,5,15,2,"TOP",15,3,"TCGA-FI-A2D5-01A-01-TSA",83,"Paclitaxel","Chemotherapy","TCGA-FI-A2D5-D31763","TCGA-FI-A2D5-R31765","EXTERNAL BEAM","Local Recurrence",NA,"YES",NA,"WITH TUMOR","Dead",421,"TCGA-FI-A2D5-F31743","TCGA-FI-A2D5",1,"FI","A2D5","YES","C54.1","8380/3","C54.1","NO","YES",-20666,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Dead",NA,421,NA,NA,"WITH TUMOR","NO",28,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2009,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28155052,27208677,2052457623,"C4CA479C-05D8-4151-B93E-4F410CE04BF6.bw","dcff8659-ecca-4798-80a3-dd6e7642ba2b","c4ca479c-05d8-4151-b93e-4f410ce04bf6","2016-08-05T01:24:57.695326-05:00","UNCID_2214823.3701ff8a-afd6-4a3d-aae4-735325390d1f.101124_UNC4-RDR3001561_00054_FC_62FKEAAXX_2.tar.gz","22063ad1-ba0d-4fb9-a5da-9b9d0e938a96",1726406920,"Illumina GA","bfe5a4e31f79892f28b5dbd1e8cd86f5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:55:46.146788-05:00","2016-05-03T11:17:14.905409-05:00","22063ad1-ba0d-4fb9-a5da-9b9d0e938a96_analysis.xml","37d862ab7ffcdaab1eb6b66f05646f94","0f47ddd0-283c-4684-a7b4-205ed6d89791",2122,"2016-08-26T07:22:16.514217-05:00","22063ad1-ba0d-4fb9-a5da-9b9d0e938a96_experiment.xml","cb9f865f215f70577c1f8b6cae855568","d05a2c4b-ad65-4b08-b1a7-1e68e022dc9f",2256,"2016-09-29T21:17:29.804301-05:00","22063ad1-ba0d-4fb9-a5da-9b9d0e938a96_run.xml","ebca1a3efed9748972ef94ad35bf3dc0","8cf95282-c5a3-4b4f-b4c6-40ba7a9a7b24",345,"2016-09-08T10:48:01.595932-05:00","TCGA-AP-A0LE","2016-09-02T18:47:52.787848-05:00","female","TCGA-AP-A0LE_demographic",1945,"white","5ac7cfe5-25b4-5521-8ed4-023f2afa3d42","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LE_diagnosis","not reported",20967,"alive","8380/3",NA,3357,"32ccea2a-8907-5b3f-8c66-1b5b68ea35ad","c54.1",-20967,"TCGA-AP-A0LE_treatment","8d17aea8-a9d0-518a-b10c-71648e9d536c","01","true","TCGA-AP-A0LE-01A",NA,"9c4a32cf-de40-4996-91a9-56f1c18d69a4",FALSE,"3EA84930-6B34-43B8-A5A8-3D2B3754155F","Primary Tumor",NA,2988,170,NA,1279065600,"11",30,"TCGA-AP-A0LE-01A-11",85,95,1,0,0,0,20,5,"2016-09-08T10:48:01.595932-05:00","2016-09-08T10:48:01.595932-05:00",5,1,0,0,"TOP","BOTTOM",1,1,"0cbd9baf-9150-4e9d-b206-aec6d5b7e1ce","96d9d98b-7fc4-4738-a05e-09ffab263250","TCGA-AP-A0LE-01A-01-TSA","TCGA-AP-A0LE-01A-01-BSA",79,94,"930e2302-3e08-46f8-86b4-7ea5b57f5346","RNA","TCGA-AP-A0LE-01A-11R","0d452409-0ee8-4d08-952d-e0f0b912061f",1.75,0.13,"UV Spec","R","23","TCGA-AP-A0LE-01A-11R-A104-07","3701ff8a-afd6-4a3d-aae4-735325390d1f",0.13,NA,75,29.296875,160,"e2738294-b55d-5312-bd0c-b06a5704885a","TCGA-AP-A0LE_exposure","UNCID_2214823.3701ff8a-afd6-4a3d-aae4-735325390d1f.101124_UNC4-RDR3001561_00054_FC_62FKEAAXX_2.tar.gz","2013-10-03T21:46:04.000Z","2013-10-03T21:58:02.000Z","22063AD1-BA0D-4FB9-A5DA-9B9D0E938A96","9C4A32CF-DE40-4996-91A9-56F1C18D69A4","Unaligned reads",1726406920,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3701FF8A-AFD6-4A3D-AAE4-735325390D1F","University of North Carolina","56607be2e4b0b37b3d99252a","DCFF8659-ECCA-4798-80A3-DD6E7642BA2B","Uterine Corpus Endometrial Carcinoma","TARGZ","930E2302-3E08-46F8-86B4-7EA5B57F5346","2013-10-03T21:58:02.000Z","0D452409-0EE8-4D08-952D-E0F0B912061F","None","NO",1,NA,"Primary Tumor","MSKCC",2988,"930E2302-3E08-46F8-86B4-7EA5B57F5346",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.164F62FF-A3BE-465D-B511-EBA500C9E7FA.txt",170,"TCGA-AP-A0LE-01A",NA,NA,"TCGA",2002,NA,NA,"TUMOR FREE","9C4A32CF-DE40-4996-91A9-56F1C18D69A4",57,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.164F62FF-A3BE-465D-B511-EBA500C9E7FA.txt","Alive",NA,"TCGA-AP-A0LE",NA,"5BFDA841-8FEB-4919-9781-0126125EA78C",NA,2986,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"999B8F72-B20E-40D8-9BDA-A2395D904916","WHITE",NA,11,30,"96D9D98B-7FC4-4738-A05E-09FFAB263250","FE0BBCDB-87D1-4585-9455-ED3867FA9EF9","UNCID_1606870.3701ff8a-afd6-4a3d-aae4-735325390d1f.sorted_genome_alignments.bam","TCGA-AP-A0LE-01A-11",85,0,1,5,20,"TOP",1,0,"TCGA-AP-A0LE-01A-01-TSA",79,NA,NA,NA,"TCGA-AP-A0LE-R3946","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,NA,2986,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LE-F3943","TCGA-AP-A0LE",1,"AP","A0LE","YES","C54.1","8380/3","C54.1","NO","YES",-20967,"FEMALE","WHITE",NA,"No","No","Alive",2986,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2002,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33333765,32500509,2432967790,"A21CA94B-2636-4C85-A7AE-6AE60336F381.bw","de4e13c8-5ad0-46d2-ae54-b9ca22b939d8","a21ca94b-2636-4c85-a7ae-6ae60336f381","2016-08-09T14:08:30.251040-05:00","UNCID_2206484.a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c.110921_UNC6-RDR300211_00125_FC_634F4AAXX_4.tar.gz","1e5277ca-41f6-41a0-8300-4a20e10edac8",2165122732,"Illumina GA","98cc9f71dd12fc7513310fec39ce7735","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:49:50.546972-05:00","2016-05-03T11:11:34.765256-05:00","1e5277ca-41f6-41a0-8300-4a20e10edac8_analysis.xml","0504e6a1d73e771de9802dd4eb4b3038","313b582e-523c-4d24-aacf-26c7de15702f",2121,"2016-10-07T15:57:40.270585-05:00","1e5277ca-41f6-41a0-8300-4a20e10edac8_experiment.xml","7ebdbd333523ba1317ee8033c26e8e27","3acf3481-677a-4b48-9df8-e0b2b265c48e",2257,"2016-09-29T19:59:55.239904-05:00","1e5277ca-41f6-41a0-8300-4a20e10edac8_run.xml","e15d7e48e6fc9960c74749fd8d916f22","5d10400e-cd9c-4431-b8a3-fceda5bf71ec",347,"2016-09-08T11:31:00.113929-05:00","TCGA-EO-A1Y8","2016-09-02T18:52:41.475608-05:00","female","TCGA-EO-A1Y8_demographic",1923,"not reported","79264be9-ce83-5574-b4de-74e520602570","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A1Y8_diagnosis","not reported",31971,"alive","8441/3",NA,1147,"4a9fc05f-f6e7-5a58-8645-d028796719a1","c54.1",-31971,"TCGA-EO-A1Y8_treatment","828ab711-9d7a-52de-99da-4314be36d2d8","01","false","TCGA-EO-A1Y8-01A",NA,"5b0a8519-3fea-46d6-8f6d-ec85c403b416",FALSE,"61143E14-52BD-499F-901C-4BD1EA83DAC1","Primary Tumor",NA,204,170,NA,1303862400,"11",30,"TCGA-EO-A1Y8-01A-11",90,NA,0,NA,0,NA,8,NA,"2016-09-08T11:31:00.113929-05:00",NA,0,NA,0,NA,"TOP",NA,2,NA,"f2965d7b-6213-468d-8e0e-6a39a1c26093",NA,"TCGA-EO-A1Y8-01A-01-TSA",NA,90,NA,"96be0012-4ef0-48ad-9fac-8216582ce84b","RNA","TCGA-EO-A1Y8-01A-11R","2f1086f9-0f75-4d9f-b6a7-0bcf3ab35035",1.86,0.17,"UV Spec","R","23","TCGA-EO-A1Y8-01A-11R-A157-07","a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c",0.17,NA,58,27.2096078063426,146,"32b589a1-f122-5c3c-8816-f299c0391668","TCGA-EO-A1Y8_exposure","UNCID_2206484.a1d4b9ef-6fe5-49b5-9bb5-686d253baa4c.110921_UNC6-RDR300211_00125_FC_634F4AAXX_4.tar.gz","2013-09-27T03:55:04.000Z","2013-09-27T04:09:02.000Z","1E5277CA-41F6-41A0-8300-4A20E10EDAC8","5B0A8519-3FEA-46D6-8F6D-EC85C403B416","Unaligned reads",2165122732,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A1D4B9EF-6FE5-49B5-9BB5-686D253BAA4C","University of North Carolina","564a3cb4e4b0298dd2c8d349","DE4E13C8-5AD0-46D2-AE54-B9CA22B939D8","Uterine Corpus Endometrial Carcinoma","TARGZ","96BE0012-4EF0-48AD-9FAC-8216582CE84B","2013-09-27T04:09:02.000Z","2F1086F9-0F75-4D9F-B6A7-0BCF3AB35035","Canada","NO",1,NA,"Primary Tumor","University Health Network",204,"96BE0012-4EF0-48AD-9FAC-8216582CE84B",NA,"EO","GIRTH_p_TCGA_b108_137_SNP_N_GenomeWideSNP_6_D05_787912.tangent.copynumber.data.txt",170,"TCGA-EO-A1Y8-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","AD2CE7DA-C43A-4D39-9710-0C95371E3D7C",87,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.838C4AC7-EF01-4F07-A1BC-A8165A744583.txt","Alive",NA,"TCGA-EO-A1Y8",NA,"EA605E68-BD67-4196-AE40-89D42CEBC558",NA,328,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",137,NA,NA,NA,NA,11,30,"F2965D7B-6213-468D-8E0E-6A39A1C26093","2F1086F9-0F75-4D9F-B6A7-0BCF3AB35035","e05892d1ff93e157f1df1fbaf7b2de29.bam","TCGA-EO-A1Y8-01A-11",90,0,0,0,8,"TOP",2,0,"TCGA-EO-A1Y8-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,"NO",608,NA,"Alive",NA,"TCGA-EO-A1Y8-F32593","TCGA-EO-A1Y8",1,"EO","A1Y8","YES","C54.1","8441/3","C54.1","NO","YES",-31971,"FEMALE",NA,NA,"No","No","Alive",328,NA,NA,NA,"TUMOR FREE","NO",26,7,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,87,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31494705,30109131,2244607182,"EABD7B13-5FAD-4CC1-A6A0-66177ACA1BB0.bw","de5abe44-6d9d-4797-a57a-5adfd71383f0","eabd7b13-5fad-4cc1-a6a0-66177aca1bb0","2016-08-04T23:21:54.157670-05:00","UNCID_2196703.3ec89fd3-b1fe-495c-99ef-122ab708e633.120216_UNC2-RDR300275_00113_FC_650PDAAXX_1.tar.gz","c246ac0b-1da6-4ef5-8396-647394bab528",1939776627,"Illumina GA","896f0d39fc486fbfcb5ec7f41386ee1c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:20:01.934344-05:00","2016-05-03T11:08:33.743897-05:00","c246ac0b-1da6-4ef5-8396-647394bab528_analysis.xml","d28faeb4be76f31cc33293e71d3e3b70","d8a9b6d7-c8dd-41bb-9013-4e1c20fd3b6e",2121,"2016-09-29T23:58:23.024492-05:00","c246ac0b-1da6-4ef5-8396-647394bab528_experiment.xml","c827ee08f5c4cbd4e265fa09e2b7e0a5","f0a84dcf-148e-47df-ae65-f4f57667a071",2257,"2016-09-29T19:07:36.306297-05:00","c246ac0b-1da6-4ef5-8396-647394bab528_run.xml","7ee8fe2955bcb9bbb44a6f1a926f5399","3c7576b0-67db-441f-bbcd-03663c562c29",347,"2016-09-09T16:42:20.658599-05:00","TCGA-AJ-A2QK","2016-09-02T18:54:01.234852-05:00","female","TCGA-AJ-A2QK_demographic",1946,"white","8ab5b506-712f-54cc-95f5-082df9ea6660","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A2QK_diagnosis","not reported",23945,"alive","8380/3",NA,643,"5266f863-323d-5f28-b48b-8f121693eebe","c54.1",-23945,"TCGA-AJ-A2QK_treatment","ee6d2a2b-9030-5817-a44f-7a4abbfcdf01","01","false","TCGA-AJ-A2QK-01A",NA,"0959f580-cc84-4702-81b8-d6ef96f5469f",FALSE,"01A114A2-098F-4AAD-9010-54910FB89B4A","Primary Tumor",NA,146,170,NA,1316563200,"11",30,"TCGA-AJ-A2QK-01A-11",60,NA,20,NA,0,NA,30,NA,"2016-09-09T16:42:20.658599-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"d0afd31b-b16b-48b3-aff4-202a99eed78a",NA,"TCGA-AJ-A2QK-01A-01-TS1",NA,60,NA,"d0c75dcc-a71d-47e8-abf4-fdd1ed6865da","RNA","TCGA-AJ-A2QK-01A-11R","1bbed407-cd5d-4193-9d53-555a452d3cb8",1.82,0.16,"UV Spec","R","23","TCGA-AJ-A2QK-01A-11R-A18M-07","3ec89fd3-b1fe-495c-99ef-122ab708e633",0.16,NA,119,49.531737773153,155,"c30cab87-fca5-51b8-9a40-094d072b53eb","TCGA-AJ-A2QK_exposure","UNCID_2196703.3ec89fd3-b1fe-495c-99ef-122ab708e633.120216_UNC2-RDR300275_00113_FC_650PDAAXX_1.tar.gz","2013-09-23T20:06:05.000Z","2013-09-23T20:18:01.000Z","C246AC0B-1DA6-4EF5-8396-647394BAB528","0959F580-CC84-4702-81B8-D6EF96F5469F","Unaligned reads",1939776627,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3EC89FD3-B1FE-495C-99EF-122AB708E633","University of North Carolina","56607c00e4b0ec1099f8e740","DE5ABE44-6D9D-4797-A57A-5ADFD71383F0","Uterine Corpus Endometrial Carcinoma","TARGZ","D0C75DCC-A71D-47E8-ABF4-FDD1ED6865DA","2013-09-23T20:18:01.000Z","1BBED407-CD5D-4193-9D53-555A452D3CB8","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",146,"D0C75DCC-A71D-47E8-ABF4-FDD1ED6865DA",NA,"AJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B814B728-9DAC-41EC-812D-8EB841B8E96F.txt",170,"TCGA-AJ-A2QK-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","CA2F93E7-E29C-4C17-BF5D-FAFB4D40DC3E",65,"nationwidechildrens.org_clinical.TCGA-AJ-A2QK.xml","Alive",NA,"TCGA-AJ-A2QK","HISPANIC OR LATINO",NA,NA,12,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,30,"D0AFD31B-B16B-48B3-AFF4-202A99EED78A","1BBED407-CD5D-4193-9D53-555A452D3CB8","UNCID_2196703.3ec89fd3-b1fe-495c-99ef-122ab708e633.120216_UNC2-RDR300275_00113_FC_650PDAAXX_1.tar.gz","TCGA-AJ-A2QK-01A-11",60,0,20,40,30,"TOP",10,20,"TCGA-AJ-A2QK-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A2QK",1,"AJ","A2QK","YES","C54.1","8380/3","C54.1","YES","NO",-23945,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",12,NA,NA,NA,"TUMOR FREE","NO",18,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2011,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
174308768,170758066,8147142266,"771434CA-23FF-4E0E-9DBA-EE7A127E255A.bw","ded408ee-053a-43ed-9bcf-1d15cd203051","771434ca-23ff-4e0e-9dba-ee7a127e255a","2016-08-25T18:07:05.424978-05:00","UNCID_2365502.e2c72ce3-f010-4f7f-832b-6277b8409f87.140114_UNC13-SN749_0325_AC339CACXX_8_AGTTCC.tar.gz","23808b91-c268-4f31-b778-c6a9996be3dc",8129895401,"Illumina HiSeq","d1bec4b420da215431a557b77db229cd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:16:15.478191-05:00","2016-05-03T11:39:34.521514-05:00","23808b91-c268-4f31-b778-c6a9996be3dc_analysis.xml","deb39ce828409f90f2b32f6571eec324","41eac4ed-1d18-4d9c-9d0d-86145ebb7a94",2124,"2016-09-29T19:17:00.764062-05:00","23808b91-c268-4f31-b778-c6a9996be3dc_experiment.xml","f73842d2d411fb8908e6f392914e8f68","4263c9a7-b4ef-4b29-8db9-2a43bea48874",2628,"2016-09-29T21:53:07.993794-05:00","23808b91-c268-4f31-b778-c6a9996be3dc_run.xml","3ef627979474f252403d3516483d50f7","a30ae0ba-0614-4f28-aaa7-0c5baf75154e",354,"2016-09-08T10:25:15.645297-05:00","TCGA-A5-A7WK","2016-09-02T18:51:29.331379-05:00","female","TCGA-A5-A7WK_demographic",1942,"black or african american","24d1e0d9-dcac-5e22-be01-d00d6ccbf4ad","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A7WK_diagnosis","not reported",26044,"alive","8441/3",NA,560,"ec380795-f14e-5b6a-bf51-f17431ec8566","c54.1",-26044,"TCGA-A5-A7WK_treatment","78db435b-9f3c-537a-98b3-7a59b1a25697","01","true","TCGA-A5-A7WK-01A",NA,"69c891f3-536d-4cb8-bbd4-a387534c1283",FALSE,"9101DD17-9216-4526-9A87-8C4E94B1F435","Primary Tumor",NA,253,160,NA,1381449600,"11",30,"TCGA-A5-A7WK-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T10:25:15.645297-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"2fd5bb02-8ebc-44be-9086-42b1b5df3851",NA,"TCGA-A5-A7WK-01A-01-TSA",NA,80,NA,"35f117f3-2b18-479c-b4a1-5892179ba1dd","RNA","TCGA-A5-A7WK-01A-11R","9e3be584-e51b-49e1-ba99-c959a5f87177",1.76,0.16,"UV Spec","R","23","TCGA-A5-A7WK-01A-11R-A34R-07","e2c72ce3-f010-4f7f-832b-6277b8409f87",0.16,NA,97,34.3679138321995,168,"381721e9-7ddb-50ce-89c7-b7cd2316be11","TCGA-A5-A7WK_exposure","UNCID_2365502.e2c72ce3-f010-4f7f-832b-6277b8409f87.140114_UNC13-SN749_0325_AC339CACXX_8_AGTTCC.tar.gz","2014-03-05T16:33:04.000Z","2014-03-05T16:57:02.000Z","23808B91-C268-4F31-B778-C6A9996BE3DC","69C891F3-536D-4CB8-BBD4-A387534C1283","Unaligned reads",8129895401,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","E2C72CE3-F010-4F7F-832B-6277B8409F87","University of North Carolina","56607554e4b0b37b3d98f715","DED408EE-053A-43ED-9BCF-1D15CD203051","Uterine Corpus Endometrial Carcinoma","TARGZ","35F117F3-2B18-479C-B4A1-5892179BA1DD","2014-03-05T16:57:02.000Z","9E3BE584-E51B-49E1-BA99-C959A5F87177","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",253,"35F117F3-2B18-479C-B4A1-5892179BA1DD",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.982A1758-B333-4AC0-96A8-9E4DEF8F7A97.txt",160,"TCGA-A5-A7WK-01A",NA,"F3EC705A-ACFA-4653-852A-BEA24B063880","TCGA",2013,"TCGA-A5-A7WK_NTE-1","Complete Remission/Response","TUMOR FREE","C851F6B6-BCEC-4A50-A88D-A9F7F7DEFB90",71,"nationwidechildrens.org_clinical.TCGA-A5-A7WK.xml","Alive",NA,"TCGA-A5-A7WK","NOT HISPANIC OR LATINO","60686FB4-6850-4C0D-9F48-1FE2E14E8666","NO",248,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",354,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"2FD5BB02-8EBC-44BE-9086-42B1B5DF3851","FB5BF454-5F35-4118-8FC8-EDC19927AEBA","UNCID_2330799.e2c72ce3-f010-4f7f-832b-6277b8409f87.sorted_genome_alignments.bam.bai","TCGA-A5-A7WK-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-A5-A7WK-01A-01-TSA",80,"Carboplatin","Chemotherapy","TCGA-A5-A7WK-D54553",NA,NA,NA,"TCGA-A5-A7WK-F63886_NTE-1","YES",560,"WITH TUMOR","Alive",NA,"TCGA-A5-A7WK-F63886","TCGA-A5-A7WK",1,"A5","A7WK","YES","C54.1","8441/3","C54.1","YES","NO",-26044,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",248,NA,"NO","YES","TUMOR FREE","YES",22,4,2014,"YES","YES","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,71,2013,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33085402,32144082,2412130296,"85D95FBF-E62B-4D99-A85D-7FA5F2FFC00D.bw","dee43082-4aa7-4650-981c-a779e9fe7b55","85d95fbf-e62b-4d99-a85d-7fa5f2ffc00d","2016-08-09T14:14:59.423220-05:00","UNCID_2210387.c0294497-87d4-481f-864a-e4fa9baab8c5.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_5.tar.gz","b7a94678-4f13-468e-ab4a-a702b8b05f67",2216647374,"Illumina GA","cea3e86b4c98c9ac161aebdd20d2b1a9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:28:51.855830-05:00","2016-05-03T11:15:47.420908-05:00","b7a94678-4f13-468e-ab4a-a702b8b05f67_analysis.xml","c2b780602c8504c2f05dca8daa8c15a3","9412fc74-4a54-4fd2-98c3-b028f67ddf30",2121,"2016-09-30T00:19:27.742111-05:00","b7a94678-4f13-468e-ab4a-a702b8b05f67_experiment.xml","fe47543ad36f73cec8404e91db92b7c3","fd9e0c98-5830-4c78-84a0-1b6e709d6be3",2257,"2016-09-29T18:17:00.265162-05:00","b7a94678-4f13-468e-ab4a-a702b8b05f67_run.xml","b7f47cabe08481ceaa4375bc0110efe6","1c957411-cb5e-484f-9b74-325f06e818c3",347,"2016-09-08T10:53:34.275324-05:00","TCGA-B5-A11H","2016-09-02T18:49:26.367494-05:00","female","TCGA-B5-A11H_demographic",1937,"white","8c9e16d5-74cd-58a5-87ae-aa6dd8a31bff","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11H_diagnosis","not reported",24556,"alive","8380/3",NA,2687,"85535d33-70d5-53e0-b4f9-738a62b34432","c54.1",-24556,"TCGA-B5-A11H_treatment","f8ae1bf0-ec07-529d-8d7d-1f9be209aee6","01","true","TCGA-B5-A11H-01A",NA,"d78d2f6b-3eb3-4082-a7ea-f7b6202cdc58",FALSE,"40813C61-4B78-4677-89A4-4B9488613F57","Primary Tumor",NA,2324,620,NA,1289865600,"11",30,"TCGA-B5-A11H-01A-11",85,85,10,10,0,0,5,5,"2016-09-08T10:53:34.275324-05:00","2016-09-08T10:53:34.275324-05:00",5,5,5,2,"BOTTOM","TOP",10,10,"a6d3cbbf-266d-4ae7-adab-c9f34fb75361","9fc6dc5a-b11d-409d-a8c5-74d6b5a128cc","TCGA-B5-A11H-01A-01-BSA","TCGA-B5-A11H-01A-01-TSA",85,85,"0c13a866-403d-4fd0-96a5-a7662e651f59","RNA","TCGA-B5-A11H-01A-11R","719c3f43-47f2-4018-9322-ab09f7a46e11",1.87,0.16,"UV Spec","R","23","TCGA-B5-A11H-01A-11R-A118-07","c0294497-87d4-481f-864a-e4fa9baab8c5",0.16,NA,101,NA,NA,"5477aabf-1d89-5a52-bfad-fba2c2a3dace","TCGA-B5-A11H_exposure","UNCID_2210387.c0294497-87d4-481f-864a-e4fa9baab8c5.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_5.tar.gz","2013-10-02T10:01:03.000Z","2013-10-02T10:14:02.000Z","B7A94678-4F13-468E-AB4A-A702B8B05F67","D78D2F6B-3EB3-4082-A7EA-F7B6202CDC58","Unaligned reads",2216647374,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C0294497-87D4-481F-864A-E4FA9BAAB8C5","University of North Carolina","56607462e4b018727fe9f1e8","DEE43082-4AA7-4650-981C-A779E9FE7B55","Uterine Corpus Endometrial Carcinoma","TARGZ","0C13A866-403D-4FD0-96A5-A7662E651F59","2013-10-02T10:14:02.000Z","719C3F43-47F2-4018-9322-AB09F7A46E11","United States","NO",1,NA,"Primary Tumor","Duke",2324,"0C13A866-403D-4FD0-96A5-A7662E651F59",NA,"B5","UNCID_1632176.c0294497-87d4-481f-864a-e4fa9baab8c5.sorted_genome_alignments.bam",620,"TCGA-B5-A11H-01A",NA,"C6410672-C5AA-4F67-8E0D-49F8751FA6F8","TCGA",2004,NA,NA,"TUMOR FREE","D78D2F6B-3EB3-4082-A7EA-F7B6202CDC58",67,"UNCID_2210387.c0294497-87d4-481f-864a-e4fa9baab8c5.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_5.tar.gz","Alive",NA,"TCGA-B5-A11H",NA,"2DB96620-D2EB-4530-8E4B-2923AA6D09C2",NA,2317,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"9FC6DC5A-B11D-409D-A8C5-74D6B5A128CC","B22C676A-F02A-40E5-960F-2EB4AEC166D1","UNCID_2210387.c0294497-87d4-481f-864a-e4fa9baab8c5.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_5.tar.gz","TCGA-B5-A11H-01A-11",85,0,10,5,5,"BOTTOM",10,5,"TCGA-B5-A11H-01A-01-BSA",85,"Megace","Hormone Therapy","TCGA-B5-A11H-D10045",NA,NA,NA,NA,"NO",2687,"TUMOR FREE","Alive",NA,"TCGA-B5-A11H-F17659","TCGA-B5-A11H",1,"B5","A11H","YES","C54.1","8380/3","C54.1","NO","YES",-24556,"FEMALE","WHITE",NA,"No","No","Alive",2317,NA,NA,NA,"TUMOR FREE","NO",27,1,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2004,"Dilation and curettage procedure",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35427649,35033940,2621372998,"F2D059E7-85BE-4401-9619-2D756EF67B67.bw","df01a5ee-e8b5-40b0-8a6a-b6b3faed9df9","f2d059e7-85be-4401-9619-2d756ef67b67","2016-08-25T16:22:30.233641-05:00","UNCID_2206668.d04855a8-fdd2-464c-967d-1a58e530539f.111006_UNC2-RDR300275_00089_FC_634EEAAXX_7.tar.gz","87f03503-9ff1-426e-95f3-d3b2d2e12308",2304165154,"Illumina GA","5ac0eafd28be9a1b340d890117b6385f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:23:55.271574-05:00","2016-05-03T11:12:13.642315-05:00","87f03503-9ff1-426e-95f3-d3b2d2e12308_analysis.xml","643a542533077e326f5f000bbdc5f432","6baebbca-e506-4991-86d1-750e2f05716f",2121,"2016-09-29T22:14:20.449679-05:00","87f03503-9ff1-426e-95f3-d3b2d2e12308_experiment.xml","9d1e171d4bb3dc4ce98b46f311c17d89","b01aaf2a-9b1c-4d26-a67f-baac480bd703",2257,"2016-09-29T18:08:38.035040-05:00","87f03503-9ff1-426e-95f3-d3b2d2e12308_run.xml","79b686d3e115176ab4bd8cfb2d46a120","1776b06d-5990-4014-8b8f-9539ad4654b2",347,"2016-09-08T10:35:37.087532-05:00","TCGA-D1-A1NX","2016-09-02T18:52:45.114199-05:00","female","TCGA-D1-A1NX_demographic",1944,"white","f0d1ed71-a6fc-526b-9a5a-8183ccd0229d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1NX_diagnosis","not reported",24441,"alive","8441/3",NA,555,"62fa317d-6ed7-5f82-8fd3-64caab7df675","c54.1",-24441,"TCGA-D1-A1NX_treatment","88869daa-0ef2-51f5-8ee6-4a5ac4435d10","01","false","TCGA-D1-A1NX-01A",NA,"1e016d9f-9fab-4191-8209-bc0a8ff0bacf",FALSE,"C2A3FA63-63A1-4424-BD92-FAEC1C377C62","Primary Tumor",NA,204,50,NA,1304899200,"11",30,"TCGA-D1-A1NX-01A-11",65,NA,0,NA,20,NA,5,NA,"2016-09-08T10:35:37.087532-05:00",NA,2,NA,4,NA,"TOP",NA,5,NA,"360b4a96-4637-44ff-b9fa-6215666be9bd",NA,"TCGA-D1-A1NX-01A-01-TS1",NA,70,NA,"2576c181-88f8-444c-b0dc-60373839dd41","RNA","TCGA-D1-A1NX-01A-11R","97d9ce59-b06a-4ccb-883e-d129431bd07b",1.81,0.18,"UV Spec","R","23","TCGA-D1-A1NX-01A-11R-A16F-07","d04855a8-fdd2-464c-967d-1a58e530539f",0.18,NA,87,34.4131956805506,159,"4deda643-90ad-5a1c-837c-277e21245210","TCGA-D1-A1NX_exposure","UNCID_2206668.d04855a8-fdd2-464c-967d-1a58e530539f.111006_UNC2-RDR300275_00089_FC_634EEAAXX_7.tar.gz","2013-09-27T18:31:04.000Z","2013-09-27T18:45:02.000Z","87F03503-9FF1-426E-95F3-D3B2D2E12308","1E016D9F-9FAB-4191-8209-BC0A8FF0BACF","Unaligned reads",2304165154,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","D04855A8-FDD2-464C-967D-1A58E530539F","University of North Carolina","564a31cbe4b093830b66343a","DF01A5EE-E8B5-40B0-8A6A-B6B3FAED9DF9","Uterine Corpus Endometrial Carcinoma","TARGZ","2576C181-88F8-444C-B0DC-60373839DD41","2013-09-27T18:45:02.000Z","97D9CE59-B06A-4CCB-883E-D129431BD07B","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",204,"2576C181-88F8-444C-B0DC-60373839DD41",NA,"D1","TCGA-D1-A1NX-01A-11R-A16E-13_mirna.bam",50,"TCGA-D1-A1NX-01A",NA,"D301630E-F403-4E02-9FB9-DDC1AA6936D5","TCGA",2010,NA,NA,"TUMOR FREE","B0BEB530-243E-4124-BCE1-010B24108674",66,"nationwidechildrens.org_clinical.TCGA-D1-A1NX.xml","Alive",NA,"TCGA-D1-A1NX","NOT HISPANIC OR LATINO","844EEBFE-AFC2-4088-A1C8-386C4F2EBB8E",NA,399,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",143,NA,"5DBFDFBF-D8A9-47C8-8DCF-D7E956038C24","WHITE",NA,11,30,"360B4A96-4637-44FF-B9FA-6215666BE9BD","97D9CE59-B06A-4CCB-883E-D129431BD07B","UNCID_602955.d04855a8-fdd2-464c-967d-1a58e530539f.111006_UNC2-RDR300275_00089_FC_634EEAAXX.7.trimmed.annotated.translated_to_genomic.bam","TCGA-D1-A1NX-01A-11",65,20,0,2,5,"TOP",5,4,"TCGA-D1-A1NX-01A-01-TS1",70,"Taxol","Chemotherapy","TCGA-D1-A1NX-D21568","TCGA-D1-A1NX-R21571","EXTERNAL BEAM","Local Recurrence",NA,"YES",555,"WITH TUMOR","Alive",NA,"TCGA-D1-A1NX-F21565","TCGA-D1-A1NX",1,"D1","A1NX","YES","C54.1","8441/3","C54.1","NO","YES",-24441,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",399,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,66,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
163912702,161499802,7703669621,"BD755511-C2CA-45C1-AD55-5BFDB8EA89B6.bw","df15901c-2508-42c9-bf06-026efd89e51f","bd755511-c2ca-45c1-ad55-5bfdb8ea89b6","2016-08-26T09:36:59.844390-05:00","UNCID_2316570.646422f2-97e3-43e4-bb4f-260277cff6f4.130909_UNC15-SN850_0326_AC2BWBACXX_1_ACTTGA.tar.gz","05c7e1d4-f9b1-4f32-8d09-af4aeef4d31c",7502381758,"Illumina HiSeq","6d7a38c184926bc7ffa494cb4d6def52","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:03:24.352669-05:00","2016-05-03T11:28:50.231867-05:00","05c7e1d4-f9b1-4f32-8d09-af4aeef4d31c_analysis.xml","abd9653c4b903f437867b67b44a68078","8411c507-c890-4178-ba6a-dc8a0e87708c",2124,"2016-09-29T23:03:32.339257-05:00","05c7e1d4-f9b1-4f32-8d09-af4aeef4d31c_experiment.xml","4287f9c318ee136ad5b663fa25493d7c","ce78167b-48ee-47e9-88ff-23c32ec79f36",2628,"2016-09-29T18:16:50.005221-05:00","05c7e1d4-f9b1-4f32-8d09-af4aeef4d31c_run.xml","2f22b9e0888f42e8ac5480632aa5ee6a","1c79d2c5-a275-444d-8a68-44013d5b9496",354,"2016-09-08T12:07:24.459791-05:00","TCGA-QF-A5YS","2016-09-02T18:51:24.521970-05:00","female","TCGA-QF-A5YS_demographic",1955,"black or african american","07f2d324-0079-5388-a28a-e7b6a3c00f3d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","QF","d777d40e-e930-5f47-995e-89adc81e9900","BLN - Baylor","not reported","c54.1","TCGA-QF-A5YS_diagnosis","not reported",20841,"alive","8380/3",NA,689,"7ef8e2f1-5575-5c40-9462-fbfc52077346","c54.1",-20841,"TCGA-QF-A5YS_treatment","e12441b5-1346-533a-b2d2-679afc1d2711","01","false","TCGA-QF-A5YS-01A",NA,"a7646717-9292-4321-9ea1-259573d8a1f0",FALSE,"2608B03E-0D29-49EF-BC3D-A26D5017C265","Primary Tumor",NA,158,120,NA,1363219200,"11",30,"TCGA-QF-A5YS-01A-11",90,NA,1,NA,0,NA,10,NA,"2016-09-08T12:07:24.459791-05:00",NA,1,NA,1,NA,"TOP",NA,0,NA,"ecc2619e-9e42-4b7a-8b5f-db7faca978c7",NA,"TCGA-QF-A5YS-01A-01-TSA",NA,90,NA,"837ce606-28e7-4a85-b578-cd14c9948fe7","RNA","TCGA-QF-A5YS-01A-11R","00479065-042b-453f-9d16-1eb8615c1d8e",1.92,0.16,"UV Spec","R","23","TCGA-QF-A5YS-01A-11R-A31O-07","646422f2-97e3-43e4-bb4f-260277cff6f4",0.16,NA,79,30.1021185794848,162,"254a1a54-f2df-50df-91e3-ac8a2dd7483d","TCGA-QF-A5YS_exposure","UNCID_2316570.646422f2-97e3-43e4-bb4f-260277cff6f4.130909_UNC15-SN850_0326_AC2BWBACXX_1_ACTTGA.tar.gz","2014-01-07T09:31:04.000Z","2014-01-07T10:07:02.000Z","05C7E1D4-F9B1-4F32-8D09-AF4AEEF4D31C","A7646717-9292-4321-9EA1-259573D8A1F0","Unaligned reads",7502381758,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","646422F2-97E3-43E4-BB4F-260277CFF6F4","University of North Carolina","564a400fe4b0298dd2c9e83c","DF15901C-2508-42C9-BF06-026EFD89E51F","Uterine Corpus Endometrial Carcinoma","TARGZ","837CE606-28E7-4A85-B578-CD14C9948FE7","2014-01-07T10:07:02.000Z","00479065-042B-453F-9D16-1EB8615C1D8E","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",158,"837CE606-28E7-4A85-B578-CD14C9948FE7",NA,"QF","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.AD17002A-950C-42A0-8590-3A491D5621A1.txt",120,"TCGA-QF-A5YS-01A",NA,"F05BDE3B-51A8-49E1-B6B0-13A9A1751181","TCGA",2012,"TCGA-QF-A5YS_NTE-1","Complete Remission/Response","TUMOR FREE","A7646717-9292-4321-9EA1-259573D8A1F0",57,"UNCID_2316570.646422f2-97e3-43e4-bb4f-260277cff6f4.130909_UNC15-SN850_0326_AC2BWBACXX_1_ACTTGA.tar.gz","Alive",NA,"TCGA-QF-A5YS","NOT HISPANIC OR LATINO","39B11ED4-8B3D-4F04-94BD-549CB4645871","NO",275,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",324,NA,"8769095D-1115-47F0-897A-C62F202BEC0A","BLACK OR AFRICAN AMERICAN",NA,11,30,"ECC2619E-9E42-4B7A-8B5F-DB7FACA978C7","3EBE2A5F-7F13-4296-B78A-4E8B797F04EF","TCGA-QF-A5YS-01A-11R-A31S-13_mirna.bam.bai","TCGA-QF-A5YS-01A-11",90,0,1,1,10,"TOP",0,1,"TCGA-QF-A5YS-01A-01-TSA",90,"Paclitaxel","Chemotherapy","TCGA-QF-A5YS-D59671","TCGA-QF-A5YS-R44657","External","Primary Tumor Field","TCGA-QF-A5YS-F58613_NTE-1","NO",689,"TUMOR FREE","Alive",NA,"TCGA-QF-A5YS-F58613","TCGA-QF-A5YS",1,"QF","A5YS","YES","C54.1","8380/3","C54.1","NO","YES",-20841,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",275,NA,"YES","YES","TUMOR FREE","YES",25,6,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,57,2012,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
112706868,111494018,5323356134,"1ACE6BB9-A332-42DD-BA4F-E9902DB413AA.bw","df27b584-fa45-4a8f-bd12-a018cc63dca1","1ace6bb9-a332-42dd-ba4f-e9902db413aa","2016-08-05T08:01:12.833886-05:00","UNCID_2168979.8bc81bd5-9814-4a83-b78d-6d5722a1a53d.130610_UNC14-SN744_0347_BD28NBACXX_5_AGTTCC.tar.gz","0a70e1ec-c1d3-4565-8b2d-ba60c93d1f00",5176445582,"Illumina HiSeq","a950faa7a8803db57e688563b3c67b4f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:45:12.683380-05:00","2016-05-03T11:13:02.631277-05:00","0a70e1ec-c1d3-4565-8b2d-ba60c93d1f00_analysis.xml","01045cfb99a647227beb3ff2b9142980","c331dc25-6eec-4f95-9fd0-2a08326aa0f3",2129,"2016-08-13T06:06:05.991624-05:00","0a70e1ec-c1d3-4565-8b2d-ba60c93d1f00_experiment.xml","09432e5ec759b628bc402148fb7c4634","93942fdf-13bc-48ab-9374-cbc73f5b6098",2600,"2016-09-29T22:30:09.614599-05:00","0a70e1ec-c1d3-4565-8b2d-ba60c93d1f00_run.xml","80a5a63c9f55c832c93596c5833621e4","b9d6f506-4612-488b-a465-4cc3ab0380cc",343,"2016-09-08T10:45:56.901418-05:00","TCGA-EY-A4KR","2016-09-02T18:50:03.461800-05:00","female","TCGA-EY-A4KR_demographic",1956,"black or african american","9c5f20e2-32ce-5806-9d65-97b768df3265","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A4KR_diagnosis","not reported",20669,"dead","8441/3",346,196,"3fc4011a-b780-5270-a1ad-0025e6e2de3f","c54.1",-20669,"TCGA-EY-A4KR_treatment","4f1943dc-bbbe-5d61-9b6d-93a9e5ce3594","01","false","TCGA-EY-A4KR-01A",NA,"db625f3a-2cf7-4b99-8fa4-ab234f1dc22d",FALSE,"D8669681-B1D2-4D39-B7BB-5207F901A937","Primary Tumor",NA,147,610,NA,1351123200,"11",30,"TCGA-EY-A4KR-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T10:45:56.901418-05:00",NA,5,NA,0,NA,"TOP",NA,3,NA,"18deaa31-6034-48b5-90ac-c0c03991d7cd",NA,"TCGA-EY-A4KR-01A-01-TS1",NA,97,NA,"4afe42f1-6b59-440d-95af-ca9d718bdb05","RNA","TCGA-EY-A4KR-01A-11R","cfff59e4-7515-4805-9a23-8ce70819fb1a",1.85,0.17,"UV Spec","R","23","TCGA-EY-A4KR-01A-11R-A27V-07","8bc81bd5-9814-4a83-b78d-6d5722a1a53d",0.17,NA,114,42.3854848304581,164,"30e92d8f-5a78-500c-8e07-b2702d3ebedd","TCGA-EY-A4KR_exposure","UNCID_2168979.8bc81bd5-9814-4a83-b78d-6d5722a1a53d.130610_UNC14-SN744_0347_BD28NBACXX_5_AGTTCC.tar.gz","2013-09-10T08:36:04.000Z","2013-09-29T01:15:01.000Z","0A70E1EC-C1D3-4565-8B2D-BA60C93D1F00","DB625F3A-2CF7-4B99-8FA4-AB234F1DC22D","Unaligned reads",5176445582,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","8BC81BD5-9814-4A83-B78D-6D5722A1A53D","University of North Carolina","564a36e8e4b09c884b22fe22","DF27B584-FA45-4A8F-BD12-A018CC63DCA1","Uterine Corpus Endometrial Carcinoma","TARGZ","4AFE42F1-6B59-440D-95AF-CA9D718BDB05","2013-09-29T01:15:01.000Z","CFFF59E4-7515-4805-9A23-8CE70819FB1A","United States","NO",1,NA,"Primary Tumor","University of North Carolina",147,"4AFE42F1-6B59-440D-95AF-CA9D718BDB05",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.1B4E7519-3FE8-4F74-9497-D50B1985669F.txt",610,"TCGA-EY-A4KR-01A",NA,"D85A2FDB-3A08-413C-B014-3B84DEB10D72","TCGA",2012,"TCGA-EY-A4KR_NTE-1","Progressive Disease","WITH TUMOR","DB625F3A-2CF7-4B99-8FA4-AB234F1DC22D",56,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.1B4E7519-3FE8-4F74-9497-D50B1985669F.txt","Alive",NA,"TCGA-EY-A4KR","NOT HISPANIC OR LATINO","51E83D3A-CA8F-4753-ADB1-EF1DC96A599F",NA,196,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8441/3","FEMALE","C54.1",289,NA,"E56E421F-1673-4D9D-8D49-F64A17432ACE","BLACK OR AFRICAN AMERICAN",NA,11,30,"18DEAA31-6034-48B5-90AC-C0C03991D7CD","ECF847D6-6049-4408-96D6-0CB2BBF861A0","TCGA-EY-A4KR-01A-11R-A27R-13_mirna.bam.bai","TCGA-EY-A4KR-01A-11",80,0,0,5,0,"TOP",3,0,"TCGA-EY-A4KR-01A-01-TS1",97,"Taxol","Chemotherapy","TCGA-EY-A4KR-D44496","TCGA-EY-A4KR-R44430","External","Primary Tumor Field","TCGA-EY-A4KR-F44431_NTE-1","NO",NA,"WITH TUMOR","Dead",346,"TCGA-EY-A4KR-F44431","TCGA-EY-A4KR",1,"EY","A4KR","YES","C54.1","8441/3","C54.1","YES","NO",-20669,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",196,NA,"YES","YES","WITH TUMOR","NO",17,1,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,56,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,"Progressive Disease",NA,12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
11444806,10804498,813069517,"47F50B4A-1646-48CB-867C-0FD49C7D3664.bw","df857bc6-fd6a-4713-bef9-6ee1301e5fb1","47f50b4a-1646-48cb-867c-0fd49c7d3664","2016-08-09T14:15:59.618132-05:00","UNCID_2211666.4fefb750-f793-4c1f-92cc-bd8fd9998cc6.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_5.tar.gz","7b75c760-6cd8-423e-98f6-8da1444f25d1",679229681,"Illumina GA","c2b3bfcadbe035455449d11adbc6b1a3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:05:19.044900-05:00","2016-05-03T11:16:29.233374-05:00","7b75c760-6cd8-423e-98f6-8da1444f25d1_analysis.xml","c31348e2f11fc3447eaeaa7e51c03735","aaa2cc35-b05f-45b1-acd4-022142aa0f64",2121,"2016-09-29T18:36:10.157917-05:00","7b75c760-6cd8-423e-98f6-8da1444f25d1_experiment.xml","7c67e4edeb571bb329baaaba99016b7d","287e067b-bb1d-44a1-89c7-6996230c8151",2257,"2016-09-29T17:44:05.702024-05:00","7b75c760-6cd8-423e-98f6-8da1444f25d1_run.xml","77a2aa5df952e3df06d8f1919dad94b0","07e0ea49-8bbd-4bc4-952a-9c51c8363595",347,"2016-09-08T10:42:50.176763-05:00","TCGA-BS-A0TI","2016-09-02T18:48:25.474117-05:00","female","TCGA-BS-A0TI_demographic",1942,"white","031b9275-feab-5a98-ab1d-ea8def8bce56","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0TI_diagnosis","not reported",23705,"alive","8380/3",NA,1882,"8c930394-3164-5af8-b62d-d93d088d0760","c54.1",-23705,"TCGA-BS-A0TI_treatment","bafba2f7-f1e5-5613-b47d-316f08719439","01","false","TCGA-BS-A0TI-01A",NA,"2f52c850-8e70-4eab-88f3-d35dc55e385b",FALSE,"60212550-2757-4AB0-B778-723AE046F6BE","Primary Tumor",NA,1507,250,NA,1282608000,"11",10,"TCGA-BS-A0TI-01A-11",98,98,0,0,0,0,0,0,"2016-09-08T10:42:50.176763-05:00","2016-09-08T10:42:50.176763-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"d2ff3c26-8eef-4dcb-a16d-27179cd22f41","9f0bd313-96df-4dab-8de3-15ae8629ab67","TCGA-BS-A0TI-01A-01-TSA","TCGA-BS-A0TI-01A-01-BSA",100,100,"ef9c965f-43ea-4175-8a7c-8fa285ea54d9","RNA","TCGA-BS-A0TI-01A-11R","5e23cc8e-7a0e-4fab-b40e-d90b8c47bbab",1.78,0.16,"UV Spec","R","23","TCGA-BS-A0TI-01A-11R-A104-07","4fefb750-f793-4c1f-92cc-bd8fd9998cc6",0.16,NA,59,22.206330686138,163,"bc4f5a2b-c8b6-580a-90fc-46e1df772ffd","TCGA-BS-A0TI_exposure","UNCID_2211666.4fefb750-f793-4c1f-92cc-bd8fd9998cc6.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_5.tar.gz","2013-10-03T00:13:05.000Z","2013-10-03T00:26:02.000Z","7B75C760-6CD8-423E-98F6-8DA1444F25D1","2F52C850-8E70-4EAB-88F3-D35DC55E385B","Unaligned reads",679229681,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4FEFB750-F793-4C1F-92CC-BD8FD9998CC6","University of North Carolina","56607bdae4b0ec1099f8e68e","DF857BC6-FD6A-4713-BEF9-6EE1301E5FB1","Uterine Corpus Endometrial Carcinoma","TARGZ","EF9C965F-43EA-4175-8A7C-8FA285EA54D9","2013-10-03T00:26:02.000Z","5E23CC8E-7A0E-4FAB-B40E-D90B8C47BBAB","None","NO",1,NA,"Primary Tumor","University of Hawaii",1507,"EF9C965F-43EA-4175-8A7C-8FA285EA54D9",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.03D002A0-05DE-4B9B-99B9-0DD455E3BAD7.txt",250,"TCGA-BS-A0TI-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","F4052639-340A-488B-810A-8403FC796000",64,"nationwidechildrens.org_clinical.TCGA-BS-A0TI.xml","Alive",NA,"TCGA-BS-A0TI","NOT HISPANIC OR LATINO","369A39B0-EFB3-43BF-BDAC-1A45E635AF80",NA,1443,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,11,10,"D2FF3C26-8EEF-4DCB-A16D-27179CD22F41","E167A522-5CAD-49FE-B6AE-12E0C0720381","TCGA-BS-A0TI-01A-11R-A103-13.isoform.quantification.txt","TCGA-BS-A0TI-01A-11",98,0,0,0,0,"BOTTOM",0,0,"TCGA-BS-A0TI-01A-01-BSA",100,NA,NA,NA,NA,NA,NA,NA,NA,1882,"TUMOR FREE","Alive",NA,"TCGA-BS-A0TI-F4406","TCGA-BS-A0TI",1,"BS","A0TI","YES","C54.1","8380/3","C54.1","NO","YES",-23705,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1443,NA,NA,NA,"TUMOR FREE","NO",19,11,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,64,2006,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
40680707,40402322,3011392701,"562291E5-AB47-4455-9C92-7904DAB14AB4.bw","dffc7091-bc27-452c-ad94-1ee214107593","562291e5-ab47-4455-9c92-7904dab14ab4","2016-08-05T02:08:20.450286-05:00","UNCID_2203758.ab3e5a04-9d4c-4289-93ed-38dba3e619b2.111103_UNC6-RDR300211_00130_FC_638P5AAXX_1.tar.gz","a9da9e9f-fca4-48a4-bf9f-241922d8a02e",2727818132,"Illumina GA","66e191e3feb89cf878e9205e8abcb793","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:00:33.801648-05:00","2016-05-03T11:10:47.515830-05:00","a9da9e9f-fca4-48a4-bf9f-241922d8a02e_analysis.xml","99eb8d61e278dc482954601a2e26ac25","8253ac56-f7ac-4481-ba5d-2e08091a198e",2121,"2016-08-28T00:44:54.473284-05:00","a9da9e9f-fca4-48a4-bf9f-241922d8a02e_experiment.xml","04d4b9600bc0e3ec1fa5c77cf831c788","1c1ff4b3-b775-4617-8daf-d79741f3145f",2257,"2016-09-29T17:36:25.256575-05:00","a9da9e9f-fca4-48a4-bf9f-241922d8a02e_run.xml","cd374b7bfd29e2e1ebab6452a22f9272","02ea5b45-e8bb-4686-b6e1-8fd9bf5db7b0",347,"2016-09-08T11:09:07.546699-05:00","TCGA-FI-A2CX","2016-09-02T18:52:52.752555-05:00","female","TCGA-FI-A2CX_demographic",1926,"white","8bd8505e-e3b3-5167-adc2-d6abce781dc6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FI","cee96273-f2ef-52a4-8f36-64f19a81eb32","Washington University","not reported","c54.1","TCGA-FI-A2CX_diagnosis","not reported",30224,"alive","8380/3",NA,2031,"c9506856-ae38-5a48-ac59-1fe58579f840","c54.1",-30224,"TCGA-FI-A2CX_treatment","759a432f-97b4-5b91-bc4a-b7feef85dfa0","01","true","TCGA-FI-A2CX-01A",NA,"b6d24830-0d69-44d7-94cf-7dfdc49e52c4",FALSE,"0F6F56E4-C4F9-4915-BE4E-1FBF4C6D93AD","Primary Tumor",NA,1067,80,NA,1308700800,"11",30,"TCGA-FI-A2CX-01A-11",98,NA,35,NA,0,NA,2,NA,"2016-09-08T11:09:07.546699-05:00",NA,40,NA,2,NA,"TOP",NA,10,NA,"a118f244-b5aa-4165-ad1b-3272e446b419",NA,"TCGA-FI-A2CX-01A-01-TSA",NA,88,NA,"1810a91b-afc1-428e-b11d-ab9aad82e74a","RNA","TCGA-FI-A2CX-01A-11R","6ae893f6-b98f-4e93-ad0d-95881be07545",1.97,0.16,"UV Spec","R","23","TCGA-FI-A2CX-01A-11R-A17B-07","ab3e5a04-9d4c-4289-93ed-38dba3e619b2",0.16,NA,52,21.6441207075963,155,"47a78112-73a2-5136-9459-e17fc52abc91","TCGA-FI-A2CX_exposure","UNCID_2203758.ab3e5a04-9d4c-4289-93ed-38dba3e619b2.111103_UNC6-RDR300211_00130_FC_638P5AAXX_1.tar.gz","2013-09-26T16:46:04.000Z","2013-09-26T17:00:02.000Z","A9DA9E9F-FCA4-48A4-BF9F-241922D8A02E","B6D24830-0D69-44D7-94CF-7DFDC49E52C4","Unaligned reads",2727818132,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","AB3E5A04-9D4C-4289-93ED-38DBA3E619B2","University of North Carolina","56607d48e4b016715ab6b5f0","DFFC7091-BC27-452C-AD94-1EE214107593","Uterine Corpus Endometrial Carcinoma","TARGZ","1810A91B-AFC1-428E-B11D-AB9AAD82E74A","2013-09-26T17:00:02.000Z","6AE893F6-B98F-4E93-AD0D-95881BE07545","United States","NO",1,NA,"Primary Tumor","Washington University",1067,"1810A91B-AFC1-428E-B11D-AB9AAD82E74A",NA,"FI","UNCID_2203758.ab3e5a04-9d4c-4289-93ed-38dba3e619b2.111103_UNC6-RDR300211_00130_FC_638P5AAXX_1.tar.gz",80,"TCGA-FI-A2CX-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","F14DD28B-9532-4DE0-A368-949BFB9E95C3",82,"nationwidechildrens.org_clinical.TCGA-FI-A2CX.xml","Alive",NA,"TCGA-FI-A2CX","NOT HISPANIC OR LATINO","83ED9815-451D-43B9-807C-47C3EEF29651",NA,1217,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"A118F244-B5AA-4165-AD1B-3272E446B419","BEB06733-CA50-4C02-80A3-7CAE3795F813","UNCID_617315.ab3e5a04-9d4c-4289-93ed-38dba3e619b2.111103_UNC6-RDR300211_00130_FC_638P5AAXX.1.trimmed.annotated.translated_to_genomic.bam.bai","TCGA-FI-A2CX-01A-11",98,0,35,40,2,"TOP",10,2,"TCGA-FI-A2CX-01A-01-TSA",88,NA,NA,NA,NA,NA,NA,NA,"NO",1207,"TUMOR FREE","Alive",NA,"TCGA-FI-A2CX-F31725","TCGA-FI-A2CX",1,"FI","A2CX","YES","C54.1","8380/3","C54.1","NO","YES",-30224,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",1217,NA,NA,NA,"TUMOR FREE","NO",27,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,82,2008,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
24059625,23779518,1771387638,"3701DD5A-B7CC-4C80-BDB6-F0FE811975A5.bw","e00f6dc5-bc8b-472d-bac3-c7823364f01e","3701dd5a-b7cc-4c80-bdb6-f0fe811975a5","2016-08-05T09:21:42.786766-05:00","UNCID_2196803.13a499dd-2bb6-4750-b24a-1c76993f5b97.120208_UNC2-RDR300275_00112_FC_64V42AAXX_3.tar.gz","983db638-b27f-4416-b9f6-6c22577347cd",1647248006,"Illumina GA","c9218c8c588446a7a738acdfe825df83","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:18:54.025465-05:00","2016-05-03T11:08:33.752363-05:00","983db638-b27f-4416-b9f6-6c22577347cd_analysis.xml","010e6b81d5558481994a36f48f11e17d","b2e2bc95-d58b-47c9-9695-542de7c16ffe",2121,"2016-09-29T23:13:16.726822-05:00","983db638-b27f-4416-b9f6-6c22577347cd_experiment.xml","d0b00278e4cc87c827231b6adc365f0a","d4b5b558-23ab-4134-b6a1-e36710d4f62a",2257,"2016-09-29T21:34:35.888891-05:00","983db638-b27f-4416-b9f6-6c22577347cd_run.xml","da6ecd39cd656a7425c5b4bdf102bb46","977e5000-d47d-4253-9015-4893390630df",347,"2016-09-08T11:10:35.421243-05:00","TCGA-AJ-A2QN","2016-09-02T18:54:03.101704-05:00","female","TCGA-AJ-A2QN_demographic",1950,"white","715f8a44-a741-5bf0-977f-2d443c2c098d","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A2QN_diagnosis","not reported",21915,"alive","8380/3",NA,1069,"42bb44bc-d039-5d7d-9b18-e9d123743198","c54.1",-21915,"TCGA-AJ-A2QN_treatment","0e34cc70-9e6d-5096-8ef4-7033a91c848d","01","false","TCGA-AJ-A2QN-01A",NA,"3fd07879-b069-4595-a704-cd7d11733f01",FALSE,"F92EF591-695A-4E48-9ACF-67497880AC20","Primary Tumor",NA,289,25,NA,1315526400,"11",25,"TCGA-AJ-A2QN-01A-11",75,NA,0,NA,0,NA,15,NA,"2016-09-08T11:10:35.421243-05:00",NA,0,NA,0,NA,"TOP",NA,10,NA,"57ea32bd-84da-4ef1-b1eb-6b82135e9677",NA,"TCGA-AJ-A2QN-01A-01-TS1",NA,75,NA,"a916e232-ba04-4d1e-af15-3177e8b9401c","RNA","TCGA-AJ-A2QN-01A-11R","c7ba0111-9c80-4c8b-bbd9-795ad49afa5f",1.8,0.17,"UV Spec","R","23","TCGA-AJ-A2QN-01A-11R-A18M-07","13a499dd-2bb6-4750-b24a-1c76993f5b97",0.17,NA,132,45.6747404844291,170,"5ed191a7-54d8-5bf9-9d49-43dda89dd33f","TCGA-AJ-A2QN_exposure","UNCID_2196803.13a499dd-2bb6-4750-b24a-1c76993f5b97.120208_UNC2-RDR300275_00112_FC_64V42AAXX_3.tar.gz","2013-09-23T22:26:05.000Z","2013-09-23T22:38:02.000Z","983DB638-B27F-4416-B9F6-6C22577347CD","3FD07879-B069-4595-A704-CD7D11733F01","Unaligned reads",1647248006,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","13A499DD-2BB6-4750-B24A-1C76993F5B97","University of North Carolina","564a3ba0e4b08c5d869193f9","E00F6DC5-BC8B-472D-BAC3-C7823364F01E","Uterine Corpus Endometrial Carcinoma","TARGZ","A916E232-BA04-4D1E-AF15-3177E8B9401C","2013-09-23T22:38:02.000Z","C7BA0111-9C80-4C8B-BBD9-795AD49AFA5F","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",289,"A916E232-BA04-4D1E-AF15-3177E8B9401C",NA,"AJ","6929718101_R02C02_Red.idat",25,"TCGA-AJ-A2QN-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","3FD07879-B069-4595-A704-CD7D11733F01",60,"nationwidechildrens.org_clinical.TCGA-AJ-A2QN.xml","Alive",NA,"TCGA-AJ-A2QN",NA,"FF08A365-B6B9-4CBA-8835-136C66B05117",NA,73,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,25,"57EA32BD-84DA-4EF1-B1EB-6B82135E9677","F3EABD22-7BA2-4ADD-B79E-2C1A2832705C","CUTES_p_TCGA_172_176_178_SNP_N_GenomeWideSNP_6_B03_863592.ismpolish.data.txt","TCGA-AJ-A2QN-01A-11",75,0,0,0,15,"TOP",10,0,"TCGA-AJ-A2QN-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,"TCGA-AJ-A2QN-F58977_NTE-1","NO",1069,"TUMOR FREE","Alive",NA,"TCGA-AJ-A2QN-F58977","TCGA-AJ-A2QN",1,"AJ","A2QN","YES","C54.1","8380/3","C54.1","YES","NO",-21915,"FEMALE","WHITE",NA,"No","No","Alive",73,NA,NA,NA,"TUMOR FREE","NO",18,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33493321,32909625,2464628373,"74CF740D-201D-4070-99B9-F007E7C4D472.bw","e055db71-f3da-43d3-a9b2-2f65dfb23d3e","74cf740d-201d-4070-99b9-f007e7c4d472","2016-08-09T14:16:44.430117-05:00","UNCID_2214774.90962783-12b4-434d-9b27-6c6f8f3b8d10.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_2.tar.gz","6781473e-0a3d-48de-9ae0-6476beadbb7d",2038496631,"Illumina GA","8b444ff429bffcd1d12e3341a4da7c04","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:53:22.491968-05:00","2016-05-03T11:17:14.905409-05:00","6781473e-0a3d-48de-9ae0-6476beadbb7d_analysis.xml","944211fa7811a26b51001ea5bdfa4c62","59177a6b-3236-4a02-b3dc-fffad660a5f7",2120,"2016-09-29T18:58:44.553365-05:00","6781473e-0a3d-48de-9ae0-6476beadbb7d_experiment.xml","8f8a413fa610c50d7fa17fed507b8ed0","36e06085-1337-4dad-84e7-cd3876722495",2256,"2016-09-29T21:27:27.489749-05:00","6781473e-0a3d-48de-9ae0-6476beadbb7d_run.xml","69a2573e83976b918c617619c73e72d4","9330f280-c546-459e-910f-cf1b2559d015",345,"2016-09-08T12:02:46.435643-05:00","TCGA-BG-A0M8","2016-09-02T18:48:05.597756-05:00","female","TCGA-BG-A0M8_demographic",1958,"white","097a59d7-4cf0-51e6-b86b-bdf1052dd68b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0M8_diagnosis","not reported",18308,"alive","8380/3",NA,2020,"abfe679c-a7cd-55a3-8b34-2a922121b9ee","c54.1",-18308,"TCGA-BG-A0M8_treatment","173d02c7-bcf6-5f10-b06a-9c846e38021b","01","true","TCGA-BG-A0M8-01A",NA,"9cfb7290-ef60-4fda-abd7-9552ae11e4e7",FALSE,"42DBC6F7-E413-41A6-994E-1391099818A0","Primary Tumor",NA,734,630,NA,1279584000,"12",30,"TCGA-BG-A0M8-01A-12",90,85,0,0,0,0,0,0,"2016-09-08T12:02:46.435643-05:00","2016-09-08T12:02:46.435643-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"420ea720-d899-4f9f-9687-52bd71b3dd5b","a0a08556-3f92-4cec-8088-187244e2139b","TCGA-BG-A0M8-01A-01-TSA","TCGA-BG-A0M8-01A-01-BSA",100,100,"8724bdfb-674b-477e-ab2a-416912a6c1da","RNA","TCGA-BG-A0M8-01A-12R","bc16df1c-124c-4818-8c69-304d09b3910f",1.84,0.15,"UV Spec","R","23","TCGA-BG-A0M8-01A-12R-A104-07","90962783-12b4-434d-9b27-6c6f8f3b8d10",0.15,NA,209,81.640625,160,"cd326d0e-def4-5d2c-a6e0-59309f61db12","TCGA-BG-A0M8_exposure","UNCID_2214774.90962783-12b4-434d-9b27-6c6f8f3b8d10.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_2.tar.gz","2013-10-03T20:56:03.000Z","2013-10-03T21:08:02.000Z","6781473E-0A3D-48DE-9AE0-6476BEADBB7D","9CFB7290-EF60-4FDA-ABD7-9552AE11E4E7","Unaligned reads",2038496631,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","90962783-12B4-434D-9B27-6C6F8F3B8D10","University of North Carolina","564a3d31e4b093830b69d6f0","E055DB71-F3DA-43D3-A9B2-2F65DFB23D3E","Uterine Corpus Endometrial Carcinoma","TARGZ","8724BDFB-674B-477E-AB2A-416912A6C1DA","2013-10-03T21:08:02.000Z","BC16DF1C-124C-4818-8C69-304D09B3910F","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",734,"8724BDFB-674B-477E-AB2A-416912A6C1DA",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E01A90AC-A64F-4AD2-8C5B-374D2F9FBF75.txt",630,"TCGA-BG-A0M8-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","9CFB7290-EF60-4FDA-ABD7-9552AE11E4E7",50,"TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted.bam","Alive",NA,"TCGA-BG-A0M8","NOT HISPANIC OR LATINO","BA603010-DC48-44C2-A267-2D4893125AE8",NA,690,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,12,30,"A0A08556-3F92-4CEC-8088-187244E2139B","D2B98C82-4A1F-44D4-B38C-2BE66DAD1710","TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted.bam","TCGA-BG-A0M8-01A-12",90,0,0,0,0,"TOP",0,0,"TCGA-BG-A0M8-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",1110,"TUMOR FREE","Alive",NA,"TCGA-BG-A0M8-F19289","TCGA-BG-A0M8",1,"BG","A0M8","YES","C54.1","8380/3","C54.1","NO","YES",-18308,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",690,NA,NA,NA,"TUMOR FREE","NO",8,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,50,2008,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
34442922,33125673,2493145755,"9E023B8F-E340-4684-B92B-A13CBDF2A321.bw","e095a927-d985-4fbd-8093-46c1c6ace4de","9e023b8f-e340-4684-b92b-a13cbdf2a321","2016-08-09T14:14:15.192591-05:00","UNCID_2211026.432f025e-4ece-432e-b573-01a8e6f9a1e5.110316_UNC2-RDR300275_00058_FC_62J26AAXX_6.tar.gz","fc32ab91-744d-4278-a604-76345c119177",2147798576,"Illumina GA","37ff7e1012158d83beb670f9dd30dfb6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:46:06.588294-05:00","2016-05-03T11:15:47.407128-05:00","fc32ab91-744d-4278-a604-76345c119177_analysis.xml","df0853088ade3fdd419dd16fca43d054","5487a431-cfdf-4d49-a7a6-b76b7903598f",2121,"2016-09-29T23:55:41.199690-05:00","fc32ab91-744d-4278-a604-76345c119177_experiment.xml","5df92af77f2a1bd68de01288e46a0fea","ef06d2e7-33e2-4dfc-aca1-22da2f364cf8",2257,"2016-09-29T19:58:11.655300-05:00","fc32ab91-744d-4278-a604-76345c119177_run.xml","dbce92e674b840c63f7612463b5bbd57","5c06eee8-fbb5-49bd-b262-8ccf8d555659",347,"2016-09-08T12:13:42.150322-05:00","TCGA-BS-A0WQ","2016-09-02T18:49:03.818500-05:00","female","TCGA-BS-A0WQ_demographic",1951,"asian","fbe59fad-77f1-5a5c-be08-9129ca24a265","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0WQ_diagnosis","not reported",20131,"alive","8380/3",NA,2022,"8c6d3454-af03-5c35-9e05-1102360a1563","c54.1",-20131,"TCGA-BS-A0WQ_treatment","cb6ae894-4038-5502-9a71-501fa8b8bc77","01","false","TCGA-BS-A0WQ-01A",NA,"b19275ba-cff5-4ec7-ac23-d6be497adef2",FALSE,"207B2565-ABB2-4F05-8B54-2280DAC57AD3","Primary Tumor",NA,1696,140,NA,1286496000,"21",30,"TCGA-BS-A0WQ-01A-21",80,85,0,0,0,0,0,0,"2016-09-08T12:13:42.150322-05:00","2016-09-08T12:13:42.150322-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"81c6cec3-158e-408f-9aa7-56c17a85ee07","b7efa40e-ff74-4b3e-9bba-482cc203a820","TCGA-BS-A0WQ-01A-02-TSB","TCGA-BS-A0WQ-01A-02-BSB",100,100,"6591d247-d9a2-4fe1-93b4-033247b4c332","RNA","TCGA-BS-A0WQ-01A-21R","87fe2e03-1b1a-43f7-af26-6d7449062bcc",1.83,0.16,"UV Spec","R","23","TCGA-BS-A0WQ-01A-21R-A109-07","432f025e-4ece-432e-b573-01a8e6f9a1e5",0.16,NA,93,36.328125,160,"85897cea-5047-5e9c-96d9-fbec70b0720f","TCGA-BS-A0WQ_exposure","UNCID_2211026.432f025e-4ece-432e-b573-01a8e6f9a1e5.110316_UNC2-RDR300275_00058_FC_62J26AAXX_6.tar.gz","2013-10-02T07:43:06.000Z","2013-10-02T07:56:03.000Z","FC32AB91-744D-4278-A604-76345C119177","B19275BA-CFF5-4EC7-AC23-D6BE497ADEF2","Unaligned reads",2147798576,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","432F025E-4ECE-432E-B573-01A8E6F9A1E5","University of North Carolina","56607cf6e4b0b37b3d9929f7","E095A927-D985-4FBD-8093-46C1C6ACE4DE","Uterine Corpus Endometrial Carcinoma","TARGZ","6591D247-D9A2-4FE1-93B4-033247B4C332","2013-10-02T07:56:03.000Z","87FE2E03-1B1A-43F7-AF26-6D7449062BCC","None","NO",1,NA,"Primary Tumor","University of Hawaii",1696,"6591D247-D9A2-4FE1-93B4-033247B4C332",NA,"BS","TCGA-BS-A0WQ-01A-21R-A108-13_mirna.bam.bai",140,"TCGA-BS-A0WQ-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","B19275BA-CFF5-4EC7-AC23-D6BE497ADEF2",55,"nationwidechildrens.org_clinical.TCGA-BS-A0WQ.xml","Alive",NA,"TCGA-BS-A0WQ","NOT HISPANIC OR LATINO","90BC14A5-31F4-4B2F-8025-D7750FF4CCCF",NA,1208,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",75,NA,NA,"ASIAN",NA,21,30,"B7EFA40E-FF74-4B3E-9BBA-482CC203A820","B69A49F9-0F8D-4C72-A5AC-A07AA67D3CA4","TCGA-BS-A0WQ-01A-21R-A108-13_mirna.bam.bai","TCGA-BS-A0WQ-01A-21",80,0,0,0,0,"TOP",0,0,"TCGA-BS-A0WQ-01A-02-TSB",100,NA,NA,NA,NA,NA,NA,NA,"NO",2022,"TUMOR FREE","Alive",NA,"TCGA-BS-A0WQ-F16701","TCGA-BS-A0WQ",1,"BS","A0WQ","YES","C54.1","8380/3","C54.1","NO","YES",-20131,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",1208,NA,NA,NA,"TUMOR FREE","NO",25,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2006,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34703837,34458643,2599661015,"EB0D68BC-5FF9-44A5-A355-CA5441BFBA0A.bw","e0d13e2d-cf48-4b66-bfc2-88f872f67d79","eb0d68bc-5ff9-44a5-a355-ca5441bfba0a","2016-08-05T05:56:52.326427-05:00","UNCID_2194563.654f3e2f-00c7-4db6-b092-e2d0d50845da.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_6.tar.gz","60b6e301-3a00-48d6-a152-9d4ddd8517a8",2177500199,"Illumina GA","9c491a496f87fee110d7b4fecc507181","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:57:26.003939-05:00","2016-05-03T11:07:49.533431-05:00","60b6e301-3a00-48d6-a152-9d4ddd8517a8_analysis.xml","62f1c1ecaf5bfec5f104ca1043f705f2","5b98b42e-81e4-48ea-a9b6-961a56be522c",2122,"2016-09-29T21:19:41.492109-05:00","60b6e301-3a00-48d6-a152-9d4ddd8517a8_experiment.xml","1170b1d504ce08a552c5a9ee015b3e0a","8e5cb630-da90-4e9b-be0a-69a4788942b0",2258,"2016-09-29T21:09:46.116943-05:00","60b6e301-3a00-48d6-a152-9d4ddd8517a8_run.xml","db8d25ca6ecb4cdc5cf243c4ea6afdc3","882bd8e7-7e0b-4e05-8983-6347e2bdf26d",349,"2016-09-09T16:35:31.525117-05:00","TCGA-EY-A1GT","2016-09-02T18:52:00.187103-05:00","female","TCGA-EY-A1GT_demographic",1942,"white","82aaf7e3-9a30-5061-b417-624d521b0883","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GT_diagnosis","not reported",25151,"alive","8380/3",NA,490,"c5270936-62ce-5d17-aea2-139f36582dbf","c54.1",-25151,"TCGA-EY-A1GT_treatment","e36d3534-acfc-5e37-bd23-6b571fac137e","01","false","TCGA-EY-A1GT-01A",NA,"20983a85-478b-4cc1-bbf9-e136773f6288",FALSE,"2F5AE4E7-9411-461D-ACD9-EB7D51CEF872","Primary Tumor",NA,225,380,NA,1297728000,"11",30,"TCGA-EY-A1GT-01A-11",60,NA,20,NA,0,NA,30,NA,"2016-09-09T16:35:31.525117-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"3ae1b8f8-f89c-4b62-a87b-c984f7cf9279",NA,"TCGA-EY-A1GT-01A-01-TSA",NA,60,NA,"34cd0df5-dbf9-4ab5-b1ad-c9635da37467","RNA","TCGA-EY-A1GT-01A-11R","6188fe9d-7073-4b92-b450-a1ab42487419",1.7,0.15,"UV Spec","R","23","TCGA-EY-A1GT-01A-11R-A13S-07","654f3e2f-00c7-4db6-b092-e2d0d50845da",0.15,NA,70,24.8015873015873,168,"411d2072-61e2-5bbd-9f78-590172514046","TCGA-EY-A1GT_exposure","UNCID_2194563.654f3e2f-00c7-4db6-b092-e2d0d50845da.120323_UNC2-RDR300275_00119_FC_64KNMAAXX_6.tar.gz","2013-09-23T01:36:04.000Z","2013-09-23T01:51:01.000Z","60B6E301-3A00-48D6-A152-9D4DDD8517A8","20983A85-478B-4CC1-BBF9-E136773F6288","Unaligned reads",2177500199,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","654F3E2F-00C7-4DB6-B092-E2D0D50845DA","University of North Carolina","564a34bae4b093830b67223c","E0D13E2D-CF48-4B66-BFC2-88F872F67D79","Uterine Corpus Endometrial Carcinoma","TARGZ","34CD0DF5-DBF9-4AB5-B1AD-C9635DA37467","2013-09-23T01:51:01.000Z","6188FE9D-7073-4B92-B450-A1AB42487419","United States","NO",1,NA,"Primary Tumor","University of North Carolina",225,"34CD0DF5-DBF9-4AB5-B1AD-C9635DA37467",NA,"EY","HORNS_p_TCGA_b110_113_SNP_N_GenomeWideSNP_6_C09_772236.nocnv_hg18.seg.txt",380,"TCGA-EY-A1GT-01A",NA,"70D61107-E630-4F30-963F-13C47C0321A3","TCGA",2010,NA,NA,"TUMOR FREE","6666209E-1E5F-4AAC-A963-851AD5402B97",68,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.ECED1752-B536-431E-AB4E-255B1046711A.txt","Alive",NA,"TCGA-EY-A1GT","NOT HISPANIC OR LATINO","2523E4BF-BDA2-4B83-AB13-D3B9E24D9D91",NA,300,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"WHITE",NA,11,30,"3AE1B8F8-F89C-4B62-A87B-C984F7CF9279","E9C02D64-D8DB-4522-AC40-C851BA7774AD","TCGA-EY-A1GT-01A-11R-A13R-13_mirna.bam.bai","TCGA-EY-A1GT-01A-11",60,0,20,40,30,"TOP",10,20,"TCGA-EY-A1GT-01A-01-TSA",60,"Carboplatin","Chemotherapy","TCGA-EY-A1GT-D12161",NA,NA,NA,NA,"NO",490,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GT-F19877","TCGA-EY-A1GT",1,"EY","A1GT","YES","C54.1","8380/3","C54.1","YES","NO",-25151,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",300,NA,NA,NA,"TUMOR FREE","NO",24,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2010,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
118902710,115270237,5490155381,"C92AD683-FD09-4DD2-A5A5-C72EA5DD9B46.bw","e17a5fca-616c-4a74-abe7-778539ecdc0b","c92ad683-fd09-4dd2-a5a5-c72ea5dd9b46","2016-08-05T05:49:27.238082-05:00","UNCID_2178301.21fd1035-30e0-4851-88c6-35d2693e6dcd.130405_UNC9-SN296_0354_AC24DCACXX_2_TTAGGC.tar.gz","acf0571e-db84-4803-84c6-1e5f847f1831",5860038985,"Illumina HiSeq","2661ba51e6e7d38d663c15ef257af9c9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:46:32.081526-05:00","2016-05-03T10:56:47.878169-05:00","acf0571e-db84-4803-84c6-1e5f847f1831_analysis.xml","5e30831d39503e6acda4f32ce690efb5","54c8163c-be28-412d-82d2-0633880e1e1d",2121,"2016-09-29T23:03:07.848648-05:00","acf0571e-db84-4803-84c6-1e5f847f1831_experiment.xml","10e64589176b4d524cf9146b49f88004","ce342790-dd3c-45c8-826b-036ba13bde85",2431,"2016-09-29T20:56:36.495727-05:00","acf0571e-db84-4803-84c6-1e5f847f1831_run.xml","5f3d452288f2333a211ac3bf79421223","7fe2b29e-c947-43d2-b845-a3c241937035",354,"2016-09-08T10:31:46.161800-05:00","TCGA-D1-A3DA","2016-09-02T18:48:42.148969-05:00","female","TCGA-D1-A3DA_demographic",1934,"white","2b099a95-8a5f-51ce-ace7-57107a9affab","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A3DA_diagnosis","not reported",28142,"alive","8380/3",NA,483,"bd1f03ea-4e86-5ba8-9410-e1280da9b765","c54.1",-28142,"TCGA-D1-A3DA_treatment","5303bc5b-0ef4-55c8-9357-e14c9c17fe69","01","true","TCGA-D1-A3DA-01A",NA,"24be1526-b1ca-4206-bc2f-533d51548565",FALSE,"8F3D4AFC-2E70-4633-A58F-C98ED00A8964","Primary Tumor",NA,128,110,NA,1321401600,"12",30,"TCGA-D1-A3DA-01A-12",85,NA,0,NA,0,NA,5,NA,"2016-09-08T10:31:46.161800-05:00",NA,2,NA,0,NA,"TOP",NA,5,NA,"7db4b34a-6726-4663-be2b-251077af3838",NA,"TCGA-D1-A3DA-01A-01-TS1",NA,90,NA,"9008cb08-3532-4e3a-8617-99d942531597","RNA","TCGA-D1-A3DA-01A-12R","fa0a04a5-4fbb-4897-9914-d088ffda9c5c",1.84,0.16,"UV Spec","R","23","TCGA-D1-A3DA-01A-12R-A213-07","21fd1035-30e0-4851-88c6-35d2693e6dcd",0.16,NA,57,24.6710526315789,152,"48224292-6770-59a2-917f-18c1430075f4","TCGA-D1-A3DA_exposure","UNCID_2178301.21fd1035-30e0-4851-88c6-35d2693e6dcd.130405_UNC9-SN296_0354_AC24DCACXX_2_TTAGGC.tar.gz","2013-09-11T23:46:09.000Z","2013-09-12T00:10:02.000Z","ACF0571E-DB84-4803-84C6-1E5F847F1831","24BE1526-B1CA-4206-BC2F-533D51548565","Unaligned reads",5860038985,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","21FD1035-30E0-4851-88C6-35D2693E6DCD","University of North Carolina","5660793be4b0ec1099f8d96c","E17A5FCA-616C-4A74-ABE7-778539ECDC0B","Uterine Corpus Endometrial Carcinoma","TARGZ","9008CB08-3532-4E3A-8617-99D942531597","2013-09-12T00:10:02.000Z","FA0A04A5-4FBB-4897-9914-D088FFDA9C5C","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",128,"9008CB08-3532-4E3A-8617-99D942531597",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.9555CB48-3997-46E2-B1A5-228F8FCFA62E.txt",110,"TCGA-D1-A3DA-01A",NA,"A049BBCE-FA19-4CD6-B42C-6E49CDA1792C","TCGA",2011,NA,NA,"TUMOR FREE","EBFF6568-13DA-4CDD-B31A-124C0A039E2A",77,"nationwidechildrens.org_clinical.TCGA-D1-A3DA.xml","Alive",NA,"TCGA-D1-A3DA","NOT HISPANIC OR LATINO","35EE8943-93C5-45F6-B363-00A2BEA0E86E",NA,8,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC1",NA,NA,NA,"8380/3","FEMALE","C54.1",201,NA,NA,"WHITE",NA,12,30,"7DB4B34A-6726-4663-BE2B-251077AF3838","60B7529B-0031-451C-B1A8-6011B4AB0A58","d014a0e9f1554b51906015e4771a786b.bam","TCGA-D1-A3DA-01A-12",85,0,0,2,5,"TOP",5,0,"TCGA-D1-A3DA-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-D1-A3DA-D41462",NA,NA,NA,"TCGA-D1-A3DA-F41456_NTE-1","NO",483,"TUMOR FREE","Alive",NA,"TCGA-D1-A3DA-F41456","TCGA-D1-A3DA",1,"D1","A3DA","YES","C54.1","8380/3","C54.1","NO","YES",-28142,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",8,NA,NA,NA,"TUMOR FREE","NO",15,2,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,77,2011,"Excisional Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
24471115,24120103,1752338928,"03AD3E27-DEFB-4952-8C37-08A90D493788.bw","e1e8dc66-467c-48a5-be56-3db4f665b9f1","03ad3e27-defb-4952-8c37-08a90d493788","2016-08-05T08:14:41.955837-05:00","UNCID_2215147.0fd52e18-275a-4c3d-8c8d-9e27859a5482.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_6.tar.gz","09209cb3-2a37-4be8-a18b-e187ddf2b000",1433060588,"Illumina GA","c67fecfa932d5f9989b5df110ac2a6bd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:21:01.278925-05:00","2016-05-03T11:17:59.899106-05:00","09209cb3-2a37-4be8-a18b-e187ddf2b000_analysis.xml","7986927bb3e69ad9e147f60d31b5bc49","44efc0b7-91a9-48de-b0ce-49349cf6863e",2122,"2016-09-29T21:35:19.706828-05:00","09209cb3-2a37-4be8-a18b-e187ddf2b000_experiment.xml","6b29d4cca68af8b3751936b06882de51","97f16774-bcc0-4d0b-bd42-9d029dfd9a73",2256,"2016-09-29T21:01:20.269448-05:00","09209cb3-2a37-4be8-a18b-e187ddf2b000_run.xml","171ea5481262e14cf55659f96d1aed7e","82d4a531-3b9e-4602-8c0b-d15c8b03b140",345,"2016-09-08T10:31:23.723170-05:00","TCGA-AP-A0LI","2016-09-02T18:54:31.544036-05:00","female","TCGA-AP-A0LI_demographic",1936,"black or african american","1e9d614e-a709-5368-ad16-6a95d293e547","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LI_diagnosis","not reported",24573,"alive","8441/3",NA,2972,"6b3033f1-7849-5ed0-b1c1-abb61ba6d85b","c54.1",-24573,"TCGA-AP-A0LI_treatment","45dce2a1-41d9-5f94-8652-e9cb0b0c05eb","01","true","TCGA-AP-A0LI-01A",NA,"981d9e3b-63c5-41e9-827f-7f1d268d62f4",FALSE,"EFEA05D7-E720-4FE4-977C-6A6369B1BA2E","Primary Tumor",NA,2567,180,NA,1278547200,"11",30,"TCGA-AP-A0LI-01A-11",90,85,0,0,0,0,0,0,"2016-09-08T10:31:23.723170-05:00","2016-09-08T10:31:23.723170-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"7141eb6f-43db-482c-8a60-6c07e290b964","21760092-2270-4e17-be41-aaa4e9acad69","TCGA-AP-A0LI-01A-01-BSA","TCGA-AP-A0LI-01A-01-TSA",100,100,"02a2899d-dbdf-4e6d-8cf6-b5b58449e656","RNA","TCGA-AP-A0LI-01A-11R","b24824f3-d109-4e65-a85c-034f6adb7518",1.94,0.15,"UV Spec","R","23","TCGA-AP-A0LI-01A-11R-A040-07","0fd52e18-275a-4c3d-8c8d-9e27859a5482",0.15,NA,86,33.1777323405733,161,"3136dde9-508c-5fca-93b7-c7f77e482162","TCGA-AP-A0LI_exposure","UNCID_2215147.0fd52e18-275a-4c3d-8c8d-9e27859a5482.101011_UNC8-RDR3001640_00037_FC_62M6WAAXX_6.tar.gz","2013-10-04T00:25:04.000Z","2013-10-04T00:37:03.000Z","09209CB3-2A37-4BE8-A18B-E187DDF2B000","981D9E3B-63C5-41E9-827F-7F1D268D62F4","Unaligned reads",1433060588,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","0FD52E18-275A-4C3D-8C8D-9E27859A5482","University of North Carolina","566077c3e4b0b37b3d990fda","E1E8DC66-467C-48A5-BE56-3DB4F665B9F1","Uterine Corpus Endometrial Carcinoma","TARGZ","02A2899D-DBDF-4E6D-8CF6-B5B58449E656","2013-10-04T00:37:03.000Z","B24824F3-D109-4E65-A85C-034F6ADB7518","None","NO",1,NA,"Primary Tumor","MSKCC",2567,"02A2899D-DBDF-4E6D-8CF6-B5B58449E656",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.7625DF56-46C8-401F-9FE3-D95D692BC04A.txt",180,"TCGA-AP-A0LI-01A",NA,"7B5BC501-0CBB-4242-8002-327283E9985D","TCGA",2003,NA,NA,"TUMOR FREE","981D9E3B-63C5-41E9-827F-7F1D268D62F4",67,"MODEM_p_TCGAb59_SNP_N_GenomeWideSNP_6_F09_680512.hg19.seg.txt","Alive",NA,"TCGA-AP-A0LI",NA,"36549C6B-BA29-45C6-9668-91E42974509D",NA,2602,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",59,NA,"F3DA80CD-337F-4782-90F1-F7D94AA9A17C","BLACK OR AFRICAN AMERICAN",NA,11,30,"7141EB6F-43DB-482C-8A60-6C07E290B964","9E5F2C16-6EB3-4F3E-A792-BAA3416AE00A","TCGA-AP-A0LI-01A-11R-A041-13_mirna.bam","TCGA-AP-A0LI-01A-11",90,0,0,0,0,"BOTTOM",0,0,"TCGA-AP-A0LI-01A-01-BSA",100,"CARBOPLATIN","Chemotherapy","TCGA-AP-A0LI-D3972","TCGA-AP-A0LI-R3975","EXTERNAL BEAM","Regional site",NA,"NO",2972,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LI-F29045","TCGA-AP-A0LI",1,"AP","A0LI","YES","C54.1","8441/3","C54.1","NO","YES",-24573,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",2602,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,2003,"Other method, specify:",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,NA,13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
28327502,28147568,2114839144,"543C5AAA-98A6-47C7-A959-34B7DB5C4BAE.bw","e297551c-a662-4677-b00d-0d9be232adca","543c5aaa-98a6-47c7-a959-34b7db5c4bae","2016-08-09T14:11:48.866430-05:00","UNCID_2206902.da204d4a-922e-4501-9db6-8034ae6b8177.110817_UNC6-RDR300211_00122_FC_6315AAXX_4.tar.gz","05804907-eebc-463d-ad79-22404e597c46",1800046779,"Illumina GA","85fdd1929be5307d74e5785a5095ce20","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:59:03.035003-05:00","2016-05-03T11:13:02.652554-05:00","05804907-eebc-463d-ad79-22404e597c46_analysis.xml","601e3f826edc4700f2c2a0945ed5db62","37103992-452b-4a78-9710-1bd868464e8e",2119,"2016-09-29T23:09:42.187499-05:00","05804907-eebc-463d-ad79-22404e597c46_experiment.xml","61f6f54b816712afa9bdf2c25bf65eb5","d26dee22-b9b5-4239-9a83-3b464c10c444",2257,"2016-09-29T18:53:15.146206-05:00","05804907-eebc-463d-ad79-22404e597c46_run.xml","f2ef41a6029b8ac33c9ce0a636af30f2","336da1b1-f42c-4bd5-99d0-a5d6c498f7fd",347,"2016-09-08T11:04:48.545352-05:00","TCGA-AX-A1CP","2016-09-02T18:51:44.353615-05:00","female","TCGA-AX-A1CP_demographic",1924,"white","5693261a-fc8a-5ba2-b87a-1fbb44a72372","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CP_diagnosis","not reported",30737,"alive","8441/3",NA,1107,"58a8b660-b3a8-53f3-822f-00a2ffdd5ee5","c54.1",-30737,"TCGA-AX-A1CP_treatment","58439707-19bc-5397-bbb4-68af79ec6be2","01","false","TCGA-AX-A1CP-01A",NA,"28542436-6afd-4198-9efe-2b69768277b0",FALSE,"E2F94D2B-C53B-4112-AFBB-06A6751CAE4B","Primary Tumor",NA,1080,110,NA,1295308800,"11",30,"TCGA-AX-A1CP-01A-11",70,NA,0,NA,35,NA,4,NA,"2016-09-08T11:04:48.545352-05:00",NA,5,NA,0,NA,"TOP",NA,1,NA,"f3e587e4-1a55-4678-8477-d798018f15aa",NA,"TCGA-AX-A1CP-01A-01-TS1",NA,60,NA,"18108555-481d-43de-b457-9ef0eb3c8395","RNA","TCGA-AX-A1CP-01A-11R","3323dcb1-4c13-4a3a-acd7-fbebf45aeefe",180,0.15,"UV Spec","R","23","TCGA-AX-A1CP-01A-11R-A137-07","da204d4a-922e-4501-9db6-8034ae6b8177",0.15,NA,55,22.6002629848784,156,"abd2bfd3-a8ec-560c-9ee6-f79c109b979d","TCGA-AX-A1CP_exposure","UNCID_2206902.da204d4a-922e-4501-9db6-8034ae6b8177.110817_UNC6-RDR300211_00122_FC_6315AAXX_4.tar.gz","2013-09-28T16:16:03.000Z","2013-09-28T16:28:03.000Z","05804907-EEBC-463D-AD79-22404E597C46","28542436-6AFD-4198-9EFE-2B69768277B0","Unaligned reads",1800046779,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","DA204D4A-922E-4501-9DB6-8034AE6B8177","University of North Carolina","56607b28e4b0b37b3d9921f9","E297551C-A662-4677-B00D-0D9BE232ADCA","Uterine Corpus Endometrial Carcinoma","TARGZ","18108555-481D-43DE-B457-9EF0EB3C8395","2013-09-28T16:28:03.000Z","3323DCB1-4C13-4A3A-ACD7-FBEBF45AEEFE","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1080,"18108555-481D-43DE-B457-9EF0EB3C8395",NA,"AX","TCGA-AX-A1CP-01A-11R-A136-13_mirna.bam",110,"TCGA-AX-A1CP-01A",NA,NA,"TCGA",2008,NA,NA,NA,"C3853FED-A81F-4E2B-8473-DDF23F35759D",84,"nationwidechildrens.org_clinical.TCGA-AX-A1CP.xml","Alive",NA,"TCGA-AX-A1CP","NOT HISPANIC OR LATINO","90254AF6-8BAA-4EA4-86FB-9878DA404A9D",NA,1107,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"F3E587E4-1A55-4678-8477-D798018F15AA","7E0C4791-D875-4810-A101-92D7045CCB5E","TCGA-AX-A1CP-01A-11R-A136-13_mirna.bam","TCGA-AX-A1CP-01A-11",70,35,0,5,4,"TOP",1,0,"TCGA-AX-A1CP-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,NA,NA,1107,NA,"Alive",NA,"TCGA-AX-A1CP-F9828","TCGA-AX-A1CP",1,"AX","A1CP","YES","C54.1","8441/3","C54.1","NO","YES",-30737,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",1107,NA,NA,NA,NA,"NO",12,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,84,2008,NA,NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
11723545,11357407,854017861,"57C9C700-2D44-41AA-A6C1-11593A0AB449.bw","e2b1d0de-5221-44a1-8fad-9708a3cada14","57c9c700-2d44-41aa-a6c1-11593a0ab449","2016-08-09T14:16:04.338229-05:00","UNCID_2211710.ece7dac4-4f09-45c9-8a63-e4375ebf4c88.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_7.tar.gz","6eaa33ea-2a84-4285-bb19-af0d66cf5bba",704118170,"Illumina GA","d2155ca7affcf839aedfb07c9f0315de","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:19:01.591734-05:00","2016-05-03T11:16:29.238681-05:00","6eaa33ea-2a84-4285-bb19-af0d66cf5bba_analysis.xml","b02a01cd266e1aa1a83e08eb0e64703e","1dbcee84-8967-4c17-8a39-7938e9056a81",2121,"2016-09-29T22:15:32.867650-05:00","6eaa33ea-2a84-4285-bb19-af0d66cf5bba_experiment.xml","d6c345979ff8c08ddbbb97fae9f07e5a","b0e1357f-82a5-46c9-8605-af4bef4f8711",2257,"2016-09-29T18:39:29.702258-05:00","6eaa33ea-2a84-4285-bb19-af0d66cf5bba_run.xml","2aed967aa0bd9d1df6e040d8b308e06b","2aaa1119-1dce-4231-b7ea-6b56ef6bc956",347,"2016-09-08T10:38:08.050572-05:00","TCGA-BS-A0UT","2016-09-02T18:48:29.969133-05:00","female","TCGA-BS-A0UT_demographic",1943,"asian","4483f9f3-4e11-52f5-bdd7-074f47cde40d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0UT_diagnosis","not reported",22775,"alive","8380/3",NA,2212,"c8e7cb30-8811-5468-920d-1c0643a8a7ed","c54.1",-22775,"TCGA-BS-A0UT_treatment","c84b6211-ff3a-5f74-a2c2-a3f49115c195","01","false","TCGA-BS-A0UT-01A",NA,"824d0dbc-293f-4893-a68c-24dedd437ea5",FALSE,"326838B8-D069-4F9C-9353-F806B56DCA48","Primary Tumor",NA,1886,90,NA,1286150400,"11",20,"TCGA-BS-A0UT-01A-11",80,70,0,0,0,0,5,25,"2016-09-08T10:38:08.050572-05:00","2016-09-08T10:38:08.050572-05:00",0,80,0,20,"TOP","BOTTOM",0,5,"02478d6c-0328-4ee3-b083-1151dd8e0c62","127548ac-fad7-4f4b-a142-9e3a7558159d","TCGA-BS-A0UT-01A-01-MS1","TCGA-BS-A0UT-01A-01-BS1",95,70,"bf01b704-9b64-43c2-89f7-a848ef0ec454","RNA","TCGA-BS-A0UT-01A-11R","f1e37c6e-1d50-407d-a171-185a5cde86b7",1.96,0.15,"UV Spec","R","23","TCGA-BS-A0UT-01A-11R-A104-07","ece7dac4-4f09-45c9-8a63-e4375ebf4c88",0.15,NA,65,28.1336565096953,152,"1d16e31a-179d-5e78-b92e-4e8bb3607b7c","TCGA-BS-A0UT_exposure","UNCID_2211710.ece7dac4-4f09-45c9-8a63-e4375ebf4c88.110216_UNC6-RDR300211_00060_FC_62J5DAAXX_7.tar.gz","2013-10-03T00:55:04.000Z","2013-10-03T01:07:02.000Z","6EAA33EA-2A84-4285-BB19-AF0D66CF5BBA","824D0DBC-293F-4893-A68C-24DEDD437EA5","Unaligned reads",704118170,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","ECE7DAC4-4F09-45C9-8A63-E4375EBF4C88","University of North Carolina","564a3440e4b09c884b222d01","E2B1D0DE-5221-44A1-8FAD-9708A3CADA14","Uterine Corpus Endometrial Carcinoma","TARGZ","BF01B704-9B64-43C2-89F7-A848EF0EC454","2013-10-03T01:07:02.000Z","F1E37C6E-1D50-407D-A171-185A5CDE86B7","None","NO",1,NA,"Primary Tumor","University of Hawaii",1886,"BF01B704-9B64-43C2-89F7-A848EF0EC454",NA,"BS","TCGA-BS-A0UT-01A-11R-A103-13_mirna.bam",90,"TCGA-BS-A0UT-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","824D0DBC-293F-4893-A68C-24DEDD437EA5",62,"TCGA-BS-A0UT-01A-01D-YYYY-23.txt","Alive",NA,"TCGA-BS-A0UT","NOT HISPANIC OR LATINO","43A0ABD8-2249-4DCC-B08B-9FF8A64B9657",NA,595,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"ASIAN",NA,11,20,"127548AC-FAD7-4F4B-A142-9E3A7558159D","F1E37C6E-1D50-407D-A171-185A5CDE86B7","TCGA-BS-A0UT-01A-11R-A103-13_mirna.bam","TCGA-BS-A0UT-01A-11",70,0,0,80,25,"BOTTOM",5,20,"TCGA-BS-A0UT-01A-01-BS1",70,NA,NA,NA,NA,NA,NA,NA,"NO",2212,"TUMOR FREE","Alive",NA,"TCGA-BS-A0UT-F16711","TCGA-BS-A0UT",1,"BS","A0UT","YES","C54.1","8380/3","C54.1","NO","YES",-22775,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",595,NA,NA,NA,"TUMOR FREE","NO",25,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2005,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
134405056,131336818,6261870318,"CDAE5912-5C56-47B3-A0E6-E61B1E880BFD.bw","e2b48d0d-57ca-400b-8598-55ef132e350e","cdae5912-5c56-47b3-a0e6-e61b1e880bfd","2016-09-29T23:02:20.178879-05:00","UNCID_2357573.7ad9720d-18e2-472f-a267-525f191a23ca.131118_UNC15-SN850_0339_AC347DACXX_4_CGATGT.tar.gz","35bc3a8a-9a27-4dc5-abe1-aeb9ccfbb195",6382022775,"Illumina HiSeq","0357bb6134a357f00d4f432fef2d3b1e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:28:57.619753-05:00","2016-05-03T11:37:12.430798-05:00","35bc3a8a-9a27-4dc5-abe1-aeb9ccfbb195_analysis.xml","b00a769f11643a188ba2eee8c22975f7","6ec68066-d39b-4687-8cf2-cf0c8bf58d1f",2124,"2016-08-13T02:03:15.953421-05:00","35bc3a8a-9a27-4dc5-abe1-aeb9ccfbb195_experiment.xml","da92d6cb59fe282412bbc0f9ac95740d","9fc5129c-b5dd-48bb-9cac-9eb5862e7406",2628,"2016-09-29T21:40:42.426927-05:00","35bc3a8a-9a27-4dc5-abe1-aeb9ccfbb195_run.xml","5126ba1d3c320cae983efb9eba1e4490","9b3d5e54-d7d9-4de4-823e-55930eb7efe0",354,"2016-09-08T11:08:12.154566-05:00","TCGA-B5-A1MW","2016-09-02T18:52:31.438464-05:00","female","TCGA-B5-A1MW_demographic",1955,"white","cb02881c-ab1f-5acf-ac66-56e28fae03c7","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A1MW_diagnosis","not reported",20183,"alive","8380/3",NA,447,"ccc0b1d6-bd6c-541a-bdd1-8c304132dc99","c54.1",-20183,"TCGA-B5-A1MW_treatment","4a1f4fbb-1ca4-50f7-84ec-4ef35f6c15ea","01","true","TCGA-B5-A1MW-01A",NA,"f886aacc-64f9-4f9e-8123-8ad25ce54d0c",FALSE,"870882D8-D89A-4A89-B516-DADAB95BE285","Primary Tumor",NA,148,340,NA,1308528000,"11",30,"TCGA-B5-A1MW-01A-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T11:08:12.154566-05:00",NA,10,NA,5,NA,"TOP",NA,3,NA,"92feb8bd-20cc-427d-a955-9fec7b1b6757",NA,"TCGA-B5-A1MW-01A-01-TSA",NA,87,NA,"5878de67-8c83-4d7c-92b6-cd6af3dfdd1e","RNA","TCGA-B5-A1MW-01A-11R","9b2d9af5-e2c7-4e64-903c-586ee32bacf6",1.7,0.15,"UV Spec","R","23","TCGA-B5-A1MW-01A-11R-A32Y-07","7ad9720d-18e2-472f-a267-525f191a23ca",0.15,NA,62,23.3354661447552,163,"7f8e7cc8-58ed-5ab8-b3b6-2192fe2bde93","TCGA-B5-A1MW_exposure","UNCID_2357573.7ad9720d-18e2-472f-a267-525f191a23ca.131118_UNC15-SN850_0339_AC347DACXX_4_CGATGT.tar.gz","2014-02-25T01:03:05.000Z","2014-02-25T01:38:02.000Z","35BC3A8A-9A27-4DC5-ABE1-AEB9CCFBB195","F886AACC-64F9-4F9E-8123-8AD25CE54D0C","Unaligned reads",6382022775,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","7AD9720D-18E2-472F-A267-525F191A23CA","University of North Carolina","56607df0e4b0ca3191650688","E2B48D0D-57CA-400B-8598-55EF132E350E","Uterine Corpus Endometrial Carcinoma","TARGZ","5878DE67-8C83-4D7C-92B6-CD6AF3DFDD1E","2014-02-25T01:38:02.000Z","9B2D9AF5-E2C7-4E64-903C-586EE32BACF6","United States","NO",1,NA,"Primary Tumor","Duke",148,"5878DE67-8C83-4D7C-92B6-CD6AF3DFDD1E",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.ED0D19FF-3919-4938-943F-EF1CDB803193.txt",340,"TCGA-B5-A1MW-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","FB8A0D68-AAE0-4C2B-AA39-EDEAA4C71EFC",55,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.ED0D19FF-3919-4938-943F-EF1CDB803193.txt","Alive",NA,"TCGA-B5-A1MW",NA,"03789953-AA4B-4472-BA02-D71B0608D64E",NA,220,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,"98991E1F-2158-47F6-8E11-50896BF4B014","WHITE",NA,11,30,"92FEB8BD-20CC-427D-A955-9FEC7B1B6757","9B2D9AF5-E2C7-4E64-903C-586EE32BACF6","UNCID_2357573.7ad9720d-18e2-472f-a267-525f191a23ca.131118_UNC15-SN850_0339_AC347DACXX_4_CGATGT.tar.gz","TCGA-B5-A1MW-01A-11",90,0,0,10,10,"TOP",3,5,"TCGA-B5-A1MW-01A-01-TSA",87,NA,NA,NA,"TCGA-B5-A1MW-R21613","RADIOISOTOPES","Local Recurrence",NA,"YES",447,"TUMOR FREE","Alive",NA,"TCGA-B5-A1MW-F21619","TCGA-B5-A1MW",1,"B5","A1MW","YES","C54.1","8380/3","C54.1","NO","YES",-20183,"FEMALE","WHITE",NA,"No","No","Alive",220,NA,NA,NA,"TUMOR FREE","NO",16,2,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
106643532,105440262,5034311837,"662222AA-D8B8-404C-B0BD-8BA166C15894.bw","e31db89c-15ac-45a4-9788-afb339b0f3bc","662222aa-d8b8-404c-b0bd-8ba166c15894","2016-08-09T13:15:41.321254-05:00","UNCID_2178336.99e76a2e-9162-4345-9155-cc7267c0325b.130328_UNC10-SN254_0443_AD238RACXX_8_GATCAG.tar.gz","b2a673ac-c425-4d5b-b97c-076b7f2a597c",4410224035,"Illumina HiSeq","b4231849d300af1e12fd44cd8a1c8128","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:53:01.178308-05:00","2016-05-03T10:56:47.878169-05:00","b2a673ac-c425-4d5b-b97c-076b7f2a597c_analysis.xml","1b6fe568381cef68439e254f71da97e5","0d975799-08c3-4851-a50b-dfed59f94a78",2123,"2016-09-29T21:14:14.852055-05:00","b2a673ac-c425-4d5b-b97c-076b7f2a597c_experiment.xml","2879e6343c8aaa459f9b37021992e3df","8afa240e-b334-4eec-99ea-66c505bf6a2c",2431,"2016-09-29T17:51:57.827937-05:00","b2a673ac-c425-4d5b-b97c-076b7f2a597c_run.xml","cb109b09cacfa5c6963de658cb6fd9e9","0ce92c07-cfcf-488f-8373-7a96ea9f5293",354,"2016-09-08T10:41:15.333655-05:00","TCGA-AX-A3G6","2016-09-02T18:48:39.948145-05:00","female","TCGA-AX-A3G6_demographic",1943,"white","4cf21d71-f8d6-515e-ab34-b6ce4a4126db","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3G6_diagnosis","not reported",24681,"alive","8441/3",NA,8,"c9b92d64-fe19-550b-b12a-17efa6df460c","c54.1",-24681,"TCGA-AX-A3G6_treatment","91ddc979-9d46-5c1d-b995-49b4de1fbb37","01","false","TCGA-AX-A3G6-01A",NA,"576ab148-2110-4f35-948a-4a0d00b4f48e",FALSE,"53586ED5-5C68-4517-8543-7508AF37F68C","Primary Tumor",NA,456,50,NA,1322784000,"11",30,"TCGA-AX-A3G6-01A-11",94,NA,0,NA,0,NA,2,NA,"2016-09-08T10:41:15.333655-05:00",NA,1,NA,1,NA,"TOP",NA,8,NA,"ee2cd7d4-0275-40b5-a6cd-d103bfcd811c",NA,"TCGA-AX-A3G6-01A-01-TS1",NA,90,NA,"cdc0f4f0-e01a-48f4-8455-2f9a1c7d3ffa","RNA","TCGA-AX-A3G6-01A-11R","4a8006f7-7f80-4f15-b403-63351d0e5d0d",1.86,0.16,"UV Spec","R","23","TCGA-AX-A3G6-01A-11R-A213-07","99e76a2e-9162-4345-9155-cc7267c0325b",0.16,NA,60,21.5138585105239,167,"ed4ba322-0100-5cd0-ae16-b1c1dda68814","TCGA-AX-A3G6_exposure","UNCID_2178336.99e76a2e-9162-4345-9155-cc7267c0325b.130328_UNC10-SN254_0443_AD238RACXX_8_GATCAG.tar.gz","2013-09-12T00:51:05.000Z","2013-09-12T01:05:01.000Z","B2A673AC-C425-4D5B-B97C-076B7F2A597C","576AB148-2110-4F35-948A-4A0D00B4F48E","Unaligned reads",4410224035,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","99E76A2E-9162-4345-9155-CC7267C0325B","University of North Carolina","56607d6be4b016715ab6b672","E31DB89C-15AC-45A4-9788-AFB339B0F3BC","Uterine Corpus Endometrial Carcinoma","TARGZ","CDC0F4F0-E01A-48F4-8455-2F9A1C7D3FFA","2013-09-12T01:05:01.000Z","4A8006F7-7F80-4F15-B403-63351D0E5D0D","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",456,"CDC0F4F0-E01A-48F4-8455-2F9A1C7D3FFA",NA,"AX","UNCID_2178336.99e76a2e-9162-4345-9155-cc7267c0325b.130328_UNC10-SN254_0443_AD238RACXX_8_GATCAG.tar.gz",50,"TCGA-AX-A3G6-01A",NA,NA,"TCGA",2010,NA,NA,NA,"DC2068A2-C9DA-4BD6-B4AA-FA3311B84EC0",67,"nationwidechildrens.org_clinical.TCGA-AX-A3G6.xml","Alive",NA,"TCGA-AX-A3G6","NOT HISPANIC OR LATINO","3B7BE568-9B2F-4AFB-8D74-55CDE24A3F62",NA,0,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",201,NA,NA,"WHITE",NA,11,30,"EE2CD7D4-0275-40B5-A6CD-D103BFCD811C","4A8006F7-7F80-4F15-B403-63351D0E5D0D","UNCID_2178336.99e76a2e-9162-4345-9155-cc7267c0325b.130328_UNC10-SN254_0443_AD238RACXX_8_GATCAG.tar.gz","TCGA-AX-A3G6-01A-11",94,0,0,1,2,"TOP",8,1,"TCGA-AX-A3G6-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3G6-F58289_NTE-1",NA,8,NA,"Alive",NA,"TCGA-AX-A3G6-F58289","TCGA-AX-A3G6",1,"AX","A3G6","YES","C54.1","8441/3","C54.1","NO","YES",-24681,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,NA,"NO",6,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,2010,"Other method, specify:",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37843631,37633552,2830733120,"B9A9F39C-35B3-4B43-B625-1A83850B12F6.bw","e3dcde4e-5def-4b89-97b4-047b8288919b","b9a9f39c-35b3-4b43-b625-1a83850b12f6","2016-08-09T14:02:47.880401-05:00","UNCID_2194808.e527020e-6b3f-4837-87d1-8f7ba68c19d6.120307_UNC2-RDR300275_00118_FC_650V8AAXX_8.tar.gz","c9290e99-4360-4e9e-bd0e-71c6f0277d60",2461347109,"Illumina GA","126ff9d59696603d2ca9e1ffe04ed83c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:34:47.583943-05:00","2016-05-03T11:07:49.533775-05:00","c9290e99-4360-4e9e-bd0e-71c6f0277d60_analysis.xml","8b15b2092e4a5343b12cf0146973b729","01ed85ec-e42e-493e-aab6-698599b1f222",2121,"2016-08-27T04:09:57.527566-05:00","c9290e99-4360-4e9e-bd0e-71c6f0277d60_experiment.xml","dcb13f794186d73f1279c14d696e950b","23b2bc76-528d-450b-8297-8bbca597da73",2257,"2016-09-29T20:57:51.959674-05:00","c9290e99-4360-4e9e-bd0e-71c6f0277d60_run.xml","b27fc025789787d8b64d1e38bc9862c5","80a56a2c-7754-4bb8-989b-1bc33cc3ba89",347,"2016-09-08T11:05:22.964737-05:00","TCGA-E6-A1M0","2016-09-02T18:52:07.112455-05:00","female","TCGA-E6-A1M0_demographic",1954,"white","11bbbb3d-ec5c-5cb7-885c-50576834f378","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","E6","39aa3c67-c7d9-5001-8ed1-3bf83eac7872","Roswell Park","not reported","c54.1","TCGA-E6-A1M0_diagnosis","not reported",20629,"alive","8380/3",NA,1793,"2613f1af-c343-5333-bf51-3cc30b0e4996","c54.1",-20629,"TCGA-E6-A1M0_treatment","1669c85b-f008-5ec1-aa37-a5811767f345","01","false","TCGA-E6-A1M0-01A",NA,"7e75ca29-183d-4bad-9ddc-527871bd7554",FALSE,"F1AF61FE-BF05-49E2-85DA-F4CE37596DEA","Primary Tumor",NA,360,160,NA,1300233600,"11",30,"TCGA-E6-A1M0-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T11:05:22.964737-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"3549fa06-5d52-4e9c-81af-0b06cc201327",NA,"TCGA-E6-A1M0-01A-01-TSA",NA,95,NA,"efa75421-2dad-4ce4-889a-b7914216a429","RNA","TCGA-E6-A1M0-01A-11R","7a5ccb7c-31b4-45a4-974d-193073d801cc",1.83,0.17,"UV Spec","R","23","TCGA-E6-A1M0-01A-11R-A144-07","e527020e-6b3f-4837-87d1-8f7ba68c19d6",0.17,NA,114,37.6535869996036,174,"9627ae8c-07b0-5e1a-bd74-10bd95ef3272","TCGA-E6-A1M0_exposure","UNCID_2194808.e527020e-6b3f-4837-87d1-8f7ba68c19d6.120307_UNC2-RDR300275_00118_FC_650V8AAXX_8.tar.gz","2013-09-23T03:36:04.000Z","2013-09-23T03:49:01.000Z","C9290E99-4360-4E9E-BD0E-71C6F0277D60","7E75CA29-183D-4BAD-9DDC-527871BD7554","Unaligned reads",2461347109,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E527020E-6B3F-4837-87D1-8F7BA68C19D6","University of North Carolina","564a3db9e4b0298dd2c92704","E3DCDE4E-5DEF-4B89-97B4-047B8288919B","Uterine Corpus Endometrial Carcinoma","TARGZ","EFA75421-2DAD-4CE4-889A-B7914216A429","2013-09-23T03:49:01.000Z","7A5CCB7C-31B4-45A4-974D-193073D801CC","United States","NO",1,NA,"Primary Tumor","Roswell Park",360,"EFA75421-2DAD-4CE4-889A-B7914216A429",NA,"E6","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.95236C17-EA65-447B-A665-5EA84796E305.txt",160,"TCGA-E6-A1M0-01A",NA,"704FF6AB-F05F-4CE7-AFB0-4E73824761C3","TCGA",2010,NA,NA,"TUMOR FREE","ABCD9BFE-3511-46E3-97FE-CB0C068FB491",56,"nationwidechildrens.org_clinical.TCGA-E6-A1M0.xml","Alive",NA,"TCGA-E6-A1M0","NOT HISPANIC OR LATINO","E7860C6C-BE99-4FEF-A3AD-CA0AD99CBB5D",NA,428,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",118,NA,NA,"WHITE",NA,11,30,"3549FA06-5D52-4E9C-81AF-0B06CC201327","99B46DF5-C200-418B-9E2C-1A23FE502D87","TCGA-E6-A1M0-01A-11R-A143-13_mirna.bam","TCGA-E6-A1M0-01A-11",85,0,0,0,0,"TOP",5,0,"TCGA-E6-A1M0-01A-01-TSA",95,"carboplatin","Chemotherapy","TCGA-E6-A1M0-D19867",NA,NA,NA,NA,"NO",519,"TUMOR FREE","Alive",NA,"TCGA-E6-A1M0-F19865","TCGA-E6-A1M0",1,"E6","A1M0","YES","C54.1","8380/3","C54.1","NO","YES",-20629,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",428,NA,NA,NA,"TUMOR FREE","NO",7,6,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2010,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31471210,30944058,2289377264,"F4F8D7E7-98B9-4145-9F69-5A1684997C87.bw","e3dcde4e-5def-4b89-97b4-047b8288919b","f4f8d7e7-98b9-4145-9f69-5a1684997c87","2016-08-06T23:19:07.486977-05:00","UNCID_2188982.a0c84298-852b-454f-aab8-fb64656834dc.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_5.tar.gz","dab2f31d-068a-4279-8e95-9ffcb82e5e05",1993035602,"Illumina GA","663029b5f9ca997b61a24f93013bc88f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:51:26.238105-05:00","2016-05-03T11:05:01.518052-05:00","dab2f31d-068a-4279-8e95-9ffcb82e5e05_analysis.xml","7ac96e254308ec6ea3740b9262b5893f","57e0ff76-6cfd-4b96-aa9b-b58b2623f8d2",2122,"2016-09-29T20:24:58.086249-05:00","dab2f31d-068a-4279-8e95-9ffcb82e5e05_experiment.xml","cf9854fbcf1ca9d7d931f2c5e05522ad","6c5ad932-dfd5-438b-a6bf-cb94eaded7f7",2258,"2016-09-29T19:32:44.798566-05:00","dab2f31d-068a-4279-8e95-9ffcb82e5e05_run.xml","504ca68480bf8d84b85b6eeb2bebeff4","4c47705b-b48d-4e80-b4d6-c307facde4a2",349,"2016-09-08T11:05:22.964737-05:00","TCGA-E6-A1M0","2016-09-02T18:52:07.112455-05:00","female","TCGA-E6-A1M0_demographic",1954,"white","11bbbb3d-ec5c-5cb7-885c-50576834f378","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","E6","39aa3c67-c7d9-5001-8ed1-3bf83eac7872","Roswell Park","not reported","c54.1","TCGA-E6-A1M0_diagnosis","not reported",20629,"alive","8380/3",NA,1793,"2613f1af-c343-5333-bf51-3cc30b0e4996","c54.1",-20629,"TCGA-E6-A1M0_treatment","1669c85b-f008-5ec1-aa37-a5811767f345","11","false","TCGA-E6-A1M0-11A",NA,"abcd9bfe-3511-46e3-97fe-cb0c068fb491",FALSE,NA,"Solid Tissue Normal",NA,360,130,NA,1300233600,"11",30,"TCGA-E6-A1M0-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T11:05:22.964737-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"6e6920df-cb08-474a-a1d4-cceeb22352e4",NA,"TCGA-E6-A1M0-11A-01-TSA",NA,0,NA,"c6832cfa-f38b-4688-9136-6b7325ad8302","RNA","TCGA-E6-A1M0-11A-11R","de046d5a-3fa2-4ae8-821d-f61b0d0f5858",1.74,0.16,"UV Spec","R","23","TCGA-E6-A1M0-11A-11R-A144-07","a0c84298-852b-454f-aab8-fb64656834dc",0.16,NA,114,37.6535869996036,174,"9627ae8c-07b0-5e1a-bd74-10bd95ef3272","TCGA-E6-A1M0_exposure","UNCID_2188982.a0c84298-852b-454f-aab8-fb64656834dc.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_5.tar.gz","2013-09-18T13:36:06.000Z","2013-09-18T13:48:01.000Z","DAB2F31D-068A-4279-8E95-9FFCB82E5E05","ABCD9BFE-3511-46E3-97FE-CB0C068FB491","Unaligned reads",1993035602,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","A0C84298-852B-454F-AAB8-FB64656834DC","University of North Carolina","566076b4e4b0ec1099f8c816","E3DCDE4E-5DEF-4B89-97B4-047B8288919B","Uterine Corpus Endometrial Carcinoma","TARGZ","C6832CFA-F38B-4688-9136-6B7325AD8302","2013-09-18T13:48:01.000Z","DE046D5A-3FA2-4AE8-821D-F61B0D0F5858","United States","NO",11,NA,"Solid Tissue Normal","Roswell Park",360,"C6832CFA-F38B-4688-9136-6B7325AD8302",NA,"E6","TCGA-E6-A1M0-11A-11R-A143-13_mirna.bam",130,"TCGA-E6-A1M0-11A",NA,"704FF6AB-F05F-4CE7-AFB0-4E73824761C3","TCGA",2010,NA,NA,"TUMOR FREE","ABCD9BFE-3511-46E3-97FE-CB0C068FB491",56,"nationwidechildrens.org_clinical.TCGA-E6-A1M0.xml","Alive",NA,"TCGA-E6-A1M0","NOT HISPANIC OR LATINO","E7860C6C-BE99-4FEF-A3AD-CA0AD99CBB5D",NA,428,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",118,NA,NA,"WHITE",NA,11,30,"6E6920DF-CB08-474A-A1D4-CCEEB22352E4","DE046D5A-3FA2-4AE8-821D-F61B0D0F5858","TCGA-E6-A1M0-11A-11R-A143-13_mirna.bam","TCGA-E6-A1M0-11A-11",0,100,0,0,0,"TOP",0,0,"TCGA-E6-A1M0-11A-01-TSA",0,"carboplatin","Chemotherapy","TCGA-E6-A1M0-D19867",NA,NA,NA,NA,"NO",519,"TUMOR FREE","Alive",NA,"TCGA-E6-A1M0-F19865","TCGA-E6-A1M0",1,"E6","A1M0","YES","C54.1","8380/3","C54.1","NO","YES",-20629,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",428,NA,NA,NA,"TUMOR FREE","NO",7,6,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2010,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31992359,30978229,2320025600,"4B18B059-0D01-422E-9BE2-27DEA86994BC.bw","e3e39474-c2b0-45af-bbe1-4c24f17cc284","4b18b059-0d01-422e-9be2-27dea86994bc","2016-08-04T23:39:35.401673-05:00","UNCID_2206506.2b56219d-b0d0-4107-acdf-b2ad9c18f090.110921_UNC6-RDR300211_00125_FC_634F4AAXX_7.tar.gz","19ba5889-83b0-4833-abc9-b419a4cbfa9a",2034278360,"Illumina GA","bcc32b1d9ff13c3fb95b5267b9543201","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:32:55.445759-05:00","2016-05-03T11:11:34.765256-05:00","19ba5889-83b0-4833-abc9-b419a4cbfa9a_analysis.xml","ad5b031b16384b21d1cbe7c9540fa49e","00c535c6-6b82-4e65-b4fb-0f9e416c90a2",2121,"2016-08-29T01:55:23.683122-05:00","19ba5889-83b0-4833-abc9-b419a4cbfa9a_experiment.xml","402b1c25aabdeb4a01b34005b4b0d240","39693c43-f853-4a2f-b5cc-350fb0e1a135",2257,"2016-09-29T18:33:32.189277-05:00","19ba5889-83b0-4833-abc9-b419a4cbfa9a_run.xml","e995da314e04c507a359b48acea122ec","26c0780b-f121-4216-9e49-af0b59bef264",347,"2016-09-08T11:10:34.022988-05:00","TCGA-EY-A1GV","2016-09-02T18:52:01.500806-05:00","female","TCGA-EY-A1GV_demographic",1935,"white","f7a149e5-b25a-58e3-8ad4-4457ffb83a89","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GV_diagnosis","not reported",27581,"alive","8441/3",NA,481,"0e70f82d-667f-5df8-a3d6-5dbbd3ab01e2","c54.1",-27581,"TCGA-EY-A1GV_treatment","b46d9d81-0276-5a48-8320-45c712937ffd","01","false","TCGA-EY-A1GV-01A",NA,"8e9dd4fb-3de9-4bce-bf90-1692904088ca",FALSE,"87A6A698-71B7-41D8-AE28-C2FCC92F9A94","Primary Tumor",NA,156,300,NA,1297728000,"11",30,"TCGA-EY-A1GV-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:10:34.022988-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"97922e37-799e-4339-a49b-82fa59c0877b",NA,"TCGA-EY-A1GV-01A-01-TSA",NA,80,NA,"ebd800fa-627c-4a95-a960-60fa807d5d91","RNA","TCGA-EY-A1GV-01A-11R","13b0027f-75d8-475c-b5e7-b22793e64f58",1.62,0.15,"UV Spec","R","23","TCGA-EY-A1GV-01A-11R-A13S-07","2b56219d-b0d0-4107-acdf-b2ad9c18f090",0.15,NA,79,29.0174471992654,165,"606cc6f6-7ef5-583f-b4ad-0698f592dd30","TCGA-EY-A1GV_exposure","UNCID_2206506.2b56219d-b0d0-4107-acdf-b2ad9c18f090.110921_UNC6-RDR300211_00125_FC_634F4AAXX_7.tar.gz","2013-09-27T05:46:03.000Z","2013-09-27T05:57:01.000Z","19BA5889-83B0-4833-ABC9-B419A4CBFA9A","8E9DD4FB-3DE9-4BCE-BF90-1692904088CA","Unaligned reads",2034278360,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2B56219D-B0D0-4107-ACDF-B2AD9C18F090","University of North Carolina","564a351ce4b0ef1218186c30","E3E39474-C2B0-45AF-BBE1-4C24F17CC284","Uterine Corpus Endometrial Carcinoma","TARGZ","EBD800FA-627C-4A95-A960-60FA807D5D91","2013-09-27T05:57:01.000Z","13B0027F-75D8-475C-B5E7-B22793E64F58","United States","NO",1,NA,"Primary Tumor","University of North Carolina",156,"EBD800FA-627C-4A95-A960-60FA807D5D91",NA,"EY","UNCID_1619659.2b56219d-b0d0-4107-acdf-b2ad9c18f090.sorted_genome_alignments.bam",300,"TCGA-EY-A1GV-01A",NA,"68408952-E0EE-4A9A-943E-4FD66C106A1E","TCGA",2010,NA,NA,"TUMOR FREE","8E9DD4FB-3DE9-4BCE-BF90-1692904088CA",75,"HORNS_p_TCGA_b110_113_SNP_N_GenomeWideSNP_6_C11_772284.ismpolish.data.txt","Alive",NA,"TCGA-EY-A1GV","NOT HISPANIC OR LATINO","F9841EE7-5BFA-4A5D-A9B6-4B1B9A27FC88",NA,257,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIIC1",NA,NA,NA,"8441/3","FEMALE","C54.1",110,NA,"82B78292-6DC4-4499-860C-4317EDFA507D","WHITE",NA,11,30,"97922E37-799E-4339-A49B-82FA59C0877B","124A047C-26CB-44E2-8E10-87F94BA5B034","TCGA-EY-A1GV-01A-11R-A13R-13_mirna.bam","TCGA-EY-A1GV-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-EY-A1GV-01A-01-TSA",80,"Carboplatin","Chemotherapy","TCGA-EY-A1GV-D12142","TCGA-EY-A1GV-R12192","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",481,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GV-F19882","TCGA-EY-A1GV",1,"EY","A1GV","YES","C54.1","8441/3","C54.1","YES","NO",-27581,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",257,NA,NA,NA,"TUMOR FREE","NO",24,5,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,75,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",12,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
102965036,78325126,3703814489,"870B6991-949A-4749-AB66-E8F27A115695.bw","e3f515f8-a940-40d1-86b0-baed0f410f2c","870b6991-949a-4749-ab66-e8f27a115695","2016-09-29T21:07:58.327350-05:00","UNCID_2316533.5deaf911-f777-4c38-95bf-19af647e7806.130924_UNC9-SN296_0403_AC2BR8ACXX_5_CTTGTA.tar.gz","c1089e67-a078-4b07-a378-35543dc4eb25",4746203392,"Illumina HiSeq","7863987b7fb83b390567d2b98643f591","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:03:13.002128-05:00","2016-05-03T11:28:50.231867-05:00","c1089e67-a078-4b07-a378-35543dc4eb25_analysis.xml","80105d5a6f498166ae8b89f6c8ccc112","5f105771-0544-4fda-bb9b-951255e15813",2122,"2016-09-30T00:20:23.530211-05:00","c1089e67-a078-4b07-a378-35543dc4eb25_experiment.xml","4d240c88720b4044a564f3cbf644c92e","fe363354-f8f1-42e1-9348-5aefb987921f",2628,"2016-09-29T19:59:17.906962-05:00","c1089e67-a078-4b07-a378-35543dc4eb25_run.xml","fa595c35632a30417819c29ffdcc451e","5cb1d866-82a9-4b80-9a06-b2979416af65",354,"2016-09-08T11:04:01.399415-05:00","TCGA-BS-A0V4","2016-09-02T18:52:16.355494-05:00","female","TCGA-BS-A0V4_demographic",1950,"white","72351cbb-af0d-50ae-b476-edbb6706eadc","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0V4_diagnosis","not reported",20777,"alive","8380/3",NA,1810,"a1b6fdf1-0714-573e-9903-953ce31f660f","c54.1",-20777,"TCGA-BS-A0V4_treatment","a6b6e318-d64f-5f22-bf53-bdb8033d0902","01","false","TCGA-BS-A0V4-01A",NA,"dd12111e-9001-4d8d-b8f3-5801b4ab529b",FALSE,"AA0FFBF8-693C-484E-A29D-02F859E1E4C5","Primary Tumor",NA,1576,310,NA,1301356800,"11",30,"TCGA-BS-A0V4-01A-11",70,80,20,20,0,0,25,20,"2016-09-08T11:04:01.399415-05:00","2016-09-08T11:04:01.399415-05:00",40,50,20,20,"TOP","BOTTOM",5,0,"2d36e6bf-3582-4d6b-b9c2-4b3547ea7732","2d72a7ff-7a6b-49b7-8e94-c424bd4a7235","TCGA-BS-A0V4-01A-01-TS1","TCGA-BS-A0V4-01A-01-BS1",70,80,"c22bf5a9-445a-4bb9-a095-459593365556","RNA","TCGA-BS-A0V4-01A-11R","5709564c-ba3e-4e54-8721-4b503964af64",1.83,0.18,"UV Spec","R","23","TCGA-BS-A0V4-01A-11R-A14D-07","5deaf911-f777-4c38-95bf-19af647e7806",0.18,NA,96,35.2617079889807,165,"936faab9-610e-5a94-83d3-b0621dcf6861","TCGA-BS-A0V4_exposure","UNCID_2316533.5deaf911-f777-4c38-95bf-19af647e7806.130924_UNC9-SN296_0403_AC2BR8ACXX_5_CTTGTA.tar.gz","2014-01-07T02:16:29.000Z","2014-01-07T04:07:02.000Z","C1089E67-A078-4B07-A378-35543DC4EB25","DD12111E-9001-4D8D-B8F3-5801B4AB529B","Unaligned reads",4746203392,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","5DEAF911-F777-4C38-95BF-19AF647E7806","University of North Carolina","564a3c47e4b09c884b24a06c","E3F515F8-A940-40D1-86B0-BAED0F410F2C","Uterine Corpus Endometrial Carcinoma","TARGZ","C22BF5A9-445A-4BB9-A095-459593365556","2014-01-07T04:07:02.000Z","5709564C-BA3E-4E54-8721-4B503964AF64","None","NO",1,NA,"Primary Tumor","University of Hawaii",1576,"C22BF5A9-445A-4BB9-A095-459593365556",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.3B2AACBD-F667-4B5E-A678-B3E0A5542839.txt",310,"TCGA-BS-A0V4-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","DD12111E-9001-4D8D-B8F3-5801B4AB529B",56,"nationwidechildrens.org_clinical.TCGA-BS-A0V4.xml","Alive",NA,"TCGA-BS-A0V4","NOT HISPANIC OR LATINO","1A536E8E-1E46-4863-B157-467F28A2B156",NA,31,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,11,30,"2D72A7FF-7A6B-49B7-8E94-C424BD4A7235","D34ABBAD-7C93-4E3D-B2AF-25F5925472CC","TCGA-BS-A0V4-01A-11R-A14C-13_mirna.bam.bai","TCGA-BS-A0V4-01A-11",80,0,20,50,20,"BOTTOM",0,20,"TCGA-BS-A0V4-01A-01-BS1",80,NA,NA,NA,NA,NA,NA,NA,"NO",1810,"TUMOR FREE","Alive",NA,"TCGA-BS-A0V4-F16710","TCGA-BS-A0V4",1,"BS","A0V4","YES","C54.1","8380/3","C54.1","NO","YES",-20777,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",31,NA,NA,NA,"TUMOR FREE","NO",25,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2006,"Dilation and curettage procedure",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34979282,34687296,2556516531,"89E4B2B8-FAEF-49F7-98AD-7D8D3DD845BE.bw","e4510c66-a60b-4b09-a4e8-74ec5b26a3a5","89e4b2b8-faef-49f7-98ad-7d8d3dd845be","2016-08-09T14:09:37.371480-05:00","UNCID_2206680.245e65eb-ec7a-4a85-a524-194afbdf67ef.111006_UNC2-RDR300275_00089_FC_634EEAAXX_2.tar.gz","ce20b412-a4b2-4b6e-8361-2c23657a65cd",2316709852,"Illumina GA","a90a703852419d1e63e615afaf9e46ed","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:04:51.944801-05:00","2016-05-03T11:11:34.764500-05:00","ce20b412-a4b2-4b6e-8361-2c23657a65cd_analysis.xml","d3d378aa013c39769d70cf24ac4a1bcf","3abff275-87b5-4ee2-b8f9-07eccee027aa",2121,"2016-09-29T19:24:11.005212-05:00","ce20b412-a4b2-4b6e-8361-2c23657a65cd_experiment.xml","04681768789da79793cc4298b05d0e92","46e6f031-6c73-43d3-b089-8672f696daa8",2257,"2016-09-29T19:59:35.420573-05:00","ce20b412-a4b2-4b6e-8361-2c23657a65cd_run.xml","e03500d379766e71ceec465742acd064","5ce0272f-15f9-45e3-8c46-c74ffb8d0ce5",347,"2016-09-08T11:04:20.167610-05:00","TCGA-AX-A2H2","2016-09-02T18:53:13.281019-05:00","female","TCGA-AX-A2H2_demographic",1922,"black or african american","f245ea87-05fb-51a2-b9fd-288a61e2424c","not hispanic or latino",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2H2_diagnosis","not reported",31524,"dead","8441/3",145,NA,"9c2e8300-e809-535d-a98f-3380cc8b409a","c54.1",-31524,"TCGA-AX-A2H2_treatment","1aa150f8-865a-5e73-a0cb-61fd3cafaeec","01","false","TCGA-AX-A2H2-01A",NA,"6d3fb251-74e8-40d5-8262-f265a5a3395a",FALSE,"1BDF6880-A5E1-4DD8-A7E5-1E91BBCF8F60","Primary Tumor",NA,1079,160,NA,1308182400,"11",30,"TCGA-AX-A2H2-01A-11",96,NA,0,NA,0,NA,1,NA,"2016-09-08T11:04:20.167610-05:00",NA,1,NA,0,NA,"TOP",NA,2,NA,"9ba08d6f-56b8-4a64-8f77-9aa202165679",NA,"TCGA-AX-A2H2-01A-01-TSA",NA,97,NA,"c3c2036b-9921-420b-a04c-84850761fb86","RNA","TCGA-AX-A2H2-01A-11R","793f4ac9-457e-40fe-91ca-9ae2e29896dd",2.36,0.17,"UV Spec","R","23","TCGA-AX-A2H2-01A-11R-A180-07","245e65eb-ec7a-4a85-a524-194afbdf67ef",0.17,NA,65,24.7675659198293,162,"d3d44258-462f-5a62-86a4-c75987339852","TCGA-AX-A2H2_exposure","UNCID_2206680.245e65eb-ec7a-4a85-a524-194afbdf67ef.111006_UNC2-RDR300275_00089_FC_634EEAAXX_2.tar.gz","2013-09-27T07:01:04.000Z","2013-09-27T07:14:02.000Z","CE20B412-A4B2-4B6E-8361-2C23657A65CD","6D3FB251-74E8-40D5-8262-F265A5A3395A","Unaligned reads",2316709852,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","245E65EB-EC7A-4A85-A524-194AFBDF67EF","University of North Carolina","56607dc8e4b0b37b3d992d63","E4510C66-A60B-4B09-A4E8-74EC5B26A3A5","Uterine Corpus Endometrial Carcinoma","TARGZ","C3C2036B-9921-420B-A04C-84850761FB86","2013-09-27T07:14:02.000Z","793F4AC9-457E-40FE-91CA-9AE2E29896DD","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1079,"C3C2036B-9921-420B-A04C-84850761FB86",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.17E73B0A-942F-4EA2-95E5-F1A0618240B3.txt",160,"TCGA-AX-A2H2-01A",NA,NA,"TCGA",2008,NA,NA,NA,"70DE86AE-B85F-4ABF-8409-38939C2B852F",86,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.17E73B0A-942F-4EA2-95E5-F1A0618240B3.txt","Dead",145,"TCGA-AX-A2H2","NOT HISPANIC OR LATINO","15DC1A2D-B989-48BB-98BD-FA8F479B77EB",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIA",NA,NA,NA,"8441/3","FEMALE","C54.1",168,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"9BA08D6F-56B8-4A64-8F77-9AA202165679","2C3D65D5-83F9-45F6-95B8-BB4DFE2BEA0B","AX-A2H2-01A-11D_BCR3730_2011-10-25_006.fsa","TCGA-AX-A2H2-01A-11",96,0,0,1,1,"TOP",2,0,"TCGA-AX-A2H2-01A-01-TSA",97,NA,NA,NA,NA,NA,NA,NA,"NO",NA,"TUMOR FREE","Dead",145,"TCGA-AX-A2H2-F31588","TCGA-AX-A2H2",1,"AX","A2H2","YES","C54.1","8441/3","C54.1","NO","YES",-31524,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,145,NA,NA,NA,"NO",28,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,86,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",6,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
27629378,26760033,1996283546,"1B0FE71F-DD59-45F7-BA73-E8BEEB7349A8.bw","e46b6434-ee88-4630-9fc3-441afc431745","1b0fe71f-dd59-45f7-ba73-e8beeb7349a8","2016-08-05T11:52:00.255506-05:00","UNCID_2206899.4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e.110817_UNC6-RDR300211_00122_FC_6315AAXX_7.tar.gz","5b8c9150-12a4-46e3-b3b4-a85500a6b0f8",1751746588,"Illumina GA","94921d71c48f6ec9ac78bccd6082a03e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:56:05.747073-05:00","2016-05-03T11:13:02.652554-05:00","5b8c9150-12a4-46e3-b3b4-a85500a6b0f8_analysis.xml","e370244453a16b4a3235d509e2a68929","ef44b268-e4da-4912-9dee-081b1b92c091",2119,"2016-09-29T19:45:07.547306-05:00","5b8c9150-12a4-46e3-b3b4-a85500a6b0f8_experiment.xml","21ecda606d01d120cbc497f7878877b9","53e6178b-1305-4d0c-841e-b556c7a4db38",2257,"2016-09-29T20:22:21.892689-05:00","5b8c9150-12a4-46e3-b3b4-a85500a6b0f8_run.xml","579de0865ac07ebc3e994c74d0e1f9db","6ab4a111-b5de-4604-b9e5-5f85e2390f28",347,"2016-09-08T12:06:51.913354-05:00","TCGA-DI-A1BY","2016-09-02T18:51:46.179341-05:00","female","TCGA-DI-A1BY_demographic",1945,"white","73986089-8e5f-5a89-8e84-674c67d66ce7","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A1BY_diagnosis","not reported",23113,"alive","8380/3",NA,1114,"a439ad3c-44d7-5d10-ae48-718f94201a2b","c54.1",-23113,"TCGA-DI-A1BY_treatment","35ae15d7-a300-558e-b83b-8d9362dd3dce","01","false","TCGA-DI-A1BY-01A",NA,"7a5cf7c9-1b05-4de9-af5d-a859171049d6",FALSE,"8B96371D-5E42-461B-B7A2-AB9641D842CD","Primary Tumor",NA,989,140,NA,1297728000,"21",30,"TCGA-DI-A1BY-01A-21",60,NA,20,NA,0,NA,30,NA,"2016-09-08T12:06:51.913354-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"963f1f32-b356-474d-a59f-49fdf57aa502",NA,"TCGA-DI-A1BY-01A-02-TSB",NA,60,NA,"3d6bf099-fb3a-4bb1-bada-e09b6ca21e78","RNA","TCGA-DI-A1BY-01A-21R","79329cbf-f670-4cb2-bd9d-4849b1cd0539",1.84,0.16,"UV Spec","R","23","TCGA-DI-A1BY-01A-21R-A137-07","4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e",0.16,NA,125,52.0291363163371,155,"a5f3f76e-b161-50a9-a3a3-e99c63378b9e","TCGA-DI-A1BY_exposure","UNCID_2206899.4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e.110817_UNC6-RDR300211_00122_FC_6315AAXX_7.tar.gz","2013-09-28T16:06:06.000Z","2013-09-28T16:17:01.000Z","5B8C9150-12A4-46E3-B3B4-A85500A6B0F8","7A5CF7C9-1B05-4DE9-AF5D-A859171049D6","Unaligned reads",1751746588,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4D54CFBB-2BB7-4A45-B870-7AC7C87CAE5E","University of North Carolina","5660796ae4b0ec1099f8da90","E46B6434-EE88-4630-9FC3-441AFC431745","Uterine Corpus Endometrial Carcinoma","TARGZ","3D6BF099-FB3A-4BB1-BADA-E09B6CA21E78","2013-09-28T16:17:01.000Z","79329CBF-F670-4CB2-BD9D-4849B1CD0539","United States","NO",1,NA,"Primary Tumor","MD Anderson",989,"3D6BF099-FB3A-4BB1-BADA-E09B6CA21E78",NA,"DI","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F17216D8-4293-45BC-8FA3-73C8A69EA573.txt",140,"TCGA-DI-A1BY-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","F3DB5635-7268-451F-BE77-4A86F9CB8524",63,"UNCID_1622797.4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e.sorted_genome_alignments.bam","Alive",NA,"TCGA-DI-A1BY","NOT HISPANIC OR LATINO","AA7E0D1A-3391-412B-880B-72313040C465",NA,1114,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,"319A5C5E-D585-49EA-BB23-00BBF9B8E6C0","WHITE",NA,21,30,"963F1F32-B356-474D-A59F-49FDF57AA502","C2C6782A-3779-43BB-BBE4-6643D1F65394","UNCID_2206899.4d54cfbb-2bb7-4a45-b870-7ac7c87cae5e.110817_UNC6-RDR300211_00122_FC_6315AAXX_7.tar.gz","TCGA-DI-A1BY-01A-21",60,0,20,40,30,"TOP",10,20,"TCGA-DI-A1BY-01A-02-TSB",60,NA,NA,NA,"TCGA-DI-A1BY-R20964","OTHER: SPECIFY IN NOTES","Regional site",NA,"NO",1114,"TUMOR FREE","Alive",NA,"TCGA-DI-A1BY-F20963","TCGA-DI-A1BY",1,"DI","A1BY","YES","C54.1","8380/3","C54.1","NO","YES",-23113,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1114,NA,NA,NA,"TUMOR FREE","NO",13,5,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2008,"Other method, specify:",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
96016956,92835370,4407807017,"44E646EC-D3DC-400C-9155-27CC5300637E.bw","e4787c7b-40e7-483c-98c0-38da03e26b56","44e646ec-d3dc-400c-9155-27cc5300637e","2016-08-07T22:44:05.765869-05:00","UNCID_2177965.9d42a9c4-305b-4e25-a260-82805d6b059a.130402_UNC10-SN254_0447_BC22WAACXX_1_GTTTCG.tar.gz","5020f6b4-fa79-4660-8206-1af430de8073",4023427610,"Illumina HiSeq","065be2eb754da39603801836763622ae","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:19:41.525521-05:00","2016-05-03T10:56:47.877475-05:00","5020f6b4-fa79-4660-8206-1af430de8073_analysis.xml","4016b36951464e6587ad42220c7bc3e8","8e5cfdb9-ef4b-4efd-9645-fe1819a55a6b",2122,"2016-09-29T20:28:38.419730-05:00","5020f6b4-fa79-4660-8206-1af430de8073_experiment.xml","00698a0afe58ed0f4adde2e7d6eaf812","6e94d73a-ddd9-4702-8b4a-2cebafdee6e9",2431,"2016-09-29T20:00:02.419546-05:00","5020f6b4-fa79-4660-8206-1af430de8073_run.xml","db3c44013fefc6bc40d7022e2a8879b6","5d26f462-308e-4bcb-925b-231aabeacc82",354,"2016-09-08T10:38:39.701848-05:00","TCGA-AX-A3GI","2016-09-02T18:48:41.380411-05:00","female","TCGA-AX-A3GI_demographic",1945,"black or african american","2d2bd541-cbc4-5496-ae3e-ce02fb8ca17d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3GI_diagnosis","not reported",24388,"alive","8441/3",NA,12,"4a075418-2792-5db0-9e64-396cb2c93fd8","c54.1",-24388,"TCGA-AX-A3GI_treatment","d8556c08-7ea4-54c6-88c7-b65f9a87e923","01","false","TCGA-AX-A3GI-01A",NA,"c5cdb056-0de5-496f-a301-87f11ce50dde",FALSE,"A803E376-399C-4841-A6AE-E82B99CD57B7","Primary Tumor",NA,300,110,NA,1323043200,"11",30,"TCGA-AX-A3GI-01A-11",98,NA,0,NA,0,NA,2,NA,"2016-09-08T10:38:39.701848-05:00",NA,0,NA,0,NA,"TOP",NA,4,NA,"beb03e92-2a77-4b41-a987-7464894843f1",NA,"TCGA-AX-A3GI-01A-01-TSA",NA,94,NA,"ffe36ec9-c51e-45b3-a992-b06e344ac66a","RNA","TCGA-AX-A3GI-01A-11R","2e416718-3f6c-4c8a-b436-52520469f38b",1.86,0.18,"UV Spec","R","23","TCGA-AX-A3GI-01A-11R-A213-07","9d42a9c4-305b-4e25-a260-82805d6b059a",0.18,NA,87,31.1950948402596,167,"1dfaa55e-f989-56e3-90d1-00c6b23ef2a7","TCGA-AX-A3GI_exposure","UNCID_2177965.9d42a9c4-305b-4e25-a260-82805d6b059a.130402_UNC10-SN254_0447_BC22WAACXX_1_GTTTCG.tar.gz","2013-09-11T20:51:04.000Z","2013-09-11T21:04:01.000Z","5020F6B4-FA79-4660-8206-1AF430DE8073","C5CDB056-0DE5-496F-A301-87F11CE50DDE","Unaligned reads",4023427610,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","9D42A9C4-305B-4E25-A260-82805D6B059A","University of North Carolina","564a3932e4b09c884b23b0a9","E4787C7B-40E7-483C-98C0-38DA03E26B56","Uterine Corpus Endometrial Carcinoma","TARGZ","FFE36EC9-C51E-45B3-A992-B06E344AC66A","2013-09-11T21:04:01.000Z","2E416718-3F6C-4C8A-B436-52520469F38B","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",300,"FFE36EC9-C51E-45B3-A992-B06E344AC66A",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4E4812F1-7DB6-4475-BBE6-DE4A4AEB82E1.txt",110,"TCGA-AX-A3GI-01A",NA,NA,"TCGA",2011,NA,NA,NA,"C5CDB056-0DE5-496F-A301-87F11CE50DDE",66,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.4E4812F1-7DB6-4475-BBE6-DE4A4AEB82E1.txt","Alive",NA,"TCGA-AX-A3GI","NOT HISPANIC OR LATINO","AD3A9BE4-1949-4C84-9965-6CAEDA1FBAD1",NA,4,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",201,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"BEB03E92-2A77-4B41-A987-7464894843F1","4DD5B1DB-C486-41DC-96E8-354E189D4781","TCGA-AX-A3GI-01A-11R-A214-13_mirna.bam","TCGA-AX-A3GI-01A-11",98,0,0,0,2,"TOP",4,0,"TCGA-AX-A3GI-01A-01-TSA",94,NA,NA,NA,NA,NA,NA,"TCGA-AX-A3GI-F58292_NTE-1",NA,12,NA,"Alive",NA,"TCGA-AX-A3GI-F58292","TCGA-AX-A3GI",1,"AX","A3GI","YES","C54.1","8441/3","C54.1","NO","YES",-24388,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",4,NA,NA,NA,NA,"NO",7,2,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,66,2011,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
33999700,33741211,2519488571,"6E930060-502B-49F5-A385-9B91DEBD05E4.bw","e49f545f-3268-4d25-b7a3-4da8e6ab2578","6e930060-502b-49f5-a385-9b91debd05e4","2016-08-05T08:52:31.661959-05:00","UNCID_2189519.e947ba64-793a-4462-9447-5c02a4a9ff39.120524_UNC2-RDR300275_00121_FC_64KREAAXX_6.tar.gz","7182689f-740e-4615-bbd9-730c7fe29779",2140630683,"Illumina GA","7836c386f70298cd3656d12b156248b7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:29:47.464556-05:00","2016-05-03T11:05:01.523277-05:00","7182689f-740e-4615-bbd9-730c7fe29779_analysis.xml","cbcfe45cbc95c6b7ac0253ca5d374fdc","4a740d27-9fd9-4e0b-a028-e0b51619c7a2",2122,"2016-09-29T17:41:52.016000-05:00","7182689f-740e-4615-bbd9-730c7fe29779_experiment.xml","4575fed8317e08df2c0734f1c4a95c53","0664b49b-bb18-4737-bb24-99be8543fa4c",2258,"2016-09-29T21:52:27.268499-05:00","7182689f-740e-4615-bbd9-730c7fe29779_run.xml","3ba0c11d9419b489d85e9daf8787933b","a29f22ce-933d-4ae5-911f-1f3e9b100f0c",349,"2016-09-08T12:13:21.000094-05:00","TCGA-D1-A1NZ","2016-09-02T18:52:18.498163-05:00","female","TCGA-D1-A1NZ_demographic",1950,"white","4a83af41-f0dd-5db8-a0bf-609e86d91d4a","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1NZ_diagnosis","not reported",22027,"alive","8380/3",NA,548,"58aae1bc-5d1c-5cc3-b192-dd6b10ecf0ac","c54.1",-22027,"TCGA-D1-A1NZ_treatment","413c8fad-cff8-5dc0-a9f6-f79a7b5e1c27","01","false","TCGA-D1-A1NZ-01A",NA,"7239e42a-f0ef-43dd-9d1f-a5a507e0e66c",FALSE,"0AFDCBC0-FA0A-4138-A0BE-E374AEB3CB25","Primary Tumor",NA,191,140,NA,1302048000,"21",30,"TCGA-D1-A1NZ-01A-21",70,NA,20,NA,10,NA,15,NA,"2016-09-08T12:13:21.000094-05:00",NA,50,NA,20,NA,"TOP",NA,5,NA,"e3566570-da09-43b7-a58c-adbe3c9106ac",NA,"TCGA-D1-A1NZ-01A-02-TSB",NA,70,NA,"179dff2a-ab4e-43df-92ab-f857243df32e","RNA","TCGA-D1-A1NZ-01A-21R","142ba0f7-1e5c-4bc8-8d21-b7eb65ac08b0",1.77,0.17,"UV Spec","R","23","TCGA-D1-A1NZ-01A-21R-A14D-07","e947ba64-793a-4462-9447-5c02a4a9ff39",0.17,NA,90,35.5998576005696,159,"220ef95e-9f1f-5b86-b085-130b6faa7b52","TCGA-D1-A1NZ_exposure","UNCID_2189519.e947ba64-793a-4462-9447-5c02a4a9ff39.120524_UNC2-RDR300275_00121_FC_64KREAAXX_6.tar.gz","2013-09-19T01:06:03.000Z","2013-09-19T01:18:01.000Z","7182689F-740E-4615-BBD9-730C7FE29779","7239E42A-F0EF-43DD-9D1F-A5A507E0E66C","Unaligned reads",2140630683,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E947BA64-793A-4462-9447-5C02A4A9FF39","University of North Carolina","564a4080e4b093830b6ae8cb","E49F545F-3268-4D25-B7A3-4DA8E6AB2578","Uterine Corpus Endometrial Carcinoma","TARGZ","179DFF2A-AB4E-43DF-92AB-F857243DF32E","2013-09-19T01:18:01.000Z","142BA0F7-1E5C-4BC8-8D21-B7EB65AC08B0","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",191,"179DFF2A-AB4E-43DF-92AB-F857243DF32E",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C38FA373-FEA7-4076-BBAA-5E7D6F2443AC.txt",140,"TCGA-D1-A1NZ-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","7239E42A-F0EF-43DD-9D1F-A5A507E0E66C",60,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C38FA373-FEA7-4076-BBAA-5E7D6F2443AC.txt","Alive",NA,"TCGA-D1-A1NZ","NOT HISPANIC OR LATINO","280E0824-49DD-408D-AB3A-141ACD67ABCF",NA,8,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,21,30,"E3566570-DA09-43B7-A58C-ADBE3C9106AC","142BA0F7-1E5C-4BC8-8D21-B7EB65AC08B0","UNCID_1603591.e947ba64-793a-4462-9447-5c02a4a9ff39.sorted_genome_alignments.bam.bai","TCGA-D1-A1NZ-01A-21",70,10,20,50,15,"TOP",5,20,"TCGA-D1-A1NZ-01A-02-TSB",70,NA,NA,NA,NA,NA,NA,NA,"NO",548,"TUMOR FREE","Alive",NA,"TCGA-D1-A1NZ-F17383","TCGA-D1-A1NZ",1,"D1","A1NZ","YES","C54.1","8380/3","C54.1","NO","YES",-22027,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",8,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
119029706,115925803,5528723777,"388D4E50-F135-45A2-91FB-3640C65DC4C5.bw","e4bccea0-0104-40c4-9e3c-2ad7262d918e","388d4e50-f135-45a2-91fb-3640c65dc4c5","2016-08-25T16:01:44.289680-05:00","UNCID_2316546.86ae75e5-6460-45a3-89f0-aaeba2462268.130909_UNC15-SN850_0326_AC2BWBACXX_3_GATCAG.tar.gz","083f29f8-2360-4d3c-89b1-7ae576b1aeea",5571165254,"Illumina HiSeq","f48fdfffa3dea8bb2a3e52539af79e2e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:15:56.432429-05:00","2016-05-03T11:28:50.207865-05:00","083f29f8-2360-4d3c-89b1-7ae576b1aeea_analysis.xml","d6bac9d9ef1ea39d9cf063106318bd25","41b21ad6-e1eb-40bc-91ae-86add4ac5685",2124,"2016-09-29T18:38:28.786460-05:00","083f29f8-2360-4d3c-89b1-7ae576b1aeea_experiment.xml","96e2830150edfe2d9d6cbf6cb5c1ecc2","2a063cdb-f16f-4085-aef9-779eab3476b5",2628,"2016-09-29T20:57:50.291445-05:00","083f29f8-2360-4d3c-89b1-7ae576b1aeea_run.xml","3755ab0c4177b2cee8fc2d6afff46b91","80a22f39-6ad5-459c-a762-43b08d5a514f",354,"2016-09-08T10:38:22.750021-05:00","TCGA-QF-A5YT","2016-09-02T18:51:25.097961-05:00","female","TCGA-QF-A5YT_demographic",1953,"black or african american","7593a65f-93eb-5143-a5a6-8e4c144e0880","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","QF","d777d40e-e930-5f47-995e-89adc81e9900","BLN - Baylor","not reported","c54.0","TCGA-QF-A5YT_diagnosis","not reported",20981,"alive","8380/3",NA,1215,"a6a42e4d-add8-57a7-8b60-f9f1f890df34","c54.0",-20981,"TCGA-QF-A5YT_treatment","0610ab27-0a85-5962-817c-8c854d4d564e","01","false","TCGA-QF-A5YT-01A",NA,"e62ea0d8-61cb-41ed-9d15-a0c5add11249",FALSE,"1CCA2D47-BA5D-46A9-89F9-681C58EFC10D","Primary Tumor",NA,804,40,NA,1363219200,"11",30,"TCGA-QF-A5YT-01A-11",90,NA,0,NA,10,NA,10,NA,"2016-09-08T10:38:22.750021-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"704726e5-220d-456d-af0b-678cd1f4c86e",NA,"TCGA-QF-A5YT-01A-01-TS1",NA,80,NA,"e2cda9df-fc5a-4f9d-8c54-c4f2da4acce8","RNA","TCGA-QF-A5YT-01A-11R","9239490a-614f-4826-936e-cecfa954b731",1.92,0.17,"UV Spec","R","23","TCGA-QF-A5YT-01A-11R-A31O-07","86ae75e5-6460-45a3-89f0-aaeba2462268",0.17,NA,146,50.5190311418685,170,"4f2b0a87-8845-524d-a20d-2e0fac7c3bf1","TCGA-QF-A5YT_exposure","UNCID_2316546.86ae75e5-6460-45a3-89f0-aaeba2462268.130909_UNC15-SN850_0326_AC2BWBACXX_3_GATCAG.tar.gz","2014-01-07T02:16:17.000Z","2014-01-07T03:07:02.000Z","083F29F8-2360-4D3C-89B1-7AE576B1AEEA","E62EA0D8-61CB-41ED-9D15-A0C5ADD11249","Unaligned reads",5571165254,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","86AE75E5-6460-45A3-89F0-AAEBA2462268","University of North Carolina","56607d82e4b018727fea335d","E4BCCEA0-0104-40C4-9E3C-2AD7262D918E","Uterine Corpus Endometrial Carcinoma","TARGZ","E2CDA9DF-FC5A-4F9D-8C54-C4F2DA4ACCE8","2014-01-07T03:07:02.000Z","9239490A-614F-4826-936E-CECFA954B731","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",804,"E2CDA9DF-FC5A-4F9D-8C54-C4F2DA4ACCE8",NA,"QF","TCGA-QF-A5YT-01A-11R-A31S-13_mirna.bam.bai",40,"TCGA-QF-A5YT-01A",NA,"975570DE-DBC9-4A2B-B9E4-1C2E973DA609","TCGA",2010,"TCGA-QF-A5YT_NTE-1","Complete Remission/Response","TUMOR FREE","E62EA0D8-61CB-41ED-9D15-A0C5ADD11249",57,"nationwidechildrens.org_clinical.TCGA-QF-A5YT.xml","Alive",NA,"TCGA-QF-A5YT","NOT HISPANIC OR LATINO","C690D984-1C98-416D-84D0-C0673D9DC634","NO",887,"No","Uterus","C54.0",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.0",324,NA,"A5E5190B-B511-41CE-A533-3CCA2FE47833","BLACK OR AFRICAN AMERICAN",NA,11,30,"704726E5-220D-456D-AF0B-678CD1F4C86E","AA3B5F9F-FAA7-4BAD-B5C9-B16F0FBFF6AC","UNCID_2316546.86ae75e5-6460-45a3-89f0-aaeba2462268.130909_UNC15-SN850_0326_AC2BWBACXX_3_GATCAG.tar.gz","TCGA-QF-A5YT-01A-11",90,10,0,0,10,"TOP",0,0,"TCGA-QF-A5YT-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-QF-A5YT-D44676","TCGA-QF-A5YT-R44678","Internal","Primary Tumor Field","TCGA-QF-A5YT-F58612_NTE-1","NO",1215,"TUMOR FREE","Alive",NA,"TCGA-QF-A5YT-F58612","TCGA-QF-A5YT",1,"QF","A5YT","YES","C54.0","8380/3","C54.0","NO","YES",-20981,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",887,NA,"YES","YES","TUMOR FREE","YES",25,6,2013,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33264169,32746378,2443815865,"3BA72C4D-DB4C-440C-B76B-036961EC8914.bw","e55dd65a-c75e-4a3c-bb24-8b3af4d65321","3ba72c4d-db4c-440c-b76b-036961ec8914","2016-08-06T17:53:12.052372-05:00","UNCID_2209933.7dc8574f-d39c-4a7d-be83-e326a577b5bb.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_3.tar.gz","efcd09c5-ba7c-46b9-8786-c76733d4c6cf",2235798412,"Illumina GA","2511c9ca8085d2a8c4cea0d47186e03d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:33:21.092001-05:00","2016-05-03T11:15:47.413267-05:00","efcd09c5-ba7c-46b9-8786-c76733d4c6cf_analysis.xml","1ac7c08e1facaa4d65fd36d410edd1e8","e1261f36-21d1-4f6c-a9a5-381b29d6d23b",2121,"2016-10-07T17:42:48.442019-05:00","efcd09c5-ba7c-46b9-8786-c76733d4c6cf_experiment.xml","b8256abe2134907d5331029516eeeeef","76657a92-d022-4eee-8dad-89429f1e8cbe",2257,"2016-09-29T18:15:18.505201-05:00","efcd09c5-ba7c-46b9-8786-c76733d4c6cf_run.xml","516a641da71b049dcf73242d6218c6f0","1b776d26-bf61-4fae-bfb3-c37a1c93dffe",347,"2016-09-08T11:33:09.170137-05:00","TCGA-D1-A17B","2016-09-02T18:50:36.610902-05:00","female","TCGA-D1-A17B_demographic",1940,"white","ecf70e7a-8b2e-57a7-82e6-a3ba6cf2ac80","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17B_diagnosis","not reported",25504,"alive","8380/3",NA,213,"adcf1940-b352-5c45-8993-318a66c3902e","c54.1",-25504,"TCGA-D1-A17B_treatment","e5846de8-424b-5e80-ab3c-0a1e668c8f94","01","false","TCGA-D1-A17B-01A",NA,"37c92c44-320d-4881-8cb3-357cc8bace5c",FALSE,"FBE330EA-52BC-4B16-A046-3858318348F5","Primary Tumor",NA,685,140,NA,1295913600,"22",30,"TCGA-D1-A17B-01A-22",70,NA,10,NA,0,NA,20,NA,"2016-09-08T11:33:09.170137-05:00",NA,30,NA,50,NA,"TOP",NA,10,NA,"cbf11380-bdba-4a0c-b0f1-fe418b05cfba",NA,"TCGA-D1-A17B-01A-02-TS2",NA,70,NA,"599db78f-1bd2-45e3-b48d-6d3ac69a8454","RNA","TCGA-D1-A17B-01A-22R","147c6696-408c-4cde-bab9-7abc80544513",1.88,0.17,"UV Spec","R","23","TCGA-D1-A17B-01A-22R-A12I-07","7dc8574f-d39c-4a7d-be83-e326a577b5bb",0.17,NA,110,41.914342325865,162,"6c11b8fe-575c-5d76-b9c8-9ec8c1fd81c5","TCGA-D1-A17B_exposure","UNCID_2209933.7dc8574f-d39c-4a7d-be83-e326a577b5bb.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_3.tar.gz","2013-10-02T02:06:04.000Z","2013-10-02T02:19:03.000Z","EFCD09C5-BA7C-46B9-8786-C76733D4C6CF","37C92C44-320D-4881-8CB3-357CC8BACE5C","Unaligned reads",2235798412,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7DC8574F-D39C-4A7D-BE83-E326A577B5BB","University of North Carolina","564a3cd6e4b09c884b24cc40","E55DD65A-C75E-4A3C-BB24-8B3AF4D65321","Uterine Corpus Endometrial Carcinoma","TARGZ","599DB78F-1BD2-45E3-B48D-6D3AC69A8454","2013-10-02T02:19:03.000Z","147C6696-408C-4CDE-BAB9-7ABC80544513","None","NO",1,NA,"Primary Tumor","Mayo Clinic",685,"599DB78F-1BD2-45E3-B48D-6D3AC69A8454",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B0A6109A-AA31-450B-AD32-4B07EB833EC4.txt",140,"TCGA-D1-A17B-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","37C92C44-320D-4881-8CB3-357CC8BACE5C",69,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B0A6109A-AA31-450B-AD32-4B07EB833EC4.txt","Alive",NA,"TCGA-D1-A17B","NOT HISPANIC OR LATINO","6F7A24AB-EDE0-4B55-A4A0-EE2CD9D4FA7B",NA,213,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,22,30,"CBF11380-BDBA-4A0C-B0F1-FE418B05CFBA","C7353096-69E3-4709-BB98-265012FF9BE7","TCGA-D1-A17B-01A-22D-A12J-09_IlluminaGA-DNASeq_exome.bam","TCGA-D1-A17B-01A-22",70,0,10,30,20,"TOP",10,50,"TCGA-D1-A17B-01A-02-TS2",70,NA,NA,NA,NA,NA,NA,NA,"NO",213,"TUMOR FREE","Alive",NA,"TCGA-D1-A17B-F20251","TCGA-D1-A17B",1,"D1","A17B","YES","C54.1","8380/3","C54.1","NO","YES",-25504,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",213,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,69,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35467469,35257427,2613607957,"D516A82D-2F77-46B2-90F7-30BA5C78AAC8.bw","e56491af-718f-4ca1-b3cd-0e5b3154697b","d516a82d-2f77-46b2-90f7-30ba5c78aac8","2016-08-05T02:35:53.289272-05:00","UNCID_2206471.543b9907-bf2a-4f64-b83f-13cc4289310b.110921_UNC2-RDR300275_00086_FC634HAAAXX_8.tar.gz","77759ac1-2574-472f-93fd-cdddb0ec6a00",2251895238,"Illumina GA","c57dcb0fd38ae25e427590db7b15118a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:35:08.477820-05:00","2016-05-03T11:11:34.768699-05:00","77759ac1-2574-472f-93fd-cdddb0ec6a00_analysis.xml","08eca8c694c864784118d558d3c1c93a","bcf11770-6c66-4d65-8d16-4a5b0afaf16d",2119,"2016-10-07T17:43:57.536692-05:00","77759ac1-2574-472f-93fd-cdddb0ec6a00_experiment.xml","8839fc505e073413443b047fcd84f6e8","768f4f0b-5dc2-4790-92b8-92a99b944a97",2257,"2016-09-30T00:11:05.146074-05:00","77759ac1-2574-472f-93fd-cdddb0ec6a00_run.xml","429e92e68c2ac233252bc8117aa9b863","f85c003c-b7a4-4165-87bf-d2a19746cd64",347,"2016-09-08T10:48:49.968514-05:00","TCGA-D1-A1NU","2016-09-02T18:52:18.017346-05:00","female","TCGA-D1-A1NU_demographic",1936,"white","0309ac57-a9e4-5985-afaa-1c22c3de13d7","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1NU_diagnosis","not reported",27272,"alive","8441/3",NA,402,"95c39d78-414a-58f7-ba98-0b27c5bbe04c","c54.1",-27272,"TCGA-D1-A1NU_treatment","d7507d19-229a-5024-a6ac-8829617c5e74","01","false","TCGA-D1-A1NU-01A",NA,"7901f084-c220-4865-a034-da0144d63a28",FALSE,"08AE92E6-EDAB-4059-AF51-4A8522EDD463","Primary Tumor",NA,87,120,NA,1301875200,"11",30,"TCGA-D1-A1NU-01A-11",65,NA,20,NA,0,NA,25,NA,"2016-09-08T10:48:49.968514-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"0d827293-8620-4e50-8eac-aaa35fd414b0",NA,"TCGA-D1-A1NU-01A-01-TSA",NA,65,NA,"32e8339a-2a46-4eb6-ad03-19b5c35e00a4","RNA","TCGA-D1-A1NU-01A-11R","a9bafdd4-2323-48d5-a1c8-c8c02d1beda2",1.81,0.18,"UV Spec","R","23","TCGA-D1-A1NU-01A-11R-A14D-07","543b9907-bf2a-4f64-b83f-13cc4289310b",0.18,NA,93,40.7876847506688,151,"594b6c30-8a08-5346-9b03-18628d0cae05","TCGA-D1-A1NU_exposure","UNCID_2206471.543b9907-bf2a-4f64-b83f-13cc4289310b.110921_UNC2-RDR300275_00086_FC634HAAAXX_8.tar.gz","2013-09-27T02:55:05.000Z","2013-09-27T03:08:03.000Z","77759AC1-2574-472F-93FD-CDDDB0EC6A00","7901F084-C220-4865-A034-DA0144D63A28","Unaligned reads",2251895238,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","543B9907-BF2A-4F64-B83F-13CC4289310B","University of North Carolina","564a36e4e4b0298dd2c6f463","E56491AF-718F-4CA1-B3CD-0E5B3154697B","Uterine Corpus Endometrial Carcinoma","TARGZ","32E8339A-2A46-4EB6-AD03-19B5C35E00A4","2013-09-27T03:08:03.000Z","A9BAFDD4-2323-48D5-A1C8-C8C02D1BEDA2","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",87,"32E8339A-2A46-4EB6-AD03-19B5C35E00A4",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8E2D8E73-9940-4E05-8463-D5174A602B15.txt",120,"TCGA-D1-A1NU-01A",NA,"EDCB855A-36CF-46CC-91F0-770C9809A095","TCGA",2010,NA,NA,"TUMOR FREE","82EACB30-B052-46EB-B69D-8CF7F7D74A8A",74,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.8E2D8E73-9940-4E05-8463-D5174A602B15.txt","Alive",NA,"TCGA-D1-A1NU","NOT HISPANIC OR LATINO","D620AD97-427C-4CDF-BFDE-7E4E246A6446",NA,312,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",121,NA,"F2D90691-D665-4D6E-8214-DB548C73E18C","WHITE",NA,11,30,"0D827293-8620-4E50-8EAC-AAA35FD414B0","A9BAFDD4-2323-48D5-A1C8-C8C02D1BEDA2","UNCID_1620861.543b9907-bf2a-4f64-b83f-13cc4289310b.sorted_genome_alignments.bam.bai","TCGA-D1-A1NU-01A-11",65,0,20,40,25,"TOP",10,20,"TCGA-D1-A1NU-01A-01-TSA",65,"Taxol","Chemotherapy","TCGA-D1-A1NU-D21640","TCGA-D1-A1NU-R21639","IMPLANTS","Primary Tumor Field",NA,"NO",402,"TUMOR FREE","Alive",NA,"TCGA-D1-A1NU-F21638","TCGA-D1-A1NU",1,"D1","A1NU","YES","C54.1","8441/3","C54.1","NO","YES",-27272,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",312,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,74,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
24299699,24029487,1807700217,"8756589A-8352-4CDA-9297-D4C146D1DF47.bw","e56c6abc-b36c-4667-a347-0a541ce4791d","8756589a-8352-4cda-9297-d4c146d1df47","2016-08-05T11:59:46.951925-05:00","UNCID_2216270.cadb8d53-b172-421d-ac3e-1583f5e55049.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_2.tar.gz","3dda9b80-7745-42af-871b-29c993cea226",1477347555,"Illumina GA","ef187a5a22499f831c702a552edd86a6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:20:24.196890-05:00","2016-05-03T11:18:47.010651-05:00","3dda9b80-7745-42af-871b-29c993cea226_analysis.xml","e3852b919936d73124138ccc3859b615","d8e68f73-ac25-4ed7-b84f-6b2448670d4e",2122,"2016-09-29T19:40:55.868050-05:00","3dda9b80-7745-42af-871b-29c993cea226_experiment.xml","ce9ba11d676f30f2be593e1324509627","514acd34-46db-4edb-ae7e-a179e831a9f0",2256,"2016-09-29T19:34:01.589670-05:00","3dda9b80-7745-42af-871b-29c993cea226_run.xml","9d8c6b478f8719f625312c6aba8d9b3f","4d054600-71e9-4d69-9499-696a97f34e42",345,"2016-09-08T10:48:50.127488-05:00","TCGA-AX-A05U","2016-09-02T18:52:43.942301-05:00","female","TCGA-AX-A05U_demographic",1952,"american indian or alaska native","f34a2659-0257-5109-8d37-63fd9d62af15","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A05U_diagnosis","not reported",20533,"alive","8380/3",NA,903,"8f4b5fbe-28bf-5a2d-b74e-970b40796eef","c54.1",-20533,"TCGA-AX-A05U_treatment","02b75a17-b9e5-53f9-913b-093874a7ec3b","01","false","TCGA-AX-A05U-01A",NA,"6327ef54-8216-4fd3-bde4-01f3192c653f",FALSE,"1F51E982-37A1-40C6-BFAC-782B93D9967F","Primary Tumor",NA,500,180,NA,1275868800,"11",30,"TCGA-AX-A05U-01A-11",90,85,0,0,2,12,3,3,"2016-09-08T10:48:50.127488-05:00","2016-09-08T10:48:50.127488-05:00",0,0,0,0,"BOTTOM","TOP",5,5,"53d02358-c0e4-446e-8138-500a38f46eb4","5181e5e0-f144-48de-8a47-717286dc6d6d","TCGA-AX-A05U-01A-01-BS1","TCGA-AX-A05U-01A-01-TS1",90,80,"dae53a81-077a-4b4c-81d3-0da6290e4698","RNA","TCGA-AX-A05U-01A-11R","a5082828-9011-4e0d-b276-fedb33b198e8",1.81,0.15,"UV Spec","R","23","TCGA-AX-A05U-01A-11R-A00V-07","cadb8d53-b172-421d-ac3e-1583f5e55049",0.15,NA,62,25.8064516129032,155,"b9ebf67c-a2ac-5851-a7fb-abc18ea206e7","TCGA-AX-A05U_exposure","UNCID_2216270.cadb8d53-b172-421d-ac3e-1583f5e55049.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_2.tar.gz","2013-10-04T07:56:03.000Z","2013-10-04T08:08:02.000Z","3DDA9B80-7745-42AF-871B-29C993CEA226","6327EF54-8216-4FD3-BDE4-01F3192C653F","Unaligned reads",1477347555,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CADB8D53-B172-421D-AC3E-1583F5E55049","University of North Carolina","56607a4ae4b0ec1099f8df5b","E56C6ABC-B36C-4667-A347-0A541CE4791D","Uterine Corpus Endometrial Carcinoma","TARGZ","DAE53A81-077A-4B4C-81D3-0DA6290E4698","2013-10-04T08:08:02.000Z","A5082828-9011-4E0D-B276-FEDB33B198E8","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",500,"DAE53A81-077A-4B4C-81D3-0DA6290E4698",NA,"AX","jhu-usc.edu_UCEC.HumanMethylation27.1.lvl-2.TCGA-AX-A05U-01A-11D-A00U-05.txt",180,"TCGA-AX-A05U-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","6327EF54-8216-4FD3-BDE4-01F3192C653F",56,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.83BDFCC6-9E1F-4683-AD35-D6978DA1A959.txt","Alive",NA,"TCGA-AX-A05U","NOT HISPANIC OR LATINO","67EC2B88-AFDC-4AC5-A6C3-4CCAB2B0313A",NA,903,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"AMERICAN INDIAN OR ALASKA NATIVE",NA,11,30,"53D02358-C0E4-446E-8138-500A38F46EB4","F9470856-296E-40D5-9F39-48BC7E59B0BC","UNCID_2216270.cadb8d53-b172-421d-ac3e-1583f5e55049.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_2.tar.gz","TCGA-AX-A05U-01A-11",90,2,0,0,3,"BOTTOM",5,0,"TCGA-AX-A05U-01A-01-BS1",90,NA,NA,NA,NA,NA,NA,NA,NA,903,"TUMOR FREE","Alive",NA,"TCGA-AX-A05U-F5579","TCGA-AX-A05U",1,"AX","A05U","YES","C54.1","8380/3","C54.1","NO","YES",-20533,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","NOT HISPANIC OR LATINO","No","No","Alive",903,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,56,2008,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
129870820,127107312,6066843882,"C60821D0-7043-45F1-8E08-56067761432A.bw","e5d64754-15e8-494e-b7f7-25cf2819fe4c","c60821d0-7043-45f1-8e08-56067761432a","2016-08-09T13:15:02.631278-05:00","UNCID_2173128.e7517bb2-68d3-49c5-b298-4203845ae7db.130509_UNC10-SN254_0462_AC232JACXX_3_ACTTGA.tar.gz","2091966f-c96f-429b-8196-a09e31eec4e5",6010058199,"Illumina HiSeq","334aee53ec6e2b66ae8433231f839e8c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:35:53.420633-05:00","2016-05-03T10:55:55.600288-05:00","2091966f-c96f-429b-8196-a09e31eec4e5_analysis.xml","c8d956a70093f96a3edbb37b795caa56","bd61a84f-5c48-4e9e-bff0-ae51ca1dee52",2123,"2016-10-07T16:45:55.481940-05:00","2091966f-c96f-429b-8196-a09e31eec4e5_experiment.xml","d1368aa99c72e2fd1ef427ab663b661b","bfe3db0b-c628-4370-9241-ccf15fc817e8",2431,"2016-09-29T18:35:41.290114-05:00","2091966f-c96f-429b-8196-a09e31eec4e5_run.xml","0dc42d436059e80b13aa83f4e5a6354f","282f43d1-a65b-4921-b07c-a511380908f3",354,"2016-09-08T10:50:03.976732-05:00","TCGA-AJ-A3I9","2016-09-02T18:48:49.256289-05:00","female","TCGA-AJ-A3I9_demographic",1959,"white","426e16e6-d6a6-50ae-a3ae-748b39b15a60","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AJ","73c4efaa-5d6f-5df9-9179-2b8c56cf6153","International Genomics Conosrtium","not reported","c54.1","TCGA-AJ-A3I9_diagnosis","not reported",19139,"dead","8380/3",519,39,"f7872574-04be-5b1b-9731-c3f881015922","c54.1",-19139,"TCGA-AJ-A3I9_treatment","d54609df-37f6-560c-aa3b-5d650d6f6dec","01","false","TCGA-AJ-A3I9-01A",NA,"53e1feb9-81c1-473d-a8ae-eb481a26b726",FALSE,"095789FC-7C20-4A6A-A6F0-13315481EBD0","Primary Tumor",NA,84,27,NA,1327449600,"11",27,"TCGA-AJ-A3I9-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T10:50:03.976732-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"628e78e1-1e95-4648-b0ee-7dd4c2e4335f",NA,"TCGA-AJ-A3I9-01A-01-TS1",NA,100,NA,"a63beb5c-aa8a-4a02-90a5-aeab21f16e18","RNA","TCGA-AJ-A3I9-01A-11R","3c04af05-74ac-4a25-99f9-366be58baec7",1.75,0.17,"UV Spec","R","23","TCGA-AJ-A3I9-01A-11R-A22K-07","e7517bb2-68d3-49c5-b298-4203845ae7db",0.17,NA,72,28.125,160,"00001051-e0ee-5249-9d57-1607d3cef8a0","TCGA-AJ-A3I9_exposure","UNCID_2173128.e7517bb2-68d3-49c5-b298-4203845ae7db.130509_UNC10-SN254_0462_AC232JACXX_3_ACTTGA.tar.gz","2013-09-09T10:36:09.000Z","2013-09-09T10:52:01.000Z","2091966F-C96F-429B-8196-A09E31EEC4E5","53E1FEB9-81C1-473D-A8AE-EB481A26B726","Unaligned reads",6010058199,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","E7517BB2-68D3-49C5-B298-4203845AE7DB","University of North Carolina","5660761ce4b0b37b3d9900ef","E5D64754-15E8-494E-B7F7-25CF2819FE4C","Uterine Corpus Endometrial Carcinoma","TARGZ","A63BEB5C-AA8A-4A02-90A5-AEAB21F16E18","2013-09-09T10:52:01.000Z","3C04AF05-74AC-4A25-99F9-366BE58BAEC7","United States","NO",1,NA,"Primary Tumor","International Genomics Conosrtium",84,"A63BEB5C-AA8A-4A02-90A5-AEAB21F16E18",NA,"AJ","UNCID_2173128.e7517bb2-68d3-49c5-b298-4203845ae7db.130509_UNC10-SN254_0462_AC232JACXX_3_ACTTGA.tar.gz",27,"TCGA-AJ-A3I9-01A",NA,"FEB5FEE5-D836-45C0-8E36-AB467D7CCC17","TCGA",2011,NA,NA,"TUMOR FREE","EEC1621B-8781-4110-B264-84E535178C9F",52,"nationwidechildrens.org_clinical.TCGA-AJ-A3I9.xml","Alive",NA,"TCGA-AJ-A3I9","NOT HISPANIC OR LATINO","26393A8F-6502-4A1D-8943-B734447EF85D",NA,39,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"EA0E2FFF-5AE1-42E6-9C0D-44E00085299D","WHITE",NA,11,27,"628E78E1-1E95-4648-B0EE-7DD4C2E4335F","3C04AF05-74AC-4A25-99F9-366BE58BAEC7","UNCID_2173128.e7517bb2-68d3-49c5-b298-4203845ae7db.130509_UNC10-SN254_0462_AC232JACXX_3_ACTTGA.tar.gz","TCGA-AJ-A3I9-01A-11",80,0,0,0,0,"TOP",0,0,"TCGA-AJ-A3I9-01A-01-TS1",100,"Taxol","Chemotherapy","TCGA-AJ-A3I9-D66211","TCGA-AJ-A3I9-R66209","Internal","Primary Tumor Field","TCGA-AJ-A3I9-F66208_NTE-1","YES",NA,"WITH TUMOR","Dead",519,"TCGA-AJ-A3I9-F66208","TCGA-AJ-A3I9",1,"AJ","A3I9","YES","C54.1","8380/3","C54.1","YES","NO",-19139,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",39,NA,NA,NA,"TUMOR FREE","NO",13,4,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,52,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29308383,26685110,1989319598,"070E540B-34DB-4016-B573-84924407F57F.bw","e5d74e47-b63f-410a-8b7a-c9aacc9aa337","070e540b-34db-4016-b573-84924407f57f","2016-08-09T14:15:55.282012-05:00","UNCID_2210471.fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_4.tar.gz","42b2c2e1-01e4-451b-9fb5-2322e51c1dc1",1792139566,"Illumina GA","ef41bd00889c53df0c6936de745fbe88","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:49:03.282443-05:00","2016-05-03T11:15:47.427352-05:00","42b2c2e1-01e4-451b-9fb5-2322e51c1dc1_analysis.xml","70a715555df6d10316a73f6e9af57653","eae241e5-1636-4c9b-b5ea-b26710e6a507",2121,"2016-08-28T04:12:14.639193-05:00","42b2c2e1-01e4-451b-9fb5-2322e51c1dc1_experiment.xml","ff9ca1a0626f8f300f450f2a1a199f54","55cceb70-95ef-427e-aa2f-df40b47e5742",2257,"2016-09-29T21:23:32.852342-05:00","42b2c2e1-01e4-451b-9fb5-2322e51c1dc1_run.xml","22bb43e8340a223cfdc6fa06ef31219e","90c20ec1-bb44-4f4c-b9b0-8683a308c553",347,"2016-09-08T11:07:07.670767-05:00","TCGA-AX-A06H","2016-09-02T18:49:23.370210-05:00","female","TCGA-AX-A06H_demographic",1948,"american indian or alaska native","d376f28e-2c9a-54ab-9426-adfa028674d4","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A06H_diagnosis","not reported",22270,"alive","8380/3",NA,833,"f8e76f0a-a24a-5a0b-8176-25c3681c2344","c54.1",-22270,"TCGA-AX-A06H_treatment","e46d0195-311d-5cee-81b3-ed09a98dec6a","01","false","TCGA-AX-A06H-01A",NA,"b26a6c7e-5eef-4129-b635-cc40e60df0dd",FALSE,"493C5DDA-E629-4324-8574-AEC67223DA9E","Primary Tumor",NA,654,110,NA,1291161600,"11",20,"TCGA-AX-A06H-01A-11",20,70,0,1,5,15,35,2,"2016-09-08T11:07:07.670767-05:00","2016-09-08T11:07:07.670767-05:00",70,24,0,1,"TOP","BOTTOM",5,15,"56925b0e-e308-42ef-a71d-ef22434a27ec","a1e105e0-7ae5-4029-9624-ca57ff394b03","TCGA-AX-A06H-01A-01-MS1","TCGA-AX-A06H-01A-01-BS1",55,68,"69e9e629-10bd-49a2-a254-97053e4316ee","RNA","TCGA-AX-A06H-01A-11R","368464aa-a97e-4edc-b085-b8e50e643a10",1.9,0.15,"UV Spec","R","23","TCGA-AX-A06H-01A-11R-A118-07","fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf",0.15,NA,98,38.28125,160,"e28ab080-7b0b-5cfc-853c-c35416cfdadc","TCGA-AX-A06H_exposure","UNCID_2210471.fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf.110406_UNC1-RDR301647_00058_FC_70EYTAAXX_4.tar.gz","2013-10-02T11:26:04.000Z","2013-10-02T11:38:03.000Z","42B2C2E1-01E4-451B-9FB5-2322E51C1DC1","B26A6C7E-5EEF-4129-B635-CC40E60DF0DD","Unaligned reads",1792139566,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","FB8CFA19-3DFB-4AD5-A64E-7F51837E56CF","University of North Carolina","564a342fe4b0298dd2c616dc","E5D74E47-B63F-410A-8B7A-C9AACC9AA337","Uterine Corpus Endometrial Carcinoma","TARGZ","69E9E629-10BD-49A2-A254-97053E4316EE","2013-10-02T11:38:03.000Z","368464AA-A97E-4EDC-B085-B8E50E643A10","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",654,"69E9E629-10BD-49A2-A254-97053E4316EE",NA,"AX","UNCID_1632040.fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf.sorted_genome_alignments.bam",110,"TCGA-AX-A06H-01A",NA,"A01AE370-01D3-4201-8F91-6291638862AA","TCGA",2008,NA,NA,"WITH TUMOR","B26A6C7E-5EEF-4129-B635-CC40E60DF0DD",60,"nationwidechildrens.org_clinical.TCGA-AX-A06H.xml","Alive",NA,"TCGA-AX-A06H","NOT HISPANIC OR LATINO","47533F41-F564-4622-8EE3-DB2D2616F57D",NA,833,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"AMERICAN INDIAN OR ALASKA NATIVE",NA,11,20,"A1E105E0-7AE5-4029-9624-CA57FF394B03","AEA92609-8331-4B70-B0E8-AE14144F15E8","UNCID_1632040.fb8cfa19-3dfb-4ad5-a64e-7f51837e56cf.sorted_genome_alignments.bam","TCGA-AX-A06H-01A-11",20,5,0,70,35,"TOP",5,0,"TCGA-AX-A06H-01A-01-MS1",55,"Paclitaxel","Chemotherapy","TCGA-AX-A06H-D9724",NA,NA,NA,NA,"NO",833,"WITH TUMOR","Alive",NA,"TCGA-AX-A06H-F29312","TCGA-AX-A06H",1,"AX","A06H","YES","C54.1","8380/3","C54.1","NO","YES",-22270,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","NOT HISPANIC OR LATINO","No","No","Alive",833,NA,NA,NA,"WITH TUMOR","NO",17,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2008,"Dilation and curettage procedure",NA,NA,NA,"G1","R1",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30994150,30696377,2140729658,"5BB1F89E-5334-4763-8790-793D60E8A9DC.bw","e604f5d4-f2c0-4404-9073-b8dbc8396778","5bb1f89e-5334-4763-8790-793d60e8a9dc","2016-08-05T05:01:18.157552-05:00","UNCID_2194931.b5ee1a9b-caca-4abf-9317-d6bf673b8e65.120306_UNC6-RDR300211_00136_FC_650PFAAXX_2.tar.gz","d8ba4373-5f20-4791-b5f1-ab0b34f0cc71",1950346697,"Illumina GA","802aaaba2c5cc3ebdc4289b50061f87a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:32:49.552974-05:00","2016-05-03T11:07:49.539899-05:00","d8ba4373-5f20-4791-b5f1-ab0b34f0cc71_analysis.xml","ad9c04ebe4f570292148327cf6972d75","7110cd46-bcdd-42e0-8f89-b67ddaf67e3b",2121,"2016-08-13T08:36:51.807602-05:00","d8ba4373-5f20-4791-b5f1-ab0b34f0cc71_experiment.xml","f3a4a6a144cc94cfaf7b693c76b35ef5","47c147ac-1bb2-4c07-a55d-e4fb4f9694cd",2257,"2016-09-29T19:34:27.956067-05:00","d8ba4373-5f20-4791-b5f1-ab0b34f0cc71_run.xml","9a43d8d8ded8309e28d97599d93c1c43","4d4c9b9f-1880-4ecc-8f77-953c309f8d23",347,"2016-09-08T11:14:02.411555-05:00","TCGA-B5-A0KB","2016-09-02T18:52:12.828010-05:00","female","TCGA-B5-A0KB_demographic",1948,"black or african american","2c9e2f40-5433-5194-ab7d-730d982de2f5","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A0KB_diagnosis","not reported",22669,"alive","8380/3",NA,824,"04bd0019-9fba-559e-8549-f05d73de63db","c54.1",-22669,"TCGA-B5-A0KB_treatment","a4dbf4c9-f936-5397-b5bc-a8ce8ada2980","01","true","TCGA-B5-A0KB-01B",NA,"fb68c314-c79f-41fb-8a28-afe26c8e5580",FALSE,"2C744545-8FF8-4A07-A8F2-A47D28B2A8E2","Primary Tumor",NA,368,430,NA,1300060800,"11",30,"TCGA-B5-A0KB-01B-11",70,NA,10,NA,0,NA,30,NA,"2016-09-08T11:14:02.411555-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"81781f54-de11-4d71-94a4-031093b1423c",NA,"TCGA-B5-A0KB-01B-01-TSA",NA,60,NA,"4a5cb203-dd6d-4438-b193-00b703a43c6e","RNA","TCGA-B5-A0KB-01B-11R","befb5ecf-ad38-4a93-85e3-14b68b6f0079",1.91,0.17,"UV Spec","R","23","TCGA-B5-A0KB-01B-11R-A14D-07","b5ee1a9b-caca-4abf-9317-d6bf673b8e65",0.17,NA,76,29.3198564870182,161,"a286396f-b102-5a6c-9739-896f8a125107","TCGA-B5-A0KB_exposure","UNCID_2194931.b5ee1a9b-caca-4abf-9317-d6bf673b8e65.120306_UNC6-RDR300211_00136_FC_650PFAAXX_2.tar.gz","2013-09-23T05:06:07.000Z","2013-09-23T05:18:01.000Z","D8BA4373-5F20-4791-B5F1-AB0B34F0CC71","FB68C314-C79F-41FB-8A28-AFE26C8E5580","Unaligned reads",1950346697,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B5EE1A9B-CACA-4ABF-9317-D6BF673B8E65","University of North Carolina","56607483e4b016715ab67633","E604F5D4-F2C0-4404-9073-B8DBC8396778","Uterine Corpus Endometrial Carcinoma","TARGZ","4A5CB203-DD6D-4438-B193-00B703A43C6E","2013-09-23T05:18:01.000Z","BEFB5ECF-AD38-4A93-85E3-14B68B6F0079","United States","NO",1,NA,"Primary Tumor","Duke",368,"4A5CB203-DD6D-4438-B193-00B703A43C6E",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FDAB5E26-83C0-46A6-859F-18727FBB2B21.txt",430,"TCGA-B5-A0KB-01B",NA,"816DA5FA-A6C2-49CC-8A7E-CD75033F3E24","TCGA",2010,NA,NA,"TUMOR FREE","FB68C314-C79F-41FB-8A28-AFE26C8E5580",62,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FDAB5E26-83C0-46A6-859F-18727FBB2B21.txt","Alive",NA,"TCGA-B5-A0KB",NA,"E84D743A-7110-4D33-AB63-2D6F60C37C63",NA,125,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,"D91BEA58-8C51-48BA-8879-D56CA1D01EFE","BLACK OR AFRICAN AMERICAN",NA,11,30,"81781F54-DE11-4D71-94A4-031093B1423C","BEFB5ECF-AD38-4A93-85E3-14B68B6F0079","UNCID_2194931.b5ee1a9b-caca-4abf-9317-d6bf673b8e65.120306_UNC6-RDR300211_00136_FC_650PFAAXX_2.tar.gz","TCGA-B5-A0KB-01B-11",70,0,10,40,30,"TOP",10,20,"TCGA-B5-A0KB-01B-01-TSA",60,"Paclitaxel","Chemotherapy","TCGA-B5-A0KB-D14638","TCGA-B5-A0KB-R14639","RADIOISOTOPES","Regional site",NA,"YES",824,"WITH TUMOR","Alive",NA,"TCGA-B5-A0KB-F32711","TCGA-B5-A0KB",1,"B5","A0KB","YES","C54.1","8380/3","C54.1","NO","YES",-22669,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"Yes","Yes","Alive",125,NA,NA,NA,"TUMOR FREE","NO",5,8,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
125311414,122122287,5830681564,"90837DC9-BC40-4642-BEF9-7D3C99B54069.bw","e6183a43-24b9-4fe1-95c3-4cff67e6c1ed","90837dc9-bc40-4642-bef9-7d3c99b54069","2016-08-05T17:23:21.156722-05:00","UNCID_2166575.24ee58d3-60c9-4808-b35a-2767594b83f8.130621_UNC14-SN744_0352_BC253TACXX_3_ACAGTG.tar.gz","c63d44f1-c9ad-4391-b1aa-0feb3713441b",5497637066,"Illumina HiSeq","e0f0b269bcbf35f41ab8d73167ac943d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:02:11.265839-05:00","2016-05-03T10:55:15.091331-05:00","c63d44f1-c9ad-4391-b1aa-0feb3713441b_analysis.xml","783fab88a7aa85e5c3be422f2c711ec0","a8b532a3-e846-43ed-a298-dc81e200a4b2",2130,"2016-09-29T22:30:22.231311-05:00","c63d44f1-c9ad-4391-b1aa-0feb3713441b_experiment.xml","2e7306fcbcb7804e33e451d6d9244da4","b9fc687a-58c8-487c-a968-d3c88d4a27d6",2600,"2016-09-29T22:24:44.908565-05:00","c63d44f1-c9ad-4391-b1aa-0feb3713441b_run.xml","60bbf9ae210dcfff21c6ef28e510c600","b672ab2f-ad82-4365-ae92-61c076f79a39",343,"2016-09-08T10:34:47.534096-05:00","TCGA-EO-A22Y","2016-09-02T18:53:57.241485-05:00","female","TCGA-EO-A22Y_demographic",1941,"white","5e0bfc08-50a0-56fd-b8fe-6dbdde64fd2e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A22Y_diagnosis","not reported",25127,"alive","8380/3",NA,1567,"c6501557-57ac-5799-85ec-44e4c15ae22b","c54.1",-25127,"TCGA-EO-A22Y_treatment","f8b5bb6c-83ad-5344-827a-dc977d0cd9d7","01","false","TCGA-EO-A22Y-01A",NA,"1fcdc9c7-5448-4a87-9ad5-cfb60837c296",FALSE,"44F2A17C-265B-4C2A-9AA0-42C55A23B592","Primary Tumor",NA,692,110,NA,1304899200,"11",30,"TCGA-EO-A22Y-01A-11",80,NA,20,NA,0,NA,15,NA,"2016-09-08T10:34:47.534096-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"0612aa32-3071-4cca-8081-000b85e065d4",NA,"TCGA-EO-A22Y-01A-01-TSA",NA,80,NA,"b2e826df-ceac-49f9-8474-f270360b1c2e","RNA","TCGA-EO-A22Y-01A-11R","4d67df35-b0b6-430b-af85-57210f825c48",1.82,0.16,"UV Spec","R","23","TCGA-EO-A22Y-01A-11R-A180-07","24ee58d3-60c9-4808-b35a-2767594b83f8",0.16,NA,NA,NA,NA,"30620e1d-2232-5827-9558-9cd84f67aadd","TCGA-EO-A22Y_exposure","UNCID_2166575.24ee58d3-60c9-4808-b35a-2767594b83f8.130621_UNC14-SN744_0352_BC253TACXX_3_ACAGTG.tar.gz","2013-08-29T15:52:21.000Z","2013-08-29T17:01:02.000Z","C63D44F1-C9AD-4391-B1AA-0FEB3713441B","1FCDC9C7-5448-4A87-9AD5-CFB60837C296","Unaligned reads",5497637066,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","24EE58D3-60C9-4808-B35A-2767594B83F8","University of North Carolina","564a3420e4b093830b66f1d4","E6183A43-24B9-4FE1-95C3-4CFF67E6C1ED","Uterine Corpus Endometrial Carcinoma","TARGZ","B2E826DF-CEAC-49F9-8474-F270360B1C2E","2013-08-29T17:01:02.000Z","4D67DF35-B0B6-430B-AF85-57210F825C48","Canada","NO",1,NA,"Primary Tumor","University Health Network",692,"B2E826DF-CEAC-49F9-8474-F270360B1C2E",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.90125C27-8268-4C34-B4B1-3CA0B40FD3A5.txt",110,"TCGA-EO-A22Y-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","362DFEE4-C69B-4B69-BBD2-C9F573CDE10D",68,"WHIRR_p_TCGA_168_169_170_redo_N_GenomeWideSNP_6_E04_845246.birdseed.data.txt","Alive",NA,"TCGA-EO-A22Y","NOT HISPANIC OR LATINO","D9244708-C668-45E9-9666-112242345E34",NA,754,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,"B4094B37-5FB3-4C10-8101-81866801F63B","WHITE",NA,11,30,"0612AA32-3071-4CCA-8081-000B85E065D4","7BD49972-3371-4CF5-B6D1-3C46DE697D63","WHIRR_p_TCGA_168_169_170_redo_N_GenomeWideSNP_6_E03_845188.hg19.seg.txt","TCGA-EO-A22Y-01A-11",80,0,20,40,15,"TOP",5,20,"TCGA-EO-A22Y-01A-01-TSA",80,NA,NA,NA,"TCGA-EO-A22Y-R56825","Internal","Primary Tumor Field","TCGA-EO-A22Y-F56824_NTE-1","NO",1567,"TUMOR FREE","Alive",NA,"TCGA-EO-A22Y-F56824","TCGA-EO-A22Y",1,"EO","A22Y","YES","C54.1","8380/3","C54.1","NO","YES",-25127,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",754,NA,NA,NA,"TUMOR FREE","NO",26,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35028178,34710759,2567985556,"B45E2407-A40C-4944-A449-58C82053327D.bw","e70465f6-1922-4eb7-b646-8b01ad3ce77b","b45e2407-a40c-4944-a449-58c82053327d","2016-08-31T11:15:54.134106-05:00","UNCID_2208105.abe099ed-caea-4903-aa4a-2729d2b28da2.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_3.tar.gz","cfdf72ea-2294-438c-b1e1-97cde0d420a7",2359041586,"Illumina GA","12bc87d4e87d0bc5739a70b9661a5fb2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:04:40.708439-05:00","2016-05-03T11:14:23.412460-05:00","cfdf72ea-2294-438c-b1e1-97cde0d420a7_analysis.xml","6ca73d6720d6ce8e8b2a0b75ca37de4c","3aa04dcd-e765-4706-8a21-f0df58226299",2121,"2016-09-29T21:57:34.835482-05:00","cfdf72ea-2294-438c-b1e1-97cde0d420a7_experiment.xml","b3abe684d9a41f2d34c4b69ff1724ffb","a5de18bf-a567-4bed-8f86-59ebe4e2d204",2257,"2016-09-29T21:15:48.237736-05:00","cfdf72ea-2294-438c-b1e1-97cde0d420a7_run.xml","12f7689deeb1ae3d0a64ae2830ff9654","8bee8d62-0ad1-4285-b3e7-59305e7aa359",347,"2016-09-08T11:34:19.815762-05:00","TCGA-D1-A16E","2016-09-02T18:50:13.068937-05:00","female","TCGA-D1-A16E_demographic",1935,"white","ee615383-004f-552b-b4bb-3ec74433dfa9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A16E_diagnosis","not reported",26859,"alive","8380/3",NA,1119,"3a94f159-3a38-550d-86eb-65f6b65800a6","c54.1",-26859,"TCGA-D1-A16E_treatment","d832fbd1-f20c-5ded-8321-bc80a7b81d63","01","false","TCGA-D1-A16E-01A",NA,"58fc1e66-39c4-44d1-bdd3-338e0d833792",FALSE,"DF926973-D344-48AE-A6F6-5901A4A8C846","Primary Tumor",NA,790,170,NA,1293062400,"22",20,"TCGA-D1-A16E-01A-22",80,NA,4,NA,0,NA,20,NA,"2016-09-08T11:34:19.815762-05:00",NA,5,NA,12,NA,"TOP",NA,0,NA,"0d3cd7be-8add-4d9b-b147-7a9e3c7fe00f",NA,"TCGA-D1-A16E-01A-02-TSB",NA,80,NA,"9938f00f-ec24-4fd9-94ca-b20e6d159919","RNA","TCGA-D1-A16E-01A-22R","ca8f7b2f-8ae6-489c-87d3-b5482afb1d99",1.83,0.15,"UV Spec","R","23","TCGA-D1-A16E-01A-22R-A12I-07","abe099ed-caea-4903-aa4a-2729d2b28da2",0.15,NA,60,25.2993759487266,154,"aeaec965-9093-51ac-b32b-c0bd1c6af66e","TCGA-D1-A16E_exposure","UNCID_2208105.abe099ed-caea-4903-aa4a-2729d2b28da2.110624_UNC6-RDR300211_00108_FC_634Y6AAXX_3.tar.gz","2013-09-30T08:55:04.000Z","2013-09-30T09:08:02.000Z","CFDF72EA-2294-438C-B1E1-97CDE0D420A7","58FC1E66-39C4-44D1-BDD3-338E0D833792","Unaligned reads",2359041586,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","ABE099ED-CAEA-4903-AA4A-2729D2B28DA2","University of North Carolina","564a3e5ee4b08c5d869272ef","E70465F6-1922-4EB7-B646-8B01AD3CE77B","Uterine Corpus Endometrial Carcinoma","TARGZ","9938F00F-EC24-4FD9-94CA-B20E6D159919","2013-09-30T09:08:02.000Z","CA8F7B2F-8AE6-489C-87D3-B5482AFB1D99","None","NO",1,NA,"Primary Tumor","Mayo Clinic",790,"9938F00F-EC24-4FD9-94CA-B20E6D159919",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.564E1D1E-8143-473D-B49A-A701458F6516.txt",170,"TCGA-D1-A16E-01A",NA,NA,"TCGA",2008,NA,NA,"TUMOR FREE","F4A2823E-A694-4036-88DC-8C27F7854DB4",73,"nationwidechildrens.org_clinical.TCGA-D1-A16E.xml","Alive",NA,"TCGA-D1-A16E","NOT HISPANIC OR LATINO","8960F329-2946-4782-984C-887C4D2438F6",NA,909,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,22,20,"0D3CD7BE-8ADD-4D9B-B147-7A9E3C7FE00F","D188D62E-B3AE-406D-8C52-D1D22F431193","UNCID_364303.TCGA-D1-A16E-01A-22R-A12I-07.110624_UNC6-RDR300211_00108_FC_634Y6AAXX.3.trimmed.annotated.translated_to_genomic.bam","TCGA-D1-A16E-01A-22",80,0,4,5,20,"TOP",0,12,"TCGA-D1-A16E-01A-02-TSB",80,NA,NA,NA,NA,NA,NA,NA,"NO",1119,"TUMOR FREE","Alive",NA,"TCGA-D1-A16E-F18558","TCGA-D1-A16E",1,"D1","A16E","YES","C54.1","8380/3","C54.1","NO","YES",-26859,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",909,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2008,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
117547018,114794203,5479230931,"DFD7454B-2F54-4D18-B57B-1D4F256F6BA0.bw","e71b3ce1-41e0-4cfc-9570-367b8c2124c1","dfd7454b-2f54-4d18-b57b-1d4f256f6ba0","2016-08-09T13:15:14.942697-05:00","UNCID_2173377.ed2e8014-4042-45fe-ae9d-78606344955b.130502_UNC12-SN629_0289_AC236KACXX_7_CGTACG.tar.gz","55ba237b-6274-4007-b940-4bc795c8dc17",5628816136,"Illumina HiSeq","25c34bf443220a4a1d5469940f774f92","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:09:45.232262-05:00","2016-05-03T10:55:55.610281-05:00","55ba237b-6274-4007-b940-4bc795c8dc17_analysis.xml","8e6167b34d354a7ee755df074374b8b5","d2775b03-418c-4b11-8d9f-78fc0d0f1e14",2123,"2016-10-07T17:24:29.938313-05:00","55ba237b-6274-4007-b940-4bc795c8dc17_experiment.xml","21f22af0a0770704cb9fd041b6ed6d64","5268cfc3-d9f5-48e2-b6b3-3e7da6ba715e",2431,"2016-09-29T19:01:37.821051-05:00","55ba237b-6274-4007-b940-4bc795c8dc17_run.xml","76d1dac8527c04fe59bc79b8486c7c86","389ee8c3-af88-4842-b4b8-fc03ca58375f",354,"2016-09-08T10:46:09.902160-05:00","TCGA-BK-A13B","2016-09-02T18:49:24.203142-05:00","female","TCGA-BK-A13B_demographic",1952,"black or african american","92a5ea75-6ced-568e-928f-d1aef0646988","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BK","45b0a8e5-a81b-50ab-8edb-279e96710b53","Christiana Healthcare","not reported","c54.1","TCGA-BK-A13B_diagnosis","not reported",21493,"alive","8380/3",NA,966,"6f7ffb2b-4f22-5c27-ab1c-9d85a9f94254","c54.1",-21493,"TCGA-BK-A13B_treatment","2b1a486b-d81a-5f2c-9f3a-8171782e237b","01","false","TCGA-BK-A13B-01A",NA,"9530bfbb-dffc-4a16-9444-d51e24f8e843",FALSE,"F8B15B22-27A6-4D7A-BCDC-B46EBCA5888E","Primary Tumor",NA,140,830,NA,1317340800,"51",23,"TCGA-BK-A13B-01A-51",80,NA,0,NA,0,NA,0,NA,"2016-09-08T10:46:09.902160-05:00",NA,0,NA,0,NA,"TOP",NA,3,NA,"335dc1cf-c47a-47b7-8e30-7a54d85bd7a5",NA,"TCGA-BK-A13B-01A-05-TS5",NA,97,NA,"cb529bbb-6538-4b3b-ac0b-db9e2fd6cc16","RNA","TCGA-BK-A13B-01A-51R","e55a2cd6-5b7d-4522-9635-aea63350058a",1.78,0.17,"UV Spec","R","23","TCGA-BK-A13B-01A-51R-A22K-07","ed2e8014-4042-45fe-ae9d-78606344955b",0.17,NA,131,45.3287197231834,170,"3b430ec6-98c1-5730-badc-fae97fc18bdb","TCGA-BK-A13B_exposure","UNCID_2173377.ed2e8014-4042-45fe-ae9d-78606344955b.130502_UNC12-SN629_0289_AC236KACXX_7_CGTACG.tar.gz","2013-09-09T17:36:08.000Z","2013-09-09T17:52:02.000Z","55BA237B-6274-4007-B940-4BC795C8DC17","9530BFBB-DFFC-4A16-9444-D51E24F8E843","Unaligned reads",5628816136,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","ED2E8014-4042-45FE-AE9D-78606344955B","University of North Carolina","564a3673e4b0298dd2c6d18c","E71B3CE1-41E0-4CFC-9570-367B8C2124C1","Uterine Corpus Endometrial Carcinoma","TARGZ","CB529BBB-6538-4B3B-AC0B-DB9E2FD6CC16","2013-09-09T17:52:02.000Z","E55A2CD6-5B7D-4522-9635-AEA63350058A","None","NO",1,NA,"Primary Tumor","Christiana Healthcare",140,"CB529BBB-6538-4B3B-AC0B-DB9E2FD6CC16",NA,"BK","TITER_p_TCGASNP_227_228_N_GenomeWideSNP_6_B08_1151428.byallele.copynumber.data.txt",830,"TCGA-BK-A13B-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","D0EC1601-662A-4FAC-9744-E639E7737248",58,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.B28F46F3-27E5-4A3D-9757-DB40F7859E76.txt","Alive",NA,"TCGA-BK-A13B","NOT HISPANIC OR LATINO","C122DBCA-ACE3-4DAA-B6D4-CBA3C0032301",NA,578,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"F4D3ED08-CD8B-47CB-AA9F-392F63D6EAD8","BLACK OR AFRICAN AMERICAN",NA,51,23,"335DC1CF-C47A-47B7-8E30-7A54D85BD7A5","E55A2CD6-5B7D-4522-9635-AEA63350058A","TCGA-BK-A13B-01A-51R-A22I-13_mirna.bam.bai","TCGA-BK-A13B-01A-51",80,0,0,0,0,"TOP",3,0,"TCGA-BK-A13B-01A-05-TS5",97,NA,NA,NA,"TCGA-BK-A13B-R21150","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",578,"TUMOR FREE","Alive",NA,"TCGA-BK-A13B-F21149","TCGA-BK-A13B",1,"BK","A13B","YES","C54.1","8380/3","C54.1","YES","NO",-21493,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",578,NA,NA,NA,"TUMOR FREE","NO",1,2,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33201758,32759295,2442975025,"0876B4BB-58BA-4C4C-84F4-E9D19EF96147.bw","e7e667be-9b31-4870-9c38-740098f37213","0876b4bb-58ba-4c4c-84f4-e9d19ef96147","2016-08-06T07:22:33.063257-05:00","UNCID_2203890.58957940-d71f-4ad5-98a8-c8f2913801c5.111018_UNC2-RDR300275_00092_FC_634BHAAXX_6.tar.gz","869d49f1-ef0a-4026-87b0-1e7383fac44e",2146681390,"Illumina GA","9c5d864fc6efd1ce33ba1c54f2274047","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:28:34.723639-05:00","2016-05-03T11:10:47.509879-05:00","869d49f1-ef0a-4026-87b0-1e7383fac44e_analysis.xml","40fdbbece83971475beb00022609bc6b","49b25990-2d9a-49cb-9b2b-492a25ad952f",2121,"2016-10-07T16:49:13.321735-05:00","869d49f1-ef0a-4026-87b0-1e7383fac44e_experiment.xml","257dbc0df07ce201614588b76d152a52","f746cf6b-8d45-4bcb-9c72-bd00b3f3ceb6",2257,"2016-09-29T23:49:18.033671-05:00","869d49f1-ef0a-4026-87b0-1e7383fac44e_run.xml","d879ce5a52015aedba6842d9c0f0d58e","eb0633db-e1ac-4439-ab51-f28b4a15a1fb",347,"2016-09-08T11:12:23.749919-05:00","TCGA-BG-A221","2016-09-02T18:52:38.257511-05:00","female","TCGA-BG-A221_demographic",1926,"white","6a80fd66-a580-51bd-b9f9-c954eb173de6","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A221_diagnosis","not reported",30960,"alive","8380/3",NA,55,"234059ae-74aa-52aa-9851-674d03cf8d59","c54.1",-30960,"TCGA-BG-A221_treatment","54302cd4-2071-5dda-a850-0217ad6ea790","01","true","TCGA-BG-A221-01A",NA,"d96882db-9a46-493a-a26b-efb7bddf34ff",FALSE,"58D68577-9022-4EF3-82E9-6EE159D41947","Primary Tumor",NA,99,240,NA,1302480000,"21",30,"TCGA-BG-A221-01A-21",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:12:23.749919-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"c3b6fa5c-49f8-41da-87bf-ab3ab1a7a9f3",NA,"TCGA-BG-A221-01A-02-TSB",NA,80,NA,"9c4f7dc8-0d95-4911-a3a2-d7efa1c2c8a3","RNA","TCGA-BG-A221-01A-21R","6be63c48-3be9-4dab-be2b-19fa15eb20f3",1.69,0.18,"UV Spec","R","23","TCGA-BG-A221-01A-21R-A157-07","58957940-d71f-4ad5-98a8-c8f2913801c5",0.18,NA,62,25.1531502292182,157,"4de3392f-10d1-5129-a1e5-9f3d19efdbdd","TCGA-BG-A221_exposure","UNCID_2203890.58957940-d71f-4ad5-98a8-c8f2913801c5.111018_UNC2-RDR300275_00092_FC_634BHAAXX_6.tar.gz","2013-09-26T07:31:04.000Z","2013-09-26T07:44:01.000Z","869D49F1-EF0A-4026-87B0-1E7383FAC44E","D96882DB-9A46-493A-A26B-EFB7BDDF34FF","Unaligned reads",2146681390,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","58957940-D71F-4AD5-98A8-C8F2913801C5","University of North Carolina","564a3713e4b093830b67e272","E7E667BE-9B31-4870-9C38-740098F37213","Uterine Corpus Endometrial Carcinoma","TARGZ","9C4F7DC8-0D95-4911-A3A2-D7EFA1C2C8A3","2013-09-26T07:44:01.000Z","6BE63C48-3BE9-4DAB-BE2B-19FA15EB20F3","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",99,"9C4F7DC8-0D95-4911-A3A2-D7EFA1C2C8A3",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8E13B416-DB5F-4D41-8126-0E55123579A2.txt",240,"TCGA-BG-A221-01A",NA,NA,"TCGA",2010,NA,NA,NA,"D96882DB-9A46-493A-A26B-EFB7BDDF34FF",84,"nationwidechildrens.org_clinical.TCGA-BG-A221.xml","Alive",NA,"TCGA-BG-A221","NOT HISPANIC OR LATINO","5E0A38BA-CE17-4259-BAE4-B72F0AA4EC82",NA,46,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",137,NA,NA,"WHITE",NA,21,30,"C3B6FA5C-49F8-41DA-87BF-AB3AB1A7A9F3","A4EFB0F3-F7EF-4878-BC1D-0ED9894628B6","UNCID_1646571.58957940-d71f-4ad5-98a8-c8f2913801c5.sorted_genome_alignments.bam","TCGA-BG-A221-01A-21",80,0,20,40,10,"TOP",10,20,"TCGA-BG-A221-01A-02-TSB",80,NA,NA,NA,NA,NA,NA,NA,"NO",55,"TUMOR FREE","Alive",NA,"TCGA-BG-A221-F28653","TCGA-BG-A221",1,"BG","A221","YES","C54.1","8380/3","C54.1","NO","YES",-30960,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",46,NA,NA,NA,NA,"NO",28,9,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,84,2010,"Dilation and curettage procedure",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
12327939,11857084,895080721,"A07ADC09-084C-422D-AF59-505DD79EDBDE.bw","e8909bdf-460c-4291-8e9b-7be12f343eae","a07adc09-084c-422d-af59-505dd79edbde","2016-08-09T14:17:42.475133-05:00","UNCID_2216179.4c101954-7344-4cf7-a1bd-4cfcf472e05d.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_5.tar.gz","d66cc30c-8feb-4ed5-90d3-4c3f740afdd5",716032827,"Illumina GA","23e530323baf459f9cfcfd295825e7c6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:42:09.234680-05:00","2016-05-03T11:18:46.986610-05:00","d66cc30c-8feb-4ed5-90d3-4c3f740afdd5_analysis.xml","9df9343da94d8865f6c023768482b201","5211d58a-229b-478b-8b0d-5b7fb40a42e8",2122,"2016-09-29T18:42:48.996015-05:00","d66cc30c-8feb-4ed5-90d3-4c3f740afdd5_experiment.xml","596a196ec75d38f9150c53c3dfdc5949","2ccf20a3-1f5b-4f63-a44b-0d1bce48ae91",2256,"2016-09-29T23:53:10.794378-05:00","d66cc30c-8feb-4ed5-90d3-4c3f740afdd5_run.xml","2435fa32d0225ea2929aee0bc94ee2d5","ed750aaf-ac56-4698-a80c-ac2525dd5ba3",345,"2016-09-08T10:44:15.204910-05:00","TCGA-AX-A063","2016-09-02T18:52:48.128213-05:00","female","TCGA-AX-A063_demographic",1941,"white","a79cde1d-b7cb-5f8f-9bfd-be728e18f270","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A063_diagnosis","not reported",23045,"alive","8380/3",NA,2417,"6f64640a-0b8c-5b5d-a19e-60719689e0aa","c54.1",-23045,"TCGA-AX-A063_treatment","c53da578-a68f-5ca8-9f73-1f1615f427e2","01","false","TCGA-AX-A063-01A",NA,"d5c708b2-29b0-42e0-980d-f54fe5e7fea1",FALSE,"E911408A-8447-4CB8-8A3F-B2C24875ACF0","Primary Tumor",NA,1950,190,NA,1275868800,"11",30,"TCGA-AX-A063-01A-11",92,92,0,0,6,8,2,6,"2016-09-08T10:44:15.204910-05:00","2016-09-08T10:44:15.204910-05:00",1,4,0,0,"BOTTOM","TOP",4,1,"4f62221c-1b56-4be0-bdd8-689975739dc5","884c5461-b1a1-4acd-8eb5-7317f85d3f2b","TCGA-AX-A063-01A-01-BS1","TCGA-AX-A063-01A-01-TS1",88,85,"d9596c8c-febe-4db2-a309-8029b6adbc17","RNA","TCGA-AX-A063-01A-11R","001177f3-efd6-48c3-b261-924d0989d2ad",1.8,0.16,"UV Spec","R","23","TCGA-AX-A063-01A-11R-A00V-07","4c101954-7344-4cf7-a1bd-4cfcf472e05d",0.16,NA,88,34.375,160,"593f60e8-985f-5033-812f-8d2089edeab9","TCGA-AX-A063_exposure","UNCID_2216179.4c101954-7344-4cf7-a1bd-4cfcf472e05d.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_5.tar.gz","2013-10-04T07:25:04.000Z","2013-10-04T07:37:02.000Z","D66CC30C-8FEB-4ED5-90D3-4C3F740AFDD5","D5C708B2-29B0-42E0-980D-F54FE5E7FEA1","Unaligned reads",716032827,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4C101954-7344-4CF7-A1BD-4CFCF472E05D","University of North Carolina","5660766fe4b018727fea0b52","E8909BDF-460C-4291-8E9B-7BE12F343EAE","Uterine Corpus Endometrial Carcinoma","TARGZ","D9596C8C-FEBE-4DB2-A309-8029B6ADBC17","2013-10-04T07:37:02.000Z","001177F3-EFD6-48C3-B261-924D0989D2AD","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1950,"D9596C8C-FEBE-4DB2-A309-8029B6ADBC17",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C40DB171-2B0B-48BD-AA20-C787378D57D3.txt",190,"TCGA-AX-A063-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","D5C708B2-29B0-42E0-980D-F54FE5E7FEA1",63,"AVOWS_p_TCGAb49_SNP_1N_GenomeWideSNP_6_C09_653350.raw.copynumber.data.txt","Alive",NA,"TCGA-AX-A063","NOT HISPANIC OR LATINO","B768BBCF-E00A-4724-AF67-9AB1B457168E",NA,2025,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"WHITE",NA,11,30,"884C5461-B1A1-4ACD-8EB5-7317F85D3F2B","B79C1CDB-0AA9-4549-AEE0-E946B7CC2A8E","TCGA-AX-A063-01A-11R-A00W-13_mirna.bam","TCGA-AX-A063-01A-11",92,6,0,1,2,"BOTTOM",4,0,"TCGA-AX-A063-01A-01-BS1",88,NA,NA,NA,NA,NA,NA,NA,NA,2025,"TUMOR FREE","Alive",NA,"TCGA-AX-A063-F5501","TCGA-AX-A063",1,"AX","A063","YES","C54.1","8380/3","C54.1","NO","YES",-23045,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2025,NA,NA,NA,"TUMOR FREE","NO",24,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2004,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29318430,29109610,2138091911,"9061C1A3-8141-4780-B3F0-4D499B0556F3.bw","e8c58d8b-51d7-4599-af79-469ee6f269db","9061c1a3-8141-4780-b3f0-4d499b0556f3","2016-08-09T14:13:54.310173-05:00","UNCID_2208071.75b0fdbd-9670-468e-b426-410c95d84426.110624_UNC2-RDR300275_00073_FC70KA5AAXX_1.tar.gz","9b2816cd-15c2-4d18-94d5-cc39dd1b5e7f",1769958228,"Illumina GA","951e8979ac52a9abfcd8d380febd5997","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:27:14.308859-05:00","2016-05-03T11:14:23.412460-05:00","9b2816cd-15c2-4d18-94d5-cc39dd1b5e7f_analysis.xml","c1f25d1ed2aae19ab4ac0874faba7937","b7fea83b-8b1d-44ab-8bbc-25c42732562d",2119,"2016-08-26T00:18:51.599993-05:00","9b2816cd-15c2-4d18-94d5-cc39dd1b5e7f_experiment.xml","7ce951e16d785dc14a76e8dd7d99d554","205c5d0b-a133-4baf-9453-d03ed003fdfe",2257,"2016-09-29T20:58:55.577145-05:00","9b2816cd-15c2-4d18-94d5-cc39dd1b5e7f_run.xml","fe35283858996ea5824a50f8acf183d9","8152a234-0e93-460c-91c2-385753ac19de",347,"2016-09-08T11:35:19.990734-05:00","TCGA-D1-A177","2016-09-02T18:50:34.680714-05:00","female","TCGA-D1-A177_demographic",1940,"white","dd1d384b-f3e5-53cb-b3e1-cff1a4d84850","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A177_diagnosis","not reported",25602,"alive","8380/3",NA,548,"2e0e272b-4997-507a-b791-0d1d28ed2cfd","c54.1",-25602,"TCGA-D1-A177_treatment","5b69be75-99d1-5c22-bb7f-f3f7fe51088a","01","false","TCGA-D1-A177-01A",NA,"97587fd4-0f6f-4af5-ac0a-7328abb40e9c",FALSE,"28FF1BEE-6F93-4BCA-A6DC-56A1EA8EA337","Primary Tumor",NA,227,190,NA,1294099200,"21",30,"TCGA-D1-A177-01A-21",60,NA,20,NA,0,NA,30,NA,"2016-09-08T11:35:19.990734-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"21ac5ebe-b9cb-4c6b-9618-dda4b8baa06d",NA,"TCGA-D1-A177-01A-02-TS2",NA,60,NA,"80ee4a64-0c0a-4344-8a48-8d241b2e347a","RNA","TCGA-D1-A177-01A-21R","34fa4406-bc22-4467-acdc-fda440db931a",1.32,0.17,"UV Spec","R","23","TCGA-D1-A177-01A-21R-A12I-07","75b0fdbd-9670-468e-b426-410c95d84426",0.17,NA,53,22.9397506925208,152,"5b9d01f1-6ff2-5183-ac55-f84e14e4619a","TCGA-D1-A177_exposure","UNCID_2208071.75b0fdbd-9670-468e-b426-410c95d84426.110624_UNC2-RDR300275_00073_FC70KA5AAXX_1.tar.gz","2013-09-30T08:16:03.000Z","2013-09-30T08:28:02.000Z","9B2816CD-15C2-4D18-94D5-CC39DD1B5E7F","97587FD4-0F6F-4AF5-AC0A-7328ABB40E9C","Unaligned reads",1769958228,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","75B0FDBD-9670-468E-B426-410C95D84426","University of North Carolina","56607910e4b016715ab6a178","E8C58D8B-51D7-4599-AF79-469EE6F269DB","Uterine Corpus Endometrial Carcinoma","TARGZ","80EE4A64-0C0A-4344-8A48-8D241B2E347A","2013-09-30T08:28:02.000Z","34FA4406-BC22-4467-ACDC-FDA440DB931A","None","NO",1,NA,"Primary Tumor","Mayo Clinic",227,"80EE4A64-0C0A-4344-8A48-8D241B2E347A",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.10E516C6-19DC-483A-ABA2-471E8FB9CB7E.txt",190,"TCGA-D1-A177-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","AAD4247B-3621-4856-8A51-46D2BA4EF136",70,"SCAUR_p_TCGA_b94_SNP_N_GenomeWideSNP_6_G08_755350.raw.copynumber.data.txt","Alive",NA,"TCGA-D1-A177","NOT HISPANIC OR LATINO","677252A6-9772-4AB4-8468-1D75DEE5441D",NA,347,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"7AE99512-DEBD-4888-A767-CF3F3C01DA77","WHITE",NA,21,30,"21AC5EBE-B9CB-4C6B-9618-DDA4B8BAA06D","464B7F76-3CA0-45A7-BEA8-410520952734","TCGA-D1-A177-01A-21R-A12H-13_mirna.bam.bai","TCGA-D1-A177-01A-21",60,0,20,40,30,"TOP",10,20,"TCGA-D1-A177-01A-02-TS2",60,NA,NA,NA,"TCGA-D1-A177-R20311","EXTERNAL BEAM","Regional site",NA,"YES",548,"TUMOR FREE","Alive",NA,"TCGA-D1-A177-F20307","TCGA-D1-A177",1,"D1","A177","YES","C54.1","8380/3","C54.1","NO","YES",-25602,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",347,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,70,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
120927050,118360871,5644460529,"5C99DD01-9C8A-4DD2-8DEF-22037BAECD9D.bw","e8c7195b-a26b-4d98-b1c5-0aa18385e9c8","5c99dd01-9c8a-4dd2-8def-22037baecd9d","2016-08-25T07:09:38.892070-05:00","UNCID_2316566.55b5dd8f-9e80-4084-9cb2-c04ccf558802.130909_UNC15-SN850_0326_AC2BWBACXX_1_GATCAG.tar.gz","586c82b7-d566-493f-86d5-ffd6d855a744",5545736226,"Illumina HiSeq","01d6b2a88835358a5e02ef0bb144c0dd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:30:58.463934-05:00","2016-05-03T11:28:50.207865-05:00","586c82b7-d566-493f-86d5-ffd6d855a744_analysis.xml","3e6260ec2f843acf45a9eb8760420dcd","df9ff3f9-b6e1-4bd9-b47a-177cf47e691a",2123,"2016-09-29T17:57:57.147931-05:00","586c82b7-d566-493f-86d5-ffd6d855a744_experiment.xml","7d11f6bf183f232f8d5662baafe88cb5","10a6c55c-71fc-493d-ad2f-e09c40594af3",2628,"2016-09-29T18:16:43.329868-05:00","586c82b7-d566-493f-86d5-ffd6d855a744_run.xml","59565251ec8f0c6f9206ebb3e8fd36b8","1c64e10c-ce04-4e15-87b6-8465172d5bf7",354,"2016-09-08T12:05:34.624534-05:00","TCGA-PG-A6IB","2016-09-02T18:51:23.766021-05:00","female","TCGA-PG-A6IB_demographic",1944,"black or african american","86dca230-c669-54c6-b78d-74b1fa5a7b19","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","PG","69bd8326-4904-56a0-8230-1615a777173b","Montefiore Medical Center","not reported","c54.1","TCGA-PG-A6IB_diagnosis","not reported",24969,"alive","8441/3",NA,648,"ea1ae058-a218-5194-81e9-51a1f83914d4","c54.1",-24969,"TCGA-PG-A6IB_treatment","0bad11d8-8e1b-5320-864d-e636cebccba9","01","true","TCGA-PG-A6IB-01A",NA,"c9c01ae7-bfdf-4077-b9d7-5d3698afd32f",FALSE,"C975AE5D-7370-4D1D-81AE-D3ABE5364055","Primary Tumor",NA,160,100,NA,1372118400,"21",20,"TCGA-PG-A6IB-01A-21",60,NA,1,NA,10,NA,20,NA,"2016-09-08T12:05:34.624534-05:00",NA,1,NA,2,NA,"TOP",NA,10,NA,"ce1616f6-ebd3-4ae0-96d2-72839f1f8719",NA,"TCGA-PG-A6IB-01A-02-TS2",NA,60,NA,"7ec4056f-5f09-48a7-99eb-ee3115db4150","RNA","TCGA-PG-A6IB-01A-21R","b76cb949-6052-412f-9a71-f4d9e366295b",1.86,0.18,"UV Spec","R","23","TCGA-PG-A6IB-01A-21R-A31O-07","55b5dd8f-9e80-4084-9cb2-c04ccf558802",0.18,NA,NA,NA,NA,"749ba3f0-ff5f-5a7d-9f1e-05fce7035ae8","TCGA-PG-A6IB_exposure","UNCID_2316566.55b5dd8f-9e80-4084-9cb2-c04ccf558802.130909_UNC15-SN850_0326_AC2BWBACXX_1_GATCAG.tar.gz","2014-01-07T02:59:21.000Z","2014-01-07T03:18:01.000Z","586C82B7-D566-493F-86D5-FFD6D855A744","C9C01AE7-BFDF-4077-B9D7-5D3698AFD32F","Unaligned reads",5545736226,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","55B5DD8F-9E80-4084-9CB2-C04CCF558802","University of North Carolina","564a3fabe4b08c5d8692df23","E8C7195B-A26B-4D98-B1C5-0AA18385E9C8","Uterine Corpus Endometrial Carcinoma","TARGZ","7EC4056F-5F09-48A7-99EB-EE3115DB4150","2014-01-07T03:18:01.000Z","B76CB949-6052-412F-9A71-F4D9E366295B","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",160,"7EC4056F-5F09-48A7-99EB-EE3115DB4150",NA,"PG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.91F3B808-ED4A-4631-8FFC-37AB68EBEF9B.txt",100,"TCGA-PG-A6IB-01A",NA,NA,"TCGA",2012,"TCGA-PG-A6IB_NTE-1","Complete Remission/Response","TUMOR FREE","C9C01AE7-BFDF-4077-B9D7-5D3698AFD32F",68,"nationwidechildrens.org_clinical.TCGA-PG-A6IB.xml","Alive",NA,"TCGA-PG-A6IB","NOT HISPANIC OR LATINO","D37DD8C5-BC62-4CC5-B08D-5FE217B69F2C","NO",277,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8441/3","FEMALE","C54.1",324,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,21,20,"CE1616F6-EBD3-4AE0-96D2-72839F1F8719","B76CB949-6052-412F-9A71-F4D9E366295B","TCGA-PG-A6IB-01A-21R-A31S-13_mirna.bam.bai","TCGA-PG-A6IB-01A-21",60,10,1,1,20,"TOP",10,2,"TCGA-PG-A6IB-01A-02-TS2",60,NA,NA,NA,NA,NA,NA,"TCGA-PG-A6IB-F59226_NTE-1","NO",470,"TUMOR FREE","Alive",NA,"TCGA-PG-A6IB-F59226","TCGA-PG-A6IB",1,"PG","A6IB","YES","C54.1","8441/3","C54.1","NO","YES",-24969,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",277,NA,NA,NA,"TUMOR FREE","YES",5,2,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,68,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32501624,32195818,2413469446,"FB44E71B-BB6A-4DED-A242-3EEBC75F4CD4.bw","e9fa66f5-282c-416a-9dcf-46714ea12fcf","fb44e71b-bb6a-4ded-a242-3eebc75f4cd4","2016-08-08T11:37:42.759405-05:00","UNCID_2196673.8fefb116-ef42-4566-a5e3-8793ca8b7cda.120216_UNC2-RDR300275_00113_FC_650PDAAXX_6.tar.gz","7d08b519-40bc-4005-9900-691de58d1329",2087617179,"Illumina GA","b29eb3b4aab3a69289135cf94a6b83c8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:52:44.640921-05:00","2016-05-03T11:07:49.541765-05:00","7d08b519-40bc-4005-9900-691de58d1329_analysis.xml","eba88051b25f6eb7768acba501684373","ed2e5342-50ee-4b40-9156-7a48e215dbfb",2121,"2016-09-29T20:02:29.680088-05:00","7d08b519-40bc-4005-9900-691de58d1329_experiment.xml","a7ada4fc9428e6f53da0ccfe6e361d9c","5ea1e02a-0116-47c4-9330-02bfedfb499c",2257,"2016-09-29T22:55:53.799591-05:00","7d08b519-40bc-4005-9900-691de58d1329_run.xml","ca069e585c439539a71b85b7997bd91f","c9c9c007-ae10-4e52-a6d3-2426b6620440",347,"2016-09-08T10:59:44.125774-05:00","TCGA-DI-A2QU","2016-09-02T18:54:18.153289-05:00","female","TCGA-DI-A2QU_demographic",1938,"white","74ad2067-0e7b-5ac0-8f46-6a3ca0f0e2c1","not hispanic or latino",2007,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A2QU_diagnosis","not reported",24488,"dead","8441/3",946,NA,"e65420d0-c503-5f87-b36b-859e397daaf4","c54.1",-24488,"TCGA-DI-A2QU_treatment","9cafd343-2663-5552-9e0e-03ff493eb811","11","false","TCGA-DI-A2QU-11A",NA,"6e54d197-a5e5-41a1-b9b8-d2a76b58a31d",FALSE,NA,"Solid Tissue Normal",NA,2296,230,NA,1315958400,"11",30,"TCGA-DI-A2QU-11A-11",0,NA,0,NA,0,NA,100,NA,"2016-09-08T10:59:44.125774-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"3af0418f-05eb-452b-9961-d3c8ee6c8c30",NA,"TCGA-DI-A2QU-11A-01-TS1",NA,0,NA,"292b3142-f335-4db8-b6b9-925f535e08bd","RNA","TCGA-DI-A2QU-11A-11R","1061d862-3835-4647-b422-03ef91345b53",1.79,0.15,"UV Spec","R","23","TCGA-DI-A2QU-11A-11R-A18M-07","8fefb116-ef42-4566-a5e3-8793ca8b7cda",0.15,NA,93,36.328125,160,"848610b9-b2ba-58bb-8576-6a6c657cf90b","TCGA-DI-A2QU_exposure","UNCID_2196673.8fefb116-ef42-4566-a5e3-8793ca8b7cda.120216_UNC2-RDR300275_00113_FC_650PDAAXX_6.tar.gz","2013-09-23T07:43:05.000Z","2013-09-23T07:54:02.000Z","7D08B519-40BC-4005-9900-691DE58D1329","6E54D197-A5E5-41A1-B9B8-D2A76B58A31D","Unaligned reads",2087617179,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8FEFB116-EF42-4566-A5E3-8793CA8B7CDA","University of North Carolina","566075e9e4b0b37b3d98fea2","E9FA66F5-282C-416A-9DCF-46714EA12FCF","Uterine Corpus Endometrial Carcinoma","TARGZ","292B3142-F335-4DB8-B6B9-925F535E08BD","2013-09-23T07:54:02.000Z","1061D862-3835-4647-B422-03EF91345B53","United States","NO",11,NA,"Solid Tissue Normal","MD Anderson",2296,"292B3142-F335-4DB8-B6B9-925F535E08BD",NA,"DI","UNCID_2196673.8fefb116-ef42-4566-a5e3-8793ca8b7cda.120216_UNC2-RDR300275_00113_FC_650PDAAXX_6.tar.gz",230,"TCGA-DI-A2QU-11A",NA,NA,"TCGA",2005,NA,NA,"WITH TUMOR","E319E562-6AF4-4A5A-B82B-94DDFB325AE8",67,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.051E4CE2-ABE2-443D-B2A6-E030EF7A01BF.txt","Dead",946,"TCGA-DI-A2QU","NOT HISPANIC OR LATINO",NA,NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,30,"3AF0418F-05EB-452B-9961-D3C8EE6C8C30","164E2E9E-7172-4699-88DB-42646D8F862B","CUTES_p_TCGA_172_176_178_SNP_N_GenomeWideSNP_6_D03_863590.CEL","TCGA-DI-A2QU-11A-11",0,0,0,5,100,"TOP",0,0,"TCGA-DI-A2QU-11A-01-TS1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-DI-A2QU",1,"DI","A2QU","YES","C54.1","8441/3","C54.1","NO","YES",-24488,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,946,NA,NA,"WITH TUMOR","NO",26,8,2011,"NO","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33590423,33331334,2500554834,"E05A16D7-DD3D-48DC-98D0-8F0DD825E2F0.bw","e9fa66f5-282c-416a-9dcf-46714ea12fcf","e05a16d7-dd3d-48dc-98d0-8f0dd825e2f0","2016-08-09T14:03:48.690910-05:00","UNCID_2196726.94746e57-a703-4b53-bcdc-11107424eb23.120216_UNC2-RDR300275_00113_FC_650PDAAXX_5.tar.gz","4b8d64ba-06e9-4928-97f8-b3547cdf11fd",2166756986,"Illumina GA","02463d2d014f9d9ed3575d1e7ab4956f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:14:15.486354-05:00","2016-05-03T11:08:33.743897-05:00","4b8d64ba-06e9-4928-97f8-b3547cdf11fd_analysis.xml","7d9d576ceade0553038ca8c9b002c0ae","b0100e40-41f2-44af-bfb8-097444140041",2121,"2016-10-07T17:48:15.625531-05:00","4b8d64ba-06e9-4928-97f8-b3547cdf11fd_experiment.xml","b02ae2fec09dcd6b7fb12447f95d1ef1","7f77f338-1e47-4135-81cf-f770147000cf",2257,"2016-09-29T23:03:15.802649-05:00","4b8d64ba-06e9-4928-97f8-b3547cdf11fd_run.xml","42d21750458db1546d9b755fe7cb0d46","ce47dd53-283e-4330-a9c1-42e62420fbbe",347,"2016-09-08T10:59:44.125774-05:00","TCGA-DI-A2QU","2016-09-02T18:54:18.153289-05:00","female","TCGA-DI-A2QU_demographic",1938,"white","74ad2067-0e7b-5ac0-8f46-6a3ca0f0e2c1","not hispanic or latino",2007,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A2QU_diagnosis","not reported",24488,"dead","8441/3",946,NA,"e65420d0-c503-5f87-b36b-859e397daaf4","c54.1",-24488,"TCGA-DI-A2QU_treatment","9cafd343-2663-5552-9e0e-03ff493eb811","01","false","TCGA-DI-A2QU-01A",NA,"e319e562-6af4-4a5a-b82b-94ddfb325ae8",FALSE,"43F1EE09-6F10-4BCE-A55C-147084A26999","Primary Tumor",NA,2296,240,NA,1315958400,"11",30,"TCGA-DI-A2QU-01A-11",90,NA,15,NA,0,NA,10,NA,"2016-09-08T10:59:44.125774-05:00",NA,8,NA,3,NA,"TOP",NA,3,NA,"e602a9dd-b0e1-4a9b-b796-c7a01591cad4",NA,"TCGA-DI-A2QU-01A-01-TS1",NA,87,NA,"6eee77ef-7b36-4f34-8c60-5ae75596050a","RNA","TCGA-DI-A2QU-01A-11R","3518a1d4-2bf8-4d50-a18e-66240e61afc8",1.8,0.17,"UV Spec","R","23","TCGA-DI-A2QU-01A-11R-A18M-07","94746e57-a703-4b53-bcdc-11107424eb23",0.17,NA,93,36.328125,160,"848610b9-b2ba-58bb-8576-6a6c657cf90b","TCGA-DI-A2QU_exposure","UNCID_2196726.94746e57-a703-4b53-bcdc-11107424eb23.120216_UNC2-RDR300275_00113_FC_650PDAAXX_5.tar.gz","2013-09-23T20:16:05.000Z","2013-09-23T21:05:01.000Z","4B8D64BA-06E9-4928-97F8-B3547CDF11FD","E319E562-6AF4-4A5A-B82B-94DDFB325AE8","Unaligned reads",2166756986,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","94746E57-A703-4B53-BCDC-11107424EB23","University of North Carolina","564a31e6e4b093830b663c1e","E9FA66F5-282C-416A-9DCF-46714EA12FCF","Uterine Corpus Endometrial Carcinoma","TARGZ","6EEE77EF-7B36-4F34-8C60-5AE75596050A","2013-09-23T21:05:01.000Z","3518A1D4-2BF8-4D50-A18E-66240E61AFC8","United States","NO",1,NA,"Primary Tumor","MD Anderson",2296,"6EEE77EF-7B36-4F34-8C60-5AE75596050A",NA,"DI","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.051E4CE2-ABE2-443D-B2A6-E030EF7A01BF.txt",240,"TCGA-DI-A2QU-01A",NA,NA,"TCGA",2005,NA,NA,"WITH TUMOR","E319E562-6AF4-4A5A-B82B-94DDFB325AE8",67,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.051E4CE2-ABE2-443D-B2A6-E030EF7A01BF.txt","Dead",946,"TCGA-DI-A2QU","NOT HISPANIC OR LATINO",NA,NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",178,NA,NA,"WHITE",NA,11,30,"E602A9DD-B0E1-4A9B-B796-C7A01591CAD4","9D65CE9B-AC78-452F-82FC-843336E7863D","2f4febc997c09b67afc21b2b65d9c74c.bam.bai","TCGA-DI-A2QU-01A-11",90,0,15,8,10,"TOP",3,3,"TCGA-DI-A2QU-01A-01-TS1",87,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-DI-A2QU",1,"DI","A2QU","YES","C54.1","8441/3","C54.1","NO","YES",-24488,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,946,NA,NA,"WITH TUMOR","NO",26,8,2011,"NO","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3","RX",NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
133213242,130066637,6203780794,"469F83C7-1993-4EDA-AC5F-563A2F8A18A6.bw","ea1c693d-490d-4816-b6e3-d12946ad7cc1","469f83c7-1993-4eda-ac5f-563a2f8a18a6","2016-08-25T23:43:52.720779-05:00","UNCID_2316531.4547d0d6-21ed-4128-9be9-34555bff3b83.131008_UNC15-SN850_0331_AC2KJ8ACXX_1_TGACCA.tar.gz","2cdc9349-21b4-43c7-9ed9-f8777cf2e461",6174699086,"Illumina HiSeq","f88b92dca6fac3f0c64104d0e0514b40","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:25:03.386766-05:00","2016-05-03T11:28:50.231867-05:00","2cdc9349-21b4-43c7-9ed9-f8777cf2e461_analysis.xml","c0f9a874c3164b20a442e51447218c35","dbdbdc73-d4da-4b04-b1af-9923f1dd6a4b",2124,"2016-08-29T16:34:58.895508-05:00","2cdc9349-21b4-43c7-9ed9-f8777cf2e461_experiment.xml","04755e1c1356061a4bd31f6b30f33d8c","673ba31f-372b-4ba9-ad12-27ad6d5f039a",2628,"2016-09-29T17:45:59.698342-05:00","2cdc9349-21b4-43c7-9ed9-f8777cf2e461_run.xml","73aa447aaa14311d3ec1ffcd9f2b8778","092850e5-882e-4fb3-b86c-6fc124b1f4e8",354,"2016-09-08T11:06:18.135535-05:00","TCGA-EY-A210","2016-09-02T18:52:41.991841-05:00","female","TCGA-EY-A210_demographic",1929,"black or african american","63c1a62a-724b-537a-ae88-6845143841c9","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A210_diagnosis","not reported",30095,"alive","8441/3",NA,383,"166ebb1b-3acb-5af6-b800-00d5930c720c","c54.1",-30095,"TCGA-EY-A210_treatment","04ef0a9b-f05f-570b-a62c-8c689c93eda4","01","false","TCGA-EY-A210-01A",NA,"3879caa4-a747-4879-8923-05232476730d",FALSE,"51A98C43-6A6A-4027-8E92-B3B9AA1A63D4","Primary Tumor",NA,70,840,NA,1303862400,"11",30,"TCGA-EY-A210-01A-11",95,NA,5,NA,0,NA,5,NA,"2016-09-08T11:06:18.135535-05:00",NA,35,NA,15,NA,"TOP",NA,0,NA,"dda817ab-29c4-497c-9d8a-73e0a0225243",NA,"TCGA-EY-A210-01A-01-TSA",NA,95,NA,"010f8ce1-fa47-45a2-a1fe-358229dbadc8","RNA","TCGA-EY-A210-01A-11R","846f1496-827e-4cb0-8459-63a933f2da54",1.94,0.17,"UV Spec","R","23","TCGA-EY-A210-01A-11R-A157-07","4547d0d6-21ed-4128-9be9-34555bff3b83",0.17,NA,63,26.2226847034339,155,"8460df12-0130-5350-af7d-03a381ec9c02","TCGA-EY-A210_exposure","UNCID_2316531.4547d0d6-21ed-4128-9be9-34555bff3b83.131008_UNC15-SN850_0331_AC2KJ8ACXX_1_TGACCA.tar.gz","2014-01-07T02:16:38.000Z","2014-01-07T04:45:01.000Z","2CDC9349-21B4-43C7-9ED9-F8777CF2E461","3879CAA4-A747-4879-8923-05232476730D","Unaligned reads",6174699086,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","4547D0D6-21ED-4128-9BE9-34555BFF3B83","University of North Carolina","564a5861e4b093830b6c00f6","EA1C693D-490D-4816-B6E3-D12946AD7CC1","Uterine Corpus Endometrial Carcinoma","TARGZ","010F8CE1-FA47-45A2-A1FE-358229DBADC8","2014-01-07T04:45:01.000Z","846F1496-827E-4CB0-8459-63A933F2DA54","United States","NO",1,NA,"Primary Tumor","University of North Carolina",70,"010F8CE1-FA47-45A2-A1FE-358229DBADC8",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CD95626D-05E0-4A37-A046-AFB888D11C6E.txt",840,"TCGA-EY-A210-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","618AFD8C-90F2-43AD-A053-FB281CAC2315",82,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.CD95626D-05E0-4A37-A046-AFB888D11C6E.txt","Alive",NA,"TCGA-EY-A210","NOT HISPANIC OR LATINO","740B88E8-7679-4895-9D47-374A9537FB46",NA,166,"No","Uterus","C54.1",NA,"Mixed serous and endometrioid",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",137,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"DDA817AB-29C4-497C-9D8A-73E0A0225243","A27EC50E-B14D-40C6-A1B8-727DDD976C8D","TCGA-EY-A210-01A-11R-A156-13_mirna.bam.bai","TCGA-EY-A210-01A-11",95,0,5,35,5,"TOP",0,15,"TCGA-EY-A210-01A-01-TSA",95,NA,NA,NA,NA,NA,NA,NA,"NO",383,"TUMOR FREE","Alive",NA,"TCGA-EY-A210-F21703","TCGA-EY-A210",1,"EY","A210","YES","C54.1","8441/3","C54.1","YES","NO",-30095,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",166,NA,NA,NA,"TUMOR FREE","NO",6,7,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Mixed serous and endometrioid",NA,0,82,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
141315122,137288430,6544192777,"8E9CAAC7-31D3-473C-821C-2DAD37B44D3A.bw","ea95897e-3fe0-4c79-b170-88b0f229794c","8e9caac7-31d3-473c-821c-2dad37b44d3a","2016-08-25T13:59:12.538783-05:00","UNCID_2581797.c590ff56-1d2d-40ea-9fba-0768d66ec12c.140408_UNC11-SN627_0351_AC3KY3ACXX_7_TGACCA.tar.gz","865ae732-7397-4d88-ab44-4c6d8cefa161",6299266167,"Illumina HiSeq","8d46bff29aae362972b44186043b085d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:03:37.493675-05:00","2016-05-03T11:55:56.226464-05:00","865ae732-7397-4d88-ab44-4c6d8cefa161_analysis.xml","b165973e63386b7835c8d446ef42d00e","39f9379b-eca1-43af-b1ea-478cc1e90b19",2124,"2016-09-29T18:15:51.723190-05:00","865ae732-7397-4d88-ab44-4c6d8cefa161_experiment.xml","13ecf4ff40b834a7f0a4ef1c492efbac","1bd43360-f549-40c2-be6e-f99a535a64c9",2628,"2016-09-29T20:15:52.581229-05:00","865ae732-7397-4d88-ab44-4c6d8cefa161_run.xml","12a264ec72dc4589b3725b7ede215f0f","66bc0924-3b8a-4931-83d3-44fb04178f81",354,"2016-09-08T13:07:15.278857-05:00","TCGA-PG-A915","2016-09-02T18:51:54.472040-05:00","female","TCGA-PG-A915_demographic",1953,"black or african american","27d1bde4-7227-5326-82a1-ce3dcf173f2d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","PG","69bd8326-4904-56a0-8230-1615a777173b","Montefiore Medical Center","not reported","c54.1","TCGA-PG-A915_diagnosis","not reported",22119,"alive","8461/3",NA,249,"f3055bcf-c763-590e-869a-dfd58ff0b510","c54.1",-22119,"TCGA-PG-A915_treatment","395b3137-55c4-5cba-9839-2c11f999844e","01","true","TCGA-PG-A915-01A",NA,"caffe64c-1fb0-4229-b355-4b798d9506b0",FALSE,"F2869E10-B5EB-4AB7-9CC9-A7B2E5DDBB7C","Primary Tumor",NA,238,410,NA,1388361600,"11",30,"TCGA-PG-A915-01A-11",95,NA,0,NA,0,NA,10,NA,"2016-09-08T13:07:15.278857-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"a1661cc6-b413-4413-bf28-6d7409f6b0e3",NA,"TCGA-PG-A915-01A-01-TSA",NA,90,NA,"77a4a074-94eb-43ec-a09d-b8be8e24f1bc","RNA","TCGA-PG-A915-01A-11R","f1e6d5fc-d3f0-4c38-9185-3ef4eb1374e1",1.89,0.18,"UV Spec","R","23","TCGA-PG-A915-01A-11R-A37O-07","c590ff56-1d2d-40ea-9fba-0768d66ec12c",0.18,NA,NA,NA,NA,"c8389749-aa97-589f-a8ab-4b3c0df261a5","TCGA-PG-A915_exposure","UNCID_2581797.c590ff56-1d2d-40ea-9fba-0768d66ec12c.140408_UNC11-SN627_0351_AC3KY3ACXX_7_TGACCA.tar.gz","2014-08-15T11:37:03.000Z","2014-08-15T11:56:50.000Z","865AE732-7397-4D88-AB44-4C6D8CEFA161","CAFFE64C-1FB0-4229-B355-4B798D9506B0","Unaligned reads",6299266167,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","C590FF56-1D2D-40EA-9FBA-0768D66EC12C","University of North Carolina","56607de2e4b018727fea34eb","EA95897E-3FE0-4C79-B170-88B0F229794C","Uterine Corpus Endometrial Carcinoma","TARGZ","77A4A074-94EB-43EC-A09D-B8BE8E24F1BC","2014-08-15T11:56:50.000Z","F1E6D5FC-D3F0-4C38-9185-3EF4EB1374E1","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",238,"77A4A074-94EB-43EC-A09D-B8BE8E24F1BC",NA,"PG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7629E5EF-DE9B-46C7-93BC-03D42328EC4A.txt",410,"TCGA-PG-A915-01A",NA,NA,"TCGA",2013,"TCGA-PG-A915_NTE-1","Complete Remission/Response","TUMOR FREE","CAFFE64C-1FB0-4229-B355-4B798D9506B0",60,"9721366013_R02C02_Red.idat","Alive",NA,"TCGA-PG-A915","NOT HISPANIC OR LATINO","07B386BC-490C-4CFF-BF77-1E16427E7062","NO",213,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8461/3","FEMALE","C54.1",381,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"A1661CC6-B413-4413-BF28-6D7409F6B0E3","BD5C2FEF-9B9B-4223-B8C3-EC7DC9353130","UNCID_2581797.c590ff56-1d2d-40ea-9fba-0768d66ec12c.140408_UNC11-SN627_0351_AC3KY3ACXX_7_TGACCA.tar.gz","TCGA-PG-A915-01A-11",95,0,0,0,10,"TOP",0,0,"TCGA-PG-A915-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,"TCGA-PG-A915-F67387_NTE-1","NO",249,NA,"Alive",NA,"TCGA-PG-A915-F67387","TCGA-PG-A915",1,"PG","A915","YES","C54.1","8461/3","C54.1","NO","YES",-22119,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",213,NA,"NO","NO","TUMOR FREE","YES",25,4,2014,"YES","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,60,2013,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
126460672,122389763,5836581497,"E39D9DB8-83DF-48A1-A43C-D24E78D53E78.bw","eb642568-30d4-4805-a295-bda314ccaaaf","e39d9db8-83df-48a1-a43c-d24e78d53e78","2016-09-29T23:37:19.510230-05:00","UNCID_2581801.916cf47a-0100-4e01-a912-2e884777186f.140408_UNC11-SN627_0351_AC3KY3ACXX_3_CAGATC.tar.gz","c0d693d1-4075-45e8-8795-eba0f2c8f583",5495823058,"Illumina HiSeq","cbbdc37cd983d07256972ef8a9c790a5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:46:13.957523-05:00","2016-05-03T11:55:56.226464-05:00","c0d693d1-4075-45e8-8795-eba0f2c8f583_analysis.xml","a67f5d1fc5835d8e211639cfd9bbfb7c","9eb12a42-f596-4d30-a0db-6ee700e283b3",2124,"2016-10-07T15:55:39.310908-05:00","c0d693d1-4075-45e8-8795-eba0f2c8f583_experiment.xml","27ff283b2845e24fa10c41f8bf83de89","3a9b9e9b-3c9a-41a4-bbd0-c428c846184b",2628,"2016-09-30T00:11:36.006195-05:00","c0d693d1-4075-45e8-8795-eba0f2c8f583_run.xml","407268247ef880b35bbcd452267c75b2","f8b1e169-2534-49cd-963b-6a12c3a92d52",354,"2016-09-08T10:34:25.378897-05:00","TCGA-E6-A8L9","2016-09-02T18:51:45.300678-05:00","female","TCGA-E6-A8L9_demographic",1951,"black or african american","f0e29733-ab34-52ea-8d38-1c603eda8865","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","E6","39aa3c67-c7d9-5001-8ed1-3bf83eac7872","Roswell Park","not reported","c54.1","TCGA-E6-A8L9_diagnosis","not reported",22333,"alive","8441/3",NA,1013,"bee9e07c-de76-5588-8add-332436e717e2","c54.1",-22333,"TCGA-E6-A8L9_treatment","cfdb0473-ab2f-5c6b-856f-3843aa400c27","01","true","TCGA-E6-A8L9-01A",NA,"04225ab6-5a39-4694-bab3-423f95d60421",FALSE,"40CB57C1-7E8C-45B0-BEDD-DFE531C9201E","Primary Tumor",NA,657,200,NA,1385942400,"21",30,"TCGA-E6-A8L9-01A-21",70,NA,1,NA,10,NA,20,NA,"2016-09-08T10:34:25.378897-05:00",NA,5,NA,1,NA,"TOP",NA,0,NA,"00af22b5-6c5a-4ead-af04-d7b43d6c333b",NA,"TCGA-E6-A8L9-01A-02-TSB",NA,70,NA,"bf8de433-036b-41fa-bd8c-312cd8136c90","RNA","TCGA-E6-A8L9-01A-21R","8b57eed4-ec7a-4cd4-b037-803acfeee916",1.92,0.17,"UV Spec","R","23","TCGA-E6-A8L9-01A-21R-A37O-07","916cf47a-0100-4e01-a912-2e884777186f",0.17,NA,78,29.7210791037952,162,"bae38ce8-a6dc-5552-a7a5-16ef70237e9f","TCGA-E6-A8L9_exposure","UNCID_2581801.916cf47a-0100-4e01-a912-2e884777186f.140408_UNC11-SN627_0351_AC3KY3ACXX_3_CAGATC.tar.gz","2014-08-15T12:07:04.000Z","2014-08-15T12:23:57.000Z","C0D693D1-4075-45E8-8795-EBA0F2C8F583","04225AB6-5A39-4694-BAB3-423F95D60421","Unaligned reads",5495823058,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","916CF47A-0100-4E01-A912-2E884777186F","University of North Carolina","564a4030e4b0ef12181bf9e2","EB642568-30D4-4805-A295-BDA314CCAAAF","Uterine Corpus Endometrial Carcinoma","TARGZ","BF8DE433-036B-41FA-BD8C-312CD8136C90","2014-08-15T12:23:57.000Z","8B57EED4-EC7A-4CD4-B037-803ACFEEE916","United States","NO",1,NA,"Primary Tumor","Roswell Park",657,"BF8DE433-036B-41FA-BD8C-312CD8136C90",NA,"E6","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9B18D6BD-ECE6-49B4-A70E-92E1B8BC3153.txt",200,"TCGA-E6-A8L9-01A",NA,"DCF63FF7-75E5-4FEF-A592-9D9AB93B9049","TCGA",2012,"TCGA-E6-A8L9_NTE-1","Complete Remission/Response","TUMOR FREE","DBAEC985-0418-4ABE-86C0-A2DDC177AD0D",61,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9B18D6BD-ECE6-49B4-A70E-92E1B8BC3153.txt","Alive",NA,"TCGA-E6-A8L9","NOT HISPANIC OR LATINO","8795919F-7955-4D9A-A627-E9F4F87E2973","NO",740,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",381,NA,"9844C934-AD21-4DD0-A546-926E15646D30","BLACK OR AFRICAN AMERICAN",NA,21,30,"00AF22B5-6C5A-4EAD-AF04-D7B43D6C333B","6E2E5514-D627-4014-AEE1-5B1E3EEFB745","UNCID_2581801.916cf47a-0100-4e01-a912-2e884777186f.140408_UNC11-SN627_0351_AC3KY3ACXX_3_CAGATC.tar.gz","TCGA-E6-A8L9-01A-21",70,10,1,5,20,"TOP",0,1,"TCGA-E6-A8L9-01A-02-TSB",70,"Carboplatin","Chemotherapy","TCGA-E6-A8L9-D58266","TCGA-E6-A8L9-R58264","Internal","Regional site","TCGA-E6-A8L9-F69832_NTE-1","NO",1013,"TUMOR FREE","Alive",NA,"TCGA-E6-A8L9-F69832","TCGA-E6-A8L9",1,"E6","A8L9","YES","C54.1","8441/3","C54.1","NO","YES",-22333,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes","No","Alive",740,NA,"YES","YES","TUMOR FREE","YES",3,4,2014,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,61,2012,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36852498,36575080,2742787036,"48BCD3B8-917F-4E8F-BCEA-1363570A6486.bw","ebc25a41-becb-4395-ae33-483a304b07d8","48bcd3b8-917f-4e8f-bcea-1363570a6486","2016-08-06T07:28:07.725450-05:00","UNCID_2194836.b408b777-f98b-4660-b01b-89fa0c607c3b.120307_UNC2-RDR300275_00118_FC_650V8AAXX_4.tar.gz","4e34b9af-adf9-4cb7-87f2-ce9c1bdfdfb7",2380677208,"Illumina GA","4957546ce70ce0368f4cc02b178eb8aa","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:11:07.375444-05:00","2016-05-03T11:07:49.533775-05:00","4e34b9af-adf9-4cb7-87f2-ce9c1bdfdfb7_analysis.xml","7a63755eeb1381da282cd44e7a7ad6f1","8907d148-cc5a-4ac0-84dc-f71e004088b6",2121,"2016-09-29T18:29:01.242733-05:00","4e34b9af-adf9-4cb7-87f2-ce9c1bdfdfb7_experiment.xml","a7a87a02ef1fcf72e634dfc180bb0889","2412df4b-393d-4cc5-8131-3928dd55bf64",2257,"2016-09-30T00:08:08.700042-05:00","4e34b9af-adf9-4cb7-87f2-ce9c1bdfdfb7_run.xml","cc4278fcf20bc1d1f34ca795d3163dd9","f68aee32-253e-4c94-ad48-1dd790ce1302",347,"2016-09-08T11:43:33.299704-05:00","TCGA-EY-A1GC","2016-09-02T18:51:50.759639-05:00","female","TCGA-EY-A1GC_demographic",1947,"white","7dd5c05e-762f-5589-8195-2e1094cbb70d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GC_diagnosis","not reported",22656,"alive","8380/3",NA,1647,"703cdc4e-e025-5a91-aaf0-de0ac7d672d3","c54.1",-22656,"TCGA-EY-A1GC_treatment","381dfebc-8325-5e88-b190-1ac9d2d9166e","01","false","TCGA-EY-A1GC-01A",NA,"06be0e15-e48e-4243-ad8d-86cca9da68f9",FALSE,"62D18250-0D82-43AB-AADE-E152D6FF74BB","Primary Tumor",NA,519,290,NA,1297900800,"11",30,"TCGA-EY-A1GC-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T11:43:33.299704-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"04b631ae-2ae9-48a9-a891-3f64e3c9d678",NA,"TCGA-EY-A1GC-01A-01-TSA",NA,100,NA,"9183d282-dd1f-40a1-94ff-3da0206bc3ed","RNA","TCGA-EY-A1GC-01A-11R","0c05631e-65b8-470f-a67b-ec546c1fea90",1.82,0.18,"UV Spec","R","23","TCGA-EY-A1GC-01A-11R-A13S-07","b408b777-f98b-4660-b01b-89fa0c607c3b",0.18,NA,96,34.4221736168382,167,"0c29e8f5-09f5-5d0b-8e8b-447979b446de","TCGA-EY-A1GC_exposure","UNCID_2194836.b408b777-f98b-4660-b01b-89fa0c607c3b.120307_UNC2-RDR300275_00118_FC_650V8AAXX_4.tar.gz","2013-09-23T04:07:07.000Z","2013-09-23T04:19:02.000Z","4E34B9AF-ADF9-4CB7-87F2-CE9C1BDFDFB7","06BE0E15-E48E-4243-AD8D-86CCA9DA68F9","Unaligned reads",2380677208,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B408B777-F98B-4660-B01B-89FA0C607C3B","University of North Carolina","56607682e4b016715ab68f5a","EBC25A41-BECB-4395-AE33-483A304B07D8","Uterine Corpus Endometrial Carcinoma","TARGZ","9183D282-DD1F-40A1-94FF-3DA0206BC3ED","2013-09-23T04:19:02.000Z","0C05631E-65B8-470F-A67B-EC546C1FEA90","United States","NO",1,NA,"Primary Tumor","University of North Carolina",519,"9183D282-DD1F-40A1-94FF-3DA0206BC3ED",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.58118A63-3A3A-4625-A75E-D8EDA915269A.txt",290,"TCGA-EY-A1GC-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","4FB947E9-0D41-4002-850C-771D676AAA4F",62,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.58118A63-3A3A-4625-A75E-D8EDA915269A.txt","Alive",NA,"TCGA-EY-A1GC","NOT HISPANIC OR LATINO","E2AB9A50-2139-4160-8420-E9F1360BDDBB",NA,138,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"WHITE",NA,11,30,"04B631AE-2AE9-48A9-A891-3F64E3C9D678","C7240DC9-B9AE-4BAD-9E45-5CF89351FBCC","UNCID_2194836.b408b777-f98b-4660-b01b-89fa0c607c3b.120307_UNC2-RDR300275_00118_FC_650V8AAXX_4.tar.gz","TCGA-EY-A1GC-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-EY-A1GC-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",138,"TUMOR FREE","Alive",NA,"TCGA-EY-A1GC-F19721","TCGA-EY-A1GC",1,"EY","A1GC","YES","C54.1","8380/3","C54.1","NO","YES",-22656,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",138,NA,NA,NA,"TUMOR FREE","NO",2,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,62,2009,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
106346022,102862798,4903370032,"D0CCA6E0-8557-491C-AB82-289DF53E57FA.bw","ec2040a3-788b-4f2c-a093-c5c4b3dc4b6c","d0cca6e0-8557-491c-ab82-289df53e57fa","2016-08-06T13:24:18.217778-05:00","UNCID_2173144.cfc3065f-652c-458b-926f-24092edb803f.130509_UNC10-SN254_0462_AC232JACXX_2_ACAGTG.tar.gz","17045a7c-6836-4d54-841c-ca649522bb45",5009129410,"Illumina HiSeq","07b9f31b6843a12c1cd03f11fc60c2fd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:08:59.084849-05:00","2016-05-03T10:55:55.600288-05:00","17045a7c-6836-4d54-841c-ca649522bb45_analysis.xml","90286478482753fc75ffd8d734519cf6","3d536f1c-8306-4c23-9754-610ca23cda63",2123,"2016-09-29T19:08:10.351240-05:00","17045a7c-6836-4d54-841c-ca649522bb45_experiment.xml","bc9d8d0546c02599f8f86833adfca520","3ccd7463-1695-4810-91a1-cea727e1811d",2431,"2016-09-29T20:58:43.127845-05:00","17045a7c-6836-4d54-841c-ca649522bb45_run.xml","e760694d2d0cd4a5c398f17c052d0307","813410f4-b571-4d31-bfab-9d6b20409ae0",354,"2016-09-08T10:53:33.509830-05:00","TCGA-B5-A3FC","2016-09-02T18:49:16.442128-05:00","female","TCGA-B5-A3FC_demographic",1953,"black or african american","17832a39-9b9c-59f2-a313-ab23798e31fa","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A3FC_diagnosis","not reported",19422,"alive","8380/3",NA,2185,"8f92a82c-7e5e-5769-ad9a-c8226ae6c174","c54.1",-19422,"TCGA-B5-A3FC_treatment","f3176092-333e-52ee-8d52-6f340ed83f29","01","true","TCGA-B5-A3FC-01A",NA,"cb538aff-c08c-455d-8dd8-e3cd0d404e00",FALSE,"4A63436E-BBC1-4F02-9B72-7ED4CC2AC1CD","Primary Tumor",NA,1814,150,NA,1321574400,"11",30,"TCGA-B5-A3FC-01A-11",95,NA,2,NA,0,NA,0,NA,"2016-09-08T10:53:33.509830-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"6a897a5d-dc69-4b74-bc89-13ff3a7502df",NA,"TCGA-B5-A3FC-01A-01-TSA",NA,95,NA,"9446f713-5dba-49bd-8327-1fc3bd0ef7a6","RNA","TCGA-B5-A3FC-01A-11R","38455dcc-32dc-4d6e-ba5c-801a650a5d01",1.83,0.17,"UV Spec","R","23","TCGA-B5-A3FC-01A-11R-A22K-07","cfc3065f-652c-458b-926f-24092edb803f",0.17,NA,76,26.609712545079,169,"15ac7684-3a9e-5e8f-928e-a644158063df","TCGA-B5-A3FC_exposure","UNCID_2173144.cfc3065f-652c-458b-926f-24092edb803f.130509_UNC10-SN254_0462_AC232JACXX_2_ACAGTG.tar.gz","2013-09-09T10:56:08.000Z","2013-09-09T11:11:01.000Z","17045A7C-6836-4D54-841C-CA649522BB45","CB538AFF-C08C-455D-8DD8-E3CD0D404E00","Unaligned reads",5009129410,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","CFC3065F-652C-458B-926F-24092EDB803F","University of North Carolina","564a361ce4b0298dd2c6b573","EC2040A3-788B-4F2C-A093-C5C4B3DC4B6C","Uterine Corpus Endometrial Carcinoma","TARGZ","9446F713-5DBA-49BD-8327-1FC3BD0EF7A6","2013-09-09T11:11:01.000Z","38455DCC-32DC-4D6E-BA5C-801A650A5D01","United States","NO",1,NA,"Primary Tumor","Duke",1814,"9446F713-5DBA-49BD-8327-1FC3BD0EF7A6",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.17669455-F951-4491-992D-E8D3748C7A22.txt",150,"TCGA-B5-A3FC-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","EEEF51B5-4F20-40B4-BFE5-CA4E5057196A",53,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.17669455-F951-4491-992D-E8D3748C7A22.txt","Alive",NA,"TCGA-B5-A3FC","NOT HISPANIC OR LATINO",NA,NA,1890,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"6A897A5D-DC69-4B74-BC89-13FF3A7502DF","6A7BC68D-C3CB-4BD6-AFCC-29F84B29DE28","TCGA-B5-A3FC-01A-11R-A22I-13_mirna.bam","TCGA-B5-A3FC-01A-11",95,0,2,1,0,"TOP",5,0,"TCGA-B5-A3FC-01A-01-TSA",95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-B5-A3FC",1,"B5","A3FC","YES","C54.1","8380/3","C54.1","NO","YES",-19422,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",1890,NA,NA,NA,"TUMOR FREE","NO",23,3,2012,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,53,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33037783,31852325,2396145104,"DB5239C5-E5C8-48C4-BB86-29E9D1987A91.bw","ec7a9d74-8b3f-4747-8926-1739a016ab2b","db5239c5-e5c8-48c4-bb86-29e9d1987a91","2016-08-06T07:14:28.394562-05:00","UNCID_2214898.20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_6.tar.gz","a0be369d-8631-4658-bdf9-d0cb0a386228",2012194876,"Illumina GA","b5ab4192ad896337d54177955a13862a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:37:36.870221-05:00","2016-05-03T11:17:14.905409-05:00","a0be369d-8631-4658-bdf9-d0cb0a386228_analysis.xml","f19c7f6f7054b8771bbb6f5a6a607460","e3cc7721-ad67-4fa9-afd4-49aff91ccd67",2120,"2016-09-30T00:12:48.704289-05:00","a0be369d-8631-4658-bdf9-d0cb0a386228_experiment.xml","49cab311c4a8c71949c03baa136940f2","f975cdc6-157d-4f95-b302-63ec07b2dc1c",2256,"2016-09-29T19:32:34.589015-05:00","a0be369d-8631-4658-bdf9-d0cb0a386228_run.xml","04cf68de4011e063c7c716ee9292b34e","4c286ee2-b892-425c-968e-9141a5a5d1a8",345,"2016-09-08T11:13:34.172754-05:00","TCGA-AX-A0J1","2016-09-02T18:54:40.934236-05:00","female","TCGA-AX-A0J1_demographic",1925,"white","e75c880e-40b7-5369-8760-575774b83938","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A0J1_diagnosis","not reported",29501,"alive","8380/3",NA,2354,"d6b774d2-1612-538f-a4b2-ffa96238483a","c54.1",-29501,"TCGA-AX-A0J1_treatment","46084428-8366-5730-95d0-4857216622bb","01","false","TCGA-AX-A0J1-01A",NA,"ac14e378-2de1-458a-b8cd-7c60131aa927",FALSE,"38FCBC4A-2CAB-46EF-805D-121BEF85912E","Primary Tumor",NA,1721,220,NA,1275609600,"11",30,"TCGA-AX-A0J1-01A-11",80,70,0,0,13,30,2,5,"2016-09-08T11:13:34.172754-05:00","2016-09-08T11:13:34.172754-05:00",0,0,1,0,"BOTTOM","TOP",10,1,"f85a049e-045d-43ab-857d-66d8f8939ea8","0708f648-98cb-4826-a6c7-5008795669c5","TCGA-AX-A0J1-01A-01-BS1","TCGA-AX-A0J1-01A-01-TS1",75,64,"c994a987-bf7e-4fe7-8625-43d8b4fe5f0c","RNA","TCGA-AX-A0J1-01A-11R","a67b79e6-b062-408d-ad85-9b0a7237cdd1",1.91,0.16,"UV Spec","R","23","TCGA-AX-A0J1-01A-11R-A040-07","20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247",0.16,NA,57,22.265625,160,"bde33b39-a469-5426-af54-8ac0c1df3b42","TCGA-AX-A0J1_exposure","UNCID_2214898.20b8dd9b-c6b1-4a16-aeeb-e5aa49e62247.101105_UNC5-RDR300700_00033_FC_62J7BAAXX_6.tar.gz","2013-10-03T22:16:06.000Z","2013-10-03T22:28:02.000Z","A0BE369D-8631-4658-BDF9-D0CB0A386228","AC14E378-2DE1-458A-B8CD-7C60131AA927","Unaligned reads",2012194876,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","20B8DD9B-C6B1-4A16-AEEB-E5AA49E62247","University of North Carolina","56607f21e4b018727fea39a9","EC7A9D74-8B3F-4747-8926-1739A016AB2B","Uterine Corpus Endometrial Carcinoma","TARGZ","C994A987-BF7E-4FE7-8625-43D8B4FE5F0C","2013-10-03T22:28:02.000Z","A67B79E6-B062-408D-AD85-9B0A7237CDD1","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1721,"C994A987-BF7E-4FE7-8625-43D8B4FE5F0C",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2EE962C0-8925-47C7-8AEA-9AE3B1375A6B.txt",220,"TCGA-AX-A0J1-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","AC14E378-2DE1-458A-B8CD-7C60131AA927",80,"TCGA-AX-A0J1-01A-11W-A062-09_IlluminaGA-DNASeq_exome.bam","Alive",NA,"TCGA-AX-A0J1","NOT HISPANIC OR LATINO","3F2EEE82-1CA5-4727-95A6-C8F540854BAB",NA,2004,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",59,NA,NA,"WHITE",NA,11,30,"F85A049E-045D-43AB-857D-66D8F8939EA8","F2665A15-9D1C-4A4A-8B38-FD5CB8BFFB36","TCGA-AX-A0J1-01A-11W-A062-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-AX-A0J1-01A-11",70,30,0,0,5,"TOP",1,0,"TCGA-AX-A0J1-01A-01-TS1",64,NA,NA,NA,NA,NA,NA,NA,NA,2004,"TUMOR FREE","Alive",NA,"TCGA-AX-A0J1-F5458","TCGA-AX-A0J1",1,"AX","A0J1","YES","C54.1","8380/3","C54.1","NO","YES",-29501,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2004,NA,NA,NA,"TUMOR FREE","NO",23,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,80,2005,"Dilation and curettage procedure",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
31319945,30656088,2293376027,"4CA054A8-5D75-40B7-94E4-0B5744832FEE.bw","edee2bf5-284c-4d77-823a-d037fe4c4b9e","4ca054a8-5d75-40b7-94e4-0b5744832fee","2016-08-05T08:34:10.251527-05:00","UNCID_2210692.740f4c64-0bc1-4691-8b37-7830ae67a080.110323_UNC3-RDR300156_00085_FC_706FWAAXX_7.tar.gz","0deaa994-963d-4a35-92ea-53f28d904352",2052620566,"Illumina GA","87e3ef3b85720a2e72103172f4545595","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:14:11.866394-05:00","2016-05-03T11:15:47.421196-05:00","0deaa994-963d-4a35-92ea-53f28d904352_analysis.xml","ca2f350df49f240b1f12fdc67174403b","d5440095-acba-426d-affa-d18a96811afe",2121,"2016-09-29T19:37:05.799323-05:00","0deaa994-963d-4a35-92ea-53f28d904352_experiment.xml","d56a76a863761b3bcc4af27410b0948c","4eecfdbe-56f3-46c3-9700-f4919111aaa3",2257,"2016-09-29T19:54:48.530631-05:00","0deaa994-963d-4a35-92ea-53f28d904352_run.xml","b7f34d9e546ebd700373b6ecbaeb0361","59f8a217-d7a3-4f96-9e70-418b83b0f8b0",347,"2016-09-08T10:37:03.333715-05:00","TCGA-BG-A0VZ","2016-09-02T18:49:00.737891-05:00","female","TCGA-BG-A0VZ_demographic",1950,"white","5671514e-c9d4-5f07-b12a-568226f20275","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0VZ_diagnosis","not reported",21414,"alive","8380/3",NA,1601,"c803212c-f333-587d-97fe-c2c670473010","c54.1",-21414,"TCGA-BG-A0VZ_treatment","a2c944f8-8d9b-5965-b09f-a309743498d3","01","true","TCGA-BG-A0VZ-01A",NA,"fa28a6f2-c6d2-4cf1-8026-fed92675bdb9",FALSE,"6CCCA758-AB3D-4260-BD25-16716E34B3BB","Primary Tumor",NA,876,70,NA,1286841600,"11",30,"TCGA-BG-A0VZ-01A-11",70,70,20,20,0,10,25,20,"2016-09-08T10:37:03.333715-05:00","2016-09-08T10:37:03.333715-05:00",40,40,30,30,"TOP","BOTTOM",5,0,"52f27067-10d6-40ae-b56c-997e9c1f9a7c","b0824090-6d45-4266-8e2c-e66247cb08a8","TCGA-BG-A0VZ-01A-01-TS1","TCGA-BG-A0VZ-01A-01-BS1",70,70,"f801a9e3-7602-410e-a43e-5828473350b5","RNA","TCGA-BG-A0VZ-01A-11R","b93c0eb5-f433-4b54-b5ec-fe7f416e4ce7",1.88,0.17,"UV Spec","R","23","TCGA-BG-A0VZ-01A-11R-A109-07","740f4c64-0bc1-4691-8b37-7830ae67a080",0.17,NA,109,40.0367309458219,165,"6617679b-2d4e-5f02-8ce7-4968d177c1fb","TCGA-BG-A0VZ_exposure","UNCID_2210692.740f4c64-0bc1-4691-8b37-7830ae67a080.110323_UNC3-RDR300156_00085_FC_706FWAAXX_7.tar.gz","2013-10-02T14:55:04.000Z","2013-10-02T15:07:02.000Z","0DEAA994-963D-4A35-92EA-53F28D904352","FA28A6F2-C6D2-4CF1-8026-FED92675BDB9","Unaligned reads",2052620566,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","740F4C64-0BC1-4691-8B37-7830AE67A080","University of North Carolina","56607c35e4b018727fea2df6","EDEE2BF5-284C-4D77-823A-D037FE4C4B9E","Uterine Corpus Endometrial Carcinoma","TARGZ","F801A9E3-7602-410E-A43E-5828473350B5","2013-10-02T15:07:02.000Z","B93C0EB5-F433-4B54-B5EC-FE7F416E4CE7","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",876,"F801A9E3-7602-410E-A43E-5828473350B5",NA,"BG","UNCID_2210692.740f4c64-0bc1-4691-8b37-7830ae67a080.110323_UNC3-RDR300156_00085_FC_706FWAAXX_7.tar.gz",70,"TCGA-BG-A0VZ-01A",NA,"F90FD7F2-A96B-40EC-BA0F-597E495ABEFE","TCGA",2008,NA,NA,"TUMOR FREE","FA28A6F2-C6D2-4CF1-8026-FED92675BDB9",58,"nationwidechildrens.org_clinical.TCGA-BG-A0VZ.xml","Alive",NA,"TCGA-BG-A0VZ","NOT HISPANIC OR LATINO","97F35507-C0E8-4867-89C1-423B9D6E7382",NA,868,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",75,NA,NA,"WHITE",NA,11,30,"B0824090-6D45-4266-8E2C-E66247CB08A8","B93C0EB5-F433-4B54-B5EC-FE7F416E4CE7","UNCID_2210692.740f4c64-0bc1-4691-8b37-7830ae67a080.110323_UNC3-RDR300156_00085_FC_706FWAAXX_7.tar.gz","TCGA-BG-A0VZ-01A-11",70,0,20,40,25,"TOP",5,30,"TCGA-BG-A0VZ-01A-01-TS1",70,"Taxol","Chemotherapy","TCGA-BG-A0VZ-D34126",NA,NA,NA,"TCGA-BG-A0VZ-F34091_NTE-1","NO",1601,"TUMOR FREE","Alive",NA,"TCGA-BG-A0VZ-F34091","TCGA-BG-A0VZ",1,"BG","A0VZ","YES","C54.1","8380/3","C54.1","NO","YES",-21414,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",868,NA,NA,NA,"TUMOR FREE","NO",17,3,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,58,2008,"Dilation and curettage procedure",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",9,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
112743030,110638922,5276318963,"CFB4B8F6-675D-4A70-BCBB-10C87EC514C4.bw","ee932b34-0114-41dc-b119-210c0ed84bcb","cfb4b8f6-675d-4a70-bcbb-10c87ec514c4","2016-08-09T13:15:28.079147-05:00","UNCID_2177881.859fec54-ae79-44fa-8021-b6dd66d529da.130402_UNC10-SN254_0447_BC22WAACXX_4_TTAGGC.tar.gz","66aa37a6-ef9c-4509-8b3d-054ee3625b1a",4788935168,"Illumina HiSeq","06f86c482899569281a69b6dbb8f7ae7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:54:52.362065-05:00","2016-05-03T10:56:47.877475-05:00","66aa37a6-ef9c-4509-8b3d-054ee3625b1a_analysis.xml","6d02ecd8988092451e0f67d2042bfcee","ee905e0a-955c-4ed9-8c82-ce7c5e38f240",2123,"2016-09-29T19:49:49.199379-05:00","66aa37a6-ef9c-4509-8b3d-054ee3625b1a_experiment.xml","b676c61de5a5853d8b1d07dddbc012d5","56d8fe59-84ab-40ed-95ee-90ee6619d441",2431,"2016-09-29T19:24:52.575764-05:00","66aa37a6-ef9c-4509-8b3d-054ee3625b1a_run.xml","744df7acd11c535dd4f45346b9786ff0","475a9ecf-72ae-4df9-9829-1c5f0285d6e8",354,"2016-09-08T10:41:08.666284-05:00","TCGA-DI-A2QT","2016-09-02T18:47:40.268189-05:00","female","TCGA-DI-A2QT_demographic",1957,"american indian or alaska native","8ab85fd8-bf9d-5f86-942f-60383f958f5b","hispanic or latino",2009,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","DI","f4604172-411f-5330-ba30-1466d87b6d7f","MD Anderson","not reported","c54.1","TCGA-DI-A2QT_diagnosis","not reported",18835,"dead","8441/3",377,NA,"06f7b4e5-837b-5466-9916-77470ee9e884","c54.1",-18835,"TCGA-DI-A2QT_treatment","d7bb4b46-3f72-5749-aef0-54d592a446e6","01","false","TCGA-DI-A2QT-01A",NA,"41ee0d15-a55b-47a4-9f5a-02a29e89e8dd",FALSE,"416DF035-67B0-4461-9523-EB4A4A1FBA5B","Primary Tumor",NA,1186,280,NA,1315958400,"12",20,"TCGA-DI-A2QT-01A-12",60,NA,5,NA,0,NA,40,NA,"2016-09-08T10:41:08.666284-05:00",NA,20,NA,5,NA,"TOP",NA,0,NA,"0063bb23-983f-4fbd-9a79-d0083805d579",NA,"TCGA-DI-A2QT-01A-01-TS1",NA,60,NA,"d8f7ebaa-f67c-41ca-b9b6-56791189524c","RNA","TCGA-DI-A2QT-01A-12R","c1b928f7-8a7b-433c-9657-b9740eda46da",1.87,0.17,"UV Spec","R","23","TCGA-DI-A2QT-01A-12R-A19W-07","859fec54-ae79-44fa-8021-b6dd66d529da",0.17,NA,62,25.4766600920447,156,"b91e4f10-fb11-56ee-9141-6d537d6069d6","TCGA-DI-A2QT_exposure","UNCID_2177881.859fec54-ae79-44fa-8021-b6dd66d529da.130402_UNC10-SN254_0447_BC22WAACXX_4_TTAGGC.tar.gz","2013-09-11T20:16:09.000Z","2013-09-11T20:30:01.000Z","66AA37A6-EF9C-4509-8B3D-054EE3625B1A","41EE0D15-A55B-47A4-9F5A-02A29E89E8DD","Unaligned reads",4788935168,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","859FEC54-AE79-44FA-8021-B6DD66D529DA","University of North Carolina","564a5850e4b0298dd2cb24bc","EE932B34-0114-41DC-B119-210C0ED84BCB","Uterine Corpus Endometrial Carcinoma","TARGZ","D8F7EBAA-F67C-41CA-B9B6-56791189524C","2013-09-11T20:30:01.000Z","C1B928F7-8A7B-433C-9657-B9740EDA46DA","United States","NO",1,NA,"Primary Tumor","MD Anderson",1186,"D8F7EBAA-F67C-41CA-B9B6-56791189524C",NA,"DI","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.155C8C74-6540-4D84-B87D-F7619D143457.txt",280,"TCGA-DI-A2QT-01A",NA,NA,"TCGA",2008,NA,NA,"WITH TUMOR","795BED2D-3BF4-42AA-A2BA-FC5349E797BF",51,"nationwidechildrens.org_clinical.TCGA-DI-A2QT.xml","Dead",377,"TCGA-DI-A2QT","HISPANIC OR LATINO",NA,NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C54.1",186,NA,NA,"AMERICAN INDIAN OR ALASKA NATIVE",NA,12,20,"0063BB23-983F-4FBD-9A79-D0083805D579","F29DED11-6534-4183-AE3F-F7D14C9E0D4F","TCGA-DI-A2QT-01A-12R-A19V-13_mirna.bam","TCGA-DI-A2QT-01A-12",60,0,5,20,40,"TOP",0,5,"TCGA-DI-A2QT-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-DI-A2QT",1,"DI","A2QT","YES","C54.1","8441/3","C54.1","NO","YES",-18835,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","HISPANIC OR LATINO","No","No","Dead",NA,377,NA,NA,"WITH TUMOR","NO",26,8,2011,"NO","NO","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,51,2008,"Dilation and curettage procedure",NA,NA,NA,"G3","R2",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
114629808,110985591,5280183878,"BF11E22A-F1B8-4815-A14E-29AE1D3473DF.bw","eeb327b4-b705-4161-ba94-647f0e14f5b4","bf11e22a-f1b8-4815-a14e-29ae1d3473df","2016-08-09T13:17:28.515777-05:00","UNCID_2177912.6fbe6214-bdfd-4688-bae3-d12a931f9989.130402_UNC10-SN254_0447_BC22WAACXX_2_GATCAG.tar.gz","6b973ca7-0c32-423e-92f3-0d7de80816e2",4853918161,"Illumina HiSeq","9a5799299b6cc5dc8f800d0b27991101","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:16:44.673268-05:00","2016-05-03T10:56:47.877475-05:00","6b973ca7-0c32-423e-92f3-0d7de80816e2_analysis.xml","fba6da6bd4b9e8c845140442ba529354","d6b254fa-180d-4b5e-a5ec-2bdc8af79c4e",2123,"2016-10-07T17:47:12.311814-05:00","6b973ca7-0c32-423e-92f3-0d7de80816e2_experiment.xml","a9bace7c279f5d04f2c4ba858b2c0d3b","5f1658b6-9bbf-4dcc-b70e-ef3585ec825c",2431,"2016-09-29T19:18:49.292825-05:00","6b973ca7-0c32-423e-92f3-0d7de80816e2_run.xml","28e73442af60cee72b85413ee3d721a6","43837928-003f-4579-afe4-e1793593a61c",354,"2016-09-08T10:41:10.875029-05:00","TCGA-B5-A3FD","2016-09-02T18:47:37.081110-05:00","female","TCGA-B5-A3FD_demographic",1939,"black or african american","e94319b4-e027-5ad2-aa86-d68b64ecca13","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A3FD_diagnosis","not reported",25813,"dead","8380/3",1197,1007,"7a2f53e6-61d9-50c5-b44e-1f576b14fbd5","c54.1",-25813,"TCGA-B5-A3FD_treatment","57be0f53-06e3-5939-a196-52352520324b","01","true","TCGA-B5-A3FD-01A",NA,"d496dc3a-fc5b-4177-8570-e8725778d186",FALSE,"7AC30D60-097A-4FED-A928-7A4BCAFB6C8D","Primary Tumor",NA,679,370,NA,1321574400,"11",30,"TCGA-B5-A3FD-01A-11",90,NA,2,NA,0,NA,5,NA,"2016-09-08T10:41:10.875029-05:00",NA,2,NA,1,NA,"TOP",NA,5,NA,"1b6d7840-d3b4-4a71-9a87-baa784731419",NA,"TCGA-B5-A3FD-01A-01-TSA",NA,90,NA,"1683058f-3d1a-4d3f-98c0-78caa9faa50e","RNA","TCGA-B5-A3FD-01A-11R","58180b99-1908-49e1-aa5a-19e3a162e449",1.81,0.17,"UV Spec","R","23","TCGA-B5-A3FD-01A-11R-A19W-07","6fbe6214-bdfd-4688-bae3-d12a931f9989",0.17,NA,115,37.9838816224072,174,"dc750726-9202-558c-8bc8-e0e961d284e2","TCGA-B5-A3FD_exposure","UNCID_2177912.6fbe6214-bdfd-4688-bae3-d12a931f9989.130402_UNC10-SN254_0447_BC22WAACXX_2_GATCAG.tar.gz","2013-09-11T21:01:10.000Z","2013-09-11T21:17:01.000Z","6B973CA7-0C32-423E-92F3-0D7DE80816E2","D496DC3A-FC5B-4177-8570-E8725778D186","Unaligned reads",4853918161,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","6FBE6214-BDFD-4688-BAE3-D12A931F9989","University of North Carolina","56607f06e4b0ec1099f8f353","EEB327B4-B705-4161-BA94-647F0E14F5B4","Uterine Corpus Endometrial Carcinoma","TARGZ","1683058F-3D1A-4D3F-98C0-78CAA9FAA50E","2013-09-11T21:17:01.000Z","58180B99-1908-49E1-AA5A-19E3A162E449","United States","NO",1,NA,"Primary Tumor","Duke",679,"1683058F-3D1A-4D3F-98C0-78CAA9FAA50E",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.4DCFD79E-47D9-4223-B907-DA116D0015D8.txt",370,"TCGA-B5-A3FD-01A",NA,"F87C9D59-FFD7-4609-8C44-C1CE6BEBF459","TCGA",2009,NA,NA,"TUMOR FREE","D9DDBD63-20FF-4A1B-8074-67A147FC14AA",70,"nationwidechildrens.org_clinical.TCGA-B5-A3FD.xml","Alive",NA,"TCGA-B5-A3FD",NA,"B2099C5B-8CFB-43D1-9992-6DE1845F17E3",NA,796,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"1B6D7840-D3B4-4A71-9A87-BAA784731419","58180B99-1908-49E1-AA5A-19E3A162E449","2aa8703ce328146b5b0bd410a771579c.bam.bai","TCGA-B5-A3FD-01A-11",90,0,2,2,5,"TOP",5,1,"TCGA-B5-A3FD-01A-01-TSA",90,"Bevacizumab","Targeted Molecular therapy","TCGA-B5-A3FD-D29601",NA,NA,NA,"TCGA-B5-A3FD-F37052_NTE-1","YES",1007,NA,"Alive",NA,"TCGA-B5-A3FD-F37052","TCGA-B5-A3FD",1,"B5","A3FD","YES","C54.1","8380/3","C54.1","NO","YES",-25813,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",796,NA,NA,NA,"TUMOR FREE","NO",26,3,2012,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,70,2009,"Dilation and curettage procedure",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
33328469,32997341,2436449115,"96968BEE-8A40-430E-B634-3EADBE8B7A28.bw","efa4c675-e35e-4f48-8d12-a40f30b63ddb","96968bee-8a40-430e-b634-3eadbe8b7a28","2016-08-05T05:53:38.759974-05:00","UNCID_2208050.2ede539e-5856-4781-bb6f-b1c6efbdf23d.110624_UNC2-RDR300275_00073_FC70KA5AAXX_6.tar.gz","4c8a0839-cd7f-4d51-b0b7-eda48e0e4a45",2066230697,"Illumina GA","631d044d3b8a2235c06009f9bc10a763","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:51:38.464542-05:00","2016-05-03T11:14:23.404443-05:00","4c8a0839-cd7f-4d51-b0b7-eda48e0e4a45_analysis.xml","39b51feba22aee9f9abf41e8b01c253f","c733e73f-147b-410f-b7b8-b0735021b513",2118,"2016-10-07T17:50:53.740712-05:00","4c8a0839-cd7f-4d51-b0b7-eda48e0e4a45_experiment.xml","4e675c178913cda7e5debb7867f4ed04","4fd24eff-575e-4ea9-94b2-61707ed73502",2257,"2016-09-29T21:29:10.240086-05:00","4c8a0839-cd7f-4d51-b0b7-eda48e0e4a45_run.xml","31e5af2687096b09ec5ef0e4c8671090","94486764-a37b-4952-bb53-a7a5487b19cb",347,"2016-09-08T11:02:44.071742-05:00","TCGA-D1-A17T","2016-09-02T18:50:45.290698-05:00","female","TCGA-D1-A17T_demographic",1943,"white","e2b366b5-54d4-52ab-9057-e2a3f7755781","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A17T_diagnosis","not reported",24652,"alive","8380/3",NA,71,"972ab98a-5ddf-54b4-8cf5-dc9bc4ebfad9","c54.1",-24652,"TCGA-D1-A17T_treatment","862ff2bc-ac37-531b-b997-11f108a392c9","01","false","TCGA-D1-A17T-01A",NA,"179bdb8c-c4fd-4949-8aca-eca735a5320f",FALSE,"D5927418-5A2B-477D-9917-7CE912628CA4","Primary Tumor",NA,318,130,NA,1294358400,"11",30,"TCGA-D1-A17T-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T11:02:44.071742-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"e0812390-895c-4233-8228-01c91a133c91",NA,"TCGA-D1-A17T-01A-01-TSA",NA,100,NA,"16453ed6-8956-4b78-b7f7-1bb010735368","RNA","TCGA-D1-A17T-01A-11R","32215674-2be3-4fed-af3f-fc47c48e53f5",1.84,0.15,"UV Spec","R","23","TCGA-D1-A17T-01A-11R-A12I-07","2ede539e-5856-4781-bb6f-b1c6efbdf23d",0.15,NA,83,32.830979787192,159,"e5107392-faf2-5049-930f-6a2803e52dc7","TCGA-D1-A17T_exposure","UNCID_2208050.2ede539e-5856-4781-bb6f-b1c6efbdf23d.110624_UNC2-RDR300275_00073_FC70KA5AAXX_6.tar.gz","2013-09-30T08:06:05.000Z","2013-09-30T08:19:02.000Z","4C8A0839-CD7F-4D51-B0B7-EDA48E0E4A45","179BDB8C-C4FD-4949-8ACA-ECA735A5320F","Unaligned reads",2066230697,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2EDE539E-5856-4781-BB6F-B1C6EFBDF23D","University of North Carolina","564a35ace4b0298dd2c69134","EFA4C675-E35E-4F48-8D12-A40F30B63DDB","Uterine Corpus Endometrial Carcinoma","TARGZ","16453ED6-8956-4B78-B7F7-1BB010735368","2013-09-30T08:19:02.000Z","32215674-2BE3-4FED-AF3F-FC47C48E53F5","None","NO",1,NA,"Primary Tumor","Mayo Clinic",318,"16453ED6-8956-4B78-B7F7-1BB010735368",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A27DCED7-D683-4251-A4A8-A087059D6F19.txt",130,"TCGA-D1-A17T-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","790141DE-88B4-476B-ABA7-74B689644757",67,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A27DCED7-D683-4251-A4A8-A087059D6F19.txt","Alive",NA,"TCGA-D1-A17T","NOT HISPANIC OR LATINO","D29B4763-75F0-4ED4-823C-2B683B6738AB",NA,71,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,11,30,"E0812390-895C-4233-8228-01C91A133C91","6C214FD8-3ADA-4B7E-A07D-45E97A44FFCA","TCGA-D1-A17T-01A-11R-A12H-13_mirna.bam","TCGA-D1-A17T-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-D1-A17T-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",71,"TUMOR FREE","Alive",NA,"TCGA-D1-A17T-F20289","TCGA-D1-A17T",1,"D1","A17T","YES","C54.1","8380/3","C54.1","NO","YES",-24652,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",71,NA,NA,NA,"TUMOR FREE","NO",14,4,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,67,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30051345,29281778,2203791700,"1DEA6525-5598-4985-9218-D61912C75437.bw","efae3940-d3cc-4988-bdb4-fa05d977aff5","1dea6525-5598-4985-9218-d61912c75437","2016-08-05T15:48:06.034810-05:00","UNCID_2214458.1fea8c9c-7f1f-40d9-944a-f542b91c16b5.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_4.tar.gz","5f35bf10-0af2-48aa-ac30-8ceab53f9781",1985748903,"Illumina GA","bb5eefa72c8b7450aff9013dbefabb30","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:29:08.952402-05:00","2016-05-03T11:17:14.896869-05:00","5f35bf10-0af2-48aa-ac30-8ceab53f9781_analysis.xml","be9168098550cd21fd525aa0e6aa4714","de73b6a9-bee8-42a6-bae5-88a86dbd0456",2121,"2016-09-29T20:07:25.147492-05:00","5f35bf10-0af2-48aa-ac30-8ceab53f9781_experiment.xml","7b8ac2ccd3e9c57f01584eacc60d58f1","6193c664-596b-4f45-a7b4-80a403d9fb81",2257,"2016-09-29T21:29:33.162482-05:00","5f35bf10-0af2-48aa-ac30-8ceab53f9781_run.xml","b8f7706df1fa263d30c9037e58b65e6b","94884e5c-efca-4939-bd09-142c0cd02e72",347,"2016-09-08T11:00:10.657670-05:00","TCGA-AP-A0LP","2016-09-02T18:47:54.177509-05:00","female","TCGA-AP-A0LP_demographic",1929,"white","23aad101-4296-5c7d-9bd5-05f34d2cba6f","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A0LP_diagnosis","not reported",27898,"alive","8380/3",NA,1875,"36b996a5-e6ab-5daf-9006-2bde00cf0a69","c54.1",-27898,"TCGA-AP-A0LP_treatment","298eb25e-d4f8-5e8e-b2f6-827091de3b50","01","true","TCGA-AP-A0LP-01A",NA,"d67450c1-8848-4b28-9c16-83aa7132e8c8",FALSE,"ECA6E3D1-141B-4DB1-90B6-FE6A2E355AD3","Primary Tumor",NA,1884,150,NA,1278547200,"12",30,"TCGA-AP-A0LP-01A-12",85,80,0,0,5,0,0,0,"2016-09-08T11:00:10.657670-05:00","2016-09-08T11:00:10.657670-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"f7a59fe8-bb75-407e-905d-b0b5ec2c7d98","5d441afd-96e7-4841-a6c5-3cf30cb711d8","TCGA-AP-A0LP-01A-01-TS1","TCGA-AP-A0LP-01A-01-BS1",95,100,"1f2a26d7-6de9-46e0-83c2-1b57a55d59ac","RNA","TCGA-AP-A0LP-01A-12R","9d81cb99-aa99-4872-91e5-1be657ca9005",1.8,0.16,"UV Spec","R","23","TCGA-AP-A0LP-01A-12R-A104-07","1fea8c9c-7f1f-40d9-944a-f542b91c16b5",0.16,NA,60,21.5138585105239,167,"a2f4f403-b2ab-5f75-bf46-00437247810c","TCGA-AP-A0LP_exposure","UNCID_2214458.1fea8c9c-7f1f-40d9-944a-f542b91c16b5.110208_UNC3-RDR300156_00070_FC_62J3NAAXX_4.tar.gz","2013-10-03T16:16:04.000Z","2013-10-03T16:27:02.000Z","5F35BF10-0AF2-48AA-AC30-8CEAB53F9781","D67450C1-8848-4B28-9C16-83AA7132E8C8","Unaligned reads",1985748903,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","1FEA8C9C-7F1F-40D9-944A-F542B91C16B5","University of North Carolina","564a3f81e4b09c884b259864","EFAE3940-D3CC-4988-BDB4-FA05D977AFF5","Uterine Corpus Endometrial Carcinoma","TARGZ","1F2A26D7-6DE9-46E0-83C2-1B57A55D59AC","2013-10-03T16:27:02.000Z","9D81CB99-AA99-4872-91E5-1BE657CA9005","None","NO",1,NA,"Primary Tumor","MSKCC",1884,"1F2A26D7-6DE9-46E0-83C2-1B57A55D59AC",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.1A47B25B-E5B8-4D98-900B-F0D2D0ABB3A8.txt",150,"TCGA-AP-A0LP-01A",NA,"DDC3DD92-E5C2-4DC7-B394-3EF8B811ED81","TCGA",2005,NA,NA,"TUMOR FREE","D67450C1-8848-4B28-9C16-83AA7132E8C8",76,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.1A47B25B-E5B8-4D98-900B-F0D2D0ABB3A8.txt","Alive",NA,"TCGA-AP-A0LP",NA,"D64247DC-6935-4607-939B-A93C93ECB971",NA,1875,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"5CEA34B8-4DCE-4592-878B-DD02DE27632B","WHITE",NA,12,30,"F7A59FE8-BB75-407E-905D-B0B5EC2C7D98","84A93A30-4712-4F20-9997-107125ADE4C0","TCGA-AP-A0LP-01A-12R-A103-13_mirna.bam","TCGA-AP-A0LP-01A-12",85,5,0,0,0,"TOP",0,0,"TCGA-AP-A0LP-01A-01-TS1",95,"MEGACE","Hormone Therapy","TCGA-AP-A0LP-D4031","TCGA-AP-A0LP-R4033","EXTERNAL BEAM","Primary Tumor Field",NA,NA,1875,"TUMOR FREE","Alive",NA,"TCGA-AP-A0LP-F4030","TCGA-AP-A0LP",1,"AP","A0LP","YES","C54.1","8380/3","C54.1","NO","YES",-27898,"FEMALE","WHITE",NA,"No","No","Alive",1875,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,76,2005,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
117141164,115138013,5490904331,"B38AB6E6-BDD0-461C-934D-DD498C32E934.bw","f04befed-6c81-4676-8715-b8c6a33cb9d1","b38ab6e6-bdd0-461c-934d-dd498c32e934","2016-08-26T05:36:10.952043-05:00","UNCID_2316575.6152d141-ed7d-4c03-9af9-4647dc455c4f.130909_UNC15-SN850_0327_BD2DT1ACXX_1_CAGATC.tar.gz","bcd42548-2741-45ab-b7ce-3cfa73c9170a",5411111906,"Illumina HiSeq","ff51bc533b4dbb70e3f7647b7e9267f7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:43:52.631524-05:00","2016-05-03T11:28:50.231867-05:00","bcd42548-2741-45ab-b7ce-3cfa73c9170a_analysis.xml","4c785a5c67e674c5872dd817daa83881","9d3336cc-9151-4271-a1c0-4dd65086583a",2124,"2016-09-29T19:37:19.760997-05:00","bcd42548-2741-45ab-b7ce-3cfa73c9170a_experiment.xml","5b162826bf07ada679887c1979972552","4f143ff6-7534-4e94-a763-68ef9fbaf5ef",2628,"2016-09-29T21:33:36.837411-05:00","bcd42548-2741-45ab-b7ce-3cfa73c9170a_run.xml","f7fa36b6ec28f0a929669f209c1e2382","96eca46d-7ed5-4298-99fc-ec08482607d6",354,"2016-09-08T11:50:24.926381-05:00","TCGA-B5-A11R","2016-09-02T18:49:34.523209-05:00","female","TCGA-B5-A11R_demographic",1957,"black or african american","e331981e-7b68-53b7-95c2-5cf15949c2ea","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11R_diagnosis","not reported",18878,"alive","8380/3",NA,2349,"f675bdd0-9c39-5e2b-8e82-80ff3efeaba3","c54.1",-18878,"TCGA-B5-A11R_treatment","6e9c26cf-668b-5358-8c88-ba394d7eb615","01","true","TCGA-B5-A11R-01A",NA,"1583391d-1489-4489-9cb8-30cd6529b307",FALSE,"0AC5670B-7EA6-438C-9326-843BB7A6A81C","Primary Tumor",NA,734,100,NA,1291680000,"11",30,"TCGA-B5-A11R-01A-11",95,70,3,3,0,0,5,30,"2016-09-08T11:50:24.926381-05:00","2016-09-08T11:50:24.926381-05:00",5,8,0,0,"BOTTOM","TOP",2,4,"953abe32-70fa-4cd3-81c9-c86a31050111","7535a431-eddb-40b1-a721-045e13cfa540","TCGA-B5-A11R-01A-01-BS1","TCGA-B5-A11R-01A-01-TS1",93,66,"02618944-a1ef-42fc-9fe0-c9c20265a1f0","RNA","TCGA-B5-A11R-01A-11R","179dfc19-8aac-4793-bbd4-6de85c6250e5",1.86,0.15,"UV Spec","R","23","TCGA-B5-A11R-01A-11R-A118-07","6152d141-ed7d-4c03-9af9-4647dc455c4f",0.15,NA,89,31.5334467120181,168,"a207a331-1040-54ce-9dc0-665bd6f79829","TCGA-B5-A11R_exposure","UNCID_2316575.6152d141-ed7d-4c03-9af9-4647dc455c4f.130909_UNC15-SN850_0327_BD2DT1ACXX_1_CAGATC.tar.gz","2014-01-07T08:31:04.000Z","2014-01-07T09:04:01.000Z","BCD42548-2741-45AB-B7CE-3CFA73C9170A","1583391D-1489-4489-9CB8-30CD6529B307","Unaligned reads",5411111906,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","6152D141-ED7D-4C03-9AF9-4647DC455C4F","University of North Carolina","566073ede4b018727fe9eb32","F04BEFED-6C81-4676-8715-B8C6A33CB9D1","Uterine Corpus Endometrial Carcinoma","TARGZ","02618944-A1EF-42FC-9FE0-C9C20265A1F0","2014-01-07T09:04:01.000Z","179DFC19-8AAC-4793-BBD4-6DE85C6250E5","United States","NO",1,NA,"Primary Tumor","Duke",734,"02618944-A1EF-42FC-9FE0-C9C20265A1F0",NA,"B5","06b0130c7bc6be3c39f1b42ed6aebf37.bam",100,"TCGA-B5-A11R-01A",NA,"B1E0D74A-021C-42D9-A46D-44D38B17EA0A","TCGA",2008,NA,NA,"TUMOR FREE","61BC32DE-9830-4146-BBC9-1F1BE04C5E1F",51,"CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_G08_735594.CEL","Alive",NA,"TCGA-B5-A11R",NA,"A2CAA4C3-2EC3-4485-AE41-795A5F79141A",NA,837,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"A79FFC86-0DF7-4B0E-B940-1FD70F0B5DA8","BLACK OR AFRICAN AMERICAN",NA,11,30,"953ABE32-70FA-4CD3-81C9-C86A31050111","CC549661-A7F4-4E21-86DC-28AF2E77C882","CARRS_p_TCGASNP_b92_N_GenomeWideSNP_6_C03_735752.tangent.copynumber.data.txt","TCGA-B5-A11R-01A-11",95,0,3,5,5,"BOTTOM",2,0,"TCGA-B5-A11R-01A-01-BS1",93,"Carboplatin","Chemotherapy","TCGA-B5-A11R-D10496","TCGA-B5-A11R-R10497","OTHER: SPECIFY IN NOTES","Regional site","TCGA-B5-A11R-F72229_NTE-1","NO",2349,"TUMOR FREE","Alive",NA,"TCGA-B5-A11R-F72229","TCGA-B5-A11R",1,"B5","A11R","YES","C54.1","8380/3","C54.1","NO","YES",-18878,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",837,NA,NA,NA,"TUMOR FREE","NO",22,2,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,51,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",5,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35184395,34838740,2608332574,"5D29C0B1-A2DC-45B2-BF53-DE0C0F798841.bw","f054a123-322f-444a-9971-53d3df371753","5d29c0b1-a2dc-45b2-bf53-de0c0f798841","2016-08-06T21:42:19.780104-05:00","UNCID_2189516.7bc83c49-3fd8-4048-adf4-b461fcffcc00.120524_UNC2-RDR300275_00121_FC_64KREAAXX_7.tar.gz","4e16c35f-a893-4b37-8e06-ae8382c3892a",2205298428,"Illumina GA","385c9189dc2b23ac991391c1fefe9309","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:51:03.058989-05:00","2016-05-03T11:05:01.523277-05:00","4e16c35f-a893-4b37-8e06-ae8382c3892a_analysis.xml","cb62e3eb8030ccecaffbeb749090354d","ec1a2d7c-ea77-47ab-91c6-afc1c2a0cdfe",2121,"2016-09-29T17:58:06.341593-05:00","4e16c35f-a893-4b37-8e06-ae8382c3892a_experiment.xml","2e6f816b8db4e49dd85cccbc4626019a","10c02c85-d1db-49b1-a68e-b43dcc50505c",2258,"2016-09-29T23:38:05.597889-05:00","4e16c35f-a893-4b37-8e06-ae8382c3892a_run.xml","7373b6d494e72b3ca5a1ea3763274a2a","e41315f8-09d4-46a1-ba67-054342839045",349,"2016-09-08T10:40:21.368593-05:00","TCGA-D1-A1O5","2016-09-02T18:52:19.106924-05:00","female","TCGA-D1-A1O5_demographic",1949,"white","5af7b769-4f26-5003-8b0c-835175118797","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A1O5_diagnosis","not reported",22580,"alive","8380/3",NA,458,"70b0e8e8-887f-58f8-9664-19fb14475c53","c54.1",-22580,"TCGA-D1-A1O5_treatment","de030ee2-e829-5b56-a962-2c5b08bec0ba","01","false","TCGA-D1-A1O5-01A",NA,"a2a2d119-29a0-4cdb-bbed-44219adddfcf",FALSE,"F8BEE46E-D0C9-4977-B1C3-DA87AF089B6D","Primary Tumor",NA,174,100,NA,1302048000,"11",30,"TCGA-D1-A1O5-01A-11",70,NA,20,NA,10,NA,15,NA,"2016-09-08T10:40:21.368593-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"76e1db7a-7aa0-486b-8dea-48f9ca932599",NA,"TCGA-D1-A1O5-01A-01-TSA",NA,70,NA,"7d260113-d1dc-4b9d-a302-6f0e3a38ebde","RNA","TCGA-D1-A1O5-01A-11R","e3cd3ab8-a341-47aa-bbf5-f2cd6543e2a3",1.79,0.17,"UV Spec","R","23","TCGA-D1-A1O5-01A-11R-A14D-07","7bc83c49-3fd8-4048-adf4-b461fcffcc00",0.17,NA,80,30.8630068284403,161,"7bd64a8d-4499-5998-8dce-1f3e8c04bdbe","TCGA-D1-A1O5_exposure","UNCID_2189516.7bc83c49-3fd8-4048-adf4-b461fcffcc00.120524_UNC2-RDR300275_00121_FC_64KREAAXX_7.tar.gz","2013-09-19T00:26:04.000Z","2013-09-19T00:39:02.000Z","4E16C35F-A893-4B37-8E06-AE8382C3892A","A2A2D119-29A0-4CDB-BBED-44219ADDDFCF","Unaligned reads",2205298428,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7BC83C49-3FD8-4048-ADF4-B461FCFFCC00","University of North Carolina","56607e12e4b0ec1099f8efbb","F054A123-322F-444A-9971-53D3DF371753","Uterine Corpus Endometrial Carcinoma","TARGZ","7D260113-D1DC-4B9D-A302-6F0E3A38EBDE","2013-09-19T00:39:02.000Z","E3CD3AB8-A341-47AA-BBF5-F2CD6543E2A3","United States","NO",1,NA,"Primary Tumor","Mayo Clinic",174,"7D260113-D1DC-4B9D-A302-6F0E3A38EBDE",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E9F2117D-AFD1-418A-8580-70586444AB0A.txt",100,"TCGA-D1-A1O5-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","BADC8D9E-E8DD-4D89-9161-3A6F2DDC35F5",61,"nationwidechildrens.org_clinical.TCGA-D1-A1O5.xml","Alive",NA,"TCGA-D1-A1O5","NOT HISPANIC OR LATINO","1482F32B-54DB-407F-BB5D-B42DD77FD148",NA,377,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",121,NA,NA,"WHITE",NA,11,30,"76E1DB7A-7AA0-486B-8DEA-48F9CA932599","E3CD3AB8-A341-47AA-BBF5-F2CD6543E2A3","UNCID_2189516.7bc83c49-3fd8-4048-adf4-b461fcffcc00.120524_UNC2-RDR300275_00121_FC_64KREAAXX_7.tar.gz","TCGA-D1-A1O5-01A-11",70,10,20,40,15,"TOP",5,20,"TCGA-D1-A1O5-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,"NO",458,"TUMOR FREE","Alive",NA,"TCGA-D1-A1O5-F21574","TCGA-D1-A1O5",1,"D1","A1O5","YES","C54.1","8380/3","C54.1","NO","YES",-22580,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",377,NA,NA,NA,"TUMOR FREE","NO",11,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2010,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32921379,32188612,2402869102,"130C8FBD-8D78-4212-8DD6-301EDFA339A9.bw","f0b3ab10-43f8-48a8-b460-66ceaaf637db","130c8fbd-8d78-4212-8dd6-301edfa339a9","2016-08-09T14:13:52.949667-05:00","UNCID_2209567.5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8.110509_UNC6-RDR300211_00102_FC_634VYAAXX_8.tar.gz","b89dbe8c-b60f-466e-b681-4df134ef6e68",2207556263,"Illumina GA","02cf0bcfc4c56c24a7768041fd0e35b5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:05:53.259661-05:00","2016-05-03T11:15:06.073526-05:00","b89dbe8c-b60f-466e-b681-4df134ef6e68_analysis.xml","5d7b183c1970207f97731da19eb686e9","15bbfe37-2b11-4161-8be6-92af6a639b65",2121,"2016-09-29T23:40:35.005532-05:00","b89dbe8c-b60f-466e-b681-4df134ef6e68_experiment.xml","d5906b6f0e90b52052dd3403493708c6","e596b38e-afa6-4512-bf87-0ff693d92a78",2257,"2016-09-29T18:05:16.559794-05:00","b89dbe8c-b60f-466e-b681-4df134ef6e68_run.xml","760d307069ef99d12a0121ae33e03ee8","1559bb17-5f8d-4391-8ae0-2df436d4bb28",347,"2016-09-08T10:47:09.867700-05:00","TCGA-D1-A175","2016-09-02T18:50:33.675886-05:00","female","TCGA-D1-A175_demographic",1961,"white","5adae4ab-9d4c-5380-ba44-2fc49810993d","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A175_diagnosis","not reported",17802,"alive","8380/3",NA,202,"5a78079f-1378-5ba1-be36-e3047a837778","c54.1",-17802,"TCGA-D1-A175_treatment","504387e3-8483-54d6-930b-87ed3e89ac8b","01","false","TCGA-D1-A175-01A",NA,"07bfbb0c-b58b-4364-b12e-dca462c5b43e",FALSE,"4A0D74F3-74A0-4CAE-960B-71D37DF4F4DE","Primary Tumor",NA,566,200,NA,1294099200,"11",30,"TCGA-D1-A175-01A-11",60,NA,20,NA,0,NA,30,NA,"2016-09-08T10:47:09.867700-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"ff05a4a2-2849-474d-b4ce-601bc8265ce6",NA,"TCGA-D1-A175-01A-01-TS1",NA,60,NA,"a197a64a-63f6-46ea-9c5e-338f1fa713d3","RNA","TCGA-D1-A175-01A-11R","9843af05-b29f-4301-80ee-b52a266ea787",1.33,0.16,"UV Spec","R","23","TCGA-D1-A175-01A-11R-A12I-07","5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8",0.16,NA,64,24.6904054627522,161,"d1aca2e9-2c87-5f53-a742-ce1e44a59000","TCGA-D1-A175_exposure","UNCID_2209567.5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8.110509_UNC6-RDR300211_00102_FC_634VYAAXX_8.tar.gz","2013-10-01T09:26:03.000Z","2013-10-01T09:39:02.000Z","B89DBE8C-B60F-466E-B681-4DF134EF6E68","07BFBB0C-B58B-4364-B12E-DCA462C5B43E","Unaligned reads",2207556263,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","5FF09A0F-1DEB-41FE-9CAD-4ED6556F2BF8","University of North Carolina","566075cfe4b016715ab6879f","F0B3AB10-43F8-48A8-B460-66CEAAF637DB","Uterine Corpus Endometrial Carcinoma","TARGZ","A197A64A-63F6-46EA-9C5E-338F1FA713D3","2013-10-01T09:39:02.000Z","9843AF05-B29F-4301-80EE-B52A266EA787","None","NO",1,NA,"Primary Tumor","Mayo Clinic",566,"A197A64A-63F6-46EA-9C5E-338F1FA713D3",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E0B67C97-4029-436E-9E17-2A5595C3CF03.txt",200,"TCGA-D1-A175-01A",NA,"29CCCE34-B8D7-406A-BD61-808B048A6C06","TCGA",2009,NA,NA,"TUMOR FREE","1E719FCF-3AEC-4208-B056-899B1DE4247A",48,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.E0B67C97-4029-436E-9E17-2A5595C3CF03.txt","Alive",NA,"TCGA-D1-A175","NOT HISPANIC OR LATINO","63EC6C1E-F931-49F7-9C4D-D6A59254771C",NA,202,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"837017F2-6CCC-491E-9103-3C21DD0569AA","WHITE",NA,11,30,"FF05A4A2-2849-474D-B4CE-601BC8265CE6","9843AF05-B29F-4301-80EE-B52A266EA787","UNCID_2209567.5ff09a0f-1deb-41fe-9cad-4ed6556f2bf8.110509_UNC6-RDR300211_00102_FC_634VYAAXX_8.tar.gz","TCGA-D1-A175-01A-11",60,0,20,40,30,"TOP",10,20,"TCGA-D1-A175-01A-01-TS1",60,"Carboplatin","Chemotherapy","TCGA-D1-A175-D20262","TCGA-D1-A175-R20246","IMPLANTS","Regional site",NA,"NO",202,"TUMOR FREE","Alive",NA,"TCGA-D1-A175-F20245","TCGA-D1-A175",1,"D1","A175","YES","C54.1","8380/3","C54.1","NO","YES",-17802,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",202,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,48,2009,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",4,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
31583324,30906391,2313641355,"B2EE8C15-DFEE-42ED-9280-A9B12EF98264.bw","f17bb238-2651-48a5-9a47-5077218efe08","b2ee8c15-dfee-42ed-9280-a9b12ef98264","2016-08-09T14:18:08.499145-05:00","UNCID_2203930.bfa1d102-0917-407f-a158-3125d4219c6c.111020_UNC6-RDR300211_00129_FC_62EA9AAXX_6.tar.gz","84f74644-babd-47b4-ae77-f09f816b4c18",2084400323,"Illumina GA","e2c18962b1fba32e0117494e8c9ecf6a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:34:35.691554-05:00","2016-05-03T11:19:30.078695-05:00","84f74644-babd-47b4-ae77-f09f816b4c18_analysis.xml","c6b2320e41a55929ce2287488f57c09a","276ff401-f543-4877-842e-8ab11ca9d03c",2121,"2016-09-29T19:13:42.947956-05:00","84f74644-babd-47b4-ae77-f09f816b4c18_experiment.xml","c4b01c572f7cc24c4928112511e7c5e7","405d0455-81cf-4319-9039-8e277d22d3b4",2257,"2016-09-29T21:55:46.315987-05:00","84f74644-babd-47b4-ae77-f09f816b4c18_run.xml","0e918ee82b411b2a7f08205679dd777d","a4c01c6d-8c5b-4684-a9c4-5262263dc4e2",347,"2016-09-08T11:23:17.773062-05:00","TCGA-EC-A1QX","2016-09-02T18:52:46.785020-05:00","female","TCGA-EC-A1QX_demographic",1939,"white","81b84182-932d-5e2e-9d97-0000ec2b42db","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EC","acc43e64-d63e-554c-a488-8bf6b93bec91","Asterand","not reported","c54.1","TCGA-EC-A1QX_diagnosis","not reported",26259,"alive","8380/3",NA,224,"c06f4aec-8182-5dd8-a6c0-80cd29a1b683","c54.1",-26259,"TCGA-EC-A1QX_treatment","7f9cfa80-e1c9-5b7b-af8a-df6c711f29af","01","true","TCGA-EC-A1QX-01A",NA,"a86cd958-656b-45d1-ab59-453896a9e839",FALSE,"0C3EABFA-0F72-47C9-9A8B-6B14F2CD2D12","Primary Tumor",NA,81,560,NA,1304035200,"31",30,"TCGA-EC-A1QX-01A-31",80,NA,20,NA,0,NA,15,NA,"2016-09-08T11:23:17.773062-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"d9cf9cab-504d-4cd5-9647-96ff4cd6a3bd",NA,"TCGA-EC-A1QX-01A-03-TSC",NA,80,NA,"0cac7ee9-cb5e-4769-8826-ea56255d14ca","RNA","TCGA-EC-A1QX-01A-31R","c8fd621d-57c9-4035-a53f-3f182b7b8792",1.79,0.17,"UV Spec","R","23","TCGA-EC-A1QX-01A-31R-A16F-07","bfa1d102-0917-407f-a158-3125d4219c6c",0.17,NA,90,34.7208826819953,161,"9ebf7955-2b0e-5732-9934-33fb1051575a","TCGA-EC-A1QX_exposure","UNCID_2203930.bfa1d102-0917-407f-a158-3125d4219c6c.111020_UNC6-RDR300211_00129_FC_62EA9AAXX_6.tar.gz","2013-10-04T16:07:05.000Z","2013-10-04T16:24:02.000Z","84F74644-BABD-47B4-AE77-F09F816B4C18","A86CD958-656B-45D1-AB59-453896A9E839","Unaligned reads",2084400323,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","BFA1D102-0917-407F-A158-3125D4219C6C","University of North Carolina","5660791ce4b0ec1099f8d8a8","F17BB238-2651-48A5-9A47-5077218EFE08","Uterine Corpus Endometrial Carcinoma","TARGZ","0CAC7EE9-CB5E-4769-8826-EA56255D14CA","2013-10-04T16:24:02.000Z","C8FD621D-57C9-4035-A53F-3F182B7B8792","Ukraine","NO",1,NA,"Primary Tumor","Asterand",81,"0CAC7EE9-CB5E-4769-8826-EA56255D14CA",NA,"EC","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F29B5B7A-0EA1-4AE8-B1FD-5D48D671F757.txt",560,"TCGA-EC-A1QX-01A",NA,"CA871009-3593-43C2-B74F-15C1BBB3894E","TCGA",2010,NA,NA,"TUMOR FREE","A86CD958-656B-45D1-AB59-453896A9E839",71,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F29B5B7A-0EA1-4AE8-B1FD-5D48D671F757.txt","Alive",NA,"TCGA-EC-A1QX","NOT HISPANIC OR LATINO","F1CCC4FA-C67C-4B59-8356-5638AC8B59D0",NA,66,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",143,NA,"444B2182-3450-42AC-89E8-3939743BB8FD","WHITE",NA,31,30,"D9CF9CAB-504D-4CD5-9647-96FF4CD6A3BD","C8FD621D-57C9-4035-A53F-3F182B7B8792","TCGA-EC-A1QX-01A-31R-A16E-13_mirna.bam","TCGA-EC-A1QX-01A-31",80,0,20,40,15,"TOP",5,20,"TCGA-EC-A1QX-01A-03-TSC",80,"Doxorubicin","Chemotherapy","TCGA-EC-A1QX-D21079","TCGA-EC-A1QX-R21083","EXTERNAL BEAM","Primary Tumor Field",NA,"YES",224,"TUMOR FREE","Alive",NA,"TCGA-EC-A1QX-F21078","TCGA-EC-A1QX",1,"EC","A1QX","YES","C54.1","8380/3","C54.1","YES","NO",-26259,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",66,NA,NA,NA,"TUMOR FREE","NO",3,8,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,71,2010,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
15841561,15449525,1164935995,"DB4FD772-CAD0-48CE-810C-7BA6C16B7580.bw","f17e446a-c145-45be-8335-a856acb0b9b8","db4fd772-cad0-48ce-810c-7ba6c16b7580","2016-08-09T14:17:51.355398-05:00","UNCID_2216167.6eb1ae77-4d92-4823-ad9e-2a15cae95db2.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_8.tar.gz","dd196884-9734-4d89-a6c2-d29d97fe844b",930285038,"Illumina GA","f60f568526e1fade8d114af006678ecf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:04:27.877914-05:00","2016-05-03T11:18:46.986610-05:00","dd196884-9734-4d89-a6c2-d29d97fe844b_analysis.xml","8b4795087d1a58a716a4b72337740e13","84c4d3e1-ed84-4280-9053-112a3ea86ccd",2122,"2016-08-13T02:26:30.483875-05:00","dd196884-9734-4d89-a6c2-d29d97fe844b_experiment.xml","d85d6933c7a29fa880247195bd2fcef8","9a029d02-4259-453c-a087-3b2a6188eb47",2256,"2016-09-29T19:18:19.080268-05:00","dd196884-9734-4d89-a6c2-d29d97fe844b_run.xml","3aef37769e3ec99ce31d0ac868725746","4338c06c-8e91-4349-a33c-11052decc9cc",345,"2016-09-08T10:30:38.141235-05:00","TCGA-AX-A06F","2016-09-02T18:52:49.966439-05:00","female","TCGA-AX-A06F_demographic",1947,"white","071110ba-b63c-5157-8a7a-12db64b4c1fd","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A06F_diagnosis","not reported",21624,"alive","8380/3",NA,1748,"14a2847c-5fdd-5988-aa1f-84e3028a4d9a","c54.1",-21624,"TCGA-AX-A06F_treatment","3089e8d4-03ad-53e4-bb31-134d12003550","01","false","TCGA-AX-A06F-01A",NA,"38df14c0-30d9-404f-a10c-f8ed4c947cea",FALSE,"4904C404-B17E-4471-AA2F-6DC705E4FBF2","Primary Tumor",NA,1267,210,NA,1275868800,"11",40,"TCGA-AX-A06F-01A-11",90,90,0,1,10,9,2,1,"2016-09-08T10:30:38.141235-05:00","2016-09-08T10:30:38.141235-05:00",0,0,0,0,"TOP","BOTTOM",8,5,"517f10b8-20eb-433c-8d8b-8f657c7d78ec","051c6061-7851-4017-b278-8ba66124b75a","TCGA-AX-A06F-01A-01-TS1","TCGA-AX-A06F-01A-01-BS1",80,85,"ae2042e5-8b67-4088-b3ab-9d3652c6422a","RNA","TCGA-AX-A06F-01A-11R","ecb447cd-dcb2-4b6a-9aef-bbc92ef646cc",1.83,0.14,"UV Spec","R","23","TCGA-AX-A06F-01A-11R-A00V-07","6eb1ae77-4d92-4823-ad9e-2a15cae95db2",0.14,NA,84,30.8539944903581,165,"39c71e3e-cf23-53e4-89b8-ecd084aa34fb","TCGA-AX-A06F_exposure","UNCID_2216167.6eb1ae77-4d92-4823-ad9e-2a15cae95db2.100908_UNC8-RDR3001640_00020_FC_62ENHAAXX_8.tar.gz","2013-10-04T07:16:04.000Z","2013-10-04T07:28:02.000Z","DD196884-9734-4D89-A6C2-D29D97FE844B","38DF14C0-30D9-404F-A10C-F8ED4C947CEA","Unaligned reads",930285038,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","6EB1AE77-4D92-4823-AD9E-2A15CAE95DB2","University of North Carolina","564a4114e4b08c5d869354f5","F17E446A-C145-45BE-8335-A856ACB0B9B8","Uterine Corpus Endometrial Carcinoma","TARGZ","AE2042E5-8B67-4088-B3AB-9D3652C6422A","2013-10-04T07:28:02.000Z","ECB447CD-DCB2-4B6A-9AEF-BBC92EF646CC","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1267,"AE2042E5-8B67-4088-B3AB-9D3652C6422A",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7C89DB66-FE87-47CA-B4CF-7A851F36F37F.txt",210,"TCGA-AX-A06F-01A",NA,"DB07FC03-5DB7-4F7C-B852-3C7DEAD35E6D","TCGA",2006,NA,NA,"TUMOR FREE","38DF14C0-30D9-404F-A10C-F8ED4C947CEA",59,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.7C89DB66-FE87-47CA-B4CF-7A851F36F37F.txt","Alive",NA,"TCGA-AX-A06F","NOT HISPANIC OR LATINO","2F89D3BC-0B90-4BE5-9FFA-519B5E5DBE9C",NA,1554,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVA",NA,NA,NA,"8380/3","FEMALE","C54.1",49,NA,NA,"WHITE",NA,11,40,"517F10B8-20EB-433C-8D8B-8F657C7D78EC","ECB447CD-DCB2-4B6A-9AEF-BBC92EF646CC","TCGA-AX-A06F-01A-11R-A00W-13_mirna.bam","TCGA-AX-A06F-01A-11",90,10,0,0,2,"TOP",8,0,"TCGA-AX-A06F-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-AX-A06F-D12757",NA,NA,NA,NA,NA,1554,"TUMOR FREE","Alive",NA,"TCGA-AX-A06F-F5555","TCGA-AX-A06F",1,"AX","A06F","YES","C54.1","8380/3","C54.1","NO","YES",-21624,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1554,NA,NA,NA,"TUMOR FREE","NO",25,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",15,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
29792757,29282358,2190163209,"2B888B1F-AED1-48DD-8E17-9EBB8323F0BA.bw","f299ad43-bb16-46ce-9617-48cc6c6f29e7","2b888b1f-aed1-48dd-8e17-9ebb8323f0ba","2016-08-09T14:17:44.889836-05:00","UNCID_2214356.514a9fc3-0b51-41f3-8c94-f6c8d8c0911e.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_4.tar.gz","a0ab5a16-b4b3-47e5-93f0-78fb4d70cf95",1845243022,"Illumina GA","9422f003150929b1c9f17de57406c13a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:01:58.730687-05:00","2016-05-03T11:17:14.896869-05:00","a0ab5a16-b4b3-47e5-93f0-78fb4d70cf95_analysis.xml","107c6bbfaaf35c59bcc264055ec48ea9","38e15e67-c5eb-4032-8281-e0b106587df2",2121,"2016-08-13T06:59:49.073503-05:00","a0ab5a16-b4b3-47e5-93f0-78fb4d70cf95_experiment.xml","6a03d3104581f45b0039ba4c50a16892","36656f74-415e-40e0-acd9-eeb760af3cbc",2257,"2016-09-29T21:03:28.798749-05:00","a0ab5a16-b4b3-47e5-93f0-78fb4d70cf95_run.xml","6a977f4f97025d8ece92578ab8ab9407","842079d5-54ad-4364-84aa-f401e2570028",347,"2016-09-08T11:18:39.596560-05:00","TCGA-BG-A0RY","2016-09-02T18:48:20.870693-05:00","female","TCGA-BG-A0RY_demographic",1942,"white","5130114a-f1c7-5f3d-ae99-e5202537213c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0RY_diagnosis","not reported",24952,"alive","8380/3",NA,469,"e7bfe550-1300-5fb3-8005-266f08b0bb5a","c54.1",-24952,"TCGA-BG-A0RY_treatment","cc9535db-b08f-5d96-875b-c6ae3c40b80b","01","true","TCGA-BG-A0RY-01A",NA,"260692e1-9b2c-4f8b-952d-1b95c042e659",FALSE,"170B34D7-94B3-4129-9B4D-E36AF7A09897","Primary Tumor",NA,49,450,NA,1280361600,"11",30,"TCGA-BG-A0RY-01A-11",85,90,0,0,0,0,0,0,"2016-09-08T11:18:39.596560-05:00","2016-09-08T11:18:39.596560-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"e48368cd-a080-432f-9cc1-e9a089b44035","bd459d69-1e1d-4d9d-875f-44f5146c4201","TCGA-BG-A0RY-01A-01-TSA","TCGA-BG-A0RY-01A-01-BSA",100,100,"52f79534-7cab-4cce-b7ae-d92e155980f4","RNA","TCGA-BG-A0RY-01A-11R","b05e6b92-c261-4c35-aa5c-33f829e883fb",1.9,0.15,"UV Spec","R","23","TCGA-BG-A0RY-01A-11R-A104-07","514a9fc3-0b51-41f3-8c94-f6c8d8c0911e",0.15,NA,118,40.8304498269896,170,"c2e79026-aab6-5333-9eac-5e9eed0f74d5","TCGA-BG-A0RY_exposure","UNCID_2214356.514a9fc3-0b51-41f3-8c94-f6c8d8c0911e.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_4.tar.gz","2013-10-03T15:13:04.000Z","2013-10-03T15:35:01.000Z","A0AB5A16-B4B3-47E5-93F0-78FB4D70CF95","260692E1-9B2C-4F8B-952D-1B95C042E659","Unaligned reads",1845243022,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","514A9FC3-0B51-41F3-8C94-F6C8D8C0911E","University of North Carolina","566073d2e4b0ca319164badf","F299AD43-BB16-46CE-9617-48CC6C6F29E7","Uterine Corpus Endometrial Carcinoma","TARGZ","52F79534-7CAB-4CCE-B7AE-D92E155980F4","2013-10-03T15:35:01.000Z","B05E6B92-C261-4C35-AA5C-33F829E883FB","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",49,"52F79534-7CAB-4CCE-B7AE-D92E155980F4",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.C6B6D0CE-40DE-4854-9839-31E44642187F.txt",450,"TCGA-BG-A0RY-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","6F9655B3-797D-4CD0-9E22-99C1D20C7938",68,"UNCID_1637146.514a9fc3-0b51-41f3-8c94-f6c8d8c0911e.sorted_genome_alignments.bam.bai","Alive",NA,"TCGA-BG-A0RY","NOT HISPANIC OR LATINO","36702A39-947C-48CB-99DD-003FF92273A3",NA,128,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"WHITE",NA,11,30,"E48368CD-A080-432F-9CC1-E9A089B44035","D72B67AD-4D14-48E5-AA99-53056C0379BD","nationwidechildrens.org_biospecimen.TCGA-BG-A0RY.xml","TCGA-BG-A0RY-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-BG-A0RY-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",469,"TUMOR FREE","Alive",NA,"TCGA-BG-A0RY-F19333","TCGA-BG-A0RY",1,"BG","A0RY","YES","C54.1","8380/3","C54.1","NO","YES",-24952,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",128,NA,NA,NA,"TUMOR FREE","NO",9,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33564241,33413481,2473690992,"15EFBC5B-C713-4718-BB6F-0EBBE4D6997F.bw","f384eb3f-92ab-4327-87eb-45b5f72a1580","15efbc5b-c713-4718-bb6f-0ebbe4d6997f","2016-08-05T00:20:37.684504-05:00","UNCID_2206474.7a5dd0ca-549d-452a-beb8-ea8a3f5528ec.110921_UNC2-RDR300275_00086_FC634HAAAXX_7.tar.gz","a0f80c97-d733-4697-9db0-98aa64b69a40",2114081301,"Illumina GA","25f648f77cdb5e3e8dc4ce9cd1136218","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:49:20.096521-05:00","2016-05-03T11:11:34.768699-05:00","a0f80c97-d733-4697-9db0-98aa64b69a40_analysis.xml","b0f8188e4cde2a26dbe1fe982c98ebc5","568a6fcb-ccfc-49ac-9084-affae758cec0",2119,"2016-08-29T11:44:23.261572-05:00","a0f80c97-d733-4697-9db0-98aa64b69a40_experiment.xml","60b1503ccb938bc45819b6176866c3b6","d360cd3c-af22-46ea-9ec7-f81682e6eb37",2257,"2016-09-29T20:46:02.565792-05:00","a0f80c97-d733-4697-9db0-98aa64b69a40_run.xml","d22154af3d638e8a8b91545120c34381","7947d14f-4942-48e0-9caf-3d40e955c91d",347,"2016-09-08T10:39:57.720338-05:00","TCGA-BG-A2AE","2016-09-02T18:52:43.910450-05:00","female","TCGA-BG-A2AE_demographic",1954,"white","8f20f1ea-97c6-5bcf-8305-b4b7451de028","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A2AE_diagnosis","not reported",21069,"alive","8441/3",NA,721,"68451be9-1a15-568b-a1b9-2cc9f3b4009d","c54.1",-21069,"TCGA-BG-A2AE_treatment","ce1d2823-37fe-5088-8103-677f5225b794","01","true","TCGA-BG-A2AE-01A",NA,"273a3b52-7613-400e-8ae1-a68c36ab6968",FALSE,"BA5BC88E-6A6C-425E-84B4-EC33DB9AC146","Primary Tumor",NA,50,460,NA,1306800000,"11",30,"TCGA-BG-A2AE-01A-11",90,NA,20,NA,0,NA,0,NA,"2016-09-08T10:39:57.720338-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"5f8063d7-18c0-4fd0-948d-14beb2210948",NA,"TCGA-BG-A2AE-01A-01-TSA",NA,90,NA,"d4998478-ff8d-4d6f-9941-57a3b2b5e09d","RNA","TCGA-BG-A2AE-01A-11R","34583eaf-46ca-41b8-8174-307c118c8149",1.9,0.18,"UV Spec","R","23","TCGA-BG-A2AE-01A-11R-A16F-07","7a5dd0ca-549d-452a-beb8-ea8a3f5528ec",0.18,NA,135,42.1335164320714,179,"49177037-cd3c-5801-bd75-03aa338475a2","TCGA-BG-A2AE_exposure","UNCID_2206474.7a5dd0ca-549d-452a-beb8-ea8a3f5528ec.110921_UNC2-RDR300275_00086_FC634HAAAXX_7.tar.gz","2013-09-27T03:06:07.000Z","2013-09-27T03:19:02.000Z","A0F80C97-D733-4697-9DB0-98AA64B69A40","273A3B52-7613-400E-8AE1-A68C36AB6968","Unaligned reads",2114081301,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","7A5DD0CA-549D-452A-BEB8-EA8A3F5528EC","University of North Carolina","564a3caee4b0298dd2c8d0b6","F384EB3F-92AB-4327-87EB-45B5F72A1580","Uterine Corpus Endometrial Carcinoma","TARGZ","D4998478-FF8D-4D6F-9941-57A3B2B5E09D","2013-09-27T03:19:02.000Z","34583EAF-46CA-41B8-8174-307C118C8149","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",50,"D4998478-FF8D-4D6F-9941-57A3B2B5E09D",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F0576BE1-156D-4AB2-B139-A4AD29B28209.txt",460,"TCGA-BG-A2AE-01A",NA,"FFCED0E8-5EDD-4DFA-BEF9-3A40085BEF56","TCGA",2011,NA,NA,NA,"5733ECF2-9865-4AA9-8476-245F3A2C90BB",57,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.F0576BE1-156D-4AB2-B139-A4AD29B28209.txt","Alive",NA,"TCGA-BG-A2AE","NOT HISPANIC OR LATINO","2E039DA7-AF00-409B-A472-04A92009C7BC",NA,327,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",143,NA,"71521F2B-CEB0-4293-AF11-08BB2E3E69E7","WHITE",NA,11,30,"5F8063D7-18C0-4FD0-948D-14BEB2210948","E966E52A-6953-4FA8-B059-823627393A27","UNCID_1620766.7a5dd0ca-549d-452a-beb8-ea8a3f5528ec.sorted_genome_alignments.bam","TCGA-BG-A2AE-01A-11",90,0,20,40,0,"TOP",10,20,"TCGA-BG-A2AE-01A-01-TSA",90,"Taxol","Chemotherapy","TCGA-BG-A2AE-D56536","TCGA-BG-A2AE-R56534","External","Primary Tumor Field","TCGA-BG-A2AE-F49553_NTE-1","NO",721,"TUMOR FREE","Alive",NA,"TCGA-BG-A2AE-F49553","TCGA-BG-A2AE",1,"BG","A2AE","YES","C54.1","8441/3","C54.1","NO","YES",-21069,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",327,NA,NA,NA,NA,"NO",28,9,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
112033286,109009558,5172595305,"14DB79EF-DE2B-4197-AD32-F657E0655FCD.bw","f42868c0-ff59-438b-90a7-489aea678de9","14db79ef-de2b-4197-ad32-f657e0655fcd","2016-08-09T14:18:19.750892-05:00","UNCID_2234484.7f9fd176-6826-4472-bf00-89632783b629.130619_UNC13-SN749_0277_BC293YACXX_1_ACAGTG.tar.gz","9f2f91a2-e9af-4f5e-8cc9-a58ecc925b0f",4789940053,"Illumina HiSeq","fd0f7913cbbe98540a330fcf889c123b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:51:14.477669-05:00","2016-05-03T11:20:13.161874-05:00","9f2f91a2-e9af-4f5e-8cc9-a58ecc925b0f_analysis.xml","47b7a0032aabdb5c25f6193a3eca66e9","32273d40-a88a-4697-8438-0a0536a4077d",2124,"2016-09-29T18:44:26.142081-05:00","9f2f91a2-e9af-4f5e-8cc9-a58ecc925b0f_experiment.xml","ecc5a765ce3e0c1cac2d2adbf3a277dd","2dd535dd-95bd-42b9-9320-91a5012cb217",2431,"2016-09-29T21:55:25.870497-05:00","9f2f91a2-e9af-4f5e-8cc9-a58ecc925b0f_run.xml","a0afa11e06fe027f3336fbfd31ccd07a","a4842828-0a5c-4295-a97c-c66fa773c455",354,"2016-09-08T10:37:39.189125-05:00","TCGA-A5-A2K7","2016-09-02T18:53:12.777027-05:00","female","TCGA-A5-A2K7_demographic",1970,"not reported","0dc5ba75-646a-5fac-be58-86ae178ea9a3","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","A5","932c7c29-cacf-5deb-b70e-fb7595f6800b","Cedars Sinai","not reported","c54.1","TCGA-A5-A2K7_diagnosis","not reported",14980,"alive","8380/3",NA,1063,"9eb35cf2-e1d7-5a6c-abdd-5f04c5a7b1dd","c54.1",-14980,"TCGA-A5-A2K7_treatment","25d41f28-b73e-50dc-aa15-c234be932e6d","01","true","TCGA-A5-A2K7-01A",NA,"b19b35dd-9431-4040-bbf1-e7490b037de7",FALSE,"1880F604-34C9-4B58-92DC-D67C7E656E3B","Primary Tumor",NA,195,170,NA,1312416000,"11",30,"TCGA-A5-A2K7-01A-11",85,NA,0,NA,0,NA,25,NA,"2016-09-08T10:37:39.189125-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"f70793ef-32f7-4bf5-b4d6-aed487bcec8a",NA,"TCGA-A5-A2K7-01A-01-TSA",NA,75,NA,"0b3ca650-6326-4286-918a-7ac746b82c04","RNA","TCGA-A5-A2K7-01A-11R","91ce03a7-5002-44f4-9763-e0f830201662",1.8,0.16,"UV Spec","R","23","TCGA-A5-A2K7-01A-11R-A180-07","7f9fd176-6826-4472-bf00-89632783b629",0.16,NA,72,29.2101099436083,157,"8a56bb29-f43a-584f-b3ff-7dd56ff8a064","TCGA-A5-A2K7_exposure","UNCID_2234484.7f9fd176-6826-4472-bf00-89632783b629.130619_UNC13-SN749_0277_BC293YACXX_1_ACAGTG.tar.gz","2013-10-18T20:51:04.000Z","2013-10-18T21:05:01.000Z","9F2F91A2-E9AF-4F5E-8CC9-A58ECC925B0F","B19B35DD-9431-4040-BBF1-E7490B037DE7","Unaligned reads",4789940053,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","7F9FD176-6826-4472-BF00-89632783B629","University of North Carolina","564a3815e4b093830b6834a9","F42868C0-FF59-438B-90A7-489AEA678DE9","Uterine Corpus Endometrial Carcinoma","TARGZ","0B3CA650-6326-4286-918A-7AC746B82C04","2013-10-18T21:05:01.000Z","91CE03A7-5002-44F4-9763-E0F830201662","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",195,"0B3CA650-6326-4286-918A-7AC746B82C04",NA,"A5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C088EF25-623E-416A-B21F-1AE65E1638A0.txt",170,"TCGA-A5-A2K7-01A",NA,"7DC9E40C-0E1A-4B30-8BA3-E84C94631C0D","TCGA",2011,NA,NA,"TUMOR FREE","B19B35DD-9431-4040-BBF1-E7490B037DE7",41,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C088EF25-623E-416A-B21F-1AE65E1638A0.txt","Alive",NA,"TCGA-A5-A2K7","HISPANIC OR LATINO","9F4ADCA0-451A-4A67-87FC-957AF1A03D8C",NA,157,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage II",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,"9515E635-29CC-4835-88E4-AD651029CEEF",NA,NA,11,30,"F70793EF-32F7-4BF5-B4D6-AED487BCEC8A","91CE03A7-5002-44F4-9763-E0F830201662","TCGA-A5-A2K7-01A-11R-A17X-13_mirna.bam.bai","TCGA-A5-A2K7-01A-11",85,0,0,1,25,"TOP",0,0,"TCGA-A5-A2K7-01A-01-TSA",75,"Carboplatin","Chemotherapy","TCGA-A5-A2K7-D19648","TCGA-A5-A2K7-R19646","IMPLANTS","Primary Tumor Field","TCGA-A5-A2K7-F54486_NTE-1","NO",1063,"TUMOR FREE","Alive",NA,"TCGA-A5-A2K7-F54486","TCGA-A5-A2K7",1,"A5","A2K7","YES","C54.1","8380/3","C54.1","YES","NO",-14980,"FEMALE",NA,"HISPANIC OR LATINO","No","No","Alive",157,NA,NA,NA,"TUMOR FREE","NO",19,12,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,41,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",5,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
33106002,31573617,2365533643,"14748E8F-6750-4920-B8EC-2B4C51DA6C8D.bw","f47df5f9-7c60-4b1a-b574-7036245af341","14748e8f-6750-4920-b8ec-2b4c51da6c8d","2016-08-05T04:41:23.587911-05:00","UNCID_2211010.8f9d6b78-c294-4f11-99ea-dc834a7f1741.110316_UNC2-RDR300275_00058_FC_62J26AAXX_1.tar.gz","332a1cc2-f304-4cd8-a5bb-fd270d334563",2076825638,"Illumina GA","414499b227a722dfc1fd8ee580246422","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:30:43.269878-05:00","2016-05-03T11:15:47.407128-05:00","332a1cc2-f304-4cd8-a5bb-fd270d334563_analysis.xml","e04985dfce71c01f657085c5f972031d","25147042-0bf0-42c6-90c8-1cfb058d5542",2121,"2016-09-29T20:01:01.667338-05:00","332a1cc2-f304-4cd8-a5bb-fd270d334563_experiment.xml","9ad6948d76d9e057b629e2ca4f78b65b","5dbb541a-65fc-44c0-bc27-2c639e0b03f8",2257,"2016-09-29T23:18:40.489875-05:00","332a1cc2-f304-4cd8-a5bb-fd270d334563_run.xml","ff3ece84760838589a601e4af1fc1a58","d7ce82a7-775c-4bcf-bfde-3f52ab9936dd",347,"2016-09-08T12:37:05.931251-05:00","TCGA-BG-A0W2","2016-09-02T18:49:01.841263-05:00","female","TCGA-BG-A0W2_demographic",1950,"white","215f190d-5fd9-57db-9461-d00abcfae4e0","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0W2_diagnosis","not reported",20998,"alive","8380/3",NA,1721,"2e957e13-19ba-579d-a39a-d6a1fa3d990f","c54.1",-20998,"TCGA-BG-A0W2_treatment","378ea897-c35f-53f3-8fda-3de9b9394435","01","true","TCGA-BG-A0W2-01A",NA,"0945d625-8d4b-4f5a-a863-a61dad5ecd34",FALSE,"D9BDB0FB-9205-4E41-9D7D-B12C206A608E","Primary Tumor",NA,1073,80,NA,1286841600,"11",30,"TCGA-BG-A0W2-01A-11",70,70,10,20,10,5,15,20,"2016-09-08T12:37:05.931251-05:00","2016-09-08T12:37:05.931251-05:00",40,40,30,30,"TOP","BOTTOM",5,5,"8a1c072d-fa15-4895-beae-96d3dc7c1d39","3467b566-fdcc-4f2e-89e2-359d6ec16402","TCGA-BG-A0W2-01A-01-TS1","TCGA-BG-A0W2-01A-01-BS1",70,70,"1b168c9c-efe9-4caa-8cee-80e88fc4dc14","RNA","TCGA-BG-A0W2-01A-11R","ef987b6b-60b7-4c58-b0ca-0b35f6ba4a5e",1.87,0.16,"UV Spec","R","23","TCGA-BG-A0W2-01A-11R-A109-07","8f9d6b78-c294-4f11-99ea-dc834a7f1741",0.16,NA,121,44.4444444444444,165,"cc9f2b0a-0a8f-5803-97d9-5d33d48abf70","TCGA-BG-A0W2_exposure","UNCID_2211010.8f9d6b78-c294-4f11-99ea-dc834a7f1741.110316_UNC2-RDR300275_00058_FC_62J26AAXX_1.tar.gz","2013-10-02T07:31:03.000Z","2013-10-02T07:44:03.000Z","332A1CC2-F304-4CD8-A5BB-FD270D334563","0945D625-8D4B-4F5A-A863-A61DAD5ECD34","Unaligned reads",2076825638,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","8F9D6B78-C294-4F11-99EA-DC834A7F1741","University of North Carolina","564a4034e4b08c5d86930c46","F47DF5F9-7C60-4B1A-B574-7036245AF341","Uterine Corpus Endometrial Carcinoma","TARGZ","1B168C9C-EFE9-4CAA-8CEE-80E88FC4DC14","2013-10-02T07:44:03.000Z","EF987B6B-60B7-4C58-B0CA-0B35F6BA4A5E","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",1073,"1B168C9C-EFE9-4CAA-8CEE-80E88FC4DC14",NA,"BG","SHUCK_p_TCGAb74and75_SNP_N_GenomeWideSNP_6_C08_730948.tangent.copynumber.data.txt",80,"TCGA-BG-A0W2-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","4FF8920B-7031-49A3-B07A-5B23FED8C977",57,"nationwidechildrens.org_clinical.TCGA-BG-A0W2.xml","Alive",NA,"TCGA-BG-A0W2",NA,"95921FF2-EEDA-4B18-8D14-FF43A3D3B70E",NA,1151,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",75,NA,NA,"WHITE",NA,11,30,"8A1C072D-FA15-4895-BEAE-96D3DC7C1D39","EF987B6B-60B7-4C58-B0CA-0B35F6BA4A5E","SHUCK_p_TCGAb74and75_SNP_N_GenomeWideSNP_6_C08_730948.hg18.seg.txt","TCGA-BG-A0W2-01A-11",70,5,20,40,20,"BOTTOM",5,30,"TCGA-BG-A0W2-01A-01-BS1",70,NA,NA,NA,NA,NA,NA,"TCGA-BG-A0W2-F49543_NTE-1","NO",1721,"TUMOR FREE","Alive",NA,"TCGA-BG-A0W2-F49543","TCGA-BG-A0W2",1,"BG","A0W2","YES","C54.1","8380/3","C54.1","NO","YES",-20998,"FEMALE","WHITE",NA,"No","No","Alive",1151,NA,NA,NA,"TUMOR FREE","NO",18,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,57,2007,"Dilation and curettage procedure",NA,NA,NA,"G1","RX",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32280915,23537197,1763484775,"CC0DD2EF-C9E3-4871-AC87-D3C9331FAC8E.bw","f4a7f2ff-be76-48d3-9f59-9223db33680e","cc0dd2ef-c9e3-4871-ac87-d3c9331fac8e","2016-08-09T14:15:29.838957-05:00","UNCID_2210397.06ee29fc-036c-4c36-b62b-f304c6ccad50.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_3.tar.gz","c1a92a62-0c76-43dd-8623-d430b8023b1b",2100992569,"Illumina GA","955ce0d991f37d762003b33924818429","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:21:25.209393-05:00","2016-05-03T11:15:47.420908-05:00","c1a92a62-0c76-43dd-8623-d430b8023b1b_analysis.xml","cbe738b7129656bb721726726b4e4055","453386dc-22c4-44a5-8e10-c1ab52da6675",2121,"2016-10-07T16:26:46.111646-05:00","c1a92a62-0c76-43dd-8623-d430b8023b1b_experiment.xml","d70519600436c40a74e8f14e621d786b","cdb04e7c-3e5d-452c-8bf5-b2c905a071af",2257,"2016-09-29T21:43:09.781867-05:00","c1a92a62-0c76-43dd-8623-d430b8023b1b_run.xml","a905398a77d72f341921b1005a20e917","9cc68eac-1597-4dda-a82b-58412290e171",347,"2016-09-08T11:04:32.221385-05:00","TCGA-AX-A06L","2016-09-02T18:49:23.996847-05:00","female","TCGA-AX-A06L_demographic",1943,"white","316d7ad8-9075-5bbb-b4b3-a38a05ae77c3","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A06L_diagnosis","not reported",23294,"alive","8380/3",NA,1845,"5ade4692-b9f4-5130-802d-4408788d54fe","c54.1",-23294,"TCGA-AX-A06L_treatment","5cfbda68-70ae-50f0-9817-479a5ed5d894","01","false","TCGA-AX-A06L-01A",NA,"cacec107-78de-47c7-9386-dbefcfc1f07a",FALSE,"926937F8-6057-4D39-BB3B-0115B0ACFE1A","Primary Tumor",NA,1499,250,NA,1291161600,"11",30,"TCGA-AX-A06L-01A-11",60,60,0,0,25,30,2,0,"2016-09-08T11:04:32.221385-05:00","2016-09-08T11:04:32.221385-05:00",12,2,1,0,"TOP","BOTTOM",8,10,"ca0dcaa3-74fa-46fe-910d-0d6557fc269e","8e604aa5-2798-4d40-9b45-d521e460119e","TCGA-AX-A06L-01A-01-TS1","TCGA-AX-A06L-01A-01-BS1",65,60,"64d6aa68-f337-4991-8fd5-7ae7b177e89e","RNA","TCGA-AX-A06L-01A-11R","31d6e8a6-2a9c-4157-9b4d-0f26f1e8c27f",1.89,0.16,"UV Spec","R","23","TCGA-AX-A06L-01A-11R-A118-07","06ee29fc-036c-4c36-b62b-f304c6ccad50",0.16,NA,112,43.2082095598164,161,"85a52fcc-f951-51f5-a7b8-240c2adde653","TCGA-AX-A06L_exposure","UNCID_2210397.06ee29fc-036c-4c36-b62b-f304c6ccad50.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_3.tar.gz","2013-10-02T10:13:04.000Z","2013-10-02T10:26:01.000Z","C1A92A62-0C76-43DD-8623-D430B8023B1B","CACEC107-78DE-47C7-9386-DBEFCFC1F07A","Unaligned reads",2100992569,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","06EE29FC-036C-4C36-B62B-F304C6CCAD50","University of North Carolina","56607796e4b016715ab69890","F4A7F2FF-BE76-48D3-9F59-9223DB33680E","Uterine Corpus Endometrial Carcinoma","TARGZ","64D6AA68-F337-4991-8FD5-7AE7B177E89E","2013-10-02T10:26:01.000Z","31D6E8A6-2A9C-4157-9B4D-0F26F1E8C27F","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1499,"64D6AA68-F337-4991-8FD5-7AE7B177E89E",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BF44A950-E005-4031-8F27-52901F8E5963.txt",250,"TCGA-AX-A06L-01A",NA,NA,"TCGA",2006,NA,NA,"WITH TUMOR","E930C349-FD0D-44EC-92AD-D94A7AA7F2CA",63,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.BF44A950-E005-4031-8F27-52901F8E5963.txt","Alive",NA,"TCGA-AX-A06L",NA,"D8127A72-8565-47A7-A17D-B479476E5FFB",NA,1480,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"CA0DCAA3-74FA-46FE-910D-0D6557FC269E","8BB08100-F4EA-45ED-8D42-4178ACD66F42","2051a76b760a8717952e489aa08f5c7f.bam","TCGA-AX-A06L-01A-11",60,25,0,12,2,"TOP",8,1,"TCGA-AX-A06L-01A-01-TS1",65,NA,NA,NA,NA,NA,NA,NA,NA,1845,"TUMOR FREE","Alive",NA,"TCGA-AX-A06L-F9726","TCGA-AX-A06L",1,"AX","A06L","YES","C54.1","8380/3","C54.1","NO","YES",-23294,"FEMALE","WHITE",NA,"No","No","Alive",1480,NA,NA,NA,"WITH TUMOR","NO",17,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2006,"Dilation and curettage procedure",NA,NA,NA,"G1","R1",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34599260,34363893,2553655248,"67A7E9D8-C2A0-4B52-95BD-BDB781E7A9D5.bw","f5261330-596e-4632-a5a3-8d3a2aa5de38","67a7e9d8-c2a0-4b52-95bd-bdb781e7a9d5","2016-08-09T14:10:07.712690-05:00","UNCID_2206476.5afaa343-65f0-4499-a44d-c3c87106443a.110921_UNC2-RDR300275_00086_FC634HAAAXX_4.tar.gz","fcb76b28-db5d-40a7-af2d-69fdd6351779",2205692419,"Illumina GA","8bd8fdd08621b456bb6fd5f4c742b9df","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:08:52.684287-05:00","2016-05-03T11:11:34.768699-05:00","fcb76b28-db5d-40a7-af2d-69fdd6351779_analysis.xml","19cdbf702902dd1d1644ba8dc9792f31","879be1be-4982-4b85-b7c8-b02eb89a307b",2118,"2016-08-28T02:28:02.816406-05:00","fcb76b28-db5d-40a7-af2d-69fdd6351779_experiment.xml","7d307fe6a2aee27ee5f332d166c1d3b2","b9364bfc-875f-4b4d-bf5a-59fba39d4eac",2257,"2016-09-29T20:23:05.767592-05:00","fcb76b28-db5d-40a7-af2d-69fdd6351779_run.xml","cff98ad09b3ca59b6b8d1db91e40a784","6b29de61-0950-4626-ac55-ab88fb7a192b",347,"2016-09-08T10:59:58.825658-05:00","TCGA-B5-A1MU","2016-09-02T18:51:48.116059-05:00","female","TCGA-B5-A1MU_demographic",1927,"white","202c205f-99be-54e1-b30f-7cc2d63ef130","not reported",2010,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A1MU_diagnosis","not reported",29027,"dead","8441/3",1548,NA,"13c28c27-513b-56ac-9f50-4a80d1dd06b2","c54.1",-29027,"TCGA-B5-A1MU_treatment","c8387477-25d3-53c1-b867-4a69dc0cb943","01","true","TCGA-B5-A1MU-01A",NA,"bb3bdc38-8011-4427-a863-eba7a6cfff69",FALSE,"FC3D9B79-4CAD-4F62-892C-C830B24E50DD","Primary Tumor",NA,1834,260,NA,1300060800,"11",30,"TCGA-B5-A1MU-01A-11",85,NA,3,NA,0,NA,15,NA,"2016-09-08T10:59:58.825658-05:00",NA,8,NA,3,NA,"TOP",NA,0,NA,"c5dd96b2-fa10-4e66-96ec-eb7356560d4f",NA,"TCGA-B5-A1MU-01A-01-TSA",NA,85,NA,"4e509b6d-76f8-41a4-ad71-03b0eecdecad","RNA","TCGA-B5-A1MU-01A-11R","d8b424e2-38c4-45e1-8a61-1795833490d2",2.01,0.16,"UV Spec","R","23","TCGA-B5-A1MU-01A-11R-A13S-07","5afaa343-65f0-4499-a44d-c3c87106443a",0.16,NA,44,20.3618862510991,147,"b6f82407-1bc9-566e-8db9-414c2becd5aa","TCGA-B5-A1MU_exposure","UNCID_2206476.5afaa343-65f0-4499-a44d-c3c87106443a.110921_UNC2-RDR300275_00086_FC634HAAAXX_4.tar.gz","2013-09-27T03:16:04.000Z","2013-09-27T03:29:02.000Z","FCB76B28-DB5D-40A7-AF2D-69FDD6351779","BB3BDC38-8011-4427-A863-EBA7A6CFFF69","Unaligned reads",2205692419,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","5AFAA343-65F0-4499-A44D-C3C87106443A","University of North Carolina","56607e45e4b0b37b3d992f69","F5261330-596E-4632-A5A3-8D3A2AA5DE38","Uterine Corpus Endometrial Carcinoma","TARGZ","4E509B6D-76F8-41A4-AD71-03B0EECDECAD","2013-09-27T03:29:02.000Z","D8B424E2-38C4-45E1-8A61-1795833490D2","United States","NO",1,NA,"Primary Tumor","Duke",1834,"4E509B6D-76F8-41A4-AD71-03B0EECDECAD",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.25E51246-A434-4281-90CE-E2577B8DC786.txt",260,"TCGA-B5-A1MU-01A",NA,"A71E75E7-A2C1-4D9C-93F4-EBF3E531705A","TCGA",2006,NA,NA,"WITH TUMOR","BB3BDC38-8011-4427-A863-EBA7A6CFFF69",79,"nationwidechildrens.org_clinical.TCGA-B5-A1MU.xml","Dead",1548,"TCGA-B5-A1MU",NA,"0848493F-30CD-4FC2-9BB8-2E096027B1A1",NA,NA,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8441/3","FEMALE","C54.1",110,NA,NA,"WHITE",NA,11,30,"C5DD96B2-FA10-4E66-96EC-EB7356560D4F","D8B424E2-38C4-45E1-8A61-1795833490D2","TCGA-B5-A1MU-01A-11R-A13R-13_mirna.bam.bai","TCGA-B5-A1MU-01A-11",85,0,3,8,15,"TOP",0,3,"TCGA-B5-A1MU-01A-01-TSA",85,"Tamoxifen","Hormone Therapy","TCGA-B5-A1MU-D14405",NA,NA,NA,NA,"YES",NA,"WITH TUMOR","Dead",1548,"TCGA-B5-A1MU-F19109","TCGA-B5-A1MU",1,"B5","A1MU","YES","C54.1","8441/3","C54.1","NO","YES",-29027,"FEMALE","WHITE",NA,"No","No","Dead",NA,1548,NA,NA,"WITH TUMOR","NO",19,7,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,79,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30146078,28397860,2139469416,"A0A315C5-8AF1-4FA8-9E1F-45819F3F68F3.bw","f5bd3902-ff7f-4233-8f74-beef3676af9a","a0a315c5-8af1-4fa8-9e1f-45819f3f68f3","2016-08-05T08:32:07.490612-05:00","UNCID_2210341.168116db-99c5-4d7a-9e9f-3858e1824298.110407_UNC6-RDR300211_00095_FC64GJRAAXX_1.tar.gz","117ceeba-545c-4cbe-955d-741f03c5935e",2005093270,"Illumina GA","4020f3762c514951e5562ba646acf88d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:44:34.960799-05:00","2016-05-03T11:15:47.420908-05:00","117ceeba-545c-4cbe-955d-741f03c5935e_analysis.xml","59dd312bd813099b3aa5b4dd1e549632","785c9fd2-dea7-4512-9824-16e65e9bb726",2119,"2016-09-29T19:19:37.683248-05:00","117ceeba-545c-4cbe-955d-741f03c5935e_experiment.xml","0a6eb505a6cd24bb93546021b988a3d7","440e89af-5606-44c3-a816-42419783ce0c",2257,"2016-09-30T00:12:50.545380-05:00","117ceeba-545c-4cbe-955d-741f03c5935e_run.xml","338efff33d31ab7a6e82a2c762830d9f","f97d1ae8-f74d-4ece-b939-fd4351071c83",347,"2016-09-08T11:32:59.198109-05:00","TCGA-B5-A11W","2016-09-02T18:49:36.358527-05:00","female","TCGA-B5-A11W_demographic",1949,"white","5a99a5f6-68c6-5de3-97e6-d1990afc1648","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11W_diagnosis","not reported",22365,"alive","8380/3",NA,593,"86b131a8-df1c-5e14-b809-1f0ff6bd3306","c54.1",-22365,"TCGA-B5-A11W_treatment","b0f777ba-d81d-502e-bc54-1018f82cfc98","01","true","TCGA-B5-A11W-01A",NA,"ac3c028c-d36b-489b-a3d9-a7f4783de5eb",FALSE,"C5762F7C-AB69-40D0-A9D0-71A6281F30AF","Primary Tumor",NA,258,310,NA,1290556800,"12",30,"TCGA-B5-A11W-01A-12",90,90,0,0,0,10,10,0,"2016-09-08T11:32:59.198109-05:00","2016-09-08T11:32:59.198109-05:00",10,10,20,0,"TOP","BOTTOM",30,10,"dac6580a-83b6-4f8f-8d94-9358862397a5","3be033f7-3527-4807-9ce3-20cf08db176f","TCGA-B5-A11W-01A-01-TSA","TCGA-B5-A11W-01A-01-BSA",60,80,"838c73c3-7464-4427-8859-66e68bb913a5","RNA","TCGA-B5-A11W-01A-12R","1995b32c-362f-459d-a7ce-43931c68b2c8",1.85,0.15,"UV Spec","R","23","TCGA-B5-A11W-01A-12R-A118-07","168116db-99c5-4d7a-9e9f-3858e1824298",0.15,NA,102,38.3906055929843,163,"c0c1cab2-2aed-526b-a4e8-f386e1db07ec","TCGA-B5-A11W_exposure","UNCID_2210341.168116db-99c5-4d7a-9e9f-3858e1824298.110407_UNC6-RDR300211_00095_FC64GJRAAXX_1.tar.gz","2013-10-02T09:43:05.000Z","2013-10-02T09:55:03.000Z","117CEEBA-545C-4CBE-955D-741F03C5935E","AC3C028C-D36B-489B-A3D9-A7F4783DE5EB","Unaligned reads",2005093270,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","168116DB-99C5-4D7A-9E9F-3858E1824298","University of North Carolina","564a393fe4b0ef121819c143","F5BD3902-FF7F-4233-8F74-BEEF3676AF9A","Uterine Corpus Endometrial Carcinoma","TARGZ","838C73C3-7464-4427-8859-66E68BB913A5","2013-10-02T09:55:03.000Z","1995B32C-362F-459D-A7CE-43931C68B2C8","United States","NO",1,NA,"Primary Tumor","Duke",258,"838C73C3-7464-4427-8859-66E68BB913A5",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.2868A3E3-9D6E-4F91-8E5D-EBDF6893272D.txt",310,"TCGA-B5-A11W-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","F2C8927B-4ECD-4668-A9EF-D63B27AFCC64",61,"nationwidechildrens.org_clinical.TCGA-B5-A11W.xml","Alive",NA,"TCGA-B5-A11W",NA,"219D2E19-B420-49C0-B36A-B3E4B40CF18B",NA,339,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,"840A2A99-B6B6-4CF9-A4B2-418B1E085273","WHITE",NA,12,30,"DAC6580A-83B6-4F8F-8D94-9358862397A5","E62F63DD-8432-4C9F-A435-956277E64EF8","TCGA-B5-A11W-01A-12R-A119-13_mirna.bam.bai","TCGA-B5-A11W-01A-12",90,10,0,10,0,"BOTTOM",10,0,"TCGA-B5-A11W-01A-01-BSA",80,NA,NA,NA,"TCGA-B5-A11W-R10638","IMPLANTS","Regional site",NA,"NO",593,"TUMOR FREE","Alive",NA,"TCGA-B5-A11W-F17779","TCGA-B5-A11W",1,"B5","A11W","YES","C54.1","8380/3","C54.1","NO","YES",-22365,"FEMALE","WHITE",NA,"No","No","Alive",339,NA,NA,NA,"TUMOR FREE","NO",4,3,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35611290,35320570,2633075889,"57CDEE2D-9B87-40D7-8DDA-17B7000F6965.bw","f6d136c7-c250-4361-9fed-50f513959a40","57cdee2d-9b87-40d7-8dda-17b7000f6965","2016-08-09T14:15:45.698229-05:00","UNCID_2211907.5706f1b9-2c2c-4906-a9fb-64ba5a57d47e.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_4.tar.gz","e947887d-2f16-4a38-813d-4fd49af1d014",2222013208,"Illumina GA","bae3404659286a768f4e1127cda74424","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:53:34.619299-05:00","2016-05-03T11:16:29.240093-05:00","e947887d-2f16-4a38-813d-4fd49af1d014_analysis.xml","ee9e95daece3644796a6a10e41372b0a","0df1b6ad-1676-4d9d-b031-1be886cb94fa",2121,"2016-09-29T22:26:45.684241-05:00","e947887d-2f16-4a38-813d-4fd49af1d014_experiment.xml","6bbd61b3a56270afcc9e6df80b74638f","b7afd8e5-7ce3-48f5-897a-35afd05677b2",2257,"2016-09-29T23:49:38.759404-05:00","e947887d-2f16-4a38-813d-4fd49af1d014_run.xml","4c2f2884ff9841f59a37c962a085c6e5","eb3d0d99-9d24-40fb-bd71-87cbbf3a4d61",347,"2016-09-08T11:12:55.940368-05:00","TCGA-B5-A11I","2016-09-02T18:49:06.636445-05:00","female","TCGA-B5-A11I_demographic",1940,"black or african american","bbb417a3-02c2-56b4-b115-92346aa6216f","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11I_diagnosis","not reported",23857,"alive","8140/3",NA,2303,"0a88bce6-1fc7-5b47-b586-c3f60a39ed68","c54.1",-23857,"TCGA-B5-A11I_treatment","1e269e8b-584c-5dbe-ad4d-2c5b8358bd59","01","true","TCGA-B5-A11I-01A",NA,"56652dde-33da-451e-a1c2-6e9884f9915a",FALSE,"850EFCC5-484B-4E09-801A-2FAFB4CFD72B","Primary Tumor",NA,1974,970,NA,1289865600,"11",30,"TCGA-B5-A11I-01A-11",90,92,25,30,0,0,3,3,"2016-09-08T11:12:55.940368-05:00","2016-09-08T11:12:55.940368-05:00",30,30,2,3,"TOP","BOTTOM",7,5,"1242e86f-9fc8-4774-be96-fd33b8886123","eb31fc61-7f1d-4e98-ad19-17842f2024c3","TCGA-B5-A11I-01A-01-TSA","TCGA-B5-A11I-01A-01-BSA",90,92,"15eacd2a-cf7e-4486-ad4a-7874ba1efc91","RNA","TCGA-B5-A11I-01A-11R","ed154bf0-f433-4d04-9a65-eb3a76044c7e",1.92,0.15,"UV Spec","R","23","TCGA-B5-A11I-01A-11R-A10J-07","5706f1b9-2c2c-4906-a9fb-64ba5a57d47e",0.15,NA,124,49.0486926941181,159,"84717fa6-8c46-51e1-8ad3-f63221b231ad","TCGA-B5-A11I_exposure","UNCID_2211907.5706f1b9-2c2c-4906-a9fb-64ba5a57d47e.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_4.tar.gz","2013-10-03T03:43:05.000Z","2013-10-03T03:56:02.000Z","E947887D-2F16-4A38-813D-4FD49AF1D014","56652DDE-33DA-451E-A1C2-6E9884F9915A","Unaligned reads",2222013208,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","5706F1B9-2C2C-4906-A9FB-64BA5A57D47E","University of North Carolina","564a3c20e4b093830b6980f0","F6D136C7-C250-4361-9FED-50F513959A40","Uterine Corpus Endometrial Carcinoma","TARGZ","15EACD2A-CF7E-4486-AD4A-7874BA1EFC91","2013-10-03T03:56:03.000Z","ED154BF0-F433-4D04-9A65-EB3A76044C7E","United States","NO",1,NA,"Primary Tumor","Duke",1974,"15EACD2A-CF7E-4486-AD4A-7874BA1EFC91",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.354106A1-BA91-416A-B95C-05ACAE0EC86B.txt",970,"TCGA-B5-A11I-01A",NA,"5F78129B-0086-47A8-BABC-2D9920ACFDF4","TCGA",2005,NA,NA,"WITH TUMOR","8338C154-FBF6-4A5E-9A89-FA825AB9BD9E",65,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.354106A1-BA91-416A-B95C-05ACAE0EC86B.txt","Alive",NA,"TCGA-B5-A11I",NA,"9FDB4311-FB23-48FA-994B-EF204B97F4D8",NA,2038,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8140/3","FEMALE","C54.1",81,NA,"1400791D-9BC3-4645-9BFC-334D9353D9F6","BLACK OR AFRICAN AMERICAN",NA,11,30,"EB31FC61-7F1D-4E98-AD19-17842F2024C3","D1C1BCAD-F4F4-480E-A2B2-A18FF95F0800","c7d4da3dbfd3dbc673a6cbab28c5999b.bam.bai","TCGA-B5-A11I-01A-11",92,0,30,30,3,"BOTTOM",5,3,"TCGA-B5-A11I-01A-01-BSA",92,"Megace","Hormone Therapy","TCGA-B5-A11I-D10059","TCGA-B5-A11I-R10451","EXTERNAL BEAM","Distant site",NA,"YES",2303,"TUMOR FREE","Alive",NA,"TCGA-B5-A11I-F17674","TCGA-B5-A11I",1,"B5","A11I","YES","C54.1","8140/3","C54.1","NO","YES",-23857,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",2038,NA,NA,NA,"WITH TUMOR","NO",27,1,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2005,"Office Endometrial Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35452512,34749414,2605757107,"B29206B9-3682-4A5A-A7ED-3DF04361440C.bw","f7010b87-a559-4501-99f9-0fcca1e986e1","b29206b9-3682-4a5a-a7ed-3df04361440c","2016-08-09T14:15:40.165501-05:00","UNCID_2210225.30f27799-c311-47c4-ad9e-6c80863a3cd2.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_6.tar.gz","048919ec-b6a5-44d4-a43b-00c875283a17",2285769239,"Illumina GA","0d3796b9e9004ba5ee404331c6992984","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:54:51.835171-05:00","2016-05-03T11:15:47.407128-05:00","048919ec-b6a5-44d4-a43b-00c875283a17_analysis.xml","bbd436b87dea66f7a215364483fad07e","346db653-b797-4980-8969-0ff6170884b4",2121,"2016-09-29T17:43:55.182814-05:00","048919ec-b6a5-44d4-a43b-00c875283a17_experiment.xml","88ad924f9087b830048be962aa0b616a","07c21a0a-a40c-406d-9e75-9b59d95cabfe",2257,"2016-09-29T22:49:48.608796-05:00","048919ec-b6a5-44d4-a43b-00c875283a17_run.xml","241dd6ebec074aea1ff53c7551aa2936","c60f3dcc-f98f-46bc-a5b1-383ba42c5a57",347,"2016-09-08T11:29:52.567193-05:00","TCGA-D1-A15V","2016-09-02T18:49:53.506759-05:00","female","TCGA-D1-A15V_demographic",1940,"white","5e0b5d34-f9df-502e-94e6-7bfeeb92a539","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A15V_diagnosis","not reported",24886,"alive","8441/3",NA,1201,"30f9ef49-9429-50d7-8a9d-1ba517fdc60a","c54.1",-24886,"TCGA-D1-A15V_treatment","b3442fbd-0bc6-5afc-bbbe-e5ebbacba46d","01","false","TCGA-D1-A15V-01A",NA,"8bf1146c-8442-47b5-83af-f7899d4a94a6",FALSE,"597F20F2-AE36-4A9F-A7AF-1647CB56B453","Primary Tumor",NA,895,250,NA,1292976000,"11",30,"TCGA-D1-A15V-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T11:29:52.567193-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"7c40e4cb-8342-42e8-8512-a15adde996a5",NA,"TCGA-D1-A15V-01A-01-TSA",NA,100,NA,"7e4f7f0f-3462-49c4-9eb1-6e54b8b293a5","RNA","TCGA-D1-A15V-01A-11R","dc71ea6c-5460-4726-b6c2-6ccc4ce4c4ae",1.86,0.16,"UV Spec","R","23","TCGA-D1-A15V-01A-11R-A118-07","30f27799-c311-47c4-ad9e-6c80863a3cd2",0.16,NA,69,26.953125,160,"efa0519e-fb97-500d-ab67-9a5912e70cb2","TCGA-D1-A15V_exposure","UNCID_2210225.30f27799-c311-47c4-ad9e-6c80863a3cd2.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_6.tar.gz","2013-10-02T07:36:04.000Z","2013-10-02T07:49:02.000Z","048919EC-B6A5-44D4-A43B-00C875283A17","8BF1146C-8442-47B5-83AF-F7899D4A94A6","Unaligned reads",2285769239,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","30F27799-C311-47C4-AD9E-6C80863A3CD2","University of North Carolina","566079b2e4b018727fea21d5","F7010B87-A559-4501-99F9-0FCCA1E986E1","Uterine Corpus Endometrial Carcinoma","TARGZ","7E4F7F0F-3462-49C4-9EB1-6E54B8B293A5","2013-10-02T07:49:02.000Z","DC71EA6C-5460-4726-B6C2-6CCC4CE4C4AE","None","NO",1,NA,"Primary Tumor","Mayo Clinic",895,"7E4F7F0F-3462-49C4-9EB1-6E54B8B293A5",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.034BEF37-E51A-43DC-8C33-A8D8423EBE75.txt",250,"TCGA-D1-A15V-01A",NA,"BC787F87-F7BF-4229-9076-00F797B0A88C","TCGA",2008,NA,NA,"TUMOR FREE","F02CC69E-E1E1-4FE3-98D0-5ACD50CE97B6",68,"TCGA-D1-A15V-01A-11R-A119-13_mirna.bam.bai","Alive",NA,"TCGA-D1-A15V","NOT HISPANIC OR LATINO","C74B62E2-BB09-40EA-908A-F4824DEF90CB",NA,1012,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",92,NA,"C602D8D2-5415-4A4E-A053-987F261963B4","WHITE",NA,11,30,"7C40E4CB-8342-42E8-8512-A15ADDE996A5","2C6AC527-792E-438B-A295-5DA6E5F9378E","UNCID_2210225.30f27799-c311-47c4-ad9e-6c80863a3cd2.110411_UNC3-RDR300156_00096_FC_70F1DAAXX_6.tar.gz","TCGA-D1-A15V-01A-11",75,0,0,0,0,"TOP",0,0,"TCGA-D1-A15V-01A-01-TSA",100,"Taxol","Chemotherapy","TCGA-D1-A15V-D18459","TCGA-D1-A15V-R18458","IMPLANTS","Primary Tumor Field",NA,"NO",1201,"TUMOR FREE","Alive",NA,"TCGA-D1-A15V-F18453","TCGA-D1-A15V",1,"D1","A15V","YES","C54.1","8441/3","C54.1","NO","YES",-24886,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1012,NA,NA,NA,"TUMOR FREE","NO",8,4,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,68,2008,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1995",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34049936,33533119,2506069699,"E624AE62-7114-44BC-8DCB-3F8A831B74CD.bw","f70a64a8-3faa-468a-a6f3-4815eb01e5a3","e624ae62-7114-44bc-8dcb-3f8a831b74cd","2016-08-05T05:55:14.350469-05:00","UNCID_2211836.bca7a3e6-57e9-44e6-b33f-a5e62011884d.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_6.tar.gz","b555da07-9e45-4dec-a58b-44f0a54beffd",2102835077,"Illumina GA","df4722e72fee74f216878481ca805ec9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:42:27.446241-05:00","2016-05-03T11:16:29.240093-05:00","b555da07-9e45-4dec-a58b-44f0a54beffd_analysis.xml","a24a31b1beb1c6a7494c7af8b94c427d","2c90a717-6afb-41b1-ac48-3f2869448f9c",2120,"2016-08-13T05:49:51.647909-05:00","b555da07-9e45-4dec-a58b-44f0a54beffd_experiment.xml","4c1b6cbe86a64874c8dedb78c87a475f","de058d6c-a334-4098-817b-b7bb789350c3",2257,"2016-09-29T23:30:03.911609-05:00","b555da07-9e45-4dec-a58b-44f0a54beffd_run.xml","69b0a8101916678a8df8bad52cb0fe2a","df04ab29-2da5-48c2-9f33-e0b86436ea1c",347,"2016-09-08T10:39:46.145759-05:00","TCGA-B5-A11X","2016-09-02T18:49:07.849230-05:00","female","TCGA-B5-A11X_demographic",1944,"black or african american","b77ca676-a31b-51be-bf22-fc4de05b5d1c","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11X_diagnosis","not reported",24217,"alive","8020/3",NA,596,"350ce20b-915b-5926-8869-acbce9450a98","c54.1",-24217,"TCGA-B5-A11X_treatment","b8017e12-f0d8-57f3-aa71-e8d91c8bab64","01","true","TCGA-B5-A11X-01A",NA,"0a9e02d6-62db-4b0e-ac92-677db018ec9c",FALSE,"89C9704E-F43C-440C-970F-872835910268","Primary Tumor",NA,246,530,NA,1290556800,"11",30,"TCGA-B5-A11X-01A-11",80,80,0,0,20,20,0,0,"2016-09-08T10:39:46.145759-05:00","2016-09-08T10:39:46.145759-05:00",20,20,10,10,"BOTTOM","TOP",10,10,"77fdc43a-b8cb-45e2-9ff4-ca487dbe1f04","96957922-fd59-46c5-a6af-6b409327ac65","TCGA-B5-A11X-01A-01-BSA","TCGA-B5-A11X-01A-01-TSA",70,70,"83c3fd26-9f3c-4874-8beb-58aa892e8033","RNA","TCGA-B5-A11X-01A-11R","5b6f5101-778f-4235-aaf8-84b98b03b9d0",1.84,0.14,"UV Spec","R","23","TCGA-B5-A11X-01A-11R-A10J-07","bca7a3e6-57e9-44e6-b33f-a5e62011884d",0.14,NA,71,27.734375,160,"4ca76d7b-6324-56b1-a042-4525a1d322eb","TCGA-B5-A11X_exposure","UNCID_2211836.bca7a3e6-57e9-44e6-b33f-a5e62011884d.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_6.tar.gz","2013-10-03T02:46:04.000Z","2013-10-03T02:59:02.000Z","B555DA07-9E45-4DEC-A58B-44F0A54BEFFD","0A9E02D6-62DB-4B0E-AC92-677DB018EC9C","Unaligned reads",2102835077,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","BCA7A3E6-57E9-44E6-B33F-A5E62011884D","University of North Carolina","56607624e4b018727fea083a","F70A64A8-3FAA-468A-A6F3-4815EB01E5A3","Uterine Corpus Endometrial Carcinoma","TARGZ","83C3FD26-9F3C-4874-8BEB-58AA892E8033","2013-10-03T02:59:02.000Z","5B6F5101-778F-4235-AAF8-84B98B03B9D0","United States","NO",1,NA,"Primary Tumor","Duke",246,"83C3FD26-9F3C-4874-8BEB-58AA892E8033",NA,"B5","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C94E9FFC-592E-41B8-9552-BAC7AE2F7404.txt",530,"TCGA-B5-A11X-01A",NA,"C9D6661D-BBA4-47C5-80D8-B2992266F842","TCGA",2010,NA,NA,"WITH TUMOR","1494CB46-3418-448F-9E16-6AF85F0E6567",66,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.C94E9FFC-592E-41B8-9552-BAC7AE2F7404.txt","Alive",NA,"TCGA-B5-A11X",NA,"E96A1B8D-C9BC-421A-82A6-D4784157F716",NA,337,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8020/3","FEMALE","C54.1",81,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"96957922-FD59-46C5-A6AF-6B409327AC65","CB47F9DE-85BA-4701-AF6F-E489B4DE1826","UNCID_2211836.bca7a3e6-57e9-44e6-b33f-a5e62011884d.110302_UNC1-RDR301647_00045_FC_62J5FAAXX_6.tar.gz","TCGA-B5-A11X-01A-11",80,20,0,20,0,"TOP",10,10,"TCGA-B5-A11X-01A-01-TSA",70,"Temsirolimus","Targeted Molecular therapy","TCGA-B5-A11X-D10581",NA,NA,NA,NA,"YES",596,"TUMOR FREE","Alive",NA,"TCGA-B5-A11X-F17790","TCGA-B5-A11X",1,"B5","A11X","YES","C54.1","8020/3","C54.1","NO","YES",-24217,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",337,NA,NA,NA,"WITH TUMOR","NO",8,3,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,66,2010,"Dilation and curettage procedure",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
104871196,103412271,4931508397,"4C62C854-F423-4F08-8516-F493AFAD1F5C.bw","f7165dea-c528-44f3-954f-e111a3d77b4e","4c62c854-f423-4f08-8516-f493afad1f5c","2016-08-09T13:15:19.151862-05:00","UNCID_2177798.48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f.130402_UNC10-SN254_0447_BC22WAACXX_8_GTGGCC.tar.gz","2d85eebd-b113-44be-a85e-879e801d1fb6",4439796149,"Illumina HiSeq","f7df8d60d27fb9748422bdcc777d56ac","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:38:51.320461-05:00","2016-05-03T10:56:47.877475-05:00","2d85eebd-b113-44be-a85e-879e801d1fb6_analysis.xml","96479145da26d23a6f6c2c3e42567c9d","4ffcc1db-4174-433a-8c45-833decff5df6",2122,"2016-09-29T20:58:22.294434-05:00","2d85eebd-b113-44be-a85e-879e801d1fb6_experiment.xml","84ad32222d182a930bd29cf13e405fbc","80fcf58f-7aba-40cf-bb91-ce3f3cfbcde3",2431,"2016-09-29T23:01:06.763237-05:00","2d85eebd-b113-44be-a85e-879e801d1fb6_run.xml","3ff0bf427ffa0f51b7283a1e274e0ef9","cce731fa-d8c1-4720-afed-4eb8577b0a00",354,"2016-09-08T10:47:28.168960-05:00","TCGA-EY-A2OP","2016-09-02T18:48:00.063770-05:00","female","TCGA-EY-A2OP_demographic",1947,"white","1e0b3a28-6504-56ef-80e0-7c9db03689ee","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A2OP_diagnosis","not reported",23090,"alive","8380/3",NA,944,"798f6013-adc5-5d9f-b366-5d6749226b43","c54.1",-23090,"TCGA-EY-A2OP_treatment","ef0fc883-1043-5e72-9912-967f0b552c99","01","false","TCGA-EY-A2OP-01A",NA,"53076e0c-46b7-4b5a-8082-2c14fabbfa73",FALSE,"E16B08BE-7F2E-4F0E-9FC8-40FCC29F7BC7","Primary Tumor",NA,521,1,NA,1318896000,"11",20,"TCGA-EY-A2OP-01A-11",85,NA,0,NA,0,NA,5,NA,"2016-09-08T10:47:28.168960-05:00",NA,0,NA,0,NA,"TOP",NA,8,NA,"96a102dc-0814-4e7e-b211-e576f6dba031",NA,"TCGA-EY-A2OP-01A-01-TS1",NA,92,NA,"16c33832-d6ab-4e27-9314-36b899fe5b28","RNA","TCGA-EY-A2OP-01A-11R","7225b59f-4b68-4fa4-946a-f052a0bc1c48",1.82,0.15,"UV Spec","R","23","TCGA-EY-A2OP-01A-11R-A19W-07","48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f",0.15,NA,57,25.3333333333333,150,"0be8c84b-36a8-51c8-9a8d-0505b621143d","TCGA-EY-A2OP_exposure","UNCID_2177798.48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f.130402_UNC10-SN254_0447_BC22WAACXX_8_GTGGCC.tar.gz","2013-09-11T18:21:04.000Z","2013-09-11T18:34:01.000Z","2D85EEBD-B113-44BE-A85E-879E801D1FB6","53076E0C-46B7-4B5A-8082-2C14FABBFA73","Unaligned reads",4439796149,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","48C88E05-4D0E-444A-8C57-8C9C0C3E7A1F","University of North Carolina","56607d95e4b0ec1099f8edbd","F7165DEA-C528-44F3-954F-E111A3D77B4E","Uterine Corpus Endometrial Carcinoma","TARGZ","16C33832-D6AB-4E27-9314-36B899FE5B28","2013-09-11T18:34:01.000Z","7225B59F-4B68-4FA4-946A-F052A0BC1C48","United States","NO",1,NA,"Primary Tumor","University of North Carolina",521,"16C33832-D6AB-4E27-9314-36B899FE5B28",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.88434549-A691-4715-AD3D-4B3B7F2F6842.txt",1,"TCGA-EY-A2OP-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","53076E0C-46B7-4B5A-8082-2C14FABBFA73",63,"nationwidechildrens.org_clinical.TCGA-EY-A2OP.xml","Alive",NA,"TCGA-EY-A2OP","NOT HISPANIC OR LATINO","D60A0501-A5C0-4821-8517-8C43A6A8AF02",NA,504,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",186,NA,NA,"WHITE",NA,11,20,"96A102DC-0814-4E7E-B211-E576F6DBA031","FC14189B-479E-441C-820F-5AEC8EE3233F","UNCID_2177798.48c88e05-4d0e-444a-8c57-8c9c0c3e7a1f.130402_UNC10-SN254_0447_BC22WAACXX_8_GTGGCC.tar.gz","TCGA-EY-A2OP-01A-11",85,0,0,0,5,"TOP",8,0,"TCGA-EY-A2OP-01A-01-TS1",92,NA,NA,NA,NA,NA,NA,"TCGA-EY-A2OP-F44831_NTE-1","NO",944,"TUMOR FREE","Alive",NA,"TCGA-EY-A2OP-F44831","TCGA-EY-A2OP",1,"EY","A2OP","YES","C54.1","8380/3","C54.1","YES","NO",-23090,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",504,NA,NA,NA,"TUMOR FREE","NO",15,11,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
32818949,32386963,2421869464,"D0BD9489-6423-41D3-9CF5-3D8DD0734553.bw","f74da4c6-4291-46d2-abd4-7d7f6ef03b00","d0bd9489-6423-41d3-9cf5-3d8dd0734553","2016-08-09T14:20:23.923181-05:00","UNCID_2214297.3ecbfdb2-c75a-47ce-9db6-ae7d36eab559.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_6.tar.gz","59f062b0-4e5a-4cee-99e5-6ec39138caf0",2066697544,"Illumina GA","872804b146011a3f197b648d8d3d85e8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:41:27.018629-05:00","2016-05-03T11:17:14.875739-05:00","59f062b0-4e5a-4cee-99e5-6ec39138caf0_analysis.xml","ecd7fb9feb99465f05d5ac8d423586c9","7667be8c-52e8-4030-9e50-9e7f8c3adafc",2121,"2016-09-29T19:40:18.478342-05:00","59f062b0-4e5a-4cee-99e5-6ec39138caf0_experiment.xml","7beb7183b5b251714dceee3c9be0aaf6","50e33da5-63b1-4747-9702-f5f0334a46cb",2257,"2016-09-29T23:31:57.283283-05:00","59f062b0-4e5a-4cee-99e5-6ec39138caf0_run.xml","85409e8ffe3ba12b30c1e6e10918e3ca","e041374c-8380-43ea-b3c3-683e354d959b",347,"2016-09-09T16:00:43.184420-05:00","TCGA-BS-A0TJ","2016-09-02T18:48:26.069927-05:00","female","TCGA-BS-A0TJ_demographic",1947,"asian","0cc93255-8851-55bd-a9eb-0619ad5f924b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0TJ_diagnosis","not reported",21663,"alive","8380/3",NA,2068,"fd64c7b5-399a-538f-9858-421b3f51f8d7","c54.1",-21663,"TCGA-BS-A0TJ_treatment","a6902149-e5e1-5fa4-b2bf-ba353bdb5130","01","false","TCGA-BS-A0TJ-01A",NA,"ac35307b-ac7f-49fc-a237-5e03ab2e2276",FALSE,"17D921D9-F2ED-4F8E-8C6F-729C9A0FE5B0","Primary Tumor",NA,1431,270,NA,1282608000,"11",30,"TCGA-BS-A0TJ-01A-11",96,90,0,1,0,0,2,10,"2016-09-09T16:00:43.184420-05:00","2016-09-09T16:00:43.184420-05:00",1,1,0,1,"TOP","BOTTOM",2,0,"de698387-3e14-4189-b75c-558f9dfb3bfd","d3d4e92d-be6b-4425-9c62-f3109c70dac0","TCGA-BS-A0TJ-01A-01-TS1","TCGA-BS-A0TJ-01A-01-BS1",96,90,"03769bc9-37e3-4cb3-9f6c-220c3868e7c4","RNA","TCGA-BS-A0TJ-01A-11R","94d62fc1-26d5-4f99-9920-d80e1dfc78e4",1.79,0.16,"UV Spec","R","23","TCGA-BS-A0TJ-01A-11R-A104-07","3ecbfdb2-c75a-47ce-9db6-ae7d36eab559",0.16,NA,88,38.0886426592798,152,"0437cab5-7535-5ecf-9b06-935f303fa392","TCGA-BS-A0TJ_exposure","UNCID_2214297.3ecbfdb2-c75a-47ce-9db6-ae7d36eab559.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_6.tar.gz","2013-10-03T15:01:04.000Z","2013-10-03T15:30:02.000Z","59F062B0-4E5A-4CEE-99E5-6EC39138CAF0","AC35307B-AC7F-49FC-A237-5E03AB2E2276","Unaligned reads",2066697544,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3ECBFDB2-C75A-47CE-9DB6-AE7D36EAB559","University of North Carolina","564a3d16e4b093830b69cf10","F74DA4C6-4291-46D2-ABD4-7D7F6EF03B00","Uterine Corpus Endometrial Carcinoma","TARGZ","03769BC9-37E3-4CB3-9F6C-220C3868E7C4","2013-10-03T15:30:02.000Z","94D62FC1-26D5-4F99-9920-D80E1DFC78E4","None","NO",1,NA,"Primary Tumor","University of Hawaii",1431,"03769BC9-37E3-4CB3-9F6C-220C3868E7C4",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.6DA84EAF-5E8E-48C1-B7D2-BC98EB76E31A.txt",270,"TCGA-BS-A0TJ-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","B3FA5912-FFE9-4CC6-A973-FDF611415B50",59,"nationwidechildrens.org_clinical.TCGA-BS-A0TJ.xml","Alive",NA,"TCGA-BS-A0TJ","NOT HISPANIC OR LATINO","FCB2465C-D3FA-426F-AF2A-C3CB2FC5C665",NA,1514,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"8E8E8898-41FC-46AD-B62D-B460B13454A4","ASIAN",NA,11,30,"D3D4E92D-BE6B-4425-9C62-F3109C70DAC0","94D62FC1-26D5-4F99-9920-D80E1DFC78E4","TCGA-BS-A0TJ-01A-11R-A103-13_mirna.bam.bai","TCGA-BS-A0TJ-01A-11",90,0,1,1,10,"BOTTOM",0,1,"TCGA-BS-A0TJ-01A-01-BS1",90,NA,NA,NA,"TCGA-BS-A0TJ-R4442","COMBINATION","Regional site",NA,NA,2068,"TUMOR FREE","Alive",NA,"TCGA-BS-A0TJ-F4441","TCGA-BS-A0TJ",1,"BS","A0TJ","YES","C54.1","8380/3","C54.1","NO","YES",-21663,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",1514,NA,NA,NA,"TUMOR FREE","NO",19,11,2010,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,59,2006,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
122606314,119149897,5684643922,"ACFA7BE8-C692-4DAB-96A4-FC5A8EDA1269.bw","f7527b5e-5330-49ea-82ce-f6f2cdccbadc","acfa7be8-c692-4dab-96a4-fc5a8eda1269","2016-08-09T14:02:51.362491-05:00","UNCID_2167301.f31b5e70-af25-4f1a-b7e3-13f17998e7e2.130613_UNC9-SN296_0375_BD27CGACXX_1_TTAGGC.tar.gz","9f10757d-a44a-425d-b3c7-623eba3b15f8",5998252372,"Illumina HiSeq","7e8b409bfda5b6dedccf23199e1c956c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:07:27.461196-05:00","2016-05-03T11:07:07.495610-05:00","9f10757d-a44a-425d-b3c7-623eba3b15f8_analysis.xml","68b727df867879802f0fdf1a3085eee0","f61b2aff-f841-4b4c-9fae-ba282b81f9af",2121,"2016-09-29T23:35:27.062676-05:00","9f10757d-a44a-425d-b3c7-623eba3b15f8_experiment.xml","c420c38c848c660d24e8716cb505fa6b","e265ece6-81bb-4a1d-8076-3e79433a168e",2431,"2016-09-29T18:55:02.814916-05:00","9f10757d-a44a-425d-b3c7-623eba3b15f8_run.xml","ef566f271bc66a9f7062d0512e2c31a3","348c142f-6f83-4993-91da-f9ddd06c2754",354,"2016-09-08T10:39:27.637024-05:00","TCGA-AX-A3G9","2016-09-02T18:49:14.055008-05:00","female","TCGA-AX-A3G9_demographic",1947,"white","3085459e-dcc9-5589-b8de-cd5e8529769b","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A3G9_diagnosis","not reported",23361,"alive","8380/3",NA,558,"40bdafb9-bf8b-55fd-8ef5-1560d7588e65","c54.1",-23361,"TCGA-AX-A3G9_treatment","97e1cb75-6659-5045-b7fe-ceef7634f7ea","01","false","TCGA-AX-A3G9-01A",NA,"739cf2f3-e9eb-4f4a-8310-2d7413e323e4",FALSE,"FADFF649-7518-4EFB-B96C-9390DD308DBD","Primary Tumor",NA,560,110,NA,1322784000,"11",30,"TCGA-AX-A3G9-01A-11",90,NA,0,NA,10,NA,5,NA,"2016-09-08T10:39:27.637024-05:00",NA,1,NA,0,NA,"TOP",NA,2,NA,"cfdd8b54-73d9-4e70-a5fd-852c0fe3ac11",NA,"TCGA-AX-A3G9-01A-01-TS1",NA,83,NA,"96b698a8-9ba6-4437-b6be-fa6d38a73466","RNA","TCGA-AX-A3G9-01A-11R","dd68d29d-2772-4328-95a5-1083dcde9139",1.85,0.16,"UV Spec","R","23","TCGA-AX-A3G9-01A-11R-A22K-07","f31b5e70-af25-4f1a-b7e3-13f17998e7e2",0.16,NA,60,25.2993759487266,154,"1a20acf7-462f-5190-9aae-8287ce168f62","TCGA-AX-A3G9_exposure","UNCID_2167301.f31b5e70-af25-4f1a-b7e3-13f17998e7e2.130613_UNC9-SN296_0375_BD27CGACXX_1_TTAGGC.tar.gz","2013-09-21T04:46:04.000Z","2013-09-21T05:02:01.000Z","9F10757D-A44A-425D-B3C7-623EBA3B15F8","739CF2F3-E9EB-4F4A-8310-2D7413E323E4","Unaligned reads",5998252372,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","F31B5E70-AF25-4F1A-B7E3-13F17998E7E2","University of North Carolina","56607f3ce4b0b37b3d9932a9","F7527B5E-5330-49EA-82CE-F6F2CDCCBADC","Uterine Corpus Endometrial Carcinoma","TARGZ","96B698A8-9BA6-4437-B6BE-FA6D38A73466","2013-09-21T05:02:01.000Z","DD68D29D-2772-4328-95A5-1083DCDE9139","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",560,"96B698A8-9BA6-4437-B6BE-FA6D38A73466",NA,"AX","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.AD5918E9-5828-4266-95F1-38E5C9F20F80.txt",110,"TCGA-AX-A3G9-01A",NA,"BFF8CB90-1B48-49DB-83B7-62E283B99B62","TCGA",2010,NA,NA,NA,"739CF2F3-E9EB-4F4A-8310-2D7413E323E4",63,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.AD5918E9-5828-4266-95F1-38E5C9F20F80.txt","Alive",NA,"TCGA-AX-A3G9","NOT HISPANIC OR LATINO","33B5241E-C2FB-4EC7-8C57-20EC15720C30",NA,254,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"42E8F9F5-DB3B-4152-997E-9D8F8F24754C","WHITE",NA,11,30,"CFDD8B54-73D9-4E70-A5FD-852C0FE3AC11","DD68D29D-2772-4328-95A5-1083DCDE9139","UNCID_2167301.f31b5e70-af25-4f1a-b7e3-13f17998e7e2.130613_UNC9-SN296_0375_BD27CGACXX_1_TTAGGC.tar.gz","TCGA-AX-A3G9-01A-11",90,10,0,1,5,"TOP",2,0,"TCGA-AX-A3G9-01A-01-TS1",83,"Carboplatin and Paclitaxel","Chemotherapy","TCGA-AX-A3G9-D21263","TCGA-AX-A3G9-R21264",NA,NA,NA,"NO",558,NA,"Alive",NA,"TCGA-AX-A3G9-F21262","TCGA-AX-A3G9",1,"AX","A3G9","YES","C54.1","8380/3","C54.1","NO","YES",-23361,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",254,NA,NA,NA,NA,"NO",7,2,2012,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2010,"Other method, specify:",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37830084,37623521,2778445922,"5E55B08E-C597-4DF7-8577-D8B15C404E59.bw","f77d7256-2ccf-42a7-9b30-332ac24ca812","5e55b08e-c597-4df7-8577-d8b15c404e59","2016-08-09T14:16:32.967389-05:00","UNCID_2214795.2ae9f382-fd01-4707-8dae-3ec3c527a226.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_7.tar.gz","1f1adacc-75ae-4d56-ac6b-a1e42fa5de79",2381690727,"Illumina GA","032ccc098629c0d3afb775ecd2d01878","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:51:15.671782-05:00","2016-05-03T11:17:14.905409-05:00","1f1adacc-75ae-4d56-ac6b-a1e42fa5de79_analysis.xml","54af6874056a7ab976140af54ae65326","c6f11267-bb16-4a04-9127-08aeec881aa7",2120,"2016-10-07T17:30:22.214132-05:00","1f1adacc-75ae-4d56-ac6b-a1e42fa5de79_experiment.xml","5b59aec2da2b10ae5ae7b4bdba607c7e","63e12169-a259-4a3b-bbd5-13f1e719a3f0",2256,"2016-09-29T18:01:41.520756-05:00","1f1adacc-75ae-4d56-ac6b-a1e42fa5de79_run.xml","c6f1a32441d1a05f4d4c72cb66ed8548","13111d9c-945c-4e23-b2af-a5f59ac825d7",345,"2016-09-08T10:57:59.503204-05:00","TCGA-BS-A0UF","2016-09-02T18:48:27.908370-05:00","female","TCGA-BS-A0UF_demographic",1939,"asian","6e7bc132-cc3f-5675-b3bf-252c8a970841","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0UF_diagnosis","not reported",23771,"alive","8380/3",NA,2611,"d22949cf-b9d3-5687-bf79-50ff6d30d208","c54.1",-23771,"TCGA-BS-A0UF_treatment","02704251-e595-565e-8de7-3aed721a87c0","01","false","TCGA-BS-A0UF-01A",NA,"c805f55a-322f-4a11-ae0c-4bbc365d1bd6",FALSE,"719E2A48-0E04-4EAD-A5CC-6416450FC68F","Primary Tumor",NA,2285,270,NA,1286323200,"11",30,"TCGA-BS-A0UF-01A-11",92,90,0,0,0,0,8,10,"2016-09-08T10:57:59.503204-05:00","2016-09-08T10:57:59.503204-05:00",3,6,0,0,"BOTTOM","TOP",10,10,"205caec2-e0f1-4ced-b843-fc1251d93318","84db9b9e-1987-4f23-b6ab-4b82362b6613","TCGA-BS-A0UF-01A-01-BS1","TCGA-BS-A0UF-01A-01-TS1",82,80,"ffbaedb2-2f8e-432c-a3eb-3afe5f5d63cf","RNA","TCGA-BS-A0UF-01A-11R","3f24d336-fd9e-4d04-bf14-aeef9a27bbd7",1.84,0.17,"UV Spec","R","23","TCGA-BS-A0UF-01A-11R-A104-07","2ae9f382-fd01-4707-8dae-3ec3c527a226",0.17,NA,57,26.3778980980147,147,"11095549-7a19-5160-9181-55880591fffc","TCGA-BS-A0UF_exposure","UNCID_2214795.2ae9f382-fd01-4707-8dae-3ec3c527a226.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_7.tar.gz","2013-10-03T21:16:04.000Z","2013-10-03T21:29:02.000Z","1F1ADACC-75AE-4D56-AC6B-A1E42FA5DE79","C805F55A-322F-4A11-AE0C-4BBC365D1BD6","Unaligned reads",2381690727,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","2AE9F382-FD01-4707-8DAE-3EC3C527A226","University of North Carolina","564a37f2e4b0298dd2c74cd4","F77D7256-2CCF-42A7-9B30-332AC24CA812","Uterine Corpus Endometrial Carcinoma","TARGZ","FFBAEDB2-2F8E-432C-A3EB-3AFE5F5D63CF","2013-10-03T21:29:02.000Z","3F24D336-FD9E-4D04-BF14-AEEF9A27BBD7","None","NO",1,NA,"Primary Tumor","University of Hawaii",2285,"FFBAEDB2-2F8E-432C-A3EB-3AFE5F5D63CF",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.27E906A3-706B-43A0-B6B4-46A029C7AB11.txt",270,"TCGA-BS-A0UF-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","C805F55A-322F-4A11-AE0C-4BBC365D1BD6",65,"CAUSE_p_TCGAb73_SNP_N_GenomeWideSNP_6_E04_698208.hg19.seg.txt","Alive",NA,"TCGA-BS-A0UF","NOT HISPANIC OR LATINO","39D85C5B-8BE4-46AD-A349-C174D9024D87",NA,1843,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"ASIAN",NA,11,30,"84DB9B9E-1987-4F23-B6AB-4B82362B6613","A4FC1F05-E6AA-4C86-81AD-88E9BD30337A","TCGA-BS-A0UF-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_1_rg.sorted.bam.bai","TCGA-BS-A0UF-01A-11",90,0,0,6,10,"TOP",10,0,"TCGA-BS-A0UF-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,"NO",2611,"TUMOR FREE","Alive",NA,"TCGA-BS-A0UF-F16712","TCGA-BS-A0UF",1,"BS","A0UF","YES","C54.1","8380/3","C54.1","NO","YES",-23771,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",1843,NA,NA,NA,"TUMOR FREE","NO",28,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2004,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35976976,35613293,2561411822,"B56357FA-E93B-411C-B100-FCD96460ACC9.bw","f7e06a10-74ca-4f52-a944-b3f22c016998","b56357fa-e93b-411c-b100-fcd96460acc9","2016-08-09T14:17:54.884801-05:00","UNCID_2215666.c60df680-5bd6-48cc-a112-985f73d9092c.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_1.tar.gz","e29fbf8e-28e8-473d-9c98-5c0f039d96d8",2222770187,"Illumina GA","798509f16c680e72f2c8ce67c5457604","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:57:38.939263-05:00","2016-05-03T11:18:46.988754-05:00","e29fbf8e-28e8-473d-9c98-5c0f039d96d8_analysis.xml","102dff92f158ed5f2c5dbcf86de51b3f","80814cdf-3786-4bff-b1f1-30e929e4ed9f",2121,"2016-10-07T16:09:37.830336-05:00","e29fbf8e-28e8-473d-9c98-5c0f039d96d8_experiment.xml","d5207d95cc2f6c9e2034ecae3e12f532","23e3fdb9-4d0c-405a-a01f-028fabaeab3c",2256,"2016-09-29T17:50:40.852593-05:00","e29fbf8e-28e8-473d-9c98-5c0f039d96d8_run.xml","96c80334eec52c70902718b1e266ab68","0c11d514-c581-4156-8eb2-2cfed9030881",345,"2016-09-08T11:46:18.253580-05:00","TCGA-AP-A05D","2016-09-02T18:52:39.520987-05:00","female","TCGA-AP-A05D_demographic",1940,"white","b9fe82c2-4fea-502e-9d7d-7bd0b98acde3","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A05D_diagnosis","not reported",24597,"alive","8441/3",NA,1758,"8e296ccc-66ee-5507-883a-618483a5d16b","c54.1",-24597,"TCGA-AP-A05D_treatment","aaf0e00f-c511-5b67-bd52-a587e3ca359c","01","true","TCGA-AP-A05D-01A",NA,"5b19af28-1179-42cb-a474-856ef2048d5b",FALSE,"3312F531-00A3-4104-8C9C-8734C32C89C0","Primary Tumor",NA,1063,190,NA,1275868800,"11",30,"TCGA-AP-A05D-01A-11",80,70,0,0,0,0,15,20,"2016-09-08T11:46:18.253580-05:00","2016-09-08T11:46:18.253580-05:00",8,10,0,0,"BOTTOM","TOP",1,1,"4279a3ff-06ff-4d47-9790-3457391e1a0d","a67301a2-467c-40ce-916f-3029c65d15dd","TCGA-AP-A05D-01A-01-BS1","TCGA-AP-A05D-01A-01-TS1",84,79,"c6284b85-c0e8-4413-8812-d308262f2e0c","RNA","TCGA-AP-A05D-01A-11R","40474521-f3ed-46ae-b500-cbe7b06f7677",1.75,0.14,"UV Spec","R","23","TCGA-AP-A05D-01A-11R-A00V-07","c60df680-5bd6-48cc-a112-985f73d9092c",0.14,NA,98,37.8071833648393,161,"3b4a3909-cac6-5612-8d54-eb48c2c59548","TCGA-AP-A05D_exposure","UNCID_2215666.c60df680-5bd6-48cc-a112-985f73d9092c.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_1.tar.gz","2013-10-04T04:46:06.000Z","2013-10-04T05:00:02.000Z","E29FBF8E-28E8-473D-9C98-5C0F039D96D8","5B19AF28-1179-42CB-A474-856EF2048D5B","Unaligned reads",2222770187,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","C60DF680-5BD6-48CC-A112-985F73D9092C","University of North Carolina","566079d0e4b0ca319164f3cf","F7E06A10-74CA-4F52-A944-B3F22C016998","Uterine Corpus Endometrial Carcinoma","TARGZ","C6284B85-C0E8-4413-8812-D308262F2E0C","2013-10-04T05:00:02.000Z","40474521-F3ED-46AE-B500-CBE7B06F7677","None","NO",1,NA,"Primary Tumor","MSKCC",1063,"C6284B85-C0E8-4413-8812-D308262F2E0C",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8949703E-7677-4A5F-9DE7-19C9EDBCF894.txt",190,"TCGA-AP-A05D-01A",NA,"C38A0BEE-B876-4DC4-9CC1-7B64ABED1AAC","TCGA",2007,NA,NA,"TUMOR FREE","5B19AF28-1179-42CB-A474-856EF2048D5B",67,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.8949703E-7677-4A5F-9DE7-19C9EDBCF894.txt","Alive",NA,"TCGA-AP-A05D",NA,"910221B2-96B4-4DA2-B0AC-AC9BD96EAFC1",NA,1364,"Yes","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IIIC2",NA,NA,NA,"8441/3","FEMALE","C54.1",49,NA,"E93F7CFF-76AE-4345-896C-8609107431D0","WHITE",NA,11,30,"A67301A2-467C-40CE-916F-3029C65D15DD","8671F660-42FF-4EBD-9D08-F60B0CAB7C16","AVOWS_p_TCGAb49_SNP_1N_GenomeWideSNP_6_B06_653300.raw.copynumber.data.txt","TCGA-AP-A05D-01A-11",80,0,0,8,15,"BOTTOM",1,0,"TCGA-AP-A05D-01A-01-BS1",84,"Cisplatin","Chemotherapy","TCGA-AP-A05D-D8497","TCGA-AP-A05D-R8496","EXTERNAL BEAM","Primary Tumor Field",NA,NA,1364,"TUMOR FREE","Alive",NA,"TCGA-AP-A05D-F6986","TCGA-AP-A05D",1,"AP","A05D","YES","C54.1","8441/3","C54.1","NO","YES",-24597,"FEMALE","WHITE",NA,"Yes","No","Alive",1364,NA,NA,NA,"TUMOR FREE","NO",1,2,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,67,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
23837734,22570509,1649592322,"282EB724-805E-48BC-B2E7-E0637008652B.bw","f8360744-6bc8-4f53-b1fc-a133789455a8","282eb724-805e-48bc-b2e7-e0637008652b","2016-08-05T09:22:12.532957-05:00","UNCID_2188980.3499b1ce-1d6d-423d-8509-77e3f6818b0c.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_6.tar.gz","b5508f06-a62f-4172-b0de-0a92af1a64bb",1415504782,"Illumina GA","11c778e0b64186d241f3b41b574e58ea","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:15:24.962463-05:00","2016-05-03T11:05:01.518052-05:00","b5508f06-a62f-4172-b0de-0a92af1a64bb_analysis.xml","6cf9cfd5a9de060224a471f6508a1866","8bac5c12-b039-44dc-bc35-c2607b0138ae",2122,"2016-08-13T03:04:34.453576-05:00","b5508f06-a62f-4172-b0de-0a92af1a64bb_experiment.xml","54420b0ed5cfe08bb9676b73fa59bebe","3d04adc3-82b4-4888-b731-a34a45e0d994",2258,"2016-09-29T18:41:57.188084-05:00","b5508f06-a62f-4172-b0de-0a92af1a64bb_run.xml","0ddcbfeab939e37ecfc81c26bc97f1cc","2c440e65-d769-4fb7-8bbf-dff6045dbc31",349,"2016-09-08T10:55:40.587516-05:00","TCGA-FL-A1YM",NA,NA,NA,NA,NA,NA,NA,NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","FL","aec534e3-8ee1-5c6c-abb4-f22d85bfcdda","University of Hawaii - Normal Study",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"11","false","TCGA-FL-A1YM-11A",NA,"c7add734-286a-4b4f-8d6c-1b30f6a2d1b0",FALSE,"5FCF83F3-5851-476C-87F6-2DEDF2669A6C","Solid Tissue Normal",NA,NA,80,NA,1302480000,"12",30,"TCGA-FL-A1YM-11A-12",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T10:55:40.587516-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"ca2318ff-f4d8-46b5-ab26-b8c1b43d262e",NA,"TCGA-FL-A1YM-11A-01-TS1",NA,0,NA,"d647f9eb-8474-4bc2-a152-4b1e2413d758","RNA","TCGA-FL-A1YM-11A-12R","379ac9ff-ac2f-4f3b-aadb-e203437550d9",1.92,0.15,"UV Spec","R","23","TCGA-FL-A1YM-11A-12R-A17B-07","3499b1ce-1d6d-423d-8509-77e3f6818b0c",0.15,NA,NA,NA,NA,NA,NA,"UNCID_2188980.3499b1ce-1d6d-423d-8509-77e3f6818b0c.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_6.tar.gz","2013-09-18T13:26:06.000Z","2013-09-18T13:34:01.000Z","B5508F06-A62F-4172-B0DE-0A92AF1A64BB","C7ADD734-286A-4B4F-8D6C-1B30F6A2D1B0","Unaligned reads",1415504782,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","3499B1CE-1D6D-423D-8509-77E3F6818B0C","University of North Carolina","56607a26e4b0ec1099f8de95","F8360744-6BC8-4F53-B1FC-A133789455A8","Uterine Corpus Endometrial Carcinoma","TARGZ","D647F9EB-8474-4BC2-A152-4B1E2413D758","2013-09-18T13:34:01.000Z","379AC9FF-AC2F-4F3B-AADB-E203437550D9","United States","NO",11,NA,"Solid Tissue Normal","University of Hawaii - Normal Study",NA,"D647F9EB-8474-4BC2-A152-4B1E2413D758",NA,"FL","UNCID_2188980.3499b1ce-1d6d-423d-8509-77e3f6818b0c.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_6.tar.gz",80,"TCGA-FL-A1YM-11A",NA,NA,"TCGA",NA,NA,NA,NA,"C7ADD734-286A-4B4F-8D6C-1B30F6A2D1B0",NA,"UNCID_2188980.3499b1ce-1d6d-423d-8509-77e3f6818b0c.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_6.tar.gz",NA,NA,"TCGA-FL-A1YM",NA,NA,NA,NA,NA,"Uterus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,156,NA,NA,NA,NA,12,30,"CA2318FF-F4D8-46B5-AB26-B8C1B43D262E","96C805C3-0F76-4215-AE91-EDBA34BF08B9","UNCID_2188980.3499b1ce-1d6d-423d-8509-77e3f6818b0c.120611_UNC2-RDR300275_00126_FC_64VV0AAXX_6.tar.gz","TCGA-FL-A1YM-11A-12",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-FL-A1YM-11A-01-TS1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
34512291,33789988,2536165932,"93618EAD-7723-4616-BBB2-2D65E45EE3D2.bw","f85bc60b-ab07-4b24-820b-6860b198e910","93618ead-7723-4616-bbb2-2d65e45ee3d2","2016-08-31T12:44:45.140675-05:00","UNCID_2203670.e93ac169-2fab-4312-9239-a9141d347763.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_6.tar.gz","37458708-3dd5-4683-9d0f-30dc50953d6a",2138921903,"Illumina GA","5c7e602261ce5f03f432c8d39c1509bd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:27:55.518003-05:00","2016-05-03T11:10:47.515830-05:00","37458708-3dd5-4683-9d0f-30dc50953d6a_analysis.xml","ef143308eb434cb800b4c79cc1316887","937d0c21-74b5-429e-8a28-bfb4ca7b13c8",2121,"2016-09-29T21:02:25.549234-05:00","37458708-3dd5-4683-9d0f-30dc50953d6a_experiment.xml","f13b4497da8afd53dec63abfb4825217","8372b6c1-e057-4cf1-930d-408013778a9d",2257,"2016-09-29T22:16:13.531070-05:00","37458708-3dd5-4683-9d0f-30dc50953d6a_run.xml","3105c0a5e6c915835b6aa07ac949f147","b14ffacf-d6bd-4c5c-abd6-ae769b57f514",347,"2016-09-08T10:46:49.443310-05:00","TCGA-BG-A0MA","2016-09-02T18:52:32.011852-05:00","female","TCGA-BG-A0MA_demographic",1948,"white","5d06e636-7e27-5d5a-8bc0-dce45ba5fa01","not hispanic or latino",2008,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A0MA_diagnosis","not reported",22036,"dead","8380/3",326,NA,"34eb0cae-e80a-5584-92dc-60f9673dac69","c54.1",-22036,"TCGA-BG-A0MA_treatment","0df877e1-4db1-558c-8841-3d961fc9c5f1","01","true","TCGA-BG-A0MA-01A",NA,"8b7459ed-d1d7-4499-b057-12bc9a5bc488",FALSE,"E5908692-5B04-407B-818A-D202756DD880","Primary Tumor",NA,805,130,NA,1280275200,"11",30,"TCGA-BG-A0MA-01A-11",80,85,0,0,20,0,0,0,"2016-09-08T10:46:49.443310-05:00","2016-09-08T10:46:49.443310-05:00",20,0,20,0,"BOTTOM","TOP",20,0,"bc079aac-396b-40b6-92ad-110baf836a6c","4b53b2b4-525c-4ec7-baf6-976ac947707c","TCGA-BG-A0MA-01A-01-MSA","TCGA-BG-A0MA-01A-01-TSA",60,100,"ac3d950c-c43c-4abe-a105-b4c2f3dc7649","RNA","TCGA-BG-A0MA-01A-11R","ed640361-de54-4d44-89f8-e8521be3fe72",1.82,0.16,"UV Spec","R","23","TCGA-BG-A0MA-01A-11R-A17B-07","e93ac169-2fab-4312-9239-a9141d347763",0.16,NA,111,38.4083044982699,170,"026328b3-8085-5a51-af6a-f112b22c732c","TCGA-BG-A0MA_exposure","UNCID_2203670.e93ac169-2fab-4312-9239-a9141d347763.111103_UNC2-RDR300275_00093_FC_62DLAAAXX_6.tar.gz","2013-09-26T15:56:04.000Z","2013-09-26T16:09:01.000Z","37458708-3DD5-4683-9D0F-30DC50953D6A","8B7459ED-D1D7-4499-B057-12BC9A5BC488","Unaligned reads",2138921903,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E93AC169-2FAB-4312-9239-A9141D347763","University of North Carolina","56607edee4b018727fea38bd","F85BC60B-AB07-4B24-820B-6860B198E910","Uterine Corpus Endometrial Carcinoma","TARGZ","AC3D950C-C43C-4ABE-A105-B4C2F3DC7649","2013-09-26T16:09:01.000Z","ED640361-DE54-4D44-89F8-E8521BE3FE72","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",805,"AC3D950C-C43C-4ABE-A105-B4C2F3DC7649",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.26F8155B-BC23-4D3E-AE18-B9B538437680.txt",130,"TCGA-BG-A0MA-01A",NA,NA,"TCGA",2008,NA,NA,"WITH TUMOR","CCC915FC-752A-44D0-8CFF-0D1E7B58C280",60,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.26F8155B-BC23-4D3E-AE18-B9B538437680.txt","Dead",326,"TCGA-BG-A0MA","NOT HISPANIC OR LATINO","A77402FB-B66B-4DEE-8666-B5CF36C6CE29",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",156,NA,NA,"WHITE",NA,11,30,"BC079AAC-396B-40B6-92AD-110BAF836A6C","9CFC14E9-4364-432F-A027-DFB53A1C5B49","TCGA-BG-A0MA-01A-11R-A17A-13_mirna.bam","TCGA-BG-A0MA-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-BG-A0MA-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,"YES",NA,"WITH TUMOR","Dead",326,"TCGA-BG-A0MA-F19281","TCGA-BG-A0MA",1,"BG","A0MA","YES","C54.1","8380/3","C54.1","NO","YES",-22036,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,326,NA,NA,"WITH TUMOR","NO",8,12,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,60,2008,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34246895,33936047,2549255251,"7560B2B5-6AF5-4600-9F0A-BE25CF99B6B9.bw","f8ac5fd2-11f2-4b3a-a3a6-ff1a6d8e1cae","7560b2b5-6af5-4600-9f0a-be25cf99b6b9","2016-08-09T14:02:21.012861-05:00","UNCID_2194835.4e6ddf28-1fb2-4527-b415-30c714ecde09.120307_UNC2-RDR300275_00118_FC_650V8AAXX_5.tar.gz","88c30b9d-b302-4422-8df8-9c1a64d7181c",2157359992,"Illumina GA","ba5d17f65b577fdd47088206dc4bfa2f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:38:47.888706-05:00","2016-05-03T11:07:49.533775-05:00","88c30b9d-b302-4422-8df8-9c1a64d7181c_analysis.xml","b548621c5de0ca483bef77b29928075d","046e7f63-cfea-4d31-8c9f-0eceeb1c3db6",2121,"2016-10-07T17:39:45.611291-05:00","88c30b9d-b302-4422-8df8-9c1a64d7181c_experiment.xml","04dcdfb3667217a95b41d87d1675efdb","6e2c7350-67e1-4412-a94f-6cb1be58468c",2257,"2016-09-29T23:01:20.690315-05:00","88c30b9d-b302-4422-8df8-9c1a64d7181c_run.xml","00e251c7504db6de7702d9b114414012","cd0c35b3-02cb-403b-b009-4c01037714a3",347,"2016-09-08T11:05:17.168241-05:00","TCGA-EY-A1GW","2016-09-02T18:52:02.091576-05:00","female","TCGA-EY-A1GW_demographic",1937,"white","3bc93350-02f7-5561-97b2-11c92a32325d","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EY","8ec8229a-8ae5-53de-8768-215b5ce53aa8","University of North Carolina","not reported","c54.1","TCGA-EY-A1GW_diagnosis","not reported",26979,"dead","8380/3",337,260,"ceb2ecff-f419-559d-b576-ccdbedc6a805","c54.1",-26979,"TCGA-EY-A1GW_treatment","e65a442e-f81e-5114-ba82-20b6a91aa90c","01","false","TCGA-EY-A1GW-01A",NA,"22cb3d87-7fab-419a-b071-1adc6b810719",FALSE,"52C26330-540E-4409-ACDF-4D56EA1E7D7F","Primary Tumor",NA,155,410,NA,1297728000,"22",30,"TCGA-EY-A1GW-01A-22",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:05:17.168241-05:00",NA,30,NA,30,NA,"TOP",NA,10,NA,"5bd9d55e-da9b-4782-a0a5-a9363bc412d4",NA,"TCGA-EY-A1GW-01A-02-TSB",NA,80,NA,"b27f3ba8-6cf2-48e1-ab4c-8ad05e498ac4","RNA","TCGA-EY-A1GW-01A-22R","f8cfda51-2338-4b6f-8ea3-4c08ea403deb",1.81,0.16,"UV Spec","R","23","TCGA-EY-A1GW-01A-22R-A13S-07","4e6ddf28-1fb2-4527-b415-30c714ecde09",0.16,NA,81,36.484843025089,149,"09704ef4-c77d-56ef-9acb-adc84fe24f1f","TCGA-EY-A1GW_exposure","UNCID_2194835.4e6ddf28-1fb2-4527-b415-30c714ecde09.120307_UNC2-RDR300275_00118_FC_650V8AAXX_5.tar.gz","2013-09-23T04:16:04.000Z","2013-09-23T04:28:01.000Z","88C30B9D-B302-4422-8DF8-9C1A64D7181C","22CB3D87-7FAB-419A-B071-1ADC6B810719","Unaligned reads",2157359992,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","4E6DDF28-1FB2-4527-B415-30C714ECDE09","University of North Carolina","56607b67e4b0ec1099f8e4a8","F8AC5FD2-11F2-4B3A-A3A6-FF1A6D8E1CAE","Uterine Corpus Endometrial Carcinoma","TARGZ","B27F3BA8-6CF2-48E1-AB4C-8AD05E498AC4","2013-09-23T04:28:01.000Z","F8CFDA51-2338-4B6F-8EA3-4C08EA403DEB","United States","NO",1,NA,"Primary Tumor","University of North Carolina",155,"B27F3BA8-6CF2-48E1-AB4C-8AD05E498AC4",NA,"EY","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F4D2FE5C-7742-4751-B59D-E7907F5F90A2.txt",410,"TCGA-EY-A1GW-01A",NA,"FA16930B-93D5-45F7-A5FC-98702C2DDF69","TCGA",2010,NA,NA,"WITH TUMOR","BCF2DE1F-4E6A-4CCD-BD41-4D895FD15DEE",73,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F4D2FE5C-7742-4751-B59D-E7907F5F90A2.txt","Alive",NA,"TCGA-EY-A1GW","HISPANIC OR LATINO","94D37229-9996-450F-92F8-C5409068F01A",NA,260,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8380/3","FEMALE","C54.1",110,NA,NA,"WHITE",NA,22,30,"5BD9D55E-DA9B-4782-A0A5-A9363BC412D4","F8CFDA51-2338-4B6F-8EA3-4C08EA403DEB","TCGA-EY-A1GW-01A-22R-A13R-13_mirna.bam.bai","TCGA-EY-A1GW-01A-22",80,0,20,30,10,"TOP",10,30,"TCGA-EY-A1GW-01A-02-TSB",80,"Carboplatin","Chemotherapy","TCGA-EY-A1GW-D12149",NA,NA,NA,NA,"YES",NA,"WITH TUMOR","Dead",337,"TCGA-EY-A1GW-F12151","TCGA-EY-A1GW",1,"EY","A1GW","YES","C54.1","8380/3","C54.1","YES","NO",-26979,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",260,NA,NA,NA,"WITH TUMOR","NO",24,5,2011,"YES","YES","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,73,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,"2009",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35133523,34318786,2567367633,"49B8F49B-1C21-4145-BCDC-403B3D37CCD5.bw","f9cf4125-0db3-4b66-b51b-bc2f0240c9ef","49b8f49b-1c21-4145-bcdc-403b3d37ccd5","2016-08-01T20:47:15.138568-05:00","UNCID_2210908.120e984a-ef3b-4240-8990-20aeadce8226.110316_UNC2-RDR300275_00058_FC_62J26AAXX_7.tar.gz","5bdcf854-fa51-4752-b518-5f5fe5e69239",2200646444,"Illumina GA","3800cdfb0cf4cec861bd9ba39c8c739d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:54:32.889899-05:00","2016-05-03T11:16:29.236069-05:00","5bdcf854-fa51-4752-b518-5f5fe5e69239_analysis.xml","38fc7c04faee2481540d2872d5825fc7","ee52ba08-b718-4465-a822-42aa1b7c4956",2121,"2016-09-29T17:56:29.914110-05:00","5bdcf854-fa51-4752-b518-5f5fe5e69239_experiment.xml","03145d373c85d2ed288f8df1eccea0aa","0fbad744-63a8-49b4-a2f1-020b0c42d989",2257,"2016-09-29T22:36:52.967676-05:00","5bdcf854-fa51-4752-b518-5f5fe5e69239_run.xml","3706416d66c6676aaf19e1f5479e8722","bdfba10d-7a87-4c9d-b4e7-d41a967bbb58",347,"2016-09-08T10:53:12.005387-05:00","TCGA-D1-A102","2016-09-02T18:49:15.395047-05:00","female","TCGA-D1-A102_demographic",1960,"white","24d81207-6d0e-56d6-9cff-9d05306baef1","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A102_diagnosis","not reported",17991,"alive","8380/3",NA,135,"8392456e-f5ba-5589-8e27-985d34a4d90b","c54.1",-17991,"TCGA-D1-A102_treatment","3d8bf7b7-1423-5bb3-ae68-af654337e0b9","01","false","TCGA-D1-A102-01A",NA,"eef5bd16-dc47-47da-baa9-295b8c28361b",FALSE,"9983D576-706A-48D2-93EE-70EABB3BD77C","Primary Tumor",NA,380,200,NA,1288656000,"11",30,"TCGA-D1-A102-01A-11",75,75,0,0,0,0,0,5,"2016-09-08T10:53:12.005387-05:00","2016-09-08T10:53:12.005387-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"dcf1de88-b781-41f0-9f63-6eb1eb0be454","22d0b59a-ca62-4fbb-a34b-50544a5761eb","TCGA-D1-A102-01A-01-BSA","TCGA-D1-A102-01A-01-TSA",100,95,"623f44d2-f3b4-4977-8fea-6862d2b7bd14","RNA","TCGA-D1-A102-01A-11R","75ab77a1-bbf1-45a1-ae2a-0c877998dece",1.8,0.17,"UV Spec","R","23","TCGA-D1-A102-01A-11R-A10J-07","120e984a-ef3b-4240-8990-20aeadce8226",0.17,NA,122,38.50523923747,178,"b0c06667-6a23-5317-8054-358ae113c515","TCGA-D1-A102_exposure","UNCID_2210908.120e984a-ef3b-4240-8990-20aeadce8226.110316_UNC2-RDR300275_00058_FC_62J26AAXX_7.tar.gz","2013-10-02T18:13:05.000Z","2013-10-02T18:26:03.000Z","5BDCF854-FA51-4752-B518-5F5FE5E69239","EEF5BD16-DC47-47DA-BAA9-295B8C28361B","Unaligned reads",2200646444,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","120E984A-EF3B-4240-8990-20AEADCE8226","University of North Carolina","56607764e4b016715ab69766","F9CF4125-0DB3-4B66-B51B-BC2F0240C9EF","Uterine Corpus Endometrial Carcinoma","TARGZ","623F44D2-F3B4-4977-8FEA-6862D2B7BD14","2013-10-02T18:26:03.000Z","75AB77A1-BBF1-45A1-AE2A-0C877998DECE","None","NO",1,NA,"Primary Tumor","Mayo Clinic",380,"623F44D2-F3B4-4977-8FEA-6862D2B7BD14",NA,"D1","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.E113E37B-D85D-48E7-9AE4-DD3FDF12155C.txt",200,"TCGA-D1-A102-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","FFC727B7-ED53-4F34-B941-0756F66E30C8",49,"TCGA-D1-A102-01A-01D-YYYY-23.txt","Alive",NA,"TCGA-D1-A102","NOT HISPANIC OR LATINO","0F4DA060-9E13-4BED-86AA-CE44F5163D60",NA,43,"Yes","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",81,NA,NA,"WHITE",NA,11,30,"DCF1DE88-B781-41F0-9F63-6EB1EB0BE454","CFEFE28F-F867-421F-96B6-3DA1C32AB555","TCGA-D1-A102-01A-11D-A10M-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-D1-A102-01A-11",75,0,0,0,0,"BOTTOM",0,0,"TCGA-D1-A102-01A-01-BSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",135,"TUMOR FREE","Alive",NA,"TCGA-D1-A102-F17750","TCGA-D1-A102",1,"D1","A102","YES","C54.1","8380/3","C54.1","NO","YES",-17991,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",43,NA,NA,NA,"TUMOR FREE","NO",8,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,49,2009,"Office Endometrial Biopsy",NA,NA,NA,"G2","RX",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
29964176,28450273,2136422039,"493213F4-637E-4BC6-8047-9B694977CA73.bw","fb7475df-30cc-4316-b9ac-37cbeeb6ba2b","493213f4-637e-4bc6-8047-9b694977ca73","2016-08-09T14:17:11.556777-05:00","UNCID_2214551.6fc8c938-15ec-452d-9cf7-16b97e0a2c8f.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_8.tar.gz","5f30c870-57b2-40db-9c5f-9a72b3eed81f",1826915047,"Illumina GA","61719d1cbd55f44c50bb0da32ea93a43","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:44:29.578590-05:00","2016-05-03T11:17:14.896869-05:00","5f30c870-57b2-40db-9c5f-9a72b3eed81f_analysis.xml","d97b49ae0a6c5f5aac5e0ee894163228","2ddd5531-4d43-41e2-a062-a027bebfeb94",2121,"2016-09-29T19:01:52.661990-05:00","5f30c870-57b2-40db-9c5f-9a72b3eed81f_experiment.xml","3af6959f2f8f3c9890f8b0e3aa39f990","38ce5bba-d40c-4137-a4d7-df87d0b1223e",2257,"2016-09-29T20:11:58.619386-05:00","5f30c870-57b2-40db-9c5f-9a72b3eed81f_run.xml","911f9c79ec54877f196699d4820a7b93","64609c58-08f8-4105-8122-c72523d0bba3",347,"2016-09-08T10:44:23.557505-05:00","TCGA-BS-A0U8","2016-09-02T18:48:27.246982-05:00","female","TCGA-BS-A0U8_demographic",1949,"white","124d1f29-524a-57e0-b4eb-6ed018678122","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0U8_diagnosis","not reported",20402,"alive","8380/3",NA,2963,"463b376c-31c6-58bb-aacc-acdb4579f6bd","c54.1",-20402,"TCGA-BS-A0U8_treatment","607c343e-0703-5c87-9365-10cb01d8618b","01","false","TCGA-BS-A0U8-01A",NA,"e3e23393-8597-4091-a343-cd544111c63b",FALSE,"EAE30BBB-B895-42B9-8AAB-937278A3EBB0","Primary Tumor",NA,2432,190,NA,1285804800,"11",30,"TCGA-BS-A0U8-01A-11",80,80,10,20,0,0,20,15,"2016-09-08T10:44:23.557505-05:00","2016-09-08T10:44:23.557505-05:00",40,30,30,40,"BOTTOM","TOP",0,5,"299ed12a-b046-43c2-89a1-0ed6a10bd83c","4f8b0437-91c9-46e9-8bf8-a876947048ac","TCGA-BS-A0U8-01A-01-BS1","TCGA-BS-A0U8-01A-01-TS1",80,80,"88b92b57-bf3e-4016-8480-eff5d29ba81f","RNA","TCGA-BS-A0U8-01A-11R","152234c5-8bfd-4b76-8521-570e344e842a",1.87,0.16,"UV Spec","R","23","TCGA-BS-A0U8-01A-11R-A104-07","6fc8c938-15ec-452d-9cf7-16b97e0a2c8f",0.16,NA,82,28.3737024221453,170,"6f983e36-96c3-5610-9a32-d9da195d3099","TCGA-BS-A0U8_exposure","UNCID_2214551.6fc8c938-15ec-452d-9cf7-16b97e0a2c8f.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_8.tar.gz","2013-10-03T17:16:03.000Z","2013-10-03T17:29:02.000Z","5F30C870-57B2-40DB-9C5F-9A72B3EED81F","E3E23393-8597-4091-A343-CD544111C63B","Unaligned reads",1826915047,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","6FC8C938-15EC-452D-9CF7-16B97E0A2C8F","University of North Carolina","56607a0fe4b018727fea23b9","FB7475DF-30CC-4316-B9AC-37CBEEB6BA2B","Uterine Corpus Endometrial Carcinoma","TARGZ","88B92B57-BF3E-4016-8480-EFF5D29BA81F","2013-10-03T17:29:02.000Z","152234C5-8BFD-4B76-8521-570E344E842A","None","NO",1,NA,"Primary Tumor","University of Hawaii",2432,"88B92B57-BF3E-4016-8480-EFF5D29BA81F",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.0A9A4E64-690F-4D6D-AA72-633B924E0ADF.txt",190,"TCGA-BS-A0U8-01A",NA,"C619C938-E981-4DAC-9ACA-62EE09AD5538","TCGA",2004,NA,NA,"TUMOR FREE","E3E23393-8597-4091-A343-CD544111C63B",55,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.0A9A4E64-690F-4D6D-AA72-633B924E0ADF.txt","Alive",NA,"TCGA-BS-A0U8","NOT HISPANIC OR LATINO","C28DBE90-6C41-44F1-BD0B-09875DF194D8",NA,2606,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,"92615CB5-4FCD-43DC-A39D-B6F993EA8AFC","WHITE",NA,11,30,"4F8B0437-91C9-46E9-8BF8-A876947048AC","F44270ED-9CD5-4E19-AC71-9303D74DFB41","UNCID_2214551.6fc8c938-15ec-452d-9cf7-16b97e0a2c8f.110208_UNC2-RDR300275_00049_FC_62J3VAAXX_8.tar.gz","TCGA-BS-A0U8-01A-11",80,0,20,30,15,"TOP",5,40,"TCGA-BS-A0U8-01A-01-TS1",80,"cisplatin","Chemotherapy","TCGA-BS-A0U8-D16707","TCGA-BS-A0U8-R16704","COMBINATION","Primary Tumor Field",NA,"NO",2963,"TUMOR FREE","Alive",NA,"TCGA-BS-A0U8-F16703","TCGA-BS-A0U8",1,"BS","A0U8","YES","C54.1","8380/3","C54.1","NO","YES",-20402,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2606,NA,NA,NA,"TUMOR FREE","NO",25,3,2011,"YES","YES","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,55,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",11,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
34940497,33388436,2498050333,"2CA15712-265C-4B81-917A-6DD374D85C4B.bw","fba80122-d8b2-4d8d-a032-9767e8160f9f","2ca15712-265c-4b81-917a-6dd374d85c4b","2016-08-09T14:03:24.443100-05:00","UNCID_2194959.ce5b0ba0-2777-4c92-ac50-483174cc5dca.120313_UNC6-RDR300211_00137_FC_650V5AAXX_7.tar.gz","c6ffa07d-51bf-44c9-a4ae-6366bb45d0be",2255210416,"Illumina GA","26185a9021505f5f48ca33c93b3a790d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:01:40.258972-05:00","2016-05-03T11:07:49.539899-05:00","c6ffa07d-51bf-44c9-a4ae-6366bb45d0be_analysis.xml","9a2b4bfa070037a0dc3a31d9656e2e38","5e1f8f6a-c4e2-4faf-9f51-9a1a3687e47c",2122,"2016-09-29T17:59:01.604629-05:00","c6ffa07d-51bf-44c9-a4ae-6366bb45d0be_experiment.xml","2816e9475876efedf7e760c2974124fa","1156ad47-1455-4947-8ae3-de70a000031e",2258,"2016-09-29T23:22:16.107511-05:00","c6ffa07d-51bf-44c9-a4ae-6366bb45d0be_run.xml","ad66355a4aa03c5e259dfdae8aa4c06e","da1452f0-22a2-4261-8384-783233a3f7f2",349,"2016-09-08T11:11:25.699377-05:00","TCGA-AX-A1CI","2016-09-02T18:51:42.250748-05:00","female","TCGA-AX-A1CI_demographic",1943,"white","0cbd2001-5067-5109-838d-3c053cfcfa55","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CI_diagnosis","not reported",22582,"alive","8380/3",NA,2600,"d475ef4a-37c4-5638-88da-84f422483574","c54.1",-22582,"TCGA-AX-A1CI_treatment","a69ff0d7-1ba1-51d6-9d28-de1cf44521a9","11","false","TCGA-AX-A1CI-11A",NA,"cad6c89d-f722-470b-93bc-e8b24c033f0f",FALSE,NA,"Solid Tissue Normal",NA,2222,100,NA,1295222400,"11",30,"TCGA-AX-A1CI-11A-11",NA,NA,NA,NA,100,NA,NA,NA,"2016-09-08T11:11:25.699377-05:00",NA,NA,NA,NA,NA,"TOP",NA,NA,NA,"320f9fb9-dee6-4e2f-a4e3-272204f2e297",NA,"TCGA-AX-A1CI-11A-01-TS1",NA,0,NA,"f4f727ea-a4e0-4c14-a1fe-538bdddf57b3","RNA","TCGA-AX-A1CI-11A-11R","ec3d1c05-d310-49b3-97cb-2135b19f3a0b",1.92,0.15,"UV Spec","R","23","TCGA-AX-A1CI-11A-11R-A137-07","ce5b0ba0-2777-4c92-ac50-483174cc5dca",0.15,NA,74,27.5133848899465,164,"15d6814f-19e0-5150-832d-700a652dde62","TCGA-AX-A1CI_exposure","UNCID_2194959.ce5b0ba0-2777-4c92-ac50-483174cc5dca.120313_UNC6-RDR300211_00137_FC_650V5AAXX_7.tar.gz","2013-09-23T05:07:04.000Z","2013-09-23T05:20:02.000Z","C6FFA07D-51BF-44C9-A4AE-6366BB45D0BE","CAD6C89D-F722-470B-93BC-E8B24C033F0F","Unaligned reads",2255210416,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CE5B0BA0-2777-4C92-AC50-483174CC5DCA","University of North Carolina","564a36c5e4b08c5d86900768","FBA80122-D8B2-4D8D-A032-9767E8160F9F","Uterine Corpus Endometrial Carcinoma","TARGZ","F4F727EA-A4E0-4C14-A1FE-538BDDDF57B3","2013-09-23T05:20:02.000Z","EC3D1C05-D310-49B3-97CB-2135B19F3A0B","None","NO",11,NA,"Solid Tissue Normal","Gynecologic Oncology Group",2222,"F4F727EA-A4E0-4C14-A1FE-538BDDDF57B3",NA,"AX","TCGA-AX-A1CI-11A-11D-A17H-05_ac5058ed-1d03-4555-8f5b-a1a88eae9cc4_Endo_normal.bam",100,"TCGA-AX-A1CI-11A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","DDD2F9E0-0AA3-425B-9D74-74FCC638CB08",61,"nationwidechildrens.org_clinical.TCGA-AX-A1CI.xml","Alive",NA,"TCGA-AX-A1CI","NOT HISPANIC OR LATINO","93AC276D-980D-4361-9428-AA5AE2EB065E",NA,2207,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"320F9FB9-DEE6-4E2F-A4E3-272204F2E297","EC3D1C05-D310-49B3-97CB-2135B19F3A0B","jhu-usc.edu_UCEC.HumanMethylation450.5.lvl-3.TCGA-AX-A1CI-11A-11D-A138-05.txt","TCGA-AX-A1CI-11A-11",NA,100,NA,NA,NA,"TOP",NA,NA,"TCGA-AX-A1CI-11A-01-TS1",0,NA,NA,NA,NA,NA,NA,NA,NA,2207,"TUMOR FREE","Alive",NA,"TCGA-AX-A1CI-F10561","TCGA-AX-A1CI",1,"AX","A1CI","YES","C54.1","8380/3","C54.1","NO","YES",-22582,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2207,NA,NA,NA,"TUMOR FREE","NO",10,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35600109,34694835,2614448449,"CF04AA5F-57B8-4360-B645-3D85428F0494.bw","fba80122-d8b2-4d8d-a032-9767e8160f9f","cf04aa5f-57b8-4360-b645-3d85428f0494","2016-08-05T16:03:20.245643-05:00","UNCID_2194757.e54b7e44-82a3-4016-bc32-129799097b4c.120313_UNC6-RDR300211_00137_FC_650V5AAXX_6.tar.gz","ae1cb1f0-8341-45fe-95e0-0a1af80c869c",2311789816,"Illumina GA","601292e065fe43a08a2c36ac1391a395","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:35:50.370430-05:00","2016-05-03T11:07:49.533775-05:00","ae1cb1f0-8341-45fe-95e0-0a1af80c869c_analysis.xml","1a1ed99e6a309128d8b7ab05e2dc8fa6","983f1c92-9313-4370-bd03-ab2c5cd4bb98",2122,"2016-09-29T19:48:42.471758-05:00","ae1cb1f0-8341-45fe-95e0-0a1af80c869c_experiment.xml","17bc482a91ecbfa5db63907895d9501b","561eba65-0afa-4109-b5d9-b3c25308ad68",2258,"2016-09-29T18:45:51.569195-05:00","ae1cb1f0-8341-45fe-95e0-0a1af80c869c_run.xml","d000ccc102de6e28fe8e0f692753ee9f","2ebe94b9-316f-4330-ba9b-760b405d4114",349,"2016-09-08T11:11:25.699377-05:00","TCGA-AX-A1CI","2016-09-02T18:51:42.250748-05:00","female","TCGA-AX-A1CI_demographic",1943,"white","0cbd2001-5067-5109-838d-3c053cfcfa55","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A1CI_diagnosis","not reported",22582,"alive","8380/3",NA,2600,"d475ef4a-37c4-5638-88da-84f422483574","c54.1",-22582,"TCGA-AX-A1CI_treatment","a69ff0d7-1ba1-51d6-9d28-de1cf44521a9","01","false","TCGA-AX-A1CI-01A",NA,"ddd2f9e0-0aa3-425b-9d74-74fcc638cb08",FALSE,"7F264403-0A76-4FAD-9A57-7C555F69375C","Primary Tumor",NA,2222,120,NA,1295222400,"11",30,"TCGA-AX-A1CI-01A-11",95,NA,0,NA,3,NA,3,NA,"2016-09-08T11:11:25.699377-05:00",NA,2,NA,0,NA,"TOP",NA,1,NA,"3f21d211-56f5-4cca-8d9c-1d28adcfd7b5",NA,"TCGA-AX-A1CI-01A-01-TS1",NA,93,NA,"2016eca2-b9bb-4661-ba59-dbf0b287a428","RNA","TCGA-AX-A1CI-01A-11R","ec675afa-2a7d-4bc7-93b0-c2ec6084cfdb",1.88,0.15,"UV Spec","R","23","TCGA-AX-A1CI-01A-11R-A137-07","e54b7e44-82a3-4016-bc32-129799097b4c",0.15,NA,74,27.5133848899465,164,"15d6814f-19e0-5150-832d-700a652dde62","TCGA-AX-A1CI_exposure","UNCID_2194757.e54b7e44-82a3-4016-bc32-129799097b4c.120313_UNC6-RDR300211_00137_FC_650V5AAXX_6.tar.gz","2013-09-23T02:56:05.000Z","2013-09-23T03:09:01.000Z","AE1CB1F0-8341-45FE-95E0-0A1AF80C869C","DDD2F9E0-0AA3-425B-9D74-74FCC638CB08","Unaligned reads",2311789816,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","E54B7E44-82A3-4016-BC32-129799097B4C","University of North Carolina","564a36c5e4b093830b67c8c5","FBA80122-D8B2-4D8D-A032-9767E8160F9F","Uterine Corpus Endometrial Carcinoma","TARGZ","2016ECA2-B9BB-4661-BA59-DBF0B287A428","2013-09-23T03:09:01.000Z","EC675AFA-2A7D-4BC7-93B0-C2EC6084CFDB","None","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",2222,"2016ECA2-B9BB-4661-BA59-DBF0B287A428",NA,"AX","bcbfebca137feee918342e841c0bb404.bam.bai",120,"TCGA-AX-A1CI-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","DDD2F9E0-0AA3-425B-9D74-74FCC638CB08",61,"nationwidechildrens.org_clinical.TCGA-AX-A1CI.xml","Alive",NA,"TCGA-AX-A1CI","NOT HISPANIC OR LATINO","93AC276D-980D-4361-9428-AA5AE2EB065E",NA,2207,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",104,NA,NA,"WHITE",NA,11,30,"3F21D211-56F5-4CCA-8D9C-1D28ADCFD7B5","EC675AFA-2A7D-4BC7-93B0-C2EC6084CFDB","bcbfebca137feee918342e841c0bb404.bam.bai","TCGA-AX-A1CI-01A-11",95,3,0,2,3,"TOP",1,0,"TCGA-AX-A1CI-01A-01-TS1",93,NA,NA,NA,NA,NA,NA,NA,NA,2207,"TUMOR FREE","Alive",NA,"TCGA-AX-A1CI-F10561","TCGA-AX-A1CI",1,"AX","A1CI","YES","C54.1","8380/3","C54.1","NO","YES",-22582,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2207,NA,NA,NA,"TUMOR FREE","NO",10,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
143677200,138032695,6578003858,"96071C27-44A0-4365-9314-296F12B3327E.bw","fbfed398-2a44-44a9-83cf-657c29cb7d28","96071c27-44a0-4365-9314-296f12b3327e","2016-08-25T16:19:37.988832-05:00","UNCID_2364784.d3473471-b625-4f56-8300-590324d48002.140114_UNC15-SN850_0348_BC35G8ACXX_5_CCGTCC.tar.gz","d49121a7-c24c-4daa-ba81-307abac51e12",6376290873,"Illumina HiSeq","70edf94784b23b6e0d712757f57e6542","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:54:22.432889-05:00","2016-05-03T11:39:34.500988-05:00","d49121a7-c24c-4daa-ba81-307abac51e12_analysis.xml","82d26f0dda854b37abb6e877f732a2da","ee35cdd7-5487-4462-a7f3-863c7b004b50",2124,"2016-09-29T20:42:11.516569-05:00","d49121a7-c24c-4daa-ba81-307abac51e12_experiment.xml","50e30194f0895ba0771629256a3e0367","76d9a871-5dbe-4b1e-abae-59f1d686434a",2628,"2016-09-29T18:03:32.318031-05:00","d49121a7-c24c-4daa-ba81-307abac51e12_run.xml","16615dafd5461e2c2fb14e8bbc561a88","143c5b13-a0b7-431d-ac5f-b5d8d3ccf34f",354,"2016-09-08T10:51:09.139576-05:00","TCGA-SJ-A6ZJ","2016-09-02T18:51:39.317902-05:00","female","TCGA-SJ-A6ZJ_demographic",1951,"black or african american","921580f9-9167-5eb6-86ee-2c4f16954e7c","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","SJ","73bf98ff-1984-5b37-9963-519695e99a1d","Albert Einstein Medical Center","not reported","c54.1","TCGA-SJ-A6ZJ_diagnosis","not reported",22597,"alive","8380/3",NA,556,"aa82239a-6f37-5408-9bce-46d482a3c695","c54.1",-22597,"TCGA-SJ-A6ZJ_treatment","cdf0c22b-fcc0-5ec8-8e54-02d949cd4822","01","false","TCGA-SJ-A6ZJ-01A",NA,"c3064816-c2c1-4af0-8f0e-89d900e47d20",FALSE,"B7C3C4EC-E494-4290-AFDA-FEFEBA8A3BA5","Primary Tumor",NA,216,580,NA,1375142400,"12",30,"TCGA-SJ-A6ZJ-01A-12",70,NA,1,NA,20,NA,10,NA,"2016-09-08T10:51:09.139576-05:00",NA,1,NA,1,NA,"TOP",NA,0,NA,"c83e38ed-f883-4679-9dcb-e36f4e5586db",NA,"TCGA-SJ-A6ZJ-01A-01-TSA",NA,70,NA,"e53d542e-b707-4f92-9825-de496c6b48cd","RNA","TCGA-SJ-A6ZJ-01A-12R","644b5730-19d5-4f58-9a80-cf8e2efae3ef",1.84,0.16,"UV Spec","R","23","TCGA-SJ-A6ZJ-01A-12R-A34R-07","d3473471-b625-4f56-8300-590324d48002",0.16,NA,132,46.7687074829932,168,"8c95d798-3ac2-52ef-a771-115ac6ee89f9","TCGA-SJ-A6ZJ_exposure","UNCID_2364784.d3473471-b625-4f56-8300-590324d48002.140114_UNC15-SN850_0348_BC35G8ACXX_5_CCGTCC.tar.gz","2014-03-04T19:33:04.000Z","2014-03-04T19:57:01.000Z","D49121A7-C24C-4DAA-BA81-307ABAC51E12","C3064816-C2C1-4AF0-8F0E-89D900E47D20","Unaligned reads",6376290873,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","D3473471-B625-4F56-8300-590324D48002","University of North Carolina","564a371be4b093830b67e543","FBFED398-2A44-44A9-83CF-657C29CB7D28","Uterine Corpus Endometrial Carcinoma","TARGZ","E53D542E-B707-4F92-9825-DE496C6B48CD","2014-03-04T19:57:01.000Z","644B5730-19D5-4F58-9A80-CF8E2EFAE3EF","United States","NO",1,NA,"Primary Tumor","Albert Einstein Medical Center",216,"E53D542E-B707-4F92-9825-DE496C6B48CD",NA,"SJ","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.272FE29A-16A0-4E92-8B02-84FCC35D8BF4.txt",580,"TCGA-SJ-A6ZJ-01A",NA,NA,"TCGA",2012,"TCGA-SJ-A6ZJ_NTE-1",NA,"TUMOR FREE","C3064816-C2C1-4AF0-8F0E-89D900E47D20",61,"nationwidechildrens.org_clinical.TCGA-SJ-A6ZJ.xml","Alive",NA,"TCGA-SJ-A6ZJ","NOT HISPANIC OR LATINO","7F6040E3-DD8C-4BFF-9C28-B3836C4CBCBE","NO",234,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",354,NA,"22B19E8C-968E-44C1-9745-0298AA7081CF","BLACK OR AFRICAN AMERICAN",NA,12,30,"C83E38ED-F883-4679-9DCB-E36F4E5586DB","A7D56BBF-2AF1-4DDF-A004-CB16142FBC84","ebd5f595594cedffdbedce80873d30be.bam","TCGA-SJ-A6ZJ-01A-12",70,20,1,1,10,"TOP",0,1,"TCGA-SJ-A6ZJ-01A-01-TSA",70,NA,NA,NA,"TCGA-SJ-A6ZJ-R51113","Internal","Primary Tumor Field","TCGA-SJ-A6ZJ-F67768_NTE-1","NO",556,"TUMOR FREE","Alive",NA,"TCGA-SJ-A6ZJ-F67768","TCGA-SJ-A6ZJ",1,"SJ","A6ZJ","YES","C54.1","8380/3","C54.1","YES","NO",-22597,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",234,NA,"YES","NO","TUMOR FREE","YES",11,11,2013,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2012,"Office Endometrial Biopsy",NA,NA,NA,"G2","R0",NA,NA,NA,NA,NA,"2009",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
30824260,30286406,2271208397,"0D60DE0D-CC42-463B-9BD6-1C11977A2056.bw","fc7315b0-9f48-4206-b197-2268c0518eb4","0d60de0d-cc42-463b-9bd6-1c11977a2056","2016-08-07T00:42:56.528777-05:00","UNCID_2209934.67f6f0d9-6581-4946-a9c7-a6629da86888.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_2.tar.gz","8cd9764a-6e07-487d-9dbb-cc56b371fd4a",2035068072,"Illumina GA","9453162765101f9c83072c04b667ec3f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:17:30.295827-05:00","2016-05-03T11:15:47.413267-05:00","8cd9764a-6e07-487d-9dbb-cc56b371fd4a_analysis.xml","a11ea2ca361f3c30c7f2b0fa0806f230","b2131a5a-ab79-4dd9-a6d0-ca0fb69b6f5d",2121,"2016-08-13T08:58:47.796702-05:00","8cd9764a-6e07-487d-9dbb-cc56b371fd4a_experiment.xml","ad73d7b0022c992820387b72e7e6d8e1","f8820483-05f6-48e5-84d0-83a7214d675c",2257,"2016-09-30T00:12:30.667560-05:00","8cd9764a-6e07-487d-9dbb-cc56b371fd4a_run.xml","be9e01a9521c9ebd2c830ea1404a4bf9","f9410342-995c-4d08-b464-3a50bec09962",347,"2016-09-08T11:13:08.306915-05:00","TCGA-D1-A174","2016-09-02T18:50:32.811179-05:00","female","TCGA-D1-A174_demographic",1959,"white","6cb2b392-7f9d-56ff-951f-50fa1961540e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","D1","7fe1c0d8-e66c-5384-bdc9-7544b8e390b3","Mayo Clinic","not reported","c54.1","TCGA-D1-A174_diagnosis","not reported",18702,"alive","8380/3",NA,594,"6d77a903-7e29-5b60-85e1-c20fcf1a0760","c54.1",-18702,"TCGA-D1-A174_treatment","1e006a92-c7dd-5a99-aa84-e7bee88b91f6","01","false","TCGA-D1-A174-01A",NA,"ad5a9cb6-b3f9-4651-b6d1-13c78010bd88",FALSE,"E45B2436-C0B2-44C3-B400-49C668114B01","Primary Tumor",NA,219,80,NA,1294099200,"11",30,"TCGA-D1-A174-01A-11",60,NA,10,NA,30,NA,30,NA,"2016-09-08T11:13:08.306915-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"7602727e-b46d-40fc-bd03-5ccf631041f8",NA,"TCGA-D1-A174-01A-01-TS1",NA,40,NA,"6e55e6d9-902f-439b-b6f1-ca296c123fd3","RNA","TCGA-D1-A174-01A-11R","1183f7c6-992d-4084-946e-adce7c52f9cc",1.3,0.16,"UV Spec","R","23","TCGA-D1-A174-01A-11R-A12I-07","67f6f0d9-6581-4946-a9c7-a6629da86888",0.16,NA,65,26.3702381435352,157,"89d19aa0-c846-5449-9dbd-986f46df02bc","TCGA-D1-A174_exposure","UNCID_2209934.67f6f0d9-6581-4946-a9c7-a6629da86888.110420_UNC2-RDR300275_00063_FC_634Y8AAXX_2.tar.gz","2013-10-02T02:13:04.000Z","2013-10-02T02:26:02.000Z","8CD9764A-6E07-487D-9DBB-CC56B371FD4A","AD5A9CB6-B3F9-4651-B6D1-13C78010BD88","Unaligned reads",2035068072,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","67F6F0D9-6581-4946-A9C7-A6629DA86888","University of North Carolina","56607c45e4b0ec1099f8e86c","FC7315B0-9F48-4206-B197-2268C0518EB4","Uterine Corpus Endometrial Carcinoma","TARGZ","6E55E6D9-902F-439B-B6F1-CA296C123FD3","2013-10-02T02:26:02.000Z","1183F7C6-992D-4084-946E-ADCE7C52F9CC","None","NO",1,NA,"Primary Tumor","Mayo Clinic",219,"6E55E6D9-902F-439B-B6F1-CA296C123FD3",NA,"D1","TCGA-D1-A174-01A-11R-A12H-13_mirna.bam",80,"TCGA-D1-A174-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","AD5A9CB6-B3F9-4651-B6D1-13C78010BD88",51,"nationwidechildrens.org_clinical.TCGA-D1-A174.xml","Alive",NA,"TCGA-D1-A174","NOT HISPANIC OR LATINO","60F8AEAE-E61C-4DBD-B659-2EC9C709704C",NA,324,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,"6ED2FCA2-3C9D-410A-AE8A-BA04A4E4E05B","WHITE",NA,11,30,"7602727E-B46D-40FC-BD03-5CCF631041F8","96203028-F824-4A90-9758-22340285062C","TCGA-D1-A174-01A-11R-A12H-13_mirna.bam","TCGA-D1-A174-01A-11",60,30,10,40,30,"TOP",0,20,"TCGA-D1-A174-01A-01-TS1",40,NA,NA,NA,"TCGA-D1-A174-R20313","IMPLANTS","Regional site",NA,"NO",594,"TUMOR FREE","Alive",NA,"TCGA-D1-A174-F20312","TCGA-D1-A174",1,"D1","A174","YES","C54.1","8380/3","C54.1","NO","YES",-18702,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",324,NA,NA,NA,"TUMOR FREE","NO",13,4,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,51,2010,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
34553487,33961764,2547388372,"A6EFEFFB-AD43-4CB3-8D3C-D7A972206678.bw","fd370e9d-2719-45e0-b8f1-048ed1ee602f","a6efeffb-ad43-4cb3-8d3c-d7a972206678","2016-08-04T23:12:02.565370-05:00","UNCID_2210362.aefe6191-1196-4614-b319-4ce263d3cc90.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_7.tar.gz","c10f3a31-4f2b-4677-a6a7-531087539f2f",2341871574,"Illumina GA","ecb69da5c2c18cdb4689a5ac4cba834f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:05:04.038553-05:00","2016-05-03T11:15:47.420908-05:00","c10f3a31-4f2b-4677-a6a7-531087539f2f_analysis.xml","fc4ae1122900903ca2ae7d712e8d3bae","3adee058-8547-4786-8571-08014db55f4e",2120,"2016-09-29T22:14:25.857007-05:00","c10f3a31-4f2b-4677-a6a7-531087539f2f_experiment.xml","84a5dc03ef20a3aa6fa8d8f391568905","b028c16d-e0b3-48ac-9268-5ecc99bef204",2257,"2016-09-29T23:03:02.559171-05:00","c10f3a31-4f2b-4677-a6a7-531087539f2f_run.xml","706659990fe40ad7114bf8f9cccbaf17","ce253d46-aaca-4b5a-a461-5d0f2625e4ef",347,"2016-09-08T11:21:23.474733-05:00","TCGA-B5-A11M","2016-09-02T18:49:27.574247-05:00","female","TCGA-B5-A11M_demographic",1964,"white","2c8ee06f-8361-510d-816f-c0e4550cdbd7","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","B5","7ba314ab-f65a-5ebf-8544-32eda22698a2","Duke","not reported","c54.1","TCGA-B5-A11M_diagnosis","not reported",16063,"alive","8380/3",NA,1362,"c2e77d56-7025-5ab5-919e-43b706b07a50","c54.1",-16063,"TCGA-B5-A11M_treatment","3e4550eb-57c8-5930-870b-461edb575bdb","01","true","TCGA-B5-A11M-01A",NA,"82f33c0d-f9dc-4463-8ab5-ae7283e85431",FALSE,"3C00B510-8D9C-4DD4-9E7C-FC058230BE97","Primary Tumor",NA,1085,40,NA,1291593600,"11",30,"TCGA-B5-A11M-01A-11",50,70,2,2,0,0,50,30,"2016-09-08T11:21:23.474733-05:00","2016-09-08T11:21:23.474733-05:00",30,30,0,0,"BOTTOM","TOP",0,0,"6fa80b2e-6374-451c-8ac8-1a0a312e9340","a1d3f157-de01-434d-9973-379e425ffc8c","TCGA-B5-A11M-01A-01-BS1","TCGA-B5-A11M-01A-01-TS1",50,70,"b02990fb-1816-4f90-9d79-7e7873847b04","RNA","TCGA-B5-A11M-01A-11R","e0cacc29-e1fd-4011-93dd-294bce61252f",1.79,0.15,"UV Spec","R","23","TCGA-B5-A11M-01A-11R-A118-07","aefe6191-1196-4614-b319-4ce263d3cc90",0.15,NA,139,59.3788713742578,153,"9d1d2e6e-5ff0-5442-98ab-8736c7b73be4","TCGA-B5-A11M_exposure","UNCID_2210362.aefe6191-1196-4614-b319-4ce263d3cc90.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_7.tar.gz","2013-10-02T09:55:04.000Z","2013-10-02T10:08:01.000Z","C10F3A31-4F2B-4677-A6A7-531087539F2F","82F33C0D-F9DC-4463-8AB5-AE7283E85431","Unaligned reads",2341871574,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","AEFE6191-1196-4614-B319-4CE263D3CC90","University of North Carolina","566075c2e4b0ec1099f8bd8e","FD370E9D-2719-45E0-B8F1-048ED1EE602F","Uterine Corpus Endometrial Carcinoma","TARGZ","B02990FB-1816-4F90-9D79-7E7873847B04","2013-10-02T10:08:01.000Z","E0CACC29-E1FD-4011-93DD-294BCE61252F","United States","NO",1,NA,"Primary Tumor","Duke",1085,"B02990FB-1816-4F90-9D79-7E7873847B04",NA,"B5","UNCID_2210362.aefe6191-1196-4614-b319-4ce263d3cc90.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_7.tar.gz",40,"TCGA-B5-A11M-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","82F33C0D-F9DC-4463-8AB5-AE7283E85431",43,"nationwidechildrens.org_clinical.TCGA-B5-A11M.xml","Alive",NA,"TCGA-B5-A11M",NA,"E18E29E7-BD0C-4BF1-84EC-9BF891BB86A6",NA,1117,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",92,NA,NA,"WHITE",NA,11,30,"A1D3F157-DE01-434D-9973-379E425FFC8C","E0CACC29-E1FD-4011-93DD-294BCE61252F","UNCID_2210362.aefe6191-1196-4614-b319-4ce263d3cc90.110407_UNC3-RDR300156_00095_FC_64GDNAAXX_7.tar.gz","TCGA-B5-A11M-01A-11",50,0,2,30,50,"BOTTOM",0,0,"TCGA-B5-A11M-01A-01-BS1",50,NA,NA,NA,NA,NA,NA,NA,"NO",1362,"TUMOR FREE","Alive",NA,"TCGA-B5-A11M-F17720","TCGA-B5-A11M",1,"B5","A11M","YES","C54.1","8380/3","C54.1","NO","YES",-16063,"FEMALE","WHITE",NA,"No","No","Alive",1117,NA,NA,NA,"TUMOR FREE","NO",10,2,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,43,2007,"Dilation and curettage procedure",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
39528858,37594861,1791602730,"20E6799E-C202-40BE-BAFE-8770F134BAE1.bw","fdb395e7-ff30-400d-861e-0cf2462ee390","20e6799e-c202-40be-bafe-8770f134bae1","2016-08-25T06:41:34.472445-05:00","UNCID_2316579.9ed0c69e-a7e6-4c99-8c93-541d7bde4be6.130628_UNC15-SN850_0317_BC2542ACXX_3_TGACCA.tar.gz","2d73e08c-868f-4b9e-9a1a-1c2957478eb1",1668342785,"Illumina HiSeq","349f4dd92ab638c58dbbd1bc519a5900","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:24:54.724503-05:00","2016-05-03T11:28:50.231867-05:00","2d73e08c-868f-4b9e-9a1a-1c2957478eb1_analysis.xml","a6eb9c0ed42a605dad815a449135625e","dbbf8312-da3e-4785-9e43-23def07758ac",2124,"2016-08-13T05:31:37.750410-05:00","2d73e08c-868f-4b9e-9a1a-1c2957478eb1_experiment.xml","c20c7ca71385675435f8a603ce88c40b","e4bcf131-e713-42db-a719-6e9323c95761",2628,"2016-09-29T22:08:30.068253-05:00","2d73e08c-868f-4b9e-9a1a-1c2957478eb1_run.xml","abdfc672f192ba69223dacb045e4f6ac","ac85996f-ca20-4f47-adb9-6aabc572da09",354,"2016-09-08T10:40:01.833623-05:00","TCGA-H5-A2HR","2016-09-02T18:53:59.497469-05:00","female","TCGA-H5-A2HR_demographic",1935,"black or african american","489ef6fd-7a84-59ac-966e-51af8f004b77","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","H5","cd7b9deb-2687-5366-b602-1566113bab7a","Medical College of Georgia","not reported","c54.1","TCGA-H5-A2HR_diagnosis","not reported",25986,"alive","8380/3",NA,39,"6fc44a29-6ceb-53af-90e4-ae25365a33e0","c54.1",-25986,"TCGA-H5-A2HR_treatment","f499d198-0fcd-5570-8409-f9d0707c2205","01","false","TCGA-H5-A2HR-01A",NA,"731428d0-5cc9-4e8d-a2be-e2e3d57745b7",FALSE,"3747A4AC-811E-49A1-8459-93807BB363C6","Primary Tumor",NA,1627,110,NA,1309478400,"11",30,"TCGA-H5-A2HR-01A-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T10:40:01.833623-05:00",NA,20,NA,10,NA,"TOP",NA,20,NA,"458630a5-6c71-4c5b-b7b0-674fe7842df0",NA,"TCGA-H5-A2HR-01A-01-TSA",NA,70,NA,"3143932f-34d3-49fa-8c6d-5067c0cfabb5","RNA","TCGA-H5-A2HR-01A-11R","68ed8045-4d79-4c93-a3da-f5e58b6ba879",1.81,0.18,"UV Spec","R","23","TCGA-H5-A2HR-01A-11R-A180-07","9ed0c69e-a7e6-4c99-8c93-541d7bde4be6",0.18,NA,95,NA,NA,"52b28882-b157-50e8-8013-bebdc39b6912","TCGA-H5-A2HR_exposure","UNCID_2316579.9ed0c69e-a7e6-4c99-8c93-541d7bde4be6.130628_UNC15-SN850_0317_BC2542ACXX_3_TGACCA.tar.gz","2014-01-07T07:46:04.000Z","2014-01-07T08:14:01.000Z","2D73E08C-868F-4B9E-9A1A-1C2957478EB1","731428D0-5CC9-4E8D-A2BE-E2E3D57745B7","Unaligned reads",1668342785,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","9ED0C69E-A7E6-4C99-8C93-541D7BDE4BE6","University of North Carolina","5660754ee4b0ec1099f8b7c9","FDB395E7-FF30-400D-861E-0CF2462EE390","Uterine Corpus Endometrial Carcinoma","TARGZ","3143932F-34D3-49FA-8C6D-5067C0CFABB5","2014-01-07T08:14:01.000Z","68ED8045-4D79-4C93-A3DA-F5E58B6BA879","United States","NO",1,NA,"Primary Tumor","Medical College of Georgia",1627,"3143932F-34D3-49FA-8C6D-5067C0CFABB5",NA,"H5","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FF5E27B1-C378-4BB7-9F66-BEF3E837F372.txt",110,"TCGA-H5-A2HR-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","C060177F-66A3-44E9-B822-0BAF0CB01756",71,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.FF5E27B1-C378-4BB7-9F66-BEF3E837F372.txt","Alive",NA,"TCGA-H5-A2HR","NOT HISPANIC OR LATINO","BEB02729-9141-4984-95E8-895BD8F2515D",NA,53,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"458630A5-6C71-4C5B-B7B0-674FE7842DF0","68ED8045-4D79-4C93-A3DA-F5E58B6BA879","TCGA-H5-A2HR-01A-11R-A17X-13_mirna.bam","TCGA-H5-A2HR-01A-11",90,0,0,20,10,"TOP",20,10,"TCGA-H5-A2HR-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-H5-A2HR-F37038_NTE-1",NA,39,"TUMOR FREE","Alive",NA,"TCGA-H5-A2HR-F37038","TCGA-H5-A2HR",1,"H5","A2HR","YES","C54.1","8380/3","C54.1","NO","YES",-25986,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",53,NA,NA,NA,"TUMOR FREE","NO",1,10,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,71,2006,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
110417676,106293285,5068401797,"4C020890-E652-4DE4-B66D-5F6F71405F64.bw","fe2e89f7-8f4d-420a-a551-4877cf0fd1d3","4c020890-e652-4de4-b66d-5f6f71405f64","2016-08-09T14:02:20.381280-05:00","UNCID_2167290.babc3b9e-a99f-490b-a277-ab4e6f6b5449.130613_UNC9-SN296_0375_BD27CGACXX_2_TGACCA.tar.gz","57d5b976-5bd1-46f3-9205-b6dc1a9b6e64",5472867851,"Illumina HiSeq","fe1f8313e4380b0deca6bfbd06c09e9b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:03:43.516998-05:00","2016-05-03T11:07:07.492763-05:00","57d5b976-5bd1-46f3-9205-b6dc1a9b6e64_analysis.xml","7ce726fa83ccb5822201f6643c880904","f3e917ab-bc89-4c61-a1b7-c27deadffea2",2121,"2016-09-29T17:35:31.892564-05:00","57d5b976-5bd1-46f3-9205-b6dc1a9b6e64_experiment.xml","20270d145e1b17b244a55108bb3bae89","025cb787-faf8-4388-8880-1fd0eed67a3c",2431,"2016-09-29T22:03:30.760556-05:00","57d5b976-5bd1-46f3-9205-b6dc1a9b6e64_run.xml","2bfee174355e8405c5bd471b65084b10","a9832660-ca3d-44d1-b935-b5844d13d0a7",354,"2016-09-08T10:45:42.531147-05:00","TCGA-EO-A3KX","2016-09-02T18:49:30.498184-05:00","female","TCGA-EO-A3KX_demographic",1931,"white","4bed5f1e-e85b-5763-bb8b-ea0029cf902d","hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","EO","8c5f8b02-c621-5bd5-b91f-d8a72974feff","University Health Network","not reported","c54.1","TCGA-EO-A3KX_diagnosis","not reported",29260,"alive","8380/3",NA,1170,"413ae3c1-4e94-59f1-b639-f1c2a0b21c74","c54.1",-29260,"TCGA-EO-A3KX_treatment","a3f5b14c-0c42-59d0-8f57-64c6b0f72033","01","false","TCGA-EO-A3KX-01A",NA,"a5cae971-eeb4-4a9e-afec-01814eab967e",FALSE,"BB1CD473-0D98-414E-801B-09037E1BF43E","Primary Tumor",NA,184,150,NA,1325721600,"11",30,"TCGA-EO-A3KX-01A-11",95,NA,1,NA,0,NA,0,NA,"2016-09-08T10:45:42.531147-05:00",NA,1,NA,0,NA,"TOP",NA,15,NA,"3ced1ad2-8680-4d52-b4cc-d214c0fff6be",NA,"TCGA-EO-A3KX-01A-01-TSA",NA,85,NA,"8efe4a96-ee7b-43f0-b0c2-3c133bc357f3","RNA","TCGA-EO-A3KX-01A-11R","dcf679f4-d7c2-4864-b93c-e8f148977939",1.83,0.17,"UV Spec","R","23","TCGA-EO-A3KX-01A-11R-A22K-07","babc3b9e-a99f-490b-a277-ab4e6f6b5449",0.17,NA,44,20.9274673008323,145,"583b0991-387a-5240-9631-155188524e6a","TCGA-EO-A3KX_exposure","UNCID_2167290.babc3b9e-a99f-490b-a277-ab4e6f6b5449.130613_UNC9-SN296_0375_BD27CGACXX_2_TGACCA.tar.gz","2013-09-21T05:07:05.000Z","2013-09-21T05:20:01.000Z","57D5B976-5BD1-46F3-9205-B6DC1A9B6E64","A5CAE971-EEB4-4A9E-AFEC-01814EAB967E","Unaligned reads",5472867851,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","BABC3B9E-A99F-490B-A277-AB4E6F6B5449","University of North Carolina","564a3a73e4b0298dd2c8198f","FE2E89F7-8F4D-420A-A551-4877CF0FD1D3","Uterine Corpus Endometrial Carcinoma","TARGZ","8EFE4A96-EE7B-43F0-B0C2-3C133BC357F3","2013-09-21T05:20:01.000Z","DCF679F4-D7C2-4864-B93C-E8F148977939","Canada","NO",1,NA,"Primary Tumor","University Health Network",184,"8EFE4A96-EE7B-43F0-B0C2-3C133BC357F3",NA,"EO","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B61C7ED5-D259-4A39-BA2A-4E31ECB0BFB7.txt",150,"TCGA-EO-A3KX-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","A5CAE971-EEB4-4A9E-AFEC-01814EAB967E",80,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.B61C7ED5-D259-4A39-BA2A-4E31ECB0BFB7.txt","Alive",NA,"TCGA-EO-A3KX","HISPANIC OR LATINO","9288244C-0490-4234-9F83-58EF2DBCEA11",NA,281,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",228,NA,"7802018D-83BE-47F2-AC71-1C8520C9EBFC","WHITE",NA,11,30,"3CED1AD2-8680-4D52-B4CC-D214C0FFF6BE","DCF679F4-D7C2-4864-B93C-E8F148977939","UNCID_2086846.babc3b9e-a99f-490b-a277-ab4e6f6b5449.sorted_genome_alignments.bam","TCGA-EO-A3KX-01A-11",95,0,1,1,0,"TOP",15,0,"TCGA-EO-A3KX-01A-01-TSA",85,NA,NA,NA,"TCGA-EO-A3KX-R39974","Internal","Primary Tumor Field","TCGA-EO-A3KX-F39933_NTE-1","NO",442,"TUMOR FREE","Alive",NA,"TCGA-EO-A3KX-F39933","TCGA-EO-A3KX",1,"EO","A3KX","YES","C54.1","8380/3","C54.1","NO","YES",-29260,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",281,NA,NA,NA,"TUMOR FREE","NO",1,6,2012,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,80,2011,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33186441,31885749,2393881925,"A5ABD7A2-7946-49ED-97D9-6E136F644E96.bw","fe4db898-3a9f-4dff-adcb-7b8c30137350","a5abd7a2-7946-49ed-97d9-6e136f644e96","2016-08-05T10:57:20.457955-05:00","UNCID_2210170.fcf451be-340a-4479-86ed-d6757d680386.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_6.tar.gz","46acb873-4ba4-4374-a66e-6c40b187b4f7",2100581764,"Illumina GA","a3497245f83dafe69b098e544fd1bb79","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:43:35.556633-05:00","2016-05-03T11:15:47.407128-05:00","46acb873-4ba4-4374-a66e-6c40b187b4f7_analysis.xml","7b1a82a21a8cafa2bca8af4da7abc628","2d520b0c-cb25-4afd-8532-47a257aa231a",2123,"2016-08-28T09:16:40.037753-05:00","46acb873-4ba4-4374-a66e-6c40b187b4f7_experiment.xml","326828d46a107d6fc3ee9ac73cc151b6","88312440-9827-445c-a608-104fde314404",2257,"2016-09-29T18:01:56.031624-05:00","46acb873-4ba4-4374-a66e-6c40b187b4f7_run.xml","c6807474e1001c9ae21ab7a0ae5faa2e","13385d88-2495-4cb9-a85a-f45fa7b4aa62",347,"2016-09-08T11:11:02.575504-05:00","TCGA-BG-A186","2016-09-02T18:49:58.380263-05:00","female","TCGA-BG-A186_demographic",1949,"black or african american","6a5cc3fe-7b5a-5d21-ae88-14f40340a5ca","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A186_diagnosis","not reported",22370,"alive","8380/3",NA,419,"fcee2d50-0927-56be-85d4-78b119adb2bb","c54.1",-22370,"TCGA-BG-A186_treatment","2c10ea7f-da05-57fc-a377-0336e6869672","01","true","TCGA-BG-A186-01A",NA,"b1645a83-57b7-4357-b977-63a5b6aee39e",FALSE,"76C588F1-ED43-485D-8FFF-32F4C5D92202","Primary Tumor",NA,104,100,NA,1294358400,"11",30,"TCGA-BG-A186-01A-11",70,NA,0,NA,20,NA,0,NA,"2016-09-08T11:11:02.575504-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"48d96243-8e15-4adc-b83a-8c52c15393b9",NA,"TCGA-BG-A186-01A-01-TSA",NA,80,NA,"db04e7ca-fe31-4a70-8bb5-67c8ca0901c8","RNA","TCGA-BG-A186-01A-11R","c3c22d6d-e257-40e1-bc8a-97e22db8c3e4",1.81,0.16,"UV Spec","R","23","TCGA-BG-A186-01A-11R-A12I-07","fcf451be-340a-4479-86ed-d6757d680386",0.16,NA,75,28.5779606767261,162,"1121a4da-a194-5229-ad12-bf3a6b1eb0e8","TCGA-BG-A186_exposure","UNCID_2210170.fcf451be-340a-4479-86ed-d6757d680386.110411_UNC1-RDR301647_00059_FC_64GKVAQAXX_6.tar.gz","2013-10-02T06:56:04.000Z","2013-10-02T07:09:02.000Z","46ACB873-4BA4-4374-A66E-6C40B187B4F7","B1645A83-57B7-4357-B977-63A5B6AEE39E","Unaligned reads",2100581764,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","FCF451BE-340A-4479-86ED-D6757D680386","University of North Carolina","564a348ee4b093830b671404","FE4DB898-3A9F-4DFF-ADCB-7B8C30137350","Uterine Corpus Endometrial Carcinoma","TARGZ","DB04E7CA-FE31-4A70-8BB5-67C8CA0901C8","2013-10-02T07:09:02.000Z","C3C22D6D-E257-40E1-BC8A-97E22DB8C3E4","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",104,"DB04E7CA-FE31-4A70-8BB5-67C8CA0901C8",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F987438A-987D-4FB1-87B9-4FAA77E7AA3C.txt",100,"TCGA-BG-A186-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","E251DCCF-5BE4-49B3-987F-F12FA0F69A1D",61,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.F987438A-987D-4FB1-87B9-4FAA77E7AA3C.txt","Alive",NA,"TCGA-BG-A186","NOT HISPANIC OR LATINO","A18F5F2C-6024-497A-9E9E-75077F4760BF",NA,230,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"48D96243-8E15-4ADC-B83A-8C52C15393B9","C3C22D6D-E257-40E1-BC8A-97E22DB8C3E4","TCGA-BG-A186-01A-11R-A12H-13_mirna.bam","TCGA-BG-A186-01A-11",70,20,0,0,0,"TOP",0,0,"TCGA-BG-A186-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,"NO",419,"TUMOR FREE","Alive",NA,"TCGA-BG-A186-F28644","TCGA-BG-A186",1,"BG","A186","YES","C54.1","8380/3","C54.1","NO","YES",-22370,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",230,NA,NA,NA,"TUMOR FREE","NO",13,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,61,2010,"Office Endometrial Biopsy",NA,NA,NA,"G2","RX",NA,NA,NA,NA,NA,"2009",9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
28245821,28047600,2045763078,"183E5584-19F3-403E-AC2C-C223800F42A3.bw","fe5f4822-37a3-4f9e-8d33-8b9f36bf6895","183e5584-19f3-403e-ac2c-c223800f42a3","2016-08-09T14:17:47.621697-05:00","UNCID_2215633.b3516570-4a66-418f-87e1-32829d67ec1c.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_2.tar.gz","7f3ebd4a-2c3f-4efe-9f37-44679808f516",1632523337,"Illumina GA","fd297ea2dee1158851fdb6e18d00779f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:00:17.776723-05:00","2016-05-03T11:18:46.977159-05:00","7f3ebd4a-2c3f-4efe-9f37-44679808f516_analysis.xml","a82d3e72e740383f081990cb50253074","82267be3-b6ad-457e-8ac3-08a271a3546b",2122,"2016-09-29T19:14:10.712804-05:00","7f3ebd4a-2c3f-4efe-9f37-44679808f516_experiment.xml","b1dd0ae1afa82b755962c96bb985a568","40a1f308-018b-46e1-95df-5d55214e9148",2256,"2016-09-29T18:16:52.376537-05:00","7f3ebd4a-2c3f-4efe-9f37-44679808f516_run.xml","c196b7778eb62f6a0a335fe3703ac69e","1c7f7380-16ea-43bc-bcf3-48721270411a",345,"2016-09-08T10:29:00.307430-05:00","TCGA-AP-A05H","2016-09-02T18:52:40.248221-05:00","female","TCGA-AP-A05H_demographic",1933,"white","73f1bca1-fc2b-5767-899a-8ff467a68d62","not reported",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AP","a5cf850f-79ad-5963-9ecb-983a892661d8","MSKCC","not reported","c54.1","TCGA-AP-A05H_diagnosis","not reported",27744,"alive","8441/3",NA,1385,"5814746b-6afc-5eda-90ad-4e03e226a6dc","c54.1",-27744,"TCGA-AP-A05H_treatment","64c69722-979e-5ecd-8ce1-c3e6c4394bcb","01","true","TCGA-AP-A05H-01A",NA,"e417cb26-f6e8-4a31-b7e0-5bb43fd587b1",FALSE,"805B997D-9755-4AC1-8695-294806148F25","Primary Tumor",NA,706,210,NA,1275868800,"11",40,"TCGA-AP-A05H-01A-11",90,75,0,0,10,15,5,10,"2016-09-08T10:29:00.307430-05:00","2016-09-08T10:29:00.307430-05:00",1,3,0,0,"BOTTOM","TOP",5,10,"a9b54b34-76e2-4a74-b319-2eecd84aaba5","268e0275-f970-496b-8ae7-276499fea6d7","TCGA-AP-A05H-01A-01-BS1","TCGA-AP-A05H-01A-01-TS1",80,65,"74b9930e-1b76-4659-907e-24c440576eff","RNA","TCGA-AP-A05H-01A-11R","33d80d70-4e03-441a-b407-c6b02a5ffae1",1.74,0.16,"UV Spec","R","23","TCGA-AP-A05H-01A-11R-A00V-07","b3516570-4a66-418f-87e1-32829d67ec1c",0.16,NA,89,38.0195651245248,153,"e67bd6f4-8e38-52c7-9e2f-4c929dca598c","TCGA-AP-A05H_exposure","UNCID_2215633.b3516570-4a66-418f-87e1-32829d67ec1c.100923_UNC4-RDR3001561_00026_FC_62HRKAAXX_2.tar.gz","2013-10-04T03:46:04.000Z","2013-10-04T03:58:01.000Z","7F3EBD4A-2C3F-4EFE-9F37-44679808F516","E417CB26-F6E8-4A31-B7E0-5BB43FD587B1","Unaligned reads",1632523337,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","B3516570-4A66-418F-87E1-32829D67EC1C","University of North Carolina","566074f7e4b016715ab67c59","FE5F4822-37A3-4F9E-8D33-8B9F36BF6895","Uterine Corpus Endometrial Carcinoma","TARGZ","74B9930E-1B76-4659-907E-24C440576EFF","2013-10-04T03:58:01.000Z","33D80D70-4E03-441A-B407-C6B02A5FFAE1","None","NO",1,NA,"Primary Tumor","MSKCC",706,"74B9930E-1B76-4659-907E-24C440576EFF",NA,"AP","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9E9C27A1-EBEF-41DC-891A-7256F805297F.txt",210,"TCGA-AP-A05H-01A",NA,"D58E5F44-7F50-4CCC-B959-F10251E843C6","TCGA",2008,NA,NA,"TUMOR FREE","E417CB26-F6E8-4A31-B7E0-5BB43FD587B1",75,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.9E9C27A1-EBEF-41DC-891A-7256F805297F.txt","Alive",NA,"TCGA-AP-A05H",NA,"EEA723C1-83DA-4D59-8345-D8AB86037C0A",NA,831,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8441/3","FEMALE","C54.1",49,NA,"2AA5112D-1E03-4567-846F-CBCC139DC7D7","WHITE",NA,11,40,"A9B54B34-76E2-4A74-B319-2EECD84AABA5","94032DBE-E7C7-4BD7-853C-7F75BD3CB42E","UNCID_1610604.b3516570-4a66-418f-87e1-32829d67ec1c.sorted_genome_alignments.bam","TCGA-AP-A05H-01A-11",90,10,0,1,5,"BOTTOM",5,0,"TCGA-AP-A05H-01A-01-BS1",80,"Paclitaxel","Chemotherapy","TCGA-AP-A05H-D3480","TCGA-AP-A05H-R3483","OTHER: SPECIFY IN NOTES","Primary Tumor Field",NA,"NO",1385,"TUMOR FREE","Alive",NA,"TCGA-AP-A05H-F29059","TCGA-AP-A05H",1,"AP","A05H","YES","C54.1","8441/3","C54.1","NO","YES",-27744,"FEMALE","WHITE",NA,"No","No","Alive",831,NA,NA,NA,"TUMOR FREE","NO",23,9,2010,"YES","YES","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,75,2008,"Dilation and curettage procedure",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
124305064,121405693,5795266693,"78F28873-E471-497A-9405-FB8955808599.bw","fe79ebe1-cd0a-4ce2-a86d-637c28354ed9","78f28873-e471-497a-9405-fb8955808599","2016-09-03T22:08:11.054428-05:00","UNCID_2160273.af153b10-b6c0-4345-b242-9ad4c676e6c4.130619_UNC13-SN749_0277_BC293YACXX_2_GCCAAT.tar.gz","519ebe82-d8a8-46fc-a29d-0cdef7144d82",5274889443,"Illumina HiSeq","347a30bdb2b9a6b3944729135a267baf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:34:30.395057-05:00","2016-05-03T11:07:07.511815-05:00","519ebe82-d8a8-46fc-a29d-0cdef7144d82_analysis.xml","33209704fe5065c57c901347a7908201","97731ef6-b3a4-47d9-80e5-464dbf552649",2122,"2016-09-29T23:17:08.404035-05:00","519ebe82-d8a8-46fc-a29d-0cdef7144d82_experiment.xml","de683218402ae13373593903d49458bc","d6ee3bd8-112a-4ac6-b1d4-adc852f604df",2431,"2016-09-29T22:29:20.542419-05:00","519ebe82-d8a8-46fc-a29d-0cdef7144d82_run.xml","24c7aba2de3ba25faea878d020ac2e30","b95418af-0b35-4567-be8f-94778c3dc6c7",354,"2016-09-08T11:16:21.793787-05:00","TCGA-AX-A2IN","2016-09-02T18:53:13.972378-05:00","female","TCGA-AX-A2IN_demographic",1944,"white","3c71ccb1-7bdf-5b48-9bbf-b4dfe7809100","not reported",2009,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","AX","11e33baf-15f1-5a74-a940-307c42b74f36","Gynecologic Oncology Group","not reported","c54.1","TCGA-AX-A2IN_diagnosis","not reported",23275,"dead","8380/3",947,NA,"101ca4ed-726d-5b08-9e58-34d3a6cd9d81","c54.1",-23275,"TCGA-AX-A2IN_treatment","afb31d48-c65b-5ff7-8d73-ee08eb562d16","01","false","TCGA-AX-A2IN-01A",NA,"c28c7656-4790-485f-bd27-c8a6a35d2dd1",FALSE,"3C67A037-8A4C-4345-B842-43F1F0A6A53E","Primary Tumor",NA,1321,60,NA,1310515200,"12",30,"TCGA-AX-A2IN-01A-12",80,NA,0,NA,20,NA,20,NA,"2016-09-08T11:16:21.793787-05:00",NA,6,NA,0,NA,"TOP",NA,10,NA,"03af3834-8515-46d9-a2f8-43d9179289fe",NA,"TCGA-AX-A2IN-01A-01-TSA",NA,60,NA,"19c68ff2-8cdc-4fc4-ad8d-75726d4b774e","RNA","TCGA-AX-A2IN-01A-12R","27990249-d5be-413c-8050-0955e9e5d032",1.82,0.17,"UV Spec","R","23","TCGA-AX-A2IN-01A-12R-A180-07","af153b10-b6c0-4345-b242-9ad4c676e6c4",0.17,NA,100,40.5695971439004,157,"39eb6b89-6cdd-59c8-bf13-1c6c7659ae2b","TCGA-AX-A2IN_exposure","UNCID_2160273.af153b10-b6c0-4345-b242-9ad4c676e6c4.130619_UNC13-SN749_0277_BC293YACXX_2_GCCAAT.tar.gz","2013-09-21T07:26:05.000Z","2013-09-21T07:40:02.000Z","519EBE82-D8A8-46FC-A29D-0CDEF7144D82","C28C7656-4790-485F-BD27-C8A6A35D2DD1","Unaligned reads",5274889443,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","AF153B10-B6C0-4345-B242-9AD4C676E6C4","University of North Carolina","56607469e4b0ec1099f8abe9","FE79EBE1-CD0A-4CE2-A86D-637C28354ED9","Uterine Corpus Endometrial Carcinoma","TARGZ","19C68FF2-8CDC-4FC4-AD8D-75726D4B774E","2013-09-21T07:40:02.000Z","27990249-D5BE-413C-8050-0955E9E5D032","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1321,"19C68FF2-8CDC-4FC4-AD8D-75726D4B774E",NA,"AX","UNCID_2160273.af153b10-b6c0-4345-b242-9ad4c676e6c4.130619_UNC13-SN749_0277_BC293YACXX_2_GCCAAT.tar.gz",60,"TCGA-AX-A2IN-01A",NA,NA,"TCGA",2007,NA,NA,"WITH TUMOR","C28C7656-4790-485F-BD27-C8A6A35D2DD1",63,"nationwidechildrens.org_clinical.TCGA-AX-A2IN.xml","Dead",947,"TCGA-AX-A2IN",NA,"D2C6AFEA-82F1-4E45-A651-A27F2E7C2185",NA,NA,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IC",NA,NA,NA,"8380/3","FEMALE","C54.1",168,NA,"BAB9C0A7-FB4D-4A09-80EE-73F7F473B1DB","WHITE",NA,12,30,"03AF3834-8515-46D9-A2F8-43D9179289FE","9F002F04-528F-42F7-AF52-1FC64A139EE5","UNCID_2160273.af153b10-b6c0-4345-b242-9ad4c676e6c4.130619_UNC13-SN749_0277_BC293YACXX_2_GCCAAT.tar.gz","TCGA-AX-A2IN-01A-12",80,20,0,6,20,"TOP",10,0,"TCGA-AX-A2IN-01A-01-TSA",60,NA,NA,NA,"TCGA-AX-A2IN-R58274",NA,"Distant site","TCGA-AX-A2IN-F58273_NTE-2","YES",NA,NA,"Dead",947,"TCGA-AX-A2IN-F58273","TCGA-AX-A2IN",1,"AX","A2IN","YES","C54.1","8380/3","C54.1","NO","YES",-23275,"FEMALE","WHITE",NA,"No","No","Dead",NA,947,NA,NA,"WITH TUMOR","NO",27,10,2011,"YES","NO","YES",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,63,2007,"Office Endometrial Biopsy",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,"1988",4,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
33835815,33190568,2479877687,"9A33172F-AEEA-4B7D-9605-0C60D7872CEA.bw","feb3e930-3638-44b4-ac0f-a5dcb01fed76","9a33172f-aeea-4b7d-9605-0c60d7872cea","2016-08-09T14:14:48.667934-05:00","UNCID_2209891.71679725-d65f-47d4-b851-e4467f9d3f62.110420_UNC6-RDR300211_00096_FC_634WMAAXX_2.tar.gz","0f4dae0b-5ece-409d-8a7e-ec09920a7a9c",2253594209,"Illumina GA","cc7c7d4f99915b9fb2bbae09d5c4600b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:45:38.181927-05:00","2016-05-03T11:15:47.414649-05:00","0f4dae0b-5ece-409d-8a7e-ec09920a7a9c_analysis.xml","98d9f04bd8d97fe3fd252875c6bf7815","9e4fee71-ae03-4b97-9534-967f4d570af3",2121,"2016-08-27T21:30:32.847430-05:00","0f4dae0b-5ece-409d-8a7e-ec09920a7a9c_experiment.xml","10517c701bb64d0b038006470e52a84e","59706096-c239-415d-a34f-f746de79ffc8",2257,"2016-09-29T21:46:52.663198-05:00","0f4dae0b-5ece-409d-8a7e-ec09920a7a9c_run.xml","033fb492caa4a11e608510454ddf2860","9f1c4f87-b857-4cfb-9547-73635e8b3ed7",347,"2016-09-08T10:28:16.797979-05:00","TCGA-BG-A18A","2016-09-02T18:50:05.138010-05:00","female","TCGA-BG-A18A_demographic",1936,"white","b2815b75-c7ba-5b55-bcdc-21aabbed3b28","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BG","a0a89c77-9121-5b8a-a93f-dd92606c651c","University of Pittsburgh","not reported","c54.1","TCGA-BG-A18A_diagnosis","not reported",27086,"alive","8380/3",NA,426,"b97bcb90-bc6a-5bf9-8f36-37104b8ed2e3","c54.1",-27086,"TCGA-BG-A18A_treatment","3858cbca-1afb-5859-a4d7-9c10d0f02411","01","true","TCGA-BG-A18A-01A",NA,"8fd0971d-40ba-46c2-b3c4-8e48a3e6c122",FALSE,"099561AC-A5E7-4CA9-8F07-EEA7B3A96EEA","Primary Tumor",NA,146,130,NA,1294358400,"21",30,"TCGA-BG-A18A-01A-21",60,NA,0,NA,0,NA,30,NA,"2016-09-08T10:28:16.797979-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"de21c689-b0c8-4436-9eb6-31599c686221",NA,"TCGA-BG-A18A-01A-02-TSB",NA,70,NA,"96bf06eb-1bad-440f-893b-accf585dacc1","RNA","TCGA-BG-A18A-01A-21R","0d5d627f-924c-4909-81c5-abbf5b193b28",1.81,0.15,"UV Spec","R","23","TCGA-BG-A18A-01A-21R-A12I-07","71679725-d65f-47d4-b851-e4467f9d3f62",0.15,NA,84,32.0073159579332,162,"30600b66-bf82-55d6-b907-4990f8da47e9","TCGA-BG-A18A_exposure","UNCID_2209891.71679725-d65f-47d4-b851-e4467f9d3f62.110420_UNC6-RDR300211_00096_FC_634WMAAXX_2.tar.gz","2013-10-02T00:13:06.000Z","2013-10-02T00:25:03.000Z","0F4DAE0B-5ECE-409D-8A7E-EC09920A7A9C","8FD0971D-40BA-46C2-B3C4-8E48A3E6C122","Unaligned reads",2253594209,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","71679725-D65F-47D4-B851-E4467F9D3F62","University of North Carolina","56607bf6e4b016715ab6b02e","FEB3E930-3638-44B4-AC0F-A5DCB01FED76","Uterine Corpus Endometrial Carcinoma","TARGZ","96BF06EB-1BAD-440F-893B-ACCF585DACC1","2013-10-02T00:25:03.000Z","0D5D627F-924C-4909-81C5-ABBF5B193B28","None","NO",1,NA,"Primary Tumor","University of Pittsburgh",146,"96BF06EB-1BAD-440F-893B-ACCF585DACC1",NA,"BG","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A76C4656-73EF-4F33-AF5F-0278428FB79A.txt",130,"TCGA-BG-A18A-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","8FD0971D-40BA-46C2-B3C4-8E48A3E6C122",74,"mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.A76C4656-73EF-4F33-AF5F-0278428FB79A.txt","Alive",NA,"TCGA-BG-A18A","NOT HISPANIC OR LATINO","A0859925-EB52-4491-919C-643A4CF9571A",NA,252,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",94,NA,NA,"WHITE",NA,21,30,"DE21C689-B0C8-4436-9EB6-31599C686221","485446F1-45A2-47D2-A27E-734ADC48A8DF","UNCID_1628885.71679725-d65f-47d4-b851-e4467f9d3f62.sorted_genome_alignments.bam","TCGA-BG-A18A-01A-21",60,0,0,0,30,"TOP",0,0,"TCGA-BG-A18A-01A-02-TSB",70,NA,NA,NA,NA,NA,NA,NA,"NO",426,"TUMOR FREE","Alive",NA,"TCGA-BG-A18A-F28647","TCGA-BG-A18A",1,"BG","A18A","YES","C54.1","8380/3","C54.1","NO","YES",-27086,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",252,NA,NA,NA,"TUMOR FREE","NO",19,5,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,74,2010,"Dilation and curettage procedure",NA,NA,NA,"G1","RX",NA,NA,NA,NA,NA,"2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
146246062,144469204,6892657942,"6DA90F71-A4FF-4AD6-A270-7FFB160D01EA.bw","ff6b5fc8-0572-4b58-b3a5-bcda41badbc8","6da90f71-a4ff-4ad6-a270-7ffb160d01ea","2016-08-25T14:15:46.763666-05:00","UNCID_2581800.6e5ab8c9-03de-4a9d-ac92-37f28170c0a0.140408_UNC11-SN627_0351_AC3KY3ACXX_2_GCCAAT.tar.gz","7a77aedf-e78f-4dc1-baad-8803bcf83098",6459576286,"Illumina HiSeq","7d6f28da0ba37cf35ce926c6590364b2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:32:54.128018-05:00","2016-05-03T11:55:56.226464-05:00","7a77aedf-e78f-4dc1-baad-8803bcf83098_analysis.xml","fc3c28f1c4d747f72b9d78e60de116ec","bb8aaa1c-1ef7-4d99-a537-803d61c04a0f",2124,"2016-08-13T07:39:14.979195-05:00","7a77aedf-e78f-4dc1-baad-8803bcf83098_experiment.xml","2cfff9020a1529a7efc9e948abe9cf62","a35ae698-f628-4d24-bedd-b9f55bd34d72",2628,"2016-09-29T17:46:12.997054-05:00","7a77aedf-e78f-4dc1-baad-8803bcf83098_run.xml","fbd657607581d09f8e6b58edb257e367","094db467-303d-40a1-a6dc-30cbd031a1e0",354,"2016-09-08T11:14:25.442673-05:00","TCGA-PG-A914","2016-09-02T18:51:47.150206-05:00","female","TCGA-PG-A914_demographic",1940,"black or african american","16d35689-c5a4-50b8-b9ee-af408c742373","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","PG","69bd8326-4904-56a0-8230-1615a777173b","Montefiore Medical Center","not reported","c54.1","TCGA-PG-A914_diagnosis","not reported",26992,"alive","8461/3",NA,687,"8e9682d1-d9d5-5299-8107-abc7b9e9c8b0","c54.1",-26992,"TCGA-PG-A914_treatment","f948624f-f941-5342-ba97-f1f3d18780c8","01","true","TCGA-PG-A914-01A",NA,"6086978b-8f73-458e-9624-b99bcd6b50c8",FALSE,"B073614D-A6E3-4A83-96C4-1F189F8D16B4","Primary Tumor",NA,263,260,NA,1388361600,"11",30,"TCGA-PG-A914-01A-11",90,NA,0,NA,0,NA,20,NA,"2016-09-08T11:14:25.442673-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"93ebb8f5-491e-4f5b-b8a9-03cb4d9423a3",NA,"TCGA-PG-A914-01A-01-TS1",NA,80,NA,"646da843-d54b-4f25-a29b-5ab873348d2d","RNA","TCGA-PG-A914-01A-11R","d9a0b4ad-66f2-4efc-ae82-0cde360a969d",1.85,0.17,"UV Spec","R","23","TCGA-PG-A914-01A-11R-A37O-07","6e5ab8c9-03de-4a9d-ac92-37f28170c0a0",0.17,NA,NA,NA,NA,"cf65b541-26e3-53f5-9587-9d1437a5d81c","TCGA-PG-A914_exposure","UNCID_2581800.6e5ab8c9-03de-4a9d-ac92-37f28170c0a0.140408_UNC11-SN627_0351_AC3KY3ACXX_2_GCCAAT.tar.gz","2014-08-15T12:06:03.000Z","2014-08-15T12:26:54.000Z","7A77AEDF-E78F-4DC1-BAAD-8803BCF83098","6086978B-8F73-458E-9624-B99BCD6B50C8","Unaligned reads",6459576286,"Controlled","Illumina HiSeq","TCGA-UCEC","RNA-Seq","Raw sequencing data","6E5AB8C9-03DE-4A9D-AC92-37F28170C0A0","University of North Carolina","56607b4ae4b018727fea29ba","FF6B5FC8-0572-4B58-B3A5-BCDA41BADBC8","Uterine Corpus Endometrial Carcinoma","TARGZ","646DA843-D54B-4F25-A29B-5AB873348D2D","2014-08-15T12:26:54.000Z","D9A0B4AD-66F2-4EFC-AE82-0CDE360A969D","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",263,"646DA843-D54B-4F25-A29B-5AB873348D2D",NA,"PG","mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.95D3256E-1073-4BD1-8097-937B3CA2CDF7.txt",260,"TCGA-PG-A914-01A",NA,NA,"TCGA",2013,"TCGA-PG-A914_NTE-1","Complete Remission/Response","TUMOR FREE","623C4DEB-DF66-4F7A-8FED-0382D816CBE4",73,"mdanderson.org_UCEC.MDA_RPPA_Core.protein_expression.Level_3.95D3256E-1073-4BD1-8097-937B3CA2CDF7.txt","Alive",NA,"TCGA-PG-A914","NOT HISPANIC OR LATINO","725BBB11-6B24-4E30-BAC2-E9567E173332","NO",393,"No","Uterus","C54.1",NA,"Serous endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8461/3","FEMALE","C54.1",381,NA,"47061257-596C-4415-A763-32D5E3B22E9B","BLACK OR AFRICAN AMERICAN",NA,11,30,"93EBB8F5-491E-4F5B-B8A9-03CB4D9423A3","F98CFF90-D3F1-4CC9-A889-D8EC83435917","UNCID_2581800.6e5ab8c9-03de-4a9d-ac92-37f28170c0a0.140408_UNC11-SN627_0351_AC3KY3ACXX_2_GCCAAT.tar.gz","TCGA-PG-A914-01A-11",90,0,0,0,20,"TOP",0,0,"TCGA-PG-A914-01A-01-TS1",80,NA,NA,NA,"TCGA-PG-A914-R64689","External","Primary Tumor Field","TCGA-PG-A914-F58807_NTE-1","NO",393,"TUMOR FREE","Alive",NA,"TCGA-PG-A914-F58807","TCGA-PG-A914",1,"PG","A914","YES","C54.1","8461/3","C54.1","NO","YES",-26992,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",393,NA,"YES","NO","TUMOR FREE","YES",23,4,2014,"YES","NO","YES",NA,NA,NA,"Endometrial","Serous endometrial adenocarcinoma",NA,0,73,2013,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","R0",NA,NA,NA,NA,"Complete Remission/Response","2009",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
35627604,35067264,2616137847,"E2A4C651-977F-4F40-B5EC-46DF75944141.bw","ff82548a-f1bb-4daa-a8f7-b3831b5843ad","e2a4c651-977f-4f40-b5ec-46df75944141","2016-08-05T04:57:03.118352-05:00","UNCID_2214787.835f4f9a-3c90-45d5-809c-6b4316a972b9.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_8.tar.gz","236f402e-3c70-4081-9005-57f509cdfeed",2173933230,"Illumina GA","f98b29d295b58a5f535cec2ad4e7d287","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:29:32.643829-05:00","2016-05-03T11:17:14.905409-05:00","236f402e-3c70-4081-9005-57f509cdfeed_analysis.xml","737d645878e49fa7db303448d0294110","6f200872-fa0e-4c99-9b37-59f3a4a4e969",2120,"2016-10-07T15:40:43.420510-05:00","236f402e-3c70-4081-9005-57f509cdfeed_experiment.xml","5081a878fe70298a9b3597db8c107932","922bf523-2c61-4b19-88ff-ad6d3f14c842",2256,"2016-09-29T22:39:40.769421-05:00","236f402e-3c70-4081-9005-57f509cdfeed_run.xml","fc4ccd16a92ff5edaf3c626d620bd05e","bfc930b6-0864-4d60-8d7c-4dcd8a6c77a2",345,"2016-09-08T12:04:23.845368-05:00","TCGA-BS-A0UJ","2016-09-02T18:48:28.479452-05:00","female","TCGA-BS-A0UJ_demographic",1936,"asian","dcfe6a13-0521-5b95-bb52-c2c413703643","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.1","TCGA-BS-A0UJ_diagnosis","not reported",25149,"alive","8380/3",NA,2506,"5a2afee1-0ff8-5d8a-a236-b0e0659d1c5a","c54.1",-25149,"TCGA-BS-A0UJ_treatment","49f364b9-f520-5866-ac3d-bbca23797d11","01","false","TCGA-BS-A0UJ-01A",NA,"2ea1339f-a5eb-4552-ac13-858fa70e606e",FALSE,"DEE9AA2E-DA73-4074-9588-C75DDEC4D29B","Primary Tumor",NA,2180,160,NA,1285545600,"12",30,"TCGA-BS-A0UJ-01A-12",85,85,0,0,0,0,0,0,"2016-09-08T12:04:23.845368-05:00","2016-09-08T12:04:23.845368-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"bfb30bb2-a660-4a51-ad3c-e125f9056b27","f309fa46-8398-43f8-a0ee-bba9dce53af2","TCGA-BS-A0UJ-01A-01-BSA","TCGA-BS-A0UJ-01A-01-TSA",100,100,"383e01b4-82bf-48a0-b6b2-acbb3afd011c","RNA","TCGA-BS-A0UJ-01A-12R","e1c99fc2-a876-4c13-b9fc-c8214de51768",1.77,0.16,"UV Spec","R","23","TCGA-BS-A0UJ-01A-12R-A104-07","835f4f9a-3c90-45d5-809c-6b4316a972b9",0.16,NA,52,21.6441207075963,155,"768e2081-e8d4-5593-93ec-ff24fa4954ab","TCGA-BS-A0UJ_exposure","UNCID_2214787.835f4f9a-3c90-45d5-809c-6b4316a972b9.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_8.tar.gz","2013-10-03T21:06:04.000Z","2013-10-03T21:19:03.000Z","236F402E-3C70-4081-9005-57F509CDFEED","2EA1339F-A5EB-4552-AC13-858FA70E606E","Unaligned reads",2173933230,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","835F4F9A-3C90-45D5-809C-6B4316A972B9","University of North Carolina","56607b37e4b018727fea2962","FF82548A-F1BB-4DAA-A8F7-B3831B5843AD","Uterine Corpus Endometrial Carcinoma","TARGZ","383E01B4-82BF-48A0-B6B2-ACBB3AFD011C","2013-10-03T21:19:03.000Z","E1C99FC2-A876-4C13-B9FC-C8214DE51768","None","NO",1,NA,"Primary Tumor","University of Hawaii",2180,"383E01B4-82BF-48A0-B6B2-ACBB3AFD011C",NA,"BS","UNCID_258814.TCGA-BS-A0UJ-01A-12R-A104-07.101124_UNC1-RDR301647_00032_FC_62HT2AAXX.8.trimmed.annotated.translated_to_genomic.bam.bai",160,"TCGA-BS-A0UJ-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","A672454B-994C-4953-8B33-A77AE28C1BA0",68,"CAUSE_p_TCGAb73_SNP_N_GenomeWideSNP_6_G09_698344.raw.copynumber.data.txt","Alive",NA,"TCGA-BS-A0UJ","NOT HISPANIC OR LATINO","967D0D0A-0EAD-45C4-9513-926074FF8C3C",NA,27,"No","Uterus","C54.1",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IA",NA,NA,NA,"8380/3","FEMALE","C54.1",73,NA,NA,"ASIAN",NA,12,30,"F309FA46-8398-43F8-A0EE-BBA9DCE53AF2","F2396266-8790-4AAA-90DF-5E82206BF23D","TCGA-BS-A0UJ-01A-12R-A103-13_mirna.bam","TCGA-BS-A0UJ-01A-12",85,0,0,0,0,"BOTTOM",0,0,"TCGA-BS-A0UJ-01A-01-BSA",100,NA,NA,NA,NA,NA,NA,NA,"NO",2506,"TUMOR FREE","Alive",NA,"TCGA-BS-A0UJ-F16700","TCGA-BS-A0UJ",1,"BS","A0UJ","YES","C54.1","8380/3","C54.1","NO","YES",-25149,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",27,NA,NA,NA,"TUMOR FREE","NO",25,3,2011,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,68,2004,"Office Endometrial Biopsy",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",2,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
36156250,35612292,2651387132,"D2101E37-DF46-42AC-B1CD-B1B3BAA71104.bw","ffaa98a0-2b69-46dc-aee5-c5c3f2abbc38","d2101e37-df46-42ac-b1cd-b1b3baa71104","2016-08-09T14:17:10.874413-05:00","UNCID_2214810.ca81a393-ec7d-4538-a64a-417ed188a320.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_6.tar.gz","26d91acf-a12d-4970-a37c-75b09410ed55",2247054411,"Illumina GA","7c452e3c26aa2226830979ad71093c0a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:09:55.447881-05:00","2016-05-03T11:17:14.905409-05:00","26d91acf-a12d-4970-a37c-75b09410ed55_analysis.xml","a6f3d7067b9e7e051bcfeebb85c05dc8","1837c5b2-bf5c-4c54-b8dd-1cca1e42baad",2120,"2016-08-26T11:04:05.215946-05:00","26d91acf-a12d-4970-a37c-75b09410ed55_experiment.xml","7be59b50e18d90c07c13b556e411ca74","4036d80a-9c89-479f-97aa-1f8cc91b8a36",2256,"2016-09-29T19:02:34.471933-05:00","26d91acf-a12d-4970-a37c-75b09410ed55_run.xml","066276d908a62e37722d2f191c5c0911","394c3880-e571-4791-bbf7-94558f4d27a3",345,"2016-09-08T11:57:38.374821-05:00","TCGA-BS-A0TD","2016-09-02T18:48:23.599395-05:00","female","TCGA-BS-A0TD_demographic",1940,"asian","29722ebf-3505-5430-ab99-d9f747ae451e","not hispanic or latino",NA,"Uterine Corpus Endometrial Carcinoma","Uterus","TCGA-UCEC","Uterine Corpus Endometrial Carcinoma","NCH","BS","6157d8b4-5413-564a-b391-9b055a95eaf5","University of Hawaii","not reported","c54.9","TCGA-BS-A0TD_diagnosis","not reported",23950,"alive","8380/3",NA,2379,"a3b06160-0aca-5799-91fe-d4b9b8999908","c54.9",-23950,"TCGA-BS-A0TD_treatment","c70e675a-5824-505d-9e3f-9058682a71b3","01","false","TCGA-BS-A0TD-01A",NA,"8bb3a057-8958-4f62-af81-976da2e92df7",FALSE,"51ABEFF0-EEA1-48CA-9E00-CC57D1A2DEB0","Primary Tumor",NA,2004,150,NA,1281484800,"11",30,"TCGA-BS-A0TD-01A-11",80,80,20,10,0,0,15,20,"2016-09-08T11:57:38.374821-05:00","2016-09-08T11:57:38.374821-05:00",40,40,20,20,"BOTTOM","TOP",5,0,"dba1647e-2099-4546-9230-092e3e2488dd","a89530c1-1494-4b21-957d-6293a07c8446","TCGA-BS-A0TD-01A-01-BSA","TCGA-BS-A0TD-01A-01-TSA",80,80,"407773d8-77dd-4dc3-aaaa-d1d91c71edbf","RNA","TCGA-BS-A0TD-01A-11R","ee077e3e-dba6-4fb6-b654-6903539eda9a",2,0.16,"UV Spec","R","23","TCGA-BS-A0TD-01A-11R-A104-07","ca81a393-ec7d-4538-a64a-417ed188a320",0.16,NA,85,35.3798126951093,155,"4642b0ee-e511-5f07-a594-309b52967410","TCGA-BS-A0TD_exposure","UNCID_2214810.ca81a393-ec7d-4538-a64a-417ed188a320.101124_UNC1-RDR301647_00032_FC_62HT2AAXX_6.tar.gz","2013-10-03T21:46:04.000Z","2013-10-03T22:05:02.000Z","26D91ACF-A12D-4970-A37C-75B09410ED55","8BB3A057-8958-4F62-AF81-976DA2E92DF7","Unaligned reads",2247054411,"Controlled","Illumina GA","TCGA-UCEC","RNA-Seq","Raw sequencing data","CA81A393-EC7D-4538-A64A-417ED188A320","University of North Carolina","564a3d48e4b0ef12181b09b4","FFAA98A0-2B69-46DC-AEE5-C5C3F2ABBC38","Uterine Corpus Endometrial Carcinoma","TARGZ","407773D8-77DD-4DC3-AAAA-D1D91C71EDBF","2013-10-03T22:05:02.000Z","EE077E3E-DBA6-4FB6-B654-6903539EDA9A","None","NO",1,NA,"Primary Tumor","University of Hawaii",2004,"407773D8-77DD-4DC3-AAAA-D1D91C71EDBF",NA,"BS","mdanderson.org_UCEC.MDA_RPPA_Core.SuperCurve.Level_2.930AAB77-0151-4616-8E43-674B780895E3.txt",150,"TCGA-BS-A0TD-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","8BB3A057-8958-4F62-AF81-976DA2E92DF7",65,"nationwidechildrens.org_clinical.TCGA-BS-A0TD.xml","Alive",NA,"TCGA-BS-A0TD","NOT HISPANIC OR LATINO","15E23316-E206-4B9E-844E-FA9B56CEA9FF",NA,2003,"No","Uterus","C54.9",NA,"Endometrioid endometrial adenocarcinoma",NA,NA,"Stage IB",NA,NA,NA,"8380/3","FEMALE","C54.9",73,NA,NA,"ASIAN",NA,11,30,"DBA1647E-2099-4546-9230-092E3E2488DD","EE077E3E-DBA6-4FB6-B654-6903539EDA9A","TCGA-BS-A0TD-01A-11R-A103-13_mirna.bam.bai","TCGA-BS-A0TD-01A-11",80,0,10,40,20,"TOP",0,20,"TCGA-BS-A0TD-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,NA,2379,"TUMOR FREE","Alive",NA,"TCGA-BS-A0TD-F4393","TCGA-BS-A0TD",1,"BS","A0TD","YES","C54.9","8380/3","C54.9","NO","YES",-23950,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",2003,NA,NA,NA,"TUMOR FREE","NO",19,11,2010,"YES","NO","NO",NA,NA,NA,"Endometrial","Endometrioid endometrial adenocarcinoma",NA,0,65,2005,"Tumor resection",NA,NA,NA,"G1","R0",NA,NA,NA,NA,NA,"1988",3,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
